2015”N“x –k—˘‘ĺŠwˆăŠw•”E‘ĺŠw•a‰@Œ¤‹†‹ĆŃW(HTML”Ĺ)


i’FŒ´–{‚ĹŒäŠm”F‰ş‚ł‚˘j



‰đ–UŠw (Źě’PˆĘ)

[Šwp˜_•ś]

110001. [Œ´’˜] Model-based verification of hypotheses on the origin of modern Japanese revisited by Bayesian inference based on genome-wide SNP data. Nakagome S1, Sato T1, Ishida H1, Hanihara T1,2, Yamaguchi T1, Kimura R1, Mano S1, Oota H1,2 (1The Asian DNA Repository Consortium): Mol Biol Evol. 2015/6; 32 (6): 1533-43. (űŒ´P•F1,2, ‘ž“c”ŽŽ÷1,2: 2‰đ–U)

110002. [Œ´’˜] How 'circumpolar' is Ainu music? A musical and genetic perspectives on the history of the Japanese archipelago. Savage PE, Matsumae H, Oota H1, Stoneking M, Currie T, Tajima A, Gillan M, Brown S: Ethnomusicology Forum 2015/9; 24 (3): 443-67. (‘ž“c”ŽŽ÷1: 1‰đ–U)

110003. [Œ´’˜] Biochemical Characterization of Medaka (Oryzias latipes) Transgulutaminases, OITGK1 and OITGK2, as Orthologues of Human Keratinocyte-Type Transgulutaminases. Kikuta A, Furukawa E, Ogawa R, Suganuma N, Saitoh M, Nishimaki T, Katsumura T1, Oota H1, Kawamoto T, Tatsukawa H, Hashimoto H, Hitomi K: PLoS One 2015/12; 10 (12): e0144194. (Ÿ‘şŒ[Žj1, ‘ž“c”ŽŽ÷1: 1‰đ–U)

110004. [Œ´’˜] Meiotic recombination counteracts male-biased mutation (male-driven evolution). Mawaribuchi S, Ito M, Ogata M, Oota H1, Katsumura T1, Takamatsu N, Miura I: Proc Biol Sci 2016/1; 283 (1823): 20152628. dx.doi.org/10.1098/rspb.20152691. (‘ž“c”ŽŽ÷1, Ÿ‘şŒ[Žj1: 1‰đ–U)

120001. [Œ´’˜] –쐜ƒƒ_ƒJ‚ÉŒŠo‚ł‚ę‚˝ůN–E‚ÉŠÖ‚ˇ‚é•a—‘gDŠw“IŠŒŠ. ź–Šr”V1, Ÿ‘şŒ[Žj2, ”ö“cł“ń, Ź‰ęŒú“ż, ŹěŒł”V2, ‘ž“c”ŽŽ÷2 (1Œ`‘ÔŒn, 2‰đ–U): ‹›•aŒ¤‹†2016/3: 51 (1); 8-14.

522001. [uŔ]yŒĂ‘ăƒQƒmƒ€‚Ĺ‚˝‚Ç‚él—ŢŽjz‘ć3‰ń: ˆâ“`î•ń‚Š‚ç‚Ý‚˝ƒlƒAƒ“ƒfƒ‹ƒ^[ƒ‹lEƒfƒjƒ\ƒl. ‘ž“c”ŽŽ÷ (‰đ–U): ×–EHŠw 2015/6; 34 (7): 702-6.


[Šw‰ďEŒ¤‹†‰ď“™]

723001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒĂ‘ăƒQƒmƒ€ƒV[ƒNƒGƒ“ƒVƒ“ƒO‚Ě‚˝‚ß‚Ě‹Zp‰ü—Ç. ‘ž“c”ŽŽ÷1, Šo’Ł—˛Žj1, ƒ‰ƒCƒAƒ“EWEƒVƒ…ƒ~ƒbƒg1, Ÿ‘şŒ[Žj1, ź‘O‚Đ‚ë‚Ý, űŒ´P•F1, ŹěŒł”V1, ŽÄ“cO‹I, ˛”Œ˜aM, •Ş•”“NH, Œˇ–{•qs, ˛“ĄäŠ°, –Ř‘ş—ş‰î, Î“c@”Ł (1‰đ–U): ‘ć69‰ń (2015”N) “ú–{l—ŢŠw‰ď‘ĺ‰ď (2015/10/10-12), “Œ‹ž.

723002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆ­”ü”ź“‡‚É‚¨‚Ż‚é“ę•śŽž‘ălœŒĂ‘ăDNA•ŞÍ. Šo’Ł—˛Žj1, ƒ‰ƒCƒAƒ“EWEƒVƒ…ƒ~ƒbƒg1, ź‘O‚Đ‚ë‚Ý, Ÿ‘şŒ[Žj1, ‘ž“c”ŽŽ÷1, űŒ´P•F1, ŹěŒł”V1, ŽÄ“cO‹I, –ÎŒ´Mś, ‹ß“Ą@C, •Ä“c@ő, ‘ŽR’ő”V, ÝŠy”ŽŒČ, ŽR“cNO (1‰đ–U): ‘ć69‰ń (2015”N) “ú–{l—ŢŠw‰ď‘ĺ‰ď (2015/10/10-12), “Œ‹ž.

723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒEƒNƒ‰ƒCƒiEƒ”ƒ@ƒeƒB[ƒo“´ŒŠlœ‚ĚŒĂˆâ“`Šw“I‰đÍ. ƒ‰ƒCƒAƒ“EWEƒVƒ…ƒ~ƒbƒg1, Šo’Ł—˛Žj1, ŹěŒł”V1, ‘ž“c”ŽŽ÷1, ź‘O‚Đ‚ë‚Ý, ŽÄ“cO‹I, ƒWƒ‡[ƒ_ƒ“EƒJ[ƒXƒeƒ“, ƒ~ƒnƒCƒIEƒ\ƒnƒgƒXƒL[ (1‰đ–U): ‘ć69‰ń (2015”N) “ú–{l—ŢŠw‰ď‘ĺ‰ď (2015/10/10-12), “Œ‹ž.

723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽŸ˘‘ăƒV[ƒPƒ“ƒT[‚É‚ć‚é–kŠC“šƒAƒCƒk‚Ě‘SƒQƒmƒ€”z—ń‰đÍ. ź‘O‚Đ‚ë‚Ý, Ź‹ŕŸş‰Ŕ]1, –Ř‘ş—ş‰î, “c“ˆ@“Ö, ‰Í‘şł“ń, ´…Œ’‘ž˜Y, ‘ž“c”ŽŽ÷1, ”ö–{ŒbŽs (1‰đ–U): ‘ć69‰ń (2015”N) “ú–{l—ŢŠw‰ď‘ĺ‰ď (2015/10/10-12), “Œ‹ž.

723005. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) œ—L‹@ŽżŽc‘śó‹ľ‚Ě“´ŒAˆâŐ‚ĆŠJ’nˆâŐ‚É‚¨‚Ż‚é”äŠr. Šo’Ł—˛Žj1, ‘ž“c”ŽŽ÷1, •Ä“c@ő (1‰đ–U): ‘ć69‰ń (2015”N) “ú–{l—ŢŠw‰ď‘ĺ‰ď (2015/10/10-12), “Œ‹ž.

723006. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒjƒzƒ“ƒUƒ‹‚ĚŒŒ’†ƒGƒXƒgƒƒQƒ“‚¨‚ć‚ŃƒvƒƒQƒXƒeƒƒ“”Z“x•Ď‰ť‚É”ş‚¤ŒŒ‹…‚Ěˆâ“`Žq”­Œť•Ď‰ť‚ĚRNA-seq ‚É‚ć‚éƒvƒƒtƒ@ƒCƒŠƒ“ƒO. Ÿ‘şŒ[Žj1, ‘ž“c”ŽŽ÷1 (1‰đ–U): ‘ć69‰ń (2015”N) “ú–{l—ŢŠw‰ď‘ĺ‰ď (2015/10/10-12), “Œ‹ž.

723007. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠŚ—â“K‰ž‚ÉŠÖ‚í‚éUCPIˆâ“`ŽqŒ^ŠÔ‚Ěƒqƒg‚É‚¨‚Ż‚é”MŽYś”˝‰ž‚Ěˆá‚˘. ź‘ş‹MF, Ÿ‘şŒ[Žj1, –{ˆä@•É, ‘ž“c”ŽŽ÷1, –ȊіΊě (1‰đ–U): ‘ć69‰ń (2015”N) “ú–{l—ŢŠw‰ď‘ĺ‰ď (2015/10/10-12), “Œ‹ž.

723008. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ŒƒAƒWƒAˆâŐo“y”n‚ĚŒĂDNA•ŞÍ‚É‚¨‚Ż‚é•ű–@˜_“I‰ü‘P‚Ć‚ť‚̉ž—p. Šo’Ł—˛Žj1, Î–Ń‘žˆę˜Y, ‹e’r‘ĺŽ÷, ŠŰŽR^Žj, ‘‚@@—´, ‰¤@@—Ń, ’ߊԘaK, •Ä“c@ő, ‘ž“c”ŽŽ÷1, ‰Í–ě—FG, ”źŕV@Œb (1‰đ–U): ‘ć28‰ń“ú–{ƒEƒ}‰ČŠw‰ďŠwpW‰ď (2015/11/30-12/1), “Œ‹ž.

723009. [Šw‰ď(‘S‘)] (ˆę”ĘŒű‰‰) ‰đ–UŠw‹łˆç (u‹`EŽŔK) ‚ÉŠÖ‚ˇ‚éˆęlŽ@. ŹěŒł”V1, ‘ž“c”ŽŽ÷1, ŽO‰Ył–ž1, Vˆä—Y‘ž1, ‹Ę–؉p–ž1 (1‰đ–U): ‘ć121‰ń“ú–{‰đ–UŠw‰ď‘‰ď‘S‘ŠwpW‰ď (2016/3/28-30), •Ÿ“‡.

723010. [Šw‰ď(‘S‘)] (ƒ|ƒXƒ^[) –쐜ƒƒ_ƒJ‚đƒ‚ƒfƒ‹‚Ć‚ľ‚˝Á‰ťŠÇ‚Ě’ˇ‚ł‚đ‹K’股‚郁ƒJƒjƒYƒ€‚Ɛi‰ťś•¨Šw“IˆÓ‹`‚ĚŒŸŘ. Ÿ‘şŒ[Žj1, ˛“Ą@Ž, ŽR‰ş‰Ŕ“ß, Šo’Ł—˛Žj1, ”ö“cł“ń, Ąˆä@ł, ‹g‰YNŽő, ŹěŒł”V1, ‘ž“c”ŽŽ÷1 (1‰đ–U): ‘ć121‰ń“ú–{‰đ–UŠw‰ď‘‰ď‘S‘ŠwpW‰ď (2016/3/28-30), •Ÿ“‡.

723011. [Šw‰ď(‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ň’ōœ•ĎŒ`ƒƒ_ƒJ‚Ě”÷×Œ`‘ÔŠw“I‚ČŠĎŽ@. źę r”V1, “ŕ“cŒ’‘ž˜Y, Ÿ‘şŒ[Žj, ‘ĺŠŃ—TŽq, ”ö“cł“ń, Ź‰ęŒú“ż, ‚‘ŠťŽm2, ‘ž“c”ŽŽ÷3, ŹěŒł”V3 (1Œ`‘ÔŒn, 2ŽŠO, 3‰đ–U): ‘ć121‰ń“ú–{‰đ–UŠw‰ď‘‰ď‘S‘ŠwpW‰ď (2016/3/28-30), •Ÿ“‡.

723012. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒjƒƒgƒŠ›z—‘ŠúéҌă‘Ě‚Š‚çěť‚ľ‚˝iPS—l×–E‚̉đÍ. ŽO‰Ył–ž (‰đ–U): ‘ć121‰ń“ú–{‰đ–UŠw‰ď‘‰ď‘S‘ŠwpW‰ď (2016/3/30), •Ÿ“‡.


‰đ–UŠw (ăă’PˆĘ)

[Šwp˜_•ś]

110005. [Œ´’˜] Arf6 guanine-nucleotide exchange factor cytohesin-2 regulates myelination in nerves. Torii T, Ohno N, Miyamoto Y, Kawahara K, Saitoh Y, Nakamura K, Takashima S, Sakagami H1, Tanoue A, Yamauchi J: Biochem Biophys Res Commun 2015/5; 460 (3): 819-25. (ăă—ms1: 1‰đ–U)

110006. [Œ´’˜] Novel splice variants in the 5'UTR of Gtf2i expressed in the rat brain: alternative 5'UTRs and differential expression in the neuronal dendrites. Shirai Y, Watanabe M, Sakagami H1, Suzuki T: J Neurochem. 2015/8; 134 (3): 578-89. (ăă—ms1: 1‰đ–U)

110007. [Œ´’˜] Arf6 mediates Schwann cell differentiation and myelination. Torii T, Miyamoto Y, Yamamoto M, Ohbuchi K, Tsumura H, Kawahara K, Tanoue A, Sakagami H1, Yamauchi J: Biochem Biophys Res Commun 2015/9; 465 (3): 450-7. (ăă—ms1: 1‰đ–U)

110008. [Œ´’˜] Data supporting Arf6 regulation of Schwann cell differentiation and myelination. Torii T, Miyamoto Y, Yamamoto M, Ohbuchi K, Tsumura H, Kawahara K, Tanoue A, Sakagami H1, Yamauchi J: Data Brief 2015/10; 5: 388-95. (ăă—ms1: 1‰đ–U)

110009. [Œ´’˜] Stimulation of Sigma-1 Receptor Ameliorates Depressive-like Behaviors in CaMKIV Null Mice. Moriguchi S, Sakagami H1, Yabuki Y, Sasaki Y, Izumi H, Zhang C, Han F, Fukunaga K: Mol Neurobiol 2015/12; 52 (3): 1210-22. (ăă—ms1: 1‰đ–U)

[Šw‰ďEŒ¤‹†‰ď“™]

722001. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) BRAG2-Arf6Œo˜H‚É‚ć‚éV‚˝‚ČAMPAŽó—e‘ĚƒVƒiƒvƒX”­Œť’˛ß‹@\. ăă—ms (‰đ–U): BMB2015 (‘ć86‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ďE‘ć38‰ń“ú–{•ŞŽqś•¨Šw‰ď) (2015/12/1-4), _ŒË.

722002. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ƒVƒiƒvƒXŒă•”‚É‚¨‚Ż‚éBRAG2-Arf6ƒVƒOƒiƒ‹Œo˜H‚đ‰î‚ľ‚˝AMPAŽó—e‘Ě—A‘—’˛ß‹@\. [’JšO1, ăă—ms1 (1‰đ–U): ‘ć121‰ń“ú–{‰đ–UŠw‰ď‘‰ď‘S‘ŠwpW‰ď (2016/3/30), •Ÿ“‡.

723013. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒOƒŠƒVƒ“ě“ŽŤƒjƒ…[ƒƒ“‚ĹCre‚đ”­Œť‚ˇ‚éƒ}ƒEƒXŒn“‚ĚŠJ”­ (Generation of a mouse line specifically expressing Cre in glycinergic neurons). Š`č—˜˜a, ăă—ms1, č‘şŒšŽi, –öě‰Eç•v (1‰đ–U): ‘ć38‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2015/7/28-31), _ŒË.

723014. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) BRAG2‚Íendophilin3‚Ć‚Ě‘ŠŒÝě—p‚đ‰î‚ľ‚ăVƒiƒvƒXŒă•”‚Ĺ‚ĚArf6‚ĚŠˆŤ‰ť‚ĆAMPAŒ^Žó—e‘Ě‚ĚƒGƒ“ƒhƒTƒCƒg[ƒVƒX‚𒲐߂ˇ‚é (BRAG2 regulates Arf6 activity and AMPAR endocytosis at postsynapses through the interaction with endophilin3). [’JšO1, ăă—ms1 (1‰đ–U): ‘ć38‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2015/7/28-31), _ŒË.

723015. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ADPƒŠƒ{ƒVƒ‹‰ťˆöŽq6 (Arf6) ‚Í”]‘wŒ`Ź‚É‚¨‚˘‚Đ_Œo×–E‚ĚˆÚ“Ž‚đ§Œä‚ˇ‚é (ADP-ribosylation factor 6 (Arf6) regulates neuronal migration through endosomal trafficking during cortical layer formation). Œ´@–FL1, ăă—ms1 (1‰đ–U): ‘ć38‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2015/7/28-31), _ŒË.

733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠC”n‹ť•ąśƒVƒiƒvƒX‚É‚¨‚Ż‚éBRAG2-Arf6ƒVƒOƒiƒ‹Œo˜H‚đ‰î‚ľ‚˝AMPAŽó—e‘Ě—A‘—‹@\. [’JšO1, ăă—ms1 (1‰đ–U): “ú–{‰đ–UŠw‰ď‘ć103‰ńŠÖ“ŒŽx•”ŠwpW‰ď (2015/11/7), ‰Ą•l.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-110001. [Œ´’˜] Positive feedback of NR2B-containing NMDA receptor activity is the initial step toward visual imprinting: a model for juvenile learning. Nakamori T, Sato K, Kinoshita M, Kanamatsu T, Sakagami H1, Tanaka K, Ohki-Hamazaki H: J Neurochem 2015/1; 132 (1): 110-23. (ăă—ms1: 1‰đ–U)


ś—Šw (ěă’PˆĘ)

[Šwp˜_•ś]

220001. [€Œ´’˜] ‚ŒŒˆłƒ‰ƒbƒg‚Ě“Ž–ŹŒn‰ťŠwŽó—e×–E‚É‚¨‚Ż‚éƒmƒ‹ƒAƒhƒŒƒiƒŠƒ“‡Źy‘fŠˆŤ‚̕ωť. ˆé’†—š1, ěă@—Ď1, ŽR–{‹Ó˜Y, ź“cGŽ÷, “ú‰ş•”’CŽO (1ś—): ‘ŽmŠÚ‘ĺŠw‘ĚˆçŒ¤‹†Š•ń 2016/3; 34: 73-4.

[Šw‰ďEŒ¤‹†‰ď“™]

723016. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒhƒŒƒiƒŠƒ“‚É‚ć‚é”|—{_Œo×–EŽ˛ő—A‘—Šˆ“Ž“x‚Ě‘‰Á‚ރtƒ[‰đÍ–@‚É‚ć‚č’č—ʉť‚ł‚ę‚˝. •Đ‘q@—˛1, ˆé’†—š1, ěă@—Ď1 (1ś—): ‘ć53‰ń“ú–{ś•¨•¨—Šw‰ď”N‰ď (2015/9/13), ‹ŕ‘ň.

723017. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Signaling of prostaglandin E receptors, EP3 and EP4 facilitates wound healing and lymphangiogenesis with enhanced recruitment of CD11b+ macrophages in mice. ×–ě‰Á“ŢŽq1,2, ˆé’†—š1, ěă@—Ď1, Ź‹{@Žü, ”n“ˆł—˛2 (1ś—, 2–ň—): ‘ć89‰ń“ú–{–ň—Šw‰ď”N‰ď (2016/3/10), ‰Ą•l.

723018. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ź‘Ěƒ‰ƒbƒg‚Ě‘ĺ”]”玿‚Š‚ç’P—Ł‚ľ‚˝ƒjƒ…[ƒƒ“‚Ě×–E•Ş—ô. ”ä—ŻŠÔO”ü (ś—): ‘ć93‰ń“ú–{ś—Šw‰ď‘ĺ‰ď (2016/3/23), ŽD–y.


ś—Šw (‰ÍŒ´’PˆĘ)

[Šwp˜_•ś]

110010. [Œ´’˜] Sex differences in behavioural and neural responsiveness to mate calls in a parrot. Eda-Fujiwara H, Satoh R1, Hata Y, Yamasaki M, Watanabe A, Zandbergen MA, Okamoto Y, Miyamoto T, Bolhuis JJ: Sci Rep 2016/1; 6: 18481. (˛“Ą—ş•˝1: 1ś—)

110011. [Œ´’˜] pH-sensitive expression of calcium-sensing receptor (CaSR) in type-B intercalated cells of the cortical collecting ducts (CCD) in mouse kidney. Yasuoka Y1, Sato Y2, Healy JM, Nonoguchi H3, Kawahara K1: Clin Exp Nephrol 201510; 19 (5): 771-82. (ˆŔ‰Ş—L‹IŽq1, ˛“Ą—Yˆę2, –ěXŒű”ŽŽj3, ‰ÍŒ´Ž‰ë1: 1ś—, 2ˆă—ÉqśŠw•”, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

520001. [‘ŕ]y“ÁW: ‘ŸŠí•‚ŽîE‚¤‚ÁŒŒ‚Ě•a‘Ô‚Ć‚ť‚ĚŽĄ—Ă–@z‘ŸŠí•‚ŽîE‚¤‚ÁŒŒ‚Ć‘Sg•‚Žî‚ĚƒƒJƒjƒYƒ€|‘ŕ|. ‰ÍŒ´Ž‰ë1, ‘ĺ“ˆ—F”ü2 (1ś—, 2ś•¨•¨—Œn): Fluid Management Renaissance 2015/4; 5 (2): 15-20.

522002. [uŔ]y“ÁW: ”ě–ž‚Ɛt‘Ÿz[”ě–ž‚ÉŠÖ‚ˇ‚é•a‘ԂƐtáŠQ] ŒŒs“Ž‘Ô‚ĚˆŮí‚ƐtáŠQ. ‰ÍŒ´Ž‰ë1, ‰ş•lF˜Y2, ‹Ń’J‚Ü‚č‚ą (1ś—, 2zŠÂŠí“ŕ): t‚Ć“§Í 2015/4; 78 (4): 507-12.

522003. [uŔ]y˜AÚ: ‚â‚ł‚ľ‚˘Äśˆă—ÁzŠî‘b•ŇI@Š˛×–E‚Ć‘gDÄś: iPS×–E‚Ö‚Ě“š . ‰ÍŒ´Ž‰ë1, ŽOˆäƒá2 (1ś—, 2”畆): t‚Ć“§Í 2015/4; 78 (4): 467-9.

522004. [uŔ]y˜AÚ: ‚â‚ł‚ľ‚˘Äśˆă—ÁzŠî‘b•ŇI@Žó¸—‘|ăó”Ő–E (“ŕ×–E‰ň)|ŽOăó—t‚đŒo‚Ä‘ŸŠíŒ`Ź‚Ö. ‰ÍŒ´Ž‰ë1, ŽOˆäƒá2 (1ś—, 2”畆): t‚Ć“§Í 2015/5; 78 (5): 651-3.

522005. [uŔ]y˜AÚ: ‚â‚ł‚ľ‚˘Äśˆă—ÁzŠî‘b•ŇI@ƒ_ƒCƒŒƒNƒgEƒŠƒvƒƒOƒ‰ƒ~ƒ“ƒO. ‰ÍŒ´Ž‰ë1, ŽOˆäƒá2 (1ś—, 2”畆): t‚Ć“§Í 2015/6; 78 (6): 795-7.

522006. [uŔ]y“ÁW1: Ž_‰–Šî•˝t‚đ—‰đ‚ˇ‚éz[Šî‘b] t‘Ÿ‚Š‚ç‚ĚŽ_”rŸ•. ‰ÍŒ´Ž‰ë1, ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2 (1ś—, 2ś•¨•¨—Œn): t‚Ć“§Í 2015/8; 79 (2): 195-200.

522007. [uŔ]y“ÁW2: 500†‹L”O: t‘Ÿ•af—Ă‚Ě—đŽj‚Ć–˘—ˆzPart 2 Œť•ŇWˆĎˆőE—đ‘ă•ŇWˆĎˆő‚Š‚ç‚Ě“Á•ĘŠńe@t”A×ŠÇ‚ĚCaŠ´’mŽó—e‘Ě: ‹ÇÝ‚Ć‹@”\. ‰ÍŒ´Ž‰ë1, ‘ĺ“ˆ—F”ü2, ˆŔ‰Ş—L‹IŽq1 (1ś—, 2ś•¨•¨—Œn): t‚Ć“§Í 2015/8; 79 (2): 290-5.

522008. [uŔ]y˜AÚ: ‚â‚ł‚ľ‚˘Äśˆă—ÁzŠî‘b•ŇII@ƒqƒgt‘Ÿ‚Ě‹NŒš: ’†ŠÔ’†ăó—tŕ‚Š‚ç‘ĚŽ˛Š˛×–Eŕ‚É. ‰ÍŒ´Ž‰ë1, ŽOˆäƒá2 (1ś—, 2”畆): t‚Ć“§Í 2015/10; 79 (4): 528-30.

522009. [uŔ]y˜AÚ: ‚â‚ł‚ľ‚˘Äśˆă—ÁzŠî‘b•ŇII@tŠ˛×–E‚ĚŒĹ’č‚Ć×–E“ą“ü—Ă–@. ‰ÍŒ´Ž‰ë1, ŽOˆäƒá2 (1ś—, 2”畆): t‚Ć“§Í 2016/1; 80 (1): 7-9.

522010. [uŔ]y“ÁW: t‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“z[‘˜_] t‘ŸƒŠƒnƒrƒŠ‚đŽx‚Ś‚éŠî‘bƒf[ƒ^. ‰ÍŒ´Ž‰ë1, ‹Ń’J‚Ü‚č‚ą, ç“cŤ”n2, –ěXŒű”ŽŽj3 (1ś—, 2“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): t‚Ć“§Í 2016/2; 80 (2): 177-81.

522011. [uŔ]y“ÁW: “d‰đŽż‚̐V‚ľ‚˘ŒŠ•űEl‚Ś•űz[˜] “d‰đŽż‚Ć×–E‹@”\§Œä. ‰ÍŒ´Ž‰ë (ś—): t‚Ć“§Í 2016/3; 80 (3): 303-8.

522012. [uŔ]y˜b‘čzt‰“ˆĘ•”ƒlƒtƒƒ“‚ĚCa—A‘—‚ĆTRPVƒ`ƒƒƒlƒ‹. ‰ÍŒ´Ž‰ë1, ‘ĺ“ˆ—F”ü2, ˆŔ‰Ş—L‹IŽq1 (1ś—, 2ś•¨•¨—Œn): t‘Ÿ“ŕ‰ČE”ĺ”AŠí‰Č 2015/12; 2 (6): 602-8.

[’˜@‘]

620001. [Šwp‘ (•Ş’SŽˇ•M)]yStŠÖ˜A‚đ[‚ߑ̉tŠÇ—‚đ‹É‚ß‚ézII. t‘Ÿ‚̑̉tŠÇ—ƒƒJƒjƒYƒ€|S•s‘SŠÇ—‚É‚Ç‚¤ŠÖ‚í‚é‚Š|@1. t‘Ÿ‚̐…“d‰đŽżƒoƒ‰ƒ“ƒX‹@\, p.24-34. ‰ÍŒ´Ž‰ë1, ‰ş•lF˜Y2 (1ś—, 2zŠÂŠí“ŕ), ŠÄC: źč‰v“ż, •Ň: ’––”FŒł2, •śŒő“°, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713001. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Phosphate depletion-induced metabolic acidosis and alikali urine may be caused by inappropriate stimulation of apical Cl-/HCO3- exchanger (Pendrin) in mouse kidney type B intercalated cells (IC-B). Yasuoka Y1, Oshima T2, Sato Y3, Nonoguchi H4, Kawahara K1: American Society of Nephrology (ASN) Kidney Week 2015 (2015/11/6), San Diego, USA. (ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2, ˛“Ą—Yˆę3, –ěXŒű”ŽŽj4, ‰ÍŒ´Ž‰ë1: 1ś—, 2ś•¨•¨—Œn, 3ˆă—ÉqśŠw•”, 4–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

713002. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Comparative analysis of vasopressin V1a and V2 receptors distribution in the mammalian kidney. Giesecke T, Koshimizu T, Kawahara K1, Bachmann S, Mutig K1: American Society of Nephrology (ASN) Kidney Week 2015 (2015/11/7), San Diego, USA. (‰ÍŒ´Ž‰ë1: 1ś—)

713003. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) HIF1a and HIF2-Induced erythropoietin production along the nephron. Izumi Y, Yasuoka Y1, Nakayama Y, Inoue H, Mukoyama M, Kawahara K1, Nonoguchi H2: American Society of Nephrology (ASN) Kidney Week 2015 (2015/11/7), San Diego, USA. (ň—Tˆę˜Y, ˆŔ‰Ş—L‹IŽq1, ’†ŽR—TŽj, ˆäăGŽ÷, ŒüŽR­Žu, ‰ÍŒ´Ž‰ë1, –ěXŒű”ŽŽj2: 1ś—, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

722003. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Roles of basolateral TASK2 in the kidney proximal tubule for the acid-base balance: lessons from TASK2 KO mice. ‰ÍŒ´Ž‰ë1, ˆŔ‰Ş—L‹IŽq1 (1ś—): ‘ć93‰ń“ú–{ś—Šw‰ď‘ĺ‰ď (2016/3/22), ŽD–y.

723019. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) t”A×ŠÇ‚É‚¨‚Ż‚éhypoxia-inducible factor 2ƒż‚Ě”­Œť‚ĚŒŸ“˘. ň—Tˆę˜Y, ˆŔ‰Ş—L‹IŽq1, ’†ŽR—TŽj, ˆäăGŽ÷, ŒüŽR­Žu, ‰ÍŒ´Ž‰ë1, –ěXŒű”ŽŽj2 (1ś—, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/5), –źŒĂ‰Ž.

723020. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) pHŠ´ŽóŤKƒ`ƒƒƒlƒ‹ (TASK2) ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚ĚŽ_‰–Šî’˛ß”\. ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2, ‘ĺ’ːłl, ˛“Ą—Yˆę3, –Ř‘ş@ő, ‰ÍŒ´Ž‰ë1 (1ś—, 2ś•¨•¨—Œn, 3ˆă—ÉqśŠw•”): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/7), –źŒĂ‰Ž.

723021. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Metabolic acidosis with alkalinuria in phosphate-depriced mice: a role of pendrin in kidney type B intercalated cells. ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2, ˛“Ą—Yˆę3, –ěXŒű”ŽŽj4, ‰ÍŒ´Ž‰ë1 (1ś—, 2ś•¨•¨—Œn, 3ˆă—ÉqśŠw•”, 4–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć93‰ń“ú–{ś—Šw‰ď‘ĺ‰ď (2016/3/23), ŽD–y.

733002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’჊ƒ“Hƒ}ƒEƒX‚̍‚CaŒŒÇ‚Ş—U”­‚ˇ‚éƒAƒ‹ƒJƒŠ”A‚Ć‘ăŽÓŤƒAƒVƒh[ƒVƒX‚Ě•ŞŽq‹@\. ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2, ‰ÍŒ´Ž‰ë1 (1ś—, 2ś•¨•¨—Œn): •˝Ź27”N“xś—Œ¤Œ¤‹†‰ďu”S–Œ–ƉuŠw‚Ć–Œ—A‘—ś—Šw‚Ě—Z‡v(2015/9/15), ‰Şč.

733003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒoŒűCa‰–-‚Ca”A‚É‚ć‚étW‡ŠÇ‚̐…EŽ_‰–Šî—A‘—‰ž“š. ˆŔ‰Ş—L‹IŽq1, ‘ĺ“ˆ—F”ü2, ˛“Ą—Yˆę3, –ěXŒű”ŽŽj4, ‰ÍŒ´Ž‰ë1 (1ś—, 2ś•¨•¨—Œn, 3ˆă—ÉqśŠw•”, 4–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć45‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2015/10/2), “Œ‹ž.


ś‰ťŠw

[Šwp˜_•ś]

110012. [Œ´’˜] Mammalian Bcnt/Cfdp1, a potential epigenetic factor characterized by an acidic stretch in the disordered N-terminal and Ser250 phosphorylation in the conserved C-terminal regions. Iwashita S, Suzuki T, Yasuda T, Nakashima K, Sakamoto T, Kohno T1, Takahashi I, Kobayashi T, Ohno-Iwashita Y, Imajoh-Ohmi S, Song SY, Dohmae N: Biosci Rep 2015/6; 35 (4) pii: e00228. (‰Í–ěr”V1: 1ś‰ť)

110013. [Œ´’˜] Serum pro-BDNF/BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: a randomized controlled trial. Matsuoka Y, Nishi D, Tanima Y, Itakura M1, Kojima M, Hamazaki K, Noguchi H, Hamazaki T: Transl Psychiatry 2015/7; 5: e596. (”‘q@˝1: 1ś‰ť)

110014. [Œ´’˜] Biochemical characterization of a heterotrimeric Gi-protein activator peptide designed from the junction between the intracellular third loop and sixth transmembrane helix in the m4 muscarinic acetylcholine receptor. Terawaki S, Matsubayashi R, Hara K, Onozuka T, Kohno T1, Wakamatsu K: Biochem Biophys Res Commun 2015/7; 463 (1-2): 64-9. (‰Í–ěr”V1: 1ś‰ť)

110015. [Œ´’˜] Direct interaction between carcinoma cells and cancer associated fibroblasts for the regulation of cancer invasion. Yamaguchi H, Sakai R1: Cancers (Basel) 2015/10; 7 (4): 2054-62. (ä@—˛ˆę1: 1ś‰ť)

110016. [Œ´’˜] 8-Nitro-cGMP Enhances SNARE Complex Formation through S-Guanylation of Cys90 in SNAP25. Kunieda K, Tsutsuki H, Ida T, Kishimoto Y, Kasamatsu S, Sawa T, Goshima N, Itakura M1, Takahashi M1, Akaike T, Ihara H: ACS Chem Neurosci 2015/10; 6 (10): 1715-25. (”‘q@˝1, ‚‹´łg1: 1ś‰ť)

110017. [Œ´’˜] Augmentation of invadopodia formation in temozolomide-resistant or adopted glioma is regulated by c-Jun terminal kinase-paxillin axis. Ueno H, Tomiyama A, Yamaguchi H, Uekita T, Shirakihara T, Nakashima K, Otani N, Wada K, Sakai R1, Arai H, Mori K: Biochem Biophys Res Commun 2015/12; 468 (1-2): 240-7. (ä@—˛ˆę1: 1ś‰ť)

110018. [Œ´’˜] Malonic acid suppresses mucin-type O-glycan degradation during hydrazine treatment of glycoproteins. Goso Y1: Anal Biochem 2016/3; 496: 35-42. (ŒÜäzsM1: 1ś‰ť)

110019. [Œ´’˜] Protein stabilizer, NDSB-195, enhances the dynamics of the ƒŔ4 -ƒż2 loop of ubiquitin. Wang H, Hosoda K, Ishii T, Arai R, Kohno T1, Terawaki S, Wakamatsu K: J Pept Sci 2016/3; 22 (3): 174-80. (‰Í–ěr”V1: 1ś‰ť)

110020. [Œ´’˜] Report of the Japan diabetes society/Japanese cancer association joint committee on diabetes and cancer, Second report. Goto A, Noto H, Noda M, Ueki K, Kasuga M, Tajima N, Ohashi K, Sakai R1, Tsugane S, Hamajima N, Tajima K, Imai K, Nakagama H: Cancer Sci 2016/3; 107 (3): 369-71. (ä@—˛ˆę1: 1ś‰ť)

120002. [Œ´’˜] FT-IRƒXƒyƒNƒgƒ‹‚đŽg‚Á‚˝“œ…—n‰tö”­‰ß’ö‚̉đÍ‚É‚ć‚鐅˜a”. ÎˆäˆčŽq1, ŽP@F”V (1ś‰ť): “ú–{Ž•‰Č‘ĺŠw‹I—v 2016/3; 45: 21-8.

[Šw‰ďEŒ¤‹†‰ď“™]

713004. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Malonic acid suppresses O-glycan degradation during hydrazine treatment of glycoproteins. Goso Y1: 23rd International Symposium on Glycoconjugates (2015/9/17), Split, Croatia. (ŒÜäzsM1: 1ś‰ť)

713005. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Identification of ALK-binding phosphotyrosine-containing proteins as the critical regulators of oncogenic properties of neuroblastoma cells. Tomiyama A, Sakai R1: 2015 Asia-pacific Symposium of Neuroblastoma (2015/11/14), Taipei. (ä@—˛ˆę1: 1ś‰ť)

713006. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Stromal fibroblasts mediate extracellular matrix remodeling and invasion of scirrhous gastric carcinoma cells. Yamaguchi H, Yanagihara K, Yashiro M, Sakai R1: Tenth AACR-JCA Joint Conference on Breakthroughs in Cancer Research (2016/2/17), Hawaii, USA. (ä@—˛ˆę1: 1ś‰ť)

722004. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) AMPAŒ^ƒOƒ‹ƒ^ƒ~ƒ“Ž_Žó—e‘ĚŒ‹‡ƒ^ƒ“ƒpƒNŽż TARPs‚Ě‹@”\‰đÍ. ”‘q@˝ (ś‰ť): ‘ć121‰ń“ú–{‰đ–UŠw‰ď‘‰ďE‘S‘ŠwpW‰ď (2016/3/30), ŒSŽR.

723022. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’á”Z“x—n‰tNMR‰đÍ‚Š‚ç–ž‚ç‚Š‚Ć‚Č‚Á‚˝ƒCƒlƒtƒBƒgƒNƒƒ€B‚ĚHKRD ƒhƒƒCƒ“‚̍\‘˘‚Ć‹@”\. ŒĂ”‹ąŽq, źƒ–’J—L‹P, JunGoo Jee, “c’†—˜D, ‰Í–ěr”V1, ‰Á“Ą‰xŽq, ŽRčrł, Ž™“ˆ’ˇŽŸ˜Y (1ś‰ť): ‘ć15‰ń“ú–{’`”’Žż‰ČŠw‰ď”N‰ď (2015/6/26), “ż“‡.

723023. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒPƒ‚ƒJƒCƒ“Žó—e‘Ě‚Ě×–E“ŕ—Ěˆć‚ÉŠÜ‚Ü‚ę‚éƒPƒ‚ƒJƒCƒ“ƒVƒOƒiƒ‹§ŒäˆöŽqƒtƒƒ“ƒgŒ‹‡—Ěˆć‚̍\‘˘ś•¨Šw“I‰đÍ. Yoshinaga S, Esaki K, Tsuji T, Toda E, Terashima Y, Saitoh T, Kohda D, ‰Í–ěr”V1, Osawa M, Ueda T, Shimada I, Matsushima K, Terasawa H (1ś‰ť): ‘ć53‰ń“ú–{ś•¨•¨—Šw‰ď”N‰ď (2015/9/15), ‹ŕ‘ň.

723024. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒLƒ‹ƒXˆÝŠŕ×–E‚É‚¨‚Ż‚éMet‹y‚щş—ŹƒVƒOƒiƒ‹“`’B•ŞŽq‚Ě‹@”\‰đÍ. ŽRŒű‰pŽ÷, ”’–ŘŒ´‘ôĆ, ä@—˛ˆę1 (1ś‰ť): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/9), –źŒĂ‰Ž.

723025. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) äX‘Ÿ‚Ş‚ń×–E‚É‚¨‚Ż‚éSide-Population×–E‚Ě“ÁŤ‚Ć‚ť‚Ě•ŞŽqŠî”Ő. ’†“‡Ž•F, ä@—˛ˆę1 (1ś‰ť): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/9), –źŒĂ‰Ž.

723026. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) _Œo‰čŽî×–E‚É‚¨‚Ż‚éSHP2‚ĆALK‚ĚŒ‹‡‚Í, _Œo‰čŽî×–E‚ĚŽîᇌ´Ť‚đ§Œä‚ˇ‚é. •xŽRV‘ž, ă–ě‰p–ž, ”’–ŘŒ´‘ôĆ, ’†“‡Ž•F, ŽRŒű‰pŽ÷, XŒ’‘ž˜Y, ä@—˛ˆę1 (1ś‰ť): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/10), –źŒĂ‰Ž.

723027. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒLƒ‹ƒXˆÝ‚Ş‚ń‚É‚¨‚Ż‚銈Ť‰ťŽó—e‘ĚŒ‹‡ƒ^ƒ“ƒpƒNŽż‚Ě“Ż’č‚Ć‹@”\‰đÍ. ”’–ŘŒ´‘ôĆ, ŽRŒű‰pŽ÷, ä@—˛ˆę1 (1ś‰ť): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/10), –źŒĂ‰Ž.

723028. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Non-detergent sulfobetaine (NDSB) ‚ރ^ƒ“ƒpƒNŽż‚Ěƒ_ƒCƒiƒ~ƒNƒX‚É‹y‚Ú‚ˇŒř‰Ę. ‰¤@ŠC”~, Îˆä@‹B, ×“c˜a’j, ‰Í–ěr”V1, Ž›˜eTˆę, Žáź@Š] (1ś‰ť): ‘ć54‰ńNMR“˘˜_‰ď (2015/11/6), ç—t.

723029. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Two post-translational modifications in mammalian Bcnt/Cfdp1, a potential epigenetic factor: S250 phosphorylation and K268 acetylation in the conserved C-terminal region. Šâ‰şV‘ž˜Y, ’†“‡Œ’‘ž˜Y, —é–ŘŒ’—T, ˆŔ“c•Žk, â–{‘׈ę, ‰Í–ěr”V1, ‚‹´ˆę˜N, Ź—эFˆŔ, ‘ĺ–ěiŽq, Ąé@”E, “°‘O@’ź, ‘v@Žž‰h (1ś‰ť): BMB2015 (‘ć38‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ďE‘ć 88‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď ‡“Ż‘ĺ‰ď) (2015/12/1), _ŒË.

723030. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) _Œo‰čŽî‚ĚALK‘jŠQÜŠ´ŽóŤ‚đ§Œä‚ˇ‚éALKŒ‹‡ƒŠƒ“Ž_‰ť’`”’ŽżŒQ. ä@—˛ˆę1, •xŽRV‘ž (1ś‰ť): BMB2015 (‘ć38‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ďE‘ć88‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď ‡“Ż‘ĺ‰ď) (2015/12/1), _ŒË.

723031. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –ł…ƒqƒhƒ‰ƒWƒ“‚É‚ć‚郀ƒ`ƒ“Œ^“œ˝Ř‚č‚ž‚ľ‚É‹y‚Ú‚ˇŽăŽ_“Y‰Á‚̉e‹ż. ŒÜäzsM (ś‰ť): BMB2015 (‘ć38‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ďE‘ć 88‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď ‡“Ż‘ĺ‰ď) (2015/12/2), _ŒË.

723032. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) VAMP7‚̓I[ƒgƒtƒ@ƒW[‚đ§Œä‚ľ‚ă~ƒgƒRƒ“ƒhƒŠƒA‚̍PíŤˆŰŽ‚Ć‘ć2‘ŠƒCƒ“ƒXƒŠƒ“•Ş”ĺ‚𒲐߂ˇ‚é. Â–ö‹¤‘ž1, Ąň”ü‰Ŕ1, ”‘q@˝2, ’š‹ŞŽi3, HŒł‹`O4, ź˜e’m˘”T1, ’†“š—mŽq1, ŠÝ–{‘ń–1, Œ´“c˛G1, ‚‹´łg2, ‰iźMĆ1 (1ˆÇ—Ń‘ĺ, 2ś‰ť, 3ŒQ”n‘ĺ, 4‘ĺă‘ĺ): BMB2015 (‘ć38‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ďE‘ć 88‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď ‡“Ż‘ĺ‰ď) (2015/12/3), _ŒË.

723033. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒbƒg‘Á‰tƒ€ƒ`ƒ“‚đ”FŽŻ‚ˇ‚郂ƒmƒNƒ[ƒiƒ‹R‘Ě‚Ěěť. ‡“c‹I1, ”Ń“c‘׍L1, –ĺ’J—Tˆę2, ě“‡@—í2, ŒÜäzsM3, ÎŒ´˜a•F4, Žsě‘¸•ś2, ŒIŒ´@˝1 (1_“ސěH‘ĺ, 2ˆă—ÉqśŠw•”, 3ś‰ť, 4•ŰŒ’‰qśę–ĺŠw‰@): BMB2015 (‘ć38‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ďE‘ć 88‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď ‡“Ż‘ĺ‰ď) (2015/12/3), _ŒË.

733004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽŠ‘R”ɐB‚Ĺ‚ÍŒn“ˆŰŽ‚ލ˘“ď‚ČSNAP-25ƒmƒbƒNƒCƒ“ƒ}ƒEƒXŒn“‚ɑ΂ˇ‚鐜BHŠw‹Zp‚Ě“K—p ‹v•Ű’n˝Ži, ˛“Ą‹M•ś, ˆ˘•”^Œĺ, ŠŒ´—Y–ç, ‚‹´@W, ŽRX‘D1, ‚‹´łg1, ˛“ĄrĆ2, “Œ@’ĺG2 (1ś‰ť, 2ŽŔ“Ž): ‘ć32‰ń“Ž•¨śBHŠwŒ¤‹†‰ď (2015/12/5), ěč.

733005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) _Œo‰čŽî‚É‚¨‚Ż‚éALKŽó—e‘ĚƒVƒOƒiƒ‹‚ĚFlotillin-1‚ĆShcC- Shp2Œo˜H‚É‚ć‚鐧Œä. ä@—˛ˆę1, •xŽRV‘ž (1ś‰ť): ‘ć7‰ń “ú–{ƒvƒƒeƒCƒ“ƒzƒXƒtƒ@ƒ^[ƒ[Œ¤‹†‰ďŠwpW‰ď (2016/1/29), ‰Şč.


•ŞŽqˆâ“`Šw

[Šwp˜_•ś]

110021. [Œ´’˜] Mirror syndrome associated with fetal transient abnormal myelopoiesis in Down syndrome. Kobayashi Y, Miyoshi T, Matsuyama T, Miyauchi J, Miyashita T1, Ishibashi-Ueda H, Yoshimatsu J: Pathol Int 2015/8; 65 (8): 443-5. (‹{‰şr”V1: 1•ŞŽqˆâ“`)

110022. [Œ´’˜] A rare case of a symptomatic tumor found in the groin area: An atypical location unexposed to the known causes. Toyonaga E, Hata H, Nakayama C, Homma E, Miyashita T1, Shimizu H: Case Rep Oncol 2015/11; 8 (3): 536-9. (‹{‰şr”V1: 1•ŞŽqˆâ“`)

110023. [Œ´’˜] Chromatin condensation of Xist genomic loci during oogenesis in mice. Fukuda A, Mitani A, Miyashita T1, Umezawa A, Akutsu H: Development 2015/12; 142 (23): 4049-55. (‹{‰şr”V1: 1•ŞŽqˆâ“`)

[’˜@‘]

610001. [Šwp‘ (•Ş’SŽˇ•M)]yProtein-Protein Interactions: Methods and Applications (Methods in Molecular Biology Vol.1278)zPart IV: Cell-Based Bimolecular Interaction Reporter Assays, Confocal microscopy for intracellular co-localization of proteins, p. 515-26. Miyashita T1, Editors: Cheryl L. Meyerkord, Haian Fu, Humana Press, USA, 2015/4. (‹{‰şr”V1: 1•ŞŽqˆâ“`)

[Šw‰ďEŒ¤‹†‰ď“™]

723034. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Establishment of the cell lines with a large genomic deletion by CRISPR/Cas9 system. ’ˇ”ö˜a‰E1, ‚ŽR‹g‰i1, ‹{‰şr”V1 (1•ŞŽqˆâ“`): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8-10), –źŒĂ‰Ž.

723035. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) CRISPR/Cas9ƒVƒXƒeƒ€‚đ—p‚˘‚˝2“_“ŻŽžŘ’f‚É‚ć‚é–Ú“IƒQƒmƒ€—Ěˆćœ‹Ž×–EŠ”‚̍쐻. ‰Á“Ąç¨, ’ˇ”ö˜a‰E1, ‰Ł—m”ü, ‚ŽR‹g‰i1, ‹TŽRFŽO1, ‹{‰şr”V1 (1•ŞŽqˆâ“`): ‘ć38‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ďE‘ć88‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď (2015/12/1-4), _ŒË.

733006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) CRISPR/Cas9ƒVƒXƒeƒ€‚đ—p‚˘‚˝LˆćŒ‡‘šƒQƒmƒ€‚đ—L‚ˇ‚é×–EŠ”‚̍쐻. ‰Á“Ąç¨, ‚ŽR‹g‰i1, ‹TŽRFŽO1, ‰Ł—m”ü, ’ˇ”ö˜a‰E1, ‹{‰şr”V1 (1•ŞŽqˆâ“`): ‘ć28‰ń–k—˘‘ĺŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€ (2015/8/6-7), ‘Š–ÍŒ´.

733007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒX‰Šú”t‚É‚¨‚Ż‚éOct4‚Ě‹@”\‰đÍ. ŽO’J@‰ˇ, ‹{‰şr”V1, ˆ˘‹v’ÉpŒ› (1•ŞŽqˆâ“`): ‘ć28‰ń–k—˘‘ĺŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€ (2015/8/6-7), ‘Š–ÍŒ´.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-320001. [Ç—á] 2‚ŠŒŽŒă‚ɉ苅‚ލđ‰Á‚ľ‚˝ˆę‰ßŤœ‘ˆŮí‘BÇ‚Ě’´‘ŽYŽ™—á. –ě‘ş—DŽq, ‹{“ŕ@, ‘ž“c‰hŽĄ, –öˆä•ś’j, ‹{‰şr”V1, ĆˆäŒN“T, ˆÉ“Ą‰x˜N, œAŁLˆę (1•ŞŽqˆâ“`):“ú–{ŹŽ™ŒŒ‰tE‚Ş‚ńŠw‰ďŽGŽ2015/3; 52 (1): 36-9.


–ň—Šw

[Šwp˜_•ś]

110024. [Œ´’˜] The role of vascular endothelial growth factor receptor-1 signaling in compensatory contralateral lung growth following unilateral pneumonectomy. Matsui Y1, Amano H2, Ito Y3, Eshima K4, Tamaki H5, Ogawa F6, Iyoda A, Shibuya M, Kumagai Y6, Satoh Y1, Majima M2: Lab Invest 2015/5; 95 (5): 456-68. (źˆäŒ[•v1, “V–ě‰pŽ÷2, ˆÉ“Ą‹`–ç3, ]“‡k“ń4, ‹Ę–؉p–ž5, ŹěŽj—m6, ŒF’J—YŽĄ6, ˛“Ą”Vr1, ”n“ˆł—˛2: 1ŒÄ‹zŠíŠO, 2–ň—, 3ŠO‰Č, 4–Ɖu, 5‰đ–U, 6—Տ°Œ¤‹†EƒvƒƒWƒFƒNƒg)

110025. [Œ´’˜] The Role of Vascular Endothelial Growth Factor Receptor-1 Signaling in the Recovery from Ischemia. Amano H1, Kato S2, Ito Y3, Eshima K4, Ogawa F5, Takahashi R6, Sekiguchi K4, Tamaki H7, Sakagami H7, Shibuya M, Majima M1: PLoS One 2015/7; 10 (7): e0131445. (“V–ě‰pŽ÷1, ‰Á“ĄL‘ž˜Y2, ˆÉ“Ą‹`–ç3, ]“‡k“ń4, ŹěŽj—m5, ‚‹´@—ş6, ŠÖŒű˜aŠé6, ‹Ę–؉p–ž7, ăă—ms7, ”n“ˆł—˛1: 1–ň—, 2zŠÂŠí“ŕ, 3ŠO‰Č, 4–Ɖu, 5—Տ°Œ¤‹†EƒvƒƒWƒFƒNƒg, 6‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 7‰đ–U)

110026. [Œ´’˜] Thromboxane A2 induces blood flow recovery via platelet adhesion to ischaemic regions. Amano H1, Ito Y2, Eshima K3, Kato S4, Ogawa F5, Hosono K1,6, Oba K7, Tamaki H8, Sakagami H8, Shibuya M, Narumiya S, Majima M1: Cardiovasc Res 2015/9; 107 (4): 509-21. (“V–ě‰pŽ÷1, ˆÉ“Ą‹`–ç2, ]“‡k“ń3, ‰Á“ĄL‘ž˜Y4, ŹěŽj—m5, ×–ě‰Á“ŢŽq1,6, ‘ĺ’ë˜al7, ‹Ę–؉p–ž8, ăă—ms8, ”n“ˆł—˛1: 1–ň—, 2ŠO‰Č, 3–Ɖu, 4zŠÂŠí“ŕ, 5—Տ°Œ¤‹†EƒvƒƒWƒFƒNƒg, 6ś—, 7“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 8‰đ–U)

110027. [Œ´’˜] Roles of mPGES-1, an inducible prostaglandin E synthase, in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model. Matsuda H1, Hosono K2,3, Tsuru S1, Kurashige C4, Sekiguchi K1, Akira S, Uematsu S, Okamoto H4, Majima M: Life Sci 2015/12; 142: 1-7. (ź“cO”ü1, ×–ě‰Á“ŢŽq2,3, ’Ă—Ż˘—˘1, ĺUdçŠG4, ŠÖŒű˜aŠé1, ‰Ş–{_Žk4, ”n“ˆł—˛3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ś—, 3–ň—, 4–ƒŒ)

110028. [Œ´’˜] Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis in a surgical sponge model. Park K1, Amano H2, Ito Y3, Kashiwagi S4, Yamazaki Y4, Takeda A4, Shibuya M, Kitasato H5, Majima M2: Biomed Pharmacother 2016/3; 78: 140-9. (–p@Œ\ˆę1, “V–ě‰pŽ÷2, ˆÉ“Ą‹`–ç3, ”–ؐT–ç4, ŽRčˆŔ°4, •“c@Œ[4, –k—˘‰p˜Y5, ”n“ˆł—˛2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–ň—, 3ŠO‰Č, 4Œ`ŹE”üŠO, 5ˆă—ÉqśŠw•”)

110029. [Œ´’˜] Vascular endothelial growth factor regulates growth of endometrial tissues and angiogenesis in a mouse transplantation model. Sekiguchi K1, Hosono K2,3, Numao A4, Honda M1, Matsuda H1, Amano H3, Kawauchi H4, Shibuya M, Unno N5, Majima M3: Kitasato Med J 2016/3; 46 (1): 15-23. (ŠÖŒű˜aŠé1, ×–ě‰Á“ŢŽq2,3, Ŕ”ö˛Žq4, –{“c‰ëŽq1, ź“cO”ü1, “V–ě‰pŽ÷3, ě“ŕ”Žl4, ŠC–ěM–ç5, ”n“ˆł—˛3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ś—, 3–ň—, 4•wl, 5ŽY‰Č)

[Šw‰ďEŒ¤‹†‰ď“™]

722005. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Roles of Prostaglandins in regulation of plasticity of lymphatics and lymph nodes. ”n“ˆł—˛1, ×–ě‰Á“ŢŽq1,2, “V–ě‰pŽ÷1, “Ą“c•üŒb1 (1–ň—, 2ś—): ‘ć89‰ń“ú–{–ň—Šw‰ď”N‰ď (2016/3/11), ‰Ą•l.

723036. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{“ŕ–ŒÇ‚Ě”­Ç‚É‚¨‚Ż‚éVEGF1Œ^Žó—e‘Ě‚Ě–đŠ„. ŠÖŒű˜aŠé1, ×–ě‰Á“ŢŽq2,3, ˛“ĄŠG—˘“Ţ, a’JłŽj, ŠC–ěM–ç4, ”n“ˆł—˛3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ś—, 3–ň—, 4ŽY‰Č): ‘ć36‰ń“ú–{‰ŠÇEÄśˆăŠw‰ď (2015/7/21-22), “Œ‹ž.

723037. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘nŽĄ–ü‚É‚¨‚Ż‚éVascular Endothelial Growth Factor Receptor 1TKƒVƒOƒiƒ‹‚Ě–đŠ„. –p@Œ\ˆę1, “V–ě‰pŽ÷2, ×–ě‰Á“ŢŽq2,3, ”–ؐT–ç4, ‚‹´@—ş1, a’JłŽj, ‹g’|r—T1, •“c@Œ[4, ”n“ˆł—˛2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–ň—, 3ś—, 4Œ`ŹE”üŠO): ‘ć36‰ń“ú–{‰ŠÇEÄśˆăŠw‰ď (2015/7/21-22), “Œ‹ž.

723038. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Role of TP signaling in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model. ź“cO”ü1, ×–ě‰Á“ŢŽq2,3, ’Ă—Ż˘—˘1, Ź‹{@Žü, ”n“ˆł—˛3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ś—, 3–ň—): ‘ć89‰ń“ú–{–ň—Šw‰ď”N‰ď (2016/3/10), ‰Ą•l.

723039. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Host Derived Bone Marrow Cells Expressing Vascular Endothelial Growth Factor Receptor 1 Regulates Growth of Endometrial Tissues and Angiogenesis in a Mouse Transplantation Model. ŠÖŒű˜aŠé1, ×–ě‰Á“ŢŽq2,3, –{“c‰ëŽq1, ě“ŕ”Žl4, ŠC–ěM–ç5, ”n“ˆł—˛3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ś—, 3–ň—, 4•wl, 5ŽY‰Č): ‘ć89‰ń“ú–{–ň—Šw‰ď”N‰ď (2016/3/10), ‰Ą•l.

723017. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Signaling of prostaglandin E receptors, EP3 and EP4 facilitates wound healing and lymphangiogenesis with enhanced recruitment of CD11b+ macrophages in mice. ×–ě‰Á“ŢŽq1,2, ˆé’†—š1, ěă@—Ď1, Ź‹{@Žü, ”n“ˆł—˛2 (1ś—, 2–ň—): ‘ć89‰ń“ú–{–ň—Šw‰ď”N‰ď (2016/3/10), ‰Ą•l.

733008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘nŽĄ–ü‚É‚¨‚Ż‚éVascular Endothelial Growth Factor Receptor 1 Tyrosine Kinase ƒVƒOƒiƒ‹‚Ě–đŠ„. –p@Œ\ˆę1, “V–ě‰pŽ÷2, ×–ě‰Á“ŢŽq2,3, ”–ؐT–ç4, ‚‹´@—ş1, a’JłŽj, ‹g’|r—T1, •“c@Œ[4, ”n“ˆł—˛2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–ň—, 3ś—, 4Œ`ŹE”üŠO): ‘ć132‰ń“ú–{–ň—Šw‰ďŠÖ“Œ•”‰ď (2015/7/4), ç—t.


”÷ś•¨Šw

[Šwp˜_•ś]

110030. [Œ´’˜] Genomics of Clostridium botulinum group III strains. Sakaguchi Y1, Suzuki T, Yamamoto Y, Nishikawa A, Oguma K: Res Microbiol 2015/5; 166 (4): 318-25. (ăŒű‹`•F1: 1”÷ś•¨)

110031. [Œ´’˜] Characterization of Pseudomonas aeruginosa phage KPP21 belonging to family Podoviridae genus N4-like viruses isolated in Japan. Shigehisa R, Uchiyama J, Kato S, Takemura-Uchiyama I, Yamaguchi K, Miyata R, Ujihara T, Sakaguchi Y1, Okamoto N, Shimakura H, Daibata M, Sakaguchi M, Matsuzaki S: Microbiol Immunol 2016/1; 60 (1): 64-7. (ăŒű‹`•F1: 1”÷ś•¨)

520002. [‘ŕ] ˆă—ĂŽ{Ý“ŕ‚̐ݔő‚â‹@Ší‚𩴐őŒš‚Ć‚ˇ‚é‰@“ੴő. —с@rŽĄ (”÷ś•¨): –k—˘ˆăŠw 2015/12; 45 (2): 87-94.

521001. [‰đŕ] Small Intestinal Bacterial Overgrowth. —с@rŽĄ (”÷ś•¨): ƒhƒNƒ^[ƒTƒƒ“ 2015/4; 59 (5): 342-6.

522013. [uŔ]y“ÁW: Helicobacter Year Book 2014`2015|HelicobacterŒ¤‹†‚̍X‚Č‚é”ň–ô|zHelicobacter pyloriˆČŠO‚ĚƒwƒŠƒRƒoƒNƒ^[‘Ž. —с@rŽĄ (”÷ś•¨): Helicobacter Research 2015/4; 19 (2): 161-8.

522014. [uŔ]yƒVƒŠ[ƒY!! ƒ{ƒcƒŠƒkƒX‹Ű‚É‚ć‚鎞Šł (ƒ{ƒcƒŠƒkƒXÇ)z‘ćˆę‰ń ƒ{ƒcƒŠƒkƒX‹Ű‚Ě”­ŒŠ‚Ě—đŽj‚ƉuŠw. ăŒű‹`•F (”÷ś•¨): ƒTƒ‰ƒ„î•ńŽu‰qś‚Ě—Fv2015/6.

522015. [uŔ]yƒVƒŠ[ƒY!! ƒ{ƒcƒŠƒkƒX‹Ű‚É‚ć‚鎞Šł (ƒ{ƒcƒŠƒkƒXÇ)z‘ć“ń‰ń ƒ{ƒcƒŠƒkƒX‹Ű‚Ě•aŒ´ˆöŽq‚ƍě—p‹@˜. ăŒű‹`•F (”÷ś•¨): ƒTƒ‰ƒ„î•ńŽu‰qś‚Ě—Fv2015/10.

522016. [uŔ]yƒVƒŠ[ƒY!! ƒ{ƒcƒŠƒkƒX‹Ű‚É‚ć‚鎞Šł (ƒ{ƒcƒŠƒkƒXÇ)z‘ćŽO‰ń ƒ{ƒcƒŠƒkƒXÇ‚Ě—Ő°Çó. ăŒű‹`•F (”÷ś•¨): ƒTƒ‰ƒ„î•ńŽu‰qś‚Ě—Fv2016/2.

540001. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]y‰ČŠwŒ¤‹†”ď•â•‹ŕEŠî”ŐŒ¤‹† (C)uCŒ^‚ĆDŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘f•ĎŠˇƒtƒ@[ƒW‚Ě”ö•”‹z’…ƒ^ƒ“ƒpƒNŽż‚ƏhŽĺ‹ŰƒŒƒZƒvƒ^[‚̉đÍ (Œ¤‹†ŠúŠÔ: •˝Ź25”N“x`•˝Ź27”N“x, Œ¤‹†‘ă•\ŽŇ: ăŒű‹`•F (”÷ś•¨))vzuCŒ^‚ĆDŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘f•ĎŠˇƒtƒ@[ƒW‚Ě”ö•”‹z’…ƒ^ƒ“ƒpƒNŽż‚ƏhŽĺ‹ŰƒŒƒZƒvƒ^[‚̉đÍvŒ¤‹†ŽŔŽ{ó‹ľ•ń‘ 2015/5.

540002. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]y‰ČŠwŒ¤‹†”ď•â•‹ŕE’§í“I–G‰čŒ¤‹†u“ÁˆŮR‘Ě‚đ—˜—p‚ľ‚˝‘˝Ü‘ϐŤ‹Ű‚̐v‘ŹŒ¤‹†–@‚ĚŠm—§‚Ć—Ő°‰ž—p‚ÉŠÖ‚ˇ‚錤‹† (Œ¤‹†ŠúŠÔ: •˝Ź23”N“x`•˝Ź25”N“x, Œ¤‹†‘ă•\ŽŇ: ‰Ş–{—šˆę (”÷ś•¨))vzu“ÁˆŮR‘Ě‚đ—˜—p‚ľ‚˝‘˝Ü‘ϐŤ‹Ű‚̐v‘ŹŒ¤‹†–@‚ĚŠm—§‚Ć—Ő°‰ž—p‚ÉŠÖ‚ˇ‚錤‹†vĹI•ń‘ 2016/3.

[’˜@‘]

620002. [Šwp‘ (•Ş’SŽˇ•M)]yƒRƒ“ƒpƒNƒg”÷ś•¨Šw (‰ü’ů‘ć4”Ĺ)z‘ć7Í –Ĺ‹Ű‚ĆÁ“Ĺ, p.155-62. •˝ˆä‹`ˆę, —с@rŽĄ1 (1”÷ś•¨), •Ň: ŹŒFœ¨“ń, –x“c@”Ž, “ě]“°, “Œ‹ž, 2015/9”­s.

620003. [Šwp‘ (•Ş’SŽˇ•M)]yƒRƒ“ƒpƒNƒg”÷ś•¨Šw (‰ü’ů‘ć4”Ĺ)z‘ć9Í ‘ŸŠíŠ´őÇ@9-6 ŒŒ‰tEƒŠƒ“ƒp‚¨‚ć‚Ń‘SgŠ´őÇ@Š´őÇ@A. ×‹Ű, p.232-6. •˝ˆä‹`ˆę, —с@rŽĄ1 (1”÷ś•¨), •Ň: ŹŒFœ¨“ń, –x“c@”Ž, “ě]“°, “Œ‹ž, 2015/9”­s.

620004. [Šwp‘ (•Ş’SŽˇ•M)]yƒRƒ“ƒpƒNƒg”÷ś•¨Šw (‰ü’ů‘ć4”Ĺ)z‘ć9Í ‘ŸŠíŠ´őÇ@9-7 ‚ť‚Ě‘ź‚ĚŠ´őÇ@A. ć“VŤŠ´őÇ‚Ů‚Š, p.242-7. ’†ž@ŽĄ, —с@rŽĄ1 (1”÷ś•¨), •Ň: ŹŒFœ¨“ń, –x“c@”Ž, “ě]“°, “Œ‹ž, 2015/9”­s.

620005. [Šwp‘ (•Ş’SŽˇ•M)]yƒsƒƒŠ‹Űœ‹ŰŽĄ—Ăƒp[ƒtƒFƒNƒgƒKƒCƒhz‘ć5Í ƒsƒƒŠœ‹ŰŽĄ—Ă‚ĚŠî‘b’mŽŻ@3. ƒsƒƒŠ‹Ű‚ĚŠî‘b’mŽŻ|’m‚Á‚Ä‚¨‚Ť‚˝‚˘ƒsƒƒŠ‹Ű‚Ě×‹ŰŠw“I“Á’Ľ, p.169-71. —с@rŽĄ (”÷ś•¨), •Ň: ĺ@MœA, “ú–{ˆăŽ–V•ńŽĐ, “Œ‹ž, 2015/10”­s.

620006. [Šwp‘ (•Ş’SŽˇ•M)]yH. pyloriœ‹Ű‚É‚ć‚éˆÝ‚Ş‚ń—\–hí—ށ@IARCƒ[ƒLƒ“ƒOƒOƒ‹[ƒv•ń‘8zSection 2: H. pyloriœ‹Ű‚É‚ć‚錒N‚Ö‚ĚŒř‰Ę‚Ɖe‹ż@Helicobacter pylori‚̏W’cœ‹Ű‚Ş×‹Ű‚Ě–ňÜ‘ϐŤ‚đ—U“ą‚ˇ‚éŠëŒŻŤ, p.64-8. —с@rŽĄ (”÷ś•¨), ŠÄ–ó: ół”Ž, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, ‘ĺă, 2016/1”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722006. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Helicobacter pyloriŠ´őÇ‚ĚŠî‘b‚ƉuŠw. —с@rŽĄ (”÷ś•¨): ‘ć21‰ń“ú–{ƒwƒŠƒRƒoƒNƒ^[Šw‰ďŠwpW‰ď (2015/6/27), _ŒË.

722007. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ×‹ŰŠ´őÇ‚É‚¨‚Ż‚éf’f–@‚ĆŽĄ—Ă–@‚ĚŠJ”­: ƒoƒNƒeƒŠƒIƒtƒ@[ƒW‚Ě—˜—p. “ŕŽR~•˝, źˆäGm, ăŒű‹`•F1, ‰Ô–؏G–ž, źč–ΓW, ăŒű‰ëO (1”÷ś•¨): ‘ć158‰ń“ú–{bˆăŠw‰ďŠwpW‰ď (2015/9/7), \˜a“c.

723040. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) •a‰@ŠÂ‹Ť×‹Ű‰˜ő‚Ě•‰‰×’ጸ‚ÉŽ‘‚ˇ‚é“ş‡‹ŕ‚Ě“ą“ü. ůŒ´•Žu1, ”¨@Ž•F, ‹ŕ“cr˜a, •x@łˆę, ’ߩۏr˜a, ‹e–ě—’ĂŽq, Ä“Ą°•v (1”÷ś•¨): “ú–{–h‹Ű–hꀊw‰ď‘ć42‰ń”NŽŸ‘ĺ‰ď (2015/9/2), ‘ĺă.

723041. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ϕϐFER‹Ű“ş‡‹ŕuƒNƒŠ[ƒ“ƒuƒ‰ƒCƒgv‚ĚŠJ”­. ”¨@Ž•F, “c’†^ŽŸ, ‘ĺÎŒbˆę˜Y, ůŒ´•Žu1 (1”÷ś•¨): “ú–{“şŠw‰ď‘ć55‰ńu‰‰‘ĺ‰ď (2015/11/3), “c.

723042. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Clostridium difficileŠ´őŠłŽŇŽüˆÍŠÂ‹Ť‚̉č–E‰˜ő. ůŒ´“S•˝, “n•Ó”ü’q‘ă, ŽR‰z—T”ü, —с@rŽĄ1, XŕV—YŽi (1”÷ś•¨): ‘ć31‰ń“ú–{ŠÂ‹ŤŠ´őŠw‰ď‘‰ďĽŠwpW‰ď (2016/2/19), ‹ž“s.

723043. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The genome sequence of Clostridium botulinum type C phage and functional analysis of gene products. ăŒű‹`•F1, Uchiyama J, Ogura Y, Yamamoto Y, Matsuzaki S, Hayashi T, Matsushita O, Oguma K, —с@rŽĄ1 (1”÷ś•¨): ‘ć89‰ń“ú–{×‹ŰŠw‰ď‘‰ď (2016/3/23), ‘ĺă.

723044. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŠúˆÝŠŕESDŒăÄ”­—\‘Ş‚É‚¨‚Ż‚éH. pylori|JRŒ´‚đ—p‚˘‚˝IgG ƒTƒuƒNƒ‰ƒX‚Ě—L—pŤ. ‰Ą“cŒ›ŽĄ, ź‰ş@ŽĄ, ŽR–{—R–íŽq, ”üŠÔŒ’•F, Œă“Ą˜a‹`, —с@rŽĄ1, ăŒű‹`•F1 (1”÷ś•¨): ‘ć89‰ń“ú–{×‹ŰŠw‰ď‘‰ď (2016/3/23), ‘ĺă.

723045. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) —Δ^‹ŰPAO1Š”‚Ćƒtƒ@[ƒWKPP22‚Ě’ZŠúŠÔi‰ť“IŒRŠg‹Ł‘–‚̉đÍ. “ߐ{ě’‰–í, “ŕŽR~•˝, —é–ؐml, ‹{“c—ć“Ţ, ŽRŒű‹ŐŠG, “ŕŽRˆÉ‘ă, ăŒű‹`•F1, ŽÄŽRŒbŒá, ăŒű‰ëO, źč–ΓW (1”÷ś•¨): ‘ć89‰ń“ú–{×‹ŰŠw‰ď‘‰ď (2016/3/23), ‘ĺă.

733009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒsƒƒŠ‹Űƒtƒ@[ƒW‚Ě•Ş—Ł‚ƉđÍ. “ŕŽR~•˝, ’|“ŕŒ[W, ‰Á“ĄLˆę˜Y, ăŒű‹`•F1, Š—śŒ[Ži, ŽŒ´—˛Žq, “ŕŽRˆÉ‘ă, “‡‘qGŸ, ĄźŽs˜N, ăŒű‰ëO, źč–ΓW (1”÷ś•¨): ‘ć2‰ńƒtƒ@[ƒWƒZƒ‰ƒs[—Տ°‰ž—pŒŸ“˘‰ď (2015/7/31), ‰Ą•l.

733010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) CŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘f•ĎŠˇƒtƒ@[ƒW‚̐ś‘ś‚É•K—v‚ČƒQƒmƒ€—Ěˆć‚̉đÍ. ăŒű‹`•F1, “ŕŽR~•˝, Mar’a A Oliva, Antonio J Martin-Galiano, JosŽ M Andreu, Ź–¸‹`r, ŽR–{—R–íŽq, źč–ΓW, —с@“N–ç, ŹŒFœ¨“ń, —с@rŽĄ1 (1”÷ś•¨): •˝Ź27”N“xAKPSŒ¤‹†W‰ďE‘ć18‰ń–k—˘”÷ś•¨ƒAƒJƒfƒ~[ (2015/8/6), ‘Š–ÍŒ´.

733011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒNƒŠƒvƒgƒXƒ|ƒŠƒWƒEƒ€‚Ě”|—{×–E‚É‚ć‚銴őŤ•]‰ż. ůŒ´•Žu1, ‹e–ě—’ĂŽq, —с@rŽĄ1 (1”÷ś•¨): •˝Ź27”N“xAKPSŒ¤‹†W‰ďE‘ć18‰ń–k—˘”÷ś•¨ƒAƒJƒfƒ~[ (2015/8/6), ‘Š–ÍŒ´.

733012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ’°‹Ű‚ĚgyrA/parCˆâ“`Žq•ĎˆŮ‚É‚ć‚éƒLƒmƒƒ“‘ϐŤ‚Í“`’B‚ł‚ę‚é‚Š? ‰Ş–{—šˆę1, —с@rŽĄ1 (1”÷ś•¨): •˝Ź27”N“xAKPSŒ¤‹†W‰ďE‘ć18‰ń–k—˘”÷ś•¨ƒAƒJƒfƒ~[ (2015/8/6), ‘Š–ÍŒ´.

733013. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒWƒFƒbƒgƒ^ƒIƒ‹‚É‚ć‚éŽčŽw‚Ě×‹Ű‰˜ő‚ĚŒŸ“˘. —с@rŽĄ (”÷ś•¨): ‘ć78‰ń_“ŢěŒ§Š´őÇˆăŠw‰ď (2015/9/12), ‰Ą•l.

733014. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) CŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘f•ĎŠˇƒtƒ@[ƒW‚ĚƒQƒmƒ€”äŠr‚Ćˆâ“`Žq‹@”\‰đÍ. ăŒű‹`•F1, “ŕŽR~•˝, Mar’a A Oliva, Antonio J Martin-Galiano, JosŽ M Andreu, Ź–¸‹`r, ŽR–{—R–íŽq, źč–ΓW, —с@“N–ç, ŹŒFœ¨“ń, —с@rŽĄ1 (1”÷ś•¨): ‘ć98‰ń“ú–{×‹ŰŠw‰ďŠw‰ďŠÖ“ŒŽx•”‘‰ď (2015/10/29), “Œ‹ž.

733015. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚‘ϐHŤŽE‹Ű“ş‡‹ŕƒtƒBƒ‹ƒ€‚É‚ć‚é‰@“ŕŠÂ‹Ť×‹Ű‰˜ő‚Ě’áŒ¸‰ť. “ŕ“c—R”üŽq, ůŒ´•Žu1 (1”÷ś•¨): •˝Ź27”N“x“ú—Ő‹Z‹ăBŽx•”ˆăŠwŒŸ¸Šw‰ď (2015/11/14), Ž­Ž™“‡.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-110002. [Œ´’˜] Identification and characterization of a vitamin D3 decomposition product bactericidal against Helicobacter pylori. Hosoda K, Shimomura H, Wanibuchi K, Masui H, Amgalanbaatar A, Hayashi S1, Takahashi T, Hirai Y: Sci Rep 2015/3; 5: 8860. (—с@rŽĄ1: 1”÷ś•¨)

H26-120001. [Œ´’˜] “ş‡‹ŕ‚ĚŽE‹Ű“ÁŤ‚É‹y‚Ú‚ˇ•\–ĘŽ_‰ť‚̉e‹ż‚ĆŽ_‰ť–hŽ~‘΍ô ůŒ´•Žu1, ˛“Ą^‹|, ”¨@Ž•F, “í@@‘ě, K@—m“ń, ˜a“cł•F, Ö“Ą°•v (1”÷ś•¨): “ş‹y‚Ń“ş‡‹ŕ 2015/3; 54 (1): 246-50.

[’˜@‘]

H26-620001. [Šwp‘ (•Ş’SŽˇ•M)]yƒoƒCƒIƒZ[ƒtƒeƒB‚đŽx‚Ś‚é (CLEAN LIFE 2015)z3Í ‰@“ੴő‚ĚŒťó‚Ć‘Îô‚̏Ť—ˆ‘œ, p.14-7. ůŒ´•Žu (”÷ś•¨), ˆę”ĘŽĐ’c–@l ŠÂ‹Ť•ś‰ť‘n‘˘Œ¤‹†Š, “Œ‹ž, 2015/1”­s.


Šńś’ŽŠw

[Šwp˜_•ś]

110032. [Œ´’˜] Evaluation of Eimeria krijgsmanni as a murine model for testing the efficacy of anti-parasitic agents. Takeo T, Tanaka T, Matsubayashi M, Tsujio M, Umemiya-Shirafuji R, Tsuji N1, Fujisaki K, Matsui T, Matsuo T: Acta Parasitol. 2015/6; 60 (2): 190-5. (’ҁ@Ž—˜1: 1Šńś’Ž)

110033. [Œ´’˜] Bacteria-induced hatching of Trichuris muris eggs occurs without direct contact between eggs and bacteria. Koyama K1: Parasitol Res 2016/1; 115 (1): 437-40. (ŹŽR_ˆę1: 1Šńś’Ž)

110034. [Œ´’˜] Collection methods of trematode eggs using experimental animal models. Tsubokawa D1, Sugiyama H, Mikami F2, Shibata K, Shibahara T, Fukuda K, Takamiya S, Yamasaki H, Nakamura T1, Tsuji N1: Parasitol Int 2016/1; pii: S1383-5769(16)00007-6. (’ؐě‘ĺŒĺ1, ŽOă–[Žq2, ’†‘ş@Œ’1, ’ҁ@Ž—˜1: 1Šńś’Ž, 2—\–hˆăŠwŒn)

110035. [Œ´’˜] Emergence of multi-acaricide resistant Rhipicephalus ticks and its implication on chemical tick control in Uganda. Vudriko P, Okwee-Acai J, Tayebwa DS, Byaruhanga J, Kakooza S, Wampande E, Omara R, Muhindo JB, Tweyongyere R, Owiny DO, Hatta T1, Tsuji N1, Umemiya-Shirafuji R, Xuan X, Kanameda M, Fujisaki K, Suzuki H: Parasit Vectors 2016/1; 9: 4. (”Ş“cŠxŽm1, ’ҁ@Ž—˜1: 1Šńś’Ž)

110036. [Œ´’˜] Functional analysis of recombinant 2-Cys peroxiredoxin from the hard tick Haemaphysalis longicornis. Kusakisako K, Masatani T, Miyata T, Galay RL, Maeda H, Talactac MR, Tsuji N1, Mochizuki M, Fujisaki K, Tanaka T: Insect Mol Biol 2016/2; 25 (1): 16-23. (’ҁ@Ž—˜1: 1Šńś’Ž)

110037. [Œ´’˜] Virucidal activity of Haemaphysalis longicornis longicin P4 peptide against tick-borne encephalitis virus surrogate Langat virus. Talactac MR, Yoshii K, Maeda H, Kusakisako K, Hernandez EP, Tsuji N1, Fujisaki K, Galay RL, Tanaka T, Mochizuki M: Parasites & Vectors 2016/2; 9: 59. (’ҁ@Ž—˜1: 1Šńś’Ž)

110038. [Œ´’˜] Transcriptional profiles of virulent and precocious strains of Eimeria tenella at sporozoite stage; novel biological insight into attenuated asexual development. Matsubayashi M, Kawahara F, Hatta T, Yamagishi J, Miyoshi T, Anisuzzaman, Sasai K, Isobe T, Kita K, Tsuji N1: Infect Genet Evol 2016/6; 40: 54-62. (’ҁ@Ž—˜1: 1Šńś’Ž)

510001. [‘ŕ] Longistatin in tick-saliva targets RAGE. Anisuzzaman, Alim MA, Tsuji N1: Oncotarget 2015/11; 6 (34): 35133-4. (’ҁ@Ž—˜1: 1Šńś’Ž)

[Šw‰ďEŒ¤‹†‰ď“™]

712001. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Parasitic and tick-borne diseaseas. Tsuji N1: JICA seminer (2015/4/20), Tsukuba. (’ҁ@Ž—˜1: 1Šńś’Ž)

712002. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Pathobiology of vector tick-host interactions and anti-inflammatory molecules in tick-saliva. Tsuji N1: Medical Entomology Symposium The 36th Annual Meeting of Taiwan Entomological Society (2015/10/30), Taiwan. (’ҁ@Ž—˜1: 1Šńś’Ž)

712003. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) An advanced method for the study of the biological characteristics of the tick, Haemaphysalis longicornis, carrying tick-borne pathogens. Hatta T1: The 2nd Tokyo Vector Encounter (2016/3/2), Tokyo. (”Ş“cŠxŽm1: 1Šńś’Ž)

723046. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Eimeria tenella‚Ěƒ~ƒgƒRƒ“ƒhƒŠƒAŒÄ‹z˝y‘fŠˆŤ‚Ě‘Ş’č‚Ć‘jŠQÜ‚É‚ć‚é’Ž‘ĚŽE–ĹŒř‰Ę. ź—с@˝, ˆî‰Şƒ_ƒjƒGƒ‹Œ’, Źź’JŒ[‰î, ”Ş“cŠxŽm1, ŽOD–Ґ°, ˆé•”@Ž, ěŒ´Žj–ç, ŽRŠÝ–ç, •FâŒ’Ž™, ˛“Ą@’g, Žu”g’qś, Œ´“c”ɏt, –k@@Œ‰, ’ҁ@Ž—˜1 (1Šńś’Ž): ‘ć158‰ń“ú–{bˆăŠw‰ďŠwpW‰ď (2015/9/8), \˜a“c.

723047. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Virucidal activity of Haemaphysalis longicornis longicin P4 peptide against tick-borne encephalitis virus surrogate Langat virus. Melbourne Rio Talactac, DˆäŒ’‘ž˜N, ’ҁ@Ž—˜1, “ĄčK‘ , “c’‡“N–ç, –]ŒŽ‰ë”ü (1Šńś’Ž): ‘ć158‰ń“ú–{bˆăŠw‰ďŠwpW‰ď (2015/9/8), \˜a“c.

723048. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒ^ƒgƒQƒ`ƒ}ƒ_ƒj‚É‚¨‚Ż‚éƒyƒ‹ƒIƒLƒVƒŒƒhƒLƒVƒ“‚Ě–đŠ„‚É‚Â‚˘‚Ä. ‘–Ř”—_‘ĺ, Remil Linggatong Galay, ”’“Ą—œ‰Â, ‘O“c‘ĺ‹P, ‘ĺ‹v•Ű˜a—m, ŒÜ\—’ˆč’j, ’ҁ@Ž—˜1, –]ŒŽ‰ë”ü, “ĄčK‘ , “c’‡“N–ç (1Šńś’Ž): ‘ć158‰ń“ú–{bˆăŠw‰ďŠwpW‰ď (2015/9/8), \˜a“c.

723049. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒxƒNƒ^[ƒ}ƒ_ƒj‘Ě“ŕ‚É‚¨‚Ż‚éBabesia ovata‘B“Ž‘Ԃɂ‚˘‚Ä‚ĚˆęlŽ@. ‘O“c‘ĺ‹P, ”Ş“cŠxŽm1, ź—с@˝, ŽOD–Ґ°, ”’“Ą—œ‰Â, ‘ĺ‹v•Ű˜a—m, ŒÜ\—’ˆč’j, ’ҁ@Ž—˜1, –]ŒŽ‰ë”ü, “ĄčK‘ , “c’‡“N–ç (1Šńś’Ž): ‘ć158‰ń“ú–{bˆăŠw‰ďŠwpW‰ď (2015/9/8), \˜a“c.

723050. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Experimental evaluation of Haemaphysalis longicornis tick as a potential biologic vector of Japanese encephalitis virus. Goto M, Shimoda H, Maeda K, Maeda H, ”Ş“cŠxŽm1, ’ҁ@Ž—˜1, Tanaka T, Mochizuki M (1Šńś’Ž): ‘ć63‰ń“ú–{ƒEƒBƒ‹ƒXŠw‰ďŠwpW‰ď (2015/11/22), •Ÿ‰Ş.

723051. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) RŒ{ƒRƒNƒVƒWƒEƒ€Ç–ň‚ĚŠJ”­‚đ–ÚŽw‚ľ‚˝Eimeria tenella Dihydroorotate dehydrogenase‚Ě”­ŒťE¸ť‚ĆŒ‹ť‰ť. ’ˇŕ_‚Ü‚Ç‚Š, ˛“Ą@’g, Žu”g’qś, ź—с@˝, ˆî‰Şƒ_ƒjƒGƒ‹Œ’, ’ҁ@Ž—˜1, –k@@Œ‰, Œ´“c”ɏt (1Šńś’Ž): BMB2015 (‘ć38‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ďE‘ć 88‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď ‡“Ż‘ĺ‰ď) (2015/12/2), _ŒË.

723052. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) —c—‚É‚¨‚Ż‚éEimeria tenellaŽă“ĹŠ”‚̍ěo‚¨‚ć‚Ń•a—‘gDŠw“I‰đÍ ź—с@˝, ěŒ´Žj–ç, ”Ş“cŠxŽm1, ŽRŠÝ–ç, ˆé•”@Ž, Ž›–{@ŒM, ‹ŕŽq@–ž, ůˆä˜a”ü, –k@@Œ‰, ’ҁ@Ž—˜1 (1Šńś’Ž): ‘ć85‰ń“ú–{Šńś’ŽŠw‰ď‘ĺ‰ď (2016/3/19), ‹{č.

723053. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒPƒjƒAŽYƒRƒCƒ^ƒ}ƒ_ƒjRhipicephalus decoloratus‚É‚¨‚Ż‚éƒŔƒAƒhƒŒƒiƒŠƒ“—lƒIƒNƒgƒpƒ~ƒ“Žó—e‘Ěˆâ“`Žq‚ĚSNP ƒ^ƒCƒsƒ“ƒO ”Ş“cŠxŽm1, Muinde Martin D, Oluga Aboge G, Odongo David O, ’|’†ş—Y, Ngethe Esther W, ’ҁ@Ž—˜1 (1Šńś’Ž): ‘ć85‰ń“ú–{Šńś’ŽŠw‰ď‘ĺ‰ď (2016/3/20), ‹{č.

723054. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒ^ƒgƒQƒ`ƒ}ƒ_ƒj‘Ě“ŕ‚É‚¨‚Ż‚éBabesia ovataˆÚs“Ž‘Ԃɂ‚˘‚Ä. ‘O“c‘ĺ‹P, ”Ş“cŠxŽm1, ’ؐě‘ĺŒĺ1, ŽOă–[Žq, ź—с@˝, ŽOD–Ґ°, ”’“Ą—œ‰Â, ‘ĺ‹v•Ű˜a—m, ŒÜ\—’ˆč’j, –]ŒŽ‰ë”ü, “ĄčK‘ , ’ҁ@Ž—˜1, “c’‡“N–ç (1Šńś’Ž): ‘ć85‰ń“ú–{Šńś’ŽŠw‰ď‘ĺ‰ď (2016/3/20), ‹{č.

723055. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒxƒlƒYƒGƒ‰•łü’Ž‚Ş—L‚ˇ‚郍ƒ“ƒMƒXƒ^ƒ`ƒ“—l•ŞŽq‚̐Ťó. ’ؐě‘ĺŒĺ1, ”Ş“cŠxŽm1, ‘O“c‘ĺ‹P, ŽOă–[Žq, ‹e’n‘אś, ŠŰŽRŽĄ•F, ’ҁ@Ž—˜1 (1Šńś’Ž): ‘ć85‰ń“ú–{Šńś’ŽŠw‰ď‘ĺ‰ď (2016/3/20), ‹{č.

731001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒ}ƒ_ƒj‚Ě‹zŒŒ‚Ć•aŒ´‘Ě“`”dƒƒJƒjƒYƒ€. ’ҁ@Ž—˜ (Šńś’Ž): Z—F‰ťŠwŠ”ŽŽ‰ďŽĐ@Œ’NE”_‹ĆŠÖ˜AŽ–‹ĆŒ¤‹†ŠƒZƒ~ƒi[ (2015/7/20), •ó’Ë.

732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ”M‘ŃŠ´őÇ‚ĆƒƒNƒ`ƒ“ ƒ}ƒ_ƒj‚̐ś‘Ô: ‹zŒŒ‚ĆŠ´őÇ”}‰î‚ĚŽd‘g‚Ý. ’ҁ@Ž—˜ (Šńś’Ž): —Ž‹…‘ĺŠw”M‘ѐś•¨Œ—Œ¤‹†ƒZƒ“ƒ^[Žs–ŻŒöŠJƒVƒ“ƒ|ƒWƒEƒ€ (2015/8/30), “ß”e.

732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ƒ}ƒ_ƒj‚̐ś‘Ô: ‹zŒŒ‚Ć•aŒ´‘Ě“`”d‚ĚŽd‘g‚Ý. ’ҁ@Ž—˜ (Šńś’Ž): ‘ć41‰ń–k—˘ˆăŠw‰ď‘‰ď (2015/12/12), ‘Š–ÍŒ´.

733016. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒ“ƒ\ƒ“ŒÇ’Ž23KDaƒvƒƒeƒA[ƒ[‚̍y‘f‰ťŠw“IŤŽż‚ɂ‚˘‚Ä. ’ؐě‘ĺŒĺ1, ”Ş“cŠxŽm1, ŽOă–[Žq, ’†‘ş@Œ’, ’ҁ@Ž—˜1 (1Šńś’Ž): ‘ć9‰ń徒ŽŒ¤‹†‰ď (2015/7/18), ŠâŽč.

733017. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒ“ƒ\ƒ“ŒÇ’ŽƒVƒXƒeƒCƒ“ƒvƒƒeƒA[ƒ[‚̏hŽĺ‘gDN“ü‚Ö‚ĚŠÖ—^. ’ؐě‘ĺŒĺ1, ”Ş“cŠxŽm1, ŽOă–[Žq, ’†‘ş@Œ’, ’ҁ@Ž—˜1 (1Šńś’Ž): ‘ć28‰ń–k—˘‘ĺŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€E‘ć18‰ń–k—˘”÷ś•¨ƒAƒJƒfƒ~[Œ¤‹†W‰ď (2015/8/6), ‘Š–ÍŒ´

733018. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒ“ƒ\ƒ“ŒÇ’ŽƒVƒXƒeƒCƒ“ƒvƒƒeƒA[ƒ[‚ŞŽ‚hŽĺ‘gDN“ü‚Ö‚ĚˆÓ‹`‚ɂ‚˘‚Ä. ’ؐě‘ĺŒĺ1, ”Ş“cŠxŽm1, ŽOă–[Žq, ’†‘ş@Œ’, ’ҁ@Ž—˜1 (1Šńś’Ž): ‘ć75‰ń“ú–{Šńś’ŽŠw‰ď“Œ“ú–{Žx•”‰ď (2015/9/26), “Œ‹ž.


•a—Šw (‘ş‰_’PˆĘ)

[Šwp˜_•ś]

110039. [Œ´’˜] L-type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling. Ichinoe M1, Yanagisawa N1, Mikami T, Hana K, Nakada N1, Endou H, Okayasu I, Murakumo Y1: Pathol Res Pract 2015/7; 211 (7): 533-8. (ˆęŒËš–ž1, –öŕVM”V1, ’‡“c“TL1, ‘ş‰_–FŽ÷1: 1•a—)

110040. [Œ´’˜] High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab. Okina S1, Yanagisawa N2, Yokoyama M1, Sakurai Y1, Numata Y3, Umezawa A3, Higashihara M4, Murakumo Y2: Int J Hematol 2015/12; 102 (6): 662-9. (‰Ľ@‘c˝1, –öŕVM”V2, ‰ĄŽR^Šě1, ŸNˆä–ő‚1, Ŕ“c‰ęŽq3, ”~‘ň“ÖŽq3, “ŒŒ´ł–ž4, ‘ş‰_–FŽ÷2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn, 4ŒŒ‰t“ŕ)

110041. [Œ´’˜] L-amino acid transporter 1 may be a prognostic marker for local progression of prostatic cancer under expectant management. Yanagisawa N1, Satoh T2, Hana K, Ichinoe M1, Nakada N1, Endou H, Okayasu I, Murakumo Y1: Cancer Biomark 2015; 15 (4): 365-74. (–öŕVM”V1, ˛“ĄˆĐ•ś2, ˆęŒËš–ž1, ’‡“c“TL1, ‘ş‰_–FŽ÷1: 1•a—, 2”ĺ”AŠí)

110042. [Œ´’˜] CD109 is a component of exosome secreted from cultured cells. Sakakura H, Mii S, Hagiwara S, Kato T, Yamamoto N, Hibi H, Takahashi M, Murakumo Y1: Biochem Biophys Res Commun 2016/1; 469 (4): 816-22. (‘ş‰_–FŽ÷1: 1•a—)

[Šw‰ďEŒ¤‹†‰ď“™]

713007. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) EXPRESSION OF CANCER-TYPE AMINO-ACID TRANSPORTER LAT1 IS A PROGNOSIS PREDICTION FACTOR IN BREAST CARCINOMA: COMPARISON BETWEEN TRIPLE NEGATIVE AND NON-TRIPLE-NEGATIVE TYPES. Ichinoe M1, Mikami T, Hana K, Yanagisawa N1, Endou H, Okayasu I, Murakumo Y1: AACR Annual Meeting 2015 (2015/4/22), Philadelphia, USA. (ˆęŒËš–ž1, –öŕVM”V1, ‘ş‰_–FŽ÷1: 1•a—)

723056. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹š‘Bă”琍Žîᇂɂ¨‚Ż‚é’áŽ_‘f‰ž“šŠÖ˜Aƒ^ƒ“ƒpƒN‚Ě”­Œť‚ĚŒŸ“˘. ’‡“c“TL1, Ŕ“c‰ęŽq2, ”~‘ň“ÖŽq2, ŸNˆä–ő‚1, ˆęŒËš–ž1, –öŕVM”V1, Ó@˘ˆŽ1, ‘ş‰_–FŽ÷1 (1•a—, 2Œ`‘ÔŒn): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/4/30), –źŒĂ‰Ž.

723057. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”x‘BŠŕ‚É‚¨‚Ż‚éDJ-1‚Ě”­Œť‚Ɛf’fƒ}[ƒJ[‚Ć‚ľ‚Ẳ”\Ť. “y‰Žg, Ó@˘ˆŽ1, ’ˇ‰–@—ş, ‘ş‰_–FŽ÷1, ŽOŽ}@M1, ˛“Ą—Yˆę (1•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/4/30), –źŒĂ‰Ž.

723058. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ń‚Ü‚ńŤ‘ĺ×–EŤB×–EƒŠƒ“ƒpŽî‚É‚¨‚Ż‚éDNAC•œƒ^ƒ“ƒpƒNREV7”­Œť. ‰Ľ@‘c˝1, –öŕVM”V2, ‰ĄŽR^Šě1, Ŕ“c‰ęŽq3, ”~‘ň“ÖŽq3, ‘ş‰_–FŽ÷2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/4/30), –źŒĂ‰Ž.

723059. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ž‡ŠOü‚É—U”­‚ł‚ę‚é“Ë‘R•ĎˆŮ‚É‚¨‚˘‚ÄDNAƒ|ƒŠƒƒ‰[ƒ[EƒC[ƒ^‚ĆƒCƒIƒ^‚ޔ畆×–E‚Ć‘gD‚ʼnʂ˝‚ˇ–đŠ„. ŸNˆä–ő‚1, ‰Ąˆä‰ëK, ’Ë–{“OĆ, ˜kŸş‰p‹@ (1•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/4/30), –źŒĂ‰Ž.

723060. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Microdissection‚ÉŠî‚Ă‚˘‚˝DNAƒ}ƒCƒNƒƒAƒŒƒC‚É‚ć‚é”x‘BŠŕ”÷Ź“ű“ސŹ•Şˆâ“`Žq”­Œť‚̉đÍ. Ó@˘ˆŽ1, ’†“‡—TN2, ”~‘ň“ÖŽq3, ’ˇ‰–@—ş4, ˛“Ą—Yˆę4, ˆęŒËš–ž1, ‘ě˜ad5, ˛“Ą”Vr2, ‘ş‰_–FŽ÷1 (1•a—, 2ŒÄ‹zŠíŠO, 3Œ`‘ÔŒn, 4ˆă—ÉqśŠw•”, 5•úŽËü (Žîá‡)): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/4/30), –źŒĂ‰Ž, “ú–{•a—Šw‰ď‰ďŽ 2015/3; 104 (1): 336.

723061. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) LAT1‚Ě”­Œť‚Í“űŠŕ‚Ě—\ŒăŠÖ˜AˆöŽq‚Ĺ‚ ‚é: triple negative“űŠŕ‚Ćnon-triple negative“űŠŕ‚Ě”äŠr. ˆęŒËš–ž1, ŽOă“N•v, –öŕVM”V1, ‰ÔŽ÷‘ă”ü, ‰““ĄŠ°Žq, ‰““Ą@m, ‰ŞˆŔ@ŒM (1•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723062. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) LAT1‚Ě”­Œť‚Í“űŠŕ‚Ě—\ŒăŠÖ˜AˆöŽq‚Ĺ‚ ‚é. ˆęŒËš–ž1, ŽOă“N•v, –öŕVM”V1, ‰ÔŽ÷‘ă”ü, ’‡“c“TL1, •űGş, ‰““Ą@m, ‰ŞˆŔ@ŒM, ‘ş‰_–FŽ÷1 (1•a—): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8), –źŒĂ‰Ž.

723063. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) REV7‚Ě—}§‚͐¸‘ƒăó×–EŽîᇂ̃VƒXƒvƒ‰ƒ`ƒ“Š´ŽóŤ‚đ‘‹­‚ˇ‚é. ŸNˆä–ő‚1, ‚‹´‰ë‰p, ‘ş‰_–FŽ÷1 (1•a—): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8), –źŒĂ‰Ž.

723064. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ń‚Ü‚ńŤ‘ĺ×–EŤB×–EƒŠƒ“ƒpŽî‚É‚¨‚Ż‚éDNAC•œƒ^ƒ“ƒpƒNREV7”­Œť‚Ć—\Œă‰đÍ. ‰Ľ@‘c˝1, –öŕVM”V2, ‰ĄŽR^Šě1, ’‡“c“TL2, ”~‘ň“ÖŽq3, Ŕ“c‰ęŽq3, ˆęŒËš–ž2, Ó@˘ˆŽ2, ‘ş‰_–FŽ÷2, “ŒŒ´ł–ž4 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn, 4ŒŒ‰t“ŕ): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8), –źŒĂ‰Ž.

723065. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹š‘Bă”琍Žîᇂɂ¨‚Ż‚é’áŽ_‘f‰ž“šŠÖ˜Aƒ^ƒ“ƒpƒN‚Ě”­Œť‚ĚŒŸ“˘. ’‡“c“TL1, Ŕ“c‰ęŽq2, ”~‘ň“ÖŽq2, ŸNˆä–ő‚1, ˆęŒËš–ž1, –öŕVM”V1, Ó@˘ˆŽ1, ‘ş‰_–FŽ÷1 (1•a—, 2Œ`‘ÔŒn): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8), –źŒĂ‰Ž.

723066. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) L-type amino-acid transporter 1 (LAT1) is prognosis related factor in breast carcinoma: Comparison triple negative breast carcinoma with non-triple-negative breast carcinoma. ˆęŒËš–ž1, ŽOă“N•v, –öŕVM”V1, ‰ÔŽ÷‘ă”ü, ‰““ĄŠ°Žq, ‰““Ą@m, ‰ŞˆŔ@ŒM, ‘ş‰_–FŽ÷1 (1•a—): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8-10), –źŒĂ‰Ž.

733019. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) cŠuŽîᇂĚ1—á. ’‡“c“TL1, ‚‹´”Ž”V1, ‘ĺ•”@˝2, ‘ş‰_–FŽ÷1 (1•a—, 2ˆă—ÉqśŠw•”): _“ސě•a—ˆă‰ď (2016/1/9), ‰Ą•l.


•a—Šw (ŽOŽ}’PˆĘ)

[Šwp˜_•ś]

110043. [Œ´’˜] FilGAP, a Rac-specific Rho GTPase-activating protein, is a novel prognostic factor for follicular lymphoma. Nishi T, Takahashi H1, Hashimura M2, Yoshida T1, Ohta Y, Saegusa M1: Cancer Med 2015/6; 4 (6): 808-18. (ź@’B–ç, ‚‹´”Ž”V1, ‹´‘ş”ü‹I2, ‹g“c@Œ÷1, ŽOŽ}@M1: 1•a—, 2Œ`‘ÔŒn)

110044. [Œ´’˜] Transcriptional upregulation of HNF-1ƒŔ by NF-ƒČB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression. Suzuki E1, Kajita S1, Takahashi H1, Matsumoto T1, Tsuruta T1, Saegusa M1: Lab Invest 2015/8; 95 (8): 962-72. (—é–ŘƒGƒŠ“Ţ1, Š“cç”ü”T1, ‚‹´”Ž”V1, ź–{r‰p1, ’ß“c’qŽq1, ŽOŽ}@M1: 1•a—)

110045. [Œ´’˜] Distinct ƒŔ-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas. Matsumoto T1, Yamazaki M2, Takahashi H1, Kajita S1, Suzuki E1, Tsuruta T1, Saegusa M1: Am J Clin Pathol 2015/9; 144 (3): 452-63. (ź–{r‰p1, ŽRč^‰l2, ‚‹´”Ž”V1, Š“cç”ü”T1, —é–ŘƒGƒŠ“Ţ1, ’ß“c’qŽq1, ŽOŽ}@M1: 1•a—, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110046. [Œ´’˜] Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1ƒż/Akt axis in glioblastoma. Inukai M1, Hara A2, Yasui Y3, Kumabe T4, Matsumoto T2, Saegusa M2: Hum Pathol 2015/10; 46 (10): 1496-505. (Œ˘Ž”@‰~1, Œ´@“ÖŽq2, ˆŔˆä”ü]3, ŒG•”rG4, ź–{r‰p2, ŽOŽ}@M2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn, 4”]ŠO)

110047. [Œ´’˜] Dual functions of Rap1 are crucial for T-cell homeostasis and prevention of spontaneous colitis. Ishihara S, Nishikimi A, Umemoto E, Miyasaka M, Saegusa M1, Katagiri K: Nat Commun 2015/12; 6: 8982. (ŽOŽ}@M1: 1•a—)

110048. [Œ´’˜] Spontaneous brain tumor imaging of aged rat by crystal X-ray interferometer-based phase-contrast X-ray CT. Lwin TT, Yoneyama A, Hara A1, Ohbu M2, Maruyama H, Taguchi M, Esashi S, Matsushima T, Terazaki K, Hyodo K, Takeda T: Acta Radiol Open 2016/2; 5 (2): 2058460115626958. (Œ´@“ÖŽq1, ‘ĺ•”@˝2: 1•a—, 2ˆă—ÉqśŠw•”)

110049. [Œ´’˜] Cooperation of Sox4 with ƒŔ-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma. Inoue H1, Takahashi H2, Hashimura M3, Eshima K4, Akiya M1, Matsumoto T2, Saegusa M2: BMC Cancer 2016/2; 16: 53. (ˆäă‹vŽq1, ‚‹´”Ž”V2, ‹´‘ş”ü‹I3, ]“‡k“ń4, H’JšŽj1, ź–{r‰p2, ŽOŽ}@M2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn, 4–Ɖu)

[Šw‰ďEŒ¤‹†‰ď“™]

723067. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ALK—zŤ—‘‘ƒEŽq‹{Œ´”­Šŕ“÷Žî‚ÍŸ÷‰tŤ‘BŠŕ‚̐Ź•Ş‚đ—L‚ˇ‚é. ŽOŽ}@M (•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723068. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) _ŒoäPŽî‚É‚¨‚Ż‚éALKˆâ“`Žq”­Œť‚ÍŽîᇌ`‘Ô‚ĆŒŒŠÇƒjƒbƒ`‚ÉŠÖŒW‚ˇ‚é. ŽOŽ}@M (•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723069. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Lefty‚͐łíŽq‹{“ŕ–Œ‚¨‚ć‚Ń—Ţ“ŕ–Œ‘BŠŕ‚Ě‘BE•Ş‰ť‚đ§Œä‚ˇ‚é. ŽOŽ}@M (•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723070. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Lefty‚Í—‘‘ƒ–ž×–EŠŕ‚̐V‹KƒoƒCƒIƒ}[ƒJ[‚Ĺ‚ ‚é. ŽOŽ}@M (•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723071. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐŤ‘ĺ’°‰ŠƒoƒCƒIƒ}[ƒJ[olfactomedin 4‚Ě‹@”\“Ż’č‚Ć‚ť‚ĚˆÓ‹`. ‘ĺŒF‘ń–ç, ‹g“c@Œ÷1, ‹´Œű@Žű, ‰Ą“c@Í, ‰ŞˆŔ@ŒM, ŽOŽ}@M1 (1•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723072. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐŤ‘ĺ’°‰Š‚É‚¨‚Ż‚éƒoƒCƒIƒ}[ƒJ[olfactomedin 4‚Ě”­Œť‹@˜. ‹´Œű@Žű, ‹g“c@Œ÷1, ‘ĺŒF‘ń–ç, ‰Ą“c@Í, ‰ŞˆŔ@ŒM, ŽOŽ}@M1 (1•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723073. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰ŠÇƒoƒCƒIƒ}[ƒJ[olfactomedin 4‚Ě”­Œť‚Š‚ç‚Ý‚˝‰ŠÇŤ’°ŽžŠł‚Ě•aˆö•a‘Ô. ‹g“c@Œ÷ (•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723074. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) FilGAP/RacƒVƒOƒiƒ‹Œn‚đ‰î‚ˇ‚é×–E‰^“Ž§Œä‚Š‚猊‚˝astrocytoma—V‘–EZ‹@\‚ĚŒŸ“˘. Œ´@“ÖŽq1, ŽOŽ}@M1 (1•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723075. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) AktŒn‚ÍäP‰čŽî‚Ě’áŽ_‘fƒjƒbƒ`ŠÂ‹Ť‚Ě‚Ş‚ńŠ˛×–E‰ťˆŰŽ‹@\‚Ĺ‚ ‚é. Œ´@“ÖŽq1, Œ˘Ž”@‰~2, ŽOŽ}@M1 (1•a—, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723076. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) isŠú’ź’°Šŕ‚ĚƒŔ-ƒJƒeƒjƒ“/EMT—U“ąŠŕŠ˛×–E‰ť‚É‚ć‚鉝ŠwE•úŽËü—Ă–@‚̑ϐŤ‹@\‚̉đÍ. ‚‹´”Ž”V1, ’†‘ş‹MŒb, ’ß“c’qŽq, ŽOŽ}@M1 (1•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723077. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒŔ-catenin‚¨‚ć‚ŃPIK3CAˆâ“`Žq•ĎˆŮ‚ÉŠî‚Ă‚­Žq‹{“ŕ–ŒÇŤ—‘‘ƒ”­Šŕ‚̉đÍ. ź–{r‰p1, ŽRč^‰l, ‚‹´”Ž”V1, Š“cç”ü”T1, —é–ŘƒGƒŠ“Ţ1, ’ß“c’qŽq, ŽOŽ}@M1 (1•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/2), –źŒĂ‰Ž.

733020. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒŔ-catenin‚¨‚ć‚ŃPIK3CAˆâ“`Žq•ĎˆŮ‚ÉŠî‚Ă‚­Žq‹{“ŕ–ŒÇŤ—‘‘ƒ”­Šŕ‚̉đÍ. ź–{r‰p1, ŽRč^‰l, ‚‹´”Ž”V1, Š“cç”ü”T1, —é–ŘƒGƒŠ“Ţ1, ’ß“c’qŽq, ŽOŽ}@M1 (1•a—): ‘ć28‰ń–k—˘‘ĺŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€E‘ć18‰ń–k—˘”÷ś•¨ƒAƒJƒfƒ~[Œ¤‹†W‰ď (2015/8/6), ‘Š–ÍŒ´.


‰qśŠw

[Šwp˜_•ś]

110050. [Œ´’˜] The immunotoxic effects of fluoride on mice after subacute administration by evaluating cytokine mRNA expression in splenocytes. Hosokawa M, Tsunoda M1, Liu Y, Nakano K, Itai K, Tsunoda H, Yokoyama K, Aizawa Y1: Fluoride 2015/12; 48 (4): 329-37. (Šp“cłŽj1, ‘ŠŕVDŽĄ1: 1‰qś)

110051. [Œ´’˜] Fluoride supplementation in pregnant women for preventing dental caries in the primary teeth of their children. Takahashi R, Ota E, Hoshi K1, Naito T, Toyoshima Y, Yuasa H, Mori R: Cochrane Database of Systematic Reviews 2015/8; Published Online. DOI: 10.1002/14651858.CD011850. (Ż@‰Ŕ–F1: 1‰qś)

110052. [Œ´’˜] The Diagnosis of Sick House Syndrome: the Contribution of Diagnostic Criteria and Determination of Chemicals in an Indoor Environment. Miyajima E1, Tsunoda M1, Sugiura Y2, Hoshi K1, Kido T, Sakamoto Y3, Sakabe K, Aizawa Y1: Tokai J Exp Clin Med 2015/5; 40 (2): 69-75. (‹{“‡]—˘Žq1, Šp“cłŽj1, ™‰Y—R”üŽq2, Ż@‰Ŕ–F1, â–{‘×—3, ‘ŠŕVDŽĄ1: 1‰qś, 2—\–hˆăŠwŒn, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

520003. [‘ŕ] ˆă—ĂŽ{Ý“ŕ‚̐ݔő‚â‹@Ší‚𩴐őŒš‚Ć‚ˇ‚é‰@“ੴő. –xŒű•ş„ (‰qś): –k—˘ˆăŠw 2015/12; 45 (2): 87-94.

530001. [‚ť‚Ě‘ź (ƒRƒƒ“ƒg)]yComment on: Biomonitoring of mercury, cadmium, and lead exposure in Japanese children: a cross-sectional study. [Environ Health Prev Med 2015]zBiomonitoring of metal exposure in children in a northern city of Japan. Horiguchi H1: Environ Health Prev Med 2015/7; 20 (4): 314-5. (–xŒű•ş„1: 1‰qś)

530002. [‚ť‚Ě‘ź (ƒRƒƒ“ƒg)]yComment on: Biomonitoring of metal exposure in children in a northern city of Japan. [Environ Health Prev Med 2015]zThe fundamentals of epidemiology and ethics in science. Horiguchi H1: Environ Health Prev Med 2016/1; 21 (1): 53. (–xŒű•ş„1: 1‰qś)

540003. [‚ť‚Ě‘ź (•śŒŁĐ‰î)] Žó“Ž‹i‰Œ‚̐¸_“I‰e‹ż. ‹{“‡]—˘Žq1, Šp“cłŽj1, ‘ŠŕVDŽĄ1 (1‰qś): ŽY‹ĆˆăŠwƒWƒƒ[ƒiƒ‹ 2015/11; 38 (6): 93-7.

[’˜@‘]

620007. [Šwp‘] (•Ş’SŽˇ•M) yŹŽ™ŽžŠłf—Ă‚Ě‚˝‚ß‚Ě•a‘Ԑś—2 ‰ü’ů5”Ĺ (ŹŽ™“ŕ‰Č2015”N47ŠŞ‘Š§†)zIX. ’†“Ł@6. d‹ŕ‘Ž (‰”, …‹â, ƒq‘f), p.959-63. Šp“cłŽj (‰qś), ‹¤•Ň:wŹŽ™“ŕ‰ČxwŹŽ™ŠO‰Čx•ŇWˆĎˆő‰ď, “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2015/11”­s.

620008. [Šwp‘ (•Ş’SŽˇ•M)]y‰ü’ů Œš’z•¨‚̊‹Ť‰qśŠÇ— (ăŠŞ) ‘ć3”Łz‘ć4Í Œš’z•¨‚̊‹Ť‰qś@4.3 Žş“ŕ‹ó‹C‚̐Ťó‚ĆŒ’N, p.280-96. Šp“cłŽj (‰qś), (Œö) “ú–{Œš’z‰qśŠÇ—‹łˆçƒZƒ“ƒ^[, “Œ‹ž, 2015/12”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713008. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The evaluation on the safety of self-assembling peptide gel after the intracranial administration to rats by using an open field test. Tsunoda M1, Sugaya C, Sugiura Y2, Nagai Y, Sakanishi K: Society of Toxicology, 55th Annual Meeting (2016/3/15), New Orleans, Louisiana, USA. (Šp“cłŽj1, ™‰Y—R”üŽq2: 1‰qś, 2—\–hˆăŠwŒn)

723078. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ť‘˘‹Ć‚É‚¨‚Ż‚é‰ő“KEę‚Ă‚­‚č‚Ě‚˝‚ß‚ĚŽó“Ž‹i‰Œ–hŽ~‘΍ô‚ÉŠÖ‚ˇ‚éˆÓŽŻ’˛¸. ‹{“‡]—˘Žq1, Šp“cłŽj1, ™‰Y—R”üŽq2, ›’J‚ż‚Ś”ü (1‰qś, 2—\–hˆăŠwŒn): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/16), ‘ĺă.

723079. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒgƒŠƒuƒ`ƒ‹ƒXƒY‚ÉŒo‘ٔՁEŒo•ę“ű‹y‚Ń—Ł“űŒăŒoŒű”˜˜I‚ł‚ę‚˝ƒƒX‚ĚTokai High Avoiderƒ‰ƒbƒg‚ĚƒI[ƒvƒ“ƒtƒB[ƒ‹ƒhŽŽŒą. Šp“cłŽj1, ™‰Y—R”üŽq2, ‹{“‡]—˘Žq1, –ŘŒË‘¸›’, ×ě‚Ü‚äŽq, –xŒű•ş„1, ‰““Ą@Ž, “n•Ó@“N (1‰qś, 2—\–hˆăŠwŒn): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/16), ‘ĺă.

723080. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“cŒ§“ŕ‚Ěˆă—Ă‹@ŠÖ‚É‚¨‚Ż‚ét‹@”\’ቺŠłŽŇ‚ɑ΂ˇ‚éƒJƒhƒ~ƒEƒ€tÇƒXƒNƒŠ[ƒjƒ“ƒO‚ĚŽŽ‚Ý. ŕV‘şšl, –xŒű•ş„1, ŹŒF‰xŽq, źěŠx‹v, ç—t•SŽq, ‘ş“cŸŒh, ‰ĄŽR˜am, ’†‘şł–ž, —OˆäGŽ÷, Źź“c“Ö (1‰qś): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/5), –źŒĂ‰Ž.

723081. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆę”ʏW’c‚É‚¨‚Ż‚鉝Šw•¨Žż‰ß•qÇ‚̉”\Ť‚Ć‹i‰Œ”˜˜I‚đŠÜ‚ß‚˝‰ťŠw•¨Žż”˜˜I—đ‚ÉŠÖ‚ˇ‚錤‹†. ‹{“‡]—˘Žq1, Šp“cłŽj1, ™‰Y—R”üŽq2, â–{‘×—3, –xŒű•ş„1, â•”@v (1‰qś, 2—\–hˆăŠwŒn, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć24‰ń“ú–{—Տ°ŠÂ‹ŤˆăŠw‰ďŠwpW‰ď (2015/6/6), “Œ‹ž.

723082. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰–‰ťƒgƒŠƒuƒ`ƒ‹ƒXƒY‚É‘ŮŽ™Šú`”­’BŠú”˜˜I‚ł‚ę‚˝ƒƒX‚ĚTokai High Avoiderƒ‰ƒbƒg‚É‚¨‚Ż‚é‹L‰ŻŠwK”\—Í‚Ě—}§: ƒVƒhƒ}ƒ““dŒ‚‰ń”đŽŽŒą‚É‚ć‚錟“˘. Šp“cłŽj1, ’ˇ’Jě‘ě–í, ›’J‚ż‚Ś”ü, ™‰Y—R”üŽq2, –xŒű•ş„1, –ŘŒË‘¸›’, –öŕV—T”V, ‰““Ą@Ž, “n•Ó@“N (1‰qś, 2—\–hˆăŠwŒn): ‘ć26‰ń“ú–{”÷—ĘŒł‘fŠw‰ďŠwpW‰ď (2015/7/5), –kŠC“š.

723083. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œ´ˆö•Ę•Ş—Ţ‚đŠˆ—p‚ľ‚˝ŽŒ`ŠO‰ČƒNƒŠƒjƒbƒN‚É‚¨‚Ż‚郊ƒXƒNƒ}ƒlƒWƒƒ“ƒg‚Ö‚ĚŽć‚č‘g‚Ý. “n粉Öç, “ŕ“c‘U”Ž1, Ż@‰Ŕ–F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2‰qś): ‘ć74‰ń“ú–{ŒöO‰qśŠw‰ď‘‰ď (2015/11/5), ’ˇč, ‘ć74‰ń“ú–{ŒöO‰qśŠw‰ď‘‰ď´˜^W 2015/10; p.486.

723084. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “Œ‹ž‚̏­”N–ě‹…/ƒTƒbƒJ[ƒ`[ƒ€Žw“ąŽŇ‚É‚¨‚Ż‚é‹Ö‰Œ‚ÉŠÖ‚ˇ‚éƒz[ƒ€ƒy[ƒWî•ń‚Ě’˛¸. Ż@‰Ŕ–F1, “ŕ“c‘U”Ž2, Šp“cłŽj1, â–{‘×—2, –xŒű•ş„1 (1‰qś, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć74‰ń“ú–{ŒöO‰qśŠw‰ď‘‰ď (2015/11/6), ’ˇč, ‘ć74‰ń“ú–{ŒöO‰qśŠw‰ď‘‰ď´˜^W 2015/10; p.228.

723085. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘S‘‚̏—Žq’†‚ś–ě‹…ƒ`[ƒ€Žw“ąŽŇ‚É‚¨‚Ż‚é‹Ö‰Œ‚ÉŠÖ‚ˇ‚éƒz[ƒ€ƒy[ƒWî•ń‚Ě’˛¸. Ż@‰Ŕ–F1, “ŕ“c‘U”Ž2, Šp“cłŽj1, â–{‘×—2, –xŒű•ş„1 (1‰qś, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć26‰ń“ú–{‰uŠw‰ďŠwp‘‰ď (2016/1/23), •ÄŽq, Journal of Epidemiology 2016/1; 26 (Suppl 1): 137.

732003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Ž{ô‚Ö‚ĚƒKƒCƒhƒ‰ƒCƒ“Šˆ—p. Ż@‰Ŕ–F (‰qś): Œúś˜J“­Č‘—§•ŰŒ’ˆă—ÉȊw‰@E•˝Ź27”N“x’ZŠúŒ¤Cu’nˆć•ŰŒ’Žx‰‡‚Ě‚˝‚ß‚Ě•ŰŒ’î•ńˆ—‹ZpŒ¤Cvu‹` (2015/12/3), ˜aŒő.

732004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ƒAƒ“ƒP[ƒg’˛¸‰‰K. ˆŔ“Ą—Yˆę, Ż@‰Ŕ–F1 (1‰qś): Œúś˜J“­Č‘—§•ŰŒ’ˆă—ÉȊw‰@E•˝Ź27”N“x’ZŠúŒ¤Cu’nˆć•ŰŒ’Žx‰‡‚Ě‚˝‚ß‚Ě•ŰŒ’î•ńˆ—‹ZpŒ¤Cvu‹` (2015/12/9), ˜aŒő.

733021. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒhƒ~ƒEƒ€”˜˜I‚đŽó‚Ż‚˝H“cŒ§‚Ě”_‹Ć]Ž–ŽŇ‚ɑ΂ˇ‚é•ŰŒ’‘΍ô. –xŒű•ş„1, ŹŒF‰xŽq, ‘ş“cŸŒh, ˛X–Ř•q, ‹{–{‰Ŕ‘ăŽq, Źź“c“Ö, ŕV‘şšl, ŕV“cŒŤˆę, —OˆäGŽ÷, ŒFŕV—R”üŽq, ‘ĺ–ě’qŽq, ’ˇ“ˆ’qŽq, ‚ŽR—TŽq, ź“c—ĽŽq, –L“ˆ—Ú”üŽq, —é–ŘŒiŽq, źěŠx‹v, ç—t•SŽq, ‰ĄŽR˜am, ˛X–Ř‹œ, ‘ĺ–{’źŽ÷, rě@–ž, “Ą“cG•ś, Ź–ě’nÍˆę, ‚‹´r–ž, ˛X–ŘŽi˜Y, •˝ŽR@Ž, ’†‘şł–ž (1‰qś): ‘ć74‰ń“ú–{ŽY‹Ć‰qśŠw‰ď“Œ–k’n•ű‰ď (2015/7/25), H“c.


ŒöO‰qśŠw

[Šwp˜_•ś]

110053. [Œ´’˜] Epigenetic Changes Caused by Occupational Stress in Humans Revealed through Noninvasive Assessment of DNA Methylation of the Tyrosine Hydroxylase Gene. Miyaki K1, Suzuki T1, Song Y, Tsutsumi A1, Kawakami N, Shimazu A, Takahashi M, Inoue A, Kurioka S, Shimbo T: J Neurol Neurol Disord 2015/6; 2 (2): doi: 10.15744/2454-4981.2.201. (‹{–؍Kˆę1, —é–Ř’mŽq1, ’ç@–žƒ1: 1ŒöO‰qś)

110054. [Œ´’˜] Relationship between sickness presenteeism (WHO-HPQ) with depression and sickness absence due to mental disease in a cohort of Japanese workers. Suzuki T1, Miyaki K1, Song Y, Tsutsumi A1, Kawakami N, Shimazu A, Takahashi M, Inoue A, Kurioka S: J Affect Disord 2015/7; 180: 14-20. (—é–Ř’mŽq1, ‹{–؍Kˆę1, ’ç@–žƒ1: 1ŒöO‰qś)

110055. [Œ´’˜] DNA Methylation Status of the Methylenetetrahydrofolate Reductase Gene is associated with Depressive Symptoms in Japanese Workers: A Cross-Sectional Study. Miyaki K1, Song Y, Suzuki T1, Eguchi H1, Kawakami N, Takahashi M, Shimazu A, Inoue A, Kurioka S, Kan C, Tsutsumi A1: J Neurol Neurol Disord 2015/9; 2 (3): doi: 10.15744/2454-4981.2.304. (‹{–؍Kˆę1, —é–Ř’mŽq1, ]Œű@Ž1, ’ç@–žƒ1: 1ŒöO‰qś)

110056. [Œ´’˜] Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism. Umakoshi H, Tanase-Nakao K, Wada N, Ichijo T, Sone M, Inagaki N, Katabami T, Kamemura K, Matsuda Y, Fujii Y, Kai T, Fukuoka T, Sakamoto R, Ogo A, Suzuki T1, Tsuiki M, Shimatsu A, Naruse M: Clin Endocrinol (Oxf) 2015/10; 83 (4): 462-7. (—é–Ř’mŽq1: 1ŒöO‰qś)

110057. [Œ´’˜] Optimum position of left adrenal vein sampling for subtype diagnosis in primary aldosteronism. Umakoshi H1, Wada N1, Ichijo T1, Kamemura K1, Matsuda Y1, Fuji Y1, Kai T1, Fukuoka T1, Sakamoto R1, Ogo A1, Suzuki T1,2, Tsuiki M1, Naruse M1 (1WAVES-J Study Group): Clin Endocrinol (Oxf) 2015/12; 83 (6): 768-73. (—é–Ř’mŽq1,2: 2ŒöO‰qś)

110058. [Œ´’˜] Shortened saline infusion test for subtype prediction in primary aldosteronism. Nanba K, Tsuiki M, Umakoshi H, Nanba A, Hirokawa Y, Usui T, Tagami T, Shimatsu A, Suzuki T1, Tanabe A, Naruse M: Endocrine 2015/12; 50 (3): 802-6. (—é–Ř’mŽq1: 1ŒöO‰qś)

110059. [Œ´’˜] Occupational differences in suicide mortality among Japanese men of working age. Wada K, Eguchi H1, Prieto-Merino D, Smith DR: J Affect Disord. 2016/1; 190: 316-21. (]Œű@Ž1: 1ŒöO‰qś)

110060. [Œ´’˜] Null association between workplace social capital and body mass index. Results from a four-wave panel survey among employees in Japan (J-HOPE study). Tsuboya T, Tsutsumi A1, Kawachi I: Soc Sci Med 2016/2; 150: 1-7. (’ç@–žƒ1: 1ŒöO‰qś)

110061. [Œ´’˜] Work Engagement as a Predictor of Onset of Major Depressive Episode (MDE) among Workers, Independent of Psychological Distress: A 3-Year Prospective Cohort Study. Imamura K, Kawakami N, Inoue A, Shimazu A, Tsutsumi A1, Takahashi M, Totsuzaki T: PLoS One 2016/2; 11 (2): e0148157. (’ç@–žƒ1: 1ŒöO‰qś)

110062. [Œ´’˜] Modification Effects of Changes in Job Demands on Associations Between Changes in Testosterone Levels and Andropause Symptoms: 2-Year Follow-up Study in Male Middle-Aged Japanese Workers. Hirokawa K, Taniguchi T, Fujii Y, Takaki J, Tsutsumi A1: Int J Behav Med 2016/8; 23 (4): 464-72. (’ç@–žƒ1: 1ŒöO‰qś)

120003. [Œ´’˜] ˜J“­ŽŇ‚ĚŽű“ü‚Ćƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX|E‚Ě•sˆŔ’萍‚É‚ć‚é”}‰îŒř‰Ę‚É’–Ú‚ľ‚ā|. ’ç@–žƒ1, ˆäă˛b, “‡’Ă–žl, ‚‹´ł–ç, ěăŒ›l, ŒI‰ŞZŽq, ]Œű@Ž1, ‹{–؍Kˆę1, ‰““c˜a•F, Ź™—R‹N, ŒË’Íč‹M•ś (1ŒöO‰qś): Œúś‚ĚŽw•W 2015/9; 62 (11): 1-8.

120004. [Œ´’˜] –Ťt‘Ÿ•a‚đ“Á’股‚éŰ‚Ě”AŒŸ¸‚Ě‘Ă“–Ť: “ú–{l’jŤ˜J“­ŽŇ‚É‚¨‚Ż‚é”N‘ă•ĘŒŸ“˘. ě“‡ł•q, ]Œű@Ž1, ˜a“ckŽĄ, Žç‰Ž—˜‰Ŕ2, ‰““c˜a•F, ’ç@–žƒ1 (1ŒöO‰qś, 2ˆăŠw‹łˆç): Œđ’ĘˆăŠw 2015/6; 69 (3/4): 81-7.

120005. [Œ´’˜] —Ť˜J“­ŽŇ‚ĚƒXƒgƒŒƒX‘΍ô: ˆęŽŸ—\–h‚Š‚çŽOŽŸ—\–h‚Ü‚Ĺ. ’ç@–žƒ1, —é–Ř’mŽq1 (1ŒöO‰qś): ŽY‹ĆƒXƒgƒŒƒXŒ¤‹† 2015; 22 (3): 197-202.

510002. [‘ŕ] A behavioral science/behavioral medicine core curriculum proposal for Japanese undergraduate medical education. Tsutsumi A1: Biopsychosoc Med 2015/11; 9: 24. (’ç@–žƒ1: 1ŒöO‰qś)

520004. [‘ŕ] ƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚ĆƒXƒgƒŒƒXƒ`ƒFƒbƒN§“x. ’ç@–žƒ (ŒöO‰qś): —\–hˆăŠw 2015/12; 57: 15-8.

522017. [uŔ]y“ÁW: ’nˆć‚Őf‚é‚ą‚ą‚ë‚ĚƒPƒAzEę‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒXƒPƒA. ’ç@–žƒ (ŒöO‰qś): ŒŽŠ§’nˆćˆăŠw 2015/8; 29 (8): 603-7.

522018. [uŔ]y“ÁW: EęŠÂ‹Ť‰ü‘P‚Ćƒ|ƒWƒeƒBƒuEƒƒ“ƒ^ƒ‹ƒwƒ‹ƒXzEęŠÂ‹Ť‰ü‘P‚Ćƒ|ƒWƒeƒBƒuEƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‚Ě—LŒřŤ. ’ç@–žƒ (ŒöO‰qś): ŽY‹Ć•ŰŒ’21 2015/10; 21 (2): 2-5.

522019. [uŔ]y“ÁW: ƒXƒgƒŒƒXƒ`ƒFƒbƒN§“x‚̉^—pEŠˆ—p‚đl‚Ś‚éz’ńŒž2: ƒXƒgƒŒƒXƒ`ƒFƒbƒN§“x‚ĚŠˆ—p‚ɂ‚˘‚ā|§“x‚Ě–Ú“I‚đ—‰đ‚ľ, Ž–‹Ćę“ŕ‚Ĺ‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚Ć‚Ě˜A“Ž‚đ}‚é‚ą‚Ɓ|. ’ç@–žƒ (ŒöO‰qś): ’n•űŒö–ąˆőˆŔ‘S‚ĆŒ’Nforum 2015/10; 25 (4): 11-5.

522020. [uŔ]y“ÁW1: •›tŽîᇂ̐f’f‚ĆŽĄ—Ă‚ĚupdatezŒ´”­ŤƒAƒ‹ƒhƒXƒeƒƒ“Ç‚Ě•aŒ^f’f‚É‚¨‚Ż‚é•›tĂ–ŹƒTƒ“ƒvƒŠƒ“ƒO‚̉ۑč: ‘˝Ž{Ýƒf[ƒ^ƒx[ƒX‚̍\’z‚Ć—Ő°“IˆÓ‹`. ”n‰z—m‹X, ˜a“c“T’j, ˆęé‹M­, ź“c—Sˆę, ‹T‘şK•˝, •Ÿ‰Ş•x˜a, “Ąˆä—Yˆę, b”ă’B–ç, â–{—łˆę, Ź‰Í@~, —é–Ř’mŽq1, ŹŠ}Œ´’CŽ÷, “ď”g‘˝‹“, —§–Ř”ü, ŹŁŒő‰h (1ŒöO‰qś): “ú–{“ŕ•Ş”ĺEbó‘BŠO‰ČŠw‰ďŽGŽ 2015; 32 (4): 220-4.

522021. [uŔ]y“ÁW: s“ŽˆăŠw‚ĚƒRƒAƒJƒŠƒLƒ…ƒ‰ƒ€zˆăŠw•”‹łˆç‚É‚¨‚Ż‚és“ŽˆăŠwEs“Ž‰ČŠw: ƒRƒAƒJƒŠƒLƒ…ƒ‰ƒ€‚Ě’ńˆÄ. ’ç@–žƒ (ŒöO‰qś): SgˆăŠw 2016/1; 56 (1): 17-23.

522022. [uŔ]y“ÁW: ƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‚ĆƒXƒgƒŒƒXƒ`ƒFƒbƒNzEę‚É‚¨‚Ż‚郁ƒ“ƒ^ƒ‹ƒwƒ‹ƒX•s’˛‚ĚƒXƒNƒŠ[ƒjƒ“ƒO. ’ç@–žƒ (ŒöO‰qś): ‘‡Œ’f 2016/3; 43 (2): 313-9.

[’˜@‘]

620009. [Šwp‘ (•Ş’SŽˇ•M)]yŽĐ‰ď‚ĆŒ’N@Œ’NŠiˇ‰đÁ‚ÉŒü‚Ż‚˝“‡‰ČŠw“IƒAƒvƒ[ƒ`z‘ć2Í E‹Ć‚ĆŒ’N, p39-56. ’ç@–žƒ1, _—Ń”ŽŽj (1ŒöO‰qś), •Ň: ěăŒ›l, ‹´–{‰pŽ÷, ‹ß“ĄŽŒČ, “Œ‹ž‘ĺŠwo”ʼnď, “Œ‹ž, 2015/4”­s.

620010. [Šwp‘ (•Ş’SŽˇ•M)]yEę‚Ěƒ|ƒWƒeƒBƒuƒƒ“ƒ^ƒ‹ƒwƒ‹ƒXz‘ćIII•” ƒZƒ‹ƒtƒ}ƒlƒWƒƒ“ƒg‚Ö‚ĚŠˆ—p@11. ƒ|ƒWƒeƒBƒuS—Šw‚̗́|–L‚Š‚ȐS—“IŽ‘–{‚ރ[ƒNEƒGƒ“ƒQƒCƒWƒƒ“ƒg‚đ‚‚ß‚é!, p.96-104. ]Œű@Ž (ŒöO‰qś), •Ň: “‡’Ă–žl, ˝M‘–[, “Œ‹ž, 2015/6”­s.

620011. [Šwp‘ (•Ş’SŽˇ•M)]ys“ŽˆăŠwƒeƒLƒXƒgz4. s“Ž‚̎Љď‰ČŠw“I—‰đ@b. s“Ž‚ƎЉď, p.66-72. ’ç@–žƒ1 (1ŒöO‰qś), •Ň: –ě‘ş@”E, ’ç@–žƒ1, “‡’Ă–žl, ’†”ö–rG, ‹g“ŕˆę_, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2015/10”­s.

620012. [Šwp‘ (•Ş’SŽˇ•M)]y“ŕ•Ş”ĺ‘ăŽÓ—Տ°Œ¤‹†ƒ}ƒjƒ…ƒAƒ‹z‘ć2Í —Տ°Œ¤‹†‚ĚŒ¤‹†ƒfƒUƒCƒ“‚ĚŽí—ށ@B. ŠĎŽ@Œ¤‹†@3. ‰Ą’fŒ¤‹†, p.15-6. —é–Ř’mŽq (ŒöO‰qś), •Ň: V•Ű‘ě˜Y, ě‘ş@F, ŹŁŒő‰h, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/9”­s.

620013. [Šwp‘ (•Ş’SŽˇ•M)]y“ŕ•Ş”ĺ‘ăŽÓ—Տ°Œ¤‹†ƒ}ƒjƒ…ƒAƒ‹z‘ć3Í Œ¤‹†Œv‰ć‘‚̍\Ź‚ƍ쐬@5. ŠĎŽ@‚â‘Ş’č, p.53-4. V•Ű‘ě˜Y, —é–Ř’mŽq1 (1ŒöO‰qś), •Ň: V•Ű‘ě˜Y, ě‘ş@F, ŹŁŒő‰h, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/9”­s.

620014. [Šwp‘ (•Ş’SŽˇ•M)]y“ŕ•Ş”ĺ‘ăŽÓ—Տ°Œ¤‹†ƒ}ƒjƒ…ƒAƒ‹z‘ć5Í “Œv‚̉đÍ@C. “Œvƒ\ƒtƒg‚ĚŽí—Ţ‚Ć“Á’Ľ, p.127-33. —é–Ř’mŽq (ŒöO‰qś), •Ň: V•Ű‘ě˜Y, ě‘ş@F, ŹŁŒő‰h, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/9”­s.

620015. [Šwp‘ (•Ş’SŽˇ•M)]y“ŕ•Ş”ĺ‘ăŽÓ—Տ°Œ¤‹†ƒ}ƒjƒ…ƒAƒ‹z‘ć8Í Œ‹‰Ę‰đÍ‚ĚŽŔ‘H ŽŔŰ‚Ěƒ\ƒtƒg‚đŽg‚Á‚Ä, p.151-201. —é–Ř’mŽq1, V•Ű‘ě˜Y (1ŒöO‰qś), •Ň: V•Ű‘ě˜Y, ě‘ş@F, ŹŁŒő‰h, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/9”­s.

620016. [Šwp‘ (•Ş’SŽˇ•M)]yŽĐ‰ďEŠÂ‹Ť‚ĆŒ’N ŒöO‰qśŠw 2016”N“x”ŁzCHAPTER 9 ¸_•ŰŒ’‘΍ô, p.97-103. •‘ň—mˆę, ’ç@–žƒ1, ’†‘şDˆę, ”öŒ`—R‹NŽq, Šžęˆę‘Ľ, ”ö“‡r”V, –q–ěLŽq (1ŒöO‰qś), •Ň: –öě@—m, âŔ—ÖáÁŸ, ‘ź, ˆăŽ•–ňo”Ĺ, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713009. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The association between occupation and education completed, and general health conditions among Japanese males in their 50s. Eguchi H1: 31st International Congress on Occupational Health (2015/6/1), Korea. (]Œű@Ž1: 1ŒöO‰qś)

713010. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Workers' mental disorders: the burden in Japan. Tsutsumi A1: ICOH International Congress Korea 2015 (2015/6/4), Seoul, Korea. (’ç@–žƒ1: 1ŒöO‰qś)

721001. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ƒXƒgƒŒƒXƒeƒXƒg‚ƐEęf’f. ’ç@–žƒ (ŒöO‰qś): ‘ć29‰ń“ú–{ˆăŠw‰ď‘‰ď (2015/4/12), ‹ž“s.

721002. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) E‹ĆŤƒXƒgƒŒƒXƒ‚ƒfƒ‹‚Ć•]‰ż‚Ě“WŠJ. ’ç@–žƒ (ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/14), ‘ĺă.

721003. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) E‹ĆŤƒXƒgƒŒƒXƒ‚ƒfƒ‹‚đ—p‚˘‚˝Œ¤‹†‚Ć‚ť‚̉ž—p@ŽdŽ–‚Ě—v‹“x\ƒRƒ“ƒgƒ[ƒ‹ƒ‚ƒfƒ‹‚Ć“w—Í•ńV•s‹Ďtƒ‚ƒfƒ‹@”äŠrl@2. “w—́|•ńV•s‹Ďtƒ‚ƒfƒ‹. ’ç@–žƒ (ŒöO‰qś): ‘ć31‰ń“ú–{ƒXƒgƒŒƒXŠw‰ďŠwp‘‰ď (2015/11/7), ‘ĺă.

722008. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ’N‚Ĺ‚ŕ‚˘‚Ť‚˘‚Ť‚Ć“­‚Ż‚éEęŠÂ‹Ť‚̏řŹ‚Ě‚˝‚߂Ɂ|ŽY‹Ć•ŰŒ’E‚É‚Ĺ‚Ť‚é‚ą‚Ɓ|. ]Œű@Ž (ŒöO‰qś): l‚đ‘ĺŘ‚É‚ˇ‚éŒo‰cŠw‰ď@‘ć2‰ń‘S‘‘ĺ‰ď (2015/9/13), “Œ‹ž.

723086. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹i‰Œ‚Ě—L–ł•Ę‚É‚Ý‚˝Šé‹Ć‚É‚¨‚Ż‚é‘gD“IŒöł‚Əd¸_áŠQ‘Š“–‚̐¸_“I•s’˛‚Ć‚ĚŠÖ˜A ˆäă˛b, ěăŒ›l, ]Œű@Ž1, ’ç@–žƒ1 (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/14), ‘ĺă.

723087. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “­‚­˘‘ă‚Ě’jŤ‚É‚¨‚Ż‚éŒÂl“I‚ȉۑč‚ƐS—“IƒXƒgƒŒƒX‘Š“–‚Ć‚ĚŠÖ˜A. ˜a“ckŽĄ, ]Œű@Ž1, ‰Ş‹vƒWƒ…ƒ“, ”óŒű‘P”V (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/14), ‘ĺă.

723088. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒT[ƒrƒX‹Ć‚ɏ]Ž–‚ˇ‚é˜J“­ŽŇ‚Ě•sˆŔ‚â”Y‚Ý‚ĚŒXŒü’˛¸. Žu“cŽOŽl˜Y, –{“c‹ËŽq, ŽR–{‚Ý‚Ç‚č, ŸOç—eŽq, ”Ń‘ş—TŽq, V‹’qŒb, ]Œű@Ž1 (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/14), ‘ĺă.

723089. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Eę‚Ö‚ĚOSHMS‚Ě“ą“ü‚Ş‚ŕ‚˝‚炡ˆŔ‘S‰qś–Ę‚Ĺ‚ĚŒř‰Ę‚ÉŠÖ‚ˇ‚錤‹†`‘ć19•ń@ŽŠŽĄ‘̐Eę‚É‚¨‚Ż‚éOSHMS’č’…‚ĆˆŔ‘S‰qśŽw•W‚⊈“Ž‚ւ̉e‹ż•]‰ż`. “n•Ó—TW, b“c–ÎŽ÷, ˛X–Ř‹B, ’ß“c—R‹IŽq, ˆÉ“ĄşD, ŒF’JM“ń, Œ´@–M•v, ’ç@–žƒ1, ŠŰŽRłŽĄ, ŽRŒűGŽ÷ (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/14), ‘ĺă.

723090. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Eę‚Ö‚ĚOSHMS‚Ě“ą“ü‚Ş‚ŕ‚˝‚炡ˆŔ‘S‰qś–Ę‚Ĺ‚ĚŒř‰Ę‚ÉŠÖ‚ˇ‚錤‹†`‘ć20•ń@ƒŠƒXƒN•]‰ż‚ÉŠî‚Ă‚­ƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚̉e‹ż•]‰ż` ’ß“c—R‹IŽq, b“c–ÎŽ÷, ˛X–Ř‹B, “n•Ó—TW, ’ç@–žƒ1, ˆÉ“ĄşD, ŒF’JM“ń, Œ´@–M•v, ŠŰŽRłŽĄ, ŽRŒűGŽ÷ (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/14), ‘ĺă.

723091. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Eę‚Ö‚ĚOSHMS‚Ě“ą“ü‚Ş‚ŕ‚˝‚炡ˆŔ‘S‰qś–Ę‚Ĺ‚ĚŒř‰Ę‚ÉŠÖ‚ˇ‚錤‹†`‘ć21•ń@ŽQ‰ÁŒ^‚ĚˆŔ‘S‰qśŠˆ“Ž‚ĹˆŔ‘S‰qśŽw•W‚đHę‚ł‚š‚˝ŽŔ‘HŽ–—á` ŠŰŽRłŽĄ, b“c–ÎŽ÷, ˛X–Ř‹B1, “n•Ó—TW, ’ß“c—R‹IŽq, ˆÉ“ĄşD, ŒF’JM“ń, Œ´@–M•v, ’ç@–žƒ1, ŽRŒűGŽ÷ (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/14), ‘ĺă.

723092. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’†Ź‹K–ÍŽ–‹ĆŠ‚É‚¨‚Ż‚éuŽQ‰ÁŒ^Eę‰ü‘Pv‚đ’Ę‚ľ‚˝ƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚ĚŽć‚č‘g‚Ý “ŕ“c—z”V, XŒűŽŸ˜Y, ŽRŞ‰p”V, …–{łŽu, ‹g‰Şçť, ŒÜ\—’ç‘ă, Ź“cŘ—DŽq, “‡’Ă–žl, ’ç@–žƒ1, ‹ŃŒË“TŽq, Œ´’J_Žj, ‹gě‰xŽq, ‹gě@“O, ěăŒ›l (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/15), ‘ĺă.

723093. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Eˆć‚É‚¨‚Ż‚é”­’BáŠQŒXŒüƒXƒNƒŠ[ƒjƒ“ƒOƒeƒXƒgAQ-short‚Ě‘Ă“–‚ČƒJƒbƒgƒIƒt’l (J-HOPE). —é–Ř’mŽq1, ‹{–؍Kˆę1, ˆäă˛b, ěăŒ›l, “‡’Ă–žl, ‚‹´ł–ç, ŒI‰ŞZŽq, ’ç@–žƒ1 (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/15), ‘ĺă.

723094. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œđ‘㐧‹Î–ą‚Ě’nˆćŒxŽ@ŠŻ‚É‚¨‚Ż‚éE‹ĆŤƒXƒgƒŒƒX‚ĆƒRƒ‹ƒ`ƒ][ƒ‹‚ĚŠÖ˜A ˆäŕVC•˝, ’ç@–žƒ1 (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/15), ‘ĺă.

723095. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆę”Ę˜J“­ŽŇ‚É‚¨‚Ż‚éŽĐ‰ďŒoĎ“Ió‹ľ‚¨‚ć‚ѐE–ą—vˆö‚Ɣ얞‚Ć‚ĚŠÖ˜A (J-HOPE). ŒI‰ŞZŽq, ˆäă˛b, ’ç@–žƒ1, ěăŒ›l, “‡’Ă–žl, ]Œű@Ž1, ‰““c˜a•F, Ź™—R‹N (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/15), ‘ĺă.

723096. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒWƒ‡ƒuEƒNƒ‰ƒtƒeƒBƒ“ƒO‚Ćƒ[ƒNEƒGƒ“ƒQƒCƒWƒƒ“ƒg‚¨‚ć‚ѐS—“IƒXƒgƒŒƒX”˝‰ž‚Ć‚ĚŠÖ˜A. ŸN’J‚ ‚ˇ‚Š, “‡’Ă–žl, ]Œű@Ž1, _ŽR‹M–¤, Œ´—Y“ń˜Y, “ď”gŽs, ěăŒ›l (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/15), ‘ĺă.

723097. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ď•aŠłŽŇ‚̏A˜JŒp‘ąŽx‰‡‚ÉŠÖ‚ˇ‚éŒťó’˛¸: ŠłŽŇƒCƒ“ƒ^ƒrƒ…[‚đ’Ę‚ś‚Ä. ]Œű@Ž1, ”óŒű‘P”V, ˜a“ckŽĄ (1ŒöO‰qś): ‘ć88‰ń“ú–{ŽY‹Ć‰qśŠw‰ď (2015/5/16), ‘ĺă.

723098. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ‹K–͐EˆćƒRƒz[ƒg‚Ĺ‚Ěˆę”ʏW’c‚É‚¨‚Ż‚é”­’BáŠQŒXŒü‚ƐEęƒXƒgƒŒƒX‹y‚ŃƒTƒ|[ƒg‚Ě—}‚¤‚“x‚ɑ΂ˇ‚é‘ŠŒÝě—p. —é–Ř’mŽq1, ‹{–؍Kˆę1, ‹{‰Ş@“™2, ‹{’nLŒá2, ]Œű@Ž1, ’ç@–žƒ1 (1ŒöO‰qś, 2¸_): ‘ć22‰ń“ú–{ŽY‹Ć¸_•ŰŒ’Šw‰ď (2015/6/26-27), “Œ‹ž.

723099. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ‹K–͐EˆćƒRƒz[ƒg‚Ĺ‚Ěˆę”ʏW’c‚É‚¨‚Ż‚é”­’BáŠQŒXŒü‚Ě•Ş•z‚Ć—}‚¤‚Â‚Ć‚ĚŠÖ˜A. ‹{–؍Kˆę1, —é–Ř’mŽq1, ‹{‰Ş@“™2, ‹{’nLŒá2, ]Œű@Ž1, ’ç@–žƒ1 (1ŒöO‰qś, 2¸_): ‘ć22‰ń“ú–{ŽY‹Ć¸_•ŰŒ’Šw‰ď (2015/6/26-27), “Œ‹ž.

723100. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX•s’˛‚Ĺ‹x‹Ć‚ľ‚˝˜J“­ŽŇ‚Ě•œE‚đŽx‰‡‚ˇ‚éfit noteŠÖ˜Aƒc[ƒ‹‚ĚŠJ”­. ’ç@–žƒ (ŒöO‰qś): ‘ć25‰ń“ú–{ŽY‹Ć‰qśŠw‰ď@ŽY‹ĆˆăEŽY‹ĆŠĹŒě‘S‘‹Ś‹c‰ď (2015/9/18), ŽRŒű.

723101. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ď•a‚đ——R‚É“­‚Ť•ű‚ɐ§–ń‚Ě‚ ‚é“Ż—ť‚ɑ΂ˇ‚éˆę”Ę˜J“­ŽŇ‚ĚˆÓŽŻ‚ÉŠÖ˜A‚ˇ‚éS—ŽĐ‰ď“I—vˆö‚ĚŒŸ“˘. ]Œű@Ž1, ˜a“ckŽĄ, ”óŒű‘P”V (1ŒöO‰qś): ‘ć25‰ń“ú–{ŽY‹Ć‰qśŠw‰ď@ŽY‹ĆˆăEŽY‹ĆŠĹŒě‘S‘‹Ś‹c‰ď (2015/9/18), ŽRŒű.

723102. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œ´”­ŤƒAƒ‹ƒhƒXƒeƒƒ“Ç‚É‚¨‚Ż‚éCT‰ć‘œ‚É‚ć‚é•a‘¤f’f—Ś‚¨‚ć‚Ń•›tĂ–ŹƒTƒ“ƒvƒŠƒ“ƒO‚Ě“K‰ž‚ÉŠÖ‚ˇ‚錟“˘. ‹T‘şK•˝, ŹŁŒő‰h, —§–Ř”ü, ”n‰z—m‹X, ź“c—Sˆę, “Ąˆä—Yˆę, •Ÿ‰Ş‹{˜a, b”ă’B–ç, Ź‰Í@~, â–{—łˆę, ˜a“c“T’j, ˆęé‹M­, —é–Ř’mŽq1 (1ŒöO‰qś): ‘ć38‰ń“ú–{‚ŒŒˆłŠw‰ď‘‰ď (2015/10/9-11), ˆ¤•Q.

723103. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Eę•œ‹Af’f‘ (fit note) ƒVƒXƒeƒ€“ą“ü‚̉ۑč. ’ç@–žƒ (ŒöO‰qś): ‘ć74‰ń“ú–{ŒöO‰qśŠw‰ď‘‰ď (2015/11/4), ’ˇč.

723104. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “­‚Ť•ű‚ɐ§–ń‚Ě‚ ‚é“Ż—ť‚ɑ΂ˇ‚éˆę”Ę˜J“­ŽŇ‚ĚˆÓŽŻ‚ÉŠÖ‚ˇ‚錟“˘. ]Œű@Ž1, ˜a“ckŽĄ, ”óŒű‘P”V (1ŒöO‰qś): ‘ć74‰ń“ú–{ŒöO‰qśŠw‰ď (2015/11/5), ’ˇč.

731002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Eę‚É‚¨‚Ż‚郁ƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô. ’ç@–žƒ (ŒöO‰qś): •˝Ź27”N“x“ú–{ŽY‹Ć‰qśŠw‰ď“ŒŠC’n•ű‰ďŠw‰ď (2015/11/14), –źŒĂ‰Ž.

731003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹ß”N‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‘΍ô‚Ě“ŽŒü. ’ç@–žƒ (ŒöO‰qś): ‘ć1‰ń“ú–{ŽY‹Ć‰qśŠw‰ď’†‘’n•ű‰ďŒ¤‹†‰ď (2016/2/13), ‰ŞŽR.

732005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™)y‹ß–˘—ˆ‚ĚŽY‹Ć‰qś•Ş–ě‚ĚŒ¤‹†‚ĆŽŔ‘H (4)zŽY‹ĆˆăŠˆ“Ž‚đ‚ľ‚Č‚Ş‚ç‚ĚŒ¤‹†Šˆ“Ž. ]Œű@Ž (ŒöO‰qś): “ú–{ŽY‹Ć‰qśŠw‰ďŠÖ“Œ’n•ű‰ď‘ć271‰ń—á‰ď (2015/12/12), “Œ‹ž.

733022. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ‹K–͐EˆćW’c‚Ĺ‚ĚŠeŽŠ•ÂÇ‚Ě“ÁŤ‚Ě•Ş•z‚Ć‚¤‚Ǐó‚Ć‚ĚŠÖ˜A. —é–Ř’mŽq1, ‹{–؍Kˆę1, ]Œű@Ž1, ’ç@–žƒ1 (1ŒöO‰qś): “ú–{ŽY‹Ć‰qśŠw‰ďE‘ć57‰ńŽY‹Ć¸_‰qśŒ¤‹†‰ď (2016/2/20), _“ސě.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H17-522001. [uŔ]yƒgƒsƒbƒNƒX: ƒhƒCƒc‚̍ŐV–ň‹ÇŽ–î (7)zƒWƒFƒlƒŠƒbƒN–ň‚ĚŽg—pó‹ľ|ŽQĆ‰żŠi§“x, Aut-idem–@“™‚É‚ć‚éŒř‰Ę. —é–Ř’mŽq1, ˛“Ą@‹Ď (1ŒöO‰qś): ŒŽŠ§–ňŽ– 2006/3; 48 (3): 411-6.

[’˜@‘]

H17-620001. [Šwp‘ (•Ş’SŽˇ•M)]y–ň‘‚í‚Š‚čƒKƒCƒhƒuƒbƒNz‘ć2Í ŒÄ‹zŠíŒn‚Ě–ň, p.36-47. •l“cNŽŸ, —é–Ř’mŽq1, ˛’|ŽŽq, ’†‘ş—RŠě, “š‰ş‰ŔŽq (1ŒöO‰qś), ŠÄC: •l“cNŽŸ, ˆăŠwŒ|pŽĐ, “Œ‹ž, 2005/7”­s.

H17-620002. [Šwp‘ (•Ş’SŽˇ•M)]y–ň‘‚í‚Š‚čƒKƒCƒhƒuƒbƒNz‘ć6Í ŒŒ‰tE‘˘ŒŒŠí‚Ě–ň@RŒŒđ–ň (1), p.110-1. •l“cNŽŸ, —é–Ř’mŽq1, ˛’|ŽŽq, ’†‘ş—RŠě, “š‰ş‰ŔŽq (1ŒöO‰qś), ŠÄC: •l“cNŽŸ, ˆăŠwŒ|pŽĐ, “Œ‹ž, 2005/7”­s.

H17-620003. [Šwp‘ (•Ş’SŽˇ•M)]y–ň‘‚í‚Š‚čƒKƒCƒhƒuƒbƒNz‘ć7Í Š´őÇ‚Ě–ň@•—ÇŒóŒQEƒCƒ“ƒtƒ‹ƒGƒ“ƒUŽĄ—Ă–ň, p.130-1. •l“cNŽŸ, —é–Ř’mŽq1, ˛’|ŽŽq, ’†‘ş—RŠě, “š‰ş‰ŔŽq (1ŒöO‰qś), ŠÄC: •l“cNŽŸ, ˆăŠwŒ|pŽĐ, “Œ‹ž, 2005/7”­s.

H18-620001. [Šwp‘ (•Ş’SŽˇ•M)]y–ň‘‚í‚Š‚čƒKƒCƒhƒuƒbƒN ‰ü’ů”ŁE‘•â”Łz‘ć2Í ŒÄ‹zŠíŒn‚Ě–ň, p.36-47. •l“cNŽŸ, —é–Ř’mŽq1, ˛’|ŽŽq, ’†‘ş—RŠě, “š‰ş‰ŔŽq (1ŒöO‰qś), ŠÄC: •l“cNŽŸ, ˆăŠwŒ|pŽĐ, “Œ‹ž, 2007/3”­s.

H18-620002. [Šwp‘ (•Ş’SŽˇ•M)]y–ň‘‚í‚Š‚čƒKƒCƒhƒuƒbƒN ‰ü’ů”ŁE‘•â”Łz‘ć6Í ŒŒ‰tE‘˘ŒŒŠí‚Ě–ň@RŒŒđ–ň (1), p.122-3. •l“cNŽŸ, —é–Ř’mŽq1, ˛’|ŽŽq, ’†‘ş—RŠě, “š‰ş‰ŔŽq (1ŒöO‰qś), ŠÄC: •l“cNŽŸ, ˆăŠwŒ|pŽĐ, “Œ‹ž, 2007/3”­s.

H18-620003. [Šwp‘ (•Ş’SŽˇ•M)]y–ň‘‚í‚Š‚čƒKƒCƒhƒuƒbƒN ‰ü’ů”ŁE‘•â”Łz‘ć7Í Š´őÇ‚Ě–ň@•—ÇŒóŒQEƒCƒ“ƒtƒ‹ƒGƒ“ƒUŽĄ—Ă–ň, p.142-3. •l“cNŽŸ, —é–Ř’mŽq1, ˛’|ŽŽq, ’†‘ş—RŠě, “š‰ş‰ŔŽq (1ŒöO‰qś), ŠÄC: •l“cNŽŸ, ˆăŠwŒ|pŽĐ, “Œ‹ž, 2007/3”­s.


–@ˆăŠw

[Šwp˜_•ś]

210001. [€Œ´’˜] The case of 2 siblings that identified not only by DNA profiling Maeda K1, Murakami C1, Irie W1, Sasaki C1, Oishi M, Nakamaru N2, Nakamura S1, Kurihara K1: Forensic Science International: Genetics Supplement Series 2015/12; 5: e555-6. (‘O“cˆę•ă1, ‘şăçŽq1, “ü]@Â1, ˛X–ؐçŽőŽq1, ’†ŠŰŽ”ü2, ‘ĺÎ“Žq, ’†‘ş–Ίî1, ŒIŒ´Ž—R1: 1–@ˆă, 2Œ`‘ÔŒn)

220002. [€Œ´’˜] S‘ŸŤ“Ë‘RŽ€‚Ěˆâ“`Žq‰đÍIII|SCN5Aˆâ“`Žq‚Ě•ĎˆŮ‰đÍ|. ‘şăçŽq1, ‘O“cˆę•ă1, “ü]@Â1, ‘ĺÎ“Žq, ˛X–ؐçŽőŽq1, ’†ŠŰŽ”ü2, ’†‘ş–Ίî1, ŒIŒ´Ž—R1 (1–@ˆă, 2Œ`‘ÔŒn): “ú–{DNA‘˝Œ^ 2015; 23: 177-80.

320001. [Ç—á•ń] ”Ŕ‘—Žž‚ĚCTŒŸ¸‚Ĺ“ŕˆöŤŠĚ‘Ÿ”j—ô‚É‚ć‚é•aŽ€‚đ‹^‚í‚ę‚˝ŠOŤŠĚ‘š‚Ě–UŒŸ—á. ‘O“cˆę•ă1, “ü]@Â1, ‘şăçŽq1, ˛X–ؐçŽőŽq1, ‘ĺÎ“Žq, ’†ŠŰŽ”ü2, ’†‘ş–Ίî1, ŒIŒ´Ž—R1 (1–@ˆă, 2Œ`‘ÔŒn): –@ˆăŠw‚ĚŽŔŰ‚ĆŒ¤‹† 2015; 58: 133-7.

[Šw‰ďEŒ¤‹†‰ď“™]

713011. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The case of 2 siblings that identified not only by DNA profiling. Maeda K1, Murakami C1, Irie W1, Sasaki C1, Oishi M2, Nakamaru N2, Nakamura S1, Kurihara K1: 26th Congress of the International Society for Forensic Genetics (2015/8/3-9/5), Krakow, Poland. (‘O“cˆę•ă1, ‘şăçŽq1, “ü]@Â1, ˛X–ؐçŽőŽq1, ‘ĺÎ“Žq2, ’†ŠŰŽ”ü2, ’†‘ş–Ίî1, ŒIŒ´Ž—R1: 1–@ˆă, 2Œ`‘ÔŒn)

723105. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –@ˆă‰đ–U‚É‚¨‚Ż‚é’†“Ĺ“Œv’˛¸‚ÉŒü‚Ż‚˝–ň•¨ƒXƒNƒŠ[ƒjƒ“ƒOƒƒ\ƒbƒh\’z‚ĚŽć‘g‚Ý (2). ˛X–ؐçŽőŽq1, ŒIŒ´Ž—R1 (1–@ˆă): ‘ć99ŽŸ“ú–{–@ˆăŠw‰ďŠwp‘S‘W‰ď (2015/6/12), ‚’m.

723106. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) DNAŒ^ŠÓ’č‚݂̂ł͐gŒł“Á’č‚Ş•s‰Â”\‚Ĺ‚ ‚Á‚˝1Ž–—á. ‘O“cˆę•ă1, ‘şăçŽq1, “ü]@Â1, ˛X–ؐçŽőŽq1, ‘ĺÎ“Žq2, ’†ŠŰŽ”ü2, ’†‘ş–Ίî1, ŒIŒ´Ž—R1 (1–@ˆă, 2Œ`‘ÔŒn): ‘ć99ŽŸ“ú–{–@ˆăŠw‰ďŠwp‘S‘W‰ď (2015/6/10-12), ‚’m.

723107. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ś‘O‚Ě‘š/Ž€Œă‚Ě‘š‰ó? “ü]@Â1, ‘şăçŽq1, ‘O“cˆę•ă1, ˛X–ؐçŽőŽq1, ‘ĺÎ“Žq2, ’†ŠŰŽ”ü2, ’†‘ş–Ίî1, ŒIŒ´Ž—R1 (1–@ˆă, 2Œ`‘ÔŒn): ‘ć99ŽŸ“ú–{–@ˆăŠw‰ďŠwp‘S‘W‰ď (2015/6/10-12), ‚’m.

723108. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) 3-Methoxy PCP‚¨‚ć‚Ńƒż-PHP‚ŞŒŸo‚ł‚ę‚˝ˆę–UŒŸ—á. ˛X–ؐçŽőŽq1, Ä“Ą@„, ŽÂ’Ë’B—Y, “ü]@Â1, ‘şăçŽq1, ‘O“cˆę•ă1, ’†ŠŰŽ”ü2, ‘ĺÎ“Žq2, ’†‘ş–Ίî1, ŒIŒ´Ž—R1 (1–@ˆă, 2Œ`‘ÔŒn): “ú–{–@’†“ĹŠw‰ď‘ć34”N‰ď (2015/6/26-27), •Ÿ‰Ş.

733023. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) D16S539‚Étri-allelic pattern‚Ş”F‚ß‚ç‚ę‚˝eŽqŠÓ’莖—á. ‘şăçŽq1, ‘O“cˆę•ă1, “ü]@Â1, ˛X–ؐçŽőŽq1, ’†ŠŰŽ”ü2, ‘ĺÎ“Žq2, ’†‘ş–Ίî1, ŒIŒ´Ž—R1 (1–@ˆă, 2Œ`‘ÔŒn): ‘ć84‰ń“ú–{–@ˆăŠw‰ďŠwpŠÖ“Œ’n•űW‰ď (2015/10/24), “Œ‹ž.

733024. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –@ˆă‰đ–U‚É‚¨‚Ż‚é’†“Ĺ“Œv’˛¸‚ÉŒü‚Ż‚˝–ň•¨ƒXƒNƒŠ[ƒjƒ“ƒOƒƒ\ƒbƒh\’z‚ĚŽć‘g‚Ý (3). ˆŔ•”Š°Žq, ‘O‹´‹ąŽq, ‘D‰zäŽi, ˛X–ؐçŽőŽq1, “Ţ—Ç–ž“Ţ, ‰œ“cŸ”Ž, ‚‘qĘ‰Ř, “c’†’źŽq, Šâ|Œö°, ă‘şŒöˆę, ŒIŒ´Ž—R1, ´…œ¨Žq, –؉ş”Ž”V, ŠâŁ”Ž‘ž˜Y (1–@ˆă): ‘ć84‰ń“ú–{–@ˆăŠw‰ďŠwpŠÖ“Œ’n•űW‰ď (2015/10/24), “Œ‹ž.


ŽŔŒą“Ž•¨Šw

[Šwp˜_•ś]

110063. [Œ´’˜] Efficacious cryopreservation of 2-cell stage mouse embryos via unvitrified ultrarapid freezing. Azuma S1: KItasato Med J 2015/9; 45 (2): 124-9. (“Œ@’ĺG1: 1ŽŔ“Ž)

110064. [Œ´’˜] Pharyngeal arch deficiencies affect taste bud development in the circumvallate papilla with aberrant glossopharyngeal nerve formation. Okubo T1, Takada S: Dev Dyn 2015/7; 244 (7): 874-87. (‘ĺ‹v•Ű’ź1: 1ŽŔ“Ž)

520005. [‘ŕ] TDP-43‚̐ś—“I‹@”\‚ĆALS•a‘Ô‚É‚¨‚Ż‚éˆÓ‹`. ˛“ĄrĆ (ŽŔ“Ž): –k—˘ˆăŠw 2015/12; 45 (2): 79-85.

522023. [uŔ]y“ÁW1: ¸_ŽžŠł“Ž•¨ƒ‚ƒfƒ‹‚̉”\Ť‚Ɖۑčz3. “‡Ž¸’˛Çƒ‚ƒfƒ‹ƒ}ƒEƒX‚̍s“Ž‰đÍ•ű–@‚ĚŽŽ‚Ý. ů‰Şr–M, ˛“Ą’ŠŽq, ’†‘ş@“O, ‘ĺ‹v•Ű’ź1, ˛“ĄrĆ1, “ĄŕVM‹`, ‘O“c‹Xr, Ź“c‰Ŕ“ŢŽq, Žđˆä´Žq, _•ŰKO, ”něŒb—œŽq, –Ř’ĂěŽŽj, –ŕŽRr•F, ŽRX“N—Y (1ŽŔ“Ž): “ú–{ś•¨Šw“I¸_ˆăŠw‰ďŽ 2015/6; 26 (2): 87-94.

[Šw‰ďEŒ¤‹†‰ď“™]

722009. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) TGF-ƒŔƒVƒOƒiƒ‹˜´i‚É‚ć‚é”]ŒŒŠÇ‚É—^‚Ś‚é‰e‹ż. ‰Á“Ą‘׉î, ŠÖŞ—L”ü, –ěč—m–ž, œAěËŽq, “Ą“cŘ“E, ˛“ĄrĆ1, źŕVł–L, Ź–쎛— (1ŽŔ“Ž): ‘ć38‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2015/7/28), _ŒË.

723109. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) D1ƒh[ƒpƒ~ƒ“Žó—e‘Ě‚Ě”­Œť‚ĚŒ¸­‚̓}ƒEƒX‚̉^“Ž—ʂ̒ቺ‚đ—U“ą‚ˇ‚é. ů‰Şr–M, ˛“Ą’ŠŽq, ‘ĺ‹v•Ű’ź1, “ĄŕVM‹`, ˛“ĄrĆ1, Ź“c‰Ŕ“ŢŽq, ‘O“c‹Xr, “c’†@–Ť, ŽR–{”ü‹u, Žđˆä´Žq, _•ŰKO, ç—t‚ł‚¨‚č, ”něŒb—œŽq, ‰ĄŽR•ő‰î (1ŽŔ“Ž): ‘ć62‰ń“ú–{ŽŔŒą“Ž•¨Šw‰ď‘‰ď (2015/5/28), ‹ž“s.

723110. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰Šúăó‚Ě‘ĚŠO”|—{‚ރ}ƒEƒX‚ĚŽYŽe”‚¨‚ć‚ŃŒÂ‘Ě‚Ě‘ŸŠíd—Ę‚É‹y‚Ú‚ˇ‰e‹ż. Ź“c‰Ŕ“ŢŽq, ˛“ĄrĆ1, ‘O“c‹Xr, Žđˆä´Žq, _•ŰKO, “ĄŕVM‹`, ‰ĄŽR•ő‰î, ů‰Şr–M (1ŽŔ“Ž): ‘ć62‰ń“ú–{ŽŔŒą“Ž•¨Šw‰ď‘‰ď (2015/5/28), ‹ž“s.

723111. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) DRPLAƒ‚ƒfƒ‹ƒ}ƒEƒX‚ɑ΂ˇ‚éƒAƒ“ƒ`ƒZƒ“ƒXƒIƒŠƒSƒkƒNƒŒƒIƒ`ƒh‚É‚ć‚鎥—Ă‚ĚŽŽ‚Ý “Ą“cŘ“E, ‰Á“Ą‘׉î, ˛“ĄrĆ1, ’ҁ@ČŽŸ, źŕVł–L, Ź–쎛— (1ŽŔ“Ž): ‘ć38‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2015/7/29), _ŒË.

723112. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) D1ƒh[ƒpƒ~ƒ“Žó—e‘Ě‚đ‰î‚ˇ‚éƒVƒOƒiƒ‹‚É‚ć‚é‰^“Ž—Ę‚ĚˆŰŽ ů‰Şr–M, ˛“Ą’ŠŽq, ’mŒŠ‘”ü, ‘O“‡@ƒ, Vˆä@Œd, ťŽR’qŽq, Ź“c‰Ŕ“ŢŽq, ‘O“c‹Xr, Žđˆä´Žq, _•ŰKO, ”něŒb—œŽq, ˛“ĄrĆ1, ‘ĺ‹v•Ű’ź1, “ĄŕVM‹`, ‰ĄŽR•ő‰î, “ě•”@“Ä (1ŽŔ“Ž): ‘ć38‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2015/7/30), _ŒË.

723113. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Lineage analysis of Ripply3 expressing cells during the mouse development. ‘ĺ‹v•Ű’ź1, Takada S (1ŽŔ“Ž): BMB2015 (‘ć38‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ďE‘ć 88‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď ‡“Ż‘ĺ‰ď) (2015/12/2), _ŒË.

723114. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) D1 dopamine receptor-mediated signal is required to maintain normal motor activity. ů‰Şr–M, ˛“Ą’ŠŽq, ’mŒŠ‘”ü, ‘ĺ‹v•Ű’ź1, ‘O“‡@ƒ, Vˆä@Œd, ťŽR’qŽq, Ź“c‰Ŕ“ŢŽq, Žđˆä´Žq, ‘O“c‹Xr, _•ŰKO, ”něŒb—œŽq, ˛“ĄrĆ1, “ĄŕVM‹`, ‰ĄŽR•ő‰î, “ě•”@“Ä (1ŽŔ“Ž): BMB2015 (‘ć38‰ń“ú–{•ŞŽqś•¨Šw‰ď”N‰ďE‘ć 88‰ń“ú–{ś‰ťŠw‰ď‘ĺ‰ď ‡“Ż‘ĺ‰ď) (2015/12/3), _ŒË.

733025. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) D1ƒh[ƒpƒ~ƒ“Žó—e‘Ě‚Ě”­Œť‚ĚŒ¸­‚̓}ƒEƒX‚̉^“Ž—ʂ̒ቺ‚đ—U“ą‚ˇ‚é. ů‰Şr–M, ˛“Ą’ŠŽq, ‘ĺ‹v•Ű’ź1, “ĄŕVM‹`, ˛“ĄrĆ1, Ź“c‰Ŕ“ŢŽq, ‘O“c‹Xr, “c’†@–Ť, ŽR–{”ü‹u, Žđˆä´Žq, _•ŰKO, ç—t‚ł‚¨‚č, ”něŒb—œŽq, ‰ĄŽR•ő‰î (1ŽŔ“Ž): •˝Ź27”N“x“ú–{ś‰ťŠw‰ďŠÖ“ŒŽx•”—á‰ďE‘ć56‰ńVŠƒś‰ťŠw§˜b‰ď (2015/6/20)CVŠƒ.

733026. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒh[ƒpƒ~ƒ“D1Žó—e‘Ě‚đ‰î‚ˇ‚é_Œo“`’B‚Í‘ĺ”]Šî’ęŠj‚Ě’źÚ˜H‚̏î•ń“`’B‚Ɖ^“Ž‚Ě”­Œť‚É•s‰ÂŒ‡‚Ĺ‚ ‚é. ů‰Şr–M, ˛“Ą’ŠŽq, ’mŒŠ‘”ü, ‘ĺ‹v•Ű’ź1, ‘O“‡@ƒ, Vˆä@Œd, ťŽR’qŽq, Ź“c‰Ŕ“ŢŽq, Žđˆä´Žq, ‘O“c‹Xr, _•ŰKO, ”něŒb—œŽq, ˛“ĄrĆ1, “ĄŕVM‹`, ‰ĄŽR•ő‰î, “ě•”@“Ä (1ŽŔ“Ž): ‘ć32‰ń“Ž•¨śBHŠwŒ¤‹†‰ď (2015/12/5)Cěč.


–ƉuŠw

[Šwp˜_•ś]

110065. [Œ´’˜] Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses. Kubo M, Nagashima R, Ohta E, Maekawa T, Isobe Y, Kurihara M, Eshima K1, Iwabuchi K1, Sasaoka T, Azuma S2, Melrose HL, Farrer MJ, Obata F: J Neuroimmunol 2016/3; 292: 1-8. (]“‡k“ń1, ŠâŸş˜a–ç1, “Œ@’ĺG2: 1–Ɖu, 2ŽŔ“Ž)

110066. [Œ´’˜] Differential dependence on nuclear factor-ƒČB-inducing kinase among natural killer T-cell subsets in their development. Noma H1, Eshima K2, Satoh M2, Iwabuchi K2: Immunology 2015/9; 146 (1): 89-99. (–ěŠÔt1, ]“‡k“ń2, ˛“Ą@‰ë2, ŠâŸş˜a–ç2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–Ɖu)

110067. [Œ´’˜] Release from Th1-type immune tolerance in spleen and enhanced production of IL-5 in Peyer's patch by cholera toxin B induce the glomerular deposition of IgA. Yamanaka T, Tamauchi H, Suzuki Y, Suzuki H, Horikoshi S, Terashima M, Iwabuchi K1, Habu S, Okumura K, Tomino Y: Immunobiology 2016/4; 221 (4): 577-85. (ŠâŸş˜a–ç1: 1–Ɖu)

110068. [Œ´’˜] Adipocyte-specific CD1d-deficiency mitigates diet-induced obesity and insulin resistance in mice. Satoh M1, Hoshino M, Fujita K, Iizuka M, Fujii S, Clingan CS, Van Kaer L, Iwabuchi K1: Sci Rep 2016/6; 6: 28473. (˛“Ą@‰ë1, ŠâŸş˜a–ç1: 1–Ɖu)

110069. [Œ´’˜] Inhibitory function of NKT cells during early induction phase of nickel allergy. Okuno H1, Satoh M2, Takeuchi E2, Eshima K2, Terashima M, Komotori J, Habu S, Tamauchi H, Iwabuchi K2: Immunobiology 2016/7; 221 (7): 833-8. (‰œ–ěL‹ł1, ˛“Ą@‰ë2, ’|“ŕŒb”üŽq2, ]“‡k“ń2, ŠâŸş˜a–ç2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–Ɖu)

522024. [uŔ]y“ÁWI : “ÁŽę‚ČƒŠƒ“ƒp‹…ŒQ‚ĚĹ‹ß‚Ě˜bzNKT×–E‚Ě•Ş‰ť‚Ć‹@”\|Ĺ‹ß‚Ě˜b‘č‚Š‚ç. ŠâŸş˜a–ç (–Ɖu): ‰ŠÇ‚ƖƉu 2015/9; 23 (5): 394-400.

522025. [uŔ]y“ÁW: NKT×–E•W“I—Ă–@‚̐V“WŠJz‘ăŽÓŤŽžŠł‚ĆNKT×–E. ˛“Ą@‰ë1, ŠâŸş˜a–ç1 (1–Ɖu): ˆăŠw‚Ě‚ ‚ä‚Ý 2015/9; 254 (13): 1169-74.

[’˜@‘]

620017. [Šwp‘ (•Ş’SŽˇ•M)]y–Ɖu—Í“O’ęŒ¤‹†zNK×–E|ŽŠ‘R–Ɖu‚ĚƒGƒtƒFƒNƒ^[ˆČă‚Ě‘śÝ, p.38-9. ŠâŸş˜a–ç (–Ɖu), •Ň: —щŽŽŽO˜Y, NPO–@l ć’[ˆă—Ă‚đ‚ł‚ł‚Ś‚é‰ď, “Œ‹ž, 2015/11”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713012. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) NKT cell- adipocyte interaction modulate adipose tissue function Satoh M1, Iwabuchi K1: CD1-MR1 2015 (2015/11/16), Mantra Lorne, Australia. (˛“Ą@‰ë1, ŠâŸş˜a–ç1: 1–Ɖu)

723115. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) On the in vivo effects of enforced expression of eomesodermin, a T-box family molecule, in naïve T cells on their differentiation and function. ]“‡k“ń1, –ěŠÔt, ŠâŸş˜a–ç1 (1–Ɖu): ‘ć44‰ń“ú–{–ƉuŠw‰ďŠwpW‰ď (2015/11/18), ŽD–y.

723116. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Differential dependence on NF-ƒČB-inducing kinase among NKT cell subsets in their development. ]“‡k“ń1, –ěŠÔt, ˛“Ą@‰ë1, ŠâŸş˜a–ç1 (1–Ɖu): ‘ć44‰ń“ú–{–ƉuŠw‰ďŠwpW‰ď (2015/11/20), ŽD–y.


ˆă—ĂŒo‰cŠw


’nˆćŽ™“ś¸_‰Čˆă—ĂŠw

[Šw‰ďEŒ¤‹†‰ď“™]

723117. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –œˆř‚Ť‚đŒJ‚č•Ô‚ľ‚˝’jŽ™‚ɂ‚˘‚Ä‚Ě—Ő°“IlŽ@|ŒÂl—Ă–@‚ƉƑ°ƒAƒvƒ[ƒ`‚Ć‚˘‚¤Ž‹“_|. Ź—ŃŽŔ‰Ô1, _’Jr‰î1, ś’n@V2, ˆäăŸ•v3 (1’nˆćŽ™“ś¸_, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3¸_): “ú–{ŽvtŠúÂ”NŠú¸_ˆăŠw‰ď‘ć28‰ń‘ĺ‰ď (2015/7/11), ‰Ą•l.

723118. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’áƒiƒgƒŠƒEƒ€ŒŒÇ‚É”ş‚¤ö—ó‘Ô‚đ‹^‚í‚ę‚˝1Ç—á|ƒŠƒGƒ]ƒ“ƒ`[ƒ€‚ĚˆÓ‹`|. _’Jr‰î1, ”’ˆä‹łŽq, ŽO‰Yƒ]2, Ź—ŃŽŔ‰Ô1, ˆäăŸ•v2, ‹{‰Ş@“™2 (1’nˆćŽ™“ś¸_, 2¸_): ‘ć28‰ń“ú–{‘‡•a‰@¸_ˆăŠw‰ď‘‰ď (2015/11/28), “ż“‡.

732006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ¸_‰ČƒŠƒGƒ]ƒ“ƒ`[ƒ€‚Ě—L—pŤ‚ɂ‚˘‚ā`ŠeŽ{Ý‚ĚŽć‚č‘g‚Ý‚ĆĄŒă‚̉ۑč. _’Jr‰î (’nˆćŽ™“ś¸_): ‘ć42‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2016/3/5), ‰Ą•l.


Äśˆă—ĂŒ`ŹŠO‰ČŠw


ŒŒ—Ź‰đÍŠw

[Šwp˜_•ś]

110070. [Œ´’˜] Dissipative energy loss within the left ventricle detected by vector flow mapping in children: Normal values and effects of age and heart rate. Hayashi T1, Itatani K2, Inuzuka R1, Shimizu N1, Shindo T1, Hirata Y1, Miyaji K3: J Cardiol 2015/11; 66 (5): 403-10. (”Â’JŒcˆę2, ‹{’n@ŠÓ3: 1“Œ‹ž‘ĺŠwŹŽ™‰Č, 2ŒŒ—Ź‰đÍ, 3S‘ŸŒŒŠÇŠO)

[Šw‰ďEŒ¤‹†‰ď“™]

713013. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Energy Dynamics of the Intraventricular Vortex after the Mitral Valve Surgery. Itatani K1, Nakashima K2, Kitamura T2, Oka N2, Horai T2, Miyazaki S1, Miyaji K2: AATS Mitral Conclave 2015 (2015/4/23-24), New York, USA. (”Â’JŒcˆę1, ’†“‡Œő‹M2, –k‘ş@—Ľ2, ‰Ş@“ż•F2, •ó—ˆ“N–ç2, ‹{čăĕ˝1, ‹{’n@ŠÓ2: 1ŒŒ—Ź‰đÍ, 2S‘ŸŒŒŠÇŠO)

713014. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Vector Flow Mapping and Fluid Dynamics. Itatani K1: ASE2015 26th Annual scientific sessions (2015/6/12-16), Boston, USA. (”Â’JŒcˆę1: 1ŒŒ—Ź‰đÍ)

713015. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Accuracy of small sized vessel flow measurements in 3D cine PC MRI with respiratory navigator gating. Miyazaki S1, Itatani K1, Hata H2, Inoue Y3: 10th World Congress for Microcirculation (2015/9/26), Kyoto, Japan. (‹{čăĕ˝1, ”Â’JŒcˆę1, `@”Ž•ś2, ˆäă—D‰î3: 1ŒŒ—Ź‰đÍ, 2•úŽËü•”, 3•úŽËü (‰ć‘œ))

723119. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰^“Ž•‰‰×SƒGƒR[‚É‚ć‚éŠg’Ł‘Šú‚̍śŽş“ŕˆłŠrˇ‚Ě”­ś‹@˜‚ĚŒŸ“˘. źˆä‚ą‚ĆŽq1, ‚‹´@Œ’1, Ź—ѐ^‹I1, ŽR“c^—œŽq1, ‹H‘ă‰ë•F1, ”Â’JŒcˆę2, ‹{’n@ŠÓ3, ´…r–ž1 (1‡“V“°‘ĺŠw, 2ŒŒ—Ź‰đÍ, 3S‘ŸŒŒŠÇŠO): ‘ć118‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2015/4/17-19), ‘ĺă, “ú–{ŹŽ™‰ČŠw‰ďŽGŽ 2015/4; 119 (2): 221.

723120. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŹŽ™‚Š‚琏l‚ĚŠg’Ł‘Šú‚̍śŽş“ŕˆłŠrˇ‚Ě”­ś‹@˜. Ź—ѐ^‹I1, ‚‹´@Œ’1, źˆä‚ą‚ĆŽq1, ŽR“c^—œŽq1, ‹H‘ă‰ë•F1, ”Â’JŒcˆę2, ‹{’n@ŠÓ3, ´…r–ž1 (1‡“V“°‘ĺŠw, 2ŒŒ—Ź‰đÍ, 3S‘ŸŒŒŠÇŠO): ‘ć118‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2015/4/17-19), ‘ĺă, “ú–{ŹŽ™‰ČŠw‰ďŽGŽ 2015/4; 119 (2): 280.

723121. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒÄ‹z‚É”ş‚¤FontanŽčpŒă‚Ěˆł—́E—Ź‘Ź•Ď“Ž‚đÄŒť‚ˇ‚é‚˝‚߂̐”’l—Ź‘̉đÍ—p‹ŤŠEđŒ‚ĚŒŸ“˘. Œă“Ą^ŽĄ1, ’†‘ş‹§“ż1, ”Â’JŒcˆę2, ‹{čăĕ˝2, ‰Ş@“ż•F3, –{“c@’4, –k‘ş@—Ľ3, •ó—ˆ“N–ç3, Îˆäł_4, ‹{’n@ŠÓ3 (1é‹Ę‘ĺŠw, 2ŒŒ—Ź‰đÍ, 3S‘ŸŒŒŠÇŠO, 4ŹŽ™): ‘ć38‰ń“ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ď”N‰ď (2015/6/6-7), “Œ‹ž, “ú–{ƒoƒCƒIƒŒƒIƒƒW[Šw‰ďŽ (B&R) 2015/6; 29 (2): 90.

723122. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šg’Ł‘Šú‚ÉŒŒ‰t—Ź“ü‚đ‹ě“Ž‚¨‚ć‚ŃŒ¸Žă‚ł‚š‚é“ńŽí—Ţ‚ĚśŽş“ŕˆłŠrˇ‚Ě”N—î‚É‚ć‚é•Ď‰ť. ‚‹´@Œ’1, Ź—ѐ^‹I1, ŽR“c^—œŽq1, ‘ĺ–썁“Ţ1, “c’†@“o1, ‹H‘ă‰ë•F1, ”Â’JŒcˆę2, ‹{’n@ŠÓ3, ´…r–ž1 (1‡“V“°‘ĺŠw, 2ŒŒ—Ź‰đÍ, 3S‘ŸŒŒŠÇŠO): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16-18), “Œ‹ž, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ 2015/7; 31 (Suppl 1): S1.219.

723123. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒtƒ@ƒ[Žl’ĽÇpŒăŠłŽŇ‚É‚¨‚Ż‚鍶Žş“ŕˆłŠrˇ‚ĚŒŸ“˘. Ź—ѐ^‹I1, ‚‹´@Œ’1, ŽR“c^—œŽq1, źˆä‚ą‚ĆŽq1, HŒł‚Š‚‚Ý1, ‹H‘ă‰ë•F1, ěčŽu•Ű—˘1, ”Â’JŒcˆę2, ‹{’n@ŠÓ3, ´…r–ž1 (1‡“V“°‘ĺŠw, 2ŒŒ—Ź‰đÍ, 3S‘ŸŒŒŠÇŠO): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16-18), “Œ‹ž, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ 2015/7; 31 (Suppl 1): S1.228.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-522001. [uŔ]y“ÁW: ŹŽ™‚Ě‰ć‘œf’f‚̐i•ŕzSƒGƒR[}‚ĹŒŒ—Ź‚đf‚é: Vector Flow Mapping‚ĚƒƒJƒjƒYƒ€. ‹{čăĕ˝1, ”Â’JŒcˆę1, ‹{’n@ŠÓ2 (1ŒŒ—Ź‰đÍ, 2S‘ŸŒŒŠÇŠO): zŠÂŠí“ŕ‰Č 2015/3; 77 (3): 192-9.


’nˆć‘‡ˆă—ĂŠw

[Šwp˜_•ś]

521002. [‰đŕ]y“ÁW: ‚ą‚ę‚ž‚Ż‚ ‚ę‚Αĺä•v! Common disease‚ĚƒGƒbƒZƒ“ƒVƒƒƒ‹ƒhƒ‰ƒbƒOzƒXƒeƒƒCƒhŠO—p–ň. Îěƒ–ç1, –Ř‘ş‘ô–1,2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă): Gƒm[ƒg 2016/2; 3 (1): 42-79.

[Šw‰ďEŒ¤‹†‰ď“™]

723124. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[)yŒťę‚Ĺ‚Ě‚Ó‚Ć‚ľ‚˝‹đ–â‚â‰Ű‘čz‚ť‚ą‚ŞŒ¤‹†‚̏o”­“_|Ý‘îˆă—Ă‚Ě—Ő°Œ¤‹†‚ÉŽć‚č‘g‚ŢŰ‚Ěá•Ç‚Ć‚ľ‚āuƒŠƒT[ƒ`ƒNƒGƒbƒVƒ‡ƒ“‚É—Ž‚Ć‚ľž‚Ý‚É‚­‚˘vuŒ¤‹†ƒfƒUƒCƒ“‚̍\’z‚É“ďa‚ˇ‚évuƒTƒ“ƒvƒ‹”‚ŞŠm•Ű‚ľ“v‚ą‚Ć‚Şl‚Ś‚ç‚ę‚é|. VX‰Á“ŢŽq (’nˆć‘‡ˆă—Ă): ‘ć17‰ń“ú–{Ý‘îˆăŠw‰ď‚ŕ‚肨‚Š‘ĺ‰ď (2015/4/25), ˇ‰Ş.

723125. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ý‘ŽŇ‚Ö‹zˆř‚đs‚¤ƒJƒe[ƒeƒ‹‚𕥐”‰ńŽg—p‚Š‚ç’P‰ńŽg—p‚Ö•ĎX‚ˇ‚é‚ƁuƒJƒe[ƒeƒ‹‚ސ´Œ‰‚Š”Ű‚Š‚Ě•sˆŔŠ´v‚ÍŒ¸‚é‚ŞuƒJƒe[ƒeƒ‹‚đ”pŠü‚ˇ‚镉’SŠ´v‚ސś‚ś‚¤‚é. VX‰Á“ŢŽq1, Ą‰iŒő•F, —ѐ^—Žq, ‹ß“ĄGˆę, ŠOŽR“N–ç, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă): ‘ć17‰ń“ú–{Ý‘îˆăŠw‰ď‚ŕ‚肨‚Š‘ĺ‰ď (2015/4/25), ˇ‰Ş.

732007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŒťę‚Ĺ‚Ě‚Ó‚Ć‚ľ‚˝‹^–â‚â‰Ű‘č@‚ť‚ą‚ŞŒ¤‹†‚̏o”­“_zÝ‘îˆă—Ă‚Ě—Ő°Œ¤‹†‚ÉŽć‚č‘g‚ŢŰ‚Ě‰Ű‘č. VX‰Á“ŢŽq1, –Ř‘ş‘ô–2 (1’nˆć‘‡ˆă—Ă, 2‘‡f—Ă): Ý‘îˆă—Ă‚É‚¨‚Ż‚錤‹†‚̐U‹ť‚ÉŒü‚Ż‚Ä‚Ěƒ[ƒNƒVƒ‡ƒbƒv (2015/11/1), “Œ‹ž.

H26”N“xˆČ‘O•Ş

[’˜@‘]

H26-620002. [Šwp‘] (•Ş’SŽˇ•M)y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz‘ć2Í ”畆‰Č“I–â‘č@1. Ô‚˘]‚Ş‚Ĺ‚Ť‚˝/2. Ô‚˘áy‚Ý‚Ě‚ ‚é”­]‚Ş‘Sg‚É‚Ĺ‚Ť‚˝/3. Šç‚ɍ•‚˘ƒfƒLƒ‚ƒm‚Ş‚Ĺ‚Ť‚˝/4. ‰A•”‚Ş‚Š‚䂢‚ń‚Ĺ‚ˇ/5. …’Ž‚Ş‚Ĺ‚Ť‚˝/6. …áv‚Ş‚Ĺ‚Ť‚˝/7. ŠŞ‚Ť’Ü‚Ş’É‚˘, p.58-73. Îěƒ–ç1 (1’nˆć‘‡ˆă—Ă), •Ň: –Ř‘ş‘ô–1,2, ź‘ş^Ži3 (2‘‡f—Ă, 3ź‘şˆă‰@‰@’ˇ), —r“yŽĐ, “Œ‹ž, 2015/3”­s.

H26-620003. [Šwp‘] (•Ş’SŽˇ•M)y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz‘ć4ÍŽŒ`ŠO‰Č“I–â‘č@1. ƒxƒbƒh˜e‚Ĺ“Ž‚Ż‚Č‚­‚Č‚Á‚˝/2. ƒJƒbƒ^[ƒiƒCƒt‚ĹŽw‚đ‚Ť‚Á‚˝/3. ‹x‚Ý‹x‚Ý‚É‚ľ‚Š•ŕ‚Ż‚Č‚˘/4. ‹}‚ɍ˜‚Ş’É‚­‚Č‚Á‚˝D‚Ź‚Á‚­‚č˜?/5. Œ¨‚Ş’É‚­‚Ä‹“‚Ş‚ç‚Č‚˘/6. Žč‚É‚Ş‚ń‚Ş‚Ĺ‚Ť‚˝?/7. ‘Ť‚đ‚Đ‚Ë‚Á‚˝/8. œ‘e頏ǂސS”z/9. ˜‚Ě’É‚Ý‚Ş‘ą‚­/10. Žč‚đœÜ‚ľ‚˝‚Š‚ŕ‚ľ‚ę‚Č‚˘‚Ě‚Ĺƒ\ƒtƒgƒV[ƒl‚đŠŞ‚­/11. ˜‚Ş’É‚˘‚Ě‚Ĺ’ŽË‚đ‚ľ‚Ä‚Ů‚ľ‚˘, p.84-107. VX‰Á“ŢŽq1 (1’nˆć‘‡ˆă—Ă), •Ň: –Ř‘ş‘ô–1,2, ź‘ş^Ži3 (2‘‡f—Ă, 3ź‘şˆă‰@‰@’ˇ), —r“yŽĐ, “Œ‹ž, 2015/3”­s.


Á‰ťŠí“ŕ‰ČŠw

[Šwp˜_•ś]

110071. [Œ´’˜] Impact of revisions of the JSCCR guidelines on the treatment of T1 colorectal carcinomas in Japan. Urabe Y, Tanaka S, Saito Y, Igarashi M1,2, Watanabe T, Sugihara K: Z Gastroenterol 2015/4; 53 (4): 291-301. (ŒÜ\—’łL1,2: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ)

110072. [Œ´’˜] Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer. Naruke A1, Azuma M1, Takeuchi A1, Ishido K1, Katada C1, Sasaki T1, Higuchi K1, Tanabe S2, Saegusa M3, Koizumi W1: Gastric Cancer 2015/4; 18 (2): 262-70. (Ź–с@“N1, “Œ@’q1, ’|“ŕ“ÖŽq1, ÎŒËŒŞŽŸ1, Œ˜“ce—˜1, ˛X–Ř“O1, ”óŒűŸ•F1, “c糁@‘2, ŽOŽ}@M3, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3•a—)

110073. [Œ´’˜] A multi-institutional survey on the practice of endoscopic ultrasound (EUS) guided pseudocyst drainage in the Asian EUS group. Teoh AYB, Ho LKY, Dhir VK, Jin ZD, Kida M1, Seo DW, Wang HP, Yang AM, Binmoeller KF, Varadarajulu S: Endosc Int Open 2015/4; 3 (2): E130-3. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

110074. [Œ´’˜] Local recurrence after endoscopic resection for large colorectal neoplasia: a multicenter prospective study in Japan. Oka S1, Tanaka S1, Saito Y1, Iishi H1, Kudo SE1, Ikematsu H1, Igarashi M1,2,3, Saitoh Y1, Inoue Y1, Kobayashi K1,3,4, Hisabe T1, Tsuruta O1, Sano Y1, Yamano H1, Shimizu S1, Yahagi N1, Watanabe T1, Nakamura H1, Fujii T1, Ishikawa H1, Sugihara K1 (1Colorectal Endoscopic Resection Standardization Implementation Working Group of the Japanese Society for Cancer of the Colon and Rectum): Am J Gastroenterol 2015/5; 110 (5): 697-707. (ŒÜ\—’łL1,2,3, Ź—ѐ´“T1,3,4: 2‚Ş‚ńŒ¤—L–ž•a‰@, 3Á‰ťŠí“ŕ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110075. [Œ´’˜] Predictive factors for complications in endoscopic resection of large colorectal lesions: a multicenter prospective study. Wada Y, Kudo SE, Tanaka S, Saito Y, Iishii H, Ikematsu H, Igarashi M1,2, Saitoh Y, Inoue Y, Kobayashi K2,3, Hisabe T, Tsuruta O, Kashida H, Ishikawa H, Sugihara K: Surg Endosc 2015 /5; 29 (5): 1216-22. (ŒÜ\—’łL1,2, Ź—ѐ´“T2,3: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110076. [Œ´’˜] Phase I trial of combination chemotherapy with gemcitabine, cisplatin, and S-1 in patients with advanced biliary tract cancer. Watanabe A1, Kida M2, Miyazawa S2, Iwai T3, Okuwaki K2, Kaneko T2, Yamauchi H2, Takezawa M2, Imaizumi H2, Koizumi W2: World J Gastroenterol 2015/5; 21(19): 5979-84. (“n糍WŽŻ1, –Ř“cŒőL2, ‹{ŕVŽu˜N2, Šâˆä’m‹v3, ‰œ˜e‹ť‰î2, ‹ŕŽq@‹œ2, ŽR“ŕ_Žj2, ’|ŕVŽO‘ăŽq2, Ąň@O2, Źň˜aŽO˜Y2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Á‰ťŠí“ŕ, 3‹~–˝)

110077. [Œ´’˜] Adalimumab for the treatment of Japanese patients with intestinal Behet's disease. Tanida S, Inoue N, Kobayashi K1,2, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Nagahori M, Motoya S, Nakamura S, Arora V, Robinson AM, Thakkar RB, Hibi T3: Clin Gastroenterol Hepatol 2015/5; 13 (5): 940-8.e3. (Ź—ѐ´“T1,2, “ú”ä‹I•ś3: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110078. [Œ´’˜] No contribution of the ABCB11 p.444A polymorphism in Japanese patients with drug-induced cholestasis. Kagawa T, Hirose S, Arase Y, Oka A, Anzai K, Tsuruya K, Shiraishi K, Orii R, Ieda S, Nakazawa T1, Tomita K, Hokari R, Miura S, Ebinuma H, Saito H, Kitamura T, Horie Y, Okuse C, Wasada M, Inoko H, Tohkin M, Saito Y, Maekawa K, Takikawa H, Mine T: Drug Metab Dispos 2015/5; 43 (5): 691-7. (’†ŕV‹MG1: 1Á‰ťŠí“ŕ)

110079. [Œ´’˜] Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Yamamoto Y1, Fujisaki J1, Omae M1, Hirasawa T1, Igarashi M1,2: Dig Endosc 2015/7; 27 (5): 551-61. (ŒÜ\—’łL1,2: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ)

110080. [Œ´’˜] Adhesion of platelets through thromboxane A2 receptor signaling facilitates liver repair during acute chemical-induced hepatotoxicity. Minamino T1, Ito Y2, Ohkubo H3, Shimuzu Y4, Kojo K4, Nishizwa N4, Amano H5, Narumiya S, Koizumi W1, Majima M5: Life Sci 2015/7; 132: 85-92. (“ě–ě@•×1, ˆÉ“Ą‹`–ç2, ‘ĺ‹v•Ű”Ž˘3, ´…—T‹M4, ŒĂé@Œ›4, źŕVL‹ą4, “V–ě‰pŽ÷5, Źň˜aŽO˜Y1, ”n“ˆł—˛5: 1Á‰ťŠí“ŕ, 2ŠO‰Č, 3S‘ŸŒŒŠÇŠO, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 5–ň—)

110081. [Œ´’˜] Elemental diet moderates 5-fluorouracil-induced gastrointestinal mucositis through mucus barrier alteration. Kawashima R1,2, Kawakami F1,2, Maekawa T1,2, Yamamoto H3, Koizumi W3, Ichikawa T1,2: Cancer Chemother Pharmacol 2015/8; 76 (2): 269-77. (ě“‡@—í1,2, ěă•ś‹M1,2, ‘Oě’B‘Ľ1,2, ŽR–{@‘n3, Źň˜aŽO˜Y3, Žsě‘¸•ś1,2: 1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3Á‰ťŠí“ŕ)

110082. [Œ´’˜] A Patient with Pancreatic Castleman's Disease Arising around the Main Pancreatic Duct. Matsumoto T1, Okuwaki K1, Kida M1, Jiang SX2, Imaizumi H1, Yamauchi H1, Miyazawa S1, Iwai T3, Takezawa M1, Tajima H4, Koizumi W1: Intern Med 2015/8; 54 (16): 2007-12. (ź–{‚–ž1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, Ó@˘ˆŽ2, Ąň@O1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v3, ’|ŕVŽO‘ăŽq1, “c“‡@O4, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2•a—, 3‹~–˝, 4ŠO‰Č)

110083. [Œ´’˜] Early evaluation of response to sorafenib for hepatocellular carcinoma by duplex Doppler ultrasonography. Hidaka H1, Nakazawa T1, Fujii S, Yanagihara M, Minamino T1, Takada J1, Tanaka Y1, Okuwaki Y1, Shibuya A2, Koizumi W1: Hepatol Res 2015/9; 45 (9): 976-85. (“ú‚@‰›1, ’†ŕV‹MG1, “ě–ě@•×1, ‚“cŽ÷ˆę1, “c’†ŒŤ–ž1, ‰œ˜e—T‰î1, a’J–ž—˛2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2ˆă—ĂŠÇ—)

110084. [Œ´’˜] Structured endoscopic ultrasonography (EUS) training program improved knowledge and skills of trainees: Results from the Asian EUS Group. Wang MH, Dy F, Vu VK, Lim LG, Tayyab GU, Ratanachu-ek T, Samarasekera DN, Dhir V, Jin ZD, Kida M1, Seo DW, Wang HP, Teoh A, Hawes R, Varadarajulu S, Yasuda K, Ho KY: Dig Endosc 2015/9; 27 (6): 687-91. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

110085. [Œ´’˜] Phase I study of TAS-102 and irinotecan combination therapy in Japanese patients with advanced colorectal cancer. Doi T, Yoshino T, Fuse N, Boku N, Yamazaki K, Koizumi W1, Shimada K, Takinishi Y, Ohtsu A: Invest New Drugs 2015/10; 33 (5): 1068-77. (Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

110086. [Œ´’˜] Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma. Takada J1, Hidaka H1, Nakazawa T1, Kondo M, Numata K, Tanaka K, Matsunaga K, Okuse C, Kobayashi S, Morimoto M, Ohkawa S, Koizumi W1: BMC Res Notes 2015/10; 8: 609. (‚“cŽ÷ˆę1, “ú‚@‰›1, ’†ŕV‹M‰p1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

110087. [Œ´’˜] Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer. Sunakawa Y, Cao S, Berger MD, Matsusaka S, Yang D, Zhang W, Ning Y, Parekh A, Stremitzer S, Mendez A, Okazaki S, Wakatsuki T, Azuma M1, Shimada K, Watanabe M2, Koizumi W1, Wu AH, Lenz HJ: Pharmacogenomics J 2015/10/27. doi: 10.1038/tpj.2015.77. (“Œ@’q1, “n粏š•F2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2ŠO‰Č)

110088. [Œ´’˜] Precordial skin burns after endoscopic submucosal dissection for gastric tube cancer. Miyagi M1, Yoshio T1, Hirasawa T1, Ishiyama A1, Yamamoto Y1, Tsuchida T1, Fujisaki J1, Igarashi M1,2: Dig Endosc 2015/11; 27 (7): 742-6. (ŒÜ\—’łL1,2: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ)

110089. [Œ´’˜] Th17 cells reflect colon submucosal pathologic changes in active eosinophilic granulomatosis with polyangiitis. Tsurikisawa N1, Oshikata C1, Tsuburai T1, Sugano S1, Nakamura Y1, Shimoda T1,2, Tamama S1,2, Adachi K1,2, Horita A1, Saito I1, Saito H1: BMC Immunol 2015/12; 16: 75. (‰ş“c‘ń–ç1,2, ‹ĘáÁr•˝1,2, ˆŔ’B@ŒŁ1,2: 1‘—§‘Š–ÍŒ´•a‰@, 2Á‰ťŠí“ŕ)

110090. [Œ´’˜] Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Horiuchi Y1, Fujisaki J1, Yamamoto N1, Shimizu T1, Miyamoto Y1, Tomida H1, Taniguchi C1, Morishige K1, Omae M1, Ishiyama A1, Yoshio T1, Hirasawa T1, Yamamoto Y1, Tsuchida T1, Igarashi M1,2, Nakajima T1, Takahashi H3: Gastric Cancer 2016/1; 19 (1): 160-5. (ŒÜ\—’łL1,2: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ, 3ş˜a‘ĺŠw“Ą‚Ş‹u•a‰@)

110091. [Œ´’˜] Chemoradiotherapy for patients with recurrent lymph-node metastasis or local recurrence of gastric cancer after curative gastrectomy. Ishido K1, Higuchi K1, Tanabe S1,2, Azuma M1, Sasaki T1, Katada C1, Komori S3, Hayakawa K3, Hosoda K4, Yamashita K4, Katada N4, Koizumi W1: Jpn J Radiol 2016/1; 34 (1): 35-42. (ÎŒËŒŞŽŸ1, ”óŒűŸ•F1, “c糁@‘1,2, “Œ@’q1, ˛X–Ř“O1, Œ˜“ce—˜1, ŹXłŽq3, ‘ě˜ad3, ×“c@Œj4, ŽR‰şŒpŽj4, •Đ“c‰Ä–ç4, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3•úŽËü (Žîá‡), 4ŠO‰Č)

110092. [Œ´’˜] Roles of Capsule Endoscopy and Single-Balloon Enteroscopy in Diagnosing Unexplained Gastrointestinal Bleeding. Ooka S1, Kobayashi K1,2, Kawagishi K1, Kodo M1, Yokoyama K1, Sada M1, Tanabe S1,3, Koizumi W1: Clin Endosc 2016/1; 49 (1): 56-60. (‘剪ł•˝1, Ź—ѐ´“T1,2, ěŠÝ‰Á“Ţ1, “n@—D1, ‰ĄŽR@ŒO1, ‹v•Ű“c”ü˜a1, “c糁@‘1,3, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3V˘‹Iˆă—ÁEć’[ˆă—Ă)

110093. [Œ´’˜] The frequency of early colorectal cancer derived from sessile serrated adenoma/polyps among 1858 serrated polyps from a single institution. Chino A1, Yamamoto N1, Kato Y1, Morishige K1, Ishikawa H1, Kishihara T1, Fujisaki J1, Ishikawa Y1, Tamegai Y1, Igarashi M1,2: Int J Colorectal Dis 2016/2; 31 (2): 343-9. (ŒÜ\—’łL1,2: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ)

110094. [Œ´’˜] Systematic review comparing endoscopic, percutaneous and surgical pancreatic pseudocyst drainage. Teoh AY, Dhir V, Jin ZD, Kida M1, Seo DW, Ho KY: World J Gastrointest Endosc 2016/3; 8 (6); 310-8. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

110095. [Œ´’˜] Radiation therapy for localized duodenal low-grade follicular lymphoma. Harada A, Oguchi M, Terui Y, Takeuchi K, Igarashi M1,2, Kozuka T, Harada K, Uno T, Hatake K: J Radiat Res 2016/3. pii: rrw011. [Epub ahead of print] (ŒÜ\—’łL1,2: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ)

120006. [Œ´’˜] _“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[‚É‚¨‚Ż‚é80ÎˆČă‚̍‚—îŽŇ‚ɑ΂ˇ‚é“ŕŽ‹‹ž“I”S–Œ‰ş‘w”—Łp (ESD) Ž{só‹ľ‚ĆˆŔ‘SŤ‚ĚŒŸŘ. ˆäŒű–őO1, Ź—с@–Š1, ŽR“c”Žş1, H“ĄŘ1, ˆäăr‘ž˜Y1, ź‘ş@ŒŤ1,2, ’†ŽR¸“T1,2, –{‹´@C1,2 (1_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): _“ސěˆăŠw‰ďŽGŽ2015/7; 42 (2): 202-5.

120007. [Œ´’˜] “–‰@‚É‚¨‚Ż‚éƒAƒjƒTƒLƒXÇ‚ĚŒť‹ľ‚Ćl-ƒƒ“ƒg[ƒ‹•â•‰ş‚Ě’Ž‘Ě“Eo. ’Ĺ–źł–ž1, š •Ş–ΔŽ1,2 (1V•S‡ƒ–‹u‘‡•a‰@, 2Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2015/12; 87 (1): 49-52.

120008. [Œ´’˜] VIŒ^Pit pattern‚ĆNBIŠg‘ĺŠĎŽ@‚É‚ć‚é‘ĺ’°T1a-bŠŕ‚̊ӕʐf’f‚ĚŒťó‚Ɛf’f•sˆę’v—á‚ĚŒŸ“˘|ESDÇ—á‚𒆐S‚Ɂ|. ‘ĺ‹÷Š°–Ř1, ˆ×‰äˆä–F˜Y1, •Đ‰ŞŻ‘ž1, ‹g…Ëˆę1, XdŒ’“ń˜Y1, ‹ŕ@–ž“N1,2, ÎěŠ°‚1, ŠÝŒ´‹Pm1, ç–쏻Žq1, ŽR–{’q—Žq1, ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2015/12; 87 (1): 58-62.

120009. [Œ´’˜] ƒ{ƒmƒvƒ‰ƒUƒ“ƒtƒ}ƒ‹Ž_‰–•š—p‚ĚHelicobacter pyloriœ‹Ű‚Ě“–‰@‚̐ŹŃ|]—ˆƒŒƒWƒƒ“‚Š‚çV‹KƒŒƒWƒƒ“‚Ö‚Ěœ‹Ű—Ś„ˆÚ|. ŽOŽ}—zˆę1,2, ”üŒ´Ă1,2, ˛“Ą@•ś1,2, ‰Á“Ą@Ę1,2, ‹gŕV“Ţ’ĂŽq1,2, ’|‰ş’me1, ŽR›˝^‹G1, ×’J@’q1, ‰HœAŒ’m1, ‹g“c@‹I1, Ąč‹Mś1, ŽO‹´—˜‰ˇ1, źŒłŽ›ŽâX1,2, ‘ĺˆä“cłl1,2 (1ŽĐ•Ű‘Š–Í–ě•a‰@, 2Á‰ťŠí“ŕ): Helicobacter Research 2016/2; 20 (1): 85-8.

210002. [€Œ´’˜ (Letters, Techniques and Images)] Future potential of EUS in the upper gastrointestinal tract: Diagnostic potential of endoscopic ultrasonography-elastography for gastric submucosal tumors. Azuma M1, Kusano C, Gotoda T: Digestive Endoscopy 2015/4; 27 (Suppl.1): 23. (“Œ@’q1: 1Á‰ťŠí“ŕ)

220003. [€Œ´’˜]y“ÁW: ‘Šú‘ĺ’°Šŕ“ŕŽ‹‹žŽĄ—ĂŒă‚Ě’†E’ˇŠúŒo‰ßzŽĺ‘čŒ¤‹†: “ŕŽ‹‹ž“EœŒă‘ĺ’°T1 (SM) Šŕ‚Ě“]ˆÚEÄ”­‚ÉŠÖ‚ˇ‚é‘˝Ž{Ý‹¤“ŻŒ¤‹†|‘ĺ’°ŠŕŒ¤‹†‰ďƒvƒƒWƒFƒNƒgŒ¤‹†‚ĚŒ‹‰Ę‚Š‚ç|. Ä“Ą—T•ă, ‰Ş@Žu˜Y, “c’†MŽĄ, Ö“Ą@–L, ’rźO˜N, ŒÜ\—’łL1,2, ˜a“cËé, H“Ąi‰p, Ź—ѐ´“T2,3, ˆäă—YŽu, ‰Y‰Şr•v, ”ѐ΍_N, ŽR–ě‘וä, ’ß“c@C, ‰i“cM“ń, ‘ Œ´Wˆę, ŽRŒű—Tˆę˜Y, ˛–ě@”J, Š~“c”ŽŽj, –xź‚”Ž, Ö“Ą˛ˆę, ă–ěGŽ÷, Î•‚ß‚Ž‚Ý, ÎěGŽ÷, –Ą‰Ş—mˆę, ‘ĺ‘qN’j, “ĄˇF”Ž, “n糑–ž, ™Œ´Œ’ˆę (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ˆÝ‚Ć’° 2015/4; 50 (4): 448-56.

220004. [€Œ´’˜] lŠÔƒhƒbƒN‚̐S‘Ÿ’´‰š”gŒŸ¸‚Ě‘I‘đ‚É‚¨‚Ż‚éV‚˝‚ČŽć‚č‘g‚Ý. ź‰ş‹G1, “n•Ó‚ ‚ˇ‚Í1, ‘“ăçť1, ŒN’ˈč‘ă1, â–{˜a‘ă1, ŹňŽüŽq1,2, ‘şă‰ë”ü1,3, “Œ–ě‹IŽq1,4, ’|ŕVŽO‘ăŽq1,2, ‰Ş“c@ƒ1,5, Ź—ѐ´“T1,2,6 (1Œ’N‰ČŠwƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ, 3zŠÂŠí“ŕ, 4äPŒ´•aEŠ´ő“ŕ, 5–k—˘‘ĺŠw•ŰŒ’‰qśę–ĺŠw‰@, 6V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘‡Œ’f 2015/9; 42 (5): 492-9.

310001. [Ç—á•ń] Peliosis hepatis disseminated rapidly throughout the liver in a patient with prostate cancer: a case report. Hidaka H1, Ohbu M2, Nakazawa T1, Matsumoto T1, Shibuya A3, Koizumi W1: J Med Case Rep 2015/9; 9: 194. (“ú‚@‰›1, ‘ĺ•”@˝2, ’†ŕV‹MG1, ź–{‚–ž1, a’J–ž—˛3, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2ˆă—ÉqśŠw•”, 3ˆă—ĂŠÇ—)

310002. [Ç—á•ń] A Patient with Pancreatic Castleman's Disease Arising around the Main Pancreatic Duct. Matsumoto T1, Okuwaki K1, Kida M1, Jiang SX2, Imaizumi H1, Yamauchi H1, Miyazawa S1, Iwai T1,3, Takezawa M1, Tajima H4, Koizumi W1: Intern Med 2015/8; 54 (16): 2007-12. (ź–{‚–ž1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, Ó@˘ˆŽ2, Ąň@O1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1,3, ’|ŕVŽO‘ăŽq1, “c“‡@O4, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2•a—, 3‹~–˝, 4ŠO‰Č)

310003. [Ç—á•ń] Electrohydraulic lithotripsy under peroral direct cholangioscopy using short-type single-balloon enteroscope for large common bile duct stone in patients with Roux-en-Y gastrectomy. Yamauchi H1, Kida M1, Miyazawa S1, Okuwaki K1, Imaizumi H1, Koizumi W1: Endoscopy 2015; 47 (S 01): E240-1. (ŽR“ŕ_Žj1, –Ř“cŒőL1, ‹{ŕVŽu˜N1, ‰œ˜e‹ť‰î1, Ąň@O1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

310004. [Ç—á•ń] Endoscopic ultrasound-guided choledochojejunostomy with a forward-viewing echoendoscope for severe benign bilioenteric stricture in a patient with Child's resection. Kida M1, Yamauchi H1, Okuwaki K1, Miyazawa S1, Imaizumi H1, Iwai T1,2, Koizumi W1: Endoscopy 2015; 47 (Suppl 1 UCTN): E303-4. (–Ř“cŒőL1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Ąň@O1, Šâˆä’m‹v1,2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2‹~–˝)

310005. [Ç—á•ń] Simultaneous side-by-side self-expanding metal stent placement using a two-channel endoscope for a bilioenteric stricture after Child's resection. Okuwaki K1, Yamauchi H1, Kida M1, Imaizumi H1, Miyazawa S1, Iwai T1,2, Koizumi W1: Endoscopy 2016; 48 (S 01): E51-2. (‰œ˜e‹ť‰î1, ŽR“ŕ_Žj1, –Ř“cŒőL1, Ąň@O1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1,2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2‹~–˝)

310006. [Ç—á•ń] Cancer emerging from the recurrence of sessile serrated adenoma/polyp resected endoscopically 5 years ago. Chino A1, Nagayama S1, Ishikawa H1, Morishige K1, Kishihara T1, Arai M1, Sugiura Y1, Motoi N1, Yamamoto N1, Tamegai Y1, Igarashi M1,2: Jpn J Clin Oncol 2016 /1; 46 (1): 89-95. (ŒÜ\—’łL1,2: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ)

320002. [Ç—á•ń] š‹‰ş“ŕŽ‹‹žŒŸ¸‚É‚ć‚éš‹‰ş•]‰ż‚ĚŽŽ‚Ý. ŽOŽ}—zˆę1,2, ”üŒ´Ă1,2, ‰Á“Ą@Ę1,2, ‹gŕV“Ţ’ĂŽq1,2, źŒłŽ›ŽâX1,2, ‘ĺˆä“cłl1,2 (1ŽĐ•Ű‘Š–Í–ě•a‰@, 2Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2015/6; 86 (1): 130-1.

320003. [Ç—á•ń] ‘˝”­SóŒ‹’°ŒeŽş‚É‚ć‚鋡ó•”ˆĘ‚ÉPTP‚Ş›Ć“ü‚ľ‚˝1—á. ”g‘˝–ě‰l‘ž1, ’†–Ú“N•˝1,2, ăŒ´ˆę”ż1, –î–ě‹MŽj1,2, Œ}@”üK1,2, Î•N_1,2, ‘ş“c@“Œ1,2, r–ؐł—Y1,2, •ŰŠ Šx—Y1, ‰Í–ě@Œĺ1 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2015/6; 86 (1): 176-7.

320004. [Ç—á•ń] •Ą”‚Ě‘ĺ’°ˆŤŤ‹ˇó‚ɑ΂ľ“ŻŽž‚É‘ĺ’°ƒXƒeƒ“ƒg‚đ‘}“ü‚ľ‚˝2—á. ěŠÝ‰Á“Ţ1, ‹ß“Ą—Y‹I1, ‰ĄŽR@ŒO1, ˛“c”ü˜a1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Progress of Digestive Endoscopy 2015/6; 86 (1): 180-1.

320005. [Ç—á•ń] ’ź’°”S–Œ’EÇŒóŒQ‚ɑ΂ľ‚Ä“ŕŽ‹‹ž“I“Eœ‚Ş—LŒř‚Ĺ‚ ‚Á‚˝1—á. ˆäă@‘ĺ1, ŠÝŒ´‹Pm1, ‘şź—Y•ă1, ‰Ş–{P•˝1, ‹ŕ@–ž“N1,2, ÎěŠ°‚1, ç–쏻Žq1, ˆ×‰äˆä–F˜Y1, ŽR–{’q—Žq1, ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2015/6; 86 (1): 184-5.

320006. [Ç—á•ń] SMZ‚đŠĎŽ@‚ľ“ž‚˝’ź’°SMŠŕ‚Ě1—á. ‹{éŠ˛Žj1, ˆ×‰äˆä–F˜Y1, ‹ŕ@–ž“N1,2, ç–쏻Žq1, ŠÝŒ´‹Pm1, ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2015/6; 86 (1): 202-3.

320007. [Ç—á•ń] ÎŠD‰ť‚Ş’˜–ž‚Čsolid pseudopapillary neoplasm‚Ě1—á. ‘ĺ‚Žjš1, –Ř“cŒőL1, ‰œ˜e‹ť‰î1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, “c“‡@O2, ‘ĺ•”@˝3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2ŠO‰Č, 3ˆă—ÉqśŠw•”): Progress of Digestive Endoscopy 2015/6; 86 (1): 224-5.

320008. [Ç—á•ń] ‰đ—ŁŤ‘ĺ“Ž–ŹáŽ”j—ô‚É‚ć‚éH“šú”j‚̐f’f‚Éă•”Á‰ťŠÇ“ŕŽ‹‹ž‚Ş—L—p‚Ĺ‚ ‚Á‚˝1—á. ŠâčGˆę˜Y1, –î–ě‹MŽj1,2, ăŒ´ˆę”ż1, ’†–Ú“N•˝1,2, Œ}@”üK1,2, Î•N_1,2, ‘ş“c@“Œ1,2, r–ؐł—Y1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2015/12; 87 (1): 90-1.

320009. [Ç—á•ń] Barrett'sH“š‚ɐś‚ś‚˝ˆŮŽžŤ‘˝”­Barrett'sH“š‘BŠŕ‚ÉESD‚đŽ{s‚ľ‚˝1—á. ‘ĺ‘O‰ëŽŔ1, “Ąč‡Žq1, –x“ŕ—T‰î1, —R—Y•q”V1, ÎŽRW˘Žu1, •˝ŕVr–ž1, ŽR–{—Šł1, “y“c’mG1, ŒÜ\—’łL1,2, ŽR–{’q—Žq1 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2015/12; 87 (1): 98-9.

320010. [Ç—á•ń] Á‰ťŠÇoŒŒ‚𔺂¤Ź’°GIST‚É‚ć‚č‹Ů‹}Žčp‚đ—v‚ľ‚˝1—á. ˛–ě@“§1, –î–ě‹MŽj2, ˜a“cŽ‹v1,2, ăŒ´ˆę”ż1, ’†–Ú“N•˝1,2, ‹gŕV“Ţ’ĂŽq1,2, Œ}@”üK1,2, Î•N_1,2, ‘ş“c@“Œ1,2, r–ؐł—Y1,2, ˛X–ŘˆęŒ›1, ‰Í–ě@Œĺ1, •—ŠÔ‹Ĺ’j1 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2015/12; 87 (1): 166-7.

320011. [Ç—á•ń] ‘Šú‘ĺ’°’á•Ş‰ť‘BŠŕ4—á‚ĚŒŸ“˘. ÎěŠ°‚1, ç–쏻Žq1, •Đ‰ŞŻ‘ž1, ‹g…Ëˆę1, ‘ĺ‹÷Š°–Ř1, XdŒ’“ń˜Y1, ŠÝŒ´‹Pm1, ˆ×‰äˆä–F˜Y1, ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): Progress of Digestive Endoscopy 2015/12; 87 (1): 180-1.

510003. [‘ŕ] Innovations and techniques for balloon-enteroscope-assisted endoscopic retrograde cholangiopancreatography in patients with altered gastrointestinal anatomy. Yamauchi H1, Kida M1, Imaizumi H1, Okuwaki K1, Miyazawa S1, Iwai T1,2, Koizumi W1: World J Gastroenterol 2015/6; 21 (21): 6460-9. (ŽR“ŕ_Žj1, –Ř“cŒőL1, Ąň@O1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1,2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2‹~–˝)

510004. [‘ŕ] Diagnosis of Obscure Gastrointestinal Bleeding. Tanabe S1,2: Clin Endosc 2016/2; doi: 10.5946/ce.2016.004. (“c糁@‘1,2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ)

520006. [‘ŕ] ’´‰š”gŒŸ¸‚É‚¨‚Ż‚é‰ćˆę‰ť‚ľ‚˝‰ć‘œěo‚đ“Ľ‚Ü‚Ś‚˝ˆăŽtE‹ZŽtŠÔ‚Ě‰ć‘œî•ń‹¤—L‰ťƒVƒXƒeƒ€‚̍\’z. •Ÿ‰i—˜ŒbŽq1, ŽRŒűGŽ÷1, ŽRč@„1, ě”¨@‹v1, ‹ŕ‘ňG‹I1, ˆŔ’B@ŒŁ1,2, ‹ŕ“cŒĺ˜Y1 (1‘—§‘Š–ÍŒ´•a‰@, 2Á‰ťŠí“ŕ): ˆă—Ă‚ĚLę 2015/5; 55 (5): 4-6.

520007. [‘ŕ] ‘ŠúˆÝŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—Ă‚ĚŒť‹ľ‚ƏŤ—ˆ“W–]. “c糁@‘1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ): –k—˘ˆăŠw 2015/6; 45 (1): 1-9.

520008. [‘ŕ] ‘ĺ’°‹˜Ž•óŽ••Ď‚É—R—ˆ‚ľ‚˝‘ĺ’°Šŕ‚Ěˆâ“`Žq•ĎˆŮƒvƒƒtƒ@ƒCƒ‹‚ÉŠÖ‚ˇ‚錟“˘. ç–쏻Žq1, ’ˇŽR@‘1, ŽR–{’q—Žq1, ‰Í“ŕ@—m1, ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): ‘ĺ˜aŘŒ”ƒwƒ‹ƒXŕ’cŒ¤‹†‹ĆŃW 2016/3; 39: 77-81.

521003. [‰đŕ]y‰đŕ: ‚ć‚­‚í‚Š‚é‘ĺ’°ESD/EMRƒKƒCƒhƒ‰ƒCƒ“z ESD/EMR‚ĚŽüpŠúŠÇ—. ŒÜ\—’łL1,2, ç–쏻Žq1, ŠÝŒ´‹Pm1, ˆ×‰äˆä–F˜Y1 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): Intestine 2015/9; 19 (5): 467-74.

522026. [uŔ]y“ÁW: ‰ŠÇŤ’°ŽžŠłf—Ă‚ĚĹ‘Oüz—Տ°Çó‚Š‚牊ÇŤ’°ŽžŠł‚𑁂­f’f‚ˇ‚éƒRƒc. Ź—ѐ´“T1,2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): “ú–{ˆăŽt‰ďŽGŽ 2015/4; 144 (1): 35-9.

522027. [uŔ]y“ÁW: isˆÝŠŕ‚ĚŽĄ—Ð헪zŽĄ–üŘœ•s”\‚ȐisEÄ”­ˆÝŠŕ‚̍ŐVŽĄ—Ð헪|V‚˝‚ČŽĄ—ĂƒIƒvƒVƒ‡ƒ“‚Ě“oę|. Źň˜aŽO˜Y (Á‰ťŠí“ŕ): Approach to Oncology 2015/4; 12: 7-9.

522028. [uŔ]y“ÁW: ’_äXEUS-FNA‚ĚƒGƒrƒfƒ“ƒX2015|‚ą‚Ě5”NŠÔ‚̐i•ŕ|zŒŒŠÇ“஡—Ă. Šâˆä’m‹v1, –Ř“cŒőL1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, ‹e’nG•F1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ’_‚ĆäX 2015/4; 36 (4): 375-8.

522029. [uŔ]y“ÁW: Á‰ťŠí“ŕŽ‹‹žf—Ă‚É‚¨‚Ż‚é“KŘ‚Č’ÁĂ–@|VƒKƒCƒhƒ‰ƒCƒ“‚̐ł‚ľ‚˘—‰đE‰^—p‚Ě‚˝‚߂Ɂ|z 4. “ŕŽ‹‹žf—Ă‚É‚¨‚Ż‚é’ÁĂ‚ĚˆÓ‹`‚Ć‚í‚Ş‘‚ĚŒť‹ľ. “c糁@‘1,2, ˛X–Ř“O2, Œ˜“ce—˜2, “Œ@’q2, ÎŒËŒŞŽŸ2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ): —ŐଏÁ‰ťŠí“ŕ‰Č 2015/4; 30 (5): 539-42.

522030. [uŔ]y“ÁW: ‰ş•”Á‰ťŠÇ: ‰ŠÇ‚Š‚ç‚Ě”­Šŕz2-2. ‰ŠÇ”­Šŕ‚̐f’f@(2) ŠëŒŻˆöŽq. Ź—ѐ´“T1,2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): Intestine 2015/7; 19 (4): 356-60.

522031. [uŔ]y“ÁW: ‘ĺ’°LST (‘¤•ű”­ˆçŒ^Žîá‡) ‚̐V“WŠJz1-4. ”­ś•”ˆĘ•Ę‚ÉŒŠ‚˝LST‚Ě“Á’Ľ. ç–쏻Žq1, XdŒ’“ń˜Y1, ÎěŠ°‚1, ŠÝŒ´‹Pm1, ˆ×‰äˆä–F˜N1, ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): —ŐଏÁ‰ťŠí“ŕ‰Č 2015/7; 30 (9): 1155-62.

522032. [uŔ]y“ÁW: ’×ᇐŤ‘ĺ’°‰Š‚ĚĹ“KŽĄ—Ă‚Ć—Ő°“I–â‘č‚Ö‚Ě‘Îôz5-ASAťÜ‚đ‚Ç‚¤Žg‚¤‚Š|‚ť‚ĚŽĄ—Ð헪|. Ź—ѐ´“T1,2, ěŠÝ‰Á“Ţ2, ‘剪ł•˝2, ‰ĄŽR@ŒO2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): Á‰ťŠí‚Ě—Ő° 2015/8; 18 (4): 345-50.

522033. [uŔ]y“ÁW: “ŕ‰Čƒvƒ‰ƒCƒ}ƒŠƒPƒA‚Ě‚˝‚ß‚ĚÁ‰ťŠíf—ĂUpdatezĄŠĚŽžŠł@”ń‘㏾ŤŠĚd•Ď. ‰œ˜e—T‰î1, a’J–ž—˛1,2 (1Á‰ťŠí“ŕ, 2ˆă—ĂŠÇ—): Medicina 2015/9; 52 (10): 1767-9.

522034. [uŔ]y“ÁW: ŒŒ•Ö‚đ‚Ý‚˝‚çz‘˜_@‰ş•”Á‰ťŠÇoŒŒ‚ɑ΂ˇ‚éf’fƒAƒ‹ƒSƒŠƒYƒ€. Ź—ѐ´“T1,2, ‘剪ł•˝2, ěŠÝ‰Á“Ţ2, ‰ĄŽR@ŒO2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): Á‰ťŠí“ŕŽ‹‹ž 2015/10; 27 (10): 1608-15.

522035. [uŔ]y“ÁWI: ’m‚Á‚Ä‚¨‚Ť‚˝‚˘@Á‰ťŠÇŠŕ –ň•¨—Ă–@‚ĚŠî–{z“úíf—Ă‚ĹŠŕ‚Ć‘˜‹ö‚ľ‚˝Žž, Á‰ťŠí“ŕ‰Čˆă‚Í‚Ç‚¤‘Ήž‚ˇ‚é‚Š. ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): Á‰ťŠí‚Ě—Ő° 2015/10; 18 (5): 435-40.

522036. [uŔ]y“ÁW: LECS (laparoscopy and endoscopy cooperative surgery) ‚̐V‚˝‚Č“WŠJz4-2. ˆÝˆČŠO‚ւ̉ž—p@(2) ‘ĺ’°‚É‚¨‚Ż‚éLECS. ˆ×‰äˆä–F˜Y1, ŠÝŒ´‹Pm1, •Ÿ’ˇ—m‰î1, ç–쏻Žq1, “Ą–{‰Ŕ–ç1, H‹g‚Žu1, Źź@‹B1, ă–ě‰ëŽ‘1, ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): —ŐଏÁ‰ťŠí“ŕ‰Č 2015/10; 30 (12): 1551-9.

522037. [uŔ]y“ÁW: ƒ}ƒ‹ƒ`ƒƒfƒBƒAŽž‘ă‚Ě“ŕŽ‹‹žf—ÁzŠe˜_ [‰ć‘œƒtƒ@ƒCƒŠƒ“ƒOƒVƒXƒeƒ€‚Ě“Á’Ľ] ƒIƒŠƒ“ƒpƒX: Solemio ENDO. ŠÝŒ´‹Pm1, ç–쏻Žq1, ŒÜ\—’łL1,2, XdŒ’“ń˜Y1, ÎěŠ°‚1, ˆ×‰äˆä–F˜Y1 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ): Á‰ťŠí“ŕŽ‹‹ž 2015/11; 27 (11): 1761-7.

522038. [uŔ]y“ÁW: ‰şˆô“ށEčň•”H“š•\ÝŠŕ‚Ě“ŕŽ‹‹žf’f‚ĆŽĄ—ÁzŒűoEˆôA“Ş‚Ě“ŕŽ‹‹žŠĎŽ@. ˜a“c‘ń–ç1, Œ˜“ce—˜1, “c糁@‘1,2, –î–ě‹MŽj1, ÎŒËŒŞŽŸ1, “Œ@’q1, ˛X–Ř“O1, ‰Á”[Fˆę3, ‰Ş–{—ˇl3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3Ž¨•@ˆôAE“ŞčňŠO): Á‰ťŠí“ŕŽ‹‹ž 2016/1; 28 (1): 27-35.

522039. [uŔ]y“ÁW: ”x‚Ş‚ńEˆÝ‚Ş‚ńE‘ĺ’°‚Ş‚ń|‚ť‚Ěƒtƒ@[ƒXƒgƒ‰ƒCƒ“‚đI‚Ś‚˝‚ç?z2. ƒZƒJƒ“ƒhƒ‰ƒCƒ“ˆČ~‚̉ťŠw—Ă–@ŽĄ—Ð헪‚Í?@2) ˆÝ‚Ş‚ń@…@HER2‰AŤˆÝ‚Ş‚ń. –î–ě‹MŽj1, ÎŒËŒŞŽŸ1, ˛X–Ř“O1 (1Á‰ťŠí“ŕ): —Տ°Žîᇃvƒ‰ƒNƒeƒBƒX 2016/2; 12 (1): 41-7.

522040. [uŔ]y“ÁW: –ĺ–Źˆł˜´iÇ‚̐§Œä|•a‘ÔŒ¤‹†‚ĆŽĄ—Â̐i“WzŠT”O, ‹@˜, f’f@‰˘•Ä‚É‚¨‚Ż‚é–ĺ–Źˆł˜´iÇŒ¤‹†|Baveno VI‚Š‚ç|.“ú‚@‰› (Á‰ťŠí“ŕ): ŠĚ’_äX 2016/2; 72 (2): 219-23.

522041. [uŔ]y“ÁW: –ĺ–Źˆł˜´iÇ‚̐§Œä|•a‘ÔŒ¤‹†‚ĆŽĄ—Â̐i“WzˆÝEH“šĂ–ŹáŽ‚Ěƒ}ƒl[ƒWƒƒ“ƒg@H“šĂ–ŹáŽ”j—ô‚ɑ΂ˇ‚éƒXƒeƒ“ƒgŽ~ŒŒ‚͉”\‚Š. •˝ŽR—Yˆę1, š •Ş–ΔŽ1,2, ÎˆäŹ–ž1, V‘q—˜Œ[1, ’Ĺ–źł–ž1, ě‘ş—Y„1, –qŽR—TŒ°1, ’†“c‚‰›1, ŒŃ“c@‘ń1, LÎ˜ał1, ˆä‰ô“š•v1 (1V•S‡ƒ–‹u‘‡•a‰@, 2Á‰ťŠí“ŕ): ŠĚ’_äX 2016/2; 72 (2): 255-9.

522042. [uŔ]y“ÁW: –ĺ–Źˆł˜´iÇ‚̐§Œä|•a‘ÔŒ¤‹†‚ĆŽĄ—Â̐i“WzŔ’k‰ďgŠĚ“ŕ’_ŠÇŠŕ: ŽĄ—ÐŹŃ‚̉ü‘P‚đ–ÚŽw‚ľ‚āh. Žs“c—˛•ś, š •Ş–ΔŽ1,2, ’J‡M•F, ’†‘şŒ’ŽĄ (1V•S‡ƒ–‹u‘‡•a‰@, 2Á‰ťŠí“ŕ): ŠĚ’_äX 2016/2; 72 (2): 349-61.

522043. [uŔ]y“ÁW: Á‰ťŠÇŒeŽş‚ĚĹ‹ß‚Ě˜b‘čz4. \“ńŽw’°ŒeŽş‚ĆŠÖ˜AŽžŠł. Ąň@O1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): —ŐଏÁ‰ťŠí“ŕ‰Č 2016/3; 31(4): 399-404.

530003. [‚ť‚Ě‘ź (ƒKƒCƒhƒ‰ƒCƒ“)] Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Watanabe T1, Itabashi M1, Shimada Y1, Tanaka S1, Ito Y1, Ajioka Y1, Hamaguchi T1, Hyodo I1, Igarashi M1,2,3, Ishida H1, Ishihara S1, Ishiguro M1, Kanemitsu Y1, Kokudo N1, Muro K1, Ochiai A1, Oguchi M1, Ohkura Y1, Saito Y1, Sakai Y1, Ueno H1, Yoshino T1, Boku N1, Fujimori T1, Koinuma N1, Morita T1, Nishimura G1, Sakata Y1, Takahashi K1, Tsuruta O1, Yamaguchi T1, Yoshida M1, Yamaguchi N1, Kotake K1, Sugihara K1 (1Japanese Society for Cancer of the Colon and Rectum): Int J Clin Oncol 2015/4; 20 (2): 207-39. (ŒÜ\—’łL1,2,3: 2‚Ş‚ńŒ¤—L–ž•a‰@, 3Á‰ťŠí“ŕ)

530004. [‚ť‚Ě‘ź (ƒKƒCƒhƒ‰ƒCƒ“)] JGES guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection. Tanaka S, Kashida H, Saito Y, Yahagi N, Yamano H, Saito S, Hisabe T, Yao T, Watanabe M, Yoshida M, Kudo SE, Tsuruta O, Sugihara K, Watanabe T, Saitoh Y, Igarashi M1,2, Toyonaga T, Ajioka Y, Ichinose M, Matsui T, Sugita A, Sugano K, Fujimoto K, Tajiri H: Dig Endosc 2015 /5; 27 (4): 417-34. (ŒÜ\—’łL1,2: 1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ)

530005. [‚ť‚Ě‘ź (ƒKƒCƒhƒ‰ƒCƒ“)] Guidelines for sedation in gastroenterological endoscopy. Obara K, Haruma K, Irisawa A, Kaise M, Gotoda T, Sugiyama M, Tanabe S1,2, Horiuchi A, Fujita N, Ozaki M, Yoshida M, Matsui T, Ichinose M, Kaminishi M: Dig Endosc 2015/5; 27 (4): 435-49. (“c糁@‘1,2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ)

540004. [‚ť‚Ě‘ź (ƒKƒCƒhƒ‰ƒCƒ“)] ERCPŒăäX‰ŠƒKƒCƒhƒ‰ƒCƒ“2015. •ő@“OĆ1, –žÎ—˛‹g1, ˆÉ“Ą“S‰p1, ěŒű‹`–ž1, ›–ě@“Ö1, –Ř“cŒőL1,2, ‰Ô“cŒhŽm1, ‹{ěG”V1, ŽRŒű•l1, X›‰•q•v1, ‰şŁě“O1, ’|ŽR‹X“T1, ^‹|r•F1 (1Œúś˜J“­Č“ŤäXŽžŠł’˛¸Œ¤‹†”ǁE“ú–{äX‘ŸŠw‰ď, 2Á‰ťŠí“ŕ): äX‘Ÿ 2015/8; 30 (4): 539-84.

[’˜@‘]

620018. [Šwp‘ (•Ş’SŽˇ•M)]yƒKƒCƒhƒ‰ƒCƒ“ƒTƒ|[ƒgƒnƒ“ƒhƒuƒbƒN@‘ĺ’°Šŕ2014”N”Łz‘ĺ’°ESD‚Ě“K‰ž‚ĆŽč‹Ză‚Ě’ˆÓ“_, p.61-2. ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ), •Ň: ™Œ´Œ’ˆę, ˆă–ňƒWƒƒ[ƒiƒ‹ŽĐ, ‘ĺă, 2015/4”­s.

620019. [Šwp‘ (•Ş’SŽˇ•M)]yĹV—Տ°‘ĺ’°ŠŕŠw|Šî‘bŒ¤‹†‚Š‚ç—Տ°‰ž—p‚ց| (“ú–{—ŐŕŹ2015‘Š§†)zVII. ‘ĺ’°Šŕ‚ĚŒŸ¸Ef’f@2. Œ´”­‘ƒ‚̐f’f@(3) Šg‘ĺ“ŕŽ‹‹žŒŸ¸‚É‚ć‚épit pattern•Ş—Ţ‚đ—p‚˘‚˝‘ĺ’°‘ŠúŠŕ‚̐[’B“xf’f, p.273-7. ç–쏻Žq1, ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ), “ú–{—Ő଎Đ, ‘ĺâ, 2015/4”­s.

620020. [Šwp‘ (•Ş’SŽˇ•M)]yˆ’u‹ď‚đŽg‚˘‚ą‚Č‚ˇ (Á‰ťŠí“ŕŽ‹‹ž8ŒŽ‘‘ĺ†)z[Á‰ťŠÇ‹ˇóE•ÂÇ‰đœ] —ǐŤ‹ˇó‰đœ@Ź’°E‰ń–Ó•”E‘ĺ’°á­Ť‹ˇó‚Ěƒoƒ‹[ƒ“Šg’Łp‚É—p‚˘‚鏈’u‹ď‚đŽg‚˘‚ą‚Č‚ˇƒRƒc, p.1341-3. ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2015/8”­s.

620021. [Šwp‘ (•Ş’SŽˇ•M)]yŒŒ‰t“ŕ‰ČƒNƒŠƒjƒJƒ‹ƒXƒ^ƒ“ƒ_[ƒh ‘ć3”ŁzIV. ‰ťŠw—Ă–@’†‚ĚŽxŽ—Ă–@@5. ŠĚ‰ŠEŠĚ‹@”\áŠQ, p.371-6. “n粐^˛1 (1Á‰ťŠí“ŕ), •Ň: “ŒŒ´ł–ž2, {‰i^Ži (2ŒŒ‰t“ŕ), •śŒő“°, “Œ‹ž, 2015/10”­s.

620022. [Šwp‘ (•Ş’SŽˇ•M)]yŽŔ—Տ°‚ɖ𗧂ÂIBD“ŕŽ‹‹žz‘ć2Í IBD‚Ě“ŕŽ‹‹žf’f@2. ‘źŽžŠł‚Ć‚ĚŠÓ•Ę 1. ’°ŠÇƒx[ƒ`ƒFƒbƒg•aE’PƒŤ’×á‡, p.37-43. Ź—ѐ´“T1,2 ‰ĄŽR@ŒO2, ˛“c”ü˜a2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ), ŠÄC: “ú”ä‹I•ś3, ŽR–{”Ž“ż, •Ň: ‹vź—ˆę, –î–ě’q‘Ľ (3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č), “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2015/10”­s.

620023. [Šwp‘ (•Ş’SŽˇ•M)]yŽŔ—Տ°‚ɖ𗧂ÂIBD“ŕŽ‹‹žz‘ć5Í “ŕŽ‹‹ž‚É‚ć‚éIBDƒ‚ƒjƒ^ƒŠƒ“ƒO@[Še˜_] ’×ᇐŤ‘ĺ’°‰Š@2. ŠO—ˆ‚Ĺ‚Ěƒ‚ƒjƒ^ƒŠƒ“ƒO@…A—Տ°Çó‚Ć“ŕŽ‹‹žŠŒŠ‚ވę’v‚ľ‚Č‚˘Ç—á (ŽĄ—Ă‹­‰ť‚đ‚Ç‚¤‚â‚Á‚ÄŒˆ‚ß‚é‚Š?), p.124-30. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ), ŠÄC: “ú”ä‹I•ś, ŽR–{”Ž“ż, •Ň: ‹vź—ˆę, –î–ě’q‘Ľ, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2015/10”­s.

620024. [Šwp‘ (•Ş’SŽˇ•M)]y–ƉuÇŒóŒQ (‘ć2”Ĺ) I|‚ť‚Ě‘ź‚̖ƉuŽžŠł‚đŠÜ‚߂ā| (•Ęű“ú–{—ŐଠV—Ěˆć•ĘÇŒóŒQƒVƒŠ[ƒY No.34)zI. ‘ŸŠí“ÁˆŮ“IŽŠŒČ–ƉuŽžŠł@4. ŽŠŒČ–ƉuŤÁ‰ťŠíŽžŠł (Á‰ťŠÇ, ŠĚ’_äX)@(1) ŽŠŒČ–ƉuŤˆĎkŤˆÝ‰Š‚̐f’f‚ĆŽĄ—Ă, p.344-7. ÎŒËŒŞŽŸ1, “c糁@‘1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă), “ú–{—Ő଎Đ, ‘ĺă, 2015/11”­s.

620025. [Šwp‘ (•Ş’SŽˇ•M)]yˆÝ‚Ş‚ń–ň•¨ŽĄ—ĂQ&Az4. ˆÝ‚Ş‚ń–ň•¨ŽĄ—Ă‚É—p‚˘‚ç‚ę‚郌ƒWƒƒ“‚ĚŽí—Ţ‚Ć“Á’Ľ‚Í?@CQ16. SP—Ă–@ (S-1+CDDP) ‚đ‚Ç‚¤Žg‚˘‚ą‚Č‚ˇ‚Š?, p.52-5. Źň˜aŽO˜Y (Á‰ťŠí“ŕ), •Ň: ˛“Ą@‰ˇ, ƒ”ƒ@ƒ“ ƒƒfƒBƒJƒ‹, “Œ‹ž, 2015/12”­s.

620026. [Šwp‘ (•Ş’SŽˇ•M)]yˆÝ‚Ş‚ń–ň•¨ŽĄ—ĂQ&Az4. ˆÝ‚Ş‚ń–ň•¨ŽĄ—Ă‚É—p‚˘‚ç‚ę‚郌ƒWƒƒ“‚ĚŽí—Ţ‚Ć“Á’Ľ‚Í?@CQ17. XP—Ă–@ (Cape+CDDP) ‚đ‚Ç‚¤Žg‚˘‚ą‚Č‚ˇ‚Š?, p.56-7. Źň˜aŽO˜Y (Á‰ťŠí“ŕ), •Ň: ˛“Ą@‰ˇ, ƒ”ƒ@ƒ“ ƒƒfƒBƒJƒ‹, “Œ‹ž, 2015/12”­s.

620027. [Šwp‘ (•Ş’SŽˇ•M)]yˆÝ‚Ş‚ń–ň•¨ŽĄ—ĂQ&Az4. ˆÝ‚Ş‚ń–ň•¨ŽĄ—Ă‚É—p‚˘‚ç‚ę‚郌ƒWƒƒ“‚ĚŽí—Ţ‚Ć“Á’Ľ‚Í?@CQ18. SOX—Ă–@ (S-1+L-OHP) ‚đ‚Ç‚¤Žg‚˘‚ą‚Č‚ˇ‚Š?, p.58-60. Źň˜aŽO˜Y (Á‰ťŠí“ŕ), •Ň: ˛“Ą@‰ˇ, ƒ”ƒ@ƒ“ ƒƒfƒBƒJƒ‹, “Œ‹ž, 2015/12”­s.

620028. [Šwp‘ (•ŇW)]y‘ĺ’°ŽžŠłNOW 2016 ‘ĺ’°Šŕ‚̐f’f‚ĆŽĄ—Ăupdatez•ŇWŽĺŠ˛: ™Œ´Œ’ˆę, •Ň: ŒÜ\—’łL1,2, “n糑–ž, ‘ĺ‘qN’j (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ), •ŇWŒÚ–â: •“Ą“Oˆę˜Y, “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2016/1”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712004. [Šw‰ď (‘Ű)] (‘Űƒ[ƒNƒVƒ‡ƒbƒv) EUS anatomy of Bilio-pancreatic system (Linear). Iwai T1: EUS phantom workshop (2015/4/25), Chia-Yi Christian Hospital, Chiayi City, Taiwan. (Šâˆä’m‹v1: 1Á‰ťŠí“ŕ)

712005. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Endoscopic ultrasonography using new functions -tissue harmonic echo, contrast echo, and elastography-. Iwai T1: 17th early GI cancer & 20th EUS meeting (2015/4/26), Chia-Yi Christian Hospital, Chiayi City, Taiwan. (Šâˆä’m‹v1: 1Á‰ťŠí“ŕ)

712006. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰) Balloon-Occluded Retrograde Transvenous Obliteration (B-RTO) from the Standpoint of Gastroenterologists. Hidaka H1: JSIR/ISIR/APCIO 2015 (2015/5/29), Miyazaki, Jpn Intervent Radiol 2015; 30 (suppl): 29. (“ú‚@‰›1: 1Á‰ťŠí“ŕ)

712007. [Šw‰ď (‘Ű)] (‹łˆçu‰‰) EUS Anatomy of Bilio-Pancreatic system (Linear). Kida M1: DEST 1st ANNUAL CONGRESS 2015 (2015/8/22-23), Taipei, Taiwan. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712008. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰) How to perform Guide-wire (GW) for Bilio-Pancreatic Endoscopy. Kida M1: DEST 1st ANNUAL CONGRESS 2015 (2015/8/22-23), Taipei, Taiwan. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712009. [Šw‰ď (‘Ű)] (‹łˆçu‰‰) New Era of Endoscopic ultrasonography using New functions-tissue harmonic echo, contrast echo, and elastography-. Kida M1: DEST 1st ANNUAL CONGRESS 2015 (2015/8/22-23), Taipei, Taiwan. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712010. [Šw‰ď (‘Ű)] (‹łˆçu‰‰) Technique of EUS-FNA. Kida M1: DEST 1st ANNUAL CONGRESS 2015 (2015/8/22-23), Taipei, Taiwan. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712011. [Šw‰ď (‘Ű)] (‹łˆçu‰‰) Endoscopic diagnosis and cancer prevention for superficial squamous cell carcinoma of the esophagus and head and neck. Katada C1: 2015 Summit Forum - Prevention, early diagnosis and treatment of esophageal cancer in China (2015/9/19), Shanghai, China. (Œ˜“ce—˜1: 1Á‰ťŠí“ŕ)

712012. [Šw‰ď (‘Ű)] (‹łˆçu‰‰) Indications of EUS-FNA. Kida M1: 1st Asian EUS Congress 2015 (2015/9/11-12), Seoul, Korea. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712013. [Šw‰ď (‘Ű)] (‹łˆçu‰‰) Submucosal Tumor (SMT) & Gastric Cancer. Kida M1: 1st Asian EUS Congress 2015 (2015/9/11-12), Seoul, Korea. (–Ř“cŒőL1: 1Á‰ťŠí“ŕ)

712014. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) The role of forward viewing echoendoscopes for interventional EUS. Imaizumi H1: The 18th National Academic Endoscopic Ultrasound Conference (2015/10/16), Shanghai, Chaina. (Ąň@O1: 1Á‰ťŠí“ŕ)

713016. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Estrogen receptor beta (ERƒŔ) gene polymorphisms as a predictor of overall survival in patients with gastric cancer (GC) from Japan and Los Angeles County (LAC). Parekh A, Sunakawa Y, Cao S, Matsusaka S, Yang D, Zhang W, Wakatsuki T, Ning Y, Stremitzer S, Mendez A, Okazaki S, Elkhoueiry R, Iqbal S, Barzi A, Azuma M1, Watanabe M2, Koizumi W1, Wu A, Lenz HJ: ASCO 2015 (2015/5/29-6/2), Chicago, USA. (“Œ@’q1, “n粏š•F2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2ŠO‰Č)

713017. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) A Case of ulcerative colitis with duodenal lesions that markedly responded to infliximab. Sasaki T1, Kawagishi K1, Yokoyama K1, Uehara K1, Kobayashi K1,2: AOCC 2015 (2015/6/18-20), Beijing, China. (˛X–Ř“NŽO1, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ăŒ´ˆę”ż1, Ź—ѐ´“T1,2: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

713018. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Current status of self-injection and associatesd problems in patients with IBD - from the viewpoint of physicians and nurses. Yokoyama K1, Kawagishi K1, Ohoka S1, Sada M1, Kobayashi K1,2, Takizawa K3, Uchida Y3, Yamaguchi Y: AOCC 2015 (2015/6/18-20), Beijing, China. (‰ĄŽR@ŒO1, ěŠÝ‰Á“Ţ1, ‘剪ł•˝1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, ‘ęŕVD3, “ŕ“c—L‰Á3: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ŠĹŒě•”)

713019. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Patients with infectious coletis suggestive of inflammatory bowel disease. Kawagishi K1, Yokoyama K1, Uehara K1, Sasaki T1, Kato A1, Kobayashi K1,2: AOCC 2015 (2015/6/18-20), Beijing, China. (ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ăŒ´ˆę”ż1, ˛X–Ř“NŽO1, ‰Á“Ą@Ę1, Ź—ѐ´“T1,2: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

713020. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Two patients suspected to have inflammatory bowel disease and autoimmune pancreatitis. Uehara K1, Kawagishi K1, Yokoyama K1, Sasaki T1, Kobayashi K1,2: AOCC 2015 (2015/6/18-20), Beijing, China. (ăŒ´ˆę”ż1, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ˛X–Ř“NŽO1, Ź—ѐ´“T1,2: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

713021. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Comparison of diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration with a core biopsy needle and a conventional aspiration needle in the same patients. Miyata E1, Kida M1, Imaizumi H1, Kaneko T1, Yamauchi H1, Okuwaki K1, Miyazawa S1, Iwai T1, Koizumi W1: 1st Asian EUS Congress 2015 (2015/9/11-12), Korea. (‹{“c‰pŽĄ1, –Ř“cŒőL1, Ąň@O1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ)

713022. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Percutaneous transesophageal gastrotubing (PTEG) for the patients that percutaneous endoscopic gastrostomy (PEG) insertion is impossible - usefulness of endoscopically assisted procedure. Murakami M, Nishino K, Murakami S, Mori K, Murakami B, Azuma M1, Tanabe S1,2, Kida M1, Koizumi W1: UEGW 2015 (2015/10/24-28), Barcelona, Spain. (“Œ@’q1, “c糁@‘1,2, –Ř“cŒőL1, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

713023. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Analyses of progressive disease patients with advanced hepatocellular carcinoma treated with sorafenib: prognoses, treatments, and progression patterns. Yamane K1, Nakazawa T1, Hidaka H1, Kubota K1, Inoue T1, Okuwaki Y1, Tanaka Y1, Takada J1, Shibuya A1,2, Koizumi W1: AASLD THE LIVER MEETING 2015 (2015/11/14), San Francisco, USA. (ŽRŞŒhŽq1, ’†ŕV‹MG1, “ú‚@‰›1, ŒE“cK‰î1, ˆäă’qm1, ‰œ˜e—T‰î1, “c’†ŒŤ–ž1, ‚“cŽ÷ˆę1, a’J–ž—˛1,2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2ˆă—ĂŠÇ—)

713024. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Prognostic analyses of progressive disease patients with advanced Hepatoma treated with sorafenib. Yamane K1, Nakazawa T1, Hidaka H1, Kubota K1, Inoue T1, Okuwaki Y1, Tanaka Y1, Takada J1, Minamino T1, Shibuya A1,2, Koizumi W1: APASL 2016 (2016/2/22), Tokyo. (ŽRŞŒhŽq1, ’†ŕV‹MG1, “ú‚@‰›1, ŒE“cK‰î1, ˆäă’qm1, ‰œ˜e—T‰î1, “c’†ŒŤ–ž1, ‚“cŽ÷ˆę1, “ě–ě@•×1, a’J–ž—˛1,2, Źň˜aŽO˜Y1: 1Á‰ťŠí“ŕ, 2ˆă—ĂŠÇ—)

713025. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Usefulness of, and factors influencing, the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) for the evaluation of short-term treatment response. Kawagishi K1, Yokoyama K1, Kobayashi K1,2: 11th Congress of ECCO (2016/3/16-19), Amsterdam, Netherlands. (ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2: 1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

722010. [Šw‰ď (‘S‘)] (Ç—á•ń) “–‰@‚ĹŒoŒą‚ľ‚˝Sister Mary Joseph's nodule‚Ě2—á. “ü]ˆős1, ‰ş“c‘ń–ç1,2, ŹŽRŽŽ÷1, ź–{—Y‘ž1, ‹ĘáÁr•˝1,2, ’†‘ş—zŽq1, ›–ě@‘1, ˆŔ’B@ŒŁ1,2, Ş–{š”V1 (1‘—§‘Š–ÍŒ´•a‰@, 2Á‰ťŠí“ŕ): ‘ć101‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2015/4/23-25), ĺ‘ä, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2015/9; 112 (—Ő‘): A907.

722011. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yŠĚd•Ď‚̕“I‚Čƒ}ƒlƒWƒƒ“ƒgz“Á”­Ť×‹ŰŤ• –Œ‰Š‚Ćƒvƒƒgƒ“ƒ|ƒ“ƒvƒCƒ“ƒqƒrƒ^[’ˇŠú“Š—^‚Ć‚ĚŠÖ˜AŤ|”ń–ÓŒŸ–łěˆ×”äŠrŽŽŒą‚Ĺ‚ĚŒŸ“˘|. “ú‚@‰›1, ’†ŕV‹MG1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/22), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A54.

722012. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŠĚŽžŠłf—ĂƒŒƒxƒ‹‚Ě‚ł‚ç‚Č‚é‹Ď‚Ä‚ń‰ť‚đ–ÚŽw‚ľ‚Ä: Œťó‚Ě”cˆŹ‚Ć–˘—ˆ‚Ö‚Ě“W–]zŠĚ×–EŠŕ‚Ě—\Œă‰ü‘P‚Ě‚˝‚ß‚Ě’nˆćˆă—Ă‚ĚˆÓ‹`. “n粐^˛1,2, ‚‹´’ől2, ‰ĄXOş2 (1Á‰ťŠí“ŕ, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/22), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A177.

722013. [Šw‰ď (‘S‘)] (ƒrƒfƒIƒ[ƒNƒVƒ‡ƒbƒv)yÁ‰ťŠÇĂ–ŹáŽ‚̐f’fEŽĄ—Ă‚ĚŒťó‚ƏŤ—ˆ“W–]: ˆŮŠŤĂ–ŹáŽ‚ŕŠÜ‚ށzˆÝĂ–ŹáŽ‚ɑ΂ˇ‚鎥—Ð헪. “ú‚@‰›1, š •Ş–ΔŽ1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V•S‡ƒ–‹u‘‡•a‰@): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/29), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 717.

722014. [Šw‰ď (‘S‘)] (ƒvƒŒƒiƒŠ[ƒZƒbƒVƒ‡ƒ“) ‰ŠÇŤ’°ŽžŠł‚Ş‹^‚í‚ę‚˝Š´őŤ’°‰Š‚ĚŒŸ“˘. ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ‰Á“Ą@Ę1, ‘剪ł•˝1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/29), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 736.

722015. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yIBDŠÖ˜AÁ‰ťŠÇŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹žf—Ẩۑč‚ƏŤ—ˆ“W–]z’×ᇐŤ‘ĺ’°‰ŠŠÖ˜AŽîᇂɑ΂ˇ‚é“ŕŽ‹‹žf’f‚Ě—L—pŤ‚Ć–â‘č“_. Ź—ѐ´“T1,2, ˛“c”ü˜a1, Źň˜aŽO˜Y1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 628.

722016. [Šw‰ď (‘S‘)] (ƒvƒŒƒiƒŠ[ƒZƒbƒVƒ‡ƒ“) “–‰@‚É‚¨‚Ż‚épŒăÄŒš’°ŠÇ‚ɑ΂ˇ‚éƒVƒ“ƒOƒ‹ƒoƒ‹[ƒ“ŽŽŹ’°‹Ť‚đ—p‚˘‚˝ERCP. ŽR“ŕ_Žj1, –Ř“cŒőL1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŹňŽüŽq1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, ‹e’nG•F1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 741.

722017. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÁ‰ťŠÇ‹ˇó‚ɑ΂ˇ‚éƒXƒeƒ“ƒgŽĄ—Ẩۑč‚ƏŤ—ˆ“W–]z’_äXŠŕ‚ĚˆŤŤ\“ńŽw’°‹ˇó‚ɑ΂ˇ‚éÁ‰ťŠÇƒXƒeƒ“ƒg—Ż’u‚ĚŒťó‚Ć–â‘č“_. Ą’JŠ°ˆČ1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/31), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 679.

722018. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y–ĺ–Źˆł˜´iÇ‚ɑ΂ˇ‚éIVRŽĄ—Ă‚ĚŒťó‚ƍĄŒă‚Ě“W–]zŒÇ—§ŤˆÝĂ–ŹáŽŽĄ—Âɑ΂ˇ‚é“ú–{‚Ɛ˘ŠE‚Ě•W€ŽĄ—Ă‚Ěˆá‚˘‚ɂ‚˘‚ā|Do not be like the Galapagos islands|. “ú‚@‰›1, š •Ş–ΔŽ1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V•S‡ƒ–‹u‘‡•a‰@): ‘ć22‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď‘‰ď (2015/9/10), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2015/8; 21 (3): 80.

722019. [Šw‰ď (‘S‘)] (—v–]‰‰‘č)yNASHEASHEƒEƒCƒ‹ƒXŤŠĚd•Ďz‘OŠĚd•Ď‘gD‚É‚¨‚Ż‚é—Ţ“´•Ç×–E‚¨‚ć‚ъ̐üˆŰ‰ťƒ}[ƒJ[”­Œť‚Ě”äŠrŒŸ“˘. ‘ĺ•”@˝1, ’†ŕV‹MG2, “ú‚@‰›2, ŒGŒł—Y‰î3 (1ˆă—ÉqśŠw•”, 2Á‰ťŠí“ŕ, 3ŠO‰Č): ‘ć22‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď‘‰ď (2015/9/11), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2015/8; 21 (3): 142.

722020. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y–ĺ–Źˆł˜´iÇ‚Ě•a‘Ô‚ĆŽĄ—Ă: Šî‘b‚Š‚ç—Տ°‚ցzPortal Hypertension‚ɉ—‚Ż‚éV‚˝‚ČŽw•W|BAVENO VIƒJƒ“ƒtƒ@ƒŒƒ“ƒX‚ć‚č|. “ú‚@‰›1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć22‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď‘‰ď (2015/9/11), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2015/8; 21 (3): 69.

722021. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y–ĺ–ŹŒŒđÇ‚ĚŽŔ‘Ô: f’f, ŽĄ—Ă, —\Œăz–{–M‚É‚¨‚Ż‚é–ĺ–ŹŒŒđÇ‚ĚŽŔ‘ԁ|‘S‘ƒAƒ“ƒP[ƒg’˛¸Œ‹‰Ę|. Ź“ˆ´ˆę˜Y1, ź’Jłˆę1, ‰—•Ű˜a•F1, ‘ž“cł”V1, Źň@~1, š •Ş–ΔŽ1,2,3, ’†–ě@–Î1, ’†‘şŒ’ŽĄ1, ’†‘ş^ˆę1, “čŒ´‹`”V1, “ú‚@‰›1,3, ź–{Í•v1, ‘ş“‡’źĆ1, “n•ÓŒMŽj1, ŹŒ´Ÿ•q1 (1“ú–{–ĺ–Źˆł˜´iÇŠw‰ďŠwpˆĎˆő‰ď, 2V•S‡ƒ–‹u‘‡•a‰@, 3Á‰ťŠí“ŕ): ‘ć22‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď‘‰ď (2015/9/11), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2015/8; 21 (3): 96.

722022. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)y•\ÝŒ^“Şčň•”ŠŕEH“šŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—Ă‚Ě’ˇŠúŒo‰ßz‘ŠúH“šŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹žŘœŒă‚É”­ś‚ˇ‚éˆŮŽžŤ‘ź‘ŸŠíŠŕ‚ĚŒŸ“˘. Œ˜“ce—˜1,2, •“Ą@Šw1 (1JEC study group, 2Á‰ťŠí“ŕ): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (JDDW 2015) (2015/10/8), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (Suppl 2): 1964.

722023. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y’_äX“ŕŽ‹‹žŒŸ¸EŽĄ—Ă‚Ěƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOzƒoƒ‹[ƒ“ŽŽŹ’°‹Ť‚đ—p‚˘‚˝ERCP‚É‚¨‚Ż‚éƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO. ŽR“ŕ_Žj1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (JDDW 2015) (2015/10/9), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (Suppl 2): 2038.

722024. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y–ĺ–Źˆł˜´iÇ: f’fEŽĄ—Ă‚ĚĄŒă‚Ě“WŠJz–ĺ–Źˆł˜´iÇ‚ɑ΂ˇ‚éOlmesartan Medoxomil‚Ě’ˇŠúŹŃ|TGF-ƒŔ1ŽYś—}§‚͐ś‘śŠúŠÔ‚đ‰„’ˇ‚ˇ‚é: 6”NŠÔ‚̒ǐՒ˛¸‚Š‚ç|. “ú‚@‰›1, š •Ş–ΔŽ1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V•S‡ƒ–‹u‘‡•a‰@): ‘ć19‰ń“ú–{ŠĚ‘ŸŠw‰ď‘ĺ‰ď (JDDW 2015) (2015/10/8), “Œ‹ž, ŠĚ‘Ÿ 2015/9; 56 (Suppl 2): A675.

722025. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yˆůŽđ‚Ć”­Šŕ: –{–M‚Ě—Ő°E‰uŠwŒ¤‹†‚ĚĹ‘OüzH“šE“Şčň•”Šŕ‚Ěfield cancerization‚ĆˆůŽđ‚ĚŠÖ˜A. Œ˜“ce—˜1, •“Ą@Šw, ‰ĄŽR@Œ° (1Á‰ťŠí“ŕ): •˝Ź27”N“xƒAƒ‹ƒR[ƒ‹E–ň•¨ˆË‘śŠÖ˜AŠw‰ď‡“ŻŠwp‘‰ď (2015/10/13), _ŒË, “ú–{ƒAƒ‹ƒR[ƒ‹E–ň•¨ˆăŠw‰ďŽGŽ 2015/8; 50 (4): 187.

722026. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yIBDŽĄ—Ă‚É‚¨‚Ż‚é“ŕ‰Č‚ĆŠO‰Č‚Ě˜AŒgz’×ᇐŤ‘ĺ’°‰Š“ü‰@—á‚É‚¨‚Ż‚éĹ‹ßŽĄ—ÐŹŃ‚Ć“Á’Ľ‚ɂ‚˘‚Ä. ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2015/9; 68 (9): 614.

722027. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yIBD‚ɑ΂ˇ‚éŠŕƒT[ƒxƒCƒ‰ƒ“ƒX‚ĚŒťó‚ƍĄŒă‚Ě“W–]z’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚éŠŕƒT[ƒxƒCƒ‰ƒ“ƒXEƒvƒƒOƒ‰ƒ€‚ĚŽŔŰ. ŽÂč@‘ĺ1, Ź—ѐ´“T2,3, ‹vź—ˆę, ’ˇŔ@˝, ‚‹´ŒŤˆę (1“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•‘Ž•a‰@ŠO‰Č, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3Á‰ťŠí“ŕ): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2015/9; 68 (9): 619.

722028. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) “Şčň•”•\ÝŠŕ‚̐f’f‚ĆŽĄ—Ă. Œ˜“ce—˜ (Á‰ťŠí“ŕ): ‘ć12‰ń“ú–{Á‰ťŠÇŠw‰ď‘‰ďŠwpW‰ď (2016/2/26), Vh.

723126. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‰ŠÇŤ’°ŽžŠł‚É‚¨‚Ż‚鍂ƒAƒ~ƒ‰[ƒ[ŒŒÇ‚ĆäX‰Š‡•š—á‚Ě—Ő°“IŒŸ“˘. ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ‘剪ł•˝1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć101‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2015/4/23), ĺ‘ä, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2015/3; 112 (—Ő‘); A384.

723127. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) TS-1‰Á—ĂŽž‚Ě• …’†5FU”Z“x‚ɑ΂ˇ‚éCART‚̉e‹ż. ‘ĺ–ě@—˛1,2, ŽR–{@‘n1,2, ˛X–Ř“NŽO2, Ą’JŠ°ˆČ2, •Ęác•üL2, ŒE“cK‰î2, Ź–ěO“ń1,2 (1ˆÉ¨Œ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć101‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2015/4/24), ĺ‘ä, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2015/3; 112 (—Ő‘); A489.

723128. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹Ů‹}ŠJ‹šŠJ• H“šˆŸ‘S“E‚đ—v‚ľ‚˝H“šˆŮ•¨ (—LŠb‹`Ž•) ‚Ě1—á. ’†–Ú“N•˝1,2, ăŒ´ˆę”ż2, –î–ě‹MŽj2, Œ}@”üK2, ‘ş“c@“Œ2, Î•N_2, r–ؐł—Y1,2, ‰Í–ě@Œĺ1 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć101‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2015/4/24), ĺ‘ä, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2015/3; 112 (—Ő‘); A490.

723129. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) NAFLDŠĚ‘gD‚É‚¨‚Ż‚é“S’ž’…‚¨‚ć‚ŃŽ_‰ťƒXƒgƒŒƒXŽY•¨”­Œť‚ĆHCC”­ś‚Ć‚ĚŠÖ˜A. ‘ĺ•”@˝1, ’†ŕV‹MG2, “ú‚@‰›2, ŒGŒł—Y‰î3 (1ˆă—ÉqśŠw•”, 2Á‰ťŠí“ŕ, 3ŠO‰Č): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/2), –źŒĂ‰Ž, “ú–{•a—Šw‰ď‰ďŽ 2015/3; 104 (1): 323.

723130. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒeƒKƒt[ƒ‹EƒMƒƒ‰ƒVƒ‹EƒIƒeƒ‰ƒVƒ‹ƒJƒŠƒEƒ€“Š—^—á‚É‚¨‚Ż‚éHBVÄŠˆŤ‰ť‘΍ô‚ĚŒťó‚Ɖۑč. ˆŔ’B@‰ő1,2, “ě–ě@•×1,2, “n粐^˛1,2, ˆäă’qm3, ŒE“cK‰î1, “c’†ŒŤ–ž1, ‚“cŽ÷ˆę1, ‰œ˜e—T‰î1, “ú‚@‰›1, ’†ŕV‹MG1, a’J–ž—˛1,4, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4ˆă—ĂŠÇ—): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/21), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A258.

723131. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) isŠĚ×–EŠŕ‚ɑ΂ˇ‚éƒ\ƒ‰ƒtƒFƒjƒuŽĄ—Á@•a‘ԐisŒQ (PD) ‚̉đÍ. ŽRŞŒhŽq1, ’†ŕV‹MG2, ěŒű—C•ă2, ŒE“cK‰î2, “ě–ě@•×2,3, ‚“cŽ÷ˆę2, “c’†ŒŤ–ž2, ‰œ˜e—T‰î2, Ź–ěO“ń2,4, “ú‚@‰›2, a’J–ž—˛1,5, Źň˜aŽO˜Y2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Á‰ťŠí“ŕ, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 4ˆÉ¨Œ´‹Ś“Ż•a‰@, 5ˆă—ĂŠÇ—): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/21), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A288.

723132. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) isŠĚ×–EŠŕ‚ɑ΂ˇ‚éƒ\ƒ‰ƒtƒFƒjƒuŽĄ—Ă‚É‚¨‚Ż‚é‰h—{Žw•W‚ĚŒŸ“˘. ěŒű—C•ă1, ’†ŕV‹MG1, ŽRŞŒhŽq2, “ě–ě@•×1,3, “c’†ŒŤ–ž1, ‚“cŽ÷ˆę1, ‰œ˜e—T‰î1, “ú‚@‰›1, a’J–ž—˛1,4, ŒE“cK‰î1, Ź–ěO“ń1,5, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 4ˆă—ĂŠÇ—, 5ˆÉ¨Œ´‹Ś“Ż•a‰@): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/21), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A294.

723133. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŽŠŒČ–ƉuŤŠĚ‰ŠŠĚ‘gD‚É‚¨‚Ż‚éIgG—zŤŒ`Žż×–EZ‚Ě—Ő°“IˆÓ‹`‚ĚŒŸ“˘@IgGƒTƒuƒNƒ‰ƒX–ˆ‚̉đÍ. rŁ‹gF1, ‰ÁěŒšO1, LŁrŽĄ1, ”’ÎŒőˆę1, Ź“ˆ´ˆę˜Y1, ‚´…áÁ“ń1, “n•ÓŒMŽj1, ’†ŕV‹MG2, “ú‚@‰›2, ź–{ŒőŽi1, •ő@“OĆ1 (1“ŒŠC‘ĺŠw, 2Á‰ťŠí“ŕ): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/21), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A296.

723134. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éƒoƒ‹[ƒ“•ÂÇ‰şŠĚ“Ž–Ź‰ťŠwÇđ—Ă–@‚̏‰ŠúŒoŒą. “c’†ŒŤ–ž1, ’†ŕV‹MG1, ŒE“cK‰î1, ŽRŞŒhŽq2, ˆäă’qm2, “ě–ě@•×1,3, ‚“cŽ÷ˆę1, ‰œ˜e—T‰î1, “ú‚@‰›1, a’J–ž—˛1,4, “n粐^˛1,3, Ź–ěO“ń1,5, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 4ˆă—ĂŠÇ—, 5ˆÉ¨Œ´‹Ś“Ż•a‰@): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/21), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A529.

723135. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) NAFLDŠĚ‘gD‚É‚¨‚Ż‚é“S’ž’…‚¨‚ć‚ŃŽ_‰ťƒXƒgƒŒƒXŽY•¨”­Œť‚ĆHCC”­ś‚Ć‚ĚŠÖ˜A. ‘ĺ•”@˝1, ’†ŕV‹MG2, “ú‚@‰›2, ŒGŒł—Y‰î3 (1ˆă—ÉqśŠw•”, 2Á‰ťŠí“ŕ, 3ŠO‰Č): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/22), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A357.

723136. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) EOB MRI‚É‚¨‚Ż‚éŠĚ×–EŠŕ”÷ŹŒŒŠÇZ‚Ě‰ć‘œf’f. ’†ŕV‹MG1, “ú‚@‰›1, ‘ĺ•”@˝2 (1Á‰ťŠí“ŕ, 2ˆă—ÉqśŠw•”): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/22), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A365.

723137. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”ń\‘˘ƒ^ƒ“ƒpƒN•ĎˆŮ‚É‚ć‚éCŒ^–ŤŠĚ‰Š‚Ě—Ő°ŒŸ“˘. ‚“cŽ÷ˆę1, ’†ŕV‹MG1, ‰œ˜e—T‰î1, ŒE“cK‰î1, ŽRŞŒhŽq2, ˆäă’qm2, “ě–ě@•×1, “c’†ŒŤ–ž1, “ú‚@‰›1, a’J–ž—˛1,3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ĂŠÇ—): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/22), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A434.

723138. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) HCV‚ɑ΂ˇ‚éInterferon FreeŽĄ—Ă:Daclatasvir (DCV)/Asunaprevir (ASV) •š—p—Ă–@‚ĚˆŔ‘SŤ. ŒĂ]N–ž1, ‚“cŽ÷ˆę1, ’†ŕV‹MG1, ‰œ˜e—T‰î1, “ě–ě@•×1, “c’†ŒŤ–ž1, “ú‚@‰›1, a’J–ž—˛1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2ˆă—ĂŠÇ—): ‘ć51‰ń“ú–{ŠĚ‘ŸŠw‰ď‘‰ď (2015/5/22), ŒF–{, ŠĚ‘Ÿ 2015/4; 56 (Suppl 1): A436.

723139. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ˆŤŤŠĚ–ĺ•”’_“š‹ˇó‚ɑ΂ˇ‚éMetallic stent‚đ—p‚˘‚˝Side by side—Ż’u–@‚ĚŒŸ“˘. ź–{‚–ž1, –Ř“cŒőL1, ‰œ˜e‹ť‰î1, ěŒű—C•ă1, ‹{“c‰pŽĄ1, ’ˇ’Jě—Í–ç1, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŹňŽüŽq1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/29), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 764.

723140. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’_ŠÇ‘}ŠÇ˘“ď—á‚ɑ΂ľ‚ÄäXŠÇƒKƒCƒhƒƒCƒ„[—Ż’u–@‚đs‚Á‚˝ERCP‚Ĺ‚ĚERCPŒăäX‰Š”­Ç—Ś‚ĚŒŸ“˘. ‹{“c‰pŽĄ1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ěŒű—C•ă1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/29), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 769.

723141. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) IgG4ŠÖ˜Ad‰ťŤ’_ŠÇ‰Š (IgG4-SC) ‚ĆŒ´”­Ťd‰ťŤ’_ŠÇ‰Š (PSC) ‚ĚŠÓ•Ę‚É‚¨‚Ż‚éERCP‚Ě—L—pŤ. ’ˇ’Jě—Í–ç1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/29), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 791.

723142. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “ŕŽ‹‹ž“IŽ•œp‚đŽŽ‚Ý‚˝SóŒ‹’°Ž˛”P“]Ç‚ĚŒŸ“˘. ‹ß“Ą—Y‹I1, ‰ĄŽR@ŒO1, âV“Ą—FĆ1, ěŠÝ‰Á“Ţ1, ‘剪ł•˝1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/29), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 814.

723143. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’´‰š”g“ŕŽ‹‹ž‰ş”X–EƒhƒŒƒi[ƒW (EUS-CD) ‚Ě’ˇŠúŹŃ‚ĆÄ”­—á‚ĚŒXŒü. ‹ŕŽq@‹œ1, –Ř“cŒőL1, ‹{ŕVŽu˜N1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, ‹e’nG•F1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 824.

723144. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) H“šŠŕ“ŕŽ‹‹ž“IŽĄ—ĂŒăŠłŽŇ‚É‚¨‚Ż‚éˆůŽđó‹ľ‚Ćƒˆ[ƒh•ső‘Ń’ö“x‚̕ωť‚ÉŠÖ‚ˇ‚錟“˘: ‘˝Ž{Ý‘OŒü‚ŤŽŽŒąJEC study‚ć‚č. –x@Œ\‰î1, ‰Ş“c—T”V1, Źźˆę’j, ’Ă“c‹Žu, Œ˜“ce—˜2, ‰ĄŽR“OŽ˘, ÎěGŽ÷, •“Ą@Šw (1‰ŞŽR‘ĺŠw•a‰@, 2Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 841.

723145. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚Ĺ‚Ě‘ĺ’°ƒXƒeƒ“ƒgŽg—pŒoŒą‚Š‚ç@—L—pŤ‚Ć’ˇŠúŒo‰ß‚Ě–â‘č“_‚ɂ‚˘‚Ä. ’†–Ú“N•˝1,2, ăŒ´ˆę”ż2, –î–ě‹MŽj2, Œ}@”üK2, Î•N_2, r–ؐł—Y1,2, ‰Í–ě@Œĺ1 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 848.

723146. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’´‚—îŽŇ‚Ě‘’_ŠÇŒ‹Î‚ɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—Â̐ŹŃ‚ĆˆŔ‘SŤ. ŽO“‡Fm1, ŽR“ŕ_Žj1, –Ř“cŒőL1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ‹ŕŽq@‹œ1, ŹňŽüŽq1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 865.

723147. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ’´‚—îŽŇ‚̕֐öŒŒ—zŤ—á‚ɑ΂ˇ‚é‘ĺ’°“ŕŽ‹‹žŒŸ¸‚ĚˆÓ‹`. âV“Ą—FĆ1, ‰ĄŽR@ŒO1, ‘剪ł•˝1, ěŠÝ‰Á“Ţ1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 868.

723148. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ăč–ĺŠÇi“W•a•Ď‚ɑ΂ˇ‚é‘ĺ’°ESD‚ĚŒŸ“˘. ź–{ˆçG1, ‘剪ł•˝1, ŽÂ–؁@Œ[, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 901.

723149. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éŒoŒű’°ŠÇôňÜƒ‚ƒrƒvƒŒƒbƒv‚ĚŽg—pŒoŒą. äřŒ´Ť—Ç1, ‘剪ł•˝1, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 953.

723150. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒ‚ƒrƒvƒŒƒbƒv800ml“ŕ•ž–@‚É‚ć‚é‘ĺ’°“ŕŽ‹‹ž‘Oˆ’u–@‚ĚŒŸ“˘. ‹v•Ű“c—z1, ‘剪ł•˝1, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 954.

723151. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) \“ńŽw’°ESD‚ĚˆŔ‘SŤ‚ƍĄŒă‚Ě“W–]: 2“_ŒĹ’č–@‚Ě—L—pŤ‚ɂ‚˘‚Ä. ŽR“c”Žş1, –{‹´@C1,2, ź‘ş@ŒŤ1,2, ’†ŽR¸“T1,2, ˆäŒű–őO1, ˆäăr‘ž˜Y1, Ź—с@ę 1, H“ĄŘ1 (1_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 959.

723152. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é’´‚—îŽŇ‚Ě‘ŠúˆÝŠŕ‚ɑ΂ˇ‚éESD‚ĚŽĄ—ÐŹŃ. ˜a“c‘ń–ç1, “c糁@‘1,2, ÎŒËŒŞŽŸ1, ˛X–Ř“O1, “Œ@’q1, Œ˜“ce—˜1, ”óŒűŸ•F1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 960.

723153. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰Č‚É‚¨‚Ż‚é“ŕŽ‹‹ž“I“ű“Ş•”Žîᇐ؏œpŒăäX‰Š‚ĚŒŸ“˘. ěŒű—C•ă1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ‹{“c‰pŽĄ1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŹňŽüŽq1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/31), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 982.

723154. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘ŠúH“šŠŕ“ŕŽ‹‹žŽĄ—Ă—á‚É‚¨‚Ż‚éˆŮŽžŤ“Şčň•”Šŕ‚ĚŒŸ“˘. ŽÂč@„1, •“Ą@Šw, Œ˜“ce—˜2, Žu‰ę´l, ’ŠˆüFG (1‘—§‚Ş‚ńŒ¤‹†ƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): ‘ć39‰ń“ú–{“Şčň•”ŠŕŠw‰ďE‘ć4‰ńƒAƒWƒA“Şčň•”ŠŕŠw‰ď (2015/6/3-6), _ŒË, “Şčň•”Šŕ 2015/5; 41 (2): 222.

723155. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‹Ł‡‚Š‚狤‘śE‹¤—L‚ց@HIHAƒlƒbƒg‚Ş–ÚŽw‚ˇ‚ŕ‚Ě (‰ď‹c˜^). “c’†–ž”ü1, ‘ĺěLˆę1, ‘ĺ–ě@—˛1,2 (1ˆÉ¨Œ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć17‰ń“ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ďŠwp‘‰ď (2015/6/12), ‘ĺă, “ú–{ˆă—Ăƒ}ƒlƒWƒƒ“ƒgŠw‰ďŽGŽ 2015/6; 16 (suppl): 183.

723156. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰Č‚ĹŒoŒą‚ľ‚˝TS1äXŠŕ‚ĚŒŸ“˘. ź–{‚–ž1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć46‰ń“ú–{äX‘ŸŠw‰ď‘ĺ‰ď (2015/6/19), –źŒĂ‰Ž, äX‘Ÿ 2015/5; 30 (3): 475.

723157. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) [ŽŔŤŽîᎂɑ΂ˇ‚é’ʏíaspiration needle‚Ćcore biopsy needle‚Ě”äŠr. Šâˆä’m‹v1, –Ř“cŒőL1, ’ˇ’Jě—Í–ç1, ‹ŕŽq@‹œ1, ŹňŽüŽq1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć46‰ń“ú–{äX‘ŸŠw‰ď‘ĺ‰ď (2015/6/20), –źŒĂ‰Ž, äX‘Ÿ 2015/5; 30 (3): 416.

723158. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚Ĺ‚ĚŽŠŒČ–ƉuŤäX‰Š‚ĚŒŸ“˘. ‹ŕŽq@‹œ1, –Ř“cŒőL1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć46‰ń“ú–{äX‘ŸŠw‰ď‘ĺ‰ď (2015/6/20), –źŒĂ‰Ž, äX‘Ÿ 2015/5; 30 (3): 509.

723159. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘ĺ‘Ú•”‰óŽ€Ť‹Ř–Œ‰Š‚đ—ˆ‚ľ‚˝äXŠÇ“ŕ“ű“Ş”S‰tŤŽîᇔj—ô‚Ě1—á. ŽR“ŕ_Žj1, Ąň@O1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ‹ŕŽq@‹œ1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć46‰ń“ú–{äX‘ŸŠw‰ď‘ĺ‰ď (2015/6/20), –źŒĂ‰Ž, äX‘Ÿ 2015/5; 30 (3): 515.

723160. [Šw‰ď (‘S‘)] (ˆę”ʉ‰‘č) B-RTOŽ{sŽž‚Ƀ}ƒCƒNƒƒJƒe[ƒeƒ‹‚É‚ć‚éˆÝ“ŕoú”j‚đ‚Ť‚˝‚ľ‚˝ˆÝĂ–ŹáŽ‚Ě1—á. ‘ëě­˜a1, •˝ěk‘ĺ1, “cŒű’qŽq1, ‘ĺX’qŽq1, “ü]ˆős1, ‰ş“c‘ń–ç1,2, ‹ĘáÁr•˝1,2, ’†‘ş—zŽq1, ›–ě@‘1,2, ˆŔ’B@ŒŁ1,2 (1‘—§‘Š–ÍŒ´•a‰@, 2Á‰ťŠí“ŕ): ‘ć22‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď‘‰ď (‘ć18‰ńB-RTOŒ¤‹†‰ď) (2015/9/11), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2015/8; 21 (3): 173.

723161. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚ĚSBE-ERCP‚đŽg—p‚ľ‚˝’_ŠÇ‹ó’°•Ť‡•”‹ˇóŠg’Łp‚̐ŹŃ. ‹{“c‰pŽĄ1, ŽR“ŕ_Žj1, –Ř“cŒőL1, ěŒű—C•ă1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŹňŽüŽq1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, ‹e’nG•F1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć51‰ń“ú–{’_“šŠw‰ďŠwpW‰ď (2015/9/18), ‰F“s‹{, ’_“š 2015/8; 29 (3): 553.

723162. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠĚ×–EŠŕ‚ɑ΂ˇ‚éŠĚ“Ž–Ź‰ťŠwÇđ—Ă–@‚É‚¨‚Ż‚éƒ~ƒŠƒvƒ‰ƒ`ƒ“‚Ě—LŒřŤ‚ÉŠÖ‚ˇ‚錟“˘: ƒGƒsƒ‹ƒrƒVƒ“‚đ‘ÎĆ‚Ć‚ľ‚˝ƒ‰ƒ“ƒ_ƒ€‰ť•ŔsŒQŠÔ”äŠrŽŽŒą. ‰œ˜e—T‰î1, ’†ŕV‹MG1, “ě–ě@•×1, ‚“cŽ÷ˆę1, “c’†ŒŤ–ž1, “ú‚@‰›1, a’J–ž—˛1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2ˆă—ĂŠÇ—): ‘ć19‰ń“ú–{ŠĚ‘ŸŠw‰ď‘ĺ‰ď (JDDW 2015) (2015/10/8), “Œ‹ž, ŠĚ‘Ÿ 2015/9; 56 (suppl 2): A732.

723163. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) isŠĚ×–EŠŕ‚ɑ΂ˇ‚éƒ\ƒ‰ƒtƒFƒjƒuŽĄ—Ă‚É‚¨‚Ż‚é’ˇŠúś‘ś—á‚ĚŒŸ“˘. ŽRŞŒhŽq1, ’†ŕV‹MG2, ěŒű—C•ă2, “ú‚@‰›2, ‰œ˜e—T‰î2, “c’†ŒŤ–ž2, ‚“cŽ÷ˆę2, “ě–ě@•×2, ŒE“cK‰î2, a’J–ž—˛2,3, Źň˜aŽO˜Y2, Ź–ěO“ń2,4, ‘ĺ–ě@—˛2,4 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Á‰ťŠí“ŕ, 3ˆă—ĂŠÇ—, 4ˆÉ¨Œ´‹Ś“Ż•a‰@): ‘ć19‰ń“ú–{ŠĚ‘ŸŠw‰ď‘ĺ‰ď (JDDW 2015) (2015/10/8), “Œ‹ž, ŠĚ‘Ÿ 2015/9; 56 (suppl 2): A749.

723164. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) is’_“šŠŕ‚ɑ΂ˇ‚éGemcitabine/Cisplatin/TS-1•š—p—Ă–@‚Ě—Ő°‘ć1‘ŠŽŽŒą. ‹{“c‰pŽĄ1, –Ř“cŒőL1, ‹{ŕVŽu˜N1, “n糍WŽŻ2, ěŒű—C•ă1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1,3, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŹňŽüŽq1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, ‹e’nG•F1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆÉ¨Œ´‹Ś“Ż•a‰@): ‘ć57‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď (JDDW 2015) (2015/10/8), “Œ‹ž, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2015/9; 112 (—Ő‘): A879.

723165. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰Č‚É‚¨‚Ż‚鏬äXŠŕ‘Šú”­ŒŠ‚Ě‚˝‚߂̐f’fƒXƒgƒ‰ƒeƒW[. ź–{‚–ž1,2, –Ř“cŒőL1, ’ˇ’Jě—Í–ç1, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2ˆÉ¨Œ´‹Ś“Ż•a‰@): ‘ć57‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď (JDDW 2015) (2015/10/9), “Œ‹ž, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2015/9; 112 (—Ő‘): A897.

723166. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Šˆ“ŽŠú’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚éInfliximab—Ă–@‚ĚŽĄ—ÐŹŃ. âV“Ą—FĆ1, ‰ĄŽR@ŒO1, ěŠÝ‰Á“Ţ1, ‘剪ł•˝1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć57‰ń“ú–{Á‰ťŠí•aŠw‰ď‘ĺ‰ď (JDDW 2015) (2015/10/10), “Œ‹ž, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2015/9; 112 (—Ő‘): A936.

723167. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yInterventional EUS: ƒGƒrƒfƒ“ƒX‚ƐV‚˝‚Č“WŠJz[ŽŔŤŽîᇂɂ¨‚Ż‚éEUS-FNA‚Ĺ‚Ěaspiration needle‚Ćcore biopsy needle‚̐ŹŃ‚Ě”äŠr. ‹ŕŽq@‹œ1, Ąň@O1, –Ř“cŒőL1 (1Á‰ťŠí“ŕ): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (JDDW 2015) (2015/10/9), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2030.

723168. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘ĺ’°“ŕŽ‹‹ž”˛‹ŽŽžŠÔ‚Ć‘BŽîŒŸo—Ś‚ĚŠÖŒW@‘˝Ž{Ý‹¤“ŻŒ¤‹†. ‰Í‘ş‘ě“ń1, ”ö“c@‹ą, Ź—ѐ´“T2,3, ź“c_“ń, “c’†šl, –Ř“cŒőL3 (1‹ž“s‘ć“ńÔ\Žš•a‰@, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3Á‰ťŠí“ŕ): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2164.

723169. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘ĺ’°ESD‚É‚¨‚Ż‚éƒfƒBƒXƒ|[ƒUƒuƒ‹ƒXƒ‰ƒCƒfƒBƒ“ƒOƒ`ƒ…[ƒu‚ĚŽg—pŒoŒą. ź–{ˆçG1, ‘剪ł•˝1, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ˛“c”ü˜a1, Ź—ѐ´“T1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2174.

723170. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰Č‚É‚¨‚Ż‚鑍’_ŠÇŒ‹ÎÇ‚ɑ΂ˇ‚éEPLBD‚ĚŽĄ—ÐŹŃ‚ĚŒŸ“˘. “n@—D1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2183.

723171. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚épŒăÄŒš’°ŠÇ‚ɑ΂ˇ‚éshort type Single Balloon Enteroscope‚đ—p‚˘‚˝ERCPŠÖ˜AŽč‹Z‚̐ŹŃ. ’ˇ’Jě—Í–ç1, ŽR“ŕ_Žj1, –Ř“cŒőL1, ŹňŽüŽq1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2188.

723172. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠĚ–ĺ•”ˆŤŤ’_“š‹ˇó‚ɑ΂ˇ‚éSide by side stenting–@‚Ě—L—pŤ. ěŒű—C•ă1, –Ř“cŒőL1, ‰œ˜e‹ť‰î1, Ą’JŠ°ˆČ1, ‹{“c‰pŽĄ1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1,2, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2ˆÉ¨Œ´‹Ś“Ż•a‰@): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2194.

723173. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) KKR•a‰@‚É‚¨‚Ż‚éƒ`[ƒ€ˆă—Ă‚ĚŒř—p‚ƍĄŒă‚Ě“W–]: ‘˝EŽíƒ`[ƒ€‚Ő„i‚ˇ‚éR‹Ű–ň‚Ě“KłŽg—p|Š´őÇę–ĺˆă•sÝ‚Ěˆă—Ă‹@ŠÖ‚Ĺ‚ŕR‹Ű–ň‚Ě“KłŽg—p‚͐„i‚Ĺ‚Ť‚é|. ěč@i1, ŽRčDŠě1,2, ěă’źŽ÷, Ź“c˜a‡1, ŕVŠCŒ’ě1 (1•˝’Ë‹¤Ď•a‰@, 2Á‰ťŠí“ŕ): ‘ć64‰ń‹¤ĎˆăŠw‰ď (2015/10/14-15), ‚ź, ‹¤Ďˆă•ń 2015/10; 64 (suppl): 85.

723174. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) HIV”˜˜IŒă—\–h“ŕ•ž–ňƒZƒbƒgěŹ‚ĚŒŸ“˘. ŕVŠCŒ’ě1, ‘“cGÍ1, ŽRčDŠě1,2, ěă’źŽ÷, ěč@i1, Ź“c˜a‡1 (1•˝’Ë‹¤Ď•a‰@, 2Á‰ťŠí“ŕ): ‘ć64‰ń‹¤ĎˆăŠw‰ď (2015/10/14-15), ‚ź, ‹¤Ďˆă•ń 2015/10; 64 (suppl): 154

723175. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰ťŠw•úŽËü—Ă–@‚Ş’˜Œř‚ľ‚˝ăč–ĺŠÇŠŕ‚Ě1—á. ‹v•Ű“c—z1,2, ŽRčDŠě1,2, ‹ß“Ą—Y‹I1,2, –kě”Ž”V1,2, ‰Íźčű‘ž˜Y1, Ź–с@“N1,2, ‹e’nG•F1,2, —˘“š“N•F1,2, ŕ_–źr–ç1, –ě“o@˝1,2 (1•˝’Ë‹¤Ď•a‰@, 2Á‰ťŠí“ŕ): ‘ć64‰ń‹¤ĎˆăŠw‰ď (2015/10/15), ‚ź, ‹¤Ďˆă•ń 2015/10; 64 (Suppl): 185.

723176. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŠÉ˜aˆă—Ă‚Ć‚ľ‚Ä‚ĚCART‚ĚˆÓ–Ą‡‚˘|14‰ńCARTŽ{s‚ľ‚˝isˆÝŠŕ‚Ě1Ç—á|. ‘ĺ–ě@—˛1,2, ’†’JŞŒá1,2, “n糗FŠG1, Ą’JŠ°ˆČ1,2, ź–{‚–ž1,2, ŽR–{@‘n1,2, Ź–ěO“ń1,2 (1ˆÉ¨Œ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć64‰ń“ú–{”_‘şˆăŠw‰ďŠwp‘‰ď (2015/10/22), H“c, “ú–{”_‘şˆăŠw‰ďŽGŽ 2015/9; 64 (3): 369.

723177. [Šw‰ď (‘S‘)] (—Տ°Œ¤CˆăƒZƒbƒVƒ‡ƒ“) TACE•s”\‚—îŽŇ‚ɑ΂ľƒ\ƒ‰ƒtƒFƒjƒu“Š—^‚É‚ć‚č’ˇŠúś‘ś‚Ş“ž‚ç‚ę‚˝1—á. ŠâčGˆę˜Y1, –î–ě‹MŽj1,2, ăŒ´ˆę”ż1,2, ’†–Ú“N•˝1,2, Œ}@”üK1,2, Î•N_1,2, ‘ş“c@“Œ1,2, r–ؐł—Y1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć64‰ń“ú–{”_‘şˆăŠw‰ďŠwp‘‰ď (2015/10/23), H“c, “ú–{”_‘şˆăŠw‰ďŽGŽ 2015/9; 64 (3): 319.

723178. [Šw‰ď (‘S‘)] (—Տ°Œ¤CˆăƒZƒbƒVƒ‡ƒ“) ŹlŽüŠúŤšq“fÇ‚Ě1—á. ‘ĺ‹v•Ű–F•F1, ”–؍_’¨1, ŽRŒűƒ‹P1, •“cKl1, ˆäŒűhˆę˜N1, “Œ•˝ăđž1, ŽR–{@‘n1,2, Ź–ěO“ń1,2, ‘ĺ–ě@—˛1,2 (1ˆÉ¨Œ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć64‰ń“ú–{”_‘şˆăŠw‰ďŠwp‘‰ď (2015/10/23), H“c, “ú–{”_‘şˆăŠw‰ďŽGŽ 2015/9; 64 (3): 330.

723179. [Šw‰ď (‘S‘)] (—Տ°Œ¤CˆăƒZƒbƒVƒ‡ƒ“) Œƒ‚ľ‚˘• ’É‚đ’ć‚ľ‚˝Źl”­Ç‚ĚƒAƒŒƒ‹ƒM[ŤŽ‡”Á•a‚Ě1—á. ˆäŒűhˆę˜N1, Ź–ěO“ń1,2, ’†’JŞŒá1,2, “n糗FŠG1, Ą’JŠ°ˆČ1,2, ź–{‚–ž1,2, ŽR–{@‘n1,2, ‘ĺ–ě@—˛1,2 (1ˆÉ¨Œ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć64‰ń“ú–{”_‘şˆăŠw‰ďŠwp‘‰ď (2015/10/23), H“c, “ú–{”_‘şˆăŠw‰ďŽGŽ 2015/9; 64 (3): 331.

723180. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘މ@Œă‚Ě“úíśŠˆ‚É‹y‚Ú‚ˇS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚̉e‹ż‚ɂ‚˘‚Ä. ˜a“c”Í•ś1, ‘ĺ–ě@—˛2,3, –ěX‘ş—e“T1 (1Šň–kŒúś•a‰@, 2ˆÉ¨Œ´‹Ś“Ż•a‰@, 3Á‰ťŠí“ŕ): ‘ć64‰ń“ú–{”_‘şˆăŠw‰ďŠwp‘‰ď (2015/10/23), H“c, “ú–{”_‘şˆăŠw‰ďŽGŽ 2015/9; 64 (3): 521.

723181. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‰Č‚É‚¨‚Ż‚éÚ‹ö‚ÉŠÖ‚ˇ‚éˆÓŽŻ’˛¸‚ĆŠˆ“Ž•ń. ]č–L‰p1, ˜a“c”Í•ś1, ‘ĺ–ě@—˛2,3, ŽR“Ą—D–í1 (1Šň–kŒúś•a‰@, 2ˆÉ¨Œ´‹Ś“Ż•a‰@, 3Á‰ťŠí“ŕ): ‘ć64‰ń“ú–{”_‘şˆăŠw‰ďŠwp‘‰ď (2015/10/23), H“c, “ú–{”_‘şˆăŠw‰ďŽGŽ 2015/9; 64 (3): 573.

723182. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Œ‹’°Œ´”­undifferentiated round cell sarcoma‚Ě1—á. ˆäăr‘ž˜Y1, Ź—с@ę 1, ŽR“c”Žş1, H“ĄŘ1, ˆäŒű–őO1, ź‘ş@ŒŤ1,2, ’†ŽR¸“T1,2, –{‹´@C1,2, ˜hŒŠŒö‘ž1, ‰ĄŁ’q”V1, ‹T“c—zˆę1, ’|ŽRšL1, ŕVč@ăÄ1, ‰–ŕV@Šw1 (1_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/30), ‹ž“s, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ 2015/9; 50 (3): 1679.

723183. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Řœ•s”\isEÄ”­‘ĺ’°Šŕ‚ɑ΂ˇ‚éRegorafenib‚Ě—LŒřŤ, ˆŔ‘SŤ‚ĚŒŸ“˘. ‚čŒ[F1, ’†ŽR¸“T1,2, ź‘ş@ŒŤ1,2, ‰–ŕV@Šw1, ‹ŕŕV@Žü1, •ĐŽR—Y‰î1, ó—˜š‘ĺ1, •ž•”—F‰ĚŽq1, ÎŽR‘׎j1, Ŕ“c@•ŕ1, –{‘ş–ÎŽ÷1, ŽđˆäƒŠƒJ (1_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/31), ‹ž“s, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ 2015/9; 50 (3): 2421.

723184. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Stage IVˆÝŠŕ‚ɑ΂ˇ‚éConversion surgery. ˛“Ą@•×1, ź‘ş@ŒŤ1,2, ’†ŽR¸“T1,2, –{‹´@C1,2, ŁăŒ°‹M1, _”öˆęŽ÷1, ‘OŕVK’j1, ’†“‡“NŽj1, ÂŽR@“O1, ‘哇@‹M1, —˜–ě@–ő1, ‰v“c@F1, ”öŒ`‚Žm1, ’ˇ@°•F1, ‹gě‹MŒČ1 (1_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/31), ‹ž“s, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ 2015/9; 50 (3): 2640.

723185. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚鑁ŠúˆÝŠŕ‚ɑ΂ˇ‚éESD‚Ě“K‰žŠO•a•Ď‚ĚŒŸ“˘. –î–ě‹MŽj1, ÎŒËŒŞŽŸ1, “c糁@‘1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/18), ‘ĺ•Ş, “ú–{ˆÝŠŕŠw‰ď‘‰ď‹LŽ– 2016/3; 88th: 240.

723186. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ESD‚ɂĈݑBG•˝ă”çŠŕ‚Ɛf’f‚ľ‚˝1—á. •{‹M_1, –î–ě‹MŽj1, “c糁@‘1,2, ‰Íź“Ţ’ĂŽq1, “n糍WŽŻ1, ˜a“c‘ń–ç1, ÎŒËŒŞŽŸ1, “Œ@’q1, Œ˜“ce—˜1, ˛X–Ř“O1, Źň˜aŽO˜Y1, ŽOd–ě_˜N3, ‘ĺ•”@˝4 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ŠO‰Č, 4ˆă—ÉqśŠw•”): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/18), ‘ĺ•Ş, “ú–{ˆÝŠŕŠw‰ď‘‰ď‹LŽ– 2016/3; 88th: 245.

723187. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚鑁ŠúˆÝŠŕ‚Ě“ŻŽž‘˝”­EˆŮŽž‘˝”­•a•Ď‚ĚŒŸ“˘. ÎŒËŒŞŽŸ1, “c糁@‘1,2, ˜a“c‘ń–ç1, –î–ě‹MŽj1, “Œ@’q1, Œ˜“ce—˜1, ˛X–Ř“O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/18), ‘ĺ•Ş, “ú–{ˆÝŠŕŠw‰ď‘‰ď‹LŽ– 2016/3; 88th: 246.

723188. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ESDŽ{sŒă‚ɈݕǓŕ“]ˆÚ‚đ”F‚ß‚˝‘ŠúˆÝŠŕ‚Ěˆę—á. –ƒśŒ’ˆę˜N1, ˜a“c‘ń–ç1, ÎŒËŒŞŽŸ1, –î–ě‹MŽj1, “Œ@’q1, Œ˜“ce—˜1, ˛X–Ř“O1, “c糁@‘1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/19), ‘ĺ•Ş, “ú–{ˆÝŠŕŠw‰ď‘‰ď‹LŽ– 2016/3; 88th: 414.

731004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’ź’°NET‚̐f’f‚ĆŽĄ—Ă. ‹v•Ű“c”ü˜a (Á‰ťŠí“ŕ): ‘ć14‰ńźĂEŒ§‰›Á‰ťŠí•aŒ¤‹†‰ď (2015/5/13), Œú–Ř.

731005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) –k—˘‘ĺŠw‚É‚¨‚Ż‚éIBDf—Á|Motivational Interviewing‚đ‚Ç‚¤Žg‚˘‚ą‚Č‚ˇ?|. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): HUMIRA IBD Meeting inŒQ”n (2015/7/10), ‘O‹´.

731006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰Š‚ĚŽĄ—Âɂ‚˘‚Ä. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ƒAƒXƒeƒ‰ƒXť–ňŽĐ“ŕu‰‰‰ď (2015/8/24), Œú–Ř.

731007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘Šú‘ĺ’°Šŕ‚Ě“ŕŽ‹‹žf’f‚Ć“ŕŽ‹‹žŽĄ—Â̐i•ŕ. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): •˝Ź27”N“xŹ“cŒ´ˆăŽt‰ď‚Ş‚ńŒŸf‘‰ď (2015/9/3), Ź“cŒ´.

731008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Œ´”­Ť’_`ŤŠĚd•Ď@ĹV‚ĚŽĄ—Ă‚Ć“úíśŠˆ. ’†ŕV‹MG (Á‰ťŠí“ŕ): ‘Š–ÍŒ´ŽsŽĺĂ“ď•au‰‰‰ď (2015/11/11), ‘Š–ÍŒ´.

731009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) IBDŽĄ—Ă‚É‚¨‚Ż‚é“ď•a§“x‰üł‚É‚ć‚銳ŽŇEˆă—Ï]Ž–ŽŇ‚̑Ήž‚̕ωť‚Ɖۑč. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ‘ć43‰ń_“ސěIBDƒ~ƒjƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/11/16), ‰Ą•l.

731010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰Š‚Ě“ŕ‰ČŽĄ—Á|”S–ŒŽĄ–ü‚ĆŒž‚¤‚Ż‚ę‚ǁEEE|. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ’×ᇐŤ‘ĺ’°‰ŠƒJƒ“ƒtƒ@ƒŒƒ“ƒX2015 (2015/11/27), ‘ĺă.

731011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Crohn•a‚ĚŽĄ—Ă‘‚í‚Š‚č. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): ‘Š–̓uƒƒbƒN@ƒNƒ[ƒ“•aŽĐ“ŕ•×‹­‰ď (2015/12/18), ‰Ą•l.

731012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) IBD‚Ě“ŕŽ‹‹žf’f|—މŽžŠł‚Ƃ̊ӕʐf’f‚âcolitic cancer‚̐f’f‚đŠÜ‚߂ā|. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć177‰ń‰Ą•lÁ‰ťŠí“ŕŽ‹‹žˆă‰ďW’k‰ď (2016/2/10), ‰Ą•l.

732008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) IBDf’f‚ĚŠî–{ƒAƒ‹ƒSƒŠƒYƒ€|—Տ°Œo‰ß‚Ć“ŕŽ‹‹žŒŸ¸‚ĚŠî–{‚đ“Ç‚Ý‰đ‚­|. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć44‰ńIBD Club JrŒ¤‹†‰ď (2015/6/6), “Œ‹ž.

732009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ˆô“ށEH“šŠŕ‚Ě“ŕŽ‹‹ž‰ć‘œf’f. Œ˜“ce—˜(Á‰ťŠí“ŕ): ‘ć3‰ń‘Š–ÍŒ´Á‰ťŠí‰ć‘œƒZƒ~ƒi[ (2015/6/15), ‘Š–ÍŒ´.

732010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ˆô“ށEH“šŠŕ‚Ě“ŕŽ‹‹žf’f‚ĆŽĄ—Ă. Œ˜“ce—˜ (Á‰ťŠí“ŕ): ‘ć8‰ńmŒË–ź’n‹ćÁ‰ťŠíŽžŠł•×‹­‰ď (2015/6/24), ç—t.

732011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰) ă•”“ŕŽ‹‹žf’f‚ĚĹ‘Oü ~•a‰@ˆă‚Ě—§ę‚Š‚ç. “Œ@’q (Á‰ťŠí“ŕ): ‘ć21‰ń_“ŢěŒ§Á‰ťŠí“ŕŽ‹‹ž§’k‰ď (2015/9/3), ‰Ą•l.

732012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ~ƒjƒŒƒNƒ`ƒƒ[) ŹäXŠŕ”­ŒŠ‚Ě‚˝‚߂̐f’fƒXƒgƒ‰ƒeƒW[. ź–{‚–ž1,2 (1Á‰ťŠí“ŕ, 2ˆÉ¨Œ´‹Ś“Ż•a‰@): ‘ć140‰ń‘Š–ÍŒ´ˆÝ‚Ć’°Œ¤‹†‰ď (2015/10/28), ‘Š–ÍŒ´.

732013. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yÁ‰ťŠÇŽžŠł‚ɑ΂ˇ‚é“ŕ‰Čˆă‚ĆŠO‰Čˆă‚ĚƒRƒ‰ƒ{ƒŒ[ƒVƒ‡ƒ“z“–‰@‚É‚¨‚Ż‚éˆÝE\“ńŽw’°Žîᇂɑ΂ˇ‚é• o‹ž“ŕŽ‹‹ž‡“ŻŽčp (LECS) ‚ĚŒŸ“˘. ÎŒËŒŞŽŸ1, “c糁@‘1,2, ˜a“c‘ń–ç1, –î–ě‹MŽj1, “Œ@’q1, Œ˜“ce—˜1, ˛X–Ř“O1, Źň˜aŽO˜Y1, ŒG–{—Y‰î3, •Đ“c‰Ä–ç3 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ŠO‰Č): ‘ć48‰ń_“ŢěŒ§Á‰ťŠí•aˆăŠw‰ď‘‰ď (2015/10/31), V‰Ą•l, _“ސěˆăŠw‰ďŽGŽ 2016/1; 43 (1): 134-5.

732014. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰) ŠĚ×–EŠŕ‚ĚMRI‚É‚ć‚éˆŤŤ“x•]‰ż‚¨‚ć‚ѐisŠĚ×–EŠŕ‚É‚¨‚Ż‚鎥—ĂŒŸ“˘. ’†ŕV‹MG (Á‰ťŠí“ŕ): ‘ć15‰ń‰ŹŒEŠĚ’_äXƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/11/18), “Œ‹ž.

732015. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ç—á•ń) Clinical hot topics in IBD: Using monitoring to tailor treatment in IBD Crohn's disease case. ‰ĄŽR@ŒO (Á‰ťŠí“ŕ): IBD Expert alliance Tokyo 2015 (2015/11/23), “Œ‹ž.

732016. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ˆô“ށEH“š‚Ş‚ń‚Ě“ŕŽ‹‹žf’fEŽĄ—Ă‚Ć—\–h|Ĺ‹ß‚Ě“ŽŒü|. Œ˜“ce—˜ (Á‰ťŠí“ŕ): ‘ć4‰ń–k—˘‘ĺŠwˆăŠw•”V˘‹IŠJ”­ƒZƒ“ƒ^[ƒVƒ“ƒ|ƒWƒEƒ€ (2015/11/26), ‘Š–ÍŒ´.

732017. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď] (ƒ[ƒNƒVƒ‡ƒbƒv)yH“š•a•Ď‚ɑ΂ˇ‚éNBIf’f‚Ě—L—pŤ‚ĆŒŔŠEzH“š•\ÝŠŕ‚ɑ΂ˇ‚éNBIŠg‘ĺŠĎŽ@‚É‚ć‚ép‘O[’B“xf’f‚̐f’f¸“x‚ĚŒŸ“˘. Œ˜“ce—˜1, ˜a“c‘ń–ç1, ÎŒËŒŞŽŸ1, –î–ě‹MŽj1, “Œ@’q1, ˛X–Ř“O1, Źň˜aŽO˜Y1, “c糁@‘1,2 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć101‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2015/12/12), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): s86.

732018. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yEUS-FNA‚̍ŐV‚̐f’f‚ĆŽĄ—ÁzŹŃEˆŔ‘SŤŒüă‚Ě‚˝‚ß‚ĚŽŔŰ‚ƍH•v|’n•űˆę”Ę•a‰@‚É‚¨‚Ż‚éEUS-FNA“ą“ü‚ĚŒťó|. “ě–ě@•×1,2, ‹ŕŽq@‹œ1,2, ’ˇ’Jě—Í–ç1,2, ˆŔ’B@‰ő1,2, ‚‹´W•F1,2, ‘ĺ’ˏr˜a1,2, “cŒ´‹v”üŽq1, “n粐^˛1,2, –Ř“cŒőL2, Źň˜aŽO˜Y2 (1–k—˘ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): ‘ć101‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2015/12/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): 106.

732019. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŠeŽ{Ý‚Ě“Á’Ľ‚𐜂Š‚ľ‚˝Á‰ťŠÇĂ–ŹáŽ‚̐f’f‚ĆŽĄ—ÁzƒqƒXƒgƒAƒNƒŠƒ‹’“ü‚âB-RTO‚đŠÜ‚߂ā@ś‘¤–ĺ–Źˆł˜´iÇ‚Ě’ˇŠú—\Œă‚ĚŒŸ“˘. ŒE“cK‰î1, “ú‚@‰›1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć101‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2015/12/13), “Œ‹ž, Prog Dig Endosc 88 (Suppl): S88.

732020. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď] (ƒVƒ“ƒ|ƒWƒEƒ€)yă•”ESD‚É‚¨‚Ż‚éTrouble Shootingz‚ą‚Ě‹Ç–Ę‚ą‚¤‚ľ‚ďć‚č‰z‚Ś‚˝ ESDŒăoŒŒ‚É‚ć‚čoŒŒŤƒVƒ‡ƒbƒN‚đ—ˆ‚ľ‹Ů‹}ŒŒŠÇ‘˘‰e (IVR) ‚ĹŽ~ŒŒˆ’u‚đŽ{s‚ľ‚˝1—á. Î‹´@˜Đ1, –î–ě‹MŽj1, “c糁@‘1,2, ˜a“c‘ń–ç1, ÎŒËŒŞŽŸ1, “Œ@’q1, Œ˜“ce—˜1, ˛X–Ř“O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć101‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2015/12/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): s99.

732021. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yEUS-FNA‚̍ŐV‚̐f’f‚ĆŽĄ—Ă: ŹŃEˆŔ‘SŤŒüă‚Ě‚˝‚ß‚ĚŽŔŰ‚ƍH•vz“–‰Č‚É‚¨‚Ż‚épancreatic fluid collection (PFC) ‚ɑ΂ˇ‚é’´‰š”g“ŕŽ‹‹ž‰şŽĄ—Â̐ŹŃ. ‹{“c‰pŽĄ1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ěŒű—C•ă1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŹňŽüŽq1, ŽR“ŕ_Žj1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, ‹e’nG•F1, “n•Ó–€–ë, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć101‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2015/12/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): s108.

732022. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) “Şčň•”•\ÝŠŕ‚̐f’f‚ĆŽĄ—Ă. Œ˜“ce—˜ (Á‰ťŠí“ŕ): ‘ć7‰ńESTABLISHŒ¤‹†‰ď (2016/2/5), Ă‰Ş.

732023. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Šî’˛u‰‰) isŠĚ×–E‚Ş‚ń‚ĚŽĄ—Ă, “–‰@‚Ě—Ő°ŒŸ“˘‚Š‚ç. ’†ŕV‹MG (Á‰ťŠí“ŕ): ƒ~ƒŠƒvƒ‰ƒGƒŠƒAƒtƒH[ƒ‰ƒ€ in Yokohama (2016/3/29), ‰Ą•l.

733027. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ç—á•ń) Ä”­‚đŒJ‚č•Ô‚ľ‚˝ƒEƒ‹ƒ\ƒfƒIƒLƒVƒR[ƒ‹Ž_‘’_ŠÇŒ‹Î‚Ě2—á. “n@—D1, ‹{ŕVŽu˜N1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, Ąň@O1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć614‰ńŠÖ“Œ’n•ű‰ď (2015/5/9), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď614‰ń 2015/5; p.29.

733028. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰)yGastroenterology Sessionzinvited Discussant. “Œ@’q (Á‰ťŠí“ŕ): The 2nd Sino-Japan Medical Exchange Forum (2015/5/13), “Œ‹ž.

733029. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) XP + ƒn[ƒZƒvƒ`ƒ“•š—p—Ă–@‚É‚ć‚čˆÝŘœp‚đŽ{s‚ľ“ž‚˝Řœ•s”\isˆÝŠŕ‚ĚŒŸ“˘. “Œ@’q (Á‰ťŠí“ŕ): Kanagawa Gastric Cancer Forum 2015 (2015/5/14), ‰Ą•l.

733030. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) 2015‚É‚¨‚Ż‚éˆÝŠŕŽĄ—Ă‚ĚŒťó. “Œ@’q (Á‰ťŠí“ŕ): ‘ć3‰ńă•”Á‰ťŠÇŠO‰Č•×‹­‰ď (2015/6/12), ‹ˇŽR.

733031. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ç—á•ń) ŠPšu‚đŒ_‹@‚É”­Ç‚ľ‚˝• •ÇŒŒŽî‚ɑ΂ľTAE‚Ş‘tŒř‚ľ‚˝1—á. ŹŽRŽŽ÷1, ‰ş“c‘ń–ç1,2, “ü]ˆős1, ź–{—Y‘ž1,2, ‹ĘáÁr•˝1,2, ’†‘ş—zŽq1, ›–ě@‘1,2, ˆŔ’B@ŒŁ1,2, •˝ěk‘ĺ1, ‘ëě­˜a1 (1‘—§‘Š–ÍŒ´•a‰@, 2Á‰ťŠí“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć615‰ńŠÖ“Œ’n•ű‰ď (2015/6/13), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď‘ć615‰ń´˜^W2015/6; p.24.

733032. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ç—á•ń) ‚Ń‚Ü‚ńZŒ^ăsŒ‹’°Œ´”­ˆŤŤƒŠƒ“ƒpŽî‚Ě2—á. ‹Ú‘ň‚ ‚č‚ł1, ˆäŒű–őO1, ‚čŒ[F1, •ž•”—F‰ĚŽq1, ŽR“c”Žş1, H“ĄŘ1, ˆäăr‘ž˜Y1, ź‘ş@ŒŤ1,2, ’†ŽR¸“T1,2, –{‹´@C1,2 (1_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć615‰ńŠÖ“Œ’n•ű‰ď (2015/6/13), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď615‰ń´˜^W 2015/6; p.25.

733033. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Á‰ťŠÇ‚Ş‚ńƒXƒNƒŠ[ƒjƒ“ƒO‚É‚¨‚Ż‚é“ŕŽ‹‹ž‚ĚˆĘ’u‚Ă‚Ż|H“šŠŕƒŠƒXƒNŒŸf–âf•[‚ÉŠî‚Ă‚˘‚˝“Şčň•”EH“š“ŕŽ‹‹žŒŸf‚Ě—Ő°“I—L—pŤ|. ‹ß“Ą—Y‹I1, Œ˜“ce—˜1, “c糁@‘1,2, ”óŒűŸ•F1, ˛X–Ř“O1, “Œ@’q1, ÎŒËŒŞŽŸ1, ˜a“c‘ń–ç1, –î–ě‹MŽj1, Źň˜aŽO˜Y1, ‰ĄŽR@Œ° (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć100‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2015/6/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/6; 87 (Suppl): 72.

733034. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Á‰ťŠÇoŒŒ‚𔺂¤Ź’°GIST‚É‚ć‚č‹Ů‹}Žčp‚đ—v‚ľ‚˝1—á. ˛–ě@“§1, –î–ě‹MŽj1,2, ăŒ´ˆę”ż1,2, ’†–Ú“N•˝1,2, Œ}@”üK1,2, Î•N_1,2, ‘ş“c@“Œ1,2, r–ؐł—Y1,2, ˛X–ŘˆęŒ›1, ‘Ščˆę—Y1 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć100‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2015/6/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/6; 87 (Suppl): 105.

733035. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ă•”“ŕŽ‹‹žŒŸ¸‚ɂĉ𗣐Ť‘ĺ“Ž–Ź”j—ô‚É‚ć‚éH“šú”j‚đŠm”F‚ľ“ž‚˝ˆę—á. ŠâčGˆę˜Y1, –î–ě‹MŽj2, ăŒ´ˆę”ż1,2, ’†–Ú“N•˝1,2, Œ}@”üK1,2, Î•N_1,2, ‘ş“c@“Œ1,2, r–ؐł—Y1,2, ‹g•@—E1 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć100‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2015/6/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/6; 87 (Suppl): 112.

733036. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Infliximab‚Ş’˜Œř‚ľ‚˝\“ńŽw’°•a•Ď‚đ—L‚ˇ‚é’×ᇐŤ‘ĺ’°‰Š‚Ě1—á. ˜a“cŽ‹v1, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ‘剪ł•˝1, ˛“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă: ‘ć100‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2015/6/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/6; 87 (Suppl): 118.

733037. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒƒLƒ\ƒvƒƒtƒFƒ“ƒiƒgƒŠƒEƒ€“ŕ•ž‚É‚ć‚čŒ°Ť‰ť‚ľ‚˝‚ƍl‚Ś‚ç‚ę‚˝ŽŠŒČ–ƉuŤŠĚ‰Š‚Ě1—á. “c’†ŒŤ–ž1, ’†ŕV‹MG1, ŒE“cK‰î1, ‚“cŽ÷ˆę1, ‰œ˜e—T‰î1, “ú‚@‰›1, “ě–ě@•×1, a’J–ž—˛1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2ˆă—ĂŠÇ—): “ú–{“ŕ‰ČŠw‰ď‘ć615‰ńŠÖ“Œ’n•ű‰ď (2015/6/13), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď615‰ń´˜^W 2015/6; p.25.

733038. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”’ŒŒ‹…œ‹Ž—Ă–@ERTNF-ƒżR‘Ě•š—p—Ă–@‚Ş—L—p‚Ĺ‚ ‚Á‚˝’×ᇐŤ‘ĺ’°‰Š‚Ě1—á. –ƒśŒ’ˆę˜N1, ‰ĄŽR@ŒO1 (1Á‰ťŠí“ŕ): ‘ć3‰ńIBD’nˆćˆă—Ă˜AŒg‚̉ď (2015/7/9), ‘Š–ÍŒ´.

733039. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) HER2—zŤˆÝŠŕ‚ɑ΂ľ‚ĉťŠw—Ă–@‚Ĺ’ˇŠúś‘ś‚ľ‚˝ˆę—á. •{‹M_1, “Œ@’q1, ‰Íź“Ţ’ĂŽq2, ŽRŞ‘‹IŽq2, —é–ؐl2, ˜a“c‘ń–ç1, –î–ě‹MŽj1, ÎŒËŒŞŽŸ1, Œ˜“ce—˜1, ˛X–Ř“O1, “c糁@‘1,3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć60‰ń_“ސěÁ‰ťŠí•aŒ¤‹†‰ď (2015/7/11), ‰Ą•l.

733040. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ç—á•ń) “Žœ§‚đŽĺ‘i‚Ć‚ľ‚˝upside down stomach‚đ’ć‚ľ‚˝H“š—ôEƒwƒ‹ƒjƒA‚Ě1—á. ”öă”üŒb1, ÎŒËŒŞŽŸ1, “c糁@‘1,2, ˜a“c‘ń–ç1, –î–ě‹MŽj1, “Œ@’q1, Œ˜“ce—˜1, ˛X–Ř“O1, Źň˜aŽO˜Y1, X’JGŒő3 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ŠO‰Č): “ú–{“ŕ‰ČŠw‰ď‘ć616‰ńŠÖ“Œ’n•ű‰ď (2015/7/19), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď616‰ń´˜^W 2015/7; p.39.

733041. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) H“šŠŕ‚̏WŠw“IŽĄ—Ă‚É‚¨‚Ż‚éV‚˝‚ȉťŠw—Ă–@‚Ě–đŠ„|DCFƒPƒ‚ƒZƒŒƒNƒVƒ‡ƒ“|. Œ˜“ce—˜1, “Œ@’q1, “c糁@‘1,2, Źň˜aŽO˜Y1, ŹXłŽq3, ÎŽR”ŽžŠ3, ‘ě˜ad3, •Đ“c‰Ä–ç4, X’JGŒő4, ŽR‰şŒpŽj4 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3•úŽËü (Žîá‡), 4ŠO‰Č): ‘ć29‰ń–k—˘ŽîᇃtƒH[ƒ‰ƒ€ (2015/7/31), ‘Š–ÍŒ´.

733042. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) äBĂ–ŹÇđ‚⋡ó‚É‹Nˆö‚ˇ‚éˆÝĂ–ŹáŽ‚Ě’ˇŠú—\Œă‚ĚŒŸ“˘. “ú‚@‰›1, ŒE“cK‰î1, ŽRŞŒhŽq2, ˆäă’qm2, ‚“cŽ÷ˆę1, “c’†ŒŤ–ž1, ‰œ˜e—T‰î1, ’†ŕV‹MG1, a’J–ž—˛1,3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ĂŠÇ—): ‘ć4‰ńäB‘ŸŒ¤‹†‰ď (2015/9/11), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2015/8; 21 (3): 185.

733043. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒ_ƒNƒ‰ƒ^ƒXƒrƒ‹EƒAƒXƒiƒvƒŒƒrƒ‹•š—p—Ă–@’†‚Ébreakthrough‚đ—ˆ‚ľ‚˝CŒ^–ŤŠĚ‰Š‚Ě7—á. ŽRŞŒhŽq1, ’†ŕV‹MG2, ˆäă’qm1, ŒE“cK‰î2, “c’†ŒŤ–ž2, ‚“cŽ÷ˆę2, ‰œ˜e—T‰î2, “ú‚@‰›2, a’J–ž—˛2,3, Źň˜aŽO˜Y2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Á‰ťŠí“ŕ, 3ˆă—ĂŠÇ—): ‘ć30‰ń_“ސěƒEƒCƒ‹ƒXŠĚ‰ŠƒZƒ~ƒi[ (2015/9/24), ‰Ą•l.

733044. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) CTRX‚Ş’˜Œř‚ľ‚˝ƒpƒ‰ƒ`ƒtƒX‚Ěˆę—á. ”‹Œ´šD, ŒE“cK‰î1, “ú‚@‰›1, ‚“cŽ÷ˆę1, “c’†ŒŤ–ž1, ‰œ˜e—T‰î1, ’†ŕV‹MG1, a’J–ž—˛1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2ˆă—ĂŠÇ—): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733045. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ESD‚ɂĈݑBG•˝ă”çŠŕ‚Ɛf’f‚ľ‚˝1—á. •{‹M_1, –î–ě‹MŽj1, ‰Íź“Ţ’ĂŽq2, —é–ؐl2, ŽRŞ‘‹IŽq2, ˜a“c‘ń–ç1, ÎŒËŒŞŽŸ1, “Œ@’q1, Œ˜“ce—˜1, ˛X–Ř“O1, Źň˜aŽO˜Y1, “c糁@‘1,3, ‘ĺ•”@˝4 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3V˘‹Iˆă—ÁEć’[ˆă—Ă, 4ˆă—ÉqśŠw•”): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733046. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) EUS-FNA‚Őf’f‚ľ“ž‚˝ŠĚ–ĺ•”_ŒoâŽî‚Ěˆę—á. ‹{“c‰pŽĄ1, ŽR“ŕ_Žj1, –Ř“cŒőL1, ěŒű—C•ă1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ŽO“‡Fm1, ‹ŕŽq@‹œ1, ŹňŽüŽq1, ‰œ˜e‹ť‰î1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ’|ŕVŽO‘ăŽq1, ‹e’nG•F1, “n•Ó–€–ç1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733047. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ICGŽŽ–ň‚đ—p‚˘‚˝ŒŒŠÇ‘˘‰eŒŸ¸‚ɂďăsŒ‹’°Ă–ŹŠďŒ`‚đ“ŕŽ‹‹ž‰ş‚ĹŠm”F‚ľ“ž‚˝1—á. ‹e“c˜a‹M1, ‰ş“c‘ń–ç1,2, ŹŽRŽŽ÷1, äřŒ´Ť—Ç1,2, “ü]ˆős1, ź–{—Y‘ž1,2, ‹ĘáÁr•˝1,2, ’†‘ş—zŽq1, ›–ě@‘1,2, ˆŔ’B@ŒŁ1,2, •˝ěk‘ĺ1, “cŒű’qŽq1, ‘ëě’qŽq1, ‘ëě­˜a1 (1‘—§‘Š–ÍŒ´•a‰@, 2Á‰ťŠí“ŕ): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733048. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‰ťŠw•úŽËü—Ă–@‚Ş’˜Œř‚ľ‚˝ăč–ĺŠĚŠŕ‚Ě1—á. ‹v•Ű“c—z1,2, ŽRčDŠě1,2, ‹ß“Ą—Y‹I1,2, –kě”Ž”V1,2, ‰Íźčű‘ž˜Y2, Ź–с@“N1,2, ‹e’nG•F1,2, —˘“š“N•F1,2, –ě“o@˝1,2 (1Á‰ťŠí“ŕ, 2•˝’Ë‹¤Ď•a‰@): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733049. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‰ťŠw•úŽËü—Ă–@‚ĆŠO‰Č“IŽĄ—Ă‚É‚ć‚čCR‚ÉŽŠ‚Á‚˝“ŻŽž3d•ĄŠŕ‚Ěˆę—á. ˜a“cŽ‹v1,2, ’†–Ú“N•˝1,2, ŽO“‡Fm1,2, ‹gŕV“Ţ’ĂŽq1,2, Œ}@”üK1,2, Î•N_1,2, ‘ş“c@“Œ1,2, r–ؐł—Y1,2 (1Á‰ťŠí“ŕ, 2‘Š–ÍŒ´‹Ś“Ż•a‰@): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733050. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠĚŠŕ‚Ć‚ĚŠÓ•Ę‚É‹ę—ś‚ľ‚˝ŠĚŽîᇂ̈ę—á. –Š@Ž‹M1, “ú‚@‰›1, ˆäă’qm2, ŽRŞŒhŽq2, ŒE“cK‰î1, ‚“cŽ÷ˆę1, “c’†ŒŤ–ž1, ‰œ˜e—T‰î1, ’†ŕV‹MG1, a’J–ž—˛1,3, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ĂŠÇ—): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733051. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) p‘Of’f‚ލ˘“ď‚Ĺ‚ ‚Á‚˝’ź’°inflammatory fibroid polyp‚Ěˆę—á. ě–ěšć’ˆ1, ˛“c”ü˜a1, ěŠÝ‰Á“Ţ1, ‘剪ł•˝1, ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1, “n粏š•F3, ˆęŒËš–ž4, ŽOŽ}@M4 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ŠO‰Č, 4•a—): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733052. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ă’°ŠÔ–Œ“Ž–ŹÇŒóŒQ‚Ć‚ĚŠÓ•Ę‚đ—v‚ľ‚˝\“ńŽw’°Šŕ‚Ěˆę—á. –k“‡ŽjŒ[1, ’†–Ú“N•˝1,2, ˜a“cŽ‹v1,2, ŽO“‡Fm1,2, ‹gŕV“Ţ’ĂŽq1,2, Œ}@”üK1,2, Î•N_1,2, ‘ş“c@“Œ1,2, r–ؐł—Y1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733053. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) V‹KProton Pomp Inhibiter (PPI): Vonoprazan fumarate‚đŽg—p‚ľ‚˝H.pyroli (HP) œ‹Ű‚Ě“–‰@‚̐ŹŃ|‘ć1•ń Rabeprazole‚Ć‚Ě”äŠr|. ŽOŽ}—zˆę1,2, ”üŒ´Ă1,2, “ü]@•ś1,2, ’|’J@Ę1,2, ×’J@’q1, ‹g“c@‹I1, źŒłŽ›ŽâX1,2, ‘ĺˆä“cłl1,2, ‹gŕV“Ţ’ĂŽq1,2, Ąč‹Mś1, “š‰ş—Y‰î1, Îˆä—˛Ži3 (1ŽĐ•Ű‘Š–Í–ě•a‰@, 2Á‰ťŠí“ŕ, 3ŒŒ‰t“ŕ): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733054. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒ_ƒNƒ‰ƒ^ƒXƒrƒ‹EƒAƒXƒiƒvƒŒƒrƒ‹•š—p—Ă–@’†‚Ébreakthrough‚đ—ˆ‚ľ‚˝CŒ^–ŤŠĚ‰Š‚Ě7—á. ŽRŞŒhŽq1, ’†ŕV‹MG2, ˆäă’qm1, ŒE“cK‰î2, “c’†ŒŤ–ž2, ‚“cŽ÷ˆę2, ‰œ˜e—T‰î2, “ú‚@‰›2, a’J–ž—˛2,3, Źň˜aŽO˜Y2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Á‰ťŠí“ŕ, 3ˆă—ĂŠÇ—): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733055. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’E•Ş‰ťŒ^Ž‰–b“÷Žî‚Ěˆę—á. ˛–ě@“§1, Œ}@”üK1,2, ˜a“cŽ‹v1,2, ŽO“‡Fm1,2, ‹gŕV“Ţ’ĂŽq1,2, Î•N_1,2, ‘ş“c@“Œ1,2, ’†–Ú“N•˝1,2, r–ؐł—Y1,2, ‘Ščˆę—Y1, ‰Í–ě@Œĺ1 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733056. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’_ÎƒCƒŒƒEƒX‚ɑ΂ľ‚Ä“d‹C…ˆłŐŒ‚”gÓp‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ˆę—á. ˆŔ’B@‰ő1,2, ‹ŕŽq@‹œ1,2, –ƒśŒ’ˆę˜N1, ’ˇ’Jě—Í–ç1,2, “ě–ě@•×1,2, “cŒ´‹v”üŽq1, “n粐^˛1,2, –Ř“cŒőL1 (1Á‰ťŠí“ŕ, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733057. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ”j—ô, oŒŒ‚ľ‚˝’PƒŤŠĚůN–E‚ɑ΂ľŒoƒJƒe[ƒeƒ‹“I“Ž–ŹÇđp (TAE) ‚đŽ{s‚ľ‚˝ˆę—á. ŽRé‘ń–ç, “n粐^˛1,2, ˆŔ’B@‰ő1,2, ’ˇ’Jě—Í–ç1,2, ‹ŕŽq@‹œ1,2, ‚‹´W•F1,2, ‘ĺ’ˏr˜a1,2, “ě–ě@•×1,2, “cŒ´‹v”üŽq1,2, ‰Ş“c•—Ď1, ‘ş“cWˆę˜Y1, •“c‰Ę—Ń1, ‰ĄXOş1 (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): “ú–{Á‰ťŠí•aŠw‰ďŠÖ“ŒŽx•”‘ć336‰ń—á‰ď (2015/9/26), “Œ‹ž.

733058. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ç—á•ń) Sister Mary Joseph's nodule‚É‚ć‚č”­ŒŠ‚ł‚ę‚˝“ŕ‘ŸˆŤŤŽîᇂĚ2—á. ‹ß“Ą—Y‹I1,2, ŽRčDŠě1,2, â“Œ@Œd1, ‹v•Ű“c—z1,2, –kě”Ž”V1,2, ‰ÍźŒ°‘ž˜Y1, Ź–с@“N1,2, ‹e’nG•F1,2, —˘“š“N•F1,2, –ě“o@˝1,2 (1•˝’Ë‹¤Ď•a‰@, 2Á‰ťŠí“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć618‰ńŠÖ“Œ’n•ű‰ď (2015/10/10), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď618‰ń´˜^W 2015/10; p.36.

733059. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) EUS-FNA‚Őf’f‚ÉŽŠ‚Á‚˝ˆŤŤƒŠƒ“ƒpŽî‚Ěˆę—á. ŒE“c@•j1, ŽO“‡Fm1,2, ˜a“cŽ‹v1,2, ‹gŕV“Ţ’ĂŽq1,2, ’†–Ú“N•˝1,2, Œ}@”üK1,2, Î•N_1,2, ‘ş“c@“Œ1,2, “n•Ó–€–ç1,2, r–ؐł—Y1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć140‰ń‘Š–ÍŒ´ˆÝ‚Ć’°Œ¤‹†‰ď (2015/10/28), ‘Š–ÍŒ´.

733060. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‘Ď“œ”\ˆŮí‚Ş”­ŒŠŒ_‹@‚Ć‚Č‚Á‚˝ŽŠŒČ–ƉuŤäX‰Š‚Ěˆę—á. –Š@Ž‹M1, ‹{ŕVŽu˜N1, ŽR“ŕ_Žj1, ‰œ˜e‹ť‰î1, Šâˆä’m‹v1, Ąň@O1, –Ř“cŒőL1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć140‰ń‘Š–ÍŒ´ˆÝ‚Ć’°Œ¤‹†‰ď (2015/10/28), ‘Š–ÍŒ´.

733061. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď] (ˆę”ĘŒű‰‰) f’f‚É‹ę—ś‚ľ‚˝äB‘ŸŒŒŠÇ“÷Žî‚Ěˆę—á. ŒE“cK‰î1, ‰œ˜e—T‰î1, “c’†ŒŤ–ž1, ‚“cŽ÷ˆę1, ’†ŕV‹MG1, “ú‚@‰›1, a’J–ž—˛2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2ˆă—ĂˆŔ‘SEŠÇ—): ‘ć48‰ń_“ŢěŒ§Á‰ťŠí•aˆăŠw‰ď‘‰ď (2015/10/31), V‰Ą•l, _“ސěˆăŠw‰ďŽGŽ 2016/1; 43 (1): 128.

733062. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ç—á•ń) ŠĚ‰ŠŒăÄś•s—ǐŤ•nŒŒ‚Ě1—á. ‘ĺ–ě‰äŽq1, ŽR–{@‘n1,2, ‘ĺ–ě@—˛1,2 (1ˆÉ¨Œ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď‘ć619‰ń´˜^W (2015/11/14), “Œ‹ž, 2015/11; p.28.

733063. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‰şsŒ‹’°‹‘ĺŒeŽş‚Ěˆę—á. V‘ş’qŒČ1, ’†–Ú“N•˝1,2, ˜a“cŽ‹v1,2, ŽO“‡Fm1,2, ‹gŕV“Ţ’ĂŽq1,2, Œ}@”üK1,2, Î•N_1,2, ‘ş“c@“Œ1,2, r–ؐł—Y1,2, ˛X–ŘˆęŒ›1, ‰Í–ě@Œĺ1, •—ŠÔ‹Ĺ’j1 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): ‘ć101‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2015/12/12), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): 123.

733064. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œëš‹‚đŽĺ‘i‚É‚ľ‚Ä—ˆ‰@‚ľ‚˝H“š‚Ş‚ń‚Ě1Ç—á@š‹‰şˆÝƒJƒƒ‰ƒpƒX‚Ě—L—pŤ‚ɂ‚˘‚Ä. ŽOŽ}—zˆę1,2, ”üŒ´Ă1,2, “ü]@•ś1,2, ’|’J@Ę1,2, Îˆä—˛Ži3, ‹´–{ƒqƒƒR4, ŽR“ŕ‹M—Y1, –î“ŕŒ´’qŽq1, Ąč‹Mś1, ‘ĺˆä“cłl1,2 (1ŽĐ•Ű‘Š–Í–ě•a‰@, 2Á‰ťŠí“ŕ, 3ŒŒ‰t“ŕ, 4t‘Ÿ“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć620‰ńŠÖ“Œ’n•ű‰ď (2015/12/12), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď‘ć620‰ń´˜^W 2015/12; p.30.

733065. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹}‘Ź‚É‘‘ĺ‚ľ‚˝‘ĺ’°Diffuse large B-cell lymphoma‚ÉR-CHOP‚Ş’˜Œř‚ľ‚˝1—á. ŒĂ“c—S‰ŔŽq, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, ‘剪ł•˝1, ‹v•Ű“c”ü˜a1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć101‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2015/12/12), “Œ‹ž.

733066. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď] (ęCˆăƒZƒbƒVƒ‡ƒ“) EUS-FNA‚É‚ć‚čp‘O•a—f’f‚ľ“ž‚˝mixed Acinar endocrine carcinoma‚Ě1—á. –Š@Ž‹M1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, ěŒű—C•ă1, ‹{“c‰pŽĄ1, ’ˇ’Jě—Í–ç1, ź–{‚–ž1, ŽR“ŕ_Žj1, ‹ŕŽq@‹œ1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ): ‘ć101‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2015/12/12), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): s116.

733067. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʉ‰‘č) Š´őŒo˜H‚Ě“Ż’č‚Ĺ‚Ť‚Č‚Š‚Á‚˝‚—î”­ÇƒAƒ[ƒoÔ—Ÿ‘ĺ’°‰Š‚Ě1—á. ‹ß“Ą—Y‹I1,2, ŽRčDŠě1,2, Šâ–{—Y‘ž˜Y1, ŽR‰ş—Žq1, ”’ě—‰i1, ‹v•Ű“c—z1,2, –kě”Ž”V1,2, ‰Íźčű‘ž˜Y1, Ź–с@“N1,2, ‹e’nG•F1,2, ŕ_–źr–ç1, —˘“š“N•F1,2, –ě“o@˝1,2 (1•˝’Ë‹¤Ď•a‰@, 2Á‰ťŠí“ŕ): ‘ć101‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“ŒŽx•”—á‰ď (2015/12/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): 128.

733068. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) •ÖöŒŒ—zŤ‚đŒ_‹@‚É–łÇó‚Ĺ”­ŒŠ‚ł‚ę‚˝’°Œ‹Šj‚Ě1—á. äřŒ´Ť—Ç1,2, ‰ş“c‘ń–ç1,2, ŹŽRŽŽ÷1, ‹e“c˜a‹M1, “ü]ˆős1, ‹ĘáÁr•˝1,2, ’†‘ş—zŽq1, ›–ě@‘1,2, ˆŔ’B@ŒŁ1,2, Œ}@”üK1,2 (1‘—§‘Š–ÍŒ´•a‰@, 2Á‰ťŠí“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć621‰ńŠÖ“Œ’n•ű‰ď (2016/2/13), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď‘ć621‰ń´˜^W 2016/2; p.31.

733069. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŠúŒ´”­Ť’_`ŤŠĚd•Ď‚đ‡•š‚ľ‚Ä‚˘‚˝‹}Ť”­ÇŒ^ŽŠŒČ–ƉuŤŠĚ‰Š‚Ě1—á. ‚‹´‰ŘŽq1, “n粐^˛1,2, •“c‰Ę—Ń1, ˆŔ’B@‰ő1,2, ’ˇ’Jě—Í–ç1,2, ‹ŕŽq@‹œ1,2, ‚‹´W•F1,2, ‘ĺ’ˏr˜a1,2, “ě–ě@•×1,2, “cŒ´‹v”üŽq1,2 (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć621‰ńŠÖ“Œ’n•ű‰ď (2016/2/13), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď‘ć621‰ń´˜^W 2016/2; p.33.

733070. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď] (ˆę”ĘŒű‰‰) SAPHOÇŒóŒQ‚Ć’×ᇐŤ‘ĺ’°‰Š‚̍‡•š‚ÉTacrolimus‚Ş’˜Œř‚ľ‚˝1—á. ‹ŕŕV@, ěŠÝ‰Á“Ţ1, ‰ĄŽR@ŒO1, Ź—ѐ´“T1,2, Źň˜aŽO˜Y1, ˜a“c’B•F3 (1Á‰ťŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3äPŒ´•aEŠ´ő“ŕ): ‘ć622‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (2016/3/12), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď622‰ń 2016/3; p.58.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-110003. [Œ´’˜] Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system. Yamaguchi T, Machida N, Morizane C, Kasuga A, Takahashi H, Sudo K, Nishina T, Tobimatsu K, Ishido K1, Furuse J, Boku N, Okusaka T: Cancer Sci 2014/9; 105 (9): 1176-81. (ÎŒËŒŞŽŸ1: 1Á‰ťŠí“ŕ)

H26-320002. [Ç—á•ń]y“ÁW: ŠÖß’ɂƔ畆ŽžŠłz—Տ°—á: ˆÝŠŕ‚Ş”­ŒŠ‚ł‚ę‚˝IgA vasculitis. •ŽRhŽq1, ŽR–{—I”ň1, ‘O“cCŽq1, —é–ؐl1,2, Œ´“c@_1, ‘‰Y‹MŽj1 (1•˝’Ë‹¤Ď•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ”畆•af—Ă 2015/2; 37 (2): 143-6.

H26-320003. [Ç—á•ń] ŒoŒű’_“š‹ž‚ޏp‘Of’f‚É—L—p‚Ĺ‚ ‚Á‚˝’_ŠÇ“ŕ“ű“ޏóŽîᇂĚ1—á. ě–ěšć’ˆ1, ‰œ˜e‹ť‰î1, –Ř“cŒőL1, Ąň@O1, ‹{ŕVŽu˜N1, Šâˆä’m‹v1, ŽR“ŕ_Žj1, ‹ŕŽq@‹œ1, ’|ŕVŽO‘ăŽq1, ‘ĺ•”@˝2, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ, 2ˆă—ÉqśŠw•”): ’_“š 2015/3; 29 (1): 103-9.

H26-522002. [uŔ]y“ÁW: ‚ą‚ą‚Ü‚Ĺ‚Ĺ‚Ť‚é! Á‰ťŠí“ŕŽ‹‹žŽĄ—ÁzÁ‰ťŠÇŽžŠł@ă•”Á‰ťŠÇoŒŒ‚ɑ΂ˇ‚é“ŕŽ‹‹ž“IŽ~ŒŒ. “c糁@‘1,2, ÎŒËŒŞŽŸ2, “Œ@’q2, Œ˜“ce—˜2, ˜a“c‘ń–ç2, –î–ě‹MŽj2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ): Źl•a‚ƐśŠˆKŠľ•a 2015/3; 45 (3): 295-302.

[’˜@‘]

H26-620004. [Šwp‘ (•Ş’SŽˇ•M)]y‚ׂŠ‚炸W2015 Don'ts in Endoscopy (Á‰ťŠí“ŕŽ‹‹ž2ŒŽ‘‘ĺ†)zuˆÝE\“ńŽw’°v‚ׂŠ‚炸@EUS (ę—p‹@E×Œaƒvƒ[ƒu), p.238-40. –Ř“cŒőL1, Ąň@O1, Źň˜aŽO˜Y1 (1Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2015/2”­s.

H26-620005. [Šwp‘ (•Ş’SŽˇ•M)]y‚ׂŠ‚炸W2015 Don'ts in Endoscopy (Á‰ťŠí“ŕŽ‹‹ž2ŒŽ‘‘ĺ†)zu‘ĺ’°v‚ׂŠ‚炸@‘ĺ’°“ŕŽ‹‹ž‘}“ü, p.260-1. ç–쏻Žq1, ŠÝŒ´‹Pm1, ŒÜ\—’łL1,2 (1‚Ş‚ńŒ¤—L–ž•a‰@, 2Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2015/2”­s.

H26-620006. [Šwp‘ (•Ş’SŽˇ•M)]y‚ׂŠ‚炸W2015 Don'ts in Endoscopy (Á‰ťŠí“ŕŽ‹‹ž2ŒŽ‘‘ĺ†)zu‘ĺ’°v‚ׂŠ‚炸@EUS|5‚‚ׂ̂Š‚炸, p.270-1. Ź—ѐ´“T1,2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2015/2”­s.

H26-620007. [Šwp‘ (•Ş’SŽˇ•M)]y‘‚í‚Š‚č Á‰ťŠí“ŕŽ‹‹žŠÖ˜AƒKƒCƒhƒ‰ƒCƒ“‚Ě‚ˇ‚×‚Ä (Á‰ťŠí“ŕŽ‹‹ž3ŒŽ‘‘ĺ†)zŠe˜_ [Á‰ťŠÇ‘S”Ę‚É‹y‚Ô‚ŕ‚Ě]@ƒGƒrƒfƒ“ƒX‚ĆƒRƒ“ƒZƒ“ƒTƒX‚đ“‡‚ľ‚˝’×ᇐŤ‘ĺ’°‰Š‚̐f—ĂƒKƒCƒhƒ‰ƒCƒ“, p.486-9. Ź—ѐ´“T1,2, ‰ĄŽR@ŒO2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2015/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H26-712001. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) How to Get Maximum Yield with EUS-FNA. Imaizumi H1: Asian EUS group 2015 (2015/2/2), Bangkok, Thai. (Ąň@O1: 1Á‰ťŠí“ŕ)

H26-731001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚ĚĹ‹ß‚Ě“ŽŒü‚Ɛf—ĂƒKƒCƒhƒ‰ƒCƒ“‰ü’ů‚ÉŒü‚Ż‚˝Žć‚č‘g‚Ý. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć28‰ńěŒűÁ‰ťŠí•a§˜b‰ď (2015/2/12), ěŒű.

H26-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ’źŽ‹Œ^EŽÎŽ‹Œ^ƒXƒR[ƒv‚É‚ć‚éInterventonal EUS. –Ř“cŒőL (Á‰ťŠí“ŕ): ‘ć14‰ń‘ŰÁ‰ťŠí“ŕŽ‹‹žƒZƒ~ƒi[ (Yokohama Live Demonstration) (2015/3/8), ‰Ą•l.

H26-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ç—á•ń) ˜’É‚Ĺ”­Ç‚ľ, ‹}Œƒ‚ɐis‚ľ‚˝‘˝‘ŸŠí•s‘S‚Ě1—á. _ŽR‹X–ç1, ’|“ŕ”ŽŽ÷1, “ěě@ăÄ1, ’F@—şŽq1, ŒE“cK‰î2, “c’†‰h‘ž˜Y1, ‰Ş“cŒöÍ1 (1ˆÉ¨Œ´‹Ś“Ż•a‰@, 2Á‰ťŠí“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć613‰ńŠÖ“Œ’n•ű‰ď (2015/3/14), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď613‰ń´˜^W 2015/3; p.56.

H26-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒ\ƒ‰ƒtƒFƒjƒu400 mgŠJŽn‚Ě—LŒřŤ‚ĆˆŔ‘SŤ‚ɂ‚˘‚Ä: ‘˝Ž{Ý‹¤“ŻŒ¤‹†‚É‚¨‚Ż‚éPropensity score-matched analysis. Ź—с@’q1, X–{@Šw1, Ŕ“c˜aŽi1, ‹ß“ĄłW1, ‘ĺěLˆę1, “ú‚@‰›2, ’†ŕV‹MG2, ‰œ˜e—T‰î2, ‰œŁçH1, ź‰iŒő‘ž˜Y1, —é–Ř’Ę”Ž1, X“c’qŽ‹1, “cŒIł—˛1, “c’†Ž–ž1 (1_“ŢěŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Á‰ťŠí“ŕ): ‘ć11‰ń“ú–{ŠĚ‚Ş‚ń•ŞŽq•W“IŽĄ—ĂŒ¤‹†‰ď (2015/1/31), “Œ‹ž, The Liver Cancer Journal 2015/6; 7 (2): 134-5.

‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č@Á‰ťŠí“ŕ‰ČŠw
Šń•uŔu‰ŠÇŤ’°ŽžŠł—Տ°Œ¤‹†uŔv

[Šwp˜_•ś]

110096. [Œ´’˜] Adalimumab for the treatment of Japanese patients with intestinal Behet's disease. Tanida S, Inoue N, Kobayashi K, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Ngahori M, Motoya S, Nkamura S, Arora V, Robinson AM, Thakkar RB, Hibi T1,2: Clin Gastroenterol Hepatol 2015/5; 13 (5): 940-8.e3. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110097. [Œ´’˜] Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C. Chu PS, Ebinuma H, Nakamoto N, Sugiyama K, Usui S, Wakayama Y, Taniki N, Yamaguchi A, Shiba S, Yamagishi Y, Wakita T, Hibi T1,2, Saito H, Kanai T: PLoS One 2015/5; 10 (5): e0125664. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110098. [Œ´’˜] Computer-Aided Prediction of Long-Term Prognosis of Patients with Ulcerative Colitis after Cytoapheresis Therapy. Takayama T, Okamoto S, Hisamatsu T, Naganuma M, Matsuoka K, Mizuno S, Bessho R, Hibi T1,2, Kanai T: PLoS One 2015/6; 10 (6): e0131197. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110099. [Œ´’˜] Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response to Treatment for Crohn's Disease: A Prospective Clinical Trial. Suzuki Y, Matsui T, Ito H, Ashida T, Nakamura S, Motoya S, Matsumoto T, Sato N, Ozaki K, Watanabe M, Hibi T1,2: Inflamm Bowel Dis 2015/9; 21 (9): 2114-22. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110100. [Œ´’˜] Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission. Hisamatsu T, Ono N, Imaizumi A, Mori M, Suzuki H, Uo M, Hashimoto M, Naganuma M, Matsuoka K, Mizuno S, Kitazume MT, Yajima T, Ogata H, Iwao Y, Hibi T1,2, Kanai T: PLoS One 2015/10; 10 (10): e0140716. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110101. [Œ´’˜] A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene, Encoding a Prostaglandin Transporter. Umeno J, Hisamatsu T, Esaki M, Hirano A, Kubokura N, Asano K, Kochi S, Yanai S, Fuyuno Y, Shimamura K, Hosoe N, Ogata H, Watanabe T, Aoyagi K, Ooi H, Watanabe K, Yasukawa S, Hirai F, Matsui T, Iida M, Yao T, Hibi T1,2, Kosaki K, Kanai T, Kitazono T, Matsumoto T: PLoS Genet 2015/11; 11 (11): e1005581. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110102. [Œ´’˜] An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease. Yoshimura N, Yokoyama Y, Matsuoka K, Takahashi H, Iwakiri R, Yamamoto T, Nakagawa T, Fukuchi T, Motoya S, Kunisaki R, Kato S, Hirai F, Ishiguro Y, Tanida S, Hiraoka S, Mitsuyama K, Ishihara S, Tanaka S, Otaka M, Osada T, Kagaya T, Suzuki Y, Nakase H, Hanai H, Watanabe K, Kashiwagi N, Hibi T1,2: BMC Gastroenterol 2015/11; 15: 163. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110103. [Œ´’˜] Risk factors for decreased bone mineral density in inflammatory bowel disease: A cross-sectional study. Wada Y, Hisamatsu T, Naganuma M, Matsuoka K, Okamoto S, Inoue N, Yajima T, Kouyama K, Iwao Y, Ogata H, Hibi T1,2, Abe T, Kanai T: Clin Nutr 2015/12; 34 (6): 1202-9. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110104. [Œ´’˜] Safety and Efficacy of AJM300, an Oral Antagonist of ƒż4 Integrin, in Induction Therapy for Patients With Active Ulcerative Colitis. Yoshimura N1, Watanabe M1, Motoya S1, Tominaga K1, Matsuoka K1, Iwakiri R1, Watanabe K1, Hibi T1,2,3 (1AJM300 Study Group): Gastroenterology 2015/12; 149 (7): 1775-1783.e2. (“ú”ä‹I•ś1,2,3: 2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110105. [Œ´’˜] Asia Pacific Consensus Statements on Crohn's disease. Part 1: Definition, diagnosis, and epidemiology: (Asia Pacific Crohn's Disease Consensus--Part 1). Ooi CJ1, Makharia GK1, Hilmi I1, Gibson PR1, Fock KM1, Ahuja V1, Ling KL1, Lim WC1, Thia KT1, Wei SC1, Leung WK1, Koh PK1, Gearry RB1, Goh KL1, Ouyang Q1, Sollano J1, Manatsathit S1, de Silva HJ1, Rerknimitr R1, Pisespongsa P1, Abu Hassan MR1, Sung J1, Hibi T1,2,3, Boey CC1, Moran N1, Leong RW1 (1Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease): J Gastroenterol Hepatol 2016/1; 31 (1): 45-55. (“ú”ä‹I•ś1,2,3: 2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110106. [Œ´’˜] Asia-Pacific consensus statements on Crohn's disease. Part 2: Management. Ooi CJ1, Makharia GK1, Hilmi I1, Gibson PR1, Fock KM1, Ahuja V1, Ling KL1, Lim WC1, Thia KT1, Wei SC1, Leung WK1, Koh PK1, Gearry RB1, Goh KL1, Ouyang Q1, Sollano J1, Manatsathit S1, de Silva HJ1, Rerknimitr R1, Pisespongsa P1, Abu Hassan MR1, Sung J1, Hibi T1,2,3, Boey CC1, Moran N1, Leong RW1 (1Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease): J Gastroenterol Hepatol 2016/1; 31 (1): 56-68. (“ú”ä‹I•ś1,2,3: 2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110107. [Œ´’˜] Efficacy and safety of two pH-dependent-release mesalamine doses in moderately active ulcerative colitis: a multicenter, randomized, double-blind, parallel-group study. Suzuki Y, Iida M, Ito H, Saida I, Hibi T1,2: Intest Res 2016/1; 14 (1): 50-9. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110108. [Œ´’˜] Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn's Disease. Suzuki Y, Iida M, Ito H, Tachikawa N, Hibi T1,2: Drugs R D 2016/3; 16 (1): 35-43. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110109. [Œ´’˜] First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis. Kobayashi T, Suzuki Y, Motoya S, Hirai F, Ogata H, Ito H, Sato N, Ozaki K, Watanabe M, Hibi T1,2: J Gastroenterol 2016/3; 51 (3): 241-51. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

120010. [Œ´’˜] ‰ŠÇŤ’°ŽžŠłŠłŽŇ‚É‚¨‚Ż‚鍂’ŁŤ’°ŠÇôňÜ (ƒ‚ƒrƒvƒŒƒbƒv) ‚ĚŽó—eŤ, —LŒřŤ, ˆŔ‘SŤ‚ĚŒŸ“˘. ‰Á“Ą–ƒ—RŽq1, Ź—с@‘ń1, ˜a“c—R‰Á—˜1, X‚˝‚ž‚Ś1, ŽÄ“c‡Žq1, ’†–ě@‰ë1, ‹ÚŕV@G1, ’ˇŔ@˝1, Î‹´‚Ć‚ć‚Ý1, ”~“c’qŽq1, “n•ÓŒ›–ž1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{‘ĺ’°ŒŸ¸Šw‰ďŽGŽ 2016/3; 32 (2): 91-8.

320012. [Ç—á•ń] ă•”Á‰ťŠÇ“ŕŽ‹‹žŒŸ¸‚Ĺ‹ô‘R”­ŒŠ‚ł‚ę‚˝Hamartomatous inverted polyp‚Ě1—á. Xě@~1, ’†–ě@‰ë1, Ź—с@‘ń1, ”~“c’qŽq1, ´…´1, ”óŒű@”Ł1, íź@—ß1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “y–{Š°“ń1, “ú”ä‹I•ś1,2, ‘ĺěš‹`1, X‰ił“ń˜Y1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Progress of Digestive Endoscopy 2015/12; 87 (1): 108-9.


521004. [‰đŕ]yˆăŠw—pŒę‰đŕz’PƒŤ’×á‡/’°ŠÇƒx[ƒ`ƒFƒbƒg•a. “ú”ä‹I•ś1,2, ‹vź—ˆę (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): G.I.Research 2015/6; 23 (3): 252-3.

521005. [‰đŕ]yˆăŠw—pŒę‰đŕzNFIL3 (E4BP4). “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): G.I.Research 2015/6; 23 (3): 254-5.

521006. [‰đŕ]yĹVE–ň•¨ŽĄ—Ă‚ĚŽŔŰz’×ᇐŤ‘ĺ’°‰Š‚É‚¨‚Ż‚é–ň•¨ŽĄ—Ă. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): CLINIC magazine 2015/8; 42 (8): 21-4.

521007. [‰đŕ]yŽż‹^‰ž“šz—Տ°ˆę”Ę [“ŕ‰Č: zŠÂŠí] ’×ᇐŤ‘ĺ’°‰Š‚ĚŠ°‰đˆŰŽ—Ă–@‚É‚¨‚Ż‚é“Š–ň‚Ć‹x–ň. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{ˆăŽ–V•ń 2015/9; 4769: 67-8.

521008. [‰đŕ]y•a‘ԁEŽĄ—ĂQ&A: “ÁŽęŒ^ƒx[ƒ`ƒFƒbƒg•az’°ŠÇŒ^ƒx[ƒ`ƒFƒbƒg•a‚ɂ‚˘‚Ä‚¨‹ł‚Ś‚­‚ž‚ł‚˘. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): —Տ°‚Ě‚ ‚ä‚Ý 2015/9; 99: 9-10.

522044. [uŔ]y“ÁW: ś•¨Šw“IťÜ‚Ş‘ń‚­IBDf—Â̐VŽž‘ăz‚ą‚ę‚Š‚çŠú‘Ň‚ł‚ę‚鐜•¨Šw“IťÜ. “ú”ä‹I•ś1,2, ‹vź—ˆę1, ꎓĄ‰rŽq1, –L‰i‹M•F1, Ź—с@‘ń1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Mebio 2015/8; 32 (8): 78-85.

522045. [uŔ]y“ÁW: “ŕ‰Čƒvƒ‰ƒCƒ}ƒŠƒPƒA‚Ě‚˝‚ß‚ĚÁ‰ťŠíf—ĂUpdatezĄŹ’°E‘ĺ’°ŽžŠł@’×ᇐŤ‘ĺ’°‰Š. —с@‘ń1, ’†–ě@‰ë1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Medicina 2015/9; 52 (10): 1714-6.

522046. [uŔ]y“ÁW: ‰ŠÇŤ’°ŽžŠł|ƒtƒ@[ƒXƒgƒ^ƒbƒ`‚Š‚ç’ˇŠúƒ}ƒlƒWƒƒ“ƒg‚܂Łz‰ŠÇŤ’°ŽžŠł‚̐f’f@•aŒ^‚ƏdÇ“x‚Ě”ť’č. Ź—с@‘ń1, ’†–ě@‰ë1, ꎓĄ‰rŽq1, –L‰i‹M•F1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ŕ‰Č 2015/10; 116 (4): 565-8.

522047. [uŔ]y“ÁW: IBDƒ`[ƒ€ˆă—Ă‚É‚¨‚Ż‚郁ƒ“ƒo[‚Ě–đŠ„‚Ć–â‘č“_‚đ–ž‚ç‚Š‚É‚ˇ‚é!zIBDƒ`[ƒ€ˆă—Ă‚É‚¨‚Ż‚éˆăŽt (Á‰ťŠíˆă) ‚Ě–đŠ„. Ź—с@‘ń1, –L‰i‹M•F1, ꎓĄ‰rŽq1, ’†–ě@‰ë1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): IBD Research 2015/12; 9 (4): 238-42.

522048. [uŔ]y“ÁW: IBDƒ`[ƒ€ˆă—Ă‚É‚¨‚Ż‚郁ƒ“ƒo[‚Ě–đŠ„‚Ć–â‘č“_‚đ–ž‚ç‚Š‚É‚ˇ‚é!zIBDƒ`[ƒ€ˆă—Ă‚É‚¨‚Ż‚é–ňÜŽt‚Ě–đŠ„. ”Ş–ŘŕVŒ[Ži1, ‚–ěĆŽq1, ’†‘şr‹M1, ŠLŔ@1, Ź—с@‘ń1, źŒ´@”Ł2, “ú”ä ‹I•ś1,3 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2–ňŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): IBD Research 2015/12; 9 (4): 257-61.

522049. [uŔ]y“ÁW: ƒ`[ƒ€ˆă—ÁEˆă—Ă˜AŒg‚đl‚Ś‚ézƒ`[ƒ€ˆă—Ă: ‰ŠÇŤ’°ŽžŠł. “ú”ä ‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ƒNƒŠƒjƒVƒAƒ“ 2016/1; 63 (1): 33-7.

522050. [uŔ]y“ÁW: –ƉuŽžŠłUpdatez‰ŠÇŤ’°ŽžŠłŽĄ—Ă‚Ě—đŽj‚ƍĄŒă‚Ě“W–]. “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ƒNƒŠƒjƒVƒAƒ“ 2016/2; 63 (2): 122-6.

522051. [uŔ]y“ÁW: ƒNƒ[ƒ“•aŽĄ—Ă‚ĚĹ‘Oüz1. ‚ǂ̂悤‚ČÇ—á‚ɍRTNF-ƒżR‘̐ťÜ‚đŽg‚¤‚ׂŤ‚Š? “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): INTESTINE 2016/3; 20 (2): 127-32.

522052. [uŔ]yf’fuŔ: Ç—á‚Š‚çŠw‚ÔIBDŠÓ•Ęf’f‚ĚƒRƒcz‘ć29‰ń: IBD‚Ć’°ŠÇƒXƒsƒƒw[ƒ^Ç. ”~“c’qŽq1, Ź—с@‘ń1, “ú”ä‹I•ś1,2, X‰ił“ń˜Y1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): IBD Research 2016/3; 10 (1): 46-51.

530006. [‚ť‚Ě‘ź (Ž‹“_)] A new start for 'Intestinal Research' as an official journal of AOCC. Hibi T1,2: Intest Res 2016/1; 14 (1): 1. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

540005. [‚ť‚Ě‘ź (‰ď‹c˜^)] ‰ŠÇŤ’°ŽžŠłŠłŽŇ‚É‚¨‚Ż‚鍂’ŁŤ’°ŠÇôňÜ (ƒ‚ƒrƒvƒŒƒbƒv) ‚ĚŽó—eŤ, —LŒřŤ, ˆŔ‘SŤ‚ĚŒŸ“˘. ‰Á“Ą–ƒ—RŽq1, ˜a“c—R‰Á—˜1, ŽÄ“c‡Žq1, Ź—с@‘ń1, X‚˝‚ž‚Ś1, Î‹´‚Ć‚ć‚Ý1, ’†–ě@‰ë1, ‹ÚŕV@G1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ŠÖ“ŒÁ‰ťŠí“ŕŽ‹‹ž‹ZŽt‰ďŽ 2015/9; 22: 5-6.

540006. [‚ť‚Ě‘ź (‰ď‹c˜^)] ‰ŠÇŤ’°ŽžŠłŠłŽŇ‚É‚¨‚Ż‚éV‹K’°ŠÇôňÜ‚ĚŽó—eŤ, —LŒřŤ, ˆŔ‘SŤ‚ĚŒŸ“˘|”ń‰ŠÇŤ’°ŽžŠłŠłŽŇ‚Ć‚Ě”äŠr|. ‰Á“Ą–ƒ—RŽq1, ˜a“c—R‰Á—˜1, ŽÄ“c‡Žq1, Ź—с@‘ń1, X‚˝‚ž‚Ś1, Î‹´‚Ć‚ć‚Ý1, “ú”ä‹I•ś1,2, ’†–ě@‰ë1, ‹ÚŕV@G1, ’ˇŔ@˝1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{Á‰ťŠí“ŕŽ‹‹ž‹ZŽt‰ď‰ď•ń 2016/3; 56: 58.

[’˜@‘]

620029. [Šwp‘ (•Ş’SŽˇ•M)]y“ÁW: “ŕ‰ČŽžŠł‚̐f’fŠî€E•aŒ^•Ş—ށEdÇ“x (“ŕ‰Č2015”N6ŒŽ‘‘ĺ†)z‘ć2Í Á‰ťŠí@‰ŠÇŤ’°ŽžŠł, p.956-9. Ź—с@‘ń1, ’†–ě@‰ë1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č), “ě]“°, “Œ‹ž, 2015/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722029. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yIBDŽĄ—Ð헪‚É‚¨‚Ż‚é“ŕŽ‹‹ž‚Ě–đŠ„z‘ĺ’°“ŕŽ‹‹ž‚Ć•Ö’†ƒoƒCƒIƒ}[ƒJ[S100A12‚đ‘g‚ݍ‡‚í‚š‚˝’×ᇐŤ‘ĺ’°‰Š‚ĚŽĄ—Ð헪. Ź—с@‘ń1, ’†–ě@‰ë1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/29), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 691.

722030. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y”S–Œ–Ɖu‚Ɣ畆–Ɖuz—Տ°–ƉuŠw“IƒAƒvƒ[ƒ`‚Š‚ç‚Ý‚˝‰ŠÇŤ’°ŽžŠł‚ĚŽžŠłŠ´ŽóŤˆâ“`Žq. Ź—с@‘ń1, ’†–ě@‰ë1, –L‰i‹M•F1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć43‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď (2015/10/23), _ŒË, “ú–{—Տ°–ƉuŠw‰ď‰ďŽ 2015/9; 38 (4): 290.

722031. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yIBD‰ć‘œf’fƒ[ƒNƒVƒ‡ƒbƒvzƒNƒ[ƒ“•a‰“ˆĘ‰ń’°ŒŸő‚É‚¨‚Ż‚éŽó“Žœ]‹Č‚“`’B‘}“ü•”“‹Ú×Œa‘ĺ’°“ŕŽ‹‹žPCF-PQ260L‚Ě—L—pŤ‚ĚŒŸ“˘|MRƒGƒ“ƒeƒƒOƒ‰ƒtƒB[‚Ć‚Ě“Ż“úŽ{s‚ĚŒoŒą‚ć‚č|. ’†–ě@‰ë,1 Ź—с@‘ń1, ’†—˘Œ\G1, ”~“c’qŽq1, –L‰i‹M•F1, ꎓĄ‰rŽq1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć33‰ń“ú–{‘ĺ’°ŒŸ¸Šw‰ď (2015/11/7), “Œ‹ž, “ú–{‘ĺ’°ŒŸ¸Šw‰ďŽGŽ 2016/3; 32 (2): 129.

722032. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)y‘ĺ’°f—Ă‚É‚¨‚Ż‚é‘˝EŽíƒ`[ƒ€ˆă—Áz‰ŠÇŤ’°ŽžŠłf—Ă‚É‚¨‚Ż‚éƒ`[ƒ€ˆă—Ă‚ĚˆÓ‹`‚ĆŽć‚č‘g‚Ý. Ź—с@‘ń1, ’†–ě@‰ë1, “n•ÓŒ›–ž1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/13), –źŒĂ‰Ž, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2015/9; 68 (9): 634.

723189. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ŠÇŤ’°ŽžŠłŠłŽŇ‚É‚¨‚Ż‚郂ƒrƒvƒŒƒbƒv‚ĚŽó—eŤ, —LŒřŤ, ˆŔ‘SŤ‚ĚŒŸ“˘. ’†–ě@‰ë1, Ź—с@‘ń1, ‰Á“Ą–ƒ—RŽq1, ˜a“c—R‰Á—˜1, X‚˝‚ž‚Ś1, ŽÄ“c‡Žq1, ‹ÚŕV@G1, ’ˇŔ@˝1, Î‹´‚Ć‚ć‚Ý1, ”~“c’qŽq1, “n•ÓŒ›–ž1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/29-31), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl.1): 820.

723190. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‚Ž‰–bHŰŽćƒ}ƒEƒX‚Ě’°“ŕ×‹Ű•Ď‰ť. •Ŕ@’q1, Ź—с@‘ń1, ’|“ŕ@C1, ŒË“c‹žŽq1, íź@—ß1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć24‰ń“ú–{—Տ°ŠÂ‹ŤˆăŠw‰ďŠwpW‰ď (2015/6/6), “Œ‹ž, “ú–{—Տ°ŠÂ‹ŤˆăŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€E´˜^W24‰ń 2015/5; p.54.

723191. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ŠÇŤ’°ŽžŠłŠłŽŇ‚É‚¨‚Ż‚éV‹K’°ŠÇôňÜ‚ĚŽó—eŤ, —LŒřŤ, ˆŔ‘SŤ‚ĚŒŸ“˘|”ń‰ŠÇŤ’°ŽžŠłŠłŽŇ‚Ć‚Ě”äŠr|. ‰Á“Ą–ƒ—RŽq1, Ź—с@‘ń1, ˜a“c—R‰Á—˜1, ŽÄ“c‡Žq1, X‚˝‚ž‚Ś1, Î‹´‚Ć‚ć‚Ý1, “ú”ä‹I•ś1,2, ’†–ě@‰ë1, ‹ÚŕV@G1, ’ˇŔ@˝1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/10/8-10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (Suppl.2): 2256.

723192. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒXƒeƒƒCƒh‚Ş‘tŒ÷‚ľ‚˝ŠÖß‰ŠÇó‡•šdÇmicroscopic colitis‚Ěˆę—á. –L‰i‹M•F1, Ź—с@‘ń1, Ä“Ą‰rŽq1, ’†–ě@‰ë1, ”~“c’qŽq1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć43‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď (2015/10/23), _ŒË, “ú–{—Տ°–ƉuŠw‰ď‰ďŽ 2015/9; 38 (4): 375.

723193. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŠłŽŇ‚É‚¨‚Ż‚éƒ^ƒNƒƒŠƒ€ƒX‚Ě•ęW’c–ň•¨“Ž‘Ô‰đÍ. ŒF”WŒä“°š‰p1, “c’†@, ŽÂčŒöˆę, Ź—с@‘ń2, ’|“ŕ@C, •Ŕ@’q, ”~“c’qŽq, –L‰i‹M•F2, Ä“Ą‰rŽq2, ’†–ě@‰ë2, ‹ÚŕV@G2, “n•ÓŒ›–ž2, “n•Ó—R‹I, Î‹´‚Ć‚ć‚Ý, Î“cËˆę1, “ú”ä‹I•ś2,3, Ä“Ą‘žŽő, Ź—Ń‹`˜a, Ä“Ą‰ër (1–ňŠw•”, 2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{–ňŠw‰ď‘ć136”N‰ď (2016/3/27-29), ‰Ą•l, “ú–{–ňŠw‰ď”N‰ď—vŽ|W 2016/3; 136”N‰ď4†: 111.

723194. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ú–{l‰ŠÇŤ’°ŽžŠłŠłŽŇ‚Ěƒ`ƒIƒvƒŠƒ“—Ă–@‚É‚¨‚Ż‚éd“Ä‚Č”’ŒŒ‹…Œ¸­Ç‚ÉŠÖ˜A‚ˇ‚éˆâ“`—vˆö‚ĚŒŸ“˘. Šâč^ˆß1, “c’†—fˆę1, ‹ŕŕV‰ˇŽq1, Â–ŘŠwˆę1, ˆŔ“Ą@q1, ‰–ŒŠ‚ß‚Ž‚Ý1, a’J@´1, ‹v•Ű“c—Œb1, “ú”ä‹I•ś2,3, Ź‹{ŽR‹MŽq1 (1–ňŠw•”, 2–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{–ňŠw‰ď‘ć136”N‰ď (2016/3/27-29), ‰Ą•l, “ú–{–ňŠw‰ď”N‰ď—vŽ|W 2016/3; 136”N‰ď4†: 148.

733071. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰)yŒ¤CˆăƒZƒbƒVƒ‡ƒ“zƒXƒNƒŠ[ƒjƒ“ƒOă•”Á‰ťŠÇ“ŕŽ‹‹žŒŸ¸‚É‚Ä‹ô‘R”­ŒŠ‚ł‚ę‚˝Hamartomatous inverted polyp‚Ě1—á. Xě@~1, ’†–ě@‰ë1, Ź—с@‘ń1, ”~“c’qŽq1, ´…´1, ”óŒű@”Ł1, íź@—ß1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “y–{Š°“ń1, “ú”ä‹I•ś1,2, ‘ĺěš‹`1, X‰ił“ń˜Y1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć100 ‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2015/6/13), “Œ‹ž, Progress of Digestive Endoscopy 2015/6; 87 (Suppl 1): 113.

733072. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰)yŒ¤CˆăƒZƒbƒVƒ‡ƒ“z\“ńŽw’°”S–Œ‰şŽîá‡‚Ć‚ĚŠÓ•Ę‚Ş˘“ď‚Ĺ‚ ‚Á‚˝Gastric mucosal prolapse polyp‚Ě1—á. …’J—m—C1, ’†–ě@‰ë1, ”~“c’qŽq1, –L‰i‹M•F1, ꎓĄ‰rŽq1, Ź—с@‘ń1, ”óŒű@”Ł1, íź@—ß1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “y–{Š°“ń1, “ú”ä‹I•ś1,2, —é–ŘŒcˆę1, X‰ił“ń˜Y1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć101‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2015/12/12), “Œ‹ž, Progress of Digestive Endoscopy 2015/12; 88 (Suppl): 121.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H24-120001. [Œ´’˜] ƒRƒŠƒ“Œ‡–RHƒ}ƒEƒX‚ĚConcanavalin A—U”­ŤŠĚáŠQ‚ɑ΂ˇ‚éEdaravone‚ĚŒř‰Ę‚ĚŒŸ“˘. ŒË“c‹žŽq1, íź@—ß1, ŒF’J’źŽ÷1, ‹ŕŽq•ś•F1, X‰ił“ń˜Y1, •˝‹v@ŽĄ1, —é–؍K’j1, “y–{Š°“ń1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Á‰ťŠí‚ƖƉu 2013.03; 49: 74-81.

H24-310001. [Ç—á•ń] A case of small intestine type steroid-naĂŻve Crohn disease in which osteomalacia was diagnosed by fractures on the transcervical bone. Ohkura E, Nakano M, Kato Y, Tsunematsu S, Serizawa H, Watanabe N, Kumagai N, Tsuchimoto K, Yajima T, Hibi T1,2: Nihon Shokakibyo Gakkai Zasshi 2012/12; 109 (12): 2082-7. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

H25-120001. [Œ´’˜] ‚Ž‰–bHƒ}ƒEƒX‚ĚConcanavalin A—U”­ŤŠĚáŠQ‚ɑ΂ˇ‚éƒGƒCƒRƒTƒyƒ“ƒ^ƒGƒ“Ž_‚ĚŒř‰Ę‚ĚŒŸ“˘. ŒË“c‹žŽq1, íź@—ß1, ´…´1, ŒF’J’źŽ÷1, ‹ŕŽq•ś•F1, X‰ił“ń˜Y1, •˝‹v@ŽĄ1, ŽR“cD‘Ľ1, “y–{Š°“ń1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Á‰ťŠí‚ƖƉu 2014/3; 50: 90-96.

H25-320001. [Ç—á•ń] ƒJƒvƒZƒ‹“ŕŽ‹‹žŒŸ¸‚Ĺ”­ŒŠ‚ł‚ę‚˝\“ńŽw’°‘BŽî‚Ě1—á. •Ÿˆä’‘ĺ1, ’†–ě@‰ë1, ‰Á“Ą—T‰ŔŽq1, Ź—с@‘ń1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, ´…´1, íź@—ß1, “y–{Š°“ń1, “ú”ä‹I•ś1,2, ×]’źŽ÷1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Progress of Digestive Endoscopy 2013/12; 83 (1): 128-9.

H25-522001. [uŔ]y“ÁW: ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ě‚ˇ‚ׂāzÁ‰ťŠÇƒTƒ‹ƒRƒCƒh[ƒVƒX@‰ŠÇŤ’°ŽžŠł‚Ć‚Ě‘Š“ŻŤ‚ɂ‚˘‚Ä. ‹Ř–ě’q‹v1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Źl•a‚ƐśŠˆKŠľ•a 2013/10; 43 (10): 1277-80.

H25-522002. [uŔ]y“ÁW: ‚ą‚ą‚Ü‚Ĺ—ˆ‚˝, ‰ŠÇŤ’°ŽžŠł‚̐V“WŠJz’×ᇐŤ‘ĺ’°‰Š‚Ě“ŕ‰ČŽĄ—Á@‹ß”N‚̕ωť. “ú”ä‹I•ś1,2, Ź—с@‘ń1, ’†–ě@‰ë1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Źl•a‚ƐśŠˆKŠľ•a 2014/3; 44 (3): 311-5.

H25-522003. [uŔ]y“ÁW: ‰ŠÇŤ’°ŽžŠł‚Ě‰ć‘œf’fmodalityz1-4. ‘ĺ’°“ŕŽ‹‹ž@(4) ’´Šg‘ĺ“ŕŽ‹‹ž. Ź—с@‘ń1, ’ˇŔ@˝1, •ű°•F1, “ú”ä‹I•ś1,2, ‹ŕˆä—˛“T1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): INTESTINE 2014/3; 18 (2): 127-32.

H25-522004. [uŔ]y“ÁW: IBDf—Ă‚É—L—p‚ČƒCƒ“ƒfƒbƒNƒX‚Í‚ą‚ę‚ž!zIBDf—Ă‚ÉŽg—p‚ł‚ę‚éƒCƒ“ƒfƒbƒNƒX‚̍ĄŒă‚Ě“W–]. Ź—с@‘ń1, ‹Ř–ě’q‹v1, ‰Á“Ą—T‰ŔŽq1, ’†–ě@‰ë1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): IBD Research 2014/3; 8 (1): 37-42.

H26-110004. [Œ´’˜] Prominent steatosis with hypermetabolism of the cell line permissive for years of infection with hepatitis C virus. Sugiyama K, Ebinuma H, Nakamoto N, Sakasegawa N, Murakami Y, Chu PS, Usui S, Ishibashi Y, Wakayama Y, Taniki N, Murata H, Saito Y, Fukasawa M, Saito K, Yamagishi Y, Wakita T, Takaku H, Hibi T1,2, Saito H, Kanai T: PLoS One 2014/4; 9 (4): e94460. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

H26-110005. [Œ´’˜] A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice. Yokoyama Y, Matsuoka K, Kobayashi T, Sawada K, Fujiyoshi T, Ando T, Ohnishi Y, Ishida T, Oka M, Yamada M, Nakamura T, Ino T, Numata T, Aoki H, Sakou J, Kusada M, Maekawa T, Hibi T1,2: J Crohns Colitis 2014/9; 8 (9): 981-91. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

H26-110006. [Œ´’˜] Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease. Watanabe M, Hibi T1,2, Mostafa NM, Chao J, Arora V, Camez A, Petersson J, Thakkar R: J Crohns Colitis 2014/11; 8 (11): 1407-16. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

H26-110007. [Œ´’˜] Alteration of angiogenesis in Helicobacter heilmannii-induced mucosa-associated lymphoid tissue lymphoma: interaction with c-Met and hepatocyte growth factor. Nakamura M, Takahashi T, Matsui H, Baniwa Y, Takahashi S, Murayama SY, Serizawa H, Suzuki H, Hibi T1,2: J Gastroenterol Hepatol 2014/12; 29 (Suppl 4): 70-6. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

H26-320004. [Ç—á•ń] “ŕŽ‹‹ž‘œ‚̕ωť‚đŠĎŽ@‰Â”\‚Ĺ‚ ‚Á‚˝Œ´”­ŤˆÝƒAƒ~ƒƒCƒh[ƒVƒX‚Ě1—á. ŽO‘î@—í1, ‹Ř–ě’q‹v1, Ź—с@‘ń1, ‰Á“Ą—T‰ŔŽq1, ’†–ě@‰ë1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “y–{Š°“ń1, ––X—F_1, X‰ił“ń˜Y1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Progress of Digestive Endoscopy 2014/6; 84 (1): 88-89.

H26-320005. [Ç—á•ń] ‘ĺ’°“ŕŽ‹‹žŒŸ¸‚Ĺ‹ô‘R”­ŒŠ‚ł‚ę‚˝–łÇŒóŤ‘ĺ’°ƒAƒjƒTƒLƒXÇ‚Ě1—á. ˛X–ŘŒŤˆę1, ‹ÚŕV@G1, ’†–ě@‰ë1, ‰Á“Ą—T‰ŔŽq1, Ź—с@‘ń1, ´…´1, íź@—ß1, “n•ÓŒ›–ž1, “y–{Š°“ń1, “ú”ä‹I•ś1,2, ––ˇ—F_1, X‰ił“ń˜Y1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Progress of Digestive Endoscopy 2014/12; 85 (1): 104-5.

H26-522003. [uŔ]y“ÁW: ’ź’°“Š—^ťÜ|‚ą‚ę‚Ü‚ĹWĎ‚ł‚ę‚˝ƒmƒEƒnƒE‚Ć–ň•¨ŽĄ—Ă‚ĚĹ‘OüzƒGƒLƒXƒp[ƒg‚ÉŠw‚Ô!@–ň•¨ŽĄ—Ă‚É‚¨‚Ż‚é’ź’°“Š—^ťÜ‚ĚˆĘ’u‚Ă‚Ż‚ĆŠˆ—p‚Ěƒ|ƒCƒ“ƒg@E’×ᇐŤ‘ĺ’°‰Š. “ú”ä‹I•ś1,2, Ź—с@‘ń1, ’†–ě@‰ë1, “n•ÓŒ›–ž1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): –ň‹Ç 2014/8; 65 (9): 2426-30.

H26-522004. [uŔ]y“ÁW: ś•¨Šw“IťÜ‚Ě“K‰ž‚Ş‚ ‚郊ƒEƒ}ƒ`—މŽžŠłz‰ŠÇŤ’°ŽžŠł. “ú”ä‹I•ś1,2, Ź—с@‘ń1, ’†–ě@‰ë1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): Rheumatology Clinical Research 2014/8; 3 (2): 78-82.

H26-522005. [uŔ]y“ÁW: ‰ŠÇŤ’°ŽžŠł|•a‘ÔŒ¤‹†‚Š‚ç•W“IŽĄ—Ă‚Ö‚Ě“WŠJ|z“ú–{”­, ˘ŠE‚Ö: “ú–{‚Š‚琢ŠE‚É”­M‚ˇ‚éV‚ľ‚˘f’fEŽĄ—Ă. “ú”ä‹I•ś1,2, Ź—с@‘ń1, ’†–ě@‰ë1, “n•ÓŒ›–ž1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ĹVˆăŠw 2015/2; 70 (2): 280-5.

H26-522006. [uŔ]y“ÁW: Šó­Á‰ťŠíŽžŠł‚ɑ΂ˇ‚é–G‰č“IŒ¤‹†‚ĚĹ‘Oüz’°ŠÇƒx[ƒ`ƒFƒbƒg•a‚Ć’PƒŤ’×ᇂ̐f’f–@‚⎥—Ă–@‚ÍŠm—§‚ľ‚˝‚Š? “ú”ä‹I•ś1,2, ‹vź—ˆę1, Ź—с@‘ń1, ’†–ě@‰ë1, ˆäă@‰r1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): •ŞŽqÁ‰ťŠí•a 2015/3; 12 (1): 43-8.

H26-530001. [‚ť‚Ě‘ź (ƒRƒƒ“ƒg)]yComment on: Health-related quality of life and disability in patients with ulcerative colitis and proctocolectomy with ileoanal pouch versus treatment with anti-TNF agents. [J Crohns Colitis. 2014]zUlcerative colitis. Which makes patients happier, surgery or anti-TNF therapy? Kobayashi T, Hibi T1,2: Nat Rev Gastroenterol Hepatol 2014/5; 11 (5): 272-3. (“ú”ä‹I•ś1,2: 1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

[’˜@‘]

H26-620008. [Šwp‘ (•Ş’SŽˇ•M)]y“ŕ‰ČŽžŠłĹV‚ĚŽĄ—Á|–ž“ú‚Ö‚ĚŽwj (“ŕ‰Č2014”N6ŒŽ‘‘ĺ†)z‘ć2Í Á‰ťŠí@’×ᇐŤ‘ĺ’°‰Š. “ú”ä‹I•ś1,2, Ź—с@‘ń1, ’†–ě@‰ë1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č), “ě]“°, “Œ‹ž, 2014/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H25-722001. [Šw‰ď (‘S‘)] (ƒvƒŒƒiƒŠ[ƒZƒbƒVƒ‡ƒ“)y“ŕ‚ŠŽĄ—ÁEŠî‘bzś•¨Šw“IťÜ‚̓Nƒ[ƒ“•a“ŕᑂɑ΂ľ–{“–‚É–łŒř‚Č‚Ě‚Š?|“ŕᑂɑ΂ˇ‚鐜•¨Šw“IťÜŽĄ—ÐŹŃ‚ĚŒŸ“˘|. Ź—с@‘ń1, ź‰ŞŽ‘P1, ’ˇŔ@˝1, ‹vź—ˆę1, ˆäă@‰r1, ‹Ř–ě’q‹v1, ’†–ě@‰ë1, “n•ÓŒ›–ž1, •ű°•F1, Šâ’j@‘×1, ‹ŕˆä—˛“T1, “ú”ä ‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć68‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2013/11/15), “Œ‹ž, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2013/9; 66 (9): 735.

H25-723001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚éƒNƒ[ƒ“•a‹ˇó•a•Ď‚ɑ΂ˇ‚é“ŕŽ‹‹ž“Iƒoƒ‹[ƒ“Šg’Łp‚Ě’ˇŠúŹŃ. Ź—с@‘ń1, ’ˇŔ@˝1, ˆäă@‰r1, ‹vź—ˆę1, ź‰ŞŽ‘P1, ‹ŕˆä—˛“T1, Šâ’j@‘×1, •ű°•F1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć85‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2013/5/10-12), ‹ž“s, Gastroenterological Endoscopy 2013/4; 55 (Suppl.1): 1044.

H25-723002. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ź’°‘ĺ’°Œ^ƒNƒ[ƒ“•a‚ɂĒʉ@’†‚Éă’°ŠÔ–ŒĂ–Ź“ŕ‚Éseptic thrombophlebitis‚đ‚Ť‚˝‚ľ‚˝1Ç—á. ‹Ř–ě’q‹v1, Ź—с@‘ń1, ’†–ě@‰ë1, “n•ÓŒ›–ž1, ‹Ú‘ň@G1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć68‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2013/11/15), “Œ‹ž, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2013/9; 66 (9): 862.

H25-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŽžŠłE•a‘Ԃɉž‚ś‚˝“KŘ‚ȏŹ’°f’fEŽĄ—Ð헪z‰“ˆĘ‰ń’°ŒŸő‚É‚¨‚Ż‚éŽó“Žœ]‹Č‚“`’B‘}“ü•”“‹Ú×Œa‘ĺ’°“ŕŽ‹‹žPCF-PQ260L‚Ě—L—pŤ‚ĚŒŸ“˘. ’†–ě@‰ë1, Ź—с@‘ń1, ’†—˘Œ\G1, ‹Ř–ě’q‹v1, ‰Á“Ą—T‰ŔŽq1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć97‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2013/12/15), “Œ‹ž, Progress of Digestive Endoscopy 2013/12; 84 (Suppl): 82.

H25-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) 5”N‚ĚŒo‰ß‚Ĺ‘˝Ę‚ČŒ`‘ԕωť‚đ’ć‚ľ‚˝Œ´”­ŤˆÝƒAƒ~ƒƒCƒh[ƒVƒX‚Ěˆę—á. ŽO‘î@—í1, ‹Ř–ě’q‹v1, Ź—с@‘ń1, ‰Á“Ą—T‰ŔŽq1, ’†–ě@‰ë1, ‹Ú‘ň@G1, “n•ÓŒ›–ž1, “y–{Š°“ń1, ––ˇ—F_1, X‰ił“ń˜Y1, ‘ĺX@‘×1, •ű°•F1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć97‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2013/12/15), “Œ‹ž, Progress of Digestive Endoscopy 2013/12; 84 (Suppl): 107.

H26-722001. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)y‰ŠÇŤ’°ŽžŠł‚ĚŽĄ—Ð헪z’×ᇐŤ‘ĺ’°‰Š847—á‚đ‘ÎŰ‚Ć‚ľ‚˝”’ŒŒ‹…œ‹Ž—Ă–@‚Ě‘ĺ‹K–ÍŽg—pŹŃ’˛¸. Ź—с@‘ń1, ź‰ŞŽ‘P1, ‰ĄŽR—zŽq1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć69‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2014/11/7-8), ‰Ą•l, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2014/9; 67 (9): 608.

H26-723001. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ’×ᇐŤ‘ĺ’°‰Š847—á‚đ‘ÎŰ‚Ć‚ľ‚˝”’ŒŒ‹…œ‹Ž—Ă–@‚Ě‘ĺ‹K–ÍŽg—pŹŃ’˛¸. Ź—с@‘ń1, ź‰ŞŽ‘P1, ‰ĄŽR—zŽq1, ŕV“cNŽj1, “ĄDŒšŽj1, ˆŔ“Ą‹M•ś1, ‘吟‰Ŕ•ś1, Î“c“N–ç1, ‰Ş@­Žu1, ŽR“c‰ëO1, ’†‘ş—˛Žu1, ˆä–ě—FŽq1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć100‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2014/4/23-26), “Œ‹ž, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2014/9; 111 (—Ő‘‘ĺ‰ď): A891.

H26-723002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ŕŽ‹‹ž“I‚É“Á’Ľ“I‚ȏŠŒŠ‚đŠĎŽ@‚ľ‚Ś‚˝dÇ’°ƒ`ƒtƒX‚Ě1—á. ”~“c’qŽq1, Ź—с@‘ń1, ‹Ř–ě’q‹v1, ‰Á“Ą—T‰ŔŽq1, ´…´1, ’†–ě@‰ë1, íź@—ß1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “y–{Š°“ń1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć87‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2014/5/15-17), •Ÿ‰Ş, Gastroenterological Endoscopy 2014/4; 56 (Suppl.1): 1170.

H26-723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰“ˆĘ‰ń’°ŒŸő‚É‚¨‚Ż‚éŽó“Žœ]‹Č‚“`’B‘}“ü•”“‹Ú×Œa‘ĺ’°“ŕŽ‹‹žPCF-PQ260L‚Ě—L—pŤ‚ĚŒŸ“˘. ’†–ě@‰ë1, Ź—с@‘ń1, ‹Ř–ě’q‹v1, ‰Á“Ą—T‰ŔŽq1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “ú”ä‹I•ś1,2, ’†—˘Œ\G1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć87‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2014/5/15-17), •Ÿ‰Ş, Gastroenterological Endoscopy 2014.04; 56 (Suppl.1): 1173.

H26-723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’°ŠÇƒXƒsƒƒw[ƒ^Ç‚Ě“ŕŽ‹‹ž“IE—Տ°•a—Šw“IŒŸ“˘. ”~“c’qŽq1, Ź—с@‘ń1, ’†–ě@‰ë1, ‹Ř–ě’q‹v1, ‰Á“Ą—T‰ŔŽq1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, X‰ił“ń˜Y1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć88‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2014/10/23-25), _ŒËGastroenterological Endoscopy 2014/9; 56 (Suppl 2): 3171.

H26-723005. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’×ᇐŤ‘ĺ’°‰Š“ü‰@ŽĄ—Ă‚É‚¨‚Ż‚é‹ÖH’°ŠÇˆŔĂ‚ĚˆÓ‹`. Ź—с@‘ń1, ’†–ě@‰ë1, ”~“c’qŽq1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, Î‹´‚Ć‚ć‚Ý1, “ú”ä‹I•ś1,2 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć101‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2015/4/23-25), ĺ‘ä, “ú–{Á‰ťŠí•aŠw‰ďŽGŽ 2015/3; 112 (—Ő‘‘‰ď): A495.

H26-732003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yIBD‚Ě“ŕŽ‹‹žf’fEŽĄ—Ă‚ĚƒRƒczƒNƒ[ƒ“•a‰“ˆĘ‰ń’°ŒŸő‚É‚¨‚Ż‚éŽó“Žœ]‹Č‚“`’B‘}“ü•”“‹Ú×Œa‘ĺ’°“ŕŽ‹‹žPCF-PQ260L‚Ě—L—pŤ‚ĚŒŸ“˘. ’†–ě@‰ë1, Ź—с@‘ń1, ”~“c’qŽq1, ”óŒű@”Ł1, ´…´1, íź@—ĺ1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, “y–{Š°“ń1, “ú”ä‹I•ś1,2, ’†—˘Œ\G1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć99‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2014/12/7), “Œ‹ž, Progress of Digestive Endoscopy 2014/12; 86 (Suppl): 89.

H26-733002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰)yŒ¤CˆăƒZƒbƒVƒ‡ƒ“z•ÂÇŤ‰Šát‚đŒ_‹@‚É”­ŒŠ‚ł‚ę‚˝Peutz-JeghersŒ^\“ńŽw’°“ű“Ş•”‰ßŒëŽî‚Ěˆę—á. Ôâääť1, ´…´1, —é–ŘŒcˆę1, ”óŒű@”Ł1, ”~“c’qŽq1, ŽO‘î@—í1, ‰Á“Ą—T‰ŔŽq1, Ź—с@‘ń1, ’†–ě@‰ë1, íź@—ß1, ‹ÚŕV@G1, “n•ÓŒ›–ž1, X‰ił“ń˜Y1, “ú”ä‹I•ś1,2, ‹ŕˆä—˛“T1, “y–{Š°“ń1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć98‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2014/6/15), “Œ‹ž, Progress of Digestive Endoscopy 2014/12; 86 (Suppl): 116.

H26-733003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Á‰ťŠÇƒ|ƒŠƒ|[ƒVƒXƒtƒHƒ[“ŕŽ‹‹ž‚ĚŰ‹ô‘R”­ŒŠ‚ł‚ę‚˝–łÇŒóŤ‘ĺ’°ƒAƒjƒTƒLƒXÇ‚Ěˆę—á. ˛X–ŘŒŤˆę1, ‹ÚŕV@G1, ’†–ě@‰ë1, ‰Á“Ą—T‰ŔŽq1, ´…´1, Ź—с@‘ń1, “n•ÓŒ›–ž1, “y–{Š°“ń1, “ú”ä‹I•ś1,2, ––ˇ—F_1, X‰ił“ń˜Y1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć98‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ďŠÖ“Œ’n•ű‰ď (2014/6/15), “Œ‹ž, Progress of Digestive Endoscopy 2014/6; 85 (Suppl): 122.

H26-733004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Šˆ“ŽŠú‚ɐ[•”Ă–ŹŒŒđÇ‚¨‚ć‚Ń”xŒŒđÇđÇ‚đ‡•š‚ľ‚˝’×ᇐŤ‘ĺ’°‰Š‚Ě1Ç—á. ŕ_“cÍ—T1, ”~“c’qŽq1, ‹ÚŕV@G1, ’†–ě@‰ë1, “n•ÓŒ›–ž1, ´…´1, Ź—с@‘ń1, “ú”ä‹I•ś1,2, ‹ŕ“c@‹v1, “y–{Š°“ń1 (1–k—˘‘ĺŠw–k—˘Œ¤‹†Š•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć613‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď, (2015/3/14), “Œ‹ž, “ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď613‰ńƒvƒƒOƒ‰ƒ€E´˜^W 2015/3; p.35.


zŠÂŠí“ŕ‰ČŠw

[Šwp˜_•ś]

110110. [Œ´’˜] Implications of pentraxin 3 levels in patients with acute aortic dissection. Arao K, Fujiwara T, Taniguchi Y, Jinnouchi H, Sasai H, Matsumoto M, Funayama H, Ako J1, Momomura S: Heart Vessels 2015/3; 30 (2): 211-7. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110111. [Œ´’˜] Flow Mediated Dilatation Is Reduced with the Progressive Stages of Glomerular Filtration Rate and Albuminuria in Type 2 Diabetic Patients without Coronary Heart Disease. Ito H, Nakashima M, Meguro K1, Furukawa H, Yamashita H, Takaki A, Yukawa C, Omoto T, Shinozaki M, Nishio S, Abe M, Antoku S, Mifune M, Togane M: J Diabetes Res 2015/4; 2015: 728127. (–ڍ•Œ’‘ž˜Y1: 1zŠÂŠí“ŕ)

110112. [Œ´’˜] Circadian variation of acute aortic dissection. Seguchi M, Wada H, Sakakura K, Nakagawa T, Ibe T, Ikeda N, Sugawara Y, Ako J1, Momomura S: Int Heart J 2015/5; 56 (3): 324-8. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110113. [Œ´’˜] Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES). Kitasato L1, Shimohama T1, Ikeda Y2, Namba S2, Hashikata T2, Kameda R1, Sato N1, Takeuchi I3, Yamaoka-Tojo M4, Tojo T1, Ako J1: Biomed Pharmacother 2015/5; 72: 6-10. (–k—˘—œŽŃ1, ‰ş•lF˜Y1, ’r“c—S‹B2, “ď”g‘–퍁2, ”˘•űŒ’G2, ‹T“c@—Ç1, ˛“ĄL—m1, ’|“ŕˆę˜Y3, “ŒžŠ”ü“ŢŽq4, “ŒžŠ‘ĺ‹P1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝, 4ˆă—ÉqśŠw•”)

110114. [Œ´’˜] Endothelial Cell Survival under High Glucose Condition: Effect of Rivaroxaban. Kitasato L1, Yamaoka-Tojo M2, Kakizaki R3, Nemoto T3, Namba S3, Hashikata T3, Hashimoto T3, Kameda R1, Shimohama T1, Tojo T1, Ako J1: Clinical Cardiology and Research 2015/5; 2 (1): 1-5. (–k—˘—œŽŃ1, “ŒžŠ”ü“ŢŽq2, Š`č—Ç‘ž3, Ş–{Ć˘Žu3, “ď”g‘–퍁3, ”˘•űŒ’G3, ‹´–{‘ń–í3, ‹T“c@—Ç1, ‰ş•lF˜Y1, “ŒžŠ‘ĺ‹P1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110115. [Œ´’˜] Early Phase Arterial Reaction Following Drug-Eluting and Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction. Nishio R, Shinke T, Morino Y, Tanabe K, Furuya J, Takizawa K, Ako J1, Kozuma K, Hibi K, Ishii H, Hirohata A, Otsuka Y, Otake H, Takaya T, Hirata K: Int Heart J 2015/7; 56 (4): 389-94. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110116. [Œ´’˜] Lower 1,5-anhydroglucitol is associated with denovo coronary artery disease in patients at high cardiovascular risk. Fujiwara T, Yoshida M, Yamada H, Tsukui T, Nakamura T, Sakakura K, Wada H, Arao K, Katayama T, Funayama H, Sugawara Y, Mitsuhashi T, Kakei M, Momomura S, Ako J1: Heart Vessels 2015/7; 30 (4): 469-76. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110117. [Œ´’˜] Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis. Namba S1, Yamaoka-Tojo M2, Hashikata T1, Ikeda Y1, Kitasato L3, Hashimoto T1, Shimohama T3, Tojo T3, Takahira N2, Masuda T2, Ako J3: BBA Clin 2015/8; 4: 76-80. (“ď”g‘–퍁1, “ŒžŠ”ü“ŢŽq2, ”˘•űŒ’G1, ’r“c—S‹B1, –k—˘—œŽŃ3, ‹´–{‘ń–í1, ‰ş•lF˜Y3, “ŒžŠ‘ĺ‹P3, ‚•˝ŽL2, ‘“c@‘ě2, ˆ˘ŒĂĆ3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3zŠÂŠí“ŕ)

110118. [Œ´’˜] Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-ƒČB Pathway. Hashikata T1, Yamaoka-Tojo M2, Namba S1, Kitasato L3, Kameda R3, Murakami M3, Niwano H, Shimohama T3, Tojo T3, Ako J3: Int Heart J 2015/9; 56 (5): 544-50. (”˘•űŒ’G1, “ŒžŠ”ü“ŢŽq2, “ď”g‘–퍁1, –k—˘—œŽŃ3, ‹T“c@—Ç3, ‘şă‰ë”ü3, ‰ş•lF˜Y3, “ŒžŠ‘ĺ‹P3, ˆ˘ŒĂĆ3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3zŠÂŠí“ŕ)

110119. [Œ´’˜] Dipeptidyl peptidase-4 inhibitors are associated with improved left ventricular diastolic function after acute myocardial infarction in diabetic patients. Fujiwara T, Yoshida M, Nakamura T, Sakakura K, Wada H, Arao K, Katayama T, Funayama H, Sugawara Y, Mitsuhashi T, Kakei M, Momomura S, Ako J1: Heart Vessels 2015/9; 30 (5): 696-701. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110120. [Œ´’˜] Major adverse cardiac and bleeding events associated with non-cardiac surgery in coronary artery disease patients with or without prior percutaneous coronary intervention. Wakabayashi Y, Wada H, Sakakura K, Yamamoto K, Mitsuhashi T, Ako J1, Momomura S: J Cardiol 2015/10; 66 (4): 341-6. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110121. [Œ´’˜] Low eicosapentaenoic acid to arachidonic acid ratio is associated with thin-cap fibroatheroma determined by optical coherence tomography. Wakabayashi Y, Funayama H, Ugata Y, Taniguchi Y, Hoshino H, Ako J1, Momomura S: J Cardiol 2015/12; 66 (6): 482-8. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110122. [Œ´’˜] Time course of left ventricular reverse remodeling in response to pharmacotherapy: clinical implication for heart failure prognosis in patients with idiopathic dilated cardiomyopathy. Ikeda Y1, Inomata T2, Iida Y1, Iwamoto-Ishida M2, Nabeta T1, Ishii S2, Sato T2, Yanagisawa T2, Mizutani T3, Naruke T2, Koitabashi T2, Takeuchi I3, Nishii M2, Ako J2: Heart Vessels 2016/4; 31 (4): 545-54. (’r“c—S‹B1, ’––”FŒł2, ”Ń“c—Sˆę˜Y1, Î“cŽO˜a2, “ç“c@Œ’1, Îˆär•ă2, ˛“Ąr[2, –öŕV’q‹`2, …’J’m‘×3, Ź–с@’2, Ź”‹´r”ü2, ’|“ŕˆę˜Y3, źˆäŠîŒp2, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3‹~–˝)

110123. [Œ´’˜] Ezetimibe enhances and stabilizes anticoagulant effect of warfarin. Hashikata T1, Yamaoka-Tojo M2, Kakizaki R1, Nemoto T1, Fujiyoshi K1, Namba S1, Kitasato L3, Hashimoto T1, Ishii S3, Kameda R3, Shimohama T3, Tojo T3, Ako J3: Heart Vessels 2016/4. [Epub ahead of print] (”˘•űŒ’G1, “ŒžŠ”ü“ŢŽq2, Š`č—Ç‘ž1, Ş–{Ć˘Žu1, “Ą‹g˜a”Ž1, “ď”g‘–퍁1, –k—˘—œŽŃ3, ‹´–{‘ń–í1, Îˆär•ă3, ‹T“c@—Ç3, ‰ş•lF˜Y3, “ŒžŠ‘ĺ‹P3, ˆ˘ŒĂĆ3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3zŠÂŠí“ŕ)

110124. [Œ´’˜] Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention. Fujiwara T, Yoshida M, Akashi N, Yamada H, Tsukui T, Nakamura T, Sakakura K, Wada H, Arao K, Katayama T, Umemoto T, Funayama H, Sugawara Y, Mitsuhashi T, Kakei M, Momomura S, Ako J1: Heart Vessels 2016/6; 31 (6): 855-62. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110125. [Œ´’˜] Pulmonary hypertension due to left heart disease: The prognostic implications of diastolic pulmonary vascular pressure gradient. Ibe T, Wada H, Sakakura K, Ikeda N, Yamada Y, Sugawara Y, Mitsuhashi T, Ako J1, Fujita H, Momomura S: J Cardiol 2016/6; 67 (6): 555-9. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110126. [Œ´’˜] Prognostic significance of beta-blocker up-titration in conjunction with cardiac resynchronization therapy in heart failure management. Nabeta T1, Inomata T2, Iida Y1, Ikeda Y1, Iwamoto-Ishida M2, Ishii S2, Naruke T2, Mizutani T3, Shinagawa H2, Koitabashi T2, Takeuchi I3, Ako J2: Heart Vessels 2016/7; 31 (7): 1109-16. (“ç“c@Œ’1, ’––”FŒł2, ”Ń“c—Sˆę˜Y1, ’r“c—S‹B1, Î“cŽO˜a2, Îˆär•ă2, Ź–с@’2, …’J’m‘×3, •iě–íl2, Ź”‹´r”ü2, ’|“ŕˆę˜Y3, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3‹~–˝)

110127. [Œ´’˜] Characteristics of Late-Acquired Incomplete Stent Apposition: A Comparison With First-Generation and Second-Generation Drug-Eluting Stents. Waseda K, Ako J1, Kume T, Fitzgerald PJ, Honda Y: J Invasive Cardiol 2016/8; 28 (8): 323-9. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

110128. [Œ´’˜] Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Hashikata T1, Yamaoka-Tojo M2, Kakizaki R1, Nemoto T1, Fujiyoshi K1, Namba S1, Kitasato L3, Hashimoto T1, Kameda R3, Maekawa E3, Shimohama T3, Tojo T3, Ako J3: Heart Vessels 2016/8; 31 (8): 1303-10. (”˘•űŒ’G1, “ŒžŠ”ü“ŢŽq2, Š`č—Ç‘ž1, Ş–{Ć˘Žu1, “Ą‹g˜a”Ž1, “ď”g‘–퍁1, –k—˘—œŽŃ3, ‹´–{‘ń–í1, ‹T“c@—Ç3, ‘OěŒb”ü3, ‰ş•lF˜Y3, “ŒžŠ‘ĺ‹P3, ˆ˘ŒĂĆ3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3zŠÂŠí“ŕ)

120011. [Œ´’˜] R‚Ä‚ń‚Š‚ń–ň“ŕ•žŠłŽŇ‚É‚¨‚Ż‚éƒuƒ‹ƒKƒ_Œ^S“d}‚ĆJ”g‚ÉŠÖ‚ˇ‚錟“˘. Î––ŹĆ1, ’ë–ěTˆę2, âV“Ął”Í3, ’†‘ş—m”Í1, “ĄÎŽě”ü1, ŒÜ\—’Œš1, ‹gŕV’qŽĄ2, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, ‹{‰Ş@“™3, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3¸_): S‘Ÿ 2015/12; 47 (Suppl 2): 212-8.

310007. [Ç—á•ń] Deficiency of creatine kinase in a ST-segment elevation myocardial infarction patient with Kartagener syndrome. Hashikata T1, Tojo T2, Namba S1, Kitasato L2, Hashimoto T1, Kameda R2, Shimohama T2, Yamaoka-Tojo M3, Takada F1, Ako J2: Int J Cardiol 2015/3; 182: 31-3. (”˘•űŒ’G1, “ŒžŠ‘ĺ‹P2, “ď”g‘–퍁1, –k—˘—œŽŃ2, ‹´–{‘ń–í1, ‹T“c@—Ç2, ‰ş•lF˜Y2, “ŒžŠ”ü“ŢŽq3, ‚“cŽj’j1, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3ˆă—ÉqśŠw•”)

310008. [Ç—á•ń] Morphological changes in mitochondria during mechanical unloading observed on electron microscopy: a case report of a bridge to complete recovery in a patient with idiopathic dilated cardiomyopathy. Ikeda Y1, Inomata T2, Fujita T1, Iida Y1, Nabeta T1, Naruke T2, Koitabashi T2, Takeuchi I3, Kitamura T4, Miyaji K4, Ako J2: Cardiovasc Pathol 2015/3-4; 24 (2): 128-31. (’r“c—S‹B1, ’––”FŒł2, “Ą“c“S•˝1, ”Ń“c—Sˆę˜Y1, “ç“c@Œ’1, Ź–с@’2, Ź”‹´r”ü2, ’|“ŕˆę˜Y3, –k‘ş@—Ľ4, ‹{’n@ŠÓ4, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3‹~–˝, 4S‘ŸŒŒŠÇŠO)

310009. [Ç—á•ń] An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting. Kishihara J1, Niwano S1, Nakamura H2, Igarashi T2, Ishizue N2, Fujiishi T2, Oikawa J1, Murakami M1, Fukaya H1, Ako J1: J Arrhythm 2016/2; 32 (1): 67-9. (ŠÝŒ´@~1, ’ë–ěTˆę1, ’†‘ş—m”Í2, ŒÜ\—’Œ’2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹yě@~1, ‘şă‰ë”ü1, [’J‰p•˝1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

310010. [Ç—á•ń] Ruptured saphenous vein graft pseudoaneurysm successfully treated with covered stents. Yonezu K, Funayama H, Katayama T, Yamaguchi A, Ako J1, Momomura S: Cardiovasc Interv Ther 2016/4; 31 (2): 161-3. (ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

521009. [‰đŕ] –ŤS•s‘S‚É‚¨‚Ż‚éR•sŽ–Ź–ňŽĄ—Ă. ’ë–ěTˆę (zŠÂŠí“ŕ): zŠÂŠí“ŕ‰Č 2015/5; 77 (5): 498-502.

521010. [‰đŕ]yBedside TeachingzV‚ľ‚˘RŒŒŹ”–ň. ‰ş•lF˜Y1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ŒÄ‹z‚ƏzŠÂ 2015/11; 63 (11): 1110-7.

522053. [uŔ]y˜AÚ: ŽăƒfƒBƒx[ƒg Debatez“Ť•‚Žî‚ɑ΂ˇ‚é‘Ήž: ‘˝Ü•š—p‚Ě—§ę‚Š‚ç. ’––”FŒł (zŠÂŠí“ŕ): Fluid Management Renaissance 2015/4; 5 (2): 84-8.

522054. [uŔ]y“ÁW: ˜V‰ť‚Ć˜V”NŽžŠł|Œ¤‹†E—Տ°‚ĚĹ‘Oüz‚—îŽŇ‚Ě–ŤŽžŠłŠÇ—: ‚—îŽŇ‚É‚¨‚Ż‚éRŒŒđ—Ă–@. [’J‰p•˝1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ˆăŠw‚Ě‚ ‚ä‚Ý 2015/5; 253 (9): 879-83.

522055. [uŔ]y“ÁW: ƒAƒŒƒ‹ƒM[ŽžŠł‚̐f—Ă‚Ěpitfalls@DŽ_‹…‚Ě—Ő°z‘ŸŠí•a•Ď‚𔺂¤DŽ_‹…‘‘˝Ç@DŽ_‹…ŤS‹Ř‰Š. ’––”FŒł (zŠÂŠí“ŕ): f’f‚ĆŽĄ—Ă 2015/5; 103 (5): 677-80.

522056. [uŔ]yŠw‰ďƒgƒsƒbƒNƒX: ‹•ŒŒŤSŽžŠł‚É‚¨‚Ż‚éR‹ĂŒĹ–ň‚ĚŽg‚˘•űzR‹ĂŒĹ–ň‚đ•K—v‚Ć‚ˇ‚銼ŽžŠłŠłŽŇ‚ւ̑Ήž. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ƒƒfƒBƒJƒ‹’Š“ú 2015/6; 44 (6): 37-9.

522057. [uŔ]y“ÁW: ŠĽ“Ž–ŹƒJƒe[ƒeƒ‹ƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“‚̍ĄŒă‚Ě“WŠJ2015zPCIS–[×“Ž—á‚É‚¨‚Ż‚éR‹ĂŒĹ–ňERŒŒŹ”–ň•š—p. [’J‰p•˝1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ICU‚ĆCCU 2015/6; 39 (6): 369-74.

522058. [uŔ]y“ÁW: S•s‘SƒNƒƒjƒNƒ‹@ŠłŽŇ‚̐lś‚ÉŠń‚č“Y‚˘‚Č‚Ş‚çf‚ézŠO—ˆŠÇ—: –Ť‚Ć‹}Ť‚Ě˜A˝‚đ’f‚żŘ‚é@[śŽşŽűk”\‚Ş’á‰ş‚ľ‚˝S•s‘S (HFrEF) ‚Ö‚Ě–ň•¨ŽĄ—Ă]@ƒtƒƒZƒ~ƒh. ’––”FŒł (zŠÂŠí“ŕ): medicina 2015/6; 52 (7): 1116-8.

522059. [uŔ]y“ÁW: zŠÂŠíŽžŠł‚Ětrends & topics 2015zŽĄ—Ă’ďRŤS•s‘S‚É‚¨‚Ż‚é–ň•¨—Ă–@‚ĚŽŔŰ. ’––”FŒł (zŠÂŠí“ŕ): Mebio 2015/7; .32 (7): 12-7.

522060. [uŔ]y“ÁW: DŽ_‹…Z‚𔺂¤ŽžŠłzŠe˜_: DŽ_‹…Z‚ƐSŽžŠł. ’––”FŒł (zŠÂŠí“ŕ): Źl•a‚ƐśŠˆKŠľ•a 2015/7; 45 (7): 853-6.

522061. [uŔ]y“ÁW: ‚—îŽŇ‚̐SŽžŠłŽĄ—Â̐i•ŕ|’áNPŽĄ—Â̐i•ŕ‚𒆐S‚Ɂ|z—Տ°‚ɖ𗧂ÂQ&A@2. ƒXƒeƒ“ƒgA‚Śž‚ÝŒă‚ĚŠłŽŇ‚ŞŽčp‚đŽó‚Ż‚éŰ‚̍RŒŒŹ”—Ö@‚ɂ‚˘‚Ä‹ł‚Ś‚Ä‚­‚ž‚ł‚˘. ‰ş•lF˜Y1, źŹ“c—ş (1zŠÂŠí“ŕ): ˜V”NˆăŠw 2015/7; 53 (7): 741-4.

522062. [uŔ]y“ÁW: S•s‘S‚Á‚ÄŽžŠł‚ś‚á‚Č‚˘!? ’m‚Á‚Ä‚˘‚é‚悤‚Ĺ’m‚ç‚Č‚˘’mŽŻ‚đˆę‹“‘Ž— ‚܂邲‚Ć‚¨‚ł‚炢! S•s‘Sz3. ‚ ‚ç‚˝‚ß‚ÄŽĄ—Ă‚ĚŠî–{‚đ‰Ÿ‚ł‚Ś‚悤! ’––”FŒł (zŠÂŠí“ŕ): HEART nursing 2015/8; 28 (8): 26-37.

522063. [uŔ]y“ÁW: dÇS•s‘S‚ĚŽĄ—Ă‚Í‚Ç‚¤•Ď‚í‚Á‚˝‚Ě‚Š, ‚Ç‚¤•Ď‚Ś‚Ä‚˘‚­‚ׂŤ‚ŠzŽĄ‚ˇ@11. —˜”A–ň‚ĚŽg‚˘•ű‚Í‚Ç‚¤•Ď‚í‚Á‚˝‚Š. ’––”FŒł (zŠÂŠí“ŕ): Heart View 2015/8; 19 (8): 82-7.

522064. [uŔ]y“ÁW: S•s‘S‚đ“O’ę—‰đ! Šî–{•Ň|ƒi[ƒX‚Ş’m‚Á‚Ä‚¨‚Ť‚˝‚˘E‚¨‚ł‚Ś‚Ä‚¨‚Ť‚˝‚˘S•s‘S‚ĚŠî–{Ž–€|z5. –ŤS•s‘S‚Ě–ň•¨—Ă–@. ’––”FŒł (zŠÂŠí“ŕ): zŠÂŠíƒi[ƒVƒ“ƒO 2015/9; 5 (9): 47-53.

522065. [uŔ]y“ÁW: S•s‘S|‰h—{ŠÇ—‚ĚŽŔ‘Hƒ|ƒCƒ“ƒgzS•s‘SŠłŽŇ‚Ěƒ`[ƒ€ˆă—Ă‚É‚ć‚éŠÇ—. ’––”FŒł (zŠÂŠí“ŕ): —Տ°‰h—{ 2015/9; 127 (3): 311-5.

522066. [uŔ]y“ÁW: ‹ˇSÇE‹•ŒŒŤSŽžŠł|ŽŔ’nf—Ă‚ĚŠî–{‚ĆQOL‚Č‚ç‚Ń‚É—\Œă‰ü‘P‚đ‚ß‚´‚ˇƒ}ƒlƒWƒƒ“ƒgzƒZƒ~ƒi[: ŽŔ’nˆă‰Ć‚ŞŠˆ—p‚ˇ‚ׂŤV‚ľ‚˘ŒŸ¸–@‚Ć‚ł‚Ü‚´‚Ü‚Č•a‘Ԃł̐f—ÁEƒ}ƒlƒWƒƒ“ƒg–@‚đŠw‚ԁ@‹•ŒŒŤSŽžŠł‚ɍ‡•š‚ˇ‚éS–[×“Ž|‚ť‚ĚŠÇ—Žwj‚ƍR‹ĂŒĹ—Ă–@|. [’J‰p•˝1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): Medical Practice 2015/10; 32 (10): 1655-60.

522067. [uŔ]y“ÁW S•s‘S‚Ěƒ`[ƒ€ˆă—Á|‚—îS•s‘SŠłŽŇ‚đ‚Ç‚¤Žx‚Ś‚é‚Š?z[Še˜_] ŠeEŽí‚̐S•s‘Sƒ`[ƒ€‚Ö‚Ě‚Š‚Š‚í‚č‚Ć–đŠ„@ŠÇ—‰h—{Žm‚ĚŽ‹“_‚Š‚ç. ’––”FŒł (zŠÂŠí“ŕ): Medical Alliance 2015/10; 1 (4): 343-9.

522068. [uŔ]y“ÁW: Šó­‚ȐSŒŒŠÇŽžŠł‚đŒŠ’ź‚ˇzDŽ_‹…‘‘˝ÇŒóŒQ‚ƐS‡•šÇ. ’––”FŒł (zŠÂŠí“ŕ): zŠÂŠí“ŕ‰Č 2015/10; 78 (4): 379-84.

522069. [uŔ]y“ÁW: DAPT‘ĺlŽ@zŠłŽŇƒAƒhƒqƒAƒ‰ƒ“ƒX‚ĆDAPT|’ˇŠú‚É‚í‚˝‚Á‚ÄŽĄ—ĂŒp‘ą‚đ‚ˇ‚é‚˝‚ß‚É. ‰ş•lF˜Y (zŠÂŠí“ŕ): Cardio Vascular Contemporary 2015/11; 4 (4): 24-9.

522070. [uŔ]yBedside TeachingzV‚ľ‚˘RŒŒŹ”–ň. ‰ş•lF˜Y1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ŒÄ‹z‚ƏzŠÂ 2015/11; 63 (11): 1110-7.

522071. [uŔ]y“ÁW: ƒŔŽŐ’f–ň‚Í‚ą‚¤Žg‚˘‚ą‚Č‚š|Šî–{‚Ě—‰đ‚Əˆ•űtips|zŽĄ‚ˇ@10. S•s‘S@b. –ŤS•s‘S‚É‚¨‚Ż‚éƒŔŽŐ’f–ň‚ĚŽg‚˘•ű. ’––”FŒł (zŠÂŠí“ŕ): Heart View 2015/12; 19 (13): 81-6.

522072. [uŔ]y“ÁW: ĄŒă‚đč‚¤|10”NŒă‚ĚPCI‚Í‚Ç‚¤•Ď‚í‚é‚Š?|z ‚—is‚Ĺ‚Ç‚¤•Ď‰ť‚ˇ‚é? –ڍ•Œ’‘ž˜Y1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): Coronary Intervention 2016/1; 12 (1): 17-21.

522073. [uŔ]y“ÁW: AKI (‹}ŤtáŠQ) ‚Ş‘Sg‚É‹y‚Ú‚ˇƒCƒ“ƒpƒNƒgzAKI‚Ɖ“Šu‘ŸŠí|S‘Ÿ. ’––”FŒł (zŠÂŠí“ŕ): t‘Ÿ“ŕ‰ČE”ĺ”AŠí‰Č 2016/1; 3 (1): 9-13.

522074. [uŔ]yĄŒŽ‚Ě“ÁW1: “úíŒŸ¸‚Š‚ç‚Ý‚Ś‚é•a‘ԁ|S“d}ŒŸ¸•Ňz•p–ŹŤ•sŽ–Ź. ’ë–ěTˆę (zŠÂŠí“ŕ): —Տ°ŒŸ¸ 2016/3; 60 (3): 270-6.

530007. [‚ť‚Ě‘ź (ƒRƒƒ“ƒg)]yComment on: Characterization of patients with angioscopically-detected in-stent mural thrombi genetics of clopidogrel responsiveness and generations of drug-eluting stents. [Circ J. 2015]zIntrastent thrombus what you see is what you get? Shimohama T1, Ako J1: Circ J 2015/1; 79 (1): 41-2. (‰ş•lF˜Y1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

530008. [‚ť‚Ě‘ź (ƒRƒƒ“ƒg)]yComment on: Association of Adventitial Vasa Vasorum and Inflammation With Coronary Hyperconstriction After Drug-Eluting Stent Implantation in Pigs In Vivo. [Circ J. 2015]zInside Out, Outside in Vasa Vasorum and Coronary Spasm. Shimohama T1, Ako J1: Circ J 2015/7; 79 (8): 1693-4. (‰ş•lF˜Y1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

530009. [‚ť‚Ě‘ź (ƒRƒƒ“ƒg)]yComment on: Circulating Fibroblast Growth Factor 23 Has a U-Shaped Association With Atrial Fibrillation Prevalence. [Circ J. 2015]zIs Circulating Fibroblast Growth Factor 23 a Surrogate Marker or Active Mediator for the Construction of Atrial Fibrillation Substrate? Niwano S1: Circ J 2015/7; 79 (8): 1685-6. (’ë–ěTˆę1: 1zŠÂŠí“ŕ)

530010. [‚ť‚Ě‘ź (ƒRƒƒ“ƒg)]yComment on: Effects of Triple Therapy in Patients With Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Regarding Thromboembolic Risk Stratification. [Circ J. 2016]zTriple Antithrombotic Therapy - Always One Too Many? Fukaya H1, Ako J1: Circ J 2016/2; 80 (2): 316-7. ([’J‰p•˝1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ)

540007. [‚ť‚Ě‘ź (Editorial Comment)] V‘q˜_•ś‚ɑ΂ˇ‚éEditorial Comment|DŽ_‹…‚ƐSŽžŠł. ’––”FŒł (zŠÂŠí“ŕ): S‘Ÿ 2015/7; 47 (7): 853.

540008. [‚ť‚Ě‘ź (Editorial Comment)] ŒĂě˜_•ś‚ɑ΂ˇ‚éEditorial Comment|”ě‘ĺŒ^S‹ŘÇ‚É‚¨‚Ż‚éV‚˝‚ČƒŠƒXƒNˆöŽq|Së•”SŽşáŽ. ’––”FŒł (zŠÂŠí“ŕ): S‘Ÿ 2016/3; 48 (3): 327.

[’˜@‘]

620030. [Šwp‘ (•Ş’SŽˇ•M)]yEBMzŠÂŠíŽžŠł‚ĚŽĄ—Ă 2015-2016zII. S•s‘S@B. ‹}ŤS•s‘SŽĄ—Á@4. ‹}ŤS•s‘SŽĄ—Ă‚É‚¨‚˘‚Ĉâ“`Žq‘gŠˇ‚ŚŒ^ƒqƒgƒŠƒ‰ƒLƒVƒ“-2‚͏Ǐó‚đŠÉ˜a‚ˇ‚é‚Š?, p.174-7. ’––”FŒł (zŠÂŠí“ŕ), ŠÄC: ŹŽşˆęŹ, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2015/4”­s.

620031. [Šwp‘ (•Ş’SŽˇ•M)]yEBMzŠÂŠíŽžŠł‚ĚŽĄ—Ă 2015-2016zIII. •sŽ–Ź245@B. •p–ŹŤ•sŽ–Ź@9. SŽş×“Ž‚ɑ΂ˇ‚é‹}ŤŠú‚Ě‘Îˆ–@‚͂ǂ̂悤‚É‚Č‚Á‚Ä‚˘‚é‚Ě‚Š?, p.291-5. ’ë–ěTˆę (zŠÂŠí“ŕ), ŠÄC: ŹŽşˆęŹ, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2015/4”­s.

620032. [Šwp‘ (•Ş’SŽˇ•M)]yƒi[ƒX•KŒg! zŠÂŠí‚Ě–ňÜƒKƒCƒh (HEART nursing 2015”NtŠú‘Š§)z[2Í ‚ ‚̏zŠÂŠíŽžŠł‚É‚Í‚Ç‚ń‚Č–ňÜ‚ŞŽg‚í‚ę‚é?] (1) S•s‘S (‹}ŤS•s‘SE–ŤS•s‘S), p192-4. ’––”FŒł (zŠÂŠí“ŕ), ŠÄC: ÔÎ@˝, ƒƒfƒBƒJo”Ĺ, ‘ĺă, 2015/4”­s.

620033. [Šwp‘ (•Ş’SŽˇ•M)]yS•s‘Sf—ĂQ&A ƒGƒLƒXƒp[ƒg105l‚Š‚ç‚̉ń“š ‰ü’ů2”ŁzII. S•s‘Sf—ĂQ&A@1. S•s‘S‚̉uŠw@6. śŽş‹ěo—Ś‚Ĺ‚ť‚̐l‚Ě—\Œă‚Ş‚í‚Š‚é‚Ě‚Ĺ‚ľ‚傤‚Š?, p.95-6. ’––”FŒł (zŠÂŠí“ŕ), •Ň: –k•—­Žj, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2015/4”­s.

620034. [Šwp‘ (•Ş’SŽˇ•M)]yS•s‘Sf—ĂQ&A ƒGƒLƒXƒp[ƒg105l‚Š‚ç‚̉ń“š ‰ü’ů2”ŁzII. S•s‘Sf—ĂQ&A@2. S•s‘S‚Ě•a‘ԁ@1. RAAŒnŠˆŤ‰ť‚Ş‚Č‚şS•s‘S‚Ć‚Â‚Č‚Ş‚é‚Ě‚Ĺ‚ˇ‚Š?, p.106-7. ’––”FŒł (zŠÂŠí“ŕ), •Ň: –k•—­Žj, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2015/4”­s.

620035. [Šwp‘ (•Ş’SŽˇ•M)]yS•s‘Sf—ĂQ&A ƒGƒLƒXƒp[ƒg105l‚Š‚ç‚̉ń“š ‰ü’ů2”ŁzII. S•s‘Sf—ĂQ&A@5. –ŤS•s‘S‚Ě–ň•¨—Ă–@@1. S‹@”\‚ވŤ‚˘‚Ż‚ę‚Ç‚ŕ, Œł‹C‚Ȑl (NYHAI“x‚Ü‚˝‚ÍII“x) ‚É“ŕ•žŽĄ—Ă‚Í•K—v‚Č‚Ě‚Ĺ‚ľ‚傤‚Š?, p.226-8. ’––”FŒł (zŠÂŠí“ŕ), •Ň: –k•—­Žj, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2015/4”­s.

620036. [Šwp‘ (•Ş’SŽˇ•M)]yS•s‘Sf—ĂQ&A ƒGƒLƒXƒp[ƒg105l‚Š‚ç‚̉ń“š ‰ü’ů2”ŁzII. S•s‘Sf—ĂQ&A@5. –ŤS•s‘S‚Ě–ň•¨—Ă–@@2. –ŤS•s‘SŠłŽŇ‚Ĺ‚ĚŽŠ“K‘̉t—ʂ͂ǂ̂悤‚ÉŒˆ‚ß‚é‚Ě‚Ĺ‚ľ‚傤‚Š?, p.229-30. ’––”FŒł (zŠÂŠí“ŕ), •Ň: –k•—­Žj, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2015/4”­s.

620037. [Šwp‘ (•Ş’SŽˇ•M)]yS•s‘Sf—ĂQ&A ƒGƒLƒXƒp[ƒg105l‚Š‚ç‚̉ń“š ‰ü’ů2”ŁzII. S•s‘Sf—ĂQ&A@10. S•s‘S‚đ‘S‘Ě‚Ć‚ľ‚Ä‚Ç‚¤‚Ć‚ç‚Ś‚é‚Š|from bench to bedside|@3. ƒ^[ƒ~ƒiƒ‹ƒPƒA‚ĚŒťó‚Ć, ĄŒă‚Ç‚¤‚Č‚é‚Š‚đ‹ł‚Ś‚Ä‚­‚ž‚ł‚˘, p.442-3. ’––”FŒł (zŠÂŠí“ŕ), •Ň: –k•—­Žj, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2015/4”­s.

620038. [Šwp‘ (•Ş’SŽˇ•M)]yS–[×“ŽˆŮ•ś‰ťŒđ—Ź`‘˝–Ę“IƒAƒvƒ[ƒ`‚Ě‚˝‚ß‚Ě‘Î’kW`z5. S•s‘S‚ƐS–[×“Ž‚Ě–§Ú‚ČŠÖŒW, p.87-106. ’––”FŒł (zŠÂŠí“ŕ), •Ň: ŽR‰ş•Žu, ˆă–ňƒWƒƒ[ƒiƒ‹, ‘ĺă, 2015/4”­s.

620039. [Šwp‘ (•Ş’SŽˇ•M)]y•sŽ–Źf—ĂƒNƒŠƒjƒJƒ‹ƒNƒGƒXƒ`ƒ‡ƒ“200z5Í •p–Ź‘˜_@Q34. narrow QRS•p”‚̐S“d}ŠÓ•Ę‚ĚŽŔŰ“I•ű–@‚Í?, p.45-6. ’ë–ěTˆę (zŠÂŠí“ŕ), •Ň: •˝”öŒŠŽO, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/4”­s.

620040. [Šwp‘ (•Ş’SŽˇ•M)]y•sŽ–Źf—ĂƒNƒŠƒjƒJƒ‹ƒNƒGƒXƒ`ƒ‡ƒ“200z5Í •p–Ź‘˜_@Q35. wide QRS•p”‚̐S“d}ŠÓ•Ę‚ĚŽŔŰ“I•ű–@‚Í?, p.47-8. ’ë–ěTˆę (zŠÂŠí“ŕ), •Ň: •˝”öŒŠŽO, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/4”­s.

620041. [Šwp‘ (•Ş’SŽˇ•M)]y‚ą‚ą‚Ü‚Ĺ–ž‚ç‚Š‚É‚Č‚Á‚˝! ”AŽ_‘ăŽÓƒ[ƒ‹ƒh‚ƍ‚”AŽ_ŒŒÇ‚Ě•a‘ԉ𖞁`f—Ă‚ĆˆăŠw‚ĚĹ‘Oü`zChapter 5@Practice `ŽíX‚ĚŽžŠłƒŠƒXƒN‚Ć‚ľ‚Ä‚Ě‚”AŽ_ŒŒÇ@1. ŠÂŠíŽžŠł‚Ć”AŽ_‘ăŽÓ‚ĚŠÖ‚í‚č@…@SŽžŠł‚Ě”­Ç‚Ć—\Œă@3) S–[×“Ž, p.62-7. ’ë–ěTˆę1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ), ŠÄC: źŕV—CŽŸ, •Ň: ‰ş‘şˆÉˆę˜Y, ‰vč—TÍ, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, ‘ĺă, 2015/6”­s.

620042. [Šwp‘ (•Ş’SŽˇ•M)]yzŠÂŠí‹}ŤŠúf—Á|Critical Care Cardiology|zƒoƒCƒIƒ}[ƒJ[: ƒgƒƒ|ƒjƒ“, p.62-5. ’––”FŒł (zŠÂŠí“ŕ), •Ň: â@r, ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 2015/6”­s.

620043. [Šwp‘ (•Ş’SŽˇ•M)]y•Sí˜B–‚ĚƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ˆă‚Ş‹ł‚Ś‚鍑ŰŠw‰ď”­•\E‰pŒę˜_•śěŹ@ŹŒ÷‚Ě”éŒz‘ć2Í ‰pŒę˜_•ś‚đ‘‚­@E. ‰pŒę˜_•śěŹ‚ĚŽŔŰ@e. •ű–@ (methods), p.126-33. ‰ş•lF˜Y1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ), •Ň: ‘şźrĆ, “ě]“°, “Œ‹ž, 2015/7”­s.

620044. [Šwp‘ (•Ş’SŽˇ•M)]yf’f‚ĆŽĄ—Ă‚ĚABC [No.106 S•s‘S] (ĹVçΛ{•Ęű)z‘ć4Í ŠÇ—EŽĄ—Á@ăŽč‚Č—˜”A–ň‚ĚŽg‚˘•ű, p.129-35. ’––”FŒł (zŠÂŠí“ŕ), •Ň: â“c‘׎j, ĹVˆăŠwŽĐ, ‘ĺă, 2015/8”­s.

620045. [Šwp‘ (•Ş’SŽˇ•M)]y•sŽ–ŹŽĄ—Ăupdate ‘ć4ŠŞ •sŽ–Ź‚ɑ΂ˇ‚é–ň•¨ŽĄ—Ă‚ĚŒťó‚Ć–˘—ˆzII. ăŽşŤ•sŽ–Ź‚ɑ΂ˇ‚é–ň•¨ŽĄ—Á@4. S–[×“Ž‚ɑ΂ˇ‚éƒAƒbƒvƒXƒgƒŠ[ƒ€—Ă–@: ŒťÝ‚Ĺ‚Í‚Ç‚¤l‚Ś‚é‚ׂŤ‚Š, p.97-101. ’ë–ěTˆę (zŠÂŠí“ŕ), •Ň: ‰œ‘ş@ŒŞ, ’r“c—˛“ż, ŽR‰ş•Žu, ˆäăkˆę, šę“c@_, ˆă–ňƒWƒƒ[ƒiƒ‹, ‘ĺă, 2015/8”­s.

620046. [Šwp‘ (•Ş’SŽˇ•M)]yElectrocardiography A to Z|S“d}‚ĚƒŠƒYƒ€‚Ć”g‚đŒŠ‹É‚ß‚é (“ú–{ˆăŽt‰ďŽGŽ ‘ć144ŠŞE“Á•Ę† (2) śŠU‹łˆçƒVƒŠ[ƒY89)zIIIÍ ”gŒ`‚ĚˆŮí@2. S‹Ř‰Š, p.110-1. ’––”FŒł (zŠÂŠí“ŕ), ŠÄC: ˆé•”ŒőÍ, ‰œ‘ş@ŒŞ, “ú–{ˆăŽt‰ď, “Œ‹ž, 2015/10”­s.

620047. [Šwp‘ (•Ş’SŽˇ•M)]yElectrocardiography A to Z|S“d}‚ĚƒŠƒYƒ€‚Ć”g‚đŒŠ‹É‚ß‚é (“ú–{ˆăŽt‰ďŽGŽ ‘ć144ŠŞE“Á•Ę† (2) śŠU‹łˆçƒVƒŠ[ƒY89)zIIIÍ ”gŒ`‚ĚˆŮí@3. S–Œ‰Š, p.112-3. ’––”FŒł (zŠÂŠí“ŕ), ŠÄC: ˆé•”ŒőÍ, ‰œ‘ş@ŒŞ, “ú–{ˆăŽt‰ď, “Œ‹ž, 2015/10”­s.

620048. [Šwp‘ (•Ş’SŽˇ•M)]y–ŤS•s‘S‚Ě‚ ‚˝‚ç‚ľ‚˘ƒPƒA‚ĆŠÇ—@ƒ`[ƒ€ˆă—ÁE’nˆć˜AŒgEÝ‘îŠÇ—EI––ŠúƒPƒA‚ĚŽŔ‘HzII Šî‘b•Ň: ‰Ÿ‚ł‚Ś‚Ä‚¨‚­‚ׂŤS•s‘S‚̍ŐV’mŽŻ@B. S•s‘S‚̐f’f‚ĆŒŸ¸–@‚̍ŐV’mŽŻ@3. ‰ESƒJƒe[ƒeƒ‹ŒŸ¸, p.122-3. ’––”FŒł (zŠÂŠí“ŕ), •Ň:•S‘şLˆę, —é–؁@˝, “ě]“°, “Œ‹ž, 2015/11”­s.

620049. [Šwp‘ (•Ş’SŽˇ•M)]yEREICU‚Ĺ‚Ě–ň‚ĚŽg‚˘•űEl‚Ś•ű2016-'17|ƒGƒLƒXƒp[ƒg‚ĚŽŔ‘H‚Ć”éŒ‚ÉŠw‚ԁ| (‹~‹}EW’†ŽĄ—Ă Vol.27—ŐŽž‘Š§†z6. zŠÂŠíŽžŠł‚Ě‹Ů‹}ŽĄ—Á@SŒšŤƒVƒ‡ƒbƒN‚ĚŽĄ—ĂŽwj, p93-5. ’––”FŒł (zŠÂŠí“ŕ), •Ň: ‰ŞŒł˜a•ś, ‘Ž‡ˆăŠwŽĐ, “Œ‹ž, 2015/12”­s.

620050. [Šwp‘ (•Ş’SŽˇ•M)]yEREICU‚Ĺ‚Ě–ň‚ĚŽg‚˘•űEl‚Ś•ű2016-'17|ƒGƒLƒXƒp[ƒg‚ĚŽŔ‘H‚Ć”éŒ‚ÉŠw‚ԁ| (‹~‹}EW’†ŽĄ—Ă Vol.27—ŐŽž‘Š§†z6. zŠÂŠíŽžŠł‚Ě‹Ů‹}ŽĄ—Á@Q30. –ŤS•s‘S, p.e217-23. ’––”FŒł (zŠÂŠí“ŕ), •Ň: ‰ŞŒł˜a•ś, ‘Ž‡ˆăŠwŽĐ, “Œ‹ž, 2015/12”­s.

620051. [Šwp‘ (•Ş’SŽˇ•M)]yEREICU‚Ĺ‚Ě–ň‚ĚŽg‚˘•űEl‚Ś•ű2016-'17|ƒGƒLƒXƒp[ƒg‚ĚŽŔ‘H‚Ć”éŒ‚ÉŠw‚ԁ| (‹~‹}EW’†ŽĄ—Ă Vol.27—ŐŽž‘Š§†z6. zŠÂŠíŽžŠł‚Ě‹Ů‹}ŽĄ—Á@S•s‘S‚ĚŽĄ—ĂŽwj, p316-8.@ ’––”FŒł (zŠÂŠí“ŕ), •Ň: ‰ŞŒł˜a•ś, ‘Ž‡ˆăŠwŽĐ, “Œ‹ž, 2015/12”­s.

620052. [Šwp‘ (•Ş’SŽˇ•M)]y‚Č‚é‚Ů‚Ç! ‚Ć‚ć‚­‚í‚Š‚é S•s‘S‚Ĺ—˜”A–ň‚đŽg‚˘‚ą‚Č‚ˇ (Fluid Management Renaissance 6-Suppl.)zPart1 S•s‘S‚Ě‚¤‚ÁŒŒƒRƒ“ƒgƒ[ƒ‹‚đ‹†‚ß‚é@III …•Ş§ŒŔ‚Í, íŽŻ‚Ĺ‚Í‚Č‚˘@S•s‘SŽĄ—Âɐ…•Ş§ŒŔ‚Í•K—v‚Š?, p.20-5. ’––”FŒł (zŠÂŠí“ŕ), •Ň: “›ˆä—T”V, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, ‘ĺă, 2016/3”­s.

620053. [Šwp‘ (•Ş’SŽˇ•M)]y‚ą‚ą‚Ş’m‚č‚˝‚˘ ‹}ŤS•s‘S‚Ě‹~‹}EW’†ŽĄ—ĂŠÇ—z3Í ‰Šú‹~‹}ŽĄ—Á@3. ‰ŠúŽĄ—Ă‚É•K—v‚ČŠî–{–ňÜ@D. ŒŒŠÇŠg’Ł–ň, p.227-37. ’––”FŒł (zŠÂŠí“ŕ), •Ň: ˛“ĄKl, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/3”­s.

620054. [Šwp‘ (•Ş’SŽˇ•M)]y‚ą‚ą‚Ş’m‚č‚˝‚˘ ‹­S–ň‚Ě‚ł‚ś‰ÁŒ¸z‘ć3Í ‹­S–ň‚đ“Š—^‚ˇ‚ׂŤ•a‘ԂƂ́@4. ‹}ŤS•s‘S|‹•ŒŒŤE”ń‹•ŒŒŤ‚Ě•a‘Ô‚ĆŽĄ—Ă‚ĚˇˆŮ, p.103-8. ’––”FŒł (zŠÂŠí“ŕ), •Ň: –k•—­Žj, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/3”­s.

620055. [Šwp‘ (•Ş’SŽˇ•M)]y‚ą‚ą‚Ş’m‚č‚˝‚˘ ‹­S–ň‚Ě‚ł‚ś‰ÁŒ¸z‘ć3Í ‹­S–ň‚đ“Š—^‚ˇ‚ׂŤ•a‘ԂƂ́@6. ‹}ŤS•s‘S|‚˘‚Š‚É‹­S–ň‚đweaning‚ˇ‚é‚Ě‚Š?, p.116-20. ’––”FŒł (zŠÂŠí“ŕ), •Ň: –k•—­Žj, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/3”­s.

620056. [Šwp‘ (•Ş’SŽˇ•M)]yzŠÂŠíŒ¤Cƒm[ƒgz‘ć1Í zŠÂŠíŒ¤C‚Ĺ‚ĚƒAƒhƒoƒCƒX@B. ˆă—ĂŒťę‚Ĺ‚ĚƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“@2. ƒ`[ƒ€ˆă—Ă, p.16-9. ’––”FŒł (zŠÂŠí“ŕ), ƒVƒŠ[ƒY‘ŠÄC/Ó”C•ŇW: ‰iˆä—ÇŽO, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2016/3”­s.

620057. [Šwp‘ (•Ş’SŽˇ•M)]y‚Ţ‚­‚݂⑧Ř‚ę‚É‚ŕ‚¤˘‚ç‚Č‚˘! —˜”A–ň‚̏ăŽč‚ČŽg‚˘•űzIII ƒP[ƒX‚Š‚çŠw‚ԐS•s‘SŠłŽŇ‚Ö‚ĚăŽč‚Č—˜”A–ň‚ĚŽg‚˘•ű@J. t‹@”\ˆŤ‰ť‚Ć—˜”A–ň‘I‘đ‚̍l‚Ś•ű|ƒ‰ƒVƒbƒNƒX‚ł͐t‹@”\‚ވŤ‰ť‚ľ‚˝‚Ş, ƒTƒ€ƒXƒJ‚Ĺ‚ÍˆŰŽ‚Ĺ‚Ť‚˝Ç—á, p.130-5. ’––”FŒł (zŠÂŠí“ŕ), •Ň: ‘ŽR@—, “ě]“°, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713026. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Structural Remodeling in Atrium can be Suppressed by Febuxostat, a Xanthine; Oxidase -Inhibitor, in the Canine Model of Atrial Fibrillation. Yoshizawa T1, Niwano S1, Niwano H, Igarashi T2, Nakamura H2, Fujiishi T2, Ishizue N2, Kishihara J1, Murakami M1, Fukaya H1, Ako J1: Annual Scientific Meeting of Heart Rhythm Society (2015/5/14), San Francisco, USA. (‹gŕV’qŽĄ1, ’ë–ěTˆę1, ŒÜ\—’Œš2, ’†‘ş—m”Í2, “ĄÎŽě”ü2, Î––ŹĆ2, ŠÝŒ´@~1, ‘şă‰ë”ü1, [’J‰p•˝1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713027. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) A case of interventional treatment for chronic thrombosis caused by iliac compression syndrome. Meguro K1: EuroPCR 2015 (2015/5/19), Paris, France. (–ڍ•Œ’‘ž˜Y1: 1zŠÂŠí“ŕ)

713028. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Aliskiren Suppresses Extracellular Matrix Genes in Atrial Fibrillation - A Global mRNA Profiling in the Canine Experimental Atrial Fibrillation Model Kishihara J1, Niwano S1, Niwano H, Satoh A1, Igarashi T2, Ishizue N2, Fujiishi T2, Yoshizawa T1, Murakami M1, Fukaya H1, Ako J1: ESC CONGRESS 2015 (2015/8/30), London, UK. (ŠÝŒ´@~1, ’ë–ěTˆę1, ˛“Ą@—z1, ŒÜ\—’Œš2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹gŕV’qŽĄ1, ‘şă‰ë”ü1, [’J‰p•˝1, ˆ˘ŒĂĆ1: 1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713029. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Linagliptin, a DPP-4 Inhibitor, Suppresses the Electrical Remodeling and Myocardial Injury in Isoproterenol-induced Myocardial Injury Model in Rat. Ishizue N1, Niwano S2, Nakamura H1, Igarashi T1, Fujiishi T1, Yoshizawa T2, Oikawa J, Kishihara J2, Murakami M2, Fukaya H2, Niwano H, Ako J2: ESC CONGRESS 2015 (2015/9/1), London, UK. (Î––ŹĆ1, ’ë–ěTˆę2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

713030. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Prediction of Upcoming Therapeutic Episodes of ICD through Routine Data in Periodic Device Clinic of ICD Patients. Fujiishi T1, Niwano S2, Murakami M2, Nakamura H1, Igarashi T1, Ishizue N1, Oikawa J, Kishihara J2, Fukaya H2, Niwano H, Ako J2: American Heart Association Scientific Sessions 2015 (2015/11/8), Orland, USA. (“ĄÎŽě”ü1, ’ë–ěTˆę2, ‘şă‰ë”ü2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, Î––ŹĆ1, ŠÝŒ´@~2, [’J‰p•˝2, ˆ˘ŒĂĆ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ)

721004. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ‚—îŽŇ‚̐S–[×“Ž‚ƍR‹ĂŒĹ—Ă–@. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć57‰ń“ú–{˜V”NˆăŠw‰ďŠwpW‰ď (2015/6/14), _“ސě.

721005. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ŠĽ“Ž–ŹƒXƒeƒ“ƒg—Ż’uŒă‚Ě3d‚̍RŒŒđ—Ă–@ŠúŠÔ‚Ě’Zk‚ɂ‚˘‚Ä‚ĚŽŽ‚Ý. ‰––ě•ű–ž1, ˛“Ą‘ĺ•ă1, ˛“ĄF“T1, ‘şź—S‰î1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ‘ć24‰ń“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ŽĄ—ĂŠw‰ď (CVIT2015) (2015/7/30), •Ÿ‰Ş.

721006. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ‰ES•s‘S‚̐f’f‚ĆŽĄ—Ă. ’––”FŒł (zŠÂŠí“ŕ): ‘ć63‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2015/9/18), ‰Ą•l.

721007. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) –Y‚ę‚Ä‚Í‚˘‚Ż‚Č‚˘ŠĽ“Ž–ŹŽžŠł‚Ě“ńŽŸ—\–h‚ƍ‡•šÇ. ‰––ě•ű–ž1, ˛“Ą‘ĺ•ă1, ˛“ĄF“T1, ‘şź—S‰î1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ‘ć63‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2015/9/19), ‰Ą•l.

721008. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ‚˘‚Ü, ‹}ŤS•s‘SŽĄ—Ă‚Í‚Ç‚¤‚ ‚é‚ׂŤ‚Š. ’––”FŒł (zŠÂŠí“ŕ): Samsca Heart Forum 2015 in Sapporo (2015/9/5), ŽD–y.

721009. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) S–[×“Ž‡•šS•s‘S‚ɑ΂ˇ‚éƒŔŽŐ’f–ň‚ĚŽg—pˆÓ‹`‚đl‚Ś‚é|S•s‘Sę–ĺˆă‚Ě—§ę‚Š‚ç|. ’––”FŒł (zŠÂŠí“ŕ): ‘ć19‰ń“ú–{S•s‘SŠw‰ďŠwpW‰ď (2015/10/22), ‘ĺă.

721010. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) Decongestion‚Ě’Ş—Ź‚Í‚Ç‚ą‚É‚ ‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): ‘ć19‰ń“ú–{S•s‘SŠw‰ďŠwpW‰ď (2015/10/24), ‘ĺă.

721011. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) S•s‘S‚Ć—˜”A–ň. ’––”FŒł (zŠÂŠí“ŕ): ‘ć25‰ń“ú–{ˆă—Ă–ňŠw‰ď”N‰ď (2015/11/21), ‰Ą•l.

721012. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) S•s‘SÇ—á‚É‚¨‚Ż‚éR‹ĂŒĹ—Ă–@. ’––”FŒł (zŠÂŠí“ŕ): CVMW2015SŒŒŠÇ‘ăŽÓTŠÔ (2015/12/12), _ŒË.

722033. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) S‘ŸƒTƒ‹ƒRƒCƒh[ƒVƒX‘˜_. ’––”FŒł (zŠÂŠí“ŕ): ‘ć2‰ńCMRƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/5/16), “Œ‹ž.

722034. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) S–[×“Ž‚Ě”][Ç—\–h-NOAC‘卬íŽž‘ă‚Ě—Ő°Œťę‚Ě‘I‘đ- ’ë–ěTˆę (zŠÂŠí“ŕ): TOPIC (Tokyo Percutaneous Cardiovascular Intervention Conference) 2015 (2015/7/9), “Œ‹ž.

722035. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) zŠÂŠíf—Ă‚É—§‹r‚ľ‚˝S‘ŸƒAƒ~ƒƒCƒh[ƒVƒX‚̐f’fƒ[ƒNƒtƒ[`f’f—ŚŒüă‚Ěƒqƒ“ƒg‚đ’T‚é. ’––”FŒł (zŠÂŠí“ŕ): ‘ć63‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2015/9/19), ‰Ą•l.

722036. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ˆă—ĂŒoĎ‚Š‚猊‚˝S•s‘Sf—Á`ƒGƒrƒfƒ“ƒX‚Í‚Ĺ‚Ť‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): ‘ć19‰ń“ú–{S•s‘SŠw‰ďŠwpW‰ď (2015/10/24), ‘ĺă.

722037. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Comment on the JACRE Registry. Late Breaking Clinical Trials/ Cohort Studies II Arrhythmia/ Hypertension. ’ë–ěTˆę (zŠÂŠí“ŕ): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/18), ĺ‘ä.

723195. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒRƒƒ“ƒe[ƒ^[. ‰––ě•ű–ž (zŠÂŠí“ŕ): slender club tokyo 2015 (2015/4/10), •iě.

723196. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Measurement of L-type fatty acid-binding protein just after cardiac or vascular surgery can predict acute kidney injury. –ڍ•Œ’‘ž˜Y1, Yamaoka H, Akashi H, Iidaka K, Nakata M, Yamashita T, Fujita M, Chinen T, Kikuchi T, Keida T, Ohira H (1zŠÂŠí“ŕ): ‘ć79‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2015/4/24), ‘ĺă.

723197. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Febuxostat, a Xanthine-Oxidase-Inhibitor, Suppresses the Structural Remodeling in Atrium through Anti-Oxidative Effect in the Canine Model of Atrial Fibrillation ‹gŕV’qŽĄ1, ’ë–ěTˆę1, ’ë–ě—TŒb, ŒÜ\—’Œš2, “ĄÎŽě”ü2, Î––ŹĆ2, ŠÝŒ´@~1, ‘şă‰ë”ü1, [’J‰p•˝1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć79‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2015/4/24), ‘ĺă.

723198. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Effect of TDI Guided Reprogramming to Reduce Inappropriate Shock in ICD Patients and Clinical Predicting Factor Even After the Repeated-Reprogramming. “ĄÎŽě”ü1, ’ë–ěTˆę2, ‘şă‰ë”ü2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, Î––ŹĆ1, ‹gŕV’qŽĄ2, ŠÝŒ´@~2, [’J‰p•˝2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć79‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2015/4/24), ‘ĺă.

723199. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Dipeptidyl Peptidase-4 Inhibitor Improves Endothelial Function Accompanied by an Increase in Anti-atherosclerotic Protein ”˘•űŒ’G1, “ŒžŠ‘ĺ‹P2, Îˆär•ă2, –k—˘—œŽŃ2, ‹´–{‘ń–í1, ‹T“c@—Ç2, ‰ş•lF˜Y2, “ŒžŠ”ü“ŢŽq3, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3ˆă—ÉqśŠw•”): ‘ć79‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2015/4/25), ‘ĺă.

723200. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Non-VKA oral anticoagulant (NOAC) in atrial fibrillation patients receiving PCI. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć79‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2015/4/25), ‘ĺă.

723201. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Anti-thrombotic strategies for CAD patients with atrial fibrillation. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć79‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2015/4/25), ‘ĺă.

723202. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Left Atrial Stretch and Dominant Frequency of Atrial Fibrillation. Hatakeyama Y, ’ë–ěTˆę1, ‹yě@~, [’J‰p•˝1, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2ˆă—ÉqśŠw•”): ‘ć79‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2015/4/25), ‘ĺă.

723203. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ú–{l‚Ě“ÁŤ‚đl—ś‚ľ‚˝RŒŒđ—Ă–@‚Ě‚ ‚č•ű|ƒKƒCƒhƒ‰ƒCƒ“‚Ć—Ő°ƒGƒrƒfƒ“ƒX‚Š‚ç‚̍lŽ@|. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć79‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2015/4/26), ‘ĺă.

723204. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Discrimination of Paroxysmal and Non-paroxysmal Atrial Fibrillation In the Patients with New-onset Atrial Fibrillation. ŒÜ\—’Œš1, ’ë–ěTˆę2, Î––ŹĆ1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ŠÝŒ´@~2, [’J‰p•˝2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć79‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2015/4/26), ‘ĺă.

723205. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Characteristic in left ventricular flow vortex and its energetic efficiency of normal and dilated myocardium. Š`č—Ç‘ž1, “ç“c@Œ’1, Îˆär‰î2, Ź”‹´r”ü2, ‹{čăĕ˝3, ’––”FŒł2, ”Â’JŒcˆę3, ‹{’n@ŠÓ4, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3ŒŒ—Ź‰đÍ, 4S‘ŸŒŒŠÇŠO): ‘ć79‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2015/4/24-26), ‘ĺă.

723206. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) R‹ĂŒĹ–ň‚ƍRŒŒŹ”–ň‚Ě•š—p. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ćˆę‰ńJ-ISCPŠwpW‰ď‘ŰSŒŒŠÇ–ň•¨—Ă–@Šw‰ď“ú–{•”‰ď (2015/6/20), ‹ž“s.

723207. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) dÇŽOŽ}•a•Ď‚𔺂¤‘ĺ“Ž–Ź•Ů‹ˇóÇ‚ÉIABP‰ş‚ÉBAV‚đŽ{s‚ľ‚˝ˆę—á. –ڍ•Œ’‘ž˜Y1, …’J’m‘×2, –öŕV’q‹`1, ‰ş•lF˜Y1, “ŒžŠ‘ĺ‹P1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‹~–˝): ‘ć6‰ń“ú–{ŒoƒJƒe[ƒeƒ‹S‘Ÿ•ŮŽĄ—ĂŠw‰ďŠwpW‰ď JTVT2015 (2015/7/5), “Œ‹ž.

723208. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Antiplatelet therapy after PCI in LMT or multivessel disease. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): TOPIC2015 (2015/7/10), “Œ‹ž.

723209. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ¸“ǂւ̑Ήž. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): TOPIC2015 (2015/7/11), “Œ‹ž.

723210. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) S‹Ř[ÇŠłŽŇ‚É‚¨‚Ż‚é”­Ç‘O‚ĚŠĽŠëŒŻˆöŽqƒRƒ“ƒgƒ[ƒ‹‚ł‚ę‚Ä‚˘‚Č‚˘ŠłŽŇ‚Ěó‹ľ‚Ć“Á’Ľ. –ڍ•Œ’‘ž˜Y1, ‹e’r’B˜Y, ŠŞ‹M”Ž, “’ěç’ߎq, ŽR‰ŞŒ[M, ‘ĺ•˝—mŽi (1zŠÂŠí“ŕ): ‘ć21‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2015/7/18), •Ÿ‰Ş.

723211. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) S•s‘SŠłŽŇ‚Ě“ü‰@‘Šú‚É•]‰ż‚ľ‚˝10m‰ő“K•ŕsŽž‚̍ō‚S””‚Í, S•s‘SÄ“ü‰@‚ƐS‘ŸŽ€‚Ě—\‘ވöŽq‚Ć‚Č‚é. ‘OěŒb”ü1, ‘“c@‘ě2, “c’†L–í3, –ěčN•˝4, ź‘ň—Ç‘ž4, ŕ_čL–ž3,4, _’JŒ’‘ž˜Y4, ŒÜ\—’ˆŸŠóŽq5, ‰Í–ě^—5, Šâ‘ş‹M”ü5, –ě“cçt1, ’––”FŒł1, “ŒžŠ”ü“ŢŽq2, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4ƒŠƒnƒrƒŠ•”, 5ŠĹŒě•”): ‘ć21‰ń“ú–{S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2015/7/19), •Ÿ‰Ş.

723212. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Linagliptin, a DPP-4 Inhibitor, Suppresses the Electrical Remodeling in Isoproterenol-induced Myocardial Injury Model in Rat. Î––ŹĆ1, ’ë–ěTˆę2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ‹yě@~, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/29), ‹ž“s.

723213. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Differences in prevalence and degree of the abnormal early systolic contraction in left bundle branch block with and without prolonged QRS duration (>150ms). Hara H, Kaida T, –xŒű@ˆ¤1, ˛“ĄL—m1, Ito H, ’ë–ěTˆę1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/29), ‹ž“s.

723214. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Predictors for Upcoming ICD Therapeutic Episodes among Common Data in Daily Device Clinic. “ĄÎŽě”ü1, ’ë–ěTˆę2, ‘şă‰ë”ü2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, Î––ŹĆ1, ‹gŕV’qŽĄ2, ‹yě@~, ŠÝŒ´@~2, [’J‰p•˝2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/29), ‹ž“s.

723215. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Factors Determining Fibrillation Cycle Length in the Surface ECG in Patients with Long-lasting Atrial Fibrillation. ŒÜ\—’Œš1, ’ë–ěTˆę2, Î––ŹĆ1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ‹yě@~, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, –ě“cçt2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/29), ‹ž“s.

723216. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The Patients' Characteristics and Reasons of Inappropriate Dose Prescription of Non-Vitamin K Dependent Anticoagulants for the Patients with Atrial Fibrillation. [’J‰p•˝1, ’ë–ěTˆę1, ’†‘ş—m”Í2, Î––ŹĆ2, ŒÜ\—’Œš2, “ĄÎŽě”ü2, ‹gŕV’qŽĄ1, ‹yě@~, ˛“Ą@—z1, ŠÝŒ´@~1, ‘şă‰ë”ü1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/30), ‹ž“s.

723217. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) A Case with Pacing Failure Caused by Automatic Pacing Threshold Adjustment|A Pit-fall of Automatic Threshold Testing Algorithm of Pacemaker|. ŠÝŒ´@~1, ’ë–ěTˆę1, ’†‘ş—m”Í2, ŒÜ\—’Œš2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹gŕV’qŽĄ1, ‹yě@~, ˛“Ą@—z1, ‘şă‰ë”ü1, [’J‰p•˝1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/30), ‹ž“s.

723218. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Differences in the Anticoagulation Strategy for Atrial Fibrillation between Cardiologists and Non-cardiologist. ˛“Ą@—z1, [’J‰p•˝1, ‹yě@~, Yasuno N, Kubo T, ’ë–ěTˆę1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/30), ‹ž“s.

723219. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The time course of the change in P wave morphology in cases with new onset atrial fibrillation ‹gŕV’qŽĄ1, ’ë–ěTˆę1, ’†‘ş—m”Í2, ŒÜ\—’Œš2, “ĄÎŽě”ü2, Î––ŹĆ2, ‹yě@~, ŠÝŒ´@~1, ˛“Ą@—z1, ‘şă‰ë”ü1, [’J‰p•˝1, ’ë–ě—TŒb, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/30), ‹ž“s.

723220. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Comparison of circadian, weekly and seasonal variations between electrical storms versus single VF events in patients with Brugada syndrome. Aizawa Y, Takatsuki S, Nakajima K, Kashimura S, Kunitomi A, Katsumata Y, Nishiyama T, Kimura T, Nishiyama N, Fukumoto K, Tanimoto Y, Kaneko Y, ’ë–ěTˆę1, Kurita T, Mitsuhashi T, Noda T, Kamakura S, Shimizu A, Horie M, Aizawa Y, Fukuda K (1zŠÂŠí“ŕ): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/30), ‹ž“s.

723221. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Importance of the Presence of J-wave as a Predictor for Life-threatening Arrhythmia in ICD-implanted patients. Î––ŹĆ1, ’ë–ěTˆę2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ‹yě@~, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/30), ‹ž“s.

723222. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Nifekalant with Rapid Ventricular Pacing Suppressed Incessant Ventricular Tachycardia after Urgent Coronary Artery Bypass Surgery in the Patient with Acute Myocardial Infarction. ’†‘ş—m”Í1, [’J‰p•˝2, ’ë–ěTˆę2, Ź–ě—Y‘ĺ2, ‹´–{‘ń–í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, Î––ŹĆ1, ‹gŕV’qŽĄ2, ŠÝŒ´@~2, ‘şă‰ë”ü2, …’J’m‘×3, ’|“ŕˆę˜Y3, –k‘ş@—Ľ4, ‹{’n@ŠÓ4, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ, 3‹~–˝, 4S‘ŸŒŒŠÇŠO): ‘ć30‰ń“ú–{•sŽ–ŹŠw‰ďŠwp‘ĺ‰ďE‘ć32‰ń“ú–{S“dŠw‰ďŠwpW‰ď ‡“ŻŠwp‘ĺ‰ď (2015/7/30), ‹ž“s.

723223. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) One year outcome of retrograde percutaneous balloon aortic valvuloplasty. –ڍ•Œ’‘ž˜Y1, Iidaka K, Nakata M, Yamashita T, Chinen T, Fujita M, Keida T, Ohira H (1zŠÂŠí“ŕ): ‘ć24‰ń“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ŽĄ—ĂŠw‰ď (CVIT2015) (2015/7/30), •Ÿ‰Ş.

723224. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Antiplatelet and anticoagulant therapy in patients with acute myocardial infarction and its complications. –ڍ•Œ’‘ž˜Y1, Iidaka K, Nakata M, Yamashita T, Chinen T, Fujita M, Keida T, Ohira H (1zŠÂŠí“ŕ): ‘ć24‰ń“ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ŽĄ—ĂŠw‰ď (CVIT2015) (2015/7/31), •Ÿ‰Ş.

723225. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é’…—pŒ^ŽŠ“Žœ×“ŽŠí (WCD) ‚ĚŽg—pŒoŒą. ŠÝŒ´@~1, ’ë–ěTˆę1, ’†‘ş—m”Í2, ŒÜ\—’Œš2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹yě@~, ‘şă‰ë”ü1, [’J‰p•˝1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć63‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2015/9/19), ‰Ą•l.

723226. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ý‘îf—Ă‚Ć•af˜AŒg‚đl‚Ś‚é: 2025”N–â‘č‚ÉŒü‚Ż‚Ä. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć63‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2015/9/20), ‰Ą•l.

723227. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) RŒŒđ–ň‚đzŠÂŠíE_Œo“ŕ‰Čˆă‚Š‚çŠw‚Ń, Á‰ťŠíˆă‚ލl‚Ś‚é ˆ˘ŒĂĆ (zŠÂŠí“ŕ): Japan Digestive Disease Week 2015 [JDDW 2015 TOKYO] (2015/10/10), “Œ‹ž.

723228. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) MazepŒă‚Ěፍ­‚đů‰ń‚ˇ‚é‹H—L‚ȍś–[ƒŠƒGƒ“ƒgƒŠ[‚É‚ć‚č•p”­‚ˇ‚é•p””­ě‚đ’ć‚ľ‚˝1—á. ŠÝŒ´@~1, [’J‰p•˝1, ’†‘ş—m”Í2, ŒÜ\—’Œ’2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹yě@~, ‘şă‰ë”ü1, ’ë–ěTˆę1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘ĺ‰ď2015 (2015/10/16), ŒSŽR.

723229. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) S“ŕ–ŒŒ‡‘šÇpŒă‚ɍ‡•š‚ľ‚˝ś‰ş”xĂ–ŹŽüˆÍ‚đ‰ń˜H‚Ć‚ˇ‚éS–[•p”‚Ě12—á|Ensite One Map‚Ě—L—pŤ‚ĆŒŔŠE|. [’J‰p•˝1, ‹M‰ŸŒ´~, ’ë–ěTˆę1, ’†‘ş—m”Í2, ŒÜ\—’Œ’2, “ĄÎŽě”ü2, Î––ŹĆ2, ‹gŕV’qŽĄ1, ‹yě@~, ˛“Ą@—z1, ‘şă‰ë”ü1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ƒJƒe[ƒeƒ‹ƒAƒuƒŒ[ƒVƒ‡ƒ“ŠÖ˜AH‹G‘ĺ‰ď2015 (2015/10/16), ŒSŽR.

723230. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’´‚—ŽĐ‰ď‚É‚¨‚Ż‚éR‹ĂŒĹ—Ă–@`RŒŒŹ”–ň‚Ć‚Ě•š—p‚Ě–â‘č“_`. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć29‰ń“ú–{ŠĽŽžŠłŠw‰ďŠwpW‰ď (2015/11/20), –kŠC“š.

723231. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰@ŠO“KŘě“Ž‚𒆐S‚Ć‚ľ‚˝’…—pŒ^ŽŠ“Žœ×“ŽŠí (WCD) ‚ĚŽg—pŒoŒą. ŠÝŒ´@~1, ’ë–ěTˆę1, ’†‘ş—m”Í2, ŒÜ\—’Œš2, Î––ŹĆ2, “ĄÎŽě”ü2, ‹yě@~, ‘şă‰ë”ü1, [’J‰p•˝1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć8‰ńAž‚݃fƒoƒCƒXŠÖ˜A“~‹G‘ĺ‰ď (2016/2/6), –k‹ăB.

723232. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Shorting the period of Triple Anti-platelet and anti-coagulation therapy: STAP trial. ‰––ě•ű–ž1, ˛“Ą‘ĺ•ă1, ˛“ĄF“T1, ‘şź—S‰î1, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/18), ĺ‘ä.

723233. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ezetimibe Enhances and Stabilizes the Anticoagulant Effect of Warfarin. ”˘•űŒ’G1, “ŒžŠ”ü“ŢŽq2, “Ą‹g˜a”Ž1, Š`č—Ç‘ž1, ‹´–{‘ń–í1, “ç“c@Œ’1, ‰ş•lF˜Y3, “ŒžŠ‘ĺ‹P3, ˆ˘ŒĂĆ3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3zŠÂŠí“ŕ): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/19), ĺ‘ä.

723234. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Importance of the Presence of J-wave as a Predictor for Life-threatening Arrhythmia in ICD patients. Î––ŹĆ1, ’ë–ěTˆę2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, “ĄÎŽě”ü1, ‹yě@~, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/19), ĺ‘ä.

723235. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Linagliptin Suppresses Atrial Electrical and Structural Remodeling in Canine Model of Atrial Fibrillation. ŒÜ\—’Œš1, ’ë–ěTˆę2, ’ë–ě—TŒb, ’†‘ş—m”Í1, Î––ŹĆ1, “ĄÎŽě”ü1, ‹gŕV’qŽĄ2, ‹yě@~, ŠÝŒ´@~2, ‘şă‰ë”ü2, [’J‰p•˝2, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/19), ĺ‘ä.

723236. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Prediction of Therapeutic Episodes of ICD through Interrogated Device Data in the Remote Monitoring. “ĄÎŽě”ü1, ’ë–ěTˆę2, ‘şă‰ë”ü2, ’†‘ş—m”Í1, ŒÜ\—’Œš1, Î––ŹĆ1, ‹yě@~, ŠÝŒ´@~2, [’J‰p•˝2, ’ë–ě—TŒb, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/20), ĺ‘ä.

723237. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Anti-oxidant component suppresses the construction of arrhythmogenic substrate in the isoproterenol induced acute myocardial injury. ‹yě@~, ’ë–ěTˆę1, ’ë–ě—TŒb, ’†‘ş—m”Í2, ŒÜ\—’Œš2, “ĄÎŽě”ü2, Î––ŹĆ2, ‹gŕV’qŽĄ1, ŠÝŒ´@~1, ˛“Ą@—z1, ‘şă‰ë”ü1, [’J‰p•˝1, Tamaki H, ˆ˘ŒĂĆ1 (1zŠÂŠí“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/20), ĺ‘ä.

731013. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚˘‚Ü, decongestion‚đ‚Ç‚¤l‚Ś‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): After-H10S•s‘SƒZƒ~ƒi[ (2015/5/13), Ž­Ž™“‡.

731014. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Ś‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒł (zŠÂŠí“ŕ): ƒTƒ€ƒXƒJ”­”„4Žü”N‹L”OS•s‘SŽĄ—ĂŠwpu‰‰‰ď (2015/5/15), ĺ‘ä.

731015. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚ß‚´‚šƒNƒŠƒAƒJƒbƒg‚ȐS•s‘SŠÇ—. ’––”FŒł (zŠÂŠí“ŕ): S•s‘SŽĄ—Ă‚đl‚Ś‚é‰ďin’šŽć (2015/6/2), ’šŽć.

731016. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚Ě”][Ç—\–h|NOAC‘卬íŽž‘ă‚Ě—Ő°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): V‹KŒoŒűR‹ĂŒĹ–ň“KłŽg—pƒZƒ~ƒi[ in •xŽR (2015/6/3), •xŽR.

731017. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SŽĄ—Ă‚Ě“W–]|–ň•¨ŽĄ—Ă‚Ć”ń–ň•¨ŽĄ—Ă‚ĚƒxƒXƒgƒ~ƒbƒNƒX|. ’––”FŒł (zŠÂŠí“ŕ): S•s‘SASVŠwpu‰‰ (2015/6/6), “Œ‹ž.

731018. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹}ŤS•s‘SŠÇ—`ƒ|ƒCƒ“ƒg‚Í‚Ç‚ą‚Š. ’––”FŒł (zŠÂŠí“ŕ): 3rd Clinical Discussion for Heart Failure (2015/6/12), ‘O‹´.

731019. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S‹Ř‘gDŤó‚ÉŠî‚Ă‚­V‚˝‚ȐS•s‘SŠÇ—`LGEƒKƒCƒhf—Ă‚ĚŽŽ‚Ý. ’––”FŒł (zŠÂŠí“ŕ): ‘ć17‰ńź]zŠÂŠíĚŤ°×Ń (2015/6/13), ź].

731020. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘Sf—ĂĹ‘Oü|‚˘‚Ü, decongestion‚đ‚Ç‚¤l‚Ś‚é‚Š|. ’––”FŒł (zŠÂŠí“ŕ): “v”gˆă—ĂŒ—˜AŒgŠwpu‰‰‰ď (2015/6/17), “v”g.

731021. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚Ě”][Ç—\–h|NOAC‘卬íŽž‘ă‚Ě—Ő°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): ƒGƒŠƒLƒ…[ƒX”­”„ˆĘŽü”N‹L”Ou‰‰ in V”­“c (2015/6/18), V”­“c.

731022. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Ś‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒł (zŠÂŠí“ŕ): ‹ž“sƒTƒ€ƒXƒJ”­”„5Žü”N‹L”Ou‰‰‰ď (2015/6/19), ‹ž“s.

731023. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚Ě”][Ç—\–h|NOAC‘卬íŽž‘ă‚Ě—Ő°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): ƒGƒŠƒLƒ…[ƒX”­”„ˆĘŽü”N‹L”Ou‰‰ in ”č (2015/6/29), ”č.

731024. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚˘‚Š‚ɐi‚ß‚é‚Š, decongestion‚Ćtolvaptan. ’––”FŒł (zŠÂŠí“ŕ): How to use Tolvaptan•×‹­‰ď (2015/6/30), ă‰z.

731025. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘S‚đ, Œn“—§‚Ä‚Ä, f‚é, ŽĄ‚ˇ. ’––”FŒł (zŠÂŠí“ŕ): ‘ć15‰ń•˝ŹzŠÂŠí—Տ°Œ¤‹†‰ď (2015/7/23), –źŒĂ‰Ž.

731026. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): RŒŒđ—Ă–@ Up to Date 2015 in –k–{ (2015/7/24), –k–{.

731027. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Ś‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒł (zŠÂŠí“ŕ): ‘ć7‰ń‘q•~S•s‘Su‰‰‰ď (2015/7/24), ‘q•~.

731028. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Ś‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒł (zŠÂŠí“ŕ): S•s‘SƒZƒ~ƒi[ (2015/8/21), “ß”e.

731029. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •ďŠ‡“IS•s‘SŠÇ—‚Ö‚Ě’§í. ’––”FŒł (zŠÂŠí“ŕ): ‘ć4‰ńzŠÂŠíƒ`[ƒ€ˆă—Ă‚đl‚Ś‚é‰ď (2015/9/4), ‹ž“s.

731030. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚˘‚Ü‚Č‚ş‚¨• ‚Č‚Ě‚Š‚Š‚ç?`S•s‘S‚ł̐V‚˝‚Č‘ŸŠí˜AŠÖ. ’––”FŒł (zŠÂŠí“ŕ): ŠĚES˜AŠÖ‚đl‚Ś‚éŠwpu‰‰‰ď (2015/9/8), ’Ź“c.

731031. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Äl: S•s‘Sf—Ă‚Ě’n—Í‚đ‚‚Ż‚é. ’––”FŒł (zŠÂŠí“ŕ): ‘ć13‰ń“Œ‹žSŒŒŠÇƒtƒH[ƒ‰ƒ€ (2015/9/11), “Œ‹ž.

731032. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): ŽO‰YŽsˆăŽt‰ďŠwpu‰‰‰ď2015 (2015/9/15), ŽO‰Y.

731033. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Ś‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒł (zŠÂŠí“ŕ): ƒTƒ€ƒXƒJ”­”„‹L”Ou‰‰‰ď (2015/9/24), ‹ŕ‘ň.

731034. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) CKD‡•šS•s‘S‚É‚¨‚Ż‚éƒgƒ‹ƒoƒvƒ^ƒ“‚Ě—L—pŤ‚ĚŒŸ“˘. ’––”FŒł (zŠÂŠí“ŕ): Samsca Conference in Kanagawa (2015/10/1), ‰Ą•l.

731035. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SŽĄ—Ă‚Ě“W–]|–ň•¨ŽĄ—Ă‚Ć”ń–ň•¨ŽĄ—Ă‚ĚƒxƒXƒgƒ~ƒbƒNƒX|. ’––”FŒł (zŠÂŠí“ŕ): ‘ć8‰ńzŠÂŒÄ‹záŠQŒ¤‹†‰ď (2015/10/2), ‰F“s‹{.

731036. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SŽĄ—Ă‚Ě“W–]|–ň•¨ŽĄ—Ă‚Ć”ń–ň•¨ŽĄ—Ă‚ĚƒxƒXƒgƒ~ƒbƒNƒX|. ’––”FŒł (zŠÂŠí“ŕ): ‘ć6‰ńŽRŒ`S•s‘SASVƒ~[ƒeƒBƒ“ƒO (2015/10/8), ŽRŒ`.

731037. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion‚đ[“Ç‚Ý‚ˇ‚é. ’––”FŒł (zŠÂŠí“ŕ): ‘ć2‰ń–k•”‹ăBS•s‘Sƒ~[ƒeƒBƒ“ƒO (2015/10/9), •Ÿ‰Ş.

731038. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): Seminar for Thrombosis update -Šú‘Ň‚ł‚ę‚éV‚˝‚Č‘I‘đŽˆ- (2015/10/19), ‰Ą•l.

731039. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SŽĄ—Ă‚Ě“W–]|–ň•¨ŽĄ—Ă‚Ć”ń–ň•¨ŽĄ—Ă‚ĚƒxƒXƒgƒ~ƒbƒNƒX|. ’––”FŒł (zŠÂŠí“ŕ): Šň•ŒASVŠwpu‰‰‰ď (2015/10/30), Šň•Œ.

731040. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹}ŤS•s‘SŠÇ—‚ĚŒü‚Š‚¤ć`ăŽşŤ•p–Ź‚É‚Ç‚¤‘Λł‚ˇ‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): CVDƒ}ƒl[ƒWƒƒ“ƒgƒZƒ~ƒi[ (2015/11/5), Ŕ’Ă.

731041. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‰ES•s‘S‚đ‚Ç‚¤f‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): ‘ć62‰ńV‚ł‚Á‚Ű‚ëS‘ŸŒŒŠÇ•×‹­‰ď (2015/11/6), ŽD–y.

731042. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Žč‚‚Š‚¸‚̐S•s‘S‘ŸŠí˜AŠÖ. ’––”FŒł (zŠÂŠí“ŕ): ‘ć12‰ń‹}ŤS•s‘SŒ¤‹†‰ď (2015/11/14), “Œ‹ž.

731043. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S‹Ř‘gDŤó‚ÉŠî‚Ă‚­V‚˝‚ȐS•s‘SŠÇ—`LGEƒKƒCƒhf—Ă‚ĚŽŽ‚Ý. ’––”FŒł (zŠÂŠí“ŕ): ‘ć107‰ń“ú–{zŠÂŠíŠw‰ďŽl‘’n•ű‰ď (2015/11/14), ‚’m.

731044. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •ďŠ‡“IS•s‘Sf—Ă‚ĚƒXƒXƒ`ĹV‚¤‚ÁŒŒŽĄ—Ă‚Š‚çƒ`[ƒ€ˆă—Â܂Ł`. ’––”FŒł (zŠÂŠí“ŕ): ”ö“šS•s‘Su‰‰‰ď (2015/11/17), ”ö“š.

731045. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Ś‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒł (zŠÂŠí“ŕ): –kŰtolvaptan conference (2015/11/19), ‚’Î.

731046. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SŽĄ—Ă‚ĚĹVƒgƒŒƒ“ƒh`decongestion‚đ[“Ç‚Ý‚ˇ‚é. ’––”FŒł (zŠÂŠí“ŕ): ‘ć5‰ńH“cS•s‘SŒ¤‹†‰ď (2015/11/20), H“c.

731047. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) V‚˝‚Čdecongestion‚Ě’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): ‘Š–ÍŒ´ƒTƒ€ƒXƒJŠwpu‰‰‰ď (2015/11/25), ‘Š–ÍŒ´.

731048. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Decongestion‚̐V‚˝‚Č’Ş—Ź. ’––”FŒł (zŠÂŠí“ŕ): ‘ć120‰ń“ú–{zŠÂŠíŠw‰ď‹ß‹E’n•ű‰ď (2015/11/28), ‘ĺă.

731049. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) V‚˝‚Čdecongestion‚Ě’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): Šƒ–čS•s‘SŽĄ—Õ׋­‰ď (2015/12/8), Šƒ–č.

731050. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion‚̐V‚˝‚Č’Ş—Ź‚Í‚Ç‚ą‚ÉŒü‚Š‚¤‚Ě‚Š. ’––”FŒł (zŠÂŠí“ŕ): ‘ć1‰ńOsaka Medical Care Conference (2015/12/10), ‘ĺă.

731051. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝ƒgƒ‹ƒoƒvƒ^ƒ“Šˆ—pƒVƒiƒŠƒI. ’––”FŒł (zŠÂŠí“ŕ): ‹ŕ‘ňDecongestion Conference (2015/12/16), ‹ŕ‘ň.

731052. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion‚̐V‚˝‚Č’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): …—˜”A‚đl‚Ś‚é‰ď (2015/12/18), ç—t.

731053. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion‚̐V‚˝‚Č’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): ‰Ą•lŽsź•”S•s‘SƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/1/22), ‰Ą•l.

731054. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): –ž“ú‚ɖ𗧂S–[×“Žƒg[ƒ^ƒ‹ƒ}ƒl[ƒWƒƒ“ƒg in ‘Š–ÍŒ´ (2016/1/26), ‘Š–ÍŒ´.

731055. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): “Ą‘ň•sŽ–Źˆă—ĂƒZƒ~ƒi[ (2016/1/27), “Ą‘ň.

731056. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SÇ—á‚É‚¨‚Ż‚éR‹ĂŒĹ—Ă–@`‰˝‚Ş‚í‚Š‚Á‚Ä‚˘‚ĉ˝‚Ş‚í‚Š‚Á‚Ä‚˘‚Č‚˘‚Ě‚Š`. ’––”FŒł (zŠÂŠí“ŕ): ƒGƒŠƒLƒ…[ƒX”­”„3Žü”N‹L”Ou‰‰‰ď (2016/2/1), ‹gËŽ›.

731057. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •ďŠ‡“IS•s‘SŠÇ—‚Ö‚Ě’§í. ’––”FŒł (zŠÂŠí“ŕ): ‘Š–ÍŒ´ˆăŽt‰ď’nˆćˆă—ĂŒ¤‹†‰ď (2016/2/9), ‘Š–ÍŒ´.

731058. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Äl: S•s‘Sf—Ă‚Ě’n—Í‚đ‚‚Ż‚é. ’––”FŒł (zŠÂŠí“ŕ): é‹Ęź•”’n‹ćS•s‘SƒZƒ~ƒi[ (2016/2/12), Š‘ň.

731059. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): Ă“ě•sŽ–Źˆă—Ă˜AŒgƒZƒ~ƒi[ (2016/2/15), “Ą‘ň.

731060. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Š´őŤS“ŕ–Œ‰Š‚ĚŠÇ—`ƒ|ƒCƒ“ƒg‚͉˝‚Š`. ’––”FŒł (zŠÂŠí“ŕ): ‘ć8‰ń’†‘¤zŠÂŠí’S“––ňÜŽtƒtƒH[ƒ‰ƒ€ (2016/2/15), ‰Ą•l.

731061. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SŠłŽŇ‚̑̉t—ĘƒRƒ“ƒgƒ[ƒ‹‚đ‚Ç‚¤l‚Ś‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): ‘ć5‰ń“ŒŠ‹“ě•”S•s‘SŽĄ—ĂƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/2/16), ‰YˆŔ.

731062. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘S‚̕“IŠÇ—‚Ćƒ`[ƒ€ˆă—Ă. ’––”FŒł (zŠÂŠí“ŕ): —Տ°–ňŠwŒ¤‹†‰ď (2016/2/18), “Œ‹ž.

731063. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Ś‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒł (zŠÂŠí“ŕ): ŠŮ—Ń’n‹ćS•s‘SŠwpu‰‰‰ď (2016/2/19), ŠŮ—Ń.

731064. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): Core Member for Thrombosis update|Šú‘Ň‚ł‚ę‚éV‚˝‚Č‘I‘đŽˆ| (2016/2/22), ěč.

731065. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S•s‘SŠłŽŇ‚̑̉t—ĘƒRƒ“ƒgƒ[ƒ‹‚đ‚Ç‚¤l‚Ś‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): ‘ć5‰ń…—˜”AŒ¤‹†‰ď (2016/2/25), ‘ĺă.

731066. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion update|—Տ°ƒVƒiƒŠƒI‚ōl‚Ś‚éƒgƒ‹ƒoƒvƒ^ƒ“|. ’––”FŒł (zŠÂŠí“ŕ): ‘ć5‰ń‰ÁŒĂěS•s‘SƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/2/26), ‰ÁŒĂě.

731067. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): R‹ĂŒĹ—Ă–@•×‹­‰ď in ŠC˜V–ź (2016/2/29), ŠC˜V–ź.

731068. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) decongestion‚̐V‚˝‚Č’Ş—Ź‚đl‚Ś‚é. ’––”FŒł (zŠÂŠí“ŕ): ˆă—Ă˜AŒg‚Š‚çl‚Ś‚éS•s‘SŽĄ—Ẩď (2016/3/3), ‹ŕ‘ň.

731069. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‰ES•s‘S‚đ‚Ç‚¤f‚é‚Š? ’––”FŒł (zŠÂŠí“ŕ): ‘ć4‰ďźŽD–yEŹ’MzŠÂŠí˜AŒg‚̉ď (2016/3/5), Ź’M.

731070. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): RŒŒđŽĄ—Ă‚đl‚Ś‚é‰ď in V‰Ą•l (2016/3/7), ‰Ą•l.

731071. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): ‘Ť•żăRŒŒđ—Ă–@‚đl‚Ś‚é‰ď (2016/3/9), ‘Ť•ż.

731072. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): –ž“ú‚ɖ𗧂S–[×“Žƒg[ƒ^ƒ‹ƒ}ƒl[ƒWƒƒ“ƒg (2016/3/11), ěč.

731073. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Ă-‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ. ’ë–ěTˆę (zŠÂŠí“ŕ): R‹ĂŒĹ—Ă–@ Up to date in Ź“cŒ´ (2016/3/15), Ź“cŒ´.

731074. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): R‹ĂŒĹ—Ă–@ƒZƒ~ƒi[@Šú‘Ň‚ł‚ę‚éV‚˝‚Č‘I‘đŽˆ (2016/3/22), ‰Ą•l.

731075. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •ďŠ‡“IS•s‘SŠÇ—‚Ö‚Ě’§í`decongestion‚đ‚˘‚Š‚ɐi‚ß‚é‚Š. ’––”FŒł (zŠÂŠí“ŕ): ˆ¤•QS•s‘SŽĄ—ĂŠwpu‰‰‰ď (2016/3/23), “Œ‰ˇ.

731076. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): –ž“ú‚̐f—Ă‚Š‚ç–đ—§‚ÂR‹ĂŒĹ—Ă–@ƒZƒ~ƒi[ (2016/3/29), ‘ĺ˜a.

732024. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): ‰Ą{‰ęŽsˆăŽt‰ďŠwpu‰‰‰ď (2015/5/11), ‰Ą{‰ę.

732025. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) S–[×“Ž‚̍RŒŒđŽĄ—Á|‘ć4‚ĚNOAC‚đŒ}‚Ś‚˝—Տ°Œťę‚Ě‘I‘đ|. ’ë–ěTˆę (zŠÂŠí“ŕ): “Ţ—Ç‚â‚Ü‚ĆzŠÂŠíƒZƒ~ƒi[ (2015/6/6), “Ţ—Ç.

732026. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) S–[×“Ž‚̍RŒŒđ—Ă–@|VKA‚ĆNOAC‚Ě–đŠ„|. ’ë–ěTˆę (zŠÂŠí“ŕ): _“ŢěŒ§–ňÜŽt‰ď–ňŠw‡“ŻŒ¤C‰ď2015 (2015/6/11), ‰Ą•l.

732027. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Šg’ŁŒ^S‹ŘÇƒŒƒWƒXƒgƒŠŒ¤‹†‚ÉŒü‚Ż‚Ä. ’––”FŒł (zŠÂŠí“ŕ): ‘ć1‰ń“ú–{S‹ŘÇŒ¤‹†‰ď (2015/7/4), “Œ‹ž.

732028. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ”ń‹•ŒŒŤSƒ|ƒ“ƒvˆŮí‚É‚¨‚Ż‚éS‹ŘÇ‚̊ӕʐf’fƒXƒeƒbƒv|‘˝Ž{Ý’˛¸‚Š‚ç‚Ý‚éŒťó‚Ć–â‘č“_|. ’––”FŒł (zŠÂŠí“ŕ): ‘ć1‰ń“ú–{S‹ŘÇŒ¤‹†‰ď (2015/7/4), “Œ‹ž.

732029. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) S‹Ř‘gD‘œ‚ÉŠî‚Ă‚­V‚˝‚ȐS•s‘SŽĄ—Ð헪. ’––”FŒł (zŠÂŠí“ŕ): ‘ć37‰ńS‹ŘśŒŸŒ¤‹†‰ď (2015/12/11), _ŒË.

732030. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‹•ŒŒŤSŽžŠł‚É‚¨‚Ż‚é“Ë‘RŽ€ˆęŽŸ—\–h|‘ĺ‹K–ÍŽŽŒą‚É‚¨‚Ż‚éƒGƒrƒfƒ“ƒX‚ĆŽŔ—Տ°|. ’ë–ěTˆę (zŠÂŠí“ŕ): S‘Ÿ“Ë‘RŽ€‚đl‚Ś‚é in ‰Ą•l (2016/2/20), ‰Ą•l.

733073. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) R‹ĂŒĹ—Ă–@‚ƍRŒŒŹ”—Ö@‚Ć‚Ě•š—p‚Ě–â‘č“_|ƒGƒrƒfƒ“ƒX‘no‚ÉŒü‚Ż‚ā|. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): —ŤzŠÂŠíˆă§˜b‰ď (JJC:JJ-Club) ‘ć4‰ńŠwpu‰‰‰ď (2015/4/25), ‘ĺă.

733074. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽŠ“K‚ČDAPTŠúŠÔ‚ĚƒRƒ“ƒgƒƒo[ƒV[|R‹ĂŒĹ‚Ć‚Ě•š—p‚Ě–â‘č‚ŕŠÜ‚߁|. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): “ú–{SŒŒŠÇƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒ“ŽĄ—ĂŠw‰ď (CVIT) ‘ć33‰ń“ŒŠC–k—¤’n•ű‰ď ’n•ű‰ďŽĺĂƒrƒfƒIƒ‰ƒCƒuƒfƒ‚ƒ“ƒXƒgƒŒ[ƒVƒ‡ƒ“ (2015/5/16), ˆ¤’m.

733075. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) SŒŒŠÇƒCƒxƒ“ƒg—}§‚đl—ś‚ľ‚˝“œ”A•aŽĄ—Ð헪`zŠÂŠíę–ĺˆă‚Ě—§ę‚Š‚ç`. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): The 32nd Live Demonstration in KOKURA (2015/5/17), •Ÿ‰Ş.

733076. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) PCIŠłŽŇ‚É‚¨‚Ż‚éRŒŒŹ”—Ö@|R‹ĂŒĹ—Ă–@‚Ć‚Ě•š—p‚Ć–â‘č‚ŕŠÜ‚߂ā|. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć5‰ń–L‹´ƒ‰ƒCƒuƒfƒ‚ƒ“ƒXƒgƒŒ[ƒVƒ‡ƒ“ (2015/5/29), ˆ¤’m.

733077. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) PCIŒă‚Ě•š—p—Ă–@‚Ě–â‘č“_‚đŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“‚Ć—Ő°ƒGƒrƒfƒ“ƒX‚Š‚çlŽ@‚ˇ‚é. ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ‘ć130‰ń“ú–{zŠÂŠíŠw‰ď–k—¤’n•ű‰ď (2015/7/12), •Ÿˆä.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-522007. [uŔ] y“ÁW: EBM‚Š‚ç‚Ý‚˝RŒŒđ–ň‚Ě‘I‘đzIII. Še˜_@3. ƒAƒeƒ[ƒ€ŒŒđÇ‚ĚÄ”­—\–h‚É‚¨‚Ż‚éRŒŒđ–ň‚Ě‘I‘đ@(2) S‹Ř[Ç. ‹´–{‘ń–í1, ˆ˘ŒĂĆ2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2zŠÂŠí“ŕ): ŒŒđ‚ƏzŠÂ 2015/1; 23 (1): 31-6.

H26-522008. [uŔ] y“ÁW: S•s‘SŽĄ—Ă‚ĚĹV“ŽŒüz–ŤS•s‘S‚ƐS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“: ‚ť‚Ě–Ú“I‚ĆŽŔŰ. –ě“cçt (zŠÂŠí“ŕ): CarioVascular Contemporary 2015/3; 4 (1): 40-7.

H26-522009. [uŔ] yƒgƒsƒbƒNƒXzŠĽ“Ž–ŹƒXƒeƒ“ƒg—Ż’uŒă‚ĚDAPT‚Ě’Zk‚Í‚Ç‚ą‚܂ʼn”\‚Š? ˆ˘ŒĂĆ (zŠÂŠí“ŕ): ƒNƒŠƒjƒVƒAƒ“ 2015/3; 62 (3): 340-5.

H26-522010. [uŔ] yƒWƒ‡ƒCƒ“ƒgƒZƒbƒVƒ‡ƒ“1 (JS1)z–ŤS•s‘S‚ɉî“ü‚ˇ‚é•ďŠ‡“IS‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚ĚŽć‚č‘g‚Ý. “ŒžŠ”ü“ŢŽq1, –q–쏲G2, ŠĄ’J‰p‹I2, “Ą‹g”Ž˜a2, š“ߏrŽ÷3, ŠÖŞŒb”üŽq3, ‚‹´—R”ü3, ‰“Œ´^ˆę3, Ź‘q@Ę1, –Ř‘ş‰ë•F1, ‘OěŒb”ü4, –ě“cçt4, ź‰i“Ä•F1, ‘“c@‘ě1, ˆ˘ŒĂĆ4 (1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ƒŠƒnƒrƒŠ•”, 4zŠÂŠí“ŕ) S‘ŸƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ 2015/3; 20 (1): 145-50.


_Œo“ŕ‰ČŠw

[Šwp˜_•ś]

110129. [Œ´’˜] Cauda equina conduction time in Guillain-BarrŽ syndrome. Matsumoto H, Hanajima R1, Terao Y, Hashida H, Ugawa Y: J Neurol Sci 2015/4; 351 (1-2): 187-90. (‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

110130. [Œ´’˜] Hyperleptinemia increases the susceptibility of the cortex to generate cortical spreading depression. Kitamura E1, Kanazawa N2, Hamada J1: Cephalalgia 2015/4; 35 (4): 327-34. (–k‘ş‰p“ń1, ‹ŕŕV’ź”ü2, ŕ_“cˆę1: 1_Œo“ŕ, 2•a‘ԁEf—ĂŒn)

110131. [Œ´’˜] Incidence and extent of TDP-43 accumulation in aging human brain. Uchino A1, Takao M, Hatsuta H, Sumikura H, Nakano Y, Nogami A, Saito Y, Arai T, Nishiyama K1, Murayama S: Acta Neuropathol Commun 2015/6; 3: 35. (“ŕ–쏲Žq1, źŽR˜a—˜1: 1_Œo“ŕ)

110132. [Œ´’˜] Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. Toyoda K, Arihiko S, Toda K, Yamagami H, Kimura K, Furui E, Terasaki T, Shiokawa Y, Kamiyama K, Takizawa S, Okuda S, Okada Y, Kameda T, Nagakane Y, Hasegawa Y, Mochizuki H, Ito Y, Nakashima T, Takamatsu K, Nishiyama K1, Kario K, Sato S, Koga M, for the SAMURAI Study Investigators: Int J Stroke 2015/8; 10 (6): 836-42. (źŽR˜a—˜1: 1_Œo“ŕ)

110133. [Œ´’˜] Effects of L-Dopa and pramipexole on plasticity induced by QPS in human motor cortex. Enomoto H, Terao Y, Kadowaki S, Nakamura K, Moriya A, Nakatani-Enomoto S, Kobayashi S, Yoshihara A, Hanajima R1, Ugawa Y: J Neural Transm (Vienna) 2015/9; 122 (9): 1253-61. (‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

110134. [Œ´’˜] I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family exhibit increased Tau phosphorylation through the AKT/GSK-3ƒŔ signaling pathway. Ohta E, Nihira T, Uchino A1, Imaizum Y, Okada Y, Akamastu W, Takahashi K, Hayakawa H, Nagai M1, Ohyama M, Ryo M, Ogino M2, Murayama S, Takashima A, Nishiyama K1, Mizuno Y, Mochizuki H, Obata F, okano H: Hum Mol Genet 2015/9; 24 (17): 4879-900. (“ŕ–쏲Žq1, ‰iˆä^‹MŽq1, —Ŕ@ł•Ł, ‰Ź–ě”üŒbŽq2, źŽR˜a—˜1: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110135. [Œ´’˜] Saccade abnormalities associated with focal cerebral lesions - How cortical and basal ganglia commands shape saccades in humans. Terao Y, Fukuda H, Tokushuge S, Nomura Y, Hanajima R1, Ugawa Y: Clin Neurophysiol 2015/9; pii: S1388-2457(15)00929-3. (‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

110136. [Œ´’˜] Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial. Takizawa S, Tanaka F, Nishiyama K1, Hasegawa Y, Nagata E, Mizuno A, Yutani S, Nakayama T, Kobayashi H, Yanagimachi N, Okazaki T, Kitagawa K; CMB-NOW Study Investigators: J Stroke Cerebrovasc Dis 2015/9; 24 (9): 2143-8. (źŽR˜a—˜1: 1_Œo“ŕ)

110137. [Œ´’˜] Modulation of error-sensitivity during a prism adaptation task in people with cerebellar degeneration. Hanajima R1, Shadmehr R, Ohminami S, Tsutsumi R1, Shirota Y, Shimizu T1, Tanaka N, Terao Y, Tsuji S, Ugawa Y, Uchimura M, Inoue M, Kitazawa S: J Neurophysiol 2015/10; 114 (4): 2460-71. (‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, ´…’G1: 1_Œo“ŕ)

110138. [Œ´’˜] Influence of Zonisamide on the LTP-like Effect Induced by Quadripulse Transcranial Magnetic Stimulation (QPS). Tanaka N, Hanajima R1, Tsutsumi R1, Shimizu T1, Shirota Y, Terao Y, Ugawa Y: Brain Stimul 2015/11-12; 8 (6): 1220-2. (‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, ´…’G1: 1_Œo“ŕ)

110139. [Œ´’˜] Is multiple system atrophy with cerebellar ataxia (MSA-C) like spinocerebellar ataxia and multiple system atrophy with parkinsonism (MSA-P) like Parkinson's disease? - A saccade study on pathophysiology. Terao Y, Fukuda H, Tokushige S, Inomata-Terada S, Yugeta A, Hamada M, Ichikawa Y, Hanajima R1, Ugawa Y: Clin Neurophysiol 2016/2; 127 (2): 1491-502. (‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

110140. [Œ´’˜] Somatosensory-evoked potential modulation by quadripulse transcranial magnetic stimulation in patients with benign myoclonus epilepsy. Nakatani-Enomoto S, Hanajima R1, Hamada M, Terao Y, Matsumoto H, Shirota Y, Ohminami S, Okabe S, Hirose M, Nakamura K, Furubayashi T, Groiss SJ, Kobayashi S, Mochizuki H, Enomoto H, Ugawa Y: Clin Neurophysiol 2016/2; 127 (2): 1560-7. (‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

110141. [Œ´’˜] Abnormal myocardial scintigraphy in a GTP cyclohydrolase 1 mutation carrier with Parkinson's disease. Someko H1, Hanajima R1, Tsutsumi R1, Tominaga N1, Nomura Y, Hoshino K, Nishiyama K1: Mov Disord 2016/3; 31 (3): 422-3. (őŹ‰pO1, ‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, •x‰i“Ţ•Ű”ü1, źŽR˜a—˜1: 1_Œo“ŕ)

310011. [Ç—á•ń] Accumulation of transportin 1 in the fused in sarcoma-positive neuronal inclusions in sporadic amyotrophic lateral sclerosis without FUS mutation. Tokushige S, Sasaki T, Hatsuta H, Uchino A1, Kakuta Y, Shimizu J, Tsuji S, Nakayama T, Imafuku I, Murayama S: Neurology and Clinical Neuroscience 2015/9; 3 (5): 194-6. (“ŕ–쏲Žq1: 1_Œo“ŕ)

310012. [Ç—á•ń] Reversible tongue muscle atrophy accelerated by early initiation of immunotherapy in anti-MuSK myasthenia gravis: A case report. Kitamura A1, Takiyama Y1, Nakamura M1, Iizuka T1, Nishiayma K1: J Neurol Sci 2016/1; 360: 10-2. (–k‘ş‰p“ń1, ‘ęŽR—eŽq1, ’†‘şŠ˛ş1, ”Ń’Ë‚_1, źŽR˜a—˜1: 1_Œo“ŕ)

520009. [‘ŕ] ĹV‚̏zŠÂŠíf—ÁE”]‘˛’†ˆă—Ă‚ĚĹ‘Oü|RŒŒđ—Ă–@up date. ˆä“‡‘ĺ•ă1, źŽR˜a—˜1 (1_Œo“ŕ): ˆÇ—ŃˆăŠw‰ďŽGŽ 2015/10; 44 (4): 125-31.

521011. [‰đŕ]yŽż‹^‰ž“šz—Տ°ˆę”Ę [“ŕ‰Č: _Œo] Š´őÇ‚Ö‚Ě‹°•|S‚Ş‹­‚˘RNMDAŽó—e‘Ě”]‰ŠŠů‰ŠłŽŇ‚ւ̑Ήž. ”Ń’Ë‚_ (_Œo“ŕ): “ú–{ˆăŽ–V•ń 2015/6; 4757: 61-2.

521012. [‰đŕ] “úíf—Âɖ𗧂‘ĺŠw‚Š‚猊‚˝î•ń: ‘‚í‚Š‚ču”]‘˛’†ŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“v‚̉ü’ůƒ|ƒCƒ“ƒg. źŽR˜a—˜ (_Œo“ŕ): _“ŕˆăƒjƒ…[ƒX 2016/1; 75: 8-9.

522075. [uŔ]yŔ’k‰ď: ƒp[ƒLƒ“ƒ\ƒ“•a‚ĚŒťÝ‚Ć–˘—ˆzƒ]ƒjƒTƒ~ƒh‚̍ě—p‚𒆐S‚ɍl‚Ś‚é. ‰Fě‹`ˆę1, ’ˇ’Jě—˛•ś, ‘O“c“N–ç, ‰Ô“‡—ĽŽq2, [’J@e (1•Ÿ“‡Œ§—§ˆă‰Č‘ĺŠw, 2_Œo“ŕ): Pharma Medica 2015/4; 33 (4): 89-95.

522076. [uŔ]y“ÁW/ƒVƒ“ƒ|ƒWƒEƒ€: ”]‘˛’†f—Ă‚ĚŒťÝ, ‰ß‹Ž, –˘—ˆzŽi‰ď‚ĚŒž—t. źŽR˜a—˜ (_Œo“ŕ): _ŒoŽĄ—ĂŠw 2015/5; 32 (3): 257.

522077. [uŔ]y“ÁW/ƒVƒ“ƒ|ƒWƒEƒ€: ALS‚ĆFTLD‚ĚŒ¤‹†EŽĄ—Ă‚ĚŒťÝ’n‚đ’m‚éz2. ‹ŘˆŢkŤ‘¤őd‰ťÇ‚ĚŒo‰ß‚É‚¨‚Ż‚é‘O“Ş‘¤“Ş—t•ĎŤÇ‡•š. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—ĂŠw 2015/5; 32 (3): 295-8.

522078. [uŔ]y“ÁW/ƒVƒ“ƒ|ƒWƒEƒ€: ALS‚ĆFTLD‚ĚŒ¤‹†EŽĄ—Ă‚ĚŒťÝ’n‚đ’m‚éz4. ‹ŘˆŢkŤ‘¤őd‰ťÇ‚Ć‘O“Ş‘¤“Ş—t•ĎŤÇ‚Ě—Ő°•a—. “ŕ–쏲Žq1, ‚”öšŽ÷ (1_Œo“ŕ): _ŒoŽĄ—ĂŠw 2015/5; 32 (3): 304-9.

522079. [uŔ]y“ÁW/ƒVƒ“ƒ|ƒWƒEƒ€:u‚ą‚ą‚ë‚ĚŽžŠÔŠwv‚Š‚ç–˘—ˆ‚̐_ŒoŽĄ—Âցz3.u‚ą‚ą‚ë‚ĚŽžŠÔv‚ւ̐_Œoś—Šw“IƒAƒvƒ[ƒ`. ‰Ô“‡—ĽŽq (_Œo“ŕ): _ŒoŽĄ—ĂŠw 2015/5; 32 (3): 379.

522080. [uŔ]y“ÁW/‘Ű‰ťE‘n–ňŠÖ˜AƒVƒ“ƒ|ƒWƒEƒ€: _ŒoŽĄ—Ă‚Ěunmet medical needs|‚ť‚Ě‰đŒˆ–@‚đ’T‚éz2. ƒŒƒZƒvƒg‚Š‚猊‚˝’nˆć‚É‚ć‚é_ŒoŽžŠłŽĄ—Â̂΂ç‚‚Ť‚Ě•ŞÍ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—ĂŠw 2015/5; 32 (3): 400-3.

522081. [uŔ]y“ÁW/‘Ű‰ťE‘n–ňŠÖ˜AƒVƒ“ƒ|ƒWƒEƒ€: _ŒoŽĄ—Ă‚Ěunmet medical needs|‚ť‚Ě‰đŒˆ–@‚đ’T‚éz3-4. ŠeŽžŠł‚É‚¨‚Ż‚éV–ňł”FEŽĄ—Ă‚ĚŽŔî‚ƍĄŒă‚Ě“W–]: ‹ŘˆŢkŤ‘¤őd‰ťÇ. ‰Ź–ě”üŒbŽq (_Œo“ŕ): _ŒoŽĄ—ĂŠw2015/5; 32 (3): 416-9.

522082. [uŔ]yŽăƒfƒBƒx[ƒgz•Đ“Ş’É‚Ě•a‘ԁ|CSD‚Ćvascular factor‚Ĺ‚Í‚Ç‚ż‚ç‚ŞŽĺ‘Ě‚Š: CSD‚ŞŽĺ‘Ě‚Ĺ‚ ‚é. ‘“c@—ă (_Œo“ŕ): Headache Clinical & Science 2015/5; 6 (1): 20-2.

522083. [uŔ]y“ÁW: ”]‚ĚŒŠ‚Ś‚鉝|\‘˘•Ňz_ŒoŽžŠłŽĄ—Ăƒm[ƒg@ƒ~ƒgƒRƒ“ƒhƒŠƒA”]‹ŘÇ. ”Ń’Ë‚_ (_Œo“ŕ): Clinical Neuroscience 2015/6; 33 (6): 712-3.

522084. [uŔ]y“ÁW: i•ŕ‚ľ‚˝_Œo“ŕ‰ČŽžŠł‚ĚŽŔ’nf—Á@ˆę”ĘŽŔ’nˆă‰Ć‚ĚŠˆ—p‚ĆŽŔ‘H‚Ě‚˝‚߂ɁzƒZƒ~ƒi[/ ŽŔ’nˆă‰Ć‚ŞŠˆ—p‚ˇ‚ׂŤ_Œo“ŕ‰ČŽžŠł‚̐f—Â̐i•ŕ‚ĆŽŔŰ@_ŒoƒTƒ‹ƒRƒCƒh[ƒVƒX. őŹ‰pO1, źŽR˜a—˜1 (1_Œo“ŕ): Medical Practice 2015/6; 32 (6): 975-80.

522085. [uŔ]y“ÁW: ŠO—ˆ‚É‚¨‚Ż‚é_ŒoŽžŠł‚̐f‚Š‚˝zŠO—ˆ‚Ĺ‘˜‹ö‚ˇ‚é‚ą‚Ć‚Ě‘˝‚˘_ŒoÇŒó@‚ß‚Ü‚˘. ‰iˆärs, źŽR˜a—˜1 (1_Œo“ŕ): —Őଂƌ¤‹† 2015/6; 92 (6): 715-21.

522086. [uŔ]y“ÁW: Žp¨E•ŕs|Something new?zŽĄ—Á@‹@”\“I’čˆĘ”]Žčp|‹ĂŒĹp‚Ɛ[•””]ŽhŒƒ—Ă–@ (DBS). ´…˜aŒh1, ‰Ô“‡—ĽŽq1 (1_Œo“ŕ): Clinical Neuroscience 2015/7; 33 (7): 831-4.

522087. [uŔ]y“ÁW: Parkinson•a‚ĚŽĄ—Á@“ŕ‰Čˆă‚É•K—v‚ȐV‚ľ‚˘’mŒŠz”]ŒŒŠÇáŠQŤƒp[ƒLƒ“ƒ\ƒjƒYƒ€‚̐V‚ľ‚˘f’f–@‚ĆŽĄ—Ă. źŽR˜a—˜1, ‹ŕŽq@Œú1 (1_Œo“ŕ): “ú–{“ŕ‰ČŠw‰ďŽGŽ 2015/8; 104 (8): 1585-90.

522088. [uŔ]y“ÁW:“ޒɐf—Â̐V“WŠJz‚Đ‚Ć‚­‚żƒƒ‚@“Ş’É‚Ćˆâ“`Žq. ”Ń’Ë‚_ (_Œo“ŕ): “ú–{ˆăŽt‰ďŽGŽ 2015/8; 144 (5): 976.

522089. [uŔ]y“ÁW: ”]‘˛’†ŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“2015z1. ”]‘˛’†‹}ŤŠúŠłŽŇ‚Ě‘SgŠÇ—. ‰Oˆä@—É1, źŽR˜a—˜1 (1_Œo“ŕ): ”]‚ƏzŠÂ 2015/9; 20 (3): 215-8.

522090. [uŔ]y“ÁW: ×‹ŰŤ‘–Œ‰Š‚Ě—Ő°‚ƍŐV‚ĚŽĄ—ÁzŠÓ•Ęf’f@Š´őŤ”]‰Š, –TŠ´őŤ”]Ç. ”Ń’Ë‚_ (_Œo“ŕ): Clinical Neuroscience 2015/11; 33 (11): 1265-7.

522091. [uŔ]yƒtƒH[ƒ‰ƒ€ƒŒƒ|[ƒg: •Đ“ޒɐf—Ă‚đ[‚ß‚é`Ç—á‚Š‚çŠw‚Ń, ‚ł‚ç‚ɐf—Ă‚Ě•‚đL‚°‚éNext Stage‚ց`zŠłŽŇ–ž‘Ť“x‚ŕf—ĂŒř—Ś‚ŕă‚°‚éƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“p: ŒŔ‚ç‚ę‚˝f—ĂŽžŠÔ‚Ě’†‚Ĺ”[“ž‚ľ‚Ä‚ŕ‚炤‚˝‚ß‚ĚƒRƒc‚Ćƒc[ƒ‹‚ĚŠˆ—pp. ”Ńƒ–’J”ü•ô (_Œo“ŕ): Headache Clinical & Science 2015/11; 6 (2): 53-4.

522092. [uŔ]y“ÁW: —Տ°_Œoś—‚ʼn˝‚Ş‚í‚Š‚é?@[1] ‹Ř“d}E_Œo“`“ąŒŸ¸EŽĽ‹CŽhŒƒzŹ”]@ƒvƒŠƒYƒ€‡‰ž. ‰Ô“‡—ĽŽq (_Œo“ŕ): Clinical Neuroscience 2016/1; 34 (1): 99-101.

522093. [uŔ]yRound Table Discussion (Ŕ’k‰ď)zƒp[ƒLƒ“ƒ\ƒ“•a‚É‚¨‚Ż‚é‘ĺ”]”玿‚̉‘YŤ. •yŽR˝•F, ‰Fě‹`ˆę, ‰|–{”Ž”V, ‰Ô“‡—ĽŽq1 (1_Œo“ŕ): Frontiers in Parkinson Disease 2015/11; 8 (4): 181-9.

522094. [uŔ]y”]‘˛’†‚Í‚ą‚¤f‚é-VƒKƒCƒhƒ‰ƒCƒ“‚ʼn˝‚Ş•Ď‚í‚Á‚˝‚ŠzŔ’k‰ď: ”]‘˛’†f—Ă‚ĚŽŔŰ|VƒKƒCƒhƒ‰ƒCƒ“‚ĆŽŔ—Տ°‚đ‚‚ȂŽ|. (Ži‰ď) źŽR˜a—˜1, –L“cˆę‘Ľ2, ’O‰H@Œ‰3 (1_Œo“ŕ, 2‘—§zŠÂŠí•aŒ¤‹†ƒZƒ“ƒ^[, 3‚É‚íƒtƒ@ƒ~ƒŠ[ƒNƒŠƒjƒbƒN): Medicina 2016/2; 53 (2): 198-205.

530011. [‚ť‚Ě‘ź (´˜^)]yPoster Communications: Theme 6 Respiratory and Nutritional ManagementzJAPANESE NEUROLOGISTS RECOMMENDATIONS TO THEIR PATIENTS AND PERSONAL CHOICES TO TRACHEOSTOMY WITH INVASIVE MECHANICAL VENTILATION(TIV) DIVERGE BUT NOT TO NON-INVASIVE MECHANICAL VENTILATION(NIV). Ogino Y1, Ogino M2: Amyotroph Lateral Scler Frontotemporal Degener 2015/10; 16 (suppl 1): 130. (‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

530012. [‚ť‚Ě‘ź (Letters)]yNew ObservationszAbnormal myocardial scintigraphy in a GTP cyclohydrolase 1 mutation carrier with Parkinson's disease. Someko H1, Hanajima R1, Tsutsumi R1, Tominaga N1, Nomura Y, Hoshino K, Nishiyama K1: Mov Disord 2016/3; 31 (3): 422-3. (őŹ‰pO1, (‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, •x‰i“Ţ•Ű”ü1, źŽR˜a—˜1: 1_Œo“ŕ)

540009. [‚ť‚Ě‘ź (´˜^)] ”DP35T‚É‹…–ƒáƒ‚Ĺ‹}Ť”­Ç‚ľ‚˝RNMDAŽó—e‘̍R‘Ě—zŤ‚Ě37Î—Ť—á. ’†‘şŠ˛ş1, ”Ń’Ë‚_1, ˆä“‡‘ĺ•ă1, ‹ŕŽq~‘ž˜Y1, źŽR˜a—˜1 (1_Œo“ŕ): —Տ°_ŒoŠw, 2015/4; 55 (4): 279.

540010. [‚ť‚Ě‘ź (´˜^)]y‘ć211‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď´˜^zƒJƒ“ƒsƒƒoƒNƒ^[Š´őŒă, ‘–Œ‰Š‚Ć”A•Â‚đ’ć‚ľ‚˝1—á. ˛X–ŘŒŤˆę, ”Ńƒ–’J”ü•ô1, ŕ_“cˆę1 (1_Œo“ŕ): —Տ°_ŒoŠw 2015/4 ; 55 (4): 283.

540011. [‚ť‚Ě‘ź (ƒKƒCƒhƒ‰ƒCƒ“)] ƒAƒZƒ^ƒ]ƒ‰ƒ~ƒh (ƒ_ƒCƒAƒ‚ƒbƒNƒX’ŽË—p) “KłŽg—pŽwj@2015”N4ŒŽ. ‚‹´@~1, ’ˇ’Jě‘׍O, •ôźˆę•v, –Ř“ŕ”Ž”V, ›‹ŕ´”Ž, źŽR˜a—˜2, ˛‰ęP•v, ‰şŁěŒb‹v, ˆŔÄr‹v, ŹŠ}Œ´–Mş, –Ř‘ş@O, ’F_ˆę˜Y, ’@˜a•v, ’†ěŒ´÷“ń, ”¨ŕV@‡, ‹{–{@‹, “ú–{”]‘˛’†Šw‰ď/“ú–{”]_ŒoŠO‰ČŠw‰ď/“ú–{_ŒoŠw‰ď/“ú–{ŠjˆăŠw‰ď/4Šw‰ď‡“ŻƒAƒZƒ^ƒ]ƒ‰ƒ~ƒh“KłŽg—pŽwjěŹˆĎˆő‰ď (1‘—§zŠÂŠí•aŒ¤‹†ƒZƒ“ƒ^[, 2_Œo“ŕ): ”]‘˛’† 2015/7; 37 (4): 281-97.

540012. [‚ť‚Ě‘ź (´˜^)] –ĄŠoáŠQ‚Ć‹L–Á—͏áŠQ‚đ’ć‚ľ‚˝RAMPAŽó—e‘Ě”]‰Š‚Ě37Î’jŤ. őŹ‰pO1, ’ç@—Á‰î1, •x‰i“Ţ•Ű”ü1, ˆä“‡‘ĺ•ă1, ”Ń’Ë‚_1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): —Տ°_ŒoŠw 2015/8; 55 (8): 612.

540013. [‚ť‚Ě‘ź (‰ď‹c˜^)]yƒtƒH[ƒ‰ƒ€ƒŒƒ|[ƒgz‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (‹łˆçu‰‰) ”]Š˛‹NŒšŕ‚Ě‘Ă“–Ť‚Ć”ń‘Ă“–Ť. ”Ń’Ë‚_1, –k‘ş‰p“ń1 (1_Œo“ŕ): Headache Clinical & Science 2015/11; 6 (2): 66.

540014. [‚ť‚Ě‘ź] Šw‰ď•ń. źŽR˜a—˜ (_Œo“ŕ): –k—˘‘ĺŠwˆăŠw•”“Ż‘‹‰ď‰ď•ń 2016/1; 71: 29-30.

[’˜@‘]

620058. [Šwp‘] (•Ş’SŽˇ•M)y–ƉuŤ_ŒoŽžŠł|Šî‘bE—Տ°Œ¤‹†‚̍ŐV’mŒŠ| (“ú–{—Ő଑Š§†No.1085)zVI. ‚ť‚Ě‘ź‚̖ƉuŤ_ŒoŽžŠł@1. ŽŠŒČ–ƉuŤ”]‰ŠE”]Ç@(3) RNMDAŽó—e‘Ě”]‰Š, p. 607-12. ”Ń’Ë‚_ (_Œo“ŕ), “ú–{—Ő଎Đ, ‘ĺă, 2015/9”­s.

620059. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚ĚŽĄ—ĂŽwj2016”N”Ĺ Ž„‚Í‚ą‚¤ŽĄ—Ă‚ľ‚Ä‚˘‚éz15. _ŒoE‹ŘŽžŠł@”]ŒŒŠÇáŠQ‚̍‡•šÇ (Œëš‹Ť”x‰Š‚𒆐S‚É), p.927-8. źŽR˜a—˜ (_Œo“ŕ), ŠÄC: ŽRŒű@“O, –kŒ´Œő•v, ‘•ŇW: •ŸˆäŽŸ–î, ‚–؁@˝, ŹŽşˆęŹ, ˆăŠw‘‰@, “Œ‹ž, 2016/1”­s.

620060. [Šwp‘] (•Ş’SŽˇ•M)y“úíf—Ă‚ÉŠˆ‚Š‚ˇf—ĂƒKƒCƒhƒ‰ƒCƒ“UP-TO-DATE [2016-2017]zVIII. ’†•_ŒoŒnŽžŠł@”]‘˛’†, p513-20. ‚‹´˜aš1, źŽR˜a—˜1 (1_Œo“ŕ), ŠÄC; –ĺ˜e@F, ŹŽşˆęŹ, ‹{’n—ÇŽ÷, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, ‘ĺă, 2016/2”­s.

620061. [Šwp‘ (•Ş’SŽˇ•M)]y”]‘˛’†ÇŒóŒQz‘ć2•” ŒŒŠÇ‹ÇÝŤÇŒó@‘ć41Í Ź”]‚̍[Ç, ‘ć42Í ‹ŤŠE—Ěˆć‚̍[Ç, ‘ć43Í ŒĂ“T“Iƒ‰ƒNƒiÇŒóŒQ, ‘ć44Í ‘ĺ”]Šî’ęŠj‚̏oŒŒ, ‘ć45Í ”]—tŒ^ (”玿‰ş) ‚̏oŒŒ, ‘ć46Í ”]Žş“ŕoŒŒ, ‘ć47Í ‚­‚ŕ–Œ‰şoŒŒ, p.452-522. ˆ˘‹v’Ă“ń•v (_Œo“ŕ), ŠÄ–ó: Ż–쐰•F, ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712015. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) M1 Interneuron function: SICI and pitfall. Hanajima R1: International Symposimu on Magnetic Stimulation (2015/6/6), Tokyo. (‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

713031. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Late cerebellar atrophy and long-term outcome in anti-NMDA receptor encephalitis. Iizuka T1, Someko H1, Ohnuma H1, Kubo A1, Nakamura M1, Ishima D1, Kaneko J1, Kitamura E1, Masuda R1, Dalmau J, Nishiyama K1: American Academy of Neurology 2015 Annual Meeting (2015/4/22), Washington, USA. (”Ń’Ë‚_1, őŹ‰pO1, ‘ĺŔLŽ÷1, ‹v•Ű“ÖŽq1, ’†‘şŠ˛ş1, ˆä“‡‘ĺ•ă1, ‹ŕŽq~‘ž˜Y1, –k‘ş‰p“ń1, ‘“c@—ă1, źŽR˜a—˜1: 1_Œo“ŕ)

713032. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Acute Bulbar Palsy as Presentation of Anti-NMDA Receptor Encephalitis: A Case Report. IIzuka T1, Nakamura M1, Ishima D1, Kaneko J1, Dalmau J, Nishiyama K1: American Academy of Neurology 2015 Annual Meeting (2015/4/22), Washington, USA. (”Ń’Ë‚_1, ’†‘şŠ˛ş1, ˆä“‡‘ĺ•ă1, ‹ŕŽq~‘ž˜Y1, źŽR˜a—˜1: 1_Œo“ŕ)

713033. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Physiology and modeling of non-invasive brain stimulation of the human motor cortex. Hanajima R1: The First International Taiwanese Congress of Neurology and 2015 Annual Meeting of Taiwan Neurological Society (2015/5/7),Taiwan. (‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

713034. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The migraine prophylactic effect of candesartan and telmisartan on rat CSD model. Kitamura E1, Hamada J1, Kanazawa N1, Nishiyama K1: 17th Congress of the International Headache Society (2015/5/14-17), Spain. (–k‘ş‰p“ń1, ŕ_“cˆę1, ‹ŕŕV’ź”ü1, źŽR˜a—˜1: 1_Œo“ŕ)

713035. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Plasticity induction. Hanajima R1: International Symposimu on Magnetic Stimulation (ŽĽ‹CŽhŒƒ‘ŰƒVƒ“ƒ|ƒWƒEƒ€) (2015/6/6), Tokyo. (‰Ô“‡—ĽŽq1: 1_Œo“ŕ)

713036. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) JAPANESE NEUROLOGISTS RECOMMENDATIONS TO THEIR PATIENTS AND PERSONAL CHOICES TO TRACHEOSTOMY WITH INVASIVE MECHANICAL VENTILATION(TIV) DIVERGE BUT NOT TO NON-INVASIVE MECHANICAL VENTILATION(NIV). Ogino Y1, Ogino M2: 26th ALS/MND international symposium 2015 (2015/12/11), Orlando, USA, Amyotroph Lateral Scler Frontotemporal Degener 2015; 16 (suppl 1): 130. (‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

722038. [Šw‰ď (‘S‘)] (Hot Topics) MELAS‚É‚¨‚Ż‚é”]‘˛’†—l”­ě‚Ě•ŞŽq•a‘Ô (Molecular Pathophysiology of Stroke-like Episodes in MELAS). ”Ń’Ë‚_ (_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/20), VŠƒ.

722039. [Šw‰ď (‘S‘)] (Hot Topics) ”˝•œ’P‘ŠŤŽl˜A”­ŽĽ‹CŽhŒƒ–@‚É‚ć‚é‰^“Ž–ě‰Â‘YŤ•Ď‰ť‚Ö‚Ě”N—î‚̉e‹ż (Age dependency of the LTP like effect by quadri-pulse stimulation (QPS) over M1). ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/21), VŠƒ.

722040. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) •Đ“Ş’É‚Ě•a‘Ô‹@˜—˜_‚̐V‚˝‚Č“WŠJ|”]Š˛‹NŒšŕ‚Ě‘Ă“–Ť‚Ć”ń‘Ă“–Ť. ŕ_“cˆę1, ”Ń’Ë‚_1 (‘ă—”­•\), –k‘ş‰p“ń1 (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/22), VŠƒ, —Տ°_ŒoŠw 2015; 55 (•Ęű) :S146.

722041. [Šw‰ď (‘S‘)] (‹łˆçu‰‰ƒx[ƒVƒbƒN)yŔ’ˇz”]‘˛’†ƒGƒLƒXƒp[ƒg‚đ–ÚŽw‚ˇ_Œo“ŕ‰Čˆă‚Ě‚˝‚ß‚ĚzŠÂŠíŠwŠî‘buŔ. é‘q@Œ’1, źŽR˜a—˜2 (1‰Ą•lŽs—§”]ŒŒŠÇˆă—ĂƒZƒ“ƒ^[, 2_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/22), VŠƒ.

722042. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹}Ť”]‰ŠE‹}Ť”]Ç‚Ě—‰đ‚đ[‚ß‚é‚˝‚߂Ɂ|RNMDAŽó—e‘Ě”]‰Š‚É‚¨‚Ż‚éf’f‚ĆŽĄ—Ïă‚Ě—ŻˆÓ“_. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć57‰ń“ú–{ŹŽ™_ŒoŠw‰ďŠwpW‰ď (2015/5/29), ‘ĺă, ”]‚Ć”­’B 2015; 47 (Suppl): S140.

722043. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ––˝_ŒoáŠQf’f‚É‚¨‚Ż‚é_Œo’´‰š”gŒŸ¸‘˜_. źŽR˜a—˜ (_Œo“ŕ): ‘ć34‰ń“ú–{”]_Œo’´‰š”gŠw‰ď‘‰ď (2015/6/5), ‹ž“s.

722044. [Šw‰ď (‘S‘)] (Controversy)yŽi‰ďzźŽR˜a—˜1, ç—t@i (1_Œo“ŕ): ‘ć9‰ńƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒX (2015/10/16), •iě.

722045. [Šw‰ď (‘S‘)] (Controversy) Œ’NH•i (“`“ˆă—Ă, ”ޏĄ“¤, …‘f…‚đŠÜ‚Ţ) ‚ÍPD‚É—L—p‚Š?: CN1-2 No. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć9‰ńƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒX (2015/10/16), “Œ‹ž, MDSJ Letters 2016; 9 (1): 1-3.

722046. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒrƒfƒIƒZƒbƒVƒ‡ƒ“) “ŒŒRƒƒ“ƒo[. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć9‰ńƒp[ƒLƒ“ƒ\ƒ“•aE‰^“ŽáŠQŽžŠłƒRƒ“ƒOƒŒƒX (2015/10/16), •iě.

722047. [Šw‰ď (‘S‘)] (‹łˆçu‰‰)yŔ’ˇzŹ”]_Œo‰ń˜H‚Ě‚Í‚˝‚ç‚Ť‚ƐśŒă”­’B. ‰Ô“‡—ĽŽq (_Œo“ŕ):‘ć45‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć52‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2015/11/6), ‘ĺă.

722048. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹ŘE_Œo•a•Ď: ƒTƒ‹ƒRƒCƒh[ƒVƒX‚̐V‚ľ‚˘f’fŠî€‚Ɛf—ĂƒKƒCƒhƒ‰ƒCƒ“‚đ‚ß‚Ž‚Á‚Ä. źŽR˜a—˜ (_Œo“ŕ): ‘ć35‰ń“ú–{ƒTƒ‹ƒRƒCƒh[ƒVƒX/“÷‰čŽîŤŽžŠłŠw‰ď‘‰ď(2015/11/7), ‘ĺă, “ú–{ƒTƒ‹ƒRƒCƒh[ƒVƒX/“÷‰čŽîŤŽžŠłŠw‰ďŽGŽ 2015; 35 (suppl 1): 34.

722049. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)ySymposium 1zRecent progresses in primary headache disorders: 1-3) Hemiplegic migraine: Is it a typical migraine with aura or a migraine subtype? ”Ń’Ë‚_ (_Œo“ŕ): ‘ć43‰ń“ú–{“Ş’ÉŠw‰ď‘‰ď (2015/11/13), “Œ‹ž, “ú–{“Ş’ÉŠw‰ďŽ 2016/7; 43 (1): 65-70.

722050. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[)yŔ’ˇz”][ÇŠłŽŇ‚É‚¨‚Ż‚鎉ŽżŠÇ—‚̏d—vŤ. ˆ˘‹v’Ă“ń•v (_Œo“ŕ): ‘ć43‰ń“ú–{“Ş’ÉŠw‰ď‘‰ď (2015/11/13), “Œ‹ž.

722051. [Šw‰ď (‘S‘)] (Žs–ŻŒöŠJuŔ) ‚ą‚ń‚Č“Ş’É, ‚ ‚ń‚Č“Ş’É, ‚ ‚Č‚˝‚Ě’m‚ç‚Č‚˘ƒzƒ“ƒg‚Ě“Ş’É. •x‰i“Ţ•Ű”ü (_Œo“ŕ): ‘ć43‰ń“ú–{“Ş’ÉŠw‰ď‘‰ď (2015/11/15), “Œ‹ž.

722052. [Šw‰ď (‘S‘)] (Žs–ŻŒöŠJuŔ•Â‰ď‚ĚˆĽŽA) ‚ą‚ń‚Č“Ş’É, ‚ ‚ń‚Č“Ş’É, ‚ ‚Č‚˝‚Ě’m‚ç‚Č‚˘ƒzƒ“ƒg‚Ě“Ş’É. źŽR˜a—˜ (_Œo“ŕ): ‘ć43‰ń“ú–{“Ş’ÉŠw‰ď‘‰ď (2015/11/15), “Œ‹ž.

722053. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŔ’ˇz_ŒoŽžŠłŽ•ž‚đ–ÚŽw‚ľ‚˝ĹV‚Ě‰ć‘œŒ¤‹† Ži‰ď‚ĚŒž—t. ‰şŕ_@r1, źŽR˜a—˜2 (1ŽD–yˆă‰Č‘ĺŠwˆăŠw•”_Œo“ŕ‰ČŠwuŔ, 2_Œo“ŕ): ‘ć33‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2015/11/27), –źŒĂ‰Ž, _ŒoŽĄ—Ă 2016; 33 (2): 184.

722054. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) ‚Ě•a‘Ô‚ĆŽĄ—Ă. źŽR˜a—˜ (_Œo“ŕ): “ú–{–ňŠw‰ď‘ć136”N‰ď (2016/3/28), ‰Ą•l.

723238. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘O•â‘Ť‰^“Ž–ěE•â‘Ť‰^“Ž–ě‚ɑ΂ˇ‚éŒo“ŞŠW”˝•œŽĽ‹CŽhŒƒ‚ŞŽ‹Šo‰^“ŽŒn—ńŠwK‚É—^‚Ś‚é‰e‹ż. ´…’G1, ‰Ô“‡—ĽŽq1, ‘ă“c—Iˆę˜Y, ’ç@—Á‰î1, “c’†Ms, “żd^ˆę, ŕ_“c@‰ë, Ž›”öˆŔś, ‰Fě‹`ˆę (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/20), VŠƒ.

723239. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒp[ƒLƒ“ƒ\ƒ“•af’f‚Ĺ‚Ě’†ƒGƒlƒ‹ƒM[ƒRƒŠƒ[ƒ^[‚đ—p‚˘‚˝MIBGƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚Ě—L—pŤ. ’†‘şŠ˛ş1, –k‘ş‰p“ń1, ‹ŕŕV’ź”ü2, ˆäă—D‰î3, źŽR˜a—˜1 (1_Œo“ŕ, 2•a‘ԁEf—ĂŒn, 3•úŽËü (‰ć‘œ)): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/20), VŠƒ.

723240. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘˝Œn“ˆŢkÇŠłŽŇ‚É‚¨‚Ż‚鐍‘Ě˜H’ĽŒó‚Ć’†•“`“ąŽžŠÔ‚ĚŒŸ“˘. ‘ĺ’ˏ\—˘, ŕ_“c@‰ë, ‰LŔ@“Ö, “żd^ˆę, ´…’O1, “c’†Ms, ‰Ô“‡—ĽŽq1, Ž›”öˆŔś, ’ҁ@ČŽŸ (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/20), VŠƒ.

723241. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Saccade abnormalities in cerebellar ataxia: comparison between SCD and MSA-C. Ž›”öˆŔś, •Ÿ“cGŽ÷, “żd^ˆę, ź“crˆę, ‹|í“cWO, ‰Ô“‡—ĽŽq1, Hanajima M, ŕ_“c@‰ë, ‰Fě‹`ˆę, ’ҁ@ČŽŸ (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/20), VŠƒ.

723242. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) QPS‚đ—p‚˘‚˝ƒp[ƒLƒ“ƒ\ƒ“•aŠłŽŇ‚É‚¨‚Ż‚éL-DOPA‚É‚ć‚é‘ĺ”]”玿‰Â‘YŤ•Ď‰ť‚ĚŒŸ“˘. “c’†Ms, ’ç@—Á‰î1, ´…’O1, Ž›“c‚ł‚Ć‚Ý, ŕ_“c@‰ë, Ž›”öˆŔś, ‰Fě‹Vˆę, ‰Ô“‡—ĽŽq1, ’ҁ@ČŽŸ (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/21), VŠƒ.

723243. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) rt-PA“Š—^ŠłŽŇ‚É‚¨‚Ż‚éASPECT‚ĆASPECT DWI‚Ě”äŠr‚Ć“ŞŠW“ŕoŒŒ‚̍‡•š‚ɂ‚˘‚Ä‚ĚŒŸ“˘. őŹ‰pO1, ‹ŕŽq~‘ž˜Y1, ‰iˆä•qs1, ‹v•Ű“ÖŽq1, ‰Oˆä@—É1, ‘ĺŔLŽ÷1, ’†‘şŠ˛ş1, ˆä“‡‘ĺ•ă1, –k‘ş‰p“ń1, ‘“c@—ă1, ”Ń’Ë‚_1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/21), VŠƒ.

723244. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰)yŔ’ˇz‹•ŒŒŤ”]‘˛’†‚ĚŠî‘b‚Ć—Ő°. źŽR˜a—˜ (_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/21), VŠƒ.

723245. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Morphine usage in ALS patients on NPPV does not make life prognosisi wors. •x‰i“Ţ•Ű”ü1, ‰Ź–ě”üŒbŽq2, ‰iˆä^‹MŽq1, ‹ŕŽq~‘ž˜Y1, –k‘ş‰p“ń1, ˆ˘‹v’Ă“ń•v1, ‹ŕŕV’ź”ü1, Ryoko Noda, Fuki Wake, źŽR˜a—˜1 (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/21), VŠƒ, —Տ°_Œo 2015; 55 (•Ęű): S345.

723246. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) pTDP-43 staging of amyotrophic lateral sclerosis,a critical review. “ŕ–쏲Žq1, Yuta Nakano, Hiroyuki Sumikura, Masaki Takao, źŽR˜a—˜1, Shigeo Murayama (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/21), VŠƒ, —Տ°_Œo 2015; 55: S350.

723247. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰@ŠO”­Ç‚Ɖ@“ŕ”­Ç”][Ç‚Ě’´‹}ŤŠúŽĄ—ĂŽ{s‚Ü‚Ĺ‚ĚŽžŠÔŒo‰ß‚Ě”äŠr. ‹v•Ű“ÖŽq1, ˆ˘‹v’Ă“ń•v1, őŹ‰pO1, ‰Oˆä@—É1, ‹ŕŽq~‘ž˜Y1, –k‘ş‰p“ń1, ‘“c@—ă1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/22), VŠƒ.

723248. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒtƒFƒCƒ“‚Ě”˝•œ’P‘ŠŤŽl˜A”­ŽĽ‹CŽhŒƒ–@ (QPS) ‚É‚ć‚é’ˇŠúŒř‰Ę‚ւ̉e‹ż. ’ç@—Á‰î1, “c’†Ms, ´…’G1, Ž›”öˆŔś, ‰Fě‹`ˆę, ‰Ô“‡—ĽŽq1 (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/22), VŠƒ.

723249. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒfƒm”şƒEƒCƒ‹ƒXƒxƒNƒ^[‚đ—p‚˘‚˝•ĎˆŮMatrin 3”­Œťƒ}ƒEƒXƒ‚ƒfƒ‹‚̍쐬. ź”öŒ\Ť, ŽR‰ş@ŒŤ, “š‹S‚‚Š‚ł, źă@•ü, •U@@–], ‘O“c@”J, ˆŔ“Œ—RŠě—Y, ‰iˆä^‹MŽq1 (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/22), VŠƒ.

723250. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”F’mÇ‚𔺂Á‚˝‹ŘˆŢkŤ‘¤őd‰ťÇ–UŒŸ”]‚̖Ɖu‘gDŠw“IŒŸ“˘. ‰iˆä^‹MŽq1, ě˜Q@•ś1, ‰Ź–ě”üŒbŽq2, źŽR˜a—˜1 (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/22), VŠƒ.

723251. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The influence of candesartan on cortical spreading depressin. –k‘ş‰p“ń1, ŕ_“cˆę1, ‹ŕ‘ň’ź”ü2, źŽR˜a—˜1 (1_Œo“ŕ, 2•a‘ԁEf—ĂŒn): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/22), VŠƒ.

723252. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰EŒű‰‰) I2020T LRRK2 iPSC-derived neurons exhibit increased Tau phosphorylation. ‘ž“c‰x˜N1, m•˝—FŽq, “ŕ–쏲Žq2,3, Ąň—zˆę4, Ôź˜a“y4, ‚‹´‰Á‘ăŽq5, ‰iˆä^‹MŽq2, ‘ĺŽR@Šw6, —Ŕ@ł•Ł, ‰Ź–ě”üŒbŽq7, ‘şŽR”É—Y3, ‚“‡–ž•F8, źŽR˜a—˜2, …–ě”ü–M, –]ŒŽGŽ÷9, Ź”Ś•ś–í1, ‰Ş–ě‰h”V4 (1ˆă—ÉqśŠw•”, 2_Œo“ŕ, 3“Œ‹ž“sŒ’N’ˇŽőˆă—ĂƒZƒ“ƒ^[E‚—îŽŇƒuƒŒƒCƒ“ƒoƒ“ƒN, 4Œcœä‹`m‘ĺ, 5—ŐŒŸ•”, 6ˆÇ—Ń‘ĺ, 7V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 8‘—§’ˇŽőˆă—ĂŒ¤‹†ƒZƒ“ƒ^[, 9‘ĺă‘ĺ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/22), VŠƒ, —Տ°_ŒoŠw 2015; 55 (•Ęű): S226.

723253. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Phosphorylated TDP-43 inclusions in the hippocampal formation of ALS patients. ‰iˆä^‹MŽq1, ě˜Q@•ś1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/23), VŠƒ.

723254. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’†”]“ŕ‘¤‚đŠÜ‚ޏŹ[Ç‚Ě—Ő°“IE•úŽËüŠw“IŒŸ“˘. ˆ˘‹v’Ă“ń•v1, ˆä“‡‘ĺ•ă1, ‹ŕŽq~‘ž˜Y1, –k‘ş‰p“ń1, ‘“c@—ă1, ‘ęŽR—eŽq1, ”Ń’Ë‚G1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/23), VŠƒ.

723255. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Clinicall Characteristics of cerebral amyloid angiopathy related inflammation. ‰Oˆä@—É1, ‘“c@—ă1, ˆä“‡‘ĺ•ă1, ‘ĺŔLŽ÷1, őŹ‰pO1, ’ç@—Á‰î1, ‘ĺŔšD, ‰iˆä^‹MŽq1, •x‰i“Ţ•Ű”ü1, Š}‘qŽŠŒž, ‹ŕŽq~‘ž˜Y1, ě˜Q@•ś1, ”Ń’Ë‚_1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/23), VŠƒ.

723256. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é”F’mÇŠO—ˆ‚ĚŒťó‚ɂ‚˘‚Ä. ě˜Q@•ś1, ‰iˆä^‹MŽq1, ‚‹´@Œb2, źŽR˜a—˜1 (1_Œo“ŕ, 2¸_): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/23), VŠƒ.

723257. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Impact of cerebellar atrophy on long-term outcome in anti-NMDAR encephalitis. ”Ń’Ë‚_1, őŹ‰pO1, ˆä“‡‘ĺ•ă1, ‹ŕŽq~‘ž˜Y1, –k‘ş‰p“ń1, ‘“c@—ă1, źŽR˜a—˜1 (1_Œo“ŕ):‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/23), VŠƒ, —Տ°_Œo 2015; 55: S463.

723258. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yŔ’ˇz‚ť‚Ě‘ź‚Ě”]‰Š. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/23), VŠƒ.

723259. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”][•”ŽhŒƒ—Ă–@Ž{sŒă‚̉Ƒ°Ťƒp[ƒLƒ“ƒ\ƒ“•a (PARK8) ‚Ěˆę–UŒŸ—á. “ŕ–쏲Žq (_Œo“ŕ): ‘ć56‰ń“ú–{_Œo•a—Šw‰ď‘‰ďŠwpŒ¤‹†‰ď (2015/6/4), •Ÿ‰Ş.

723260. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) I2020T LRRK2 iPSC-derived neurons exhibit increased Tau phosphorylation. ‘ž“c‰x˜N1, m•˝—FŽq, “ŕ–쏲Žq2, Ąň—zˆę, ‰Ş“c—m•˝, Ôź˜a“y, ‰iˆä^‹MŽq2, ‚‹´‰Á‘ăŽq3, ‘ĺŽR@Šw, —Ŕ@ł•Ł, ‰Ź–ě”üŒbŽq4, ‘şŽR”É—Y, ‚“‡–ž•F, źŽR˜a—˜2, …–ě”ü–M, –]ŒŽGŽ÷, Ź”Ś•ś–í1, ‰Ş–ě‰h”V (1ˆă—ÉqśŠw•”, 2_Œo“ŕ, 3—ŐŒŸ•”, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć38‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2015/7/28), _ŒË.

723261. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”F’mÇ‚𔺂¤‹ŘˆŢkŤ‘¤őd‰ťÇ‚Ě—Ő°E•a—Šw“I•]‰ż. ‰iˆä^‹MŽq1, ě˜Q@•ś1, ‹ß“Ą—TŽq1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć34‰ń“ú–{”F’mÇŠw‰ďŠwpW‰ď (2015/10/2), ÂX, Dementia Japan 2015/9; 29 (3): 356.

723262. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) _ŒoŞŽĽ‹CŽhŒƒ–@‚É‚ć‚éă•”˜r_Œo‘páŠQ‚ĚŒŸo. ź–{‰p”V, “żd^ˆę, –{ŠÔ—[Žq, Ô–x‚‚Ž‚Ý, ‰Ş•”TŒá, ‰Ô“‡—ĽŽq1, Ž›”öˆŔś, ‰Fě‹`ˆę (1_Œo“ŕ): ‘ć45‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć52‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2015/11/5), ‘ĺă, —Տ°_Œoś—Šw 2015/10; 43 (5): 461.

723263. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘O•â‘Ť‰^“Ž–ěE•â‘Ť‰^“Ž–ě‚ɑ΂ˇ‚é”˝•œŒo“ŞŠWŽĽ‹CŽhŒƒ‚ŞŽ‹Šo‰^“ŽŒn—ńŠwK‚É—^‚Ś‚é‰e‹ż. ´…’G1, ‰Ô“‡—ĽŽq1, ’ç@—Á‰î1, “c’†Ms, “żd^ˆę, ŕ_“c@‰ë, Ž›”öˆŔś, ‰F‰ę‹`ˆę (1_Œo“ŕ): ‘ć45‰ń“ú–{—Տ°_Œoś—Šw‰ďŠwp‘ĺ‰ď/‘ć52‰ń“ú–{—Տ°_Œoś—Šw‰ď‹ZpuK‰ď (2015/11/6), ‘ĺă, —Տ°_Œoś—Šw 2015/10; 43 (5): 402.

723264. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŠjăŤś’Ž‹–ƒáƒ‚Ĺ”­Ç‚ľ‚˝Ź×–E”xŠŕ‚ɐ”ş‚ˇ‚é–TŽîᇐŤŠOŠá‹Ř–ƒáƒ‚Ě1—á. ‹ŕŽq@Œú1, ”Ń’Ë‚_1, •x‰i“Ţ•Ű”ü1, ˆä“‡‘ĺ•ă1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć33‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2015/11/26), –źŒĂ‰Ž, _ŒoŽĄ—ĂŠw 2015/9; 32 (5): 757.

723265. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Brachial amyotrophic diplegia‚Ćsensory neuronopathy‚đ‡•š‚ľ‚˝ƒVƒF[ƒOƒŒƒ“ÇŒóŒQ‚Ě1—á. •x‰i“Ţ•Ű”ü1, ”Ń’Ë‚_1, ‹ŕŽq@Œú1, ˆä“‡‘ĺ•ă1, źŽR˜a—˜1 (1_Œo“ŕ); ‘ć33‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2015/11/27), –źŒĂ‰Ž, _ŒoŽĄ—ĂŠw 2015/9; 32 (5): 782.

723266. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yŔ’ˇzˆăŽtƒ|ƒXƒ^[ŽŠŒČ–ƉuŤ”]Ç: ƒP[ƒXƒJƒ“ƒtƒ@ƒŒƒ“ƒX. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć33‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2015/11/27), –źŒĂ‰Ž.

723267. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) I2020T mutant LRRK2 iPSC-derived neurons exhibit increased Tau phosphorylation. ‘ž“c‰x˜N1, m•˝—FŽq, “ŕ–쏲Žq2, Ąň—zˆę, ‰Ş“c—m•˝, Ôź˜a“y, ‚‹´‰Á‘ăŽq3, ‰iˆä^‹MŽq2, ‘ĺŽR@Šw, —Ŕ@ł•Ł, ‰Ź–ě”üŒbŽq4, ‘şŽR”É—Y, ‚“‡–ž•F, źŽR˜a—˜2, …–ě”ü–M, –]ŒŽGŽ÷, Ź”Ś•ś–í1, ‰Ş–ě‰h”V (1ˆă—ÉqśŠw•”, 2_Œo“ŕ, 3—ŐŒŸ•”, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć15‰ń“ú–{Äśˆă—ĂŠw‰ď‘‰ď (2016/3/17-19), ‘ĺă.

731077. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _Œo“ŕ‰Čˆă‚Í”]‘˛’†‚É‚˘‚Š‚ÉŠÖ‚í‚é‚ׂŤ‚Š. źŽR˜a—˜ (_Œo“ŕ): ‘ć17‰ń“ż“‡”]ŒŒŠÇáŠQƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/5/16), “ż“‡.

731078. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Œn—ńŠwK‰Ű‘č‚Ć”˝•œŒo“ŞŠWŽĽ‹CŽhŒƒ‚đ—p‚˘‚˝‘O•â‘Ť‰^“Ž–ěE•â‘Ť‰^“Ž–ě‚Ě‹@”\‰đÍ. ´…’G (_Œo“ŕ): ‘ć7‰ń‘Š–ÍŒ´E–k—˘_Œo‰ČŠwƒtƒH[ƒ‰ƒ€ (2015/6/8), _“ސě.

731079. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŽŠŒČ–ƉuŤ_ŒoŽžŠł‚̐_ŒoÇŒóŠw|f’f‚ĆŽĄ—Ïă‚Ěpitfall|. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć12‰ńĂ‰Ş_Œo–ƉuƒtƒH[ƒ‰ƒ€(2015/7/3), Ă‰Ş.

731080. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŽŠŒČ–ƉuŤ”]‰Š‚Ɛ¸_Çó: ŽŠŒČ–Ɖu‹@˜‚Š‚ç‚Ý‚˝¸_áŠQ‚Ě—Ő°‚Ć•a‘Ô. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć12‰ń•xŽR—Տ°¸__ŒoˆăŠwŒ¤‹†‰ď (2015/9/11), •xŽR.

731081. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz1Ç—á‚Š‚çŽn‚ß‚éV‹KŽŠŒČR‘Ě‚Ě’Tő. źŽR˜a—˜ (_Œo“ŕ): _“ŢěŒ§_Œo–ƉuŽžŠłŠwpu‰‰‰ď (2015/10/6), ‘Š–ÍŒ´.

731082. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzƒp[ƒLƒ“ƒ\ƒ“•a‚̍ŐVî•ń|f’f‚ĆŽĄ—Á|. źŽR˜a—˜ (_Œo“ŕ): ‘ć5‰ń_“ސěƒp[ƒLƒ“ƒ\ƒ“•aƒtƒH[ƒ‰ƒ€ (2015/10/9), ‰Ą•l.

731083. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a/ƒp[ƒLƒ“ƒ\ƒ“ÇŒóŒQ‚ĚŒŸ¸‹y‚ŃŽĄ—Ă. ´…˜aŒh (_Œo“ŕ): ‘Š–ÍŒ´ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—ĂŒ¤‹†‰ď (2015/10/13), ‘Š–ÍŒ´.

731084. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŽŠŒČ–ƉuŤ”]‰Š‚̐_ŒoÇŒóŠw|“ä‚Ş‰đ‚Ť–ž‚Š‚ł‚ę‚é‚Ü‚Ĺ‚Ě‹ę”Y‚ĆŠ‹“Ą|. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć4‰ńKyoto Young Kamogawa Conference (2015/10/30), ‹ž“s.

731085. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—Ă‚ĚŠî‘b. ´…’G (_Œo“ŕ): Š”ŽŽ‰ďŽĐƒGƒtƒs[ŽĐ“ŕu‰‰ (2015/11/18), “Œ‹ž.

731086. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Ž•“Ë‹NŽüˆÍ‚̉ŠÇŤŽžŠł‚ɂ‚˘‚Ä. ˆ˘‹v’Ă“ń•v (_Œo“ŕ): ‘ć191‰ńĂ“ě_Œo’k˜b‰ď (2016/1/12), •˝’Ë.

731087. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzƒp[ƒLƒ“ƒ\ƒ“•a‚Ě–ň•¨ŽĄ—Á|ƒƒ`ƒSƒ`ƒ““\•tÜ‚ĚŒř‰Ę‚Ć–â‘č“_‚đŠÜ‚߂ā|. źŽR˜a—˜ (_Œo“ŕ): ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—ĂŒ¤‹†‰ď (2016/1/15), ‘Š–ÍŒ´.

731088. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz‹}ŤŠúV‹K”][ÇŽĄ—Ă–ň‚Ě“W–]. –k‘ş‰p“ń (_Œo“ŕ): ‘ć3‰ń_“ސě”]‘˛’†ƒRƒ“ƒ\[ƒVƒAƒ€ (2016/1/22), ‰Ą•l.

731089. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Uí‚Ě•a‘Ԑś—. ‰Ô“‡—ĽŽq (_Œo“ŕ): ‘ć6‰ńƒp[ƒLƒ“ƒ\ƒ“•aQOL§˜b‰ď (2016/2/24), L“‡.

731090. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz‘ĺ”]Šî’ęŠj‚Ɖ^“Ž§Œä. źŽR˜a—˜ (_Œo“ŕ): ‘ć17‰ń_“ސěMovement DisorderƒtƒH[ƒ‰ƒ€ (2016/3/2), ‰Ą•l.

731091. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŽŠŒČ–ƉuŤ”]‰Š‚É‚¨‚Ż‚éĹ‹ß‚Ě“ŽŒü. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć4‰ń‘q•~_Œo–ƉuŽžŠłƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/3/10), ‘q•~.

732031. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Šî’˛u‰‰Ŕ’ˇ) ˆă—Ă‘i×‚É‚¨‚Ż‚éR‹ĂŒĹ—Ă–@. źŽR˜a—˜ (_Œo“ŕ): Kanagawa Stroke Core Member Meeting (2015/4/17), ‰Ą•l.

732032. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Session2Ži‰ďEClosing Remarks) źŽR˜a—˜ (_Œo“ŕ): źĂ|Œ§‰›_Œo“ŕ‰Čƒlƒbƒgƒ[ƒN (2015/4/21), Œú–Ř.

732033. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ŕ’k‰ď)yŔ’ˇzQOL‚đl—ś‚ľ‚˝ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—Âց|CDSŽŔŒť‚Ě‚˝‚߂̐V‚˝‚Č‚é‘I‘đŽˆ@ƒƒ`ƒSƒ`ƒ““\•tÜ|. źŽR˜a—˜ (_Œo“ŕ): 2015/6/22, ‘Š–ÍŒ´ (Clinical Neuroscience ŒfÚ—\’č).

732034. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ŕ’k‰ďƒfƒBƒXƒJƒbƒTƒ“ƒg) QOL‚đl—ś‚ľ‚˝ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—Âց|CDSŽŔŒť‚Ě‚˝‚߂̐V‚˝‚Č‚é‘I‘đŽˆ@ƒƒ`ƒSƒ`ƒ““\•tÜ|. ’ˇ’JěˆęŽq1, •Ÿ“c—Ď–ç2, ‰Ô“‡—ĽŽq1 (1_Œo“ŕ, 2ˆă—ÉqśŠw•”): 2015/6/22, ‘Š–ÍŒ´ (Clinical Neuroscience ŒfÚ—\’č).

732035. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŔ’ˇz‘ęŽR—eŽq (_Œo“ŕ): ‘ć11‰ńŽáŽč_Œo“ŕ‰Čˆă‚Ě‚˝‚ß‚ĚPDf—ĂŽŔ‘Hƒ[ƒNƒVƒ‡ƒbƒv (2015/7/1), ‰Ą•l.

732036. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŠJ‰ďˆĽŽA) źŽR˜a—˜ (_Œo“ŕ): ‘ć1‰ńŽń“sŒ—_ŒoŽžŠłƒtƒH[ƒ‰ƒ€ (2015/9/18), Vh.

732037. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Session1)yŔ’ˇzNeurovascular unit‚Ě—§ę‚Š‚ç‚Ý‚˝”]ŒŒŠÇáŠQ‚ĚŠî‘b‚Ć—Ő°. źŽR˜a—˜ (_Œo“ŕ): ‘ć1‰ńŽń“sŒ—_ŒoŽžŠłƒtƒH[ƒ‰ƒ€ (2015/9/18), Vh.

732038. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒTƒeƒ‰ƒCƒgƒVƒ“ƒ|ƒWƒEƒ€) Opening Remarks. źŽR˜a—˜ (_Œo“ŕ): ‘ć2‰ń_Œo‹Ř’´‰š”gŒ¤‹†‰ď (2015/11/5), ‘ĺă.

732039. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‘‡Ŕ’ˇ) źŽR˜a—˜ (_Œo“ŕ): Žń“sŒ—”]‘˛’†ƒlƒbƒgƒ[ƒNu‰‰‰ď (2015/12/1), ‘Š–ÍŒ´.

732040. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŠJ‰ď‚ĚŽŤE•Â‰ď‚ĚŽŤ) źŽR˜a—˜ (_Œo“ŕ): •˝Ź27”N“x ‘ć30‰ń_Œo“ď•aŒ¤C‰ď (2015/12/2), ‘Š–ÍŒ´.

732041. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒŒƒNƒ`ƒƒ[) ’nˆćˆă—Ă˜AŒg‚đÄl‚ˇ‚é|ĹV‚ĚŽĄ—Ă–@‚đŽó‚Ż‚₡‚­‚ˇ‚éˆ×‚ɐi•ŕ‚ˇ‚éALS‚Ö‚ĚŽĄ—Ă–@‚đŒŠ˜‚Ś‚ā|ƒ‰ƒWƒJƒbƒg“_“HŽĄ—ÂƑΉž/NPPV. ‰iˆä^‹MŽq (_Œo“ŕ): •˝Ź27”N“x‘ć30‰ń_Œo“ď•aŒ¤C‰ď (2015/12/2), ‘Š–ÍŒ´.

732042. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Special Lecture)yŔ’ˇz‹}ŤŠú”]ŽĺŠ˛“Ž–Ź•ÂÇ‚ɑ΂ˇ‚錌ŠÇ“஡—Ă‚Ě•ŕ‚Ý‚ĆĹ‹ß‚Ě˜b‘č. źŽR˜a—˜ (_Œo“ŕ): Sagami Stroke Seminar (2015/12/4), ‘Š–ÍŒ´.

732043. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŠJ‰ď‚ĚˆĽŽAEˆę”ʍu‰‰)yŔ’ˇzƒe[ƒ}: ”]ŒŒŠÇ‚̍\‘˘‚Ć‹@”\‚Š‚ç”][Ç”­Ç‹@\‚Ě‘Šˆá‚đ’T‚é. źŽR˜a—˜ (_Œo“ŕ): ‘ć8‰ń‘Š–ÍŒ´E–k—˘_Œo‰ČŠwƒtƒH[ƒ‰ƒ€ (2015/12/7), ‘Š–ÍŒ´.

732044. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) –ƉuŤ”]_ŒoŽžŠł‚Ě•a‘ԂƐf’f. ”Ń’Ë‚_ (_Œo“ŕ): ‘ć1‰ńMDSJ’nˆćŒ¤C‰ďin Ehime (2016/2/14), ˆ¤•Q.

733078. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒqƒg‘ĺ”]‰^“Ž–ě‚É‚¨‚Ż‚é”ńNP“I‚ČƒVƒiƒvƒX‰Â‘YŤ‚ĚŒ¤‹†. ‰Ô“‡—ĽŽq (_Œo“ŕ): źĂ|Œ§‰›_Œo“ŕ‰Čƒlƒbƒgƒ[ƒN (2015/4/21), Œú–Ř.

733079. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—Ă‚ĚĹ‘Oü|‚ć‚č—Ç‚˘ŽĄ—Ă‚đˆę‚ɍě‚é|. ‘ęŽR—eŽq (_Œo“ŕ): ‘ć69‰ń–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[Žs–ŻuŔ (2015/5/16), é‹Ę.

733080. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) RMOGR‘Ě‚Ş‘‰t‚Ě‚Ý‚Š‚猟o‚ł‚ę‚˝‹}‘ŹisŤŇ‘‰Š‚Ě27Î’jŤ—á. –ö“c“ÖŽq1, ‹ŕŽq~‘ž˜Y1, ‰iˆärs1, ‰Oˆä@—É1, ‰Ô“‡—ĽŽq1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć213‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2015/6/6), “Œ‹ž, —Տ°_ŒoŠw 2015/10; 55 (10): 774.

733081. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Žń‰ş‚Ş‚č‚Ě‚Ý‚đ”F‚ß‚˝MSA‚Ěˆę–UŒŸ—á. ‚‹´ł”N, ź–{^ˆę, “ŕ–쏲Žq1, ‘şŽR”É—Y (1_Œo“ŕ): ‘ć110‰ńŠÖ“Œ—Տ°_Œo•a—§˜b‰ď(2015/7/4), “Œ‹ž.

733082. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’ˇŠúŠÔ‚Ě—Ő°Œo‰ß‚đŠĎŽ@‚ľ“ž‚˝81Î’jŤƒp[ƒLƒ“ƒ\ƒ“•a‚Ěˆę–UŒŸ—á. ’†–ě—Y‘ž, ‹ŕŠŰ˜a•x, “ŕ–쏲Žq1, “żŠŰˆ˘–ë, “Ąƒ–čƒŽq, ‘şŽR”É—Y (1_Œo“ŕ): ‘ć110‰ńŠÖ“Œ—Տ°_Œo•a—§˜b‰ď(2015/7/4), “Œ‹ž.

733083. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‹}‘Ź‚ČŒo‰ß‚đ‚˝‚Ç‚Á‚˝‹ŘˆŢkŤ‘¤őd‰ťÇ‚Ěˆę—á. ˜aň—BM, “ŕ–쏲Žq1, •“Ą_•˝, Š@˝™Z (1_Œo“ŕ): ‘ć110‰ńŠÖ“Œ—Տ°_Œo•a—§˜b‰ď(2015/7/4), “Œ‹ž.

733084. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Ascites praecox‚đ—ˆ‚ľ‚˝ŽűkŤS–Œ‰Š‚Ě1—á. “‡“c@Œb, H“ĄŽ÷•F, ”óŒű@”Ł, ”Ńƒ–’J”ü•ô1, Žu…Gs, ÔÎ@˝ (1_Œo“ŕ): ‘ć616‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (2015/7/19), “Œ‹ž.

733085. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇz‘ĺ“Ž–ŹŒ´Ť”]ÇđÇ‚ɑ΂ˇ‚éV‚˝‚ČŽĄ—Ð헪|‘ŠúĎ‹É“IŽ‰ŽżŽĄ—Ă‚Ě—L—pŤ|. źŽR˜a—˜ (_Œo“ŕ): ESUS-SEM in Yokohama (2015/9/1), ‰Ą•l.

733086. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) _ŒoBehcet•a‚Ć‚ĚŠÓ•Ę‚đ—v‚ľ, RMOGR‘Ě‚Ş—zŤ‚Ĺ‚ ‚Á‚˝RNMDAŽó—e‘Ě”]‰Š‚Ě46Î’jŤ—á. ˆ˘•”—L‹N1, ‘“c@—ă1, ˆä“‡‘ĺ•ă1, ”Ń’Ë‚_1, ˆ˘‹v’Ă“ń•v1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć214‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2015/9/5), “Œ‹ž.

733087. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇz•Ď‚í‚é!! ”]‘˛’†—\–h. źŽR˜a—˜ (_Œo“ŕ): Œ§‰›AF Network Meeting (2015/9/29), ‘Š–ÍŒ´.

733088. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʉ‰‘č) CMT1‚ĆCIDP•š‘ś—á‚É‚¨‚Ż‚éIVIg—Ă–@‚ĚŒŸ“˘. ŽRč—š, ´…˜aŒh1 (1_Œo“ŕ): _“ŢěŒ§_Œo–ƉuŽžŠłŠwpu‰‰‰ď (2015/10/6), ‘Š–ÍŒ´.

733089. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)u”F’mÇv‚ĆŒž‚í‚ę‚˝‚ç: ‰Ć’ë‚Ĺ‚Ĺ‚Ť‚é‚ą‚Ć. ě˜Q@•ś (_Œo“ŕ): ‚Ý‚ń‚Č‚ĆƒIƒŒƒ“ƒWƒJƒtƒF (–ƒ•z’n‹ćŽ–‹ĆuŔ) (2015/10/14), “Œ‹ž.

733090. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)u”F’mÇv‚ĆŒž‚í‚ę‚˝‚ç: ‰Ć’ë‚Ĺ‚Ĺ‚Ť‚é‚ą‚Ć. ě˜Q@•ś (_Œo“ŕ): ‚Ý‚ń‚Č‚ĆƒIƒŒƒ“ƒWƒJƒtƒF (Ôâ’n‹ćŽ–‹ĆuŔ) (2015/10/21), “Œ‹ž.

733091. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Ĺ‹ß‚Ě˜b‘č)yŔ’ˇzźŽR˜a—˜ (_Œo“ŕ): ‘ć17‰ń_“ŢěŒ§_Œo–ƉuƒtƒH[ƒ‰ƒ€ (2015/12/2), ‰Ą•l.

733092. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) _Œo“ď•a‚ĚŽĺ—v‚ČÇŒó‚ɂ‚˘‚Ä. ‰Ô“‡—ĽŽq (_Œo“ŕ): •˝Ź27”N“x ‘ć30‰ń_Œo“ď•aŒ¤C‰ď (2015/12/2), ‘Š–ÍŒ´.

733093. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇzźŽR˜a—˜ (_Œo“ŕ): ‘ć215‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2015/12/5), “Œ‹ž.

733094. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) CMT1A‚ÉCIDP—l‚Ě•a‘Ô‚đ‡•š‚ľ‚˝47Î—Ť—á. ´…˜aŒh1, ‰Ô“‡—ĽŽq1, ‰Oˆä@—É1, ‹ß“Ą—TŽq1, –ö“c“ÖŽq1, ˆ˘‹v’Ă“ń•v1, ”Ń’Ë‚_1, źŽR˜a—˜1 (1_Œo“ŕ): ‘ć215‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2015/12/5), “Œ‹ž.

733095. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚Ĺ‚ĚCADASIL 5 Ç—á‚Ě‚Ü‚Ć‚ß. ˆä“‡‘ĺ•ă (_Œo“ŕ): ‘ć8‰ń‘Š–ÍŒ´E–k—˘_Œo‰ČŠwƒtƒH[ƒ‰ƒ€ (2015/12/7), ‘Š–ÍŒ´.

733096. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ALS-FTD-Q‰Ą’f’˛¸. “n•Ó•Ű—T, ˆÉ“Ą@Œĺ, ‘Ť—§@ł, ‘Ť—§–FŽ÷, ‰Ô“‡—ĽŽq1, ‰Ź–ě”üŒbŽq2, źŽR˜a—˜1, –Ř‘ş‰p‹I, –‘“c“šl, ”M“c’źŽ÷, “n•ÓG‹v, ‘c•ƒ]Œł, ‹ŔęˆčŽq, Žsě”Ž—Y, ‹g–ě@‰p, ‰Ą“c@C, ˜aň—BM, –î•”—El, –ěŒłłO, ’ˇ’JěˆęŽq, D“c‰ë–ç, “팊Œö‹`, _’ë@˝, Â–Ř“NĆ, œA]‚䂤, ’†“‡Œ’“ń (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹Ću_Œo•ĎŤŽžŠł—Ěˆć‚É‚¨‚Ż‚éŠî”Ő“I’˛¸Œ¤‹†v•˝Ź27”N“x”ljď‹c (2015/12/18), “Œ‹ž.

733097. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)u”F’mÇv‚ĚƒTƒCƒ“‚É‹C‚Ă‚˘‚˝‚ç. ě˜Q@•ś (_Œo“ŕ): ‚Ý‚ń‚Č‚ĆƒIƒŒƒ“ƒWƒJƒtƒF (–ƒ•z’n‹ćŽ–‹ĆuŔ) (2016/1/13), “Œ‹ž.

733098. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•aŠłŽŇ‚É‚¨‚Ż‚é‹@”\“I’čˆĘ”]ŽčpŽĄ—Ă‚ĆCDS‚ĚŽŔŒť. ´…˜aŒh (_Œo“ŕ): ƒp[ƒLƒ“ƒ\ƒ“•aŽĄ—ĂŒ¤‹†‰ď (2016/1/15), ‘Š–ÍŒ´.

733099. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“•a‚̐ł‚ľ‚˘—‰đ‚ƍŐVŽĄ—Ă–@. źŽR˜a—˜ (_Œo“ŕ): ƒxƒlƒbƒZ‚Ě’nˆćˆă—ĂƒZƒ~ƒi[ (2016/3/6), ’Ź“c.

733100. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) “ŕŽ‹‹žśŒŸ‚É‚ć‚čf’f‚ľ‚˝\“ńŽw’°Gangliocytic Palaganglioma (GP) ‚Ě1—á. ‘O‚䂤‚Ť, ”~“c’qŽq, ”óŒű@”Ł, ’†–ě@‰ë, Ź—с@‘ń, íź@—ß, ‹ÚŕV@G, —é–ŘŒcˆę, ”Ńƒ–’J”ü•ô1, X‰ił“ń˜Y (1_Œo“ŕ): ‘ć622‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (2016/3/12), “Œ‹ž.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-521001. [‰đŕ]y_Œo‘hśƒKƒCƒhƒ‰ƒCƒ“z_ŒoŒn‚Ě‘hś‚đ—v‚ˇ‚鎞Šł‚Ć•a‘Ô (Źl) ”]ŒŒŠÇáŠQ •aŒ^Šm’č‘O‚̏‰—Ă. źŽR˜a—˜ (_Œo“ŕ): “ú–{_Œo‹~‹}Šw‰ďŽGŽ 2015/3; 27 (2): 17-8.

H26-522011. [uŔ]ySymposium 22-1: ŽŠŒČ–ƉuŤ”]‰Š‚ĚĹ‹ß‚Ě’mŒŠzRNMDAŽó—e‘Ě”]‰Š‚É‚¨‚Ż‚é—Տ°ƒXƒyƒNƒgƒ‰ƒ€‚ĆŽĄ—Ð헪: Œťó‚Ć–â‘č“_. ”Ń’Ë‚_1, ˆä“‡‘ĺ•ă1, ‹ŕŽq~‘ž˜Y1, źŽR˜a—˜1 (1_Œo“ŕ): —Տ°_ŒoŠw 2014; 54 (12): 1098-102.

H26-540001. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†ˆĎ‘ő”ď (“ŤŽžŠł“™Ž•žŒ¤‹†Ž–‹Ć)u‘˝”­Ťd‰ťÇś‘ĚŽŽ‘ĚŽŽ—żƒoƒ“ƒN‚đŠˆ—p‚ľ‚˝ƒAƒWƒAl“Á—L‚Ěˆâ“`ŽqŠÂ‹ŤˆöŽq’Tő‚É‚ć‚é•a‘ԉ𖞁vzˆâ“`EŠÂ‹ŤˆöŽqƒŠƒXƒN‰đÍ|RNMDAŽó—e‘Ě”]‰Š‚É‚¨‚Ż‚鎥—Ă‚ĚŒťó‚Ć–â‘č“_. źŽR˜a—˜1, ”Ń’Ë‚_1, ˆä“‡‘ĺ•ă1, •x‰i“Ţ•Ű”ü1, ‹ŕŽq~‘ž˜Y1 (1_Œo“ŕ):Œúś˜J“­‰ČŠwŒ¤‹†ˆĎ‘ő”ď (“ŤŽžŠł“™Ž•žŒ¤‹†Ž–‹Ć)u‘˝”­Ťd‰ťÇś‘ĚŽŽ‘ĚŽŽ—żƒoƒ“ƒN‚đŠˆ—p‚ľ‚˝ƒAƒWƒAl“Á—L‚Ěˆâ“`ŽqŠÂ‹ŤˆöŽq’Tő‚É‚ć‚é•a‘ԉ𖞁v•˝Ź26”N“xˆĎ‘ő‹Ć–ąŹ‰Ę•ń‘ 2015/3; p.13-5.

H26-540002. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]y•˝Ź26”N“xŒúś˜J“­ČŒúś˜J“­‰ČŠwŒ¤‹†ˆĎ‘ő”ď (“ŤŽžŠłŽŔ—p‰ťŒ¤‹†Ž–‹Ć)uƒ~ƒgƒRƒ“ƒhƒŠƒA•af—Ă‚ĚŽż‚đ‚‚ß‚é, ƒŒƒWƒXƒgƒŠƒVƒXƒeƒ€‚̍\’z, f’fŠî€Ef—ĂƒKƒCƒhƒ‰ƒCƒ“‚̍ô’肨‚ć‚ѐf’fƒVƒXƒeƒ€‚̐Ž”ő‚đs‚¤—Տ°Œ¤‹†vzƒ~ƒgƒRƒ“ƒhƒŠƒA•af—ĂƒKƒCƒhƒ‰ƒCƒ“‚̍ô’č. •Ä“c@˝, ’†ěł–@, ‚“ˆ@”Ž, ”Ń’Ë‚_1, ‹ŕ“c‘ĺ‘ž, ŒĂ‰ę–ő•q (1_Œo“ŕ): Œúś˜J“­‰ČŠwŒ¤‹†ˆĎ‘ő”ď (“ŤŽžŠłŽŔ—p‰ťŒ¤‹†Ž–‹Ć)uƒ~ƒgƒRƒ“ƒhƒŠƒA•af—Ă‚ĚŽż‚đ‚‚ß‚é, ƒŒƒWƒXƒgƒŠƒVƒXƒeƒ€‚̍\’z, f’fŠî€Ef—ĂƒKƒCƒhƒ‰ƒCƒ“‚̍ô’肨‚ć‚ѐf’fƒVƒXƒeƒ€‚̐Ž”ő‚đs‚¤—Տ°Œ¤‹†v•˝Ź26”N“xˆĎ‘ő‹Ć–ąŹ‰Ę•ń‘ 2015/3; p.22-8.

H26-540003. [‚ť‚Ě‘ź (Œ¤‹†‰ďŽ‘—ż•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹Ću_Œo•ĎŤŽžŠł—Ěˆć‚É‚¨‚Ż‚éŠî”Ő“I’˛¸Œ¤‹†vz‹ŘˆŢkŤ‘¤őd‰ťÇ‚¨‚ć‚Ń‘O“Ş‘¤“ŞŒ^”F’mÇ‚É‚¨‚Ż‚éALS-FTD-Q’˛¸Œ¤‹†. “n•Ó•Ű—T, ‘Ť—§–FŽ÷, źŽR˜a—˜1, ‰Ô“‡—ĽŽq1, ‰Ź–ě”üŒbŽq2, ´…r•v, –Ř‘ş‰p‹I, ‘c•ƒ]Œł, “n•ÓG‹v, ”M“c’źŽ÷, –‘“c“šl, ‹ŔęˆčŽq, Žsě”Ž—Y, ‹g–ě@‰p, ‰Ą“c@C, ’r“c@Šw, ˜aň—BM, –ěŒłłO, Â–ؐłŽu, ’ˇ’JěˆęŽq1, D“c‰ë–ç, ’†“‡Œ’“ń (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹Ću_Œo•ĎŤŽžŠł—Ěˆć‚É‚¨‚Ż‚éŠî”Ő“I’˛¸Œ¤‹†v•˝Ź26”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2015/3; p.64-7.

[’˜@‘]

H16-620001. [Šwp‘ (•Ş’SŽˇ•M)]y–Ú‚ĹŒŠ‚éƒvƒŠƒIƒ“•az”­ÇŽž‚ɍś•s‘S•Đ–ƒáƒ‚đ’ć‚ľ‚˝ƒRƒhƒ“200•ĎˆŮCJD, p.62-3. ˆÉ“Ą”Ž–ž, ŒĂŕV‰p–ž, ‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2, Ö“Ą–L˜a, ˛X–ؐ^‹| (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •Ň: “’ó—´•F, V‹ťˆăŠwo”ĹŽĐ, “Œ‹ž, 2004/7”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H26-713001. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Variability of quadri-pulse stimulation (QPS) induced plasticity: age effect. Hanajima R1, Tanaka N, Tsutsumi R1, Enomoto H, Abe M, Nakamura K, Kobayashi S, Hamada M, Shimizu T, Terao Y, Ugawa Y: 1st International Brain Stimulation Conference (2015/3/2-4), Singapore. (‰Ô“‡—ĽŽq1, ’ç@—Á‰î1: 1_Œo“ŕ)

H26-713002. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Pathological phenotype of I2020T mutant LRRK2 iPSC-derived neurons in the Sagamihara family. Ohta E, Nihira T, Imaizumi Y, Akamatsu W, Nagai M1, Takahashi K, Ohyama M, Mizuno Y, Mochizuki H, Obata F, Okano H: The 12th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2015) (2015/3/19), Nice, France. (‰iˆä^‹MŽq1: 1_Œo“ŕ)


ŒŒ‰t“ŕ‰ČŠw

[Šwp˜_•ś]

110142. [Œ´’˜] Acute leukemia during pregnancy: an investigative survey of the past 11 years. Nakajima Y, Hattori Y, Ito S, Ohshima R, Kuwabara H, Machida S, Shirasugi Y, Miyazaki K1, Sakai R, Tomita N, Ando K, Higashihara M1, Ishigatsubo Y, Fujisawa S: International Journal of Laboratory Hematology 2015/4; 37 (2): 174-80. (‹{č_“ń1, “ŒŒ´ł–ž1: 1ŒŒ‰t“ŕ)

110040. [Œ´’˜] High expression of REV7 is an independent prognostic indicator in patients with diffuse large B-cell lymphoma treated with rituximab. Okina S1, Yanagisawa N2, Yokoyama M1, Sakurai Y1, Numata Y3, Umezawa A3, Higashihara M4, Murakumo Y2: Int J Hematol 2015/12; 102 (6): 662-9. (‰Ľ@‘c˝1, –öŕVM”V2, ‰ĄŽR^Šě1, ŸNˆä–ő‚1, Ŕ“c‰ęŽq3, ”~‘ň“ÖŽq3, “ŒŒ´ł–ž4, ‘ş‰_–FŽ÷2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn, 4ŒŒ‰t“ŕ)

110143. [Œ´’˜] Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia. Miyazaki K1, Koike Y, Kunishima S, Ishii R1, Danbara M1, Horie R1, Yatomi Y, Higashihara M1: Hematology 2015/12; 20 (10): 587-92. (‹{č_“ń1, Îˆä—˛Ži1, ’hŒ´Š˛ś1, –x]—Lję1, “ŒŒ´ł–ž1: 1ŒŒ‰t“ŕ)

[’˜@‘]

620062. [Šwp‘ (•Ş’SŽˇ•M)]y“ŕ‰ČŽžŠł‚̐f’fŠî€E•aŒ^•Ş—ށEdÇ“x (“ŕ‰Č 2015”N6ŒŽ‘‘ĺ†)z<‘ć9Í ŒŒ‰t>@“Á”­ŤŒŒŹ”ÂŒ¸­ŤŽ‡”Á•a, p.1308-10. ‹{č_“ń (ŒŒ‰t“ŕ), “ě]“°, “Œ‹ž, 2015/6”­s.

620063. [Šwp‘ (•Ş’SŽˇ•M)]yAnnual Review ŒŒ‰t 2016zV. ŒŒŹ”ÂŒn@3. ITPŽĄ—Ă‚ĚĹ‘Oü, p.179-90. “ŒŒ´ł–ž1, ‰HŽRŒdˆČ1, ‹{č_“ń1 (1ŒŒ‰t“ŕ), •Ň: ‚‹vŽj–›, ŹŕVŒh–ç, ‹ŕ‘q@÷, Ź“‡¨“ń, –î•y@—T, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2016/1”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713037. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The Tail Mutations of MYH9 Inhibit the Disassembly of Non-muscle Myosin IIA. Miyazaki K1, Komatsu S, Jung HS, Higashihara M1, Craig R, Ikebe M: The 20th Annual Congress of the European Hematology Association (EHA) (2015/6/12), Vienna, Austria. (‹{č_“ń1, “ŒŒ´ł–ž1: 1ŒŒ‰t“ŕ)

713038. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) BLEEDING RISK OF SURGERY IN PATIENTS WITH INHERITED PLATELET FUNCTION DISORDERS (IPFD): OUTCOME OF 389 SURGERIES IN 205 PATIENTS. Gresele P, Noris P, Orsini S, Heller P, Santoro C, Bury L, Rezan K, Mezzano D, Falcinelli E, Butta N, Cid AR, Pozo RJ, Miyazaki K1, Fabris F, Fouassier M, Flaujac C, Ozdemir CN, Otomewo O, Melazzini F, Favier R, Cattaneo M, Bussel J, De Maistre E, Henskens Y, De Candia E, Bermejo N, Schlegel N. On behalf of EHA-SWG on thrombocytopenias and platelet function disorders: 20th Congress of European Hematology Association (EHA) (2015/6/13), Vienna, Austria. (‹{č_“ń1: 1ŒŒ‰t“ŕ)

723058. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ń‚Ü‚ńŤ‘ĺ×–EŤB×–EƒŠƒ“ƒpŽî‚É‚¨‚Ż‚éDNAC•œƒ^ƒ“ƒpƒNREV7”­Œť. ‰Ľ@‘c˝1, –öŕVM”V2, ‰ĄŽR^Šě1, Ŕ“c‰ęŽq3, ”~‘ň“ÖŽq3, ‘ş‰_–FŽ÷2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/4/30), –źŒĂ‰Ž.

723064. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ń‚Ü‚ńŤ‘ĺ×–EŤB×–EƒŠƒ“ƒpŽî‚É‚¨‚Ż‚éDNAC•œƒ^ƒ“ƒpƒNREV7”­Œť‚Ć—\Œă‰đÍ. ‰Ľ@‘c˝1, –öŕVM”V2, ‰ĄŽR^Šě1, ’‡“c“TL2, ”~‘ň“ÖŽq3, Ŕ“c‰ęŽq3, ˆęŒËš–ž2, Ó@˘ˆŽ2, ‘ş‰_–FŽ÷2, “ŒŒ´ł–ž4 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn, 4ŒŒ‰t“ŕ): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8), –źŒĂ‰Ž.


ŒÄ‹zŠí“ŕ‰ČŠw

[Šwp˜_•ś]

110144. [Œ´’˜] Impact of Smoking History on the Efficacy of Gefitinib in Patients with Non-Small Cell Lung Cancer Harboring Activating Epidermal Growth Factor Receptor Mutations. Igawa S1, Sasaki J2, Otani S1, Ishihara M, Takakura A1, Katagiri M3, Masuda N1: Oncology 2015/9; 89 (5): 275-80. (ˆäě@‘1, ˛X–ŘŽĄˆę˜Y2, ‘ĺ’JçŽq1, ‚‘q@W1, •Đ‹Ë^l3, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—ÉqśŠw•”)

110145. [Œ´’˜] Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910. Yamada K, Saito H, Kondo T, Murakami S, Masuda N1, Yamamoto M1, Igawa S1, Katono K1, Takiguchi Y, Iwasawa S, Kurimoto R, Okamoto H, Shimokawa T, Hosomi Y, Takagi Y, Kishi K, Ohba M, Oshita F, Watanabe K: Anticancer Res 2015/12; 35 (12): 6705-11. (‰v“c“TK1, ŽR–{—ĎŽq1, ˆäě@‘1, ă‰“–ěŒ’1: 1ŒÄ‹zŠí“ŕ)

110146. [Œ´’˜] S100A16 is a Prognostic Marker for Lung Adenocarcinomas. Saito K1, Kobayashi M, Nagashio R2, Ryuge S3, Katono K3, Nakashima H4, Tsuchiya B, Jiang SX5, Saegusa M5, Satoh Y4, Masuda N3, Sato Y2: Asian Pac J Cancer Prev 2015; 16 (16): 7039-44. (âV“ĄŒcš1, ’ˇ‰–@—ş2, —´‰ŘTˆę˜Y3, ă‰“–ěŒ’3, ’†“‡—TN4, Ó@˘ˆŽ5, ŽOŽ}@M5, ˛“Ą”Vr4, ‰v“c“TK3, ˛“Ą—Yˆę2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3ŒÄ‹zŠí“ŕ, 4ŒÄ‹zŠíŠO, 5•a—)

110147. [Œ´’˜] Serum Anti-Gal-3 Autoantibody is a Predictive Marker of the Efficacy of Platinum-Based Chemotherapy against Pulmonary Adenocarcinoma. Yanagita K1, Nagashio R2, Ryuge S3, Katono K3, Jiang SX4, Tsuchiya B, Nakashima H5, Fukuda E, Goshima N, Saegusa M4, Satoh Y5, Masuda N3, Sato Y2: Asian Pac J Cancer Prev 2015; 16 (17): 7959-65. (–ö“cŒ›Œá1, ’ˇ‰–@—ş2, —´‰ŘTˆę˜Y3, ă‰“–ěŒ’3, Ó@˘ˆŽ4, , ’†“‡—TN5, ŽOŽ}@M4, ˛“Ą”Vr5, ‰v“c“TK3, ˛“Ą—Yˆę2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3ŒÄ‹zŠí“ŕ, 4•a—, 5ŒÄ‹zŠíŠO)

110148. [Œ´’˜] Clinicopathological Significance of S100A10 Expression in Lung Adenocarcinomas. Katono K1, Sato Y2, Jiang SX3, Kobayashi M, Saito K, Nagashio R2, Ryuge S1, Satoh Y4, Saegusa M3, Masuda N1: Asian Pac J Cancer Prev 2016/2; 17 (1): 289-94. (ă‰“–ěŒ’1, ˛“Ą—Yˆę2, Ó@˘ˆŽ3, ’ˇ‰–@—ş2, —´‰ŘTˆę˜Y1, ˛“Ą”Vr4, ŽOŽ}@M3, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2ˆă—ÉqśŠw•”, 3•a—, 4ŒÄ‹zŠíŠO)

110149. [Œ´’˜] Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer. Fukui T1, Itabashi M, Ishihara M1, Hiyoshi Y1, Kasajima M1, Igawa S1, Sasaki J2, Masuda N1: BMC Cancer 2016/3; 16: 197. (•Ÿˆä•ü–ç1, ÎŒ´–˘ŠóŽq1, “ú‹gNO1, Š}“‡^Žu1, ˆäě@‘1, ˛X–ŘŽĄˆę˜Y2, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

310013. [Ç—á•ń] Successful chemotherapy with carboplatin and nab-paclitaxel for thymic large cell neuroendocrine carcinoma: A case report. Igawa S1, Yanagisawa N2, Niwa H1, Ishihara M1, Hiyoshi Y1, Otani S1, Katono K1, Sasaki J3, Satoh Y4, Masuda N1: Oncol Lett 2015/12; 10 (6): 3519-22. (ˆäě@‘1, –öŕVM”V2, ’O‰H‰p”V1, ÎŒ´–˘ŠóŽq1, “ú‹gNO1, ‘ĺ’JçŽq1, ă‰“–ěŒ’1, ˛X–ŘŽĄˆę˜Y3, ˛“Ą”Vr4, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2•a—, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 4ŒÄ‹zŠíŠO)

320013. [Ç—á•ń] TBLB‚ĆEBUS-TBNA‚Ě•š—p‚ɂĐf’f‚ľ“ž‚˝“ŻŽžŤ‘˝”­”xŠŕ‚Ě1—á. ă‰“–ěŒ’1, Œ´“c^–ç1, “ú‹gNO1, Š}“‡^Žu1, ‹v•Ű“cŸ1, –î“ߐŁM—Y2, ‰v“c“TK1 (1ŒÄ‹zŠí“ŕ, 2ŠĹŒěŠw•”): ‹CŠÇŽxŠw 2015/9; 37 (5): 521-5.

[’˜@‘]

620064. [Šwp‘ (•Ş’SŽˇ•M)]yV”Ĺ ”xŠŕ“ŕ‰Čf—Ăƒ}ƒjƒ…ƒAƒ‹`EBM‚ĆŽŔ—Տ°‚Ě—§ę‚Š‚ç`zIIIÍ ‚ť‚Ě‘ź‚ĚˆŤŤŽîᇁ@3-1. ˆŤŤ‹š–Œ’†”çŽî, 3-2. ‹š‘BŽîĽ‹š‘BŠŕ, p.152-9. ÎŒ´–˘ŠóŽq1, ˆäě@‘1 (1ŒÄ‹zŠí“ŕ), ŠÄC: ŽR–{M”V, •Ň: ÔźO˜N, h’JˆĐm, ŽO‰Y@—, çݎL’m, ˆă–ňƒWƒƒ[ƒiƒ‹, ‘ĺă, 2015/4”­s.

620065. [Šwp‘ (–|–óE•Ş’SŽˇ•M)]yƒŒƒbƒNƒi[ŒÄ‹zŠíŠwzII•Ň: ŒÄ‹zŠíŽžŠłŠłŽŇ‚Ě•]‰ż@14Í Šî–{“I‹š•”fŽ@‚ĚŽŔ‘H‚ƉđŽß, p.125-32. ‹v•Ű“cŸ (ŒÄ‹zŠí“ŕ), ŠÄ–ó: •Ÿ’n‹`”V•, –{ŠÔś•v, ŠŰ‘Po”Ĺ, “Œ‹ž, 2015/4”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722055. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ŒÄ‹z‹@”\ŒŸ¸Žw•W‚Ě–â‘č“_ (V‚ľ‚˘łí’l‚â‚ś‚ń”x–@‚Ć‚ĚŠÖ˜A‚đŠÜ‚ß‚Ä). ‹v•Ű“cŸ (ŒÄ‹zŠí“ŕ): ‘ć55‰ń“ú–{ŒÄ‹zŠíŠw‰ďŠwpu‰‰‰ď (2015/4/18), “Œ‹ž.

722056. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‰‰ńŽĄ—Ă‚É‚¨‚Ż‚éEGFR-TKI‚ĚŽg‚˘•Ş‚Ż. ˆäě@‘ (ŒÄ‹zŠí“ŕ): ‘ć56‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2015/11/26), ‰Ą•l.

723268. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠis”xŠŕ‚ɑ΂ˇ‚鉝Šw•úŽËü—Ă–@Œř‰Ę‚ĚEGFRˆâ“`Žq•ĎˆŮ‚Ě—L–ł‚Ĺ‚Ě”äŠr. ÎŒ´–˘ŠóŽq, ˆäě@‘1, –Ř‘ş”ü’qŽq, Š}“‡^Žu1, “ú‹gNO1, ‘ĺ’JçŽq1, ă‰“–ěŒ’1, —´‰ŘTˆę˜Y1, •Ÿˆä•ü–ç1, ŽO“Ą@‹v2, ‹v•Ű“cŸ1, ˛X–ŘŽĄˆę˜Y3, ‰v“c“TK1 (1ŒÄ‹zŠí“ŕ, 2ŠĹŒěŠw•”, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć55‰ń“ú–{ŒÄ‹zŠíŠw‰ďŠwpu‰‰‰ď (2015/4/17), ‹ž“s.

723269. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒGƒNƒ\ƒ][ƒ€ŠÜ—L’`”’Žż‚đ–ƉuŒš‚ɍ쐻‚ľ‚˝R‘Ě‚Ě”x‘BŠŕ‚É‚¨‚Ż‚錌´f’fƒ}[ƒJ[‚Ć‚ľ‚Ä‚Ě—L—pŤ‚ɂ‚˘‚Ä. ’ˇ‰–@—ş, –ö“cŒ›Œá, ”Ť‘ş˜a’j, —´‰ŘTˆę˜Y1, Ó@˘ˆŽ2, ’†“‡—TN3, “y‰Žg, ‘ş‰_–FŽ÷2, ŽOŽ}@M2, ˛“Ą—Yˆę (1ŒÄ‹zŠí“ŕ, 2•a—, 3ŒÄ‹zŠíŠO): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/4/30), –źŒĂ‰Ž.

723270. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒgƒŠƒVƒ“2ŽŸŒł“d‹C‰j“Ž–@‚É‚ć‚čŠl“ž‚ľ‚˝S100A16ƒ^ƒ“ƒpƒNŽż‚̐V‹K”x‘BŠŕ—\Œă—\‘ރ}[ƒJ[‚Ć‚ľ‚Ä‚Ě—L—pŤ. Ä“ĄŒc‘ż, Ź—с@M, ’ˇ‰–@—ş, ”Ť‘ş˜a’j, ‰v“c“TK1, ˛“Ą”Vr2, Ó@˘ˆŽ3, ‘ş‰_–FŽ÷3, ŽOŽ}@M3, ˛“Ą—Yˆę (1ŒÄ‹zŠí“ŕ, 2ŒÄ‹zŠíŠO, 3•a—): ‘ć104‰ń“ú–{•a—Šw‰ď‘‰ď (2015/5/1), –źŒĂ‰Ž.

723271. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”A“ŏǐŤ‹š–Œ‰Š‚É‚¨‚Ż‚é‹ÇŠ–ƒŒ‰ş‹šo‹žŒŸ¸‚ĚˆÓ‹`. •Ÿˆä•ü–ç1, ŽO“Ą@‹v2, ÎŒ´–˘ŠóŽq, Š}“‡^Žu1, “ú‹gNO1, ‘ĺ’JçŽq1, ă‰“–ěŒ’1, ‚‘q@W1, ˆäě@‘1, ‰Ąęł“T3, ‹v•Ű“cŸ1, •Đ‹Ë^l3, –î“ߐŁM—Y2, ‰v“c“TK1 (1ŒÄ‹zŠí“ŕ, 2ŠĹŒěŠw•”, 3ˆă—ÉqśŠw•”): ‘ć38‰ń“ú–{ŒÄ‹zŠí“ŕŽ‹‹žŠw‰ďŠwpW‰ď (2015/6/12), “Œ‹ž.

723272. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Evaluation of gefitinib efficacy according to body surface area in patients with NSCLC harboring an EGFR mutation. Š}“‡^Žu1, ˆäě@‘1, ÎŒ´–˘ŠóŽq, –Ř‘ş”ü’qŽq, “팴­ˆę˜Y1, Œ´“c^–ç1, ‘ĺ’JçŽq1, ă‰“–ěŒ’1, ˛X–ŘŽĄˆę˜Y2, ‰v“c“TK1 (1ŒÄ‹zŠí“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć13‰ń“ú–{—Տ°Žîᇊw‰ďŠwpW‰ď (2015/7/18), ŽD–y.

723273. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰ťŠw—Ă–@–˘Ž{s‚—îŽŇispŒăÄ”­”xG•˝ă”çŠŕ‚ɑ΂ˇ‚éƒlƒ_ƒvƒ‰ƒ`ƒ“’PÜ—Ă–@‚Ě‘ćII‘ŠŽŽŒą. ‘ž—Ç“N•F, h’JˆĐl, ŽO‰Y@—, Ź•éŒ[l, ˆäě@‘1, ŽR–{M”V, ‚‹´—˜–ž (1ŒÄ‹zŠí“ŕ): ‘ć56‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2015/11/28), ‰Ą•l.

733101. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œ¸Š´ě—Ă–@‚É‚ć‚莥—ĂŒp‘ą‚މ”\‚Ć‚Č‚Á‚˝ƒAƒŒƒNƒ`ƒjƒu‚É‚ć‚é–ň]‚Ěˆę—á. ”’ŕVš”V1, ‹v•Ű“cŸ1, ’O‰H‰p”V1, ‚‘q@W1, ‰Ąęł“T2, –î“ߐŁM—Y3, ‰v“c“TK1, “n‘\@W (1ŒÄ‹zŠí“ŕ, 2ˆă—ÉqśŠw•”, 3ŠĹŒěŠw•”): ‘ć174‰ń“ú–{”xŠŕŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2015/12/5), “Œ‹ž.

733102. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘˝‘ŸŠí‚É•a•Ď‚đ—L‚ľ‹}Ť‘ˆŤ‚đ—ˆ‚ľ‚˝ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ě1—á. ”’ŕVš”V1, ’†Œ´‘P˜N1, ‘O‘şŒ’ŽĄ, Œ´“c^–ç1, ’O‰H‰p”V1, ÎŒ´–˘ŠóŽq, Š}“‡^Žu1, “ú‹gNO1, ‹v•Ű“cŸ1, ‰v“c“TK1 (1ŒÄ‹zŠí“ŕ): ‘ć621‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (2016/2/13), “Œ‹ž.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-110008. [Œ´’˜] Prognostic significance of MYH9 expression in resected non-small cell lung cancer. Katono K1, Sato Y2, Jiang SX3, Kobayashi M, Nagashio R2, Ryuge S1, Fukuda E, Goshima N, Satoh Y4, Saegusa M3, Masuda N1: PLoS One 2015/3; 10 (3): e0121460. (ă‰“–ěŒ’1, ˛“Ą—Yˆę2, Ó@˘ˆŽ3, ’ˇ‰–@—ş2, —´‰ŘTˆę˜Y1, ˛“Ą”Vr4, ŽOŽ}@M3, ‰v“c“TK1: 1ŒÄ‹zŠí“ŕ, 2ˆă—ÉqśŠw•”, 3•a—, 4ŒÄ‹zŠíŠO)


“ŕ•Ş”ĺ‘ăŽÓ“ŕ‰ČŠw

[Šwp˜_•ś]

110150. [Œ´’˜] Regulation of growth hormone secretion by (pro)renin receptor. Tani Y1, Yamada S, Inoshita N, Hirata Y, Shichiri M1: Sci Rep 2015/6; 5: 10878. (’J@—SŽŠ1, Žľ—˘áÁ‹`1: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ)

110151. [Œ´’˜] SGLT2 inhibitors provide an effective therapeutic option for diabetes complicated with insulin antibodies. Hayashi A1, Takano K1, Kawai S1, Shichiri M1: Endocr J 2016/2; 63 (2): 187-91. (—с@“N”Í1, ‚–ěK˜H1, ‰Í‡š—FŠó1, Žľ—˘áÁ‹`1: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ)

110152. [Œ´’˜] Contrasting effects of stanniocalcin-related polypeptides on macrophage foam cell formation and vascular smooth muscle cell migration. Yamamoto K, Tajima Y, Hasegawa A, Takahashi Y, Kojima M, Watanabe R, Sato K, Shichiri M1, Watanabe T: Peptides 2016/8; 82: 120-7. (Žľ—˘áÁ‹`1: 1“ŕ•Ş”ĺ‘ăŽÓ“ŕ)

120012. [Œ´’˜] VŠî€GDM”D•w‚ɑ΂ˇ‚錌“œŽŠŒČ‘Ş’č (SMBG) “ą“ü‚Ě—L‰vŤ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. Žsě—‹Žt1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): “œ”A•a‚Ć”DP, 2016; 16 (1): 11-6.

320014. [Ç—á•ń] Žö“ű‚É‚ć‚錌“œ’ቺ‚đCGM‚ĹŠm”F‚ľ“ž‚˝CSIIŽg—p’†1Œ^“œ”A•a‚Ě2Ç—á. “‰€@–ž1, Žsě—‹Žt1, ‰Í‡š—FŠó1, ŻŽRˆťŽq1, ˆäăŒőŽq1, —é–Ř—z•F1, ł–ŘŽkl1, ‚ˆä‹vm—f1, ŽRŠÝ‹M—m1, Źě“Ő˜Y1, —с@“N”Í1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): “œ”A•a‚Ć”DP 2016; 16 (1): 66-71.

[’˜@‘]

620066. [Šwp‘ (•Ş’SŽˇ•M)]y“ěŽR“°ˆăŠw‘厍“T ‘ć20”Łz‚”AŽ_ŒŒÇ, ‘ź, p.816, ‘ź. Žľ—˘áÁ‹` (“ŕ•Ş”ĺ‘ăŽÓ“ŕ), “ěŽR“°, “Œ‹ž, 2015/4”­s.

620067. [Šwp‘ (•Ş’SŽˇ•M)]y‚â‚ł‚ľ‚˘äXEÁ‰ťŠÇ_Œo“ŕ•Ş”ĺŽîᇠ–ň•¨ŽĄ—Ă‚Ö‚ĚƒAƒvƒ[ƒ`zII. ‰uŠwEf’f@2. äXEÁ‰ťŠÇ_Œo“ŕ•Ş”ĺŽîᇂ̗Տ°Çó‚Ɛf’f, p.16-24. ‚–ěK˜H (“ŕ•Ş”ĺ‘ăŽÓ“ŕ), •Ň: ‰œâ‘ńŽu, ˆă–ňƒWƒƒ[ƒiƒ‹, ‘ĺă, 2015/5”­s.

620068. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̏ŹŽ™ŽĄ—ĂŽwj (‘ć16”Ĺ)z7. “ŕ•Ş”厞Šł@ƒgƒ‰ƒ“ƒWƒVƒ‡ƒ“Šú‚̉ş‚‘Ě‹@”\’ቺÇ‚Ć•›t‰ßŒ`ŹÇ‚ĚŽĄ—Ă, p.260-1. ‚–ěK˜H (“ŕ•Ş”ĺ‘ăŽÓ“ŕ), ‘•ŇW: …Œű@‰ë, Žs‹´@Œő, čŽR@O, ˆăŠw‘‰@, “Œ‹ž, 2015/9”­s.

620069. [Šwp‘ (•Ş’SŽˇ•M)]yƒNƒbƒVƒ“ƒOÇŒóŒQf—Ăƒ}ƒjƒ…ƒAƒ‹ ‰ü’ů‘ć2”ŁzIII. —Տ°•Ň (Še˜_)@A. ACTHˆË‘śŤƒNƒbƒVƒ“ƒOÇŒóŒQ@4. ƒNƒbƒVƒ“ƒO•a‚ĚŠÖ˜AŽžŠł@f. ˆâ“`ŤƒNƒbƒVƒ“ƒOÇŒóŒQ (MEN, MAS), p.133-5. ‚–ěK˜H (“ŕ•Ş”ĺ‘ăŽÓ“ŕ), •Ň: •˝“cŒ‹Šě, ŹŁŒő‰h, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/12”­s.

620070. [Šwp‘ (•Ş’SŽˇ•M)]yƒNƒbƒVƒ“ƒOÇŒóŒQf—Ăƒ}ƒjƒ…ƒAƒ‹ ‰ü’ů‘ć2”ŁzIII. —Տ°•Ň (Še˜_)@B. ACTH”ńˆË‘śŤƒNƒbƒVƒ“ƒOÇŒóŒQ@4. ƒNƒbƒVƒ“ƒOÇŒóŒQ‚ĚŠÖ˜AŽžŠł@c. PPNAD, p.213-5. ‚–ěK˜H (“ŕ•Ş”ĺ‘ăŽÓ“ŕ), •Ň: •˝“cŒ‹Šě, ŹŁŒő‰h, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/12”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

723274. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) dÇŹlŹ’ˇƒzƒ‹ƒ‚ƒ“•Ş”ĺ•s‘SÇ‚ɑ΂ˇ‚鐏’ˇƒzƒ‹ƒ‚ƒ“•â[—Ă–@‚É‚ć‚éˆŔĂŽž‘ăŽÓ—Ę, ‘Ě‘gŹ•Ď‰ť‚ĚŒŸ“˘. —с@“N”Í1, ‚–ěK˜H1, “‰€@–ž1, ‰Í‡š—FŠó1, ŠCŁˆťŽq1, ˆäăŒőŽq1, —é–Ř—z•F1, Žsě—‹Žt1, Š™“c—T“ń1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć88‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwp‘‰ď (2015/4/23-25), “Œ‹ž, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ 2015/4; 91 (1): 268.

723275. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) 2‰ń‚ĚŽŠ‘R”DP•Ş•Ř‚đŒoŒą‚ľ‚˝‰–—Ţ‘rŽ¸Œ^ć“VŤ•›t‰ßŒ`Ź‚Ě1—á. ˆäăŒőŽq1, Š™“c—T“ń1, —é–Ř—z•F1, –öŕV^ŽŔ1, —с@“N”Í1, Žsě—‹Žt1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć88‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwp‘‰ď(2015/4/23-25), “Œ‹ž, 2015/4; 91 (1): 339.

723276. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “Ż‘¤•›t‚ɃAƒ‹ƒhƒXƒeƒƒ“ŽYś‘BŽî (APA) ‚Ćaldosterone-producing cell cluster (APCC) ‚đ”F‚ß‚˝Œ´”­ŤƒAƒ‹ƒhƒXƒeƒƒ“Ç (PA) ‚ɃRƒ‹ƒ`ƒ][ƒ‹‰ßč•Ş”ĺ‚𔺂Á‚˝1—á. ‰Í‡š—FŠó1, ŽRŠÝ‹M—m1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć88‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwp‘‰ď (2015/4/23-25), “Œ‹ž, 2015/4; 91 (1): 365.

723277. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒCƒ“ƒXƒŠƒ“—Ă–@Ž{s’†‚̔얞‡•š2Œ^“œ”A•a‚ɑ΂ˇ‚éƒ_ƒpƒOƒŠƒtƒƒWƒ“‚ĚŒř‰Ę‚đ‚Ý‚˝2—á. Vˆä—œˆß“ß1, —с@“N”Í1, ŽRŠÝ‹M—m1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć88‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwp‘‰ď (2015/4/23-25), “Œ‹ž, 2015/4; 91 (1): 392.

723278. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) dÇŹlŹ’ˇƒzƒ‹ƒ‚ƒ“•Ş”ĺ•s‘SÇ‚ɑ΂ˇ‚鐏’ˇƒzƒ‹ƒ‚ƒ“•â[—Ă–@‚É‚ć‚é“œ‘ăŽÓEŽ‰Žż‘ăŽÓ•Ď‰ť‚ĚŒŸ“˘. ‚–ěK˜H1, —с@“N”Í1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć58‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2015/5/21-24), ‰şŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-228.

723279. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽYŒă‚Ě“œ‘ăŽÓˆŮí‚Ě•]‰ż‚Í75gOGTT‚ł悢‚Š`Continuous Glucose Monitoring (CGM) ‚É‚ć‚錟“˘`. ˛X–ŘŽŃ–ç‰Á1, —с@“N”Í1, ŠCŁˆťŽq1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć58‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2015/5/21-24), ‰şŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-274.

723280. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) CGM‚đ—p‚˘‚˝“œ‘ăŽÓˆŮí‡•š”D•w‚̐HŒăŒŒ“œpeakŽžŠÔ‚ĚŒŸ“˘`łí‘Ď“œ”\”D•w‚Ć‚Ě”äŠr`. –öŕV^ŽŔ1, —с@“N”Í1, ˛X–ŘŽŃ–ç‰Á1, ‹g–쉑”ü2, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć58‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2015/5/21-24), ‰şŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-274.

723281. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒCƒ“ƒXƒŠƒ“—Ă–@’†‚̔얞2Œ^“œ”A•a5—á‚Ö‚Ěƒ_ƒpƒOƒŠƒtƒƒWƒ“‚ĚŒŒ“œ•Ď“ŽE‘Ě‘gŹ•Ď‰ťE”A“œ”rŸ•—ʕωť‚ĚŒŸ“˘. ŽRŠÝ‹M—m1, Vˆä—œˆß“ß1, —с@“N”Í1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć58‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2015/5/21-24), ‰şŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-296.

723282. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚—p—ĘSU–ňŽg—pŠłŽŇ‚É‚¨‚Ż‚é, ƒŒƒpƒOƒŠƒjƒh‚𒆐S‚Ć‚ľ‚˝ƒƒgƒzƒ‹ƒ~ƒ“, ƒrƒ‹ƒ_ƒOƒŠƒvƒ`ƒ“‚Ě•š—pŽĄ—Ă‚Ö‚Ě•ĎX‚ÉŠÖ‚ˇ‚é52TŠÔ‚ĚŒŸ“˘. ‰Í‡š—FŠó1, —с@“N”Í1, ‚ˆä‹vm—f1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć58‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2015/5/21-24), ‰şŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-299.

723283. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) CGM‚Ĺ–ž‚ç‚Š‚Ć‚Č‚Á‚˝“œ”A•aŒŒ‰t“§ÍŠłŽŇ‚ĚŒŒs“Ž‘Ô‚Ě“Á’Ľ. —с@“N”Í1, —é–Ř—z•F1, ł–ŘŽkl1, ‚ˆä‹vm—f1, Źě“Ő˜Y1, ŹěŒ°Žj2, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć58‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2015/5/21-24), ‰şŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-329.

723284. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’ጌ“œ‚đŽĺ‘i‚É–k—˘‘ĺŠw•a‰@‚đ‹Ů‹}Žóf‚ľ‚˝ŠłŽŇ‚Ě‹ß”N‚Ě—Ő°“I“Á’Ľ. ‘ş“cH•ä1, —с@“N”Í1, “‰€@–ž1, ˆäăŒőŽq1, ç“cŤ”n1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć58‰ń“ú–{“œ”A•aŠw‰ď”NŽŸŠwpW‰ď (2015/5/21-24), ‰şŠÖ, “œ”A•a 2015/4; 58 (Suppl 1): S-448.

723285. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚ĹŒoŒą‚ľ‚˝Rbó‘B–ň‚É‚ć‚é–łč÷—ą‹…Ç‚Ě—Ő°“I“Á’Ľ. ŻŽRˆťŽq1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć58‰ń“ú–{bó‘BŠw‰ďŠwpW‰ď (2015/11/5-7), •Ÿ“‡, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 2015; 91 (Suppl): 91.

723286. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) 2Œ^“œ”A•a‡•š”D•w‚Ě•Ş•Ř‘OŒă‚ĚƒCƒ“ƒXƒŠƒ“Žů—v—ʂ̕ωť. Žsě—‹Žt1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć31‰ń“ú–{“œ”A•aE”DPŠw‰ď”NŽŸŠwpW‰ď (2015/11/20-21), “Œ‹ž, “œ”A•a‚Ć”DP 2015/10; 15 (2): S72.

723287. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽYŒă‚Ě“œ‘ăŽÓˆŮí‚Ě•]‰ż‚Ć‚ľ‚ăOƒŠƒRƒAƒ‹ƒuƒ~ƒ“‚Ě—L—pŤ`CGM‚É‚ć‚錟“˘`. ˛X–ŘŽŃ–ç‰Á1, —с@“N”Í1, “‰€@–ž1, ‰Í‡š—FŠó1, ‰Ťčiˆę˜Y1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć31‰ń“ú–{“œ”A•aE”DPŠw‰ď”NŽŸŠwpW‰ď (2015/11/20-21), “Œ‹ž, “œ”A•a‚Ć”DP 2015/10; 15 (2): S85.

723288. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”A•öÇ‚Ě’ˇŠúŒo‰ßŠĎŽ@’†‚ÉˆĆă•a•Ď‚Ş‹}‘Ź‚É‘‘ĺ‚ľ‚˝ˆę—á. “‰€@–ž1, ł–ŘŽkl1, ˆäăŒőŽq1, ç“cŤ”n1, —с@“N”Í1, ‰Ťčiˆę˜Y1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1, ˆä‰şŽŽq, ŽR“cłŽO (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć25‰ń—Տ°“ŕ•Ş”ĺ‘ăŽÓUpdate (2015/11/27-28), “Œ‹ž, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 2015; 91: 788.

723289. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •ĎŒ`ŤŒŇŠÖßÇ‚Ĺ”­ŒŠ‚ł‚ę‚˝‰Ć‘°Ť‰ş‚‘Ě‘BŽî‚Ş‹^‚í‚ę‚é1—á. ˆäăŒőŽq1, Žsě—‹Žt1, ‰Í‡š—FŠó1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć25‰ń—Տ°“ŕ•Ş”ĺ‘ăŽÓUpdate (2015/11/27-28), “Œ‹ž, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 2015; 91: 789.

723290. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “Ť–ŤäX‰Š‹}Ť‘ˆŤ‚É‚ć‚éäX‰tᑂđ”F‚ß‚˝MEN1Œ^‚Ěˆę—á. “cŒű@•ü1, ç“cŤ”n1, Vˆä—œˆß“ß1, ‘ş“cH•ä1, ‰Í‡š—FŠó1, “‰€@–ž1, ˆäăŒőŽq1, ł–ŘŽkl1, —с@“N”Í1, ‰Ťčiˆę˜Y1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć25‰ń—Տ°“ŕ•Ş”ĺ‘ăŽÓUpdate (2015/11/27-28), “Œ‹ž, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 2015; 91: 833.

723291. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ű`•Ş”ĺ•s‘S‚đŒ_‹@‚ɐf’f‚ł‚ę‚˝ƒŠƒ“ƒp‹…Ť‰ş‚‘̉Š‚Ě1—á. Vˆä—œˆß“ß1, Š™“c—T“ń1, —é–Ř—z•F1, ŽRŠÝ‹M—m1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć25‰ń—Տ°“ŕ•Ş”ĺ‘ăŽÓUpdate (2015/11/27-28), “Œ‹ž, “ú–{“ŕ•Ş”ĺŠw‰ďŽGŽ, 2015; 91: 844.

723292. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) RathkeůN–E‚Ć‚ĚŠÓ•Ę‚É‹ę—ś‚ľ‚˝, “ŞŠWˆô“ŞŽîEŠáâ|ć’[•”Ž‹_Œo‰Š‚̍‡•š—á. ł–ŘŽkl1, ‚–ěK˜H1, ŽR“cłŽO, ˆä‰şŽŽq (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć26‰ń“ú–{ŠÔ”]‰ş‚‘ĚŽîᇊw‰ď (2016/2/19-20), •Ÿ“‡.

732045. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) 1Œ^“œ”A•aCSIIÇ—á‚É‚¨‚Ż‚éŽö“ű’†‚ĚŒŒ“œ“Ž‘Ô. Žsě—‹Žt1, “‰€@–ž1, —с@“N”Í1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć21‰ń“ú–{ŹŽ™EŽvtŠú“œ”A•aŒ¤‹†‰ď”NŽŸŠwpW‰ď (2015/7/12), “Œ‹ž, ‘ć21‰ń“ú–{ŹŽ™EŽvtŠú“œ”A•aŒ¤‹†‰ď”NŽŸŠwpW‰ďƒvƒƒOƒ‰ƒ€Eu‰‰—vŽ| 2015; p.21-2.

733103. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒWƒAƒ]ƒLƒTƒCƒh‚Ĺ”ÄŒŒ‹…Œ¸­‚đ‚Ť‚˝‚ľ‚˝ƒCƒ“ƒXƒŠƒm[ƒ}‚Ě1—á. Ź–ě‘ו˝, ç“cŤ”n1, ˛X–ŘŽŃ–ç‰Á1, ŠCŁˆťŽq1, ŽRŠÝ‹M—m1, ‰Ťčiˆę˜Y1, Žsě—‹Žt1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ)F‘ć615‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď—á‰ď (2015/6/13), “Œ‹ž.

733104. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) 2Œ^“œ”A•a‚đ”wŒi‚ɍ‚—î‚Ĺ”­Ç‚ľ‚˝bó‘BŽŠŒČR‘Ě—zŤ, Œ€Ç1Œ^“œ”A•a‚Ě1—á. Vˆä—œˆß“ß1, Žsě—‹Žt1, ‹ŕ‘ň@, ŠCŁˆťŽq1, “‰€@–ž1, —é–Ř—z•F1, —с@“N”Í1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć32‰ń_“Ţě“œ”A•aŒ¤‹†‰ď (2015/6/27), ‰Ą•l.

733105. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) RathkeůN–E‚Ć‚ĚŠÓ•Ę‚É‹ę—ś‚ľ‚˝, “ŞŠWˆô“ŞŽîEŠáâ|ć’[•”Ž‹_Œo‰Š‚̍‡•š—á. ł–ŘŽkl1, ‚–ěK˜H1, “cŒű@•ü1, ‰Í‡š—FŠó1, “‰€@–ž1, Š™“c—T“ń1, ˆä‰şŽŽq, ŽR“cłŽO, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć16‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠÖ“ŒbM‰zŽx•”ŠwpW‰ď (2015/9/25-26), –‹’Ł.

733106. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ˜•”Ň’ŒŠÇ‹ˇóÇ‚É‚ć‚čŒ°Ť‰ť‚ľ, •‰‰×ŽŽŒą‚Ćˆâ“`ŽqŒŸő‚ĹŠm’čf’f‚Ĺ‚Ť‚˝‚—îŽŇGitelmanÇŒóŒQ‚Ě1—á. ˆäăŒőŽq1, —с@“N”Í1, “‰€@–ž1, Š™“c—T“ń1, ‚–ěK˜H1, –ě’ĂŠ°‘ĺ, ”Ń“‡ˆę˝, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć16‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠÖ“ŒbM‰zŽx•”ŠwpW‰ď (2015/9/25-26), –‹’Ł.

733107. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‹‘ĺ‘BŽî—lbó‘BŽî‚É‚ć‚č‹C“š‹ˇó‚đ—ˆ‚ľ‚˝1Œ^“œ”A•a‡•šŽŠŒČ–ƉuŤ‘˝“ŕ•Ş”ĺ‘BÇŒóŒQ‚Ě1—á. Źă–ž—˘ŠG, “cŒű@•ü1, —с@“N”Í1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć619‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď—á‰ď (2015/11/14), “Œ‹ž.

733108. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) 2Œ^“œ”A•a‚đ”wŒi‚ɍ‚—î‚Ĺ”­Ç‚ľ‚˝bó‘BŽŠŒČR‘Ě—zŤ, Œ€Ç1Œ^“œ”A•a‚Ě1—á. Vˆä—œˆß“ß1, Žsě—‹Žt1, ŠCŁˆťŽq1, —é–Ř—z•F1, —с@“N”Í1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć53‰ń“ú–{“œ”A•aŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/1/23), ‰Ą•l.

733109. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒ‰ƒ“ƒŒƒIƒ`ƒh‚É‚ć‚éƒCƒ“ƒXƒŠƒ“•Ş”ĺ’ቺ, ‚ŒŒ“œ‚đ”F‚ß‚˝ć’[‹‘ĺÇ‚Ě1—á. –öŕV^ŽŔ1, ˆäăŒőŽq1, ‰Í‡š—FŠó1, “‰€@–ž1, Š™“c—T“ń1, ‚–ěK˜H1, Žľ—˘áÁ‹`1 (1“ŕ•Ş”ĺ‘ăŽÓ“ŕ): ‘ć53‰ń“ú–{“œ”A•aŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/1/23), ‰Ą•l.


t‘Ÿ“ŕ‰ČŠw

[Šwp˜_•ś]

110153. [Œ´’˜] Curative haploidentical BMT in a murine model of X-linked chronic granulomatous disease. Takeuchi Y1, Takeuchi E2, Ishida T, Onodera M, Nakauchi H, Otsu M: Int J Hematol 2015; 102 (1): 111-20. (’|“ŕN—Y1, ’|“ŕŒb”üŽq2: 1t‘Ÿ“ŕ, 2–Ɖu)

110154. [Œ´’˜] Incidence and clinical significance of anti-moesin autoantibodies in small-vessel vasculitis. Murano J1, Kamata K1, Naito S1, Okamoto T1, Kamata M1, Okina C1, Sano T1, Takeuchi Y1, Aoyama T1: Kitasato Med J 2015/9; 45 (2): 105-13. (‘ş–ě‡–ç1, Š™“cvšć1, “ŕ“Ął‹g1, ‰Ş–{’qŽq1, Š™“c^—Žq1, ‰ĽçŽq1, ˛–ě@—˛1, ’|“ŕN—Y1, ÂŽR“ŒŒÜ1: 1t‘Ÿ“ŕ)

120013. [Œ´’˜] tŽžŠł‚É‚¨‚Ż‚é”DPŠÇ—|–Ťt‘Ÿ•a (CKD) ŠłŽŇ‚Ě”DP‚ƏoŽY34—á‚ĚŒoŒą|. Š™“cvšć1, “V–ě@ŠŽ2, ’|“ŕN—Y3, ’ˇę@‘×3, ˛–ě@—˛3, ÂŽR“ŒŒÜ3, “Ą“c˜aŒČ, ´…Œ’Žj, –q–앐Žu, ‹´–{ƒqƒƒR3, ’†–ě‘fŽq, “ŕ“Ął‹g3, ‰Ş–{’qŽq3, ‘ş–ě‡–ç3, ‰ĽçŽq3, Š™“c^—Žq3, ‹{ŕVšŽq, Źě‚Ý‚ä‚Ť4, ŽđˆäŒ’Žj3, Š™“c•‡”ü3 (1‘Š–Í‘ĺ–ě“ŕ‰ČEtƒNƒŠƒjƒbƒN, 2ŽY‰Č, 3t‘Ÿ“ŕ, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): t‚Ć“§Í 2015/11; 79 (5): 782-5.

120014. [Œ´’˜] “§Í“ą“üŠú‚É‚¨‚Ż‚éƒNƒGƒ“Ž_‘ć“ń“S…˜a•¨ (ƒŠƒIƒiŇ) ‚ĚƒŠƒ“ŠÇ—‚¨‚ć‚Ń•nŒŒ‚ɑ΂ˇ‚é—Տ°Œř‰Ę. ’ˇę@‘×1,2, ‘ş–ě‡–ç1,2, Š™“c^—Žq1,2, “‡“c–F—˛1,2, –q–앐Žu, ’ˇę@G, –ěXŒű”ŽŽj1, “‡“c@”Ł (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2t‘Ÿ“ŕ): V–ň‚Ć—Ő° 2015/9; 64(9): 983-9.

220005. [€Œ´’˜] ŒŠ‚鎉Žż‚Ěƒy[ƒWqŽ‰Žż‘ăŽÓˆŮírLCATŒ‡‘šÇ‚ĚŠp–ŒŠŒŠ‚Ɛt‘gD•a•Ď‚Ě“Á’Ľ. “ŕ“Ął‹g1, Š™“cvšć1 (1t‘Ÿ“ŕ): The Lipid 2015/4; 26 (2): 96-9.

320015. [Ç—á•ń] ŒŒ‰t“§Í“ą“üŽž‚É‚Ý‚ç‚ę‚˝‹UŤ”xÇđÇ‚𔺂¤ƒwƒpƒŠƒ“‹NˆöŤŒŒŹ”ÂŒ¸­Ç (HIT) ‚Ě1—á. “n˜đ—œŽŃŽq1, ÂŽR“ŒŒÜ1, Š™“c^—Žq1, ‹{ŕVšŽq1, Źě‚Ý‚ä‚Ť2, ‰ĽçŽq, ‘ş–ě‡–ç1, “c’†@Œ\, ÂŽR‰ë‘Ľ, ’†–ě‘fŽq, ˛–ě@—˛1, Š™“cvšć1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{t‘ŸŠw‰ďŽ 2015/10; 57 (7): 1248-52.

320016. [Ç—á•ń] ŒŒŤ‹š…‚đ’ć‚ľ‹šo‹ž‰ş‹š–ŒśŒŸ‚É‚Ä”A“ŏǐŤ‹š–Œ‰Š‚Ɛf’f‚ľ‚˝ˆŰŽŒŒ‰t“§ÍŠłŽŇ‚Ě3—á. ˛–ě@—˛1, ‚‹´@—É1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1, ‚‘q@W3, ŽO“Ą@‹v4, Š™“cvšć5 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŒÄ‹zŠí“ŕ, 4ŠĹŒěŠw•”, 5‘Š–Í‘ĺ–ě“ŕ‰ČEtƒNƒŠƒjƒbƒN): “§Í‰ďŽ 2016/3; 49 (3): 233-9.

522095. [uŔ] yŒŠ‚鎉Žż‚Ěƒy[ƒW <Ž‰Žż‘ăŽÓˆŮí>zLCATŒ‡‘šÇ‚ĚŠp–ŒŠŒŠ‚Ɛt‘gD•a•Ď‚Ě“Á’Ľ. “ŕ“Ął‹g1, Š™“cvšć1 (1t‘Ÿ“ŕ): The Lipid 2015/4; 26 (2): 4-7.

522096. [uŔ] ˆÚAŠłŽŇ‚ւ̉h—{Žw“ą‚̏d—vŤ|“ŕ‰Čˆă‚Ě—§ę‚Š‚ç|. “ŕ“Ął‹g1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ): Current Issues in Nutriton 2015; 28: 3-4.

522097. [uŔ]y“ÁW: “d‰đŽż‚̐V‚ľ‚˘ŒŠ•űEl‚Ś•űz [Ž_‰–Šîƒoƒ‰ƒ“ƒX‚Ć“d‰đŽżˆŮí]@‘ăŽÓŤƒAƒVƒh[ƒVƒX‚ĆƒJƒŠƒEƒ€ˆŮí. –ěXŒű”ŽŽj1, ’ˇę@‘×1,2, “‡“c–F—˛1,2, “‡“c@”Ł (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2t‘Ÿ“ŕ): t‚Ć“§Í 2016/3; 80 (3): 375-8.

[Šw‰ďEŒ¤‹†‰ď“™]

713039. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The Glomerular Parietal Epithelial Cell Phenotype Depends On SPARC Levels. Naito S1: American Society of Nephrology (ASN) Kidney Week 2015 ( 2015/11/5), San Diego, USA. (“ŕ“Ął‹g1: 1t‘Ÿ“ŕ)

723293. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –Ťt‘Ÿ•a (CKD) ŠłŽŇ‚É‚¨‚Ż‚éFebuxostat‚ĚŒř‰Ę‚ɂ‚˘‚Ä. ł–Ř‹M‹ł1, ÂŽR“ŒŒÜ1, ‚‹´@—É1, “‡“c–F—˛1, ‹{ŕVšŽq1, ‰Ş–{’qŽq1, “ŕ“Ął‹g1, ˛–ě@—˛1, ’|“ŕN—Y1, Š™“cvšć2 (1t‘Ÿ“ŕ, 2‘Š–Í‘ĺ–ě“ŕ‰ČEtƒNƒŠƒjƒbƒN): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/5), –źŒĂ‰Ž, 2015/4; 57 (3): 525.

723294. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –Ťt‘Ÿ•a (CKD) ‚̐t‹@”\áŠQis‚É”ş‚¤‘㏾ŤtK”rŸ•”\‚Ě‘˝—lŤ. Źě‚Ý‚ä‚Ť1, â–{Ž“o2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—Ă‹Zp‹łˆç): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/5), –źŒĂ‰Ž, 2015/4; 57 (3): 543.

723295. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒlƒtƒ[ƒ[ÇŒóŒQ‚đ‡•š‚ľ‚˝ANCAŠÖ˜AŒŒŠÇ‰ŠÇ—á‚ĚŒŸ“˘. ’ˇę@‘×1,2, –q–앐Žu, ‘ş–ě‡–ç1,2, Š™“c^—Žq1,2, “‡“c–F—˛1,2, –ěXŒű”ŽŽj1, “‡“c@”Ł (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2t‘Ÿ“ŕ): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/6), –źŒĂ‰Ž, 2015/4; 57 (3): 548.

723296. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”źŒŽ‘ĚŒ`ŹŤt‰Š‚É‚¨‚Ż‚éƒ{[ƒ}ƒ“ůN•Ç×–E‚Ě×–E‘B‚ĆEMT‚É‚¨‚Ż‚éSM22ƒż‚Ě–đŠ„. “ŕ“Ął‹g1, Š™“cvšć2, ƒXƒ`ƒ…ƒA[ƒgEƒVƒƒƒ“ƒNƒ‰ƒ“ƒh (1t‘Ÿ“ŕ, 2‘Š–Í‘ĺ–ě“ŕ‰ČEtƒNƒŠƒjƒbƒN): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/7), –źŒĂ‰Ž.

723297. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠˆŤŽ_‘f‚̓AƒŠƒXƒgƒƒLƒAŽ_‚É‚ć‚é‹}ŤtáŠQis‚đ‰ü‘P‚ˇ‚é. ’|“ŕN—Y1, ’|“ŕŒb”üŽq2, Š™“cvšć1, ‰ÍŒ´Ž‰ë3 (1t‘Ÿ“ŕ, 2–Ɖu, 3ś—): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/7), –źŒĂ‰Ž.

723298. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “Ťƒlƒtƒ[ƒ[ÇŒóŒQ‚đ’ć‚ľŽ…‹…‘Ě‚É‘ƒó•ŞßŤd‰ť•a•Ď‚đ”F‚ß‚˝SLE‚Ěˆę—á. ŠÖ–{ŒbŽq1, ˛–ě@—˛1, ˆ˘•”“N–ç1, ŠÖ“c—ĺŽq1, ‚‹´@—É1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Š™“c^—Žq1, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1, óˆä—FŠî, Ź–“łŽq, ŽćGK (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/5-7), –źŒĂ‰Ž, 2015/4; 57 (3): 947.

723299. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘SgŤ•‚Žî, ŒŒŹ”ÂŒ¸­, t‹@”\’ቺ‚Ĺ”­Ç‚ľ‚˝POEMSÇŒóŒQ‚Ě1—á. ˆ˘•”“N–ç1, ˛–ě@—˛1, ŠÖ–{ŒbŽq1, ŠÖ“c—ĺŽq1, ‚‹´@—É1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Š™“c^—Žq1, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/5-7), –źŒĂ‰Ž, 2015/4; 57 (3): 950.

723300. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) PTUŠÖ˜AANCAŒŒŠÇ‰Š‚É–ŒŤtÇ‚𔺂Á‚˝ˆę—á. “‡“c–F—˛1, “ŕ“Ął‹g1, ŠÖ–{ŒbŽq1, ˆ˘•”“N–ç1, ‚‹´@—É1, ł–Ř‹M‹ł1, Š™“c^—Žq1, ‘ş–ě‡–ç1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/5-7), –źŒĂ‰Ž, 2015/4; 57 (3): 966.

723301. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‚—î”­ÇMCNSŠ°‰đŒă‚ÉSLE‚đ”­Ç‚ľ‚˝1—á. ł–Ř‹M‹ł1, “ŕ“Ął‹g1, ˆ˘•”“N–ç1, ŠÖ–{ŒbŽq1, ŠÖ“c—ĺŽq1, ‚‹´@—É1, “‡“c–F—˛1, ’|“ŕ˜a”Ž2, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/5-7), –źŒĂ‰Ž, 2015/4; 57 (3): 980.

723302. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆŤŤƒŠƒ“ƒpŽî‚đ‡•š‚ľ‚˝ImmunotactoidtÇ‚Ě1—á. ‚‹´@—É1, Š™“c^—Žq1, ˆ˘•”“N–ç1, ŠÖ–{ŒbŽq1, ŠÖ“c—ĺŽq1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/5-7), –źŒĂ‰Ž, 2015/4; 57 (3): 1011.

723303. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘˝”­ŒŒŠÇ‰ŠŤ“÷‰čŽîÇ (GPA) ŽĄ—Ă’†‚ɍDŽ_‹…Z‚𔺂¤”畆ŒŒŠÇ‰Š‚đ‡•š‚ľ‚˝ŒŒ‰t“§ÍŠłŽŇ‚Ěˆę—á. “‡“c–F—˛1, ˛–ě@—˛1, ŠÖ“c—ĺŽq1, ‚‹´@—É1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž,2, ‹{ŕVšŽq1, Źě‚Ý‚ä‚Ť,2, Š™“c^—Žq1, ‘ş–ě‡–ç1, ‰Ş–{’qŽq1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1, Š™“cvšć3 (1t‘Ÿ“ŕ, ,2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‘Š–Í‘ĺ–ě“ŕ‰ČEtƒNƒŠƒjƒbƒN): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/26), ‰Ą•l, “ú–{“§ÍˆăŠw‰ďŽGŽ 2015/5; 48 (suppl 1): 83.

723304. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “§Í“ą“üŠú‚É‚¨‚Ż‚éƒNƒGƒ“Ž_‘ć“ń“S…˜a•¨ (ƒŠƒIƒi) ‚Ě•nŒŒ‚ɑ΂ˇ‚éŒř‰Ę‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ’ˇę@‘×1, –q–앐Žu, ‘ş–ě‡–ç1,2, Š™“c^—Žq1,2, “‡“c–F—˛1, –ěXŒű”ŽŽj1, “‡“c@”Ł (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, ,2t‘Ÿ“ŕ): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/26), ‰Ą•l, “ú–{“§ÍˆăŠw‰ďŽGŽ 2015/5; 48 (suppl 1): 191.

723305. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Š´őŤS“ŕ–Œ‰Š‚đ”­Ç‚ľGaƒVƒ“ƒ`ƒOƒ‰ƒtƒB‚ސf’f‚É—L—p‚Ĺ‚ ‚Á‚˝ˆŰŽ“§ÍŠłŽŇ‚Ě1—á. ł–Ř‹M‹ł1, ÂŽR“ŒŒÜ1, ˆ˘•”“N–ç1, ŠÖ–{ŒbŽq1, ŠÖ“c—ĺŽq1, ‚‹´@—É1, “‡“c–F—˛1, ’|“ŕ˜a”Ž2, ‹{ŕVšŽq1, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‰ĽçŽq1, ‘ş–ě‡–ç1, ‰Ş–{’qŽq1, “ŕ“Ął‹g1, ˛–ě@—˛1, ’|“ŕN—Y1, Š™“cvšć3 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‘Š–Í‘ĺ–ě“ŕ‰ČEtƒNƒŠƒjƒbƒN): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/28), ‰Ą•l, “ú–{“§ÍˆăŠw‰ďŽGŽ 2015/5; 48 (suppl 1): 160.

723306. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹š–ŒśŒŸ‚ɂĐüˆŰ‘fŤ‹š–Œ‰Š‚đ”F‚ß‚˝ˆŰŽŒŒ‰t“§ÍŠłŽŇ‚Ě3—á. ˛–ě@—˛1, ŠÖ“c—ĺŽq1, ‚‹´@—É1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, ‹{ŕVšŽq1, Š™“c^—Žq1, Źě‚Ý‚ä‚Ť2, ‰ĽçŽq1, ‘ş–ě‡–ç1, ‰Ş–{’qŽq1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1, Š™“cvšć3 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‘Š–Í‘ĺ–ě“ŕ‰ČEtƒNƒŠƒjƒbƒN): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/28), ‰Ą•l, “ú–{“§ÍˆăŠw‰ďŽGŽ 2015/5; 48 (suppl 1): 284.

732046. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ŒŒ‰t“§Í‚É‚¨‚Ż‚éHŽ–—Ă–@. “ŕ“Ął‹g (t‘Ÿ“ŕ): ‘ć11‰ń‚ł‚Ş‚Ý–ěŒŒ‰tň‰ť‹Zp§˜b‰ď‘‰ďE•×‹­‰ď (2015/7/12), ’Ź“c.

732047. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) t‘Ÿ‚Ě‚¨˜b. “ŕ“Ął‹g (t‘Ÿ“ŕ): Œ’NƒtƒFƒXƒ^ (2015/10/17), ‘Š–ÍŒ´.

733110. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) t‘ŸMRI‚Őt‘Ÿ•Ó‰—DˆĘ‚É‘˝”‚Ě”÷ŹůN–E‚đ”F‚ß‚˝t‹@”\’ቺŠłŽŇ‚Ě1—á. ŠÖ–{ŒbŽq1, ÂŽR“ŒŒÜ1, ˆ˘•”“N–ç1, ‚‹´@—É1, ’|“ŕ˜a”Ž2, ł–Ř‹M‹ł1, “‡“c–F—˛1, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ˛–ě@—˛1, ’|“ŕN—Y1, Š™“cvšć3 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‘Š–Í‘ĺ–ě“ŕ‰ČEtƒNƒŠƒjƒbƒN): ‘ć89‰ń_“ސětŒ¤‹†‰ď (2015/5/23), ‰Ą•l.

733111. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “÷Šá“IŒŒ”A‚ޏoŒť‚ľ‹}‘Ź‚ɐtáŠQ‚ސis‚ľ‚˝“œ”A•aŤtÇ‚Ěˆę—á. ˆ˘•”“N–ç1, ÂŽR“ŒŒÜ1, ŠÖ–{ŒbŽq1, ‚‹´@—É1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Š™“c^—Žq1, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ˛–ě@—˛1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć64‰ń_“ސět‰ŠŒ¤‹†‰ď (2015/9/19), ‰Ą•l.

733112. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “Ťƒlƒtƒ[ƒ[ÇŒóŒQ‚đ’ć‚ľŽ…‹…‘Ě‚É‘ƒó•ŞßŤd‰ť•a•Ď‚đ”F‚ß‚˝SLE‚Ěˆę—á. ŠÖ–{ŒbŽq1, ˛–ě@—˛1, ˆ˘•”“N–ç1, ŠÖ“c—ĺŽq1, ‚‹´@—É1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Š™“c^—Žq1, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1, óˆä—FŠî3, Ź–“łŽq3, ŽćGK3 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŠC˜V–ź‘‡•a‰@): ‘ć45‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2015/10/2), “Œ‹ž.

733113. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘SgŤ•‚Žî, ŒŒŹ”ÂŒ¸­, t‹@”\’ቺ‚Ĺ”­Ç‚ľ‚˝POEMSÇŒóŒQ‚Ě1—á. ˆ˘•”“N–ç1, ˛–ě@—˛1, ŠÖ–{ŒbŽq1, ŠÖ“c—ĺŽq1, ‚‹´@—É1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Š™“c^—Žq1, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć45‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2015/10/2), “Œ‹ž.

733114. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) PTUŠÖ˜AANCAŒŒŠÇ‰Š‚É–ŒŤtÇ‚𔺂Á‚˝ˆę—á. “‡“c–F—˛1, “ŕ“Ął‹g1, ŠÖ–{ŒbŽq1, ˆ˘•”“N–ç1, ‚‹´@—É1, ł–Ř‹M‹ł1, Š™“c^—Žq1, ‘ş–ě‡–ç1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ): ‘ć45‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2015/10/2), “Œ‹ž.

733115. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‚—î”­ÇMCNSŠ°‰đŒă‚ÉSLE‚đ”­Ç‚ľ‚˝1—á. ł–Ř‹M‹ł1, “ŕ“Ął‹g1, ˆ˘•”“N–ç1, ŠÖ–{ŒbŽq1, ŠÖ“c—ĺŽq1, ‚‹´@—É1, “‡“c–F—˛1, ’|“ŕ˜a”Ž2, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć45‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2015/10/2), “Œ‹ž.

733116. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ˆŤŤƒŠƒ“ƒpŽî‚đ‡•š‚ľ‚˝ImmunotactoidtÇ‚Ě1—á. ‚‹´@—É1, Š™“c^—Žq1, ˆ˘•”“N–ç1, ŠÖ–{ŒbŽq1, ŠÖ“c—ĺŽq1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Źě‚Ý‚ä‚Ť2, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ˛–ě@—˛1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć45‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2015/10/3), “Œ‹ž.

733117. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “§Í“ą“ü1”N”źŒă‚ɍĔ­‚đ”F‚ß‚˝RŠî’ę–ŒR‘ĚŒ^t‰Š‚Ěˆę—á. ’ˇę@‘×1, “‡“c–F—˛1, ‘ş–ě‡–ç1,2, Š™“c^—Žq1,2, –q–앐Žu, –ěXŒű”ŽŽj1, “‡“c@”Ł (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2t‘Ÿ“ŕ): ‘ć45‰ń“ú–{t‘ŸŠw‰ď“Œ•”Šwp‘ĺ‰ď (2015/10/3), “Œ‹ž, “ú–{t‘ŸŠw‰ďŽ 2015/9; 56 (7): 967.

733118. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒ{[ƒ}ƒ“ůN•Ç‘O‹ě×–E‚Ě’˛ßˆöŽq. “ŕ“Ął‹g (t‘Ÿ“ŕ): ‘ć28‰ń–ž“ú‚̐t‘Ÿ•a“œ”A•a‚đl‚Ś‚éŽáŽč‚̉ď (2015/10/10), ‰Ą•l.

733119. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “§Í“ą“üŠú‚ɓŤ• …‚đ‡•š‚ľ• oĂ–ŹƒVƒƒƒ“ƒg—Ż’u‚É‚ÄŒy‰ő‚ľ‚˝íőF‘Ě—DŤ‘˝”­Ť”X–Et‚Ě1—á. •x‰i‘ĺŽu, ˛–ě@—˛1, ˆ˘•”“N–ç1, ŠÖ–{ŒbŽq1, ‚‹´@—É1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, Źě‚Ý‚ä‚Ť2, Š™“c^—Žq1, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1, ’|“ŕN—Y1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć90‰ń_“ސětŒ¤‹†‰ď (2015/11/22), ‰Ą•l.

733120. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Žs”Ě’Á’É–ň•ž—pŒă‚É”­Ç‚ľ‚˝‰Ą–ä‹Ř—Z‰đÇ‚Ě1—á. —é–Ř—´‘ž˜Y, ’ˇę@‘×1,2, “‡“c–F—˛1,2, —é–؍š—R”ü, ‰Ş“c”Ž”ü, ‚‹´‰ŘŽq, ŽRč‘ń–ç, –ěXŒű”ŽŽj1, “‡“c@”Ł, œAŁ—˛ˆę1,3 (1–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 2t‘Ÿ“ŕ, 3_Œo“ŕ): “ú–{“ŕ‰ČŠw‰ď‘ć620‰ńŠÖ“Œ’n•ű‰ď (2015/12/12), “Œ‹ž.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H25-540001. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]y•ś•”‰ČŠwČ‰ČŠwŒ¤‹†”ď•â•‹ŕuœ‘‘˘ŒŒŠ˛×–E‘B§ŒäƒVƒXƒeƒ€‚đ—p‚˘‚˝œ‘ƒLƒƒŠƒYƒ€“ą“ü‚ĆƒqƒgŽžŠłƒ‚ƒfƒ‹ŽĄ—Ă (Œ¤‹†‘ă•\ŽŇ: ’|“ŕN—Y)vz’|“ŕN—Y (t‘Ÿ“ŕ): 2010`2012”N“xŒ¤‹†Ź‰Ę•ń‘ 2015/6; 1-5.

H26-110009. [Œ´’˜] A new mouse experimental model of focal segmental glomerulosclerosis produced by the administration of polyclonal anti-mouse nephrin antibody. Okina C1, Kamata K1, Okamoto T1, Kamata M1, Murano J1, Naito S1, Aoyama T1, Yamanaka N: Kitasato Med J 2015/3; 45 (1): 29-37. (‰ĽçŽq1, Š™“cvšć1, ‰Ş–{’qŽq1, Š™“c^—Žq1, ‘ş–ě‡–ç1, “ŕ“Ął‹g1, ÂŽR“ŒŒÜ1: 1t‘Ÿ“ŕ)

H26-320006. [Ç—á•ń] ”DP––Šú‚Ƀlƒtƒ[ƒ[ÇŒóŒQ‚đ’ć‚ľŽ…‹…‘̏ă”ç×–E‚É’˜–ž‚ȕϐŤ‘œ‚đ”F‚ß‚˝ˆę—á. ‚‹´@—É1, ÂŽR“ŒŒÜ1, ŠÖ“c—ĺŽq1, “‡“c–F—˛1, ł–Ř‹M‹ł1, ’|“ŕ˜a”Ž2, ŽđˆäŒ’Žj1, Źě‚Ý‚ä‚Ť2, ‹{ŕVšŽq1, Š™“c^—Žq1, ‰ĽçŽq1, ‘ş–ě‡–ç1, ‰Ş–{’qŽq1, “ŕ“Ął‹g1, ˛–ě@—˛1, ’|“ŕN—Y1, Š™“cvšć1 (1t‘Ÿ“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): t‰ŠÇ—ጤ‹† 2015/2; 31: 127-46.


äPŒ´•aEŠ´ő“ŕ‰ČŠw

[Šwp˜_•ś]

110155. [Œ´’˜] Enhanced expression of mRNA for FLT3 in bone marrow CD34+ cells in rheumatoid arthritis. Hirohata S1, Yanagida T, Tomita T, Yoshikawa H: Inflammation Regeneration 2015; 35 (5): 255-60. (œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

110156. [Œ´’˜] Liver damage in patients with polymyositis and dermatomyositis. Wada T1, Abe G1, Kudou T1, Ogawa E1, Nagai T1, Tanaka S1, Hirohata S1: Kitasato Med J 2016/3; 46 (1): 40-6. (˜a“c’B•F1, ˆŔ•”Šw˜N1, H“Ą—Y‘ĺ1, Źě‰p—C1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

110157. [Œ´’˜] Effects of certolizumab pegol on human monocytes. Hoshiyama T1, Matsueda Y2, Tono T2, Arinuma Y2, Nagai T2, Hirohata S2: Kitasato Med J 2016/3; 46 (1): 60-6. (ŻŽR—˛s1, źŽ}@—C2, “Œ–ěr—T2, —LŔ—ǍK2, ‰iˆä—§•v2, œA”¨rŹ2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2äPŒ´•aEŠ´ő“ŕ)

110158. [Œ´’˜] Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus. Ogawa E1, Nagai T1, Sakuma Y2, Arinuma Y1, Hirohata S1: Mod Rheumatol 2016/6; 26 (3): 377-83. (Źě‰p—C1, ‰iˆä—§•v1, ˛‹vŠÔ—TŽq2, —LŔ—ǍK1, œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

320017. [Ç—á•ń] ‘¤“Ş“Ž–ŹśŒŸ‚Ĺ‹×–EŤ“Ž–Ź‰Š‚đ”F‚ß‚˝HLA-B52—zŤ‘ĺ“Ž–Ź‰Š‚Ěˆę—á. ‘‘@M”Ž1, ’J@@–ź1, źŽ}@—C1, Œ´@—ş—S1, ˆŔ•”Šw˜N1, —LŔ—ǍK1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ŠÖ“ŒƒŠƒEƒ}ƒ` 2015/5; 48: 177-84.

320018. [Ç—á•ń] “Ť‚ĚÄ”­Ť”xŒ‹ßŤ•a•Ď‚ɑ΂ľ‚ÄRituximab‚Ě‘tŒř‚ľ‚˝Granulomatosis with Polyangitis (GPA) ‚Ěˆę—á. Ž™‹Ę‰ŘŽq1, H“Ą—Y‘ĺ1, —LŔ—ǍK1, ’J@@–ź1, źŽ}@—C1, ‘‘@M”Ž1, ˆŔ•”Šw˜N1, Źě‰p—C1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ŠÖ“ŒƒŠƒEƒ}ƒ` 2016/3; 49: 261-7.

522098. [uŔ]y“ÁW: ƒGƒŠƒeƒ}ƒg[ƒfƒX‚đf‚éz_Œo‡•šÇ (CNSƒ‹[ƒvƒX) ‚̐f’f‚ĆŽĄ—Ă. œA”¨rŹ (äPŒ´•aEŠ´ő“ŕ): MB Derma 2015/9; 235: 53-60.

522099. [uŔ]y–ƉuŤ_ŒoŽžŠł|•a‘ԉ𖞂ƎĄ—Ă‚ĚĹ‘OüzŠe˜_ [‚ť‚Ě‘ź‚̖ƉuŤ_ŒoŽžŠł]@‘SgŤƒGƒŠƒeƒ}ƒg[ƒfƒX‚Ě’†•_Œo•a•Ď. œA”¨rŹ (äPŒ´•aEŠ´ő“ŕ): ˆăŠw‚Ě•ŕ‚Ý 2015/10; 255 (5): 549-56.

522100. [uŔ]y“ÁW: ”x‚ŒŒˆłÇf—Ă‚Ě–ÚŽw‚ˇƒS[ƒ‹zState of the Art: äPŒ´•a‚É”ş‚¤”x‚ŒŒˆłÇ. “c’†Z–ž (äPŒ´•aEŠ´ő“ŕ): Pulmonary Hypertension Update 2015/11; 1 (2): 236-43.

522101. [uŔ]yŽăƒ[ƒNƒVƒ‡ƒbƒv: äPŒ´•a‚̐V‹KŽĄ—Ázƒx[ƒ`ƒFƒbƒg•a‚̐_Œo•a•Ď. œA”¨rŹ (äPŒ´•aEŠ´ő“ŕ): —Տ°ƒŠƒEƒ}ƒ` 2015; 27 (4): 288-95.

[’˜@‘]

611002. [Šwp‘ (•ŇW)]yBehcet's Disease: Progress in recent years and unmet needs for the futurez Editor: Hirohata S1, Nova Science Publishers, USA, 2015/10. (œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

620071. [Šwp‘ (•Ş’SŽˇ•M)]y–ƉuŤ_ŒoŽžŠł|Šî‘bE—Տ°Œ¤‹†‚̍ŐV’mŒŠ| (“ú–{—Ő଑Š§† (No.1085)zVI. ‚ť‚Ě‘ź‚̖ƉuŤ_ŒoŽžŠł@2. äPŒ´•a‚¨‚ć‚їމŽžŠł‚É”ş‚¤_ŒoE‹ŘáŠQ@(6) _ŒoBehcet•a, p.673-9. œA”¨rŹ (äPŒ´•aEŠ´ő“ŕ), “ú–{—Ő଎Đ, ‘ĺă, 2015/9”­s.

620072. [Šwp‘ (•Ş’SŽˇ•M)]yƒŠƒEƒ}ƒ`EäPŒ´•af—ĂƒnƒCƒOƒŒ[ƒh •ŞŽq•W“I/BioŽž‘ă‚ĚƒŠƒEƒ}ƒ`EäPŒ´•aŽĄ—ĂƒXƒgƒ‰ƒeƒW[z6Í ‹­”çÇ@3. ”x‚ŒŒˆłÇ‚̐f’f, —Տ°•Ş—Ţ‚ĆŽĄ—Ă, p.233-44. “c’†Z–ž (äPŒ´•aEŠ´ő“ŕ), ƒVƒŠ[ƒY•ŇW: ŽOXŒo˘, ŒK–źł—˛, ƒQƒXƒg•ŇW: ź–{@Œ÷, •Ű“cW•, •śŒő“°, “Œ‹ž, 2015/10”­s.

620073. [Šwp‘ (•Ş’SŽˇ•M)]y`‘Šúf’fEŽĄ—Ă‚Ě‚˝‚߂́`”x‚ŒŒˆłÇ Q&AzPart 2 ”x‚ŒŒˆłÇ‚Ě‘Šúf’f‚đ‚ß‚´‚ˇ@Q3 ”x‚ŒŒˆłÇ‚Ě‘Šúf’f‚Í‚Č‚ş‚Ђ‚悤‚Č‚Ě‚Ĺ‚ľ‚傤‚Š. ŽĄ—Éî“ü‚Ěƒ^ƒCƒ~ƒ“ƒO‚Ş—\Œă‚É‹y‚Ú‚ˇ‰e‹ż‚đ‹ł‚Ś‚Ä‚­‚ž‚ł‚˘, p.88-91. “c’†Z–ž (äPŒ´•aEŠ´ő“ŕ), •Ň: •Ÿ“cŒbˆę, ć’[ˆăŠwŽĐ, “Œ‹ž, 2015/10”­s.

621001. [Šwp‘ (•ŇW)]yƒx[ƒ`ƒFƒbƒg•az•Ň: œA”¨rŹ (äPŒ´•aEŠ´ő“ŕ), •śŒő“°, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713040. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Characteristic changes in histopathology of synovial tissues from patients with rheumatoid arthritis treated with tocilizumab. Hirohata S1, Abe A, Murasawa A, Tomita T, Yoshikawa H: EULAR 2015 (2015/6/12), Rome, Italy. (œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

713041. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Blood-brain barrier damages in the pathogenesis of acute confusional state in systemic lupus erythematosus. Hirohata S1, Arinuma Y1, Yanagida T, Yoshio T: LUPUS 2015 (2015/9/4), Vienna, Austria. (œA”¨rŹ1, —LŔ—ǍK1: 1äPŒ´•aEŠ´ő“ŕ)

713042. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Long-term outcome of chronic progressive neurological manifestations in Behcet's disease Hirohata S1, Kikuchi H, Sawada S, Nagafuchi H, Kuwana M, Takeno M, Ishigatsubo Y: 22rd World Congress of Neurology (WCN 2015) (2015/11/2), Santiago, Chile. (œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

713043. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The Expression of mRNA for Peptidylarginine Deiminase Type 2 and Type 4 in CD34+ Cells of the Bone Marrow in Rheumatoid Arthritis. Nagai T1, Tomita T, Yoshikawa H, Hirohata S1: 2015 ACR/ARHP Annual Meeting (2015/11/8), San Francisco, USA. (‰iˆä—§•v1, œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

713044. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Association of Antibodies to the NR1 Subunit of N-Methyl-D-Aspartate Receptors with Neuropsychiatric Systemic Lupus Erythematosus. Ogawa E1, Nagai T1, Sakuma Y, Arinuma Y1, Hirohata S1: 2015 ACR/ARHP Annual Meeting (2015/11/9), San Francisco, USA. (Źě‰p—C1, ‰iˆä—§•v1, —LŔ—ǍK1, œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

713045. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Association of Anti-Glutamate Receptor Subunit NR2 Antibody and Psychiatric Disorder in Patients with Primary Sjšgren Syndrome. Arinuma Y1, Sakuma Y, Ogawa E1, Wada T1, Nagai T1, Tanaka S1, Hirohata S1: 2015 ACR/ARHP Annual Meeting (2015/11/10), San Francisco, USA. (—LŔ—ǍK1, Źě‰p—C1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

713046. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Differential Effects of IL-6 Blockade Tocilizumab and TNF Inhibitors on the Reduced Angiogenesis and Lining Layer Degeneration in Synovial Tissues from Patients with Rheumatoid Arthritis. Hirohata S1, Arinuma Y1, Yanagida T, Yoshio T: 2015 ACR/ARHP Annual Meeting (2015/11/10), San Francisco, USA. (œA”¨rŹ1, —LŔ—ǍK1: 1äPŒ´•aEŠ´ő“ŕ)

713047. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Influences of Various Factors on Survival of Patients Treated with Pulmonary Arterial Hypertension-Specific Drugs Combination Therapy in Patients with Connective Tissue Diseases. Tanaka S1, Matsueda Y, Ogawa E1, Okada J, Hirohata S1: 2015 ACR/ARHP Annual Meeting (2015/11/10), San Francisco, USA. (“c’†Z–ž1, Źě‰p—C1, œA”¨rŹ1: 1äPŒ´•aEŠ´ő“ŕ)

722057. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “Ť’†•_Œoƒ‹[ƒvƒX‚Ě•a‘Ô. œA”¨rŹ (äPŒ´•aEŠ´ő“ŕ): ‘ć59‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2015/4/24), –źŒĂ‰Ž.

722058. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ŽŠŒČ–ƉuŽžŠł‚Ě’†•_Œo•a•Ď. œA”¨rŹ (äPŒ´•aEŠ´ő“ŕ): ‘ć43‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď (2015/10/22), _ŒË.

723307. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é‘SgŤƒGƒŠƒeƒ}ƒg[ƒfƒXŠłŽŇ‚Ě”DP‚ƏoŽY‚ɂ‚˘‚Ä. ’J@@–ź1, —LŔ—ǍK1, ‰iˆä—§•v1, Ž™‹Ę‰ŘŽq1, źŽ}@—C1, ‘‘@M”Ž1, Źě‰p—C1, ˜a“c’B•F1, “c’†Z–ž1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć59‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2015/4/23), –źŒĂ‰Ž.

723308. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ŤƒXƒeƒBƒ‹•a‚ɑ΂ˇ‚éƒgƒVƒŠƒYƒ}ƒu (TCZ) ‚Ě—LŒřŤ‚ÉŠÖ‚ˇ‚錟“˘. Ž™‹Ę‰ŘŽq1, ‘‘@M”Ž1, “c’†Z–ž1, ’J@@–ź1, źŽ}@—C1, Źě ‰p—C1, —LŔ—ǍK1, ‰iˆä—§•v1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć59‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2015/4/23), –źŒĂ‰Ž.

723309. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) NinJa2013‚É‚¨‚Ż‚éƒ^ƒNƒƒŠƒ€ƒX‚𒆐S‚Ć‚ľ‚˝2Ü•š—p—Ă–@‚̉đÍ. Źě‰p—C1, “c’†Z–ž1, źŽ}@—C1, ‘‘@M”Ž1, —LŔ—ǍK1, ˜a“c’B•F1, ‰iˆä—§•v1, œA”¨rŹ1, źˆä—˜_, ácŠÔdl (1äPŒ´•aEŠ´ő“ŕ): ‘ć59‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2015/4/24), –źŒĂ‰Ž.

723310. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒZƒ‹ƒgƒŠƒYƒ}ƒuƒyƒSƒ‹‚Ěƒqƒg’P‹…‚ɑ΂ˇ‚éŒř‰Ę‚ĚŒŸ“˘. ŻŽR—˛s, ˛‹vŠÔ—TŽq, —LŔ—ǍK1, ‰iˆä—§•v1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć59‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2015/4/24), –źŒĂ‰Ž.

723311. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`ŠłŽŇœ‘CD34—zŤ×–E‚É‚¨‚Ż‚éPAD2 mRNA‚Ě”­Œť‚ĚŒŸ“˘. ‰iˆä—§•v1, •y“c“N–ç, ‹gěGŽ÷, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć59‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2015/4/24), –źŒĂ‰Ž.

723312. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰Č‚ĹŒoŒą‚ľ‚˝Clinically Amyopatic Dermatomyositis (CADM) ‚É‚¨‚Ż‚éRCADMR‘Ě‚đŠÜ‚ß‚˝—Տ°“I“Á’Ľ‚ĚŒŸ“˘. ‘‘@M”Ž1, ’J@@–ź1, Ž™‹Ę‰ŘŽq1, źŽ}@—C1, Źě‰p—C1, —LŔ—ǍK1, ˜a“c’B•F1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć59‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2015/4/24), –źŒĂ‰Ž.

723313. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) LILRA4‘˝Œ^‚Ć‘SgŤƒGƒŠƒeƒ}ƒg[ƒfƒX‚ĚŠÖ˜A‚ĚŒŸ“˘. ěč@ˆť, ŒĂě@G, ‹ß“Ą—T–ç, ˆÉ“Ą@‘, ź–{@Œ÷, ‘ś^‹K—Y, “V–ě_•ś, {“cşŽq, ’ˇ‰ŞÍ•˝, ŁŒËŒű‹žŒá, ‰iˆä—§•v1, œA”¨rŹ1, “‡“c_‘ž, ™ˆäÍ“ń, ‰Ş–{@‹, ç—tŽŔs, ––ź‰hˆę, ‘ĺ–ě@Ž , •ĐŽR‰ë•v, ‰Ş–{–žŽq, ‰Í–ě@”Ł, ‚č–FŹ, ‹´–{”ŽŽj, Z“cF”V, ácŠÔdl, “y‰ŽŽ”V (1äPŒ´•aEŠ´ő“ŕ): ‘ć59‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2015/4/25), –źŒĂ‰Ž.

723314. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’†•_Œoƒ‹[ƒvƒX‚É‚¨‚Ż‚錌´C5”Z“x‚ĚŒŸ“˘. ˛‹vŠÔ—TŽq, —LŔ—ǍK1, ‰iˆä—§•v1, ŻŽR—˛s, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć59‰ń“ú–{ƒŠƒEƒ}ƒ`Šw‰ď‘‰ďEŠwpW‰ď (2015/4/25), –źŒĂ‰Ž.

723315. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Long-term outcome of chronic progressive neuro-Behcet's disease. œA”¨rŹ1, ‹e’nO•q, ‘ň“c“NŽĄ, ‰iŸş—TŽq, ŒK–źł—˛, Šx–ěŒő—m, Îƒ–’Ř—Ç–ž (1äPŒ´•aEŠ´ő“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/23), VŠƒ.

723316. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒZƒ‹ƒgƒŠƒYƒ}ƒuƒyƒSƒ‹‚Ěƒqƒg’P‹…‚ɑ΂ˇ‚éŒř‰Ę‚ĚŒŸ“˘. ŻŽR—˛s, źŽ}@—C1, ‰iˆä—§•v1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć43‰ń“ú–{—Տ°–ƉuŠw‰ď‘‰ď (2015/10/22), _ŒË.

723317. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’†•_Œoƒ‹[ƒvƒX‚É‚¨‚Ż‚éC5a‚ĚŒŸ“˘. ˛‹vŠÔ—TŽq, źŽ}@—C1, ŻŽR—˛s, ‰iˆä—§•v1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć43‰ń“ú–{–ƉuŠw‰ď‘‰ď (2015/10/22), _ŒË.

723318. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éHIV/AIDSŠłŽŇ‚̏A˜Jó‹ľ‚ɂ‚˘‚Ä. ‰Á“Ą@Î, ˜a“c’B•F1, ꎓĄ‘Žq2, źŽRW‘ă2, —F“c‹g‘Ľ3, ź–{Œ\—S3, ‘O“cŒiŽq2, ‚ŽR—zŽq4 (1äPŒ´•aĽŠ´ő“ŕ, 2ŠĹŒě•”, 3–ňÜ•”, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć29‰ń“ú–{ƒGƒCƒYŠw‰ďŠwpW‰ďE‘‰ď (2015/11/30), “Œ‹ž.

733121. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ÁˆŮ‚Ȕ畆Çó‚đ’ć‚ľ‚˝d•ĄŠŕ‡•š”畆‹Ř‰Š‚Ě1—á. •x‰i‘ĺŽu, ‘‘@M”Ž1, ’J@@–ź1, Ž™‹Ę‰ŘŽq1, źŽ}@—C1, Źě‰p—C1, —LŔ—ǍK1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć614‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (2015/5/9), “Œ‹ž.

733122. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹‘ĺ‹ó“´Ť•a•Ď‚𔺂Á‚˝HIV/AIDSŠłŽŇ‚Ěˆę—á. ˆäăG‰î, Ž™‹Ę‰ŘŽq1, ˜a“c’B•F1, ’J@@–ź1, “c’†’mŽ÷1, ˆŔ•”Šw˜N1, H“Ą—Y‘ĺ1, Źě‰p—C1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć78‰ń_“ŢěŒ§Š´őÇˆăŠw‰ď (2015/9/12), ‰Ą•l.

733123. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘˝”­ŒŒŠÇ‰ŠŤ“÷‰čŽîÇ‚̉Á—Ă’†‚ɃmƒJƒ‹ƒWƒAŠ´őÇ‚𔺂Á‚˝ˆę—á. ’J@@–ź1, ‰iˆä—§•v1, “c’†’mŽ÷1, Ž™‹Ę‰ŘŽq1, ˆŔ•”Šw˜N1, H“Ą—Y‘ĺ1, Źě‰p—C1, “c’†Z–ž1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć78‰ń_“ŢěŒ§Š´őÇˆăŠw‰ď (2015/9/12), ‰Ą•l.

733124. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’˜–ž‚Č”’Žż•a•Ď‚đ’ć‚ľ‘˝Ę‚Č’†•_ŒoÇó‚ĚÄ”R‚đŒJ‚č•Ô‚ľŽĄ—Ă‚É“ďa‚ľ‚˝NPSLE‚Ě1—á. ě‹v•Ű•ŕ, Źě‰p—C1, ’J@@–ź1, Ž™‹Ę‰ŘŽq1, “c’†’mŽ÷1, ˆŔ•”Šw˜N1, H“Ą—Y‘ĺ1, ‰iˆä—§•v1, “c’†Z–ž1, œA”¨rŹ1 (1äPŒ´•aEŠ´ő“ŕ): ‘ć618‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (2015/10/10), “Œ‹ž.

733125. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ŘŒ´Ťy‘f‚̏㏸‚Ć’˜–ž‚Čš‹‰şáŠQ‚đ—ˆ‚˝‚ľ‘˝”­Ť‹Ř‰Š‚ĆŽv‚í‚ę‚˝1—á. ‹ŕ•Ł—DŽ÷, ‰iˆä—§•v1, ’J@@–ź1, ˆŔ•”Šw˜N1, H“Ą—Y‘ĺ1, Źě‰p—C1, “c’†Z–ž1, œA”¨rŹ1, Žş@Œc’ź (1äPŒ´•aEŠ´ő“ŕ): ‘ć621‰ń“ú–{“ŕ‰ČŠw‰ďŠÖ“Œ’n•ű‰ď (2016/2/13), “Œ‹ž.

H26”N“xˆČ‘O•Ş

[’˜@‘]

H26-620009. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚̐f’fŽwj (‘ć7”Ĺ)zII. ŽžŠł•Ň@2. _ŒoE‹ŘŽžŠł@_ŒoBehet•a, p.683-5. œA”¨rŹ (äPŒ´•aEŠ´ő“ŕ), ‘•ŇW: ‹ŕŕVˆę˜Y, ‰iˆä—ÇŽO, ˆăŠw‘‰@, “Œ‹ž, 2015/3”­s.


ŠO‰ČŠw
[Šwp˜_•ś]

110159. [Œ´’˜] Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure model. Tanaka M, Shinoda M, Takayanagi A, Oshima G, Nishiyama R1, Fukuda K, Yagi H, Hayashida T, Masugi Y, Suda K, Yamada S, Miyasho T, Hibi T, Abe Y, Kitago M, Obara H, Itano O, Takeuchi H, Sakamoto M, Tanabe M, Maruyama I, Kitagawa Y: J Surg Res 2015/4; 194 (2): 571-80. (źŽR@—ş1: 1ŠO‰Č)

110160. [Œ´’˜] Preoperative administration of polysaccharide Kureha and reduced plasma transforming growth factor-ƒŔ in patients with advanced gastric cancer: A randomized clinical trial. Yamashita K1, Sakuramoto S, Mieno H1, Nemoto M, Shibata T, Katada N, Ohtsuki S, Sakamoto Y2, Hoshi K3, Wang G, Hemmi O, Satoh T, Kikuchi S4, Watanabe M1: Mol Clin Oncol 2015/5; 3 (3): 471-8. (ŽR‰şŒpŽj1, ŽOd–ě_˜N1, •Đ“c‰Ä–ç1, â–{‘×—2, Ż@‰Ŕ–F3, ‹e’rŽj˜Y4, “n粏š•F1: 1ŠO‰Č, 2—Տ°Œ¤‹†EŠé‰ć, 3‰qś, 44•a‰@˜AŒg‹łˆç)

110161. [Œ´’˜] Prognostic impact of venous invasion in stage IB node-negative gastric cancer. Araki I1, Hosoda K1, Yamashita K1, Katada N1, Sakuramoto S, Moriya H1, Mieno H1, Ema A1, Kikuchi S2, Mikami T, Watanabe M1: Gastric Cancer 2015/6; 18 (2): 297-305. (r–Řˆę•ş‘ž1, ×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, ŽOd–ě_˜N1, ]ŠÔ@—ć1, ‹e’rŽj˜Y2, “n粏š•F1: 1ŠO‰Č, 24•a‰@˜AŒg‹łˆç)

110162. [Œ´’˜] Laparoscopic versus open distal gastrectomy for early gastric cancer in Japan: long-term clinical outcomes of a randomized clinical trial. Yamashita K1, Sakuramoto S, Kikuchi S2, Futawatari N1, Katada N1, Hosoda K1, Moriya H1, Mieno H1, Watanabe M1: Surg Today 2015/7. DOI: 10.1007/s00595-015-1221-4. (ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “ń“nM]1, •Đ“c‰Ä–ç1, ×“c@Œj1, X’JGŒő1, ŽOd–ě_˜N1, “n粏š•F1: 1ŠO‰Č, 24•a‰@˜AŒg‹łˆç)

110163. [Œ´’˜] Clinicopathological Evaluation and Prognostic Analysis in Breast Cancer Patients with Brain Metastasis. Minatani N1, Tanino H2, Kosaka Y2, Kikuchi M2, Nishimiya H2, Waraya M2, Katoh H2, Enomoto T2, Sengoku N2, Watanabe M2: Journal of Cancer Therapy 2015/8; 6 (8): 727-34. (“ě’JŘ•äŽq1, ’J–ě—Tˆę2, Źâ–ůŒŤ2, ‹e’r^—Žq2, ź‹{—mŽj2, ˜m’J”ü“Ţ2, ‰Á“Ą@O2, ‰|–{‘ń–Î2, ĺÎ‹I•F2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

110164. [Œ´’˜] Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13. Kawamata H1, Yamashita K1, Kojo K2, Ushiku H2, Ooki A1, Watanabe M1: Genomics 2015/8; 106 (2): 71-5. (‰Í–”@Š°1, ŽR‰şŒpŽj1, ŒĂé@Œ›2, ‹‹vGŽ÷2, ‘ĺ–؁@‹Ĺ1, “n粏š•F1: 1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110165. [Œ´’˜] Multicenter comparative study of laparoscopic and open distal pancreatectomy using propensity score-matching. Nakamura M1, Wakabayashi G1, Miyasaka Y1, Tanaka M1, Morikawa T1, Unno M1, Tajima H1,2, Kumamoto Y1,2, Satoi S1, Kwon M1, Toyama H1, Ku Y1, Yoshitomi H1, Nara S1, Shimada K1, Yokoyama T1, Miyagawa S1, Toyama Y1, Yanaga K1, Fujii T1, Kodera Y1, Tomiyama Y3, Miyata H3, Takahara T3, Beppu T3, Yamaue H3, Miyazaki M3, Takada T3 (1Study Group of JHBPS, 3Study Group of JSEPS): J Hepatobiliary Pancreat Sci 2015/10; 22 (10): 731-6. (“c“‡@O1,2, ŒGŒł—Y‰î1,2: 2ŠO‰Č)

110166. [Œ´’˜] A Risk Model for Surgical Site Infection in the Gastric Cancer Surgery Using Data of 790 Patients. Ushiku H1, Hosoda K2, Yamashita K2, Katada N2, Kikuchi S3, Tsuruta H4, Watanabe M2: Dig Surg 2015/10; 32 (6): 472-9. (‹‹vGŽ÷1, ×“c@Œj2, ŽR‰şŒpŽj2, •Đ“c‰Ä–ç2, ‹e’rŽj˜Y3, ’ß“c—z˜a4, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç, 4ˆă—ÉqśŠw•”)

110167. [Œ´’˜] Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype. Waraya M1, Yamashita K1, Ema A1, Katada N1, Kikuchi S2, Watanabe M1: PLoS One 2015/10; 10 (10): e0139902. (˜m’J”ü“Ţ1, ŽR‰şŒpŽj1, ]ŠÔ@—ć1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏š•F1: 1ŠO‰Č, 24•a‰@˜AŒg‹łˆç)

110168. [Œ´’˜] Overview of multimodal therapy for adenocarcinoma of the esophagogastric junction. Hosoda K1, Yamashita K1, Katada N1, Watanabe M1: Gen Thorac Cardiovasc Surg 2015/10; 63 (10): 549-56. (×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, “n粏š•F1: 1ŠO‰Č)

110169. [Œ´’˜] Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test. Yamashita K1, Ushiku H2, Katada N1, Hosoda K1, Moriya H1, Mieno H1, Kikuchi S3, Hoshi K4, Watanabe M1: Eur J Surg Oncol 2015/10; 41 (10): 1324-32. (ŽR‰şŒpŽj1, ‹‹vGŽ÷2, •Đ“c‰Ä–ç1, ×“c@Œj1, X’JGŒő1, ŽOd–ě_˜N1, ‹e’rŽj˜Y3, Ż@‰Ŕ–F4, “n粏š•F1: 1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 34•a‰@˜AŒg‹łˆç, 4‰qś)

110170. [Œ´’˜] The Impact of c-Fos/Activator Protein-1 Inhibition on Allogeneic Pancreatic Islet Transplantation. Yoshida T, Yamashita K, Watanabe M1, Koshizuka Y, Kuraya D, Ogura M, Asahi Y, Ono H, Emoto S, Mizukami T, Kobayashi N, Shibasaki S, Tomaru U, Kamachi H, Matsushita M, Shiozawa S, Hirono S, Todo S: Am J Transplant 2015/10; 15 (10): 2565-75. (“n粏š•F1: 1ŠO‰Č)

110171. [Œ´’˜] A peripheral primitive neuroectodermal tumor originating from the pancreas: a case report and review of the literature. Nishizawa N1, Kumamoto Y2, Igarashi K1, Nishiyama R2, Tajima H2, Kawamata H2, Kaizu T2, Watanabe M2: Surg Case Rep 2015/12; 1: 80. (źŕVL‹ą1, ŒGŒł—Y‰î2, ŒÜ\—’ˆę°1, źŽR@—ş2, “c“‡@O2, ‰Í–”@Š°2, ŠC’Ă‹MŽj2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

110172. [Œ´’˜] Predictive factors for lymph node metastasis in additional gastrectomy after endoscopic resection of cT1aN0 gastric cancer. Ishii S1, Yamashita K2, Kato H2, Nishizawa N1, Ushiku H1, Mieno H2, Moriya H2, Hosoda K2, Katada N2, Kikuchi S3, Tanabe S4, Koizumi W5, Saegusa M6, Watanabe M2: Surg Today 2015/12. DOI: 10.1007/s00595-015-1281-5. (Îˆä@’q1, ŽR‰şŒpŽj2, ‰Á“Ą@O2, źŕVL‹ą1, ‹‹vGŽ÷1, ŽOd–ě_˜N2, X’JGŒő2, ×“c@Œj2, •Đ“c‰Ä–ç2, ‹e’rŽj˜Y3, “c糁@‘4, Źň˜aŽO˜Y5, ŽOŽ}@M6, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç, 4V˘‹Iˆă—ÁEć’[ˆă—Ă, 5Á‰ťŠí“ŕ, 6•a—)

110173. [Œ´’˜] Randomized Controlled Trial of Zoledronic Acid plus Chemotherapy versus Chemotherapy Alone as Neoadjuvant Treatment of HER2-Negative Primary Breast Cancer (JONIE Study). Hasegawa Y1, Tanino H1,2, Horiguchi J1, Miura D1, Ishikawa T1, Hayashi M1, Takao S1, Kim SJ1, Yamagami K1, Miyashita M1, Konishi M1, Shigeoka Y1, Suzuki M1, Taguchi T1, Kubota T1, Akazawa K1, Kohno N1 (1JONIE Study Group): PLoS One 2015/12; 10 (12): e0143643. (’J–ě—Tˆę1,2: 2ŠO‰Č)

110174. [Œ´’˜] Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer. Kikuchi M1, Yamashita K2, Waraya M2, Minatani N1, Ushiku H1, Kojo K1, Ema A2, Kosaka Y2, Katoh H2, Sengoku N2, Enomoto T2, Tanino H2, Sawanobori M, Watanabe M2: Oncotarget 2016/1; 7 (2): 1741-53. (‹e’r^—Žq1, ŽR‰şŒpŽj2, ˜m’J”ü“Ţ2, “ě’JŘ•äŽq1, ‹‹vGŽ÷1, ŒĂé@Œ›1, ]ŠÔ@—ć2, Źâ–ůŒŤ2, ‰Á“Ą@O2, ĺÎ‹I•F2, ‰|–{‘ń–Î2, ’J–ě—Tˆę2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

110175. [Œ´’˜] Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis. Nakayama N, Yamashita K1, Tanaka T2, Kawamata H1, Ooki A1, Sato T1, Nakamura T1, Watanabe M1: Clin Exp Metastasis 2016/1; 33 (1): 3-13. (ŽR‰şŒpŽj1, “c’†r“š2, ‰Í–”@Š°1, ‘ĺ–؁@‹Ĺ1, ˛“Ą•˜Y1, ’†‘ş—˛r1, “n粏š•F1: 1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110176. [Œ´’˜] Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer. Minatani N1, Waraya M2, Yamashita K2, Kikuchi M1, Ushiku H1, Kojo K1, Ema A2, Nishimiya H2, Kosaka Y2, Katoh H2, Sengoku N2, Tanino H2, Sidransky D, Watanabe M2: PLoS One 2016/1; 11 (1): e0144862. (“ě’JŘ•äŽq1, ˜m’J”ü“Ţ2, ŽR‰şŒpŽj2, ‹e’r^—Žq1, ‹‹vGŽ÷1, ŒĂé@Œ›1, ]ŠÔ@—ć2, ź‹{—mŽj2, Źâ–ůŒŤ2, ‰Á“Ą@O2, ĺÎ‹I•F2, ’J–ě—Tˆę2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

110177. [Œ´’˜] Laparoscopic Surgery is Useful for Preventing Recurrence of Small Bowel Obstruction After Surgery for Postoperative Small Bowel Obstruction. Nakamura T1, Sato T1, Naito M1, Ogura N, Yamanashi T1, Miura H1, Tsutsui A1, Yamashita K1, Watanabe M1: Surg Laparosc Endosc Percutan Tech 2016/2; 26 (1): e1-4. (’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŽR‰şŒpŽj1, “n粏š•F1: 1ŠO‰Č)

110178. [Œ´’˜] Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer. Yamashita K1, Hosoda K1, Ema A1, Watanabe M1: Eur J Surg Oncol 201/3. doi: 10.1016/j.ejso.2016.03.001. (ŽR‰şŒpŽj1, ×“c@Œj1, ]ŠÔ@—ć1, “n粏š•F1: 1ŠO‰Č)

110179. [Œ´’˜] Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy. Kosaka Y1, Tanino H1, Sengoku N1, Minatani N2, Kikuchi M2, Nishimiya H1, Waraya M2, Katoh H1, Enomoto T1, Sato T1, Kuranami M, Watanabe M1: Support Care Cancer 2016/3; 24 (3): 1405-11. (Źâ–ůŒŤ1, ’J–ě—Tˆę1, ĺÎ‹I•F1, “ě’JŘ•äŽq2, ‹e’r^—Žq2, ź‹{—mŽj1, ˜m’J”ü“Ţ2, ‰Á“Ą@O1, ‰|–{‘ń–Î1, ˛“Ą•˜Y1, “n粏š•F1: 1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110180. [Œ´’˜] Anatomical Knowledge for the Infra-Pyloric Vein Preservation during the Laparoscopy-Assisted Pylorus-Preserving Gastrectomy. Nishizawa N1, Yamashita K2, Shinohara H, Sakuramoto S, Hosoda K2, Watanabe M2: Dig Surg 2016; 33 (5): 363-70. (źŕVL‹ą1, ŽR‰şŒpŽj2, ×“c@Œj2, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

110181. [Œ´’˜] Potential benefits of laparoscopy-assisted proximal gastrectomy with esophagogastrostomy for cT1 upper-third gastric cancer. Hosoda K1, Yamashita K1, Katada N1, Moriya H1, Mieno H1, Shibata T, Sakuramoto S, Kikuchi S2, Watanabe M1: Surg Endosc 2016/8; 30 (8): 3426-36. (×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, ŽOd–ě_˜N1, ‹e’rŽj˜Y2, “n粏š•F1: 1ŠO‰Č, 24•a‰@˜AŒg‹łˆç)

110182. [Œ´’˜] A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1). Sato T1, Hayakawa K2, Tomita N, Noda M, Kamikonya N, Watanabe T, Kato D, Sakai Y, Hiraoka M, Shimada M, Ikushima H, Baba H, Oya N, Oya M, Nemoto-Murofushi K, Takeuchi M, Watanabe M1: Radiother Oncol 2016/8; 120 (2): 222-7. (˛“Ą•˜Y1, ‘ě˜ad2, “n粏š•F1: 1ŠO‰Č, 2•úŽËü (Žîá‡))

310014. [Ç—á•ń] Liver Metastasis from Mixed Acinar-Endocrine Carcinoma of the Pancreas: A Case Report and Review of the Literature. Kumamoto Y1, Kaizu T1, Tajima H1, Kawamata H1, Nishiyama R1, Watanabe M1: J Liver Clin Res 2015/4; 2 (2): 1015. (ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, ‰Í–”@Š°1, źŽR@—ş1, “n粏š•F1: 1ŠO‰Č)

310015. [Ç—á•ń] Case report of a laparoscopically resected rectal villous tumor associated with electrolyte depletion syndrome. Igarashi K1, Nakamura T1, Sato T1, Tsutsui A1, Miura H1, Ogura N, Naito M1, Yamanashi T1, Watanabe M1: Asian J Endosc Surg 2015/5; 8 (2): 185-7. (ŒÜ\—’ˆę°1, ’†‘ş—˛r1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, Ź‘q’źl, “ŕ“Ął‹K1, ŽR—œ‚L1, “n粏š•F1: 1ŠO‰Č)

310016. [Ç—á•ń] Two Cases of Pathological Complete Response to Neoadjuvant Chemoradiation Therapy in Pancreatic Cancer. Fujii-Nishimura Y, Nishiyama R1, Kitago M, Masugi Y, Ueno A, Aiura K, Kawachi S, Kawaida M, Abe Y, Shinoda M, Itano O, Tanimoto A, Sakamoto M: Keio J Med 2015/6; 64 (2): 26-31. (źŽR@—ş1: 1ŠO‰Č)

310017. [Ç—á•ń] A rapidly growing epidermoid cyst in an intrapancreatic accessory spleen treated by laparoscopic spleen-preserving distal pancreatectomy: Report of a case. Kumamoto Y1, Kaizu T1, Tajima H1, Kubo H1, Nishiyama R1, Watanabe M1: Int Surg 2015/6/2. [Epub ahead of print] (ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, ‹v•Ű”CŽj1, źŽR@—ş1, “n粏š•F1: 1ŠO‰Č)

310018. [Ç—á•ń] Retroperitoneal schwannoma between the inferior vena cava and the abdominal aorta resected by laparoscopic surgery: A case report. Nishizawa N1, Kumamoto Y2, Hirata M3, Watanabe M2: Asian J Endosc Surg 2015/8; 8 (3): 361-4. (źŕVL‹ą1, ŒGŒł—Y‰î2, •˝“cŒő”Ž3, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

320019. [Ç—á•ń] –Ó’°ŒeŽşoŒŒTAEŒă‚É’°ŠÇ‹•ŒŒ‚Ě‚˝‚ß• o‹ž•â•‰şŽčp‚đŽ{s‚ľ‚˝1—á. ”‹Œ´çŒb1, ’†‘ş—˛r1, ƒEƒbƒhƒnƒ€ƒX—ćŽq2, ”óŒű@Ši1, b”ă“c•Žu1, ŽR—œ‚L1, “ŕ“Ął‹K1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č, 2•úŽËü (‰ć‘œ)): “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ 2016/3; 36 (3): 609-12.

520010. [‘ŕ]yLower G.I./Colon and Rectum Cancer ‘ĺ’°ŠŕzIII. Œ‹’°E’ź’°Šŕ‚ɑ΂ˇ‚é•â•‰ťŠwE‰ťŠw•úŽËü—Ă–@. ˛“Ą•˜Y1, ’†‘ş—˛r1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, Źâ–ůŒŤ1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): Šŕ‚ƉťŠw—Ă–@ 2015/11; 42 (11): 1368-73.

522102. [uŔ]y“ÁW: ‘ĺ’°• o‹ž‰şŽčp|‡•šÇƒ[ƒ‚đ‚ß‚´‚ľ‚˝”éô|zŽčpŽč‹Z@• o‹ž‰ş‰ĄsŒ‹’°Řœp Ź‘q’źl, “n粏š•F1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1 (1ŠO‰Č): Žčp 2015/4; 69 (5): 705-12.

522103. [uŔ]y“ÁW: ‘ĺ’°Šŕf—ĂUpdatezŠî‘b‚ĚUpdate@‘ĺ’°Šŕ‚Ěˆâ“`ŽqˆŮí‚Ě“Á’Ľ‚Ɛś•¨Šw“IˆÓ‹`. ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ˆăŠw‚Ě‚ ‚ä‚Ý 2015/6; 253 (10): 945-51.

522104. [uŔ]yuŔ: ‘ć28‰ń–k—˘ŽîᇃtƒH[ƒ‰ƒ€z• o‹ž‰ş‘ĺ’°ŠŕŽčp‚Í’áNP‚Ć‚˘‚Ś‚é‚Š. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): –k—˘ˆăŠw 2015/6; 45 (1): 41-6.

522105. [uŔ]y“ÁW: ‘̍o‹ž‰ş ă•”Á‰ťŠÇŽčpz‘̍o‹ž‰şH“šŠŕŽčpzIII. ‚ť‚Ě‘ź@2. ‹t—ŹŤH“š‰Š. •Đ“c‰Ä–ç1, X’JGŒő1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ŠO‰Č 2015/7; 77 (7): 805-11.

522106. [uŔ]y“ÁW: ƒGƒLƒXƒp[ƒg‚̏Á‰ťŠÇ•Ť‡‚đŠw‚ԁz‘ĺ’°ŠO‰Č‚É‚¨‚Ż‚éÁ‰ťŠÇ•Ť‡‚ĚƒRƒc|Œ‹’°. “ŕ“Ął‹K1, ’†‘ş—˛r1, ˛“Ą•˜Y1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŒĂé@Œ›2, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): —Տ°ŠO‰Č 2015/10; 70 (10): 1231-4.

522107. [uŔ]y“ÁW: “ŕŽ‹‹žŠO‰ČŽčp‚̏Á‰ťŠÇ•Ť‡|ƒRƒc‚ĆƒsƒbƒgƒtƒH[ƒ‹zII. Œ‹’°E’ź’°—Ěˆć@1. • o‹ž‰şŒ‹’°Řœp‚É‚¨‚Ż‚éˆŔ‘S‚Č‘ĚoŠO‹@”\“I’[X•Ť‡. ŽR—œ‚L1, ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ×“c@Œj1, Ź‘q’źl, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): Žčp 2016/1; 70 (1): 29-34.

522108. [uŔ]y“ÁW: ‘ĺ’°ESD/EMRƒKƒCƒhƒ‰ƒCƒ“‚̐ł‚ľ‚˘‰^—p‚Ě‚˝‚߂Ɂz3. ŠO‰Čˆă‚Ě—§ę‚Š‚ç‚Ý‚˝VƒKƒCƒhƒ‰ƒCƒ“‚Ć‚ť‚̉ۑč. ˛“Ą•˜Y1, ’†‘ş—˛r1, Źâ–ůŒŤ1, “ŕ“Ął‹K1, ŽR—œ‚L1, “n粏š•F1 (1ŠO‰Č): —ŐଏÁ‰ťŠí“ŕ‰Č 2016/1; 31 (1): 77-83.

522109. [uŔ]y“ÁW: ‚Ş‚ń’áNPŽĄ—Ă‚ĚĹV’mŒŠz[Šî‘b] Á‰ťŠÇ‚Ş‚ń (H“šEˆÝE‘ĺ’°) ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚ĚŒť‹ľ‚Ć“W–]. ŽR—œ‚L1, ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ×“c@Œj1, Ź‘q’źl, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ĹVçΛ{ 2016/3; 71 (3): 365-71.

522110. [uŔ]y“ÁW: is‘ĺ’°Šŕ‚ɑ΂ˇ‚é“ŕŽ‹‹žŠO‰ČŽčp‚ĚŒŔŠEzII. Še˜_@5. ‹ÇŠis’ź’°Šŕ‚ɑ΂ˇ‚é“ŕŽ‹‹ž‰şŽčp. ŽO‰YŒ[Žő1, ’†‘ş—˛r1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, “›ˆä“ÖŽq1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ŠO‰Č 2016/3; 78 (3): 256-63.

[’˜@‘]

620074. [Šwp‘ (•Ş’SŽˇ•M)]y‚í‚Š‚č‚₡‚˘Á‰ťŠíŠŕŽĄ—Ă‚ĚƒRƒ“ƒZƒ“ƒTƒX (Á‰ťŠíŠO‰Č2015”N4ŒŽ‘Š§†)zIII. ‘ĺ’°Šŕ‚̐f’f‚ĆŽĄ—Á@4. Œ‹’°Šŕ‚ĚŠO‰ČŽĄ—Á@2) • o‹ž‰şŽčp, p.635-9. “ŕ“Ął‹K1, “n粏š•F1 (1ŠO‰Č), •Ň:uÁ‰ťŠíŠO‰Čv•ŇWˆĎˆő‰ď, ‚ւ邡o”Ĺ, “Œ‹ž, 2015/4”­s.

620075. [Šwp‘ (•Ş’SŽˇ•M)]yÁ‰ťŠíEˆę”ĘŠO‰ČŽčp‚ĚPearls & Tips|ƒƒ“ƒ‰ƒ“ƒNă‚ĚŽčp‚đ’BŹ‚ˇ‚é‹Z‚Ć’mŒb (—Տ°ŠO‰Č2015”N10ŒŽ† (‘Š§†))z1. H“š@H“šƒAƒJƒ‰ƒVƒAŽčp, p.34-40. •Đ“c‰Ä–ç1, X’JGŒő1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, ×“c@Œj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç), ˆăŠw‘‰@, “Œ‹ž, 2015/10”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713048. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic surgery for locally advanced sigmoid colon cancer: short and long-term clinical outcomes. Yamanashi T1, Sato T1, Tsutsui A1, Miura H1, Ogura N, Naito M1, Nakamura T1, Watanabe M1: Digestive Disorders Federation 2015 (DDF2015) (2015/6/22), London, UK. (ŽR—œ‚L1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, “ŕ“Ął‹K1, ’†‘ş—˛r1, “n粏š•F1: 1ŠO‰Č)

713049. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic surgery for rectal cancer after preoperative chemoradiotherapy. Nakamura T1, Sato T1, Tsutsui A1, Miura H1, Ogura N, Naito M1, Yamanashi T1, Watanabe M1: Digestive Disorders Federation 2015(DDF2015) (2015/6/22), London, UK. (’†‘ş—˛r1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, “ŕ“Ął‹K1, ŽR—œ‚L1, “n粏š•F1: 1ŠO‰Č)

713050. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) A risk model for surgical site infection in the gastric cancer surgery using date of 790 patients. Hosoda K1: 46th World Congress of Surgery (2015/8/26), Bangkok, Thai. (×“c@Œj1: 1ŠO‰Č)

713051. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic surgery with the vascular pedicleligation using automatic stapling device for until T2 left side colon cancer. Naito M1, Sato T1, Nakamura T1, Ogura N, Yamanashi T1, Miura H1, Tsutsui A1, Kojo K2, Yokoi K2, Watanabe M1: 3rd International Conference of Federation of Asia Clinical Oncology (FACO) (2015/10/30), Kyoto. (“ŕ“Ął‹K1, ˛“Ą•˜Y1, ’†‘ş—˛r1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŒĂé@Œ›2, ‰ĄˆäŒ\Œĺ2, “n粏š•F1: 1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713052. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Early and accurate prediction of pathological response by magnetic resonance imaging andultrasonography in patients undergoing neoadjuvant chemotherapy for operable breast cancer. Kaise H, Ishikawa T, Miura D, Hasegawa Y, Horiguchi J, Hayashi M, Takao S, Kim SJ, Tanino H1, Miyashita M, Konishi M, Shigeoka Y, Yamagami K, Suzuki M, Taguchi T, Akazawa K, Kohno N: 38th Annual Meeting of San Antonio Breast Cancer Symposium (2015/12/11), San Antonio, USA. (’J–ě—Tˆę1: 1ŠO‰Č)

713053. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Exploring immunomodulatory effects of zoledronic acid in breast cancer from clinical trial result of neoadjuvant chemotherapy with zoledronic acid: JONIE-1 study. Sangai T, Sato E, Ishikawa T, Kaise H, Hasegawa Y, Miura D, Takao S, Suzuki M, Tanino H1, Horiguchi J, Akazawa K, Yamada A, Kohno N: 38th Annual Meeting of San Antonio Breast Cancer Symposium (2015/12/11), San Antonio, USA. (’J–ě—Tˆę1: 1ŠO‰Č)

713054. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) EN-BLOC STAPLING TRANSECTION OF GLISSONIAN PEDICLES AND LHV FOR LAPAROSCOPIC LEFT LATERAL SECTIONECTOMY. Kaizu T1, Kumamoto Y1, Tajima H1, Nishiyama R1, Kawamata H1, Watanabe M1: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES2016) (2016/3/16), Boston, USA. (ŠC’Ă‹MŽj1, ŒG–{—Y‰î1, “c“‡@O1, źŽR@—ş1, ‰Í–”@Š°1, “n粏š•F1: 1ŠO‰Č)

713055. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Technically safety and oncological validity of laparoscopic surgery in elderly patients with colon cancer. Kojo K1, Naito M2, Watanabe M2, Yamanashi T2, Miura H2, Tsutsui A2, Ogura N, Yokoi K1, Sato T2, Nakamura T2: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES2016) (2016/3/16), Boston, USA. (ŒĂé@Œ›1, “ŕ“Ął‹K2, “n粏š•F2, ŽR—œ‚L2, ŽO‰YŒ[šć2, “›ˆä“ÖŽq2, ‰ĄˆäŒ\Œĺ1, ˛“Ą•˜Y2, ’†‘ş—˛r2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č)

713056. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The validity for the laparoscopic colorectal surgery using the absorbable adhesion barrier made of oxidized regenerated cellulose. Naito M1, Watanabe M1, Kojo K2, Yamanashi T1, Ogura N, Miura H1, Tsutsui A1, Sato T1, Nakamura T1: Society of American Gastrointestinal and Endoscopic Surgeons (SAGES2016) (2016/3/16), Boston, USA. (“ŕ“Ął‹K1, “n粏š•F1, ŒĂé@Œ›2, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ˛“Ą•˜Y1, ’†‘ş—˛r1: 1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

722059. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yH“šŠŕ‚̏p‘O•â•—Ă–@‚ĚŒ÷ßz•â•—Ă–@–łŒř—á‚Ě‘I•Ę‚ĆŽüpŠú‚Ě‘Îô|H“šŠŕ‚̏p‘O•â•—Ă–@‚ĚŒ÷ß|. ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, Œ˜“ce—˜2, ”óŒűŸ•F, ×“c@Œj1, ŽOd–ě_˜Y1, ŹXłŽq3, ‹e’rŽj˜Y4, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ, 3•úŽËü (Žîá‡), 44•a‰@˜AŒg‹łˆç): ‘ć69‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2015/7/3), ‰Ą•l, ‘ć69‰ń“ú–{H“šŠw‰ďŠwpW‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2015/7; 69: 27.

722060. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) H“šŠŕ‚ĚƒGƒsƒQƒmƒ€‰đÍ‚ĆŽĄ—ĂŒÂ•Ę‰ť‚Ö‚Ě“W–]. ŽR‰şŒpŽj1, ‹‹vGŽ÷2, X’JGŒő1, ×“c@Œj1, ŽOd–ě_˜N1, ]ŠÔ@—ć1, •Đ“c‰Ä–ç1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s.

722061. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‘ĺ’°Šŕ‚Ě•â•‰ťŠw—Ă–@‚ĚŒÂ•Ę‰ť‚đ–ÚŽw‚ľ‚Ä. ˛“Ą•˜Y1, ’†‘ş—˛r1, “ŕ“Ął‹K1, “n粏š•F1 (1ŠO‰Č): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/30), ‹ž“s.

722062. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‹ÇŠis‰ş•”’ź’°Šŕ‚ɑ΂ˇ‚éWŠw“IŽĄ—Á`p‘O‰ťŠw•úŽËü—Ă–@ (NCRT) ‚đ—p‚˘‚˝í—ށ`. ˛“Ą•˜Y1, ’†‘ş—˛r1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž.

722063. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) –TƒXƒg[ƒ}ƒwƒ‹ƒjƒA‚ĚŠëŒŻˆöŽq‚ĚŒŸ“˘. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž.

722064. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ƒƒ{ƒbƒgŽx‰‡ˆÝŘœp‚Ě“ą“ü‚ÉŰ‚ˇ‚éˆŔ‘SŠÇ—: Team STEPPS‚Ć‚Ě—Z‡. •Đ“c‰Ä–ç1, ×“c@Œj1, ŽOd–ě_˜N1, œA–ěŒbŽq, —§–ě@‘, rˆä—L”ü, X’JGŒő1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/12), ‘ĺă.

722065. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) The clinical outcome of conversion surgery after DCS chemotherapy in unresectable gastric cancer. ×“c@Œj1, X’JGŒő1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, “n粏š•F1 (1ŠO‰Č): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/19), ‘ĺ•Ş.

723319. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) A single center experience of Laparoscopic liver resections with a central focus on the right posterior sectionectomy. ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, ‹v•Ű”CŽj1, “c“‡@O1, źŽR@—ş1, “n粏š•F1 (1ŠO‰Č): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/16), –źŒĂ‰Ž.

723320. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚“xisˆÝŠŕ‚ɑ΂ˇ‚éDocetaxel + CDDP + S-1 (DCS) —Ă–@Œă‚ĚŽčpŹŃ. ŽOd–ě_˜N1, •Đ“c‰Ä–ç1, X’JGŒő1, ×“c@Œj1, ”óŒűŸ•F2, ŽR‰şŒpŽj1, ‹e’rŽj˜Y3, Źň˜aŽO˜Y2, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ, 34•a‰@˜AŒg‹łˆç): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/16), –źŒĂ‰Ž.

723321. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“šŠŕNear T4Ç—á‚ɑ΂ˇ‚鎥—Ð헪. ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, ×“c@Œj1, ŽOd–ě_˜N1, ]ŠÔ@—ć1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/16), –źŒĂ‰Ž.

723322. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘¤‰çˆĘ‹C‹š + ƒƒ“ƒ|ƒCƒ“ƒg”ź• ‰çˆĘ–@‚É‚ć‚é’čŒ^Žčp. •Đ“c‰Ä–ç1, X’JGŒő1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, ×“c@Œj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/16), –źŒĂ‰Ž.

723323. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘˝•Ď—ʉđÍ‚đ—p‚˘‚˝‘ŠúˆÝŠŕESDŒă’ljÁŠO‰ČŘœÇ—á‚É‚¨‚Ż‚郊ƒ“ƒpß“]ˆÚ—\‘ވöŽqSM2ˆČ[‚¨‚ć‚э‚“xƒŠƒ“ƒpŠÇNP (ly2/ly3) ‚Ě“Ż’č. Îˆä@’q1, ŽR‰şŒpŽj2, ŽOd–ě_˜N2, X’JGŒő2, ×“c@Œj2, •Đ“c‰Ä–ç2, ‹e’rŽj˜Y3, Źň˜aŽO˜Y4, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç, 4Á‰ťŠí“ŕ): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/16), –źŒĂ‰Ž.

723324. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “űŠŕŠ”‰ť×–E‚ɑ΂ˇ‚éƒtƒFƒjƒ‹ƒuƒ`ƒŒ[ƒg‚ĚŒř‰Ę‹y‚ŃŽĄ—ĂŒř‰Ę—\‘ވâ“`Žq‚Ě’Tő. ‹e’r^—Žq1, ŽR‰şŒpŽj1, ˜m’J”ü“Ţ1, “ě’JŘ•äŽq2, ‹‹vGŽ÷2, ŒĂé@Œ›2, ]ŠÔ@—ć1, ź‹{—mŽj1, Źâ–ůŒŤ1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/16), –źŒĂ‰Ž.

723325. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹‘ĺH“š—ôEƒwƒ‹ƒjƒA‚ɑ΂ˇ‚éŠO‰ČŽĄ—Ă‚ĚŽĄ—ĂŒř‰Ę‚Ć–â‘č“_`ˆÝH“š‹t—Ź‚Ě•a‘Ô•]‰ż‚ĚŠĎ“_‚Š‚ç`. ×“c@Œj1, •Đ“c‰Ä–ç1, ŽOd–슰˜N1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/17), –źŒĂ‰Ž.

723326. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) p‘O‰ťŠw•úŽËüŽĄ—ĂŒă‚Ě• o‹ž‰şŽčp. ’†‘ş—˛r1, ˛“Ą•˜Y1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, “n粏š•F1 (1ŠO‰Č): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/17), –źŒĂ‰Ž.

723327. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ’°Šŕ‚É‚¨‚Ż‚éSurgicalsiteinfection‚ĚƒŠƒXƒNˆöŽq—\‘Ş. “c’†r“š1, ˛“Ą•˜Y2, ŽR‰şŒpŽj2, “›ˆä“ÖŽq2, ŽO‰YŒ[šć2, ŽR—œ‚L2, Ź‘q’źl, “ŕ“Ął‹K2, ’†‘ş—˛r2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/17), –źŒĂ‰Ž.

723328. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ’°Šŕ‡•š’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚éŠO‰ČŽĄ—Ă‚Ě•Ď‘J‚ƐŹŃ. “ŕ“Ął‹K1, ’†‘ş—˛r1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/17), –źŒĂ‰Ž.

723329. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş—H–ĺ•Ű‘śˆÝŘœp (Laparoscopy-Assisted Pylorus-Preserving Gastrectomy: LAPPG) ‚É‚¨‚Ż‚é—H–剺Ă–Ź‚Ě•ŞŽ}ƒpƒ^[ƒ“‚ĆŽčpŹŃ. źŕVL‹ą1, ŽR‰şŒpŽj2, ŸN–{Mˆę, Îˆä@’q1, ‹‹vGŽ÷1, ]ŠÔ@—ć2, ŽOd–ě_˜N2, X’JGŒő2, ×“c@Œj2, •Đ“c‰Ä–ç2, ‹e’rŽj˜Y3, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/17), –źŒĂ‰Ž.

723330. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠŕ‚É‚¨‚Ż‚éŠŕ“ÁˆŮ“ICysteine dioxygenase type 1 (CDO1) ˆâ“`Žq‚ĚDNAƒƒ`ƒ‹‰ť‚Ě—Ő°“IˆÓ‹`. ×“c@Œj1, ŽR‰şŒpŽj1, ‹‹vGŽ÷2, ŽOd–ě_˜N1, X’JGŒő1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y3, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/17), –źŒĂ‰Ž.

723331. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Stage I/II‘ĺ’°Šŕ‚É‚¨‚Ż‚éÄ”­ŠëŒŻˆöŽq‚¨‚ć‚Ń—\Œă—\‘ވöŽq‚ĚŒŸ“˘. ŒĂé@Œ›1, “ŕ“Ął‹K2, ŽR‰şŒpŽj2, ˛“Ą•˜Y2, Ź‘q’źl, ŽR—œ‚L2, ŽO‰YŒ[šć2, “›ˆä“ÖŽq2, ’†‘ş—˛r2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/18), –źŒĂ‰Ž.

723332. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠŕ‚É‚¨‚Ż‚éŠŕ“ÁˆŮ“ICysteine dioxygenase type 1 (CDO1) ˆâ“`Žq‚ĚDNAƒƒ`ƒ‹‰ť ‚Ě—Ő°“IˆÓ‹`. ]ŠÔ@—ć1, ŽR‰şŒpŽj1, ‹‹vGŽ÷2, ŽOd–ě_˜N1, X’JGŒő1, ×“c@Œj1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y3, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/18), –źŒĂ‰Ž.

723333. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹‘ĺH“š—ôEƒwƒ‹ƒjƒA‚ɑ΂ˇ‚éŠO‰ČŽĄ—Ă‚ĚŽĄ—ĂŒř‰Ę‚Ć–â‘č“_`ˆÝH“š‹t—Ź‚Ě•a‘Ô•]‰ż‚ĚŠĎ“_‚Š‚ç`. X’JGŒő1, •Đ“c‰Ä–ç1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/18), –źŒĂ‰Ž.

723334. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠisSóŒ‹’°Šŕ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚Ě—L—pŤ|T4Ç—á‚É‚¨‚Ż‚éŽčpŽč‹Z‚Ěƒ|ƒCƒ“ƒg|. ŽR—œ‚L1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, Ź‘q’źl, “ŕ“Ął‹K1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/18), –źŒĂ‰Ž.

723335. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) pŒă•â•‰ťŠw—Ă–@‚đŽ{s‚ł‚ę‚˝StageIIIŒ‹’°Šŕ‚Ě—\ŒăˆöŽq‰đÍ. ‰ĄˆäŒ\Œĺ1, “ŕ“Ął‹K2, ŽR‰şŒpŽj2, ŒĂé@Œ›1, “›ˆä“ÖŽq2, ŽO‰YŒ[šć2, ŽR—œ‚L2, Ź‘q’źl, ˛“Ą•˜Y2, ’†‘ş—˛r2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/18), –źŒĂ‰Ž.

723336. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ŕŽ‹‹žŽĄ—Ă‚É‚ć‚čŒ‹Îœ‹Ž‚đs‚Á‚˝ŹŽ™‘’_ŠÇŒ‹Î2—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć52‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠwpW‰ď (2015/5/28), _ŒË.

723337. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Borderline resectableäXŠŕ‚Ć‚ť‚ĚŽĄ—Ă•űjBorderline resectableäXŠŕ‚ĆUnresectableäXŠŕ‚ɑ΂ľ, p‘OŽĄ—ĂŒă‚ÉR0Řœ‚ľ‚˝Ç—á‚̏p‘O‰ć‘œ‚Ć•a—‚Ě˜¨—Ł. “c“‡@O1, ŒGŒł—Y‰î1, źŽR@—ş1, ‹v•Ű”CŽj1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć27‰ń“ú–{ŠĚ’_äXŠO‰ČŠw‰ďEŠwpW‰ď (2015/6/11), “Œ‹ž.

723338. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –Ŕ‚í‚Č‚˘ŠmŽŔ‚ČäX•Ť‡p‚đ–ÚŽw‚ľ‚Ä Š`“cŒ´–@‚ĚƒRƒ“ƒZƒvƒg‚𒉎Ŕ‚ɍČť‚ˇ‚é‚˝‚ß‚ĚäX‹ó’°ŠŃ’Ę–§’…•Ť‡–@‚̍H•v. ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, ‹v•Ű”CŽj1, źŽR@—ş1, •Đ‹ËŠ°”V, ŒĂ“cˆę“ż, ‚‹´’ől1, “n粏š•F1 (1ŠO‰Č): ‘ć27‰ń“ú–{ŠĚ’_äXŠO‰ČŠw‰ďEŠwpW‰ď (2015/6/11), “Œ‹ž.

723339. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰şŠĚŘœ‚É‚¨‚Ż‚é×ŒaççŽq‚̉ž—p. ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “c“‡@O1, ‹v•Ű”CŽj1, źŽR@—ş1, “n粏š•F1 (1ŠO‰Č): ‘ć27‰ń“ú–{ŠĚ’_äXŠO‰ČŠw‰ďEŠwpW‰ď (2015/6/12), “Œ‹ž.

723340. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) äX”X–EŤŽžŠł‚ĚŽĄ—Ă•űj IPMN‚ĚŽčp“K‰ž‚ĆŽŠ“KpŽŽ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. źŽR@—ş1, ŒGŒł—Y‰î1, “c“‡@O1, ‹v•Ű”CŽj1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć27‰ń“ú–{ŠĚ’_äXŠO‰ČŠw‰ďEŠwpW‰ď (2015/6/12), “Œ‹ž.

723341. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹~‹}ŠO—ˆ‚Ĺ‘}ŠÇ‚đŽ{s‚ľ‚˝čň•”ůN–EŤŽîáŽ2—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1, ˆŔ“Ą@Žő3, ‰iˇ—T‰ŔŽq3, Œ´ŒűŒ[”V‰î3 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ŹŽ™): ‘ć29‰ń“ú–{ŹŽ™‹~‹}ˆăŠw‰ďŠwpW‰ď (2015/6/12), ‚ł‚˘‚˝‚Ü.

723342. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) f’fEŽĄ—Ă‚É‹ę—ś‚ľ‚˝“űŽ™‹}Ť‰AůNÇ2Ç—á. ćс@—T—ş1, “c’†@Œ‰2, •“cŒ›Žq1, Š`Œ´@’m1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć29‰ń“ú–{ŹŽ™‹~‹}ˆăŠw‰ďŠwpW‰ď (2015/6/12), ‚ł‚˘‚˝‚Ü.

723343. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) IPMN‚̏pŒăfollow‚ÉŠÖ‚í‚鏔–â‘č IPMNpŒă‚ĚŽcäXÄ”­‚ĆŽcäXIPMN‚ɂ‚˘‚Ä‚ĚŒŸ“˘. źŽR@—ş1, ŒGŒł—Y‰î1, “c“‡@O1, ‹v•Ű”CŽj1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć46‰ń“ú–{äX‘ŸŠw‰ď‘ĺ‰ď (2015/6/20), –źŒĂ‰Ž.

723344. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) IPMN‚̏pŒăfollow‚ÉŠÖ‚í‚鏔–â‘č IPMNpŒăŽcäXŘœ88—á‚ĚŒŸ“˘‚Š‚猊‚˝pŒăfollow‚Ě–â‘č“_. ‘ëě@ő, –k‹˝@ŽŔ, ‰Í–”@Š°1, ”–ě@—, źˆä~ˆę (1ŠO‰Č): ‘ć46‰ń“ú–{äX‘ŸŠw‰ď‘ĺ‰ď (2015/6/20), –źŒĂ‰Ž.

723345. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “űŠŕ‚É‚¨‚Ż‚éHOPXˆâ“`Žqƒƒ`ƒ‹‰ť‚Ě—Ő°“IˆÓ‹`. ‹e’r^—Žq1, ŽR‰şŒpŽj1, ˜m’J”ü“Ţ1, “ě’JŘ•äŽq2, ź‹{—mŽj1, ‰Á“Ą@O1, Źâ–ůŒŤ1, ĺÎ‹I•F1, ‰|–{‘ń–Î1, ’J–ě—Tˆę1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć23‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2015/7/2), “Œ‹ž.

723346. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “űŠŕp‘O‰ťŠw—Ă–@ (PST) Ç—á‚É‚¨‚Ż‚éSPECT/CT‚đ—p‚˘‚˝ƒZ ƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpß”­Œť‚Ě•ŞÍ. ĺU•Ŕ@Ÿ, ź‹{—mŽj1, ˜m’J”ü“Ţ1, ĺÎ‹I•F1, ’J–ě—Tˆę1, “n粏š•F1 (1ŠO‰Č): ‘ć23‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2015/7/2), “Œ‹ž.

723347. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) FECŽ{s“űŠŕŠłŽŇ‚É‚¨‚Ż‚é”­”MŤD’†‹…Œ¸­Ç”­Ç‚ÉŠÖ‚ˇ‚錟“˘. Œď]‚ß‚Ž‚Ý1, ‹e’r^—Žq1, “ě’JŘ•äŽq2, ź‹{—mŽj1, ‰Á“Ą@O1, Źâ–ůŒŤ1, ‰|–{‘ń–Î1, ĺÎ‹I•F1, ’J–ě—Tˆę1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć23‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2015/7/3), “Œ‹ž.

723348. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) p‘O‰ťŠw—Ă–@‚đŽ{s‚ľ‚˝triple negative“űŠŕÇ—á‚É‚¨‚Ż‚é BRCAness‚ÉŠÖ‚ˇ‚錟“˘. –žÎ’čŽq, ŹâŒŤ–ů1, “ě’JŘ•äŽq2, ‹e’r^—Žq1, ˜m’J”ü“Ţ1, ‰|–{‘ń–Î1, ĺÎ‹I•F1, ’J–ě—Tˆę1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć23‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2015/7/3), “Œ‹ž.

723349. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éPTX + Bv| FEC‚É‚ć‚éPST‚ĚŒŸ“˘. “Ą–ěŽjD1, ‰Í–ě—uŽq1, “ě’JŘ•äŽq2, ‹e’r^—Žq1, ź‹{—mŽj1, ˜m’J”ü“Ţ1, ‰Á“Ą@O1, ‰|–{‘ń–Î1, ’J–ě—Tˆę1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć23‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2015/7/3), “Œ‹ž.

723350. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “űŠŕŽĄ—Ă‚É‚¨‚Ż‚étri-weekly nab-paclitaxel ‚Ćweekly paclitaxel ‚Ě•›ě—p’˛¸. ź‹{—mŽj1, ˜m’J”ü“Ţ1, Źâ–ůŒŤ1, ĺÎ‹I•F1, ’J–ě—Tˆę1, Œú“cKˆę˜Y2 (1ŠO‰Č, 2–ňÜ•”): ‘ć23‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2015/7/3), “Œ‹ž.

723351. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “űŠŕ‚É‚¨‚Ż‚éCDO1ˆâ“`Žqƒƒ`ƒ‹‰ť‚Ć—Ő°•a—Šw“IˆöŽq‚ĚŒŸ“˘. ˜m’J”ü“Ţ1, ‹e’r^—Žq1, ź‹{—mŽj1, Źâ–ůŒŤ1, ‰Á“Ą@O1, ‰|–{‘ń–Î1, ĺÎ‹I•F1, ’J–ě—Tˆę1, “n粏š•F1 (1ŠO‰Č): ‘ć23‰ń“ú–{“űŠŕŠw‰ďŠwp‘‰ď (2015/7/2-4), “Œ‹ž.

723352. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“šˆÝŠÇŠíŠB•Ť‡‚̍H•v. X’JGŒő1, •Đ“c‰Ä–ç1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć69‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2015/7/3), ‰Ą•l.

723353. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“š‰^“ŽáŠQ‚̐f—Á|V‚ľ‚˘f’f–@‚ĆĹ‚ŕ—LŒř‚ČŽĄ—Âɂ‚˘‚ā|ƒAƒJƒ‰ƒVƒA‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚̐ŹŃ‚Ć–â‘č“_: ’źüŒ^‚ĆƒVƒOƒ‚ƒCƒhŒ^‚Ě”äŠr. •Đ“c‰Ä–ç1, X’JGŒő1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć69‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2015/7/3), ‰Ą•l.

723354. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“šŠŕ‚̏p‘O•â•—Ă–@‚ĚŒ÷ß|•â•—Ă–@–łŒř—á‚Ě‘I•Ę‚ĆŽüpŠú‚Ě‘Îô: H“šŠŕ‚̏p‘O•â•—Ă–@‚ĚŒ÷ß. ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, Œ˜“ce—˜2, ”óŒűŸ•F2, ×“c@Œj1, ŽOd–ě_˜Y1, ŹXłŽq3, ‹e’rŽj˜Y4, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ, 3•úŽËü (Žîá‡), 44•a‰@˜AŒg‹łˆç): ‘ć69‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2015/7/3), ‰Ą•l.

723355. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“šŠŕpŒă‡•šÇ‚ĚƒŠƒXƒN‰đÍ. ×“c@Œj1, •Đ“c‰Ä–ç1, X’JGŒő1, źŕVL‹ą2, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, ‹e’rŽj˜Y3, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć69‰ń“ú–{H“šŠw‰ďŠwpW‰ď (2015/7/3), ‰Ą•l.

723356. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Š`“cŒ´–@‚ĚƒRƒ“ƒZƒvƒg‚đŽŔŒť‚ˇ‚é‚˝‚ß‚ĚäX‹ó’°ŠŃ’Ę–§’…•Ť‡–@‚É‚¨‚Ż‚éH•v. ŒGŒł—Y‰î1, ŠC’Ă‹MŽj1, “c“‡@O1, ‹v•Ű”CŽj1, źŽR@—ş1, •Đ‹ËŠ°”V, ŒĂ“cˆę“ż, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/15), •lź.

723357. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹šo‹ž‰şH“šŠŕŽčp: ‘¤‰çˆĘ‹C‹š+ƒƒ“ƒ|ƒCƒ“ƒg”ź• ‰çˆĘ–@‚É‚ć‚écŠuƒŠƒ“ƒpßŠf´‚̍H•v. •Đ“c‰Ä–ç1, X’JGŒő1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, ×“c@Œj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/15), •lź.

723358. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –ü’…ŤƒCƒŒƒEƒX‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚ĚŒŸ“˘. “›ˆä“ÖŽq1, ’†‘ş—˛r1, ŽO‰YŒ[šć1, ŒĂé@Œ›2, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, ˛“Ą•˜Y1, Îˆä—ǍK, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/15), •lź.

723359. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) cStage II/IIIH“šŠŕ‚ɑ΂ˇ‚éDCF“ą“ü—Ă–@‚É‚ć‚échemoselection‚Ě—Ő°“Iƒ|ƒeƒ“ƒVƒƒƒ‹. ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, Œ˜“ce—˜2, X’JGŒő1, ×“c@Œj1, ŽOd–ě_˜N1, ŹXłŽq3, ‹e’rŽj˜Y4, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ, 3•úŽËü (Žîá‡), 44•a‰@˜AŒg‹łˆç): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/16), •lź.

723360. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠisŒ‹’°Šŕ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚Ě—L—pŤ|T4Ç—á‚É‚¨‚Ż‚éŽčpŽč‹Z|. ŽR—œ‚L1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, Ź‘q’źl, “ŕ“Ął‹K1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/16), •lź.

723361. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“š—ŢŠî’ę×–EŠŕ (BSC) ‚Ě—Ő°•a—Šw“I“Á’Ľ‚Ć–â‘č“_. ”óŒű@Ši1, X’JGŒő1, “Ą—ŃĐ”ü, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y2, ‘ĺ•”@˝3, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç, 3ˆă—ÉqśŠw•”): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/16), •lź.

723362. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) isˆÝŠŕŠłŽŇ‚É‚¨‚Ż‚épŒă•â•‰ťŠw—Ă–@Š´ŽóŤ—\‘Ş-Cysteine dioxygenase type 1ˆâ“`ŽqDNAƒƒ`ƒ‹‰ť‚đ—p‚˘‚Ä. ]ŠÔ@—ć1, ŽR‰şŒpŽj1, ‹‹vGŽ÷2, ŽOd–ě_˜N1, X’JGŒő1, ×“c@Œj1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y3, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/16), •lź.

723363. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • –Œ“]ˆÚ—zŤ (P1 and/or CY1) ˆÝŠŕ‚ɑ΂ˇ‚éDCS—Ă–@Œă‚Ěconversion surgery. ŽOd–ě_˜N1, •Đ“c‰Ä–ç1, X’JGŒő1, ×“c@Œj1, ”óŒűŸ•F, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, Źň˜aŽO˜Y3, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç, 3Á‰ťŠí“ŕ): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/16), •lź.

723364. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Collard•Ď–@—p‚˘‚˝H“šˆÝŠÇ•Ť‡‚̍H•v`ŠmŽŔ‚ČÄŒš‚đ–ÚŽw‚ľ‚ā`. X’JGŒő1, •Đ“c‰Ä–ç1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/17), •lź.

723365. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) IPMN‚ĚŽčp“K‰ž‚ɂ‚˘‚Ä‚ĚŒŸ“˘. źŽR@—ş1, ŒGŒł—Y‰î1, “c“‡@O1, ‹v•Ű”CŽj1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/17), •lź.

723366. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰ď‰A‘nŠ´ő‚ĚŠëŒŻˆöŽq‚ĚŒŸ“˘. ’†‘ş—˛r1, ˛“Ą•˜Y1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/17), •lź.

723367. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠis’ź’°Šŕ‚ɑ΂ˇ‚鎊“K‚ȏWŠw“IŽĄ—Ă‚đŒŸ“˘‚ˇ‚é`p‘O‰ťŠw•úŽËü—Ă–@‚Ć• o‹ž‰şŽčp‚ĚŽĄ—ÐŹŃ`. “ŕ“Ął‹K1, ˛“Ą•˜Y1, ’†‘ş—˛r1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/17), •lź.

723368. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œ‹’°ŠŕpStage III‚Ě“–‰@‚É‚¨‚Ż‚鎥—ÐŹŃ (75ÎˆČă‚Ć74ÎˆČ‰ş‚Ě”äŠr). ŽO‰YŒ[šć1, ’†‘ş—˛r1, “›ˆä“ÖŽq1, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/17), •lź.

723369. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“šˆÝÚ‡•”‘ŠúŠŕ‚ĚŽĄ—Ð헪. ×“c@Œj1, •Đ“c‰Ä–ç1, ŽR‰şŒpŽj1, X’JGŒő1, ŽOd–ě_˜N1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/17), •lź.

723370. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰şÄŠĚŘœÇ—á‚ĚŒŸ“˘. ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, źŽR@—ş1, “c“‡@O1, ‹v•Ű”CŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/17), •lź.

723371. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş”ö‘¤äXŘœ‚Ĺ‚ĚƒsƒbƒgƒtƒH[ƒ‹‚Ć‚ť‚̍H•v. “c“‡@O1, ŒGŒł—Y‰î1, źŽR@—ş1, ‹v•Ű”CŽj1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{Á‰ťŠíŠO‰ČŠw‰ď‘‰ď (2015/7/17), •lź.

723372. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ’°Šŕi“W‚É‚¨‚Ż‚鍜‘—R—ˆ—}§×–E‚ĚˆÓ‹`. ‰Á“Ą@O1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć24‰ń“ú–{‚Ş‚ń“]ˆÚŠw‰ďŠwpW‰ďE‘‰ď (2015/7/24), ‘ĺă.

723373. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒgƒ}•Â˝‘n‚đ—˜—p‚ľ‚˝• o‹ž‰şŠĚŘœ. “Ą“căĕ˝1, ŠC’Ă‹MŽj1, “Ą”örˆň1, ’†ź@—ş1, źŽR@—ş1, ‰Í–”@Š°1, “c“‡@O1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): 4th Reduced Port Surgery Forum 2015 in Akita (2015/8/1), H“c.

723374. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş”ö‘¤äXŘœ (LDP) ‚Ĺ‚Ě×ŒaƒŠƒgƒ‰ƒNƒ^[‚ĚŽg—pŒoŒą. “c“‡@O1, ŒGŒł—Y‰î1, źŽR@—ş1, ‰Í–”@Š°1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): 4th Reduced Port Surgery Forum 2015 in Akita (2015/8/1), H“c.

723375. [Šw‰ď (‘S‘)] (ˆę”ʉ‰‘č) ’_“š•Â˝ÇpŒă–ĺ–Źˆł˜´iÇ‚É”ş‚¤ˆÝH“šĂ–ŹáŽ‚ɑ΂ľ“ŕŽ‹‹ž“IĂ–ŹáŽŒ‹ăFpEVL‚đs‚˘, ŠĚˆÚA‚Ü‚Ĺ—ÇD‚ÉŒo‰ß‚Ĺ‚Ť‚˝“űŽ™‚Ě1—á. •“cŒ›Žq1, “ú‚@‰›2, ŽRŞŒhŽq3, “c’†@Œ‰4, Š`Œ´@’m1, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć22‰ń“ú–{–ĺ–Źˆł˜´iÇŠw‰ď‘‰ď (2015/9/10), ‰Ą•l, “ú–{–ĺ–Źˆł˜´iÇŠw‰ďŽGŽ 2015/8; 21 (3): 148.

723376. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’_ůN‰źŤ“Ž–ŹáŽ”j—ô‚É‚ć‚č’_”X“ŕoŒŒ‚đ—ˆ‚ľ‚˝1—á. ‰Í–”@Š°1, ‘ëě@ő, źˆä~ˆę (1ŠO‰Č): ‘ć51‰ń“ú–{’_“šŠw‰ďŠwpW‰ď (2015/9/17), ‰F“s‹{.

723377. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) PPARƒÂ‚ÍCD11b + CD103 + Ž÷ó×–E‚đ‰î‚ľ‚ĉŠÇŠÖ˜A‘ĺ’°Žîá‡. ‰Á“Ą@O1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8), –źŒĂ‰Ž.

723378. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş‘ĺ’°ŠŕŽčp‚Í’áNP‚Ć‚˘‚Ś‚é‚Š. ’†‘ş—˛r1, “n粏š•F1, ˛“Ą•˜Y1 (1ŠO‰Č): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8), –źŒĂ‰Ž.

723379. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“šŠŕ‚É‚¨‚Ż‚é—\Œă—\‘ރoƒCƒIƒ}[ƒJ[ CDO1ˆâ“`Žqƒƒ`ƒ‹‰ť. ŽR‰şŒpŽj1, ‹‹vGŽ÷2, ]ŠÔ@—ć1, X’JGŒő1, ×“c@Œj1, ŽOd–ě_˜N1, •Đ“c‰Ä–ç1, ‰Á“Ą@O1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/9), –źŒĂ‰Ž.

723380. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) is‰ş•”’ź’°Šŕ‚ɑ΂ˇ‚ép‘O‰ťŠw•úŽËü—Ă–@‚ĚŽĄ—Ă•]‰ż‚Ć’ˇŠú—\Œă. ’†‘ş—˛r1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (JDDW 2015) (2015/10/9), “Œ‹ž.

723381. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ’°Šŕ‚ĚŠĚ“]ˆÚÇ—á‚ɑ΂ˇ‚鎥—Ð헪. ˛“Ą•˜Y (ŠO‰Č): ‘ć23‰ń“ú–{Á‰ťŠíŠÖ˜AŠw‰ďTŠÔ (JDDW 2015) (2015/10/9), “Œ‹ž.

723382. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Pure laparoscopic caudate hepatectomy for cancer:Surgical technique and a report of a case. źŽR@—ş1, ŠC’Ă‹MŽj1, ‰Í–”@Š°1, “c“‡@O1, ŒG–{—Y‰î1, “n粏š•F1 (1ŠO‰Č): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s.

723383. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Siewert type IIH“šˆÝÚ‡•”‘BŠŕ‚ɑ΂ˇ‚郊ƒ“ƒpßŠs´Œř‰Ę‚ĆŽŠ“KŠs´”͈Í. ×“c@Œj1, •Đ“c‰Ä–ç1, ŽR‰şŒpŽj1, X’JGŒő1, ŽOd–ě_˜N1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s.

723384. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Stage II/IIIŒ‹’°Šŕ‚ĚÄ”­ƒŠƒXƒN—\‘Ş‚Ć‚ľ‚Ä‚ĚOncotype Dx Colon Cancer Assay‚Ě—L—pŤ. ‹ŕŕVˆŽé, ŽR’†’|t, ŽRčŒ’‘ž˜Y, ŽRŒűŒ¤Ź, Žş@@Œ\, ’r“cłF, “í–{“N–ç, A’|G”V, ˛“Ą•˜Y1, ‰Á“ĄŒ’Žu, m‰Č’q—T, ‰Ť@‰pŽŸ, Ô–؁@‹†, ‘ĺ‹´–ő—Y, ‹g–ěF”V (1ŠO‰Č): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s.

723385. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“šŠŕ‚ĚƒGƒsƒQƒmƒ€‰đÍ‚ĆŽĄ—ĂŒÂ•Ę‰ť‚Ö‚Ě“W–]. ŽR‰şŒpŽj1, ‹‹vGŽ÷2, X’JGŒő1, ×“c@Œj1, ŽOd–ě_˜N1, ]ŠÔ@—ć1, •Đ“c‰Ä–ç1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s.

723386. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‹łŽş‚É‚¨‚Ż‚éStage IIIŒ‹’°Šŕ‚ɑ΂ˇ‚é• o‹ž‰şŒ‹’°Žčp‚Ě’ˇŠúŹŃ. ‰ĄˆäŒ\Œĺ1, “ŕ“Ął‹K2, “c’†r“š1, ŒĂé@Œ›1, “›ˆä“ÖŽq2, ŽO‰YŒ[šć2, ŽR—œ‚L2, Ź‘q’źl, ’†‘ş—˛r2, ˛“Ą•˜Y2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/30), ‹ž“s.

723387. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş‘ĺ’°Řœ‚đŽ{s‚ľ‚˝Stage I/II Œ‹’°Šŕ‚É‚¨‚Ż‚é—\ŒăˆöŽq‚ĚŒŸ“˘. ŒĂé@Œ›1, “ŕ“Ął‹K2, ‰Á“Ą@O2, ˛“Ą•˜Y2, ’†‘ş—˛r2, Ź‘q’źl, ŽR—œ‚L2, ŽO‰YŒ[šć2, “›ˆä“ÖŽq2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/30), ‹ž“s.

723388. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”牺–„‚ߍž‚ÝŒ^’†SĂ–Źƒ|[ƒg‚̍‡•šÇ‚ĚŒŸ“˘. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/31), ‹ž“s.

723389. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒvƒƒvƒ‰ƒmƒ[ƒ‹“ŕ•ž‚É‚ć‚čkŹ‚đ”F‚ß‚˝Klippel-TrenaunayÇŒóŒQ‚Ě1—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć31‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďH‹GƒVƒ“ƒ|ƒWƒEƒ€ (2015/10/31), ŒF–{.

723390. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Japan Clinical Oncology Group Study JCOG0404 (ŠJ• vs• o‹ž‘ĺ’°Řœ) ‚É‚¨‚Ż‚éŽ{ÝŠÔˇ‚̉đÍ. •ĐŽR@G, ŽR–{šˆę˜Y, âV“Ą“T’j, âV“ĄCŽĄ, “Ąˆäłˆę, Źź•ś—Y, Ä“c–F‹v, ’ˇ’Jě”Žr, ‰Ş“‡łƒ, @‘œN”Ž, ˛“Ą•˜Y1, ”ş“oGs, ‰ÔˆäPˆę, ’––“‰ëŽj, –k–쐳„, “‡“cˆŔ”Ž (1ŠO‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž.

723391. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Laparoscopic surgery for locally advanced T4a colon cancer –treatment outcomes and prognostic factors-. ŽR—œ‚L1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, Ź‘q’źl, “ŕ“Ął‹K1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž.

723392. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) StageIII‘ĺ’°ŠŕpŒă‚ĚŽŠ“K‚ČƒT[ƒxƒCƒ‰ƒ“ƒX‚ɑ΂ˇ‚錟“˘. ŒĂé@Œ›1, “ŕ“Ął‹K2, ˛“Ą•˜Y2, ’†‘ş—˛r2, Ź‘q’źl, ŽR—œ‚L2, ŽO‰YŒ[šć2, “›ˆä“ÖŽq2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž.

723393. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚—’°ŠŕŠłŽŇ‚É‚¨‚Ż‚épŒă•â•—Ă–@‚Ě•K—vŤ. ŽO‰YŒ[šć1, ’†‘ş—˛r1, “›ˆä“ÖŽq1, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž.

723394. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚é• o‹ž‰ş‘ĺ’°‘S“Ep‚Ě—L—pŤ‚ĚŒŸ“˘‚Ć•‹y‚Ě‚˝‚ß‚ĚH•v. “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŹŕV•˝‘ž1, ’r“c@“Ä1, ŒĂé@Œ›2, ’†‘ş—˛r1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž.

723395. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éstage 4‘ĺ’°Šŕ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚ĚŒŸ“˘. “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, ŒĂé@Œ›2, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, ’†‘ş—˛r1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž.

723396. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) 85ÎˆČă‚Ě’´‚—îŽŇ‚ɑ΂ˇ‚é‘ĺ’°ŠŕŽčp‚Ě‘Ă“–Ť‚ɂ‚˘‚Ä‚ĚŒŸ“˘. óŒ´Žj‘ě, źˆä~ˆę, Î“c—mŽ÷, ŠÖ–{Nl, Ź‘qłŽĄ, ‰Í–”@Š°1, ‚ŽR@L, ‘ëě@ő, Œ´“c—T‹v, ˛“Ą“š•v (1ŠO‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/13-14), –źŒĂ‰Ž.

723397. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠisŒ‹’°ŠŕT4aÇ—á‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚ĚŒŸ“˘|ŽĄ—ÐŹŃ‚Ć—\Œă—\‘ވöŽq|. ŽR—œ‚L1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, Ź‘q’źl, “ŕ“Ął‹K1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/13-14), –źŒĂ‰Ž.

723398. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) 3 ESDŽ{sŒă‚ɒljÁŘœ‚đs‚Á‚˝‘ŠúˆÝŠŕ‚Ě1—á. •˝—ÇŽŃŒŽ, ŽOd–ě_˜N1, Œ´“cG‹P1, ŽO‘ş—I—S, ‰Ą“c˜aŽq1, X’JGŒő1, ×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723399. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒRƒ“ƒsƒ…[ƒ^ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚É‚ć‚éˆÝŠŕ‚̐V‚ľ‚˘f’f–@: MD-CT‚đ—p‚˘‚˝ŽîᇂĚ3ŽŸŒł—§‘̍\’z, ‘̐ϒl‘Ş’č‚Ě—Ő°“IˆÓ‹`‚ƏŤ—ˆ‚Ö‚Ě“W–]. ‹e’rŽj˜Y1, ŽOd–ě_˜N2, X’JGŒő2, ×“c@Œj2, ŽR‰şŒpŽj2, •Đ“c‰Ä–ç2, “n粏š•F2 (14•a‰@˜AŒg‹łˆç, 2ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723400. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒƒ{ƒbƒgŽx‰‡ˆÝŘœp‚Ě“ą“ü‚ÉŰ‚ˇ‚éƒsƒbƒgƒtƒH[ƒ‹‚Ć‘Îô. •Đ“c‰Ä–ç1, ×“c@Œj1, ŽOd–ě_˜N1, X’JGŒő1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723401. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹Ů‹}ŽčpŒă‹~–˝‚ľ“ž‚˝, ’_ŠÇƒXƒeƒ“ƒgˆí’E‚É‚ć‚鏬’°úE‚Ě1—á. ŽO‘ş—I—S, ×“c@Œj1, Œ´“cG‹P1, ‰Ą“c˜aŽq1, ŽOd–ě_˜N1, X’JGŒő1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723402. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽcˆÝŠŕŽčp—á‚É‚¨‚Ż‚é—Տ°•a—Šw“I—\ŒăˆöŽq‚ĚŒŸ“˘‚ĆˆÓ‹`. ]ŠÔ@—ć1, ŽR‰şŒpŽj1, “ě’JŘ•äŽq2, ‹‹vGŽ÷2, źŕVL‹ą2, Îˆä@’q2, ŽOd–ě_˜N1, X’JGŒő1, ×“c@Œj1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y3, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 34•a‰@˜AŒg‹łˆç): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723403. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ă•”“ŕŽ‹‹ž“I”S–Œ‰ş‘w”—Łp (ESD) Œă‚ɒljÁŘœ‚đs‚Á‚˝‘ŠúˆÝ‘BG•˝ă”çŠŕ‚Ěˆę—á. ź–{ŒőŒ\, ŽOd–ě_˜N1, •yˆä‘ĺ“ń˜Y, ‰Ą“c˜aŽq1, Œ´“cG‹P1, X’JGŒő1, ×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, “n粏š•F1 (1ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723404. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“šŠŕ‚ɑ΂ˇ‚é Minimally invasive surgery (MIS). ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, ×“c@Œj1, ŽOd–ě_˜N1, “n粏š•F1 (1ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723405. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰şŽčp‚É‚ÄŘœ‚ľ“ž‚˝‚“x’_ŠÇZ‚𔺂¤‘ĺ’°ŠŕŠĚ“]ˆÚ‚Ě2—á. Îčƒ˜Y, źŽR@—ş1, “Ą“căĕ˝1, “Ą”örˆň1, ’†ź@—ş1, ‰Í–”@Š°1, “c“‡@O1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723406. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş‘ĺ’°ŠŕŽčp‚É‚¨‚Ż‚é‘nŠ´őŠëŒŻˆöŽq‚ĚŒŸ“˘. ’†‘ş—˛r1, ˛“Ą•˜Y1, ŽR‰şŒpŽj1, “ŕ“Ął‹K1, ŽR—œ‚L1, Ź‘q’źl, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723407. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž•â•‰ş•Ź–呤ˆÝŘœŒă‚ĚMII-pH study‚đ—p‚˘‚˝•a‘Ô‰đÍ. ŸN’J”ü‹MŽq1, •Đ“c‰Ä–ç1, X’JGŒő1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723408. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) —ź‘¤“űŠŕpŒă‚ĚŒo‰ß’†‚É”F‚ß‚˝ƒCƒŒƒEƒX‚𔺂¤’ź’°“]ˆÚ‚Ě1—á. ‰iˆäˆŸˆß, ĺÎ‹I•F1, “Ą–ěŽjD1, ‰Í–ě—uŽq1, M‘žşŽq1, ‹e’r^—Žq1, “ě’JŘ•äŽq2, ˜m’J”ü“Ţ1, Źâ–ůŒŤ1, ‰|–{‘ń–Î1, ’J–ě—Tˆę1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.

723409. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) MII|pH‚ŞŽĄ—Ă•űjŒˆ’č‚É—L—p‚Ĺ‚ ‚Á‚˝‹‘ĺH“š—ôEƒwƒ‹ƒjƒA‚Ěˆę—á. ‰Ą“c˜aŽq1, X’JGŒő1, Œ´“cG‹P1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/27), •Ÿ‰Ş.

723410. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) iNŤƒCƒŒƒEƒX‚đ—ˆ‚ľ‚˝MeckelŒeŽş‚Ěˆę—á. ‰––ĄŒcŽq, Ź›¸Œc‘ž, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, ˛“Ą•˜Y1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/27), •Ÿ‰Ş.

723411. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) pŒăŠĚ”^á‡‚đ‡•š‚ľ‚˝–Ó’°Šŕ‚Ě1—á. ”óŒű@Ši1, ’†‘ş—˛r1, ”‹Œ´çŒb1, b”ă“c•Žu1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/27), •Ÿ‰Ş.

723412. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) —ŤŠO‰Čˆă‚Ş–ÚŽw‚ˇf—ÉȂÖ. “›ˆä“ÖŽq1, •“cŒ›Žq1, ˜m’J”ü“Ţ1, M‘žşŽq1, ‹e’r^—Žq1, “ě’JŘ•äŽq2, ’†‘ş—˛r1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/27), •Ÿ‰Ş.

723413. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­ŤŹ’°‹ˇó‚Ě1—á. Ź›¸Œc‘ž, ’†‘ş—˛r1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, ˛“Ą•˜Y1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/27), •Ÿ‰Ş.

723414. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş‚ÉŽčp‚ľ‚Ś‚˝–Ó’°ŒeŽşoŒŒTAEŒă‚ɔĔ­Ť• –Œ‰Š‚đ’ć‚ľ‚˝1—á. ”‹Œ´çŒb1, ’†‘ş—˛r1, ˛“Ą•˜Y1, ”óŒű@Ši1, b”ă“c•Žu1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/27), •Ÿ‰Ş.

723415. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) p‘Od—ąŽqüŽĄ—Ă‚đs‚Á‚˝äX“Ş•”Šŕ‚Ěˆę—á. “Ą”örˆň1, ŠC’Ă‹MŽj1, “Ą“căĕ˝1, ’†ź@—ş1, źŽR@—ş1, ‰Í–”@Š°1, “c“‡@O1, ŒGŒł—Y‰î1, ‰Ş“c’ź”ü, ˆŔź@˝, ŽR“c@Ž , ˆéč—R‰Ŕ, “n粏š•F1 (1ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/28), •Ÿ‰Ş.

723416. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž•â•‰şˆÝ‘S“Ep‚É‚¨‚Ż‚éH“š‹ó’°•Ť‡–@|Orvil‚Š‚çFEEA‚ց|. ×“c@Œj1, •Đ“c‰Ä–ç1, ŽOd–ě_˜N1, X’JGŒő1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/28), •Ÿ‰Ş.

723417. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ä`•”ŹŘŠJ•˘•zÚ’…“ŕ—e‰t”rœŒă‚É“Eo‚ľ‚˝ă• •”ŹnŠďŒ`Žî‚Ě1—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć57‰ń“ú–{ŹŽ™ŒŒ‰tE‚Ş‚ńŠw‰ďŠwpW‰ď (2015/11/27), b•{.

723418. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –{–M‚ĚSSI—\–hƒoƒ“ƒhƒ‹‚ĚŒü‚Š‚¤ć‚Í? ’†‘ş—˛r (ŠO‰Č): ‘ć28‰ń“ú–{ŠO‰ČŠ´őÇŠw‰ď‘‰ďŠwpW‰ď (2015/12/3), –źŒĂ‰Ž.

723419. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Orvil‚đŽg—p‚ľ‚˝• o‹ž‰ş•Ź–呤ˆÝŘœp‚É‚¨‚Ż‚éH“šŽcˆÝ•Ť‡. ×“c@Œj1, •Đ“c‰Ä–ç1, ŽR‰şŒpŽj1, X’JGŒő1, ŽOd–ě_˜N1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/10), ‘ĺă.

723420. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰ĄsŒ‹’°Šŕ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚Ě’čŒ^‰ť‚Ö‚ĚŽć‚č‘g‚Ý. Ź‘q’źl, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, ŽR—œ‚L1, “ŕ“Ął‹K1, ’†‘ş—˛r1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/10), ‘ĺă.

723421. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ž_‰ťÄśƒZƒ‹ƒ[ƒX‡Ź‹zŽűŤ–ü’…–hŽ~ÜƒCƒ“ƒ^[ƒV[ƒh‚ĚˆŔ‘SŤE—L—pŤ‚ɑ΂ˇ‚é‘OŒü‚Ť–łěˆ×”äŠrŽŽŒą. ŽO‰YŒ[šć1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, “›ˆä“ÖŽq1, ’†‘ş—˛r1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/10), ‘ĺă.

723422. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘¤‰çˆĘ‹šo‹ž‰şH“šŘœp‚Ĺ‚Ěp–ě“WŠJ‚̍H•v. X’JGŒő1, •Đ“c‰Ä–ç1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/10), ‘ĺă.

723423. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş‚ɐ؏œ‰Â”\‚Ĺ‚ ‚Á‚˝Œă• –ŒŒ´”­Ť‚̐ŹnůN–EŤŠďŒ`Žî‚Ě1—á. b”ă“c•Žu1, ŽO‰YŒ[šć1, ”‹Œ´çŒb1, ”óŒű@Ši1, “›ˆä“ÖŽq1, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, ’†‘ş—˛r1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/10), ‘ĺă.

723424. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰şˆÝŠÇěŹ‚̍H•v. ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, ×“c@Œj1, ŽOd–ě_˜N1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/10), ‘ĺă.

723425. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) PHYSIOMESHTM‚đ—p‚˘‚Ä• o‹ž‰şƒwƒ‹ƒjƒAC•œp‚đs‚Á‚˝Spigelƒwƒ‹ƒjƒA‚Ě1—á. Œ´“cG‹P1, ×“c@Œj1, ‰Ą“c˜aŽq1, ŽOd–ě_˜N1, X’JGŒő1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

723426. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠisSóŒ‹’°Šŕ‚ɑ΂ˇ‚é• o‹ž‰şŽčp|ŽĄ—ÐŹŃ‚Ć—\ŒăˆöŽq‚ĚŒŸ“˘|. ŽR—œ‚L1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, Ź‘q’źl, “ŕ“Ął‹K1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

723427. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒeŽş‰Š‚É‚ć‚éSóŒ‹’°äNă÷ᑂɑ΂ˇ‚é• o‹ž‰şŽčp6—á‚ĚŒŸ“˘. Îˆä@’q1, ’†‘ş—˛r2, “›ˆä“ÖŽq2, ŽO‰YŒ[šć2, ŽR—œ‚L2, “ŕ“Ął‹K2, ˛“Ą•˜Y2, ŽR‰şŒpŽj2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

723428. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) pŒă‰ń•œ‘Łi‚đ–ÚŽw‚ľ‚˝pŒăáu’ÉŠÇ—`ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“Ă’‰t‚đŽg—p‚ľ‚ā`. “ŕ“Ął‹K (ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

723429. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰Č‚Ĺ‚Ě• o‹ž‰şŠĚŘœ‚É‚¨‚Ż‚éPringle–@‚ĚŽč‹Z‚ƐŹŃ. źŽR@—ş1, ŠC’Ă‹MŽj1, ‰Í–”@Š°1, “c“‡@O1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

723430. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰şˆÝŘœ‚É‚¨‚Ż‚é, Šs´•”ˆĘ‚ɉž‚ś‚˝ƒfƒoƒCƒX‚ĚŽg‚˘•Ş‚Ż. ŽOd–ě_˜N1, •Đ“c‰Ä–ç1, X’JGŒő1, ×“c@Œj1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

723431. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹žŒ‹’°ŠŕŽčp‚̏pŒă‡•šÇ‚ĚŒŸ“˘. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

723432. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –ü’…Ť’°•ÂÇ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚Ě—L—pŤ‚ĚŒŸ“˘. “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, ˛“Ą•˜Y1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/12), ‘ĺă.

723433. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚é• o‹ž‰ş‘ĺ’°‘S“Ep‚ĚŽĄ—ÐŹŃ. “ŕ“Ął‹K1, ˛“Ą•˜Y1, ’†‘ş—˛r1, ŹŕV•˝‘ž1, ’r“c@“Ä1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ŒĂé@Œ›2, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/12), ‘ĺă.

723434. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ŕŽ‹‹žŠO‰ČŽčp‚Ě‹łˆç‚ĹĹ‚ŕ‘ĺŘ‚Č‚ą‚Ƃ͉˝‚Š? ˛“Ą•˜Y1, ’†‘ş—˛r1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/12), ‘ĺă.

723435. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş‚ɐ؏œ‚ľ‚Ś‚˝, • •ÇŽ‰–bŽî‚Ěˆę—á. ‰Ą“c˜aŽq1, ’†‘ş—˛r1, ‘ĺň—z‰î2, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, ŽR—œ‚L1, “ŕ“Ął‹K1, ŽR‰şŒpŽj1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/12), ‘ĺă.

723436. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰şŽčp‚É‚ÄŘœ‚ľ“ž‚˝‚“x’_ŠÇZ‚𔺂¤‘ĺ’°ŠŕŠĚ“]ˆÚ‚Ěˆę—á. “Ą“căĕ˝1, źŽR@—ş1, ’†ź@—ş1, ‰Í–”@Š°1, “c“‡@O1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/12), ‘ĺă.

723437. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş”ö‘¤äXŘœ‚Ě’čŒ^‰ť‚Ö‚ĚŽŽ‚Ý. “c“‡@O1, ŒGŒł—Y‰î1, źŽR@—ş1, ‰Í–”@Š°1, ŠC’Ă‹MŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/12), ‘ĺă.

723438. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ᑍEE”^á‡‚đ‡•š‚ľ‚˝ƒNƒ[ƒ“•a‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚Ě’ZŠúŹŃ. ŒĂé@Œ›1, “ŕ“Ął‹K2, ’†‘ş—˛r2, ˛“Ą•˜Y2, Ź‘q’źl, ŽR—œ‚L2, ŽO‰YŒ[šć2, “›ˆä“ÖŽq2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/12), ‘ĺă.

723439. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž•â•‰ş‚ɐ؏œ‚ľ‚˝‰ń’°’°ŠÇd•ĄÇ‚Ě3—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/12), ‘ĺă.

723440. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) pŒă’°•ÂÇ‚ɑ΂ˇ‚é• o‹ž‰şŽčp‚Ě—L—pŤ. ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć52‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2016/3/3), “Œ‹ž.

723441. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{čňŠŕ‚ɑ΂ľ‚ĉťŠw•úŽËü—Ă–@Œă‚ɈŸ‹}ŤŠú‚É’°•ÂÇ‚đ‚Ť‚˝‚ľ‚˝1—á. Îˆä@’q1, ’†‘ş—˛r2, ˛“Ą•˜Y2, “ŕ“Ął‹K2, ŽR—œ‚L2, “c’†r“š1, ŽR‰şŒpŽj2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć52‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2016/3/4), “Œ‹ž, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ 2016/2; 36 (2): 469.

723442. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ź’°úE‚𐜂ś‚˝IIŒ^’°ŠÇÇŒ^T×–EŤƒŠƒ“ƒpŽî‚Ě1—á. ‘ĺ—F’źŽ÷1, X’JGŒő1, Žt”ö”ɍF, b”ă“c•Žu1, ”óŒű@Ši1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć52‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2016/3/3-4), “Œ‹ž, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ 2016/2; 36 (2): 453.

723443. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠŕ‚É‚¨‚Ż‚éHelicobacter PyloriŠ´ő‚ĆŠŕ/¸‘ƒRŒ´ (CTA) ˆâ“`Žq”­Œť‚ĚŠÖ˜AŤ‚ĚŒŸ“˘. ]ŠÔ@—ć1, “ń“nM]1, •ŸŽR@—˛, ‚‹´’ől1, ź@”ŞŽk, “n粏š•F1 (1ŠO‰Č): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/18), •Ę•{.

723444. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ę–ʂɉž‚ś‚Ä“d‹CƒƒX‚ĆLCS‚đŽg‚˘•Ş‚Ż‚éNo.6Šs´. ŽOd–ě_˜N1, ŽR‰şŒpŽj1, ×“c@Œj1, X’JGŒő1, •Đ“c‰Ä–ç1, “n粏š•F1 (1ŠO‰Č): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/18), •Ę•{.

723445. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H“šˆÝÚ‡•”Šŕ‚ɑ΂ˇ‚éWŠw“IŽĄ—Ă. ×“c@Œj1, ŽR‰şŒpŽj1, X’JGŒő1, ŽOd–ě_˜N1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/18), •Ę•{.

723446. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş•Ź–呤ˆÝŘœp‚É‚¨‚Ż‚éŠĎ‰šŠJ‚Ť–@‚É‚ć‚éH“šŽcˆÝ•Ť‡. ×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, ŽOd–ě_˜N1, X’JGŒő1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/18), •Ę•{.

723447. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Challenge for peritoneal dissemination of gastric cancer from a molecular point of view. ×“c@Œj1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, ]ŠÔ@—ć1, ‹‹vGŽ÷2, X’JGŒő1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/19), •Ę•{.

723448. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The clinical outcome of conversion surgery after DCS chemotherapy in unresectable gastric cancer Department of Surgery. ŽR‰şŒpŽj1, ŽOd–ě_˜N1, ]ŠÔ@—ć1, ‹‹vGŽ÷2, ×“c@Œj1, X’JGŒő1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć88‰ń“ú–{ˆÝŠŕŠw‰ď‘‰ď (2016/3/19), •Ę•{.

733126. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “Ë”­ŤŹ’°‹ˇó‚Ěˆę—á. Ź›¸Œc‘ž, ’†‘ş—˛r1, ˛“Ą•˜Y1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć41‰ń_“ސě‘ĺ’°ăč–厞Šł§˜b‰ď (2015/5/12), ‰Ą•l.

733127. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ś‘¤Œ‹’°Šŕ‚ɑ΂ˇ‚é• o‹ž‰şŽčpŽč‹Z|äBœ]‹Č•”Žö“Ž‚Ěƒ|ƒCƒ“ƒg|. ŽR—œ‚L1, ˛“Ą•˜Y1, “›ˆä“ÖŽq1, ŽO‰YŒ[šć1, Ź‘q’źl, “ŕ“Ął‹K1, ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć69‰ńŽčpŽč‹ZŒ¤‹†‰ď (2015/5/15), ‚č.

733128. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Collard•Ď–@‚É‚ć‚éH“šˆÝŠÇ‹@ŠB•Ť‡‚̍H•v. X’JGŒő1, •Đ“c‰Ä–ç1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć69‰ńŽčpŽč‹ZŒ¤‹†‰ď (2015/5/15), ‚č.

733129. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹‘ĺ• •Çፍ­ƒwƒ‹ƒjƒA‚ɑ΂ˇ‚é• o‹ž‰şŽčp. ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “c“‡@O1, źŽR@—ş1, ‹v•Ű”CŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć69‰ńŽčpŽč‹ZŒ¤‹†‰ď (2015/5/15), ‚č.

733130. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş—H–呤ˆÝŘœp‚ł̊ȕցEˆŔ‘S‚Č‹t従ŽRoux-en-YÄŒš. ŽOd–ě_˜N1, •Đ“c‰Ä–ç1, Ź›¸Œc‘ž, X’JGŒő1, ×“c@Œj1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć69‰ńŽčpŽč‹ZŒ¤‹†‰ď (2015/5/15), ‚č.

733131. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ’°pŒă‚̓Ť‡•šÇ‚ɑ΂ˇ‚錟“˘‚Ć‘Îô. ’†‘ş—˛r1, “n粏š•F1 (1ŠO‰Č): ‘ć69‰ńŽčpŽč‹ZŒ¤‹†‰ď (2015/5/16), ‚č.

733132. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –Ó’°ŒeŽşoŒŒ‚ɑ΂ľ‚ÄTAEŒă‚ɔĔ­Ť• –Œ‰Š‚đ’ć‚ľ‚˝ˆę—á. ”‹Œ´çŒb1, ’†‘ş—˛r1, ˛“Ą•˜Y1, ”óŒű@Ši1, b”ă“c•Žu1, “ŕ“Ął‹K1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć837‰ńŠO‰ČW’k‰ď (2015/6/13), “Œ‹ž.

733133. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ’°ŠŕŠĚ“]ˆÚÇ—á‚ɑ΂ˇ‚éŠĚŘœp‚ĚŒŸ“˘. Ź–ě—˘q1, ç–ěTˆę˜Y1, ]ŠÔ@—ć1, ˜a“c@ŽĄ1, ‹v•Ű”CŽj1, ‹ß“ĄNŽj1, ‚‹´’ől1, ź@”ŞŽk, “n粏š•F1 (1ŠO‰Č): ‘ć83‰ń‘ĺ’°ŠŕŒ¤‹†‰ď (2015/7/3), ‹v—Ż•Ä.

733134. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚̐isEÄ”­‘ĺ’°Šŕ‚ɑ΂ˇ‚éCurBÇ—á‚ĚŽĄ—ÐŹŃ. ŽO‰YŒ[šć1, ’†‘ş—˛r1, “›ˆä“ÖŽq1, ŽR—œ‚L1, Ź‘q’źl, “ŕ“Ął‹K1, ˛“Ą•˜Y1, “n粏š•F1 (1ŠO‰Č): ‘ć83‰ń‘ĺ’°ŠŕŒ¤‹†‰ď (2015/7/3), ‹v—Ż•Ä.

733135. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠŕ‚ɑ΂ˇ‚郍ƒ{ƒbƒgŽx‰‡• o‹ž‰şˆÝŘœp‚Ě“ą“ü. ×“c@Œj1, •Đ“c‰Ä–ç1, ŽOd–ě_˜N1, ŽR‰şŒpŽj1, X’JGŒő1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć48‰ń_“ސěˆÝŠŕŽĄ—ĂŒ¤‹†‰ď (2015/7/4), ‰Ą•l.

733136. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝH“š‹t—ŹÇó‚đ’ć‚ł‚Č‚Š‚Á‚˝‹‘ĺH“š—ôEƒwƒ‹ƒjƒA2Ç—á‚ĚŽĄ—ĂŒoŒą. ‰Ą“c˜aŽq1, X’JGŒő1, Œ´“cG‹P1, ŽOd–ě_˜N1, ×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć24‰ńÁ‰ťŠíŽžŠł•a‘ÔŽĄ—ĂŒ¤‹†‰ď (2015/9/12), “Œ‹ž.

733137. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‹łŽş‚É‚¨‚Ż‚é• o‹ž‰şƒCƒŒƒEƒX‰đœp‚ɑ΂ˇ‚éŽč‹Z‚̍H•v. “n•”WŽq, “ŕ“Ął‹K1, ˛“Ą•˜Y1, ’†‘ş—˛r1, Ź‘q’źl, ŽR—œ‚L1, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, ’†”nŠî”Ž1, “n粏š•F1 (1ŠO‰Č): ‘ć143‰ń_“ŢěŒ§—Տ°ŠO‰ČˆăŠw‰ďW’k‰ď (2015/9/26), ‰Ą•l.

733138. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Klippel-TrenaunayÇŒóŒQ‚ɃŔƒuƒƒbƒJ[“ŕ•žŽĄ—Ă‚Ş—LŒř‚Ĺ‚ ‚Á‚˝1—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć63‰ń_“ސ쏬Ž™Žîᇌ¤‹†‰ď (2015/10/3), ‰Ą•l.

733139. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) CDO1ˆâ“`Žqƒvƒƒ‚[ƒ^[—Ěˆć‚̍‚ƒƒ`ƒ‹‰ť‚ÍStage II/IIIˆÝŠŕ, Stage IIIŒ‹’°Šŕ‚É‚¨‚Ż‚鉝Šw—Ă–@Š´ŽóŤ‚Ć‘ŠŠÖ‚ˇ‚é. ‰ĄˆäŒ\Œĺ1, ŽR‰şŒpŽj2, Îˆä@’q1, “c’†r“š1, źŕVL‹ą1, ‰Á“Ą@O2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć35‰ń“ú–{•ŞŽqŽîᇃ}[ƒJ[Œ¤‹†‰ď (2015/10/7), –źŒĂ‰Ž.

733140. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ’°Šŕ‚É‚¨‚Ż‚éŠĚ“]ˆÚ”\Šl“ž‚ÉŠÖ˜A‚ˇ‚égenomic gain‚ɂ‚˘‚Ä. “c’†r“š1, ŽR‰şŒpŽj2, Îˆä@’q1 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć35‰ń“ú–{•ŞŽqŽîᇃ}[ƒJ[Œ¤‹†‰ď (2015/10/7), –źŒĂ‰Ž.

733141. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠŕ• o×–Ef‚É‚¨‚Ż‚éƒoƒCƒIƒ}[ƒJ[‚Ć‚ľ‚Ä‚ĚCDO1ˆâ“`ŽqDNAƒƒ`ƒ‹‰ť‚ĚŒŸ“˘. ‹‹vGŽ÷1, ŽR‰şŒpŽj2, ]ŠÔ@—ć2, ˜m’J”ü“Ţ2, ‰Á“Ą@O2, ×“c@Œj2, X’JGŒő2, ŽOd–ě_˜N2, ŒĂé@Œ›1, ‹e’r^—Žq2, “ě’JŘ•äŽq1, Îˆä@’q1, “c’†r“š1, ‰ĄˆäŒ\Œĺ1, źŕVL‹ą1, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć35‰ń“ú–{•ŞŽqŽîᇃ}[ƒJ[Œ¤‹†‰ď (2015/10/7), –źŒĂ‰Ž.

733142. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “űŠŕ‚É‚¨‚Ż‚éCDO1ˆâ“`ŽqMethylation‚Ě—Ő°•a—Šw“IˆÓ‹`. “ě’JŘ•äŽq1, ŽR‰şŒpŽj2, ź‹{—mŽj2, ˜m’J”ü“Ţ2, Źâ–ůŒŤ2, ‹e’r^—Žq2, ŒĂé@Œ›1, ‹‹vGŽ÷1, ]ŠÔ@—ć2, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č): ‘ć35‰ń“ú–{•ŞŽqŽîᇃ}[ƒJ[Œ¤‹†‰ď (2015/10/7), –źŒĂ‰Ž.

733143. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “űŠŕŠ”‰ť×–E‚ɑ΂ˇ‚éƒtƒFƒjƒ‹ƒuƒ`ƒŒ[ƒg‚Ě—}§Œř‰Ę‹y‚Ń’ďRŤŒ´ˆöˆâ“`Žq‚Ě’Tő. ‹e’r^—Žq1, ŽR‰şŒpŽj1, ˜m’J”ü“Ţ1, Źâ–ůŒŤ1, “ě’JŘ•äŽq2, ź‹{—mŽj1, ‹‹vGŽ÷2, ŒĂé@Œ›2, ]ŠÔ@—ć1, “n粏š•F1 (1ŠO‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć35‰ń“ú–{•ŞŽqŽîᇃ}[ƒJ[Œ¤‹†‰ď (2015/10/7), –źŒĂ‰Ž.

733144. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ć“VŤ\“ńŽw’°•Â˝ÇpŒă‚ÉäXŠÇŠg’Ł‚ĆäXŠÇ“ŕƒKƒX‚đ”F‚ß‚˝2—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2015/10/10), ‚ł‚˘‚˝‚Ü.

733145. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ä`ŠOŽîáŽ‚Ş‘‘ĺ‚ľ‚˝Beckwith-WiedemannÇŒóŒQ‚Ě1—á. “Ą”örˆň1, •“cŒ›Žq1, Š`Œ´@’m1, “c’†@Œ‰2 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć50‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2015/10/10), ‚ł‚˘‚˝‚Ü.

733146. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒ}ƒEƒX• –Œ‰Š‚ɑ΂ˇ‚é‰z›X‰ÁžQ“’‚̍R‰ŠÇě—p‚ĚŒŸ“˘. •“cŒ›Žq1, “c’†@Œ‰2, Š`Œ´@’m1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć20‰ń“ú–{ŹŽ™ŠO‰ČŠż•űŒ¤‹†‰ď (2015/10/30), ŒF–{.

733147. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž•â•‰ş‚ɈŔ‘S‚ɐ؏œ‚ľ“ž‚˝‰ń’°’°ŠÇd•ĄÇ‚Ě3—á. Š`Œ´@’m1, “c’†@Œ‰2, •“cŒ›Žq1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć35‰ń“ú–{ŹŽ™“ŕŽ‹‹žŠO‰ČEŽčpŽč‹ZŒ¤‹†‰ď (2015/10/30), ŒF–{.

733148. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ––˝Ă–Ź‘}“üŽŽ’†SĂ–ŹƒJƒe[ƒeƒ‹”˛‹Ž˘“ď—á‚ĚŒŸ“˘. ‰Ş–{–˘‹FŽq1, “c’†@Œ‰2, •“cŒ›Žq1, Š`Œ´@’m1, “n粏š•F1 (1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć45‰ń“ú–{ŹŽ™ŠO‰Č‘ăŽÓŒ¤‹†‰ď (2015/10/30), ŒF–{.

733149. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ“Ž–ŹŽüˆÍƒŠƒ“ƒpß“]ˆÚ‚𔺂¤isˆÝŠŕ‚ɑ΂ˇ‚éDCS—Ă–@Œă‚ĚŽčpŹŃ. ŽOd–ě_˜N1, •Đ“c‰Ä–ç1, X’JGŒő1, “Œ@’q2, ×“c@Œj1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y3, Źň˜aŽO˜Y2, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ, 34•a‰@˜AŒg‹łˆç): ‘ć45‰ńˆÝŠO‰ČEpŒăáŠQŒ¤‹†‰ď (2015/11/6), –źŒĂ‰Ž.

733150. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰şˆÝŘœ‚É‚¨‚Ż‚é“d‹CƒƒX‚đ—p‚˘‚˝—H–剺ƒŠƒ“ƒpßŠs´Žč‹Z. ×“c@Œj1, ŽR‰şŒpŽj1, ŽOd–ě_˜N1, X’JGŒő1, •Đ“c‰Ä–ç1, “n粏š•F1 (1ŠO‰Č): ‘ć45‰ńˆÝŠO‰ČEpŒăáŠQŒ¤‹†‰ď (2015/11/7), –źŒĂ‰Ž.

733151. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Telangiectatic/inflammatory adenoma‚ĆŽv‚í‚ę‚éŠĚŒ‹ßŤ•a•Ď‚Ěˆę—á. źŽR@—ş1, ‘ĺ•”@˝2, ‰Í–”@Š°1, “c“‡@O1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č, 2ˆă—ÉqśŠw•”): ‘ć52‰ńŠĚŠŕÇ—ጟ“˘‰ď (2015/11/7), “Œ‹ž.

733152. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰şŠĚŘœ‚É‚¨‚Ż‚éPringle–@‚ĚŽč‹Z‚ƐŹŃ`“Á‚ɉE—tŒnŽîᇂɑ΂ˇ‚éŠĚŘœ‚ĚŒŸ“˘`. źŽR@—ş1, ŠC’Ă‹MŽj1, ‰Í–”@Š°1, “c“‡@O1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č): ‘ć9‰ńŠĚ‘Ÿ“ŕŽ‹‹žŠO‰ČŒ¤‹†‰ď (2015/11/25), •Ÿ‰Ş.

733153. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰şŠĚŘœ‚É‚¨‚Ż‚é’_`˜R‘΍ô. ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, źŽR@—ş1, “c“‡@O1, ‰Í–”@Š°1, “n粏š•F1 (1ŠO‰Č): ‘ć9‰ńŠĚ‘Ÿ“ŕŽ‹‹žŠO‰ČŒ¤‹†‰ď (2015/11/25), •Ÿ‰Ş.

733154. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) NAC-DCS‚Ş’˜Œř‚ľŘœ‰Â”\‚Ć‚Č‚Á‚˝• o“ŕ‹‘ĺŽîᎂ𔺂¤isˆÝŠŕ‚Ěˆę—á. ‘ĺ—F’źŽ÷, b”ă“c•Žu1, ”óŒű@Ši1, Žt”ö”ɍF, ŽOd–ě_˜N1, X’JGŒő1, ×“c@Œj1, ŽR‰şŒpŽj1, “n粏š•F1 (1ŠO‰Č): ‘ć49‰ń_“ސěˆÝŠŕŽĄ—ĂŒ¤‹†‰ď (2015/12/5), ‰Ą•l.

733155. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) p‘Of’f‚É“ďa‚ľ‚˝ˆÝNeuroendocrine cell carcinoma‚Ě1—á. ”óŒű@Ši1, ŽOd–ě_˜N1, X’JGŒő1, ×“c@Œj1, ŽR‰şŒpŽj1, ‹e’rŽj˜Y2, “n粏š•F1 (1ŠO‰Č, 24•a‰@˜AŒg‹łˆç): ‘ć49‰ń_“ސěˆÝŠŕŽĄ—ĂŒ¤‹†‰ď (2015/12/5), ‰Ą•l.

733156. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Řœ•s”\ˆÝŠŕ‚ɑ΂ˇ‚éDocetaxel + CDDP + S-1 (DCS) —Ă–@Œă‚ĚŽčpŹŃ. ŽOd–ě_˜N1, ŽR‰şŒpŽj1, X’JGŒő1, ×“c@Œj1, “Œ@’q2, “c糁@‘3, Źň˜aŽO˜Y2, “n粏š•F1 (1ŠO‰Č, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć49‰ń_“ސěˆÝŠŕŽĄ—ĂŒ¤‹†‰ď (2015/12/5), ‰Ą•l.

733157. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) TAMISŽč‹Z, ŽčpŠí‹ď‚đ—p‚˘‚˝• o‹ž‰ş• ‰ď‰AŽŽ’ź’°Ř’fp. ˛“Ą•˜Y1, ’†‘ş—˛r1, “ŕ“Ął‹K1, ŽR—œ‚L1, ŽO‰YŒ[šć1, ě‘ş”ü‹IŽq2, źŒ´N”ü3, ´‹{”ü‰r3, —F‰i—T”ü3, “n•ÓšD2, “n粏š•F1 (1ŠO‰Č, 2“Œ•a‰@ŠĹŒě•”, 3ŠĹŒě•”): ‘ć38‰ń_“ސěƒXƒg[ƒ}Œ¤‹†‰ď (2015/12/19), _“ސě, ‘ć38‰ń_“ސěƒXƒg[ƒ}Œ¤‹†‰ďƒvƒƒOƒ‰ƒ€´˜^W 2015/12; p.16.

733158. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “Ť“ű‘B”^ᇂ̈ę—á. “Ą–ěŽjD1, ĺÎ‹I•F1, ‰Í–ě—uŽq1, ‹e’r^—Žq1, M‘žşŽq1, ˜m’J”ü“Ţ1, Źâ–ůŒŤ1, ‰Á“Ą@O1, ‰|–{‘ń–Î1, ’J–ě—Tˆę1, “n粏š•F1 (1ŠO‰Č): ‘ć839‰ńŠO‰ČW’k‰ď (2015/12/12), “Œ‹ž.

733159. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • o‹ž‰ş”ö‘¤äXŘœp‚Ĺ‚ĚŒoŒą‚ƍH•v. “c“‡@O1, ŒGŒł—Y‰î1, źŽR@—ş1, ‰Í–”@Š°1, ŠC’Ă‹MŽj1, •Đ‹ËŠ°”V1, “n粏š•F1 (1ŠO‰Č): ‘ć7‰ńäX‘Ÿ“ŕŽ‹‹žŠO‰ČŒ¤‹†‰ď (2015/12/13), ‹ž“s.

733160. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • –Œ”dŽí‚đ‚Ć‚ŕ‚Č‚¤Ç—á‚É‚¨‚Ż‚é“KŘ‚ČM1•Ş—Ţ–@‚ĚŒŸ“˘. “ŕ“Ął‹K1, ’†‘ş—˛r1, ˛“Ą•˜Y1, ŽR—œ‚L1, Ź‘q’źl, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, “n粏š•F1 (1ŠO‰Č): ‘ć84‰ń‘ĺ’°ŠŕŒ¤‹†‰ď (2016/1/15), ŒF–{.

733161. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰ťŠw—Ă–@Ž{sŒă‚É‘ĺ’°ŠŕŠĚ“]ˆÚ‚Ş‹^‚í‚ę‚˝1—á. “Ą”örˆň1, źŽR@—ş1,‘ĺ•”@˝2, ‰Í–”@Š°1, “c“‡@O1, ŠC’Ă‹MŽj1, ŒGŒł—Y‰î1, “n粏š•F1 (1ŠO‰Č, 2ˆă—ÉqśŠw•”): ‘ć840‰ńŠO‰ČW’k‰ď (2016/3/12), “Œ‹ž.

733162. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰E‘¤‰ĄsŒ‹’°Šŕ‚ɑ΂ˇ‚é’†Œ‹’°“Ž–Ź—Ěˆć‚ĚƒŠƒ“ƒpßŠs´Žč‹Z. “›ˆä“ÖŽq (ŠO‰Č): _“ސě‘ĺ’°ŽžŠł• o‰şŽčpƒZƒ~ƒi[‘ć17‰ńŠwpW‰ď (2016/3/25), ‰Ą•l.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-110010. [Œ´’˜] Benefit of neoadjuvant chemotherapy for Siewert type II esophagogastric junction adenocarcinoma. Hosoda K1, Yamashita K1, Katada N1, Moriya H1, Mieno H1, Sakuramoto S, Kikuchi S2, Watanabe M1: Anticancer Res 2015/1; 35 (1): 419-25. (×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, ŽOd–ě_˜N1, ‹e’rŽj˜Y2, “n粏š•F1: 1ŠO‰Č, 24•a‰@˜AŒg‹łˆç)

H26-110011. [Œ´’˜] Impact of lower mediastinal lymphadenectomy for the treatment of esophagogastric junction carcinoma. Hosoda K1, Yamashita K1, Katada N1, Moriya H1, Mieno H1, Sakuramoto S, Kikuchi S2, Watanabe M1: Anticancer Res 2015/1; 35 (1): 445-56. (×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, ŽOd–ě_˜N1, ‹e’rŽj˜Y2, “n粏š•F1: 1ŠO‰Č, 24•a‰@˜AŒg‹łˆç)

H26-110012. [Œ´’˜] Preoperative tumor size is a critical prognostic factor for patients with Borrmann type III gastric cancer. Hosoda K1, Yamashita K1, Katada N1, Moriya H1, Mieno H1, Sakuramoto S, Kikuchi S2, Watanabe M1: Surg Today 2015/1; 45 (1): 68-77. (×“c@Œj1, ŽR‰şŒpŽj1, •Đ“c‰Ä–ç1, X’JGŒő1, ŽOd–ě_˜N1, ‹e’rŽj˜Y2, “n粏š•F1: 1ŠO‰Č, 24•a‰@˜AŒg‹łˆç)

H26-110013. [Œ´’˜] Survival outcome of Borrmann type IV gastric cancer potentially improved by multimodality treatment. Yamashita K1, Hosoda K1, Katada N1, Moriya H1, Mieno H1, Higuchi K2, Sasaki T2, Katada C2, Sakuramoto S, Tanabe S3, Koizumi W2, Kikuchi S4, Watanabe M1: Anticancer Res 2015/2; 35 (2): 897-906. (ŽR‰şŒpŽj1, ×“c@Œj1, •Đ“c‰Ä–ç1, X’JGŒő1, ŽOd–ě_˜N1, ”óŒűŸ•F2, ˛X–Ř“O2, Œ˜“ce—˜2, “c糁@‘3, Źň˜aŽO˜Y2, ‹e’rŽj˜Y4, “n粏š•F1: 1ŠO‰Č, 2Á‰ťŠí“ŕ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă, 44•a‰@˜AŒg‹łˆç)

H26-310001. [Ç—á•ń] Laparoscopic resection of a small-bowel gastrointestinal stromal tumor (GIST): a case of report Ishii S1, Nakamura T2, Kojima K1, Tsutsui A2, Miura H2, Sato T2, Jiang SX3, Watanabe M2: Kitasato Med J 2015/3; 45 (1): 86-9. (Îˆä@’q1, ’†‘ş—˛r2, Ź›¸Œc‘ž1, “›ˆä“ÖŽq2, ŽO‰YŒ[Žő2, ˛“Ą•˜Y2, Ó@˘ˆŽ3, “n粏š•F2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 3•a—)

H26-310002. [Ç—á•ń] The first case report of reduced port surgery for preoperatively diagnosed intestinal malrotation in an adult. Watanabe E, Nakamura T1, Tanaka K2, Miura H1, Tsutsui A1, Takeda N1, Watanabe M1: Kitasato Med J 2015/3; 45 (1): 90-3. (’†‘ş—˛r1, “c’†@Œ‰2, ŽO‰YŒ[šć1, “›ˆä“ÖŽq1, •“cŒ›Žq1, “n粏š•F1: 1ŠO‰Č, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

H26-320007. [Ç—á•ń] ƒAƒ“ƒP[ƒg’˛¸‚ÉŠî‚Ă‚˘‚˝_“ŢěŒ§Žĺ—vŽ{Ý‚É‚¨‚Ż‚é‰EŒ‹’°Šŕ‚ɑ΂ˇ‚é• o‹žŽčp‚ĚŽĄ—ĂŒť‹ľ. ŠÖě_Ži, •Ç“‡N˜Y, ˛“Ą•˜Y1, ‰–ŕV@Šw, źŽR•Ű”äŒĂ, š ęK‹Ď, ‹{“‡L‹X, “c’†~ˆę (1ŠO‰Č): _“ސěˆăŠw‰ďŽGŽ 2015/1; 42 (1): 7-11.

H26-320008. [Ç—á•ń] HER2—zŤStage IVH“šZˆÝŠŕ‚ɑ΂ľ‚ÄCapecitabine+Cisplatin + Trastuzumab•š—p—Ă–@‚Ş‘tŒř‚ľ‚˝1—á. Îˆä@’q1, ×“c@Œj2, •Đ“c‰Ä–ç2, X’JGŒő2, ŽR‰şŒpŽj2, ŽOd–ě_˜N2, ’‡“c“TL3, ‹e’rŽj˜Y4, “n粏š•F2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠO‰Č, 3•a—, 44•a‰@˜AŒg‹łˆç) “ú–{ŠO‰ČŒn˜A‡Šw‰ďŽ 2015/2; 40 (1): 35-43.

H26-522012. [uŔ] yŔ’k‰ďz’ź’°Šŕ‚ɑ΂ˇ‚鎥—Ă•űj‚đl‚Ś‚é. ‘ĺ“cv—R, Žsě–őŽj, ˛“Ą•˜Y1, “c’†@˛, “n糁@ƒ (1ŠO‰Č): Šŕ‚Ě—Ő° 2015/3; 61 (2): 131-8.

[’˜@‘]

H26-620010. [Šwp‘ (•Ş’SŽˇ•M)]y• o‹ž‰şÁ‰ťŠíŠO‰ČŽčp@•W€Žč‹ZƒVƒŠ[ƒY1@ă•”Á‰ťŠÇzI. H“šŽžŠł‚ɑ΂ˇ‚é“ŕŽ‹‹žŠO‰ČŽčp@—ǐŤŽžŠł‚ĚŽčp@‹t—ŹŤH“š‰Š‚ĚŽčp, p.14-23. •Đ“c‰Ä–ç1, X’JGŒő1, “n粏š•F1 (1ŠO‰Č), •Ň: –kě—YŒő, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2015/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H26-723006. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ś‰şŽˆŽî’Ż‚đŽĺ‘i‚Ć‚ľ‚Đf’f‚ł‚ę‚˝ś‘’°œ“Ž–ŹáŽ‚ɉş‘ĺĂ–ŹŒŒđÇ‚đ‡•š‚ľ‚˝ˆę—á. ŠÖ–{Nl, Œ´“c—T‹v, Î“c—mŽ÷, Ź‘qłŽĄ, ‰Í–”@Š°1, óŒ´Žj‘ě, ‘ëě@ő, ‚ŽR@L, ˛“Ą“š•v, źŒ´Œ’‘ž˜Y, ”öŒ´G–ž, źˆä~ˆę, –kě—YŒő (1ŠO‰Č): ‘ć51‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2015/3/5-6), ‹ž“s, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ 2015/2; 35 (2): 437.

H26-723007. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆÝŠŕpŒă‚ɏcŠu”^á‡‚đ‚Ť‚˝‚ľ‚˝1—á. ó‰Ş‰ël, ˛“Ą“š•v, ŠÖ–{Nl, Î“c—mŽ÷, Œ´“c—S‹v, ‚ŽR@L, ‘ëě@ő, óŒ´Žj‘ě, Ź‘qłŽĄ, ‰Í–”@Š°1, źˆä~ˆę (1ŠO‰Č): ‘ć51‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2015/3/5-6), ‹ž“s, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ 2015/2; 35 (2): 485.

H26-723008. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) äXŠÇoŒŒ‚đŒ_‹@‚É”­ŒŠ‚ł‚ę‚˝äXŠŕ‚Ě1—á. Î“c—mŽ÷, ‘ëě@ő, ‰Í–”@Š°1, ŠÖ–{Nl, Ź‘qłŽĄ, óŒ´Žj‘ě, ‚ŽR@L, Œ´“c—T‹v, ˛“Ą“š•v, źˆä~ˆę (1ŠO‰Č): ‘ć51‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2015/3/5-6), ‹ž“s, “ú–{• •”‹~‹}ˆăŠw‰ďŽGŽ 2015/2; 35 (2): 521.


S‘ŸŒŒŠÇŠO‰ČŠw

[Šwp˜_•ś]

110183. [Œ´’˜] Useful surgical instruments for the resection of subaortic stenosis. Tanaka Y1, Miyamoto T1, Minami K2, Miyaji K1: J Thorac Cardiovasc Surg 2015/8; 150 (2): 421-2. (“c’†—C‹M1, ‹{–{—˛Ži1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2–kŠÖ“ŒzŠÂŠí•a‰@)

110184. [Œ´’˜] Optimal Graft Size of Modified Blalock-Taussig Shunt for Biventricular Circulation in Neonates and Small Infants. Shibata M1, Itatani K2, Oka N1, Yoshii T1, Nakamura Y1, Kitamura T1, Horai T1, Miyaji K1: Int Heart J 2015/9; 56 (5): 533-6. (ŽÄ“c[á1, ”Â’JŒcˆę2, ‰Ş@“ż•F1, ‹gˆä@„1, ’†‘ş—SŠó1, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ŒŒ—Ź‰đÍ)

110185. [Œ´’˜] Total Cavopulmonary Connection is Superior to Atriopulmonary Connection Fontan in Preventing Thrombus Formation: Computer Simulation of Flow-Related Blood Coagulation. Sughimoto K1, Okauchi K, Zannino D, Brizard CP, Liang F, Sugawara M, Liu H, Tsubota K: Pediatr Cardiol 2015/10; 36 (7): 1436-41. (™–{Wˆę1: 1S‘ŸŒŒŠÇŠO)

110186. [Œ´’˜] Forward Flow Through the Pulmonary Valve After Bidirectional Cavopulmonary Shunt Benefits Patients at Fontan Operation. Sughimoto K1, Zannino D, Mathew J, Weintraub RG, Brizard CP, d'Udekem Y, Konstantinov IE: Ann Thorac Surg 2015/10; 100 (4): 1390-6; discussion 1396-7. (™–{Wˆę1: 1S‘ŸŒŒŠÇŠO)

110187. [Œ´’˜] Impact of the entry site on late outcome in acute Stanford type B aortic dissectionő. Kitamura T1, Torii S2, Oka N1, Horai T1, Itatani K3, Yoshii T1, Nakamura Y1, Shibata M1, Tamura T1, Araki H1, Matsunaga Y1, Sato H4, Miyaji K1: Eur J Cardiothorac Surg 2015/11; 48 (5): 655-61. (–k‘ş@—Ľ1, ’šˆäWŽO2, ‰Ş@“ż•F1, •ó—ˆ“N–ç1, ”Â’JŒcˆę3, ‹gˆä@„1, ’†‘ş—SŠó1, ŽÄ“c[á1, “c‘ş’q‹I1, r‹Lt“Ţ1, ź‰iŒc—ő1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3ŒŒ—Ź‰đÍŠw, 4‘—§•ŰŒ’ˆă—ÉȊw‰@)

110188. [Œ´’˜] Norwood Procedure Performed on a Patient With Trisomy 13. Oka N1, Inoue T1, Shibata M1, Yoshii T1, Nakamura Y1, Araki H1, Matsunaga Y1, Tamura T1, Itatani K2, Horai T1, Kitamura T1, Torii S3, Miyaji K1: Int Heart J 2016/1; 57 (1): 121-2. (‰Ş@“ż•F1, ˆäă’“š1, ŽÄ“c[á1, ‹gˆä@„1, ’†‘ş—SŠó1, r‹Lt“Ţ1, ź‰iŒc—ő1, “c‘ş’q‹I1, ”Â’JŒcˆę2, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO3, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ŒŒ—Ź‰đÍ, 3ˆă—Ă‹Zp‹łˆç)

110189. [Œ´’˜] Influence of Cardiac Function and Loading Conditions on the Myocardial Performance Index - Theoretical Analysis Based on a Mathematical Model. Inuzuka R, Kuwata S, Kurishima C, Liang F, Sughimoto K1, Senzaki H: Circ J 2016/1; 80 (1): 148-56. (™–{Wˆę1: 1S‘ŸŒŒŠÇŠO)

110190. [Œ´’˜] Mid-term outcome with pericardial patch augmentation for redo left atrioventricular valve repair in atrioventricular septal defectő. Sughimoto K1, d'Udekem Y, Konstantinov IE, Brizard CP: Eur J Cardiothorac Surg 2016/1; 49 (1): 157-66. (™–{Wˆę1: 1S‘ŸŒŒŠÇŠO)

120015. [Œ´’˜] ‹ěo—Ś‚̒ቺ‚ľ‚˝śŽş‚É‚¨‚˘‚Ä‹ěoŠú‚É‚¨‚Ż‚é‰Q‚ĚŽ‘ąŽžŠÔ‚͉„’ˇ‚ˇ‚é: vector flow mapping‚É‚ć‚é‰đÍ. •Ÿ“c‰„ş1, ”Â’JŒcˆę2, –Ř‘şŒöˆę3, ŠC˜VŒ´•ś4, ŞŠÝˆę–ž5, ‰F–슿Ź3, ‹{’n@ŠÓ6, ‘q—ѐł•F1, ’|’†@Ž7 (1ŒQ”n‘ĺŠw‘ŸŠí•a‘Ô“ŕ‰ČŠw, 2ŒŒ—Ź‰đÍ, 3“Œ‹ž‘ĺŠwˆăŠw•”•t‘Ž•a‰@zŠÂŠí“ŕ‰Č, 4‚Ş‚ńŒ¤‹†‰ď—L–ž•a‰@ŒŸ¸•”, 5ƒƒ“ƒW[ƒXŒ¤‹†Šƒ^ƒXƒ}ƒjƒA, 6S‘ŸŒŒŠÇŠO, 7“ú–{‘ĺŠw”‹´•a‰@zŠÂŠí“ŕ‰Č): ’´‰š”gˆăŠw 2016/3; 43 (2): 291-301.

210003. [€Œ´’˜] Single ventricle: repair of atrioventricular valve using the bridging technique. Konstantinov IE, Sughimoto K1, Brizard CP, d'Udekem Y: Multimed Man Cardiothorac Surg 2015/9; 2015. pii: mmv027. doi: 10.1093/mmcts/mmv027. Print 2015. (™–{Wˆę1: 1S‘ŸŒŒŠÇŠO)

210004. [€Œ´’˜] Skeletonization of the Recurrent Laryngeal Nerve During Norwood Procedure and Aortic Arch Repair. Sughimoto K1, Pratap H, Konstantinov IE, Brizard CP, d'Udekem Y: Ann Thorac Surg 2015/10; 100 (4): 1473-5. (™–{Wˆę1: 1S‘ŸŒŒŠÇŠO)

310019. [Ç—á•ń] Perioperative Multiple Pulmonary Embolism in a Patient with Giant Right Atrial Myxoma: Report of a Case. Nakashima K1, Hanayama N1, Kitamura T1, Sakaki K1, Nie M2, Miyaji K1: Kyobu Geka 2016/2; 69 (2): 152-5. (’†“‡Œő‹M1, ‰ŘŽR’ź“ń1, –k‘ş@—Ľ1, ĺŒ’Ži˜N1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ŠC˜V–ź‘‡•a‰@)

310020. [Ç—á•ń] Emergency Surgery for Acute Pulmonary Embolism. Sakaki K1, Nie M2, Sasahara A1, Nakashima K1, Ohara K2, Miyaji K1: Kyobu Geka 2016/3; 69 (3): 197-200. (ĺŒ’Ži˜N1, ůŒ´‘–L1, ’†“‡Œő‹M1, ‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO, 2ŠC˜V–ź‘‡•a‰@)

521013. [‰đŕ]yŽż‹^‰ž“šz[ŠO‰Č: S‘ŸŒŒŠÇ] ŹŽ™S‘ŸŠO‰Č—Ěˆć‚É‚¨‚Ż‚é“ŕŽ‹‹ž‰şŽčp. ‹{’n@ŠÓ1, ‘ĺ’ˏrĆ2 (1S‘ŸŒŒŠÇŠO, 2“Œ‹ž“s—§‘˝–€‘‡ˆă—ĂƒZƒ“ƒ^[): “ú–{ˆăŽ–V•ń 2015/9; 4767: 59-60.

521014. [‰đŕ]yŽż‹^‰ž“šz[ŠO‰Č: S‘ŸŒŒŠÇ] ŽŠŒČS–Œ‚đŽg—p‚ľ‚˝‘ĺ“Ž–Ź•ŮÄŒšp. ”öčd”V1, ‹{’n@ŠÓ2 (1“Œ–M‘ĺŠwˆă—ĂƒZƒ“ƒ^[‘ĺ‹´•a‰@, 2S‘ŸŒŒŠÇŠO): “ú–{ˆăŽ–V•ń 2015/9; 4769: 63.

522111. [uŔ] y“ÁW: S‘ŸŒŒŠÇŠO‰Č ‘O•ŇzpŽŽ•Ę‚ÉŠw‚ԐS‘ŸŒŒŠÇŽčp: dÇS•s‘S@3. ‹@”\Ť‘m–X•Ů•Â˝•s‘SÇ‚ɑ΂ˇ‚éŠO‰ČŽčp‚Ě“K‰ž‚Ćƒ^ƒCƒ~ƒ“ƒO. •ó—ˆ“N–ç (S‘ŸŒŒŠÇŠO): Intensivist 2015/10; 7 (4): 871-7.

[’˜@‘]

620076. [Šwp‘] (•Ş’SŽˇ•M)yp‘O&pŒăƒPƒA‚ŕ‚Ž‚ń‚Ž‚ń‚í‚Š‚é@–Ú‚ĹŒŠ‚Ä—‰đ! ƒi[ƒX‚Ě‚˝‚߂̐S‘ŸŠO‰ČŽčp‚̏pŽŽ•ĘƒPƒAƒrƒWƒ…ƒAƒ‹ƒKƒCƒh (ƒn[ƒgƒi[ƒVƒ“ƒO2015”NH‹G‘Š§)z‘ć4Í –Ú‚ĹŒŠ‚Ä—‰đ!@S‘ŸŠO‰ČŽčp‚̏pŽŽ•pŽŽ•ĘƒPƒAƒć“VŤSŽžŠł‚ɑ΂ˇ‚éŽčp„ [5] ƒtƒ@ƒ[Žl’ĽÇ‚ɑ΂ˇ‚éŽčp, p.188-93. ‹{’n@ŠÓ1, ěă‘ĺ•ă2 (1S‘ŸŒŒŠÇŠO, 2ŠĹŒě•”), ŠÄC: ‹{–{L“ń, ƒƒfƒBƒJo”Ĺ, ‘ĺă, 2015/10”­s.

620077. [Šwp‘] (•Ş’SŽˇ•M)yS‘ŸŠO‰Čf—Ă‚É‚Ý‚éˆăŠw—ŻŠw‚Ö‚ĚƒpƒXƒ|[ƒg@ƒVƒŠ[ƒY“ú•ÄˆăŠwŒđ—ŹNo.15z•’ʂ́g‘h‚Ě•’ʂ́g•a‰@h‚Ĺ‚ĚƒgƒŒ[ƒjƒ“ƒO, p.197-214. –k‘ş@—Ľ (S‘ŸŒŒŠÇŠO), •Ň: Œö‰vŕ’c–@l“ú•ÄˆăŠwˆă—ĂŒđ—Źŕ’c, ‚͂鏑–[, “Œ‹ž, 2015/10”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713057. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Video-assisted thoracoscopic interruption of patent ductus arteriosus (VATS-PDA). Miyaji K1: The 9th International Joint Meeting China,Germany and Japan 2015 (2015/9/17), Bad Oeynhausen, Germany. (‹{’n@ŠÓ1: 1S‘ŸŒŒŠÇŠO)

713058. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Clinical usefulness of compression stockings for asymptomatic deep vein thrombosis of the lower extremity. Ohkubo H1: The 16th congress of Asian society for vascular surgery and The 10th Asian Venous forum 2015 (2015/12/1-4), Thailand. (‘ĺ‹v•Ű”Ž˘1: 1S‘ŸŒŒŠÇŠO)

713059. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Fusion of 3D Ultrasound and Cardiac-MRI Shows Motional Intra-Cardiac Blood Flow In the Whole Cardiac Cycle. Sughimoto K1, Shimamura Y2, Liu H3, Tsubota K3, Miyaji K1, Yoshii T1, Torii S4, Kitamura T1, Hirata M5, Mishima T1, Horai T1, Haneishi H2: HVS Scientific Meeting 2016 (2016/3/17-19), New York, USA. (™–{Wˆę1, ‹{’n@ŠÓ1, ‹gˆä@„1, ’šˆäWŽO4, –k‘ş@—Ľ1, •˝“cŒő”Ž5, ”ü“‡—˜ş1, •ó—ˆ“N–ç1: 1S‘ŸŒŒŠÇŠO, 2ç—t‘ĺŠwƒtƒƒ“ƒeƒBƒAˆăHŠwƒZƒ“ƒ^[, 3ç—t‘ĺŠw‘ĺŠw‰@HŠwŒ¤‹†‰Č, 4ˆă—Ă‹Zp‹łˆç, 5V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

721013. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) Blood flow dynamic improvement with aneurysm repair detected by a patient-specific model of multiple aortic aneurysms. ™–{Wˆę (S‘ŸŒŒŠÇŠO): ‘ć29‰ń“ú–{S‘ŸŒŒŠÇ“ŕŽ‹‹žŠw‰ď (2015/9/26), ‘ĺă.

723449. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹}ŤAŒ^‘ĺ“Ž–Ź‰đ—ŁŽčp‚É‚¨‚Ż‚éăs‘ĺ“Ž–Ź’źÚ‘—ŒŒ–@. ŽR–{Ms1, ćс@łŠî1, ůŒ´‘–L2, ŹŒ´–M‹`1, •ó—ˆ“N–ç2, –k‘ş@—Ľ2, ‹{’n@ŠÓ2 (1ŠC˜V–ź‘‡•a‰@, 2S‘ŸŒŒŠÇŠO): ‘ć43‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2015/6/3-5), ‰Ą•l, “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2015/6; 24 (3): 339.

723450. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) AŒ^‹}Ť‘ĺ“Ž–Ź‰đ—ŁŽčpŽž‚̐^o’źÚ‘—ŒŒ. –k‘ş@—Ľ1, ’šˆäWŽO2, ‰Ş@“ż•F1, •˝“cŒő”Ž3, •ó—ˆ“N–ç1, ”Â’JŒcˆę4, “c‘şK•ä1, ”ü“‡—˜ş1, ‹gˆä@„1, ’†‘ş—SŠó1, “c‘ş’q‹I1, r‹Lt“Ţ1, ź‰iŒc—ő1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 4ŒŒ—Ź‰đÍ): ‘ć43‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2015/6/3-5), ‰Ą•l, “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2015/6; 24 (3): 427.

723451. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ź‘zŽčpsimulation‚đ—p‚˘‚˝‹|•”‘ĺ“Ž–ŹáŽ‚ĚŽĄ—Ð헪: DebranchTEVAR‚Ć‘S‹|•”’uŠˇ‚ĚŒŒ—Ź“Ž‘Ô•]‰ż. •ó—ˆ“N–ç1, ”Â’JŒcˆę2, “c‘ş’q‹I1, –k‘ş@—Ľ1, ‹{čăĕ˝2, ’šˆäWŽO3, •˝“cŒő”Ž4, ‰Ş@“ż•F1, “c‘şK•ä1, ”ü“‡—˜–ž1, ’†‘ş—SŠó1, ŽÄ“c[á1, r‹Lt“Ţ1, ‹gˆä@„1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ŒŒ—Ź‰đÍ, 3ˆă—Ă‹Zp‹łˆç, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć43‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2015/6/3-5), ‰Ą•l, “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2015/6; 24 (3): 512.

723452. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚銴őŤ• •”‘ĺ“Ž–ŹáŽ‚ɑ΂ˇ‚éŽčpŒoŒą. ”ü“‡—˜ş1, •˝“cŒő”Ž2, “c‘şK•ä1, ‘ĺ‹v•Ű”Ž˘1, ’šˆäWŽO3, –k‘ş@—Ľ1, ‰Ş@“ż•F1, •ó—ˆ“N–ç1, ”Â’JŒcˆę4, ’†‘ş—SŠó1, ŽÄ“c[á1, “c‘ş’q‹I1, r‹LtŘ1, ź‰iŒc—ő1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—Ă‹Zp‹łˆç, 4ŒŒ—Ź‰đÍ): ‘ć43‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2015/6/3-5), ‰Ą•l, “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2015/6; 24 (3): 570.

723453. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ś‘ĺ‘Ú“Ž–ŹúŽh‚É‚ć‚éPCIŽ{sŒă‚ÉŠ´őŤ‰źŤ‘ĺ‘Ú“Ž–ŹáŽ‚đ‡•š‚ľ‚˝1ŽčpÇ—á. ůŒ´‘–L1, ćс@łŠî2, ŽR–{Ms2, ŹŒ´–M‹`2, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ŠC˜V–ź‘‡•a‰@): ‘ć43‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2015/6/3-5), ‰Ą•l, “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2015/6; 24 (3): 602.

723454. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) EVARpŒă, ‹r•ÂÇ‚ɑ΂ľ‚ĒljÁŽĄ—Ă‚đ—v‚ľ‚˝2—á. “c‘şK•ä1, •˝“cŒő”Ž2, ”ü“‡—˜ş1, ‘ĺ‹v•Ű”Ž˘1, ź‰iŒc—ő1, r‹Lt“Ţ1, “c‘ş’q‹I1, ŽÄ“c[á1, ’†‘ş—SŠó1, ”Â’JŒcˆę3, •ó—ˆ“N–ç1, ‰Ş@“ż•F1, –k‘ş@—Ľ1, ’šˆäWŽO4, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ŒŒ—Ź‰đÍ, 4ˆă—Ă‹Zp‹łˆç): ‘ć43‰ń“ú–{ŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2015/6/3-5), ‰Ą•l, “ú–{ŒŒŠÇŠO‰ČŠw‰ďŽGŽ 2015/6; 24 (3): 690.

723455. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ńdƒpƒbƒ`•Â˝–@‚É‚ć‚éSŽş’†ŠuúEŽčp‚̐ŹŃ. •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO2, “c‘ş’q‹I1, r‹Lt“Ţ1, ”Â’JŒcˆę3, ‰Ş@“ż•F1, ’†‘ş—SŠó1, ź‰iŒc—ő1, •˝“cŒő”Ž4, “c‘şK•ä1, ”ü“‡—˜ş1, ‹gˆä@„1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3ŒŒ—Ź‰đÍ, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć20‰ń“ú–{ŠĽ“Ž–ŹŠO‰ČŠw‰ďŠwp‘ĺ‰ď (2015/7/9-10), ‹ž“s, “ú–{ŠĽ“Ž–ŹŠO‰ČŠw‰ďŽGŽ 2015/7; Suppl: 103.

723456. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) V‚ľ‚˘ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“ˆăŠw‚̏ŹŽ™zŠÂŠíˆă—Âւ̉ž—p|ƒRƒ“ƒsƒ…[ƒ^[ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚É‚ć‚錌s“Ž‘ԏ㮩“KŒ`ó‚ÉŠî‚Ă‚˘‚˝”x“Ž–ŹŒ`Źp|. ‹{’n@ŠÓ1, ‹{čăĕ˝2, ”Â’JŒcˆę2, ‰Ş@“ż•F1, ’†‘ş—SŠó1, ‹gˆä@„1, ź‰iŒc—ő1 (1S‘ŸŒŒŠÇŠO, 2ŒŒ—Ź‰đÍ): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16-18), “Œ‹ž, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ 2015/7; 31 (Suppl 1): S1.104.

723457. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘̏d1 kg–˘–ž‚Ě’´’áoś‘̏dŽ™‚ɑ΂ˇ‚é“ŕŽ‹‹ž‰ş“Ž–ŹŠÇ•Â˝p. ‹{’n@ŠÓ1, ‰Ş@“ż•F1, ’†‘ş—SŠó1, ‹gˆä@„1, ź‰iŒc—ő1, Îˆäł_2 (1S‘ŸŒŒŠÇŠO, 2ŹŽ™): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16-18), “Œ‹ž, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ 2015/7; 31 (Suppl 1): S1.163.

723458. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šg’Ł‘ŠúśŽş“ŕˆłŠrˇ‚¨‚ć‚эśŽş•ĎŒ`•]‰ż‚É‚ć‚é, ŹŽ™‚Ş‚ńŽĄ—ĂŒă‚̐S‹@”\’ቺ‚Ě‘Šú”­ŒŠ. dŒőK‰h1, ‚‹´@Œ’1, ŽR“c^—œŽq1, HŒł‚Š‚‚Ý1, âŒű˛’m1, “Ą‘şƒ–ç1, Ä“Ął”Ž1, ‹H‘ă‰ë•F1, ‹{’n@ŠÓ2, ”Â’JŒcˆę3, ´…r–ž1 (1‡“V“°‘ĺŠw, 2S‘ŸŒŒŠÇŠO, 3ŒŒ—Ź‰đÍ): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16-18), “Œ‹ž, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ 2015/7; 31 (Suppl 1): S1.228.

723459. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ć“VŤSŽžŠłC•œpŒă30”NˆČăŒo‰ß‚ľ‚˝”x‚ŒŒˆł‚𔺂¤”x“Ž–Ź•Ů‹t—Ź‚ɑ΂ˇ‚é”x“Ž–Ź•Ů’uŠˇp‚Ě2—á. ‰Ş@“ż•F1, ’†‘ş—SŠó1, ź‰iŒc—ő1, r‹Lt“Ţ1, “c‘ş’q‹I1, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO2, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16-18), “Œ‹ž, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ 2015/7; 31 (Suppl 1): S1.385.

723460. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ˇŹ‘ĺ“Ž–Ź•Ů—ւ𔺂¤IAA/CoA complex‚ɑ΂ˇ‚é“–‰@‚É‚¨‚Ż‚鎥—Ă•űj‚ĚŒŸ“˘. ‹gˆä@„1, ’†‘ş—SŠó1, ‘ĺ—F—EŽ÷1, ’šˆäWŽO2, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, “c’†—C‹M1, ‹ß“Ą@^1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç): ‘ć68‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/10/19), _ŒË, “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2015/10; suppl: 81.

723461. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –ŤBŒ^‘ĺ“Ž–Ź‰đ—Ł‚ɑ΂ˇ‚é‘ć1˘‘ăTEVAR‚̉“ŠuŹŃ. –k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, •ó—ˆ“N–ç1, ‹gˆä@„1, ’†‘ş—SŠó1, “c’†—C‹M1, ‹ß“Ą@^1, ‘ĺ—F—EŽ÷1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć68‰ń“ú–{‹š•”ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/10/19), _ŒË, “ú–{‹š•”ŠO‰ČŠw‰ďŽGŽ 2015/10; suppl: 162.

723462. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ńdƒpƒbƒ`•Â˝–@‚É‚ć‚éSŽş’†ŠuúEŽčp‚̐ŹŃ. •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO2, “c’†—C‹M1, ‹ß“Ą@^1, ™–{Wˆę1, ‹gˆä@„1, ź‘ă‘ě–ç1, •˝“cŒő”Ž3, ”ü“‡—˜ş1, ‘ĺ‹v•Ű”Ž˘1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć29‰ń“ú–{ŠĽŽžŠłŠw‰ďŠwpW‰ď (2015/11/20-21), ŽD–y.

723463. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) A Larger Bioprosthetic Valve Provides Lower Pressure Gradient across the Pulmonary Valve for Redo Pulmonary Valve Replacement in Adolescents and Adults. ™–{Wˆę1, ‹{’n@ŠÓ1, ‹gˆä@„1, ’šˆäW‘˘2, –k‘ş@—Ľ1, •˝“cŒő”Ž3, ”ü“‡—˜ş1, •ó—ˆ“N–ç1, —F•Ű‹M”Ž1, Îˆäł_4, –Ř‘şƒl4, ˆŔ“Ą@Žő4, –kě“ÄŽj4, •ô”öŒb—œ4, ‰Ş@“ż•F1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 4ŹŽ™): ‘ć18‰ń“ú–{Źlć“VŤSŽžŠłŠw‰ď‘‰ďEŠwpW‰ď (2016/1/16), ‘ĺă.

723464. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) śS’áŒ`ŹÇŒóŒQ‚ɑ΂ˇ‚鍇•šÇ‰ń”đ‚ÉŒü‚Ż‚˝ŽĄ—Ð헪. ‹gˆä@„1, ź‘ă‘ě–ç1, ’†‘ş—SŠó1, ™–{Wˆę1, ‹ß“Ą@^1, “c’†—C‹M1, ‘ĺ‹v•Ű”Ž˘1, •ó—ˆ“N–ç1, ”ü“‡—˜ş1, •˝“cŒő”Ž2, –k‘ş@—Ľ1, ’šˆäWŽO3, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3ˆă—Ă‹Zp‹łˆç): ‘ć46‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/2/15-17), –źŒĂ‰Ž.

723465. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) bulging sinus•tePTFE monocusp patch‚¨‚ć‚Ńtricusp conduit‚đ—p‚˘‚˝RVOTR‚Ě’†ŠúŹŃ. ź‘ă‘ě–ç1, ™–{Wˆę1, ’†‘ş—SŠó1, ‹gˆä@„1, ’šˆäWŽO2, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, •˝“cŒő”Ž3, ”ü“‡—˜ş1, —F•Ű‹M”Ž1, ‘ĺ‹v•Ű”Ž˘1, “c’†—C‹M1, ‹ß“Ą@^1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć46‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/2/15-17), –źŒĂ‰Ž.

723466. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) AŒ^‹}Ť‘ĺ“Ž–Ź‰đ—ŁŽčpŽž‚̐^o’źÚ‘—ŒŒ. ‹ß“Ą@^1, –k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, •ó—ˆ“N–ç1, ’†‘ş—SŠó1, ‹gˆä@„1, “c’†—C‹M1, ‘ĺ—F—EŽ÷1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć46‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/2/15-17), –źŒĂ‰Ž.

723467. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚銴őŤS“ŕ–Œ‰Š‚ɑ΂ˇ‚鎥—ĂŒoŒą. •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, ”ü“‡—˜ş1, “c’†—C‹M1, ‘ĺ‹v•Ű”Ž˘1, ‹ß“Ą@^1, ™–{Wˆę1, ‹gˆä@„1, ’†‘ş—SŠó1, ź‘ă‘ě–ç1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć46‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/2/15-17), –źŒĂ‰Ž.

723468. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹CŠÇ“Ž–Źá‘‚ɑ΂ˇ‚éƒXƒeƒ“ƒgƒOƒ‰ƒtƒg“ŕ‘}p‚Ě2—á. ‘ĺ‹v•Ű”Ž˘1, ”ü“‡—˜ş1, •˝“cŒő”Ž2, ‹ß“Ą@^1, “c’†—C‹M1, ‹gˆä@„1, ’†‘ş—SŠó1, ™–{Wˆę1, •ó—ˆ“N–ç1, –k‘ş@—Ľ1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć46‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/2/15-17), –źŒĂ‰Ž.

733163. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘ĺ“Ž–Ź‰đ—Ł“ŕ–Œ‹T—ô‚ĚŒđ˜A‰Ą’f‚É‹Nˆö‚ˇ‚閝Ť‘ĺ“Ž–Ź•Ů•Â˝•s‘SÇ‚Ě1—á. ‹ß“Ą@^1, –k‘ş@—Ľ1, ’šˆäWŽO2, •˝“cŒő”Ž3, •ó—ˆ“N–ç1, ”Â’JŒcˆę4, ’†‘ş—SŠó1, ‹gˆä@„1, “c’†—C‹M1, ‘ĺ—F—EŽ÷1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 4ŒŒ—Ź‰đÍ): ‘ć168‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2015/6/27), “Œ‹ž, “ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2015/6; 168: 11.

733164. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”xĂ–Ź•Â˝, ”xĂ–Ź’áŒ`Ź‚Ěˆę—á. ‹{“c—L—Œb1, ’†‘ş—SŠó2, ‹ß“Ą@^2, ‘ĺ—F—EŽ÷2, “c’†—S‹M2, ‹gˆä@„2, •ó—ˆ“N–ç2, –k‘ş@—Ľ2, ’šˆäWŽO3, ‹{’n@ŠÓ2 (1Œ¤Cˆă, 2S‘ŸŒŒŠÇŠO, 3ˆă—Ă‹Zp‹łˆç): ‘ć168‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2015/6/27), “Œ‹ž, “ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2015/6; 168: 12.

733165. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Long segment CoA‚ɑ΂ľlHŒŒŠÇ‚É‚ć‚éinterposition‚đŽ{s‚ľ‚˝12ÎŽ™‚Ě1—á. ™–{Wˆę1, ‹{’n@ŠÓ1, ‹gˆä@„1, ‹ß“Ą@^1, Îˆäł_2, –Ř‘şƒl2, ˆŔ“Ą@Žő2, –kě“ÄŽj2, •ô”öŒb—œ2 (1S‘ŸŒŒŠÇŠO, 2ŹŽ™): ‘ć11‰ń_“ސ쏬Ž™zŠÂŠíŒ¤‹†‰ď (2015/10/31), ‰Ą•l.

733166. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‰E˝œ‰ş“Ž–Ź‹NŽnˆŮí‚𔺂¤‹}ŤAŒ^‘ĺ“Ž–Ź‰đ—Ł‚ɑ΂ˇ‚é2Šú“IŽčp. ŽO’J—D‘ž˜N1, –k‘ş@—Ľ2, ’šˆäWŽO3, •ó—ˆ“N–ç2, ź‘ă‘ě–ç2, •˝“cŒő”Ž4, ”ü“‡—˜–ž2, ‘ĺ‹v•Ű”Ž˘2, ™–{Wˆę2, ‹gˆä@„2, —F•Ű‹M”Ž2, ‹ß“Ą@^2, ‹{’n@ŠÓ2 (1Œ¤Cˆă, 2S‘ŸŒŒŠÇŠO, 3ˆă—Ă‹Zp‹łˆç, 4V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć169‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2015/11/7), “Œ‹ž, “ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2015/11; 169: 16.

733167. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŹlŠú‚ɐS•s‘S‚đ”­Ç‚ľ‚˝Cł‘ĺŒŒŠÇ“]ˆĘ‚Ě1—á. ź‘ă‘ě–ç1, ™–{Wˆę1, ’†‘ş—SŠó1, ‹gˆä@„1, ’šˆäWŽO2, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, —F•Ű‹M”Ž1, “c’†—C‹M1, ‹ß“Ą@^1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç): ‘ć169‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2015/11/7), “Œ‹ž, “ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2015/11; 169: 37.

733168. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒtƒ@ƒ[Žl’ĽÇ, ”x“Ž–Ź•Â˝, Žĺ—v‘Ě”x‘¤•›ŒŒs, ’†S”x“Ž–Ź’áŒ`Ź‚ɑ΂ľ‚ďW‡‰ť‚đs‚킸‚ÉŞŽĄŽčp‚đŽ{s‚ľ‚Ś‚˝1—á. ‹ß“Ą@^1, ™–{Wˆę1, ‹gˆä@„1, ’šˆäWŽO2, –k‘ş@—Ľ1, •ó—ˆ“N–ç1, —F•Ű‹M”Ž1, ź‘ă‘ě–ç1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç): ‘ć170‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/3/12), ‰Ą•l, “ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2016/3; 170: 7.

733169. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Žá”NŽŇŠ´őŤS“ŕ–Œ‰Š‚ɑ΂ľ‚Ä‘m–X•ŮEäFőE“ű“Ş‹Ř‚đˆę–‡‚ĚŽŠŒČS–Œ‚ŏC•œ‚ľ‚˝ˆę—á. —с@GŒ›1, ŽR–{Ms, –k‘ş@—Ľ1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO): ‘ć170‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/3/12), ‰Ą•l, “ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2016/3; 170: 21.

733170. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ÄX”­‚đ—ˆ‚˝‚ľ‚˝S‘Ÿ”S‰tŽî‚Ěˆę—á. ź‘ă‘ě–ç1, •ó—ˆ“N–ç1, ’šˆäWŽO2, •˝“cŒő”Ž3, –k‘ş@—Ľ1, ”ü“‡—˜ş1, —F•Ű‹M”Ž1, ‘ĺ‹v•Ű”Ž˘1, ™–{Wˆę1, ‹gˆä@„1, ‹ß“Ą@^1, ‹{’n@ŠÓ1 (1S‘ŸŒŒŠÇŠO, 2ˆă—Ă‹Zp‹łˆç, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć170‰ń“ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2016/3/12), ‰Ą•l, “ú–{‹š•”ŠO‰ČŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď—vŽ|W 2016/3; 170: 22.


ŒÄ‹zŠíŠO‰ČŠw

[Šwp˜_•ś]

110191. [Œ´’˜] Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance. Nakashima H1, Jiang SX2, Sato Y3, Hoshi K4, Matsumoto T2, Nagashio R3, Kobayashi M, Matsuo Y, Shiomi K1, Hayakawa K5, Saegusa M2, Satoh Y1: Pathol Int 2015/4; 65 (4): 183-92. (’†“‡—TN1, Ó@˘ˆŽ2, ˛“Ą—Yˆę3, Ż@‰Ŕ–F4, ź–{r‰p2, ’ˇ‰–@—ş3, ‰–ŒŠ@˜a1, ‘ě˜ad5, ŽOŽ}@M2, ˛“Ą”Vr1: 1ŒÄ‹zŠíŠO, 2•a—, 3ˆă—ÉqśŠw, 4‰qś, 5•úŽËü (Žîá‡))

110024. [Œ´’˜] The role of vascular endothelial growth factor receptor-1 signaling in compensatory contralateral lung growth following unilateral pneumonectomy. Matsui Y1, Amano H2, Ito Y, Eshima K3, Tamaki H4, Ogawa F5, Iyoda A, Shibuya M, Kumagai Y5, Satoh Y1, Majima M2: Lab Invest 2015/5; 95 (5): 456-68. (źˆäŒ[•v1, “V–ě‰pŽ÷2, ]“‡k“ń3, ‹Ę–؉p–ž4, ŹěŽj—m5, ŒF’J—YŽĄ5, ˛“Ą”Vr1, ”n“ˆł—˛2: 1ŒÄ‹zŠíŠO, 2–ň—, 3–Ɖu, 4‰đ–U, 5—Տ°Œ¤‹†EƒvƒƒWƒFƒNƒg)

110192. [Œ´’˜] Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma. Saito Y, Nagae G, Motoi N, Miyauchi E, Ninomiya H, Uehara H, Mun M, Okumura S, Ohyanagi F, Nishio M, Satoh Y1, Aburatani H, Ishikawa Y: Cancer Sci 2016/3; 107 (3): 320-5. (˛“Ą”Vr1: 1ŒÄ‹zŠíŠO)

310021. [Ç—á•ń] Abnormal branching of the left lingular pulmonary artery diagnosed by three-dimensional computed tomographic angiography in a patient with lung cancer: a case report. Sonoda D1, Mikubo M2, Shiomi K1, Satoh Y1: J Cardiothorac Surg 2016/1; 11: 17. (‰€“c@‘ĺ1, ŽOŒEŤŽj2, ‰–ŒŠ@˜a1, ˛“Ą”Vr1: 1ŒÄ‹zŠíŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

320020. [Ç—á•ń] EBUS-TBNA‚ĹŠm’čf’f‚É‚˘‚˝‚炸‹šo‹ž‰şcŠuƒŠƒ“ƒpßśŒŸ‚Őf’f‚ľ‚˝ƒzƒWƒLƒ“ƒŠƒ“ƒpŽî1—á. Ź–ěŒłŽk1, ‰€“c@‘ĺ1, ’†“‡—TN1, ‰–ŒŠ@˜a1, âŒű@”E, ‹g“c@Œ÷2, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2•a—): _“ސě×–E‰ďŽ 2015/9; 20 (1): 46-50.

522112. [uŔ] “ú–{”xŠŕŠw‰ďE“ú–{—Տ°×–EŠw‰ď@2Šw‰ď‡“ŻˆĎˆő‰ď•ń: ”x‚Ş‚ńŒŸf‚É‚¨‚Ż‚éš\ႍזEf‚̐f’fˆę’vŤ‚Ć•W€‰ť. ˛“Ą‰ë”ü, ŽÄ@Œő”N, âV“Ą‘׋I, ˛“Ą”Vr1, a’J@Œ‰, “y“cŒh–ž, ’†ŽR•x—Y, •ó—ˆ@ˆĐ, ’r“c“ż•F, ‰ÍŒ´@‰h, ŽO‰YO”V, ’†“ˆ—˛‘ž˜Y, “cŒű–ž”ü, –î‰H“cˆęM, “‡Š_“ń‰ŔŽq, _”ö~Žq, ’ˇ”ö@—Î, ŽO‘î^Ži, ‰şěKO, “c’†—Ç‘ž, ‰““ĄçŒ° (1ŒÄ‹zŠíŠO) ”xŠŕ 2015/12; 55 (6): 859-65.

540015. [‚ť‚Ě‘ź]yŒ¤‹†‚ĚŽü•Ó‚Š‚çzŒÄ‹zŠíŠO‰Čˆă‚ĆŒ¤‹†. ˛“Ą”Vr (ŒÄ‹zŠíŠO): ŒÄ‹z 2015/8; 34 (8): 741-2.

[’˜@‘]

621002. [Šwp‘ (•ŇW)]y×–EfƒKƒCƒhƒ‰ƒCƒ“4@ŒÄ‹zŠíE‹š‘BE‘̍o‰tEƒŠƒ“ƒpß 2015”N”Łz•Ň: “ú–{—Տ°×–EŠw‰ď (•›ˆĎˆő’ˇ: ˛“Ą”Vr (ŒÄ‹zŠíŠO)), ‹ŕŒ´o”Ĺ, “Œ‹ž, 2015/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713060. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) High vimentin expression in micropapillary component of lung adenocarcinomas. Nakashima H1, Jiang SX2, Sato Y, Hoshi K3, Matsumoto T2, Nagashio R, Kobayashi M, Matsuo Y, Shiomi K1, Hayakawa K4, Saegusa M2, Satoh Y1: The 16th World Conference on Lung Cancer (2015/9/7), Denver, USA. (’†“‡—TN1, Ó@˘ˆŽ2, Ż@‰Ŕ–F3, ź–{r‰p2, ‰–ŒŠ@˜a1, ‘ě˜ad4, ŽOŽ}@M2, ˛“Ą”Vr1: 1ŒÄ‹zŠíŠO, 2•a—, 3‰qś, 4•úŽËü (Žîá‡))

713061. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Pleomorphic carcinoma of the lung: a clinicopathologic study of 23 resected cases. Sonoda D1, Ono M1, Kondo Y1, Hayashi S1, Mikubo M2, Nakashima H1, Matsui Y1, Ichinoe M3, Shiomi K1, Jiang SX3, Murakumo Y3, Satoh Y1: The 16th World Conference on Lung Cancer (2015/9/7), Denver, USA. (‰€“c@‘ĺ1, Ź–ěŒłŽk1, ‹ß“Ą‘אl1, —с@ËŽq1, ŽOŒEŤŽj2, ’†“‡—TN1, źˆäŒ[•v1, ˆęŒËš–ž3, ‰–ŒŠ@˜a1, Ó@˘ˆŽ3, ‘ş‰_–FŽ÷3, ˛“Ą”Vr1: 1ŒÄ‹zŠíŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3•a—)

713062. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Investigation for the Optimum Resectable Pathological Size of Small Solitary Metastasis from Colorectal Cancers. Sakao Y, Kuroda H, Okumura T, Boku N, Hishida T, Ohde Y, Yoshiya K, Higashiyama M, Adachi H, Satoh Y1, Kameyama K, Kanzaki M, Yoshimura M, Hata Y, Matsuura M, Chen F, Yoshida K, Sasaki H, Horio H, Takenoyama M, Yamashita M, Hashimoto T, Fujita A, Okumura M, Funai K, Shiono S, Asano H, Suzuki M, Hoshi E, Shiraishi Y, Nakayama M, Yamazaki N, Matsuo T, Miyazawa H, Sato Y, Takao M, Nakayama H, Yamada S, Shimizu K, Kataoka M, Nakamura H, Watanabe T, Suzuki H, Akamine S, Tsunezuka Y, Nakata M, Kadokura M, Hyodo I, Mori K, Kondo H: The 16th World Conference on Lung Cancer (2015/9/8), Denver, USA. (˛“Ą”Vr1: 1ŒÄ‹zŠíŠO)

723469. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”xë•”‘O•ű‹š•ÇZ”xŠŕ‚ɑ΂ˇ‚é‹šœł’†ŘŠJ‚ÉŒz•”ŘŠJ‚đ‰Á‚Ś‚˝ƒAƒvƒ[ƒ``ƒVƒ“ƒvƒ‹‚Š‚”ėpŤ‚ލ‚‚˘`. ‰–ŒŠ@˜a (ŒÄ‹zŠíŠO): ‘ć32‰ń“ú–{ŒÄ‹zŠíŠO‰ČŠw‰ď‘‰ď (2015/5/14), ‚ź.

723470. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”xë•”‘O•űZ”xŠŕ‚ɑ΂ľ‹šœł’†ŘŠJ‚ÉŒz•”ŘŠJ‚đ‰Á‚Ś‚Đ؏œ‚đs‚Á‚˝1—á`ƒVƒ“ƒvƒ‹‚Š‚”ėpŤ‚̍‚‚˘ƒAƒvƒ[ƒ``. ‰–ŒŠ@˜a1, ŽOŒEŤŽj2, źˆäŒ[•v1, ‰€“c@‘ĺ1, ‹ß“Ą‘אl1, Ź–ěŒłŽk1, ’†“‡—TN1, –k‘ş@—Ľ3, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3S‘ŸŒŒŠÇŠO): ‘ć32‰ń“ú–{ŒÄ‹zŠíŠO‰ČŠw‰ď‘‰ď (2015/5/15), ‚ź.

723471. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –Ĺ‹Ű’˛Žƒ^ƒ‹ƒN‚É‚ć‚é–ü’…—Ă–@Œă‚Ě‹šo“ŕ‚̏ó‘Ô. —с@ËŽq1, ˆäă€l, –x“cˆťŽq, âV“Ąś˜N, Ź–ěŒłŽk1, ‹ß“Ą‘אl1, ‰€“c@‘ĺ1, ŽOŒEŤŽj2, ’†“‡—TN1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŒÄ‹zŠí“ŕ, 4•a—): ‘ć32‰ń“ú–{ŒÄ‹zŠíŠO‰ČŠw‰ď‘‰ď (2015/5/15), ‚ź.

723472. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) EBUS-TBNA‚ĹƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ɛf’f‚ľŒo‰ßŠĎŽ@’†‚Éš\ႍזEf‚É‚Ä”­ŒŠ‚ł‚ę‚˝”x‘BŠŕ‚Ěˆę—á. Ź–ěŒłŽk1, ‹ß“Ą‘אl1, —с@ËŽq1, ‰€“c@‘ĺ1, ŽOŒEŤŽj2, ’†“‡—TN1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ’O‰H‰p”V3, ‚‘q@W3, ‹v•Ű“cŸ3, ‰v“c“TK3, –öŕVM”V4, ˆęŒËš–ž4, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŒÄ‹zŠí“ŕ, 4•a—): ‘ć38‰ń“ú–{ŒÄ‹zŠí“ŕŽ‹‹žŠw‰ďŠwpW‰ď (2015/6/12), “Œ‹ž.

723473. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Highly frequent postoperative up- staging of lung adenocarcinomas with micropapillary component. ’†“‡—TN1, Ó@˘ˆŽ2, ŽOŽ}@M2, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2•a—): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8-10), –źŒĂ‰Ž.

723474. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) micropapillary component‚đ—L‚ˇ‚é”x‘BŠŕ‚ƏpŒă•a—•aŠúup-staging‚Ć‚ĚŠÖ˜A. ’†“‡—TN1, Ó@˘ˆŽ2, Ź–ěŒłŽk1, —с@ËŽq1, ‰€“c@‘ĺ1, źˆäŒ[•v1, ‰–ŒŠ@˜a1, ŽOŽ}@M2, ˛“Ą”Vr1 (1ŒÄ‹zŠíŠO, 2•a—): ‘ć56‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2015/11/26-28), ‰Ą•l.

H26”N“xˆČ‘O•Ş

[Šw‰ďEŒ¤‹†‰ď“™]

H26-733005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) dÇ‹Ř–ł—͏ǂɑ΂ˇ‚錕ó“Ë‹N‰şƒAƒvƒ[ƒ` (+ ‘¤‹š•”•â•ƒ|[ƒg) ‚É‚ć‚é‹šo‹ž‰şŠg‘ĺ‹š‘B“Eop‚Ě’čŒ^‰ť. ‰–ŒŠ@˜a (ŒÄ‹zŠíŠO): ‘ć34‰ń“ú–{‹š‘BŒ¤‹†‰ď (2015/2/7), ‘Š–ÍŒ´.


”]_ŒoŠO‰ČŠw

[Šwp˜_•ś]

110193. [Œ´’˜] Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients. Kanamori M, Higa T, Sonoda Y, Murakami S, Dodo M, Kitamura H, Taguchi K, Shibata T, Watanabe M, Suzuki H, Shibahara I, Saito R, Yamashita Y, Kumabe T1, Yamamoto M, Motohashi H, Tominaga T: Neuro Oncol 2015/4; 17 (4): 555-65. (ŒG•”rG1: 1”]ŠO)

110194. [Œ´’˜] Vaginal Delivery under Epidural Analgesia in Pregnant Women with a Diagnosis of Moyamoya Disease. Sato K1, Yamada M1, Okutomi T2, Kato R3, Unno N4, Fujii K1, Kumabe T1: J Stroke Cerebrovasc Dis 2015/5; 24 (5): 921-4. (˛“ĄŒör1, ŽR“c@Ÿ1, ‰œ•xr”V2, ‰Á“Ą—˘ŠG3, ŠC–ěM–ç4, “Ąˆä´F1, ŒG•”rG1: 1”]ŠO, 2–ƒŒ, 3V˘‹Iˆă—ÁEć’[ˆă—Ă, 4ŽY‰Č)

110195. [Œ´’˜] Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor. Yang X, Saito R, Nakamura T, Zhang R, Sonoda Y, Kumabe T1, Forsayeth J, Bankiewicz K, Tominaga T: Drug Deliv 2015/7: 1-6. [Epub ahead of print] (ŒG•”rG1: 1”]ŠO)

110196. [Œ´’˜] Moist-condition Training for Cerebrovascular Anastomosis: A Practical Step after Mastering Basic Manipulations. Shimizu S1, Sekiguchi T1, Mochizuki T, Sato K1, Koizumi H2, Nakayama K, Yamamoto I, Kumabe T1: Neurol Med Chir (Tokyo) 2015/8; 55 (8): 689-92. (´…@ú1, ŠÖŒű•üŽq1, –]ŒŽ’O, ˛“ĄŒör1, ŹňŠ°”V2, ’†ŽRŒŤŽi, ŽR–{—E•v, ŒG•”rG1: 1”]ŠO, 2‹~–˝)

110197. [Œ´’˜] Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors. Takami H, Fukushima S, Fukuoka K, Suzuki T, Yanagisawa T, Matsushita Y, Nakamura T, Arita H, Mukasa A, Saito N, Kanamori M, Kumabe T1, Tominaga T, Kobayashi K, Nagane M, Iuchi T, Tamura K, Maehara T, Sugiyama K, Nakada M, Kanemura Y, Nonaka M, Yokogami K, Takeshima H, Narita Y, Shibui S, Nakazato Y, Nishikawa R, Ichimura K, Matsutani M: J Neurooncol 2015/8; 124 (1): 23-32. (ŒG•”rG1: 1”]ŠO)

110198. [Œ´’˜] Intraoperative Ultrasonography during Drainage for Chronic Subdural Hematomas: A Technique to Release Isolated Deep-seated Hematomas--Technical Note. Shimizu S1, Mochizuki T, Osawa S1, Kumabe T1: Neurol Med Chir (Tokyo) 2015/9; 55 (9): 761-5. (´…@ú1, –]ŒŽ’O, ‘ĺŕVŹ”V1, ŒG•”rG1: 1”]ŠO)

110199. [Œ´’˜] Edamame sigh in syringomyelia: a pattern of syrinx dilation correlated with spared thermal nociception. Shimizu S1, Mochizuki T, Sekiguchi T1, Osawa S1, Kawai T, kohno M, Sagiuchi T, Kumabe T1: J Spine Res 2015/9; 6 (9): 1407-15. (´…@ú1, –]ŒŽ’O, ŠÖŒű•üŽq1, ‘ĺŕVŹ”V1, ‰Íˆä‘ě–ç, ‰Í–ěS”Í, ë“ŕ—˛—Y, ŒG•”rG1 :1”]ŠO)

110200. [Œ´’˜] Intraoperative monitoring during decompression of the spinal cord and spinal nerves using transcranial motor-evoked potentials: The law of twenty percent. Tanaka S, Hirao J, Oka H1, Akimoto J, Takanashi J, Yamada J: J Clin Neurosci 2015/9; 22 (9): 1403-7. (‰Ş@GG1: 1”]ŠO)

110201. [Œ´’˜] Hypoxia-mediated cancer stem cells in pseudopalisades with activation of hypoxia-inducible factor-1/Akt axis in glioblastoma. Inukai M1, Hara A2, Yasui Y3, Kumabe T4, Matsumoto T2, Saegusa M2: Hum Pathol 2015/10; 46 (10): 1496-505. (Œ˘Ž”@‰~1, Œ´@“ÖŽq2, ˆŔˆä”ü]3, ŒG•”rG4, ź–{r‰p2, ŽOŽ}@M2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn, 4”]ŠO)

110202. [Œ´’˜] A comparative study of the extent of cerebral microvascular injury following whole-brain irradiation versus reduced-field irradiation in long-term survivors of intracranial germ cell tumors. Li L, Mugikura S, Kumabe T1, Murata T, Mori E, Takase K, Jingu K, Takahashi S: Radiother Oncol 2015/11; 117 (2): 302-7. (ŒG•”rG1: 1”]ŠO)

110203. [Œ´’˜] Modified One-piece Supraorbital Approach for Orbital Tumors: Widely Preserved Orbital Roof in a Self-fitting Flap. Shimizu S1, Osawa S1, Sekiguchi T1, Mochizuki T, Oka H1, Kumabe T1: J Neurol Surg B Skull Base 2015/12; 76 (6): 459-63. (´…@ú1, ‘ĺŕVŹ”V1, ŠÖŒű•üŽq1, –]ŒŽ’O, ‰Ş@GG1, ŒG•”rG1: 1”]ŠO)

110204. [Œ´’˜] Low Stroke Rate of Carotid Stenosis Under the Guideline-Oriented Medical Treatment Compared With Surgical Treatment. Sato K1, Fujiyoshi K2, Hoshi K3, Noda C4, Yamaoka-Tojo M5, Ako J4, Kumabe T1: Int Heart J 2016/1; 57 (1): 80-6. (˛“ĄŒör1, “Ą‹g˜a”Ž2, Ż@‰Ŕ–F3, –ě“cçt4, “ŒžŠ”ü“ŢŽq5, ˆ˘ŒĂĆ4, ŒG•”rG1: 1”]ŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‰qś, 4zŠÂŠí“ŕ, 5ˆă—ÉqśŠw•”)

110205. [Œ´’˜] Divergent clonal selection dominates medulloblastoma at recurrence. Morrissy AS, Garzia L, Shih DJ, Zuyderduyn S, Huang X, Skowron P, Remke M, Cavalli FM, Ramaswamy V, Lindsay PE, Jelveh S, Donovan LK, Wang X, Luu B, Zayne K, Li Y, Mayoh C, Thiessen N, Mercier E, Mungall KL, Ma Y, Tse K, Zeng T, Shumansky K, Roth AJ, Shah S, Farooq H, Kijima N, Holgado BL, Lee JJ, Matan-Lithwick S, Liu J, Mack SC, Manno A, Michealraj KA, Nor C, Peacock J, Qin L, Reimand J, Rolider A, Thompson YY, Wu X, Pugh T, Ally A, Bilenky M, Butterfield YS, Carlsen R, Cheng Y, Chuah E, Corbett RD, Dhalla N, He A, Lee D, Li HI, Long W, Mayo M, Plettner P, Qian JQ, Schein JE, Tam A, Wong T, Birol I, Zhao Y, Faria CC, Pimentel J, Nunes S, Shalaby T, Grotzer M, Pollack IF, Hamilton RL, Li XN, Bendel AE, Fults DW, Walter AW, Kumabe T1, Tominaga T, Collins VP, Cho YJ, Hoffman C, Lyden D, Wisoff JH, Garvin JH Jr, Stearns DS, Massimi L, Sch_ller U, Sterba J, Zitterbart K, Puget S, Ayrault O, Dunn SE, Tirapelli DP, Carlotti CG, Wheeler H, Hallahan AR, Ingram W, MacDonald TJ, Olson JJ, Van Meir EG, Lee JY, Wang KC, Kim SK, Cho BK, Pietsch T, Fleischhack G, Tippelt S, Ra YS, Bailey S, Lindsey JC, Clifford SC, Eberhart CG, Cooper MK, Packer RJ, Massimino M, Garre ML, Bartels U, Tabori U, Hawkins CE, Dirks P, Bouffet E, Rutka JT, Wechsler-Reya RJ, Weiss WA, Collier LS, Dupuy AJ, Korshunov A, Jones DT, Kool M, Northcott PA, Pfister SM, Largaespada DA, Mungall AJ, Moore RA, Jabado N, Bader GD, Jones SJ, Malkin D, Marra MA, Taylor MD: Nature 2016/1; 529 (7586): 351-7. (ŒG•”rG1: 1”]ŠO)

110206. [Œ´’˜] Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease. Sato K1, Yamada M1, Kuroda H1, Yamamoto D1, Asano Y2, Inoue Y2, Fujii K, Kumabe T1: Am J Neuroradiol 2016/3; 37: 1244-8. (˛“ĄŒör1, ŽR“c@Ÿ1, •“c”Ž‹I1, ŽR–{‘ĺ•ă1, ó–ě—Y“ń2, ˆäă—D‰î2, ŒG•”rG1: 1”]ŠO, 2•úŽËü (‰ć‘œ))

110207. [Œ´’˜] Peri-tumoral leakage during intra-tumoral convection-enhanced delivery has implications for efficacy of peri-tumoral infusion before removal of tumor. Yang X, Saito R, Nakamura T, Zhang R, Sonoda Y, Kumabe T1, Forsayeth J, Bankiewicz K, Tominaga T: Drug Deliv 2016; 23 (3): 771-6. (ŒG•”rG1: 1”]ŠO)

220006. [€Œ´’˜] –Ź—‘p (choroidal fissure) ‹ß–T‚ĚŽčp‚É•K—v‚Č”÷ŹŠO‰Č‰đ–U. ‰Ş@GG1, ‰Í“‡‰ë“ž, ´…@ú1, ‘ĺŕVŹ”V1, ˛“ĄŒör1, ‹v{”ü^—1, “Ąˆä´F1, Albert L Rhoton Jr (1”]ŠO): ”]_ŒoŠO‰ČƒWƒƒ[ƒiƒ‹ 2015/10; 24 (Suppl 2): 73-9.

310022. [Ç—á•ń] Chronic Phase Intracranial Hemorrhage Caused by Ruptured Pseudoaneurysm Induced by Carmustine Wafer Implantation for Insulo-opercular Anaplastic Astrocytoma: A Case Report. Sato K1, Dan M1, Yamamoto D1, Miyajima Y, Hara A2, Kumabe T1: Neurol Med Chir (Tokyo) 2015/11; 55 (11): 848-51. (˛“ĄŒör1, ’h@@[1, ŽR–{‘ĺ•ă1, ‹{“‡—Ç‹P, Œ´@“ÖŽq2, ŒG•”rG1: 1”]ŠO, 2•a—)

310023. [Ç—á•ń] The Appropriate Surgical Approach to a Greater Petrosal Nerve Schwannoma in the Setting of Temporal Lobe Edema. Kusumi M1, Oka H1, Aliabadi H, Sato S1, Kumabe T1: World Neurosurg 2016/1; 85: 364. (‹v{”ü^—1, ‰Ş@GG1, ˛“ĄŸl1, ŒG•”rG1: 1”]ŠO)

521015. [‰đŕ]yƒeƒNƒjƒJƒ‹Eƒm[ƒgzŠO‘¤Œă“މşƒAƒvƒ[ƒ`‚É‚¨‚Ż‚éd–ŒˆęŽŸ•Â˝‚̍H•v|ƒtƒBƒuƒŠƒ“ŒĐƒR[ƒeƒB[ƒ“ƒO‚É‚ć‚éd–Œ‚Ě•ŰŽź|. ´…@ú1, –]ŒŽ’O, ‘ĺŕVŹ”V1, ŠÖŒű•üŽq1, ŒG•”rG1 (1”]ŠO): ”]_ŒoŠO‰Č 2015/8; 43 (8): 709-12.

521016. [‰đŕ]y‰đ–U‚𒆐S‚Ć‚ľ‚˝”]_ŒoŽčpŽč‹ZzŇ‘‘“ŕŽîᇎčp‚É‚¨‚Ż‚éŇ‘‘O•ű‚Ě”÷ŹŠO‰Č‰đ–U‚ĆŽčp‚ĚŽŔŰ. ŽOˆäŒö•F, ´…@ú1, ŽO“‡‘ĺ“ż (1”]ŠO): ”]_ŒoŠO‰Č 2016/1; 44 (1): 19-28.

521017. [‰đŕ]yƒeƒNƒjƒJƒ‹Eƒm[ƒgzLkŽŽƒXƒgƒ‰ƒbƒv‚đ—p‚˘‚˝ŠJ“ޏp’†‚Ě‹zˆřŠÇ—Ž‰ş–hŽ~. ´…@ú1, –]ŒŽ’O, ‘ĺŕVŹ”V1, ŠÖŒű•üŽq1, ŹňŠ°”V2, ŒG•”rG1 (1”]ŠO, 2‹~–˝): ”]_ŒoŠO‰Č 2016/2; 44 (2): 111-3.

522113. [uŔ]y“ÁW: –ƒŒ‰Čˆă‚É•K—v‚Č”]_Œoƒ‚ƒjƒ^ƒŠƒ“ƒOz”]_ŒoŠO‰Č‚É‚¨‚Ż‚éABR. ˛“ĄŸl1, Ź–ěŕV—T–ç2, ŒG•”rG1, ‰Ş–{_Žk3 (1”]ŠO, 2—ŐŒŸ•”, 3–ƒŒ): –ƒŒ 2015/5; 64 (5): 502-7.

[’˜@‘]

610003. [Šwp‘ (•Ş’SŽˇ•M)]yPosterior fossa tumots in childrenz[Pathologies in Pediatric Posterior Fossa Tumors: Rare Tumors] Posterior Fossa Choroid Plexus Tumor, p.723-43. Morota N, Kumabe T1, Kakita A1 Editors: … MM, Cinalli G, Maixer W, Sainte-Rose C, Springer, 2015. (ŒG•”rG1: 1”]ŠO)

620078. [Šwp‘] (•Ş’SŽˇ•M)yŹŽ™ŒŒ‰tEŽîᇊwz‘ć2Í ŹŽ™‚Ş‚ń@D ŹŽ™‚Ş‚ń‚É‚¨‚Ż‚鎥—Ă–@@[ŠO‰ČŽĄ—Ă]@1 ”]Žîá‡, p.147-52. ŒG•”rG (”]ŠO), •Ň: “ú–{ŹŽ™ŒŒ‰tE‚Ş‚ńŠw‰ď, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/11”­s.

620079. [Šwp‘ (•Ş’SŽˇ•M)]y”]ŒŒŠÇ“஡—Â̐i•ŕ2016@ŽĄ—͢“ď‚Č”]“Ž–ŹáŽ|‚Ç‚¤ŽĄ—Ă‚ˇ‚é‚Š?`”]ŒŒŠÇ“஡—Ăƒuƒ‰ƒbƒVƒ…ƒAƒbƒvƒZƒ~ƒi[2015`zIV. Ž„‚Č‚ç‚ą‚¤ŽĄ—Ă‚ˇ‚é, ‚ą‚¤ŽĄ—Ă‚ľ‚˝|‹}ŤÄŠJ’ʂȂǁ@…@CT based revascularization|ÄŠJ’ĘŽžŠÔ’Zk‚É‚ć‚é“]‹AŒüă‚ĚŽŽ‚݁|, p.87-91. ‹ß“Ą—łŽj1, ź–{NŽj (1”]ŠO), •Ň: âˆäMK, ]–ʐłK, źŠŰ—SŽi, ‹{’n@–Î, ‹g‘şaˆę, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/11”­s.

620080. [Šwp‘] (•Ş’SŽˇ•M)yVNS NOW No.4@”]EŇ‘ŽîᇓEo‚Ě‚˝‚ß‚Ěˆř‚Ťo‚ľ@ŽîᇓEo‚ĚƒRƒc‚ĆƒsƒbƒgƒtƒH[ƒ‹zII Še˜_@ƒOƒŠƒI[ƒ}“Eop@ŒŒŠÇ‘š‚đ”đ‚Ż‚é‚˝‚ß‚É, p.66-73. ŒG•”rG (”]ŠO), •Ň: X“c–ž•v, ˆÉ’B@ŒM, ‹e“cŒ’ˆę˜Y, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2015/12”­s

620081. [Šwp‘] (•Ş’SŽˇ•M)y”]_ŒoŠO‰ČŠw ‰ü’ů12”Ĺ IIz11Í ”]Žîᇁ@3. ŽĄ—Á@1. Žčp, p.1408-22. ŒG•”rG (”]ŠO), ‘•ŇW: ‘ž“c•x—Y, •Ň: ěŒ´M—˛, –ěčˆę•F, ‹g•ôrŽ÷, Žá—яr•F, ‹ŕ–F“°, 2016/3”­s.

620082. [Šwp‘ (•Ş’SŽˇ•M)]y”]_ŒoŠO‰ČŠw ‰ü’ů12”Ĺ IIz11Í ”]Žîᇁ@6. ‘ŮŽ™ŤŽîá‡, p.1583-603. ‰Ş@GG (”]ŠO), ‘•ŇW: ‘ž“c•x—Y, •Ň: ěŒ´M—˛, –ěč˜a•F, ‹g•ôrŽ÷, Žá—яr•F, ‹ŕ–F“°, ‹ž“s, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

711001. [Šw‰ď (‘Ű)] (“Á•Ęu‰‰) Surgeries of gliomas and perforating arteries. Kumabe T1: The 9th Symposium of CHA Neurological Center (2015/11/14), Pangyo, Korea. (ŒG•”rG1: 1”]ŠO)

712016. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) Stereotactic radiosurgery for recurrent malignant neuroepithelial tumors. Kumabe T1, Jokura H, Akabane A, Saito R, Kanamori M, Yamashita Y, Sonoda Y, Kawagishi J, Kawai K, Tominaga T: ‘ć12‰ń‘Ű’čˆĘ•úŽËüŽĄ—ĂŠw‰ďŠwp‘ĺ‰ď (2015/6/8), ‰Ą•l. (ŒG•”rG1, é‘q‰pŽj, Ô‰H@“Ö, âV“Ą—ł‘ž, ‹ŕX­”V, ŽR‰ş—m“ń, ‰€“c‡•F, ěŠÝ@, ě‡ŒŞ‰î ,•y‰i’î“ń: 1”]ŠO)

713063. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Germinomas can be diagnosed without histrogical verification. Saito R, Sonoda Y, Kanamori M, Kawaguchi T, Kumabe T1, Tominaga T: The 4th International CNS Germ Cell Tumour Symposium (2015/4/14), Tokyo. (ŒG•”rG1: 1”]ŠO)

713064. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Differences of histrogical and clinical characterstics in the teratoma during the treatment for intracranial germ cell tumors. Kanamori M, Kumabe T1, Watanabe M, Saito R, Yamashita Y, Sonoda Y, Tominaga T: The 4th International CNS Germ Cell Tumour Symposium (2015/4/15), Tokyo. (ŒG•”rG1: 1”]ŠO)

713065. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Intraoperative ultrasonography during drainage for chronic subdural hematomas: A technique to release isolated deep-seated hematomas -Technical Note-. Shimizu S1, Mochizuki T, Osawa S1, Kumabe T1: 83rd American Association of Neurological Surgeons Annual Scientific Meeting (2015/5/2-6), Washington DC, USA. (´…@ú1, –]ŒŽ’O, ‘ĺŕVŹ”V1, ŒG•”rG1: 1”]ŠO)

713066. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) Repeat surgery and stereotactic radiosurgery for recurrent malignant neuroepithelial tumors. Kumabe T1: 12th Meeting of the Asian Society for Neuro-Oncology (2015/9/17), Manila, Philippine. (ŒG•”rG1: 1”]ŠO)

713067. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Re-evaluation of the usefulness of intraoperative computed tomography for neurosurgical procedures in intraoperative magnetic resonance imaging era. Dan M1, Yamamoto D1, Sato Y, Kuroda H1, Miyajima Y, Sato K1, Kumabe T1: The 20th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (2015/11/20), San Antonio, USA. (’h@@[1, ŽR–{‘ĺ•ă1, ˛“Ą—Yˆę, •“c”Ž‹I1, ‹{“‡—Ç‹P, ˛“ĄŒör1, ŒG•”rG1: 1”]ŠO)

713068. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Multicenter retrospective study to compare chemoradiotherapy with temozolomide or ACNU in 535 anaplastic gliomas Muragaki Y, Narita Y, Kumabe T1, Nakamura H, Nagane M, Ikuta S, Maruyama T, Uzuka T, Ito T, Beppu T, Takano S, Arakawa Y, Kobayashi H, Wakabayashi T, Sugiyama K, Hashimoto N, Saito R, Nishikawa R, Kayama T, Shibui S: The 20th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (2015/11/20), San Antonio, USA. (ŒG•”rG1: 1”]ŠO)

713069. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) Surgeries of gliomas and perforating arteries. Kumabe T1: 1st Quadrennial Meeting of Walter E. Dandy Neurosurgical Society (2015/11/22), Dubai, UAE. (ŒG•”rG1: 1”]ŠO)

721014. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ŠoÁ‰şŽčp‚ÉŠÖ‚ˇ‚é“d‹Cś—Šw‚ĚŠî–{. ˛“ĄŸl (”]ŠO): ‘ć13‰ń“ú–{Awake SurgeryŠw‰ď (2015/9/24), –źŒĂ‰Ž.

722066. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) IDH–쐜Œ^grade 3_ŒoäPŽî‚Ě•a—‘œ‚Ć—\Œă. ‰€“c‡•F, —é–Ř”Ž‹`, “n•Ó‚Ý‚Š, ŽÄŒ´ˆę—z, âV“Ą—ł‘ž, ‹ŕX­”V, ŒG•”rG1, •y‰i’î“ń (1”]ŠO): ‘ć33‰ń“ú–{”]Žîᇕa—Šw‰ď (2015/5/29), ‚ź.

722067. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) ”]ŽîᇓEop‚É‚¨‚Ż‚é‰A‹É’P‹É”玿ŽhŒƒ‚É‚ć‚éMEPƒ‚ƒjƒ^ƒŠƒ“ƒO. ˛“ĄŸl1, Ź–ěŕV—T–ç2, ‹{“‡—Ç‹P, ŒG•”rG1 (1”]ŠO, 2—ŐŒŸ•”): ‘ć21‰ń“ú–{”]_Œoƒ‚ƒjƒ^ƒŠƒ“ƒOŠw‰ď (2015/6/27), “Œ‹ž.

722068. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) Œ‹ßŤd‰ťÇ‚É”ş‚Á‚˝ăˆß‰ş‹×–EŻ×–EŽî‚ĚŽĄ—Ă. ŒG•”rG (”]ŠO): ‘ć3‰ń“ú–{Œ‹ßŤd‰ťÇŠw‰ďŠwp‘‰ď (2015/10/17), “Œ‹ž.

722069. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) _ŒoäPŽî“Eo‚Ě—đŽj|Ĺ‘ĺŒŔ‚ĚŽîᇓEo‹y‚эŏŹŒŔ‚ĚŽčp‡•šÇ‚đ–ÚŽw‚ľ‚ā|. ŒG•”rG (”]ŠO): ‘ć35‰ń“ú–{”]_ŒoŠO‰ČƒRƒ“ƒOƒŒƒX‘‰ď (2015/5/9), ‰Ą•l.

722070. [Šw‰ď (‘S‘)] (‹łˆçƒZƒ~ƒi[) ŠoÁ‰şŽčp: Summary of Awake Surgery for Gliomas. ŒG•”rG (”]ŠO): ‘ć20‰ń“ú–{”]Žîᇂ̊O‰ČŠw‰ď (2015/9/26), –źŒĂ‰Ž.

722071. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€“™) –{–M‰‚̍ŐV3D_Œo“ŕŽ‹‹ž (Visionsense V3) ‚Ě”]_ŒoŽčp‚Ö‚Ě“ą“ü‚ÉŒü‚Ż‚Ä. ‰Ş@GG1, ‹v{”ü^—1, ‹ß“ĄGŽĄ1 (1”]ŠO): ‘ć25‰ń”]_ŒoŠO‰ČŽčp‚Ć‹@ŠíŠw‰ď (2016/3/26), VŠƒ.

723475. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”]_ŒoŠO‰ČŽčp‚É‚¨‚Ż‚éVŒ^ƒoƒCƒ|[ƒ‰ [ƒxƒUƒŠƒEƒX]: ‚ť‚ĚŠî‘b‚¨‚ć‚Ń—Ő°ă‚Ě“Á’Ľ. ‰Ş@GG1, ‹v{”ü^—1, ‹ß“ĄG–č1 (1”]ŠO): ‘ć24‰ń”]_ŒoŠO‰ČŽčp‚Ć‹@ŠíŠw‰ď (2015/4/3), ‘ĺă.

723476. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “ŕčň“Ž–Ź‚Ć‘¤•›ŒŒs˜H•]‰ż‚ÉŠî‚Ă‚˘‚˝Œă“ŞŠWâ|ƒAƒvƒ[ƒ`. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄG–č1, ŒG•”rG1 (1”]ŠO): ‘ć24‰ń”]_ŒoŠO‰ČŽčp‚Ć‹@ŠíŠw‰ď (2015/4/3), ‘ĺă.

723477. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Vim-thalamotomy Œă‚̐_ŒoS—Šw“IŒŸ“˘. ˛“ĄŸl1, ‘ęŽR—eŽq2, “n•ÓŽŹ, ‹{“‡—Ç‹P, źŽR˜a—˜2, ŒG•”rG1 (1”]ŠO, 2_Œo“ŕ): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/20), VŠƒ.

723478. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) NF1‚ɍ‡•š‚ľ‚˝pleomorphic xanthoastrocytoma. •“c”Ž‹I1, ŒG•”rG1, “’ŕV@ň1, Œ´@“ÖŽq2, âV“Ą—ł‘ž, ‰€“c‡•F, “n•Ó‚ä‚Š, •y‰i’î“ń (1”]ŠO, 2•a—): ‘ć33‰ń“ú–{”]Žîᇕa—Šw‰ďŠwpW‰ď (2015/5/29), ‚ź.

723479. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŢŒ`ŹŤ_ŒoäPŽî‚É‚¨‚Ż‚éIDH1 R132Hƒ^ƒ“ƒpƒNŽż‚Ć—\Œă‚ÉŠÖ‚ˇ‚錟“˘. ‹ŕX­”V, “n•Ó‚Ý‚Š, —é–Ř”Ž‹`, ŽÄŒ´ˆę—z, âV“Ą—ł‘ž, ‰€“c‡•F, ŒG•”rG1, •y‰i’î“ń (1”]ŠO): ‘ć33‰ń“ú–{”]Žîᇕa—Šw‰ďŠwpW‰ď (2015/5/29-30), ‚ź.

723480. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) –Ťd–Œ‰şŒŒŽîƒhƒŒƒi[ƒWp‚É‚¨‚Ż‚ép’†ƒGƒR[: ŒÇ—§‚ľ‚˝[•”ŒŒŽî‚đŠJ•ú‚ˇ‚éŽč‹Z. ´…@ú1, –]ŒŽ’O, ‘ĺŕVŹ”V1, ŒG•”rG1 (1”]ŠO): ‘ć15‰ń“ú–{p’†‰ć‘œî•ńŠw‰ď (2015/6/20), “Œ‹ž.

723481. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”]ŠO‰ČŽčp‚É‚¨‚Ż‚ép’†CT‚Ě—L—pŤ. ’h@@[1, ŽR–{‘ĺ•ă1, •“c”Ž‹I1, ‹{“‡—Ç‹P, ˛“ĄŒör1, ŒG•”rG1 (1”]ŠO): ‘ć15‰ń“ú–{p’†‰ć‘œî•ńŠw‰ď (2015/6/20), “Œ‹ž.

723482. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ň‘d–Œ“ŽĂ–Źá‘‚É‚¨‚Ż‚éƒVƒƒƒ“ƒg‚Ć“ąoĂ–Źd–ŒŠŃ’Ę•”‚̍‚ˆĘ•sˆę’v. ‘ĺŕVŹ”V1, ´…@ú1, –]ŒŽ’O, ’†ŽRŒŤŽi, ŽR–{—E•v, ‹ß“Ą—łŽj1, ŒG•”rG1 (1”]ŠO): ‘ć30‰ń“ú–{Ň‘ŠO‰ČŠw‰ď (2015/6/25), ŽD–y.

723483. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆŤŤ_ŒoäPŽî‚É‚¨‚Ż‚éNRF2Œo˜HŠˆŤ‰ť‚Ć—\Œă‚ÉŠÖ‚ˇ‚錟“˘. ‹ŕX­”V, ”ä‰Ă„Žu, ‰€“c‡•F, ‘şăš•˝, –k‘ş‘ĺŽu, •SX”ü“Ţ, ŽÄ“c—´O, “n粂݂Š, —é–Ř”Ž‹`, ŽÄŒ´ˆę—z, âV“Ą—ł‘ž, ŽR‰ş—m“ń, ŒG•”rG1, ŽR–{‰ë”V, –{‹´‚Ů‚Ă‚Ý, •y‰i’î“ń (1”]ŠO): ‘ć16‰ń“ú–{•ŞŽq”]_ŒoŠO‰ČŠw‰ď (2015/8/29), •lź.

723484. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Ň‘‘“ŕŽîᇎčp‚É‚¨‚Ż‚éŇ‘‘O•ű‚Ě”÷Ź‰đ–U. ŽOˆäŒö•F, ´…@ú1, ŽO“‡‘ĺ“ż (1”]ŠO): ‘ć22‰ń“ú–{Ň’ŁEŇ‘_ŒoŽčpŽč‹ZŠw‰ďŠwpW‰ď (2015/9/18), “Œ‹ž.

723485. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘O°“Ë‹N‘–ŒŽî‚ɑ΂ˇ‚é‘O°“Ë‹NŘœ‚Ě•K—vŤ. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄGŽĄ1, ŒG•”rG1 (1”]ŠO): ‘ć20‰ń“ú–{”]Žîᇂ̊O‰ČŠw‰ď (2015/9/25), –źŒĂ‰Ž.

723486. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒL[ƒz[ƒ‹Žčp‚Ĺ“Eo‰Â”\‚Ĺ‚ ‚Á‚˝ăˆß‰ş‹‘ĺ×–EŤŻ×–EŽî‚Ě1—á. ‹ß“ĄGŽĄ1, ‹v{”ü^—1, ‰Ş@GG1 (1”]ŠO): ‘ć20‰ń“ú–{”]Žîᇂ̊O‰ČŠw‰ď (2015/9/26), –źŒĂ‰Ž.

723487. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚ĹŒoŒą‚ľ‚˝3—á‚ĚGorlinÇŒóŒQ‚Ě•ŞŽqˆâ“`Šw“IŒŸ“˘. ź–{çq1, ‹{‰şr”V2, ‰Ş@GG1, ŒG•”rG1 (1”]ŠO, 2•ŞŽqˆâ“`): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwp‘‰ď (2015/10/14), ŽD–y.

723488. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) —Տ°“I‚Ésecondary glioblastoma‚Ć”ť’f‚ł‚ę‚éäP‰čŽî‚ĚIDHˆâ“`ŽqˆŮí. ˛“Ą—Yˆę1, Œ˘Ž”@‰~2, Œ´@“ÖŽq3, ŒG•”rG4 (1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3•a—, 4”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwp‘‰ď (2015/10/14), ŽD–y.

723489. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘O°“Ë‹N‘–ŒŽî‚ɑ΂ˇ‚é‘O°“Ë‹NŘœ‚Ě•K—vŤ. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄGŽĄ1, ŒG•”rG1 (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwp‘‰ď (2015/10/14), ŽD–y.

723490. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) čň•”•úŽËüĆŽËŒăčň“Ž–Ź‹ˇó‚ɑ΂ˇ‚éƒXƒeƒ“ƒg—Ż’up. ŽR–{‘ĺ•ă1, ‹ß“Ą—łŽj1, ‹{â˜aO1, ŹňŠ°”V2, ’†Œ´–Mť, ŒG•”rG1 (1”]ŠO, 2‹~–˝): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwp‘‰ď (2015/10/14), ŽD–y.

723491. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) PACS‚đ—p‚˘‚˝‹@”\“I’čˆĘ”]Žčp’†Xü‰ć‘œˆ—. ˛“ĄŸl1, “n•ÓŽŹ, ’h@@[1, ´…˜aŒh2, ‰Ô“‡—ĽŽq2, ŒG•”rG1 (1”]ŠO, 2_Œo“ŕ): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwpW‰ď (2015/10/14), ŽD–y.

723492. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) –Ťd–Œ‰şŒŒŽîƒhƒŒƒi[ƒWp‚É‚¨‚Ż‚ép’†ƒGƒR[: ŒÇ—§‚ľ‚˝[•”ŒŒŽî‚đŠJ•ú‚ˇ‚éŽč‹Z. ´…@ú1, –]ŒŽ’O, ‘ĺŕVŹ”V1, ŒG•”rG1 (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwpW‰ď (2015/10/14), ŽD–y.

723493. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ˆŤŤ_ŒoäPŽî‚ɑ΂ˇ‚éƒJƒ‹ƒ€ƒXƒ`ƒ“ƒEƒGƒn[ƒXEƒeƒ‚ƒ]ƒƒ~ƒhEƒxƒoƒVƒYƒ}ƒu•Ą‡—Ă–@‚É•K—v‚Ć‚ˇ‚é”ď—p. ŒG•”rG1, ’h@@[1, ŽR–{‘ĺ•ă1, •“c”Ž‹I1, ˛“Ą—Yˆę2, ‹{“‡—Ç‹P, ˛“ĄŸl1 (1”]ŠO, 2ˆă—ÉqśŠw•”): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwpW‰ď (2015/10/15), ŽD–y.

723494. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”j—ô’ōœ“Ž–ŹáŽ‚ɑ΂ˇ‚ée“Ž–Ź•ÂÇp‚Ě’ˇŠú“]‹A. ‹ß“Ą—łŽj1, ŒG•”rG1, ź–{NŽj, ˛“ĄŒ’ˆę, ‰““Ą‰p“ż, •y‰i’î“ń (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwpW‰ď (2015/10/15), ŽD–y.

723495. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”]ŠO‰ČŽčp‚É‚¨‚Ż‚ép’†CT‚Ě—L—pŤ. ’h@@[1, ŽR–{‘ĺ•ă1, •“c”Ž‹I1, ‹{“‡—Ç‹P, ˛“ĄŒör1, ŒG•”rG1 (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwp‘‰ď (2015/10/15), ŽD–y.

723496. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éˆŤŤ_ŒoäPŽî‚ɑ΂ˇ‚éƒJƒ‹ƒ€ƒXƒ`ƒ“ƒEƒGƒn[ƒXŽg—pÇ—á‚ĚŽĄ—ÐŹŃ‚ƍ‡•šÇ. •“c”Ž‹I1, ˛“Ą—Yˆę2, ‹{â˜aO1, ’h@@[1, ŽR–{‘ĺ•ă1, ‹{“‡—Ç‹P, ˛“ĄŸl1, ŒG•”rG1 (1”]ŠO, 2ˆă—ÉqśŠw•”): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwpW‰ď (2015/10/16), ŽD–y.

723497. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) MRIƒ‚ƒjƒ^ƒŠƒ“ƒO‰şƒjƒgƒƒ\ƒEƒŒƒAÜConvection-enhanced delivery‚É‚ć‚é_ŒoŽîV‹KŽĄ—Ă–@‚ĚŠJ”­. âV“Ą—ł‘ž, ‰€“c‡•F. ŻŽi‘ń‘ĺ, jśV–ç, áÁ–ě@—B, ’ˇ“ě‰ëŽu, ‹ŕX­”V, ŒG•”rG1, •y‰i’î“ń (1”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwp‘‰ď (2015/10/16), ŽD–y.

723498. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “ŞŠWˆô“ŞŽî‚ɑ΂ˇ‚é_Œo“ŕŽ‹‹žŽčpí—Ş. ‰Ş@GG1, Scheithauer BW, Perry A, Prevedello DM, Ludecke DK, Perneczky A (1”]ŠO): ‘ć22‰ń“ú–{_Œo“ŕŽ‹‹žŠw‰ď (2015/11/5), ź“‡.

723499. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒL[ƒz[ƒ‹Žčp‚Ĺ“Eo‰Â”\‚Ĺ‚ ‚Á‚˝ăˆß‰ş‹×–EŤŻ×–EŽî‚Ě1—á. ‹ß“ĄGŽĄ1, ‹v{”ü^—1, ‰Ş@GG1 (1”]ŠO): ‘ć22‰ń“ú–{_Œo“ŕŽ‹‹žŠw‰ď (2015/11/6), ź“‡.

723500. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”]“Ž–ŹáŽ‚ɑ΂ˇ‚é᎓ŕÇđpŒă‚ɐú’ĘŽ}[Ç‚𐜂ś‚˝2—á. ‹{â˜aO1, ‹ß“Ą—łŽj1, ŽR–{‘ĺ•ă1, ŹňŠ°”V2, ’†Œ´–Mť, ŒG•”rG1 (1”]ŠO, 2‹~–˝): ‘ć31‰ńNPO–@l“ú–{”]_ŒoŒŒŠÇ“஡—ĂŠw‰ďŠwp‘‰ď (2015/11/20), ‰ŞŽR.

723501. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) čň•”•úŽËüĆŽËŒă‚ɐś‚ś‚˝čň“Ž–Ź‹ˇó‚ɑ΂ˇ‚éƒXƒeƒ“ƒg—ŻŽĄp‚Ě“Á’Ľ‹y‚ŃŽĄ—ÐŹŃ. ŽR–{‘ĺ•ă1, ‹ß“Ą—łŽj1, ‹{â˜aO1, ŹňŠ°”V2, ’†Œ´–Mť, ŒG•”rG1 (1”]ŠO, 2‹~–˝): ‘ć31‰ńNPO–@l“ú–{”]_ŒoŒŒŠÇ“஡—ĂŠw‰ďŠwp‘‰ď (2015/11/20), ‰ŞŽR.

723502. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‰Šú‰ć‘œ•]‰ż‚ÉCT‚đ—p‚˘‚˝ŒŒđ‰ńŽű—Ă–@‚Ě—LŒřŤ‚ĆˆŔ‘SŤ. ‹ß“Ą—łŽj1, ’†Œ´–Mť, ˆ˘•”Ž’q1, ŽR–{‘ĺ•ă1, ’h@@[1, ‹{â˜aO1, ŒG•”rG1, ˆä“‡‘ĺ•ă2, źŽR˜a—˜2 (1”]ŠO, 2_Œo“ŕ): ‘ć31‰ńNPO–@l“ú–{”]_ŒoŒŒŠÇ“஡—ĂŠw‰ďŠwp‘‰ď (2015/11/20), ‰ŞŽR, JNET: Journal of Neuroendovascular Therapy 2015; 9 (6): S271.

723503. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éˆŤŤ_ŒoäPŽî‚ɑ΂ˇ‚éƒJƒ‹ƒ€ƒXƒ`ƒ“ƒEƒGƒn[ƒXŽg—pÇ—á‚ÉŽĄ—ÐŹŃ‚ƍ‡•šÇ. ŒG•”rG1, ’h@@[1, •“c”Ž‹I1, ‹{â˜aO1, ŽR–{‘ĺ•ă1, ‹{“‡—Ç‹P, ‘ĺŕVŹ”V1, ˛“ĄŸl1 (1”]ŠO): ‘ć33‰ń“ú–{”]Žîᇊw‰ďŠwpW‰ď (2015/12/6), ‹ž“s.

723504. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Bevacizumab‚đ•š—p‚ľ‚˝Ä”­diffuse intrinsic pontine glioma‚ĚŽĄ—Ă. ˛“Ą—Yˆę1, ’h@@[2, ŽR–{‘ĺ•ă2, •“c”Ž‹I2, Œ˘Ž”@‰~3, Œ´@“ÖŽq4, ŒG•”rG2 (1ˆă—ÉqśŠw•”, 2”]ŠO, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4•a—): ‘ć33‰ń“ú–{”]Žîᇊw‰ďŠwpW‰ď (2015/12/6), ‹ž“s.

723505. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) äP‰čŽî‚Ě‹Uňó”z—ń•”—Ěˆć‚É‚¨‚Ż‚éHIF-1/AktŒnŠˆŤ‰ť‚đ‰î‚ľ‚˝‚Ş‚ńŠ˛×–E‰ťˆŰŽ. Œ˘Ž”@‰~1, Œ´@“ÖŽq2, ˆŔˆä”ü]3, ŽOŽ}@M2, ŒG•”rG4 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn, 4”]ŠO): ‘ć33‰ń“ú–{”]Žîᇊw‰ďŠwpW‰ď (2015/12/6-8), ‹ž“s.

723506. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠmŽŔ‚ČŽOł_Œo’ÉŽčp‚đ–ÚŽw‚ľ‚Ä: —lX‚ČŒ´ˆö‚Š‚ç. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄGŽĄ1, ŒG•”rG1 (1”]ŠO): ‘ć18‰ń“ú–{”]_ŒoŒ¸ˆłpŠw‰ď (2016/1/21), ĺ‘ä.

723507. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘O°“Ë‹N‹ß–T‘–ŒŽî‚ɑ΂ˇ‚é‘O°“Ë‹NŘœ‚̍H•v: ƒhƒŠƒ‹‚ƍœççŽq‚Ŏ葁‚­s‚¤•ű–@. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄGŽĄ1, ŒG•”rG1 (1”]ŠO): ‘ć25‰ń”]_ŒoŠO‰ČŽčp‚Ć‹@ŠíŠw‰ď (2016/3/25), VŠƒ.

731092. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _ŒoäPŽîŽčp‚Ć“K‰ž‚Ć•ű–@. ŒG•”rG (”]ŠO): ‘ć79‰ńŽRŒ`”]_ŒoŠO‰Č§˜b‰ď (2015/4/25), ŽRŒ`.

731093. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ”]Žîᇂɂ¨‚Ż‚éƒAƒoƒXƒ`ƒ“—Ă–@‚ɂ‚˘‚Ä. ŒG•”rG (”]ŠO): ‘q•~”]ŽîᇃJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/5/14), ‘q•~.

731094. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _ŒoäPŽî‚ĚŽčp: ’čŒ^“IŽčp‚đ–ÚŽw‚ľ‚Ä. ŒG•”rG (”]ŠO): ‘ć8‰ńSkill-building Neurosurgical Conference (2015/5/16), ŽD–y.

731095. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Long insular artery. ŒG•”rG (”]ŠO): ‘ć5‰ńƒOƒŠƒI[ƒ}ŽčpŽč‹ZƒCƒ“ƒ^[ƒlƒbƒgƒ‰ƒCƒuƒZƒ~ƒi[ (2015/6/3), “Œ‹ž.

731096. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _ŒoäPŽîŽčp: Gliadel ‚đ•š—p‚ľ‚Ä. ŒG•”rG (”]ŠO): ŽOdƒOƒŠƒI[ƒ}u‰‰‰ď (2015/6/5), “Œ‹ž.

731097. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒAƒoƒXƒ`ƒ“‚đ•š—p‚ľ‚˝äP‰čŽî‚ĚŽĄ—Ă‚ĆŒť’iŠK‚Ü‚Ĺ‚ĚŒ‹‰Ę. ŒG•”rG (”]ŠO): ‘ć2‰ńˆŤŤ_ŒoäPŽîƒZƒ~ƒi[ (2015/7/15), “Œ‹ž.

731098. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ˆŤŤ_ŒoäPŽî‚ɑ΂ˇ‚éBevacizumab‚đ—p‚˘‚˝WŠw“IŽĄ—Âɂ‚˘‚Ä. ŒG•”rG (”]ŠO): ’†ŠOeƒZƒ~ƒi[on Brain Tumor (2015/7/29), “Œ‹ž.

731099. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒOƒŠƒI[ƒ}‚ɑ΂ˇ‚éƒAƒoƒXƒ`ƒ“‚Ě–đŠ„. ŒG•”rG (”]ŠO): ˆŤŤ”]ŽîᇃJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/9/4), ‰Ą•l.

731100. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ˆŤŤ_ŒoäPŽî‚ɑ΂ˇ‚鉝Šw—Ă–@‚đ‘O’ń‚Ć‚ľ‚˝‰Â‹y“I“Eop. ŒG•”rG (”]ŠO): ŽO‰Í”]ŽîᇎĄ—ĂŒ¤‹†‰ď (2015/9/24), ˆŔé.

731101. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‰ťŠw—Ă–@‚đ‘O’ń‚Ć‚ľ‚˝_ŒoäPŽî“Eop. ŒG•”rG (”]ŠO): ‘ć8‰ńěŒ§”]Žîᇊwpu‰‰‰ď (2015/10/30), ‚ź.

731102. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _ŒoäPŽî (ˆŤŤ”]Žîá‡) ‚ĚŽĄ—Âɂ‚˘‚Ä. ŒG•”rG (”]ŠO): •˝Ź27”N“x“ě“Œ–k˜A‡ŠwpŠw‰ď (2015/11/3), ŒSŽR.

731103. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒMƒŠƒAƒfƒ‹‚đ•š—p‚ľ‚˝ˆŤŤ_ŒoäPŽî‚ĚŽčp. ŒG•”rG (”]ŠO): ƒOƒŠƒI[ƒ}u‰‰‰ď (2015/11/28), Ă‰Ş.

731104. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ”]_ŒoŠO‰Č‚É‚¨‚Ż‚éŽîᇐŤŽžŠł‚̍ŐVŠO‰ČŽĄ—Ă. ‰Ş@GG (”]ŠO): EPA Stroke Clinical Seminar (2016/2/10), ă”ö.

731105. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Žčp‚É”äd‚đ‚¨‚˘‚˝optic hypothalamic glioma‚ĚŽĄ—Ă. ŒG•”rG (”]ŠO): ‰ą‹ˇŠÔ”]_ŒoŠO‰ČŠwpu‰‰‰ď (2016/2/26), –źŒĂ‰Ž.

731106. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _ŒoäPŽîŽčp: ‰˝‚đ–Ú•W‚Ć‚ľ‚Đś‚Ť‚é‚Ě‚Š? ŒG•”rG (”]ŠO): Neurosurgery conference in Akita (2016/3/4), H“c.

731107. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) VŽčˆř‚ŤEŠCŠOƒKƒCƒhƒ‰ƒCƒ“‚ĚŽĄ—Ă–Ú•W’l‚Ć‚ť‚ĚÝ’čŞ‹’ƒGƒrƒfƒ“ƒX. ‰Ş@GG (”]ŠO): ƒAƒNƒƒƒKƒŠ[ (2016/3/5), “Œ‹ž.

732048. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) “‡•”_ŒoäPŽî‚ĚŽčp (Surgery of insular gliomas). ŒG•”rG (”]ŠO): ‘ć29‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ď (2015/4/12), –źŒĂ‰Ž.

732049. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) 10”NŠÔś–˝—\Œă‰„’ˇ‚đ–ÚŽw‚ľ‚˝ƒAƒNƒƒƒKƒŠ[f—ĂĹ‘Oü. ‰Ş@GG (”]ŠO): “Œ“ú–{Ŕ’k‰ď (2015/11/20), “Œ‹ž.

733171. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) čň“Ž–ŹE‰đ–U‚đl‚Ś‚˝ăřĂ–ŹEŽîᇎčp. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄGŽĄ1, ŒG•”rG1 (1”]ŠO): ‘ć29‰ń“ú–{”÷Ź”]_ŒoŠO‰Č‰đ–UŒ¤‹†‰ď (2015/4/11), –źŒĂ‰Ž.

733172. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’Ž_ŒoŽîᇂɑ΂ˇ‚é“ந“š‰đ•úŽž‚É’ˆÓ‚ľ‚Ä‚˘‚é‚ą‚Ć. ‹v{”ü^—1, ‰Ş@GG1, ‹ß“ĄGŽĄ1, ŒG•”rG1 (1”]ŠO): ‘ć70‰ńŠÖ“Œ”]_ŒoŠO‰Č§˜b‰ď (2015/6/13), “Œ‹ž.

733173. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ăó×–EŽî‚Ö‚Ě•úŽËüŽĄ—Ă27”NŒă‚É”]“Ž–ŹáŽ”j—ô‚đŒJ‚č•Ô‚ľ‚˝1—á. •“c”Ž‹I1, ’h@@[1, ŽR–{‘ĺ•ă1, ˆ˘•”Ž’q1, ŹňŠ°”V2, ’†Œ´–Mť, ˛“ĄŒör1, ‹ß“Ą—łŽj1, ŒG•”rG1 (1”]ŠO, 2‹~–˝): ‘ć9‰ńŠÖ“ŒŹŽ™”]ŽîᇃJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/8/22), “Œ‹ž.

733174. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ”j—ô‰E“ŕŒz“Ž–ŹŒăŒđ’Ę“Ž–Ź•ŞŠň•””]“Ž–ŹáŽ‚ɑ΂ˇ‚é᎓ŕÇđpŒă‚ÉŒăŒđ’Ę“Ž–Źú’ĘŽ}—Ěˆć‚ɍ[Ç‚đ’ć‚ľ‚˝1—á. ‹{â˜aO1, ‹ß“Ą—łŽj1, ŽR–{‘ĺ•ă1, ŹňŠ°”V2, ’†Œ´–Mť, ŒG•”rG1 (1”]ŠO, 2‹~–˝): ‘ć127‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2015/9/12), “Œ‹ž.

733175. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) _Œo“ŕŽ‹‹ž‰şŒŒŽîœ‹Ž‚É‚Ä‹~–˝‚ľ“ž‚˝ŠOŤŹ”]oŒŒ‚Ěˆę—á. ‹TŽRšK1, ŹňŠ°”V2, ŽR–{‘ĺ•ă1, ’h@@[1, ŒG•”rG1 (1”]ŠO, 2‹~–˝): ‘ć127‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2015/9/12), “Œ‹ž.

733176. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‘ĺ”]Š™ƒeƒ“ƒg‘–ŒŽî‚ɍ‡•š‚ľ‚˝d–Œ“ŽĂ–Źá‘‚Ě1—á. ŽR–{‘ĺ•ă1, ‹ß“Ą—łŽj1, ‹{â˜aO1, ˛“Ą—Yˆę2, ŹňŠ°”V3, ŒG•”rG1 (1”]ŠO, 2ˆă—ÉqśŠw•”, 3‹~–˝): ‘ć127‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2015/9/12), “Œ‹ž.

733177. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Occipital trans-tentorial approach‚É‚Ä‘S“E‚ľ“ž‚˝”]_Œo‚𔭐ś•ę’n‚Ć‚ş‚¸‘ĺ‚Ť‚­‹´‚ɐi“W‚ľ‚˝ƒeƒ“ƒg‰_ŒoâŽî‚Ě1—á. ˛“Ą—Yˆę1, ’h@@[2, H’JšŽj3, Œ´@“ÖŽq3, ŒG•”rG2 (1ˆă—ÉqśŠw•”, 2”]ŠO, 3•a—): ‘ć127‰ń“ú–{”]_ŒoŠO‰ČŠw‰ďŠÖ“ŒŽx•”ŠwpW‰ď (2015/9/12), “Œ‹ž.

733178. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Non-Vitamin K Antagonist Oral Anticoagulant (NOACs) “ŕ•žŠłŽŇ‚É‚¨‚Ż‚é“ŞŠW“ŕoŒŒ‚Ě“Á’Ľ. ‹ß“Ą—łŽj1, ŒG•”rG1, ˆä“‡‘ĺ•ă2, źŽR˜a—˜2 (1”]ŠO, 2_Œo“ŕ): ‘ć27‰ń_“ސěStroke Forum (2016/3/11), ‰Ą•l.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-110014. [Œ´’˜] OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy. Shibahara I1, Saito R, Zhang R, Chonan M, Shoji T, Kanamori M, Sonoda Y, Kumabe T1, Kanehira M, Kikuchi T, So T, Watanabe T, Takahashi H, Iwabuchi E, Tanaka Y, Shibahara Y, Sasano H, Ishii N, Tominaga T: Mol Cancer 2015/2; 14 (1): 41. (ŽÄŒ´ˆę—z1, ŒG•”rG1: 1”]ŠO)

H26-310003. [Ç—á•ń] Vim thalamotomy in a patient with Holmes' tremor and palatal tremor - Pathophysiological considerations. Maki F, Sato S1, Watanabe K, Yanagisawa T, Hagiwara Y, Shimizu T, Hasegawa Y: BMC Neurol 2015/3; 15: 26. (˛“ĄŸl1: 1”]ŠO)

[’˜@‘]

H26-620011. [Šwp‘ (•Ş’SŽˇ•M)]y“ŕŒz“Ž–ŹáŽ (ICA Aneurysm) ‚Ě‚ˇ‚ׂā|‰“ˆĘ•” (supraclinoid)z4Í ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚ĆŽčpEIVR ‚ĚŽŔŰ@<2> ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚ĆIVR ‚ĚŽŔŰ@(B) ÇŒóŤIC-PC (2), p.179-81. ‹ß“Ą—łŽj1, ź–{NŽj (1”]ŠO), ŠÄC: •ó‹ŕ´”Ž, •Ň: ˆäě–[•v, ‹{’n@–Î, ƒƒfƒBƒJo”Ĺ, , 2015/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H26-723009. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”]“ŕoŒŒ‚Ĺ”­Ç‚ľ‚˝ŠO‰ČŒă–Ź—‘p“Ž–Ź–•Á•”‚ĚŠ´őŤ”]“Ž–ŹáŽ‚Ěˆę—á. ’Jč‹`“ż, ”Ń“cG•v, ˆ˘•”Ž’q1, ‹ß“Ą—łŽj1, ŒG•”rG1 (1”]ŠO): ‘ć44‰ń“ú–{”]‘˛’†‚ĚŠO‰ČŠw‰ď (2015/3/26), L“‡.


ŹŽ™‰ČŠw

[Šwp˜_•ś]

110208. [Œ´’˜] Clinical utility of the plasma brain natriuretic peptide level in monitoring tetralogy of fallot patients over the long term after initial intracardiac repair: considerations for pulmonary valve replacement. Kitagawa A1, Oka N2, Kimura S1, Ando H1, Honda T1, Takanashi M1, Mineo E1, Miyaji K3, Ishii M1: Pediatr Cardiol 2015/4; 36 (4): 752-8. (–kě“ÄŽj1, ‰Ş@“ż•F2, –Ř‘şƒl1, ˆŔ“Ą@Žő1, –{“c@’1, ‚—œ@Šw1, •ô”öŒb—œ1, ‹{’n@ŠÓ3, Îˆäł_1: 1ŹŽ™, 2˜a‰ĚŽRŒ§—§ˆă‰Č‘ĺŠw, 3S‘ŸŒŒŠÇŠO)

110209. [Œ´’˜] The efficacy of levetiracetam for focal seizures and its blood levels in children. Iwasaki T1, Toki T1, Nonoda Y1, Ishii M1: Brain Dev 2015/9; 37 (8): 773-9. (Šâčr”V1, “yŠň@•˝1, –ěX“c–L1, Îˆäł_1: 1ŹŽ™)

110210. [Œ´’˜] The Effectiveness of Lamotrigine and Its Blood Levels for Pediatric Epilepsy. Iwasaki T1, Toki T1, Nonoda Y1, Ishii M1: Am J Ther 2015/8/20. [Epub ahead of print] doi: 10.1097/MJT.0000000000000332. (Šâčr”V1, “yŠň@•˝1, –ěX“c–L1, Îˆäł_1: 1ŹŽ™)

120016. [Œ´’˜] ’´‘ŽYŽ™‚Ě–˘nŽ™“Ž–ŹŠÇ‚ɑ΂ˇ‚é“ŕŽ‹‹ž‰ş“Ž–ŹŠÇ•Â˝p‚Ě—\ŒăÝ‘Ů25TˆČ‰ş‚đ‘ÎŰ‚Ć‚ľ‚˝ŒŸ“˘. çݎ@Šw1, ‹{’n@ŠÓ2, ŽRŒűˆť”T1, ‘剪–ƒ—1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, ŒĎč‰ëŽq1, ‚—œ@Šw1, “Ą•‹`l1,3, Îˆäł_1 (1ŹŽ™, 2S‘ŸŒŒŠÇŠO, 3‘Š–Í‘ä•a‰@): “ú–{ŽüŽYŠúEVśŽ™Šw‰ďŽGŽ 2015/12; 51 (4): 1161-6.

120017. [Œ´’˜] Œ{—‘ƒAƒŒƒ‹ƒM[‚Ɛڎí—Ę‚Ş‘—Ę‚Ć‚Č‚Á‚˝ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒƒNƒ`ƒ“‚Ě ˆŔ‘SŤ‚ÉŠÖ‚ˇ‚錟“˘. ‘ĺ’J´F1,2, “Ą–{‚Ü‚ä1 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™): “ú–{ŹŽ™ƒAƒŒƒ‹ƒM[Šw‰ďŽGŽ 2015/12; 29 (5): 665-75.

120018. [Œ´’˜] “űŽ™‚ɑ΂ˇ‚é•sŠˆ‰ťƒƒNƒ`ƒ““ŻŽžÚŽí‚Ě—LŠQŽ–Ű‚ÉŠÖ‚ˇ‚錟“˘. ‘ĺ’J´F1,2, ź–{“TŽq1, “Ą–{‚Ü‚ä1, ˆîŠ_@“ľ1,2, ‰ĄŠÖ—Sˆę˜Y1,2, ‹k“cˆę‹P1,2, ŠJ“c”ü•Ű3, ŒĎč‰ëŽq2, ’†‘şM–ç1,2, ‰Ą“csŽj2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): “ú–{”_‘şˆăŠw‰ďŽGŽ 2016/1; 64 (5): 798-807.

310024. [Ç—á•ń] Azuki Bean Allergy in a Japanese Child: a Case Report. Ohtani K1,2, Fujimoto M1, Inagaki H1, Kitsuda K1, Kitsunezaki M2, Nakamura S1,2: Juntendo Medical Journal 2015/6; 61 (3): 302-4. (‘ĺ’J´F1,2, “Ą–{‚Ü‚ä1, ˆîŠ_@“ľ1, ‹k“cˆę‹P1, ŒĎč‰ëŽq2, ’†‘şM–ç1,2: 1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™)

310025. [Ç—á•ń] Right ventricular failure with high echoic ventricular wall change after foetoscopic laser photocoagulation: a case report of a donor in twin-to-twin transfusion syndrome. Mineo E1, Honda T1, Ishii M1: Cardiology in the Young 2016/1 (1): 155-7. (•ô”öŒb—œ1, –{“c@’1, Îˆäł_1: 1ŹŽ™)

320021. [Ç—á•ń] ěč•a•s‘SŒ^‚Ć‚ľ‚ÄŽĄ—Ă‚ł‚ę‚˝‚ˆŔ“Ž–Ź‰Š‚Ě”N’ˇŽ™—á. ‹´–{‰č‹v”ü1, ]”gŒËF•ă1, îŒ´‹`l1, •űš•˝1, Îˆäł_1 (1ŹŽ™): S‘Ÿ 2015/12; 47 (12): 1466-7.

320022. [Ç—á•ń] –ƉuƒOƒƒuƒŠƒ““Š—^Œă‚ɃAƒiƒtƒBƒ‰ƒV[‚đ”F‚ß, ‰‰ńŽĄ—Ă‚Ć‚ľ‚ăCƒ“ƒtƒŠƒVƒLƒ}ƒu‚đŽg—p‚ľ‚˝ěč•aÄ”­—á. îŒ´‹`l1, •űš•˝1, ]”gŒËF•ă1, Îˆäł_1 (1ŹŽ™): S‘Ÿ 2015/12; 47 (12): 1471-2.

320023. [Ç—á•ń] _ŒoŠw“I‚É—\Œă—ǍD‚Ĺ‚ ‚Á‚˝“ÁŽęŽĄ—Ă‚đŽ{s‚ľ‚˝‹}Ť‰óŽ€Ť”]Ç‚Ě2Ç—á. ”’ˆäG’ź1, ˆŔ“Ą@Žő1, •ô”öŒb—œ1, –ěX“c–L1, Šâér”V1, Îˆäł_1 (1ŹŽ™): “ú–{ŹŽ™‹~‹}ˆăŠw‰ďŽGŽ 2015/12; 15 (1): 51-4.

320024. [Ç—á•ń] ESBLŽYś‘ĺ’°‹Ű‚É‚ć‚éVśŽ™‚̏dÇ×‹ŰŤ‘–Œ‰Š‚Ě1—á. ‚—œ@Šw1, çݎ@Šw1, ŽRŒűˆť”T1, ‘剪–ƒ—1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, ˆÉ“ĄŽŽu2, ŒĎč‰ëŽq1, –ě“nł•F3, Îˆäł_1 (1ŹŽ™, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, 3‚ˇ‚­‚ˇ‚­‚ ‚Š‚ż‚á‚ń‚ą‚Ç‚ŕƒNƒŠƒjƒbƒN): “ú–{ŽüŽYŠúEVśŽ™Šw‰ďŽGŽ 2015/12; 51 (4): 1253-9.

521018. [‰đŕ]y‰đŕ: ˆă—p’´‰š”gz”x‘ĚŒŒ—Ź”ä‚đ’´‰š”g‚Ĺ•]‰ż‚ˇ‚é. –{“c@’1, Îˆäł_1 (1ŹŽ™): ’´‰š”gTECHNO 2015/8; 27 (4): 72-6.

522114. [uŔ]y“ÁW: ƒ}ƒ‹ƒ`ƒ‚ƒ_ƒŠƒeƒB‚É‚ć‚éCardiac Imaging 2015 [—Տ°•Ň]|”ńNP“IS‘Ÿ‰ć‘œf’f‚ĚŒ`‘ԏî•ń‚Š‚ç‹@”\•]‰ż‚Ö‚Ě“WŠJ|zIII. US‚ĚƒXƒgƒ‰ƒeƒW[ & ƒAƒEƒgƒJƒ€@E—Տ°Ž{Ý‚Š‚ç‚Ě•ń|SƒGƒR[‚Ě—Ő°“I—L—pŤ‚Ć‹Zpi•ŕ@4. ŹŽ™zŠÂŠíf—Ă‚É‚¨‚Ż‚é’´‰š”gf’f‘•’u‚Ě—L—pŤ|Vector Flow MappingƒGƒR[‚ĹŒŒ—Ź‚đf‚é. –{“c@’1, ”Â’JŒcˆę2, Îˆäł_1 (1ŹŽ™, 2ŒŒ—Ź‰đÍ): INNERVISION 2015/5; 30 (5): 58-60.

522115. [uŔ]yInformation: “ú–{zŠÂŠíŠw‰ď@‘ć11‰ńƒvƒŒƒXƒZƒ~ƒi[@ć“VŤS‘Ÿ•a‚Ěˆęś‚đf‚é. iŠw, A‹Ć, ”DP, oŽYzŹlć“VŤSŽžŠł‚Ě”DP‚Ć•Ş•Ř. Îˆäł_ (ŹŽ™): THERAPEUTIC RESEARCH 2015/9; 36 (9): 831-2.

[’˜@‘]

620083. [Šwp‘] (•Ş’SŽˇ•M)y—\–hÚŽí‚ĚŒťę‚ō˘‚ç‚Č‚˘@‚Ü‚é‚í‚Š‚čƒƒNƒ`ƒ“Q•A@‘ć1”ŁzII. Q&A@1. ƒƒNƒ`ƒ“‘S”Ę, p.102-4, p.105-7, p.108-9. ˛“Ą‰Á‘ăŽq1, Îˆäł_1 (1ŹŽ™), •Ň: ’†–ě‹MŽi, “ú–{ˆăŽ–V•ńŽĐ, “Œ‹ž, 2015/4”­s.

620084. [Šwp‘] (•Ş’SŽˇ•M)y“ŕ‰ČˆăEŹŽ™‰ČŒ¤Cˆă‚Ě‚˝‚߂́@ŹŽ™‹~‹}ŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“@‰ü’ů‘ć3”ŁzIII. ‚¨‚ŕ‚Č‹~‹}ŽžŠł@C. zŠÂŠíŽžŠł@4. ěč•a, p.241-6. Îˆäł_1, îŒ´‹`l1 (1ŹŽ™), •Ň: ŽsěŒő‘ž˜Y, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/4”­s.

620085. [Šwp‘] (•Ş’SŽˇ•M)yĂ’—p–ƉuƒOƒƒuƒŠƒ“ťÜƒnƒ“ƒhƒuƒbƒNz “K‰žŽžŠł‚ĆŽĄ—Á@4) ěč•a‹}ŤŠú, p.93-102. Îˆäł_ (ŹŽ™), ŠÄC: ł‰Ş@“O, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, ‘ĺă, 2015/4”­s.

620086. [Šwp‘] (•Ş’SŽˇ•M)yěč•a‚ĚŠî–{ ‘ć1”Ĺ‘ć1üz‡•šÇ: S‘ŸŒŒŠÇŒn‚̍‡•šÇ, p.54-61. Îˆäł_ (ŹŽ™), ‘ŠÄC: ěč•xě, ŠÄC: ŕ_‰ŞŒšé, ă‘ş@–Î, ěŹ: “ú–{ěč•aŠw‰ď, ‹Ś˜aŠé‰ć, “Œ‹ž, 2015/5”­s.

620087. [Šwp‘] (•Ş’SŽˇ•M)yĄ“ú‚̏ŹŽ™ŽĄ—ĂŽwj@‘ć16”Łz14. zŠÂŠíŽžŠł@‘”xĂ–ŹŠŇ—ŹˆŮí, p.514-5. Îˆäł_ (ŹŽ™), ‘•ŇW: …Œű@‰ë, Žs‹´@Œő, čŽR@O, ˆăŠw‘‰@, “Œ‹ž, 2015/9”­s.

620088. [Šwp‘] (•Ş’SŽˇ•M)yŹlć“VŤSŽžŠłƒp[ƒtƒFƒNƒgƒKƒCƒhzIII. –˘ŽĄ—Â̐Źlć“VŤSŽžŠł‚Ě•a‘Ô‚ĆŽĄ—Á@7. ěč•aŤŠĽ“Ž–ŹáŽ, p.157-62. Îˆäł_1, –´“cL”ü2 (1ŹŽ™, 2”Ń’ËŽs—§•a‰@), •Ň: Ô–Ř’ő–č, ˆÉ“Ą@_, •śŒő“°, “Œ‹ž, 2015/9”­s.

620089. [Šwp‘] (•Ş’SŽˇ•M)y—v“_‚đ‚¨‚ł‚Ś‚鏬Ž™‹~‹}Eƒvƒ‰ƒCƒ}ƒŠƒPƒA@ƒsƒbƒgƒtƒH[ƒ‹Ç—á‚Š‚çŠw‚Ú‚¤!zIVÍ. ’m‚Á‚Ä‚¨‚­‚ׂŤÇŒó‚Ć‚ť‚̑Ήž@I. ěč•a, p.186-8. Îˆäł_ (ŹŽ™), •Ň: ŽsěŒő‘ž˜Y, “ě]“°, “Œ‹ž, 2015/11”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713070. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) First experiences of Penumbra coil 400 in small children: two cases report. Takanashi M1, Kimura S1, Mineo E1, Honda T1, Kitagawa A1, Ando H1, Tomita H2, Ishii M1: PICS-AICS AP 2015 (2015/4/1-4), Taipei, Taiwan. (‚—œ@Šw1, –Ř‘şƒl1, •ô”öŒb—œ1, –{“c@’1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, •x“c@‰p2, Îˆäł_1: 1ŹŽ™, 2ş˜a‘ĺŠw‰Ą•lŽs–k•”•a‰@zŠÂŠíƒZƒ“ƒ^[)

713071. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Clinical Utility of the Level of Plasma Brain Natriuretic Peptide in Tetralogy of Fallot Patients Long-Term After Initial Intracardiac Repair: Consideration for Pulmonary Valve Replacement. Kitagawa A1, Oka N2, Mineo E1, Takanashi M1, Honda T1, Ando H1, Kimura S1, Miyaji K2, Ishii M1: The 11th Asian Society for Pediatric Research (2015/4/16), Osaka. (–kě“ÄŽj1, ‰Ş@“ż•F2, •ô”öŒb—œ1, ‚—œ@Šw1, –{“c@’1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‹{’n@ŠÓ2, Îˆäł_1: 1ŹŽ™, 2S‘ŸŒŒŠÇŠO)

713072. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Analysis of Immunological Function of Infants with Congenital Heart Disease after Cardiopulmonary Bypass Surgery: Evaluation of the Optimum Timing of Vaccination. Takanashi M1, Ogata S1, Honda T1, Nomoto K1, Mineo E1, Kitagawa A1 , Ando H1, Kimura S1, Oka N2, Miyaji K2, Ishii M1: The 11th Asian Society for Pediatric Research (2015/4/16), Osaka. (‚—œ@Šw1, •űš•˝1, –{“c@’1, –ěŒł‚Ż‚˘Žq1, •ô”öŒb—œ1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‰Ş@“ż•F2, ‹{’n@ŠÓ2, Îˆäł_1: 1ŹŽ™, 2S‘ŸŒŒŠÇŠO)

713073. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Long-term prognosis after methylpredonisolone-pulse combination therapy for refractory Kawasaki Disease. Ebato T1, Ogihara Y1, Ogata S1, Ishii M1: The 11th Asian Society for Pediatric Research (2015/4/16), Osaka. (]”gŒËF•ă1, îŒ´‹`l1, •űš•˝1, Îˆäł_1: 1ŹŽ™)

713074. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Importance of measuring blood levels of topiramate as polytherapy for epileptic children. Toki T1, Iwsaki T1, Ishii M1: The 13th Asian and Oceanian Congress of Child Neurology (2015/5/14-17), Taipei, Taiwan. (“yŠň@•˝1, Šâér”V1, Îˆäł_1: 1ŹŽ™)

713075. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The Influence of Aortic Dilatation and Aortic Valve Regurgitation for Plasma Brain Natriuretic Peptide Level in Patients with Fontan Procedure. Kitagawa A1, Kimura S1, Mineo E1, Takanashi M1, Honda T1, Ando H1, Miyaji K2, Ishii M1: 49th Annual Meeting of the Association for European Paediatric and Congenital Cardiology (AEPC 2015), (2015/5/20-23), Prague, Czech. (–kě“ÄŽj1, –Ř‘şƒl1, •ô”öŒb—œ1, ‚—œ@Šw1, –{“c@’1, ˆŔ“Ą@Žő1, ‹{’n@ŠÓ2, Îˆäł_1: 1ŹŽ™, 2S‘ŸŒŒŠÇŠO)

721015. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ƒ`[ƒ€‚Ě—Í: ‘ŮŽ™Šú‚ɏdÇS•s‘S‚đ’ć‚ľ‚˝‘ĺ“Ž–ŹśŽşƒgƒ“ƒlƒ‹Ç‚Ěˆę—á. –Ř‘şƒl1, ˆŔ“Ą@Žő1, –kě“ÄŽj1, –{“c@’1, ‚—œ@Šw1, •ô”öŒb—œ1, çݎ@Šw1, ‹{’n@ŠÓ2, Îˆäł_1 (1ŹŽ™, 2S‘ŸŒŒŠÇŠO): ‘ć22‰ń“ú–{‘ŮŽ™S‘Ÿ•aŠw‰ďŠwpW‰ď (2016/2/19), “Œ‹ž.

722072. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) V‹KR‚Ä‚ń‚Š‚ń–ň‚É‚ÍŒŒ’†”Z“x‘Ş’č‚Í•K—v‚Č‚˘?`TDM‚ÉŠî‚Ă‚˘‚˝ŽĄ—Ð헪‚Ě‚ˇ‚ˇ‚߁`. Šâčr”V (ŹŽ™): ‘ć57‰ń“ú–{ŹŽ™_ŒoŠw‰ďŠwpW‰ď (2015/5/28), ‘ĺă.

722073. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ěč•aŒ¤‹† Up to Date@–ƉuƒOƒƒuƒŠƒ“‚̍R‰ŠÇƒƒJƒjƒYƒ€: V‹K•ŞŽq‹@\‚̉đ–ž. •űš•˝ (ŹŽ™): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16), “Œ‹ž.

722074. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŒŒ—Ź‰ÂŽ‹‰ť‹Zp (VFM) ‚ŞŘ‚čŠJ‚­V‚˝‚ȏzŠÂŠí‰ć‘œf’f. –{“c@’1, ”Â’JŒcˆę2, ‹{čăĕ˝2, ‚—œ@Šw1, •ô”öŒb—œ1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‰Ş@“ż•F3, ‹{’n@ŠÓ3, Îˆäł_1 (1ŹŽ™, 2ŒŒ—Ź‰đÍ, 3S‘ŸŒŒŠÇŠO): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16), “Œ‹ž.

722075. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒCƒuƒjƒ“ƒOƒVƒ“ƒ|ƒWƒEƒ€: ƒXƒeƒƒCƒh‰Šú•š—p—Ă–@‚ĚŒř‰Ę‚ĚŒŸŘzěč•a‰‰ń–ƉuƒOƒƒuƒŠƒ“—Ă–@•s‰ž—\‘ŞŒQ‚ɑ΂ˇ‚郁ƒ`ƒ‹ƒvƒŒƒhƒjƒ“ƒpƒ‹ƒX•š—p—Ă–@‚Ě’ˇŠúŒo‰ß: ’PŽ{ÝŒă•űŽ‹–ě“IŒŸ“˘. •űš•˝1, îŒ´‹`l1, ]”gŒËF•ă1, Îˆäł_1 (1ŹŽ™): ‘ć35‰ń“ú–{ěč•aŠw‰ďEŠwpW‰ď (2015/10/9), Ž­Ž™“‡.

723508. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒIƒvƒ\ƒNƒ[ƒkƒXEƒ~ƒIƒNƒ[ƒkƒXÇŒóŒQ‚Š‚ç_Œo‰čŽî‚Ɛf’f, ‘Šú‚ÉŽĄ—Éî“ü‚ľ‚˝1—á. Ž–ě@Žő1, “yŠň@•˝1, Š@L–ç1, ˆŔ“Ą@Žő1, Šâčr”V1, Îˆäł_1 (1ŹŽ™): ‘ć118‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2015/4/17), ‘ĺă.

723509. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘J‰„Ť‰Šát, ŠĚ•s‘S‚đ‚Ť‚˝‚ľ‚˝ƒTƒ‰ƒZƒ~ƒA‚Ě1—á. “c‘ş—C•˝1, HŽR˜a­1, ”’ˆäG’ź1, ‰iˇ—T‰ŔŽq1, ŽRŒűˆť”T1, ‰ĄŠÖ—Sˆę˜Y1, ŒĎč‰ëŽq1, “Ą•‹`l1, çݎ@Šw1, Îˆäł_1 (1ŹŽ™): ‘ć118‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2015/4/17), ‘ĺă.

723510. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ĹŒoŒą‚ľ‚˝äPŒ´•a‡•š”DP75Ç—á‚Ě•ę‘Ě‹y‚ŃŽ™‚Ě“Á’Ľ. ŽRŒűˆť”T1, îŒ´‹`l1, ‘剪–ƒ—1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, ŒÇč‰ëŽq1, çݎ@Šw1, •űš•˝1, â“Œ—R‹I1,2, Îˆäł_1 (1ŹŽ™, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć118‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2015/4/19), ‘ĺă.

723511. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ÁˆŮ“IIgE’l‚̐„ˆÚ‚ƐH•¨ŒoŒű•‰‰×ŽŽŒą‚ĚŒ‹‰Ę‚ɂ‚˘‚Ä. ‘ĺ’J´F1,2, ˆîŠ_@“ľ1,2, ‰ĄŠÖ—Sˆę˜Y1,2, ’†‘şM–ç1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™): ‘ć118‰ń“ú–{ŹŽ™‰ČŠw‰ďŠwpW‰ď (2015/4/17-19), ‘ĺă.

723512. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{“ŕ”­ˆç’x‰„ƒ‰ƒbƒgƒ‚ƒfƒ‹‚ĚŠŒFŽ‰–b‘gD‚É‚¨‚Ż‚é’E‹¤–đ’`”’Žż1‚¨‚ć‚ŃƒAƒNƒAƒ|ƒŠƒ“7‚Ě”­Œť‚ĚŒŸ“˘. ‹k“cˆę‹P1, ŽÄŽRŒ[Žq1, ‘ĺ’ÐŹ”V1, ‰Ą“csŽj2, “c‹v•ŰŒ›s3, ź‰YM•v4 (1ŹŽ™, 2‘Š–ÍŒ´‹Ś“Ż•a‰@, 3‡“V“°‘ĺŠw, 4š“ż‘ĺŠw): ‘ć88‰ń“ú–{“ŕ•Ş”ĺŠw‰ďŠwp‘‰ď (2015/4/23), “Œ‹ž.

723513. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ÁˆŮ“IIgE’l‚̐„ˆÚ‚ƐH•¨ŒoŒű•‰‰×ŽŽŒą‚ĚŒ‹‰Ę‚ɂ‚˘‚Ä. ‘ĺ’J´F1,2, ˆîŠ_@“ľ1,2, ‰ĄŠÖ—Sˆę˜Y1,2, ’†‘şM–ç1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™): ‘ć64‰ń“ú–{ƒAƒŒƒ‹ƒM[Šw‰ďŠwp‘ĺ‰ď (2015/5/26-28), “Œ‹ž.

723514. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œƒ‘‚ˇ‚éACHD: ‰äX‚É‹‚ß‚ç‚ę‚Ä‚˘‚é‚ť‚ĚŠoŒĺ. Îˆäł_ (ŹŽ™): The Echo Live2015 (2015/5/30), ‘ĺă.

723515. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚鏬Ž™ŠOŠłŽŇ‚ĚŒŸ“˘. “c‘ş—C•˝1, •ô”öŒb—œ1, ź–{“TŽq1, ˆŔ“Ą@Žő1, Îˆäł_1 (1ŹŽ™): ‘ć29‰ń“ú–{ŹŽ™‹~‹}ˆăŠw‰ďŠwpW‰ď (2015/6/12), ‘ĺ‹{.

723516. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒÄ‹z•â•‚đ—v‚ľ‚˝RSƒEƒCƒ‹ƒXŠ´őÇ—á‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ź–{“TŽq1, ‹ŕŽq’‰O1, •ô”öŒb—œ1, ˆŔ“Ą@Žő1, Îˆäł_1 (1ŹŽ™): ‘ć29‰ń“ú–{ŹŽ™‹~‹}ˆăŠw‰ďŠwpW‰ď (2015/6/13), ‘ĺ‹{.

723517. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰@ŹŽ™‰Č‚ĹŒoŒą‚ľ‚˝‹ß”N‚̐­”N‚É‚¨‚Ż‚鎊ŽE4Ç—á. •’ms•ă1, ź–{“TŽq1, •ô”öŒb—œ1, ˆŔ“Ą@Žő1, Îˆäł_1 (1ŹŽ™): ‘ć29‰ń“ú–{ŹŽ™‹~‹}ˆăŠw‰ďŠwpW‰ď (2015/6/13), ‘ĺ‹{.

723518. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –˘nŽ™PDA‚ĚŽčpŽžŠú‚Ş’ZŠú—\Œă‚É—^‚Ś‚é‰e‹ż‚ɂ‚˘‚Ä çݎ@Šw1, ŽRŒűˆť”T1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, ŒĎč‰ëŽq1, Îˆäł_1 (1ŹŽ™): ‘ć51‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2015/7/11), •Ÿ‰Ş.

723519. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒWƒAƒ]ƒLƒVƒh‚É‚ć‚č•‚Žî, –R”A‚đ—ˆ‚ľ‚˝Beckwith-WiedemannÇŒóŒQ (BWS) ‚Ěˆę—á. ”’ˆäG’ź1, HŽR˜a­1, ŽRŒűˆť”T1, ‰ĄŠÖ—Sˆę˜Y1, ŒĎč‰ëŽq1, çݎ@Šw1, Îˆäł_1 (1ŹŽ™): ‘ć51‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2015/7/11), •Ÿ‰Ş.

723520. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “œ”A•a•ę‘Ě‚ć‚čoś‚ľ‚˝, dÇ“x‚ĚˆŮ‚Č‚é”ö•”‘ލsÇŒóŒQ‚Ě2—á. ŽRŒűˆť”T1, çݎ@Šw1, ‚—œ@Šw1, ‘剪–ƒ—1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, ŒĎč‰ëŽq1, ‹ŕˆä—Y“ń2, ŠC–ěM–ç2, Îˆäł_1 (1ŹŽ™, 2ŽY‰Č): ‘ć51‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2015/7/11), •Ÿ‰Ş.

723521. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Speckle Tracking of tricuspid annular displacement‚đ—p‚˘‚˝ŹŽ™Šúć“VŤSŽžŠł‚É‚¨‚Ż‚é‰EŽşŽűk”\•]‰ż. –Ř‘şƒl1, ˆŔ“Ą@Žő1, –kě“ÄŽj1, –{“c@’1, ‚—œ@Šw1, •ô”öŒb—œ1, Îˆäł_1 (1ŹŽ™): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16), “Œ‹ž.

723522. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ć“VŤSŽžŠł‚ĚŒŒs“Ž‘ԕωť•]‰ż: microRNAƒAƒŒƒC‰đÍ. –{“c@’1, ‚—œ@Šw1, –ěŒł‚Ż‚˘Žq1, •ô”öŒb—œ1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‰Ş@“ż•F2, ‹{’n@ŠÓ2, Îˆäł_1 (1ŹŽ™, 2S‘ŸŒŒŠÇŠO): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16), “Œ‹ž, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ 2015/7; 31 (Suppl 1): S1.192.

723523. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –˘nŽ™“Ž–ŹŠÇŠJ‘śÇ‚ɑ΂ˇ‚é“ŕŽ‹‹ž‰ş“Ž–ŹŠÇ•Â˝p (Video-assisted thoraco-scopic surgical interruption of patent ductus arteriosus; VATS-PDA) ‚Ě—L—pŤ. •ô”öŒb—œ1, –Ř‘şƒl1, ‚—œ@Šw1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, ‹{’n@ŠÓ2, Îˆäł_1 (1ŹŽ™, 2S‘ŸŒŒŠÇŠO): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16), “Œ‹ž, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ 2015/7; 31 (Suppl 1): S1.249.

723524. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰E–[“ŕˆŮíŠu•Ç‚ƐSŽG‰š‚Ĺ”­ŒŠ‚ł‚ę‚˝Valsalva“´‰E–[ᑂ̓űŽ™—á. ‚—œ@Šw1, –Ř‘şƒl1, •ô”öŒb—œ1, –{“c@’1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, Îˆäł_1 (1ŹŽ™): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16), “Œ‹ž.

723525. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒHƒ“ƒ^ƒ“pŒă‰“ŠuŠú‚É‚¨‚Ż‚錌s“Ž‘Ô•]‰ż: S‘ŸMRI‚¨‚ć‚Ń”]ŤƒiƒgƒŠƒEƒ€—˜”Aƒyƒvƒ`ƒh‚ĚŠÖ˜AŤ. –kě“ÄŽj1, ‰Ş@“ż•F2, •ô”öŒb—œ1, ‚—œ@Šw1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‹{’n@ŠÓ2, Îˆäł_1 (1ŹŽ™, 2S‘ŸŒŒŠÇŠO): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16), “Œ‹ž, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ 2015/7; 31 (Suppl 1): S1.319.

723526. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) V‚ľ‚˘ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“ˆăŠw‚̏ŹŽ™zŠÂŠíˆă—Âւ̉ž—p|ŒŒ—Ź‰ÂŽ‹‰ť‹Zp (VFM) ‚ŞŘ‚čŠJ‚­V‚˝‚ȏzŠÂŠí‰ć‘œf’f|. –{“c@’1, ”Â’JŒcˆę2, ‹{čăĕ˝2, ‚—œ@Šw1, •ô”öŒb—œ1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‰Ş@“ż•F3, ‹{’n@ŠÓ3, Îˆäł_1 (1ŹŽ™, 2ŒŒ—Ź‰đÍ, 3S‘ŸŒŒŠÇŠO): ‘ć51‰ń“ú–{ŹŽ™zŠÂŠíŠw‰ď‘‰ďEŠwpW‰ď (2015/7/16-18), “Œ‹ž, “ú–{ŹŽ™zŠÂŠíŠw‰ďŽGŽ 2015/7; 31 (Suppl 1): S1.103.

723527. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ“Ž–Ź•Ů•Â˝•s‘SÇ‚̓tƒHƒ“ƒ^ƒ“pŒă‰“ŠuŠú‚É‚¨‚Ż‚éS‹@”\áŠQ‚ĚŠëŒŻˆöŽq‚ƂȂ肤‚é‚Š? S‘ŸMRI‚É‚ć‚錟“˘. –kě“ÄŽj1, •ô”öŒb—œ1, ˆŔ“Ą@Žő1, ‹{’n@ŠÓ2, Îˆäł_1 (1ŹŽ™, 2S‘ŸŒŒŠÇŠO): ‘ć63‰ń“ú–{S‘Ÿ•aŠw‰ďŠwpW‰ď (2015/9/19), ‰Ą•l.

723528. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘Š‘ΓI‚ȍ‚ƒJƒ‹ƒVƒEƒ€”AÇ‚ć‚čƒJƒ‹ƒVƒEƒ€Š´’mŽó—e‘Ě‚ĚŠˆŤŒ^•ĎˆŮ‚đf’f‚ľ“ž‚˝1—á. ‹k“cˆę‹P1, –ěŒł‚Ż‚˘Žq1, “c‹v•ŰŒ›s2, ‘ĺ’ÐŹ”V1, ŽÄŽRŒ[Žq1, •—’ŁáÁ—R”ü3, ‰Ą“csŽj4, Îˆäł_1 (1ŹŽ™, 2‡“V“°‘ĺŠwˆăŠw•”ŹŽ™‰Č, 3•—‚ĚŽq‚ą‚Ç‚ŕƒNƒŠƒjƒbƒN, 4‚ć‚ą“c‚ą‚Ç‚ŕƒNƒŠƒjƒbƒN): ‘ć49‰ń“ú–{ŹŽ™“ŕ•Ş”ĺŠw‰ďŠwpW‰ď (2015/10/9), “Œ‹ž.

723529. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “Ťěč•a‚É‚¨‚Ż‚é3rd line‚Ě—L—pŤ, ˆŔ‘SŤ: ’PŽ{ÝŒŸ“˘. ]”gŒËF•ă1, îŒ´‹`l1, •űš•˝1, Îˆäł_1 (1ŹŽ™): ‘ć35‰ń“ú–{ěč•aŠw‰ďEŠwpW‰ď (2015/10/10), Ž­Ž™“‡.

723530. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’†•_ŒoÇó‚đ‡•š‚ľ‚˝ěč•a‚Ě—Ő°“IŒŸ“˘. ]”gŒËF•ă1, îŒ´‹`l1, •űš•˝1, Îˆäł_1 (1ŹŽ™): ‘ć35‰ń“ú–{ěč•aŠw‰ďEŠwpW‰ď (2015/10/10), Ž­Ž™“‡.

723531. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ĹŒoŒą‚ľ‚˝‹‘劼“Ž–ŹáŽ‡•šěč•a‚Ě—Ő°“IŒŸ“˘. îŒ´‹`l1, ]”gŒËF•ă1, •űš•˝1, Îˆäł_1 (1ŹŽ™): ‘ć35‰ń“ú–{ěč•aŠw‰ďEŠwpW‰ď (2015/10/10), Ž­Ž™“‡.

723532. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@10”NŠÔ‚Ě’´’áoś‘̏dŽ™‚É‚¨‚Ż‚éÁ‰ťŠÇúE‚đ‹^‚˘ŠO‰Č“Iˆ’u‚đs‚Á‚˝Ç—á‚ĚŒŸ“˘. çݎ@Šw1, ŽRŒűˆť”T1, ‘剪–ƒ—1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, ŒĎč‰ëŽq1, Îˆäł_1 (1ŹŽ™): ‘ć60‰ń“ú–{VśŽ™ŹˆçˆăŠw‰ďEŠwpW‰ď (2015/10/24), ˇ‰Ş.

723533. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) NICUƒxƒbƒg‚Ě‘°‚Ş’nˆćŽüŽYŠúˆă—Ă‚É‚ŕ‚˝‚ç‚ľ‚˝‰e‹ż. ŒĎč‰ëŽq1, çݎ@Šw1, ŽRŒűˆť”T1, ‘剪–ƒ—1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, ‘吟—fŽq2, –]ŒŽƒŽq2, Îˆäł_1, ŠC–ěM–ç2 (1ŹŽ™, 2ŽY‰Č): ‘ć60‰ń“ú–{VśŽ™ŹˆçˆăŠw‰ďEŠwpW‰ď (2015/10/25), ˇ‰Ş.

723534. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Late PretermŽ™‚ĚŒÄ‹záŠQ‚ɂ‚˘‚Ä. ŽRŒűˆť”T1, çݎ@Šw1, ‰iˇ—T‰ŔŽq1, ‘剪–ƒ—1, HŽR˜a­1, ‰ĄŠÖ—Sˆę˜Y1, ŒĎč‰ëŽq1, “Ą•‹`l, ĄˆäƒD1, Îˆäł_1 (1ŹŽ™): ‘ć60‰ń“ú–{VśŽ™ŹˆçˆăŠw‰ďEŠwpW‰ď (2015/10/25), ˇ‰Ş.

723535. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Extreme delta brush‚ލRNMDAŽó—e‘Ě”]‰Š‚̐f’f‚É—L—p‚Ĺ‚ ‚Á‚˝14Î—Žq—á. “yŠň@•˝1, Šâčr”V1, Îˆäł_1, ‚‹´K—˜2 (1ŹŽ™, 2Ă‰Ş‚Ä‚ń‚Š‚ń_Œoˆă—ĂƒZƒ“ƒ^[): ‘ć49‰ń“ú–{‚Ä‚ń‚Š‚ńŠw‰ďŠwpW‰ď (2015/10/31), ’ˇč.

723536. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒqƒgƒƒ^ƒjƒ…[ƒ‚ƒEƒCƒ‹ƒXŠ´őÇ‚ɑ΂ˇ‚éModified Pulmonary Index Score‚Ě—L—pŤ. ‘ĺ’J´F1,2, ˆîŠ_@“ľ1,2, ‚—œ@Šw1, źě‹ĹŽq1, ‰ĄŠÖ—Sˆę˜Y1, ’†‘şM–ç1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™): ‘ć47‰ń“ú–{ŹŽ™Š´őÇŠw‰ď‘‰ďEŠwpW‰ď (2015/10/31-11/1), •Ÿ“‡.

723537. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆŮ‚Č‚éŒo‰ß‚đ’H‚Á‚˝ŹŽ™dÇ–ň]2—á‚Ě—Ő°“I“Á’Ľ. Ž–ě@Žő1, “Ą–{‚Ü‚ä, ]”gŒËF•ă1, îŒ´‹`l1, •űš•˝1, Îˆäł_1 (1ŹŽ™): ‘ć52‰ń“ú–{ŹŽ™ƒAƒŒƒ‹ƒM[Šw‰ď (2015/11/22), “Ţ—Ç.

723538. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”D•w‚ɑ΂ˇ‚鎙‚ĚƒAƒŒƒ‹ƒM[ŽžŠł‚ÉŠÖ‚ˇ‚éˆÓŽŻ’˛¸. ‘ĺ’J´F1,2, ˆîŠ_@“ľ1, ‚—œ@Šw1, źě‹ĹŽq1, ‰ĄŠÖ—Sˆę˜Y1, ’†‘şM–ç1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™): ‘ć52‰ń“ú–{ŹŽ™ƒAƒŒƒ‹ƒM[Šw‰ď (2015/11/21-22), “Ţ—Ç.

723539. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒtƒHƒ“ƒ^ƒ“pŒă‰“ŠuŠúÇ—á‚ɑ΂ˇ‚éƒ{ƒZƒ“ƒ^ƒ“‚ĚŽĄ—ĂŒř‰Ę: S‘ŸMRI‚đ—p‚˘‚˝ŒŸ“˘. –kě“ÄŽj1, •ô”öŒb—œ1, ‚—œ@Šw1, –{“c@’1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‹{’n@ŠÓ2, Îˆäł_1 (1ŹŽ™, 2S‘ŸŒŒŠÇŠO): ‘ć18‰ń“ú–{Źlć“VŤSŽžŠłŠw‰ď‘‰ďEŠwpW‰ď (2016/1/16), ‘ĺă.

723540. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰EŽş—Źo˜HŒ`ŹpŒă‰“ŠuŠú‚É‚¨‚Ż‚éS‘ŸMRI‚Ě—L—pŤ: SƒGƒR[‚¨‚ć‚ŃŒŒŠÇ‘˘‰e‚Ć‚Ě”äŠr. –kě“ÄŽj1, •ô”öŒb—œ1, ‚—œ@Šw1, –{“c@’1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‹{’n@ŠÓ2, Îˆäł_1 (1ŹŽ™, 2S‘ŸŒŒŠÇŠO): ‘ć18‰ń“ú–{Źlć“VŤSŽžŠłŠw‰ď‘‰ďEŠwpW‰ď (2016/1/16), ‘ĺă.

723541. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ü‹Č‚𔺂Á‚˝––˝Ť”x“Ž–Ź‚̍‚“x‹ˇó•a•Ď‚ɑ΂ˇ‚鎥—ĂŒoŒą: ƒoƒ‹[ƒ“Šg’ŁŒ^ƒXƒeƒ“ƒg‚Ć’´‚‘Ďˆłƒoƒ‹[ƒ“‚đ—p‚˘‚˝1Ç—á. –kě“ÄŽj1, –Ř‘şƒl1, •ô”öŒb—œ1, ‚—œ@Šw1, ˆŔ“Ą@Žő1, •x“c@‰p2, Îˆäł_1 (1ŹŽ™, 2ş˜a‘ĺŠw‰Ą•lŽs–k•”•a‰@): ‘ć27‰ń“ú–{Pediatric Interventional CardiologyŠw‰ďŠwpW‰ď (2016/1/28), L“‡.

723542. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) V‘fŢ‚ĚƒRƒCƒ‹‚đ—p‚˘‚Ä‘¤•›ŒŒs˜H‚ɃRƒCƒ‹Çđp‚đŽ{s‚ľ‚˝6—á‚Ě—Ő°ŒŸ“˘. ‚—œ@Šw1, –Ř‘şƒl1, •ô”öŒb—œ1, –{“c@’1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, •x“c@‰p2, Îˆäł_1 (1ŹŽ™, 2ş˜a‘ĺŠw‰Ą•lŽs–k•”•a‰@): ‘ć27‰ń“ú–{Pediatric Interventional CardiologyŠw‰ďŠwpW‰ď (2016/1/28), L“‡.

723543. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) •sŽ–ŹŒšŤ‰EŽşS‹ŘÇ‚Í‘ŮŽ™Šú‚É”­Ç‚ľ‚¤‚é: TMEM43ˆâ“`Žq•ĎˆŮ‚𔺂Á‚˝1—á. –{“c@’1, ‹ŕˆä—Y“ń2, ‘ĺ–쐚Žq, ˆŔ“Ą@Žő1, –{“c‰ëŽq2, ’ë–ěTˆę3, Îˆäł_1 (1ŹŽ™, 2ŽY‰Č, 3zŠÂŠí“ŕ): ‘ć22‰ń“ú–{‘ŮŽ™S‘Ÿ•aŠw‰ďŠwpW‰ď (2016/2/19), “Œ‹ž.

723544. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Micro RNA Array Analysis in Infants with Ventricular Septal Defect. –{“c@’1, ‚—œ@Šw1, •ô”öŒb—œ1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, Îˆäł_1 (1ŹŽ™): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/20), ĺ‘ä.

723545. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Four-Dimensional Magnetic Resonance Imaging (4D-MRI) Flow Energy Loss: New Insight into Fontan Circulation in Adult Patients. –kě“ÄŽj1, ”Â’JŒcˆę2, •ô”öŒb—œ1, ‚—œ@Šw1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‹{’n@ŠÓ3, Îˆäł_1 (1ŹŽ™, 2ŒŒ—Ź‰đÍ, 3S‘ŸŒŒŠÇŠO): ‘ć80‰ń“ú–{zŠÂŠíŠw‰ďŠwpW‰ď (2016/3/20), ĺ‘ä.

731108. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ěč•a‚ĚŒř‰Ę“I‹}ŤŠúŽĄ—Ă: ƒƒJƒjƒYƒ€‚̉đ–ž. Îˆäł_ (ŹŽ™): ‘ć8‰ńŠň•Œ–ƉuEŠ´őEěč•aŒ¤‹†‰ď (2015/7/23), Šň•Œ.

731109. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Źlć“VŤSŽžŠł‚đŽć‚芪‚­”–â‘č. Îˆäł_ (ŹŽ™): “ú–{zŠÂŠíŠw‰ďî•ńL•ńˆĎˆő‰ď‘ć11‰ńƒvƒŒƒXƒZƒ~ƒi[ (2015/8/4), “Œ‹ž.

731110. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒCƒ“ƒtƒ‹ƒGƒ“ƒU‚̍ŐV‚Ě’mŒŠ. Îˆäł_ (ŹŽ™): ‘ć27‰ńˆëŠň“‡Œ’N‘ĺŠwu‰‰‰ď (2015/11/28), ’ˇč.

731111. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “Ťěč•a‚ɑ΂ˇ‚é–k—˘‘ĺŠwŹŽ™‰Č‚Ě‹}ŤŠúŽĄ—Ð헪: SŒŒŠÇ‡•šÇ‚ĚŒŸ“˘. Îˆäł_ (ŹŽ™): ‘ć11‰ń_“ŢěŒ§ěč•aŒ¤‹†‰ď (2016/2/27), V‰Ą•l.

733179. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹}Œƒ‚ČŒo‰ß‚đ‚˝‚Ç‚Á‚˝”xĂ–Ź•Â˝Ç (CPVA) ‚Ě1—á. ‹{“c—L—Œb1, –kě“ÄŽj2, •’ms•ă2, ˆŔ“Ą@Žő2, –Ř‘şƒl2, çݎ@Šw2, Îˆäł_2, ’†‘ş—SŠó3, ‹{’n@ŠÓ3 (1Œ¤Cˆă, 2ŹŽ™, 3S‘ŸŒŒŠÇŠO): ‘ć34‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ŢěŒ§’n•ű‰ď (2015/4/11), ‰Ą•l, _“ސěˆăŠw‰ďŽGŽ 2015/7; 42 (2): 294.

733180. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ěč•a•s‘SŒ^‚Ć‚ľ‚ÄŽĄ—Ă‚ł‚ę‚˝‚ˆŔ“Ž–Ź‰Š‚Ě1—Ž™—á. ‹´–{‰č‹v”ü1, ]”gŒËF•ă1, îŒ´‹`l1, •űš•˝1, Îˆäł_1 (1ŹŽ™): ‘ć34‰ńŠÖ“Œěč•aŒ¤‹†‰ď (2015/6/20), “Œ‹ž.

733181. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) –ƉuƒOƒƒuƒŠƒ““Š—^Œă‚ɃAƒiƒtƒBƒ‰ƒLƒV[—lÇó‚đ”F‚ß‚˝‚˝‚ß, ‰‰ńŽĄ—Ă‚Ć‚ľ‚ăCƒ“ƒtƒŠƒVƒLƒ}ƒu‚đŽg—p‚ľ‚˝ěč•aÄ”­—á. îŒ´‹`l1, ]”gŒËF•ă1, •űš•˝1, Îˆäł_1 (1ŹŽ™): ‘ć34‰ńŠÖ“Œěč•aŒ¤‹†‰ď (2015/6/20), “Œ‹ž.

733182. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ázš‚đ‰”­‚Ć‚ľ‚˝”í‹s‘ŇŽ™‚Ě1—á. ź“cŽŽj1, ˆŔ“Ą@Žő1, ”’ˆäG’ź1, ź–{“TŽq1, “yŠň@•˝1, •ô”öŒb—œ1, “Ą•‹`l1,2, Îˆäł_1 (1ŹŽ™, 2‘Š–Í‘ä•a‰@): ‘ć335‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ŢěŒ§’n•ű‰ďE‘‰ď (2015/6/27), ‰Ą•l.

733183. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “úíf—Ă‚É‚¨‚Ż‚éŠë‹}“IÇ—á@‹}Ť”]Ç. “yŠň@•˝ (ŹŽ™): ‘ć394‰ń‘Š–ÍŒ´ŽsŹŽ™‰Čˆă‰ďŒŽ—፧˜b‰ď (2015/7/22), ‘Š–ÍŒ´.

733184. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Clinically isolated syndrome‚É‚¨‚Ż‚éŠÓ•Ę‚É‘gDśŒŸ‚Ş—L—p‚Ĺ‚ ‚Á‚˝”]Š˛ƒOƒŠƒI[ƒ}‚Ě8Î’jŽ™—á. “yŠň@•˝1, Šâčr”V1, Îˆäł_1 (1ŹŽ™): ‘ć56‰ń_“ސ쏬Ž™_Œo§˜b‰ď (2015/7/25), ‰Ą•l.

733185. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒAƒgƒs[Ť”畆‰Š@f—Ă‚ĚƒRƒc. ‘ĺ’J´F1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™): ƒ}ƒ‹ƒzŠ”ŽŽ‰ďŽĐŽĐ“ŕŒ¤C‰ď (2015/10/13), Œú–Ř.

733186. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ć“VŤSŽžŠłŽ™‚É‚¨‚Ż‚élHS”xŽčpŒă‚ĚŽŠ“K—\–hÚŽíŽžŠú. ‚—œ@Šw (ŹŽ™): ‘ć14‰ń–k—˘Pediatrics Seminar (‘ć396‰ń‘Š–ÍŒ´ŹŽ™‰Čˆă‰ďŒŽ—˜b‰ď) (2015/10/28), ‘Š–ÍŒ´.

733187. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”N’ˇŽ™ƒtƒ@ƒ[Žl’ĽÇ‚Ěˆę—á. –Ř‘şƒl1, ˆŔ“Ą@Žő1, –{“c@’1, –kě“ÄŽj1, ‚—œ@Šw1, •ô”öŒb—œ1, Îˆäł_1 (1ŹŽ™): ‘ć11‰ń_“ސ쏬Ž™zŠÂŠíŒ¤‹†‰ď (2015/10/31), ‰Ą•l.

733188. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) śSŽş“ŕEnergy Loss‚͉˝‚𔽉f‚ˇ‚é‚ŠH|SŽşŠÖ˜A‚ÉŠÖ‚ˇ‚éV‚˝‚Č’mŒŠ|. –{“c@’1, ”Â’JŒcˆę2, ‚—œ@Šw1, –kě“ÄŽj1, ˆŔ“Ą@Žő1, –Ř‘şƒl1, ‹{čăĕ˝2, ‹{’n@ŠÓ3, Îˆäł_1 (1ŹŽ™, 2ŒŒ—Ź‰đÍ, 3S‘ŸŒŒŠÇŠO): ‘ć5‰ńŒŒ—Ź‰ď (2015/11/21), “Œ‹ž.

733189. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H•¨ƒAƒŒƒ‹ƒM[‚ĚŠÇ—‚Í‚Ç‚¤‚ˇ‚éH`”­Ç‹@˜‚¨‚ć‚Ń“ÁˆŮ“IIgE’l‚̐„ˆÚ‚ĆŠ°‰đ‚ɂ‚˘‚ā`. ‘ĺ’J´F1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™): ‘˝–€“ě•”’nˆć•a‰@’nˆć˜AŒg‰ď (2015/11/25), “Œ‹ž.

733190. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’´‰š”gŒŸ¸‚Ş‹t—ŹŤtÇ‚Ě‘Šú”­ŒŠ‚É—L—p‚ž‚Á‚˝1—á. ‹ŕŽq‰ë‹I1, Š@L–ç2, źě‹ĹŽq1, ’†‘şM–ç1, ź@ˇG3, Îˆäł_1 (1ŹŽ™, 2‹~–˝, 3”ĺ”AŠí): ‘ć337‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ސě’n•ű‰ď/‘ć57‰ńŹŽ™‰Č•Ş‰Č‰ď (2015/11/28), ‰Ą•l.

733191. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ä‚ń‚Š‚ńˆă—Ă‚ĚĹ‘Oü|”­ě—}§‚Ě‚˝‚߂Ɂ|. Šâér”V (ŹŽ™): Žs–ŻŒöŠJuŔ (2015/12/12), _“ސě.

733192. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’ˇŠúŠÔ‚̉şŽˆ’ɂ𔺂˘f’f‚É‹ę—ś‚ľ‚˝ƒ}ƒCƒRƒvƒ‰ƒYƒ}Š´őÇ‚Ě1—á. ‚—œ@Šw (ŹŽ™): ‘ć399‰ń‘Š–ÍŒ´ŽsŹŽ™‰Čˆă‰ďŒŽ—˜b‰ď (2016/1/20), ‘Š–ÍŒ´.

733193. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) H•¨ƒAƒŒƒ‹ƒM[‚Ě‚˘‚Ü, ‚ą‚ę‚Š‚ç. ‘ĺ’J´F1,2 (1‘Š–ÍŒ´‹Ś“Ż•a‰@, 2ŹŽ™): ‘ć31‰ńŽs–ŻŒöŠJuŔ (2016/1/25), ‘Š–ÍŒ´.

733194. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‚Ç‚ŕ‚Ě‚Ä‚ń‚Š‚ń|Šî–{“I’mŽŻ‚ƐśŠˆ‚ɂ‚˘‚ā|. Šâér”V (ŹŽ™): •˝Ź27”N“xŹŽ™–Ť“Á’莞•au‰‰‰ď (2016/2/12), _“ސě.

733195. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ěč•a‚ĚŽŠ‘R–Ɖu§Œä‹@\‚̉đ–ž: ěč•aImmune-Profile‰đÍ. ]”gŒËF•ă1, •űš•˝1, îŒ´‹`l1, Îˆäł_1 (1ŹŽ™): ‘ć11‰ń_“ŢěŒ§ěč•aŒ¤‹†‰ď (2016/2/27), V‰Ą•l.

733196. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) •ďŠ‡ˆă—Ч“x‰ş‚Ĺ‚Ě”N’ˇěč•aŽ™‚ɑ΂ˇ‚é–ƉuƒOƒƒuƒŠƒ“—Ă–@‚Ě–â‘č“_. Ž–ě@Žő1, •űš•˝1, ]”gŒËF•ă1, îŒ´‹`l1, rˆäN•v2, Îˆäł_1 (1ŹŽ™, 2f—Ïî•ńŠÇ—Žş): ‘ć11‰ń_“ŢěŒ§ěč•aŒ¤‹†‰ď (2016/2/27), V‰Ą•l.

733197. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’ˇŠúŠÔ‚̉şŽˆ’ɂ𔺂˘f’f‚É‹ę—ś‚ľ‚˝ƒ}ƒCƒRƒvƒ‰ƒYƒ}Š´őÇ‚Ě1—á. ‚—œ@Šw (ŹŽ™): ‘ć2‰ń–k‘ŠE‘˝–€’nˆćŹŽ™‰Č˜AŒgƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/2/29), _“ސě.

733198. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) dÇSgáŠQŽ™‚ĚÝ‘îŽx‰‡‚É‚¨‚Ż‚é‘ĺŠw•a‰@‚Ć‚ľ‚Ä‚ĚŽŽ‚Ý. Šâčr”V1, Œ´ŒűŒ[”V‰î1, ŒĎč‰ëŽq1, Îˆäł_1 (1ŹŽ™): ‘ć339‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ŢěŒ§’n•ű‰ď/‘ć33‰ń_“ސ쏬Ž™‰Čˆă‰ď‘‰ď (2016/3/12), ‰Ą•l.

733199. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”xŒŒÇŤÇđÇ (septic pulmonary embolism: SPE) ‚đ‡•š‚ľ‚˝‰ť”^Ťĺ’°ŠÖß‰Š‚Ě1’jŽ™—á. ě‘ş“TŽq1, ě“cF‘ž1, ‹ŕŽq’‰O1, Îˆäł_1 (1ŹŽ™): ‘ć339‰ń“ú–{ŹŽ™‰ČŠw‰ď_“ŢěŒ§’n•ű‰ď/‘ć33‰ń_“ސ쏬Ž™‰Čˆă‰ď‘‰ď (2016/3/12), ‰Ą•l.

733200. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ć“VŤŠĚ‰čŽî‚Ěˆę—á. ź“cŽŽj1, Źă—T‰ŔŽq1, Š`Œ´@’m2, HŽR˜a­1, ŒĎč‰ëŽq1, •“cŒ›Žq2, çݎ@Šw1, “c’†@Œ‰3, Îˆäł_1 (1ŹŽ™, 2ŠO‰Č, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć64‰ń_“ސ쏬Ž™Žîᇌ¤‹†‰ď (2016/3/26), ‰Ą•l.


ŽY‰ČŠw^•wl‰ČŠw

[Šwp˜_•ś]

110211. [Œ´’˜] Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A). Kato T, Takashima A, Kasamatsu T, Nakamura K, Mizusawa J, Nakanishi T, Takeshima N, Kamiura S, Onda T1, Sumi T, Takano M, Nakai H, Saito T, Fujiwara K, Yokoyama M, Itamochi H, Takehara K, Yokota H, Mizunoe T, Takeda S, Sonoda K, Shiozawa T, Kawabata T, Honma S, Fukuda H, Yaegashi N, Yoshikawa H, Konishi I, Kamura T (Gynecologic Oncology Study Group of the Japan Clinical Oncology Group): Gynecol Oncol 2015/4; 137 (1): 34-9. (‰ś“c‹MŽu1: 1•wl)

110212. [Œ´’˜] Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients. Iwase H1, Takada T1, Iitsuka C, Nomura H, Abe A, Taniguchi T, Takizawa K: J Gynecol Oncol 2015/10; 26 (4): 303-10. (ŠâŁtŽq1, ‚“c‹ąb1: 1•wl)

110213. [Œ´’˜] Establishment and Characterization of an In Vitro Model of Ovarian Cancer Stem-like Cells with an Enhanced Proliferative Capacity. Ishiguro T, Sato A, Ohata H, Ikarashi Y, Takahashi RU, Ochiya T, Yoshida M, Tsuda H, Onda T1, Kato T, Kasamatsu T, Enomoto T, Tanaka K, Nakagama H, Okamoto K: Cancer Res 2016/1; 76 (1): 150-60. (‰ś“c‹MŽu1: 1•wl)

110029. [Œ´’˜] Vascular endothelial growth factor regulates growth of endometrial tissues and angiogenesis in a mouse transplantation model. Sekiguchi K1, Hosono K2,3, Numao A4, Honda M1, Matsuda H1, Amano H3, Kawauchi H4, Shibuya M, Unno N5, Majima M3: Kitasato Med J 2016/3; 46 (1): 15-23. (ŠÖŒű˜aŠé1, ×–ě‰Á“ŢŽq2,3, Ŕ”ö˛Žq4, –{“c‰ëŽq1, ź“cO”ü1, “V–ě‰pŽ÷3, ě“ŕ”Žl4, ŠC–ěM–ç5, ”n“ˆł—˛3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ś—, 3–ň—, 4•wl, 5ŽY‰Č)

120019. [Œ´’˜] ‹ćˆć’Á’É–@‚É‚ć‚é–ł’É•Ş•Ř‚ĆŽq‹{’ęˆł”—–@. źŕVW‘ă1, “V–ě@ŠŽ1, “‡‰Ş‹ś1, ŠÖŒű˜aŠé2, ‘吟—fŽq1, ‰Í–ěĆŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŽGŽ 2015/9; 51 (3): 1003-8.

120020. [Œ´’˜] “–‰@‚É‚¨‚Ż‚鏃ˆŒ^Žq‹{‘Ě•”Ÿ÷‰tŤ‘BŠŕ13—á‚ĚŽĄ—ÐŹŃ. ŒĂěł‹`1, ŠâŁtŽq1, Ź–ěd–ž1, ‚“c‹ąb1, Vˆä@“w1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): _“ސěŽY‰Č•wl‰ČŠw‰ďŽ 2015/9; 52 (1): 19-23.

320025. [Ç—á•ń] ‘Ů”Őƒ|ƒŠ[ƒv‚̐f’fEŽĄ—Ă‚É‚¨‚Ż‚é3D-CTA‚Ě—L—pŤ. ‰ş“c—˛m1, ě“ŕ”Žl1, ”‘q˛Žq1, ‰Ź–ě‹|ŠóŽq1, ‰ś“c‹MŽu1, ŠC–ěM–ç2 (1•wl, 2ŽY‰Č): _“ŢěŒ§ŽY‰Č•wl‰ČŠw‰ďŽ 2015/9; 52 (1): 24-7.

320026. [Ç—á•ń] •Ş•ŘŒă‘ĺ—ʏoŒŒ2Ç—á‚ɑ΂ˇ‚éBakriƒoƒ‹[ƒ“‚ĚŽg—pŒoŒą. ‰““Ą^ˆę1, –]ŒŽƒŽq2, ‰Í–ěĆŽq2, “‡‰Ş‹ś2, źŕVW‘ă2, Îě—˛ŽO2, ‘吟—fŽq2, ‹ŕˆä—Y“ń2, ŠC–ěM–ç2 (1•wl, 2ŽY‰Č): _“ŢěŒ§ŽY‰Č•wl‰ČŠw‰ďŽ 2015/9; 52 (1): 57-9.

320027. [Ç—á•ń] ‰‰ńŽĄ—ĂŽž‚ÍŽq‹{‹ŘŽî‚Ɛf’f‚ł‚ę, ”x“]ˆÚ‚đ‚Ť‚˝‚ľ—‘‘ƒŤőŽîᇗގ—Žq‹{ŽîᇂƔť–ž‚ľ‚˝ˆę—á. ‹g‘ş‰ĂL1, VˆäłG1, Ź–ěd–ž1, ‚“c‹ąb1, ŠâŁtŽq1, Š“cç”ü”T2, ‘ĺ•”@˝3, ‰ś“c‹MŽu1 (1•wl, 2•a—, 3ˆă—ÉqśŠw•”): _“ŢěŒ§ŽY‰Č•wl‰ČŠw‰ďŽ 2016/2; 52 (2): 148-53.

510005. [‘ŕ] Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives. Matsumoto K, Onda T1, Yaegashi N: Jpn J Clin Oncol 2015/5; 45 (5): 408-10. (‰ś“c‹MŽu1: 1•wl)

510006. [‘ŕ] Minimization of curative surgery for treatment of early cervical cancer: a review. Arimoto T, Kawana K, Adachi K, Ikeda Y, Nagasaka K, Tsuruga T, Yamashita A, Oda K, Ishikawa M, Kasamatsu T, Onda T1, Konishi I, Yoshikawa H, Yaegashi N (Gynecologic Cancer Study Group of the Japan Clinical Oncology Group): Jpn J Clin Oncol 2015/7; 45 (7): 611-6. (‰ś“c‹MŽu1: 1•wl)

[Šw‰ďEŒ¤‹†‰ď“™]

713076. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Age-Related Normograms of AMH Level in Infertile Women in Japan. Kamisawa E, Nakayama M, Kawauchi H1, Asada Y: IFFS/JSRM international meeting 2015 (2015/4/26-29), Yokohama, Japan. (ě“ŕ”Žl1: 1•wl)

722076. [Šw‰ď (‘S‘)] (ƒNƒŠƒjƒJƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) |—‘‘ƒ‚Ş‚ń‰ťŠw—Ă–@‚Ěƒ^ƒCƒ~ƒ“ƒO‚Ć—\Œă|—‘‘ƒŠŕ‚É‚¨‚Ż‚éNAC‚Ć—\Œă. ‰ś“c‹MŽu (•wl): ‘ć12‰ń•wl‰Č‚Ş‚ń‰ď‹c (2015/6/26-27), Œyˆä‘ň.

722077. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Treatment invasiveness of neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers. ‰ś“c‹MŽu (•wl): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29-31), ‹ž“s.

722078. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ĐŠQŽž‚É‚¨‚Ż‚éŽüŽYŠúˆă—ĂŽů—v‹Ďt‚ÉŠÖ‚ˇ‚錟“˘. •ž•”‹żŽq (ŽY‰Č): ‘ć21‰ń“ú–{W’cĐŠQˆăŠw‰ď‘‰ďEŠwpW‰ď (2016/2/27-29), ŽRŒ`.

723546. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{“Ž–ŹÇđpŒă‚Ě•Ş•Ř—\Œă. źŽRD1, “‡‰Ş‹ś1, •ž•”‹żŽq1, źŕVW‘ă1, Îě—˛ŽO1, ‘吟—fŽq1, ‰Í–ěĆŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ƒEƒbƒhƒnƒ€ƒX—ćŽq2, ‰ś“c‹MŽu3, ŠC–ěM–ç1 (1ŽY‰Č, 2•úŽËü (‰ć‘œ), 3•wl): ‘ć67‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/4/9-12), ‰Ą•l.

723547. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒŹ”ÂŒ¸­ŤŽžŠł‡•š”DP7Ç—á‚ÉŽ{s‚ľ‚˝ƒŒƒ~ƒtƒFƒ“ƒ^ƒjƒ‹‚É‚ć‚éŒoĂ–Ź“IŠłŽŇŽŠŒČ’˛ß’Á’É–@‚ĚˆŔ‘SŤ‚ĚŒŸ“˘. źŕVW‘ă1, –]ŒŽƒŽq1, ‘吟—fŽq1, ‰Í–ěĆŽq1, Îě—˛ŽO1, “‡‰Ş‹ś1, ŠÖŒű˜aŠé2, ‹ŕˆä—Y“ń1, “V–ě@ŠŽ1, ‰Á“Ą—˘ŠG3, ŠC–ěM–ç1 (1ŽY‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć67‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/4/9-12), ‰Ą•l.

723548. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ŮŽ™ƒwƒŠƒJƒ‹3D-CT‚Ć‘ŮŽ™MRI‚ɂďoś‘O‚É”n”ö‘ލsÇŒóŒQ (caudal regression syndrome) ‚Ɛf’f‚ľ‚˝ˆę—á. ‹g‘ş‰ĂL1, ‹ŕˆä—Y“ń1, ‘吟—fŽq1, ‰Í–ěĆŽq1, Îě—˛ŽO1, “‡‰Ş‹ś1, źŕVW‘ă1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć67‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/4/9-12), ‰Ą•l.

723549. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{čň•”_Œo“ŕ•Ş”ĺŽîᇂɑ΂ˇ‚éWŠw“IŽĄ—Ă‚đ’Tő‚ˇ‚é‘˝Ž{Ý‹¤“ŻŠĎŽ@Œ¤‹†. ÎěŒő–ç, Š}ź‚O, ‰Á“Ą’B–î, ‰Ş“c’qŽu, ‚–쐭Žu, ‰×ŒŠ‚悤Žq, —é–؉Ŕ˘, ’JŒű‹`ŽŔ, ‚‹´ˆę˛, —L–{‹M‰p, ‹ŕ“c—eG, Šâ“c@‘ě, Ź–ěd–ž1, Ž™‹ĘČ“ń, ‹{–{@‹­, ’†ź@“§, …–ě”ü, ”nę@’ˇ, ź–{‰Ŕ–ç, ’†ˆä‰pŸ, –ě‰ÍF[, —L‹g˜a–ç, ˆäă‹MŽj, ‰ĄŽRłr, âV“Ą•ś—_, ě”¨‹X‘ă, ‹v‚@˜j, ‰ś“c‹MŽu1, ”ޏdŠ~Lś (1•wl): ‘ć67‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/4/9-12), ‰Ą•l.

723550. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{čň‚Ş‚ń‚ɑ΂ˇ‚鍪ŽĄ“IRT/CCRTŒă‚ĚŽîᇎc‘ś—á‚É‚¨‚Ż‚éŽq‹{“Eop‚ĚŽŔŽ{ó‹ľ|JCOG•wl‰ČŽîᇃOƒ‹[ƒv‚É‚¨‚Ż‚éƒAƒ“ƒP[ƒg’˛¸|. •ŒG@F, ‘ž“csM, Š}ź‚O, ŠŽRL–ž, ě‘ş’źŽ÷, Šě‘˝ě—ş, ŻŽq’‰G, ‚–ě’‰•v, ’|Œ´˜aG, Ź—Ń—T–ž, ‰ś“c‹MŽu1, ”ޏdŠ~Lś (1•wl): ‘ć67‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/4/9-12), ‰Ą•l.

723551. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ˆŮŠŤ”DP‚ɑ΂ˇ‚é”ńŠĎŒŒŽĄ—Ă‚ĚŒŸ“˘. –{“c‰ëŽq1, Šâ’[r•ă2, ”‘q˛Žq2, ě“ŕ”Žl2, ‰ś“c‹MŽu2, ŠC–ěM–ç3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•wl, 3ŽY‰Č): ‘ć67‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/4/9-12), ‰Ą•l.

723552. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) —‘ŠÇŠÔŽż•””DP‚ɑ΂ˇ‚é”ńŠĎŒŒ“IŽĄ—Ă‚ĚŒŸ“˘. Šâ’[r•ă1, –{“c‰ëŽq2, ”‘q˛Žq1, ě“ŕ”Žl1, ‰ś“c‹MŽu1, ŠC–ěM–ç3 (1•wl, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŽY‰Č): ‘ć67‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/4/9-12), ‰Ą•l.

723553. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ĹdÇŒ^ƒżƒTƒ‰ƒZƒ~ƒAś‘ś—á‚Ěˆâ“`Šw“I‰đÍ. –{“c‰ëŽq1, –]ŒŽƒŽq2, HŽR˜a­3, ŒĎč‰ëŽq3, r–؏Ž”ü, ‘吟—fŽq2, ŠC–ěM–ç2, ‚“cŽj’j1 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽY‰Č, 3ŹŽ™): ‘ć39‰ń“ú–{ˆâ“`ƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ď (2015/6/25-28), ç—t.

723554. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éVŒ^oś‘OŒŸ¸‚ĚŒťó‚Ć, ƒAƒ“ƒP[ƒg‚Š‚ç“ž‚ç‚ę‚˝ŒŸ¸‚ĚŽó‚ŻŽ~‚߁EˆÓŽuŒˆ’č‰ß’ö‚Ě’j—ˇ‚ɂ‚˘‚Ä. r–؏Ž”ü, •Ÿ“c@—ß, –x‚ ‚ˇ‚Š, –]ŒŽƒŽq1, ‚“cŽj’j2 (1ŽY‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć39‰ń“ú–{ˆâ“`ƒJƒEƒ“ƒZƒŠƒ“ƒOŠw‰ď (2015/6/25-28), ç—t.

723555. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰–Ž_ƒŠƒgƒhƒŠƒ“’ˇŠúŽ‘ąĂ–Ź“ŕ“Š—^‚ĚˆŔ‘SŤ‚ĚŒă•űŽ‹“IŒŸ“˘. “‡‰Ş‹ś1, –]ŒŽƒŽq1, •ž•”‹żŽq1, ŠÖŒű˜aŠé2, źŕVW‘ă1, Îě—˛ŽO1, ‘吟—fŽq1, ‰Í–ěĆŽq1, ‹ŕˆä—Y“ń1, ŠC–ěM–ç1 (1ŽY‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć51‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2015/7/10-12), •Ÿ‰Ş.

723556. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ńăO–Ń–Œ“ń—r–Œ‘o‘Ů, ˆęŽ™”­ˆç•s‘S‚É‚¨‚Ż‚éVśŽ™—\Œă‚ÉŠÖ‚ˇ‚錟“˘. ‰Í–ěĆŽq1, “‡‰Ş‹ś1, źŕVW‘ă1, ‘吟—fŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć51‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2015/7/12), •Ÿ‰Ş.

723036. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{“ŕ–ŒÇ‚Ě”­Ç‚É‚¨‚Ż‚éVEGF1Œ^Žó—e‘Ě‚Ě–đŠ„. ŠÖŒű˜aŠé1, ×–ě‰Á“ŢŽq2,3, ˛“ĄŠG—˘“Ţ, a’JłŽj, ŠC–ěM–ç4, ”n“ˆł—˛3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ś—, 3–ň—, 4ŽY‰Č): ‘ć36‰ń“ú–{‰ŠÇÄśˆăŠw‰ď‘‰ď (2015/7/21-22), “Œ‹ž.

723557. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”]“]ˆÚ‚đŠÜ‚Ţ‘˝‘ŸŠí“]ˆÚ‚đ—ˆ‚ľ‚Č‚Ş‚ç—Տ°“IŠŽ‘SŠ°‰đ‚ÉŽŠ‚Á‚˝’á•Ş‰ťŒ^Žq‹{‘Ě•”—Ţ“ŕ–Œ‘BŠŕ4BŠú‚Ěˆę—á. ŕV’n—R‹IŽq1, ŠâŁtŽq1, ’†‘şŠîŠ°1, ŒĂ]–žŽq1, ‘P•˝š–퍁1, ˛“Ą‰p‹M1, Ź–ěd–ž1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć57‰ń“ú–{•wl‰ČŽîᇊw‰ďŠwpu‰‰‰ď (2015/8/7-9), ˇ‰Ş.

723558. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{‘ĚŠŕ‚ĚÄ”­—lŽŽ‚ĆÄ”­•”ˆĘ•ĘŽĄ—ÐŹŃ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ŠâŁtŽq1, ˛“Ą‰p‹M1, Ź–ěd–ž1, Vˆä@“w1, ‚“c‹ąb1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć57‰ń“ú–{•wl‰ČŽîᇊw‰ďŠwpu‰‰‰ď (2015/8/7-9), ˇ‰Ş.

723559. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‰ES–[“ŕ‚܂ł̐ÖŹ“ŕi“W‚đ”F‚ß‚˝Žq‹{“ŕ–ŒŠÔŽż“÷Žî‚Ěˆę—á. ‰““Ą^ˆę1, ‚“c‹ąb1, ‹g‘ş‰ĂL1, ˛“Ą‰p‹M1, Ź–ěd–ž1, ŠâŁtŽq1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć57‰ń“ú–{•wl‰ČŽîᇊw‰ďŠwpu‰‰‰ď (2015/8/7-9), ˇ‰Ş.

723560. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) CDGP‚đ—p‚˘‚˝CCRT‚ĚŒŸ“˘. ‘P•˝š–퍁1, ‚“c‹ąb1, ˛“Ą‰p‹M1, Ź–ěd–ž1, ŠâŁtŽq1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć57‰ń“ú–{•wl‰ČŽîᇊw‰ďŠwpu‰‰‰ď (2015/8/7-9), ˇ‰Ş.

723561. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Žq‹{čň•”_Œo“ŕ•Ş”ĺŽîᇂɑ΂ˇ‚é‘˝Ž{Ý‹¤“ŻŠĎŽ@Œ¤‹†|isŠúÇ—á‚̉đÍ|. ÎěŒő–ç, Š}ź‚O, ’†ź@“§, …–ě”ü, ”nę@’ˇ, ź–{‰Ŕ–ç, ’†ˆä‰pŸ, –ě‰ÍF[, —L‹g˜a–ç, ˆäă‹MŽj, ‰ĄŽRłr, âV“Ą•ś—_, ě”¨‹X‘ă, ‹v‚@˜j, ’Ă“c@‹Ď, •Ÿ‰i^ŽĄ, â–{–s•F, ‰Á—ˆPšć, ‰ś“c‹MŽu1, ”ޏdŠ~Lś (1•wl): ‘ć57‰ń“ú–{•wl‰ČŽîᇊw‰ďŠwpu‰‰‰ď (2015/8/7-9), ˇ‰Ş.

723562. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{čň•”_Œo“ŕ•Ş”ĺŽîᇂɑ΂ˇ‚é‘˝Ž{Ý‹¤“ŻŠĎŽ@Œ¤‹†|‘ŠúÇ—á‚̉đÍ|. ÎěŒő–ç, Š}ź‚O, ‰Á“Ą’B–î, ‰Ş“c’qŽu, ‚–쐭Žu, ‰×ŒŠ‚悤Žq, —é–؉Ŕ˘, ’JŒű‹`ŽŔ, Šâ“c@‘ě, ‚‹´ˆę˛, —L–{‹M‰p, ‹ŕ“c—eG, Ź–ěd–ž1, Ž™‹ĘČ“ń, ‹{–{@‹­, ’Ă“c@‹Ď, •Ÿ‰i^ŽĄ, â–{–s•F, ‰Á—ˆPšć, ”ޏdŠ~Lś (1•wl): ‘ć57‰ń“ú–{•wl‰ČŽîᇊw‰ďŠwpu‰‰‰ď (2015/8/7-9), ˇ‰Ş.

723563. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • •”–c–ž‚đ10”NŠÔ•ú’u‚ľ‚Ä‚˘‚˝’´‹‘ĺ—‘‘ƒŠŕ‚Ěˆę—á. źŽRD1, VˆäłG1, ˛“Ą‰p‹M1, Ź–ěd–ž1, ‚“c‹ąb1, ŠâŁtŽq1, ‰ś“c‹MŽu1 (1•wl): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29-31), ‹ž“s.

723564. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Žq‹{čňŠŕIB2, IIA2, IIBŠúŽčpÇ—á‚Ě—Ő°“IŒŸ“˘. ‚“c‹ąb1, ˛“Ą‰p‹M1, ‘P•˝š–퍁1, Ź–ěd–ž1, ŠâŁtŽq1, VˆäłG1, ‰ś“c‹MŽu1 (1•wl): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29-31), ‹ž“s.

723565. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹š…×–Ef—zŤ‚Ĺ—Ő°isŠú…˘Šú‚Ć‚Č‚Á‚˝—‘‘ƒ”S‰tŤ‹ŤŠEˆŤŤŽîᇂĚ1—á. ŒĂěł‹`1, VˆäłG1, –öŕVM”V2, ‘P•˝š–퍁1, “cŽG—L‹I3, ˛“Ą‰p‹M1, Ź–ěd–ž1, ‚“c‹ąb1, ŠâŁtŽq1, ‘ş‰_–FŽ÷2, ‰ś“c‹MŽu1 (1•wl, 2•a—, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć54‰ń“ú–{—Տ°×–EŠw‰ďHŠú‘ĺ‰ď (2015/11/21-22), –źŒĂ‰Ž.

723039. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Host Derived Bone Marrow Cells Expressing Vascular Endothelial Growth Factor Receptor 1 Regulates Growth of Endometrial Tissues and Angiogenesis in a Mouse Transplantation Model. ŠÖŒű˜aŠé1, ×–ě‰Á“ŢŽq2,3, –{“c‰ëŽq1, ě“ŕ”Žl4, ŠC–ěM–ç5, ”n“ˆł—˛3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ś—, 3–ň—, 4•wl, 5ŽY‰Č): ‘ć89‰ń“ú–{–ň—Šw‰ď”N‰ď (2016/3/10), ‰Ą•l.

731112. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) —‘‘ƒŽîᇍ‡•š”DP‚Ě2—á. ŠâŁtŽq (•wl): •˝Ź27”N“xĂ‰ŞŽY‰Č•wl‰ČŠw‰ďŠwpW‰ď (2015/11/15), •lź.

731113. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Žq‹{‘Ě‚Ş‚ń‚ĚĹ‹ß‚ĚŒXŒü‚Ć˜b‘č|f’f‚Š‚玥—Â܂Ł| ŠâŁtŽq (•wl): Žq‹{‚Ş‚ńW’cŒŸfˆăŽtuK‰ď (Ă‰ŞŒ§ŽY‰Č•wl‰ČŠw‰ď) (2015/11/15), •lź.

733201. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) •Ű‘ś“I‚ÉŠÇ—‚ľ‚˝—Տ°“I–ü’…‘ٔՂĚ1—á. “‡‰Ş‹ś1, ‹g‘ş‰ĂL1, •ž•”‹żŽq1, źŕVW‘ă1, ŠÖŒű˜aŠé2, Îě—˛ŽO1, ‘吟—fŽq1, ‰Í–ěĆŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć129‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď‘‰ďEŠwpW‰ď (2015/6/20-21), “Œ‹ž.

733202. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Žqᒔ­ě‚ɑ΂ˇ‚é—°Ž_ƒ}ƒOƒlƒVƒEƒ€ŽĄ—Ă‚ĚƒsƒbƒgƒtƒH[ƒ‹. ‰““Ą^ˆę1, ŠÖŒű˜aŠé2, “‡‰Ş‹ś1, ‰Í–ěĆŽq1, ‘吟—fŽq1, Îě—˛ŽO1, źŕVW‘ă1, •ž•”‹żŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ‰ś“c‹MŽu3, ŠC–ěM–ç1 (1ŽY‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3•wl): ‘ć373‰ńŽl…‰ď (2015/7/1), “Œ‹ž.

733203. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”DP’†‚É”’ŒŒ•a‚Ɛf’f‚ľ‚˝2Ç—á. ˆÉ“ĄŽŔ1, źŽRD1, ‘吟—fŽq1, ‰Í–ěĆŽq1, Îě—˛ŽO1, “‡‰Ş‹ś1, źŕVW‘ă1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć410‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/7/4), ‰Ą•l.

733204. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é40ÎˆČă‚Ě’P‘ُ‰ŽY—á‚ĚŽüŽYŠú—\Œă. ‹g‘ş‰ĂL1, ‹gŒ´@ˆę1, ”‘q˛Žq2, źˆä•ś”T, ˆŔ“ĄG”ü, –ě“c–Fl, –]ŒŽˆ¤˜Y2 (1ŽY‰Č, 2•wl): ‘ć130‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď‘‰ďEŠwpW‰ď (2015/10/24-25), “Œ‹ž.

733205. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚éƒxƒoƒVƒcƒ}ƒuŽĄ—ĂÇ—á‚ĚŒŸ“˘. Vˆä@“w1, ‰““Ą^ˆę1, Vˆä‰r”ü2, ’F@‰pŽ÷1, –x“cˆťŽq, âV“Ąś˜N (1•wl, 2ŽY‰Č): ‘ć412‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/11/14), ‘Š–Í‘ĺ–ě.

733206. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) WunderlichÇŒóŒQ‚ĆOHVIRA|‚ť‚̐f’f‚ĆŽĄ—Á|. źŽRD1, ě“ŕ”Žl1, –{“c‰ëŽq2, Šâ’[r•ă1, ”‘q˛Žq1, ‰ś“c‹MŽu1, ŠC–ěM–ç3 (1•wl, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŽY‰Č): ‘ć412‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/11/14), ‘Š–Í‘ĺ–ě.

733207. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‚ŕ‚â‚ŕ‚â•a‡•š”DP3Ç—á‚Ě•Ş•ŘŠÇ—. ˆÉ“ĄŽŔ1, ‘吟—fŽq1, “‡‰Ş‹ś1, ‰Í–ěĆŽq1, źŕVW‘ă1, Îě—˛ŽO1, ŠÖŒű˜aŠé2, •ž•”‹żŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć412‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/11/14), ‘Š–Í‘ĺ–ě.

733208. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚é150cmˆČ‰ş‚Ě’P‘ُ‰ŽY—á‚ĚŽüŽYŠú—\Œă. ‹g‘ş‰ĂL1, ‹gŒ´@ˆę1, ”‘q˛Žq2, źˆä•ś”T, ˆŔ“ĄG”ü, –ě“c–Fl, –]ŒŽˆ¤˜Y2 (1ŽY‰Č, 2•wl): ‘ć412‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/11/14), ‘Š–Í‘ĺ–ě.

733209. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ”DP‰E’†Šú‚ɐ[•”Ă–ŹŒŒđÇ‚đ”­Ç‚ľ‚˝4Ç—á‚ĚŽüŽYŠúŠÇ—. •‰i@’q, ‰Í–ěĆŽq1, źŕVW‘ă1, “‡‰Ş‹ś1, ‘吟—fŽq1, Îě—˛ŽO1, ŠÖŒű˜aŠé2, •ž•”‹żŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)): ‘ć412‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2015/11/14), ‘Š–Í‘ĺ–ě.

733210. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‰ES–[“ŕ‚܂ŐÖŹ“ŕi“W‚đ”F‚ß‚˝Žq‹{“ŕ–ŒŠÔŽż“÷Žî‚Ěˆę—á. ‰““Ą^ˆę1, ‚“c‹ąb1, ‹g‘ş‰ĂL1, ˛“Ą‰p‹M1, Ź–ěd–ž1, ŠâŁtŽq1, VˆäłG1, ŠC–ěM–ç2, ‰ś“c‹MŽu1 (1•wl, 2ŽY‰Č): ‘ć374‰ńŽl…‰ď (2015/12/2), “Œ‹ž.

733211. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) •˝Ź26”N“x”­ŒŠŽq‹{‚Ş‚ńÇ—á. VˆäłG (•wl): ‘Š–ÍŒ´ŽsŽY•wl‰Čˆă‰ďEŽq‹{‚Ş‚ńŒŸf•”‰ď‡“ŻŒ¤C‰ď (2016/2/17), ‘Š–Í‘ĺ–ě.

733212. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”Ŕ‘—Œă‚ĚŒo‰ß. “‡‰Ş‹ś (ŽY‰Č): ‘Š–ÍŒ´ŽsŽY•wl‰Čˆă‰ďEŽq‹{‚Ş‚ńŒŸf•”‰ď‡“ŻŒ¤C‰ď (2016/2/17), ‘Š–Í‘ĺ–ě.

733213. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽüŽYŠúˆă—ĂƒAƒbƒvƒf[ƒg (•Ş•ŘŠÄŽ‹‚ĆŠO—ˆ‚Ĺ‚Ě’ˆÓ“_) •a“‚É‚¨‚Ż‚éŽüŽYŠúˆă—Ă: •Ş•ŘŠÄŽ‹“lje‰đŕ. –]ŒŽƒŽq (ŽY‰Č): ‘ć20‰ń_“ŢěŒ§Œ§ˆć’n‹ćŽY•wl‰ČŒ¤C‰ď (2016/3/10), ‘Š–Í‘ĺ–ě.

733214. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{ŽčpŒă”DP‚ɑ΂ľƒŠƒXƒN•]‰ż‚ƏpŽŽ‚É‹ę—ś‚ľ‚˝ˆę—á. çݎ“ޏ”ü, •ž•”‹żŽq1, źŕVW‘ă1, “‡‰Ş‹ś1, Îě—˛ŽO1, ‰Í–ěĆŽq1, ‘吟—fŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć413‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2016/3/12), ‰Ą•l.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H25-320002. [Ç—á•ń] Žq‹{‚Ş‚ńŒŸf‚ĹAGC‚Ɛf’f‚ł‚ę‚˝•Ş—tó“ŕčň•”‘B‰ßŒ`Ź‚Ě1—á. •ž•”‹żŽq1, źˆä•ś”T, Ş–{—ćŽq, ‘ĺ–ě@•×, ‘ĺ‰ÍŒ´‘, ’‡“c“TL2, ă–V•qŽq (1ŽY‰Č, 2•a—): “ú–{—Տ°×–EŠw‰ď_“ŢěŒ§Žx•”‰ďŽ 2013/7; 18 (1): 75-80.

H26-120002. [Œ´’˜] ‘S‘ŽY•wl‰ČˆăŽt‚̋ΖąŽŔ‘Ô‚ÉŠÖ‚ˇ‚錤‹†|“ú–{ŽY‰Č•wl‰ČŠw‰ďˆă—ÉüŠvˆĎˆő‰ďE“ú–{ŽY•wl‰Čˆă‰ď‹Î–ąˆă•”‰ď‹¤“Ż’˛¸|. ’†ˆäÍl, ŠC–ěM–ç1 (1ŽY‰Č): “ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŽGŽ 2015/1; 50 (4): 1281-8.

H26-320009. [Ç—á•ń] Žq‹{‹ŘŽîŠjopŒă‚É”­ś‚ľ‚˝Žq‹{“ŕ–ŒŠÔŽż•˝ŠŠ‹ŘŹ‡ŽîᇂĚ1—á. —é–ŘŒ¤Ž‘, ‚“c‹ąb1, “Ąˆä’B–ç, ˛ŽR°—ş, ”Â‰Ş“Ţ‰›, Źň”ü“ŢŽq, Š`–ؐŹŽq, ’†“c^–Ř, Ź“‡rs (1•wl): “Œ‹žŽY‰Č•wl‰ČŠw‰ď‰ďŽ 2014; 63 (2): 255-60.

[Šw‰ďEŒ¤‹†‰ď“™]

H19-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{čň•”‚É”­ś‚ľ‚˝adenoid cystic carcinoma (ACC) ‚Ě1—á. ŠÖŒű˜aŠé1, Ŕ“c@Ę1, Ąˆä@ˆ¤1, Ź–ěd–ž1, Šp“cV•˝1, ă–V•qŽq1, ŠC–ěM–ç1 (1ŽY•w): ‘ć380‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ď_“ސě’n•ű•”‰ď (2007/11/11), _“ސě.

H23-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹}ŤäX‰Š‡•š”DP‚Ěˆę—á. ŒĂěł‹`1, –]ŒŽƒŽq1, •ž•”‹żŽq1, ŠÖŒű˜aŠé1, “V–ě@ŠŽ1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć396‰ń_“ŢěŒ§ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2011/11/13), ‘Š–ÍŒ´.

H24-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) MCA-PSV‚đŽw•W‚Ć‚ľ‚˝twin anemia-polycythemia sequence (TAPS) ‚Ě1—á. ‘P•˝š–퍁1, “‡‰Ş‹ś1, –]ŒŽƒŽq1, ‹ŕˆä—Y“ń1, “V–ě@ŠŽ1, ‰ś“c‹MŽu2, ŠC–ěM–ç1 (1ŽY‰Č, 2•wl): ‘ć401‰ń_“ސěŽY‰Č•wl‰ČŠw‰ď (2013/3/9), ‰Ą•l.

H25-722002. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ”DP‚ŒŒˆłÇŒóŒQ^”DP‚ŒŒˆłtÇ‚Ě”DPE•Ş•Ř—\Œă. ‰Í–ěĆŽq1, •ž•”‹żŽq1, “c“‡ˆťŽq1, “‡‰Ş‹ś1, źŕVW‘ă1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, “V–ě@ŠŽ1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć117‰ń“ú–{ŽY‰Č–ƒŒŠw‰ďŠwpW‰ď (2013/11/30), “Œ‹ž.

H25-723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Žq‹{“ŕ—eœ‹ŽpŒă‚É”­ś‚ľ‚˝Žq‹{“ŽĂ–ŹŠďŒ`‚Ěˆę—á. ‰Í–ěĆŽq1, ‹ŕˆä—Y“ń1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć86‰ń“ú–{’´‰š”gˆăŠw‰ďŠwpW‰ď (2013/5/24-26), ‘ĺă.

H25-723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{“ŕ–ŒŠŕ‚É‚¨‚Ż‚ésurvivin variant forms‚Ě”­Œť‚ĆƒKƒ“×–E‘B§Œä‹@\‚É‹y‚Ú‚ˇ‰e‹ż. “cŽG—L‹I1, Œ´@“ÖŽq2, ‹´‘ş”ü‹I3, ŽOŽ}@M2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—, 3Œ`‘ÔŒn): ‘ć102‰ń“ú–{•a—Šw‰ď‘‰ď (2013/6/6-8), ŽD–y.

H25-723005. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •Ş•ŘŒăŠë‹@“IoŒŒ‚ɑ΂ˇ‚éŒoƒJƒe[ƒeƒ‹“I“Ž–ŹÇđp (TAE) ‚Ě—L—pŤ. “‡‰Ş‹ś1, ‘P•˝š–퍁1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, “V–ě@ŠŽ1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć49‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2013/7/14-16), ‰Ą•l.

H25-723006. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ˆęŽ™‚ŞDandy WalkerÇŒóŒQ‚ĚˆęăO–Ń–Œ“ń—r–Œ‘o‘Ů—á. ŒĂ]–žŽq1, –]ŒŽƒŽq1, ‘吟—fŽq1, ‹ŕˆä—Y“ń1, “V–ě@ŠŽ1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć49‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2013/7/14-16), ‰Ą•l.

H25-723007. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) łŠúŽYŒoäT•Ş•Ř‚É‚¨‚Ż‚éˆę‰ßŤ‘˝ŒÄ‹z‚ÉŠÖ‚ˇ‚錟“˘. ‰Í–ěĆŽq1, “V–ě@ŠŽ1, –]ŒŽƒŽq1, ‹ŕˆä—Y“ń1, ‘吟—fŽq1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć49‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2013/7/14-16), ‰Ą•l.

H25-723008. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘ŮŽ™’†‘ĺ”]“Ž–ŹŒŒ—Ź‘Ź“x (MCA-PSV) ‚đŽw•W‚ÉŠÇ—‚ľ‚˝TAPS (twin anemia-polycythemia sequence) ‚Ěˆę—á. ‘P•˝š–퍁1, “‡‰Ş‹ś1, –]ŒŽƒŽq1, ‹ŕˆä—Y“ń1, “V–ě@ŠŽ1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć49‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2013/7/14-16), ‰Ą•l.

H25-723009. [Šw‰ď (‘S‘)] ˆę”ĘŒű‰‰) –ł’É•Ş•Ř‚É‚¨‚Ż‚éŽq‹{’ęˆł”—–@‚ĚŽŔŽ{ó‹ľ‚ƍ‡•šÇ. źŕVW‘ă1, ‘吟—fŽq1, ‰Í–ěĆŽq1, ‹ŕˆä—Y“ń1, –]ŒŽƒŽq1, “V–ě@ŠŽ1, ŠC–ěM–ç1 (1ŽY‰Č): ‘ć117‰ń“ú–{ŽY‰Č–ƒŒŠw‰ďŠwpW‰ď (2013/11/30), “Œ‹ž.

H25-733002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Dienogest“Š—^’†‚ÉŒŒ‰t”Zk‚đ”F‚ß‚˝Ç—á‚ĚŒŸ“˘. ‹g‘ş‰ĂL1, ě“ŕ”Žl1, ”‘q˛Žq1, ‰Ź–ě‹|ŠóŽq1, Îě‰ëˆę1, ‰ś“c‹MŽu1, ŠC–ěM–ç2 (1•wl, 2ŽY‰Č): ‘ć125‰ńŠÖ“Œ˜A‡ŽY‰Č•wl‰ČŠw‰ď‘‰ďEŠwpW‰ď (2013/6/15-16), “Œ‹ž.

H26-712002. [Šw‰ď (‘Ű)] (Oral session) The Effect of Lifestyle Factors on Anti-Mullerian Hormone (AMH) l evels in infertile Japanese women. Nakayama M, Kamisawa E, Kawauchi H1, Asada Y: American Society for Reproductive Medicine (ASRM) 2014 Annual Meeting (2014/10/18-22), hawaii, Honolulu. (ě“ŕ”Žl1: 1•wl)

H26-722002. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Ä”­—‘‘ƒ‚Ş‚ń‚ĚŽĄ—Ð헪|QOL‚ĚˆŰŽ‚đ–ÚŽw‚ľ‚ā|. ŠâŁtŽq (•wl): ‘ć66‰ń“ú–{ŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď (2014/4/18-20), “Œ‹ž.

H26-723010. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žq‹{“ŕ–ŒŠŕ‚É‚¨‚Ż‚éSurvivin-ƒ˘Ex3‚ĚƒAƒ|ƒg[ƒVƒX—U“ą”\‚ĚŘ–ž‚Ć‚ť‚Ě•ŞŽqƒƒJƒjƒYƒ€‚̉đ–ž. “cŽG—L‹I1, Œ´@“ÖŽq2, ŽOŽ}@M2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2•a—): ‘ć103‰ń“ú–{•a—Šw‰ď‘‰ď (2014/4/26), L“‡.

H26-723011. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) AMH‚ÉŠÖ˜A‚ˇ‚鐜ŠˆKŠľ‚Ć•ę–ş‚̐˘‘ăŠÔ”D›s. ăŕV‰xŽq, ’†ŽR”ü—R‹I, ě“ŕ”Žl1, ó“c‹`ł, ‰–’J‰ë‰p, ‹g“cmH, ŒŠ”ö•ŰK, –Ľ‰Y”Ž”V (1•wl): ‘ć59‰ń“ú–{śBˆăŠw‰ďŠwpu‰‰‰ďE‘‰ď (2014/12/4-5), “Œ‹ž.

H26-733006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽY•wl‰Čˆă—ÉüŠvƒOƒ‰ƒ“ƒhƒfƒUƒCƒ“2015‚ɂ‚˘‚Ä. ŠC–ěM–ç (ŽY‰Č): ‘ć43‰ń‹{éŒ§ŽüŽYŠúˆă—ͧ˜b‰ďE‘ć595‰ń‹{éŽY‰Č•wl‰ČŠw‰ďW’k‰ď (2015/1/17), ĺ‘ä.

H26-733007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”DP’†‚ÉŒ´ˆö•s–ž‚Ě”w•”’É‚đ—ˆ‚˝‚ľ‚˝1—á. ‰ş“c—˛m1, ‹gŒ´@ˆę1, ”‘q˛Žq2, źˆä•ś”T, ˆŔ“ĄG”ü. “cŒű@–ž (1ŽY‰Č, 2•wl): ‘ć409‰ń_“ސěŽY‰Č•wl‰ČŠw‰ďŠwpu‰‰‰ď(2015/3/7), ‰Ą•l.


ŽŒ`ŠO‰ČŠw

[Šwp˜_•ś]

110214. [Œ´’˜] Should we use cortical bone screws for cortical bone trajectory? Ueno M, Sakai R1, Tanaka K2, Inoue G3, Uchida K3, Imura T3, Saito W3, Nakazawa T3, Takahira N1, Mabuchi K1, Takaso M3: J Neurosurg Spine 2015/4; 22 (4): 416-21. (Žđˆä—˜“Ţ1, “c’†Œ’˝2, ˆäă@Œş3, “ŕ“cŒ’‘ž˜Y3, ˆä‘ş‹M”V3, âV“Ą@˜j3, ’†ŕVr”V3, ‚•˝ŽL1, ”nŸş´Ž‘1, ‚‘ŠťŽm3: 1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ŽŠO)

110215. [Œ´’˜] Acceleration of callus formation during fracture healing using basic fibroblast growth factor-kidney disease domain-collagen-binding domain fusion protein combined with allogenic demineralized bone powder. Saito W1, Uchida K1, Matsushita O, Inoue G1, Sekiguchi H1, Aikawa J2, Fujimaki H2, Takaso M1: J Orthop Surg Res 2015/5; 10: 59. (âV“Ą@˜j1, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, ŠÖŒű—T”V1, ‘Šě@~2, “ĄŠŞŽőŽq2, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

110216. [Œ´’˜] Safety and Efficacy of Continuous Epidural Anesthesia Following Scoliosis Surgery in Respiratory-Impaired Neuromuscular Children: A Pilot Study. Saito W1, Inoue G1, Imura T1, Takenami T2, Ueno M, Nakazawa T1, Uchida K1, Takahira N3, Takaso M1: Spine Deformity 2015/5; 3 (3): 272-6. (âV“Ą@˜j1, ˆäă@Œş1, ˆä‘ş‹M”V1, ’|˜Q–Ż]2, ’†ŕVr”V1, “ŕ“cŒ’‘ž˜Y1, ‚•˝ŽL3, ‚‘ŠťŽm1: 1ŽŠO, 2–ƒŒ, 3ˆă—ÉqśŠw•”)

110217. [Œ´’˜] Triclosan-coated sutures reduce wound infections after spinal surgery: a retrospective, nonrandomized, clinical study. Ueno M, Saito W1, Yamagata M, Imura T1, Inoue G1, Nakazawa T1, Takahira N2, Uchida K1, Fukahori N, Shimomura K, Takaso M1: Spine J 2015/5; 15 (5): 933-8. (âV“Ą@˜j1, ˆä‘ş‹M”V1, ˆäă@Œş1, ’†ŕVr”V1, ‚•˝ŽL2, “ŕ“cŒ’‘ž˜Y1, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

110218. [Œ´’˜] CD11c(+) macrophages and levels of TNF-ƒż and MMP-3 are increased in synovial and adipose tissues of osteoarthritic mice with hyperlipidaemia. Uchida K1, Satoh M2, Inoue G1, Onuma K1, Miyagi M1, Iwabuchi K2, Takaso M1: Clin Exp Immunol 2015/6; 180 (3): 551-9. (“ŕ“cŒ’‘ž˜Y1, ˛“Ą@‰ë2, ˆäă@Œş1, ŹŔŒŤŽĄ1, ‹{éłs1, ŠâŸş˜a–ç2, ‚‘ŠťŽm1: 1ŽŠO, 2–Ɖu)

110219. [Œ´’˜] Loxoprofen sodium and celecoxib for postoperative pain in patients after spinal surgery: a randomized comparative study. Sekiguchi H1, Inoue G2, Nakazawa T2, Imura T2, Saito W2, Uchida K2, Miyagi M2, Takahira N3, Takaso M2: J Orthop Sci 2015/7; 20 (4): 617-23. (ŠÖŒű—T”V1, ˆäă@Œş2, ’†ŕVr”V2, ˆä‘ş‹M”V2, âV“Ą@˜j2, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ‚•˝ŽL3, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3ˆă—ÉqśŠw•”)

110220. [Œ´’˜] Mini-Open Anterior Retroperitoneal Lumbar Interbody Fusion: Oblique Lateral Interbody Fusion for Lumbar Spinal Degeneration Disease. Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Miyagi M1, Kamoda H, Suzuki M, Kubota G, Sakuma Y, Oikawa Y, Inage K, Sainoh T, Sato J, Fujimoto K, Shiga Y, Abe K, Toyone T, Inoue G1, Takahashi K: Yonsei Med J 2015/7; 56 (4): 1051-9. (‹{éłs1, ˆäă@Œş1: 1ŽŠO)

110221. [Œ´’˜] More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kuniyoshi K, Aoki Y, Nakamura J, Miyagi M1, Suzuki M, Kubota G, Inage K, Sainoh T, Sato J, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Inoue G1, Takahashi K: Asian Spine J 2015/8; 9 (4): 573-80. (‹{éłs1, ˆäă@Œş1: 1ŽŠO)

110222. [Œ´’˜] Treatment of nocturnal leg cramps by blockade of the medial branch of the deep peroneal nerve after lumbar spine surgery. Imura T1, Inoue G1, Nakazawa T1, Miyagi M1, Saito W1, Uchida K1, Namba T1, Shirasawa E1, Takahira N2, Takaso M1: Brain Behav 2015/9; 5 (9): e00370. (ˆä‘ş‹M”V1, ˆäă@Œş1, ’†ŕVr”V1, ‹{éłs1, âV“Ą@˜j1, “ŕ“cŒ’‘ž˜Y1, “ď”gF“ż1, ”’ŕV‰hŽ÷1, ‚•˝ŽL2, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

110223. [Œ´’˜] Anti-RANKL antibodies decrease CGRP expression in dorsal root ganglion neurons innervating injured lumbar intervertebral discs in rats. Sato M, Inage K, Sakuma Y, Sato J, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kuniyoshi K, Aoki Y, Nakamura J, Miyagi M1, Suzuki M, Kubota G, Sainoh T, Fujimoto K, Shiga Y, Abe K, Kanamoto H, Inoue G1, Takahashi K, Ohtori S: Eur Spine J 2015/9; 24 (9): 2017-22. (‹{éłs1, ˆäă@Œş1: 1ŽŠO)

110224. [Œ´’˜] Efficacy of Direct Injection of Etanercept into Knee Joints for Pain in Moderate and Severe Knee Osteoarthritis. Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Miyagi M1, Kamoda H, Suzuki M, Kubota G, Sakuma Y, Oikawa Y, Inage K, Sainoh T, Sato J, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Toyone T, Inoue G1, Takahashi K: Yonsei Med J 2015/9; 56 (5): 1379-83. (‹{éłs1, ˆäă@Œş1: 1ŽŠO)

110225. [Œ´’˜] Diffusion tensor imaging of lumbar spinal nerve in subjects with degenerative lumbar disorders. Oikawa Y, Eguchi Y, Inoue G1, Yamauchi K, Orita S, Kamoda H, Ishikawa T, Miyagi M1, Suzuki M, Sakuma Y, Kubota G, Inage K, Saino T, Sato H, Ando H, Kojima M, Okumura K, Masuda Y, Watanabe A, Takahashi K, Ohtori S: Magn Reson Imaging 2015/10; 33 (8): 956-61. (ˆäă@Œş1, ‹{éłs1: 1ŽŠO)

110226. [Œ´’˜] Interleukin-6 and interleukin-6 receptor expression, localization, and involvement in pain-sensing neuron activation in a mouse intervertebral disc injury model. Sainoh T, Orita S, Miyagi M1, Sakuma Y, Yamauchi K, Suzuki M, Kubota G, Oikawa Y, Inage K, Sato J, Fujimoto K, Shiga Y, Inoue G1, Aoki Y, Takahashi K, Ohtori S: J Orthop Res 2015/10; 33 (10): 1508-14. (‹{éłs1, ˆäă@Œş1: 1ŽŠO)

110227. [Œ´’˜] Decreased calcitonin gene-related peptide expression in the dorsal root ganglia of TNF-deficient mice in a monoiodoacetate-induced knee osteoarthritis model. Taniguchi A, Ishikawa T, Miyagi M1, Kamoda H, Sakuma Y, Oikawa Y, Kubota G, Inage K, Sainoh T, Nakamura J, Aoki Y, Toyone T, Inoue G1, Suzuki M, Yamauchi K, Suzuki T, Takahashi K, Ohtori S, Orita S: Int J Clin Exp Pathol 2015/10; 8 (10): 12967-71. (‹{éłs1, ˆäă@Œş1: 1ŽŠO)

110228. [Œ´’˜] Alendronate does not prevent long bone fragility in an inactive rat model. Naruse K1, Uchida K1, Suto M, Miyagawa K, Kawata A, Urabe K1, Takaso M1, Itoman M, Mikuni-Takagaki Y: J Bone Miner Metab 2015/10. [Epub ahead of print] (ŹŁNŽĄ1, “ŕ“cŒ’‘ž˜Y1, č•”@Œ›1, ‚‘ŠťŽm1: 1ŽŠO)

110229. [Œ´’˜] Modified Open-Door Laminoplasty Using a Ceramic Spacer and Suture Fixation for Cervical Myelopathy. Ozawa T, Toyone T, Shiboi R, Inada K, Oikawa Y, Takahashi K, Ohtori S, Inoue G1, Miyagi M1, Ishikawa T, Shirahata T, Kudo Y, Inagaki K: Yonsei Med J 2015/11; 56 (6): 1651-5. (ˆäă@Œş1, ‹{éłs1: 1ŽŠO)

110230. [Œ´’˜] Efficacy of hyaluronic acid or steroid injections for the treatment of a rat model of rotator cuff injury. Yamaguchi T, Ochiai N, Sasaki Y, Kijima T, Hashimoto E, Sasaki Y, Kenmoku T1, Yamazaki H, Miyagi M1, Ohtori S, Takahashi K: J Orthop Res 2015/12; 33 (12): 1861-7. (ŒŠ–Ú’q‹I1, ‹{éłs1: 1ŽŠO)

110231. [Œ´’˜] Elution Characteristics of Vancomycin, Gentamicin, and Vancomycin/Gentamicin Combination from Calcium Phosphate Cement. Uchino M1, Sugo K, Naruse K1, Uchida K1, Hirakawa N1, Toyama M1, Miyajima M1, Urabe K1: Advances in Orthopedic Surgery 2015; 2015: Article ID 257925, 5 pages. (“ŕ–쐳—˛1, ŹŁNŽĄ1, “ŕ“cŒ’‘ž˜Y1, •˝ě‹IŽq1, “hŽRłG1, ‹{“‡Œş—z1, č•”@Œ›1: 1ŽŠO)

110232. [Œ´’˜] Hyaluronic Acid (800 kDa) Supplementation of University of Wisconsin Solution Improves Viability of Osteochondral Grafts and Reduces Matrix Metalloproteinase Expression during Cold Preservation. Yamada T1, Uchida K2, Onuma K2, Inoue G2, Aikawa J1, Takano S1, Sekiguchi H1, Fujimaki H1, Miyagi M2, Takaso M2: Scientific World Journal 2015; 2015: 631369. (ŽR“c‘ńĆ1, “ŕ“cŒ’‘ž˜Y2, ŹŔŒŤŽĄ2, ˆäă@Œş2, ‘Šě@~1, ‚–쏸‘ž˜Y1, ŠÖŒű—T”V1, “ĄŠŞŽőŽq1, ‹{éłs2, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO)

110233. [Œ´’˜] Synovial macrophage-derived IL-1ƒŔ regulates the calcitonin receptor in osteoarthritic mice. Takano S1, Uchida K1, Miyagi M2, Inoue G2, Aikawa J1, Fujimaki H1, Minatani A2, Sato M3, Iwabuchi K3, Takaso M2: Clin Exp Immunol 2016/1; 183 (1): 143-9. (‚–쏸‘ž˜Y1, “ŕ“cŒ’‘ž˜Y2, ‹{éłs2, ˆäă@Œş2, ‘Šě@~1, “ĄŠŞŽőŽq1, “ě’J@~2, ˛“Ą@‰ë3, ŠâŸş˜a–ç3, ‚‘ŠťŽm2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO, 3–Ɖu)

120021. [Œ´’˜] “Ć•ŕ‰Â”\‚Č”]Ť–ƒáƒŽ™‚ĚŒŇŠÖß‹ü‹ČSk, ˜’Ĺ‘Oœ^•ĎŒ`‚ɑ΂ˇ‚éŒŇŠÖß‹Ř‰đ—Łp‚ĚŒř‰Ę. ź”ö@“Ä, ź”ö@—˛, ‘Šě@~1, ŠâŁ@‘ĺ2, “ĄŠŞŽőŽq1 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): “ú–{”]Ť–ƒáƒ‚ĚŠO‰ČŒ¤‹†‰ďŽ 2015/6; 25: 5-9.

120022. [Œ´’˜] yŒoŒą‚ƍlŽ@zŽčŞŠÇÇŒóŒQ‚ɑ΂ˇ‚ép‘O‚Š‚ç‚ĚƒƒNƒVƒjƒAƒEƒCƒ‹ƒXÚŽí‰Ć“e‰ŠÇ”畆’Šo‰t“Š—^‚Ě—LŒřŤ‚ĚŒŸ“˘. ŒŠ–Ú’q‹I1, Šâ‘qŘ•äŽq, ŹŔŒŤŽĄ1, ‚•˝ŽL2, ‰Á“Ą‹`ŽĄ, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ŽŒ`ŠO‰Č 2015/7; 66 (7): 615-9.

120023. [Œ´’˜] ‚˘‚í‚ä‚éborderline dysplasia‚ɑ΂ˇ‚éŒŇŠÖß‹žŽ‹‰şŽčp‚ƍœŘ‚čp‚ĚŽĄ—ÐŹŃ‚Ě”äŠr. •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, X’JŒőr1, ŽR–{‹–ž1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): Hip Joint 2015/8; 41 (Suppl): 48-50.

120024. [Œ´’˜] ŒŇŠÖßœŘ‚čp‚Ĺ‹r‰„’ˇ‚ŕ“ŻŽž‚ɍs‚Ś‚˝3Ç—á. ŽR–{‹–ž1, “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, X’JŒőr1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): Hip Joint 2015/8; 41 (Suppl): 154-8.

120025. [Œ´’˜] ŠłŽŇ—§‹rŒ^ŒŇŠÖßŽžŠł•]‰ż–@ (JHEQ) ‚đ—p‚˘‚˝ŒŇŠÖß‰ˇ‘śŽčp‚ĚŒpŽž“I‚Č—Ő°ŹŃ. X’JŒőr1, “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): Hip Joint 2015/8; 41 (Suppl): 171-5.

120026. [Œ´’˜] ŒŇŠÖßO‘šŠłŽŇ‚̉şŽˆ‹@”\‚ÉŠÖ‚ˇ‚錟“˘|femoroacetabular impingement‚Ć‚ť‚Ě‘ź‚̐Źˆö‚Ĺ‚Ě”äŠr|. Žsě‹M•ś, š“ߏrŽ÷, …–ěŒö•ă, —é–Ř—Ç˜a, •Ÿ“‡Œ’‰î1, “ŕŽRŸ•ś1, ‚‘ŠťŽm1, ‚•˝ŽL2 (1ŽŠO, 2ˆă—ÉqśŠw•”): Hip Joint 2015/8; 41 (Suppl): 304-8.

120027. [Œ´’˜] PCRƒ‰ƒeƒ‰ƒ‹ƒtƒ[–@‚đ—p‚˘‚˝ŒŇŠÖß×‹ŰŒŸ¸‚Ě—L—pŤ‚ɂ‚˘‚Ä‚ĚŒŸ“˘|×‹Ű”|—{ŒŸ¸‚Ć‚Ě”äŠr|. •őŠÝ—mŽŸ˜Y1, “ŕŽRŸ•ś1, ŽR–{‹–ž1, X’JŒőr1, •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, Žë–ě—Lě3, ź‘ş–žl, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”, 3—ŐŒŸŠw): Hip Joint 2015/8; 41 (Suppl): 763-8.

120028. [Œ´’˜] ŽŠ‰Ćƒnƒ€ƒXƒgƒŠƒ“ƒOƒXäF‚đ—p‚˘‚˝‘ŤŠÖß‹žŽ‹‰ş‘O‹—äCx‘Ń, ćůäCx‘ŃÄŒšp‚ĚŒoŒą. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{‘Ť‚ĚŠO‰ČŠw‰ďŽGŽ 2015/9; 36 (1): 189-94.

120029. [Œ´’˜] “]ˆÚŒ^‘ĺ‘ڍœčň•”œÜ‚ɑ΂ˇ‚éanterolateral-supine approach‚É‚ć‚élHŒŇŠÖß‘S’uŠˇp‚ĚŒoŒą. “hŽRłG1, ‹{“‡Œş—z1, •˝ě‹IŽq1, ŹŁNŽĄ1, “ŕ–쐳—˛1, č•”@Œ›1 (1ŽŠO): “ú–{lHŠÖßŠw‰ďŽ 2015/12; 45: 197-8.

120030. [Œ´’˜] “ŻŽíœˆÚAp‚đ•š—p‚ľ‚˝lH•GŠÖßÄ’uŠˇp‚ĚŽĄ—ÐŹŃ. ŠâŁ@‘ĺ1, ‘Šě@~2, “ŒŽR—玥1, “ě’J@~1, ‚–쏸‘ž˜Y2, Œ}@@Šw1, ŹŁNŽĄ1, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{lHŠÖßŠw‰ďŽ 2015/12; 45: 687-8.

120031. [Œ´’˜] ă˜rœ‹ßˆĘ•”œÜ‚ɑ΂ˇ‚é“ŕŒĹ’č–@‚Ě”äŠr. Žđˆä—˜“Ţ1, ”nŸş´Ž‘1, “ŕ–쐳—˛2, č•”@Œ›2, ˆÉ“Ą‘ĺŠí, “c’†Œ’˝, ’†”öŤ‹P (1ˆă—ÉqśŠw•”, 2ŽŠO): œÜ 2016/2; 38 (1): 210-4.

310026. [Ç—á•ń] Surgical treatment of an atlantoaxial fracture after a delayed diagnosis in a comatose patient. Imura T1, Inoue G1, Nakazawa T1, Saito W1, Takaso M1: Eur Spine J 2015/5; 24 (Suppl 4): S623-7. (ˆä‘ş‹M”V1, ˆäă@Œş1, ’†ŕVr”V1, âV“Ą@˜j1, ‚‘ŠťŽm1: 1ŽŠO)

320028. [Ç—á•ń] ŽĄ—Ă‚É“ďa‚ľ‚˝Gaucher•a‚É‚ć‚é•ĎŒ`ŤŒŇŠÖßÇ‚ɑ΂ľ‚Ä—ź‘¤lHŒŇŠÖß’uŠˇp‚đŽ{s‚ľ‚˝1—á (A case of bilateral total hip arthroplasty in Gaucher disease-related osteoarthritis). ”’ŕV‰hŽ÷1, ŽR–{‹–ž1, “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, X’JŒőr1, ‚‘ŠťŽm1, ‚•˝ŽL2 (1ŽŠO, 2ˆă—ÉqśŠw•”): ŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŽGŽ 2015/4; 46 (2): 80-5.

320029. [Ç—á•ń] —ź‘¤‚É”­ś‚ľ‚˝äCœ‹ŘázŤG•˝‘Ť‚ɑ΂ľAccessory Anterolateral Talar Facet‚Ě‹žŽ‹‰şŘœp‚Ş’˜Œř‚ľ‚˝1—á. ŻŽi^‘ž˜Y1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ŹŁNŽĄ1, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{‘Ť‚ĚŠO‰ČŠw‰ďŽGŽ 2015/9; 36 (1): 329-33.

320030. [Ç—á•ń] —ź‘¤‘ŤŠÖßŠO‘¤•sˆŔ’čÇ‚ɑ΂ľ—ź‘¤“ŻŽž‚ÉŽŠ‰Ć”–‹ŘäF‚É‚ć‚éŠÖß‹ž‰şATFLÄŒšp‚đŽ{s‚ľ‚˝1—á. ’叡@Ę, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{‘Ť‚ĚŠO‰ČŠw‰ďŽGŽ 2015/9; 36 (1): 345-8.

320031. [Ç—á•ń] ŽĄ—Ă‚É“ďa‚ľ‚˝lH•GŠÖß’uŠˇpŒăč÷ăœÜ‚Ě1—á: “ŻŽíœˆÚA‚đ—p‚˘‚Ä‚Ě‘Îˆ. Œ}@@Šw1, ŠâŁ@‘ĺ1, ‘Šě@~2, “ŒŽR—玥1, “ě’J@~1, ‚–쏸‘ž˜Y2, ŹŁNŽĄ1, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{lHŠÖßŠw‰ďŽ 2015/12; 45: 585-6.

522116. [uŔ]yŽăƒVƒ“ƒ|ƒWƒEƒ€: ŒŇŠÖß‹ž‚ĚŒťó‚Ɖ”\ŤzFAI‚ĆŠ°œ‰PŒ`Ź•s‘S‚Ě•a‘Ô‚ĆŠT”O. •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): —Տ°ŽŒ`ŠO‰Č 2015/5; 50 (5): 405-508.

522117. [uŔ]y“ÁW: lHŠÖßŽüˆÍŠ´őzPJIf’f‚É‚¨‚Ż‚éV‚ľ‚˘•ŞŽqś•¨Šw“IŽč–@‚ĚŽŽ‚݁|PCRƒ‰ƒeƒ‰ƒ‹ƒtƒ[–@‚É‚ć‚év‘Źˆâ“`Žq×‹ŰŒŸ¸–@|. “ŕŽRŸ•ś1, ŸNˆäŒc‘˘2, •őŠÝ—mŽŸ˜Y1, ŽR–{‹–ž1, X’JŒőr1, •Ÿ“‡Œ’‰î1, ‚•˝ŽL3, Žë–ě—Lě4, ‚‘ŠťŽm1 (1ŽŠO, 2—ŐŒŸ•”, 3ˆă—ÉqśŠw•”, 4—ŐŒŸŠw): ŠÖßŠO‰Č 2015/9; 34 (9): 28-34.

522118. [uŔ]yŹ“ÁW: R‹Ű–ňER^‹Ű–ň‚đˆŔ‘S‚ÉŽg‚˘‚ą‚Č‚ˇ|•›ě—p‚đ–h‚ŽĹV’mŒŠ‚Š‚çzƒŠƒ|ƒyƒvƒ`ƒhŒn–ň: ƒ_ƒvƒgƒ}ƒCƒVƒ“. “ŕŽRŸ•ś1, ‚ŽR—zŽq2, ‰Ô–؏G–ž (1ŽŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Š´ő‚ƍR‹Ű–ň 2015/9; 18 (3): 279-83.

522119. [uŔ]y“ÁW: lHŒŇŠÖß’uŠˇpzœPrimary THA@lHŒŇŠÖßŽüˆÍœÜ‚ɑ΂ˇ‚鎥—Ă‚ĚƒRƒc‚ĆƒsƒbƒgƒtƒH[ƒ‹. “ŕŽRŸ•ś1, ‚•˝ŽL2, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, X’JŒőr1, •őŠÝ—mŽŸ˜Y1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): Bone Joint Nerve 2015/10; 5 (4): 785-93.

522120. [uŔ]y“ÁW: 3Dƒ‚ƒfƒ‹E3DƒvƒŠƒ“ƒ^[‚đ—˜—p‚ľ‚˝ŽŒ`ŠO‰ČŽčpzII. ŽŒ`ŠO‰Č•Ş–ě‚ւ̉ž—p@ŒŇŠÖßŠO‰Č‚É‚¨‚Ż‚éŽOŽŸŒłƒ‚ƒfƒ‹‚ĚŠˆ—p. •Ÿ“‡Œ’‰î1, “ŕŽRŸ•ś1, ‚‘ŠťŽm1, ‚•˝ŽL2 (1ŽŠO, 2ˆă—ÉqśŠw•”): ŠÖßŠO‰Č 2016/2; 35 (2): 154-9.

530013. [‚ť‚Ě‘ź (´˜^)]yThe International Society for Technology in Arthroplasty (ISTA), 27th Annual CongresszHEMIARTHROPLASTY FOR THE TREATMENT OF ELDERLY PROXIMAL HUMERUS PSEUDOARTHROSIS: CASE REPORT. Kenmoku T1, Miyajima G1, Higashiyama R1, Takahira N2, Takaso M1: Bone Joint J 2016/1; 98-B (SUPP 2): 100. (ŒŠ–Ú’q‹I1, ‹{“‡Œş—z1, “ŒŽR—玥1, ‚•˝ŽL2, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

[’˜@‘]

620090. [Šwp‘ (•Ş’SŽˇ•M)]yă˜rE•IE‘O˜r‚ĚŽčp@ŽŒ`ŠO‰ČŽčpƒCƒ‰ƒXƒgƒŒƒCƒeƒbƒhzI. i“ü–@@ă˜r‚Ö‚ĚƒAƒvƒ[ƒ`@ă˜rœœč÷•”‚Ö‚ĚƒAƒvƒ[ƒ`, p.2-5. č•”@Œ›1, “ŕ–쐳—˛1 (1ŽŠO), ‘•ŇW: ŒËŽR–Fş, ę–ĺ•ŇW: ‹ŕ’J•ś‘Ľ, ’†ŽR‘“X, “Œ‹ž, 2015/6”­s.

620091. [Šwp‘ (•Ş’SŽˇ•M)]y‘ŸŠíˆÚA‚Ć‚ť‚ĚƒR[ƒfƒBƒl[ƒVƒ‡ƒ“ Šî‘b‚Š‚牞—p‚܂ŁzŠî‘bˆăŠw@ˆÚA‚ÉŠÖ‚í‚é‘ŸŠí‘gD‚̉đ–Uś—, p.218-22. —Տ°ˆăŠw@‘ŸŠí“Eop‚ĆˆÚAp‚ĚŽŔŰ, p.500-4. ŹŁNŽĄ1, č•”@Œ›1, Ž…–žˇŒ› (1ŽŠO), ŠÄC: Ž›‰Ş@Œd, •Ň: ‚‹´Žj˜N, •Ÿ›¸‹łˆĚ, ‰Ą“c—Ts, ˆ°Š ~‘ž˜Y, Ź’†ßŽq, “ú–{ˆăŠwŠŮ, “Œ‹ž, 2015/6”­s.

620092. [Šwp‘ (•Ş’SŽˇ•M)]yŽŒ`ŠO‰Č—Ěˆć‚É‚¨‚Ż‚éˆÚAˆă—Ă (•ĘűŽŒ`ŠO‰ČNo.68)zI. ‘˜_@2. “ŻŽíœˆÚA‚ƍœƒoƒ“ƒN@lHŒŇŠÖßÄ’uŠˇp‚É‚¨‚Ż‚é”F’č‘gDƒoƒ“ƒN‚Š‚ç‹Ÿ‹‹‚ł‚ę‚˝•Ű‘ś“ŻŽíœ‚ĚˆŔ‘SŤ‚Ć—L—pŤ, p.59-63. “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, X’JŒőr1, •őŠÝ—mŽŸ˜Y1, ˆäă@Œş1, ‚‘ŠťŽm1, ‚•˝ŽL2, Š}Œ´‚Ý‚Ç‚č3, Ž…–žˇŒ›3 (1ŽŠO, 2ˆă—ÉqśŠw•”, 3–k—˘‘ĺŠw•a‰@œƒoƒ“ƒN), •Ň: ‘ĺě@~, “ě]“°, “Œ‹ž, 2015/10”­s.

620093. [Šwp‘ (•Ş’SŽˇ•M)]yŽŒ`ŠO‰Č—Ěˆć‚É‚¨‚Ż‚éˆÚAˆă—Ă (•ĘűŽŒ`ŠO‰ČNo.68)zI. ‘˜_@2. “ŻŽíœˆÚA‚ƍœƒoƒ“ƒN@–k—˘‘ĺŠw•a‰@œƒoƒ“ƒN’ń‹Ÿ“ŻŽíœ‚É‚¨‚Ż‚éƒgƒŒ[ƒTƒrƒŠƒeƒB‚đ—p‚˘‚˝ˆŔ‘SŤ‚ĚŒŸŘ, p.64-8. •Ÿ“‡Œ’‰î1, ˆäă@Œş1, č•”@Œ›1, “ŕŽRŸ•ś1, “ŕ“cŒ’‘ž˜Y1, ŹŁNŽĄ1, Š}Œ´‚Ý‚Ç‚č, Ž…–žˇŒ›, ‚‘ŠťŽm1 (1ŽŠO), •Ň: ‘ĺě@~, “ě]“°, “Œ‹ž, 2015/10”­s.

620094. [Šwp‘ (•Ş’SŽˇ•M)]y‘Ě‘€—Ă–@ƒI[ƒ‹ƒuƒbƒN ‚Đ‚Ć‚ß‚Ĺ‚í‚Š‚éŒř‰Ę“I‚Č‹Ř‚ĚŽg‚˘•űz3Í ŽŔ‘H ‚˘‚´‘Ě‘€‚ĚŽw“ą@|Œ’N‘i‚Ě‚˝‚ß‚Ě‘Ě‘€|@08. ƒƒRƒ‚‘Ě‘€, p.88-9. •Ÿ“‡Œ’‰î1, ‚•˝ŽL2 (1ŽŠO, 2ˆă—ÉqśŠw•”), •Ň: ‚•˝ŽL2, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712017. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) the current status and trends in bone grafting and the issue of banked bone allografts in Japan based on the sixth nationwide survey of bone grafting from 2010 to 2014. Urabe K1: 24th Congress of the European Association of Tissue Banks (2015/10/1), Spilt, Croatia. (č•”@Œ›1: 1ŽŠO)

713077. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) A Case Report Of Brodie Abscess Treated With Ankle Arthroscopy And Mini-Open Curettage. Nakawaki M1, Higasiyama R1, Aikawa J2, Iwase D1, Minatani A1, Sekiguchi H2, Takano S2, Takahira N3, Takano S1: Congrs AFJO 2015 Association France-Japon d'OrthopŽdie (2015/6/5), Saint-Malo, France. (’†˜e[Í1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ‚•˝ŽL3, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”)

713078. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Anatomical Arthroscopic ATFL and CFL Reconstruction Using An Autogenous Hamstring Tendon By 3-portal Technique. Higasiyama R1, Aikawa J2, Iwase D1, Minatani A1, Sekiguchi H2, Yoshihira T1, Nakawaki M1, Watanabe H, Kenmoku T1, Fukushima K1, Takaso M1: Congrs AFJO 2015 Association France-Japon d'OrthopŽdie (2015/6/5), Saint-Malo, France. (“ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‘P•˝“N•v1, ’†˜e[Í1, “n粗T”V, ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713079. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Lateral Ligament Reconstruction Of The Ankle Using Bone-Patellar Tendon-Bone Allograft: A Case Report Of Two Patients. Minatani A1, Higasiyama R1, Aikawa J2, Iwase D1, Takano S2, Uchida K1, Watanabe H, Urabe K1, Takaso M1: Congrs AFJO 2015 Association France-Japon d'OrthopŽdie (2015/6/5), Saint-Malo, France. (“ě’J@~1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, ‚–쏸‘ž˜Y2, “ŕ“cŒ’‘ž˜Y1, “n粗T”V, č•”@Œ›1, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713080. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Popliteofibular Ligament Reconstruction Using A Remnant Of The Lateral Collateral Ligament: A Report Of Two Cases. Iwase D1, Higasiyama R1, Aikawa J2, Minatani A1, Takano S2, Watanabe H, Uchida K1, Naruse K1, Urabe K1, Inoue G1, Takaso M1: Congrs AFJO 2015 Association France-Japon d'OrthopŽdie (2015/6/5), Saint-Malo, France. (ŠâŁ@‘ĺ1, “ŒŽR—玥1, ‘Šě@~2, “ě’J@~1, ‚–쏸‘ž˜Y2, “n粗T”V, “ŕ“cŒ’‘ž˜Y1, ŹŁNŽĄ1, č•”@Œ›1, ˆäă@Œş1, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713081. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Arthroscopic Anterior Talofibular Ligament Reconstruction And Arthroscopy-Assisted Calcaneofibular Ligament Reconstruction Using An Autogenous Hamstring Tendon. Higasiyama R1, Aikawa J2, Minatani A1, Iwase D1, Sekiguchi H2, Takano S2, Shoji S1, Watanabe H, Kenmoku T1, Fukushima K1, Watanabe E, Takaso M1: 10th Biennial ISAKOS congress 2015 (2015/6/7), Lyon, France. (“ŒŽR—玥1, ‘Šě@~2, “ě’J@~1, ŠâŁ@‘ĺ1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ŻŽi^‘ž˜Y1, “n粗T”V, ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, “n糉pˆę˜Y, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

713082. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Treatment of nocturnal leg cramps by medial branch blockade of the deep peroneal nerve following lumbar surgery. Imura T1: ISSLS 2015 (2015/6/11), San Francisco, USA (ˆä‘ş‹M”V1: 1ŽŠO)

713083. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Arthroscopic Anterior Talofibular Ligament Reconstruction with Arthroscopy-Assisted or Arthroscopic Calcaneofibular Ligament Reconstruction Using an Autogenous Hamstirng Tendon. Higasiyama R1, Aikawa J2, Iwase D1, Minatani A1, Yoshihira T1, Sekiguchi H2, Shoji S1, Watanabe H, Kenmoku T1, Fukushima K1, Naruse K1, Urabe K1, Watanabe H, Takaso M1: American Orthopaedic Foot and Ankle Society (AOFAS) Annual Meeting 2015 (2015/7/15), Long Beach, California, USA. (“ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‘P•˝“N•v1, ŠÖŒű—T”V2, ŻŽi^‘ž˜Y1, “n粗T”V, ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ŹŁNŽĄ1, č•”@Œ›1, “n糉pˆę˜Y, ‚‘ŠťŽm1: 1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

721016. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ŒŇŠÖß‹ž‚ĚƒZƒbƒgƒAƒbƒv|ŒŇŠÖßŠO‰Čˆă‚ŞŒŇŠÖß‹ž‚đŽn‚ß‚é‚˝‚ß‚É, ‚ť‚ľ‚Ä‘ą‚Ż‚Ä‚˘‚­‚˝‚߂Ɂ|. •Ÿ“‡Œ’‰î (ŽŠO): ‘ć42‰ń“ú–{ŒŇŠÖßŠw‰ďŠwpW‰ď (2015/10/30), ‘ĺă.

722079. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‘ŤŠÖßŒă•űƒCƒ“ƒsƒ“ƒWƒƒ“ƒgÇŒóŒQ‚Ć‘ŤŠÖßŠO‘¤•sˆŔ’čÇ‚̍‡•š—á‚ĚŽĄ—ĂŒoŒą. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‘P•˝“N•v1, ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć7‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (JOSKAS) (2015/6/18), ŽD–y.

722080. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) FAI‚ÉŠÖ‚ˇ‚éŒŇŠÖßŠw‰ďf’fŽwj‚ÉŠî‚Ă‚­‘˝Ž{Ý‰uŠw’˛¸. •Ÿ“‡Œ’‰î1, ŽRč‘ô–, Ź—Ń’źŽŔ, “Ąˆä‰p‹I, ‹´–{TŒá, “Ąˆä­“ż, ’†“‡N°, “ŕŽRŸ•ś1, ‚•˝ŽL2 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć42‰ń“ú–{ŒŇŠÖßŠw‰ďŠwpW‰ď (2015/10/30), ‘ĺă

722081. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Revision THA‚É‚¨‚Ż‚鍜ƒoƒ“ƒN‚đŠˆ—p‚ľ‚˝‚“xœŒ‡‘š‘Ώˆ–@. “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, X’JŒőr1, •őŠÝ—mŽŸ˜Y1, ˆäă@Œş1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć42‰ń“ú–{ŒŇŠÖßŠw‰ďŠwpW‰ď (2015/10/31), ‘ĺă.

722082. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) “–‰Č‚É‚¨‚Ż‚é, lHŒŇŠÖßŠ°œ‰P‘¤|ƒZƒƒ“ƒgƒŒƒXƒJƒbƒv‚É‹‚ß‚é‚ŕ‚́|. •Ÿ“‡Œ’‰î1, “ŕŽRŸ•ś1, Žđˆä—˜“Ţ2, X’JŒőr1, ŽR–{‹–ž1, ”nŸş´Ž‘2, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć43‰ń“ú–{ŠÖß•aŠw‰ď (2015/11/5), ŽD–y.

722083. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) lHŒŇŠÖß’uŠˇppŒăŠ´ő‚ĚŽĄ—Á|R‹Ű–ňŠÜ—LƒZƒƒ“ƒgƒXƒy[ƒT[‚đ—p‚˘‚˝“ńŠú“IÄ’uŠˇp|. “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, X’JŒőr1, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y1, ‚‘ŠťŽm1, ‚•˝ŽL2 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć43‰ń“ú–{ŠÖß•aŠw‰ď (2015/11/6), ŽD–y, ‘ć43‰ń“ú–{ŠÖß•aŠw‰ď´˜^W 2015; p.455.

723566. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`•IŠÖßŽü•ÓœÜ‚ɑ΂ˇ‚éˆęŠú“IlH•IŠÖß’uŠˇp‚ĚŽĄ—ĂŒoŒą. ŹŔŒŤŽĄ1, “Ą“c@Œě, “ŕŽRŸ•ś1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): “ú–{ƒŠƒEƒ}ƒ`Šw‰ďŠwpW‰ď (2015/4/25), –źŒĂ‰Ž.

723567. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽOŽŸŒł‰ć‘œˆ—ƒ[ƒNƒXƒe[ƒVƒ‡ƒ“‚đ—p‚˘‚˝Š°œ‰PŤ”핢‚ĚŒ`‘ÔŒv‘ށ|ZedHip‚É‚ć‚鍜Ť”핢‚Ć‚Ě”äŠr|. X’JŒőr1, “ŕŽRŸ•ś1, ‚•˝ŽL2, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć88‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2015/5/21), _ŒË.

723568. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) lH•GŠÖß’uŠˇppŒăŠ´ő‚ɑ΂ľƒCƒ“ƒvƒ‰ƒ“ƒg‰ˇ‘ś‚đŽŽ‚Ý‚˝Ç—á‚ĚŒŸ“˘. ŠâŁ@‘ĺ1, ‘Šě@~2, “ŒŽR—玥1, “ě’J@~1, ‚–쏸‘ž˜Y2, č•”@Œ›1, ŹŁNŽĄ1, “Ą“c@Œě, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć88‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2015/5/23), _ŒË.

723569. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘nŠOŒĹ’čŠíMultiPlanar MiniRail‚đŽg—p‚ľ‚˝ŹŽ™’‹ŒŤžôœ“Ş’E‰P‚ɑ΂ˇ‚éŽÚœ‹¸łœŘ‚čp‚ĚŽĄ—ĂŒoŒą. ŹŔŒŤŽĄ1, ’†˜e[Í1, ŒŠ–Ú’q‹I1, “ĄŠŞŽőŽq2, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć88‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2015/5/23), _ŒË.

723570. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽOŽŸŒłCT‰ć‘œ‚đ—p‚˘‚˝Š°œ‰P‰ń“]œŘ‚čp (CPO) ‘OŒă‚ĚŠ°œ‰P”핢‚Ě’č—Ę“I•]‰ż. “cŕV@—Č1, X’JŒőr1, “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć88‰ń“ú–{ŽŒ`ŠO‰ČŠwpW‰ď (2015/5/24), _ŒË.

723571. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽŠ‰Ćƒnƒ€ƒXƒgƒŠƒ“ƒOƒXäF‚É‚ć‚éŠÖß‹ž‰şATFLÄŒšp‚Ɗ֐ߋžŽx‰‡‰şCFLÄŒšp. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ŻŽi^‘ž˜Y1, “n粗T”V, č•”@Œ›1, “n糉pˆę˜Y, ‚‘ŠťŽm1 (11ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć88‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2015/5/24), _ŒË.

723572. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –ě‹…•I‚ĆŒŇŠÖß‰Â“Žˆć§ŒŔ‚Ć‚ĚŠÖ˜AŤ‚ÉŠÖ‚ˇ‚錟“˘. ŒŠ–Ú’q‹I1, –ź‘q’źd2, ŹŔŒŤŽĄ1, ’†˜e[Í1, “cŕV@—Č1, •Ÿ“‡Œ’‰î1, “ŒŽR—玥1, ‚•˝ŽL3, ‹{“‡Œş—z1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć88‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2015/5/24), _ŒË.

723573. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆăŠwś‚É‚¨‚Ż‚鐎Œ`ŠO‰ČŠw‚Ě”FŽŻ’˛¸: ŽŒ`ŠO‰Č‚đŽu–]‚ˇ‚é‚Ť‚Á‚Š‚Ż‚Í? ŒŠ–Ú’q‹I1, ‘‘Tˆę˜Y, —é–ؐ’‹v, —é–Ř“Ő–ç, —é–Ř—´‘ž˜Y, âŒű@•–, âV“ĄˆŸŠó, –Ř”Ś‚ ‚â“ß, ˆäă@Œş1, ’†ŕVr”V1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć88‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠwp‘‰ď (2015/5/21-24), _ŒË.

723574. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@ŽŒ`ŠO‰Č•a“‚É‚¨‚Ż‚éƒ_ƒvƒgƒ}ƒCƒVƒ“‚ĚˆŔ‘SŤ‚Ć—LŒřŤ. “ŕŽRŸ•ś1, ‚ŽR—zŽq2, ‰Ô–؏G–ž, ˜a“c’B•F3, ’†‘şłŽ÷, ˛“ĄçŒb4, “ń–{–öL5, ‘ĺěŒ´—TŽ÷6, •őŠÝ—mŽŸ˜Y1, ťěŒc‰î7, ‚‘ŠťŽm1 (1ŽŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3äPŒ´•aEŠ´ő“ŕ, 4‹~–˝, 5—ŐŒŸ•”, 6–ňÜ•”, 7Š´őŠÇ—Žş): ‘ć63‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď (2015/6/5), “Œ‹ž, ‘ć63‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď´˜^W 2015; p.164.

723575. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “Ż‘¤lHŒŇŠÖßElH•GŠÖßpŒăŠ´ő‚ɑ΂ľ‚Ä‘ĺ‘ڍœ‘S’ˇ‚̍R‹Ű–ňŠÜ—LƒZƒƒ“ƒgƒXƒy[ƒT[‚đŽ{s‚ľ‚˝1—á. •őŠÝ—mŽŸ˜Y1, “ŕŽRŸ•ś1, ‚ŽR—zŽq2, ‰Ô–؏G–ž, “ń–{–öL3, ’†‘şłŽ÷, ˛“ĄçŒb4, ťěŒc‰î5, ‚‘ŠťŽm1 (1ŽŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3—ŐŒŸ•”, 4‹~–˝, 5Š´őŠÇ—Žş): ‘ć63‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď (2015/6/5), “Œ‹ž, ‘ć63‰ń“ú–{‰ťŠw—Ă–@Šw‰ď‘‰ď´˜^W 2015; p.193.

723576. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é•GŠÖß‹žSk‚ɑ΂ˇ‚éŠÖß‹žŽ‹‰şŽó“Žp‚ĚŽĄ—ÐŹŃ. ŠâŁ@‘ĺ1, ‘Šě@~2, “ŒŽR—玥1, “ě’J@~1, ‚–쏸‘ž˜Y2, ŹŁNŽĄ1, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć7‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (JOSKAS) (2015/6/19), ŽD–y.

723577. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “§ÍŠłŽŇ‚É”­ś‚ľ‚˝‘ĺ‘ÚŽl“Ş‹ŘäF’f—ô‚Ěˆę—á. ‚“c@Œ¤1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‘P•˝“N•v1, ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć7‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (JOSKAS) (2015/6/19), ŽD–y.

723578. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) —ź‘¤•GŠÖß‹žŽčpŒă‚ɐ[•”Ă–ŹŒŒđÇ, ”xÇđÇ‚đ”­Ç‚ľ‚˝1—á. “ě’J@~1, ‘Šě@~2, “ŒŽR—玥1, ŠâŁ@‘ĺ1, ‚–쏸‘ž˜Y2, ’†˜e[Í1, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć7‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (JOSKAS) (2015/6/19), ŽD–y.

723579. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) äCœœEěŹ‚đH•v‚ľ‚˝‰đ–UŠw“I‹žŽ‹‰şATFL/CFLÄŒšp‚̏ŹŒoŒą. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‘P•˝“N•v1, ŠÖŒű—T”V2, ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć7‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (JOSKAS) (2015/6/19), ŽD–y.

723580. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) äF”Â’f—ô‚Ć•ĎŒ`ŤŒŇŠÖßÇ‚Ěáu’ɈöŽq‚Ě”äŠr@RT-PCR–@‚đ—p‚˘‚˝ŒŸ“˘. ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, ’†˜e[Í1, “ŒŽR—玥1, —Ž‡M–ő, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć7‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (JOSKAS) (2015/6/19), ŽD–y.

723581. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “Ż‘¤lHŒŇŠÖßlH•GŠÖßpŒăMRSAŠ´ő‚ɑ΂ľ‚Ä“ńŠú“I‚ɐlH‘ĺ‘ڍœ’uŠˇp‚đŽ{s‚ľ‚˝1—á. •őŠÝ—mŽŸ˜Y1, “ŕŽRŸ•ś1, ŽR–{‹–ž1, X’JŒőr1, ŠâŁ@‘ĺ1, ’†˜e[Í1, •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć38‰ń“ú–{œEŠÖßŠ´őÇŠw‰ď (2015/7/3), ě, ‘ć38‰ń“ú–{œEŠÖßŠ´őÇŠw‰ď´˜^W 2015; p.101.

723582. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Propidium monoazide ˆ—‚É‚ć‚莥—ĂŒř‰Ę‚𔝒č‚Ĺ‚Ť‚˝lHŒŇŠÖßpŒăMRSAŠ´ő‚Ě1—á. “ŕŽRŸ•ś1, •őŠÝ—mŽŸ˜Y1, ŽR–{‹–ž1, •Ÿ“‡Œ’‰î1, X’JŒőr1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć38‰ń“ú–{œEŠÖßŠ´őÇŠw‰ď (2015/7/4), ě, ƒvƒƒOƒ‰ƒ€E´˜^W 2015; p.135.

723583. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ŻŽíœˆÚAp‚̐f—Ă•ńV‰ü’č‚ÉŒü‚Ż‚˝‘̐ς ‚˝‚č‚Ě“ŻŽíœ‘gDěť”ď—p‚ĚŽZo. Š}Œ´‚Ý‚Ç‚č, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, ‘ĺ’JŒö‹M, “ŕŽRŸ•ś1, ˆä‘ş‹M”V1, •Ÿ“‡Œ’‰î1, ŹŁNŽĄ1, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć14‰ń“ú–{‘gDˆÚAŠw‰ď‘‰ďEŠwpW‰ď (2015/8/29), ‘ĺă.

723584. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ŻŽíœ•t‚ŤƒAƒLƒŒƒXäF‚đ—p‚˘‚˝ŠÖß‹žŽ‹‰ş‘O‹—äCx‘ŃÄŒšp‚đŽ{s‚ľ‚˝1—á. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, “ŕ“cŒ’‘ž˜Y1, ŹŁNŽĄ1, č•”@Œ›1, ˆäă@Œş1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć14‰ń“ú–{‘gDˆÚAŠw‰ď‘‰ďEŠwpW‰ď (2015/8/29), ‘ĺă.

723585. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”ńś‘Ěƒhƒi[‚Š‚çĚŽć‚ľ‚˝äFEx‘Ń‘gDˆÚA‚ĚŒťó. ‘ĺ’JŒö‹M, ˆäă@Œş1, “ŕ“cŒ’‘ž˜Y1, “ŒŽR—玥1, “ŕŽRŸ•ś1, ’†ŕVr”V1, ŒŠ–Ú’q‹I1, ŹŁNŽĄ1, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć14‰ń“ú–{‘gDˆÚAŠw‰ď‘‰ďEŠwpW‰ď (2015/8/29), ‘ĺă.

723586. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰đ–UŠw“I2d‘ŠACLÄŒšp‚É‹žŽ‹‰şALLÄŒšp‚đ•š—p‚ľ‚˝1—á. “ŒŽR—玥1, ‘P•˝“N•v1, ŠÖŒű—T”V2, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, “n糉pˆę˜Y, “n粗T”V, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć41‰ń“ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď (2015/9/11), ‹ž“s.

723587. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) •GŠÖß‹žŽ‹‰ş‘OŠO‘¤x‘Ń (ALL) •â‹­p‚ĚCadaver‚Ĺ‚ĚŽŽ‚Ý. “ŒŽR—玥1, “n糉pˆę˜Y, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‘P•˝“N•v1, ŠÖŒű—T”V2, ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć41‰ń“ú–{ŽŒ`ŠO‰ČƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď (2015/9/11), ‹ž“s.

723588. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŇŠÖß‹žŽ‹‰şŽčpŠłŽŇ‚É‚¨‚Ż‚éáu’É‚ĆŠŠ–Œ“ŕ‰ŠÇŤƒTƒCƒgƒJƒCƒ“”­Œť‚ĚŠÖ˜A. •Ÿ“‡Œ’‰î1, ˆäă@Œş1, “ĄŠŞŽőŽq2, “ŕ“cŒ’‘ž˜Y1, ‹{éłs1, ŽR–{‹–ž1, X’JŒőr1, “ŕŽRŸ•ś1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć30‰ń“ú–{ŽŒ`ŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2015/10/22), •xŽR.

723589. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŇŠÖß‹žŽ‹‰şŽčp‚É‚¨‚Ż‚é[•”Ă–ŹŒŒđÇ‚Ě”­ś—Ś. •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, X’JŒőr1, ŽR–{‹–ž1, ŒŠ–Ú’q‹I1, “ŒŽR—玥1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć7‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2015/10/24-25), ŽD–y.

723590. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŇŠÖß‹žŽčp‚ÍŒŇŠÖß‰ˇ‘śŽčp‚Ě1‚‚ɂȂ蓞‚é‚Š?|50ÎˆČă‚ÉŽ{s‚ľ‚˝ŒŇŠÖß‹žŽ‹‰şŽčp‚ĚŽĄ—ÐŹŃ|. X’JŒőr1, •Ÿ“‡Œ’‰î1, “ŕŽRŸ•ś1, ‚•˝ŽL2, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć7‰ń“ú–{ŠÖß‹žE•GEƒXƒ|[ƒcŽŒ`ŠO‰ČŠw‰ď (2015/10/24-25), ŽD–y.

723591. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ŻŽíƒAƒLƒŒƒXäF‚đ—p‚˘‚˝‰đ–UŠw“I‹žŽ‹‰şATFLECFLÄŒšp‚đŽ{s‚ľ‚˝ƒoƒŒƒŠ[ƒi‚Ě1—á. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, “cŕV@—Č1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć40‰ń“ú–{‘Ť‚ĚŠO‰ČŠw‰ďŠwpW‰ď (2015/10/29), ç—t.

723592. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) äCœ‹ŘäF’E‰P‚ɑ΂ľŒă‘Ť•”“ŕŽ‹‹ž‰şPeroneal Groove Deepening‚đŽ{s‚ľ‚˝1—á. “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ‘P•˝“N•v1, ŠÖŒű—T”V2, ‚–쏸‘ž˜Y2, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć40‰ń“ú–{‘Ť‚ĚŠO‰ČŠw‰ďŠwpW‰ď (2015/10/29), ç—t.

723593. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽOŽŸŒł‰ć‘œˆ—ƒ[ƒNƒXƒe[ƒVƒ‡ƒ“‚É‚ć‚銰œ‰P‘OEŒă”P‚Ě•]‰ż|łíŒŇ‚ĆŠ°œ‰P‰ń“]œŘ‚čp (CPO) —á‚Ć‚Ě”äŠr|. X’JŒőr1, “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć42‰ń“ú–{ŒŇŠÖßŠw‰ďŠwpW‰ď (2015/10/31), ‘ĺă, ‘ć42‰ń“ú–{ŒŇŠÖßŠw‰ďŠwpW‰ď´˜^W 2015; p.488.

723594. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Hip Spine Syndrome: ŒŇŠÖß’É‚đŽĺ‘i‚É—ˆ‰@‚ľ‚˝ŠłŽŇ‚̐ҒŒƒAƒ‰ƒCƒƒ“ƒg‚ÉŠÖ‚ˇ‚錟“˘. ‹{éłs1, •Ÿ“‡Œ’‰î1, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, âV“Ą@˜j1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć49‰ń“ú–{‘¤œ]ÇŠw‰ď (2015/11/5), VŠƒ.

723595. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) 2014”N‚Ü‚Ĺ‚Ě4”NŠÔ‚Ě•xŽmŽs’†ŠwZ‰^“Ž‰ďŽí–ځu‚Ţ‚Š‚Ĺ‹Ł‘–v‚ĚŠO’˛¸. “ŒŽR—玥1, Ż@‰Ŕ–F2, ‘Šě@~3, ŠâŁ@‘ĺ1, “ě’J@~1, ŒŠ–Ú’q‹I1, •Ÿ“‡Œ’‰î1, ˆäă@Œş1, “n粗T”V, ‚•˝ŽL4, Ź–ě‰Ă[, –Ř“‡ä”Ž, “n糉pˆę˜Y, ‚‘ŠťŽm1 (1ŽŠO, 2‰qś, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—Տ°ƒXƒ|[ƒcˆăŠw‰ďŠwpW‰ď (2015/11/8), _ŒË, “ú–{—Տ°ƒXƒ|[ƒcˆăŠw‰ďŽ 2015/10; 23 (4): S277.

723596. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) d“x”]Ť–ƒáƒŽ™‚ɑ΂ˇ‚éăŽˆ‹Ř‰đ—ŁpŽčp‚ĚŒř‰Ę. ź”ö@“Ä, ź”ö@—˛, ‚–ŘŒ’Žu, ’Ă‹vˆä—m•˝, ‘Šě@~1, ŠâŁ@‘ĺ2, “í–{‘׎m (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć26‰ń“ú–{ŹŽ™ŽŒ`ŠO‰ČŠw‰ďŠwpW‰ď (2015/12/4), Šň•Œ.

723597. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ŕ‘ŽƒAƒŒƒ‹ƒM[ŠłŽŇ‚ɑ΂ˇ‚élH•GŠÖßÄ’uŠˇp‚ĚŒŸ“˘. “ě’J@~1, ‘Šě@~2, “ŒŽR—玥1, ŠâŁ@‘ĺ1, ‚–쏸‘ž˜Y2, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć46‰ń“ú–{lHŠÖßŠw‰ď (2016/2/26), ‘ĺă.

723598. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) lHŒŇŠÖßƒZƒƒ“ƒgƒŒƒXƒJƒbƒv‚Ě•\–ĘŒ`ó‚Ş‚ŕ‚˝‚炡‰ŠúŒĹ’萍‚Ö‚ĚŒř‰Ę‚ĚŒŸ“˘. •Ÿ“‡Œ’‰î1, Žđˆä—˜“Ţ2, “ŕŽRŸ•ś1, X’JŒőr1, ŽR–{‹–ž1, ‚•˝ŽL2, ”nŸş´Ž‘2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć46‰ń“ú–{lHŠÖßŠw‰ď (2016/2/27), ‘ĺă.

723599. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ńŽŸŤ•ĎŒ`ŤŒŇŠÖßÇ‚ɑ΂ˇ‚éE1ƒ‰ƒCƒi[‚đ—p‚˘‚˝THAŒă‚Ě–€–ŐŒv‘ށ|‹ŕ‘Žœ“Ş‚ĆƒZƒ‰ƒ~ƒbƒNœ“Ş‚Ě‘OŒü‚Ť–łěˆ×‰ť‘˝Ž{Ý‹¤“ŻŒ¤‹†|. ‹´@OŽk1, —k@—TŒ’1, FŠ™@—ş1, –؉ş_ˆę2, ‹ŕŽq”Ž“ż3, “ŕŽRŸ•ś4, ‹ŕŽĄ—L•F5 (1’†’Ă•a‰@, 2•Ÿ‰Ş‘ĺ, 3–k—˘Œ¤‹†Š•a‰@, 4ŽŠO, 5Œc‘ĺ): ‘ć46‰ń“ú–{lHŠÖßŠw‰ď (2016/2/27), ‘ĺă, ‘ć46‰ń“ú–{lHŠÖßŠw‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2016; 46th: 418.

723600. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’ZŠú‚ĹƒlƒbƒN‚ސܑš‚ľ‚˝ModularŒ^ƒZƒƒ“ƒgƒŒƒXlHŒŇŠÖß‚ĚŒ´ˆö’˛¸‚ĆÄ”­–hŽ~ô‚ĚŒŸ“˘. “ŕŽRŸ•ś1, ŽR–{‹–ž1, X’JŒőr1, •Ÿ“‡Œ’‰î1, •őŠÝ—mŽŸ˜Y1, ‚‘ŠťŽm1, Gio Rgini Luca2, Pressacco Michele2, ‚•˝ŽL3 (1ŽŠO, 2“ú–{ƒŠƒ}, 3ˆă—ÉqśŠw•”): ‘ć46‰ń“ú–{lHŠÖßŠw‰ď (2016/2/27), ‘ĺă, ‘ć46‰ń“ú–{lHŠÖßŠw‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2016; 46th: 463.

723601. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ‘ڍœ‘oŒ`‘ԂƐlHŒŇŠÖßƒXƒeƒ€ŽüˆÍ•”‚É‚¨‚Ż‚鉞—Í•Ş•z‚ĚŠÖŒW. •Ä”öነł1, ”nŸş´Ž‘2, Žđˆä—˜“Ţ2, ’†”öŤ‹P1, ‚•˝ŽL2, “ŕŽRŸ•ś3, •Ÿ“‡Œ’‰î3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3ŽŠO): ‘ć46‰ń“ú–{lHŠÖßŠw‰ď (2016/2/27), ‘ĺă, ‘ć46‰ń“ú–{lHŠÖßŠw‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2016; 46th: 475.

723602. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ś•¨Šw“IťÜŽg—p‚É”ş‚¤lHŒŇŠÖß’x”­ŤŠ´ő‚đ‹^‚Á‚˝Ç—á‚ĚŒŸ“˘. X’JŒőr1, “ŕŽRŸ•ś1, •őŠÝ—mŽŸ˜Y1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć46‰ń“ú–{lHŠÖßŠw‰ď (2016/2/27), ‘ĺă, ‘ć46‰ń“ú–{lHŠÖßŠw‰ď´˜^W 2016; p.563.

723603. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŇŠÖß’É‚đ—L‚ˇ‚銳ŽŇ‚̐ҒŒƒAƒ‰ƒCƒƒ“ƒg: Hip Spine Syndrome‚Ě•a‘Ô‚ÉŠÖ‚ˇ‚錟“˘. ‹{éłs1, •Ÿ“‡Œ’‰î1, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, âV“Ą@˜j1, “ď”gF“ż1, ”’ŕV‰hŽ÷1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć6‰ń“ú–{ŹlŇ’Œ•ĎŒ`Šw‰ď (2016/3/12), VŠƒ.

723604. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŇŠÖß’ÉŠłŽŇ‚É‚¨‚Ż‚鍜”ŐŒXŽÎŠp‘Ş’čŒëˇ‚ÉŠÖ‚ˇ‚錟“˘. ŻŽi^‘ž˜Y1, ‹{éłs1, •Ÿ“‡Œ’‰î1, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, âV“Ą@˜j1, “ď”gF“ż1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć6‰ń“ú–{ŹlŇ’Œ•ĎŒ`Šw‰ď (2016/3/12), VŠƒ.

723605. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŹlŇ’Œ•ĎŒ`Žčp‚É‚¨‚Ż‚épŒă–ž‘Ť“x‚ÉŠÖ‚ˇ‚錟“˘. “ď”gF“ż1, ˆäă@Œş1, ’†ŕVr”V1, ˆä‘ş‹M”V1, ‹{éłs1, âV“Ą@˜j1, ”’ŕV‰hŽ÷1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć6‰ń“ú–{ŹlŇ’Œ•ĎŒ`Šw‰ď (2016/3/12), VŠƒ.

731114. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŹŁNŽĄ (ŽŠO): é‹ĘŒ§‘ĺ‹{ŽsˆăŽt‰ďŠwpu‰‰‰ď (2015/4/1), ‚ł‚˘‚˝‚Ü.

731115. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŹŁNŽĄ (ŽŠO): ‘ć3‰ńé‹Ę‰^“ŽŠíáu’ɃZƒ~ƒi[ (2015/4/8), é‹Ę.

731116. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) FAI‚ĆŠ°œ‰PŒ`Ź•s‘S‚Ě•a‘Ô”cˆŹ. •Ÿ“‡Œ’‰î (ŽŠO): Hip arthroscopy basic course (2015/4/11), “Œ‹ž.

731117. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) FAI‚ĚŠT”O‚Ɛf’f. •Ÿ“‡Œ’‰î (ŽŠO): Hip arthroscopic basic course (2015/4/11), “Œ‹ž.

731118. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŒŇŠÖßŠO‰Čˆă‚ŞŒŇŠÖß‹ž‚đ‚ˇ‚éˆÓ–Ą‚Ć‚ť‚Ě‚˝‚ß‚Ě€”ő. •Ÿ“‡Œ’‰î (ŽŠO): Hip arthroscopic basic course (2015/4/11), “Œ‹ž.

731119. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŹŁNŽĄ (ŽŠO): L“‡Œ§—Տ°ŽŒ`ŠO‰Čˆă‰ď (2015/4/11), L“‡.

731120. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚—îŽŇœ‘e頏ǂ̓Á’Ľ‚ƏT1‰ńƒeƒŠƒpƒ‰ƒ`ƒhŽĄ—Á|œÜŽĄ–ü‘ŁiŒř‰Ę‚𒆐S‚Ɂ|. ŹŁNŽĄ (ŽŠO): ‘ć1‰ńœ‘e頏ǐŤœÜ—\–hƒZƒ~ƒi[ (2015/6/11), ˆďé.

731121. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Evidence‚Š‚ç‚Ý‚éFAI. •Ÿ“‡Œ’‰î (ŽŠO): ‘ć9‰ńOsaka hip meeting under 50 (2015/9/12), ‘ĺă.

731122. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‰şŽˆ‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. “ŒŽR—玥 (ŽŠO): ‘ć8‰ńƒZƒ‰ƒsƒXƒgŽ‘ŠiŒp‘ąŒ¤C‰ď (2015/10/10), ç—t.

731123. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŒŇŠÖßŠO‰Čˆă‚ލs‚¤ŒŇŠÖß‹ž|“K‰ž”ť’f, ƒZƒbƒgƒAƒbƒv, ŽčpŽč‹Z|. •Ÿ“‡Œ’‰î (ŽŠO): ŒŇŠÖßŽáŽč‚̉ď 2015 (2015/11/28), “Œ‹ž.

732050. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) allograft‚ł̉đ–UŠw“IACLÄŒšp‚̍H•v. “ŒŽR—玥 (ŽŠO): ‘ć31‰ń_“ސ쐎Œ`ŽčpŽč‹ZŒ¤‹†‰ď (2015/6/12), ‰Ą•l.

732051. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ŠÖßƒŠƒEƒ}ƒ`ŽčŽwŽÚ‘¤•ÎˆĘ‚ɑ΂ˇ‚鎥—Ð헪. ŹŔŒŤŽĄ1, “Ą“c@Œě, “c“‡Gˆę˜Y1, “ĄŠŞŽőŽq2, ŒŠ–Ú’q‹I1, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć115‰ń_“ސ쐎Œ`ĐŠQŠO‰ČŒ¤‹†‰ď (2015/9/5), ‰Ą•l.

732052. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) “]ˆÚŤŇ’ĹŽîᇂɑ΂ˇ‚éŽčpŹŃ. ˆä‘ş‹M”V1, ˆäă@Œş1, ’†ŕVr”V1, ‹{éłs1, “ď”gF“ż1, ’†˜e[Í1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć156‰ń_“ސ쐎Œ`ĐŠQŠO‰ČŒ¤‹†‰ď (2016/3/12), ‰Ą•l.

733215. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’ZŠúŠÔ‚Ě‚¤‚ż‚ɐL‹ŘäF’E‰P‚É‚ć‚éŽčŽwL“WáŠQ‚𐜂ś‚˝ŠÖßƒŠƒEƒ}ƒ`‚Ě1—á. “c“‡Gˆę˜Y1, ŹŔŒŤŽĄ1, ‚‘ŠťŽm1 (1ŽŠO): –k‘ŠŽŒ`ŠO‰ČŒ¤‹†‰ď (2015/6/11), ‘Š–ÍŒ´.

733216. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰ťŠw•¨Žż‰ß•qÇ‚đ‡•š‚ľ‚˝ŠłŽŇ‚̐lHŒŇŠÖßÄ’uŠˇp‚đŽ{s‚ľ‚˝1—á. ‘ş“cK—C1, •Ÿ“‡Œ’‰î1, “ŕŽRŸ•ś1, X’JŒőr1, ŽR–{‹–ž1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŒŽ—á‰ď‘ć677‰ńŽŒ`ŠO‰ČW’k‰ď“Œ‹ž’n•ű‰ď (2015/6/27), “Œ‹ž.

733217. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “Ż‘¤lHŒŇŠÖßElH•GŠÖßpŒăMRSAŠ´ő‚ɑ΂ľ‚Ä“ńŠú“IlH‘ĺ‘ڍœ‘S’uŠˇp‚đŽ{s‚ľ‚˝1—á. •őŠÝ—mŽŸ˜Y1, “ŕŽRŸ•ś1, ŽR–{‹–ž1, X’JŒőr1, •Ÿ“‡Œ’‰î1, ‚‘ŠťŽm1, ‚ŽR—zŽq2, ˜a“c’B•F3, “ń–{–öL4, ‚•˝ŽL5, ‰Ô–؏G–ž (1ŽŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3äPŒ´•aEŠ´ő“ŕ, 4—ŐŒŸ•”, 5ˆă—ÉqśŠw•”): MRSAƒtƒH[ƒ‰ƒ€ (2015/7/11), “Œ‹ž.

733218. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) lHŒŇŠÖß‚މˇ‘ś‚Ĺ‚Ť‚˝pŒă‘ŠúMRSAŠ´ő‚Ě2—á. “ŕŽRŸ•ś1, ‚ŽR—zŽq2, ‰Ô–؏G–ž, X’JŒőr1, ˜a“c’B•F3, “ń–{–öL4, ŸNˆäŒc‘˘4, “Ą–Ř‚­‚ÉŽq5, ’†‘şłŽ÷6, ˛“ĄçŒb7, ‘ĺěŒ´—TŽ÷8, ťěŒc‰î5, ‚‘ŠťŽm1 (1ŽŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3äPŒ´•aEŠ´ő“ŕ, 4—ŐŒŸ•”, 5Š´őŠÇ—Žş, 6ˆă—ÉqśŠw•”, 7‹~–˝, 8–ňÜ•”): MRSAƒtƒH[ƒ‰ƒ€2015 (2015/7/11), “Œ‹ž.

733219. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽŒ`ŠO‰ČŽžŠł‚É‚¨‚Ż‚éMRSAŠ´ő‚ɑ΂ˇ‚éƒoƒ“ƒRƒ}ƒCƒVƒ“‚Ě—LŒřŤ. “c“‡Gˆę˜Y1, “ŕŽRŸ•ś1, ŽR–{‹–ž1, X’JŒőr1, •Ÿ“‡Œ’‰î1, ‚‘ŠťŽm1, ‚ŽR—zŽq2, ˜a“c’B•F3, “ń–{–öL4, ‚•˝ŽL5, ‰Ô–؏G–ž (1ŽŠO, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3äPŒ´•aEŠ´ő“ŕ, 4—ŐŒŸ•”, 5ˆă—ÉqśŠw•”): MRSAƒtƒH[ƒ‰ƒ€2015 (2015/7/11), “Œ‹ž.

733220. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) lHŠÖß’uŠˇpŒă‚ĚŠ´ő‚ɑ΂ˇ‚é“–‰@‚Ĺ‚ĚŽŽ‚Ý. “ŕŽRŸ•ś (ŽŠO): ‘ć2‰ńMRSAŠ´őÇƒZƒ~ƒi[ (2015/7/17), ‰Ą•l.

733221. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖß‰ˇ‘śŽčp (time saving surgery) ‚ĆˆĘ’u‚Ă‚Ż‚ç‚ę‚éŒŇŠÖß‹žŽ‹‰şŽčp. •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, “ŕŽRŸ•ś1, X’JŒőr1, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć23‰ńHip Forum (2015/7/31), _ŒË, ‘ć23‰ńHip Forum´˜^W 2015; p.21.

733222. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ž„‚͋‰çˆĘBauerƒAƒvƒ[ƒ`‚Š‚ç‹Â‰çˆĘ‘O‘¤•űƒAƒvƒ[ƒ`‚Ö•Ď‚Ś‚˝. ‚•˝ŽL1, •Ÿ“‡Œ’‰î2, ŽR–{‹–ž2, X’JŒőr2, “ŕŽRŸ•ś2 (1ˆă—ÉqśŠw•”, 2ŽŠO): ‘ć23‰ńHip Forum (2015/7/31), _ŒË, ‘ć23‰ńHip Forum´˜^W 2015: p.36.

733223. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒXƒeƒƒCƒhŤ•Gœ‰óŽ€‚É‚ć‚éL”͈͍œ“Œ‡‘š‚ɑ΂ˇ‚鎊‰Ćœ“ˆÚAp‚ĚŽĄ—ÐŹŃ. •˝ě‹IŽq1, ŹŁNŽĄ1, “ě’J@~1, “ŒŽR—玥1, ŠâŁ@‘ĺ1, “hŽRłG1, ‹{“‡Œş—z1, “ŕ–쐳—˛1, ‚‘ŠťŽm1, č•”@Œ›1 (1ŽŠO): ‘ć64‰ń“Œ“ú–{ŽŒ`ĐŠQŠO‰ČŠw‰ď (2015/9/11), •Ÿ“‡.

733224. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) lHŠÖßŽüˆÍŠ´ő‚É‚¨‚Ż‚é16SƒŠƒ{ƒ][ƒ€RNA—zŤ—á‚ĚƒV[ƒPƒ“ƒX‰đÍ‚É‚ć‚é‹N‰Š‹ŰŒŸő‚ĚŽŽ‚Ý. “ŕŽRŸ•ś1, ŸNˆäŒc‘˘2, •őŠÝ—mŽŸ˜Y1, X’JŒőr1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, Žë–ě—Lě3, ‚•˝ŽL4, ‚‘ŠťŽm1 (1ŽŠO, 2—ŐŒŸ•”, 3—ŐŒŸŠw, 4ˆă—ÉqśŠw•”): ‘ć64‰ń“Œ“ú–{ŽŒ`ĐŠQŠO‰ČŠw‰ď (2015/9/11), •Ÿ“‡, “Œ“ú–{ŽĐ‰ďŽ 2015; 27 (3): 293.

733225. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰E‰şŽˆ“ŽĂ–ŹŠďŒ`‚𔺂Á‚˝•ĎŒ`ŤŒŇŠÖßÇ‚ɑ΂ľlHŒŇŠÖß‘S’uŠˇp‚đŽ{s‚ľ‚˝1—á. ‘ĺ’|—IĆ1, “ŕŽRŸ•ś1, X’JŒőr1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, •“cW‹`1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć64‰ń“Œ“ú–{ŽŒ`ĐŠQŠO‰ČŠw‰ď (2015/9/11), •Ÿ“‡, “Œ“ú–{ŽĐ‰ďŽ 2015; 27 (3): 298.

733226. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŇŠÖßŒă•ű’E‰P‚𔺂¤‘ĺ‘ڍœœ“ލœÜ‚ɑ΂ľsurgical dislocation‚đ—p‚˘‚˝œÚ‡pŒă‚ɐś‚ś‚˝•ĎŒ`ŤŒŇŠÖßÇ‚Ě1—á. •“cW‹`1, “ŕŽRŸ•ś1, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, X’JŒőr1, ‘ĺ’|—IĆ1, ’†˜e[Í1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć64‰ń“Œ“ú–{ŽŒ`ĐŠQŠO‰ČŠw‰ď (2015/9/11), •Ÿ“‡, “Œ“ú–{ŽĐ‰ďŽ 2015; 27 (3): 301.

733227. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’ZŠúŠÔ‚Ě‚¤‚ż‚ɐL‹ŘäF’E‰P‚É‚ć‚éŽčŽwL“WáŠQ‚𐜂ś‚˝ŠÖßƒŠƒEƒ}ƒ`‚Ě1—á. “c“‡Gˆę˜Y1, ŹŔŒŤŽĄ1, ŒŠ–Ú’q‹I1, “ĄŠŞŽőŽq2, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć64‰ń“Œ“ú–{ŽŒ`ĐŠQŠO‰ČŠw‰ď (2015/9/11), •Ÿ“‡.

733228. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŇŠÖßO‘šŠłŽŇ‚ĚŽĄ—Ă•űj‚ĚŒˆ’č‚Épain DETECT‚Ş—L—p‚Ĺ‚ ‚Á‚˝1—á. ’†˜e[Í1, •Ÿ“‡Œ’‰î1, X’JŒőr1, ŽR–{‹–ž1, “ŕŽRŸ•ś1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć11‰ń“ú–{ŒŇŠÖß‹žŒ¤‹†‰ď (2015/9/5), ‰ŞŽR

733229. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Pincer•ĎŒ`‚𔺂¤ŠŠ–ŒŤœ“ŽîÇ‚ɑ΂ˇ‚鎥—ĂŒoŒą. X’JŒőr1, •Ÿ“‡Œ’‰î1, “ŕŽRŸ•ś1, ŽR–{‹–ž1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć11‰ń“ú–{ŒŇŠÖß‹žŒ¤‹†‰ď (2015/9/5), ‰ŞŽR.

733230. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖß‰tCRP’l‘Ş’č‚͐lHŠÖßŽüˆÍŠ´őÇ‚̐f’f‚É—L—p‚Š? •őŠÝ—mŽŸ˜Y1, “ŕŽRŸ•ś1, ŸNˆäŒc‘˘2, ŽR–{‹–ž1, X’JŒőr1, •Ÿ“‡Œ’‰î1, ŠâŁ@‘ĺ1, Žë–ě—Lě3, ‚•˝ŽL4, ‚‘ŠťŽm1 (1ŽŠO, 2—ŐŒŸ•”, 3—ŐŒŸŠw, 4ˆă—ÉqśŠw•”): ‘ć43‰ńŠÖ“ŒŒŇŠÖß§˜b‰ď (2015/9/26), “Œ‹ž.

733231. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) JefferyŒ^œÜ‚ɍ‡•š‚ľ‚˝“ŕ‘¤ăč÷‹UŠÖß‚ɑ΂ľ‹UŠÖßŽčp‚đs‚Á‚˝1—á. ŹŽR’q‹v1, ŹŔŒŤŽĄ1, ŒŠ–Ú’q‹I1, ‚“c@Œ¤1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć21‰ń_“ސěăŽˆŠO‰ČŒ¤‹†‰ď (2015/10/17), ‰Ą•l.

733232. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽOŽŸŒł‘Ş’č‚đ—p‚˘‚˝ŒŇŠÖß‚É“­‚­—Í‚Ě’č—Ę•]‰ż‚Ö‚Ě’§í. ŠâŁ@‘ĺ1, ‘Šě@~2, “ĄŠŞŽőŽq2, “ŒŽR—玥1, “ě’J@~1, ‚‘ŠťŽm1, ź”ö@—˛, ź”ö@“Ä, ]’[ˆę”Ž (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć32‰ń“ú–{”]Ť–ƒáƒ‚ĚŠO‰ČŒ¤‹†‰ď (2015/10/17), ‘ĺă.

733233. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”]Ť–ƒáƒë‘Ť•ĎŒ`‚ɑ΂ˇ‚鉺‘ÚŽO“Ş‹Ř‰„’ˇpŒă‚Ěćů‘Ť•ĎŒ`. ź”ö@“Ä, ź”ö@—˛, ‚–ŘŒ’Žu, ‘Šě@~1, ŠâŁ@‘ĺ2, “ĄŠŞŽőŽq1, “í–{‘׎m (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŽŠO): ‘ć32‰ń“ú–{”]Ť–ƒáƒ‚ĚŠO‰ČŒ¤‹†‰ď (2015/10/17), ‘ĺă.

733234. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) •GŠÖßŒă•űŠÖß”X“ŕ‚É‘śÝ‚ˇ‚éŠÖß“ŕ—V—Ł‘̂ɑ΂ľŠÖß‹žŽ‹‰ş“Eop‚đs‚Á‚˝2—á. č•”@Œ›1, “ŕ–쐳—˛1, •˝ě‹IŽq1, “hŽRłG1, ‹{“‡Œş—z1 (1ŽŠO): –k‘Ť—§ŒSŽsˆăŽt‰ďˆăŠw‰ď (2015/10/17), é‹Ę.

733235. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠOŤL”͈͓Œ‡‘š‚ɑ΂ľŽŠ‰Ć”|—{“×–EˆÚAp‚đs‚Á‚˝2—á. č•”@Œ›1, ŹŁNŽĄ1, “ŕ–쐳—˛1, •˝ě‹IŽq1, “hŽRłG1, ‹{“‡Œş—z1 (1ŽŠO): –k‘Ť—§ŒSŽsˆăŽt‰ďˆăŠw‰ď (2015/10/17), é‹Ę.

733236. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) 12Î”­Ç, L”͈͉󎀃yƒ‹ƒeƒX•a‚ÉŽ{s‚ľ‚˝“ŕ”˝‰ń“]œŘ‚čp (ROWO) ‚Ě1—á. •őŠÝ—mŽŸ˜Y1, “ŕŽRŸ•ś1, X’JŒőr1, ŽR–{‹–ž1, •Ÿ“‡Œ’‰î1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć13‰ńŒŇOsteotomy‚đŒę‚é‰ď (2015/10/31), ‘ĺă.

733237. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŇŠÖß‹žŽ‹‰ş‚ɉÁ—Ă‚ľ‚˝F‘fŤăO–ŃŒ‹ßŤŠŠ–Œ‰Š‚Ě1—á. •“cW‹`1, •Ÿ“‡Œ’‰î1, “ŕŽRŸ•ś1, X’JŒőr1, ŽR–{‹–ž1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć47‰ń–kE‘ŠŽŒ`ŠO‰Čˆă‰ď (2015/11/19), ‘Š–ÍŒ´.

733238. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) •GŠWœ’E‰P‚Ć‘O\ŽščՑђf—ô‚đ“ŻŽž‚Ɏ󏝂ľ‚˝ˆęÇ—á. ‘ş“cK—C1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŹŽR’q‹v1, •“cW‹`1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): –k‘ŠŽŒ`ŠO‰Čˆă‰ď (2015/11/19), ‘Š–ÍŒ´.

733239. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) äF”Â’f—ô‚Ć•ĎŒ`ŤŒŇŠÖßÇ‚Ěáu’ɈöŽq‚Ě”äŠr. ŒŠ–Ú’q‹I1, ‹{éłs1, “ŒŽR—玥1, ˆäă@Œş1, ‚‘ŠťŽm1 (1ŽŠO): ‘ć1322‰ńç—tˆăŠwŠEŽŒ`ŠO‰Č—á‰ď (2015/12/6), ç—t.

733240. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) •GŠWœ’E‰P‚Ć‘O\Žšx‘Ń’f—ô‚đ“ŻŽž‚Ɏ󏝂ľ‚˝1Ç—á. ‘ş“cK—S1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, “ě’J@~1, ŹŽR’q‹v1, •“cW‹`1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć679‰ńŠÖ“ŒŽĐŠOŠO‰ČŠw‰ď@ŒŽ—á‰ď (2015/12/19), “Œ‹ž.

733241. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ceramic-on-polyethylene THApŒă‚ɍœ—n‰đ‚𔺂¤“î•”‘gD•a•Ď‚𐜂ś‚˝1—á. X’JŒőr1, “ŕŽRŸ•ś1, ‚•˝ŽL2, •Ÿ“‡Œ’‰î1, ŽR–{‹–ž1, •őŠÝ—mŽŸ˜Y1, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć56‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď (2016/3/25), •iě, ŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŽGŽ 2016/3; 47 (—ŐŽž‘Š§): 64.

733242. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) 12Î”­Ç, L”͈͉󎀃yƒ‹ƒeƒX•a‚ɑ΂ľ‚Ä“ŕ”˝‰ń“]œŘ‚čp‚đŽ{s‚ľ‚˝1—á. “ŕŽRŸ•ś1, •őŠÝ—mŽŸ˜Y1, •Ÿ“‡Œ’‰î1, X’JŒőr1, ŽR–{‹–ž1, ‚•˝ŽL2, ‚‘ŠťŽm1 (1ŽŠO, 2ˆă—ÉqśŠw•”): ‘ć56‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď (2016/3/25), •iě, ŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ďŽGŽ 2016/3; 47 (—ŐŽž‘Š§): 65.

733243. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”–‹ŘäF‚đ—p‚˘‚˝‹žŽ‹‰şŒă‹—äCčՑэȚp‚Ěcadaver‚Ĺ‚ĚŽŽ‚Ý. “ŒŽR—玥1, ‘Šě@~2 ŠâŁ@‘ĺ1, “ě’J@~1, ŻŽi^‘ž˜Y1, ‚‹´ŒŞ“ń, “y‰Ž–žO, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć56‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď (2016/3/25), •iě.

733244. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) 85ÎˆČă‚Ě’´‚—îŽŇ‚ɑ΂ˇ‚élH•GŠÖß‘S’uŠˇp‚Ě’ZŠúŹŃ. •“cW‹`1, ŠâŁ@‘ĺ1, ‘Šě@~2, “ŒŽR—玥1, “ě’J@~1, ‚–쏸‘ž˜Y2, ŹŽR’q‹v1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć56‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď (2016/3/26), •iě.

733245. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ŻŽíœ•t‚Ť•GŠWäF‚đ—p‚˘‚˝’ˇ•űŒ`œE‘O\ŽščՑэȚpŒă‚Ě•G‹Ř—Í‚ĚŒŸ“˘. “ě’J@~1, “ŒŽR—玥1, ‘Šě@~2, ŠâŁ@‘ĺ1, ‚–쏸‘ž˜Y2, “ŕ“cŒ’‘ž˜Y1, ˆäă@Œş1, č•”@Œ›1, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć56‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď (2016/3/26), •iě.

733246. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠÖßƒŠƒEƒ}ƒ`ŽčŠÖß•a•Ď‚ɑ΂ˇ‚éWrist fusion rod—p‚˘‚˝ŽčŠÖß‘SŒĹ’čp‚ĚŽĄ—ĂŒoŒą. ŹŔŒŤŽĄ1, “Ą“c@Œě, ŒŠ–Ú’q‹I1, •ě_Žm1, “ĄŠŞŽőŽq2, ‚•˝ŽL3, ‚‘ŠťŽm1 (1ŽŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć56‰ńŠÖ“ŒŽŒ`ĐŠQŠO‰ČŠw‰ď (2016/3/26), •iě.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-110015. [Œ´’˜] Effectioveness of deep peronel nerve block for the manegement of lumbar disease with leg cramps. Imura T1, Inoue G1, Nakazawa T1, Ueno M, Saito W1. Uchida K1, Adachi K, Takahira N2, Takaso M1: Journal of spine research 2015/2; 6 (2): 119-24. (ˆä‘ş‹M”V1, ˆäă@Œş1, ’†ŕVr”V1, âV“Ą@˜j1. “ŕ“cŒ’‘ž˜Y1, ‚•˝ŽL2, ‚‘ŠťŽm1: 1ŽŠO, 2ˆă—ÉqśŠw•”)

[Šw‰ďEŒ¤‹†‰ď“™]

H26-731002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŹŁNŽĄ (ŽŠO): ”ތːŽŒ`ŠO‰Čˆă‰ďŠwpu‰‰‰ď (2014/7/9), ”ŞŒË.


Œ`ŹŠO‰ČE”ü—eŠO‰ČŠw

[Šwp˜_•ś]

110234. [Œ´’˜] Free flap transfer to preserve main arterial flow in early reconstruction of open fracture in the lower extremity. Nemoto M1, Ishikawa S1, Kounoike N1, Sugimoto T1, Takeda A1: Plast Surg Int 2015; 2015: 213892. (Ş–{@[1, ÎěS‰î1, ƒ’r“Ţ’ĂŽq1, ™–{F”V1, •“c@Œ[1: 1Œ`ŹE”üŠO)

110235. [Œ´’˜] Clinical features of primary vein grafts in free tissue transfers. Nemoto M1, Kumazawa K2, Uchinuma E, Kounoike N1, Takeda A1: Plast Surg Int 2015; 2015: 481402. (Ş–{@[1, ŒFŕVŒ›ˆę2, “ŕŔ‰hŽ÷, ƒ’r“Ţ’ĂŽq1, •“c@Œ[1: 1Œ`ŹE”üŠO, 2‹~–˝)

110236. [Œ´’˜] Five-year efficacy of finasteride in 801 Japanese men with androgenetic alopecia. Yoshitake T, Takeda A1, Ohki K, Inoue Y, Yamawaki T, Otsuka S, Akimoto M1, Nemoto M1, Shimakura Y1, Sato A: J Dermatol 2015/7; 42 (7): 735-8. (•“c@Œ[1, H–{•ôŽ1, Ş–{@[1, “‡‘qNl1: 1Œ`ŹE”üŠO)

110237. [Œ´’˜] Facial nerve palsy and Frey's syndrome in parotid surgery. Sugimoto T1, Akimoto M1, Nemoto M1, Kounoike N1, Ishikawa S1, Himi K, Uchinuma E, Takeda A1: Kitasato Med J 2015/9; 45 (2): 114-7. (™–{F”V1, H–{•ôŽ1, Ş–{@[1, ƒ’r“Ţ’ĂŽq1, ÎěS‰î1, “ŕŔ‰hŽ÷, •“c@Œ[1: 1Œ`ŹE”üŠO)

110238. [Œ´’˜] Surgical treatment of cutaneous squamous cell carcinoma in Japanese patient aged 85 years and older compared with below 85 years. Kounoike N1, Akimoto M1, Nemoto M1, Ishikawa S1, Sugimoto T1, Takeda A1: Kitasato Med J 2015/9; 45 (2): 118-23. (ƒ’r“Ţ’ĂŽq1, H–{•ôŽ1, Ş–{@[1, ÎěS‰î1, ™–{F”V1, •“c@Œ[1: 1Œ`ŹE”üŠO)

110239. [Œ´’˜] Investigation of factors affecting postoperative recurrence of basal cell carcinomas. Sugimoto Y1, Takeda A1, Akimoto M1, Sugimoto T1, Kajita S2, Uchinuma E: Kitasato Med J 2016/3; 46 (1): 47-52. (™–{‰Ŕ1, •“c@Œ[1, H–{•ôŽ1, ™–{F”V1, Š“cç”ü”T2, “ŕŔ‰hŽ÷: 1Œ`ŹE”üŠO, 2•a—)

110028. [Œ´’˜] Vascular endothelial growth factor receptor-1 (VEGFR-1) signaling enhances angiogenesis in a surgical sponge model. Park K1, Amano H2, Ito Y3, Kashiwagi S4, Yamazaki Y4, Takeda A4, Shibuya M, Kitasato H5, Majima M2: Biomed Pharmacother 2016/3; 78: 140-9. (–p@Œ\ˆę1, “V–ě‰pŽ÷2, ˆÉ“Ą‹`–ç3, ”–ؐT–ç4, ŽRčˆŔ°4, •“c@Œ[4, –k—˘‰p˜Y5, ”n“ˆł—˛2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–ň—, 3ŠO‰Č, 4Œ`ŹE”üŠO, 5ˆă—ÉqśŠw•”)

120032. [Œ´’˜] “–‰Č‚ĹŒoŒą‚ľ‚˝Žč•”Ž‰–bŽî9—á‚ĚŒŸ“˘. ÎěS‰î1, ™–{F”V1, ƒ’r“Ţ’ĂŽq1, Ş–{@[1, •“c@Œ[1 (1Œ`ŹE”üŠO): –k—˘ˆăŠw 2015/6; 45 (1): 21-6.

520011. [‘ŕ] “€Œ‹•Ű‘śŽŠ‰Ćœ‘gD—R—ˆŠÔ—tŒn×–E‚ĚˆÓ‹`. ŽRčˆŔ°1, •“c@Œ[1 (1Œ`ŹE”üŠO): –k—˘ˆăŠw 2015/6; 45 (1): 11-20.

522121. [uŔ]y“ÁW: ”ü—eˆă—Ă‚Ě‡•šÇ‚Š‚çŠw‚Ô1|ƒtƒBƒ‰[•Ň|zƒnƒCƒhƒƒLƒVƒAƒpƒ^ƒCƒg’“üÜ‚É‚ć‚錌ŠÇÇđ‚Ş‹^‚í‚ę‚˝1—á. “‡‘qNl1, •“c@Œ[1 (1Œ`ŹE”üŠO): Œ`ŹŠO‰Č 2015/9; 58 (9): 968-71.

[’˜@‘]

620095. [Šwp‘ (•Ş’SŽˇ•M)]yŽč‘Ť‚̐ć“VˆŮí‚Í‚ą‚¤ŽĄ—Ă‚ˇ‚é (PEPARS No.103)z‘˝ćä, ‘˝‡ćäÇ, p.78-85. Ş–{@[1, •“c@Œ[1 (1Œ`ŹE”üŠO), •Ň: •Ÿ–{ŒbŽO, ‘S“ú–{•a‰@o”ʼnď, “Œ‹ž, 2015/7”­s.

620096. [Šwp‘ (•Ş’SŽˇ•M)]y”ü—eŠO‰Č‚É•K{‚ĚŒ`ŹŠO‰Č‚ĚŠî–{’mŽŻ‚ĆŽč‹Z (Œ`ŹŠO‰Č‘ć58ŠŞ‘Š§†)zVII. ”畆Š×‰š•ĎŒ`‚Ö‚ĚŽ‰–bˆÚA (’“ü)@”畆Š×‰š•ĎŒ`‚Ö‚ĚŽ‰–bˆÚA (’“ü)¨[Šç–Ę‚Ě‚ľ‚í‚Ć‚č, —ÖŠsŒ`Ź], S138-45. “‡‘qNl1, •“c@Œ[1, Žđˆä’ź•F2 (1Œ`ŹE”üŠO, 2é–{ƒNƒŠƒjƒcƒN‹âŔ‰@), Ž˝“°o”Ĺ, “Œ‹ž, 2015/9”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713084. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Multidisciplinary Treatment for Correction of Malocclusion due to Maxillofacial Deformity from Fracture. Yamazaki Y1, Sugimoto T1, Takeda A1: ‘ć16‰ń‘Ű“ŞŠWŠç–ĘŠO‰ČŠw‰ď (2015/9/17), ç—t. (ŽRčˆŔ°1, ™–{F”V1, •“c@Œ[1: 1Œ`ŹE”üŠO)

722084. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘ĺŠw‚É‚¨‚Ż‚éŒ`ŹŠO‰ČˆăŽtˆçŹ‚Ě‚˝‚ß‚Ě‹łˆç. •“c@Œ[1, Ş–{@[1, “‡‘qNl1, H–{•ôŽ1, ™–{F”V1, ŽRčˆŔ°1, “ŕŔ‰hŽ÷ (1Œ`ŹE”üŠO): ‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď (2015/4/9), ‹ž“s.

722085. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ”ü—eŠO‰Č‡•šÇ (“–‰@‚É‚¨‚Ż‚é”ü—eˆă—͇•šÇ—á‚ĚŒŸ“˘). •“c@Œ[1, “‡‘qNl1, ÎěS‰î1 (1Œ`ŹE”üŠO): ‘ć38‰ń“ú–{”ü—eŠO‰ČŠw‰ď‘‰ď (2015/9/22), ‰Ą•l.

722086. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “€Œ‹•Ű‘śŽŠ‰Ć‘gD—R—ˆŠÔ—tŒn×–E‚ĚˆÓ‹`. ŽRčˆŔ°1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć24‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2015/10/8), ŠâŽč.

722087. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) “–Ž{Ý‚É‚¨‚Ż‚錌ŠÇ•Ť‡•”ŒŒđ‚ɑ΂ˇ‚é‹~ĎŽčp. Ş–{@[1, ŒFŕVŒ›ˆę2, H–{•ôŽ1, ƒ’r“Ţ’ĂŽq1, •“c@Œ[1 (1Œ`ŹE”üŠO, 2‹~–˝): ‘ć42‰ń“ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ďŠwpW‰ď (2015/11/26), é‹Ę.

723606. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Invasive Extramammary Paget's Disease‚ĚŒŸ“˘. H–{•ôŽ1, ƒ’r“Ţ’ĂŽq1, Žç’JˆŸŠóŽq, ••”—í“Ţ, •ş“Ş“O–ç1, •Ÿˆä’‘ĺ1, ŒĂě‹M–ç, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď (2015/4/8-10), ‹ž“s.

723607. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”w•”Osteolipoma‚Ě1—á. ŒĂě‹M–ç, H–{•ôŽ1, Žç’JˆŸŠóŽq, ƒ’r“Ţ’ĂŽq1, •Ÿˆä’‘ĺ1, •ş“Ş“O–ç1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď (2015/4/8-10), ‹ž“s.

723608. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) V‹K–D‡‘n—pƒnƒCƒhƒƒRƒƒCƒh‘n”핢Ţ‚ĚŽg—pŒoŒą. ƒ’r“Ţ’ĂŽq1, Žç’JˆŸŠóŽq, •ş“Ş“O–ç1, •Ÿˆä’‘ĺ1, H–{•ôŽ1, Ş–{@[1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď (2015/4/8-10), ‹ž“s.

723609. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ™ů‹Ř“ŕŒŒŠÇŠďŒ`‚Ě1—á. Žç’JˆŸŠóŽq, ™–{F”V1, H–{•ôŽ1, ÎěS‰î1, •XŒŠ˜a–¤, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď (2015/4/8-10), ‹ž“s.

723610. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œ´ˆö•s–ž‚Ě• ’ɁE”­”M‚Ĺ”­Ç‚ľ, ‹Ř•Ů‚É‚ć‚éÄŒš‚đs‚Á‚˝’pœœ‘‰Š‚Ě‹}Ť‘žˆŤ. ˆęŽr˘, ŽR“c’źl1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć58‰ń“ú–{Œ`ŹŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď (2015/4/8-10), ‹ž“s.

723611. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) 16ÎˆČ~‚ɍs‚Á‚˝Žčć“VˆŮíCłp‚ĚŒŸ“˘. Ş–{@[1, ŒFŕVŒ›ˆę2, ÎěS‰î1, H–{•ôŽ1 (1Œ`ŹE”üŠO, 2‹~–˝): ‘ć58‰ń“ú–{ŽčŠO‰ČŠw‰ďŠwpW‰ď (2015/4/16-17), “Œ‹ž.

723612. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •Đ‘¤OŠ{ŒűŠW—ô‚ĚŠ{‹¸łŽčpŒă‚Ě•]‰ż. ŽRčˆŔ°1, ™–{F”V1, Î“n–ő•v, ŁčWˆę˜Y1, •“c@Œ[1, “ŕŔ‰hŽ÷ (1Œ`ŹE”üŠO): ‘ć39‰ń“ú–{ŒűŠW—ôŠw‰ď‘‰ďEŠwpW‰ď (2015/5/21), “Œ‹ž.

723613. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰Č‚ōs‚Á‚Ä‚˘‚éăŠ{‹“ăp‚ɂ‚˘‚Ä. ™–{F”V1, ŽRčˆŔ°1, •“c@Œ[1, Î“n–ő•v, ˆî–іΖÚ, •{ěr•F (1Œ`ŹE”üŠO): ‘ć25‰ń“Á’č”ń‰c—˜Šˆ“Ž–@l“ú–{Š{•ĎŒ`ÇŠw‰ď‘‰ďEŠwp‘ĺ‰ď (2015/6/4), “Œ‹ž.

723614. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘OŽ••”Ž•“÷œ–Œ‚đ‰ˇ‘ś‚ľ‚˝Le Fort IŒ^œŘ‚čp. ŽRčˆŔ°1, ’r–{”ɍO, ™–{F”V1, •“c@Œ[1, ˆî–ŃŽœŽŠ, •{ěr•F (1Œ`ŹE”üŠO): ‘ć25‰ń“Á’č”ń‰c—˜Šˆ“Ž–@l“ú–{Š{•ĎŒ`ÇŠw‰ď‘‰ďEŠwp‘ĺ‰ď (2015/6/5), “Œ‹ž.

723615. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰Č‚ōs‚Á‚Ä‚˘‚éăŠ{œŒăp‚Ě•]‰ż. ™–{F”V1, ŽRčˆŔ°1, •“c@Œ[1, Î“n–ő•v, ˆî–ŃŽœŽŠ, •{ěr•F (1Œ`ŹE”üŠO): ‘ć25‰ń“Á’č”ń‰c—˜Šˆ“Ž–@l“ú–{Š{•ĎŒ`ÇŠw‰ď‘‰ďEŠwp‘ĺ‰ď (2015/6/5), “Œ‹ž.

723616. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) dƒNƒƒ€Ž_ƒJƒŠƒEƒ€‚É‚ć‚鉝Šw‘š‚Ě1—á. •Ÿˆä’‘ĺ1, ŒFŕVŒ›ˆę1, •ş“Ş“O–ç1, H–{•ôŽ1, Ş–{@[1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć41‰ń“ú–{”MŠw‰ď‘‰ďEŠwpW‰ď (2015/6/18), –źŒĂ‰Ž.

723037. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘nŽĄ–ü‚É‚¨‚Ż‚éVascular Endothelial Growth Factor Receptor 1 TKƒVƒOƒiƒ‹‚Ě–đŠ„. –p@Œ\ˆę1, “V–ě‰pŽ÷2, ×–ě‰Á“ŢŽq2,3, ”–ؐT–ç4, ‚‹´@—ş1, a’JłŽj, ‹g’|r—T1, •“c@Œ[4, ”n“ˆł—˛2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–ň—, 3ś—, 4Œ`ŹE”üŠO): ‘ć36‰ń“ú–{‰ŠÇEÄśˆăŠw‰ď (2015/7/21-22), “Œ‹ž.

723617. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”ńƒXƒeƒƒCƒhR‰ŠÇ–ň‚É‚ć‚čoŒŒŒXŒü‚ޏ•’ˇ‚ł‚ę‚˝“Ş•”Ž‰–bŽî‚Ě1—á. ÎěS‰î1, •–ö”ü—˘1, ƒ’r“Ţ’ĂŽq1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć7‰ń“ú–{‘nŠO‰ČŠw‰ď‘‰ďEŠwpW‰ď (2015/7/24-25), “Œ‹ž.

723618. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ź‰@‚ĹŽ{s‚ł‚ę‚˝Šááىş‚Žčp‚̏Cł‚đ‚Ç‚¤‚ˇ‚é‚Š. “‡‘qNl1, •“c@Œ[1 (1Œ`ŹE”üŠO): ‘ć38‰ń“ú–{”ü—eŠO‰ČŠw‰ď‘‰ď (2015/9/22), ‰Ą•l.

723619. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –Ń•ďÄśˆă—Ă‚Ě‘O—Տ°ŽŽŒąƒ‚ƒfƒ‹‚ĚŠJ”­. ‹g’|r—T1, •“c@Œ[2, Ş–{@[2, H–{•ôŽ2, –öŕVł”V, –L“‡Œö‰h, ’ҁ@@F, ˛“Ą–ž’j (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Œ`ŹE”üŠO): ‘ć24‰ń“ú–{Œ`ŹŠO‰ČŠw‰ďŠî‘bŠwpW‰ď (2015/10/8), ŠâŽč.

723620. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰Č‚ōs‚Á‚Ä‚˘‚éăŠ{œ‹“ăp. ™–{F”V1, •“c@Œ[1, ŽRčˆŔ°1 (1Œ`ŹE”üŠO): ‘ć33‰ń“ú–{“ŞŠWŠ{Šç–ĘŠO‰ČŠw‰ďŠwpW‰ď (2015/11/12), •ó’Ë.

723621. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “€Œ‹•Ű‘śä`‘Ń—R—ˆŠÔ—tŒn×–E‚̍œŒ`Ź”\‚ĚŒŸ“˘. ”nęŽq, ŽRčˆŔ°1, ‘]Ş—R”üŽq2, Î•‹§Žj, ™–{F”V1, ŒFŕVŒ›ˆę3, •“c@Œ[1 (1Œ`ŹE”üŠO, 2•a‘ԁEf—ĂŒn, 3‹~–˝): ‘ć15‰ń“ú–{Äśˆă—ĂŠw‰ď‘‰ď (2016/3/17), ‘ĺă.

723622. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “€Œ‹•Ű‘ś‚ł‚ę‚˝ƒqƒgœ‘gD—R—ˆŠÔ—tŒn×–E‚Ě”|—{ă´‚É‚ć‚鍜Œ`Ź”\. ™–{F”V1, ŽRčˆŔ°1, ŒFŕVŒ›ˆę2, ‘]Ş—R”üŽq3, •“c@Œ[1 (1Œ`ŹE”üŠO, 2‹~–˝, 3•a‘ԁEf—ĂŒn): ‘ć15‰ń“ú–{Äśˆă—ĂŠw‰ď‘‰ď (2016/3/17), ‘ĺă.

723623. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘gDˆÚA‚đ—˜—p‚ľ‚˝ƒqƒg”畆Œn•Ű—LSCIDƒ}ƒEƒX‚ĚŠJ”­. ‹g’|r—T1, •“c@Œ[2, Ş–{@[2, H–{•ôŽ2, “‡‘qNl2, ™–{F”V2, –öŕVł”V, –L“‡Œö‰h, ’ҁ@@F, ˛“Ą–ž’j (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Œ`ŹE”üŠO): ‘ć15‰ń“ú–{Äśˆă—ĂŠw‰ď‘‰ď (2016/3/19), ‘ĺă.

731124. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) –Ń”ŻŽĄ—Ă‚ĚŒťó‚Ɖ”\Ť. •“c@Œ[ (Œ`ŹE”üŠO): ‘ć98‰ń‹ăBE‰Ť“ęŒ`ŹŠO‰ČŠw‰ď (2015/6/27), •Ÿ‰Ş.

733008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘nŽĄ–ü‚É‚¨‚Ż‚éVascular Endothelial Growth Factor Receptor 1 Tyrosine KinaseƒVƒOƒiƒ‹‚Ě–đŠ„. –p@Œ\ˆę1, “V–ě‰pŽ÷2, ×–ě‰Á“ŢŽq2,3, ”–ؐT–ç4, ‚‹´@—ş1, a’JłŽj, ‹g’|r—T1, •“c@Œ[4, ”n“ˆł—˛2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–ň—, 3ś—, 4Œ`ŹE”üŠO): ‘ć132‰ń“ú–{–ň—Šw‰ďŠÖ“Œ•”‰ď (2015/7/4), ç—t.

733247. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’†Žčœ–ü‡Ç‚Ě1—á. Ş–{@[ (Œ`ŹE”üŠO): ‘ć7‰ńŠÖ“ŒăŽˆć“VˆŮíÇ—ጟ“˘‰ď (2015/7/15), `‹ć.

733248. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŒűOŒűŠW—ôŠłŽŇ‚ĚŠO‰Č“I‹¸łŽĄ—Ă. ŽRčˆŔ° (Œ`ŹE”üŠO): •˝Ź27”N“x‰Ä‚ĚŒűO—ôEŒűŠW—ô‹¸łŽĄ—Õ׋­‰ď (2015/8/27), _“ސě.

733249. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) WŠw“I™ů‡ÄŒš‚É‚¨‚Ż‚鎕‰ČƒCƒ“ƒvƒ‰ƒ“ƒgŽĄ—Ă‚ĚˆÓ‹`. ŽRčˆŔ° (Œ`ŹE”üŠO): International Team for Implantology study club (2015/9/4), _“ސě.

733250. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’…ˆß’…‰Î”M‚Ě3—á. •Ÿˆä’‘ĺ1, ŒFŕVŒ›ˆę2, H–{•ôŽ1, Ş–{@[1, •“c@Œ[1 (1Œ`ŹE”üŠO, 2‹~–˝): ‘ć23‰ńVh”MƒtƒH[ƒ‰ƒ€ (2015/9/11), Vh‹ć.

733251. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ÇŠ‰Aˆł•Â˝—Ă–@‚đŽg—p‚ľ‚ÄŽĄ—Ă‚đs‚Á‚˝‹šœœ‘‰Š. ˆęŽr˘, ŽR“c’źl1 (1Œ`ŹE”üŠO): ‘ć18‰ń–k—˘Œ`ŹŠO‰ČƒtƒH[ƒ‰ƒ€ (2015/10/12), _“ސě.

733252. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ő‚Ş”äŠr“I–Ú—§‚˝‚Č‚˘ŒűŠp‹“ăŽčp. “‡‘qNl (Œ`ŹE”üŠO): ‘ć6‰ńJAAS“Œ‹žƒ‰ƒCƒuƒtƒH[ƒ‰ƒ€ (2015/10/25), “Œ‹ž.

733253. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Žá”N—Ť‚̉A•”‚É”­Ç‚ľ‚˝“î•”Žîá‡. ˆęŽr˘, ŽR“c’źl1 (1Œ`ŹE”üŠO): •˝Ź27”N_“ŢěŒ§Œ`ŹŠO‰ČÇ—ጟ“˘‰ď (2015), _“ސě.

733254. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Žč•””M‚̐A”çŒĹ’č‚ÉNPWT‚đ—p‚˘‚˝3—á. •ş“Ş“O–ç1, ŒFŕVŒ›ˆę2, Ş–{@[1, •–ö”ü—˘1, H–{•ôŽ1, •“c@Œ[1 (1Œ`ŹE”üŠO, 2‹~–˝): ‘ć24‰ń“ú–{”MŠw‰ďŠÖ“Œ’n•ű‰ď (2016/2/20), “Œ‹ž.

733255. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚édÇ”MŠłŽŇÝ‰@“ú”‚ĚŒťó. Ş–{@[1, ŒFŕVŒ›ˆę2, H–{•ôŽ1, ƒ’r“Ţ’ĂŽq1, ó—˜@–ő2, •“c@Œ[1 (1Œ`ŹE”üŠO, 2‹~–˝): ‘ć24‰ń“ú–{”MŠw‰ďŠÖ“Œ’n•ű‰ď (2016/2/20), “Œ‹ž.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H25-110001. [Œ´’˜] Immediate Reconstruction After Removal of Nasal Prosthesis Using Diced Cartilage Wrapped With Temporal Fascia. Takeda A1, Akimoto M1, Ishikawa S1, Sugimoto T1, Himi K, Shimakura Y1, Furuyama N, Nakakita N: J Craniofac Surg 2014/3; 25 (2): 535-8. (•“c@Œ[1, H–{•ôŽ1, ÎěS‰î1, ™–{F”V1, “‡‘qNl1: 1Œ`ŹE”üŠO)

H25-522005. [uŔ]y“ÁW2: Žč‚Í‚ś‚ß‚Ć‚ˇ‚é˜Io•”‚É‚¨‚Ż‚éMicrosurgical reconstruction‚̐Ž—e“I”z—śz”ç•ŮCł‚đ—v‚ľ‚˝ŽlŽˆÄŒš—á‚ĚŒŸ“˘|‹@”\“I, Ž—e“IŽlŽˆÄŒš‚đ–ÚŽw‚ľ‚ā|. Ş–{@[1, ŒFŕVŒ›ˆę2, ÎěS‰î1, ƒ’r“Ţ’ĂŽq1, “ŕŔ‰hŽ÷3 (1Œ`ŹE”üŠO, 2‹~–˝, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[) “ú–{ƒ}ƒCƒNƒƒT[ƒWƒƒƒŠ[Šw‰ď‰ďŽ 2013/; 26 (2): 55-60.

H26-110016. [Œ´’˜] Development of cultured dermal substitute composed of hyaluronic acid and collagen spongy sheet containing fibroblasts and epidermal growth factor. Kuroyanagi M1, Yamamoto A, Shimizu N, Ishihara E, Ohno H, Takeda A1, Kuroyanagi Y: J Biomater Sci Polym Ed 2014; 25 (11): 1133-43. (•–ö”ü—˘1, •“c@Œ[1: 1Œ`ŹE”üŠO)

H26-110017. [Œ´’˜] Development of anti-adhesive spongy sheet composed of hyaluronic acid and collagen containing epidermal growth factor. Kuroyanagi M1, Yamamoto A, Shimizu N, Toi A, Inomata T, Takeda A1, Kuroyanagi Y: J Biomater Sci Polym Ed 2014; 25 (12): 1253-65. (•–ö”ü—˘1, •“c@Œ[1: 1Œ`ŹE”üŠO)

[Šw‰ďEŒ¤‹†‰ď“™]

H26-722003. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) •@•”’“üŽĄ—͇•šÇ‚Ě5—á “‡‘qNl1, •“c@Œ[1, ’r“c‹Óś, Xěˆę•F (1Œ`ŹE”üŠO): ‘ć37‰ń“ú–{”ü—eŠO‰ČŠw‰ď‘‰ď (2014/9/4), “Œ‹ž.

H26-723012. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’ˇŠú“€Œ‹•Ű‘ś‚ł‚ę‚˝ƒqƒgœ‘gD—R—ˆŠÔ—tŒn×–E‚ĚˆŔ‘SŤ. ™–{F”V1, ŽRčˆŔ°1, ‘]Ş—R”üŽq2, ŒFŕVŒ›ˆę3, •“c@Œ[1 (1Œ`ŹE”üŠO, 2•a‘ԁEf—ĂŒn, 3‹~–˝): ‘ć14‰ń“ú–{Äśˆă—ĂŠw‰ď‘‰ď (2015/3/19), _“ސě.

H26-733008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) —ź‘¤žô‘¤—ńŒ`Ź•s‘S‚Ě1—á|ĄŒă‚ĚŽĄ—Ă•űj‚ɂ‚˘‚ā|. Ş–{@[ (Œ`ŹE”üŠO): ‘ć6‰ńŠÖ“ŒăŽˆć“VˆŮíÇ—ጟ“˘‰ď (2015/1/18), `‹ć.


”畆‰ČŠw

[Šwp˜_•ś]

110240. [Œ´’˜] From hair to heart: nestin-expressing hair-follicle-associated pluripotent (HAP) stem cells differentiate to beating cardiac muscle cells. Yashiro M1, Mii S1, Aki R1, Hamada Y2, Arakawa N, Kawahara K3, Hoffman RM, Amoh Y1: Cell Cycle 2015/7; 14 (14): 2362-6. (‰Ž‘㐳W1, ŽOˆäƒá1, ˆŔĺY—Lję1, •l“c—SŽq2, ‰ÍŒ´Ž‰ë3, “V‰HN”V1: 1”畆, 2•a‘ԁEf—ĂŒn, 3ś—)

110241. [Œ´’˜] Long-Term Extensive Ectopic Hair Growth on the Spinal Cord of Mice from Transplanted Whisker Follicles. Cao W, Li L, Mii S1, Amoh Y1, Liu F, Hoffman RM: PLoS One 2015/8; 10 (8): e0133475. (ŽOˆäƒá1, “V‰HN”V1: 1”畆)

110242. [Œ´’˜] Cryopreservation of the Hair Follicle Maintains Pluripotency of Nestin-Expressing Hair Follicle-Associated Pluripotent Stem Cells. Kajiura S1, Mii S1, Aki R1, Hamada Y2, Arakawa N, Kawahara K3, Li L, Katsuoka K, Hoffman RM, Amoh Y1: Tissue Eng Part C Methods 2015/8; 21 (8): 825-31. (Š‰Y’qŽk1, ŽOˆäƒá1, ˆŔĺY—Lję1, •l“c—SŽq2, ‰ÍŒ´Ž‰ë3, “V‰HN”V1: 1”畆, 2•a‘ԁEf—ĂŒn, 3ś—)

110243. [Œ´’˜] Reduced expression of dermcidin, a peptide active against propionibacterium acnes, in sweat of patients with acne vulgaris. Nakano T, Yoshino T, Fujimura T1, Arai S, Mukuno A, Sato N1, Katsuoka K: Acta Derm Venereol 2015/9; 95 (7): 783-6. (“Ą‘ş‹ż’j1, ˛“Ą’źĆ1: 1”畆)

110244. [Œ´’˜] Extensive Hair-Shaft Elongation by Isolated Mouse Whisker Follicles in Very Long-Term GelfoamŇ Histoculture. Cao W, Li L, Mii S1, Amoh Y1, Liu F, Hoffman RM: PLoS One 2015/10; 10 (9): e0138005. (ŽOˆäƒá1, “V‰HN”V1: 1”畆)

110245. [Œ´’˜] NUP160-SLC43A3 is a novel recurrent fusion oncogene in angiosarcoma. Shimozono N, Jinnin M, Masuawa M1, Masuzawa M, Wang Z, Hirano A, Tomozawa Y, Etho-Kira T, Kajihara I, Harada M, Fukushima S, Ihn H: Cancer Res 2015/11; 75 (21): 4458-65. (‘ŕV^ŽŔŽq1: 1”畆)

120033. [Œ´’˜] ƒQƒ€ƒVƒ^ƒrƒ“‚Ş‘tŒř‚ľ‚˝isŠú‹Űó‘§“÷Ç‚Ě2—á‚ĆŠCŠO•ń—á‚Ě•śŒŁ“IlŽ@. ‘ŕV^ŽŔŽq1, ‚{@”Ž1, “V‰HN”V1 (1”畆): Šŕ‚ƉťŠw—Ă–@ 2015/12; 42 (13): 2451-5.

210005. [€Œ´’˜]yNotezImmune Milk Suppresses Herpes Simplex Virus Type 1. Masuzawa M, Masuzawa M1, Arakawa N, Hamada Y2, Tamauchi H, Morita M, Nishiyama S, Sato Y: J Nutr Sci Vitaminol (Tokyo) 2016; 62 (1): 67-70. (‘ŕV^ŽŔŽq1, •l“c—SŽq2: 1”畆, 2•a‘ԁEf—ĂŒn)

310027. [Ç—á•ń] A case of Kikuchi's disease (histiocytic necrotizing lymphoadenitis) with histiocytic cutaneous involvement. Obara K1, Amoh Y1: Rheumatol Int 2015/6; 35 (6): 1111-3. (ŹŒ´GĆ1, “V‰HN”V1: 1”畆)

540016. [‚ť‚Ě‘ź (ƒKƒCƒhƒ‰ƒCƒ“)]y“ú–{”畆‰ČŠw‰ďƒKƒCƒhƒ‰ƒCƒ“z“Ş•”ŒŒŠÇ“÷Žîf—ĂƒKƒCƒhƒ‰ƒCƒ“. ‘ŕVŠ˛’j, ’|’†G–ç, ‘ş“c@“N, ‘şăMŽi, “cŒű—˘Žj, ó‰zŒ’ŽĄ, ‘ŕV^ŽŔŽq1, ‘ě˜ad2, ŒĂ‰ęOŽu, “y“c“N–ç (1”畆, 2•úŽËü (Žîá‡)): “ú–{”畆‰ČŠw‰ďŽGŽ 2015/9; 125 (10): 1871-88.

540017. [‚ť‚Ě‘ź (Šw‰ď´˜^)]y“Œ‹ž’n•ű‰ď‘ć863‰ń`‘ć864‰ń—á‰ď (Žl’n‹ć•Ş‰ď)zˆâ“`Ť•â‘ĚŒ‡‘šÇ‚đ‹^‚Á‚˝DLE‚Ě1—á. ‘O“‡‰pŽ÷1, “n˜đ@W1, ŽOˆäƒá1, “V‰HN”V1, “c’†Z–ž2 (1”畆, 2äPŒ´•aĽŠ´ő“ŕ): “ú–{”畆‰ČŠw‰ďŽGŽ 2016/2; 126 (2): 190.

[Šw‰ďEŒ¤‹†‰ď“™]

713085. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Effect of Pazopanib for advanced cutaneous angiosarcoma as a second-line treatment after Taxane chemotherapy. Masuzawa M1, Hori T1, Obara K1, Mii S1, Amoh Y1: 23rd World congress of Dermatology (2015/6/8-13), Vancouver, Canada. (‘ŕV^ŽŔŽq1, –x@’qs1, ŹŒ´GĆ1, ŽOˆäƒá1, “V‰HN”V1: 1”畆)

713086. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The Nestin Expressing cells in the hair follicle innervated injured nerve differentiate into neurons in vitro and vivo. Mii S1, Duong J, Uchugonova A, Liu F, Tran B, Amoh Y1, Hoffman RM: 9th World Congress for Hair Research (2015/11/19), Miami, USA. (ŽOˆäƒá1, “V‰HN”V1: 1”畆)

713087. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Hair follicle pluripotent stem cells can differentiate to cardiac muscle cells. Amoh Y1, Yashiro M1, Mii S1, Aki R1, Hamada Y2, Arakawa N, Kawahara K3, Hoffman RM: 9th World Congress for Hair Research (2015/11/20), Miami, USA. (“V‰HN”V1, ‰Ž‘㐳W1, ŽOˆäƒá1, ˆŔĺY—Lję1, •l“c—SŽq2, ‰ÍŒ´Ž‰ë3: 1”畆, 2•a‘ԁEŒ`‘ÔŒn, 3ś—)

723624. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ––˝_Œo‚É‚ ‚éƒlƒXƒ`ƒ“—zŤ×–E‚͐_ŒoáŠQŽž‚ɐ_Œo×–E‚ɕމť‚ˇ‚é. ŽOˆäƒá1, “V‰HN”V1, Hoffman RM (1”畆): ‘ć30‰ń“ú–{Ň‘ŠO‰ČŠw‰ď (2015/6/26), ŽD–y.

723625. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “Ş•”ŒŒŠÇ“÷Žî‚ɑ΂ˇ‚éTomotherapy‚É‚ć‚é‘S“Ş”ç•úŽËüŽĄ—Ă: L”͐Z—á‚ɑ΂ˇ‚é’§í“IŽĄ—Ă. ‘ŕV^ŽŔŽq1, –x@’qs1, ‚–ě“N˜Y1, “n˜đ@W1, ŠÖŒűˆŠˆß2, ŽOˆäƒá1, “V‰HN”V1, ‘ě˜ad2 (1”畆, 2•úŽËü (Žîá‡)): ‘ć31‰ń“ú–{”畆ˆŤŤŽîᇊw‰ďŠwp‘ĺ‰ď (2015/7/3), ‘ĺă, “ú–{”畆ˆŤŤŽîᇊw‰ďŠwp‘ĺ‰ďƒvƒƒOƒ‰ƒ€E´˜^W 2015/7; 31: 132.

723626. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Enterococcus faecalis EC-12‚̐ێ悪qíŤ‚´áŒ‚É‹y‚Ú‚ˇ‰e‹ż. ˆÉ’n’m“Nś, ˛“Ą’źĆ1, “Ą‘ş‹ż’j1 (1”畆): “ú–{“űŽ_‹ŰŠw‰ď2015”N“x‘ĺ‰ď (2015/7/11), Žsě.

723627. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Pencil in cup‚đl‚Ś‚é. ‘O“‡‰pŽ÷1, źŽR_”ü, ˆŔĺY—Lję1, “n˜đ@W1, “V‰HN”V1 (1”畆): ‘ć30‰ń“ú–{ŠŁáŠw‰ďŠwp‘ĺ‰ď (2015/9/4), –źŒĂ‰Ž.

723628. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Unique regions in the Mycobacterium leprae Mce1A protein associated with the initial transmission of leprosy. Viesta Fadlitha beby, ˛“Ą’źĆ1, Idris Irfan, Rachman Fatul, “Ą‘ş‹ż’j1, Takimoto H (1”畆): ‘ć89‰ń“ú–{×‹ŰŠw‰ď‘‰ď (2016/3/24), ‘ĺă.

732053. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) –ѕ×–E‚Ě‘˝•Ş‰Â”\|S‘Ÿ‚ɖт͐ś‚Ś‚Č‚˘‚Ş–Ń‚Š‚çS‘Ÿ‚Í‚Ĺ‚Ť‚é|. “V‰HN”V (”畆): ‘ć79‰ń“ú–{”畆‰ČŠw‰ď“Œ‹žE“Ş•”Žx•”‡“ŻŠwp‘ĺ‰ď (2016/2/20), “Œ‹ž.

733256. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ––˝_ŒoüˆŰ‚ĚƒlƒXƒ`ƒ“—zŤ×–E‚͏ŠQC•œ‰ß’ö‚Ő_ŒoEƒOƒŠƒA×–E‚ɕމť‚ˇ‚é. ŽOˆäƒá1, ‰ÍŒ´Ž‰ë2, Robert M Hoffman, “V‰HN”V1 (1”畆, 2ś—): ś—ŠwŒ¤‹†ŠŒ¤‹†‰ďś‘ĚƒVƒOƒiƒ‹ƒ_ƒCƒiƒ~ƒNƒX (2015/9/3), ‰Şč.

733257. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Coma blister‚Ě1—á. ŽOˆäƒá1, “V‰HN”V1 (1”畆): ‘ć862‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď (2015/9/12), “Œ‹ž.

733258. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’܍b‰ş”^ᇂƎv‚í‚ę‚˝ƒqƒgƒpƒsƒ[ƒ}ƒEƒBƒ‹ƒX (HPV) 11Œ^—zŤ‚Ě’Ü°ƒ{[ƒGƒ“•a. ‘ŕV^ŽŔŽq1, “n˜đ@W1, “V‰HN”V1, ƒ’r“Ţ’ĂŽq2, Œ´@˜a–î, –k—˘‰p˜Y3 (1”畆, 2Œ`ŹE”üŠO, 3ˆă—ÉqśŠw•”): ‘ć863‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď (2015/11/14), “Œ‹ž.

733259. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘˝”­ŒŒŠÇ‰ŠŤ“÷‰čŽîÇ (Wegener“÷‰čŽî) ‚Ě1—á. •ĐŽR’qŒbŽq1, “ż‰içt2, Œ´@”ü•ü2, ŽRč@“N2, ŽRă”ü]3 (1”畆, 2‘ĺ˜aŽs—§•a‰@, 3‘Š–Í‘ä•a‰@): “ú–{”畆‰ČŠw‰ď‘ć864‰ń“Œ‹ž’n•ű‰ď (2015/12/19), _“ސě.

733260. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) KL-6‚̍‚’l‚đŽŚ‚ľ‚˝ˆŤŤŽîᇍ‡•š”畆‹Ř‰Š‚Ě3—á. ŽOˆäƒá1, ˆŔĺY—Lję1, ‘ŕV^ŽŔŽq1, ‹{ŕV—ŒbŽq1, “ŕŠC—F—1, “V‰HN”V1 (1”畆): ‘ć39‰ń”畆–ŹŠÇEäPŒ´•aŒ¤‹†‰ď (2016/1/22), ‚’m.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H14-522001. [uŔ]y“ÁW: ŹŽ™‚̔畆•az—Տ°—á: ––˝ŒŒŠ˛×–EˆÚAŒă‚ɐś‚ś‚˝GVHD. ˆŔĺY—Lję1, Œ´“c°”ü, ‰q“Ą@Œő (1”畆): ”畆•af—Ă 2003/3; 25 (3): 299-302.

H16-522001. [uŔ]y“ÁW: ‘Ťćä‚̉óásE’×ᇁz—Տ°—á: •ÂÇŤ“Ž–Źd‰ťÇ. ˆŔĺY—Lję1, óˆä‚Ć‚ľŽq, VˆätŽ} (1”畆): ”畆•af—Ă 2005/1; 27 (1): 47-50.

H18-522001. [uŔ]y“ÁW: •ˇ‚ŤŠľ‚ę‚Č‚˘ÇŒóŒQz—Տ°—á: OlmstedÇŒóŒQ. ˆŔĺY—Lję1, Œ´“c°”ü, ‰q“Ą@Œő, ˆŔź—L‹I, ‘ĺ–î’B’j (1”畆): ”畆•af—Ă 2006/12; 28 (12): 299-302.

H22-110001. [Œ´’˜] Analysis of clinical, radiological and laboratory variables in psoriatic arthritis with 25 Japanese patients. Maejima H1, Taniguchi T1, Watarai A1, Aki R1, Katsuoka K1: J Dermatol 2010/7; 37 (7): 647-56. (‘O“‡‰pŽ÷1, ’JŒű—F‘Ľ1, “x˜đ@W1, ˆŔĺY—Lję1, Ÿ‰ŞŒ›ś1: 1”畆)

H22-120001. [Œ´’˜] ƒIƒƒpƒ^ƒWƒ“‰–Ž_‰– (ƒAƒŒƒƒbƒN) ‚Ě–Ť“Á”­Ťĺ@–ƒ]‚ɑ΂ˇ‚鑝—ĘŒř‰Ę‚ĚŒŸ“˘. VŽRŽj˜N1, ’JŒű—F‘Ľ1, “c•ÓŒ’ˆę1, ‘O“cˆŸŠóŽq, ˆŔĺY—Lję1, ŽOˆäƒá1, “í@@•‘, “V‰HN”V1, ‘O“‡‰pŽ÷1, Œü–ě@“N1, âV“Ą“T[1, Vˆä@’B1, Ÿ‰ŞŒ›ś1 (1”畆): Progress in Medicine 2010/8; 30 (8): 2233-7.

H24-110001. [Œ´’˜] Fluorescent proteins enhance UVC PDT of cancer cells. Momiyama M, Suetsugu A, Kimura H, Kishimoto H, Aki R1, Yamada A, Sakurada H, Chishima T, Bouvet M, Bulgakova NN, Endo I, Hoffman RM: Anticancer Res 2012/10; 32 (10): 4327-30. (ˆŔĺY—Lję1: 1”畆)

H24-110002. [Œ´’˜] Imaging the efficacy of UVC irradiation on superficial brain tumors and metastasis in live mice at the subcellular level. Momiyama M, Suetsugu A, Kimura H, Kishimoto H, Aki R1, Yamada A, Sakurada H, Chishima T, Bouvet M, Endo I, Hoffman RM: J Cell Biochem 2013/2; 114 (2): 428-34. (ˆŔĺY—Lję1: 1”畆)

H26-522013. [uŔ]y‘ć30‰ń“ú–{”畆ˆŤŤŽîᇊw‰ďƒVƒ“ƒ|ƒWƒEƒ€6zŠÉ˜aˆă—ÂƔ畆‰Č2014: ”畆Šŕ‚ĆƒŠƒ“ƒpŠÇáŠV@ƒŠƒ“ƒp•‚Žî‚É‘ą”­‚ˇ‚é–ŹŠÇ“÷Žî. ‘ŕV^ŽŔŽq (”畆): Skin Cancer 2014/11; 29 (2): 131-3.

[Šw‰ďEŒ¤‹†‰ď“™]

H26-733009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒJƒŒƒC‚Ě‹›—‘‚É‚ć‚éƒAƒiƒtƒBƒ‰ƒLƒV[‚Ě1—á. “Œ‹V“ß’ĂŽq1, ‰Ž‘ă–˘‰Ŕ1, ‘O“‡‰pŽ÷1, ‚{@”Ž1, “V‰HN”V1, “í@@•‘ (1”畆):“ú–{”畆‰ČŠw‰ď‘ć857‰ń“Œ‹ž’n•ű‰ď (2014/11/15), ç—t, “ú–{”畆‰ČŠw‰ďŽGŽ 2014/9; 124 (10): 1963.

H26-733010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠO‰Č“IŘœ‚ƏpŒă‰ťŠw—Ă–@‚Ş—LŒř‚Ĺ‚ ‚Á‚˝‹š•”‚Ě•úŽËüĆŽËŒăŒŒŠÇ“÷Žî. ‘ŕV^ŽŔŽq1, Š‰Y’qŽk1, “V‰HN”V1, H–{•ôŽ (1”畆): ‘ć859‰ń“ú–{”畆‰ČŠw‰ď“Œ‹ž’n•ű‰ď (2015/1/17), “Œ‹ž.

H26-733011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ž•“÷•Ó—΂ɐś‚ś‚˝qíŤ“VávጂĚ1—á. •ĐŽR’qŒbŽq1, âV“Ą‹ąŽq1, “ż‰içt2, ŹŕV’m—Ď2, Îˆä•śl, ‹´–{@—˛3 (1”畆, 2‘ĺ˜aŽs—§•a‰@, 3‹v—Ż•Ä‘ĺŠw): “ú–{”畆‰ČŠw‰ď‘ć859‰ń“Œ‹ž’n•ű‰ď (2015/1/17), _“ސě.


”ĺ”AŠí‰ČŠw

[Šwp˜_•ś]

110246. [Œ´’˜] Conditional survival after radical nephroureterectomy for upper tract carcinoma. Ploussard G, Xylinas E, Lotan Y, Novara G, Margulis V, Roupret M, Matsumoto K1, Karakiewicz PI, Montorsi F, Remzi M, Seitz C, Scherr DS, Kapoor A, Fairey AS, Rendon R, Izawa J, Black PC, Lacombe L, Shariat SF, Kassouf W: Eur Urol 2015/4; 67 (4): 803-12. (ź–{˜aŤ1: 1”ĺ”AŠí)

110247. [Œ´’˜] Laparoscopic pyeloplasty for secondary ureteropelvic junction obstruction: long-term results. Nishi M1, Tsuchida M1, Ikeda M1, Matsuda D1, Iwamura M1: Int J Urol 2015/4; 22 (4): 368-71. (ź@ˇG1, “y“c–š”ü1, ’r“cŸb1, ź“c‘ĺ‰î1, Šâ‘şłŽk1: 1”ĺ”AŠí)

110248. [Œ´’˜] Laparoscopic Retroperitoneal Nephroureterectomy is a Safe and Adherent Modality for Obese Patients with Upper Urinary Tract Urothelial Carcinoma. Matsumoto K1, Hirayama T1, Kobayashi K1, Hirano S1, Nishi M1, Ishii D1, Tabata K1, Fujita T1, Iwamura M1: Asian Pac J Cancer Prev 2015/4; 16 (8): 3223-7. (ź–{˜aŤ1, •˝ŽR‹M”Ž1, Ź—ŃŒ’‘ž˜Y1, •˝–ěC•˝1, ź@ˇG1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, “Ą“c“N•v1, Šâ‘şłŽk1: 1”ĺ”AŠí)

110249. [Œ´’˜] Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS). Saito S, Ito K, Yorozu A, Aoki M, Koga H, Satoh T1, Ohashi T, Shigematsu N, Maruo S, Kikuchi T, Kojima S, Dokiya T, Fukushima M, Yamanaka H: Int J Clin Oncol 2015/4; 20 (2): 375-85. (˛“ĄˆĐ•ś1: 1”ĺ”AŠí)

110250. [Œ´’˜] Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression. Noguchi M, Arai G, Matsumoto K1, Naito S, Moriya F, Suekane S, Komatsu N Matsueda S, Sasada T, Yamada A, Kakuma T, Itoh K: Cancer Immunol Immunother 2015/4; 64 (4): 493-505. (ź–{˜aŤ1: 1”ĺ”AŠí)

110251. [Œ´’˜] A multicenter retrospective analysis of sequential treatment of abiraterone acetate followed by docetaxel in Japanese patients with metastatic castration-resistant prostate cancer. Ueda Y, Matsubara N, Takizawa I, Nishiyama T, Tabata K1, Satoh T1, Kamiya N, Suzuki H, Kawahara T, Uemura H: Jpn J Clin Oncol 2015/4; 45 (8): 774-9. (“c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1: 1”ĺ”AŠí)

110252. [Œ´’˜] Enhanced central memory cluster of differentiation 8+ and tumor antigen-specific T cells in prostate cancer patients receiving repeated in situ adenovirus-mediated suicide gene therapy. Kubo M1, Satoh T2, Tabata K2, Tsumura H2, Iwamura M2, Baba S2, Thompson TC, Obata F1: Mol Clin Oncol 2015/5; 3 (3): 515-21. (‹v•Ű@˝1, ˛“ĄˆĐ•ś2, “c”¨Œ’ˆę2, ’Ă‘şGN2, Šâ‘şłŽk2, ”nęŽu˜Y2, Ź”Ś•ś–í1: 1ˆă—ÉqśŠw•”, 2”ĺ”AŠí)

110253. [Œ´’˜] Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model. Abe T, Ishii D1, Gorbacheva V, Kohei N, Tsuda H, Tanaka T, Dvorina N, Nonomura N, Takahara S, Valujskikh A, Baldwin WM 3rd, Fairchild RL: Am J Transplant 2015/5; 15 (5): 1192-204. (Îˆä‘ĺ•ă1: 1”ĺ”AŠí)

110254. [Œ´’˜] AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies. Omlin A, Jones RJ, van der Noll R, Satoh T1, Niwakawa M, Smith SA, Graham J, Ong M, Finkelman RD, Schellens JHM, Zivi A, Crespo M, Riisnaes R, Nava-Rodrigues D, Malone MD, Dive C, Sloane R, Moore D, Alumkal JJ, Dymond A, Dickinson PA, Ranson M, Clack G, de Bono J, Elliott T: Invest New Drugs 2015/6; 33 (3): 679-90. (˛“ĄˆĐ•ś1: 1”ĺ”AŠí)

110255. [Œ´’˜] GLIPR1-ƒ˘TM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells. Karanika S, Karantanos T, Kurosaka S1, Wang J, Hirayama T1, Yang G, Park S, Golstov AA, Tanimoto R, Li L, Thompson TC: Mol Cancer 2015/6; 14 (122): 1-13. (•âáÁ“ń1, •˝ŽR‹M”Ž1: 1”ĺ”AŠí)

110256. [Œ´’˜] Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study. Nuhn P, Novara G, Seitz C, Gupta A, Matsumoto K1, Kassouf W, Walton TJ, Fritsche HM, Tritschler S, Martinez-Salamanca JI, Ficarra V, Karakiewicz PI, Mazzoleni G, Shariat SF, Bastian PJ: World J Urol 2015/7; 33 (7): 1005-13. (ź–{˜aŤ1: 1”ĺ”AŠí)

110257. [Œ´’˜] Protein expression profile related to cisplatin resistance in bladder cancer cell lines detected by two-dimensional gel electrophoresis. Taoka Y1, Matsumoto K1, Ohashi K, Minamida S1, Hagiwara M1, Nagi S1, Saito T2, Kodera Y2, Iwamura M1: Biomed Res 2015/8; 36 (4): 253-61. (“c‰Ş‰ŔŒ›1, ź–{˜aŤ1, “ě“c@—@1, ”‹Œ´ł”Ž1, –ź–؏l1, Ö“Ą’B–ç2, ŹŽ›‹`’j2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2—Šw•”)

110258. [Œ´’˜] Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma. Fujii Y, Ikeda M1, Kurosawa K, Tabata M, Kamigaito T, Hosoda C, Okaneya T: Int J Clin Oncol 2015/8; 20 (4): 802-7. (’r“cŸb1: 1”ĺ”AŠí)

110259. [Œ´’˜] Effect of Ang-2-VEGF-A Bispecific Antibody in Renal Cell Carcinoma. Bessho H1, Wong B, Huang D, Tan J, Ong CK, Iwamura M1, Hart S, Dangl M, Thomas M, Teh BT: Cancer Invest 2015/9; 33 (8): 378-86. (•ĘŠ‰pŽĄ1, Šâ‘şłŽk1: 1”ĺ”AŠí)

110260. [Œ´’˜] Impact of adjuvant chemotherapy on patients with pathological Stage T3b and/or lymph node metastatic bladder cancer after radical cystectomy. Tabata M, Ikeda M1, Urakami S, Takahashi S, Sakaguchi K, Kurosawa K, Okaneya T: Jpn J Clin Oncol 2015/10; 45 (10): 963-7. (’r“cŸb1: 1”ĺ”AŠí)

110261. [Œ´’˜] Recovery of serum testosterone following neoadjuvant and adjuvant androgen deprivation therapy in men treated with prostate brachytherapy. Tsumura H1, Satoh T1, Ishiyama H2, Hirano S1, Tabata K1, Kurosaka S1, Matsumoto K1, Fujita T1, Kitano M2, Baba S1, Hayakawa K2, Iwamura M1: World J Radiol 2015/12; 7 (12): 494-500. (’Ă‘şGN1, ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2, •˝–ěC•˝1, “c”¨Œ’ˆę1, •âáÁ“ń1, ź–{˜aŤ1, “Ą“c“N•v1, –k–ě‰ëŽj2, ”nęŽu˜Y1, ‘ě˜ad2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2•úŽËü (Žîá‡))

110262. [Œ´’˜] An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy. Noguchi M, Matsumoto K1, Uemura H, Arai G, Eto M, Naito S, Ohyama C, Nasu Y, Tanaka M, Moriya F, Suekane S, Matsueda S, Komatsu N, Sasada T, Yamada A, Kakuma T, Itoh K: Clin Cancer Res 2016/1; 22 (1): 54-60. (ź–{˜aŤ1: 1”ĺ”AŠí)

110263. [Œ´’˜] Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-GuŽrin Instillation Therapy for Nonmuscle Invasive Bladder Cancer. Yokomizo A, Kanimoto Y, Okamura T, Ozono S, Koga H, Iwamura M1, Tanaka H, Takahashi S, Tsushima T, Kanayama H, Akaza H, Shinohara N, Mugiya S, Nomata K, Nakamura T, Naito S: J Urol 2016/1; 195 (1): 41-6. (Šâ‘şłŽk1: 1”ĺ”AŠí)

110264. [Œ´’˜] Incremental Expression of 14-3-3 Protein Beta/Alpha in Urine Correlates with Advanced Stage and Poor Survival in Patients with Clear Cell Renal Cell Carcinoma. Kaneko S1, Matsumoto K1, Minamida S1, Hirayama T1, Fujita T1, Kodera Y2, Iwamura M1: Asian Pac J Cancer Prev 2016/2; 17 (3): 1399-404. (‹ŕŽqŽu•Ű1, ź–{˜aŤ1, “ě“c@—@1, •˝ŽR‹M”Ž1, “Ą“c“N•v1, ŹŽ›‹`’j2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2—Šw•” (•¨—))

120034. [Œ´’˜] ƒAƒ‹ƒMƒ“Ž_ƒiƒgƒŠƒEƒ€‚đ—p‚˘‚˝ƒZƒ‹ƒuƒƒbƒN–@‚ĚŒŸ“˘. “c’†@Œ\1, ź‘ş—R—˘1,2, rˆä‚ä‚čŽq2, Š`ŔœA–M3, ’Ź“c‘ĺ•ă3, ŽR‰ş˜a–ç3, ź–{˜aŤ4, ‘ĺ•”@˝2, ˛“Ą—Yˆę2, •ž•”@Šw2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3•a—•”, 4”ĺ”AŠí): _“ސě×–E‰ďŽ 2015/8; 20 (1): 15-23.

120035. [Œ´’˜] Œă• –Œ“î•”“÷Žî‚Ě—Ő°•a—Šw“IŒŸ“˘‚ĆŽĄ—ÐŹŃ. •ŕV˜aG, ‰YăTŽi, ’r“cŸb1, “c”¨^—œŽq, ‘ş“c_Ž, ‰ŞŞ’J—˜ˆę (1”ĺ”AŠí): ”ĺ”AŠí‰Č‹I—v 2015/11; 61 (11): 419-26.

220007. [€Œ´’˜]y‘ć79‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď‹L˜^W@ƒVƒ“ƒ|ƒWƒEƒ€I: ”ĺ”AŠí‰Č—ĚˆćPETf’f‚Ěcutting edgez‘O—§‘BŠŕ‚ɑ΂ˇ‚éV‹KPETf’f|F-18•WŽŻ”ń“V‘RŒ^ƒAƒ~ƒmŽ_‚đ—p‚˘‚˝‘ćI/II‘ŠŽŽŒą|. ‹ŕŽqŽu•Ű1, ˛“ĄˆĐ•ś1, ˆäă—D‰î2, ó–ě—Y“ń2, “c”¨Œ’ˆę1, ’Ă‘şGN1, ‚Œű@‘ĺ1, Œ´@•qŤ2, ÎŽR”ŽžŠ3, ‘ě˜ad3, ”nęŽu˜Y1, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (‰ć‘œ), 3•úŽËü (Žîá‡)): ”ĺ”AŠíŠO‰Č 2015/5; 28 (—Ő‘): 577-9.

220008. [€Œ´’˜]y‘ć79‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď‹L˜^W@ƒVƒ“ƒ|ƒWƒEƒ€5: ƒnƒCƒŠƒXƒN‘O—§‘BŠŕ‚Ö‚Ě’§íz3. Very-high-risk‘O—§‘BŠŕ‚ɑ΂ˇ‚é“ŕ•Ş”ĺ—Ă–@‚ĆŠOĆŽË•š—p‚É‚ć‚éHDR brachytherapy‚Ě—L—pŤ. ’Ă‘şGN1, ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2, “c”¨Œ’ˆę1, –k–ě‰ëŽj2, •âáÁ“ń1, ŠÖŒűˆŠˆß2, ěăłŒĺ2, ŹXłŽq2, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ”ĺ”AŠíŠO‰Č 2015/5; 28 (—Ő‘): 623-5.

220009. [€Œ´’˜]y‘ć79‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď‹L˜^W@ƒVƒ“ƒ|ƒWƒEƒ€9: ŒŔ‹ÇŤ‘O—§‘BŠŕ‚ĚƒAƒEƒgƒJƒ€‚đ—\‘Ş‚ˇ‚é|”A‹Ö§EŤ‹@”\‚Ě“_‚Š‚çz3. ŒŔ‹ÇŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚é•úŽËüŽĄ—Ă: Ť‹@”\‚ĚŒŸ“˘. Ź—ŃŒ’‘ž˜Y1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, “c”¨Œ’ˆę1, –Ř‘şŤ‹M, ™“c@“Ö1, ź‰şˆęm, Žu‘ş@“N, –]ŒŽN•˝1, ÎŽR”ŽžŠ2, ‘ě˜ad2, ”nęŽu˜Y1, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ”ĺ”AŠíŠO‰Č 2015/5; 28 (—Ő‘): 689-91.

220010. [€Œ´’˜]y‘ć79‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď‹L˜^W@ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“: ‚ƒŠƒXƒNŒŔ‹ÇŤE‹ÇŠZ‘O—§‘B‚Ş‚ń‚ĚŽĄ—Ð헪z3. HDRƒuƒ‰ƒLƒZƒ‰ƒs[‚ĚˆÓ‹`. •˝–ěC•˝1, ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2, –k–ě‰ëŽj, ’Ă‘şGN1, “c”¨Œ’ˆę1, Ź—ŃŒ’‘ž˜Y1, –]ŒŽN•˝1, ‹ŕŽqŽu•Ű1, ŠÖŒűˆŠˆß2, ěăłŒĺ2, ’|’†_“ń2, ‘ě˜ad2, ”nęŽu˜Y1, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ”ĺ”AŠíŠO‰Č 2015/8; 28 (8): 1433-5.

320032. [Ç—á•ń] •Ű‘ś“IŽĄ—Ă‚Ş‘tŒř‚ľ‚˝‹CŽîŤäNă÷‰Š‚Ě1—á. ™“c‰ŔŽq, ÝŠy•q–ç, “Ą“c“N•v1 (1”ĺ”AŠí): —Տ°”ĺ”AŠí‰Č 2015/4; 69 (5): 405-7.

320033. [Ç—á•ń] ƒzƒ‹ƒ~ƒEƒ€Eƒ„ƒOƒŒ[ƒU[‚É‚ć‚é•\ÝŤäNă÷Žîᇐ؏œp (Holmium: YAG Laser Resection of Bladder Tumor: HoLRBT) ‚Ě1—á. ™“c‰ŔŽq, ÝŠy•q–ç, •˝ŽR‹M”Ž1, “Ą“c“N•v1 ,‹g“cˆęŹ2, ‹v•ŰŻˆę, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ”ĺ”AŠí‰Č‹I—v 2015/10; 61 (10): 401-3.

320034. [Ç—á•ń] ”A“šƒXƒeƒ“ƒg‚ĚˆÚ“Ž‚É‚ć‚é”A“š‹ˇóÇ—á‚ɑ΂ľŒo‰ď‰A“I‚É”A“šŒ`Źp‚Ćƒzƒ‹ƒ~ƒEƒ€Eƒ„ƒOƒŒ[ƒU[‘O—§‘BŠjop‚đŽ{s‚ľ‚˝1—á. ™“c‰ŔŽq, ÝŠy•q–ç, •˝ŽR‹M”Ž1, “Ą“c“N•v1, ‹g“cˆęŹ2, ‹v•ŰŻˆę, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ”ĺ”AŠíŠO‰Č 2015/12; 28 (12): 1933-8.

320035. [Ç—á•ń] ŠJ• ƒhƒŒƒi[ƒWp‚ĹŒy‰ő‚ľ‚˝”牺‹CŽî‚𔺂¤‹CŽîŤtṐt‰Š‚Ě1—á. Žu‘ş‘sˆę˜N1, “c”¨Œ’ˆę1, ‚Œű@‘ĺ1, “V–ě“”V1, ź@ˇG1, “Ą“c“N•v1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, Šâ‘şłŽk1 (1”ĺ”AŠí): ”ĺ”AŠí‰Č‹I—v 2015/12; 61 (12): 493-7.

520012. [‘ŕ]yPresent and Futurez‘O—§‘BŠŕ‚ɑ΂ˇ‚éfocal therapy: AUA2015‚Ĺ‚ĚƒfƒBƒx[ƒg‚đ“Ľ‚Ü‚Ś‚Ä. ˛“ĄˆĐ•ś (”ĺ”AŠí): Urology Today 2016/3; 23 (1): 66-7.

522122. [uŔ] ‹ĂŒĹEŽ~ŒŒƒfƒoƒCƒX‚ĚˆŔ‘S‚ČŽg‚˘•ű. Šâ‘şłŽk (”ĺ”AŠí): “ú–{”ĺ”AŠí‰ČŠw‰ď2015”N‘˛Œă‹łˆçƒeƒLƒXƒg 2015/4; 20 (1): 206-15. (‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď 2015‘˛Œă‹łˆçƒvƒƒOƒ‰ƒ€)

522123. [uŔ]yŽż‹^‰ž“šzProĚPro [”ĺ”AŠí‰Č] ‘O—§‘BŠŕ•úŽËüŽĄ—ĂŒă‚Ě‹ÇŠÄ”­‚Ö‚Ě‘Îô (‰Ąa@W¨˛“ĄˆĐ•ś). ‰Ąa@W, ˛“ĄˆĐ•ś1 (1”ĺ”AŠí): “ú–{ˆăŽ–V•ń 2015/6; 4756: 59.

522124. [uŔ]yŽż‹^‰ž“šzProĚPro [”ĺ”AŠí‰Č] ‘O—§‘BŠŕ•úŽËüŽĄ—ĂŒă‚̐Ť‹@”\áŠQ‚ւ̑Ήž (˛“ĄˆĐ•ś¨–Ř‘şŤ‹M). ˛“ĄˆĐ•ś1, –Ř‘şŤ‹M (1”ĺ”AŠí): “ú–{ˆăŽ–V•ń 2015/8; 4766: 58-9.

522125. [uŔ]y“ÁW: “d‹C‰j“Ž‚Ěƒtƒƒ“ƒeƒBƒA2015zäNă÷ŠŕŠÖ˜A’`”’‚Ě“Ż’č`“ńŽŸŒł“d‹C‰j“Ž‚đŠÜ‚ŢƒvƒƒeƒI[ƒ€‰đÍ`. ź–{˜aŤ (”ĺ”AŠí): “d‹C‰j“Ž 2015 2015/9; 59 (2): 121-2.

522126. [uŔ]y“ÁW2: ‘O—§‘B”ě‘ĺÇŽčp‚ĚƒRƒc‚Ćƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒOz3. HoLEP (ƒzƒ‹ƒ~ƒEƒ€ƒŒ[ƒU[‚É‚ć‚é‘O—§‘BŠjop) ‚ĚƒRƒc‚Ćƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO. ÝŠy•q–ç, ™“c‰ŔŽq, ‹v•ŰŻˆę, •˝ŽR‹M”Ž1, Šâ‘şłŽk1 (1”ĺ”AŠí): Prostate Journal 2015/10; 2 (2): 261-7.

522127. [uŔ]y‘ć28‰ń–k—˘ŽîᇃtƒH[ƒ‰ƒ€zƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B‘S“Eœp‚ĚŽčpŹŃ|• o‹ž‰şŞŽĄ“I‘O—§‘B‘S“Eœp‚Ć‚Ě”äŠr|. “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, •˝ŽR‹M”Ž1, ź@ˇG1, “Ą“c“N•v1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): –k—˘ˆăŠw 2015/12; 45 (2): 103-7.

522128. [uŔ]y“ÁW: ‘O—§‘BŠŕ|Šî‘bE—Տ°Œ¤‹†‚̍ŐV’mŒŠ|zIII. ĹV‚Ě—Ő°Œ¤‹†@11. ‘O—§‘BŠŕœ“]ˆÚ‚̐f’f‚ƏWŠw“IŽĄ—Ă‚ĚĹV’mŒŠ. ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2 (1”ĺ”AŠí, 2•úŽËü (‰ć‘œ)): “ú–{—Őଠ2016/1; 74 (1): 129-36.

540018. [‚ť‚Ě‘ź] •›‰@’ˇ (f—Ă’S“–) ‚ɏA”C‚ľ‚Ä. Šâ‘şłŽk (”ĺ”AŠí): –k—˘‘ĺŠw•a‰@ƒjƒ…[ƒX 2015/8; 510: 2.

540019. [‚ť‚Ě‘ź]yŔ’k‰ď z‹Ž¨’ďRŤ‘O—§‘BŠŕ (CRPC) ‚ւ̐V‚˝‚ČƒAƒvƒ[ƒ` `CRPCŽĄ—Ă‚É‚¨‚Ż‚é–ňÜ‘I‘đ‚ĚƒL[ƒ|ƒCƒ“ƒg`. Ži‰ď: ⨁@‘Ps, oČŽŇ: Eleni Efstathiou, —é–ŘŒ[‰x, ˛“ĄˆĐ•ś1 (1”ĺ”AŠí): ”ĺ”AŠíŠO‰Č 2015/8; 28 (8): 1467-73.

540020. [‚ť‚Ě‘ź] tˆÚAƒ`[ƒ€‚Š‚ç”­M‚ˇ‚étˆÚAŠłŽŇ‚̉h—{ŠÇ—. ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): CION‰h—{EHŽ–ƒjƒ…[ƒX 2015/10; 28: 1.

540021. [‚ť‚Ě‘ź] tˆÚAŠłŽŇ‚ւ̉h—{Žw“ą‚Ě•K—vŤ, ŽwŽŚ‚Ěƒ|ƒCƒ“ƒg|ŠO‰Čˆă‚Ě—§ę‚Š‚ç|. Îˆä‘ĺ•ă (”ĺ”AŠí): CION‰h—{EHŽ–ƒjƒ…[ƒX 2015/10; 28: 2-3.

540022. [‚ť‚Ě‘ź] –k—˘ˆÚAƒZƒ~ƒi[‚ÉŠń‚š‚ā|ƒWƒFƒlƒŠƒbƒNˆă–ň•i‚ւ̑Ήž|. Îˆä‘ĺ•ă (”ĺ”AŠí): 17th KITASATOˆÚAŽs–ŻƒZƒ~ƒi[ 2015/10; p.4.

540023. [‚ť‚Ě‘ź] ”ĺ”AŠí‰Č‚É‚¨‚Ż‚é• o‹žŽčp. Šâ‘şłŽk1, ‰Í“ŕ–žG, ŹŒ´@q (1”ĺ”AŠí): –ž“ú‚ĚŽĄ—ĂŽwj 2015/12; ƒ‰ƒWƒINIKKEI ˆăŠw“Á•Ę”Ô‘g.

[’˜@‘]

620097. [Šwp‘] (•Ş’SŽˇ•M)y‰Ć‘°ŤŽîᇊw|‰Ć‘°ŤŽîᇂ̍ŐVŒ¤‹†“ŽŒü| (“ú–{—Őଠ‘Š§†No.1083)zII. Še˜_@1. ÇŒóŒQ@(21) Hereditary papillary renal cell carcinoma (ˆâ“`Ť“ű“ޏót×–EŠŕ), p.153-6. “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí), “ú–{—Ő଎Đ, ‘ĺă, 2015/8”­s.

620098. [Šwp‘] (•Ş’SŽˇ•M)yTumor syndromes (—Տ°‰ć‘œ2015”N10ŒŽ‘Š§†)z[‘ć5Í] ˆâ“`ŤtŽîᇁ@2. ˆâ“`Ť“ű“ޏót×–EŠŕ (HPRC)@CLINICAL Findings p.165-6. “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí), Šé‰ćE•Ň: ‘Δn‹`l, •Ň: ŽR“cłM, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2015/9”­s.

620099. [Šwp‘] (•Ş’SŽˇ•M)yĄ“ú‚̏ŹŽ™ŽĄ—ĂŽwj (‘ć16”Ĺ)z17. śBŠíŽžŠł@•ďŒs, ‹T“Ş•ď”牊, p.659. Šâ‘şłŽk (”ĺ”AŠí), ‘•ŇW: …Œű@‰ë, Žs‹´@Œő, čŽR@O, ˆăŠw‘‰@, “Œ‹ž, 2015/9”­s.

620100. [Šwp‘] (•Ş’SŽˇ•M)y‘O—§‘BŠŕ‚Ć’jŤœ‘e頏ǁ|ĹVœŠÇ—ƒ}ƒjƒ…ƒAƒ‹ (‰ü’ů‘ć2”Ĺ)zœ“]ˆÚf’f‚É‚¨‚Ż‚éPET/CT, p174-5. ˛“ĄˆĐ•ś (”ĺ”AŠí), •Ň: ×ˆäF”V, ź“‡@í, ˆăŠw}‘o”Ĺ, “Œ‹ž, 2015/10”­s.

620101. [Šwp‘] (•Ş’SŽˇ•M)yĄ“ú‚ĚŽĄ—ĂŽwj (2016”N”Ĺ)z19. ”ĺ”AŠí‰ČŽžŠł@”A“šŽîᇠ(”A“šƒJƒ‹ƒ“ƒNƒ‹‚đŠÜ‚Ţ), p1201. Šâ‘şłŽk (”ĺ”AŠí), ŠÄC: ŽRŒű@“O, –kŒ´Œő•v, ‘•ŇW: •ŸˆäŽŸ–î, ‚–؁@˝, ŹŽşˆęŹ, ˆăŠw‘‰@, “Œ‹ž, 2016/1”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712018. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Focal Therapy for Pca. Satoh T1: 110th Annual Meeting American Urological Association (2015/5/18), New Orleans, USA. (˛“ĄˆĐ•ś1: 1”ĺ”AŠí)

712019. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Tips and Tricks of Laparoscopy Pyeloplasty -Conventional Laparosocopy. Iwamura M1: The 32rd Japan-Korea Urological Congress (2015/9/19), Seoul, Korea. (Šâ‘şłŽk1: 1”ĺ”AŠí)

713088. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Prognostic impact of C-reactive protein kinetics for advanced renal cell carcinoma treated with sunitinib. Fujita T1, Tabata K1, Ishii D1, Matsumoto K1, Yoshida K2, Iwamura M1: 2015 ASCO Annual Meeting (2015/5/29), Chicago, USA. (“Ą“c“N•v1, “c”¨Œ’ˆę1, Îˆä‘ĺ•ă1, ź–{˜aŤ1, ‹g“cˆęŹ2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

713089. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Everolimus Combined With Early Tacrolimus Minimization In Renal Transplantation: Multicenter Study In Japan. Hattori Y, Teranishi J, Ishii D1, Yoshida K2, Imai N, Kawarazaki H, Shibagaki Y, Sasaki H, Chikaraishi T, Tomikawa S, Marui Y, Nakamura M: 14th Congress of the Asian Society of Transplantation (2015/8/24), Singapore. (Îˆä‘ĺ•ă1, ‹g“cˆęŹ2: 1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

713090. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Survey On Anxiety And Behavior For Overseas Travel Of Renal Transplant Patients. Ikeda M1, Ishii D1, Noguchi F2, Tanaka M2, Iwamura M1, Yoshida K3: 14th Congress of the Asian Society of Transplantation (2015/8/24), Singapor. (’r“cŹ]1, Îˆä‘ĺ•ă1, –ěŒű•ś”T2, “c’†”üŽ÷2, Šâ‘şłŽk1, ‹g“cˆęŹ3: 1”ĺ”AŠí, 2ŠĹŒě•”, 3V˘‹Iˆă—ÁEć’[ˆă—Ă)

713091. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Three Year Clinical Outcomes Of Once-Daily Tacrolimus Extented-Release Formulation versus Twice-Daily Tacrolimus In De Novo Kidney Transplantation. Yoshida K1,2, Ishii D2, Kohguchi D2, Ohyama T2, Mochizuki K2, Takeuchi Y3, Wakai H, Noguchi F4, Tanaka M4, Ikeda M2: 14th Congress of the Asian Society of Transplantation (2015/8/24), Singapore. (‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2, ‚Œű@‘ĺ2, ‘ĺŽR“N•˝2, –]ŒŽN•˝2, ’|“ŕN—Y3, Žáˆä—zŠó, –ěŒű•ś”T4, “c’†”üŽ÷4, ’r“cŹ]2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí, 3t‘Ÿ“ŕ, 4ŠĹŒě•”)

713092. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Long-Term Follow-Up Of Anti-HLA Antibodies Post Kidney Transplantation Using With Flow-Panel Reactive Antibody. Ishii D1, Kobayashi K1, Hirano S1, Hirayama T1, Tabata K1, Wakai H, Takeuchi Y2, Noguchi F3, Ikeda M1, Iwamura M1, Yoshida K4: 14th Congress of the Asian Society of Transplantation (2015/8/25), Singapore. (Îˆä‘ĺ•ă1, Ź—ŃŒ’‘ž˜Y1, •˝–ěC•˝1, •˝ŽR‹M”Ž1, “c”¨Œ’ˆę1, Žáˆä—zŠó, ’|“ŕN—Y2, –ěŒű•ś”T3, ’r“cŹ]1, Šâ‘şłŽk1, ‹g“cˆęŹ4: 1”ĺ”AŠí, 2t‘Ÿ“ŕ, 3ŠĹŒě•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă)

713093. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) BUILDING A BALANCED TRUST RELATIONSHIP BETWEEN THE RENAL TRANSPLANT PATIENT ASSOCIATION AND RENAL TRANSPLANT MEDICAL PROFESSIONALS. Ikeda M1, Ishii D1, Hirano S1, Noguchi F2 Yoshida T3, Sakamoto M, Komagata K, Iwamura M1, Yoshida K4: 17th Congress of the European Society for Organ Transplantation (2015/9/13), Brussels, Belgium. (’r“cŹ]1, Îˆä‘ĺ•ă1, •˝–ěC•˝1, –ěŒű•ś”T2, ‹g“c•üŽq3, Šâ‘şłŽk1, ‹g“cˆęŹ4: 1”ĺ”AŠí, 2ŠĹŒě•”, 3‰h—{•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă)

713094. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) EVEROLIMUS, TAC-ER AND MMF DE NOVO RENAL TRANSPLANT RESULTED GOOD GRAFT FUNCTION. Yoshida K1,2, Ishii D2, Takeuchi Y3, Wakai H, Kohguchi D2, Noguchi F4, Ikeda M2, Tanaka M4: 17th Congress of the European Society for Organ Transplantation (2015/9/16), Brussels, Belgium. (‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2, ’|“ŕN—Y3, Žáˆä—zŠó, ‚Œű@‘ĺ2, –ěŒű•ś”T4, ’r“cŹ]2, “c’†”üŽ÷4: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí, 3t‘Ÿ“ŕ, 4ŠĹŒě•”)

713095. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Renal functional outcomes after laparoscopic partial nephrectomy using dynamic renal scintigraphy. Fujita T1, Nishi M1, Tabata K1, Matsumoto K1, Yoshida K2, Iwamura M1: 33rd World Congress of Endourology & SWL (2015/10/2), London, UK. (“Ą“c“N•v1, ź@ˇG1, “c”¨Œ’ˆę1, ź–{˜aŤ1, ‹g“cˆęŹ2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

713096. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Transition to robot-assisted laparoscopic prostatectomy is associated with a reduction of positive surgical margin. Tabata K1, Sato T1, Matsumoto K1, Tsumura H1, Hirayama T1, Nishi M1, Fujita T1, Ishii D1, Yoshida K2, Iwamura M1: 33rd World Congress of Endourology & SWL (2015/10/3), London, UK. (“c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ź–{˜aŤ1, ’Ă‘şGN1, •˝ŽR‹M”Ž1, ź@ˇG1, “Ą“c“N•v1, Îˆä‘ĺ•ă1, ‹g“cˆęŹ2, Šâ‘şłŽk1: 1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă)

713097. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) Impact of prior platinum on patients receiving salvage systemic therapy for advanced urothelial carcinoma. Sonpavde G, Pond GR, Di Lorenzo G, Buonerba C, Rozzi A, Lanzetta G, Necchi A, Giannatempo P, Raggi D, Matsumoto K1, Choueiri TK, Mullane S, Niegisch G, Albers P, Lee JL, Kitamura H, Kume H, Bellmunt J: 2016 Genitourinary Cancers Symposium (2016/1/7), San Francisco, USA. (ź–{˜aŤ1: 1”ĺ”AŠí)

713098. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) High-grade hydronephrosis is sustained even in patents with improved renal function after laparoscopic pyeloplasty for ureteropelvic junction obstruction. Nishi M1, Matsumoto K1, Tabata K1, Ishii D1, Tsumura H1, Hirayama T1, Fujita T1, Iwamura M1: EAU 2016 (The 31st European Association of Urology Congress) (2016/3/12), Munchen, Germany. (ź@ˇG1, ź–{˜aŤ1, “c”¨Œ’ˆę1, Îˆä‘ĺ•ă1, ’Ă‘şGN1, •˝ŽR‹M”Ž1, “Ą“c“N•v1, Šâ‘şłŽk1: 1”ĺ”AŠí)

722088. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) • o‹ž‰şt“Eœp‚ĚŠî–{Žč‹Z`ENSEAL‚ĚŽg‚˘•ű`. Šâ‘şłŽk (”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

722089. [Šw‰ď (‘S‘)] (‘˛Œă‹łˆçƒvƒƒOƒ‰ƒ€) ”ĺ”AŠí• o‹žŽčp‚ĚŠî–{Žč‹Z. Ž›’n•q˜Y, ‰HŸş—F‘Ľ, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/19), ‹ŕ‘ň.

722090. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‘Šú‚Ş‚ń‚ĚŽĄ—Ă (”ńŠĎŒŒ“IŽĄ—Ă). ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć18‰ń“ú–{ˆăŠw‰ďŒöŠJƒtƒH[ƒ‰ƒ€ (2015/7/4), “Œ‹ž.

722091. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) äNă÷ŠŕŠÖ˜A’`”’‚Ě“Ż’č`“ńŽŸŒł“d‹C‰j“Ž‚đŠÜ‚ŢƒvƒƒeƒI[ƒ€‰đÍ`. ź–{˜aŤ (”ĺ”AŠí): ‘ć66‰ń“ú–{“d‹C‰j“ŽŠw‰ď‘‰ď (2015/9/5), “Œ‹ž.

722092. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) tˆÚA‚É‚¨‚Ż‚é–ň•¨—Ă–@‚̏d—vŤ. ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć9‰ń“ú–{t‘Ÿ•a–ň•¨—Ă–@Šw‰ď ŠwpW‰ďE‘‰ď2015 (2015/10/25), ĺ‘ä.

722093. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv ) ‘O—§‘BŠŕœ“]ˆÚ‚ɑ΂ˇ‚éƒ]ƒŒƒhƒƒ“Ž_‘Šú•š—p“ŕ•Ş”ĺ—Ă–@‚Ě—LŒřŤ: ZAPCAŽŽŒąŒ‹‰Ę•ń. _”g‘ĺŒČ, ‰ę–{•qs, •Ŕ–؏rˆę, “Ą–{´G, ˛“Ą•śŒ›, Ź“cL‘ž˜Y, ˛“ĄˆĐ•ś1, âV“Ą‰p˜Y, ™ŒłŠ˛Žj, ’ŕ“‡@~, ‘CX’źĆ, ‰oě@W, Žđˆä‰pŽ÷, Ž›’n•q˜Y, Źě@C (1”ĺ”AŠí): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s.

722094. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv )y‘O—§‘B: ‘O—§‘B‚Ş‚ń•úŽËü—Ă–@‚̐V‚˝‚ȍH•vz•úŽËüŽĄ—ĂŒă‚Ě‹ÇŠÄ”­‘O—§‘BŠŕ‚ɑ΂ˇ‚éfocal salvage HDR brachytherapy‚ĚŒŸ“˘. ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2, ’Ă‘şGN1, “c”¨Œ’ˆę1, Œ´@•qŤ3, –öŕVM”V4, ’r“cŸb1, •âáÁ“ń1, –k–ě‰ëŽj2, ”nęŽu˜Y1, ˆäă—D‰î3, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡), 3•úŽËü (‰ć‘œ), 4•a—): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ 2015/9; 50 (3): 387.

722095. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ŽŔ—Տ°‚Š‚çl‚Ś‚鍡Œă‚ĚCRPCŽĄ—Ð헪`“ú–{‚Š‚ç‚ĚƒGƒrƒfƒ“ƒX‚ĆŽg—pŒoŒą‚đ“Ľ‚Ü‚Ś‚ā`. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s.

722096. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv ) ”ń“]ˆÚŤtŠŕ‚É‚¨‚Ż‚郊ƒ“ƒpßŠs´‚Ě–đŠ„. ‰YăTŽi, •ŕV˜aG, ’r“cŸb1, ăŒű˜aŽ , ˆŔHt‹P, ‰i–{Ťˆę, ‰Ş@@—D, ‰ŞŞ’J—˜ˆę (1”ĺ”AŠí): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/30), ‹ž“s.

722097. [Šw‰ď (‘S‘)] (JSE‹łˆçƒvƒƒOƒ‰ƒ€) • o‹žŽčp‚É‚¨‚Ż‚éƒgƒ‰ƒuƒ‹ƒVƒ…[ƒeƒBƒ“ƒO. Šâ‘şłŽk (”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/19), Vh, Japanese Journal of Endourology 2015; 28 (3): 150/

722098. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ă• •”Žčp—đ‚Ě‚ ‚é•›tEt• o‹ž‰şŽčp. “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/21), Vh.

722099. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) • •”ŽčpŠů‰—đ‚̓ƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B‘S“Eœp (RALP) ‚ɉe‹ż‚đ‹y‚Ú‚ˇ‚Š? Šâ‘şłŽk1, “c”¨Œ’ˆę1, ’Ă‘şGN1, ˛“ĄˆĐ•ś1 (1”ĺ”AŠí): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

722100. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) • o‹ž‰ş‘O—§‘B‘S“E“Eop‚É‚¨‚Ż‚鍂‰đ‘œ“x3DƒCƒ[ƒWƒVƒXƒeƒ€‚Ě—L—pŤ: ‚‰đ‘œ“x2DƒCƒ[ƒWƒVƒXƒeƒ€‚Ć‚Ě–łěˆ×”äŠrŽŽŒą. –؉şG•ś, ’†ě@Œ’, ‰PˆäK’j, Šâ‘şłŽk1, ˆÉ“Ą–žG, ‹{“ˆ@“N, Ż@ş•v, rˆä—zˆę, ”nęŽu˜Y1, Ž›’n•q˜Y, ź“cŒöŽu (1”ĺ”AŠí): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

722101. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) tˆÚA‚É‚¨‚Ż‚éƒ`[ƒ€ˆă—Ă‚Ěd—vŤ (ƒI[ƒo[ƒrƒ…[). ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2, –ěŒű•ś”T3, ’r“cŹ]2, ‹{â—Dl4, ‹g“c•üŽq5, ź‘ň—Ç‘ž6 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí, 3ŠĹŒě•”, 4–ňÜ•”, 5‰h—{•”, 6ƒŠƒnƒrƒŠ•”): ‘ć49‰ń“ú–{—Տ°tˆÚAŠw‰ď (2016/3/24), ’šŽć.

722102. [Šw‰ď (‘S‘)] (Educational Lecture) ”ĺ”AŠí• o‹ž‹Zp”F’č‚ÉŒü‚Ż‚˝ŞŽĄ“It“Eœp‚ĚŠî–{Žč‹Z. Šâ‘şłŽk (”ĺ”AŠí): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/10), ‘ĺă.

723629. [Šw‰ď (‘S‘)] (‘‰ďÜ‰ž•ĺƒ|ƒXƒ^[EŒű‰‰) ƒnƒCƒŠƒXƒN‘O—§‘BŠŕ‚É‚¨‚Ż‚éHigh-dose-rate brachytherapy: —\Œă—\‘ވöŽq‚Ć‚ľ‚Ä‚ĚPSA nadir‚ĚŒŸ“˘. ’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, ěăłŒá2, ŠÖŒűˆŠˆß2, ŹXłŽq2, ’r“cŸb1, •âáÁ“ń1, “Ą“c“N•v1, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň, “ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€´˜^W (CD|ROM) 2015; 103rd: ROMBUNNO. AOP-132.

723630. [Šw‰ď (‘S‘)] (‘‰ďÜ‰ž•ĺƒ|ƒXƒ^[EŒű‰‰) t”AŠÇ‘S“Eœp‚É‚¨‚Ż‚郊ƒ“ƒpßŠs´‚ĚŽĄ—Ă“IˆÓ‹`. ’r“cŸb1, ź–{˜aŤ1, —§‰Ô‹MŽj1, •˝–ěC•˝1, ăŒű˜aŽ , •ŕV˜aG, ‰YăTŽi, “Ą“c“N•v1, ‰ŞŞ’J—˜ˆę, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723631. [Šw‰ď (‘S‘)] (‘‰ďÜ‰ž•ĺƒ|ƒXƒ^[EŒű‰‰) “œ”A•aŒŒ‰t“§ÍŠłŽŇ‚Ö‚ĚŠČ•Ö‚ČŒŒ“œŠÇ—HŽ–—Ă–@: Šî‘bƒJ[ƒ{ƒJƒEƒ“ƒg–@—L—pŤ‚¨‚ć‚Ń‚ť‚Ě•K—vŤ‚ĚŒŸ“˘. •ş“Ą@“§, ŽOăŒ›Žq, –k“‡KŽ}, ”ň“c”ü•ä, ‘q“cN‹v, Îˆä‘ĺ•ă1,Žáˆä—zŠó, ‰““Ą’‰—Y, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723632. [Šw‰ď (‘S‘)] (‘‰ďÜ‰ž•ĺƒ|ƒXƒ^[EŒű‰‰) äNă÷Šŕ•a—–{•W–{‚É‚¨‚Ż‚éperiplakin”­Œť‚ÉŠÖ‚ˇ‚錟“˘. •˝–ěC•˝1, ź–{˜aŤ1, ’r“cŸb1, Ź—ŃŒ’‘ž˜Y1, Š™“c—TŽq, ŽÔ@‰pr, “Ą“c“N•v1, ˛“Ą—Yˆę2, ‰oě@W, Šâ‘şłŽk1 (1”ĺ”AŠí, 2ˆă—ÉqśŠw•”): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723633. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 2ŽŸtˆÚAŒă‘Šú‚É1ŽŸˆÚAt‚É”­Ç‚ľ‚˝‹CŽîŤtṐt‰Š. Ź—ŃŒ’‘ž˜Y1, ‹g“cˆęŹ2, Îˆä‘ĺ•ă1, –]ŒŽN•˝1, ‘ĺŽR“N•˝1, ‚Œű@‘ĺ1, ě‘ş•ä1, ‚‹´—Tˆę˜Y, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723634. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŒŒ´periplakin‚ĚäNă÷ŠŕÇ—á‚Ĺ‚Ě“Ž‘Ô‚ÉŠÖ‚ˇ‚錟“˘. —§‰Ô‹MŽj1, ź–{˜aŤ1, –]ŒŽN•˝1, •˝ŽR‹M”Ž1, ź@ˇG1, Îˆä‘ĺ•ă1, Ÿ“c^s, “Ą“c“N•v1, ˛“Ą—Yˆę2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2ˆă—ÉqśŠw•”): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723635. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŽŠŒČR‘̉đÍ‚đ—˜—p‚ľ‚˝äNă÷ŠŕŠłŽŇ‚É‚¨‚Ż‚錌´’†Žîᇊ֘ARŒ´‚Ě’Tő. –]ŒŽN•˝1, ź–{˜aŤ1, •˝ŽR‹M”Ž1, Ź—ŃŒ’‘ž˜Y1, ź@ˇG1, ’Ă‘şGN1, “c”¨Œ’ˆę1 ,“Ą“c“N•v1, ˛“Ą—Yˆę2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2ˆă—ÉqśŠw•”): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723636. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”DP…tÇ‚ĚŒŸ“˘. “y‹´łl1, •˝ˆäËŽi, •˝ŽR‹M”Ž1, “c”¨Œ’ˆę1, “Ą“c“N•v1 ,Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723637. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠŒF×–EŽî‚ĚŽčp’†•sˆŔ’č‚ȏzŠÂ“Ž‘Ô‚đ—\‘Ş‚ˇ‚éˆöŽq‚ĚŒŸ“˘. ăŒű˜aŽ , ‰Ş@@—D, ‚‹´^‘ž˜N, “c”¨^—œŽq, ’r“cŸb1, •ŕV˜aG, ‰YăTŽi, ‰ŞŞ’J—˜ˆę (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723638. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Gemcitabin/Docetaxel•š—p‰ťŠw—Ă–@ (GD—Ă–@) ‚É‚ć‚čSD‚đˆŰŽ‚ľ‚Ä‚˘‚éÄ”­Œă• –ŒŽ‰–b“÷Žî (”S‰tŒ^) ‚Ěˆę—á. “c”¨^—œŽq, ‚‹´^‘ž˜N, ăŒű˜aŽ , ’r“cŸb1, •ŕV˜aG, ‰YăTŽi, ‰ŞŞ’J—˜ˆę (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723639. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”x–ŹŠÇ‹ŘŽîÇ‚ɍ‡•š‚ľ‚˝‘˝”­tŒŒŠÇ‹ŘŽ‰–bŽî‚Ě1—á. ‚‹´^‘ž˜N, “c”¨^—œŽq, ăŒű˜aŽ , ’r“cŸb1, •ŕV˜aG, ‰YăTŽi, ‰ŞŞ’J—˜ˆę (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723640. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹Ř‘w”ńZŤäNă÷Šŕ‚ɑ΂ˇ‚鏉‰ńTURBTŽž‚ĚŽîᇐ؏œŽüˆÍ, ’ę•”śŒŸ‚ĚŒŸ“˘. ‘şă‘א´1, ‘呐@—m, “Ąé‹M‹ł, ‰F“s‹{‘ńŽĄ (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723641. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒhƒŒƒi[ƒW‚đ—v‚ľ‚˝Œ‹ÎŤtṐt‰Š‚Ě—Ő°“IŒŸ“˘. ‘OŽR—Ç‘ž1, ŽR“c‘׎j1, ‘ĺě‚ ‚łŽq, ěă’B‰›, ź“c‘ĺ‰î1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723642. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”A˜H’°ŠÇᑂɑ΂ľ‚ÄOTSC (Over The Scope Clip) ƒVƒXƒeƒ€‚đŽg—p‚ľ‚˝2Ç—á. ŽR“c‘׎j1, ‘OŽR—Ç‘ž1, ‘ĺě‚ ‚łŽq, ‰œ–ě‹I•F, ěă’B‰›, ź“c‘ĺ‰î1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/18), ‹ŕ‘ň.

723643. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) isŤt×–EŠŕ‚ɑ΂ˇ‚éIL-2 + IFN-a + tegafur uracil (IAT) —Ă–@‘ćII‘ŠŽŽŒą. ‰Á“Ą’qK, Šâ‘şłŽk1 ,“Ą“c“N•v, Ąˆä’q”V, Ö“Ą˝ˆę, ‘ĺé‹g‘Ľ, ě“c@–], •y“c‘P•F (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/19), ‹ŕ‘ň.

723644. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‰ťŠw—Ă–@ŠůŽĄ—ÐisŤ”A˜Hă”çŠŕ‚ɑ΂ˇ‚éGemcitabin/Nedaplatin—Ă–@‚ĚŒŸ“˘. ź–{˜aŤ1, •˝ŽR‹M”Ž1, ’r“cŸb1, ź@ˇG1, ’Ă‘şGN1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, “Ą“c“N•v1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/19), ‹ŕ‘ň.

723645. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹Ž¨’ďRŤ‘O—§‘BŠŕ‚É‚¨‚Ż‚éEnzalutamide‚ĚŽg—pŒoŒą. Žu‘ş‘sˆę˜N1, “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, “V–ě“”V1, ě‘ş•ä1, —§‰Ô‹MŽj1, Ş–{—Žq1, Îˆä‘ĺ•ă1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/19), ‹ŕ‘ň.

723646. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚éV‹KŽĄ—Ă–ň‚ĚŽg—pŒoŒą. ‘ĺŽR“N•˝1, Žá“c•”—zŽi1, ‰œ–ě‹I•F, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/19), ‹ŕ‘ň.

723647. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) TUR-P, HolepŒă‚ÉŒŠ‚‚Š‚Á‚˝‘O—§‘BŠŕ‚Ě—Ő°“IŒŸ“˘. ‰œ–ě‹I•F, Žá“c•”—zŽi1, ‘ĺŽR“N•˝1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/19), ‹ŕ‘ň.

723648. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘Šú‘O—§‘B‚Ş‚ń‚ɑ΂ľ‚ăAƒ“ƒhƒƒQƒ“œ‹Ž—Ă–@‚É‚ć‚é‘O—§‘B‘̐ϏkŹŒă‚ÉŽ{s‚ľ‚˝Œo”A“š“Iƒ}ƒCƒNƒ”g‚‰ˇ“x—Ă–@‚É‚ć‚鑁Šú‘O—§‘BŠŕ‚Ě—LŒř‚ČŽĄ—Ă–@: 12”N‚ĚŽĄ—ĂŒoŒą. aŒűG”V, ŹŽÄ@Œ’, dé@—T, —é–Ř—˛‘ĺ, ‘ŠŒ´łO, ’†žŠO—˛, ™“c@“Ö1, Žu‘ş@“N (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/19), ‹ŕ‘ň.

723649. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B‘S“Eœp‚̏‰ŠúŽĄ—ÐŹŃ: • o‹ž‰ş‘O—§‘B‘S“Eœp‚Ć‚Ě”äŠr. “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, Ź—ŃŒ’‘ž˜Y1, •˝ŽR‹M”Ž1, ź@ˇG1, Žu‘ş‘sˆę˜N1, “V–ě“”V1, “Ą“c“N•v1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/20), ‹ŕ‘ň.

723650. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŞŽĄ“I‘O—§‘B‘S“EœpŒă‚Ě”AŽ¸‹Ö‚É‚¨‚Ż‚élH”A“šŠ‡–ń‹Ř‚Ě—L—pŤ. •˝ŽR‹M”Ž1, •âáÁ“ń1, Žu‘ş‘sˆę˜N1, ě‘ş•ä1, •˝–ěC•˝1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/20), ‹ŕ‘ň.

723651. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) isŤt×–EŠŕ‚ɑ΂ˇ‚éƒ`ƒƒVƒ“ƒLƒi[ƒ[‘jŠQ–ňŽĄ—Ă‚É‚¨‚Ż‚éC”˝‰žŤ’`”’‚ĚˆÓ‹`. “Ą“c“N•v1, •˝ŽR‹M”Ž1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, ź–{˜aŤ1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/20), ‹ŕ‘ň.

723652. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚郍ƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B“Eœp‚̏‰ŠúŒoŒą. ‚“cŽĄŽq1, ‰Š@‰p–Î, Žá“c•”—zŽi1, “y‹´łl1, ‘ĺ–x@—, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/20), ‹ŕ‘ň.

723653. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é‹CäNă÷‰şcohen–@‚ĚŽĄ—ÐŹŃ. ě‘ş•ä1, ź@ˇG1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, “c”¨Œ’ˆę1, Îˆä‘ĺ•ă1, “Ą“c“N•v1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/20), ‹ŕ‘ň.

723654. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é• o‹ž‰şäNă÷‘S“Eœp‚Ě—Ő°“IŒŸ“˘. –ź–؏l1, •˝–ěC•˝1, ’r“cŸb1, “ě“c@—@1, “c”¨Œ’ˆę1, ‰Š@‰p–Î, “c‰Ş‰ŔŒ›1, Â@‹Pş, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/20), ‹ŕ‘ň.

723655. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “ŻŽí‘˘ŒŒŠ˛×–EˆÚAŒă‚ĚƒEƒBƒ‹ƒXŤoŒŒŤäNă÷‰Š‚ɑ΂ˇ‚é”ĺ”AŠí‰Č“IŠO‰ČŽĄ—Ă‚ĚˆÓ‹`. •ŕV˜aG, ‚‹´^‘ž˜N, “c”¨^—œŽq, ăŒű˜aŽ , ’r“cŸb1, ‰YăTŽi, ‘ş“c_Ž, ‰ŞŞ’J—˜ˆę, Î–ČˆęĆ, ’JŒűCˆę (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/20), ‹ŕ‘ň.

723656. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚錋ÎŤtṐt‰Š‚Ě—Ő°“IŒŸ“˘. Žá“c•”—zŽi1, ‰œ–ě‹I•F, ‘ĺŽR“N•˝1 (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/20), ‹ŕ‘ň.

723657. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒAƒ“ƒhƒƒQƒ“œ‹Ž—Ă–@‚É”ş‚¤œ‘e頏Ç: ƒfƒmƒXƒ}ƒu60 mgťÜ‚É‚¨‚Ż‚é’áƒJƒ‹ƒVƒEƒ€ŒŒÇ‚ĚŒŸ“˘. ‚Œű@‘ĺ1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, “c”¨Œ’ˆę1, Ź—ŃŒ’‘ž˜Y1, –]ŒŽN•˝1, •˝ŽR‹M”Ž1, ‹ŕŽqŽu•Ű1, “ě“c@—@1, ‰Şč”ü‘ăŽq2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2–ňÜ•”): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/21), ‹ŕ‘ň.

723658. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) tˆÚAŒă‚̐t”A˜HŒnˆŤŤŽîᇔ­śÇ—á‚ĚŒŸ“˘. Îˆä‘ĺ•ă1, ‹g“cˆęŹ2, –]ŒŽN•˝1, Ź—ŃŒ’‘ž˜Y1, •˝–ěC•˝1, Ş–{—Žq1, Žáˆä—zŠó, ’r“cŹ]1, “Ą“c“N•v1, ‰““Ą’‰—Y, ‚‹´—Tˆę˜Y, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/21), ‹ŕ‘ň.

723659. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘O—§‘BŠŕ‘Ň‹@—Ă–@‚É‚¨‚Ż‚éV‹KƒoƒCƒIƒ}[ƒJ[: ‚Ş‚ńŒ^ƒAƒ~ƒmŽ_ƒgƒ‰ƒ“ƒXƒ|[ƒ^[LAT1‚Ě—L—pŤ. ˛“ĄˆĐ•ś1, –öŕVM”V2, ‰ŞˆŔ@ŒM2, “c”¨Œ’ˆę1, ’Ă‘şGN1, ‰““Ą@m, ”nęŽu˜Y1, ‘ş‰_–FŽ÷2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•a—): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/21), ‹ŕ‘ň.

723660. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “ŕ•Ş”ĺ—Ă–@’†‚Ě‘O—§‘BŠŕÇ—á‚Ě‘O—§‘B”ě‘ĺÇ‚ɑ΂ľƒzƒ‹ƒ~ƒEƒ€EƒŒ[ƒU[‘O—§‘BŠjop (HoLEP) ‚đŽ{s‚ľ‚˝2—á. ™“c‰ŔŽq, ÝŠy•q–ç, ™“c@“Ö1, •˝ŽR‹M”Ž1, “Ą“c“N•v1, Žu‘ş@“N, ‹g“cˆęŹ2, ‹v•ŰŻˆę, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/21), ‹ŕ‘ň.

723661. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) •›tŽčp89Ç—á‚ĚŒŸ“˘. ‰ŞŞ’J—˜ˆę, ‰YăTŽi, •ŕV˜aG, ’r“cŸb1, ăŒű˜aŽ , “c”¨^—œŽq, ‚‹´^‘ž˜N, –ěčŒ\‰Ä (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/21), ‹ŕ‘ň.

723662. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) tŠŕ‚É‚¨‚Ż‚郊ƒ“ƒpßŠs´‚ĚˆÓ‹`‚đÄl‚ˇ‚é. ‰YăTŽi, •ŕV˜aG, ’r“cŸb1, “c”¨^—œŽq, ăŒű˜aŽ , ‚‹´V‘ž˜N, ‰Ş@@—D, ‰ŞŞ’J—˜ˆę (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/21), ‹ŕ‘ň.

723663. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) PCA3ƒXƒRƒA‚ĆPSA free/total”ä‚đ—p‚˘‚˝—vŽĄ—Ă‘O—§‘BŠŕ—\‘ރmƒ‚ƒOƒ‰ƒ€‚̍쐬. ‘ĺ“Œ‹MŽu, •ĘŠ‰pŽĄ1, ‰z“c’|˜N, rě@F, …–ě—˛ˆę, ’†“‡@~ (1”ĺ”AŠí): ‘ć103‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/4/21), ‹ŕ‘ň.

723664. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) tŠŕ‚ĚÄ”­‚͍‚—ŽŇ‚Ů‚Ç—\Œă•s—Ç‚Š? ‰ŞŞ’J—˜ˆę, ’r“cŸb1, ăŒű˜aŽ , •ŕV˜aG, “c”¨^—œŽq, ‚‹´^‘ž˜N, ‰YăTŽi (1”ĺ”AŠí): ‘ć28‰ń“ú–{˜V”N”ĺ”AŠí‰ČŠw‰ď (2015/5/9), •lź.

723665. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) LDL‹z’…—Ă–@‚ĆŒŒ‰t“§Í‚Ě“ŻŽž•š—p—Ă–@Ž{s‚ɂ‚˘‚Ä‚ĚŽŽ‚Ý. ‰Í‘ş”ŽŽq, Žáˆä—zŠó, ŕ_čG—ćŽq, “c•Ó–˘—ˆ, “n粒qŽq, ˆ˘•”“Ţ’Ă”ü, –Ř‘şŠG”ü, •ş“Ą@“§, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/26), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 640.

723666. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”p—pÇŒóŒQŠłŽŇ‚Ş•ŕs‰Â”\‚Ć‚Č‚Á‚˝Ç—á`ˆ¤‘ˇ‚Ćƒo[ƒWƒ“ƒ[ƒh‚đ•ŕ‚Ţ‚˝‚߂Ɂ`. ŠÚ–ě—Y‹M, –Ř‘şŠG”ü, œA]–r–¤, ”üK—Ż”ü, ›@—L‹I, Žáˆä—zŠó, •ş“Ą@“§, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/26), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 686.

723667. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–ƒNƒŠƒjƒbƒN‚É‚¨‚Ż‚éVAŠÇ—‚ĚŒŸ“˘. ŒK“c”䍻], ă‘ş@ŒO, ‹ŕ“cKi, ‚‹´”ÍŽq, Ź—Ń˜a‘ă, “ş’J_”ü, ŠŰŽR–ƒ—˘, Žsě@–ž, ´‹{—Ç‘ž, ‹g“c@ŕˆ, Îˆä‘ĺ•ă1, ‹g“cˆęŹ2, óˆä’qŠî (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/26), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 703.

723668. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–ƒNƒŠƒjƒbƒN‚Ě‹łˆçŽĺ”C‚Ć‚ľ‚ĐVlŠĹŒěŽt‚Ö‚ĚŽw“ą`“–ƒNƒŠƒjƒbƒN‚Ěƒ}ƒjƒ…ƒAƒ‹‚đŠî‚ÉŽw“ą‚đŽn‚ß‚Ä. ––‰i—TŽq, —Ž‡^Šó, ‚‹´@—ş, ‚‹´_—Y, Šp“c—˛r, —é–؁@‘ĺ, ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2, ‚‹´—Tˆę˜Y (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/26), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 729.

723669. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘OŠóŽßon-line HDF‚ÍFGF-23‚̏œ‹Ž‚É—D‚ę‚Ä‚˘‚é. ŒIŒ´‰ŔF, ŽR“ŕ•‡”ü, ×’JLŠC, ’r糓ޕێq, ’J—Ń—R”ü, •˝“cŒbˆę, Š™“c‚Ż‚˘Žq, •ŕVD, âV“Ą@‹B, Îˆä‘ĺ•ă1, ˛“ĄˆĐ•ś1, Žá—Ń–ő‹v, ŸNˆäŒ’ŽĄ (1”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 558.

723670. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ˆÚAt‹@”\”pâŒă‚ɍݑ‰t“§Í‚đ“ą“ü‚ľ‚˝7Ç—á. Žáˆä—zŠó, ˆ˘•”“Ţ’Ă”ü, ‰Í‘ş”ŽŽq, ™–{’źŽq, –Ř‘şŠG”ü, ŽR’†—˘‰Ŕ, •ş“Ą@“§, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 753.

723671. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚¨‚Ż‚é•n˘ŠłŽŇ‚ɑ΂ˇ‚éˆŰŽ“§Í“ą“ü‚ĚŒoŒą. ŠĂ—˜‰ŔŽj, ’†“ˆÍ‹M, źŒ´O˜a, Žáˆä—zŠó, “č‘ş—F—˛, ’ˇŔrG, Ź‹v•ŰŒŞˆę, •ş“Ą@“§, ŽÄŒ´L‹v, ‹g“cˆęŹ1,2, ěźGŽ÷, ě‘ş–ž•v (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 756.

723672. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚¨‚Ż‚铧Í‰t´ň‰ť. ‰Y•Órˆę˜Y, Ź“‡@–G, “č‘ş—F—˛, –Ř‘şŠG”ü, ˆ˘•”“Ţ’Ă”ü, ×–ě‚Žu, Žáˆä—zŠó, Ź‹v•ŰŒŞˆę, ’†“‡Í‹M, •ş“Ą@“§, ‹g“cˆęŹ1,2, ’|ŕV^Œá, ěźGŽ÷ (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 756.

723673. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒ~ƒƒƒ“ƒ}[‚É‚¨‚Ż‚铧Í‰t´ň‰ťŽx‰‡Šˆ“Ž. –Ř‘şŠG”ü, ˆ˘•”“Ţ’Ă”ü, Ź“‡@–G, ÷‘ň‹Mr, ÷‘ň—ž”T, ‰Y•Órˆę˜Y, ‘ëŕVˆŸ—R”ü, ˆŔ•”‹M”V, Ź—Ń‚ą‚¸Œb, “č‘ş—F—˛, Ź‹v•ŰŒŞˆę, Žáˆä—zŠó, •ş“Ą@“§, ‹g“cˆęŹ1,2, ěźGŽ÷, ě‘ş–ž•v (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 756.

723674. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒxƒgƒiƒ€‚É‚¨‚Ż‚铧Í‰t´ň‰ť‚Ö‚ĚŽć‚č‘g‚ÝŽx‰‡. źŒ´O˜a, Ź‹v•ŰŒŞˆę, “c’†łŒČ, Ź“‡@–G, “č‘ş—F—˛, Žáˆä—zŠó, ’†“ˆÍ‹M, •ş“Ą@“§, ŽÄŒ´L‹v, ‹g“cˆęŹ1,2, ’|ŕV^Œá, ěźGŽ÷, ě‘ş–ž•v (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 756.

723675. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚¨‚Ż‚铧ÍŠÖ˜Aˆă—Ï]Ž–ŽŇˆçŹŽx‰‡ƒvƒƒWƒFƒNƒg. Žáˆä—zŠó, •ş“Ą@“§, Ź‹v•ŰŒŞˆę, “č‘ş—F—˛, ’ˇŔrG, ’†“ˆÍ‹M, ŽÄŒ´L‹v, ‹g“cˆęŹ1,2, ěźGŽ÷, ě‘ş–ž•v (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 757.

723676. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒxƒgƒiƒ€Eƒ~ƒƒƒ“ƒ}[EƒJƒ“ƒ{ƒWƒA‚É‚¨‚Ż‚ét“§ÍŠÖ˜AŠwp‘gD‚̏ó‹ľ. źŒ´O˜a, Ź‹v•ŰŒŞˆę, Ź“‡@–G, “č‘ş—F—˛, Žáˆä—zŠó, ’†“ˆÍ‹M, •ş“Ą@“§, ŽÄŒ´L‹v, ‹g“cˆęŹ1,2, ’|ŕV^Œá, ŽR‰ş–ž‘×, ěźGŽ÷, ě‘ş–ž•v (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 757.

723677. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “œ”A•a“§ÍŠłŽŇ‚̉ž—pƒJ[ƒ{ƒJƒEƒ“ƒg“ą“üŒř‰Ę. ŽOăŒ›Žq, •ş“Ą@“§, ‘ĺ’†‰ŔŽq, “c”¨Œ’ˆę1, “Ą“c“N•v1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, ”ň“c”ü•ä, ‘q“cN‹v, –k“‡KŽ} (1”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 788.

723678. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ut•s‘Sƒ`[ƒ€ˆă—ĂŒ¤‹†‰ďv‚Ö‚Ć“WŠJ‚ľ‚˝6”NŠÔ‚ĚŠˆ“Ž. ’r“cŹ]1, –ěŒű•ś”T2, “c’†”üŽ÷2, ŹâŽu•Ű, Îˆä‘ĺ•ă1, ‹g“cˆęŹ3 (1”ĺ”AŠí, 2ŠĹŒě•”, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 793.

723679. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) tˆÚAŒă‚Ě“§ÍÄ“ą“üÇ—á‚Ě—Ő°“IŒŸ“˘. Îˆä‘ĺ•ă1, Ź—ŃŒ’‘ž˜Y1, •˝–ěC•˝1, ź–{˜aŤ1, Žáˆä—zŠó, ’r“cŹ]1, –ěŒű•ś”T2, ’|“ŕN—Y3, Šâ‘şłŽk1, ‹g“cˆęŹ4 (1”ĺ”AŠí, 2ŠĹŒě•”, 3t‘Ÿ“ŕ, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 811.

723680. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒKƒ“ƒ}ü–ŋۉń˜H‚ĚŽg—pŒoŒą. •˝–ě’¨‹v, Â–Ř–ÎŽ÷, ‚‹´@—ş, ‚‹´_—Y, Šp“c—˛r, —é–؁@‘ĺ, ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2, ‚‹´—Tˆę˜Y (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 853.

723681. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒjƒvƒŽĐťƒwƒ‚ƒ_ƒCƒAƒtƒBƒ‹ƒ^FIX-210Seco‚̐Ť”\•]‰ż. ×’JLŠC, ŽR“ŕ•‡”ü, ŒIŒ´‰ŔF, ’r糓ޕێq, ’J—Ń—R”ü, •˝“cŒbˆę, •ŕVD, —é–؁@•ŕ, âV“Ą@‹B, Îˆä‘ĺ•ă1, ˛“ĄˆĐ•ś1, ‹g“cˆęŹ2, ŸNˆäŒ’ŽĄ (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/28), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 922.

723682. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “œ”A•aHDŠłŽŇ‚Ĺ‚ĚDPP-4‘jŠQ–ňƒTƒLƒTƒOƒŠƒvƒ`ƒ“‚ĚŒř‰Ę: ƒCƒ“ƒXƒŠƒ““Š—^—ĘŒ¸­Œř‰ĘÇ—á‚Ě‘śÝ. •ş“Ą@“§, ’|ěŸŽĄ, Žu‘ş@“N, Ź–““ń–ç, “ŕ“c–Lş, ‰““Ą’‰—Y, ”nęŽu˜Y1, ”ň“c”ü•ä, ‘q“cN‹v, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/28), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 931.

723683. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‰EtŒ‹Î‚É‚ć‚č”sŒŒÇ‚đ’ć‚ľ‚˝“§ÍÇ—á‚ɑ΂ľƒzƒ‹ƒ~ƒEƒ€EƒŒ[ƒU[‚đŽg—p‚ľ‚˝Œo”A“š“I”AŠÇŒ‹Î”jÓp‚đŽ{s‚ľ‚˝ˆę—á. ™“c‰ŔŽq, ÝŠy•q–ç, ˛“Ą’ź”V, ‘ĺ’JŠ°”V, ˆÉŒ´Œş‰p, ™“c@“Ö1, Žu‘ş@“N, ˜ZŠp@Žü, “Ą“c“N•v1, ‹g“cˆęŹ2, ‹v•ŰŻˆę, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/28), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 949.

723684. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “§ÍƒNƒŠƒjƒbƒN‚É‚¨‚Ż‚éî•ńƒZƒLƒ…ƒŠƒeƒB‘΍ô. “n糗FŽq, ŽR’†—˘‰Ŕ, –kč‘Žq, ‹g•G”ü, ‘ëŽR—tŽq, ”üK—Ż”ü, Žáˆä—zŠó, •ş“Ą@“§, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/28), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 960.

723685. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‹ß—׏Z–Ż‚ĚŠń•t‚É‚ć‚蓧Í“ą“ü‚ÉŽŠ‚Á‚˝ƒJƒ“ƒ{ƒWƒA‚Ĺ‚Ě––Šút•s‘SŠłŽŇ‚Ě“§Íó‹ľ‚Ɖh—{ó‘Ô. Žáˆä—zŠó, ’ˇŔrG, •ş“Ą@“§, ‹g“cˆęŹ1,2, ěźGŽ÷, –k“‡KŽ}, “c‘ş’qŽq (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć3‰ń“ú–{t•s‘S‰h—{Œ¤‹†‰ďŠwpW‰ďE‘‰ď (2015/7/5), ‰Ą•l.

723686. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‹ĂŒĹ—Ă–@Œp‘ą‰ş‚ĹŽ{s‚ľ‚˝ƒzƒ‹ƒ~ƒEƒ€EƒŒ[ƒU[‚đ—p‚˘‚˝Œo”A“š“I”AŠÇÓÎp‚ĚŒŸ“˘. ™“c‰ŔŽq, ‹v•ŰŻˆę, •˝ŽR‹M”Ž1, “Ą“c“N•v1, ‹g“cˆęŹ2, ÝŠy•q–ç, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{”A˜HŒ‹ÎÇŠw‰ď‘ć25‰ńŠwpW‰ď (2015/8/28), ˆŽě, “ú–{”A˜HŒ‹ÎÇŠw‰ďŽ 2015; 14 (2): 96-7.

723687. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ”ńƒVƒXƒ`ƒ“Œ‹Î‚đ‘ÎŰ‚Ć‚ľ‚˝ŹŽ™Œ‹ÎŽĄ—Ă‚ĚŒoŒą. ź@ˇG1, “Ą“c“N•v1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, ź–{˜aŤ1, Îě@–í1, ˆŔ“Ą–š”ü1, ě‘ş•ä1, ŠŰ@“T•v, Šâ‘şłŽk1 (1”ĺ”AŠí): “ú–{”A˜HŒ‹ÎÇŠw‰ď‘ć25‰ńŠwpW‰ď (2015/8/29), ˆŽě, “ú–{”A˜HŒ‹ÎÇŠw‰ďŽ 2015; 14 (2): 202-3.

723688. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚É‚¨‚Ż‚étˆÚAŒă‚̍RHLAR‘ĚŒŸ¸‚ɂ‚˘‚Ä‚ĚŒŸ“˘. Îˆä‘ĺ•ă1, ”‹Œ´ł”Ž1, Ź—ŃŒ’‘ž˜Y1, •˝–ěC•˝1, ź–{˜aŤ1, Žáˆä—zŠó, ’r“cŹ]1, –ěŒű•ś”T2, “ü–Ř‹GŒb2, ‹g“cˆęŹ3, Šâ‘şłŽk1 (1”ĺ”AŠí, 2ŠĹŒě•”, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć24‰ń“ú–{‘gD“K‡ŤŠw‰ď‘ĺ‰ď (2015/9/10), …ŒË.

723689. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) tˆÚAŒă‚Ěƒmƒ“ƒAƒhƒqƒAƒ‰ƒ“ƒX‚É‚ć‚ét‹@”\ˆŤ‰ťÇ—á‚ɂ‚˘‚Ä‚ĚŒŸ“˘. Îˆä‘ĺ•ă1, •˝–ěC•˝1, ź–{˜aŤ1, •˝ŽR‹M”Ž1, ’r“cŹ]1, Žáˆä—zŠó, ‹{â—Dl2, ˆî–ě@Š°2, –ěŒű•ś”T3, Šâ‘şłŽk1, ‹g“cˆęŹ4 (1”ĺ”AŠí, 2–ňÜ•”, 3ŠĹŒě•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć51‰ń“ú–{ˆÚAŠw‰ď‘‰ď (2015/10/2), ŒF–{): ˆÚA 2015; 50 (‘‰ď—ŐŽž): 322.

723690. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) tˆÚAŠłŽŇ‚Ć“§ÍŠłŽŇ‚Ě•ž–ňŠÇ—, ‹Ů‹}ĐŠQŽž‚Ě”ő‚Ś‚ĚŽŔ‘Ô’˛¸. ’r“cŹ]1, –ěŒű•ś”T2, Ź‘q—TK, ‹{â—Dl3, Îˆä‘ĺ•ă1, Šâ‘şłŽk1, ‹g“cˆęŹ4 (1”ĺ”AŠí, 2ŠĹŒě•”, 3–ňÜ•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć51‰ń“ú–{ˆÚAŠw‰ď‘‰ď (2015/10/3), ŒF–{, ˆÚA 2015; 50 (‘‰ď—ŐŽž): 380.

723691. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŒŒ´periplakin‚đ—p‚˘‚˝äNă÷Šŕ‚É‚¨‚Ż‚éŽîᇃ}[ƒJ[‚ĚŒŸ“˘. –]ŒŽN•˝1, ź–{˜aŤ1, “c”¨Œ’ˆę1 ,“Ą“c“N•v1, ’Š’ˇ@‹B, –ě‘ş•ś•v, ˛“Ą—Yˆę2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2ˆă—ÉqśŠw•”): ‘ć74‰ń“ú–{ŠŕŠw‰ďŠwp‘‰ď (2015/10/8), –źŒĂ‰Ž.

723692. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒnƒCƒŠƒXƒN‘O—§‘BŠŕ‚É‚¨‚Ż‚éHDR brachytherapy: —\Œă—\‘ވöŽq‚Ć‚ľ‚Ä‚ĚPSA nadir‚ĚŒŸ“˘. ’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, ěăłŒĺ2, ŠÖŒűˆŠˆß2, ŹXłŽq2, ’r“cŸb1, •âáÁ“ń1, “Ą“c“N•v1, ”nęŽu˜Y1, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s, “ú–{ŠŕŽĄ—ĂŠw‰ďŽ 2015/9; 50 (3): 940.

723693. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚éAbiraterone“Š—^Œă‚Ě "ALP-bounce" ‚ĚŒŸ“˘. “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, •˝ŽR‹M”Ž1, ź@ˇG1, “Ą“c“N•v1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s.

723694. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚éƒAƒrƒ‰ƒeƒƒ“Œă‚ĚƒhƒZƒ^ƒLƒZƒ‹ŽĄ—Ă: ‘˝Ž{Ý‹¤“ŻŒă•ű“IŽŽŒą. ă‘ş”ŽŽi, ‰ÍŒ´’Ži, ă“c—T“ń˜Y, ‘ëŕVˆí‘ĺ, źŽR@•×, “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, _’J’źl, —é–ŘŒ[‰x, źŒ´LW (1”ĺ”AŠí): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/29), ‹ž“s.

723695. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) C”˝‰žŤ’`”’‚’l‚̐isŤt×–EŠŕ‚ɑ΂ˇ‚éƒXƒjƒ`ƒjƒuŽĄ—Ă‚É‚¨‚Ż‚éŒř‰Ę—\‘ވöŽq‚ĚŒŸ“˘. “Ą“c“N•v1, ’Ă‘şGN1, “c”¨Œ’ˆę1, Îˆä‘ĺ•ă1, ź–{˜aŤ1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/30), ‹ž“s.

723696. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ă•””A˜Hă”çŠŕ‚Ĺ‚ĚŒă• –ŒƒAƒvƒ[ƒ`t᱔AŠÇ‘S“Eœp‚ɑ΂ˇ‚éBMI‚̉e‹ż‚ɂ‚˘‚Ä. ź–{˜aŤ1, •˝ŽR‹M”Ž1, ź@ˇG1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/30), ‹ž“s.

723697. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) t”AŠÇ‘S“Eœp‚É‚¨‚Ż‚郊ƒ“ƒpßŠs´‚Ě–đŠ„. ’r“cŸb1, ź–{˜aŤ1, ăŒű˜aŽ , •ŕV˜aG, ‰YăTŽi, “Ą“c“N•v1, “ü]@Œ[1, ‰ŞŞ’J—˜ˆę, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/30), ‹ž“s.

723698. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) äNă÷Šŕ‚ɑ΂ˇ‚éäNă÷‘S“Eœp‚ĚŽĄ—ÐŹŃ: ‘˝Ž{Ý‹¤“ŻŒ¤‹†. ź–{–ž•F, ’†ě@“O, ‹ŕ’J~Žu, ’r“cŸb1, ’†ź‘׈ę, ě‡„l, ‹{ěm•˝, “cŒű@Œd, —é–ŘŠî•ś, ŒĂ‰ę•ś—˛, ’ˇŁ@‘×, ‹ß“Ą–őŽi, ‰ŞŞ’J—˜ˆę, “c’†—Ç“T, –{ŠÔ”V•v (1”ĺ”AŠí): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/30), ‹ž“s.

723699. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) äNă÷”A˜Hă”çŠŕ‚É‚¨‚Ż‚é“]ˆÚ‘ƒŘœp. ’†ě@“O, ‹ŕ’J~Žu, ’r“cŸb1, ź–{–ž•F, ě‡„l, ‹g“c•c, “cŒű@Œd, •Ä’Ž—Ljň, ‰i“c­‹`, ’ˇŁ@‘×, ‹ß“Ą–őŽi, •y“c‹žˆę, “c’†—Ç“T, ‹v•ÄtŠě, –{ŠÔ”V•v (1”ĺ”AŠí): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/30), ‹ž“s.

723700. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Œă• –Œ“î•”“÷Žî‚Ě—Ő°•a—Šw“IŒŸ“˘‚ĆŽĄ—ÐŹŃ. •ŕV˜aG, ‰Ş@@—D, ‰i–{Ťˆę, ˆŔHt‹P, ăŒű˜aŽ , ’r“cŸb1, ‰YăTŽi, ‘ş“c_Ž, ‰ŞŞ’J—˜ˆę (1”ĺ”AŠí): ‘ć53‰ń“ú–{ŠŕŽĄ—ĂŠw‰ďŠwpW‰ď (2015/10/31), ‹ž“s.

723701. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é‘O—§‘BśŒŸƒpƒXƒoƒŠƒAƒ“ƒX•ŞÍ|‡•šÇŒ¸­‚ĚŽŽ‚݁|. Ôˆä–ő], ‘şă‘א´1, ×’JŘ•ä”ü, •U@—DŽq, ‘ŠŒ´˜aŽ}, ‘ĺ’ˍFŽq, “Ąé‹M‹ł, ‰F“s‹{‘ńŽĄ, ‚–ě–őŒá (1”ĺ”AŠí): ‘ć16‰ń“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ďŠwpW‰ď (2015/11/13), •‘•l.

723702. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B‘S“EœpŒă‚Ě‘Šú”A‹Ö§‚É‚¨‚Ż‚é”AŽ¸‹Ö—Ś (ULR) ‚ĚŒŸ“˘. “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, ź–{˜aŤ1, ź@ˇG1, •˝ŽR‹M”Ž1, Îˆä‘ĺ•ă1, –Ȋс@ăÄ1, â“c—T‰î1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/19), Vh.

723703. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Œ´”­•s–žŠŕ‚̐f’f‚É‚¨‚Ż‚é• o‹ž‰şŽîᇐśŒŸp‚Ě—L—pŤ. Ź—ŃŒ’‘ž˜Y1, “Ą“c“N•v1, ”‹Œ´ł”Ž1, Ş–{—Žq1, •˝–ěC•˝1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/19), Vh.

723704. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Œă• –ŒŒ´”­_ŒoŒ´ŤŽîᇂɑ΂ˇ‚é• o‹ž‰ş“Eœp. •˝ŽR‹M”Ž1, “Ą“c“N•v1, ”‹Œ´ł”Ž1, Ź—ŃŒ’‘ž˜Y1, ź@ˇG1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/19), Vh.

723705. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • o‹ž‰şäNă÷‘S“Eœp‚ĚŒŸŘ|ŠJ• äNă÷‘S“Eœp‚Ć‚Ě”äŠrŒŸ“˘|. “ě“c@—@1, –ź–؏l1, •˝–ěC•˝1, ‚Œű@‘ĺ1, “c”¨Œ’ˆę1, ‰Š@‰p–Î, “c‰Ş‰ŔŒ›1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/19), Vh.

723706. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) tĚŽćEŸó—ŹŒă‚ɐtŒ‹Î‚đ“Eo‚ľˆÚA‚ľ‚˝ś‘̐tˆÚA‚Ě2Ç—á. Îˆä‘ĺ•ă1, •˝–ěC•˝1, ”‹Œ´ł”Ž1, Ź—ŃŒ’‘ž˜Y1, ź@ˇG1, “Ą“c“N•v1, ź–{˜aŤ1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/20), Vh, Japanese Journal of Endourology 2015; 28 (3): 189.

723707. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Źl‚̐…tÇ‚ɑ΂ˇ‚é• o‹ž‰şt᱌`Źp3—á‚ĚŒŸ“˘. ‰ŞŞ’J—˜ˆę, ’r“cŸb1, Šâ‘şłŽk1, ‰Ş@@—D, “c”¨^—œŽq, ăŒű˜aŽ , •ŕV˜aG, ‰YăTŽi (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/20), Vh.

723708. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “–‰@‚É‚¨‚Ż‚é• o‹ž‰şt᱌`Źp. ź@ˇG1, “Ą“c“N•v1, •˝–ěC•˝1, “c”¨Œ’ˆę1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/20), Vh.

723709. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘ź‰ČˆŤŤŽîᇂɔş‚¤…tÇ‚ɑ΂ˇ‚é‹ŕ‘Ž”AŠÇƒXƒeƒ“ƒg‚̏‰ŠúŽg—pŒoŒą. ”‹Œ´ł”Ž1, “Ą“c“N•v1, “V–ě“”V1, Žu‘ş‘sˆę˜N1, —§‰Ô‹MŽj1, •˝–ěC•˝1, Ź—ŃŒ’‘ž˜Y1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/20), Vh.

723710. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • o‹ž‰şt᱌`Źp‚É‚¨‚Ż‚épŒă‘Šú…tÁŽ¸—á‚Ɛ…t•s•Ď—á‚ĚŠłŽŇ”wŒi‚ɂ‚˘‚Ä‚ĚŒŸ“˘. •˝–ěC•˝1, ź@ˇG1, Ź—ŃŒ’‘ž˜Y1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, “c”¨Œ’ˆę1, “Ą“c“N•v1, ź–{˜aŤ1, ˛“ĄˆĐ•ś1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/20), Vh.

723711. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “ŕŽ‹‹ž‚đŽg—p‚ľ‚Č‚˘’jŤ‚Ě”AŠÇƒXƒeƒ“ƒgŒđŠˇ‚ĚŒŸ“˘. ‘şă‘א´1, ‘呐@—m, “Ąé‹M‹ł, ‰F“s‹{‘ńŽĄ (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/20), Vh.

723712. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰şŞŽĄ“IäNă÷“Eœp‚É‚¨‚Ż‚éŽüpŠúŹŃ‚ɂ‚˘‚ā`‰ŠúÇ—á‚ĚŒ‹‰Ę`. ź–{˜aŤ1, “c”¨Œ’ˆę1, •˝ŽR‹M”Ž1, ”‹Œ´ł”Ž1, ’Ă‘şGN1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/21), Vh.

723713. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é• o‹ž‰şt•”•ŞŘœp‚̏‰ŠúŒoŒą. ‚Œű@‘ĺ1, “ě“c@—@1, –ź–؏l1, •˝–ěC•˝1, “Ą“c“N•v1, “c‰Ş‰ŔŒ›1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/21), Vh.

723714. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) • o‹ž‰şt•”•ŞŘœp‚É‚¨‚Ż‚éR.E.N.A.L. Nephrometry score ‚ĚŒŸ“˘. “Ą“c“N•v1, ź@ˇG1, •˝ŽR‹M”Ž1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć29‰ń“ú–{”ĺ”AŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/11/21), Vh.

723715. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒCƒRƒfƒLƒXƒgƒŠƒ““§Í‰t‚ĹŽct‹@”\’ˇŠúˆŰŽ‚މ”\‚Ĺ‚ ‚Á‚˝1—á. •˝–ěC•˝1, Îˆä‘ĺ•ă1, ”‹Œ´ł”Ž1, —§‰Ô‹MŽj1, Žáˆä—zŠó, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć21‰ń“ú–{• –Œ“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/11/28), ĺ‘ä.

723716. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒƒ{ƒbƒgŽx‰‡• o‹ž‰ş‘O—§‘B“Eœp‚ĚŽüpŠú‡•šÇ‚Ć’ZŠúŹŃ. ‰Š@‰p–Î, ‚“cŽĄŽq1, –]ŒŽN•˝1, Žá“c•”—zŽi1, “y‹´łl1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/10), ‘ĺă.

723717. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Źl—á‚ɑ΂ˇ‚é• o‹ž‰şäNă÷”AŠÇV•Ť‡p. ź@ˇG1, “Ą“c“N•v1, Îˆä‘ĺ•ă1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

723718. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) t“Ž‘ÔƒVƒ“ƒ`ƒOƒ‰ƒtƒB[‚đ—p‚˘‚˝• o‹ž‰şt•”•ŞŘœpŒăt‹@”\‚ĚŒŸ“˘. “Ą“c“N•v1, ź@ˇG1, “c”¨Œ’ˆę1 ,Îˆä‘ĺ•ă1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/12), ‘ĺă.

723719. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) íőF‘Ě—DŤ‘˝”­ŤůN–EtŠłŽŇ‚ɑ΂ˇ‚étˆÚA‚ĚŒŸ“˘. Îˆä‘ĺ•ă1, ”‹Œ´ł”Ž1, ě‘ş•ä1, Žáˆä—zŠó, ź–{˜aŤ1, •˝ŽR‹M”Ž1, –ěŒű•ś”T2, ’|“ŕN—Y3, ‹g“cˆęŹ4, Šâ‘şłŽk1 (1”ĺ”AŠí, 2ŠĹŒě•”, 3t‘Ÿ“ŕ, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć49‰ń“ú–{—Տ°tˆÚAŠw‰ď (2016/3/23), •ÄŽq.

723720. [Šw‰ď (‘S‘)] (Award Session) ˆę”ĘŽs–Ż‚Ö‚Ě‘ŸŠíˆÚA•‹yŒ[”­‚Ě’ˇŠúŒp‘ąŠˆ“Ž‚ĚŽŔŰ‚Ćƒ|ƒCƒ“ƒg. ’r“cŹ]1, Îˆä‘ĺ•ă1, ě‘ş•ä1, –ěŒű•ś”T2, rě–@Žq2, ‚‹´@Œb2, ‹g“c•üŽq3, “c’†”üŽ÷2, Šâ‘şłŽk1, ‹g“cˆęŹ4 (1”ĺ”AŠí, 2ŠĹŒě•”, 3‰h—{•”, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć49‰ń“ú–{—Տ°tˆÚAŠw‰ď (2016/3/24), •ÄŽq.

723721. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒƒTƒ‰ƒWƒ“‚É‚ć‚étáŠQ‚ɑ΂ľtˆÚAŽ{sŒă‚ÉUC‚ލĔR‚ľ‚˝ˆę—á. ”‹Œ´ł”Ž1, Îˆä‘ĺ•ă1, •˝–ěC•˝1, Ş–{—Žq1, ě‘ş•ä1, •˝ŽR‹M”Ž1, ‹g“cˆęŹ2, –ěŒű•ś”T3, ’r“cŹ]1, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă, 3ŠĹŒě•”): ‘ć49‰ń“ú–{—Տ°tˆÚAŠw‰ď (2016/3/25), •ÄŽq.

731125. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) • o‹ž‰şt‘Ÿ“Eop‹Zp”F’čˆăŽć“ž‚đ–ÚŽw‚ľ‚Ä. Šâ‘şłŽk (”ĺ”AŠí): ‘ć6‰ń‘ĺăEndo UrologyŒ¤‹†‰ď (2015/5/22), ‘ĺă.

731126. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Office Urology‚É‚¨‚Ż‚émCRPCŽĄ—Ă: ƒAƒrƒ‰ƒeƒƒ“Žg—p‚Ěƒ|ƒCƒ“ƒg‚ƑΉž. ˛“ĄˆĐ•ś (”ĺ”AŠí): _“ސěCRPC Seminar (2015/5/28), ‰Ą•l.

731127. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚鎥—ĂƒXƒgƒ‰ƒ^ƒW[‚̍čl. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć85‰ńL“‡”ĺ”AŠí‰Čˆă‰ď (2015/6/13), L“‡.

731128. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) • o‹žEƒƒ{ƒbƒgŽčp‚É‚¨‚Ż‚郊ƒXƒNŠÇ—|ƒmƒ“EƒeƒNƒjƒJƒ‹ƒXƒLƒ‹‚̏d—vŤ‚ɂ‚˘‚ā|. Šâ‘şłŽk (”ĺ”AŠí): ‘ć138‰ń“Œ–k”ĺ”AŠí‰Č’k˜b‰ďE‘ć8‰ń‘O—§‘BŠŕƒZƒ~ƒi[ (2015/6/29), ĺ‘ä.

731129. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒAƒrƒ‰ƒeƒƒ“‚Ě“ÁŤ‚đ—‰đ‚ˇ‚é|—Տ°Žg—p‚É‚¨‚Ż‚éƒ}ƒl[ƒWƒƒ“ƒg‚Ěƒ|ƒCƒ“ƒg|. ˛“ĄˆĐ•ś (”ĺ”AŠí): CRPC WEBƒZƒ~ƒi[ (2015/7/2), “Œ‹ž.

731130. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚鎥—ĂƒXƒgƒ‰ƒeƒW[‚̍čl. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć20‰ńă_‘O—§‘BŽžŠłƒZƒ~ƒi[ (2015/7/16), ź‹{.

731131. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŹŽ™‚Ě• o‹žŽčp. ź@ˇG (”ĺ”AŠí): Œŕ”ĺ”AŠí‰Č‰ď (2015/7/16), Œŕ.

731132. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) RALP“ą“ü‰Šú100—á‚ĚŽĄ—ĂŽŔŃ`LRP600—á‚Ć‚Ě”äŠr`. Šâ‘şłŽk (”ĺ”AŠí): ‘ć5‰ńŽs“ŕ‚Ĺ‘O—§‘BŠŕ‚đl‚Ś‚é‰ď (2015/7/24), L“‡.

731133. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ADPKDf—Ă‚ÉŠÖ‚ˇ‚éĹ‹ß‚Ě˜b‘č|ůN–EtŠO—ˆ‚Ćƒgƒ‹ƒoƒvƒ^ƒ“|. ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘Š–ÍŒ´ADPKD•af˜AŒg‚̉ď (2015/7/24), ‘Š–ÍŒ´.

731134. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •ďŠ‡“I‘O—§‘B‚Ş‚ń’nˆć˜AŒg: Kitasato Prostate Cancer Network (KP-Net) ‚É‚ć‚銳ŽŇŽx‰‡‚ĚŽć‚č‘g‚Ý‚ĆŒř‰Ę`CRPC‚ɑ΂ˇ‚éV‚˝‚Č“WŠJ`. ˛“ĄˆĐ•ś (”ĺ”AŠí): CRPC‚đl‚Ś‚é‰ď (2015/7/30), ‰Ą•l.

731135. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) isŤäNă÷Šŕ‚ĚŽĄ—Ă. ź–{˜aŤ (”ĺ”AŠí): –k‹ăBŽs”ĺ”AŠí‰Čˆă‰ď•˝Ź27”N“x‘ć3‰ńŒ¤C‰ď (2015/7/30), –k‹ăB.

731136. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘O—§‘BŠŕ‚̐f’f‚ĆŽĄ—ĂƒAƒbƒvƒf[ƒg2015. ˛“ĄˆĐ•ś (”ĺ”AŠí): ’nˆć˜AŒgŠwpu‰‰‰ď (2015/8/26), ‘O‹´.

731137. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚鎥—ĂƒXƒgƒ‰ƒeƒW[‚̍čl. ˛“ĄˆĐ•ś (”ĺ”AŠí): CRPCŠwpu‰‰‰ď (2015/8/27), b•{.

731138. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) MOCRPC‚ĚƒXƒgƒ‰ƒeƒW[‚ɂ‚˘‚Ä. ˛“ĄˆĐ•ś (”ĺ”AŠí): Prostate Cancer Academia (2015/9/5), “Œ‹ž.

731139. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) MO CRPC‚ɑ΂ˇ‚é‹~Ď•úŽËü—Ă–@. ’Ă‘şGN (”ĺ”AŠí): ‘O—§‘BŠŕŽĄ—Íu‰‰‰ď (2015/9/8), ‘Š–ÍŒ´.

731140. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹Zp”F’č‚ÉŒü‚Ż‚˝”ĺ”AŠí• o‹žŽčp‚ĚŠî–{Žč‹Z. Šâ‘şłŽk (”ĺ”AŠí): ‘ć71‰ń“ú–{”ĺ”AŠí‰ČŠw‰ďŒQ”n’n•ű‰ď (2015/10/24), ‚č.

731141. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) LRP‚ĚŒoŒą‚ÍRALP“ą“ü‚ɐś‚Š‚ł‚ę‚é‚Š? Šâ‘şłŽk (”ĺ”AŠí): Expert Operation Forum for Urologist (2015/11/6), ‘ĺă.

731142. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “–‰@‚É‚¨‚Ż‚étˆÚAƒ`[ƒ€ˆă—Í\Ź. ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć11‰ń“ě‘ĺătˆÚAE“§Íˆă—ĂŒ¤‹†‰ď (2015/11/19), ‘ĺă.

731143. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) •ďŠ‡“I‘O—§‘B‚Ş‚ń’nˆć˜AŒg: kitasato Prostate Cancer Network (KP-Net) ‚É‚ć‚銳ŽŇŽx‰‡‚ĚŽć‚č‘g‚Ý‚ĆŒř‰Ę`CRPC‚ɑ΂ˇ‚éV‚˝‚Č“WŠJ`. ˛“ĄˆĐ•ś (”ĺ”AŠí): CRPC‚Ě˜AŒg‚đl‚Ś‚é‰ď (2015/11/26), •Ÿ‰Ş.

731144. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Office Urology‚É‚¨‚Ż‚é‹Ž¨’ďRŤ‘O—§‘BŠŕ`V‚ľ‚˘—Տ°•]‰ż‚ƐV‚˝‚Č“W–]`. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć130‰ń‘˝–€”ĺ”AŠí‰Čˆă‰ď (2015/11/27), •‘ –ě.

731145. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “–‰@‚É‚¨‚Ż‚é”r”AáŠQ‚ĚŽĄ—Âɂ‚˘‚Ä. •˝ŽR‹M”Ž (”ĺ”AŠí): ‘ć6‰ńUrology Conference in Sagamihara (2016/1/27), ‘Š–ÍŒ´.

731146. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒV[ƒh—Ă–@‘˜_. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć19‰ńƒˆƒE‘f125ƒV[ƒhüŒš‚É‚ć‚é‘O—§‘BŠŕ‰i‹v‘}“ü–§••ŹüŒšŽĄ—Ă‚ĚˆŔ‘SŽćˆľuK‰ď (2016/2/27), “Œ‹ž.

732054. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‘O—§‘B”ě‘ĺÇ‡•š‰ßŠˆ“ŽäNă÷Ç—á‚ɑ΂ˇ‚éƒiƒtƒgƒsƒWƒ‹‚Ě—L—pŤ‚ĚŒŸ“˘: ƒiƒtƒgƒsƒWƒ‹’P“ĆŒQ VS ƒiƒtƒgƒsƒWƒ‹ + RƒRƒŠƒ“Ü`‘ŠúŽŠŠoÇó‰ü‘PŒř‰Ę‚Ě”äŠr`. ź@ˇG1, ‘şă‘א´1, ‘呐@—m, “Ąé‹M‹ł, ‰F“s‹{‘ńŽĄ, ÝŠy•q–ç, •âáÁ“ń1, Ź—ŃŒ’‘ž˜Y1, ‘OŽR—Ç‘ž1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć9‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2015/4/4), “Œ‹ž.

732055. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Ç—á‚Š‚çŠw‚Ô‘O—§‘B‚Ş‚ń–ň•¨ŽĄ—Ă: ŠĎŽ@‚Ěƒ|ƒCƒ“ƒg‚Ć•›ě—p‘΍ô. ˛“ĄˆĐ•ś (”ĺ”AŠí):ŠĹŒěŽtWEBƒVƒ“ƒ|ƒWƒEƒ€ (2015/6/18), “Œ‹ž.

732056. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ƒAƒ“ƒhƒƒQƒ“‚Ć‹Ž¨’ďRŤ‘O—§‘BŠŕ: WŠw“IEŒQ—YŠ„‹’ŽĄ—Â𐎗‚ˇ‚é. ˛“ĄˆĐ•ś (”ĺ”AŠí):‘ć15‰ń“ú–{Men's HealthˆăŠw‰ď (2015/9/4), é‹Ę.

732057. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ŠeƒŠƒXƒN‚É‚¨‚Ż‚鎥—ĂƒXƒgƒ‰ƒeƒW[‚ĚŽŔŰ. ź–{˜aŤ (”ĺ”AŠí):‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/26), Vh.

732058. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) T1bÇ—á‚ɑ΂ˇ‚ét•”•ŞŘœp. “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí):‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/26), Vh.

732059. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ƒAƒrƒ‰ƒeƒƒ“‚ĚƒGƒrƒfƒ“ƒX‚ĆĹ“K‚ČŠłŽŇ‘œ‚Ć‚Í? ˛“ĄˆĐ•ś (”ĺ”AŠí):‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/26), Vh.

732060. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) ‘O—§‘BŠŕ‹ÇŠŽĄ—ĂŒă‚Ě‹ÇŠÄ”­f’fƒXƒgƒ‰ƒeƒW[. ˛“ĄˆĐ•ś (”ĺ”AŠí):‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), Vh.

732061. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) t×–EŠŕŽĄ—Ă‚É‚¨‚Ż‚郔ƒFƒgƒŠƒGƒ“ƒg‚Ě–đŠ„. ’†“‡MK, –ě–{„Žj, “Ą“c“N•v1 (1”ĺ”AŠí):WEST KANAGAWA RCC CONFERENCE (2015/10/9), Œú–Ř.

732062. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒrƒfƒIƒfƒBƒXƒJƒbƒVƒ‡ƒ“) • o‹ž‰şt᱌`Źp. Šâ‘şłŽk (”ĺ”AŠí):‘ć13‰ńMB”ĺ”AŠíŽčpƒrƒfƒIƒfƒBƒXƒJƒbƒVƒ‡ƒ“ (2015/10/10), ź–{.

732063. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) V‚˝‚Č’mŒŠ‚Š‚ç, ‚ą‚ę‚Š‚ç‚Ě“ú–{‚ĚŽŔ—Տ°‚đl‚Ś‚é`CRPC‚ł͉˝‚đdŽ‹‚ˇ‚é‚ׂŤ‚Č‚Ě‚Š`. ˛“ĄˆĐ•ś (”ĺ”AŠí):Update on CRPC in TOKYO (2015/10/24), “Œ‹ž.

732064. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ~ƒjƒŒƒNƒ`ƒƒ[) –k—˘‘ĺŠw‚É‚¨‚Ż‚ét×–E‚Ş‚ń•›ě—pƒ}ƒl[ƒWƒƒ“ƒg‚Ě‚˝‚ß‚Ě–âf•[“ą“ü‚ĚŒoˆÜ. “Ą“c“N•v (”ĺ”AŠí):‘ć10‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2015/11/7), Vh.

732065. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Kitasato Prostate Cancer Network (KP-Net)‚É‚ć‚銳ŽŇŽx‰‡‚ĚŽć‚č‘g‚Ý‚ĆŒř‰Ę: CRPC‚É‚¨‚Ż‚éV‚˝‚Č”­“W. ˛“ĄˆĐ•ś (”ĺ”AŠí):‘ć89‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2015/11/14), V‰Ą•l.

733261. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ’ź’°ŠŕpŒă ”AŠÇ‘š, ŠŽ‘S—Ł’f‚Ěˆę—á. –ź–؏l1, “ě“c@—@1, “c‰Ş‰ŔŒ›1, ’ŘˆärŽ÷ (1”ĺ”AŠí):‘ć9‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2015/4/4), Vh.

733262. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) • o‹ž‰şt“Eœp‚É‚¨‚Ż‚étĂ–Ź‘š‚Ě1—á. ‚“cŽĄŽq1, ‰Š@‰p–Î (1”ĺ”AŠí):‘ć9‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2015/4/4), Vh.

733263. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) “–‰@‚Ĺ‚Ě‘ź‰Č‚ĚŽčp‚̍‡•šÇ‚Ć‚ť‚̑Ήž‚ɂ‚˘‚Ä. ‘ĺŽR“N•˝1, Žá“c•”—zŽi1, ‰œ–ě‹I•F (1”ĺ”AŠí):‘ć9‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2015/4/4), Vh.

733264. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) 2Œ^“œ”A•a‚É‚ć‚é––Šút•s‘SŠłŽŇ‚ɑ΂ˇ‚étˆÚA‚ĚŒŸ“˘. Îˆä‘ĺ•ă1, •˝–ěC•˝1, Ź—ŃŒ’‘ž˜Y1, ’r“cŹ]1, –ěŒű•ś”T2, Žáˆä—zŠó, Šâ‘şłŽk1, ’|“ŕN—Y3, ‹g“cˆęŹ4 (1”ĺ”AŠí, 2ŠĹŒě•”, 3t‘Ÿ“ŕ, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć26‰ń_“ސěˆÚAˆăŠw‰ď (2015/6/6), ‰Ą•l.

733265. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) 2Œ^“œ”A•a‚É‚ć‚é––Šút•s‘SŠłŽŇ‚ɑ΂ˇ‚étˆÚA‚ĚŒŸ“˘. •˝–ěC•˝1, Îˆä‘ĺ•ă1, Ź—ŃŒ’‘ž˜Y1, ’r“cŹ]1, –ěŒű•ś”T2, ’|“ŕN—Y3, Žáˆä—zŠó, Šâ‘şłŽk1, ‹g“cˆęŹ4 (1”ĺ”AŠí, 2ŠĹŒě•”, 3t‘Ÿ“ŕ, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć21‰ń“ú–{ˆÚA–ň•¨—Ă–@Œ¤‹†‰ď (2015/6/13), “Œ‹ž, Ą“ú‚ĚˆÚA 2015; 28 (6): 696-7.

733266. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‰Œo‚É‚ć‚Á‚Ä–ž‚ç‚Š‚É‚Č‚Á‚˝WunderlichÇŒóŒQ‚Ěˆę—á. –Ȋс@ăÄ1, ź@ˇG1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, “Ą“c“N•v1, ˛“ĄˆĐ•ś1, ź–{˜aŤ1, ”‹Œ´ł”Ž1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć88‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2015/6/13), ‰Ą•l.

733267. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) tŠŕ‚Ć‚ĚŠÓ•Ę‚Ş˘“ď‚ž‚Á‚˝tˆŤŤƒŠƒ“ƒpŽî‚Ě1—á. ‘ĺŽR“N•˝1, Žá“c•”—zŽi1, ‰œ–ě‹I•F (1”ĺ”AŠí):‘ć88‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2015/6/13), ‰Ą•l.

733268. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ś‘̐tˆÚAŒă”AŠÇ‹ˇó‚ɑ΂ľ‚ÄŽŠŒČtṁ|ˆÚAt”t•Ť‡‚đ‚¨‚ą‚Č‚Á‚˝1Ç—á. Îˆä‘ĺ•ă1, Ź—ŃŒ’‘ž˜Y1, •˝–ěC•˝1, –]ŒŽN•˝1, Žáˆä—zŠó, Šâ‘şłŽk1, ‹g“cˆęŹ2 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć24‰ń“ú–{t•s‘SŠO‰ČŒ¤‹†‰ď (2015/7/3), –k‹ăB.

733269. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Non-metastatic castration resistant prostate cancer‚ɑ΂ˇ‚é‹~Ď•úŽËü—Ă–@‚ĚŒŸ“˘. ’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, Žu‘ş‘sˆę˜N1, “Ą“c“N•v1, Šâ‘şłŽk1, ěăłŒĺ2, ŠÖŒűˆŠˆß2, –k–ě‰ëŽj2, ÎŽR”ŽžŠ2, ‘ě˜ad2 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć32‰ń_“ŢěŒ§‘O—§‘BŽîᇌ¤‹†‰ď (2015/7/4), V‰Ą•l.

733270. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) • o‹ž‰şś‘̐tˆÚAƒhƒi[‚̏pŒăƒtƒHƒ[ƒAƒbƒv‚Ć—\Œă‚ɂ‚˘‚Ä‚ĚŒŸ“˘. Îˆä‘ĺ•ă1, Ź—ŃŒ’‘ž˜Y1, •˝–ěC•˝1, •˝ŽR‹M”Ž1, “Ą“c“N•v1, “c’†”üŽ÷2, –ěŒű•ś”T2, ‹g“c•üŽq3, ’r“cŹ]1, Žáˆä—zŠó, ’|“ŕN—Y4, Šâ‘şłŽk1, ‹g“cˆęŹ5 (1”ĺ”AŠí, 2ŠĹŒě•”, 3‰h—{•”, 4t‘Ÿ“ŕ, 5V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć31‰ńtˆÚAEŒŒŠÇŠO‰ČŒ¤‹†‰ď (2015/7/10), “úŒő.

733271. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) _“ŢěŒ§‚É‚¨‚Ż‚étˆÚAˆă—ÁEt•s‘SŽĄ—Ă‚Ěî•ń‹¤—LŠˆ“Ž‚ĚŽć‚č‘g‚Ý. ’r“cŹ]1, –ěŒű•ś”T2, ’†–ڐ^—Žq, ŸNˆä—TŽq, Ö“Ą—R”üŽq, ŹâŽu•Ű, “c’†”üŽ÷2, Îˆä‘ĺ•ă1, Šâ‘şłŽk1, ‹g“cˆęŹ3 (1”ĺ”AŠí, 2ŠĹŒě•”, 3V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć31‰ńtˆÚAEŒŒŠÇŠO‰ČŒ¤‹†‰ď (2015/7/11), “úŒő.

733272. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) C”˝‰žŤ’`”’‚’lÇ—á‚ɑ΂ˇ‚éƒXƒjƒ`ƒjƒuŽĄ—Ă‚É‚¨‚Ż‚éŒř‰Ę—\‘ވöŽq‚ĚŒŸ“˘. “Ą“c“N•v1, “c”¨Œ’ˆę1, Îˆä‘ĺ•ă1, ź–{˜aŤ1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć46‰ńtŠŕŒ¤‹†‰ď (2015/7/19), •iě.

733273. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) tŽîᇂƂ̊ӕʂđ—v‚ľ‚˝PEComa‚Ě1—á. V‘ş’qŒČ, ‘şă‘א´1, “Ąé‹M‹ł, ‰F“s‹{‘ńŽĄ, Šâ‘şłŽk1 (1”ĺ”AŠí):‘ć52‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (2015/9/17), ‰Ą•l, ”ĺ”AŠíŠO‰Č 2016/1; 29 (1): 90.

733274. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Žá”NŤtŠŕE‘˝”­ŠĚ“]ˆÚÇ—á‚Ƀpƒ]ƒpƒjƒu‚Ş’˜Œř‚ľ‚˝1—á. Žá“c•”—zŽi1, ‘ĺŽR“N•˝1, ‰œ–ě‹I•F (1”ĺ”AŠí):‘ć52‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (2015/9/17), ‰Ą•l, ”ĺ”AŠíŠO‰Č 2016/1; 29 (1): 90.

733275. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) calciphylaxisis‚É‚ć‚č‰AŒsŘ’f‚ÉŽŠ‚Á‚˝–ŤˆŰŽ“§ÍŠłŽŇ‚Ěˆę—á. â“c—T‰î1, Îˆä‘ĺ•ă1, •˝–ěC•˝1, ”‹Œ´ł”Ž1, ź@ˇG1, “c”¨Œ’ˆę1, “Ą“c“N•v1, ź–{˜aŤ1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć52‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (2015/9/17), ‰Ą•l, ”ĺ”AŠíŠO‰Č 2016/1; 29 (1): 92.

733276. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) tᱟ󗬌‹Î—n‰đ—Ă–@‚Ş‘tŒř‚ľ‚˝ƒVƒXƒ`ƒ“Œ‹Î‚Ě2Ç—á3Œ‹Î. —§‰Ô‹MŽj1, ˆŔ“Ą–š”ü1, Îě@–í1, ŠŰ@“T•v, Šâ‘şłŽk1 (1”ĺ”AŠí):‘ć52‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (2015/9/17), ‰Ą•l, ”ĺ”AŠíŠO‰Č 2016/1; 29 (1): 93.

733277. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‹ßÚ‘ŸŠí‡•šŘœ‚đ—v‚ľ‚˝ŠŒF×–EŽî. â“c—T‰î1, •˝ŽR‹M”Ž1, ě‘ş•ä1, Ź—ŃŒ’‘ž˜Y1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/26), Vh.

733278. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Non-metastatic castration resistant prostate cancer‚ɑ΂ˇ‚é‹~Ď•úŽËü—Ă–@‚ĚŒŸ“˘. ’Ă‘şGN1, ˛“ĄˆĐ•ś1, “c”¨Œ’ˆę1, ÎŽR”ŽžŠ2, ěăłŒá2, ŠÖŒűˆŠˆß2, Žu‘ş‘sˆę˜N1, •˝ŽR‹M”Ž1, â“c—T‰î1, •âáÁ“ń1, “Ą“c“N•v1, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡)): ‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), Vh.

733279. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠŽ‘Sd•Ąt᱔AŠÇ‚ɍ‡•š‚ľ‚˝äNă÷”AŠÇ‹t—ŹÇ‚ɑ΂ˇ‚é‹CäNă÷‰şäNă÷”AŠÇV•Ť‡p. –Ȋс@ăÄ1, ź@ˇG1, Žu‘ş‘sˆę˜N1, ”‹Œ´ł”Ž1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, “Ą“c“N•v1, ˛“ĄˆĐ•ś1, ź–{˜aŤ1, ‚‹´—Tˆę˜Y, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), Vh.

733280. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) •úŽËüŽĄ—ĂŒă‚Ě‹ÇŠÄ”­‘O—§‘BŠŕ‚ɑ΂ˇ‚éfocal salvage HDR brachytherapy‚ĚŒŸ“˘: prospective pilot study. —§‰Ô‹MŽj1, ˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2, ’Ă‘şGN1 ,“c”¨Œ’ˆę1, Œ´@•qŤ3, –öŕVM”V4, ’r“cŸb1, •âáÁ“ń1, –k–ě‰ëŽj2, ”nęŽu˜Y1, ‘ě˜ad2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2•úŽËü (Žîá‡), 3•úŽËü (‰ć‘œ), 4•a—): ‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), Vh.

733281. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠO‰A•”‚É”­ś‚ľ‚˝’E•Ş‰ťŒ^Ž‰–b“÷Žî‚Ě1—á. ˆŔHt‹P, ‰Ş@@—D, ‰i–{Ťˆę, ăŒű˜aŽ , ’r“cŸb1, •ŕV˜aG, ‰YăTŽi ,‰ŞŞ’J—˜ˆę (1”ĺ”AŠí):‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), Vh.

733282. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) 35Î–˘–ž‚É”­ś‚ľ‚˝äNă÷Šŕ‚Ě—Ő°“I“Á’Ľ‚ɂ‚˘‚Ä. •˝–ěC•˝1, ź–{˜aŤ1, ŽR“c‘׎j1, •˝ŽR‹M”Ž1, ź@ˇG1, ’Ă‘şGN1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí):‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), Vh.

733283. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ‹Ž¨’ďRŤ‘O—§‘BŠŕ‚ɑ΂ˇ‚éAbiraterone“Š—^Žž‚ĚALP-bounce‚ĚŒŸ“˘. “c”¨Œ’ˆę1, ˛“ĄˆĐ•ś1, ’Ă‘şGN1, •˝ŽR‹M”Ž1, –Ȋс@ăÄ1, â“c—T‰î1, Žu‘ş‘sˆę˜N1, “V–ě“”V1, —§‰Ô‹MŽj1, Îˆä‘ĺ•ă1, Šâ‘şłŽk1 (1”ĺ”AŠí):‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), Vh.

733284. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ”AŠÇäNă÷ˆÚs•”‚ĚÄ”­”A˜Hă”çŠŕ‚ɑ΂ľ‚Ä, •”•ŞŘœpEäNă÷”AŠÇV•Ť‡p‚đŽ{s‚ľ‚˝1—á. Žu‘ş‘sˆę˜N1, ź–{˜aŤ1, â“c—T‰î1, ”‹Œ´ł”Ž1, ź@ˇG1, ’Ă‘şGN1, “c‰Ş‰ŔŒ›1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), Vh.

733285. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ”畆‹Ř‰Š‚đ‡•š‚ľ‚˝”AŠÇŠŕ‚Ě1—á. “V–ě“”V1, ź–{˜aŤ1, –Ȋс@ăÄ1, ě‘ş•ä1, Îˆä‘ĺ•ă1, “c”¨Œ’ˆę1, “ü]@Œ[1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), Vh.

733286. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ”AŠÇŽîᇂɑ΂ľ‚Ä”AŠÇ‹ž‰şƒŒ[ƒU[Řœp‚đs‚Á‚˝1—á. ŽR‰ş‰p”V1, Îˆä~ˆę˜Y1, –{“c’qŽk1, X‰ił“ń˜Y, ‚“ˆ—Í–í, ‚‹´—Tˆę˜Y, –ĺ˜e˜ab, “ü]@Œ[1 (1”ĺ”AŠí): ‘ć80‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď“Œ•”‘‰ď (2015/9/27), “Œ‹ž.

733287. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) CRPCŽĄ—Ă‚É‚¨‚Ż‚鍡Œă‚Ě“W–]. ˛“ĄˆĐ•ś (”ĺ”AŠí): ‘ć22‰ń“Œ‹ž‘O—§‘BŠŕƒtƒH[ƒ‰ƒ€ (2015/10/17), “Œ‹ž.

733288. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠeŽ{Ý‚ĚŒťó•ń. Îˆä‘ĺ•ă1, ‚‹´@Œb (1”ĺ”AŠí): ‘ć2‰ń‘S‘‘ŸŠíˆÚAˆă—ĂŽx‰‡•”–ĺu‰‰‰ď (2015/10/24), –źŒĂ‰Ž.

733289. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) f’f‚É‹ę—ś‚ľ‚˝SóŒ‹’°äNă÷ᑂ̈ę—á. “V–ě“”V1, ŽR‰ş‰p”V, ’r“cŸb1, “ü]@Œ[1 (1”ĺ”AŠí): ‘ć10‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2015/11/7), Vh.

733290. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒ}ƒSƒbƒgƒeƒ‰ƒs[‚đs‚Á‚˝‰AůN”^ᇂ̈ę—á. ŽR“c‘׎j1, ‘OŽR—Ç‘ž1, ź“c‘ĺ‰î1, Ż@@‹œ (1”ĺ”AŠí): ‘ć10‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2015/11/7), Vh.

733291. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Œo’ź’°“I‘O—§‘BśŒŸ‘O‚Ě•Ö”|—{‚É‚ć‚étargetingR‹Ű–ň“Š—^‚Ě—L—pŤ‚ɂ‚˘‚Ä. Žu‘ş‘sˆę˜N1, ‚Œű@‘ĺ1, “ě“c@—@1, “c‰Ş‰ŔŒ›1 (1”ĺ”AŠí): ‘ć10‰ń–k—˘”ĺ”AŠí‰Č§˜b‰ď (2015/11/7), Vh.

733292. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) Œo’ź’°“I‘O—§‘BśŒŸŒă—L”MŤŠ´őÇ‚ɑ΂ˇ‚éƒZƒtƒƒ^ƒ][ƒ‹‚Ě—LŒřŤ‚ĚŒŸ“˘. ‘şă‘א´1, –{“c’qŽk1, Ź—ŃŒ’‘ž˜Y1, ‘呐@—m, “Ąé‹M‹ł, ÝŠy•q–ç, ‰F“s‹{‘ńŽĄ (1”ĺ”AŠí): ‘ć67‰ńź“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/11/7), •Ÿ‰Ş, ź“ú–{”ĺ”AŠí‰ČŠw‰ďŽ 2015/10; 77 (‘Š§): 134.

733293. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) “űâô‹š‚đ‡•š‚ľ‚˝IgG4ŠÖ˜AŒă• –ŒüˆŰÇ‚Ě1—á. ŕF’J—z•˝, ‘şă‘א´1, ‘呐@—m, “Ąé‹M‹ł, ‰F“s‹{‘ńŽĄ (1”ĺ”AŠí): ‘ć67‰ńź“ú–{”ĺ”AŠí‰ČŠw‰ď‘‰ď (2015/11/7), •Ÿ‰Ş, ź“ú–{”ĺ”AŠí‰ČŠw‰ďŽ 2015/10; 77 (‘Š§): 168.

733294. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ‹Ř‘w”ńZŤäNă÷Šŕ‚ɑ΂ˇ‚éBCG“ą“üEˆŰŽ—Ă–@‚ÉŠÖ‚ˇ‚錟“˘. ź–{˜aŤ1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, “c”¨Œ’ˆę1, “Ą“c“N•v1, “ü]@Œ[1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć8‰ńBCG’“ü—Ă–@Œ¤‹†‰ď (2015/11/13), “Œ‹ž.

733295. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) •›t•s‘S‚đ‡•š‚ľ‚˝—ź‘¤•›tˆŤŤƒŠƒ“ƒpŽî‚Ěˆę—á. â“c—T‰î1, ’Ă‘şGN1, –Ȋс@ăÄ1, ě‘ş•ä1, ”‹Œ´ł”Ž1, ‰Í‡š—FŠó2, ‚–ěK˜H2, ƒEƒbƒhƒnƒ€ƒX—ćŽq3, •˝ŽR‹M”Ž1, “c”¨Œ’ˆę1, “Ą“c“N•v1, Šâ‘şłŽk1 (1”ĺ”AŠí, 2“ŕ•Ş”ĺ‘ăŽÓ“ŕ, 3•úŽËü (‰ć‘œ)): ‘ć89‰ń_“ŢěŒ§”ĺ”AŠí‰Čˆă‰ď (2015/11/14), V‰Ą•l.

733296. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) HIVŠ´őŽŇ‚É”­Ç‚ľ‚˝äNă÷Šŕ‚Ě1—á. â“c—T‰î1, •˝ŽR‹M”Ž1, ě‘ş•ä1, ź–{˜aŤ1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć16‰ń_“ސ쐍Š´őÇŠw‰ď (2016/2/13), ‰Ą•l.

733297. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ”AŠÇƒXƒeƒ“ƒg‚đ—Ż’u‚š‚¸Œo‰ßŠĎŽ@‚ľ“ž‚˝”Aᑂđ—L‚ˇ‚é•ĄŽG[ÝŤt‘š‚Ěˆę—á. –Ȋс@ăÄ1, ź@ˇG1, ě‘ş•ä1, •˝ŽR‹M”Ž1, ’Ă‘şGN1, “Ą“c“N•v1, ˛“ĄˆĐ•ś1, ź–{˜aŤ1, –ź–؏l1, ‹g“cˆęŹ2, Šâ‘şłŽk1 (1”ĺ”AŠí, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć53‰ń“ú–{”ĺ”AŠí‰ČŠw‰ď_“ސě’n•ű‰ď (2016/2/18), ‰Ą•l.

733298. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ŠŽ‘Sd•Ąt–Đ”AŠÇ‡•šäNă÷”AŠÇ‹t—ŹÇ‚ɑ΂ˇ‚é‹CäNă÷‰şäNă÷”AŠÇV•Ť‡p. ź@ˇG1, –Ȋс@ăÄ1, ”‹Œ´ł”Ž1, •˝ŽR‹M”Ž1, “Ą“c“N•v1, ź–{˜aŤ1, Šâ‘şłŽk1 (1”ĺ”AŠí): ‘ć12‰ń_“ސě”ĺ”AŠíƒrƒfƒIƒtƒH[ƒ‰ƒ€ (2016/3/5), ‰Ą•l.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-110018. [Œ´’˜] Targeting Poly (ADP-Ribose) Polymerase and the c-Myb-TopBP1-ATR-Chk1 Signaling Pathway in Castration-Resistant Prostate Cancer. Li L, Chang W, Yang G, Ren C, Park S, Karantanos T, Karanika S, Wang J, Yin J, Shah PK, Hirayama T1, Dobashi M1, Zhang W, Efstathiou E, Maity SN, Aparicio AM, Li Ning Tapia EM, Troncoso P, Broom B, Xiao L, Lee HS, Lee JS, Corn PG, Navone N, Thompson TC: Sci Signal 2014/5; 7 (326): 1-25. (•˝ŽR‹M”Ž1, “y‹´łl1: 1”ĺ”AŠí)

H26-110019. [Œ´’˜] Postmortem radiation safety and issues pertaining to permanent prostate seed implantation in Japan. Satoh T1, Dokiya T, Yamanaka H, Saito S, Ishiyama H2, Itami J, Shibuya H, Nakano T, Shigematsu N, Aoki M, Egawa S, Hashimoto M, Nishimura T, Yorozu A: Brachytherapy 2015/3; 14 (2): 136-41. (˛“ĄˆĐ•ś1, ÎŽR”ŽžŠ2: 1”ĺ”AŠí, 2•úŽËü (Žîá‡))

[Šw‰ďEŒ¤‹†‰ď“™]

H26-723013. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒAƒ‹ƒMƒ“Ž_ƒiƒgƒŠƒEƒ€‚đ—p‚˘‚˝ƒZƒ‹ƒuƒƒbƒN–@‚É‚¨‚Ż‚éĹ“Kěť–@‚ĚŠm—§‚¨‚ć‚Ń‚ť‚Ě“Á’Ľ. “c’†@Œ\1, ź‘ş—R—˘1, rˆä‚ä‚čŽq2, Š`ŔœA–M3, ’Ź“c‘ĺ•ă3, ŽR‰ş˜a–ç3, ź–{˜aŤ4, ‘ĺ•”@˝2, ˛“Ą—Yˆę2, •ž•”@Šw2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3•a—•”, 4”ĺ”AŠí): ‘ć53‰ń“ú–{—Տ°×–EŠw‰ďHŠú‘ĺ‰ď (2014/11/8), ‰şŠÖ.

H26-733012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒ|ƒXƒ^[) ƒAƒ‹ƒMƒ“Ž_ƒiƒgƒŠƒEƒ€‚đ—p‚˘‚˝ƒZƒ‹ƒuƒƒbƒN–@‚ĚŒŸ“˘. “c’†@Œ\1, ź‘ş—R—˘1, rˆä‚ä‚čŽq2, Š`ŔœA–M3, ’Ź“c‘ĺ•ă3, ŽR‰ş˜a–ç3, ź–{˜aŤ4, ‘ĺ•”@˝2, ˛“Ą—Yˆę2, •ž•”@Šw2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3•a—•”, 4”ĺ”AŠí): ‘ć33‰ń_“ŢěŒ§—Տ°×–EŠw‰ďŠwpW‰ď (2014/10/4), ‘Š–ÍŒ´.


Šá‰ČŠw

[Šwp˜_•ś]

110265. [Œ´’˜] Comparison of Astigmatic Correction after Femtosecond Lenticule Extraction and Small-Incision Lenticule Extraction for Myopic Astigmatism. Kobashi H1, Kamiya K1, Mohamed A Ali2, Igarashi A1, Mohamed Ehab M Elewa2, Shimizu K1 (2Department of Ophthalmology, Faculty of Medicine, Minia University, Minia, Egypt): PLoS One 2015/4; 10 (4): e0123408. (Ź‹´‰p’ˇ1, _’J˜aF1, ŒÜ\—’ÍŽj1, ´…Œö–ç1: 1Šá‰Č)

110266. [Œ´’˜] Anterior and Posterior Corneal Astigmatism after Refractive Lenticule Extraction for Myopic Astigmatism. Kamiya K1, Shimizu K1, Yamagishi M, Igarashi A1, Kobashi H1: J Ophthalmol 2015/5; 2015: 915853. (_’J˜aF1, ´…Œö–ç1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1: 1Šá‰Č)

110267. [Œ´’˜] Computer Simulation of Color Confusion for Dichromats in Video Device Gamut under Proportionality Law. Fukuda H, Hara S, Asakawa K1, Ishikawa H1, Noshiro M, Katuya M: IPSJ Transactions on Computer Vision and Applications 2015/5; 7: 41-9. (óě@ŒŤ1, Îě@‹Ď1: 1ˆă—ÉqśŠw•”)

110268. [Œ´’˜] Effect of Myopic Defocus on Visual Acuity after Phakic Intraocular Lens Implantation and Wavefront-guided Laser in Situ Keratomileusis. Kamiya K1, Shimizu K1, Igarashi A1, Kawamorita T2: Scientific Reports 2015/5; 5: 10456. (_’J˜aF1, ´…Œö–ç1, ŒÜ\—’ÍŽj1, ěŽç“c‘ńŽu2: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

110269. [Œ´’˜] Clinical utility of femtosecond laser-assisted astigmatic keratotomy after cataract surgery. Nejima R1,2, Terada Y1, Mori Y1,2, Ogata M1, Minami K1, Miyata K1: Jpn J Ophthalmol 2015/5; 59 (4): 209-15. (Žq“‡—Ç•˝1,2, X@—mÄ1,2: 1‹{“cŠá‰Č•a‰@, 2Šá‰Č)

110270. [Œ´’˜] Swedish Interactive Threshold Algorithm for central visual field defects unrelated to nerve fiber layer. Hirasawa K1, Shoji N1: Graefes Arch Clin Exp Ophthalmol 2016/5; 254 (5): 845-54. (•˝ŕVˆę–@1, ŻŽiMs1: 1ˆă—ÉqśŠw•”)

110271. [Œ´’˜] Effects of Different Levels of Intraocular Stray Light on Kinetic Perimetry Findings. Hirasawa K1, Shoji N1, Isono K, Tsuchiya M: PLoS One 2015/5; 10 (5): e0127159. (•˝ŕVˆę–@1, ŻŽiMs1: 1ˆă—ÉqśŠw•”)

110272. [Œ´’˜] Enhanced Depth Imaging of Central Laminar Thickness in Optic Neuropathy: Comparison with Normal Eyes. Suntaree Thitiwichienlert, Ishikawa H1, Asakawa K1, Ikeda T2, Shimizu K2: Neuro-Ophthalmology 2015/6; 39 (4): 166-74. (Îě@‹Ď1, óě@ŒŤ1, ’r“c“N–ç2, ´…Œö–ç2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

110273. [Œ´’˜] Effect of Intraocular Forward Scattering and Corneal Higher-Order Aberrations on Visual Acuity after Descemet's Stripping Automated Endothelial Keratoplasty Kamiya K1, Asato H1, Shimizu K1, Kobashi H1, Igarashi A1: PLoS One 2015/6; 10 (6): e0131110. (_’J˜aF1, ˆŔ—˘@“ľ1, ´…Œö–ç1, Ź‹´‰p’ˇ1, ŒÜ\—’ÍŽj1: 1Šá‰Č)

110274. [Œ´’˜] Long-term observation of surface light scattering in a foldable acrylic intraocular lens. Mitaya K1, Honbo M1, Nejima R1,2, Minami K1, Amano S1: J Cataract Refract Surg 2015/6; 41 (6): 1205-9. (Žq“‡—Ç•˝1,2: 1‹{“cŠá‰Č•a‰@, 2Šá‰Č)

110275. [Œ´’˜] Pupillary Size and Light Reflex in Premature Infants. Ikeda T1, Ishikawa H2, Shimizu K1, Asakawa K2, Goseki T1: Neuro-Ophthalmology 2015/7; 39 (4): 175-8. (’r“c“N–ç1, Îě@‹Ď2, ´…Œö–ç1, óě@ŒŤ2, ŒăŠÖ—˜–ž1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

110276. [Œ´’˜] Comparison of Subjective Refraction under Binocular and Monocular Conditions in Myopic Subjects. Kobashi H1, Kamiya K1, Handa T2, Ando W1, Kawamorita T2, Igarashi A1, Shimizu K1: Scientific Reports 2015/7; 5: 12606. (Ź‹´‰p’ˇ1, _’J˜aF1, ”ź“c’m–ç2, ˆŔ“Ą˜a‰ĚŽq1, ěŽç“c‘ńŽu2, ŒÜ\—’ÍŽj1, ´…Œö–ç1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

110277. [Œ´’˜] Repeatability, Reproducibility, and Comparability of Subjective and Objective Measurements of Intraocular Forward Scattering in Healthy Subjects. Iijima A1, Shimizu K2, Kobashi H2, Saito A2, Kamiya K2: Biomed Res Int 2015/7; 2015: 925217. (”Ń“‡ˆč‰Ă1, ´…Œö–ç2, Ź‹´‰p’ˇ2, âV“Ą@Ę2, _’J˜aF2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Šá‰Č)

110278. [Œ´’˜] Revalidating the usefulness of a "sector-wise regression" approach to predict glaucomatous visual function progression. Hirasawa K1, Murata H, Asaoka RInvest Ophthalmol Vis Sci 2015/7; 56 (8): 4332-5. (•˝ŕVˆę–@1: 1ˆă—ÉqśŠw•”)

110279. [Œ´’˜] Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery. Igarashi A1, Kamiya K1, Kobashi H1, Shimizu K1: Cornea 2015/8; 34 (8): 895-900. (ŒÜ\—’ÍŽj1, _’J˜aF1, Ź‹´‰p’ˇ1, ´…Œö–ç1: 1Šá‰Č)

110280. [Œ´’˜] Effect of Optical Defocus on the Kinetic Perimetry in Young Myopic Participants. Hirasawa K1, Shoji N1: Curr Eye Res 2015/8; 40 (8): 847-52. (•˝ŕVˆę–@1, ŻŽiMs1: 1ˆă—ÉqśŠw•”)

110281. [Œ´’˜] The Relationship Between Visual Acuity and the Reproducibility of Visual Field Measurements in Glaucoma Patients. Matsuura M, Hirasawa K1, Murata H, Asaoka R: Invest Ophthalmol Vis Sci 2015/8; 56 (9): 5630-5. (•˝ŕVˆę–@1: 1ˆă—ÉqśŠw•”)

110282. [Œ´’˜] Effects of mydriasis and miosis on kinetic perimetry findings in normal participants. Hirasawa K1, Shoji N1, Kobashi C, Yamanashi A: Graefes Arch Clin Exp Ophthalmol 2015/8; 253 (8): 1341-6. (•˝ŕVˆę–@1, ŻŽiMs1: 1ˆă—ÉqśŠw•”)

110283. [Œ´’˜] Intraocular Scattering after Instillation of Diquafosol Ophthalmic Solution. Kobashi H1, Kamiya K1, Igarashi A1, Miyake T1, Shimizu K1: Optom Vis Sci 2015/9; 92 (9): e303-9. (Ź‹´‰p’ˇ1, _’J˜aF1, ŒÜ\—’ÍŽj1, ŽO‘îr”V1, ´…Œö–ç1: 1Šá‰Č)

110284. [Œ´’˜] Correlation between disc damage likelihood scale with stereoscopic fundus camera and visual field index of Humphrey field analyzer. Asakawa K1, Kato S: The Journal of Ophthalmic Photography 2015/10; 37 (2): 67-70. (óě@ŒŤ1: 1ˆă—ÉqśŠw•”)

110285. [Œ´’˜] Intraocular lens power calculation in cases with posterior keratoconus. Tamaoki A1,2, Kojima T3, Hasegawa A2, Nakamura H2, Tanaka K1, Ichikawa K2,4: J Cataract Refract Surg 2015/10; 41 (10): 2190-5. (Žsěˆę•v2,4: 1MB‘ĺŠw‘ĺŠw‰@‘‡HŠwŒnŒ¤‹†‰Č, 2ŽĐ‰ď•ŰŒŻ’†‹ž•a‰@, 3Šň•ŒÔ\Žš•a‰@, 4Šá‰Č)

110286. [Œ´’˜] Assessment of Anterior, Posterior, and Total Central Corneal Astigmatism in Eyes With Keratoconus. Kamiya K1, Shimizu K1, Igarashi A1, Miyake T1: Am J Ophthalmol 2015/11; 160 (5): 851-7. (_’J˜aF1, ´…Œö–ç1, ŒÜ\—’ÍŽj1, ŽO‘îr”V1: 1Šá‰Č)

110287. [Œ´’˜] Central islands: rate and effect on visual recovery after phototherapeutic keratectomy. Hashimoto A, Kamiya K1, Shimizu K1, Igarashi A1, Kobashi H1: Jpn J Ophthalmol 2015/11; 59 (6): 409-14. (‹´–{“Ä•ś, _’J˜aF1, ´…Œö–ç1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1: 1Šá‰Č)

110288. [Œ´’˜] SUPPLEMENTAL SCLERAL BUCKLE IN VITRECTOMY FOR THE REPAIR OF RHEGMATOGENOUS RETINAL DETACHMENT: A Systematic Review of Literature and Meta-Analysis. Totsuka K, Inui H, Roggia MF, Hirasawa K1, Noda Y, Ueta T: Retina 2015/11; 35 (11): 2423-31. (•˝ŕVˆę–@1: 1ˆă—ÉqśŠw•”)

110289. [Œ´’˜] Comparison of the Normal, Preperimetric Glaucoma, and Glaucomatous Eyes with Upper-Hemifield Defects Using SD-OCT. Fujimura F1, Shoji N1, Hirasawa K1, Matsumura K2, Morita T2,3, Shimizu K2: Open Journal of Ophthalmology 2015/11; 5 (4): 167-73. (“Ą‘ş•‡˛Žq1, ŻŽiMs1, •˝ŕVˆę–@1, ź‘şˆęO2, X“c“N–ç2,3, ´…Œö–ç2: 1ˆă—ÉqśŠw•”, 2Šá‰Č, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

110290. [Œ´’˜] Area densitometry using rotating Scheimpflug photography for posterior capsule opacification and surface light scattering analyses. Minami K1, Honbo M1, Mori Y1,2, Kataoka Y1, Miyata K1: J Cataract Refract Surg 2015/11; 41 (11): 2444-9. (X@—mÄ1,2: 1‹{“cŠá‰Č•a‰@, 2Šá‰Č)

110291. [Œ´’˜] Visual and refractive outcomes of small incision lenticule extraction for the correction of myopia: 1-year follow-up. Kamiya K1, Shimizu K1, Igarashi A1, Kobashi H1: BMJ Open 2015/11; 5 (11): e008268. (_’J˜aF1, ´…Œö–ç1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1: 1Šá‰Č)

110292. [Œ´’˜] Predictability of Intraocular Lens Power Calculation After Simultaneous Pterygium Excision and Cataract Surgery. Kamiya K1, Shimizu K1, Iijima K2, Shoji N3, Kobashi H1: Medicine (Baltimore) (2015/12; 94 (52): e2232. (_’J˜aF1, ´…Œö–ç1, ”Ń“‡@Œh2, ŻŽiMs3, Ź‹´‰p’ˇ1: 1Šá‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”)

110293. [Œ´’˜] Modified iPad for treatment of amblyopia: a preliminary study. Handa T1, Ishikawa H1, Shoji N1, Ikeda T2, Totsuka S2, Goseki T2, Shimizu K2: J AAPOS 2015/12; 19 (6): 552-4. (”ź“c’m–ç1, Îě@‹Ď1, ŻŽiMs1, ’r“c“N–ç2, ŒË’ˁ@Œĺ2, ŒăŠÖ—˜–ž2, ´…Œö–ç2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

120036. [Œ´’˜] ƒŒƒ{ƒtƒƒLƒTƒVƒ“1.5%“_Šá‰t‚É‚ć‚鏬Ž™‚ĚŠá‰ČŽüpŠú‚É‚¨‚Ż‚錸‹Ű‰ť—Ă–@‚ĚŒŸ“˘. ŠL“c’qŽq1, Ž›“c—T‹IŽq2, Žq“‡—Ç•˝1,3, –ěŒű‚ä‚Š‚č1, ‹{“c˜a“T1 (1‹{“cŠá‰Č•a‰@, 2“Œ‹žˆă‰ČŽ•‰Č‘ĺŠw, 3Šá‰Č): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2015/4; 32 (4): 573-6.

120037. [Œ´’˜] “ú–{”­‚ĚŽŸ˘‘ă—źŠáŽ‹‹@”\ŒŸ¸EŒP—ű‘•’u|3D Visual Function Trainer-ORTe|. ”ź“c’m–ç (ˆă—ÉqśŠw•”): Šá‰Č—Տ°‹I—v 2015/5; 8 (5): 332-7.

120038. [Œ´’˜] ƒqƒg…ť‘̏ă”ç×–E‚ĚŠj, ×–EŽż”ä‚ÉŠÖ‚ˇ‚é’˛¸. ó–ě@—ş1, ”n“ˆ´”@2, “ŕ“ĄŽ‹v3, ŽR–{’źŽ÷4, Žsěˆę•v3,5 (1“Ć—§s­–@l’nˆćˆă—Ă‹@”\„i‹@\’†‹ž•a‰@, 2Šá‰Č–žŠá‰@, 3’†‹žŠá‰Č, 4“Ą“c•ŰŒ’‰qś‘ĺŠw‹¤“Ż—˜—pŒ¤‹†Ž{Ý•ŞŽqś•¨Šw, 5Šá‰Č): “ú–{”’“ŕáŠw‰ďŽ 2015/6; 27: 63-7.

120039. [Œ´’˜] –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éŽÎˆĘ‹ßŽ‹‚ĚŽčpŹŃ. ˛“Ą@Ži1, ŒăŠÖ—˜–ž1, ĺŒ´Žľd2, Îě@‹Ď2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): Šá‰Č—Տ°‹I—v 2015/6; 8 (6): 399-402.

120040. [Œ´’˜] ‘˝Ĺ“_Šá“ŕƒŒƒ“ƒY‚Ě—Ő°ŹŃ. ‚‹´ł‰p1,2, Źź^—3,4, _’J˜aF4, Ź‹´‰p’ˇ4, ŒÜ\—’ÍŽj4, ´…Œö–ç4 (1ŽR‰¤•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‘Űˆă—Ă•ŸŽƒ‘ĺŠwŽO“c•a‰@, 4Šá‰Č): IOL&RS 2015/6; 29 (2): 238-45.

120041. [Œ´’˜] ŒÄ‹zƒŠƒYƒ€‚Ş“ľEŒa‚Ě—h‚ç‚Ź‚É—^‚Ś‚é‰e‹ż. –]ŒŽ_Žu1, –ĺ”nˆ¤”ü1, Vˆä“cF—T1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw•ŰŒ’ˆă—ĂŠw•”Ž‹‹@”\—Ă–@Šw‰Č, 2Šá‰Č): _ŒoŠá‰Č 2015/6; 32 (2): 148-53.

120042. [Œ´’˜] łíŽŇE•s“ŻŽ‹ŽăŽ‹ŠłŽŇ‚É‚¨‚Ż‚éˆŮ‚Č‚Á‚˝đŒ‰ş‚Ĺ‚ĚŒőŽhŒƒ‚É‚ć‚é‘ÎŒő”˝ŽË‚ĚŒŸ“˘. ŒË’ˁ@Œĺ1, Îě@‹Ď2, ŒăŠÖ—˜–ž1, ’r“c“N–ç1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): _ŒoŠá‰Č 2015/6; 32 (2): 154-60.

120043. [Œ´’˜] ’ˇŠúŠÔÄ”­‚đŒJ‚č•Ô‚ľ‚˝Šáâ|ŒŒŽî‚Ě1—á. Î“c@‹Ĺ1,2, ź–{_”V1,2, ’r“c“N–ç2, œA“c’¨•v3, ´…Œö–ç2 (1‰Ą{‰ęŽs—§‚¤‚í‚Ü‚ż•a‰@Šá‰Č, 2Šá‰Č, 3‰Ą{‰ęŽs—§‚¤‚í‚Ü‚ż•a‰@”]_ŒoŠO‰Č): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2015/6; 32 (6): 913-7.

120044. [Œ´’˜] ŽŐ•ÂƒŒƒ“ƒY (ƒIƒNƒ‹ƒAŇ) ‚É‚ć‚éŽăŽ‹ŽĄ—Âւ̉ž—p. ‰i–ě‰ëŽq1, ‘ĺˆä“c‹I˜a1, ŽRčK‰Á1, źX—çŽq1, Îˆä—SŽq1, “ě‰_@Š˛1, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): Šá‰Č—Տ°‹I—v 2015/7; 8 (7): 484-7.

120045. [Œ´’˜] “Œ‹ž“sAŹŠwZ‚É‚¨‚Ż‚é‹üÜ•Ş•z’˛¸. ĺŒ´Žľd1, Îě@‹Ď1, Ôč–ƒˆß2, ŽOˆä‹`‹v2 (1ˆă—ÉqśŠw•”, 2‹îž‚݂‚˘Šá‰Č): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2015/7; 32 (7): 1057-60.

120046. [Œ´’˜] ŠOŤ—Γŕá‚ɑ΂ľTrabectome҂đ—p‚˘‚˝üˆŰ’Œ‘ѐ؊Jp‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ˆę—á. ŹŒű@—D1, Œ´@CĆ1, “n糎OŒP2,3, Žsěˆę•v2,3 (1‘ĺ—Y‰ď‘ćˆę•a‰@Šá‰Č, 2’†‹žŠá‰Č, 3Šá‰Č): Šá‰Č—Տ°‹I—v 2015/9; 8 (9): 661-4.

120047. [Œ´’˜] Navigation laser NAVILAS҂Ŗэ׌ŒŠÇ᎒źÚ‹ĂŒĹ‚đs‚Á‚˝“œ”A•a‰Š”ÁÇ3—á5Šá‚ĚŒo‰ß. ˛“Ą—T”V1, Žsěˆę•v2,3, “ŕ“ĄŽ‹v2, ‹g“c‘Ľ•F4, ˛”Œ’‰Ž’˜N5, ‰ĄŽR@ăÄ5, X@r’j1, ŽđˆäKO2 (1”Ń“cŽs—§•a‰@Šá‰Č, 2’†‹žŠá‰Č, 3Šá‰Č, 4Šň•ŒÔ\Žš•a‰@Šá‰Č, 5JCHO’†‹ž•a‰@Šá‰Č): Šá‰Č—Տ°‹I—v 2015/9; 8 (9): 679-84.

120048. [Œ´’˜] ”’“ŕáÇ—á‚É‚¨‚Ż‚éƒt[ƒŠƒGƒhƒƒCƒ“•űŽŽ‚Ćƒ^ƒCƒ€ƒhƒƒCƒ“•űŽŽ‚É‚ć‚éŒőŠwŽŽŠáŽ˛’ˇ‘Ş’č‚Ě”äŠr. ‹Ę’u–ž–ě1,2, Ź“‡—˛Ži3, ’ˇ’JěˆŸ—˘1, ’†‘ş‰pŽ÷1, ‹´’Ü—Ç‘ž1, ˆÉ“ĄŽu‘ă”ü1, “c’†@´2, Žsěˆę•v1,4,5 (1’†‹ž•a‰@, 2MB‘ĺŠw‘ĺŠw‰@‘‡HŠwŒnŒ¤‹†‰Č, 3Šň•ŒÔ\Žš•a‰@, 4’†‹žŠá‰Č, 5Šá‰Č): IOL&RS 2015/9; 29 (3): 378-83.

120049. [Œ´’˜] Laser in situ keratomileusis‚ĆSmall incision lenticule extraction‚̏pŒăŹŃ‚Ě”äŠr. ŕV–ŘˆťŽq1, ’ˇ’JěˆŸ—˘2, Ź“‡—˛Ži1,2, ’†‘ş—Fş2, •Đ‰Ş“”Ž2, Žsěˆę•v3,4 (1Šň•ŒÔ\Žš•a‰@, 2–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 3’†‹žŠá‰Č, 4Šá‰Č): IOL&RS 2015/9; 29 (3): 384-90.

120050. [Œ´’˜] –Ô–ŒF‘f•ĎŤÇ‚Ě㵖žś‹N‚É‚¨‚Ż‚é“ÁˆŮ“I”g’ˇ. ŽR“c–žŽq1,2, Vˆä“cF—T2,3, x•‰ł—Y2, ’‡”‘@‘1 (1‘—§áŠQŽŇƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“ƒZƒ“ƒ^[•a‰@, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠw‘ĺŠw‰@ˆă—Ă•ŸŽƒŠwŒ¤‹†‰Č•ŰŒ’ˆă—ĂŠwęUŽ‹‹@”\—Ă–@Šw•Ş–ě, 3Šá‰Č): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2015/9; 32 (9): 1349-54.

120051. [Œ´’˜] Œ’íŽŇ‚É‚¨‚Ż‚éˆĂ‡‰žŽžŠÔ‚ŞRAPDx_‚Ě‘Ş’čŒ‹‰Ę‚ĆÄŒťŤ‚É‹y‚Ú‚ˇ‰e‹ż. ˛“Ą@Ži1, ŒăŠÖ—˜–ž1, óě@ŒŤ2, Îě@‹Ď2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): _ŒoŠá‰Č 2015/9; 32 (3): 263-8.

120052. [Œ´’˜] ‘яóŠp–Œ•ĎŤÇ‚Ćƒyƒ‹[ƒVƒhŠp–Œ•ĎŤÇ‚Ě•š”­—á‚ɃGƒLƒVƒ}ƒŒ[ƒU[‹üÜ‹¸łŽčp•š—pŠp–ŒƒRƒ‰[ƒQƒ“ƒNƒƒXƒŠƒ“ƒLƒ“ƒO‚đŽ{s‚ľ‚˝1Ç—á. –Ř‘ş“TŒh1, Ź‹´‰p’ˇ1, ŒÜ\—’ÍŽj1, _’J˜aF1, ´…Œö–ç1 (1Šá‰Č): IOL&RS 2015/12; 29 (4): 528-32.

120053. [Œ´’˜] ^‹ŰŤŠp–Œ‰Š‚ÉŠÖ‚ˇ‚é‘˝Ž{Ý‹¤“Ż‘OŒü‚ŤŠĎŽ@Œ¤‹†|ŠłŽŇ”wŒiE—Տ°ŠŒŠEŽĄ—ÁE—\Œă‚ĚŒť‹ľ|. ˆäăKŽŸ1, ‘ĺ‹´—Tˆę2, —é–؁@’2, ‰ş‘ş‰Ăˆę3, •Ÿ“cš•F3, ŠO‰€çŒb4, `–ě@Š°5, ]Œű@—m6, ˛X–؍‚é7, Ż@Ĺ’q8, ť“c~Žq9, ó—˜˝Žu9, –îŒű‹MŽu10, ꠑş_ˆę11, ‰Ą‘qr“ń12, –]ŒŽ´•ś13, –ĺ“c—V14, Žq“‡—Ç•˝15,16; ^‹ŰŤŠp–Œ‰Š‘˝Ž{ÝƒXƒ^ƒfƒBƒOƒ‹[ƒv (1’šŽć‘ĺŠw, 2ˆ¤•Q‘ĺŠw, 3‹ß‹E‘ĺŠw, 4‹ž“s•{—§ˆă‰Č‘ĺŠw, 5ƒ‹ƒ~ƒl‚Í‚˝‚ĚŠá‰Č, 6“ż“‡‘ĺŠw, 7o“cŠá‰Č•a‰@, 8“ĄŽ}Žs—§‘‡•a‰@, 9‘ĺă‘ĺŠwˆăŠw•”•‘Ž•a‰@—Տ°ŒŸ¸•”, 10ç—t‘ĺ^‹ŰˆăŠwŒ¤‹†ƒZƒ“ƒ^[, 11’é‹ž‘ĺŠwˆă^‹ŰŒ¤‹†ƒZƒ“ƒ^[, 12“Œ–k‘ĺŠw, 13Šň•Œ‘ĺŠw, 14‹v—Ż•Ä‘ĺŠw, 15‹{“cŠá‰Č•a‰@, 16Šá‰Č): “ú–{Šá‰Č›{˜đŽGŽ 2016/1; 120 (1): 5-16.

120054. [Œ´’˜] ^‹ŰŤŠp–Œ‰Š‚ÉŠÖ‚ˇ‚é‘˝Ž{Ý‹¤“Ż‘OŒü‚ŤŠĎŽ@Œ¤‹†|^‹Ű‚Ě“Ż’č‚Ć–ňÜŠ´ŽóŤŒŸ¸‚ɂ‚˘‚ā|. ť“c~Žq1, ó—˜˝Žu1, ˆäăKŽŸ2, ‘ĺ‹´—Tˆę3, —é–؁@’3, ‰ş‘ş‰Ăˆę4, •Ÿ“cš•F4, ŠO‰€çŒb5, `–ě@Š°6, ]Œű@—m7, ˛X–؍‚é8, Ż@Ĺ’q9, –îŒű‹MŽu10, ꠑş_ˆę11, ‰Ą‘qr“ń12, –]ŒŽ´•ś13, –ĺ“c—V14, Žq“‡—Ç•˝15,16; ^‹ŰŤŠp–Œ‰Š‘˝Ž{ÝƒXƒ^ƒfƒBƒOƒ‹[ƒv (1‘ĺă‘ĺŠwˆăŠw•”•‘Ž•a‰@—Տ°ŒŸ¸•”, 2’šŽć‘ĺŠw, 3ˆ¤•Q‘ĺŠw, 4‹ß‹E‘ĺŠw, 5‹ž“s•{—§ˆă‰Č‘ĺŠw, 6ƒ‹ƒ~ƒl‚Í‚˝‚ĚŠá‰Č, 7“ż“‡‘ĺŠw, 8o“cŠá‰Č•a‰@, 9“ĄŽ}Žs—§‘‡•a‰@, 10ç—t‘ĺŠw^‹ŰˆăŠwŒ¤‹†ƒZƒ“ƒ^[, 11’é‹ž‘ĺŠwˆă^‹ŰŒ¤‹†ƒZƒ“ƒ^[, 12“Œ–k‘ĺŠw, 13Šň•Œ‘ĺŠw, 14‹v—Ż•Ä‘ĺŠw, 15‹{“cŠá‰Č•a‰@, 16Šá‰Č): “ú–{Šá‰Č›{˜đŽGŽ 2016/1; 120 (1): 17-27.

120055. [Œ´’˜] 3D Visual Function Trainer-ORTe‚ĚŠáˆĘEŠá‹…‰^“ŽŒŸ¸‚Ě‘ź‹@Ží‚Ć‚ĚŒÝŠˇŤŒŸ“˘ (Measurements of eye position and movements using 3D Visual Function Trainer ORTe-comparison with other instruments-). ŒË’˘aŽq1, Îě@‹Ď2, ”ź“c’m–ç2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): Šá‰Č—Տ°‹I—v 2016/2; 9 (2): 169-72.

120056. [Œ´’˜] Œ’íŽá”NŠá‚É‚¨‚Ż‚鍂ŽŸ”g–ĘŽűˇ‚Ć”N—î•Ď‰ť: ‘ć2•ń (Relationship between higher-order wavefront aberrations and age in children). âV“Ą@Ę1, ˆÉ“Ą”üšŠG2, ěŽç“c‘ńŽu2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): Šá‰Č—Տ°‹I—v 2016/2; 9 (2): 173-8.

120057. [Œ´’˜] Ž‹ü‰đÍ‘•’u‚É‚ć‚鉓ŒŠE‹ßŒŠ‚Ĺ‚Ě•ĐŠáŽŐ•ÂŽž‚ĚŠáˆĘ‘Ş’č‚ĆŒđ‘ăƒvƒŠƒYƒ€ŽŐ•ÂŽŽŒą‚Ĺ‚ĚŠáˆĘ‚Ě”äŠr. Žl”V‹{—C”n1, ‚‹´—RŽk1, –ěă‹Žu1, Vˆä“cF—T1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw•ŰŒ’ˆă—ĂŠw•”Ž‹‹@”\—Ă–@Šw‰Č, 2Šá‰Č): Šá‰Č—Տ°‹I—v 2016/3; 9 (3): 230-3.

120058. [Œ´’˜] Ž‹ü‰đÍ‘•’u‚đ—˜—p‚ľ‚˝—Z‘œœ‹ŽŠáˆĘ‘Ş’č‚É‚¨‚Ż‚éŽŐ•ÂŽžŠÔ‚ĚŒŸ“˘. ‚‹´—RŽk1, Žl”V‹{—C”n1, –ěă‹Žu1, Vˆä“cF—T1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw•ŰŒ’ˆă—ĂŠw•”Ž‹‹@”\—Ă–@Šw‰Č, 2Šá‰Č): Šá‰Č—Տ°‹I—v 2016/3; 9 (3): 234-7.

120059. [Œ´’˜] ”]—ŔŒ‡‘šÇ‚ÉŽ—‚˝‚“x…“ޏǏǗá‚Ě—źŠáŽ‹‹@”\. –]ŒŽ_Žu1, Œ´@’źl1,3, “ŕŽRmŽu1, Ź’Ź—SŽq1, ’ËŒ´–ƒ—R‰Ŕ2, Ź–ě—˘‹KŽq2, Vˆä“cF—T1,3 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw•ŰŒ’ˆă—ĂŠw•”Ž‹‹@”\—Ă–@Šw‰Č, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠw•a‰@Šá‰Č, 3Šá‰Č): Šá‰Č—Տ°‹I—v 2016/3; 9 (3): 264-7.

310028. [Ç—á•ń] Fixation Duration Changes in Rett Syndrome after Habilitation Intervention. Hirano D, Hayashi K, Onose Y, Ishii M, Miyauchi M, Sekimori H, Taniguchi T, Shimoizumi H, Niida T1,2: Int J Phys Med Rehabil 2015/4; 3 (3): 1000271. (Vˆä“cF—T1,2: 1‘Űˆă—Ă•ŸŽƒ‘ĺŠw•ŰŒ’ˆă—ĂŠw•”Ž‹‹@”\—Ă–@Šw‰Č, 2Šá‰Č)

310029. [Ç—á•ń] Processes and effects of correction with eyeglasses in a child with severe motor and intellectual disabilities: A case report. Hirano D, Minagawa C, Umehara S, Hayashi K, Onose Y, Sekimorim H, Taniguchi T, Komachi Y, Shimoizumi H, Niida T1,2: Clinical Case Reports and Reviews 2015/9; 1 (8): 179-81. (Vˆä“cF—T1,2: 1‘Űˆă—Ă•ŸŽƒ‘ĺŠw•ŰŒ’ˆă—ĂŠw•”Ž‹‹@”\—Ă–@Šw‰Č, 2Šá‰Č)

310030. [Ç—á•ń] Interface Fluid Syndrome Induced by Uncontrolled Intraocular Pressure Without Triggering Factors After LASIK in a Glaucoma Patient: A Case Report. Shoji N1, Ishida A2, Haruki T2, Matsumura K2, Kasahara M2, Shimizu K2: Medicine (Baltimore) (2015/9; 94 (39): e1609. (ŻŽiMs1, Î“c@‹Ĺ2, t–ؐ’G2, ź‘şˆęO2, Š}Œ´łs2, ´…Œö–ç2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

320036. [Ç—á•ń] Šá‹ŘŒ^dÇ‹Ř–ł—͏ǂɂć‚閃აŤŠOŽÎŽ‹‚ɑ΂ľ, ă‰ş’ź‹Ř‘S•ˆÚ“Žp‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ˆę—á. —´ˆä‰‘Žq1, ŒăŠÖ—˜–ž2, Îě@‹Ď3, ´…Œö–ç2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Šá‰Č, 3ˆă—ÉqśŠw•”): _ŒoŠá‰Č 2015/6; 32 (2): 161-4.

320037. [Ç—á•ń] ‰E“Ş’¸Œă“Ş—toŒŒ‚É‚ć‚čçt–Š•s‘SŒ^ŠOŽÎŽ‹‚đ”­Ç‚ľ‚˝1—á. Š—ś^—1, Œ´@’źl1,2,3, ŒN“‡^ƒ1, —é–Ř—T”ü1,3, Œü–ě˜a—Y1,3 (1_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 3Šá‰Č): _ŒoŠá‰Č 2015/12; 32 (4): 377-83.

320038. [Ç—á•ń] Ä”­ŤŽ‹_Œo‰Š‚ĚÇ—á‚ÉIgG4ŠÖ˜AŠáŽžŠł‚ĚŠÖ—^‚Ş‹^‚í‚ę‚˝ˆę—á. X@@—D1,2, ŽRă–žŽq1,3, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,3 (1ˆäăŠá‰Č•a‰@, 2“Œ‹ž—Žqˆă‰Č‘ĺŠw, 3Šá‰Č): _ŒoŠá‰Č 2016/3; 33 (1): 32-6.

410001. [—Տ°ŽŽŒą] Effect of femtosecond laser setting on visual performance after small-incision lenticule extraction for myopia. Kamiya K1, Shimizu K1, Igarashi A1, Kobashi H1: Br J Ophthalmol 2015/10; 99 (10): 1381-7. (_’J˜aF1, ´…Œö–ç1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1: 1Šá‰Č)

510007. [‘ŕ] Pupil light response to predict the state of retinal degeneration in rabbits with rhodopsin P347L mutation. Asakawa K1: NEW JOURNAL STUDIES-Academy Express Asia Pacific Edition- 2015/10. (óě@ŒŤ1: 1ˆă—ÉqśŠw•”)

520013. [‘ŕ] Leberˆâ“`ŤŽ‹_ŒoÇ”F’čŠî€. ’†‘ş@˝1, ŽO‘ş@ŽĄ2, Žá‘q‰ë“o3,4, ˆî’J@‘ĺ5, ’†ŕV@“O6, ”’_Žj—Y7 (1_ŒË‘ĺŠw‘ĺŠw‰@ˆăŠwŒ¤‹†‰ČŠá‰ČŠw•Ş–ě, 2•şŒÉˆă‰Č‘ĺŠwŠá‰ČŠw‹łŽş, 3ˆäăŠá‰Č•a‰@, 4Šá‰Č, 5•Ÿˆä‘ĺŠwˆăŠw•”Šá‰ČŠw‹łŽş, 6“Œ–k‘ĺŠw‘ĺŠw‰@ˆăŠwŒnŒ¤‹†‰ČŠá‰ČŠw•Ş–ě, 7‰ŞŽR‘ĺŠw‘ĺŠw‰@ˆăŽ•–ň‘‡Œ¤‹†‰ČŠá‰ČŠw): “ú–{Šá‰Č›{˜đŽGŽ 2015/5; 119 (5): 339-46.

521019. [‰đŕ] ĄŽž‚Ě–ď‰î‚ČŠłŽŇ‚É‚¤‚Ü‚­‘Ώˆ‚ˇ‚é‚É‚Í. _’J˜aF (Šá‰Č): VISION TIMES 2015/8; 22 (3): 19-25.

521020. [‰đŕ]yŽčpŠí‹ďzƒoƒCƒIƒƒgƒŠ[IOLƒ}ƒXƒ^[700. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): IOL&RS 2015/9; 29 (3): 403-5.

521021. [‰đŕ]y”’“ŕá‚Ě‚Š‚ˇ‚݁E‚Ú‚â‚ŻE“ńdŽ‹E‚Ü‚Ô‚ľ‚ł‚ޏÁ‚Ś‚˝! ŽŠ—Í‚ĹˆŤ‰ť‚đ–h‚˘‚ĹƒrƒbƒNƒŠ‰ń•œ! Ž‹ŠEƒNƒŠƒA! –Ú‚Ě‘÷‚čŽć‚č‘ŹŒřƒNƒŠƒjƒbƒNz˜VŠá‚Í, ŽŔ‚Í”’“ŕá‚̏‰ŠúÇó‚Ĺ, ˜VŠá‚Ő…ť‘Ě‚Ě’e—Í‚Ş’á‰ş‚ľ‚Ä”’‘÷‚ސi‚Ţ‚Ć‚í‚Š‚Á‚˝. ´…Œö–ç (Šá‰Č): ‚í‚Š‚ł–˛MOOK 2015/11; 15: 10-1.

521022. [‰đŕ]y”’“ŕá‚Ě‚Š‚ˇ‚݁E‚Ú‚â‚ŻE“ńdŽ‹E‚Ü‚Ô‚ľ‚ł‚ޏÁ‚Ś‚˝! ŽŠ—Í‚ĹˆŤ‰ť‚đ–h‚˘‚ĹƒrƒbƒNƒŠ‰ń•œ! Ž‹ŠEƒNƒŠƒA! –Ú‚Ě‘÷‚čŽć‚č‘ŹŒřƒNƒŠƒjƒbƒNzl‹C‚̋ߎ‹‹¸łŽčp [ƒŒ[ƒVƒbƒN] ‚đs‚Á‚˝l‚ÍŽá‚­‚ľ‚Ä”’“ŕá‚É‚Č‚é‹°‚ę‚Ş‚ ‚č—v’ˆÓ. ´…Œö–ç (Šá‰Č): ‚í‚Š‚ł–˛MOOK 2015/11; 15: 12.

521023. [‰đŕ]yŠá‰Čˆă‚ĚŽčˆř‚Ť <852>z‹üÜ‹¸łŽčp‚Ě‚ ‚˝‚ç‚ľ‚˘“WŠJ@SMILE. _’J˜aF (Šá‰Č): “ú–{‚ĚŠá‰Č 2015/11; 86 (11): 1584-5.

521024. [‰đŕ]y_ŒoŠá‰Č“ü–ĺƒVƒŠ[ƒY107z‹ÇÝf’f|Ž‹_Œo‚̊ӕʐf’f|. Žs糋`Í1,2 (1_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2Šá‰Č): _ŒoŠá‰Č 2015/12; 32 (4): 387-93.

521025. [‰đŕ] ”’“ŕáE‹üÜŽčp‚Ě˜_“_: ‹üÜ‹¸łŽčpŒă‚̋ߎ‹‰ť. Ź‹´‰p’ˇ (Šá‰Č): IOL&RS 2015/12; 29 (4): 569-71.

522129. [uŔ]y“ÁW (2): ŠáŽžŠł‚ĆŽÎŽ‹Žčpz”’“ŕá‚ĆŽÎŽ‹Žčp. ŒăŠÖ—˜–ž (Šá‰Č): Šá‰ČŽčp 2015/4; 28 (2): 183-8.

522130. [uŔ]y“ÁW: Šp–ŒˆÚAp‚̍Őć’[‚Ć“K‰žz4. ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚É‚ć‚éPKP. _’J˜aF (Šá‰Č): OCULISTA 2015/5; 26: 23-9.

522131. [uŔ]y“ÁW3: ”’“ŕá‚ĆQOLz”’“ŕá‚Ɖ^“]. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): “ú–{”’“ŕáŠw‰ďŽ 2015/6; 27: 45-6.

522132. [uŔ]y“ÁW: —Źo˜HÄŒšp‚Ě“K‰ž‚Ć”äŠrz9. —Źo˜HÄŒšp‚Ě”äŠr. ŻŽiMs (ˆă—ÉqśŠw•”): OCULISTA 2015/6; 27: 58-67.

522133. [uŔ]y“ÁW: o‘ľ‚Á‚˝ƒg[ƒŠƒbƒNŠá“ŕƒŒƒ“ƒYz“ÁW‚É‚ ‚˝‚Á‚Ä. _’J˜aF1, ‘ĺ“ŕ‰ë”V2 (1Šá‰Č, 2‘ĺ“ŕŠá‰Č): IOL&RS 2015/6; 29 (2): 188.

522134. [uŔ]y“ÁW: o‘ľ‚Á‚˝ƒg[ƒŠƒbƒNŠá“ŕƒŒƒ“ƒYzŒă–[Œ^ƒg[ƒŠƒbƒN—L…ť‘ĚŠá“ŕƒŒƒ“ƒY. ŒÜ\—’ÍŽj (Šá‰Č): IOL&RS 2015/6; 29 (2): 189-92.

522135. [uŔ]y“ÁW: NMOĹ‘OüzRƒAƒNƒAƒ|ƒŠƒ“4R‘Ě—zŤŽ‹_Œo‰Š‚ĚŽ‹–ěáŠQƒpƒ^[ƒ“‚ĚŒŸ“˘. ŽRă–žŽq1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): _ŒoŠá‰Č 2015/6; 32 (2): 135-41.

522136. [uŔ]y_ŒoŠá‰Č“ü–ĺƒVƒŠ[ƒY105z‹ÇÝf’f|“ľEŠŒŠ‚Š‚çÓ”C•a‘ƒ‚đ„‘Ş‚ˇ‚é|. Îě@‹Ď (ˆă—ÉqśŠw•”): _ŒoŠá‰Č 2015/6; 32 (2): 168-70.

522137. [uŔ]y“ÁW: ĹV‚̗ΓŕáŽĄ—Áz—Γŕá‚̐VŽčp2: MIGS ‚Ć‚ą‚ę‚ÉŠÖ˜A‚ľ‚˝V‚ľ‚˘pŽŽ. ŻŽiMs (ˆă—ÉqśŠw•”): ‚ ‚˝‚ç‚ľ‚˘Šá‰Č 2015/6; 32 (6): 813-20.

522138. [uŔ]yCLƒoƒgƒ‹ƒƒCƒ„ƒ‹ƒT[ƒhƒXƒe[ƒW@‘ć40‰ńzƒn[ƒhƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚ĚƒPƒA. ‰F’ĂŒŠ‹`ˆę1,2 (1‰F’ĂŒŠŠá‰Čˆă‰@, 2Šá‰Č): “ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ďŽ 2015/6; 57 (2): 87-96.

522139. [uŔ]y˜AÚ: p‘OEpŒăŠÇ—‚̍˘“ď‚ČŠłŽŇ‚ւ̑Ήžz“ű—cŽ™‚¨‚ć‚ѐ¸_”­’B’x‘؂̗ΓŕáŠłŽŇ‚ւ̑Ήž. ź‘şˆęO1, ŻŽiMs2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): Šá‰ČŽčp 2015/7; 28 (3): 393-6.

522140. [uŔ]y“ÁW: —Ž‹‚̐f—Ăupdatez2. [—Ž‹‚ĆŽ‹‹@”\] ł—Ž‹E•sł—Ž‹‚ĆŽ‹‹@”\. _’J˜aF (Šá‰Č): OCULISTA 2015/8; 29: 7-13.

522141. [uŔ]y“ÁW: —Ž‹‚̐f—Ăupdatez3. [—Ž‹‚ĚŒŸ¸–@E•]‰ż–@-1] ł—Ž‹‚ĚŒŸ¸–@‚Ć•]‰ż–@. ”Ń“c‰Ă•F (Šá‰Č): OCULISTA 2015/8; 29: 14-20.

522142. [uŔ]y“ÁW: Šá‰Čˆă‚Ě‚˝‚߂̐SgˆăŠwz7. _ŒoŠá‰Č‚ƐSgˆăŠw. ŽRă–žŽq1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): OCULISTA 2015/9; 30: 46-50.

522143. [uŔ]y“ÁW: –Ô–ŒEŽ‹_Œo‚̐_Œo•ŰŒě‚ƍĐśz˜˜_. Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): _ŒoŠá‰Č 2015/9; 32 (3): 233.

522144. [uŔ]y˜AÚ: –ÚŽw‚š! Šá‚ĚŒ`ŹŠO‰ČƒGƒLƒXƒp[ƒgz‰şŠááŮ“ŕ”˝ÇŽčp|ŒŐ‚ĚŠŞ! ź–{_”V1,2 (1‰Ą{‰ęŽs—§‚¤‚í‚Ü‚ż•a‰@, 2Šá‰Č): —Տ°Šá‰Č 2015/10; 69 (10): 1464-9.

522145. [uŔ]y‚í‚Š‚č‚₡‚˘—Տ°uŔz•Đ“Ş’É‚ĚŠá‰Č—Տ°‚ĆŽ‹‹@”\ˆŮí. Œ´@’źl1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2Šá‰Č): “ú–{‚ĚŠá‰Č 2015/11; 86 (11): 1565-72.

522146. [uŔ]y‘ć“ń“ÁW: Šá‰ČƒXƒ^ƒbƒt‚ŕ‚ą‚ą‚Ü‚Ĺ’m‚Á‚Ä‚¨‚Ť‚˝‚˘!@‘OŠá•”‚̍ŐVŽčpz<1> ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚É‚ć‚éŠp–ŒˆÚAp. _’J˜aF (Šá‰Č): Šá‰ČƒPƒA 2015/12; 17 (12): 66-9.

522147. [uŔ]y“ÁW: Šá“ŕƒŒƒ“ƒY‚Ěƒ|ƒCƒ“ƒg‚ƍ‡•šÇ‘΍ôz2. Šá“ŕƒŒƒ“ƒY‚É‚ć‚郂ƒmƒrƒWƒ‡ƒ“. ˆÉ“Ą”üšŠG1, ´…Œö–ç2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): OCULISTA 2015/12; 33: 10-6.

522148. [uŔ]y“ÁW: Šá“ŕƒŒƒ“ƒY‚Ěƒ|ƒCƒ“ƒg‚ƍ‡•šÇ‘΍ôz5. ‰~Šp–ŒŠá‚É‚¨‚Ż‚éŠá“ŕƒŒƒ“ƒY‚Ě‘I‘đ. ŒÜ\—’ÍŽj (Šá‰Č): OCULISTA 2015/12; 33: 31-6.

522149. [uŔ]y“ÁW: Šá“ŕƒŒƒ“ƒY‚Ěƒ|ƒCƒ“ƒg‚ƍ‡•šÇ‘΍ôz7. ’´’ZŠáŽ˛’ˇŠá‚ɑ΂ˇ‚éIOL piggyback. ”Ń“c‰Ă•F (Šá‰Č): OCULISTA 2015/12; 33: 46-50.

522150. [uŔ]y“ÁW: LASIKŒŸŘz“ÁW‚É‚ ‚˝‚Á‚Ä. ’†‘ş—Fş1, _’J˜aF2 (1–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 2Šá‰Č): IOL&RS 2015/12; 29 (4): 496.

522151. [uŔ]y“ÁW: LASIKŒŸŘz’ˇŠúŹŃ. Ź‹´‰p’ˇ (Šá‰Č): IOL&RS 2015/12; 29 (4): 508-10.

522152. [uŔ]y—Տ°ƒZƒ~ƒi[zLASIKŠá‚ĚIOL“x”ŒvŽZŽŽ. ”Ń“c‰Ă•F (Šá‰Č): IOL&RS 2015/12; 29 (4): 582-5.

522153. [uŔ]y˜AÚ: Therapeuticsz‚ ‚Č‚˝‚ŕ‚Ĺ‚Ť‚é_ŒoŠá‰ČŽžŠł‚ĚŽĄ—Á@ŠááقŻ‚˘‚ę‚ń. ŒăŠÖ—˜–ž (Šá‰Č): Šá‰ČƒOƒ‰ƒtƒBƒbƒN 2015/12; 4 (6): 581-4.

522154. [uŔ]y“ÁW: Šá“ŕƒŒƒ“ƒYƒAƒbƒvƒf[ƒgzLASIKŠá‚ĚŠá“ŕƒŒƒ“ƒY‚Ě‘I‚Ń•ű. _’J˜aF (Šá‰Č): —Տ°Šá‰Č 2016/1; 70 (1): 48-57.

522155. [uŔ]y“ÁW: ‹c˜_‚Ě‘˝‚˘ŠáŽĄ—Á|Œš‘O‚Ć–{‰š|z5. ”’“ŕáŽčp|’PĹ“_ƒŒƒ“ƒY VS. ‘˝Ĺ“_ƒŒƒ“ƒY|. _’J˜aF (Šá‰Č): Šá‰Č 2016/1; 58 (1): 31-5.

522156. [uŔ] Šp–Œ‹üÜ‹¸łŽčpŒă‚Ě”’“ŕáŽčp. ”Ń“c‰Ă•F (Šá‰Č): “ú–{‚ĚŠá‰Č 2016/2; 87 (2): 29-34.

522157. [uŔ]y“ÁW: –ƒáƒŤŽÎŽ‹z–ƒáƒŤŽÎŽ‹‚Ě”ńŠĎŒŒ“IŽĄ—Ă. ŒăŠÖ—˜–ž (Šá‰Č): _ŒoŠá‰Č 2016/3; 33 (1): 16-22.

530014. [‚ť‚Ě‘ź (Letters Reply)]yLetters ReplyzMyopic eyes develop cataracts at an earlier age. Iijima K1,2, Shimizu K3, Kamiya K3, Igarashi A3, Komatsu M3,4: J Cataract Refract Surg 2015/5; 41 (5): 1126-7. (”Ń“‡@Œh1,2, ´…Œö–ç3, _’J˜aF3, ŒÜ\—’ÍŽj3, Źź^—3,4: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ŠC˜V–ź‘‡•a‰@, 3Šá‰Č, 4‘Űˆă—Ă•ŸŽƒ‘ĺŠwŽO“c•a‰@)

530015. [‚ť‚Ě‘ź (Letters to the Editor)] Why do melanopsin-containing retinal ganglion cells have the greatest sensitivity to blue light? Asakawa K1, Ishikawa H1: Acta Ophthalmol 2015/6; 93 (4): e308-9. (óě@ŒŤ1, Îě@‹Ď1: 1ˆă—ÉqśŠw•”)

530016. [‚ť‚Ě‘ź (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“)]yAsian SectionzApplication of Functional Near-infrared Spectroscopy to Ophthalmology. Iwata Y1, Ishikawa H2: _ŒoŠá‰Č 2015/6; 32 (2): 207-10. (Šâ“c@—y1, Îě@‹Ď2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”)

530017. [‚ť‚Ě‘ź (Letters to the Editor)] Peep Into Visual Acuity Chart Through an Opening: A New Concept of Binocular Open-view Visual Acuity Test. Handa T1, Shoji N1, Shimizu K2: J Refract Surg 2015/7; 31 (7): 493-4. (”ź“c’m–ç1, ŻŽiMs1, ´…Œö–ç2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

530018. [‚ť‚Ě‘ź (Letters to the Editor)] Effects of pupil dilation on objective refraction. Iwata Y1, Handa T2, Shoji N2, Ishikawa H2, Shimizu K3: Acta Ophthalmol 2015/7; 2015: 12792. (Šâ“c@—y1, ”ź“c’m–ç2, ŻŽiMs2, Îě@‹Ď2, ´…Œö–ç3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3Šá‰Č)

530019. [‚ť‚Ě‘ź (’˛¸Œ¤‹†•ń)] Functional and morphological study of retinal photoreceptor cell degeneration in transgenic rabbits with a Pro347Leu rhodopsin mutation. Asakawa K1, Ishikawa H1, Uga S2, Mashimo K2, Shimizu K2, Kondo M, Terasaki H: Jpn J Ophthalmol 2015/9; 59 (5): 353-63. (óě@ŒŤ1, Îě@‹Ď1, ‰F‰ę–ÎŽO2, áÁ‰ş‹I”ü‘ă2, ´…Œö–ç2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

540024. [‚ť‚Ě‘ź (ƒIƒ“ƒ‰ƒCƒ“‹LŽ–)] ‚Ś, ’m‚ç‚Č‚Š‚Á‚˝!@Ž‹—Í‚É”Y‚Ţ“­‚Ť—Žq‚É‹ł‚Ś‚˝‚˘uICLvŽčp‚Ć‚Í. ´…Œö–ç (Šá‰Č): BizLady 2015/4; http://bizlady.jp/archives/98927.

540025. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] Žg—p–@Žç‚čƒgƒ‰ƒuƒ‹–h‚Ž@’†‚ś‚Ĺ‘‚Ś‚éƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY. ‰F’ĂŒŠ‹`ˆę1,2 (1‰F’ĂŒŠŠá‰Čˆă‰@, 2Šá‰Č): ’Š“úV•ˇ‘S‘”Ĺ 2015/5/6.

540026. [‚ť‚Ě‘ź (ŠŞ“ŞŒž)] Leberˆâ“`ŤŽ‹_ŒoÇ|‚ť‚Ě–â‘č“_‚ƍĄŒă‚̉ۑč|(Leber's Hereditary Optic Neuropathy: The Problems and Future Challenges). Îě@‹Ď (ˆă—ÉqśŠw•”): “ú–{Šá‰Č›{˜đŽGŽ 2015/5; 119 (5): 337-8.

540027. [‚ť‚Ě‘ź (ƒgƒsƒbƒNƒX)]yŠw‰ďƒgƒsƒbƒNƒX: ‘ć38‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ďzƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚ĚĹ‘Oü. ´…Œö–ç (Šá‰Č): “ú–{Šá‰Č›{˜đŽGŽ 2015/5; 119 (5): 363-4.

540028. [‚ť‚Ě‘ź] (ŠÄ–ó) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[”’“ŕáŽčp‚̍‡•šÇ‚đ‰ń”đ‚ˇ‚é‚˝‚ß‚É. _’J˜aF (Šá‰Č): VISION TIMES 2015/5; 22 (2): 5-11.

540029. [‚ť‚Ě‘ź (ŠO‘Ž—v——) ‰~Šp–Œ‚ɑ΂ˇ‚éŒă–[Œ^—Ž‹‹¸ł—L…ť‘ĚŠá“ŕƒŒƒ“ƒY‘}“üp‚̏pŒă3”NŹŃ. _’J˜aF1, ´…Œö–ç1, Ź‹´‰p’ˇ1, ŒÜ\—’ÍŽj1, Źź^—1,2, ’†‘ş’O—Y3, Ź“‡—˛Ži4, ’†‘ş—Fş5 (1Šá‰Č, 2ŽR‰¤•a‰@Šá‰Č, 3’†‘şŠá‰Č, 4Šň•ŒÔ\Žš•a‰@Šá‰Č, 5–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN): “ú–{Šá‰Č›{˜đŽGŽ 2015/6; 119 (6): 423.

540030. [‚ť‚Ě‘ź (‘•])]yBook Review ‘•]zu_ŒoŠá‰Čf—Ă‚Ě‚Ä‚Ń‚Ť@•a—đ‚ƐfŽ@‚Š‚ç“ą‚­ŠÓ•ĘŽžŠłvÎě@O. u_ŒoŠá‰ČŠw‚đŠw‚Ԑl‚Ě‚˝‚߂ɁvŽO‘ş@ŽĄ. u_ŒoŠá‰Čf’fƒNƒ[ƒYƒAƒbƒvv•~“‡ŒhŒĺ. Œü–ě˜a—Y1,2 (1_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2Šá‰Č): _ŒoŠá‰Č 2015/6; 32 (2): 179-81.

540031. [‚ť‚Ě‘ź (ŠCŠO•śŒŁĐ‰î)] Journal of Neurophysiology. Vˆä“cF—T1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2Šá‰Č): _ŒoŠá‰Č 2015/6; 32 (2): 204-5.

540032. [‚ť‚Ě‘ź (Šw‰ď•ń)] Asia ARVO 2015•ń. Îě@‹Ď (ˆă—ÉqśŠw•”): _ŒoŠá‰Č 2015/6; 32 (2): 200-1.

540033. [‚ť‚Ě‘ź (ƒgƒsƒbƒNƒX)] SMILE. _’J˜aF (Šá‰Č): Šá‰ČŽčp 2015/7; 28 (3): 369-71.

540034. [‚ť‚Ě‘ź (’˛¸•ń)] ‚¨’m‚ç‚š: Šá‰ČŠwZˆă‚ĚŠwZ‚É‚¨‚Ż‚éƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠÖ˜A‚ĚŒ[”­ŽŔŽ{‚ĚŽŔ‘Ô’˛¸WŒv•ń. ŽR‰şG–ž1, ‚‹´˜a”Ž1, ”ˆä^—Žq1, Š`“c“N•F1, ‰F’ĂŒŠ‹`ˆę1,2, ‹{‰Y@“O1, •Ÿ‰şŒöŽq1, ŽRŠÝ’ź–î1, ‚–ě@”É1 (1“ú–{Šá‰Čˆă‰ď, 2Šá‰Č): “ú–{‚ĚŠá‰Č 2015/8; 86 (8): 1183-9.

540035. [‚ť‚Ě‘ź (Šw‰ďˆóŰ‹L)] ‘ć32‰ń“ú–{ŠáŽîᇊw‰ď@Šw‰ďˆóŰ‹L@ˆę”ʍu‰‰ (1). ”–؍LĆ1,2, ‹v•Ű“c•qM3 (1Ă‰ŞŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Šá‰Č, 3–źŒĂ‰Žˆă—ĂƒZƒ“ƒ^[): “ú–{ŠáŽîᇊw‰ďŽ 2015/9; 4: 19-20.

540036. [‚ť‚Ě‘ź (•ŇWŠé‰ć)]y“ÁW: Šá‰Čˆă‚Ě‚˝‚߂̐SgˆăŠwz•ŇWŠé‰ć‚É‚ ‚˝‚Á‚āc. Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): OCULISTA 2015/9; 30: ‘O•t1.

540037. [‚ť‚Ě‘ź (Šw‰ďˆóŰ‹L)] ISOO 2015‚ÉŽQ‰Á‚ľ‚Ä. ”–؍LĆ1,2 (1Œ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[, 2Šá‰Č): “ú–{ŠáŽîᇊw‰ďŽ 2015/9; 4: 44-5.

540038. [‚ť‚Ě‘ź (ƒŒƒ|[ƒg)]yĹV‹@ŠíƒŒƒ|[ƒgz–Ô–Œ“dˆĘRETeval (ƒŒƒ`ƒoƒ‹) Introduction. ŒăŠÖ—˜–ž (Šá‰Č): _ŒoŠá‰Č 2015/9; 32 (3): 309.

540039. [‚ť‚Ě‘ź (ƒŒƒ|[ƒg)]yĹV‹@ŠíƒŒƒ|[ƒgz–Ô–Œ“dˆĘRETeval (ƒŒƒ`ƒoƒ‹) User's Comments. óě@ŒŤ1, ŽO‘îr”V2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): _ŒoŠá‰Č 2015/9; 32 (3): 311-2.

540040. [‚ť‚Ě‘ź (ŠŞ“ŞŒž)] ŠŞ“ŞŒž|Ą‚ť‚ą‚É‚ ‚éŠë‹@|. _’J˜aF (Šá‰Č): Šá‰ČŽčp 2015/10; 28 (4): 475.

540041. [‚ť‚Ě‘ź (ŽGŽ‹LŽ–)] ŽŸ˘‘ă‹ßŽ‹‹¸łuŠá“ŕƒRƒ“ƒ^ƒNƒgv‚ĹˆŔS•–ž‘Ť‚ȐśŠˆ. ´…Œö–ç (Šá‰Č): CREA 2015/10; 312: 142-3.

540042. [‚ť‚Ě‘ź] (ŠÄ–ó) ‘˝Ĺ“_Ť‚É‘ă‚í‚éIOL‚Ě‘I‘đŽˆ IOL Alternatives to Multifocality. _’J˜aF (Šá‰Č): VISION TIMES 2015/11; 22 (4): 8-12.

540043. [‚ť‚Ě‘ź (•ŇWŠé‰ć)]y“ÁW: Šá“ŕƒŒƒ“ƒY‚Ěƒ|ƒCƒ“ƒg‚ƍ‡•šÇ‘΍ôz•ŇWŠé‰ć‚É‚ ‚˝‚Á‚āc. ´…Œö–ç (Šá‰Č): OCULISTA 2015/12; 33: ‘O•t1.

540044. [‚ť‚Ě‘ź] Šw‰ď‚֍s‚ą‚¤@‘ć4‰ń. _’J˜aF (Šá‰Č): IOL&RS 2015/12; 29 (4): 597-8.

540045. [‚ť‚Ě‘ź (Q&A)]yƒRƒ“ƒTƒ‹ƒe[ƒVƒ‡ƒ“ƒR[ƒi[zƒGƒLƒXƒp[ƒg‚É•ˇ‚­: ‰ń“š2. _’J˜aF (Šá‰Č): IOL&RS 2015/12; 29 (4): 606-7.

540046. [‚ť‚Ě‘ź (ŠCŠO•śŒŁĐ‰î)] Journal of Neurophysiology 113 (3) (4) (6) (9), 2015. Vˆä“cF—T1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2Šá‰Č): _ŒoŠá‰Č 2015/12; 32 (4): 415-7.

540047. [‚ť‚Ě‘ź (—Տ°•ń)] AŠwŽžŒ’Nf’f‚É‚¨‚Ż‚é‰Ć’남‚ć‚ŃŒ’fŽžŽ‹—ÍŒŸ¸Œ‹‰Ę‚Ě”äŠrŒŸ“˘. “Ą‘ş•‡˛Žq1, ”ź“c’m–ç1, ěŽç“c‘ńŽu1, ŻŽiMs1, Ží“c–F˜Y2,3, ´…Œö–ç3 (1ˆă—ÉqśŠw•”, 2Ží“cŠá‰Čˆă‰@, 3Šá‰Č): —Տ°Šá‰Č 2016/1; 70 (1): 97-101.

540048. [‚ť‚Ě‘ź (ŽGŽ‹LŽ–)] Ą, ’–ڂ̐V‚ľ‚˘‹ßŽ‹‹¸łp: Šá“ŕƒRƒ“ƒ^ƒNƒguICLvŽĄ—Âʼnő“K‚Č–ˆ“ú! ´…Œö–ç (Šá‰Č): GINGER 2016/2; 8 (2): 178-9.

540049. [‚ť‚Ě‘ź (ƒgƒsƒbƒNƒX)]yŠw‰ďƒgƒsƒbƒNƒX: ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ďz˜VŽ‹‹¸ł‚̍ŐVî•ń. ´…Œö–ç (Šá‰Č): “ú–{Šá‰Č›{˜đŽGŽ 2016/2; 120 (2): 131.

540050. [‚ť‚Ě‘ź (ƒŒƒ|[ƒg)]yĹV‹@ŠíƒŒƒ|[ƒgzTobiiŽĐť@Šá‹…‰^“ŽŒv‘Ş‘•’u@Introduction. ŒăŠÖ—˜–ž (Šá‰Č): _ŒoŠá‰Č 2016/3; 33 (1): 47.

540051. [‚ť‚Ě‘ź (Šw‰ďˆóŰ‹L)] ‘ć31‰ń‘Ű“ľEŠw‰ď. Šâ“c@—y (‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): _ŒoŠá‰Č 2016/3; 33 (1): 53.

540052. [‚ť‚Ě‘ź (Šw‰ďˆóŰ‹L)] The 8th Asian Neuro-Ophthalmology Society (ASNOS) Meeting. óě@ŒŤ (ˆă—ÉqśŠw•”): _ŒoŠá‰Č 2016/3; 33 (1): 54-6.

540053. [‚ť‚Ě‘ź (ŠCŠO•śŒŁĐ‰î)] Journal of Neurophysiology 114 (2) (3) (5), 2015. Vˆä“cF—T1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2Šá‰Č): _ŒoŠá‰Č 2016/3; 33 (1): 60-1.

[’˜@‘]

610004. [Šwp‘] (•Ş’SŽˇ•M)ySmall Incision Lenticule Extraction (SMILE): Principles, Techniques, Complication Management, and Future ConceptszOverview of Clinical Results for Low and Moderate Myopia, p.75-82. Shimizu K1, Kamiya K1, Igarashi A1, Kobashi H1, Ikeuchi R1,2, Editor: Sekundo W, Springer, 2015/8. (´…Œö–ç1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1, ’r“ŕ—œŠG1,2: 1Šá‰Č, 2–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[)

620102. [Šwp‘] (•Ş’SŽˇ•M)yŠá‰Č‹ÇŠŽĄ—Ă–ňƒf[ƒ^ƒuƒbƒNzVII. ŽU“ľ, ’˛ß–ƒáƒ–ň@ŠT—v‚ĆŽg‚˘•ű. ŒăŠÖ—˜–ž (Šá‰Č), •Ň: ‹g•yŒ’Žu, “‡č@, ‘ş“c•q‹K, ƒƒWƒJƒ‹ƒŒƒrƒ…[ŽĐ, “Œ‹ž, 2015/4”­s.

620103. [Šwp‘] (•Ş’SŽˇ•M) ‘ć109‰ńˆăŽt‘‰ĆŽŽŒą–â‘č‰đŕ‘. Žs糋`Í1,2 (1_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒNŠá‰Č, 2Šá‰Č), •Ň: ˆăŽt‘‰ĆŽŽŒą–â‘č‰đŕ‘•ŇWˆĎˆő‰ď, ˆăŠw•]˜_ŽĐ, “Œ‹ž, 2015/4”­s.

620104. [Šwp‘] (•Ş’SŽˇ•M) ‘ć109‰ńˆăŽt‘‰ĆŽŽŒą–â‘č‰đŕ‘. ŒăŠÖ—˜–ž (Šá‰Č), •Ň: ˆăŽt‘‰ĆŽŽŒą–â‘č‰đŕ‘•ŇWˆĎˆő‰ď, ˆăŠw•]˜_ŽĐ, “Œ‹ž, 2015/4”­s.

620105. [Šwp‘] (•Ş’SŽˇ•M)yę–ĺˆă‚Ě‚˝‚ß‚ĚŠá‰Čf—ĂƒNƒIƒŠƒtƒ@ƒCIII@Šá‰Čf—Ă‚ĆŠÖ˜A–@‹Kz3. ˆă–ň•iˆă—Ă‹@Ší“™–@ (‹Œ–ňŽ––@) ‚ĆƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY@ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚̏ˆ•ű‚Ɣ̔„‚̏ó‹ľ. ‰F’ĂŒŠ‹`ˆę1,2 (1‰F’ĂŒŠŠá‰Čˆă‰@, 2Šá‰Č), •Ň: ’šŽR—Cˆę3, ‘ş“c•q‹K3 (3MB‘ĺŠw), ’†ŽR‘“X, “Œ‹ž, 2015/8”­s.

620106. [Šwp‘] (•Ş’SŽˇ•M)y•af˜AŒgVŽž‘ă!@Šá‰ČŠJ‹Ćˆă‚Ě‚˝‚߂̐f—ÁE˜AŒgƒ|ƒCƒ“ƒg30z3. Šááىş‚@‰Á—‚Ě‚Ý‚Ĺ‚Í‚Č‚˘. ŒŠ“Ś‚ˇ‚Ć•|‚˘—Ž‚Ć‚ľŒŠ! ŒăŠÖ—˜–ž1 (1Šá‰Č), •Ň: źŒł@r2, ‹gěŒ[Ži3 (2“Œ‹ž’üM•a‰@, 3‹gěŠá‰ČƒNƒŠƒjƒbƒN), f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/10”­s.

620107. [Šwp‘] (•Ş’SŽˇ•M)yŽŠ—Ľ_Œo‹@”\ŒŸ¸ ‘ć5”ŁzŠe˜_@F. Šá‹…Œn@5. ’˛ß‹@”\ŒŸ¸. óě@ŒŤ1, Îě@‹Ď1, Œü–ě˜a—Y2,3 (1ˆă—ÉqśŠw•”, 2_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 3Šá‰Č), •Ň: “ú–{ŽŠ—Ľ_ŒoŠw‰ď, •śŒő“°, “Œ‹ž, 2015/10”­s.

620108. [Šwp‘] (•Ş’SŽˇ•M)yŠá‰Č—Տ°ƒGƒLƒXƒp[ƒg@—ΓŕáŽĄ—Ă‚ĚƒAƒbƒvƒf[ƒgz‘ć7Í ƒgƒ‰ƒxƒNƒƒgƒ~[‚Ć—Źo˜HÄŒšp@V ƒgƒ‰ƒxƒNƒƒgƒ~[‚̗މŽčp. ŻŽiMs (ˆă—ÉqśŠw•”), •Ň: ™ŽR˜a‹v, ’JŒ´GM, ˆăŠw‘‰@, “Œ‹ž, 2015/10”­s.

620109. [Šwp‘] (•Ş’SŽˇ•M)yŠá‰Č—Տ°ƒGƒLƒXƒp[ƒg@’m‚Á‚Ä‚¨‚Ť‚˝‚˘ŠáŽîᇐf—Áz‘ć2Í@‘˜_@Topics@‘ź‰Č—Ěˆć‚ĚˆŤŤŽîᇎĄ—Ă‚É”ş‚¤Šá‰Č“I‡•šÇ‚Ć‘Îô. ”–؍LĆ1,2 (1Ă‰ŞŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Šá‰Č), •Ň: ‘哇_ˆę, Œă“Ą@_, ˆăŠw‘‰@, “Œ‹ž, 2015/10”­s.

620110. [Šwp‘] (•Ş’SŽˇ•M)yŠá‰Č—Տ°ƒGƒLƒXƒp[ƒg@’m‚Á‚Ä‚¨‚Ť‚˝‚˘ŠáŽîᇐf—Áz‘ć2Í@‘˜_@Topics@ƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpßśŒŸ. ”–؍LĆ1,2 (1Ă‰ŞŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Šá‰Č), •Ň: ‘哇_ˆę, Œă“Ą@_, ˆăŠw‘‰@, “Œ‹ž, 2015/10”­s.

620111. [Šwp‘] (•Ş’SŽˇ•M)yƒ`[ƒ€Š`č‚ĚŠO—ˆŠáŒ`ŹŽčpz[‰şŠááٓŕEŠO”˝Ç]@Kakizaki–@. ź–{_”V1,2 (1‰Ą{‰ęŽs—§‚¤‚í‚Ü‚ż•a‰@, 2Šá‰Č), •Ň’˜: Š`č—T•F3 (3ˆ¤’mˆă‰Č‘ĺŠw), ƒƒfƒBƒJo”Ĺ, ‘ĺă, 2016/1”­s.

620112. [Šwp‘] (•Ş’SŽˇ•M)yƒ`[ƒ€Š`č‚ĚŠO—ˆŠáŒ`ŹŽčpz[‰şŠááٓŕEŠO”˝Ç]@Wheeler-Hisatomi–@. ź–{_”V1,2 (1‰Ą{‰ęŽs—§‚¤‚í‚Ü‚ż•a‰@, 2Šá‰Č), •Ň’˜: Š`č—T•F3 (3ˆ¤’mˆă‰Č‘ĺŠw), ƒƒfƒBƒJo”Ĺ, ‘ĺă, 2016/1”­s.

620113. [Šwp‘] (•Ş’SŽˇ•M)yŠá‰ČŽžŠłĹV‚ĚŽĄ—Ă2016-2018z‚ć‚­‚Ý‚éŠáÇŒó‚Ɗӕʐf’f@8. Šááى^“ŽˆŮí (‚Ü‚Ô‚˝‚ŞŠJ‚Š‚Č‚˘). Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č), •Ň: ‘ĺ‹´—Tˆę, ”’_Žj—Y, ‘şă@ť, “ě]“°, “Œ‹ž, 2016/3”­s.

620114. [Šwp‘] (•Ş’SŽˇ•M)yŠá‰ČŽžŠłĹV‚ĚŽĄ—Ă2016-2018zIV. ‚ť‚Ě‘ź‚ĚŽžŠł@4. _ŒoŠá‰ČŽžŠł@1 “ľE‹Ů’ŁÇ. Îě@‹Ď (ˆă—ÉqśŠw•”), •Ň: ‘ĺ‹´—Tˆę, ”’_Žj—Y, ‘şă@ť, “ě]“°, “Œ‹ž, 2016/3”­s.

620115. [Šwp‘] (•Ş’SŽˇ•M)yŠá‰ČŽžŠłĹV‚ĚŽĄ—Ă2016-2018zIV. ‚ť‚Ě‘ź‚ĚŽžŠł@4. _ŒoŠá‰ČŽžŠł@9 ’˛ßázš. ´…Œö–ç1, ŒăŠÖ—˜–ž1 (1Šá‰Č), •Ň: ‘ĺ‹´—Tˆę, ”’_Žj—Y, ‘şă@ť, “ě]“°, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

711002. [Šw‰ď (‘Ű)] (“Á•Ęu‰‰) Rotation of Toric IOL. Shimizu K1: 20th Annual Joint Meeting of SOI, OSN & AICCER (2015/5/17), Milan, Italy. (´…Œö–ç1: 1Šá‰Č)

712020. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Redefining Refractive Boundaries with the Visian ICL "Long-term outcomes after KS-AquaPORT (Central Hole ICL)". Shimizu K1: 2015 Panel Symposium Series at the ASCRS San Diego (2015/4/19), San Diego, USA. (´…Œö–ç1: 1Šá‰Č)

712021. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) My career: 20/20. Shimizu K1: 2015 G. F. Jan Worst Medal Lectureship at ASCRS (2015/4/19), San Diego, USA. (´…Œö–ç1: 1Šá‰Č)

712022. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Development and Clinical Result of Hole ICL (KS-AP). Shimizu K1: 20th Annual Joint Meeting of SOI, OSN & AICCER (2015/5/16), Milan, Italy. (´…Œö–ç1: 1Šá‰Č)

712023. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) New Viscoless Pre-loaded Injector (2007 & Now). Shimizu K1: APACRS-SEF Symposium (SNEC 25th Anniversary International Meeting) (2015/5/23), Singapore. (´…Œö–ç1: 1Šá‰Č)

712024. [Šw‰ď (‘Ű)] ƒVƒ“ƒ|ƒWƒEƒ€)yŔ’ˇzSolutions To Symmetry - Correcting Astigmatism. Pangputhipong P, Shimizu K1: 28th APACRS Annual Meeting (2015/8/6), Kuala Lumpur, Malaysia. (´…Œö–ç1: 1Šá‰Č)

712025. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Rotation of Toric IOL. Shimizu K1: 28th APACRS Annual Meeting (2015/8/6), Kuala Lumpur, Malaysia. (´…Œö–ç1: 1Šá‰Č)

712026. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Phakic IOLs. Shimizu K1: 28th APACRS Annual Meeting (2015/8/7), Kuala Lumpur, Malaysia. (´…Œö–ç1: 1Šá‰Č)

712027. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Top Gun - Refractive & Cataract Surgery Tips. Shimizu K1: 28th APACRS Annual Meeting (2015/8/8), Kuala Lumpur, Malaysia. (´…Œö–ç1: 1Šá‰Č)

712028. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Long-term Clinical Outcomes of the Visian ICL KS-AP. Shimizu K1: 12th Visian ICL International Experts Symposium in Barcelona (2015/9/3), Barcelona, Spain. (´…Œö–ç1: 1Šá‰Č)

712029. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Rod, cone and melanopsin-containing retinal ganglion cell contributions to the pupil light response. Asakawa K1: The 8th Asian Neuro-Ophthalmology Society Congress (2015/10/24), Beijing, China. (óě@ŒŤ1: 1ˆă—ÉqśŠw•”)

713099. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Correlation between factors related with previous myopic laser in situ keratomileusis and refractive error after intraocular lens implantation. Minami K1, Mori Y1,2, Amano S1,3, Miyata K1, Kamiya K2, Shimizu K2: ARVO 2015 Annual Meeting (2015/5/5), Denver, USA. (X@—mÄ1,2, _’J˜aF2, ´…Œö–ç2: 1‹{“cŠá‰Č•a‰@, 2Šá‰Č, 3ˆäăŠá‰Čˆă‰@)

713100. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) CHARACTERISTIC OF "SIZE MODULATION STANDARD AUTOMATED PERIMETRY" WITH OCTOPUS600 PERIMETER FOR GLAUCOMATOUS VISUAL FIELD LOSS. Hirasawa K1, Matsumura K2, Kasahara M2, Ikeuchi R2, Takahashi M2, Tujisawa T2, Shoji N1, Shimizu K2: 6th WORLD GLAUCOMA CONGRESS (2015/6/6-9),Hong Kong, China. (•˝ŕVˆę–@1, ź‘şˆęO2, Š}Œ´łs2, ’r“ŕ—œŠG2, ‚‹´ŽŔŠóŽq2, ’ŇŕV’C•F2, ŻŽiMs1, ´…Œö–ç2: 1ˆă—ÉqśŠw•”, 2Šá‰Č)

713101. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Two cases of conjunctival squamous cell carcinoma requiring orbital exenteration. Kashiwagi H1,2, Onitsuka T, Nakagawa M, Ito I, Yoshikawa S, Suda T, Komori M: XVIIth International Society of Ocular Oncology (2015/6/19), Paris, France. (”–؍LĆ1,2: 1Ă‰ŞŒ§—§‚Ş‚ńƒZƒ“ƒ^[, 2Šá‰Č)

713102. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰EFree Paper) Visual and Refractive Outcomes of Small Incision Lenticule Extraction for the Correction of Myopia: Three-Year Follow-Up. Kobashi H1: 28th APACRS Annual Meeting (2015/8/7), Kuala Lumpur, Malaysia. (Ź‹´‰p’ˇ1: 1Šá‰Č)

713103. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Effect of pupil dilation on objective and subjective refraction. Iwata Y1, Ishikawa H2: 31st International Pupil Colloquium 2015 (2015/9/14-16), Oxford, UK. (Šâ“c@—y1, Îě@‹Ď2: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”)

713104. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Pupillary size and light reflex in premature infants. Ikeda T1, Ishikawa H2, Asakawa K2, Goseki T1, Shimizu K1: 31st International Pupil Colloquium 2015 (2015/9/14-16), Oxford, UK. (’r“c“N–ç1, Îě@‹Ď2, óě@ŒŤ2, ŒăŠÖ—˜–ž1, ´…Œö–ç1: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

713105. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰EFree Paper) Adenoid cystic carcinoma manifesting as unilateral eye movement limitation and anisocoria: a case report. Chen SC, Sato N1, Ikeda T1, Goseki T1, Ishikawa H2, Tseng G-l, Chen C-C, Woung L-C, Liou S-W: IPOS VII Pre-Academy Meeting "Strabismus and Pediatric Plastics" (2015/11/13), Las Vegas, USA. (˛“ĄM”V1, ’r“c“N–ç1, ŒăŠÖ—˜–ž1, Îě@‹Ď2: 1Šá‰Č, 2ˆă—ÉqśŠw•”)

721017. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) …ť‘Ě‚¨‚ć‚ŃIOL‚Ě“§‰ß“ÁŤ‚Ě–đŠ„. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć54‰ń“ú–{”’“ŕáŠw‰ď‘‰ďE‘ć41‰ń…ť‘ĚŒ¤‹†‰ď (2015/9/19), ˆ¤’m.

721018. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ’m‚Á‚ĈŔSgć“VFŠoˆŮíh, ’m‚ç‚Č‚˘‚Ć•|‚˘gŒă“VFŠoˆŮíh. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć57‰ń“ú–{ŽY‹ĆE˜J“­EŒđ’ĘŠá‰ČŠw‰ď (2015/10/31), ’ˇ–ě.

722103. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šp–ŒŽžŠł‚ĚŠá‹…ŒőŠw“ÁŤ (Optical Quality in Eyes with Corneal Disease). _’J˜aF (Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

722104. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Šp–ŒŒ`óŽžŠł‚Ě”’“ŕáŽčp. _’J˜aF (Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

722105. [Šw‰ď (‘S‘)] (ŽóÜu‰‰) Water Cleft‚É‚¨‚Ż‚éŒőŠwƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“. ‚‹´ˆËŽq1, ěŽç“c‘ńŽu2, ŠÖ@—S‰î1, ŽO“c“N‘ĺ1, ‹v•Ű]—1, ˛X–Ř—m1 (1‹ŕ‘ňˆă‘ĺ, 2ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/17), –kŠC“š.

722106. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) —Ž‹‚ĆŽ‹‹@”\. _’J˜aF (Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/17), –kŠC“š.

722107. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˆă—ĂŽŇ‚ĚŒž“Ž‚ƐS—ĂŠá‰Č The role of ophthalmic psychomedicine on various ocular discomforts. Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/17), –kŠC“š.

722108. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yŔ’ˇzSWEPT SourceƒoƒCƒIƒƒgƒŠ[TM IOLƒ}ƒXƒ^[700`ŒŸ¸¸“x‚ĚŒüă‚Ĺ, Žčp‚ŕX‚ɐ¸Šm‚Ɂ`. Žsěˆę•v1,2 (1’†‹ž•a‰@, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/17), –kŠC“š.

722109. [Šw‰ď (‘S‘)] (Best of AAO)y‰đŕŽŇz”’“ŕá‚¨‚ć‚Ń‹üÜRefractive Surgery. _’J˜aF1, ŽOŒË‰ŞŽĆ2 (1Šá‰Č, 2–kŒË“c‰w‘O‚Ý‚Ć‚¨‚ŠŠá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/18), –kŠC“š.

722110. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ORTe‚ĆOcclu-pad҂ɂć‚éƒpƒ‰ƒ_ƒCƒ€ƒVƒtƒg`—źŠáŠJ•ú‰ş‚É‚¨‚Ż‚éí—Ş“IŽ‹”\‹¸łŒv‰ć`. ”ź“c’m–ç (ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/18), –kŠC“š.

722111. [Šw‰ď (‘S‘)] (‹łˆçƒZƒ~ƒi[) Ž‹‹@”\‚É‚¨‚Ż‚éF‚Ě–đŠ„ (The color role in visual function). Žsěˆę•v1,2 (1’†‹ž•a‰@, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/19), –kŠC“š.

722112. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) Šáˆł•âł’lIOPcc‚̍ĄŒă‚Ě“W–]`Ž‹–ě‚Ć‚ĚŠÖ˜AŤ`. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć4‰ń“ú–{Ž‹–ěŠw‰ďŠwpW‰ď (2015/5/31), Îě.

722113. [Šw‰ď (‘S‘)] (ƒI[ƒvƒ“ƒtƒH[ƒ‰ƒ€) “ú–{‚ĚƒXƒ^ƒ“ƒ_[ƒh‚͐˘ŠE‚ĚƒXƒ^ƒ“ƒ_[ƒh‚Š?|JSCRS‰ďˆőƒAƒ“ƒP[ƒg’˛¸‚ĆŠCŠO‚Ě”äŠr| (Do Japanese standards match international standards? -Comparison of JSCRS member surveys and those of US and Europe). Richard A Lewis, Roberto Bellucci, Damien Gatinel, Masaki Sato, _’J˜aF1 (1Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/19), “Œ‹ž.

722114. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’†‹žŠá‰Č‚É‚¨‚Ż‚éƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[”’“ŕáŽčp‚Ě—Ő°ŽŔŃ. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/19), “Œ‹ž.

722115. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‚Ý‚ń‚Č‚Ĺl‚Ś‚é”’“ŕáŽčp@‰˝ŒĚăŽč‚­‚˘‚Š‚Č‚˘‚Ě‚Š, ‚Ç‚¤‹ł‚Ś‚ę‚Ηǂ˘‚Ě‚Š. —é–Ř‹v°1, ŽOŒË‰ŞŽĆ2, ‘ĺ“ŕ‰ë”V3, ”Ń“c‰Ă•F4 (1“ú–{ˆă‘ĺE•‘ Ź™, 2–kŒË“c‰w‘O‚Ý‚Ć‚¨‚ŠŠá‰Č, 3‘ĺ“ŕŠá‰Č, 4Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/19), “Œ‹ž.

722116. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX)yƒI[ƒKƒiƒCƒU[z‚Ý‚ń‚Č‚Ĺl‚Ś‚é”’“ŕáŽčp: QOV‚É‚ą‚ž‚í‚낤. ”Ń“c‰Ă•F1, ŽÄ@‘ô–ç2 (1Šá‰Č, 2“Œ‹žŽœŒbˆă‘ĺ‘ćŽO•a‰@): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/19), “Œ‹ž.

722117. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‚Ý‚ń‚Č‚Ĺl‚Ś‚é”’“ŕáŽčp: QOV‚É‚ą‚ž‚í‚낤. ”Ń“c‰Ă•F1, ŽÄ@‘ô–ç2, Œă“ĄŒ›m3, Źě’qˆę˜Y4, ’š‹GŹ5 (1Šá‰Č, 2“Œ‹žŽœŒbˆă‘ĺ‘ćŽO•a‰@, 3ŕՋŚˆă‘ĺ, 4“Œ‹žŽœŒbˆă‘ĺ, 5Œcœä‘ĺ): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/19), “Œ‹ž.

722118. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yŔ’ˇzIOLƒ}ƒXƒ^[700Ž‹Šo‰ťƒoƒCƒIƒƒgƒŠ[Žž‘ă‚Ě“ž—ˆ. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/19), “Œ‹ž.

722119. [Šw‰ď (‘S‘)] (‹L”Ou‰‰)yŽi‰ďzJSCRS 30Žü”N‹L”Ou‰‰. ´…Œö–ç (Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

722120. [Šw‰ď (‘S‘)] (JSCRSƒvƒ‰ƒNƒeƒBƒX)yƒ‚ƒfƒŒ[ƒ^[z‹üÜ‹¸łŽčpŠłŽŇ‚̐fŽ@–@. Îˆä@´1, _’J˜aF2 (1‚ł‚˘‚˝‚ܐԏ\Žš•a‰@, 2Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

722121. [Šw‰ď (‘S‘)] (JSCRSƒvƒ‰ƒNƒeƒBƒX) ‹üÜ‹¸ł–@‚ĆŠáŒőŠw`•Ű‘ś—Ă–@‚ĆŽčp—Ă–@‚Ěˆá‚˘`. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

722122. [Šw‰ď (‘S‘)] (JSCRSƒvƒ‰ƒNƒeƒBƒX) Šp–Œ‹üÜ‹¸łŽčp‚ĆŠáŒőŠw. _’J˜aF (Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

722123. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) Œőü’ǐՓx”ŒvŽZOKULIX‚É‚¨‚Ż‚éOA-2000‚̉”\Ť. ‘ĺ’JLˆę˜Y1,2 (1Ž­Ž™“‡‹{“cŠá‰Č, 2Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

722124. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) LuxORTM LX3: ”’“ŕáŽčp‚É“Á‰ť‚ľ‚˝V‚ľ‚˘Œ°”÷‹ž. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

722125. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) JSCRS “Á•Ę•ń`JSCRS ƒAƒ“ƒP[ƒg’˛¸ƒ[ƒLƒ“ƒOƒOƒ‹[ƒv`‹üÜ‹¸łŽčpƒAƒ“ƒP[ƒg’˛¸. _’J˜aF (Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/21), “Œ‹ž.

722126. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Best of JSCRS@ˆę”ʉ‰‘č‘•] (‹üÜ‹¸łŽčpŠÖ˜A). _’J˜aF1, •B“c@–q2 (1Šá‰Č, 2‹ž“s•{ˆă‘ĺ): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/21), “Œ‹ž.

722127. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šp–ŒŽžŠł‚Ö‚Ěƒg[ƒŠƒbƒNŠá“ŕƒŒƒ“ƒY. _’J˜aF (Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/21), “Œ‹ž.

722128. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŽĄ—ĂI@”ńŠĎŒŒ“IE•Ű‘ś“IŽĄ—Ă. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć71‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć40‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď (2015/7/3), •şŒÉ.

722129. [Šw‰ď (‘S‘)] (‹łˆçƒZƒ~ƒi[) Œ‹–ŒůNíÝ‹Ű. Žq“‡—Ç•˝1,2 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): ‘ć52‰ń“ú–{ŠáŠ´őÇŠw‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/11), ‘ĺă.

722130. [Šw‰ď (‘S‘)] (ŽŔK)yƒCƒ“ƒXƒgƒ‰ƒNƒ^[z‘ć6‰ńJAOI“h–•ŒŸ‹žƒXƒLƒ‹ƒgƒ‰ƒ“ƒXƒtƒ@[. ˆäă’q”V1, Žq“‡—Ç•˝2,3, –ěŒű‚ä‚Š‚č2, ŒË“c—Ç‘ž˜Y4, –Lě^O5, ˛X–Ř—T”ü6, ]Œű@—m7, Ź”Ś”Žl8, ŒËŠ‘ĺ•ă9, —é–؁@’10, ‹ßŠÔ‘׈ę˜Y4, ’†ě@Ž11, `–ě@Š°12, Ż@Ĺ’q13 (1‘˝Ş‹L”OŠá‰Č•a‰@, 2‹{“cŠá‰Č•a‰@, 3Šá‰Č, 4L“‡‘ĺ, 5“Œ–k‘ĺŠw•a‰@f—Ă‹Zp•”, 6ă‘ĺ”÷ś•¨•aŒ¤‹†‰ď—Տ°ŒŸ¸•”, 7‹ß‹E‘ĺEä, 8ŽŠŽĄˆă‘ĺ, 9ŒQ”n‘ĺ, 10ˆ¤•Q‘ĺ, 11“ż“‡f—ÏŠ, 12ƒ‹ƒ~ƒl‚Í‚˝‚ĚŠá‰Č, 13‘—§’ˇŽőˆă—ĂŒ¤‹†ƒZƒ“ƒ^[): ‘ć52‰ń“ú–{ŠáŠ´őÇŠw‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/11), ‘ĺă.

722131. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[zQOV & ADL. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/11), ˆ¤’m.

722132. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) —źŠáŽ‹‚ł݂鎋–ěáŠQ‚Ö‚ĚƒAƒvƒ[ƒ`. ”ź“c’m–ç (ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/11), ˆ¤’m.

722133. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) —ΓŕáŽĄ—Ă‚É”ş‚¤Šá•\–ʏíÝ×‹Ű‘p‚ւ̉e‹ż|”’“ŕáŽüpŠú‚̍RśÜ‚Ě‘I‘đ|. ‘ĺ’JLˆę˜Y1,2 (1Ž­Ž™“‡‹{“cŠá‰Č, 2Šá‰Č): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/12), ˆ¤’m.

722134. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‘ą”­—Γŕá‚Ě”’“ŕáŽčp. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/12), ˆ¤’m.

722135. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[z”’“ŕá‚Ě—\–h‚ĆŽĄ—Ă. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć54‰ń“ú–{”’“ŕáŠw‰ď‘‰ďE‘ć41‰ń…ť‘ĚŒ¤‹†‰ď (2015/9/19), ˆ¤’m.

722136. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) …ť‘Ě‚Ě˜c‚Ý‚ĆŠá“ŕƒŒƒ“ƒY. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć54‰ń“ú–{”’“ŕáŠw‰ď‘‰ďE‘ć41‰ń…ť‘ĚŒ¤‹†‰ď (2015/9/19), ˆ¤’m.

722137. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ”’“ŕá‚Ě•›•aŒ^‚ĆŽčp“K‰ž. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‘ć54‰ń“ú–{”’“ŕáŠw‰ď‘‰ďE‘ć41‰ń…ť‘ĚŒ¤‹†‰ď (2015/9/20), ˆ¤’m.

722138. [Šw‰ď (‘S‘)] (Žs–ŻŒöŠJ) ƒ{ƒPE•s–°ÇE‚ŒŒˆłÇ‚Ü‚ĹŽĄ‚é”’“ŕáŽĄ—Ă. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć54‰ń“ú–{”’“ŕáŠw‰ď‘‰ďE‘ć41‰ń…ť‘ĚŒ¤‹†‰ď (2015/9/20), ˆ¤’m.

722139. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) —L…ť‘ĚŠá“ŕƒŒƒ“ƒY. _’J˜aF (Šá‰Č): ‘ć51‰ń“ú–{ŠáŒőŠwŠw‰ď‘‰ď (2015/9/26), ‰ŞŽR.

722140. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) —§‘ĚŽ‹‚Ć—§‘̉f‘œ’mŠo‚Ě•]‰żŽ˛. ”ź“c’m–ç (ˆă—ÉqśŠw•”): ‘ć51‰ń“ú–{ŠáŒőŠwŠw‰ď‘‰ď (2015/9/26), ‰ŞŽR.

722141. [Šw‰ď (‘S‘)] (‹łˆçƒZƒ~ƒi[) Ž‹—ÍŒŸ¸‚ÉŠÖ‚ˇ‚é‘˝Ž{ÝƒAƒ“ƒP[ƒg’˛¸. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‘ć51‰ń“ú–{ŠáŒőŠwŠw‰ď‘‰ď (2015/9/26), ‰ŞŽR.

722142. [Šw‰ď (‘S‘)] (Hands-onƒZƒ~ƒi[) ƒ{ƒcƒŠƒkƒX“Ĺ‘fťÜ‚ĚŽćˆľ‚˘‚ɂ‚˘‚Ä. ŒăŠÖ—˜–ž (Šá‰Č): “ú–{ƒ{ƒcƒŠƒkƒXŽĄ—ĂŠw‰ď‘ć2‰ńŠwp‘ĺ‰ď (2015/10/2), “Œ‹ž.

722143. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) “ŕŽ‹‹ž•š—pÉŽq‘ĚŽčp@—L—pŤ‚Ć’iŠK“IK“ž–@. ‹g“c‘Ľ•F1, ˛“Ą—T”V2, ź‰iŒ÷ˆę3, X@r’j2, ‰ĄŽR@ăÄ4, ‰Á‰ę’BŽu4,5 (1Šň•ŒÔ\Žš•a‰@, 2”Ń“cŽs—§•a‰@, 3ŠŰ‚Ě“ŕ‚Ü‚Â‚Č‚ŞŠá‰Č, 4’†‹ž•a‰@, 5Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/22), ˆ¤’m.

722144. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‰~Šp–Œ‚ɑ΂ˇ‚é‹üÜ‹¸łŽčp. _’J˜aF (Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722145. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒI[ƒKƒiƒCƒU[z˜VŽ‹‹¸ł‚̍ŐVî•ń. ´…Œö–ç1, ƒrƒbƒZƒ“‹{“‡OŽq2 (1Šá‰Č, 2“Œ‹žŽ•‘ĺE…“š‹´): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722146. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šá“ŕƒŒƒ“ƒY‚É‚ć‚郂ƒmƒrƒWƒ‡ƒ“–@. ”Ń“c‰Ă•F (Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722147. [Šw‰ď (‘S‘)] (ŽóÜu‰‰) Žü•Ó•”ó‘O–[Šá‚Ě‘OŒü‚ŤŒ¤‹†‚Ě’†ŠÔ‰đÍ: Šp–Œ“ŕ”ç×–E–§“x‚Ć‹÷Šp‹žŠŒŠ‚̕ωť. ŽO“ˆOˆę1, –“–Ř’ź”ü2, äo“ߌ´—Žq3, ‘ĺ’JLˆę˜Y4,5, Žđˆä@Š°3, •xŠ“Ö’j6, ‘ŠŒ´@ˆę7, ‹{“c˜a“T4, ŕVŒűşˆę3, ŠâŁˆ¤Žq8, V‰Ć@áÁ2 (1“Œ‹ž’üM•a‰@, 2ŠÖ“Œ’†‰›•a‰@, 3—Ž‹…‘ĺ, 4‹{“cŠá‰Č•a‰@, 5Šá‰Č, 6“Œ’†–ě‚Ć‚Ý‚Ç‚ą‚ëŠá‰Č, 7Žl’J‚ľ‚ç‚ĆŠá‰Č, 8‚˝‚ś‚݊␣Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722148. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) Ç—á‚Š‚çŠw‚ÔŠp–ŒŠ´őÇ‚ĚŽĄ—Ð헪. —é–؁@’1,2, ]Œű@—m2,3, Žq“‡—Ç•˝2,4,5, ŻĹ’q2,6, •ž•”‹M–ž2,7, ˆäă’q”V2,8, ŒËŠ‘ĺ•ă2,9 (1ˆ¤•Q‘ĺ, 2OMICŒ¤‹†‰ď, 3‹ß‹E‘ĺEä, 4‹{“cŠá‰Č•a‰@, 5Šá‰Č, 6‘—§’ˇŽőˆă—ĂŒ¤‹†ƒZƒ“ƒ^[, 7“Œ‹žˆă‘ĺ, 8‘˝Ş‹L”OŠá‰Č•a‰@, 9ŒQ”n‘ĺ): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722149. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) –ž“ú‚Š‚炡‚ŽŽŔ‘H! ‚‹@”\Šá“ŕƒŒƒ“ƒY‚̏ăŽč‚ČŽg‚˘•ű. ‹{“c˜a“T1, _’J˜aF2, ’†‘ş–M•F3, –xŒű_Žj4, ŞŠÝˆę”T5 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č, 3‚˝‚Č‚ľ’†‘şŠá‰Č, 4“Œ‹žŽœŒbˆă‘ĺE‘ćŽO, 5Œcœä‘ĺ): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722150. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) “œ”A•aŠłŽŇ‚ĚŽĄ—Ă•űj10|‚ą‚ń‚ČŽž‚Ç‚¤‚ˇ‚é|. ‰Á“Ą@‘1, A–Ř–ƒ—˘2, ‚–ě‰ë•F3,4, ˆŔ“ĄL˜N5, ź‘ş”ü‘ă6 (1“Œ‹ž‘ĺ, 2‘ĺăˆă‘ĺ, 3‘Űˆă—Ă•ŸŽƒ‘ĺE”MŠC, 4Šá‰Č, 5VŠƒ‘ć“ń•a‰@, 6‰i“cŠá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722151. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) ŽĄ—ĂƒKƒCƒhƒ‰ƒCƒ“‚ĚŒŸ“˘‚Ć‹qŠĎ“IŽĄ—Ă•]‰ż–@‚ĚŒŸ“˘. Žsěˆę•v1,2 (1’†‹ž•a‰@, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722152. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‹É‘Šú—Γŕá‚ĚŽĄ—Ă. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722153. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[)yŔ’ˇz‰ˇŒĚ’mV@Šp–ŒŒ`ó‰đÍ‚Ć—Ž‹‹¸łp. Ź—с@Œ°1, _’J˜aF2 (1‹ŕ‘ň‘ĺŠw, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722154. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) My Career 20/20. ´…Œö–ç (Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

722155. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ‘OŠá•”pŽŇ‚Ě‚˝‚ß‚Ě, ”j”XE‡•šÇˆ—ƒtƒ‹ƒR[ƒX. ”Ń“c‰Ă•F1, ‘ĺ“ŕ‰ë”V2, ź“‡”Ž”V3, ‘ž“cr•F4 (1Šá‰Č, 2‘ĺ“ŕŠá‰Č, 3ŕՋŚˆă‘ĺ, 4‡“V‘ĺEĂ‰Ş): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

722156. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ŠwZŒ’f‚É‚¨‚Ż‚éFŠoŒŸ¸‚Ě‚ ‚č•ű‚Ć—Ő°f’f‚¨‚ć‚ŃŽw“ą. Žsěˆę•v1,2, ’†‘ş‰pŽ÷3, ‘ş–Ř‘•c4, ’†‘ş‚Š‚¨‚é5, ŽRoVˆę4, ‰Ş“‡@C6, “c•ÓŮŽq1 (1’†‹žŠá‰Č, 2Šá‰Č, 3’†‹ž•a‰@, 4Ž ‰ęˆă‘ĺ, 5—Žqˆă‘ĺ, 6”ޏdF‘哇Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

722157. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) ”’“ŕáƒT[ƒWƒƒƒ“‚ŕ•KŒŠ! LI•s—v! ŠŃ’ʍE•t‚Ť—L…ť‘ĚŠá“ŕƒŒƒ“ƒY‚đƒ}ƒXƒ^[‚ľ‚悤. ’†‘ş—Fş1, Žsěˆę•v2,3, _’J˜aF3, –kŕV˘Žu”Ž4, ´…Œö–ç3 (1–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 2’†‹ž•a‰@, 3Šá‰Č, 4_ŒË_“ސěƒAƒCƒNƒŠƒjƒbƒN): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

722158. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒNƒ‹ƒYƒX) Ž‹_Œo‰Šf’f, ŒŸ¸‚ĚĹ‘Oü. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

722159. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yŔ’ˇz”ň–ô‚ˇ‚郌ƒ“ƒYƒXƒ^[‚Ě‘‡—Í. ´…Œö–ç (Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

722160. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) LS900‚đ—p‚˘‚˝Šp–Œ‹üÜ‹¸łŽčpŒă‚ĚIOL“x”ŒvŽZ. ”Ń“c‰Ă•F (Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

722161. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) –{–M‚É‚¨‚Ż‚éƒgƒ‰ƒxƒNƒg[ƒ€Žčp‚Ě’ˇŠúŹŃ. “n糎OŒP1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

722162. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) ƒgƒ‰ƒxƒNƒg[ƒ€Žčp: Ÿˆ‚Ş•ˇ‚Ť‚˝‚˘Part II. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

722163. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[)yŔ’ˇzICL‚Š‚çŽn‚ß‚é‹üÜ‹¸łŽčp. ´…Œö–ç1, Žsěˆę•v1,2 (1Šá‰Č, 2’†‹žŠá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

722164. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) ICL‚Š‚çŽn‚ß‚é‹üÜ‹¸łŽčp. ŒÜ\—’ÍŽj (Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

722165. [Šw‰ď (‘S‘)] (ƒtƒFƒAƒEƒFƒ‹ƒZƒ~ƒi[)yŔ’ˇzŹŽ™‚ĚƒRƒ“ƒgƒNƒgƒŒƒ“ƒY‚Ě–â‘č“_. ‰F’ĂŒŠ‹`ˆę1,2 (1‰F’ĂŒŠŠá‰Čˆă‰@, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/25), ˆ¤’m.

722166. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) Šá‹…ŒőŠwŒn‚¨‚ć‚ŃŽ‹ŠoŒn‚̉Á—î•Ď‰ť‚ĆŒđ’ĘˆŔ‘S. ěŽç“c‘ńŽu (ˆă—ÉqśŠw•”): ‘ć57‰ń“ú–{ŽY‹ĆE˜J“­EŒđ’ĘŠá‰ČŠw‰ď (2015/10/31), ’ˇ–ě.

722167. [Šw‰ď (‘S‘)] (“˘˜_‰ď)yŔ’ˇzFŠoŒŸ¸‚ƐFŠoˆŮí. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć57‰ń“ú–{ŽY‹ĆE˜J“­EŒđ’ĘŠá‰ČŠw‰ď (2015/10/31), ’ˇ–ě.

722168. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) FŠoŒŸ¸‚Ě–˘—ˆ@ŒŠ‚Ś•ű‚̐”’l‰ť. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć57‰ń“ú–{ŽY‹ĆE˜J“­EŒđ’ĘŠá‰ČŠw‰ď (2015/10/31), ’ˇ–ě.

722169. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yŔ’ˇz“ü–ĺ@ŠááŮázš. Îě@‹Ď1, ŒăŠÖ—˜–ž2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/7), é‹Ę.

722170. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yŔ’ˇzAŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘fťÜ@ƒ{ƒgƒbƒNƒXҁ@uKEŽŔ‹ZƒZƒ~ƒi[ (ŽÎŽ‹). Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/7), é‹Ę.

722171. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) AŒ^ƒ{ƒcƒŠƒkƒX“Ĺ‘fťÜ@ƒ{ƒgƒbƒNƒXҁ@uKEŽŔ‹ZƒZƒ~ƒi[ (ŽÎŽ‹). ŒăŠÖ—˜–ž (Šá‰Č): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/7), é‹Ę.

722172. [Šw‰ď (‘S‘)] (śŠU‹łˆçƒZƒ~ƒi[) “ľE‚Ě–đŠ„E”˝‰ž‚̍čl. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć56‰ń“ú–{Ž‹”\‹¸łŠw‰ď (2015/11/7), “Œ‹ž.

722173. [Šw‰ď (‘S‘)] (‹łˆçƒZƒ~ƒi[) Šp–Œƒp[ƒcˆÚA‚Ě“K‰ž‚Ə€”ő. Žq“‡—Ç•˝1,2 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/29), •Ÿ‰Ş.

722174. [Šw‰ď (‘S‘)] (‹łˆçƒZƒ~ƒi[) ”’“ŕápŒăŠá“ŕ‰Š. X@—mÄ1,2 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/30), •Ÿ‰Ş.

722175. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX)yƒI[ƒKƒiƒCƒU[z—ΓŕáŽčpŠí‹ďƒgƒ‰ƒxƒNƒg[ƒ€‚É‚ć‚é—Źo˜HÄŒšp‚ĚŠT—v‚ĆŽčp“K‰ž, ŽčpŹŃ‚ɂ‚˘‚Ä. Žsěˆę•v1,2, “n糎OŒP1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/30), •Ÿ‰Ş.

722176. [Šw‰ď (‘S‘)] (ƒCƒ“ƒXƒgƒ‰ƒNƒVƒ‡ƒ“ƒR[ƒX) —ΓŕáŽčpŠí‹ďƒgƒ‰ƒxƒNƒg[ƒ€‚É‚ć‚é—Źo˜HÄŒšp‚ĚŠT—v‚ĆŽčp“K‰ž, ŽčpŹŃ‚ɂ‚˘‚Ä. “n糎OŒP1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/30), •Ÿ‰Ş.

722177. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‹}Ť–Ô–Œ‰óŽ€‚ɑ΂ˇ‚鑁ŠúÉŽq‘ĚŽčp. ‚–ě‰ë•F1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠwE”MŠC, 2Šá‰Č): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/30), •Ÿ‰Ş.

722178. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ś‘Ě”FŘ“Š‰e‘•’uƒT[ƒWƒJƒ‹ƒKƒCƒ_ƒ“ƒX‚ĚƒGƒrƒfƒ“ƒX. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/31), •Ÿ‰Ş.

722179. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šp–Œ‹üÜ‹¸łpŒă‚ĚŽ‹‹@”\. X@—mÄ1,2 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18), ’ˇ–ě.

722180. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Šp–Œ•ĎŤÇ‚ĚŽ‹‹@”\. _’J˜aF (Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18), ’ˇ–ě.

722181. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yŔ’ˇzLa Derni`ere Classe|ĹŒă‚Ě, Žö‹Ć|Šp–ŒŽžŠł‚Ö‚Ěƒg[ƒŠƒbƒNIOL‚̉ž—p. ´…Œö–ç (Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18), ’ˇ–ě.

722182. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ŠeŽíƒg[ƒŠƒbƒNIOL‚̏pŒă‰ń“]ŹŃ. X@—mÄ1,2 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18), ’ˇ–ě.

722183. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‰~Šp–Œ‚Ö‚Ěƒg[ƒŠƒbƒNIOL‚ĚŽg—pŹŃ. ŽO‘îr”V1,2 (1‰Ą{‰ęŽs‚¤‚í‚Ü‚ż•a‰@, 2Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18), ’ˇ–ě.

722184. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yŔ’ˇzŠp–Œ! ƒiƒCƒgƒXƒN[ƒv in Œyˆä‘ň. ´…Œö–ç (Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18), ’ˇ–ě.

722185. [Šw‰ď (‘S‘)] (ƒCƒuƒjƒ“ƒOƒZƒ~ƒi[) •S•ˇ‚͈ę—Ü‚É‚ľ‚Š‚¸, , , , —܂̓Eƒ\‚đ‚‚Š‚Č‚˘!? ”ź“c’m–ç (ˆă—ÉqśŠw•”): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18), ’ˇ–ě.

722186. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yŔ’ˇzŠp–Œ‚đG‚ç‚Č‚˘‹üÜ‹¸łŽčp. ´…Œö–ç (Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/19), ’ˇ–ě.

722187. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) Ž„‚ŞLASIK‚đ‚â‚ß‚ÄKS-AP‚đ‘I‘đ‚ˇ‚é——R. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/19), ’ˇ–ě.

722188. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) Šp–Œ‹üÜ‹¸łŽčp‚ĆKS-AP‚Ě”äŠr. ŒÜ\—’ÍŽj (Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/19), ’ˇ–ě.

722189. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) ‘ć2‰ń‘S‘Šp–Œ‘IŽčŒ 2016. ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1, ‚‹´ł‰p1 (1Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/19), ’ˇ–ě.

722190. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yŔ’ˇzi‰ť‚ˇ‚éŠp–ŒŽčp@p’†OCT‚ĆFSƒŒ[ƒU[‚ʼn˝‚Ş•Ď‚í‚é‚Ě‚Š? ´…Œö–ç (Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/19), ’ˇ–ě.

722191. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) i‰ť‚ˇ‚éŠp–ŒŽčp@p’†OCT‚ĆFSƒŒ[ƒU[‚ʼn˝‚Ş•Ď‚í‚é‚Ě‚Š? _’J˜aF (Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/19), ’ˇ–ě.

722192. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[)yŔ’ˇzƒŒ[ƒU[Šp–ŒŽčpŠv–˝! Part…˘ ƒŒ[ƒU[Šp–ŒˆÚA10”N‚Ě”­“W‚Ć‚ą‚ę‚Š‚ç. ´…Œö–ç (Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/20), ’ˇ–ě.

722193. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) Šp–ŒˆÚA‚É‚¨‚Ż‚郌[ƒU[‚ĚŒ÷Ń. _’J˜aF (Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/20), ’ˇ–ě.

723722. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒ^ƒuƒŒƒbƒgŒ^Ž‹”\ŒP—ű‘•’u (Occlu-padŇ) ‚đ—p‚˘‚˝ŽăŽ‹ŒP—ű•ń. ”ź“c’m–ç1, Îě@‹Ď1, ŻŽiMs1, ’r“c“N–ç2, ŒË’ˁ@Œĺ2, ´…Œö–ç2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723723. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹}Ť–Ô–Œ‰óŽ€‚ɑ΂ˇ‚éƒKƒ“ƒVƒNƒƒrƒ‹ÉŽq‘Ě“ŕ’ŽË. ‰ĂŽRŽŔŠóŽq1, Žs糋`Í1,2, Š}Œ´łs1, ‚‹´ł‰p1, –ö“c’q•F1, ´…Œö–ç1 (1Šá‰Č, 2_“ސ쎕‰Č‘ĺE‰Ą•lƒNƒŠƒjƒbƒN): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723724. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽžŠł•Ę‚É‚¨‚Ż‚éFunctional Vision Score•Ş—Ţ‚đ—p‚˘‚˝Ž‹ŠoáŠQ“™‹‰‚Ě—L—pŤ. –öŕV”üˆßŽq1,2, ‰Á“Ą@‘1, Ź—Ń‚ß‚Ž‚Ý1, “n糖œ—˘Žq1, —Ž‡áÁ‹IŽq1 (1“Œ‹ž‘ĺ, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723725. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰~Šp–ŒŠá‚É‚¨‚Ż‚éŠp–Œ‘O–Ę‚¨‚ć‚ŃŒă–Ę—Ž‹•Ş•z. ŒÜ\—’ÍŽj1, _’J˜aF1, Ź‹´‰p’ˇ1, ŽO‘îr”V1, ’r“ŕ—œŠG1, ěŽç“c‘ńŽu2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723726. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒXƒŠƒbƒgƒXƒLƒƒƒ“‚ĆSS-OCT‚É‚ć‚éHaigisŽŽ‚̏pŒă‹üÜŒëˇ‚ĚŒŸ“˘. ‹Ę’u–ž–ě1,2, Ź“‡—˛Ži3, ’†‘ş‰pŽ÷1, ‹´’Ü—Ç‘ž1, “c’†@´2, Žsěˆę•v1,4,5 (1’†‹ž•a‰@, 2MB‘ĺE‘‡HŠw, 3Šň•ŒÔ\Žš•a‰@, 4’†‹žŠá‰Č, 5Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723727. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ľEŒa‚Ş—‡ŠáŽ‹—Í‚¨‚ć‚ŃŽŠŠo‹üÜ‚Ö‹y‚Ú‚ˇ‰e‹ż‚ĚŒŸ“˘. Ź‹´‰p’ˇ1, ”ź“c’m–ç2, _’J˜aF1, ŒÜ\—’ÍŽj1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723728. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹üÜEŽ‹‹@”\2. _’J˜aF (Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723729. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) _ŒoŠá‰Č1. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723730. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ž‹_Œo‰Š‚Ě•aŒ^‚Ć—Ő°‘œ‚ĚŒŸ“˘. ”’ŕ_V‘˝˜N1,2, •“érŽ2, ŕV‘ş—Tł2, “c’†—Œb2, ŽRă–žŽq3,4, ´ŕVŒšO5, Žá‘q‰ë“o3,4 (1JR“Œ‹ž‘‡•a‰@, 2“Œ‹ž‘ĺ, 3ˆäăŠá‰Č•a‰@, 4Šá‰Č, 5´ŕVŠá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723731. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒhƒ‰ƒCƒAƒC‚ĆŠááŮázš‚̐f’f‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ťěLŠC1, ŽRă–žŽq1,2, Žá‘q‰ë“o1,2, ˆäăŒŤŽĄ1 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723732. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹‘ĺ“ű“Ş‚Ě—Ő°‘œ‚ĆŽ‹–쏩ŒŠ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. X@@—D1, ŽRă–žŽq1,2, XŽR@—Á1, Žá‘q‰ë“o1,2, ˆäăŒŤŽĄ1 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723733. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠáŽ˛’ˇ‚ĆŠp–Œ‘O–ʁEŒă–Ę‹Č—Ś”źŒa‚ĚŒŸ“˘. íœAr‘ž˜Y1, ´…Œö–ç1, Šąě—˘ŠG1, ”Ń“c‰Ă•F1, “V–ě—Œb1, ˛“ĄM”V1, ”Ń“‡@Œh1 (1Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723734. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰~Šp–Œ‚ɑ΂ˇ‚é”’“ŕáŽčp‚Ě—\‘ސŤ‚Əp‘OˆöŽq‚ĚŒŸ“˘. ”Ń“‡@Œh1, ´…Œö–ç1, Ź‹´‰p’ˇ1, “V–ě—Œb1, _’J˜aF1 (1Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723735. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šp–Œ‹üÜ‹¸łŽčpŠá‚É‚¨‚Ż‚éŠp–Œ‹Č—Ś”źŒa‘OŒă–Ę”ä‚ĆŠp–Œ‹üÜ—Í. ”Ń“c‰Ă•F1, ´…Œö–ç1, Šąě—˘ŠG1, íœAr‘ž˜Y1, “V–ě—Œb1, ˛“ĄM”V1, ”Ń“‡@Œh1 (1Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723736. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒhƒ‰ƒCƒAƒC‚ŠŠááŮázš‚Š•´‚ç‚í‚ľ‚˘Ç—á‚ɑ΂ˇ‚郌ƒoƒ~ƒsƒh‚ĚŒř‰Ę. ‰Í–{‚Đ‚ë”ü1, ŽRă–žŽq1,2, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723737. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 3D Visual Function Trainer ORTe‚đ—p‚˘‚˝ŽăŽ‹ŒP—ű•ń. ŒË’ˁ@Œĺ1, ”ź“c’m–ç2, Îě@‹Ď2, ŻŽiMs2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723738. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŽÎŽ‹ƒXƒNƒŠ[ƒjƒ“ƒO‚Ě‚˝‚ß‚ĚŽŠ‹LŽŽŽż–â•\‚ĚŠJ”­y‘ć“ń•ńz. ŒăŠÖ—˜–ž1, Îě@‹Ď2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723739. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘Š–ÍŒ´ŽsAŠw‘OŒ’Nf’f‚É‚¨‚Ż‚鎋—ÍŒŸ¸ŽŔŽ{•ń. “Ą‘ş•‡˛Žq1, ”ź“c’m–ç1, ěŽç“c‘ńŽu1, Šâ“c@ęĄ2, ŻŽiMs1, ´…Œö–ç3 (1ˆă—ÉqśŠw•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723740. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “Œ‹ž“sŹŠ}Œ´‘ş‚̏Ź’†Šwś‚É‚¨‚Ż‚鎋—Í‚ĚŒo”N„ˆÚ. ˆÉ“Ą”üšŠG1, ´…Œö–ç2, ěŽç“c‘ńŽu1, ŻŽiMs1 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723741. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‰“Ž‹Šá‚É‚¨‚Ż‚é‹üÜˇ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. Šąě—˘ŠG1, ˆÉ“Ą”üšŠG2, ěŽç“c‘ńŽu2, ŻŽiMs2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723742. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Hole ICL‚ĚƒŒƒ“ƒYŒXŽÎ‚ŞŠá‹…“ŕ–[…‹““Ž‚É—^‚Ś‚é‰e‹ż. ěŽç“c‘ńŽu1, ˆÉ“Ą”üšŠG1, ŻŽiMs1, ´…Œö–ç2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723743. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “Eo‰Ć“e“ľEŽU‘ĺ‹Ř‚ɑ΂ˇ‚éBrimonidine‚Ě–ň—ě—p. —´ˆä‰‘Žq1, Îě@‹Ď2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/16), –kŠC“š.

723744. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “ľEŒa‚đl—ś‚ľ‚˝Šá“ŕƒŒƒ“ƒY‚É‚ć‚郂ƒmƒrƒWƒ‡ƒ“–@‚Ě—Ő°ŹŃ. ]•—Ft1, “V–ě—Œb1, ”Ń“c‰Ă•F1, ˆÉ“Ą”üšŠG2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/17), –kŠC“š.

723745. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yŔ’ˇzŠwp“WŽŚ@—ΓŕáŽ‹–ě. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/17), –kŠC“š.

723746. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “œ”A•a‰Š”Á•‚Žî‚ɑ΂ˇ‚郉ƒjƒrƒYƒ}ƒuÉŽq‘Ě’ŽË‚Ě’ZŠúŽĄ—ÐŹŃ. ’h”Vă˜a•F1, ™’J“Ä•F1, ź‰Ş‘ĺ•ă2, •˝ŕVˆę–@3 (1‚ž‚ń‚Ě‚¤‚ŚŠá‰ČƒNƒŠƒjƒbƒN, 2ěč‚¨‚Ž‚çŠá‰ČƒNƒŠƒjƒbƒN, 3ˆă—ÉqśŠw•”): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/17), –kŠC“š.

723747. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) OCTOPUS600Ž‹–ěŒv24-2‚ĆHumphreyŽ‹–ěŒv24-2‚Ě”äŠr. •˝ŕVˆę–@1, Š}Œ´łs2, ź‘şˆęO2, ’r“ŕ—œŠG2, ŻŽiMs1, ´…Œö–ç2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć119‰ń“ú–{Šá‰ČŠw‰ď‘‰ď (2015/4/17), –kŠC“š.

723748. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆę”ʍu‰‰II. ”’“yéĆ1, ŻŽiMs2 (1Žl’J‚ľ‚ç‚ĆŠá‰Č, 2ˆă—ÉqśŠw•”): ‘ć4‰ń“ú–{Ž‹–ěŠw‰ďŠwpW‰ď (2015/5/30), Îě.

723749. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šp–Œ‹üÜ—͂̕ωť‚ŞOCTŽB‘œ‚É‹y‚Ú‚ˇ‰e‹ż. •˝ŕVˆę–@1, ŻŽiMs1 (1ˆă—ÉqśŠw•”): ‘ć4‰ń“ú–{Ž‹–ěŠw‰ďŠwpW‰ď (2015/5/31), Îě.

723750. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘}“ü‘O, Œă‚É‚¨‚Ż‚éIOL‘S’ˇ‚̕ωť: ‰ć‘œ‰đÍ‚đŽg—p‚ľ‚˝”äŠr. ”n“ˆ´”@1, Žsě@Œc2, ŽđˆäKO3, “ŕ“ĄŽ‹v3,4, ˆé’JŽ‹P4, •Đ‰Ş“”Ž4, ’†‘ş—Fş4, Žsěˆę•v3,5 (1Šá‰Č–žŠá‰@, 2Šň•ŒÔ\Žš•a‰@, 3’†‹žŠá‰Č, 4–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 5Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/19), “Œ‹ž.

723751. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”’“ŕáŽčp‘OŠłŽŇ‚ĆŒ’NŹl‚ĚŒ‹–Œ”XíÝ‹Ű‘p‚Ć–ňÜŠ´ŽóŤ‚Ě”äŠrŒŸ“˘. ‰Á‰ę’J•śŠG1, ‹{•‰‘y‰î2, Źa’Žj2, Žq“‡—Ç•˝2,3, –ěŒű‚ä‚Š‚č2, ”Ş–Ř˛Žq2, Šâč‘ô–ç2, ‹{“c˜a“T2 (1Ž­Ž™“‡‹{“cŠá‰Č, 2‹{“cŠá‰Č, 3Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

723752. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[”’“ŕáŽčp‚É‚¨‚Ż‚鎊ŠoƒAƒ“ƒP[ƒg‹y‚яp‘OŒă‚ĚŠá•\–ʏáŠQ‚ĚŒŸ“˘. ‚–Ř–ƒ—˘1, Ź“‡—˛Ži2, ’†‘ş‰pŽ÷1, Žsě@Œc2, “´ˆä—˘ŠG3, ŽđˆäKO3, “ŕ“ĄŽ‹v3, Žsěˆę•v3,4 (1’†‹ž•a‰@, 2Šň•ŒÔ\Žš•a‰@, 3’†‹žŠá‰Č, 4Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

723753. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹üÜ‹¸łŽčp‚É‚¨‚Ż‚éƒtƒ‰ƒbƒvěť‚Ě—L–ł‚ރIƒLƒ…ƒ‰[ƒT[ƒtƒFƒX‚É‹y‚Ú‚ˇ‰e‹ż: ƒƒ^ƒAƒiƒŠƒVƒX. Ź‹´‰p’ˇ1, _’J˜aF1, ŒÜ\—’ÍŽj1, ´…Œö–ç1 (1Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

723754. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šp–Œ—Ž‹Šá‚ɑ΂ˇ‚éƒmƒ“ƒg[ƒŠƒbƒNŒă–[Œ^—L…ť‘ĚŠá“ŕƒŒƒ“ƒY‚̏pŒăŽ‹—͂ɉe‹ż‚đ‹y‚Ú‚ˇˆöŽq‚ĚŒŸ“˘. ŒÜ\—’ÍŽj1, _’J˜aF1, Ź‹´‰p’ˇ1, ´…Œö–ç1 (1Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

723755. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ICLpŒă‚Ě”’“ŕá. ’†‘ş—Fş1, ‹g“c—zŽq1, ˆé’JŽ‹P1, •Đ‰Ş“”Ž1, Ź“‡—˛Ži2, Žsěˆę•v3,4 (1–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 2Šň•ŒÔ\Žš•a‰@, 3’†‹žŠá‰Č, 4Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

723756. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO‚̏‰ŠúE’†ŠúŹŃ‚Ě•ń. Ź“‡—˛Ži1, Xě“Žq2, “n•”@ŠÂ3, ˛“Ą—T–ç3, ’†‘ş—Fş2, ‹Ę’u–ž–ě4, Žsěˆę•v5,6 (1Šň•ŒÔ\Žš•a‰@, 2–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 3˛“Ą—T–çŠá‰Čˆă‰@, 4’†‹ž•a‰@, 5’†‹žŠá‰Č, 6Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

723757. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[”’“ŕáŽčp‚Ć’Ęí‚Ě”’“ŕáŽčp‚̏pŒă–Ô–ŒŒú‚Ě”äŠr. Žsě@Œc1, Ź“‡—˛Ži1, “´ˆä—˘ŠG2, ŽđˆäKO2, ‰Á“ĄKm2, ‚–Ř–ƒ—˘3, ‹Ę’u–ž–ě3, ’†‘ş‰pŽ÷3, Žsěˆę•v3,4 (1Šň•ŒÔ\Žš•a‰@, 2’†‹žŠá‰Č, 3’†‹ž•a‰@, 4Šá‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/20), “Œ‹ž.

723758. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šá“ŕƒŒƒ“ƒY•ÎˆĘÇ—á‚Ě”wŒiˆöŽq‚ĚŒŸ“˘. ˛“ĄM”V1, ”Ń“c‰Ă•F1, ´…Œö–ç1, ”Ń“‡@Œh2, íœAr‘ž˜Y1, ŠFě—FŒ›1, “V–ě—Œb1 (1Šá‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć30‰ńJSCRSŠwp‘‰ď (2015/6/21), “Œ‹ž.

723759. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) 3D Visual Function Trainer-ORTe‚É‚ć‚鎥—Ă‚Ş‘tŒř‚ľ‚˝çt–Š•s‘S‚ĚˆęÇ—á. ‚–ě”ü‘ă1, ŹŠ}Œ´F—S1, ”ź“c’m–ç2 (1ŹŠ}Œ´Šá‰ČƒNƒŠƒjƒbƒN, 2ˆă—ÉqśŠw•”): ‘ć71‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć40‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď (2015/7/3), •şŒÉ.

723760. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “Œ‹ž“sŹŠ}Œ´‘ş‚̏Ź’†Šwś‚É‚¨‚Ż‚é—‡ŠáŽ‹—͂̐„ˆÚ. ˆÉ“Ą”üšŠG1, ´…Œö–ç2, ěŽç“c‘ńŽu1, ŻŽiMs1 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć71‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć40‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď (2015/7/3), •şŒÉ.

723761. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 3D Visual Function Trainer-ORTe‚ĚŠáˆĘEŠá‹…‰^“ŽŒŸ¸‚Ě‘ź‹@Ží‚Ć‚ĚŒÝŠˇŤŒŸ“˘. ŒË’˘aŽq1, Îě@‹Ď2, ”ź“c’m–ç2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć71‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć40‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď (2015/7/3), •şŒÉ.

723762. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 3D Visual Function Trainer-ORTe‚̏ăŽÎ‹Ř–ƒáƒŠłŽŇ‚ւ̉ž—p. •Ű‰Č”üŠó1, Îě@‹Ď2, ŒăŠÖ—˜–ž1, ”ź“c’m–ç2, ŒË’˘aŽq1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć71‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć40‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď (2015/7/3), •şŒÉ.

723763. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Œ’íŽá”NŠá‚É‚¨‚Ż‚鍂ŽŸ”g–ĘŽűˇ‚Ć”N—î: ‘ć2•ń. Ö“Ą@Ę1, ˆÉ“Ą”üšŠG2, ěŽç“c‘ńŽu2, Îě@‹Ď2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć71‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć40‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď (2015/7/3), •şŒÉ.

723764. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ž‹ü‰đÍ‘•’u‚É‚ć‚鉓ŒŠE‹ßŒŠ‚Ĺ‚Ě•ĐŠáŽŐ•ÂŽž‚ĚŠáˆĘ‘Ş’č‚ĆAPCT‚Ĺ‚ĚŠáˆĘ‚Ě”äŠr. Žl”V‹{—C”n1, ‚‹´—RŽk1, –ěă‹Žu1, Vˆä“cF—T1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺ, 2Šá‰Č): ‘ć71‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć40‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď (2015/7/3), •şŒÉ.

723765. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Ž‹ü‰đÍ‘•’u‚đ—˜—p‚ľ‚˝—Z‘œœ‹ŽŠáˆĘ‘Ş’č‚É‚¨‚Ż‚éŽŐ•ÂŽžŠÔ‚ĚŒŸ“˘. ‚‹´—RŽk1, Žl”V‹{—C”n1, –ěă‹Žu1, Vˆä“cF—T1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺ, 2Šá‰Č): ‘ć71‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć40‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď (2015/7/3), •şŒÉ.

723766. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”]—ŔŒ‡‘šÇ‚ÉŽ—‚˝‚“x…“ޏǏǗá‚Ě—źŠáŽ‹‹@”\. –]ŒŽ_Žu1, Œ´@’źl1,2, “ŕŽRmŽu1, Ź’Ź—SŽq1, ’ËŒ´–ƒ—R‰Ŕ3, Ź–ě—˘‹KŽq3, Vˆä“cF—T1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺ, 2Šá‰Č, 3‘Űˆă—Ă•ŸŽƒ‘ĺ•a‰@): ‘ć71‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć40‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď (2015/7/3), •şŒÉ.

723767. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”ć‚ę–Ú, “Ş’É‚ĚŒ[”­‚É‚ć‚č—ˆ‰@‚ľ‚˝ŠłŽŇ‚ĚŽžŠł‚Ć‹üÜ‹¸ł‚̏d—vŤ. ŒN“‡^ƒ1, Œ´@’źl1,2,3, Žs糋`Í1,3, “ŕŽRmŽu2, ×’J—R‹IŽq1, Š—ś^—1, Œü–ě˜a—Y1,3 (1_“ސ쎕‘ĺE‰Ą•lƒNƒŠƒjƒbƒN, 2‘Űˆă—Ă•ŸŽƒ‘ĺEŽ‹‹@”\—Ă–@, 3Šá‰Č): ‘ć71‰ń“ú–{ŽăŽ‹ŽÎŽ‹Šw‰ď‘‰ď/‘ć40‰ń“ú–{ŹŽ™Šá‰ČŠw‰ď‘‰ď (2015/7/3), •şŒÉ.

723768. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ×‹ŰŤŠp–Œ‰ŠÇ—á‚É‚¨‚Ż‚é”N—î‘w•Ę‚Ě•Ş—Ł‹Ű‚Ć–ňÜŠ´ŽóŤ‚ĚŒŸ“˘. Žq“‡—Ç•˝1,2, ‹{•‰‘y‰î1, –ěŒű‚ä‚Š‚č1, ”Ş–Ř˛Žq1, Šâč‘ô–ç1, ‹{“c˜a“T1 (1‹{“cŠá‰Č, 2Šá‰Č): ‘ć52‰ń“ú–{ŠáŠ´őÇŠw‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/10), ‘ĺă.

723769. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Moraxella‘Ž‚É‚ć‚éŠp–Œ‰Š‚Ě‘˝Ž{Ý’˛¸. ˆäă‰p‹I1,2, —é–؁@’1,2, •ž•”‹M–ž2,3, Žq“‡—Ç•˝2,4,5, ŒËŠ‘ĺ•ă2,6, Ż@Ĺ’q2, ]Œű@—m2, ‘ĺ‹´—Tˆę1 (1ˆ¤•Q‘ĺ, 2OMIC working group, 3“Œ‹žˆă‘ĺ, 4‹{“cŠá‰Č, 5Šá‰Č, 6ŒQ”n‘ĺ): ‘ć52‰ń“ú–{ŠáŠ´őÇŠw‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/10), ‘ĺă.

723770. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œ‹–ŒůN“ŕ‚¨‚ć‚Ń•@o“ŕ‚ć‚č•Ş—Ł‚ł‚ę‚˝MRSE‚Ě“ŻˆęŤ‚ĚŒŸ“˘. â–{‘Ľ•q1, ´…Œö–ç1, ’†‘şłŽ÷2, –k—˘‰p˜Y2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć52‰ń“ú–{ŠáŠ´őÇŠw‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/11), ‘ĺă.

723771. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒPƒA1. ‰F’ĂŒŠ‹`ˆę1,2 (1‰F’ĂŒŠŠá‰Čˆă‰@, 2Šá‰Č): ‘ć58‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/11), ‘ĺă.

723772. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) MPSŽg—pŽŇ‚ĚƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYƒPƒAŽw“ą‚ĚŒř‰Ę‚ĆƒŒƒ“ƒYƒP[ƒX‚Ě×‹Ű”‚ĚŠÖŒW. “ŕŽRmŽu1, ŒĂěŽě‹I1, ‰Á“Ą@•‘1, —é–Řˆ¤”ü1, œAŁ^—R1, [’Ă—L‰Ŕ—˘1, ŒĂěŒb“Ţ1, ‰F’ĂŒŠ‹`ˆę2,3, Vˆä“cF—T1,3 (1‘•Ÿ‘压‹@”\, 2‰F’ĂŒŠŠá‰Čˆă‰@, 3Šá‰Č): ‘ć58‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/11), ‘ĺă.

723773. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •˝Ź26”N“x‰Ą•lŽs, “Ą‘ňŽs‚Ě’†‚ś‚ĚƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—pó‹ľ’˛¸. â–{‘Ľ•q1,2, ŽOˆäŒ’ł1, ‰F’ĂŒŠ‹`ˆę1,2, Ží“c–F˜Y1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ‘ć58‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/11), ‘ĺă.

723774. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •˝Ź26”N“x_“ŢěŒ§‚ĚŠwZ‚ĚƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—p’˛¸. ‰F’ĂŒŠ‹`ˆę1,2, â–{‘Ľ•q1,2, ŹŒű˜a‹v1, ‰Ş“c@—T1, ‰œ˜eŒŤˆę1,2, ‹ŕˆä@Œő1, Ź’r@Œ’1, Ží“c–F˜Y1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ‘ć58‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/11), ‘ĺă.

723775. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •˝Ź26”N“x_“ŢěŒ§‚ĚŠwZ‚ĚƒJƒ‰[ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—p’˛¸. ‰F’ĂŒŠ‹`ˆę1,2, â–{‘Ľ•q1,2, ŹŒű˜a‹v1, ‰Ş“c@—T1, ‰œ˜eŒŤˆę1,2, ‹ŕˆä@Œő1, Ź’r@Œ’1, Ží“c–F˜Y1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ‘ć58‰ń“ú–{ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŠw‰ď‘‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/11), ‘ĺă.

723776. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ťŠw—Ă–@‚â•úŽËü—Ă–@‚É‚ć‚é—Ü“šáŠQ‚É, —܊ǃ`ƒ…[ƒu‘}“ü‚đŽ{s‚ľ‚˝18—á‚ĚŒŸ“˘. ”–؍LĆ1,2, ˆŔˆä”ŽŽj3, ź‘ş˝ˆę˜Y4, ‘şŽRds5, {“c–ŤŽm6 (1Œ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[, 2Šá‰Č, 3Œ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[Á‰ÎŠí“ŕ‰Č, 4Œ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[“ű‘BŠO‰Č, 5Œ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[—zŽqüŽĄ—ÉČ, 6Œ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[“Şčň•”ŠO‰Č): ‘ć4‰ń“ú–{—Ü“šE—܉tŠw‰ď‘‰ď (ƒtƒH[ƒTƒ€2015‘ĺă) (2015/7/11), ‘ĺă.

723777. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒŠƒpƒXƒWƒ‹‰–Ž_‰–…˜a•¨“_Šá‰t‚Ş‘ÎŒő”˝ŽË‚¨‚ć‚Ń‹ßŒŠ”˝‰ž‚É‹y‚Ú‚ˇ‰e‹ż. ˛“Ą@Ži1, Îě@‹Ď2, ŒăŠÖ—˜–ž1, óě@ŒŤ2, ŽRŒű@ƒ1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć35‰ń“ú–{Šá–ň—Šw‰ď (2015/9/6), “Œ‹ž.

723778. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒgƒ‰ƒxƒNƒg[ƒ€Žčp‚ŞŠp–Œ“ŕ”ç×–E–§“x‚Ö‹y‚Ú‚ˇ‰e‹ż. Š}Œ´łs1, ŻŽiMs2, X“c“N–ç1, ź‘şˆęO1, ‰Í–ě—Y—ş1, –Ř‘ş“TŒh1, •ÄŽR@—Č1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/11), ˆ¤’m.

723779. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) OCTOPUS600Ž‹–ěŒv10-2‚ĆHumphreyŽ‹–ěŒv10-2‚Ě”äŠr. ‚‹´‰ÄŽŔ1, ˛“Ą@Ži1, ź‘şˆęO1, Š}Œ´łs1, •˝ŕVˆę–@2, ŻŽiMs2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/11), ˆ¤’m.

723780. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ž‹–ě‚ĚÄŒťŤ‚ĆŽ‹—Í‚ĚŠÖ˜A. ź‰YŤl1, •˝ŕVˆę–@2, ‘ş“c”ŽŽj1, ’Š‰Ş@—ş1 (1“Œ‹ž‘ĺ, 2ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/11), ˆ¤’m.

723781. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —ΓŕáŠá‚É‚¨‚Ż‚éFŽ‹—Í‘Ş’č‚ĚŒŸ“˘. ‘ĺ“ŕ‡Žq1, –ʍ‚@Žq1, ˛“Ą‚͂鍁1, ‘ĺ—˘“N–ç1, ˛“Ą—T”V1, ˆÉ“Ą@ˆ˛1, ‘ŠŕV“Ţ”żŽq1, “c’†–FŽ÷2, š •ű•FŽu1, Žsěˆę•v2,3, ’†ŕV@“O1 (1“Œ–k‘ĺ, 2’†‹žŠá‰Č, 3Šá‰Č): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/11), ˆ¤’m.

723782. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —Ž‹űÇŒóŒQ‚̐V‚ľ‚˘ˆâ“`ŽqˆŮíCACNA1A. ”öč•őś1, aŒűŽ‘Ľ2, ’†–ě‘Žq3, ^“çLˆę4, —с@@Œ¤4, •—ŠÔŹ‘×5, o“c—˛ˆę6, X@—mÄ7,8, ‹{“c˜a“T7, ™ŽR˜a‹v9, “Œo•ü–¤9, çŒ´‰x•v10, ˆäăŒŤŽĄ11, ÎŽq’qŽm12, ‹g“cW•q12, –ö@šG13, –Ř“ŕ—Ç–ž13, ‘ŠŒ´@ˆę14, ‘ĺ‹´@•×15, ŸNˆäŽő–ç16, ™–{‹MŽq17, ’†”nGŽ÷17, X@˜a•F18, ˆî’J@‘ĺ19, ‹v•Ű“c•qş3, ‹g‘ş’ˇ‹v20, Tin Aung21, Chiea Chuen Khor22 (1”öčŠá‰Č, 2aŒűŠá‰Č, 3‘ĺ•Ş‘ĺ, 4—ŃŠá‰Č•a‰@, 5VéŠá‰Čˆă‰@, 6o“cŠá‰Č•a‰@, 7‹{“cŠá‰Č•a‰@, 8Šá‰Č, 9‹ŕ‘ň‘ĺ, 10çŒ´Šá‰Č, 11ˆäăŠá‰Č•a‰@, 12ˆŽěˆă‘ĺ, 13L“‡‘ĺ, 14“Œ‹ž‘ĺ, 15‘ĺ‹´Šá‰Č, 16‘˝Ş‹L”OŠá‰Č•a‰@, 17‹{č‘ĺ, 18‹ž“s•{ˆă‘ĺ, 19•Ÿˆä‘ĺ, 20‹ž“s‘ĺ, 21Singapore National Eye Center, 22Genome Institute of Singapore): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/11), ˆ¤’m.

723783. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘˝Ü“_Šá•š—p—ΓŕáŠłŽŇ‚ɃŠƒpƒXƒWƒ‹‰–Ž_‰–…˜a•¨“_Šá–ň‚̒ljÁ“Š—^‚đ‚¨‚ą‚Č‚Á‚˝Ç—á‚ĚŠáˆł‰ş~Œř‰Ę. –Ř‘ş“TŒh1, ‰Í–ě—Y—ş1, Š}Œ´łs1, ź‘şˆęO1, ŻŽiMs2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/11), ˆ¤’m.

723784. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) łíŠáˆł—ΓŕáŠłŽŇ‚É‚¨‚Ż‚éƒGƒNƒXƒvƒŒƒX—ΓŕáŹŃ‚Ě’†ŠÔ•ń. Źa’Žj1, ‘ŠŒ´@ˆę2, ”’“yéĆ3, ‘ĺ’JLˆę˜Y4,5, o“c—˛ˆę6, ‹´–{‹`O7, ‹{“c˜a“T1 (1‹{“cŠá‰Č, 2“Œ‹ž‘ĺ, 3Žl’J‚ľ‚ç‚ĆŠá‰Č, 4Ž­Ž™“‡‹{“cŠá‰Č, 5Šá‰Č, 6o“cŠá‰Č, 7^ł‰ď•xŽR•a‰@): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/12), ˆ¤’m.

723785. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒŒŠÇVś—Γŕá‚É‚¨‚Ż‚éTrabeculectomy‚ĆEX-PRESSҕš—pŕh‰ßŽčp‚Ě”äŠr. ‰Í–ě—Y—ş1, ŻŽiMs2, ź‘şˆęO1, Š}Œ´łs1, –Ř‘ş“TŒh1, •ÄŽR@—Č1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/12), ˆ¤’m.

723786. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)yŔ’ˇz‰ć‘œ1. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/12), ˆ¤’m.

723787. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Šp–Œś‘Ě—ÍŠw“ÁŤ‚đl—ś‚É“ü‚ę‚˝2Ží‚ĚŠáˆłŒv‚ĚŠáˆł’l‚Ě”äŠr. ‹˝‰E‹ß”ŽN1, •˝ŕVˆę–@2, Š}Œ´łs1, ź‘şˆęO1, ŻŽiMs2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/12), ˆ¤’m.

723788. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹@”\“Iŕh‰ß–E‚đ—L‚ˇ‚銳ŽŇ‚É‚¨‚Ż‚錋–ŒíÝ×‹Ű‘p‚Ě“Á’Ľ. ‘ĺ’JLˆę˜Y1,2, ‘ŠŒ´@ˆę3, ó—˜˝Žu4, ”Ş–Ř˛Žq1, Źa’Žj1, Šâč‘ô–ç1, ‹{“c˜a“T1 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č, 3“Œ‹ž‘ĺ, 4‘ĺă‘ĺ): ‘ć26‰ń“ú–{—ΓŕáŠw‰ď (2015/9/12), ˆ¤’m.

723789. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”’“ŕáŽčp‘OŒă‚ĚŽ†FŽ‹—Í‚đ—p‚˘‚˝FŽ‹—Í‚Ě”äŠr‚ɂ‚˘‚Ä. ‰ĄŽR@ăÄ1, “c’†–FŽ÷2, ’†‘ş‰pŽ÷1, “c粏َq3, “´ˆä—ŠG3, ‰Á“ĄKm3, “c’†@´4, Žsěˆę•v2,5 (1’†‹ž•a‰@, 2’†‹žƒƒfƒBƒJƒ‹, 3’†‹žŠá‰Č, 4MB‘ĺŠwŠwpŒ¤‹†‰@HŠw•”, 5Šá‰Č): ‘ć54‰ń“ú–{”’“ŕáŠw‰ď‘‰ďE‘ć41‰ń…ť‘ĚŒ¤‹†‰ď (2015/9/18), ˆ¤’m.

723790. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ßÔŠO•ŞŒő–@‚đ—p‚˘‚˝VśŽ™‚Ě‘źŠo“IŽ‹‹@”\ŒŸ¸‚ĚŽŽ‚Ý (‘ć2•ń). Šâ“c@—y1, ’r“c“N–ç2, Îě@‹Ď3, ”ź“c’m–ç3, ´…Œö–ç2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Šá‰Č, 3ˆă—ÉqśŠw•”): ‘ć51‰ń“ú–{ŠáŒőŠwŠw‰ď‘‰ď (2015/9/26), ‰ŞŽR.

723791. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) 3ŽŸŒł¸–§…ť‘Ěƒ‚ƒfƒ‹‚đ—p‚˘‚˝’˛ß‚Ě—ÍŠwƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‰đÍ. ěŽç“c‘ńŽu1, ´…Œö–ç2 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć51‰ń“ú–{ŠáŒőŠwŠw‰ď‘‰ď (2015/9/26), ‰ŞŽR.

723792. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[‚É‚¨‚Ż‚é, ‚Ô‚Ç‚¤–ŒˆŤŤ•FŽî14—á‚Ě‘Š‡. ”–؍LĆ1,2, ´…Ë•v1, ‹gěŽü˛1, ˆÉ“ĄˆČ’m˜Y1, “n粗íŽq1, ’†ě‰ë—T1, ‘˝‹v‰ŔŹ3, {‰ęş•F4 (1Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[, 2Šá‰Č, 3Ă‰ŞŒ§—§•a‰@Žîᇓŕ‰Č, 4Ă‰ŞĎś‰ď•a‰@ŠÉ˜aˆă—ÉČ): ‘ć33‰ń“ú–{ŠáŽîᇊw‰ď (2015/10/3), “‡Ş.

723793. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Laser in situ keratomileusis‚Ćphotorefractive keratectomypŒă10”N‚ĚˆŔ’萍‚Ě”äŠr. X@—mÄ1,2, ”Ş–Ř—I•ă1, ”ö•ű”ü—R‹I1, Žq“‡—Ç•˝1,2, “ěŒcˆę˜Y1, _’J˜aF2, ‹{“c˜a“T1 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/22), ˆ¤’m.

723794. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Small Incision Lenticule Extraction (SMILE) ‚ĚƒGƒlƒ‹ƒM[Ĺ“K‰ť‚ĚŒŸ“˘. _’J˜aF1, ´…Œö–ç1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1 (1Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/22), ˆ¤’m.

723795. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠŃ’ʍE•t‚ŤŒă–[Œ^—L…ť‘ĚŠá“ŕƒŒƒ“ƒY‘}“üpŒă‚É‚¨‚Ż‚鎊Šo“I‘O•űŽU—‚Ě’č—Ę“IŒŸ“˘. ”Ń“‡ˆč‰Ă1, ´…Œö–ç1, ŽRŠÝ^‹|, Ź‹´‰p’ˇ1, ŒÜ\—’ÍŽj1, _’J˜aF1 (1Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/22), ˆ¤’m.

723796. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”’“ŕáŽčp—pƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚đ—p‚˘‚˝—Ž‹‹¸łp‚̏pŒă’ZŠúŹŃ. Žsě@Œc1, Ź“‡—˛Ži1, “´ˆä—ŠG2, ŽđˆäKO2, ‰Á“ĄKm2, ‚–Ř–ƒ—˘3, ‹Ę’u–ž–ě3, ’†‘ş‰pŽ÷3, Žsěˆę•v2,4 (1Šň•ŒÔ\Žš•a‰@, 2’†‹žŠá‰Č, 3’†‹ž•a‰@, 4Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/22), ˆ¤’m.

723797. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰~Šp–ŒŠá‚ĆƒtƒFƒ€ƒZƒJƒ“ƒhƒŒ[ƒU[‘S‘wŠp–ŒˆÚAŒă‰~Šp–ŒŠá‚ĚŽ‹‹@”\”äŠr. ŒÜ\—’ÍŽj1, _’J˜aF1, Ź‹´‰p’ˇ1, ´…Œö–ç1 (1Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/22), ˆ¤’m.

723798. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) LENSTAR@LS900‚̉ÁŽZˆ—‚É‚ć‚é‘Ş’č‰Â”\—Ś‚ƏpŒă‹üÜŒëˇ. –îƒm–Ú‹ž•˝1, ”Ń“c‰Ă•F1,2, ´…Œö–ç1 (1Šá‰Č, 2“Œ–źŒú–Ř•a‰@): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/22), ˆ¤’m.

723799. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˜A‘ą‰~Œ`Ř”XpŽž‚̐…ť‘Ě“Ž—h‚đŠî‚É‚ľ‚˝ƒ`ƒ“Ź‘ѐƎă’ö“x‚Ě•Ş—Ţ‚đp’†ŠŒŠ. ’JŒűd—Y1, Ź‘ň’‰•F1, “c’†—Tˆę˜N1, –ŘŒ´^ˆę1, ‘ĺ’Î’qG1,2, Œă“Ą—m•˝1, —é–ؐçt1, Ž›č@Ę1, ”ˇ–{@É1 (1Ź‘ňŠá‰Č“ŕ‰Č•a‰@, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/22), ˆ¤’m.

723800. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŽüpŠú‚É‚¨‚Ż‚éR‹Ű“_Šá–ň‚ĚŒ‹–ŒůNíÝ‹Ű‚ɑ΂ˇ‚éŒoŽž“I‰e‹ż. Žq“‡—Ç•˝1,2, X@—mÄ1,2, ‹{•‰‘y‰î1, —ŃŽ›@Œ’1, Źa’Žj1, ŠL“c’qŽq1, –ěŒű‚ä‚Š‚č1, ”Ş–Ř˛Žq1, ‹{“c˜a“T1 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/22), ˆ¤’m.

723801. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œ’íŽŇ‚ĚRAPDx_‘Ş’čŒ‹‰Ę‚É‚¨‚Ż‚鐍•ĘE”N—î‚̉e‹ż‚ĆŠî€’l‚ĚŒŸ“˘. ˛“Ą@Ži1, ŒăŠÖ—˜–ž1, óě@ŒŤ2, Îě@‹Ď2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

723802. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) GoldmannŽ‹–ě‚É‚¨‚Ż‚éŽŔ‘ŞIII-4e‚Ɛ„‘ŞIII-4e‚đ—p‚˘‚˝Functional Field Score‚Ě”äŠr. –öŕV”üˆßŽq1,2, ‰Á“Ą@‘1, Ź—Ń‚ß‚Ž‚Ý1, –kŕV–œ—˘Žq1, —Ž‡áÁ‹IŽq1 (1“Œ‹ž‘ĺ, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

723803. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽOŽŸŒł‰ć‘œ‚đŽg—p‚ľ‚˝ƒqƒg…ť‘Ě‚Ě‘ĚĎ‘Ş’č. ”n“ˆ´”@1, Žsě@Œc2, ŽđˆäKO3, “ŕ“ĄŽ‹v3, ˆé’JŽ‹P4, •Đ‰Ş“”Ž4, ’†‘ş—Fş4, Žsěˆę•v3,5 (1–žŠá‰@, 2Šň•ŒÔ\Žš•a‰@, 3’†‹žŠá‰Č, 4–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 5Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

723804. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) p‘O‹¸łŽ‹—͗ǍD—á‚É‚¨‚Ż‚é”’“ŕáŽčpÇ—á‚Ě”wŒiˆöŽq‚ĚŒŸ“˘. ŠFě—FŒ›1, ´…Œö–ç1, ˛“ĄM”V1, ”Ń“c‰Ă•F1 (1Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

723805. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘˝Ĺ“_Šá“ŕƒŒƒ“ƒYŒđŠˇÇ—á‚Ě”wŒiˆöŽq‚ĚŒŸ“˘. Î“c@‹Ĺ1, ´…Œö–ç1, ”Ń“c‰Ă•F1, ˆÉ“Ą”üšŠG2 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

723806. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šá“ŕƒŒƒ“ƒY‚É‚ć‚郂ƒmƒrƒWƒ‡ƒ“–@‚Ě—źŠáŽ‹‹@”\‚ĚŒŸ“˘. ˆÉ“Ą”üšŠG1, ´…Œö–ç2, ”Ń“c‰Ă•F2, ěŽç“c‘ńŽu1, ŻŽiMs1 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

723807. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) isŤ‰~Šp–ŒÇ—á‚É‚¨‚Ż‚éŠp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO‘OŒă‚ĚŠp–Œ‚̐ś‘Ě—ÍŠw“ÁŤ‚̕ωť. Ź“‡—˛Ži1,2, ź“c’m–ç2, ’†‘ş—Fş2, Žsěˆę•v3,4 (1Šň•ŒÔ\Žš•a‰@, 2–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 3’†‹žŠá‰Č, 4Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

723808. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽĄ—Ă’ďRŤ‚ĚŠ´őŤŠp–Œ’×ᇂɑ΂ľ‚ÄŠp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO•š—p‚Ş’˜Œř‚ľ‚˝ˆę—á. ‰Í–ě—Y—ş1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1, ´…Œö–ç1 (1Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/23), ˆ¤’m.

723809. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œ’íŽŇ‚É‚¨‚Ż‚éƒuƒŠƒ‚ƒjƒWƒ““_Šá‘OŒă‚Ě‹üÜE“ľEŒa•Ď‰ť. ‰Á“ĄŽŃ–1, _’J˜aF1, ŒÜ\—’ÍŽj1, Ź‹´‰p’ˇ1, ´…Œö–ç1 (1Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723810. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹üÜ‹¸łŽčpŒă‚Ě–éŠÔƒOƒŒƒAEƒnƒ[‚ɑ΂ˇ‚éƒuƒŠƒ‚ƒjƒWƒ““_ŠáŒř‰Ę‚ĚŒŸ“˘. ˆŔ“Ą˜a‰ĚŽq1, _’J˜aF1, ŒÜ\—’ÍŽj1, ´…Œö–ç1 (1Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723811. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’ˇ[“x‘OŠá•”ŒőŠąÂ’f‘wŒv‚đ—p‚˘‚˝–Ń—laŠÔ‹——Ł‚Ě’źÚŒv‘Ş‚Ć—\‘ވöŽq‚ĚŒŸ“˘. ‚‹´ł‰p1,2, ˛“ĄM”V3, Ź‹´‰p’ˇ3, ŒÜ\—’ÍŽj3, _’J˜aF3, ´…Œö–ç3 (1ŽR‰¤•a‰@, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723812. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) íőF‘Ě—DŤŽ‹_ŒoˆŢk‹^‚˘—á‚É‚¨‚Ż‚éOPA1ˆâ“`Žq•ĎˆŮ. “ĄŠŞ‘ń˜Y1, –öě@ˆ¤1, ‚@@’O1, Vˆä‰p‰î1, Šâ“c•ś”T1,2, ’†’J@’q1, ˆî’J@‘ĺ3, A–Ř’qŽu4, ]–{”Ž•ś5, ŸŠC@C6, ŽO‘ş@ŽĄ7, Žá‘q‰ë“o6,8, ‘şă@ť1 (1‡“V‘ĺ, 2‚˘‚í‚˝Šá‰Č, 3•Ÿˆä‘ĺ, 4VŠƒ‘ĺ, 5ˆă‰ČŽ•‰Č‘ĺ, 6ˆäăŠá‰Č•a‰@, 7•şŒÉ‘ĺ, 8Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723813. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘S‘wŠp–ŒˆÚAŒă‚É‚¨‚Ż‚éŽU—‚ĆŽűˇ‚ŞŽ‹‹@”\‚É‹y‚Ú‚ˇ‰e‹ż. Ź‹´‰p’ˇ1, _’J˜aF1, ŒÜ\—’ÍŽj1, ´…Œö–ç1 (1Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723814. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘S‘wŠp–ŒˆÚAp‚ĆŠp–Œ“ŕ”çˆÚAp‚É‚¨‚Ż‚épŒă’ˇŠú‚ĚŽ‹‹@”\‚Ě”äŠr. ‹{•‰‘y‰î1, “ż—Żr•F1, —с@Ž›Œ’1, X@—mÄ1,2, Žq“‡—Ç•˝1,2, ‹{“c˜a“T1 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723815. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)yŔ’ˇz—Γŕá: Žčp1. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723816. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[)yŔ’ˇz‹üÜ‹¸łEŽ‹‹@”\2. _’J˜aF (Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723817. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) SMILEŽčp‚É‚¨‚Ż‚éŠp–ŒŒă–ʕωť‚ɂ‚˘‚Ä. ‹g“c—zŽq1, ’†‘ş—Fş1, •Đ‰Ş“”Ž1, •Đ‰Ş–ƒ—R1, ˆé’JŽ‹P1, Ź“‡—˛Ži1,2,3, Žsěˆę•v3,4 (1–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 2Šň•ŒÔ\Žš•a‰@, 3’†‹ž•a‰@, 4Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723818. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) —Ź‘Ě—ÍŠw‰đÍ‚đ—p‚˘‚˝Hole ICL‚Ě–[…“Ž‘Ô‚ŞŠp–Œ“ŕ”ç‚É—^‚Ś‚é‰e‹ż. ěŽç“c‘ńŽu1, ´…Œö–ç2, ˆÉ“Ą”üšŠG1, ŻŽiMs1 (1ˆă—ÉqśŠw•”, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723819. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Accu-Temp_‚É‚ć‚錋–Œ’oŠÉÇŽčp. ’†ź@Šî1,2, _’J˜aF1, ´…Œö–ç1 (1Šá‰Č, 2•‘ –ěÔ\Žš•a‰@): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723820. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠÔŸ[ŤŠOŽÎŽ‹‚̐łˆĘ‰ť‚É”ş‚¤çt–Š, ’˛ß•Ď‰ť|ŽÎˆĘ‹ßŽ‹‚Ě—L–ł‚Ĺ‚Ě”äŠr|. ĺŒ´Žľd1, Îě@‹Ď1, ŒăŠÖ—˜–ž2, ’r“c“N–ç2, —´ˆä‰‘Žq3, ´…Œö–ç2 (1ˆă—ÉqśŠw•”, 2Šá‰Č, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723821. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒ^ƒuƒŒƒbƒgŒ^Ž‹”\ŒP—ű‘•’uOcclu-pad҂đ—p‚˘‚˝ŽăŽ‹ŒP—űŒř‰Ę. ŒË’ˁ@Œĺ1, ”ź“c’m–ç2, Îě@‹Ď2, ŻŽiMs2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723822. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) –k—˘‘ĺŠw•a‰@‚Ć‚ť‚ĚŠÖ˜A•a‰@‚É‚¨‚Ż‚é–˘nŽ™–Ô–ŒÇf—Ă‚ĚŒťó. ’r“c“N–ç1, ´…Œö–ç1, —´ˆä‰‘Žq2, Î“c@‹Ĺ1, ŒăŠÖ—˜–ž1, Îě@‹Ď3 (1Šá‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723823. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) RAQP4R‘Ě—zŤŽ‹_Œo‰Š‚Ě”­ÇŽžŠú‚¨‚Ż‚é‹Gß“I•Ď“Ž‚ĚŒŸ“˘. ŽRă–žŽq1,2, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723824. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‹}Ťœ‘Ť”’ŒŒ•aœ‘Š°‰đŠú‚ɍĔ­‚đŒJ‚č•Ô‚ľ‚˝ZŤŽ‹_ŒoÇ‚Ě1—á. ’ră–őŽq1, “c’†rˆę1,2, ‚‹´”üK1,2, ‚–ě–í“Ţ1 (1•‘ –ěÔ\Žš•a‰@, 2Šá‰Č): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/24), ˆ¤’m.

723825. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —ΓŕáŠłŽŇ‚ĚQOL‚̕“I•]‰ż‹y‚ŃQOL‚ɉe‹ż‚đ—^‚Ś‚éˆöŽq‚ĚŒŸ“˘. •˝ŕV—T‘ă1, ź‰YŤl1, •˝ŕVˆę–@1,2, ‘ş“c”ŽŽj1, ŠÔŽRçq1, ’Š‰Ş@—ş1 (1“Œ‹ž‘ĺ, 2ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/25), ˆ¤’m.

723826. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —ΓŕáŠłŽŇ‚ĚQOL‚̕“I•]‰ż‚Ě‚˝‚ß‚Ěitem bank‚̍쐬. •˝ŕVˆę–@1,2, ź‰YŤl1, •˝ŕV—T‘ă1, ‘ş“c”ŽŽj1, ŠÔŽRçq1, ’Š‰Ş@—ş1 (1“Œ‹ž‘ĺ, 2ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/25), ˆ¤’m.

723827. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —Ž‹űÇŒóŒQ‚É‚¨‚Ż‚éLOXL1ˆâ“`ŽqˆŮí‚Ě“ÁŽęŤ. ”öč•őś1, aŒűŽ‘Ľ2, ’†–ě‘Žq3, ^“çLˆę4, —с@@Œ¤4, •—ŠÔŹ‘×5, o“c—˛ˆę6, X@—mÄ7,8, ‹{“c˜a“T7, ™ŽR˜a‹v9, “Œo•ü–¤9, çŒ´‰x•v10, ˆäăŒŤŽĄ11, ÎŽq’qŽm12, ‹g“cW•q12, –ö@šG13, –Ř“ŕ—Ç–ž13, ‘ŠŒ´@ˆę14, ‘ĺ‹´@•×15, ŸNˆäŽő–ç16, ™–{‹MŽq17, ’†”nGŽ÷17, X@˜a•F18, ˆî’J@‘ĺ19, ‹v•Ű“c•qş3, ‹g‘ş’ˇ‹v20, Tin Aung21, Chiea Chuen-Khor22 (1”öčŠá‰Č, 2aŒűŠá‰Č, 3‘ĺ•Ş‘ĺ, 4—ŃŠá‰Č•a‰@, 5VéŠá‰Čˆă‰@, 6o“cŠá‰Č•a‰@, 7‹{“cŠá‰Č•a‰@, 8Šá‰Č, 9‹ŕ‘ň‘ĺ, 10çŒ´Šá‰Č, 11ˆäăŠá‰Č•a‰@, 12ˆŽěˆă‘ĺ, 13L“‡‘ĺ, 14“Œ‹ž‘ĺ, 15‘ĺ‹´Šá‰Č, 16‘˝Ş‹L”OŠá‰Č•a‰@, 17‹{č‘ĺ, 18‹ž“s•{ˆă‘ĺ, 19•Ÿˆä‘ĺ, 20‹ž“s‘ĺ, 21Singapore Nat Eye Ctr, 22Genome Inst of Singapore): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/25), ˆ¤’m.

723828. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)yŔ’ˇz_ŒoŠá‰Č. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/25), ˆ¤’m.

723829. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”]Ň‘‰tŒ¸­Ç‚Ě‘śÝ‚Ş”ť–ž‚ľ‚˝“Şčň•”ŠOŒă‚ĚŠáÇó‚ĚŒŸ“˘. Vˆä‚ä‚č‚ 1, ŽRă–žŽq1,2, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2, ‚‹´_ˆę3 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č, 3ŽR‰¤•a‰@): ‘ć69‰ń“ú–{—Տ°Šá‰ČŠw‰ď (2015/10/25), ˆ¤’m.

723830. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —⊴Ü‚Ě—L–ł‚É‚ć‚éŠáŽüˆÍ‰ˇăŞ–@‚ŞŽ‹‹@”\‚â”]Šˆ“Ž‚É—^‚Ś‚é‰e‹ż. “‡“c—TŽq1, ”ѐXŘŒŽ1, ˆäŠ_’ʐl1, Šâ“c@—y2, óě@ŒŤ3, Îě@‹Ď3 (1‰Ô‰¤Š”ŽŽ‰ďŽĐƒp[ƒ\ƒiƒ‹ƒwƒ‹ƒXƒPƒAŒ¤‹†Š, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć68‰ń“ú–{ŽŠ—Ľ_ŒoŠw‰ď‘‰ď (2015/10/30), ˆ¤’m.

723831. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒQ[ƒ€‹@Ší‚ދߌŠ”˝‰ž‚É—^‚Ś‚é‰e‹ż. ‘ž“c@—¤1, Œ´@’źl2,3, Œü–ě˜a—Y3,4 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw‘ĺŠw‰@, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 3Šá‰Č, 4_“ސ쎕‰Č‘ĺŠw•t‘Ž‰Ą•lƒNƒŠƒjƒbƒN): ‘ć68‰ń“ú–{ŽŠ—Ľ_ŒoŠw‰ď‘‰ď (2015/10/30), ˆ¤’m.

723832. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)yŔ’ˇzˆę”ʍu‰‰I. Žsěˆę•v1,2 (1’†‹žŠá‰Č, 2Šá‰Č): ‘ć57‰ń“ú–{ŽY‹ĆE˜J“­EŒđ’ĘŠá‰ČŠw‰ď (2015/10/31), ’ˇ–ě.

723833. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —ôEŒ´Ť–Ô–Œ”—Ł‚ɑ΂ˇ‚éŠá“ŕ“ŕŽ‹‹ž‚đ•š—p‚ľ‚˝ŹŘŠJÉŽq‘ĚŽčp‚̐ŹŃ. ‰ĄŽR@ăÄ1, ‰Á‰ę’BŽu1,2, X@r’j3, ź“c‘וă1, ˛”Œ’‰Ž’˜N1, ˛“Ą—T”V3, ‹g“c‘Ľ•F4, ™‰Ş—EŠó1, ’šˆärŠó1, Žsěˆę•v2,5 (1’†‹ž•a‰@, 2Šá‰Č, 3”Ń“cŽs—§•a‰@, 4Šň•ŒÔ\Žš•a‰@, 5’†‹žŠá‰Č): ‘ć57‰ń“ú–{ŽY‹ĆE˜J“­EŒđ’ĘŠá‰ČŠw‰ď (2015/10/31), ’ˇ–ě.

723834. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) dS“Ž—hŒvUM-BAR II‚đ—p‚˘‚˝ÄŒťŤ‚ĚŒŸ“˘. ‹ŕŕVłŒp1, óě@ŒŤ2, ěŽç“c‘ńŽu2, ‹›—˘@”Ž3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3‘ĺălŠÔ‰ČŠw‘ĺŠw): ‘ć57‰ń“ú–{ŽY‹ĆE˜J“­EŒđ’ĘŠá‰ČŠw‰ď (2015/10/31), ’ˇ–ě.

723835. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) 3Œ^3FŠo‚đ—p‚˘‚˝‚—îŽŇFŠoÄŒť–@‚ĚŒŸ“˘. “B‹{@I1, “c’†–FŽ÷2, “c’†@´1, ‰ĄŽR@ăÄ3, ’†‘ş‰pŽ÷3, Žsěˆę•v2,4, “c粏َq2 (1MB‘ĺŠw, 2’†‹žŠá‰Č, 3’†‹ž•a‰@, 4Šá‰Č): ‘ć57‰ń“ú–{ŽY‹ĆE˜J“­EŒđ’ĘŠá‰ČŠw‰ď (2015/10/31), ’ˇ–ě.

723836. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)yŔ’ˇzŠáâ|EŽîᇑź. ŽRă–žŽq1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/6), é‹Ę.

723837. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰)yŔ’ˇz‚ŽŸŽ‹‹@”\E“ľEEŒŸ¸. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/6), é‹Ę.

723838. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŹŽ™•Đ“Ş’É‚Ě’˛ß‹@”\áŠQ‚Š‚ç‚Ý‚˝Ž‹Šo•a‘Ԑś—‚̍lŽ@. Œ´@’źl1,2, ŒN“‡^ƒ3, Š—ś^—4, —é–Ř—T”ü2,3, Žs糋`Í2,3, Vˆä“cF—T1,2, Œü–ě˜a—Y2,3, ŒÜ\—’‹v‰Ŕ4 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw, 2Šá‰Č, 3_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 4•xŽm’ĘƒNƒŠƒjƒbƒN“Ş’ÉŠO—ˆ): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/6), é‹Ę.

723839. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 㵖žŠłŽŇ‚É‚Ý‚ç‚ę‚˝Ž‹°‚Ć‘Ńó‰ń‚Ě”]“œ‘ăŽÓ˜´i. —é–؍K‹v1,2,3, ´ŕVŒšO2,4, Žá‘q‰ë“o5,6, Î“nŠěˆę3, ‘ĺ–ě‹žŽq2, ÎˆäŒŤ“ń3 (1ŽO“‡‘‡•a‰@, 2“Œ‹žˆă‰ČŽ•‰Č‘ĺŠw, 3“Œ‹ž“sŒ’N’ˇŽőˆă—ĂƒZƒ“ƒ^[_Œo‰ć‘œŒ¤‹†ƒ`[ƒ€, 4´ŕVŠá‰Čˆă‰@, 5ˆäăŠá‰Č•a‰@, 6Šá‰Č): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/6), é‹Ę.

723840. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘˝”­Ťd‰ťÇ‚ĆŽ‹_ŒoŇ‘‰Š‚É‚¨‚Ż‚鉊”Á•”–Ô–Œ“ŕ‘wŒú‚Ě”äŠrŒŸ“˘. Ź–ě—˘‹KŽq1, Œ´@’źl1,2,3, “cě’ŠŽq1, ’ËŒ´–ƒ—R‰Ŕ1, …—Ź’‰•F1, X@Œ\‰î1, Vˆä“cF—T1,2,3 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw•a‰@, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠw•ŰŒ’ˆă—ĂŠw•”Ž‹‹@”\—Ă–@Šw‰Č, 3Šá‰Č): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/6), é‹Ę.

723841. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) •s“ŻŽ‹ŽăŽ‹‚É‚¨‚Ż‚é“ľE”˝ŽË‚̍ś‰Eˇ. ŒË’ˁ@Œĺ1, Îě@‹Ď2, ŒăŠÖ—˜–ž1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/6), é‹Ę.

723842. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒ^ƒuƒŒƒbƒgŒ^Ž‹‹@”\ŒŸ¸ŒP—űŠíOcclu-Pad‚ĚŽ‹Šo–ě‚ɑ΂ˇ‚éŒř‰ĘŒŸŘ. Šâ“c@—y1, Îě@‹Ď2, ”ź“c’m–ç2, ´…Œö–ç3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3Šá‰Č): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/6), é‹Ę.

723843. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “ŞˆĘ•ĎŠˇ‚É”ş‚¤Šááىş‚‚Ěˆę—á. ”Ń“‡@ˆť1, ŒăŠÖ—˜–ž1, Îě@‹Ď2, ´…Œö–ç1, ‹v{”ü^—3 (1Šá‰Č, 2ˆă—ÉqśŠw•”, 3”]ŠO): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/6), é‹Ę.

723844. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ž‹_ŒoŽžŠł‚É‚¨‚Ż‚éRAPDx҂đ—p‚˘‚˝‘Š‘ΓI“ľE‹S˜HáŠQ‚¨‚ć‚Ń‘ÎŒő”˝ŽË‚Ě•]‰ż. ˛“Ą@Ži1, ŒăŠÖ—˜–ž1, Îě@‹Ď2, óě@ŒŤ2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/6), é‹Ę.

723845. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œ‹–Œ—ôŒă–ü’…‚É‚ć‚éŠO“]áŠQ‚Ě1—á. ŽRă–žŽq1,2, ‰–ě”ü“ŢŽq1, Šâ˛^‹|1, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/7), é‹Ę.

723846. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œ´ˆö•s–ž‚ĚŽ‹_ŒoˆŢk‚Ĺƒ~ƒgƒRƒ“ƒhƒŠƒADNA•ĎˆŮ‚đ”F‚ß‚˝ŹŽ™‚Ě1—á. Šâ˛^‹|1, Vˆä‚ä‚č‚ 1, ŽRă–žŽq1,2, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/7), é‹Ę.

723847. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒŒ[ƒxƒ‹ˆâ“`ŤŽ‹_ŒoÇ‚̐V‹K”­ÇŽŇ”‚ÉŠÖ‚ˇ‚é‰uŠw’˛¸. ă“cD1, X›‰—SŠî2, ”’_Žj—Y2, •~“‡ŒhŒĺ3, Îě@‹Ď4, Žá‘q‰ë“o5,6, ’†‘ş@˝1 (1_ŒË‘ĺŠw, 2‰ŞŽR‘ĺŠw, 3“Œ‹žŽœŒbˆă‰Č‘ĺŠw, 4ˆă—ÉqśŠw•”, 5ˆäăŠá‰Č•a‰@, 6Šá‰Č): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/7), é‹Ę.

723848. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”ń“TŒ^“I‚Č“Ž–Ź‰ŠŤ‹•ŒŒŤŽ‹_ŒoÇ‚Ě2—á. ŠL“c’qŽq1, ‰Ô’J~Žq2, ’†‘şƒ„ƒXŽq2, ’†Œ´ł˛1, ‘ĺ’JLˆę˜Y2,3, ‹{“c˜a“T1, ’†”nGŽ÷4 (1‹{“cŠá‰Č•a‰@, 2Ž­Ž™“‡‹{“cŠá‰Č, 3Šá‰Č, 4‹{č‘ĺŠw): ‘ć53‰ń“ú–{_ŒoŠá‰ČŠw‰ď‘‰ď (2015/11/7), é‹Ę.

723849. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹łˆçEƒ[ƒrƒWƒ‡ƒ“E”­’B. ”ź“c’m–ç1, Vˆäç‰ęŽq (1ˆă—ÉqśŠw•”): ‘ć56‰ń“ú–{Ž‹”\‹¸łŠw‰ď (2015/11/7), “Œ‹ž.

723850. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŒĹŽ‹–Ú•W‚Ě‘ĺ‚Ť‚ł‚Ěˆá‚˘‚É‚ć‚鎋–ěŒŸ¸’†‚ĚŽ‹ü“Ž—h. •˝ŕVˆę–@1, ‰Ş–ě‰ÄŘ, ‰z’n—šŽq, M–ŘŽáŘ, ŻŽiMs1 (1ˆă—ÉqśŠw•”): ‘ć56‰ń“ú–{Ž‹”\‹¸łŠw‰ď (2015/11/7-8), “Œ‹ž.

723851. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŻóÉŽq‘ĚÇ‚É‚¨‚Ż‚éÉŽq‘ĚŽčp‘OŒă‚̐FŽ‹—͂̕ωť. ‰ĄŽR@ăÄ1, ‰Á‰ę’BŽu1,2, ‹g“c‘Ľ•F3, ˛“Ą—T”V4, ź“c‘וă1, X@r’j4, ™‰Ş—EŠó1, “c’†–FŽ÷5, “c’†@´6, Žsěˆę•v2,7 (1’†‹ž•a‰@, 2Šá‰Č, 3Šň•ŒÔ\Žš•a‰@, 4”Ń“cŽs—§•a‰@, 5Š”ŽŽ‰ďŽĐ’†‹žƒƒfƒBƒJƒ‹, 6MB‘ĺEHŠw•”, 7’†‹žŠá‰Č): ‘ć54‰ń“ú–{–Ô–ŒÉŽq‘ĚŠw‰ď‘‰ďE‘ć32‰ń“ú–{ŠázŠÂŠw‰ď‡“ŻŠw‰ď (2015/12/5), “Œ‹ž.

723852. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) FC-304&FL-301 (VŒ^“ŕŽ‹‹ž) ‚ĆFT203F (‹ŒŒ^) ‚Ě—Ő°‚É‚¨‚Ż‚é”äŠr. ‰Á‰ę’BŽu1,2, ‹g“c‘Ľ•F3, ˛“Ą—T”V4, ź“c‘וă1, ‰ĄŽR@ăÄ1, X@r’j4 (1’†‹ž•a‰@, 2Šá‰Č, 3Šň•ŒÔ\Žš•a‰@, 4”Ń“cŽs—§•a‰@): ‘ć54‰ń“ú–{–Ô–ŒÉŽq‘ĚŠw‰ď‘‰ďE‘ć32‰ń“ú–{ŠázŠÂŠw‰ď‡“ŻŠw‰ď (2015/12/5), “Œ‹ž.

723853. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ó‹C’uŠˇ‰ş‚Ě“ŕŽ‹‹žŽčpŽž‚É”­ś‚ˇ‚鎋”FŤ’ቺ‚ĚŒ´ˆö‚Ć‘Îô. ź“c‘וă1, ‰Á‰ę’BŽu1,2, Žsěˆę•v2,3, ‹g“c‘Ľ•F4, ˛“Ą—T”V5, ‰ĄŽR@ăÄ1, X@r’j5, “ˆ@çq3 (1’†‹ž•a‰@, 2Šá‰Č, 3’†‹žŠá‰Č, 4Šň•ŒÔ\Žš•a‰@, 5”Ń“cŽs—§•a‰@): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/29), •Ÿ‰Ş.

723854. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šp–Œ“ŕ”ç×–E–§“xŒ¸­—á‚É‚¨‚Ż‚é”’“ŕáŽčp‚̐ŹŃ. ‹{•‰‘y‰î1, X@—mÄ1,2, Ź–ě@‹Ş1, ”ö•ű”ü—R‹I1, ‹{“c˜a“T1 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/30), •Ÿ‰Ş.

723855. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰Š”Á‰şŒŒŽî‚ɑ΂ˇ‚é–Ô–Œ‰ş“ŕŽ‹‹žŽčp. ‰Á‰ę’BŽu1,2, ‹g“c‘Ľ•F3, ˛“Ą—T”V4, ź“c‘וă1, ‰ĄŽR@ăÄ1, X@r’j4, Žsěˆę•v2,5 (1’†‹ž•a‰@, 2Šá‰Č, 3Šň•ŒÔ\Žš•a‰@, 4”Ń“cŽs—§•a‰@, 5’†‹žŠá‰Č): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/30), •Ÿ‰Ş.

723856. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –ŤŠú–Ô–ŒĂ–Ź•ŞŽ}•ÂÇÇ‚̉Š”Á•‚Žî‚ɑ΂ˇ‚éƒiƒrƒQ[ƒVƒ‡ƒ“ƒŒ[ƒU[‚ĚŒř‰Ę‚ĚŒŸ“˘. ˛“Ą—T”V1, ‰Á‰ę’BŽu2,3, Žsěˆę•v3,4, ‹g“c‘Ľ•F5, ‰ĄŽR@ăÄ2, X@r’j1, ź“c‘וă2, “ŕ“ĄŽ‹v4 (1”Ń“cŽs—§•a‰@, 2’†‹ž•a‰@, 3Šá‰Č, 4’†‹žŠá‰Č, 5Šň•ŒÔ\Žš•a‰@): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/30), •Ÿ‰Ş.

723857. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘OůNŘŠJ’źŒă‚ƏpI—š’ź‘O‚Ě‘OůNŘŠJ‘‹‚Ě”äŠr. ”n“ˆ´”@1, Žsě@Œc2, ŽđˆäKO3, “ŕ“ĄŽ‹v3, ˆé’JŽ‹P4, •Đ‰Ş“”Ž4, ’†‘ş—Fş4, Žsěˆę•v3,5 (1Šá‰Č–žŠá‰@, 2Šň•ŒÔ\Žš•a‰@, 3’†‹žŠá‰Č, 4–źŒĂ‰ŽƒAƒCƒNƒŠƒjƒbƒN, 5Šá‰Č): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/30), •Ÿ‰Ş.

723858. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[”’“ŕáŽčp‚Ć’Ęí‚Ě”’“ŕáŽčp‚̏pŒăŽä‹NŠp–Œ—Ž‹‚Ě”äŠr. Žsě@Œc1, Ź“‡—˛Ži1, “´ˆä—ŠG2, ŽđˆäKO2, ‰Á“ĄKm2, ‚–Ř–ƒ—˘3, ‹Ę’u–ž–ě3, Žsěˆę•v2,4 (1Šň•ŒÔ\Žš•a‰@, 2’†‹žŠá‰Č, 3’†‹ž•a‰@, 4Šá‰Č): ‘ć39‰ń“ú–{Šá‰ČŽčpŠw‰ďŠwp‘‰ď (2016/1/30), •Ÿ‰Ş.

723859. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) č÷—ąóŠp–Œ•ĎŤ‚É‚¨‚Ż‚é‘O•űEŒă•űŽU—‚¨‚ć‚ŃŽűˇ‚ŞŽ‹‹@”\‚É‹y‚Ú‚ˇ‰e‹ż‚ĚŒŸ“˘. _’J˜aF1, Ź‹´‰p’ˇ1, ŒÜ\—’ÍŽj1, ´…Œö–ç1 (1Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18), ’ˇ–ě.

723860. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —܉tbreak pattern‚Ě–Ô—…“I‰đÍ. ’†ź@Šî1,2, ––œA@~3, ŒÜ\—’ÍŽj1, _’J˜aF1, ´…Œö–ç1 (1Šá‰Č, 2•‘ –ěÔ\Žš•a‰@, 3ƒgƒvƒRƒ“): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/20), ’ˇ–ě.

723861. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) …ávŤŠp–ŒÇ‚ɑ΂ˇ‚éŠp–ŒƒNƒƒXƒŠƒ“ƒLƒ“ƒO‚ĚŒř‰Ę‚Ě’ˇŠú“IŒŸ“˘. Ź–ě@‹Ş1, Ž›“c—T‹IŽq2, X@—mÄ1,3, Žq“‡—Ç•˝1,3, ”ö•ű”ü—R‹I1, “ěŒcˆę˜Y1, ‹{“c˜a“T1 (1‹{“cŠá‰Č•a‰@, 2“Œ‹ž“sŒ’N’ˇŽőˆă—ĂƒZƒ“ƒ^[, 3Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18-20), ’ˇ–ě.

723862. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Šp–ŒˆÚA•Đ•s‘S—á‚ɑ΂ˇ‚éBoston keratoprosthesis‚Ć‘S‘wŠp–ŒˆÚAp‚̏pŒăŹŃ”äŠr. —ŃŽ›@Œ’1, “ż—Żr•F1, Ź–ě@‹Ş1, ‹{•‰‘y‰î1, Žq“‡—Ç•˝1,2, X@—mÄ1,2, ‹{“c˜a“T1 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18-20), ’ˇ–ě.

723863. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Šp–Œ“ŕ”çˆÚApŒă‚ĚŽűˇEŽU—‚ŞŽ‹‹@”\‚É‹y‚Ú‚ˇ‰e‹ż‚ĚŒŸ“˘. ˆŔ—˘@“ľ1,2, ŒÜ\—’ÍŽj2, Ź‹´‰p’ˇ2, _’J˜aF2, —é–؉ëM1,2, ´…Œö–ç2 (1‘Űˆă—Ă•ŸŽƒ‘ĺ, 2Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18-20), ’ˇ–ě.

723864. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘S‘wŠp–ŒˆÚApŒăƒhƒ‰ƒCƒAƒC‚É‚¨‚Ż‚郌ƒoƒ~ƒsƒgEƒWƒNƒAƒzƒ\ƒ‹ƒiƒgƒŠƒEƒ€“_ŠáŒř‰Ę”äŠr. Ź‹´‰p’ˇ1, _’J˜aF1, ŒÜ\—’ÍŽj1, ´…Œö–ç1 (1Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18-20), ’ˇ–ě.

723865. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Boston KeratoprosthesisŒă‚ÉŠ´őŤŠp–Œ‰Š‚đ”­Ç‚ľ‚˝3—á‚ĚŒŸ“˘. Žq“‡—Ç•˝1,2, X@—mÄ1,2, —ŃŽ›@Œ’1, Ź–ě@‹Ş1, –ěŒű‚ä‚Š‚č1, ‹{“c˜a“T1 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18-20), ’ˇ–ě.

723866. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Šp–Œ‘O–Ę“|—Ž‹Ç—á‚É‚¨‚Ż‚é‘OŠá•”OCT‚Ĺ‘Ş’č‚ľ‚˝Keratometric‚ĆReal‚̍ˇ‚ĚŒŸ“˘. ’ˇ’JěˆŸ—˘1, Ź“‡—˛Ži2, ‹Ę’u–ž–ě1, ŽR–{^Ř1, ‰Á‰ę’BŽu1,3, Žsěˆę•v3,4 (1’†‹ž•a‰@, 2Šň•ŒÔ\Žš•a‰@, 3Šá‰Č, 4’†‹žŠá‰Č): Šp–ŒƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX2016 (‘ć40‰ń“ú–{Šp–ŒŠw‰ď‘‰ďE‘ć32‰ń“ú–{Šp–ŒˆÚAŠw‰ď) (2016/2/18-20), ’ˇ–ě.

731147. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) —Γŕá‚ĚŽĄ—Ă‹­‰ť‚Ěƒ^ƒCƒ~ƒ“ƒO. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć3‰ńŠÖ“ŒGlaucoma Meet The Specialist (2015/4/25), “Œ‹ž.

731148. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzŹŽ™‚̋ߎ‹is–hŽ~‚̍l‚Ś•ű. Ží“c–F˜Y1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ‘ć128‰ń_“ŢěŒ§Šá‰ČW’k‰ď (‘ć57‰ń_“ސěˆăŠw‰ď•Ş‰Č‰ď) (2015/5/24), _“ސě.

731149. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzŠáŠ´őÇƒP[ƒXƒtƒ@ƒCƒ‹. _’J˜aF (Šá‰Č): ‘ć6‰ńOSKA (Ocular Surface Seminar in Kanagawa) (2015/6/4), _“ސě.

731150. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “ú“ŕ•Ď“Ž‚đl—ś‚ľ‚˝—ΓŕáŽĄ—Ă. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć9‰ń‚ł‚Ş‚ÝŠá‰ČŒ¤‹†‰ď (2015/6/26), _“ސě.

731151. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzOCT‚đ—p‚˘‚˝‰Á—”Á•ĎŤ‚̐f’fƒAƒbƒvƒf[ƒg. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć9‰ń‚ł‚Ş‚ÝŠá‰ČŒ¤‹†‰ď (2015/6/26), _“ސě.

731152. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz•Ď‰ť‚ľ‚‚‚ ‚é—ΓŕáŽĄ—Ă. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć15‰ń_“ސěŠá‰ČƒZƒ~ƒi[ (2015/7/2), _“ސě.

731153. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz—ΓŕáŽĄ—Ă Update. ŻŽiMs (ˆă—ÉqśŠw•”): —ΓŕáŽĄ—Ă‚É‚¨‚Ż‚éROCK‘jŠQ–ň‚đl‚Ś‚é‰ď (2015/7/8), _“ސě.

731154. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŽŸ˘‘ă‚Ě‹üÜ‹¸łŽčp@ReLExEHole ICL. _’J˜aF (Šá‰Č): ‘ć2‰ń‘ĺXŠp–ŒƒiƒCƒgƒZƒ~ƒi[ (2015/7/27), “Œ‹ž.

731155. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) OCT‚đ—p‚˘‚˝—Γŕáf’f. ŻŽiMs (ˆă—ÉqśŠw•”): ƒAƒCƒtƒ@ƒKƒ“Ň“_Šá‰t0.1%”­”„3Žü”Nƒ‹ƒ~ƒKƒ“Ň“_Šá‰t0.03%”­”„5Žü”N‹L”Ou‰‰‰ďin_“ސě (2015/8/20), _“ސě.

731156. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz—Γŕá‚ĚĹ‹ß‚Ě˜b‘č. ´…Œö–ç (Šá‰Č): ƒAƒCƒtƒ@ƒKƒ“Ň“_Šá‰t0.1%”­”„3Žü”Nƒ‹ƒ~ƒKƒ“Ň“_Šá‰t0.03%”­”„5Žü”N‹L”Ou‰‰‰ďin_“ސě (2015/8/20), _“ސě.

731157. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇzˆă—Ă‘i×‚ĚŒťó‚Ć–â‘č`Šá‰ČŽ–—á‚𒆐S‚Ɂ`. ‰F’ĂŒŠ‹`ˆę1,2 (1‰Ą•lŽsŠá‰Čˆă‰ď, 2Šá‰Č): ‘ć17‰ń‰Ą•lŠá‰Č—Տ°ƒtƒH[ƒ‰ƒ€ (2015/9/30), _“ސě.

731158. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz“Á•Ęu‰‰. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć51‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސě.

731159. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) My Career 20/20. ´…Œö–ç (Šá‰Č): ‘ć13‰ńBay Ophthalmic Surgical Seminar (2015/10/31), _“ސě.

731160. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz“Á•Ęu‰‰…@. ‰F’ĂŒŠ‹`ˆę1,2 (1‰Ą•lŽsŠá‰Čˆă‰ď, 2Šá‰Č): ‘ć13‰ń‰Ą•l—Տ°Šá‰ČƒVƒ“ƒ|ƒWƒEƒ€ (2015/11/21), _“ސě.

731161. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰)yŔ’ˇz‰~‚đŠÜ‚ß‚˝ƒIƒLƒ…ƒ‰[ƒT[ƒtƒFƒX‚̍ĐśEÄŒš (—\’č). _’J˜aF (Šá‰Č): ‘ć7‰ńOSKA (Ocular Surface Seminar in Kanagawa) (2015/12/3), _“ސě.

732066. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —ΓŕáŽĄ—Ă‚Ěl‚Ś•ű. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć6‰ńSaitama Ophthalmology Seminar (2015/4/4), é‹Ę.

732067. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ŠwZˆă‚Ě’nˆćˆă—Âւ̑Ήž. ‰F’ĂŒŠ‹`ˆę1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ‘ć128‰ń_“ŢěŒ§Šá‰ČW’k‰ď (‘ć57‰ń_“ސěˆăŠw‰ď•Ş‰Č‰ď) (2015/5/24), _“ސě.

732068. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzŠeŽ{Ý‚Š‚ç‚Ě”­•\. Žs糋`Í1,2 (1_“ސ쎕‰Č‘ĺŠw•t‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2Šá‰Č): ‘ć10‰ń_“ސ쉊”ÁŒ¤‹†‰ď (2015/5/30), _“ސě.

732069. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) “–‰@‚É‚¨‚Ż‚鉊”ÁŽžŠłf—Âɂ‚˘‚Ä. “c–ě‹Mr1,2 (1‘Űˆă—Ă•ŸŽƒ‘ĺŠw”MŠC•a‰@, 2Šá‰Č): ‘ć10‰ń_“ސ쉊”ÁŒ¤‹†‰ď (2015/5/30), _“ސě.

732070. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“˘˜_‰ď) DME‚̐f’f‚¨‚ć‚ŃŽĄ—Ă‘I‘đŽˆ. Žs糋`Í1,2, ”’’J@“O2, ŒüŒă“ń˜Y3, —é–ؐ’O4 (1_“ސ쎕‰Č‘ĺŠw•t‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2Šá‰Č, 3šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠw•a‰@, 4“ŒŠC‘ĺŠwˆăŠw•”ę–ĺf—ĂŠwŒn): ‘ć10‰ń_“ސ쉊”ÁŒ¤‹†‰ď (2015/5/30), _“ސě.

732071. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —Տ°_ŒoŠá‰Č`–ž“ú‚Š‚çŽg‚Ś‚éƒRƒc`. ŒăŠÖ—˜–ž (Šá‰Č): –kŠC“š‘ĺŠwŠá‰ČƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/6/1), –kŠC“š.

732072. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) My Career 20/20. ´…Œö–ç (Šá‰Č): ‘ć48‰ń“š“ěŠá‰ČW’k‰ď (2015/6/6), –kŠC“š.

732073. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Ž‹×–EŠOß‚Ě•a‹C. Žs糋`Í1,2 (1_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2Šá‰Č): ‘ć8‰ń‰Ą•lŠá‰ČfX˜AŒg‚̉ď (2015/6/12), _“ސě.

732074. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) IFIS‚ĚŒ´ˆö‚ƐŹˆö`Ž„‚̏Ź‚ł‚Č’ďR`. ‘ĺ–ěWŽi1,2 (1‘ĺ–ěŠá‰Čˆă‰@, 2Šá‰Č): ‘ć8‰ń‰Ą•lŠá‰ČfX˜AŒg‚̉ď (2015/6/12), _“ސě.

732075. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) _“ސ쎕‰Č‚É‚¨‚Ż‚éŽÎŽ‹Žčp. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć8‰ń‰Ą•lŠá‰ČfX˜AŒg‚̉ď (2015/6/12), _“ސě.

732076. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Ç—á’掌 (ŒäĐ‰î—á‚Ě’†‚Š‚ç). Œü–ě˜a—Y1,2 (1_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2Šá‰Č): ‘ć8‰ń‰Ą•lŠá‰ČfX˜AŒg‚̉ď (2015/6/12), _“ސě.

732077. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‰Á—î‚Ć‚ĚăŽč‚Ȃ‚Ť‚ ‚˘•ű. ´…Œö–ç (Šá‰Č): ‘ć65‰ńŠá‰ČƒZƒ~ƒi[ (Šá‰Č—F‚̉ď) (2015/6/14), “Œ‹ž.

732078. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —˜”AÜ‚Ş‘tŒř‚ľ‚˝‚ĆŽv‚í‚ę‚錌ŠÇ•a•Ď‚𔺂í‚Č‚˘–Ô–ŒF‘fă”甍—Ł‚Ě1—á. “c–ě‹Mr1,2 (1Šá‰Č, 2‘Űˆă—Ă•ŸŽƒ‘ĺŠw”MŠC•a‰@): ‘ć2‰ńAMD Expert Clinical Conference`AMDŽĄ—Ă‚É‚¨‚Ż‚éRVEGF–ň‚Ě–đŠ„‚đl‚Ś‚é` (2015/7/5), “Œ‹ž.

732079. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇz–ł…ť‘ĚŠá‚É‚¨‚˘‚Ä–D’…‚đ•K—v‚Ć‚ľ‚Č‚˘V‚ľ‚˘–Ń—laŒĹ’čŠá“ŕƒŒƒ“ƒY‚ĚŒŸ“˘. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć48‰ńĂźŠá‰Č—Տ°ƒtƒH[ƒ‰ƒ€ (2015/7/9), _“ސě.

732080. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“˘˜_‰ď) ƒI[ƒvƒ““˘˜_‰ď. Žs糋`Í1,2, ź–{_”V2,3 (1_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2Šá‰Č, 3‰Ą{‰ęŽs—§‚¤‚í‚Ü‚ż•a‰@): ‘ć12‰ń_“ŢěŒ§Šá‰ČDMƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/8/1), _“ސě.

732081. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇz“ú–{_ŒoŠá‰ČŠw‰ď”F’čuK‰ď. ŒăŠÖ—˜–ž (Šá‰Č): ‘ć31‰ń^’߃Zƒ~ƒi[ (_ŒoŠá‰Čh”‘•×‹­‰ď) (2015/8/30), VŠƒ.

732082. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Ĺ‹ß‚Ě•ŰŒŻż‹‚ɂ‚˘‚Ä. ź–{_”V1,2 (1‰Ą{‰ęŽs—§‚¤‚í‚Ü‚ż•a‰@, 2Šá‰Č): Š™‘q‚Č‚Ź‚ł‚̉ď (2015/9/1), _“ސě.

732083. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzFŠo‚Ě‘˝—lŤ‚ƐF‚ĚƒoƒŠƒAƒtƒŠ[. ‰F’ĂŒŠ‹`ˆę1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ‘ć6‰ń_“ސěŠá‰Čˆă—Ï]Ž–ŽŇ•×‹­‰ď|ƒRƒƒfƒBƒJƒ‹, ˆăŽt‚Ý‚ń‚Č‚Ěu‰‰‰ď| (2015/9/26), _“ސě.

732084. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇz_ŒoŠá‰Č‚Ĺˆľ‚¤ŽžŠł‚Ć‚ť‚ĚŽĄ—Ă. Ží“c–F˜Y1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ‘ć6‰ń_“ސěŠá‰Čˆă—Ï]Ž–ŽŇ•×‹­‰ď|ƒRƒƒfƒBƒJƒ‹, ˆăŽt‚Ý‚ń‚Č‚Ěu‰‰‰ď| (2015/9/26), _“ސě.

732085. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) _ŒoŠá‰Č‚Ĺˆľ‚¤ŽžŠł‚Ć‚ť‚ĚŽĄ—Ă. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć6‰ń_“ސěŠá‰Čˆă—Ï]Ž–ŽŇ•×‹­‰ď|ƒRƒƒfƒBƒJƒ‹, ˆăŽt‚Ý‚ń‚Č‚Ěu‰‰‰ď| (2015/9/26), _“ސě.

732086. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzV‚ľ‚˘Ž‹_ŒoŽžŠł‚ĚŽĄ—Ă‚Ě“W–]|iPS×–E‚đ—p‚˘‚˝Äśˆă—Ă‚Ć‘n–ň|. ‰F’ĂŒŠ‹`ˆę1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ‘ć16‰ń_“ŢěŒ§Šá‰ČŠwpu‰‰‰ď (2015/9/26), _“ސě.

732087. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇz‹łˆçu‰‰. _’J˜aF (Šá‰Č): ‘ć51‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސě.

732088. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ”’“ŕáŽčp‚ĚƒgƒsƒbƒNƒX. ”Ń“c‰Ă•F (Šá‰Č): ‘ć51‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސě.

732089. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ŠC˜V–ź‘‡•a‰@‚É‚¨‚Ż‚éŽčpŽĄ—Ă‚ĚŽŔŰ`”’“ŕá, Šp–ŒˆÚA, —L…ť‘ĚŠá“ŕƒŒƒ“ƒY`. ‘ŠŕV‘ĺ•ă1,2 (1ŠC˜V–ź‘‡•a‰@, 2Šá‰Č): ĂźŠá‰Čˆă‰ďŠwpu‰‰‰ďEƒXƒ^ƒbƒtuK‰ď (2015/10/3), _“ސě.

732090. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) “ü–ĺ_ŒoŠá‰Č. ŒăŠÖ—˜–ž (Šá‰Č): ĂźŠá‰Čˆă‰ďŠwpu‰‰‰ďEƒXƒ^ƒbƒtuK‰ď (2015/10/3), _“ސě.

732091. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ”’“ŕá‚ĆŒž‚í‚ę‚˝‚ç. ´…Œö–ç (Šá‰Č): ‘ć14‰ń–k—˘‘ĺŠwˆăŠw•”“Ż‘‹‰ď@Žs–ŻŒöŠJuŔ (2015/10/10), _“ސě.

732092. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzu‰‰‰ď. Žs糋`Í1,2 (1_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2Šá‰Č): ‘ć33‰ń_“Ţěƒ[ƒrƒWƒ‡ƒ“ƒlƒbƒgƒ[ƒN (KLVN) Œ¤C‰ď (2015/10/10), _“ސě.

732093. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Ž‹_ŒoŽžŠł‚ɂ‚˘‚Ä. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć33‰ń_“Ţěƒ[ƒrƒWƒ‡ƒ“ƒlƒbƒgƒ[ƒN (KLVN) Œ¤C‰ď (2015/10/10), _“ސě.

732094. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzŽ‹_ŒoÇ‚Ć‚ť‚Ě—ŢŽ—ŽžŠł. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć6‰ńĂźŠá‰ČƒAƒJƒfƒ~[ (2015/10/14), _“ސě.

732095. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Ž‹_ŒoÇ‚Ć‚ť‚Ě—ŢŽ—ŽžŠł. Žs糋`Í1,2 (1_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2Šá‰Č): ‘ć6‰ńĂźŠá‰ČƒAƒJƒfƒ~[ (2015/10/14), _“ސě.

732096. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇz“ďÇ—á‚̐…ť‘ĚÄŒšp. ´…Œö–ç (Šá‰Č): ‘ć6‰ńĂźŠá‰ČƒAƒJƒfƒ~[ (2015/10/14), _“ސě.

732097. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“˘˜_‰ď)yŔ’ˇz”’“ŕáŽčp“Ç—á. —é–ؐ’O1, ”Ń“c‰Ă•F2 (1“ŒŠC‘ĺŠw, 2Šá‰Č): ‘ć6‰ńƒRƒ‹ƒjƒAƒtƒFƒCƒRƒZƒ~ƒi[ (2015/11/27), _“ސě.

732098. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇz‚—îŽŇ—Γŕá‚Ě—ŻˆÓ“_‚Ć‚ ‚˝‚ç‚ľ‚˘–ň•¨ŽĄ—Ẩ”\Ť. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć49‰ńĂźŠá‰Č—Տ°ƒtƒH[ƒ‰ƒ€ (2015/12/10), _“ސě.

732099. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇz•˝Ź26”N_“ŢěŒ§’†ŠwZE‚Z‚ĚƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—pó‹ľ. Ží“c–F˜Y1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ‘ć5‰ń_“ŢěŒ§Ž‹”\ŒP—űŽm‚̉ď (2016/1/23), _“ސě.

732100. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) •˝Ź26”N_“ŢěŒ§’†ŠwZE‚Z‚ĚƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYŽg—pó‹ľ. ‰F’ĂŒŠ‹`ˆę1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ‘ć5‰ń_“ŢěŒ§Ž‹”\ŒP—űŽm‚̉ď (2016/1/23), _“ސě.

732101. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —Տ°‚ɖ𗧂Ž‹—ÍŒŸ¸‚̐V‚˝‚ČƒAƒvƒ[ƒ`. ”ź“c’m–ç (ˆă—ÉqśŠw•”): ‘ć5‰ń_“ŢěŒ§Ž‹”\ŒP—űŽm‚̉ď (2016/1/23), _“ސě.

732102. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇz–k—˘‘ĺŠwŠá‰Č‚ĚŠe”Ç‚ĚŽć‚č‘g‚Ý‚ĆŒťó. ´…Œö–ç (Šá‰Č): ‘ć12E13‰ń–k—˘Šá‰Č•af˜AŒg‰ď (2016/1/28), _“ސě.

732103. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ŽÎŽ‹E_ŒoŠá‰Č‚ɂ‚˘‚Ä. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć12E13‰ń–k—˘Šá‰Č•af˜AŒg‰ď (2016/1/28), _“ސě.

732104. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) Šp–Œ, ‹üÜ‹¸łŽčp‚ɂ‚˘‚Ä. _’J˜aF (Šá‰Č): ‘ć12E13‰ń–k—˘Šá‰Č•af˜AŒg‰ď (2016/1/28), _“ސě.

732105. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ”’“ŕá‚ɂ‚˘‚Ä. ”Ń“c‰Ă•F (Šá‰Č): ‘ć12E13‰ń–k—˘Šá‰Č•af˜AŒg‰ď (2016/1/28), _“ސě.

732106. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —Γŕá‚ɂ‚˘‚Ä. ź‘şˆęO (Šá‰Č): ‘ć12E13‰ń–k—˘Šá‰Č•af˜AŒg‰ď (2016/1/28), _“ސě.

732107. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) –Ô–ŒÉŽq‘̂ɂ‚˘‚Ä. –ö“c’q•F (Šá‰Č): ‘ć12E13‰ń–k—˘Šá‰Č•af˜AŒg‰ď (2016/1/28), _“ސě.

732108. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzOCT‚đ•š—p‚ˇ‚éŠá’ę“lje‚ĚŽŔŰ. ŽRě–퐜1,2 (1‘ĺ˜aŽs—§•a‰@, 2Šá‰Č): ‘ĺ˜aŽsŠwpu‰‰‰ď (2016/2/3), _“ސě.

732109. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇz‚ß‚Ü‚˘‚ĆŠáU. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć3‰ń_“ސ쏬Ž™Šá‰ČE_ŒoŠá‰ČƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/2/4), _“ސě.

732110. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™)yŔ’ˇzƒJƒ‰[ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒY‚đ‚Ć‚č‚Ü‚­”–â‘č|ƒŒƒ“ƒY‚Ě‘P‚ľˆŤ‚ľ‚Ćƒ†[ƒU[•Ę‘Ώˆ–@|. ‰F’ĂŒŠ‹`ˆę1,2 (1_“ŢěŒ§Šá‰Čˆă‰ď, 2Šá‰Č): ƒRƒ“ƒ^ƒNƒgƒŒƒ“ƒYƒZƒ~ƒi[EƒCƒ“_“ސě (2016/2/6), _“ސě.

732111. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) “úíR¸‚É‚¨‚Ż‚钍ˆÓ“_. ź–{_”V1,2 (1‰Ą{‰ęŽs—§‚¤‚í‚Ü‚ż•a‰@, 2Šá‰Č): •˝Ź27”N“x_“ŢěŒ§Šá‰Čˆă‰ď@Œ’•Ű§˜b‰ď (2016/2/27), _“ސě.

733299. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Šáâ|“ŕ‹‘ĺŠC–ČóŒŒŠÇŽî‚Ěˆę—á. ’ră–őŽq1, “c’†rˆę1,2, ’†ź@Šî1,2, ăb@Šo1, ‚‹´”üK1,2, X“c—F”ü1,2, Œ´@–r–ç1, ‹Ę’ułŽj1, ŒËŞ@C1 (1•‘ –ěÔ\Žš•a‰@, 2Šá‰Č): ‘ć6‰ń“Œ‹ž‘˝–€Šá‰Č˜AŒgƒZƒ~ƒi[ (2015/4/25), “Œ‹ž.

733300. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘¤“Ş“Ž–Ź‰Š—l‚ĚÇŒó‚đ’ć‚ľ, Ž‹_Œo–Ô–Œ‰Š—lŠá’ę‚đŽŚ‚ľ‚˝“Á”­Ť”ěŒúŤd–Œ‰Š‚Ě1—á. ‹g“c@Š°1,2, ’†‘ş@´1, ›’JŒcŽO1 (1“Œ‹ž“s—§_Œo•a‰@, 2Šá‰Č): ‘ć6‰ń“Œ‹ž‘˝–€Šá‰Č˜AŒgƒZƒ~ƒi[ (2015/4/25), “Œ‹ž.

733301. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) –D’…‚ ‚ę‚ą‚ę. ”Ń“c‰Ă•F (Šá‰Č): ‘ć5‰ńƒRƒ‹ƒjƒAƒtƒFƒCƒRƒZƒ~ƒi[ (2015/5/21), _“ސě.

733302. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Šá“ŕƒŒƒ“ƒY•ÎˆĘÇ—á‚Ě”wŒiˆöŽq‚ĚŒŸ“˘. ”Ń“c‰Ă•F1, ´…Œö–ç1, ˛“ĄM”V1, “V–ě—Œb1, íœAr‘ž˜Y1, ”Ń“‡@Œh2, ŠFě—FŒ›1 (1Šá‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć7‰ń_“ސěŠá‰ČŠw‰ď (2015/5/24), _“ސě.

733303. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Šá“ŕƒŠƒ“ƒpŽî‚đ‹^‚˘ÉŽq‘ĚŽčp‚đŽ{s‚ľ‚˝Ç—á‚ĚŒŸ“˘. ’Ň‘ň’C•F1, ŽO‘îr”V1, ”’’J@“O1, –ö“c’q•F1, ´…Œö–ç1 (1Šá‰Č): ‘ć7‰ń_“ސěŠá‰ČŠw‰ď (2015/5/24), _“ސě.

733304. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇz‰‰‘č6-11. ŻŽiMs (ˆă—ÉqśŠw•”): ‘ć7‰ń_“ސěŠá‰ČŠw‰ď (2015/5/24), _“ސě.

733305. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŒŒŠÇVś—Γŕá‚É‚¨‚Ż‚éTrabeculectomy‚ĆEX-PRESSҗŻ’up‚Ě”äŠr. ‰Í–ě—Y—ş1, Š}Œ´łs1, ź‘şˆęO1, ŻŽiMs2, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć7‰ń_“ސěŠá‰ČŠw‰ď (2015/5/24), _“ސě.

733306. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Šá‹ŘŒ^dÇ‹Ř–ł—͏ǂɂć‚閃აŤŠOŽÎŽ‹‚ɑ΂ľ, ă‰ş’ź‹Ř‘S•ˆÚ“Žp (ź“c–@) ‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ˆę—á. —´ˆä‰‘Žq1, ŒăŠÖ—˜–ž2, Îě@‹Ď3, ´…Œö–ç2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Šá‰Č, 3ˆă—ÉqśŠw•”): ‘ć7‰ń_“ސěŠá‰ČŠw‰ď (2015/5/24), _“ސě.

733307. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) …ávŤŠp–ŒÇ‚ɑ΂ˇ‚é‘S‘wŠp–ŒˆÚAp‚ĆŠp–Œ“ŕ”çˆÚAp‚̏pŒă3”N‚̐ŹŃ”äŠr. —ŃŽ›@Œ’1, “ż—Żr•F1, ‹{•‰‘y‰î1, X@—mÄ1,2, Žq“‡—Ç•˝1,2, ‹{“c˜a“T1 (1‹{“cŠá‰Č•a‰@, 2Šá‰Č): ‘ć85‰ń‹ăBŠá‰ČŠw‰ď (2015/5/29), Ž­Ž™“‡.

733308. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Šp–ŒˆÚAŒă‚ĚŠá•\–Ę‚ĆŽ‹‹@”\. Ź‹´‰p’ˇ (Šá‰Č): ƒ€ƒRƒXƒ^“_Šá‰t”­”„3Žü”Nu‰‰‰ď (2015/6/11), _“ސě.

733109. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒOƒ‰ƒiƒeƒbƒN“_Šá‰t0.4%‚ĚŽg—pŒoŒą|‘ĺŠw•a‰@‹Î–ąˆă‚Ě—§ę‚Š‚ç|. –Ř‘ş“TŒh (Šá‰Č): —ΓŕáŽĄ—Ă‚É‚¨‚Ż‚éROCK‘jŠQ–ň‚đl‚Ś‚é‰ď (2015/7/8), _“ސě.

733310. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‰şŒü‚Ť“ŞˆĘ‚ĹŠááىş‚‚ޏoŒť‚ˇ‚éˆę—á. ”Ń“‡@ˆť1, ŒăŠÖ—˜–ž1, Îě@‹Ď2, ´…Œö–ç1, ‹v{”ü^—3 (1Šá‰Č, 2ˆă—ÉqśŠw•”, 3”]ŠO): ‘ć31‰ń^’߃Zƒ~ƒi[ (_ŒoŠá‰Čh”‘•×‹­‰ď) (2015/8/29), VŠƒ.

733311. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‹ßÔŠO•ŞŒő–@‚ĚŠá‰Č—Ěˆć‚ւ̉ž—p. Šâ“c@—y1, ’r“c“N–ç2, ”ź“c’m–ç3, Îě@‹Ď3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2Šá‰Č, 3ˆă—ÉqśŠw•”): ‘ć31‰ń^’߃Zƒ~ƒi[ (_ŒoŠá‰Čh”‘•×‹­‰ď) (2015/8/29), VŠƒ.

733312. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Œđ’ĘŠOŒă‚Ě’˛ßáŠQ‚ÉBlood PatchŽĄ—Ă‚Ş—LŒř‚Ĺ‚ ‚Á‚˝1—á. ”Ÿş‹ąŽq1, ŽRă–žŽq1,2, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2, Îě@‹Ď3, ‚‹´_ˆę4 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č, 3ˆă—ÉqśŠw•”, 4ŽR‰¤•a‰@): ‘ć31‰ń^’߃Zƒ~ƒi[ (_ŒoŠá‰Čh”‘•×‹­‰ď) (2015/8/29), VŠƒ.

733313. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Œ´ˆö•s–ž‚ĚŽ‹_ŒoˆŢk‚Ĺƒ~ƒgƒRƒ“ƒhƒŠƒADNA•ĎˆŮ‚đ”F‚ß‚˝ŹŽ™‚Ě1—á. Šâ˛^‹|1, Vˆä‚ä‚č‚ 1, ŽRă–žŽq1,2, ˆäăŒŤŽĄ1, Žá‘q‰ë“o1,2 (1ˆäăŠá‰Č•a‰@, 2Šá‰Č): ‘ć31‰ń^’߃Zƒ~ƒi[ (_ŒoŠá‰Čh”‘•×‹­‰ď) (2015/8/30), VŠƒ.

733314. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇzˆę”ʉ‰‘č. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć51‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސě.

733315. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) IOLŒĹ’荢“ďÇ—á‚ɑ΂ˇ‚éSulcus-subcapsular fixation ‚Ě—Ő°ŹŃ. ’Ň‘ň’C•F1, ´…Œö–ç1, Î“c@‹Ĺ1, ˛“ĄM”V1, ”Ń“c‰Ă•F1 (1Šá‰Č): ‘ć51‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސě.

733316. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Ă‰ŞŒ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[ŠJ‰@‚Š‚ç13”NŠÔ‚Ě‘Š‡. ”–؍LĆ1,2, ´…Œö–ç2 (1Ă‰ŞŒ§—§Ă‰Ş‚Ş‚ńƒZƒ“ƒ^[Šá‰Č, 2Šá‰Č): ‘ć51‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސě.

733317. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚ĆŠÖ˜A•a‰@‚É‚¨‚Ż‚é–˘nŽ™–Ô–ŒÇ‚̐f—ÐŹŃ. ’r“c“N–ç1, —´ˆä‰‘Žq2, Î“c@‹Ĺ1, ŒăŠÖ—˜–ž1, Îě@‹Ď3, ´…Œö–ç1 (1Šá‰Č, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3ˆă—ÉqśŠw•”): ‘ć51‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސě.

733318. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒtƒFƒ€ƒgƒZƒJƒ“ƒhƒŒ[ƒU[‚đ—p‚˘‚˝‘S‘wŠp–ŒˆÚA‚Ć•\‘wŠp–ŒˆÚA‚Ě—Ő°ŹŃ. Ź‹´‰p’ˇ1, _’J˜aF1, ŒÜ\—’ÍŽj1, ´…Œö–ç1 (1Šá‰Č): ‘ć51‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސě.

733319. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) p‘OŠáˆł•Ę‚É•Ş‚Ż‚˝ƒgƒ‰ƒxƒNƒg[ƒ€Žčp‚̐ŹŃ. Š}Œ´łs1, ŻŽiMs2, ź‘şˆęO1, ‰Í–ě—Y—ş1, –Ř‘ş“TŒh1, •ÄŽR@—Č1, X“c“N–ç1,3, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”, 3–k—˘‘ĺŠwƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[): ‘ć51‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސě.

733320. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚é‰ß‹Ž5”NŠÔ‚Ě—ôEŒ´Ť–Ô–Œ”—Ł‚̏pŒăŹŃ. ”Ń“‡@ˆť1, –ö“c’q•F1, ”’’J@“O1, ŠFě—FŒ›1, ‹ŕŽRr‰î1, ´…Œö–ç1 (1Šá‰Č): ‘ć51‰ń–k—˘‘ĺŠwE_“ŢěŒ§Šá‰Čˆă‰ď‡“ŻƒŠƒT[ƒ`ƒJƒ“ƒtƒ@ƒŒƒ“ƒX (2015/10/1), _“ސě.

733321. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) RTNF-ƒżƒ‚ƒmƒNƒ[ƒiƒ‹R‘ĚŽĄ—ĂŒo‰ß’†‚É”]Š˛•a•Ď‚É‚ć‚éăŽÎ‹Ř–ƒŒ‚đ”F‚ß‚˝1—á. Žs糋`Í1,2 (1_“ސ쎕‰Č‘ĺŠw•‘Ž‰Ą•lƒNƒŠƒjƒbƒN, 2Šá‰Č): Infliximab Conference on Behcet Disease2015 (2015/10/2), “Œ‹ž.

733322. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰)yŔ’ˇzˆę”ʉ‰‘č/“Á•Ęu‰‰. —é–؍N”V1, ŻŽiMs2 (1“ŒŠC‘ĺŠw, 2ˆă—ÉqśŠw•”): ‘ć13‰ńBay Ophthalmic Surgical Seminar (2015/10/31), _“ސě.

733323. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) Šá“ŕƒŒƒ“ƒY–D’…pÇ—á‚Ě”wŒiˆöŽq‚ĆŽčp‚̍H•v. ”Ń“c‰Ă•F (Šá‰Č): ‘ć13‰ńBay Ophthalmic Surgical Seminar (2015/10/31), _“ސě.

733324. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŽčpI—šŽž‚ĚŠáˆł•Ę‚É•Ş‚Ż‚˝ƒgƒ‰ƒxƒNƒg[ƒ€Žčp‚Ě’ZŠúŹŃ. ’Ň‘ň’C•F1, Š}Œ´łs1, ŻŽiMs2, ź‘şˆęO1, –Ř‘ş“TŒh1, ‹ŕŽRr‰î1, X“c“N–ç1, •ÄŽR@—Č1, ´…Œö–ç1 (1Šá‰Č, 2ˆă—ÉqśŠw•”): ‘ć32‰ń_“ŢěŒ§—Γŕá’k˜b‰ď (2016/2/13), _“ސě.

733325. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) SˆöŤŽ‹ŠoáŠQ‚Ɗ펿Ť_ŒoŠá‰ČŽžŠł. Îě@‹Ď (ˆă—ÉqśŠw•”): ‘ć8‰ń_“ސěƒNƒƒXƒI[ƒo[ƒVƒ“ƒ|ƒWƒEƒ€ (2016/3/19), _“ސě.


Ž¨•@ˆôA‰ČŠw

[Šwp˜_•ś]

110294. [Œ´’˜] A case of atypical teratoid/rhabdoid tumor in the internal auditory canal. Yamaguchi T1, Oka H2, Kijima C, Sano H3, Watanabe H1, Okamoto M1: Auris Nasus Larynx 2015/4; 42 (2): 163-6. (ŽRŒű’mŽq1, ‰Ş@GG2, ˛–ě@”Ł3, “n•Ó—T”V1, ‰Ş–{–ql1: 1Ž¨•@ˆôAE“ŞčňŠO, 2”]ŠO, 3ˆă—ÉqśŠw•”)

110295. [Œ´’˜] One hundred supracricoid laryngectomies with cricohyoidoepiglottopexy: do we achieve better local control? Nakayama M1, Miyamoto S1, Seino Y1, Okamoto T1, Kano K1, Hasebe M1, Okamoto M1: Jpn J Clin Oncol. 2015 /8; 45 (8): 732-7. (’†ŽR–žm1, ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ’ˇ’J•”ł”V1, ‰Ş–{–ql1: 1Ž¨•@ˆôAE“ŞčňŠO)

120060. [Œ´’˜]yU40ƒVƒ“ƒ|ƒWƒEƒ€9: Larynx/Pharynx/Esophagusz“–‰@‚É‚¨‚Ż‚éŒoŒű“I“ŕŽ‹‹ž‰şŽčp‚Ě—Ő°“IŒŸ“˘. ‰Á”[Fˆę1, ‹{–{r•ă1, ’†ŽR–žm1, Œ˜“ce—˜2, ´–ě—R”y1, ‰Ş–{—ˇl1 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ):“Şčň•”Šŕ 2015/10; 41 (3): 339-42.

310031. [Ç—á•ń] Congenital mucocele of the gland Bandin-Nuhn. Ochiai A1, Nakayama M1: Oxf Med Case Reports 2015/12; 2015 (12): 374-5. (—Ž‡@“Ö1, ’†ŽR–žm1: 1Ž¨•@ˆôAE“ŞčňŠO)

310032. [Ç—á•ń] Remarkably improved intractable otitis media by treatment in accordance with clinical practice guidelines for the diagnosis and management of acute otitis media in children: a case report. Ochiai A1, Suzuki T1: Kitasato Med J 2016/3; 46 (1): 81-5. (—Ž‡@“Ö1, —é–Ř—§r1: 1Ž¨•@ˆôAE“ŞčňŠO)

310033. [Ç—á•ń] Endoscopic sinus surgery under the navigation system for a frontal sinus cyst: a case report. Ochiai A1, Suzuki T1: Kitasato Med J 2016/3; 46 (1): 86-90. (—Ž‡@“Ö1, —é–Ř—§r1: 1Ž¨•@ˆôAE“ŞčňŠO)

320039. [Ç—á•ń] ‘˝”­Ť_Œo–ƒáƒ‚đ—ˆ‚ľ‚˝ŹŽ™ˆôŒă”^ᇂĚ1—á. ‘ĺŒ´‘ěĆ1, ‰Ş–{—ˇl1, ’ˇŔ‰p–ž2, –q@“ÖŽq1, “ߐ{–ě’qŒő1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{Ž¨•@ˆôA‰ČŠw‰ď‰ď•ń 2015/5; 118 (5): 657-61.

320040. [Ç—á•ń] Œ‹Šj‚É‚ć‚ččňĂ–ŹÇŒóŒQ‚¨‚ć‚Ń”ěŒúŤd–Œ‰Š‚đ’ć‚ľ‚˝1—á. ‹{–{r•ă1, ’†ŽR–žm1, ‰Ş–{—ˇl1 (1Ž¨•@ˆôAE“ŞčňŠO): A“Ş 2015/12; 27 (2): 108-13.

320041. [Ç—á•ń] ŠO•@ÄŒšp‚đŽ{s‚ľ‚˝’´‚—î•@oŠŕ—á. ‰Á”[Fˆę1, ‹{–{r•ă1, ’†ŽR–žm1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): Ž¨•@ˆôA‰Č—Տ° 2016/1; 109 (1): 35-40.

522158. [uŔ]y“ÁW: ĹV‚Ě•â’ŽŠíf—Á|•â’ŽŠí‚É‚ć‚é’ŽŠoƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“z‚ą‚ę‚Š‚ç•â’ŽŠíŠO—ˆ‚đ‚Í‚ś‚ß‚é‚˝‚ß‚É. ˛–ě@”Ł (Ž¨•@ˆôAE“ŞčňŠO): Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰Č 2015/4; 87 (4): 294-301.

522159. [uŔ]y“ÁW: “ŕŽ‹‹žŽĄ—Á|“ŕ‰Č‚ĆŠO‰Č‚ĚƒRƒ‰ƒ{ƒŒ[ƒVƒ‡ƒ“zŠe˜_@Ž¨•@ˆôA‰Č‚ƏÁ‰ťŠí“ŕ‰Č‚Ě˜AŒg‚É‚ć‚éˆô“Ş•\ÝŠŕ‚ɑ΂ˇ‚éELPS. ‰Á”[Fˆę1, ‰Ş–{—ˇl1, Œ˜“ce—˜2, ˆęŒËš–ž3, ’†ŽR–žm1, ‹{–{r•ă1, ´–ě—R”y1, ˜a“c‘ń–ç2, “c糁@‘4 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ, 3•a—, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): Á‰ťŠí“ŕŽ‹‹ž 2015/9; 27 (9): 1506-12.

522160. [uŔ]y‘ć29‰ń–k—˘ŽîᇃtƒH[ƒ‰ƒ€zA“ŞŠŕ‚Ě‹@”\‰ˇ‘śŽĄ—Á|‰ťŠw•úŽËü—Ă–@‚ƍA“ވŸ‘S“Eop‚Ě–đŠ„|. ŒĂ–ŘČŒá1, ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ’†ŽR–žm1 (1Ž¨•@ˆôAE“ŞčňŠO): –k—˘ˆăŠw 2015/12; 45 (2): 109-12.

[’˜@‘]

620116. [Šwp‘] (•Ş’SŽˇ•M)y“Ë”­Ť“ď’Župdate (ENTONI No.183)z“Ë”­Ť“ď’Ž‚ĆƒXƒgƒŒƒX, p. 51-7. “n•Ó—T”V1, ˛–ě@”Ł2 (1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”), •Ň: ˆÉ“Ą˛‹I, ‘S“ú–{•a‰@o”ʼnď,“Œ‹ž, 2015/8”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712030. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Supracricoid laryngectomy: 17 years' experience in Japan. Nakayama M1, Miyamoto S1, Seino Y1, Okamoto T1, Kano K1, Hasebe M1: World Congress on Larynx Cancer 2015 (2015/6/26-30), Cairns, Australia. (’†ŽR–žm1, ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ’ˇ’J•”ł”V1: 1Ž¨•@ˆôAE“ŞčňŠO)

712031. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Transoral surgeries for s uperficial hypopharyngeal cancers. Nakayama M1: 16th Japan-Korea Joint meeting of Otorhinolaryngology-Head and neck Surgery (2016/3/29), Tokyo. (’†ŽR–žm1: 1Ž¨•@ˆôAE“ŞčňŠO)

713106. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The Transitions of Treatment and Survival of Patients with Hypopharyngeal Carcinoma During 43 Years. Miyamoto S1, Nakayama M1, Seino Y1, Okamoto T1, Kano K1, Hasebe M1, Hayakawa K2, Okamoto M1: ‘ć39‰ń“ú–{“Şčň•”ŠŕŠw‰ďE‘ć4‰ńƒAƒWƒA“Şčň•”ŠŕŠw‰ď (2015/6/4), _ŒË. (‹{–{r•ă1, ’†ŽR–žm1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ’ˇ’J•”ł”V1, ‘ě˜ad2, ‰Ş–{–ql1: 1Ž¨•@ˆôAE“ŞčňŠO, 2•úŽËü (Žîá‡))

713107. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) “ŕŽ‹‹ž“IˆôA“ŞŽčp (ELPS) ‚Ě“K‰ž‚ĆŒŔŠE. ‰Ş–{—ˇl1, ’†ŽR–žm1, Œ˜“ce—˜2, ‹{–{r•ă1, ‰Á”[Fˆę1, ´–ě—R”y1, ×–ě_Žj1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ): ‘ć39‰ń“ú–{“Şčň•”ŠŕŠw‰ďE‘ć4‰ńƒAƒWƒA“Şčň•”ŠŕŠw‰ď (2015/6/4), _ŒË.

713108. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) p‘O‰ťŠw—Ă–@‚É‚ć‚č•a—Šw“ICR‚Ş“ž‚ç‚ę‚˝’†ˆô“Ş‘¤•ÇŠŕ‚Ě2Ç—á. ’ˇ’J•”ł”V1, ‹{–{r•ă1, ‰Á”[Fˆę1, ‰Ş–{—ˇl1, ´–ě—R”y1, ’†ŽR–žm1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć39‰ń“ú–{“Şčň•”ŠŕŠw‰ďE‘ć4‰ńƒAƒWƒA“Şčň•”ŠŕŠw‰ď (2015/6/4), _ŒË.

713109. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) One Hundred Supracricoid Laryngectomies with Cricohyoidoepiglottopexy. Nakayama M1, Miyamoto S1, Seino Y1, Okamoto T1, Kano K1, Hasebe M1: ‘ć39‰ń“ú–{“Şčň•”ŠŕŠw‰ďE‘ć4‰ńƒAƒWƒA“Şčň•”ŠŕŠw‰ď (2015/6/5), _ŒË. (’†ŽR–žm1, ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ’ˇ’J•”ł”V1: 1Ž¨•@ˆôAE“ŞčňŠO)

713110. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Clinical Study of Transoral Endoscopic Pharyngeal Surgery. Kano K1, Miyamoto S1, Nakayama M1, Katada C2, Seino Y1, Okamoto T1, Okamoto M1: ‘ć39‰ń“ú–{“Şčň•”ŠŕŠw‰ďE‘ć4‰ńƒAƒWƒA“Şčň•”ŠŕŠw‰ď (2015/6/5), _ŒË. (‰Á”[Fˆę1, ‹{–{r•ă1, ’†ŽR–žm1, Œ˜“ce—˜2, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Ş–{–ql1: 1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ)

713111. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Persistent Symptoms patients with Idiopathic Sudden Sensorineural Hearing Loss. Sano H1, Watanabe H2, Ino T2, Maki A2, Nakagawa T2, Okamoto M2: 3rd Congress of European ORL-HNS (2015/6/7-11), Prague, Czech Republic. (˛–ě@”Ł1, “n•Ó—T”V2, ’–@Œ’Žu2, –q@“ÖŽq2, ’†ě‹Mm2, ‰Ş–{–ql2: 1ˆă—ÉqśŠw•”, 2Ž¨•@ˆôAE“ŞčňŠO)

713112. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Invertigation of Status Against Stress Load Before Onset of Idiopathic Sudden Sensorineural Hearing Loss. Watanabe H1, Sano H2, Maki A1, Ino T1, Ono Y, Nakagawa T1, Okamoto M1: 3rd Congress of European ORL-HNS (2015/6/7-11), Prague, Czech Republic. (“n•Ó—T”V1, ˛–ě@”Ł2, –q@“ÖŽq1, ’–@Œ’Žu1, Ź–ě—Yˆę, ’†ě‹Mm1,‰Ş–{–ql1: 1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”)

713113. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Anti-Leukotriene Strategy by Endoscopic Sinussurgery. Yamaguchi T1, Ishii T1, Yamamoto K, Okamoto M1: 3rd Congress of European ORL-HNS (72015/6/7-11), Prague, Czech Republic. (ŽRŒű’mŽq1, Îˆä–L‘ž1, ŽR–{ˆę”Ž, ‰Ş–{–ql1: 1Ž¨•@ˆôAE“ŞčňŠO)

713114. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Arandomized Double-Blind,Placebo-Controlled Clinical Trial to Evalute the Efficacy of Hangekobokuto in Adult Patients with Chronic Tinnitus. Ino T1, Odaguchi H, Wakasugi A, Sano H2, Watanabe H1, Okamoto M1, Hoshi K3, Hanawa T4: 3rd Congress of European ORL-HNS (72015/6/7-11), Prague, Czech Republic. (’–@Œ’Žu1, Ź“cŒű_, Žá™ˆŔŠó”T, ˛–ě@”Ł2, “n•Ó—T”V1, ‰Ş–{–ql1, Ż@‰Ŕ–F3, ‰Ô—Öšć•F4: 1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”, 3‰qś, 4“Œ—mˆăŠw‹łˆç)

713115. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Prognosis and laryngeal preservation of supraglottic cancer versus glottic cancer. Miyamoto S1, Nakayama M1, Seino Y1, Okamoto T1, Kano K1, Hasebe M1, Okamoto M1: World Congress on Larynx Cancer 2015 (2015/6/26-30), Cairns, Australia. (‹{–{r•ă1, ’†ŽR–žm1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ’ˇ’J•”ł”V1, ‰Ş–{–ql1: 1Ž¨•@ˆôAE“ŞčňŠO)

713116. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Long-term swallowing outcome and displacement of preserved larynx after supracricoid laryngectomy with cricohyoidepiglotto-pexy. Seino Y1, Nakayama M1, Miyamoto S1, Kano K1, Okamoto M1: World Congress on Larynx Cancer 2015. 2015.6.26-30. Cairns, Australia. (´–ě—R”y1, ’†ŽR–žm1, ‹{–{r•ă1, ‰Á”[Fˆę1, ‰Ş–{–ql1: 1Ž¨•@ˆôAE“ŞčňŠO)

713117. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Two cases of laryngeal schwannoma resected by different approaches. Kano K1, Miyamoto S1, Nakayama M1, Seino Y1, Hasebe M1, Okamoto M1: World Congress on Larynx Cancer 2015 (2015/6/26-30), Cairns, Australia. (‰Á”[Fˆę1, ‹{–{r•ă1, ’†ŽR–žm1, ´–ě—R”y1, ’ˇ’J•”ł”V1, ‰Ş–{–ql1: 1Ž¨•@ˆôAE“ŞčňŠO)

713118. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) A case that is superficial HPC resected by hybrid approaches. Hasebe M1, Miyamoto S1, Kano K1, Okamoto T1, Nakayama M1, Okamoto M1: World Congress on Larynx Cancer 2015 (2015/6/26-30), Cairns, Australia. (’ˇ’J•”ł”V1, ‹{–{r•ă1, ‰Á”[Fˆę1, ‰Ş–{—ˇl1, ’†ŽR–žm1, ‰Ş–{–ql1: 1Ž¨•@ˆôAE“ŞčňŠO)

713119. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Actions to be taken for foreign children with hearing loss. Maki A1, Sano H2, Nakagawa T1, Yamashita T1: 16th Japan-Korea Joint Meeting of Otolaryngology-Head and Neck Surgery (2016/3/28-30), Tokyo. (–q@“ÖŽq1, ˛–ě@”Ł2, ’†ě‹Mm1, ŽR‰ş@‘ń1: 1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”)

722194. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) “Şčň•”Šŕ‚ɑ΂ˇ‚é’áNPŽĄ—Â̐V“WŠJ|A“ŞŠŕ: ‰ťŠw•úŽËü—Ă–@‚ĚŽž‘ă‚É‚¨‚Ż‚éA“ވŸ‘S“Eop‚ĚˆĘ’u‚Ă‚Ż|. ’†ŽR–žm (Ž¨•@ˆôAE“ŞčňŠO): ‘ć116‰ń“ú–{Ž¨•@ˆôA‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/5/20-23), “Œ‹ž, “ú–{Ž¨•@ˆôA‰ČŠw‰ď‰ď•ń 2015/10; 118: 1204-11.

722195. [Šw‰ď (‘S‘)] (ƒ‚[ƒjƒ“ƒOƒZƒ~ƒi[) ‹qŠĎ“I•]‰ż–@FAQ: •@ŒÄ‹zś—‚Ě—‰đ‚Ć‹qŠĎ“I•]‰ż–@‚̉ž—p. ‘ĺ–ŘŠ˛•ś (Ž¨•@ˆôAE“ŞčňŠO): ‘ć54‰ń“ú–{•@‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/3), L“‡.

722196. [Šw‰ď (‘S‘)] (ƒrƒfƒIƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“) A“ވŸ‘S“Eop: pŒă”­ş‚ĚƒƒJƒjƒYƒ€. ’†ŽR–žm (Ž¨•@ˆôAE“ŞčňŠO): ‘ć60‰ń“ú–{‰šşŒžŒęˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/15), –źŒĂ‰Ž.

723867. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆŮ‚Č‚é•ű–@‚Ő؏œ‚ľ‚˝A“ސ_ŒoâŽî‚Ě2—á. ‰Á”[Fˆę1, ‹{–{r•ă1, ’†ŽR–žm1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć27‰ń“ú–{A“Ş‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/4/9), “Œ‹ž.

723868. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚é”ńş–ĺŒ^A“ŞŠŕ‚ɑ΂ˇ‚鎥—ÐŹŃ. ‹{–{r•ă1, ’†ŽR–žm1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć27‰ń“ú–{A“Ş‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/4/9), “Œ‹ž.

723869. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) š‹‰şŽž’ɂ𔺂¤čň’Ĺ‘Ocx‘эœ‰ťÇ‚É‚¨‚˘‚ÄŽčpŽĄ—Ă‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ˆęÇ—á. ´–ě—R”y1, —é–Ř—§r1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć27‰ń“ú–{A“Ş‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/4/10), “Œ‹ž.

723870. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰şˆô“ŞŠŕ‚Ě“ŕŽ‹‹žf’f•ű–@‚̍H•v. ‰Ş–{—ˇl1, ×–ě_Žj1, ’†ŽR–žm1, ‹{–{r•ă1, ‰Á”[Fˆę1, ´–ě—R”y1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć27‰ń“ú–{A“Ş‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/4/10), “Œ‹ž.

723871. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw•a‰@ŒűŠW—ôƒ`[ƒ€f—Ă‚É‚¨‚Ż‚鎨•@ˆôA‰ČŽóf‚ɂ‚˘‚Ä‚ĚŒŸ“˘. –q@“ÖŽq1, ‘ĺŒ´‘ěĆ1, –Ř‘şŽé—˘1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć10‰ń“ú–{ŹŽ™Ž¨•@ˆôA‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/5/8), Œyˆä‘ň.

723872. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚鏬Ž™‹CŠÇŘŠJÇ—á‚ĚŒŸ“˘. –Ř‘şŽé—˘1, ‘ĺŒ´‘ěĆ1, –q@“ÖŽq1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć10‰ń“ú–{ŹŽ™Ž¨•@ˆôA‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/5/8), Œyˆä‘ň.

723873. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŹŽ™‡–°Žž–łŒÄ‹zÇŒóŒQ‚É‚¨‚Ż‚éOSA-18“ú–{Œę”Ĺ‚Ě—L—pŤ‚ĚŒŸ“˘. ‘ĺŒ´‘ěĆ1, –q@“ÖŽq1, –Ř‘şŽé—˘1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć10‰ń“ú–{ŹŽ™Ž¨•@ˆôA‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/5/9), Œyˆä‘ň.

723874. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Clinical Study of Transoral Endoscopic Pharyngeal Surgery. ‰Á”[Fˆę1, ‹{–{r•ă1, ’†ŽR–žm1, Œ˜“ce—˜2, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ): ‘ć39‰ń“ú–{“Şčň•”ŠŕŠw‰ďE‘ć4‰ńƒAƒWƒA“Şčň•”ŠŕŠw‰ď (2015/6/3-6), _ŒË, “Şčň•”Šŕ 2015/5; 41 (2): 155.

723875. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ŕŽ‹‹ž“IˆôA“ŞŽčp (ELPS) ‚Ě“K‰ž‚ĆŒŔŠE. ‰Ş–{—ˇl1, ’†ŽR–žm1, Œ˜“ce—˜2, ‹{–{r•ă1, ‰Á”[Fˆę1, ´–ě—R”y1, ×–ě_Žj1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO, 2Á‰ťŠí“ŕ): ‘ć39‰ń“ú–{“Şčň•”ŠŕŠw‰ďE‘ć4‰ńƒAƒWƒA“Şčň•”ŠŕŠw‰ď (2015/6/3-6), _ŒË, “Şčň•”Šŕ 2015/5; 41 (2): 197.

723876. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ă‚É”­ś‚ľ‚˝_ŒoâŽîÇ—á. ’†ě‹Mm1, ’†ŽR–žm1, ‰Á”[Fˆę1, –ŕŽR•Ű1, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć77‰ńŽ¨•@ˆôA‰Č—Տ°Šw‰ď‘‰ďEŠwpu‰‰‰ď (2015/6/25), •lź.

723877. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ESS‚É•K—v‚Č”S–ŒŘŠJŽč‹Z‚ĚŠî–{‚Ɖž—p. —é–Ř—§r1, –ŕŽR•Ű1, —é–ŘˆťŽq1, ‰Ş–{–ql1, ‘ĺ–ŘŠ˛•ś1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć54‰ń“ú–{•@‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/3), L“‡.

723878. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ZŒ^•›•@o^‹ŰÇ‹^‚˘—á‚ւ̑Ήž|ŽŠŒą—á‚Š‚ç‚̍lŽ@|. –ŕŽR•Ű1, —é–Ř—§r1, —é–ŘˆťŽq1, ‰Ş–{–ql1, ‘ĺ–ŘŠ˛•ś1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć54‰ń“ú–{•@‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/3), L“‡.

723879. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •@ŒÄ‹záŠQ‚ĆŒűo“੣‘‡‚Ć‚ĚŠÖŒW‚ɂ‚˘‚ÄŒŸ“˘. ‘ĺ–ŘŠ˛•ś1, ’†ŔŽ‘ŽŔ1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć54‰ń“ú–{•@‰ČŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/3), L“‡.

723880. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚éRamsay HuntÇŒóŒQ‚̐…“—‘яóáv]R‘̉ż‚̐„ˆÚ‚ĆŠç–ʐ_Œo–ƒáƒ‚Ě—\Œă. ŽRŒű’mŽq1, ˛–ě@”Ł2, ‰Ş–{–ql1 (1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”): ‘ć25‰ń“ú–{Ž¨‰ČŠw‰ď‘‰ďŠwpu‰‰‰ď (2015/10/7-10), ’ˇč.

723881. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŘˆĎkŤ‘¤őd‰ťÇ (ALS) ‚Ěš‹‰ş“ŕŽ‹‹žŒŸ¸‚ĚŒŸ“˘. ×–ě_Žj1, ´–ě—R”y1, ˆŔ“cŘ•ä, á–{—R”ü, ‹gŕVŒ’‘ž˜Y, •Ÿ“c—Ď–ç2 (1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”): ‘ć60‰ń“ú–{‰šşŒžŒęˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/16), –źŒĂ‰Ž.

723882. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) A“ވŸ‘S“Eop‚É‚¨‚Ż‚éš‹‰şŽž‚̐Vş–ĺ‹@”\. ´–ě—R”y1, ’†ŽR–žm1, ‹{–{r•ă1, —é–Ř—§r1, ‰Á”[Fˆę1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć60‰ń“ú–{‰šşŒžŒęˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/16), –źŒĂ‰Ž.

723883. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —v‰îŒě‚—îŽŇ‚Ě’ŽŠo•]‰ż|’Ž—ÍŒŸ¸|. ˆäă—ŠG, —é–ŘŒbŽq1, ”~Œ´KŒb, `@ŽáŘ1, ´…@•˝, ˛–ě@”Ł1, ‰Ş–{–ql2 (1ˆă—ÉqśŠw•”, 2Ž¨•@ˆôAE“ŞčňŠO): ‘ć60‰ń“ú–{’ŽŠoˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/22), “Œ‹ž.

723884. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —v‰îŒě‚—îŽŇ‚Ě’ŽŠo•]‰ż|‰îŒěEˆő‚Ě“ď’Ž”FŽŻ‚Ɖî“ü‘O‚̑Ήž|. —é–ŘŒbŽq1, ˆäă—ŠG, ”~Œ´KŒb, `@ŽáŘ1, ´…@•˝, ˛–ě@”Ł1, ‰Ş–{–ql2 (1ˆă—ÉqśŠw•”, 2Ž¨•@ˆôAE“ŞčňŠO): ‘ć60‰ń“ú–{’ŽŠoŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/22), “Œ‹ž.

723885. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éŒăŠú‚—îŽŇ‚Ě•â’ŽŠí‘•—p‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ”~Œ´KŒb, ˆäă—ŠG, —é–ŘŒbŽq1, Œ´@—R‹I1, ’†ě‹Mm2, –q@“ÖŽq2, ˛–ě@”Ł1 (1ˆă—ÉqśŠw•”, 2Ž¨•@ˆôAE“ŞčňŠO): ‘ć60‰ń“ú–{’ŽŠoˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/22), “Œ‹ž.

723886. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •â’ŽŠí•Đ‘¤‘•—p‚É‚ć‚é’Ž—̓Œƒxƒ‹‚ĆŒę‰š–ž—Ä“x‚̕ωť‚ÉŠÖ‚ˇ‚錟“˘. ’†ě‹Mm1, –q@“ÖŽq1, ˆäă—ŠG, ”~Œ´KŒb, —é–ŘŒbŽq2, Œ´@—R‹I2, ˛–ě@”Ł2 (1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”): ‘ć60‰ń“ú–{’ŽŠoˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/22), “Œ‹ž.

723887. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒyE’†“™“x“ď’Ž‚ɑ΂ˇ‚é•â’ŽŠíw“ü•Ź§“x‚đ—˜—p‚ľ‚˝ŹŽ™Ç—á‚ĚŒŸ“˘. –q@“ÖŽq1, ˆäă—ŠG, ”~Œ´KŒb, ’†ě‹Mm1, Œ´@—R‹I2, —é–ŘŒbŽq2, ˛–ě@”Ł2 (1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”): ‘ć60‰ń“ú–{’ŽŠoˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/10/23), “Œ‹ž.

723888. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Œo•@‚—Ź—ĘŽ_‘f“Š—^ (Nasal High FlowTM) Žg—pŠłŽŇ‚Ěš‹‰ş•]‰ż‚ƑΉž. —é–Ř—§r1, ´–ě—R”y1, ×–ě_Žj1, V“c‹`—m1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć67‰ń“ú–{‹CŠÇH“š‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2015/11/19), •Ÿ“‡.

723889. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŽŠ‘î—Ă—{‚É‚ć‚čŰHš‹‰şáŠQ‚̉ü‘P‚Ş‚Ý‚ç‚ę‚˝”F’mÇŠłŽŇ‚Ě1—á. V“c‹`—m1, —é–Ř—§r1, ´–ě—R”y1, ×–ě_Žj1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć67‰ń“ú–{‹CŠÇH“š‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2015/11/19), •Ÿ“‡.

723890. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ž•‚ĚŠš‚Ý•Č‚ĚCł‚É‚ć‚č‰ü‘P‚ľ‚˝CostenÇŒóŒQ—á. —Ž‡@“Ö1, “ż‘Œú“ń, ’†ě‹M”V1, ’ˇŔ‰p–ž2 (1Ž¨•@ˆôAE“ŞčňŠO, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć74‰ń“ú–{‚ß‚Ü‚˘•˝tˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/11/26), Šň•Œ, Equilibrium Res (—\eW) 2015; 74 (5): 472.

723891. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “நáŠQ‚ĆƒXƒgƒŒƒX‚ĚŠÖ˜AŤ‚̉𖞁|Inositol trisphosphate receptor type|1ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚Ě’ŽŠoáŠQ. ’ˇŔ‰p–ž1, Ö“Ą—Yˆę˜Y, ‰ÍŒ´Ž‰ë2, ‰Ş–{–ql3, “ż‘Œú“ń, ŒäŽqŽÄŽ•F (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ś—, 3Ž¨•@ˆôAE“ŞčňŠO): ‘ć74‰ń“ú–{‚ß‚Ü‚˘•˝tˆăŠw‰ď‘‰ďEŠwpu‰‰‰ď (2015/11/27), Šň•Œ, Equilibrium Res (—\eW) 2015; 74 (5): 435.

723892. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŠO‰Č“IŽĄ—Ă‚đs‚Á‚˝—ź‘¤ˆŮŽžŤ‹š˝ŠÖß”^ᇏǗá. ‰Á”[Fˆę1, ‹{–{r•ă1, ’†ŽR–žm1, –ŕŽR•Ű1, ´–ě—R”y1, ‰Ş–{—ˇl1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć26‰ń“ú–{“Şčň•”ŠO‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2016/1/28), –źŒĂ‰Ž.

723893. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “ŕŽ‹‹ž‰ş—֏óˆô“Ş‹ŘŘ’fp‚đŽ{s‚ľ‚˝‘˝”­Ť‹Ř‰Š‚É‚ć‚éš‹‰şáŠQ‚Ě1Ç—á. ´–ě—R”y1, —é–Ř—§r1, ’ˇ’J•”ł”V1, ’†ŽR–žm1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć26‰ń“ú–{“Şčň•”ŠO‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2016/1/28), –źŒĂ‰Ž.

723894. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Supracricoid Laryngectomy‚̏pŒăŠ´ő‚đŒ¸­‚ł‚š‚é‚˝‚ß‚Ě—ŻˆÓ“_. ‹{–{r•ă1, ’†ŽR–žm1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, –ŕŽR•Ű1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć26‰ń“ú–{“Şčň•”ŠO‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2016/1/29), –źŒĂ‰Ž.

723895. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •›ˆô“ŞŠÔŒ„Œs“Ë‘O‹ć‚̗ǐŤŽîᇂɑ΂ˇ‚épŽŽ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. –ŕŽR•Ű1, ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ’†ŽR–žm1 (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć26‰ń“ú–{“Şčň•”ŠO‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď (2016/1/29), –źŒĂ‰Ž.

723896. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–ƒZƒ“ƒ^[‚É‚¨‚Ż‚é•›ˆô“ŞŠÔŒ„Žîá‡114—á‚ĚŒŸ“˘. ź–؁@’1, ŽO‰YO‹K, ‘˝“c—Yˆę˜Y, ‘•Ł’B•v, •šŒŠç’ˆ, ’––“@“O, ›–ěçŒh, ‰Ş–{ˆÉě (1Ž¨•@ˆôAE“ŞčňŠO): ‘ć26‰ń“ú–{“Şčň•”ŠO‰ČŠw‰ď‘‰ď‚Č‚ç‚Ń‚ÉŠwpu‰‰‰ď. (2016/1/29), –źŒĂ‰Ž.

733326. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č“ď’Žf—Ă‚ĚŒť‹ľ. ’†ě‹Mm (Ž¨•@ˆôAE“ŞčňŠO): ‘Š–ÍŒ´Ž¨•@‰Čˆă‰ď (2015/6/18), ‘Š–Í‘ĺ–ě.

733327. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚鏬Ž™čň•””^ᇂ̌Ÿ“˘. ‘ĺŒ´‘ěĆ (Ž¨•@ˆôAE“ŞčňŠO): ‘ć9‰ń‘Š–ÍŒ´DRIAOMSu‰‰‰ď (2015/6/30), ’Ź“c.

733328. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ď‹É“I‚ČŠÉ˜aƒPƒA‚đŽ{s‚ľ‚˝bó‘Bŕh–EŠŕ‚Ěˆę—á. ’ˇ’J•”ł”V1, ’†ŽR–žm1, ’ç@ăĕ˝1, ‰Á”[Fˆę1, ‰Ş–{—ˇl1, ´–ě—R”y1, ‹{–{r•ă1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď ‘ć171‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2015/7/11), ‰Ą•l.

733329. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚éĆŽËŒăÄ”­—á‚ɑ΂ˇ‚é“Ş•”Šs´p. ‰Á”[Fˆę (Ž¨•@ˆôAE“ŞčňŠO): ‘ć28‰ń_“ŢěŒ§Ž¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŽčpŽč‹ZŒ¤‹†‰ď (2015/7/16), ‰Ą•l.

733330. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “Şčň•”EH“š“ŻŽžŤd•ĄŠŕ‚ɑ΂ˇ‚鎥—Ă‚ĚŒă•űŽ‹“IŒŸ“˘. ‰Ş–{—ˇl (Ž¨•@ˆôAE“ŞčňŠO): ‘ć32‰ńEGMRŒ¤‹†‰ď (2015/7/17), “Œ‹ž.

733331. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •@•›•@oŽčpÇ—á‚É‚¨‚Ż‚éDŽ_‹…Ť•›•@o‰Š‚ĚŒŸ“˘. —é–ŘˆťŽq1, ‰iˆä_–¤1, ’ç@ăĕ˝1, —é–Ř—§r1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć172‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2015/9/5), ‰Ą•l.

733332. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘ŠúŠOŘŠJ‚Ş—LŒř‚Ĺ‚ ‚Á‚˝•s‰Âčň•””^ᇂĚ2Ç—á. V“c‹`—m1, ´–ě—R”y1, ’ç@ăĕ˝1, ’†ŽR–žm1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć172‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2015/9/5), ‰Ą•l.

733333. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŹŽ™‚Ě•@ƒAƒŒƒ‹ƒM[‚Ɛ‡–°áŠQ. ‘ĺ–ŘŠ˛•ś (Ž¨•@ˆôAE“ŞčňŠO): ‘ć1‰ńŒ§‰›’nˆćŽ¨•@ˆôA‰ČŒ¤‹†‰ď (2015/11/11), –k–{.

733334. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰@‚̐f—Ă‚ĚŒťó. ‘ĺ‹´Œ’‘ž˜Y (Ž¨•@ˆôAE“ŞčňŠO): ‘ć1‰ńŒ§‰›’nˆćŽ¨•@ˆôA‰ČŒ¤‹†‰ď (2015/11/11), –k–{.

733335. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŹŽ™‚̐‡–°Žž–łŒÄ‹z‚ɂ‚˘‚Ä. ‘ĺŒ´‘ěĆ (Ž¨•@ˆôAE“ŞčňŠO): ‘Š–ÍŒ´Ž¨•@‰Čˆă‰ďŠwpu‰‰‰ď (2015/11/12), ’Ź“c.

733336. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) •›ˆô“ŞŠÔŒ„Œs‘O‹ć‚Ě‘˝Œ`‘BŽî‚ɑ΂ˇ‚épŽŽ‚ɂ‚˘‚Ä. –ŕŽR•Ű1, ‹{–{r•ă1, ´–ě—R”y1, ‰Ş–{—ˇl1, ‰Á”[Fˆę1, ’ˇ’J•”ł”V1, ’†ŽR–žm1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć173‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2015/12/5), ‰Ą•l.

733337. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŹŽ™ˆô“ŞŠO‚Ě—Ő°“IŒŸ“˘. ’ç@ăĕ˝1, ‘ĺŒ´‘ěĆ1, ’ˇ’J•”ł”V1, ’†ŽR–žm1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć173‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2015/12/5), ‰Ą•l.

733338. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) p‘Of’f‚É‹ę—ś‚ľ‚˝•@oŽîᇂĚ1—á. –Ř‘şŽé—˘1, “n•Ó—T”V1, ’–@Œ’Žu1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć173‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2015/12/5), ‰Ą•l.

733339. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “–‰Č‚É‚¨‚Ż‚鏬Šwś‚ĚƒƒjƒG[ƒ‹•a. —Ž‡@“Ö1, ’†ě‹M”V1, ’ˇŔ‰p–ž2 (1Ž¨•@ˆôAE“ŞčňŠO, 2V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć17‰ń_“ސě‚ß‚Ü‚˘ƒtƒH[ƒ‰ƒ€ (2016/2/4), ‰Ą•l.

733340. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒAƒŒƒ‹ƒM[Ť•@‰ŠŽĄ—Ă‚ĚĹV“ŽŒü. —é–Ř—§r (Ž¨•@ˆôAE“ŞčňŠO): Alergy Forum in Sagamihara`ƒfƒBƒŒƒOƒ‰”­”„3Žü”N‹L”Ou‰‰‰ď (2016/2/18), ’Ź“c.

733341. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒfƒBƒŒƒOƒ‰”z‡ů‚ĚŽg—pŒoŒą‚ɂ‚˘‚Ä. ’–@Œ’Žu (Ž¨•@ˆôAE“ŞčňŠO): Alergy Forum in Sagamihara`ƒfƒBƒŒƒOƒ‰”­”„3Žü”N‹L”Ou‰‰‰ď (2016/2/18), ’Ź“c.

733342. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) —ź‘¤lH“ந–„‚ߍž‚ݏp‚đs‚Á‚˝ŹŽ™—á‚Ě’ˇŠúŒo‰ß. –q@“ÖŽq1, ˛–ě@”Ł2, ’†ě‹Mm1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO, 2ˆă—ÉqśŠw•”): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć174‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2015/3/26), ‰Ą•l.

733343. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ŒoH“šSƒGƒR[‚É‚ć‚鉺ˆô“ŞŠO‚Ěˆę—á. ŒĂ–ŘČŒá1, ‰iˆä_–¤1, ŽR‰ş@‘ń1 (1Ž¨•@ˆôAE“ŞčňŠO): “ú–{Ž¨•@ˆôA‰ČŠw‰ď_“ŢěŒ§’n•ű•”‰ď‘ć174‰ńŽ¨•@ˆôA‰ČE“Şčň•”ŠO‰ČŠwpu‰‰‰ď (2015/3/26), ‰Ą•l.


¸_‰ČŠw

[Šwp˜_•ś]

110296. [Œ´’˜] Epileptogenesis and epileptic maturation in phosphorylation site-specific SNAP-25 mutant mice. Watanabe S1, Yamamori S2, Otsuka S, Saito M3, Suzuki E, Kataoka M, Miyaoka H3, Takahashi M2: Epilepsy Research 2015/9; 115: 30-44. (“n•Ó@Ž 1, ŽRX‘D2, âV“Ął”Í3, ‹{‰Ş@“™3, ‚‹´łg2: 1ś•¨•¨—Œn, 2ś‰ť, 3¸_)

110297. [Œ´’˜] Social skills training improves clinical residents' communication skills. Yutani M, Takahashi M1, Takizawa T, Miyaoka H1: Kitasato Med J 2016/3; 46 (1): 53-9. (–ű’JŒł‹K, ‚‹´@Œb1, ‘ęŕV‹B–î, ‹{‰Ş@“™1: 1¸_)

120061. [Œ´’˜] ”F’mÇŠłŽŇ‚ɑ΂ˇ‚鎕‰Čf—Ă‚Ě˘“‚Ć‚ť‚Ě”wŒi—vˆö‚ÉŠÖ‚ˇ‚錤‹†. ‰ş‘ş—TŒŠŽq, ‘ĺÎ@’q1, œA‰ŞF—z1, ‚‹´@Œb1, ‹{‰Ş@“™1 (1¸_): “ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ďŽ 2015/6; 17 (2): 116-22.

120062. [Œ´’˜] ’nˆć‚̉‡•E‚ŞŠ´‚ś‚Ä‚˘‚é”F’mÇƒPƒA‚đŽŔ‘H‚ˇ‚éă‚ł̉ۑč‚Ć‚ť‚Ě”wŒi—vˆö‚ÉŠÖ‚ˇ‚錤‹†|‘Š–ÍŒ´Žs‚ĚƒAƒ“ƒP[ƒg’˛¸‚Š‚çlŽ@‚ˇ‚é|. ‰ş‘ş—TŒŠŽq, ‘ĺÎ@’q1, œA‰ŞF—z1, ‚‹´@Œb1, ‹{‰Ş@“™1 (1¸_): “ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ďŽ 2016/3; 18 (1): 10-8.

521026. [‰đŕ]yŽż‹^‰ž“šzProĚPro [¸_‰Č] ƒxƒ“ƒ]ƒWƒAƒ[ƒsƒ“Œn–ň•¨‚É‚¨‚Ż‚éí—p—ĘˆË‘ś‚ĚŒ`Ź‹@˜. ŕVŽR@“§ (¸_): “ú–{ˆăŽ–V•ń 2015/9; 4769: 63-4.

522161. [uŔ]y—Տ°ŒŸ¸ƒJƒŒƒbƒW: ”F’mÇz”F’mÇ‚Ě‘Šúf’f‚ɖ𗧂”]”g. âV“Ął”Í (¸_): ˆă—Ă‚ĆŒŸ¸‹@ŠíĽŽŽ–ň 2015/6; 38 (3): 295-9.

522162. [uŔ]y“Á•ĘŠé‰ć: ˆË‘ś‚ĆšnD|‚â‚ß‚ç‚ę‚Č‚˘S—zS—E‚Ö‚ĚŠú‘Ň. ‹{‰Ş@“™ (¸_): ‚ą‚ą‚ë‚̉Ȋw 2015/7; 182: 1.

522163. [uŔ]y“Á•ĘŠé‰ć: ˆË‘ś‚ĆšnD|‚â‚ß‚ç‚ę‚Č‚˘S—zŠ—ś—TŽi, ‹{‰Ş@“™1 (1¸_): ‚ą‚ą‚ë‚̉Ȋw 2015/7; 182: 11.

522164. [uŔ]y“Á•ĘŠé‰ć: ˆË‘ś‚ĆšnD|‚â‚ß‚ç‚ę‚Č‚˘S—zˆË‘śÇ‚Ćšn•ČáŠQ@ƒAƒ‹ƒR[ƒ‹ˆË‘śÇ‚̐S—‚Ć‚ť‚ĚŽx‰‡. ŕVŽR@“§ (¸_): ‚ą‚ą‚ë‚̉Ȋw 2015/7; 182: 32-6.

522165. [uŔ]y“ÁW: ŽŒřŤ’ŽËťÜ‚ĚˆÓ‹`Älz“ÁW‚É‚ ‚˝‚Á‚Ä. ‹{‰Ş@“™ (¸_): ¸_‰ČŽĄ—ĂŠw 2015/7; 30 (7): 865.

522166. [uŔ]y“ÁW: ŽŔ’n“ŕ‰Čˆă‚đ–K‚ę‚é‘ź‰Č‚ĚŽžŠł‚Ě“úíf—Ă‚Ć‘Îˆ–@|‚ť‚Ě1 (ŹŽ™‰ČE¸_‰ČE”畆‰ČEŽŒ`ŠO‰Č)zŠe˜_: ŽŔ’n“ŕ‰Čˆă‚̐f—ÂƐę–ĺˆă‚Ć‚Ě˜AŒg‚ĚŽŔŰ‚Ć—ŻˆÓ“_@¸_‰ČŽžŠł: ƒAƒ‹ƒR[ƒ‹ˆË‘śÇ. ŕVŽR@“§ (¸_): Medical Practice 2015/8; 32 (8): 1307-12.

522167. [uŔ]y“ÁW: ŽŠ•ÂÇƒXƒyƒNƒgƒ‰ƒ€áŠQ‚Ě—Ő°‚đ–₤|ŒŠŽ¸‚í‚ę‚˝¸_—Ă–@“IŽ‹“_z<‘ć1•”: ¸_—Ă–@“IŽ‹“_>@‘ĺl‚ĚŽŠ•ÂÇƒXƒyƒNƒgƒ‰ƒ€áŠQ‚̐¸_‰Čˆă—Á|ŽĄ—Ă‚É‚Â‚Č‚Ş‚é–ʐځ|. ‹{‰Ş@“™ (¸_): ¸_—Ă–@ 2015/8; 41 (4): 14-8.

522168. [uŔ]y˜AÚ: “ŕ‰Čˆă‚Ş’m‚Á‚Ä‚¨‚­‚ׂŤ¸_ŽžŠł‚Ě’mŽŻz‘Ě‚Ş‚ž‚é‚­‚Ä, “f‚Ť‹C‚Ş‚ˇ‚é‚ń‚Ĺ‚ˇ. ‚˛”Ń‚ŕH‚ׂç‚ę‚Č‚˘‚Ě‚Ĺ, “_“H‚ľ‚ĉş‚ł‚˘. ŕVŽR@“§ (¸_): “ŕ‰Č 2015/9; 116 (3): 511-6.

522169. [uŔ]y“ÁW: ŽĄ—Ă‚đi‚ß‚éă‚Ĺ‚Ě•aŽŻ, •aŠ´IIzŹŽ™‚Ě”­’BáŠQ‚É‚¨‚˘‚Ä•aŽŻ‚đŠl“ž‚ł‚š‚é‚ą‚Ƃ̐Ľ”ń‚đ‚ß‚Ž‚Á‚Ä. ˆäăŸ•v (¸_): ¸_‰ČŽĄ—ĂŠw 2015/10; 30 (10): 1315-20.

522170. [uŔ]y“ÁW: ƒXƒgƒŒƒXƒ`ƒFƒbƒN§“x‚Ě‹`–ą‰ť‚ƐEę‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒXz‹łˆő‚Ěƒƒ“ƒ^ƒ‹ƒwƒ‹ƒX‚̉ۑč‚ĆŽć‚č‘g‚Ý. ‘ĺÎ@’q1, ‹{‰Ş@“™1 (1¸_): ¸_‰ČŽĄ—ĂŠw 2016/1; 31 (1): 89-94.

522171. [uŔ]y‘ć15‰ńˆă—ĂƒtƒH[ƒ‰ƒ€ƒŒƒ|[ƒg ‰şz’nˆć•ďŠ‡ƒPƒAŽž‘ă‚É‚¨‚Ż‚é”F’mÇ’nˆć˜AŒgƒNƒŠƒeƒBƒJƒ‹ƒpƒXˆă—ÁE‰îŒě‚Ě‚ą‚ę‚Š‚ç‚Ě’Ş—Ź. ‰ş‘ş—TŒŠŽq, ‘ĺÎ@’q1, ‹{‰Ş@“™1 (1¸_): ƒƒfƒBƒJƒ‹ƒNƒI[ƒ‹ 2016/2; 255: 26-30.

540054. [‚ť‚Ě‘ź]y’n•ű‰ď•ń: “Œ‹ž¸_ˆăŠw‰ď‘ć103‰ńŠwpW‰ďz‰ş‚‘Ě‘BŽî‚đ‡•š‚ľ‚˝dÇ‚¤‚•a‚ĚÇ—á‚É‚¨‚Ż‚éCłŒ^“d‹C‚Ż‚˘‚ę‚ń—Ă–@. “n糁@Œ÷1, —›@‰p_1, âV“Ął”Í1, ‹{‰Ş@“™1 (1¸_): ¸__ŒoŠwŽGŽ 2015/11; 117 (11): 941.

[Šw‰ďEŒ¤‹†‰ď“™]

721019. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) yŽi‰ďz‚˘‚Ě‚ż‚ɂ‚˘‚čl‚Ś‚é. ˆäăŸ•v (¸_): ‘ć33‰ń“ú–{Â”NŠú¸_—Ă–@Šw‰ď‘‰ď (2015/11/28), ”މ¤Žq.

722197. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ¸_ˆăŠw‚ĆƒƒfƒBƒAƒŠƒeƒ‰ƒV[. ‹{‰Ş@“™ (¸_): ‘ć111‰ń“ú–{¸__ŒoŠw‰ďŠwp‘‰ď (2015/6/4), ‘ĺă.

722198. [Šw‰ď (‘S‘)] (‹łˆçu‰‰)yŽi‰ďz‚¤‚•a‚Ě–ň•¨—Ă–@‚̏”–â‘č. ˆäăŸ•v (¸_): “ú–{ŽvtŠúÂ”NŠú¸_ˆăŠw‰ď‘ć28‰ń‘ĺ‰ď (2015/7/12), ‰Ą•l.

722199. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ‚¤‚•a‚Ě–ň•¨—Ă–@‚̏”–â‘č. ‹{‰Ş@“™ (¸_): “ú–{ŽvtŠúÂ”NŠú¸_ˆăŠw‰ď‘ć28‰ń‘ĺ‰ď (2015/7/12), ‰Ą•l.

722200. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ƒPƒAƒ}ƒl[ƒWƒƒ[‚Š‚猊‚˝ˆă—ÂƉîŒě‚Ě˜AŒgƒc[ƒ‹‚Ć‚ľ‚Ä‚Ě”F’mÇ’nˆć˜AŒgƒNƒŠƒjƒJƒ‹ƒpƒX. ‰i–ěŒb”üŽq, –{‘˝—], ‘ĺÎ@’q1, –؉ş—ćŽq1, ’†‘ş“Ţ“Ţ, ‰ş‘ş—TŒŠŽq, ‹{‰Ş@“™1 (1¸_): ‘ć16‰ń“ú–{ƒNƒŠƒjƒJƒ‹ƒpƒXŠw‰ďŠwpW‰ď (2015/11/14), ‰YˆŔ.

722201. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) _“ŢěŒ§‚̐¸_‰Č‹~‹}ˆă—ÂƉüł¸_•ŰŒ’•ŸŽƒ–@|–â‘č“_‚ƑΉž|. ‹{‰Ş@“™ (¸_): ‘ć23‰ń“ú–{¸_‰Č‹~‹}Šw‰ďŠwp‘‰ď (2015/12/11), –źŒĂ‰Ž.

723897. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) í—p—Ę‚Ěnortriptyline•ž—p’†‚ɐ¸_‰^“Ž”­ě‚đ‚Ť‚˝‚ľ‚˝ˆę—á. ‹´–{@Ž÷1, ‰ÄŽR@‘ě2, ‹{’nLŒá1, ‘ĺÎ@’q1, ‹{‰Ş@“™1 (1¸_, 2’nˆćŽ™“ś¸_): ‘ć111‰ń“ú–{¸__ŒoŠw‰ďŠwp‘‰ď (2015/6/4), ‘ĺă.

723898. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –k—˘‘ĺŠw“Œ•a‰@‚É‚¨‚Ż‚é_ŒoŤ–łH—~Ç‚Ě“ü‰@s“Ž§ŒŔ—Ă–@‚ĚŽŔ‘Ô. ŽRŠp@Œ\1, ‹´–{š–ő1, —Lˆä_ˆę1, ŸNˆäGŽ÷1, ‚‹´Œb—1, ˆäăŸ•v1, Ö“Ął”Í1, ‹{‰Ş@“™1 (1¸_): ‘ć111‰ń“ú–{¸__ŒoŠw‰ďŠwp‘‰ď (2015/6/5), ‘ĺă.

723899. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) _“ŢěŒ§‘Š–ÍŒ´Žs‚É‚¨‚Ż‚é”F’mÇ’nˆć˜AŒgƒpƒX‚ĚŒťó‚Ɖۑč. ›I@‘P‹M1, ‘ĺÎ@’q1, ‹{‰Ş@“™1 (1¸_): ‘ć111‰ń“ú–{¸__ŒoŠw‰ďŠwp‘‰ď (2015/6/6), ‘ĺă.

723900. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œ’íŽŇ‚¨‚ć‚ŃŒy“x”F’máŠQŠłŽŇ‚É‚¨‚Ż‚é”F’m‹@”\‚̉Á—•Ď‰ť‚ɂ‚˘‚Ä. ÎˆäŒőŽ÷, ‚‹´@Œb1, ‘ęŕV‹B–î2, ‘ĺÎ@’q1, Vˆä‹v–Ť3, ‹{‰Ş@“™1 (1¸_, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3‹~–˝): ‘ć30‰ń“ú–{˜V”N¸_ˆăŠw‰ď (2015/6/13), ‰Ą•l.

723117. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –œˆř‚Ť‚đŒJ‚č•Ô‚ľ‚˝’jŽ™‚ɂ‚˘‚Ä‚Ě—Ő°“IlŽ@|ŒÂl—Ă–@‚ƉƑ°ƒAƒvƒ[ƒ`‚Ć‚˘‚¤Ž‹“_|. Ź—ŃŽŔ‰Ô1, _’Jr‰î1, ś’n@V2, ˆäăŸ•v3 (1’nˆćŽ™“ś¸_, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3¸_): “ú–{ŽvtŠúÂ”NŠú¸_ˆăŠw‰ď‘ć28‰ń‘ĺ‰ď (2015/7/11), ‰Ą•l.

723901. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Rey-Osterrieth@•ĄŽG}Œ`ŒŸ¸|”˝‰ž}‚Ě—ŢŒ^‰ť‚Ć”­’BáŠQŽĺf’f‚Ć‚ĚŠÖ˜A|. ˆäăŸ•v1, ŽÄ@—ćŽq, ˜a“c^—Žq, ‹{‰Ş@“™1 (1¸_): ‘ć56‰ń“ú–{Ž™“śÂ”N¸_ˆăŠw‰ď‘‰ď (2015/9/30), ‰Ą•l.

723902. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[)yŽi‰ďz’nˆć˜AŒg@Žx‰‡. ˆäăŸ•v (¸_): ‘ć56‰ń“ú–{Ž™“śÂ”N¸_ˆăŠw‰ď‘‰ď (2015/9/30), ‰Ą•l.

723903. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ¸_•aÇó‚đ‡•š‚ľ‚˝dÇ_ŒoŤ‚â‚šÇ‚Ě2Ç—á. –k–ƒŠóŽq1, —Lˆä_ˆę1, ‚‹´Œb—1, ‹{‰Ş@“™1 (1¸_): ‘ć19‰ń“ú–{ŰHáŠQŠw‰ďŠwpW‰ď (2015/10/24), •Ÿ‰Ş.

723118. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’áƒiƒgƒŠƒEƒ€ŒŒÇ‚É”ş‚¤ö—ó‘Ô‚đ‹^‚í‚ę‚˝1Ç—á|ƒŠƒGƒ]ƒ“ƒ`[ƒ€‚ĚˆÓ‹`|. _’Jr‰î1, ”’ˆä‹łŽq, ŽO‰Yƒ]2, Ź—ŃŽŔ‰Ô1, ˆäăŸ•v2, ‹{‰Ş@“™2 (1’nˆćŽ™“ś¸_, 2¸_): ‘ć28‰ń“ú–{‘‡•a‰@¸_ˆăŠw‰ď‘‰ď (2015/11/28), “ż“‡.

731162. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚¤‚•a: –ň•¨—Ă–@ˆČ‘O‚ɍl‚Ś‚é‚ׂŤ‚ą‚Ć. ‹{‰Ş@“™ (¸_): ‘ć32‰ńˆ¤•QŒ§¸__ŒoŠw‰ď (2015/6/13), źŽR.

731163. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Eˆć‚É‚¨‚Ż‚邤‚•a‚Ć‚ť‚ĚŽü•Ó‚ւ̑Ήž. ‹{‰Ş@“™ (¸_): ŽY‹Ćƒƒ“ƒ^ƒ‹ƒwƒ‹ƒXŒ¤C‰ď (•Ÿ“‡ˆăŽt‰ďEˆÉ’BˆăŽt‰ďEˆŔ’BˆăŽt‰ď) (2016/2/12), •Ÿ“‡.

731164. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Œ´ˆö‚ĚŒŠ‚‚Š‚ç‚Č‚˘’É‚Ý‚Ěl‚Ś•ű‚ƑΉž. ‹{‰Ş@“™ (¸_): ‘ć43‰ń•şŒÉŒ§¸_ˆă—ĂŠwpu‰‰‰ď (2016/3/12), _ŒË.

732112. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçƒZƒ~ƒi[) ’m”\E”F’m‚Ě”­’B‚Ć’m”\ŒŸ¸. ˆäăŸ•v (¸_): ‘ć17‰ń“ú–{ŹŽ™¸_ˆăŠwŒ¤‹†‰ď (2015/8/21), _ŒË.

732113. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) R‚Ä‚ń‚Š‚ń–ň‚̏ˆ•ű•ĎX‚ɂ‚˘‚Ä âV“Ął”Í (¸_): ‘Š–ÍŒ´’†–k•”‚Ě‚Ä‚ń‚Š‚ńŽĄ—Ă‚đl‚Ś‚é‰ď (2015/11/17), ‘Š–ÍŒ´.

732114. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰) ‘ĺl‚Ě”­’BáŠQ‚Ƃ́H`Šî–{“I‚Č—‰đ‚ƑΉž‚ĚŽd•ű‚ɂ‚˘‚ā`. ‹{‰Ş@“™ (¸_): •˝Ź27”N“x”DPEoŽYŽx‰‡‘̐§‚Ă‚­‚莖‹ĆŒ¤C‰ď _“ŢěŒ§Œú–Ř•ŰŒ’•ŸŽƒŽ––ąŠ‘ĺ˜aƒZƒ“ƒ^[ (2016/2/3), ‘ĺ˜aŽs.

732115. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŔ’ˇz¸_‰ČƒŠƒGƒ]ƒ“ƒ`[ƒ€‚Ě—L—pŤ‚ɂ‚˘‚ā`ŠeŽ{Ý‚ĚŽć‚č‘g‚Ý‚ĆĄŒă‚̉ۑč. ŽR–{ŒŤŽi, ‹{’n‰p—Y1 (1¸_): ‘ć42‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2016/3/5), ‰Ą•l.

732116. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) S—–Ę‚É”z—ś‚ľ‚˝–ʐڂƐ¸_—Ă–@. ‹{‰Ş@“™ (¸_): ‘ć42‰ń_“ŢěŒ§SgˆăŠw‰ďŠwp‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2016/3/5), ‰Ą•l.

732006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ¸_‰ČƒŠƒGƒ]ƒ“ƒ`[ƒ€‚Ě—L—pŤ‚ɂ‚˘‚ā`ŠeŽ{Ý‚ĚŽć‚č‘g‚Ý‚ĆĄŒă‚̉ۑč. _’Jr‰î (’nˆćŽ™“ś¸_): ‘ć42‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2016/3/5), ‰Ą•l.

733344. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒp[ƒLƒ“ƒ\ƒ“•a‚Ɛf’f‚ł‚ę‚˝–ňÜŤ‘ĚŠO˜HÇó. ˆäă•üŽq1, ‰ÄŽR@‘ě2, ‹{‰Ş@“™1 (1¸_, 2’nˆćŽ™“ś¸_): “Œ‹ž¸_ˆăŠw‰ď‘ć104‰ńŠwpW‰ď (2015/7/4), “Œ‹ž.

733345. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹CŽż•Ş—Ţdifficult child‚ƍl‚Ś‚ç‚ę‚˝ŹŠwś—Ž™‚ĚŽĄ—ĂŒo‰ß. ˆäăŸ•v (¸_): ‘ć64‰ń_“ސ쎙“śÂ”N¸_ˆăŠwŒ¤‹†‰ď (2015/7/11), ‰Ą•l.

733346. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŰHš‹‰ş‚Ě–â‘č‚ĹŽ•‰Čę–ĺŠO—ˆ‚đŽóf‚ľ‚˝Ž™“ś‚ɑ΂ˇ‚鐸_‰Čˆă‚Ě‚Š‚Š‚í‚č‚ɂ‚˘‚Ä. ‹{’n‰p—Y1, ŽR–{š’ź, ‘ĺ‹v•Ű^ˆß (1¸_): ‘ć41‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2015/9/26), ‰Ą•l.

733347. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) m-ECT‚đŽŔŽ{‚ľ‚˝‹‘ĺ‚­‚ŕ–Œ‚Ě‚¤–E‚đ‡•š‚ľ‚˝dÇ‚¤‚•aÇ—á. ‹´–{š–ő1, ‰ÄŽR@‘ě2, ‹{’nLŒá1, ‘ĺÎ@’q1, ‹{‰Ş@“™1 (1¸_, 2’nˆćŽ™“ś¸_): “Œ‹ž¸_ˆăŠw‰ď‘ć105‰ńŠwpW‰ď (2015/11/14), “Œ‹ž.

733348. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Rbó‘BŽŠŒČR‘Ě—zŤ‚đ‚ľ‚ß‚ľ‚˝ŽYĺńŠú¸_•a‚Ě1—á. ‘ş™@–G1, ł–؍—Ń1, ›I@‘P‹M1, ‹g‘ş—LŠó1, ‰ÄŽR@‘ě2, ‹{’nLŒá1, ‘ĺÎ@’q1, ‹{‰Ş@“™1 (1¸_, 2’nˆćŽ™“ś¸_): “Œ‹ž¸_ˆăŠw‰ď‘ć105‰ńŠwpW‰ď (2015/11/14), “Œ‹ž.

733349. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”­Ç‚Š‚玥—ĂŠJŽn‚Ü‚Ĺ‚ÉŽžŠÔ‚đ—v‚ľ‚˝_Œo”~“Ĺ‚Ě1—á. ‹g‘ş—LŠó1, ›I@‘P‹M1, ‘ĺÎ@’q1, ‹{‰Ş@“™1 (1¸_): “Œ‹ž¸_ˆăŠw‰ď‘ć105‰ńŠwpW‰ď (2015/11/14), “Œ‹ž.

733350. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠÔŒ‡Ť”š”­Ç‚Ş‹^‚í‚ę‚˝ŹŠwś—Ž™‚ĚŽĄ—ĂŒo‰ß. ˆäăŸ•v (¸_): ‘ć29‰ń“ú–{ŹŽ™¸_ˆăŠwŒ¤‹†‰ď (2016/2/27), ‘ĺ’Ă.

733351. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘˝—l‚Ȑ¸_Çó‚đ’ć‚ľ, ƒrƒ^ƒ~ƒ“B12Œ‡–RŤ”]Ç‚đ‹^‚Á‚˝1—á. ŹŕV@Šî1, ›I@‘P‹M1, ‘ĺÎ@’q1, ‹{‰Ş@“™1 (1¸_): “Œ‹ž¸_ˆăŠw‰ď‘ć106‰ńŠwpW‰ď (2016/3/12), “Œ‹ž.


•úŽËü‰ČŠw (‰ć‘œf’fŠw)

[Šwp˜_•ś]

110298. [Œ´’˜] Methods of CT Dose Estimation in Whole-Body 18F-FDG PET/CT. Inoue Y1, Nagahara K2, Tanaka Y2, Miyatake H2, Hata H2, Hara T1: J Nucl Med 2015/5; 56 (5): 695-700. ( ˆäă—D‰î1, ‰iŒ´˜aŒ›2, “c’†’ől2, ‹{•”ä˜CŽ÷2, `@”Ž•ś2, Œ´@•qŤ1: 1•úŽËü (‰ć‘œ), 2•úŽËü•”)

110299. [Œ´’˜] Effect of the Energy Window Width on the Estimation of Renal Function from Dynamic Renal Scintigraphy with 99mTc-MAG3. Asano Y1, Ohzeki Y2, Inoue Y1: Open J Med Imaging 2015/6 ; 5 (2): 37-41. (ó–ě—Y“ń1, ‘ĺŠÖ—T‰î2, ˆäă—D‰î1: 1•úŽËü (‰ć‘œ), 2•úŽËü•”)

110300. [Œ´’˜] Assessment of MRI Contrast Agent Kinetics via Retro-Orbital Injection in Mice: Comparison with Tail Vein Injection. Wang F1,2, Nojima M3, Inoue Y4, Ohtomo K5, Kiryu S1: PLoS One 2015/6; 10 (6): e0129326. (ˆäă—D‰î4: 1“Œ‹ž‘ĺŠw, 2ŽR“Œ‘ĺŠw (’†‘), 3“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š, 4•úŽËü (‰ć‘œ), 5“Œ‹ž‘ĺŠw‘ĺŠw‰@)

110301. [Œ´’˜] Validity of the mediastinum as a reference region to evaluate cardiac accumulation of iodine-123 metaiodobenzylguanidine. Inoue Y1, Abe Y2, Asano Y1, Kikuchi K2: Ann Nucl Med 2015/8; 29 (7): 650-7. (ˆäă—D‰î1, ˆ˘•”@–L2, ó–ě—Y“ń1, ‹e’r@Œh2: 1•úŽËü (‰ć‘œ), 2•úŽËü•”)

110302. [Œ´’˜] MONITORING DOSE-LENGTH PRODUCT IN COMPUTED TOMOGRAPHY OF THE CHEST CONSIDERING SEX AND BODY WEIGHT. Inoue Y1, Nagahara K2, Hayakawa N2, Hanawa H2 , Hata H2: Radiat Prot Dosimetry 2015/9. pii: ncv401. [Epub ahead of print] (ˆäă—D‰î1, ‰iŒ´˜aŒ›2, ‘ě’ź“š2, ”ˇ@G“T2, `@”Ž•ś2: 1•úŽËü (‰ć‘œ), 2•úŽËü•”)

110303. [Œ´’˜] Source analysis of stimulus-preceding negativity constrained by functional magnetic resonance imaging. Kotani Y1, Ohgami Y1, Ishiwata T2, Arai J3, Kiryu S4, Inoue Y5: Biol Psychol 2015/10; 111: 53-64. (ˆäă—D‰î5: 1“Œ‹žH‹Ć‘ĺŠw, 2—§‹ł‘ĺŠw, 3ƒ_ƒCƒLƒ“H‹ĆŠ”ŽŽ‰ďŽĐ, 4“Œ‹ž‘ĺŠw, 5•úŽËü (‰ć‘œ))

110304. [Œ´’˜] Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial. Suzuki H1, Inoue Y2, Fujimoto H3, Yonese J4, Tanabe K5, Fukasawa S6, Inoue T7, Saito S8, Ueno M9, Otaka A10: Jpn J Clin Oncol 2016/2; 46 (2): 152-62. (ˆäă—D‰î2: 1“Œ–M‘ĺŠwˆă—ĂƒZƒ“ƒ^[˛‘q•a‰@”ĺ”AŠí‰Č, 2•úŽËü (‰ć‘œ), 3‘—§‚Ş‚ńŒ¤‹†ƒZƒ“ƒ^[”ĺ”AŠí‰Č, 4Œö‰vŕ’c–@l‚Ş‚ńŒ¤‹†‰ď—L–ž•a‰@”ĺ”AŠí‰Č, 5“Œ‹ž—Žqˆă‰Č‘ĺŠw•a‰@t‘Ÿ•a‘‡ˆă—ĂƒZƒ“ƒ^[”ĺ”AŠí‰Č, 6ç—tŒ§‚Ş‚ńƒZƒ“ƒ^[”ĺ”AŠí‰Č, 7‰Ą•lŽs—§‘ĺŠw•‘Ž•a‰@”ĺ”AŠí‰Č, 8“Ć—§s­–@l‘—§•a‰@‹@\“Œ‹žˆă—ĂƒZƒ“ƒ^[”ĺ”AŠí‰Č, 9é‹Ęˆă‰Č‘ĺŠw‘Űˆă—ĂƒZƒ“ƒ^[”ĺ”AŠíŽîᇉČ, 10“ú–{ƒƒWƒtƒBƒWƒbƒNƒXŠ”ŽŽ‰ďŽĐ)

511001. [‰đŕ] Interventional radiology for critical hemorrhage in obstetrics: Japanese Society of Interventional Radiology (JSIR) procedural guidelines. Sone M1, Nakajima Y2, Woodhams R3, Shioyama Y4, Tsurusaki M5, Hiraki T6, Yoshimatsu M2, Hyodoh H7, Kubo T8, Takeda S9, Minakami H10: Jpn J Radiol 2015/4; 33 (4): 233-40. (ƒEƒbƒhƒnƒ€ƒX—ćŽq3: 1‘—§‚Ş‚ńŒ¤‹†ƒZƒ“ƒ^[’†‰›•a‰@•úŽËüf’f‰Č, 2šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠwˆăŠw•”•úŽËüˆăŠw, 3•úŽËü (‰ć‘œ), 4ŕՋŚˆă‰Č‘ĺŠw•úŽËüˆăŠwuŔ, 5‹ß‹E‘ĺŠwˆăŠw•”•úŽËüˆăŠwuŔ•úŽËüf’fŠw, 6‰ŞŽR‘ĺŠwˆăŠw•”•úŽËüˆăŠw, 7ŽD–yˆă‰Č‘ĺŠwˆăŠw•”•úŽËüf’fŠw, 8‘—§Źˆçˆă—ĂŒ¤‹†ƒZƒ“ƒ^[ŽüŽYŠúE•ęŤf—ĂƒZƒ“ƒ^[ŽY‰Č, 9‡“V“°‘ĺŠwˆăŠw•”ŽY•wl‰ČŠwuŔ, 10–kŠC“š‘ĺŠw‘ĺŠw‰@ˆăŠwŒ¤‹†‰ČˆăŠwęUśBE”­’BˆăŠwuŔŽY‰ČEśBˆăŠw•Ş–ě)

520014. [‘ŕ]y“ÁW: ”]_ŒoE“Şčň•”‚̐f’f‚ĆŽĄ—Ăupdatez‘ŕ: “Ş•”MRIŠgŽU‹­’˛‘œ‚É‚¨‚Ż‚é—ź‘¤‘ĺ”]”ź‹…‘˝”­—ąó‚M†ˆć. Œ´@•qŤ1, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ)): —Տ°•úŽËü 2015/5; 60 (5): 613-20.

521027. [‰đŕ]y‚ą‚ą‚Ş’m‚č‚˝‚˘!z‰ć‘œf’f2015”N1ŒŽ†“ÁWu•@•›•@o—Ěˆć‚Ě‰ć‘œf’f|minimum requirement|v. ‰Á“Ą”ŽŠî, •‚F—´‘ž˜Y1 (1•úŽËü (‰ć‘œ)): ‰ć‘œf’f 2015/5; 35 (7): 864-7.

[’˜@‘]

620117. [Šwp‘] (•Ş’SŽˇ•M)y‹~‹}‰ć‘œf’f‚Ě‚ˇ‚×‚Ä (—Տ°•úŽËü2015”N11ŒŽ—ŐŽž‘Š§† (60ŠŞ 11†))zĄ‘˜_@“Şčň•”, p.1356-9. •‚F—´‘ž˜Y (•úŽËü (‰ć‘œ)), •Ň: —Տ°•úŽËü•ŇWˆĎˆő‰ď, ‹ŕŒ´o”Ĺ, “Œ‹ž, 2015/11”­s.

620118. [Šwp‘] (•Ş’SŽˇ•M)y“Şčň•”‰ć‘œf’f‚É•K—v•s‰ÂŒ‡‚Č—Ő°E‰ć‘œ‰đ–Uz5. “ŞŠW’ę, p.70-86. “Ą“cWŽj1, Žđˆä@C2, ™–{‰pŽĄ1, –L“cŒ\Žq3, Îě–qŽq4, ’Ë–{@_5, X@@¤6, •‚F—´‘ž˜Y7, Ź‹Ę—˛’j8, ’ˇ“ęT“ń9, ’r“ckŽm10, ‘OŒ´@–Ť11, ŕV“c@•q11, ’†ŽRŒ\Žq12, ‰Ş‘şŒő‰p13, •Ä’ÍNˆę14, ’†‘ş@‘ě14, –Ř‘şKŠó15, “c’†GŽq16, Šp@”ü˛14 (1ŽŠŽĄˆă‰Č‘ĺŠw•úŽËüˆăŠwuŔ, 2ƒ{ƒXƒgƒ“‘ĺŠwEƒ{ƒXƒgƒ“ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[•úŽËü‰Č, 3’é‹ž‘ĺŠwˆăŠw•”•úŽËü‰ČŠwuŔ, 4š—ꉥ•l•a‰@•úŽËüf’f‰Č, 5Ă‰ŞŽs—§´…•a‰@•úŽËüf’f‰Č, 6“Œ‹ž‘ĺŠw‘ĺŠw‰@ˆăŠwŒnŒ¤‹†‰Čś‘Ě•¨—ˆăŠwęU•úŽËüˆăŠwuŔ•úŽËüf’fŠw•Ş–ě, 7•úŽËü (‰ć‘œ), 8‹{č‘ĺŠwˆăŠw•”•a‘Ô‰đÍˆăŠwuŔ•úŽËüˆăŠw•Ş–ě, 9–źŒĂ‰Ž‘ĺŠw‘ĺŠw‰@ˆăŠwŒnŒ¤‹†‰Č‘‡ˆăŠwęU‚ŽŸˆă—p‰ČŠwuŔ—ĘŽqˆăŠw•Ş–ě, 10ŠÖźˆă‰Č‘ĺŠw•‘Ž‘ęˆä•a‰@•úŽËü‰Č, 11ŠÖźˆă‰Č‘ĺŠw•‘Ž–‡•ű•a‰@, 12Žs—§ˆÉ’O•a‰@•úŽËü‰Č, 13Ďś‰ď’†’Ă•a‰@PETƒZƒ“ƒ^[, 14’ˇč‘ĺŠwŽ•Šw•”“Şčň•”•úŽËüŠw•Ş–ě, 15ş˜a‘ĺŠwŽ•Šw•”Œűo•a‘Ԑf’f‰ČŠwuŔŽ•‰Č•úŽËüˆăŠw•”–ĺ, 16‚Ş‚ńŒ¤‹†‰ď—L–ž•a‰@‰ć‘œf’f•”), •Ň: ”öK”Ž–ç17 (17“Œ‹žŽœŒb‰ďˆă‰Č‘ĺŠw•úŽËüˆăŠwuŔ), ŠwŒ¤ƒƒfƒBƒJƒ‹GŽĐ, “Œ‹ž, 2015/4”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712032. [Šw‰ď (‘Ű)] (‘ŰŽx‰‡) IR management for obstetric hemorrhage. Woodhams R1: JCR‘ŰŽx‰‡Šˆ“Ž (2016/3/18-22), Ho Chi Minh, Vietnam. (ƒEƒbƒhƒnƒ€ƒX—ćŽq1: 1•úŽËü (‰ć‘œ))

713120. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Anticipation process is faster for facial stimulus than for word and symbolic stimuli: fMRI con-strained source analysis on stimulus-preceding negativity. Kotani Y1, Ohgami Y1, Arai J2, Kiryu S3, Inoue Y4: 2015 Annual Meeting of the Organization of Human Brain Mapping (2015/6/14-18), Honolulu, USA, Poster Listing Book 2015; p.79. (ˆäă—D‰î4: 1“Œ‹žH‹Ć‘ĺŠw, 2ƒ_ƒCƒLƒ“H‹ĆŠ”ŽŽ‰ďŽĐ, 3“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 4•úŽËü (‰ć‘œ))

713121. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Spatial components of stimulus-preceding negativity prior to unilateral stimulus presentation. Ohgami Y1, Kotani Y1, Arai J2, Kiryu S3, Inoue Y4: 2015 Annual Meeting of the Organization of Human Brain Mapping (2015/6/14-18), Honolulu, USA, Poster Listing Book 2015; p.80. (ˆäă—D‰î4: 1“Œ‹žH‹Ć‘ĺŠw, 2ƒ_ƒCƒLƒ“H‹ĆŠ”ŽŽ‰ďŽĐ, 3“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 4•úŽËü (‰ć‘œ))

713122. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Double D technique for saccular aortic aneurysm: a solution to challenging anatomy for bifurcated stent-graft placement. Woodhams R1, Nishimaki H2, Sakurai Y2, Murakami K3, Ogawa Y3, Chiba K2, Ono H2, Chikada M2, Hase S4, Nishimura J4, Miyairi T2: CIRSE2015 (2015/9/26-30), Lisbon, Portugal. (ƒEƒbƒhƒnƒ€ƒX—ćŽq1: 1•úŽËü (‰ć‘œ), 2šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠwS‘ŸŒŒŠÇŠO‰Č, 3šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠw•úŽËüˆăŠw, 4ěčK•a‰@•úŽËüIVR‰Č)

713123. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) A multi-institutional survey of transcatheter arterial embolization for type II endoleak after endovascular aortic repair: a retrospective study of technical aspects and outcomes. Ogawa Y1, Nishimaki H2, Osuga K3, Ikeda O4, Hongo N5, Iwakoshi S6, Kawasaki R7, Woodhams R8, Yamaguchi M9, Kamiya M10, Kanematsu M11, Honda M12, Kaminou T13, Koizumi J14, Kichikawa K15: CIRSE2015 (2015/9/29), Lisbon, Portugal. (ƒEƒbƒhƒnƒ€ƒX—ćŽq8: 1šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠw•úŽËüˆăŠw, 2šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠwS‘ŸŒŒŠÇŠO‰Č, 3‘ĺă‘ĺŠw•úŽËüˆăŠw, 4ŒF–{‘ĺŠw•úŽËü‰Č, 5‘ĺ•Ş‘ĺŠwˆăŠw•”•úŽËüˆăŠwuŔ, 6“Ţ—ÇŒ§—§ˆă‰Č‘ĺŠw•úŽËü‰Č, 7•şŒÉŒ§—§•P˜HzŠÂŠí•aƒZƒ“ƒ^[, 8•úŽËü (‰ć‘œ), 9_ŒË‘ĺŠw‘ĺŠw‰@ˆăŠwŒ¤‹†‰Č“ŕ‰ČŒnuŔ•úŽËüˆăŠw•Ş–ě, 10•lźˆă‰Č‘ĺŠw•úŽËüˆăŠw, 11Šň•Œ‘ĺŠwˆăŠw•”•‘Ž•a‰@•úŽËü‰Č, 12Ďś‰ď‰F“s‹{•a‰@•úŽËü‰Č, 13’šŽć‘ĺŠw•úŽËü‰Č, 14“ŒŠC‘ĺŠwˆăŠw•”•‘Ž•a‰@‰ć‘œf’f‰Č, 15“Ţ—ÇŒ§—§ˆă‰Č‘ĺŠw•úŽËü‰Č)

713124. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Neural substrates of early and late stimulus-preceding negativity: fMRI-constrained ERP source analysis (poster version). Kotani Y1, Ohgami Y1, Arai J2, Kiryu S3, Inoue Y4: The 55th Annual Meeting of Society for Psychophysiological Research (2015/9/30-10/4), Seattle, USA, Psychophysiology 2015; 52 (suppl 1): S72. (ˆäă—D‰î4: 1“Œ‹žH‹Ć‘ĺŠw, 2ƒ_ƒCƒLƒ“H‹ĆŠ”ŽŽ‰ďŽĐ, 3“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 4•úŽËü (‰ć‘œ))

713125. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Effect of unilateral stimulus presentation on components of stimulus-preceding negativity. Ohgami Y1, Kotani Y1, Arai J2, Kiryu S3, Inoue Y4: The 55th Annual Meeting of Society for Psychophysiological Research (2015/9/30-10/4), Seattle, USA, Psychophysiology 2015; 52 (suppl 1): S72. (ˆäă—D‰î4: 1“Œ‹žH‹Ć‘ĺŠw, 2ƒ_ƒCƒLƒ“H‹ĆŠ”ŽŽ‰ďŽĐ, 3“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 4•úŽËü (‰ć‘œ))

713126. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Abnormal Low Signal on T2-weighted MR imaging in Head and Neck Tumors and Tumor-like Conditions. Ukisu R1, Inoue Y1: AOCNR2015 (2015/11/5-7), Fukuoka, AOCNR2015 Program and Abstract 2015/8; p.135. (•‚F—´‘ž˜Y1, ˆäă—D‰î1: 1•úŽËü (‰ć‘œ))

721020. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ŽŔ‘H! ŠjˆăŠw“lje‚ĚƒRƒc‹ł‚Ś‚Ü‚ˇ. ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć51‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď (2015/10/2), ˇ‰Ş, ‘ć51‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď´˜^W 2015/9; p.S392.

722202. [Šw‰ď (‘S‘)] (‹łˆçu‰‰)y“ű‘B: “ű‘B‚c‚v‚h‚Ćăüâ|ƒŠƒ“ƒpßUS‚Ěupdate informationz“ű‘BŠgŽU‹­’˛‰ć‘œ‚Ě‘‡—‰đ. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ‘ć74‰ń“ú–{ˆăŠw•úŽËüŠw‰ď‘‰ď (2015/4/18), ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ 2015/2; p.S119.

722203. [Šw‰ď (‘S‘)] (‹łˆç“WŽŚ) CT and MR Imaging of Head and Neck Lesions in the Immunocompromised Patients. •‚F—´‘ž˜Y1, ŽRŞ‘ń˜Y1, ‘ĺ’ˈŸš–˘1, “‡“c—Œb1, Œ´@•qŤ1, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ)): ‘ć74‰ń“ú–{ˆăŠw•úŽËüŠw‰ď‘‰ď (2015/4/16-19), ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ 2015/2; p.S149-50.

722204. [Šw‰ď (‘S‘)] (‹łˆç“WŽŚ) Key points on adrenal venous sampling. •›tĂ–ŹƒTƒ“ƒvƒŠƒ“ƒO‚Ě—v“_. ŹŠ}Œ´‹1, ˆäă—D‰î1, •‚F—´‘ž˜Y1, ź‰iŒh“ń1, ƒEƒbƒhƒnƒ€ƒX—ćŽq1, ó–ě—Y“ń1, “Ąˆä@Š]1, “ü]‚‚Ž‚Ý1, Œ´@•qŤ1, ŽRŞ‘ń˜Y1 (1•úŽËü (‰ć‘œ)): ‘ć74‰ń“ú–{ˆăŠw•úŽËüŠw‰ď‘‰ď (2015/4/16-19), ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ 2015/2; p.S165.

722205. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ‘O’u–ü’…‘ٔՂɑ΂ˇ‚éIVR. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ‘ć51‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2015/7/12), •Ÿ‰Ş, “ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŽGŽ 2015/6; 51 (2): 610.

722206. [Šw‰ď (‘S‘)] (‹łˆç“WŽŚ) čň“Ž–Źâ|‰đ–UEŽB‘œEf’f|. •‚F—´‘ž˜Y1, ›Œ´’g“l1, ŽRŞ‘ń˜Y1, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ)): ‘ć51‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď (2015/10/2-4), ˇ‰Ş, ‘ć51‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď´˜^W 2015/9; p.S513.

723904. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Peritumoral liver parenchymal enhancement on GD-EOB-DTPA-enhanced MRI invarious liver tumors (Gd-EOB-DTPA‘˘‰eMRI‚ĚŽîᇎüŠĚŽŔŽż‘‹­Œř‰Ę‚ĚŒŸ“˘). ź‰iŒh“ń1, ˆäă—D‰î1, ŹŠ}Œ´‹1, “Ąˆä@Š]1, “‡“c—Œb1, ƒEƒbƒhƒnƒ€ƒX—ćŽq1, ŽRŞ‘ń˜Y1, ‘ĺ’ˈŸš–˘1, —é–Ř•ś•v1, ‰ş–ěŒ\ˆę˜Y1 (1•úŽËü (‰ć‘œ)): ‘ć74‰ń“ú–{ˆăŠw•úŽËüŠw‰ď‘‰ď (2015/4/17), ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ 2015/2; p.S201.

723905. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠÔŽżŤMR ƒŠƒ“ƒp‘˘‰e‚É‚ć‚éƒ}ƒEƒX‰ŠÇŤƒŠƒ“ƒpß‚ĚŒŸ“˘: ‚•ŞŽqƒ~ƒZƒ‹‘˘‰eÜ‚Ćgadofl uorine P‚Ě”äŠr. (Assessment of infl ammatory lymph nodes in mice with intersitital MR lymphography: comparative study with polymeric micelle MR contrast agent and gadofl uorine P). ÔˆäGs1, ‹Ëś@–Î1, ”’Îvˆę2, ‰ĄŽRšK2, ’†”W—ǍN1, ˆäă—D‰î3, ‘ĺ—F@–M4 (1“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 2“Œ‹žŽœŒb‰ďˆă‰Č‘ĺŠw‘‡ˆă‰ČŠwŒ¤‹†ƒZƒ“ƒ^[, 3•úŽËü (‰ć‘œ), 4“Œ‹ž‘ĺŠwˆăŠw•”•úŽËü‰Č): ‘ć10‰ń“ú–{•ŞŽqƒCƒ[ƒWƒ“ƒOŠw‰ď (2015/5/20), “Œ‹ž, JSMI Report 2015/4; 8 (2): 131.

723906. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) •Đ‘¤ŽhŒƒ’掌‚ĆŠÖ˜A‚ˇ‚éŽhŒƒćs‰AŤ“dˆĘ (SPN) ‚Ě‹óŠÔŹ•Ş. ‘ĺăi”ü1, Ź’J‘בĽ1, Vˆäˆę˜Y2, ‹Ëś@–Î3, ˆäă—D‰î4 (1“Œ‹žH‹Ć‘ĺŠw, 2ƒ_ƒCƒLƒ“H‹ĆŠ”ŽŽ‰ďŽĐ, 3“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 4•úŽËü (‰ć‘œ)): ‘ć33‰ń“ú–{ś—S—Šw‰ď‘ĺ‰ď (2015/5/23-24), ‘ĺă, ‘ć33‰ń“ú–{ś—S—Šw‰ď‘ĺ‰ďƒvƒƒOƒ‰ƒ€Ľ—\eW 2015/5; p.14.

723907. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŠçŽhŒƒ—\Šú‚Í‹L†ŽhŒƒ—\Šú‚ć‚č‚ŕ‘‚­ˆ—‚ł‚ę‚é|fMRI§–ń•t‚Ťƒ_ƒCƒ|[ƒ‹•ŞÍ|. Ź’J‘בĽ1, ‘ĺăi”ü1, Vˆäˆę˜Y2, ‹Ëś@–Î3, ˆäă—D‰î4 (1“Œ‹žH‹Ć‘ĺŠw, 2ƒ_ƒCƒLƒ“H‹ĆŠ”ŽŽ‰ďŽĐ, 3“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 4•úŽËü (‰ć‘œ)): ‘ć33‰ń“ú–{ś—S—Šw‰ď‘ĺ‰ď (2015/5/23-24), ‘ĺă, ‘ć33‰ń“ú–{ś—S—Šw‰ď‘ĺ‰ďƒvƒƒOƒ‰ƒ€Ľ—\eW 2015/5; p.14.

723908. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) The correlation between recanalization of embolized artery and blood coagulation parameters during TAE for primary postpartum hemorrhage. ƒEƒbƒhƒnƒ€ƒX—ćŽq1, “Ąˆä@Š]1, ŹŠ}Œ´‹1, ŽRŞ‘ń˜Y1, ‰ş–ěŒ\ˆę˜Y1, Œ´@•qŤ1, ź‰iŒh“ń1, źŠŞ@”Ž2, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ), 2šƒ}ƒŠƒAƒ“ƒiˆă‰Č‘ĺŠwS‘ŸŒŒŠÇŠO‰Č): ‘ć44‰ńIVRŠw‰ď‘‰ď (2015/5/30), ‹{č, “ú–{ƒCƒ“ƒ^[ƒxƒ“ƒVƒ‡ƒiƒ‹ƒ‰ƒWƒIƒƒW[Šw‰ďŽGŽ 2015/5; 30 (Suppl): 51.

723909. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”ńƒAƒ‹ƒR[ƒ‹ŤŽ‰–bŠĚ‰Šƒ‚ƒfƒ‹ƒ}ƒEƒX‚̍‚•ŞŽqƒ~ƒZƒ‹‘˘‰eMRI‚É‚¨‚Ż‚éT1ŠÉ˜aŽžŠÔ‘Ş’č‚Ě•]‰ż. ‹Ëś@Ž 1, ”’Î@v2, ‰ĄŽRšK2, ÔˆäGs1, ’†•°—ǍN1, ˆäă—D‰î3, ‘ĺ—F@–M4 (1“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•úŽËü‰Č, 2“Œ‹žŽœŒbˆă‰Č‘ĺŠw‘‡ˆă‰ČŠwŒ¤‹†ƒZƒ“ƒ^[, 3•úŽËü (‰ć‘œ), 4“Œ‹ž‘ĺŠwˆăŠw•”•úŽËü‰Č): ‘ć43‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ď (2015/9/10), “Œ‹ž, “ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ďŽGŽ 2015/8; 35 (suppl): 333.

723910. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŠĚ“]ˆÚŽüˆÍ‚É‚¨‚Ż‚éGd-EOB-DTPA‘˘‰eMRI‘‹­Œř‰ĘˆŮí‚Ě•a—Šw“IŒŸ“˘. ź‰iŒh“ń1, ˆäă—D‰î1, ŽOŽ}@M2, ŹŠ}Œ´‹1, “Ąˆä@Š]1, ƒEƒbƒhƒnƒ€ƒX—ćŽq1, ŽRŞ‘ń˜Y1, ‘ĺ’ˈŸš–˘1, ‰ş–ěŒ\ˆę˜Y1, ›Œ´’g“l1 (1•úŽËü (‰ć‘œ), 2•a—): ‘ć43‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ď (2015/9/11), “Œ‹ž, “ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ďŽGŽ (2015/8; 35 (suppl): 269.

723911. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‚•ŞŽqƒ~ƒZƒ‹‚đ—p‚˘‚˝ƒ}ƒEƒXŠÔŽżŤMRƒŠƒ“ƒp‘˘‰e‚Ě•]‰ż: gadofluorine P‚Ć‚Ě”äŠr. ÔˆäGs1, ‹Ëś@–Î1, ”’Îvˆę2, ‰ĄŽRšK2, ’†”W—ǍN1, ˆäă—D‰î3, ‘ĺ—F@–M4 (1“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•t‘Ž•a‰@•úŽËü‰Č, 2“Œ‹žŽœŒbˆă‰Č‘ĺŠw‘‡ˆă‰ČŠwŒ¤‹†ƒZƒ“ƒ^[, 3•úŽËü (‰ć‘œ), 4“Œ‹ž‘ĺŠw‘ĺŠw‰@ˆăŠwŒnŒ¤‹†‰Č•úŽËüˆăŠwuŔ): ‘ć43‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ď (2015/9/11), “Œ‹ž, “ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ďŽGŽ 2015/8; 35 (suppl): 353.

723912. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Navigator-gating‚đ—p‚˘‚˝Gd-EOB-DTPA‘˘‰eMRI‚̉掿•]‰ż. ŹŠ}Œ´‹1, ˆäă—D‰î1, ź‰iŒh“ń1, “Ąˆä@Š]1, `@”Ž•ś2, ‹{–{”ä˜CŽ÷2, ŠâŠŮ—YŽĄ3 (1•úŽËü (‰ć‘œ), 2•úŽËü•”, 3GEƒwƒ‹ƒXƒPƒAEƒWƒƒƒpƒ“): ‘ć43‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ď (2015/9/12), “Œ‹ž, “ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ďŽGŽ 2015/8; 35 (suppl): 306.

723913. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) 3T MRI‘•’u‚Ĺ‚ĚGd-EOB-DTPA‘˘‰eMRI‚É‚¨‚Ż‚é‹ĎˆęŤ•âł‚ŞŠĚM†’č—ĘŽw•W‚É—^‚Ś‚é‰e‹ż. ŹŠ}Œ´‹1, ˆäă—D‰î1, ź‰iŒh“ń1, “Ąˆä@Š]1, `@”Ž•ś2 (1•úŽËü (‰ć‘œ), 2•úŽËü•”): ‘ć43‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ď (2015/9/12), “Œ‹ž, “ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ďŽGŽ 2015/8; 35 (suppl): 309.

723914. [Šw‰ď (‘S‘)] (PDFƒ|ƒXƒ^[) “Ş•”MRI“lje‚É‚¨‚Ż‚é‰ć‘œ•\ŽŚđŒ’˛Ž–@‚ÉŠÖ‚ˇ‚錟“˘. Œ´@•qŤ1, ˆäă—D‰î1, •‚F—´‘ž˜Y1, `@”Ž•ś2, ˆä—́@~2 (1•úŽËü (‰ć‘œ), 2•úŽËü•”): ‘ć43‰ń“ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ď (2015/9/10-12), “Œ‹ž, “ú–{ŽĽ‹C‹¤–ˆăŠw‰ď‘ĺ‰ďŽGŽ 2015/8; 35 (suppl): 421.

723915. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒCƒ[ƒWƒCƒ“ƒ^[ƒvƒŠƒe[ƒVƒ‡ƒ“ƒZƒbƒVƒ‡ƒ“1 Ç—á3 (o‘č‚Ɖđŕ). •‚F—´‘ž˜Y (•úŽËü (‰ć‘œ): ‘ć51‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď (2015/10/3), ˇ‰Ş.

723916. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) A“ސ_ŒoâŽî‚Ě2—á. ›Œ´’g“l1, •‚F—´‘ž˜Y1, ŽRŞ‘ń˜Y1, ˆäă—D‰î1, ‰Á”[Fˆę2, —é–ŘƒGƒŠ“Ţ3, ŽOŽ}@M3, Ó@˘ˆŽ3 (1•úŽËü (‰ć‘œ), 2Ž¨•@ˆôAE“ŞčňŠO, 3•a—): ‘ć51‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď (2015/10/4), ˇ‰Ş, ‘ć51‰ń“ú–{ˆăŠw•úŽËüŠw‰ďH‹G—Տ°‘ĺ‰ď´˜^W 2015/9; p.S553.

723917. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “Ş•”ˆČŠO‚ĚˆŤŤŽîᇐf’f–Ú“I‚ĹŽ{s‚ł‚ę‚˝‘SgFDG-PET/CT‚Ĺ‚Ě“Ş•”ŠŒŠ‚Ě•]‰ż. ó–ě—Y“ń1, ˆäă—D‰î1, ‘ĺ’ˈŸš–˘1, ŽRŞ‘ń˜Y1, Œ´@•qŤ1, ‹{•”ä˜CŽ÷2 (1•úŽËü (‰ć‘œ), 2•úŽËü•”): ‘ć55‰ń“ú–{ŠjˆăŠw‰ďŠwp‘‰ď (2015/11/6), “Œ‹ž, ŠjˆăŠw 2015/9; 52 (3): 283.

731165. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “úíf—Ă‚Ĺ‚ľ‚΂ľ‚Α˜‹ö‚ˇ‚é“Şčň•”ŽžŠł|CTEMRI‚Ě‚ą‚ą‚É’–ځ|. •‚F—´‘ž˜Y (•úŽËü (‰ć‘œ)): ‘ć24‰ńŽR—zĽŽR‰ARadiologyUpdateŠwpu‰‰‰ď (2015/5/16), ‰ŞŽR.

731166. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŽY‰ČoŒŒIVR‚ĚŒťÝ‚ĚƒRƒ“ƒZƒ“ƒTƒX‚ƍĄŒă‚Ě“W–]. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ)): ‘ć13‰ńˆ¤’mŽq‹{‹ŘŽîÇđ—Ă–@ŒŸ“˘‰ď (2015/6/19), ’ˇ‹vŽč.

731167. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) FDG PET/CT‚Ě—L—pŤ‚Ć—ŻˆÓ“_. ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć23‰ńMBŠjˆăŠwŒ¤‹†‰ď (2015/6/27), ź–{.

731168. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) PET/CT‚Ěƒƒ“ƒ|ƒCƒ“ƒgƒŒƒbƒXƒ“|Žîᇐf—Ă‚ÉŠˆ‚Š‚ˇ‚˝‚߂Ɂ|. ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć44‰ń’f‘w‰f‘œŒ¤‹†‰ď (2015/10/23), “Œ‹ž.

731169. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) S‹ŘŒŒ—ŹSPECT: ‚ť‚̏ŠŒŠ‚Í–{•¨‚Ĺ‚ˇ‚Š? ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć44‰ń’f‘w‰f‘œŒ¤‹†‰ď (2015/10/24), “Œ‹ž, ’f‘w‰f‘œŒ¤‹†‰ďŽGŽ 2015/9; 42 (2): 20.

731170. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) Çó‚Š‚ç‚Ý‚˝“Şčň•”CTEMRIf’f‚̐i‚ß•ű. •‚F—´‘ž˜Y (•úŽËü (‰ć‘œ)): ‘ć26‰ńŽR‰AƒfƒWƒ^ƒ‹‰ć‘œŒ¤‹†‰ď (2016/2/13), ź].

732117. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) PETf’f‚Ěƒtƒƒ“ƒgƒ‰ƒCƒ“ ƒAƒ~ƒmŽ_ƒCƒ[ƒWƒ“ƒO (FACBC). ˆäă—D‰î (•úŽËü (‰ć‘œ)): ‘ć29‰ńJCRƒ~ƒbƒhƒEƒBƒ“ƒ^[ƒZƒ~ƒi[ (2016/1/24), •Ÿ‰Ş.

732118. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) –ڐV‚ľ‚˘EŽ¨V‚ľ‚˘ŽžŠł‚Ě‰ć‘œf’f@ŠjˆăŠw. ˆäă—D‰î (•úŽËü (‰ć‘œ)): “ú–{ˆăŠw•úŽËüŠw‰ďŠÖ“Œ’n•ű‰ďƒZƒ~ƒi[ (2016/2/7), “Œ‹ž.

733352. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ăA“ސ_ŒoâŽî‚Ě1—á. ŽRŞ‘ń˜Y1, •‚F—´‘ž˜Y1, ‘ĺ’ˈŸš–˘1, “‡“c—Œb1, ˆäă—D‰î1, ‰Á”[Fˆę2, —é–ŘƒGƒŠ“Ţ3, ŽOŽ}@M3 (1•úŽËü (‰ć‘œ), 2Ž¨•@ˆôAE“ŞčňŠO, 3•a—): ‘ć44‰ń“Şčň•”E‹š•”‰ć‘œŒ¤‹†‰ď (2015/5/23), “Œ‹ž.

733353. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) “Ş•”MRIŠgŽU‹­’˛‘œ‚É‚¨‚Ż‚é—ź‘¤‘ĺ”]”ź‹…‘˝”­—ąó‚M†ˆć. Œ´@•qŤ (•úŽËü (‰ć‘œ)): ‘ć10‰ń–k—˘ŒŒŠÇƒtƒH[ƒ‰ƒ€ (2015/6/1), ‘Š–ÍŒ´.

733354. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) “Ş•”ˆČŠO‚ĚˆŤŤŽîᇐf’f–Ú“I‚ĹŽ{s‚ł‚ę‚˝FDG-PET/CT‚Ĺ‚Ě“Ş•”ŠŒŠ‚ɂ‚˘‚Ä. ó–ě—Y“ń1, ˆäă—D‰î1, ‘ĺ’ˈŸš–˘1, ›Œ´’g“l1, ‰ş–ěŒ\ˆę˜Y1, ŽRŞ‘ń˜Y1, Œ´@•qŤ1, ‹{•”ä˜CŽ÷2, ‹e’r@Œh2 (1•úŽËü (‰ć‘œ), 2•úŽËü•”): ‘ć83‰ń“ú–{ŠjˆăŠw‰ďŠÖ“ŒbM‰z’n•ű‰ď (2015/7/11), “Œ‹ž, ŠjˆăŠw 2015/11; 52 (4): 390-1.

733355. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ž~ŒŒ‚É“ďa‚ľ‚˝ŽY‰ČoŒŒ‚Ěˆę—á. ƒEƒbƒhƒnƒ€ƒX—ćŽq (•úŽËü (‰ć‘œ): ‘ć479‰ń“Œ‹žƒAƒ“ƒMƒIEIVR‰ď (2016/1/14), “Œ‹ž.

733356. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) A case of chronic expanding hematoma after total hip arthroplasty; Angiographic findings at preoperative embolization. ›Œ´’g“l1, ƒEƒbƒhƒnƒ€ƒX—ćŽq1, “Ąˆä@Š]1, “ŕŽRŸ•ś2, ˆäă—D‰î1 (1•úŽËü (‰ć‘œ), 2ŽŠO): ‘ć27‰ń“ú–{œ“î•”•úŽËüŒ¤‹†‰ď (2016/1/29), “Œ‹ž.


•úŽËü‰ČŠw (•úŽËüŽîᇊw)

[Šwp˜_•ś]

110305. [Œ´’˜] Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403. Nagata Y, Hiraoka M, Shibata T, Onishi H, Kokubo M, Karasawa K, Shioyama Y, Onimaru R, Kozuka T, Kunieda E, Saito T, Nakagawa K, Hareyama M, Takai Y, Hayakawa K1, Mitsuhashi N, Ishikura S: Int J Radiat Oncol Biol Phys 2015/12; 93 (5): 989-96. (‘ě˜ad1: 1•úŽËü (Žîá‡))

110306. [Œ´’˜] Multi-institutional retrospective analysis of learning curves on dosimetry and operation time before and after introduction of intraoperatively built custom-linked seeds in prostate brachytherapy. Ishiyama H1, Satoh T2, Yorozu A, Saito S, Kataoka M, Hashine K, Nakamura R, Tanji S, Masui K, Okihara K, Ohashi T, Momma T, Aoki M, Miki K, Kato M, Morita M, Katayama N, Nasu Y, Kawanaka T, Fukumori T, Ito F, Shiroki R, Baba Y, Inadome A, Yoshioka Y, Takayama H, Hayakawa K1: J Radiat Res 2016/1; 57 (1): 68-74. (ÎŽR”ŽžŠ1, ˛“ĄˆĐ•ś2, ‘ě˜ad1: 1•úŽËü (Žîá‡), 2”ĺ”AŠí)

110307. [Œ´’˜] Dosimetry of permanent interstitial prostate brachytherapy for an interoperative procedure, using O-arm based CT and TRUS. Ishiyama H1, Sekiguchi A1, Satoh T2, Tsumura H2, Takenaka K1, Kawakami S1, Tabata K2, Kobayashi K2, Iwamura M2, Hayakawa K1: J Contemp Brachytherapy 2016/2; 8 (1): 7-16. (ÎŽR”ŽžŠ1, ŠÖŒűˆŠˆß1, ˛“ĄˆĐ•ś2, ’Ă‘şGN2, ’|’†_“ń1, ěăłŒĺ1, “c”¨Œ’ˆę2, Ź—ŃŒ’‘ž˜Y2, Šâ‘şłŽk2, ‘ě˜ad1: 1•úŽËü (Žîá‡), 2”ĺ”AŠí)

521028. [‰đŕ] ‹š•”•úŽËüĆŽË’ljÁ‚Ě“K‰žÇ—á‚Ě‘I‘đ‚É‚ÍŒŸ“˘‚Ş•K—v. ‘ě˜ad (•úŽËü (Žîá‡)): The Mainichi Medical Journal 2016/1; 11 (6): 331.

522172. [uŔ]y“ÁW: ‘ĺ’°Šŕf—ĂUpdatezŽĄ—Ă‚ĚUpdate@E‘ĺ’°Šŕ‚ɑ΂ˇ‚é•úŽËüŽĄ—Ă‚ĚˆÓ‹`‚Ɖž—p. ‘ě˜ad (•úŽËü (Žîá‡)): ˆăŠw‚Ě‚ ‚ä‚Ý 2015/6; 253 (10): 1059-64.

522173. [uŔ]y“ÁW: ”x‚Ş‚ńŠłŽŇ‚ĚŽĄ—Ă‚ĆƒPƒAĹ‘Oüz ”x‚Ş‚ń‚ĚŽĄ—Ă–@‚đ’m‚é@•úŽËü—Ă–@. ‘ě˜ad (•úŽËü (Žîá‡)): ‚Ş‚ńŠĹŒě 2015/9; 20 (6): 613-5.

522174. [uŔ]y“ÁW: —LŠQŽ–Ű‚đ‚˘‚Š‚É–hŽ~‚ˇ‚é‚Š?z‚Í‚ś‚ß‚É. ‘ě˜ad1, ‚ˆä—ǐq (1•úŽËü (Žîá‡)): —Տ°•úŽËü 2015/10; 60 (10): 1205-7

[’˜@‘]

610005. [Šwp‘ (•Ş’SŽˇ•M)]yStereotactic Body Radiation Therapy: Principles and PracticeszChapter 12. International Experience, p.151-62. Hayakawa K1, Editor: Nagata Y, Springer, 2015/8. (‘ě˜ad1: 1•úŽËü (Žîá‡))

[Šw‰ďEŒ¤‹†‰ď“™]

712033. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Combined Use of Molecular Targeting Drugs in Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer. Hayakawa K1: ICRR2015 (2015/5/26), Kyoto, ICRR2015 Pocket Program 2015/5; 15th: 72. (‘ě˜ad1: 1•úŽËü (Žîá‡))

712034. [Šw‰ď (‘Ű)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yŔ’ˇzHayakawa K1: ICRR2015 (2015/5/29), Kyoto, ICRR2015 Pocket Program 2015/5; 15th: 205. (‘ě˜ad1: 1•úŽËü (Žîá‡))

713127. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Assessment of Intraoperative CT By The O-armŇ Imaging System: Early Experience. Kawakami S1, Ishiyama H1, Satoh T2, Tsumura H2, Sekiguchi A1, Takenaka K1, Komori S1, Soda I1, Iwamura M2, Hayakawa K1: ICRR2015 (2015/5/26), Kyoto, ICRR2015 Pocket Program 2015/5; 15th: 97. (ěăłŒĺ1, ÎŽR”ŽžŠ1, ˛“ĄˆĐ•ś2, ’Ă‘şGN2, ŠÖŒűˆŠˆß1, ’|’†_“ń1, ŹXłŽq1, ‘“c@Ši1, Šâ‘şłŽk2, ‘ě˜ad1: 1•úŽËü (Žîá‡), 2”ĺ”AŠí)

713128. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Retrospective Evaluation of the Feasibility of Definitive CRT after Treatment with Docetaxel, Cisplatin, and 5-Fluorouracil in ESCC. Komori S1, Katada C2, Katada N3, Sugawara M4, Takahashi K5, Ishiyama H1, Higuchi K2, Yamashita K3, Moriya H3, Tanabe S6, Koizumi W2, Hayakawa K1: ICRR2015 (2015/5/26), Kyoto, ICRR2015 Pocket Program 2015/5; 15th: 155. (ŹXłŽq1, Œ˜“ce—˜2, •Đ“c‰Ä–ç3, ›Œ´[L4, ‚‹´‚Š‚¨‚é5, ÎŽR”ŽžŠ1, ”óŒűŸ•F2, ŽR‰şŒpŽj3, X’JGŒő3, “c糁@‘6, Źň˜aŽO˜Y2, ‘ě˜ad1: 1•úŽËü (Žîá‡), 2Á‰ťŠí“ŕ, 3ŠO‰Č, 4–ňÜ•”, 5ŠĹŒě•”, 6V˘‹Iˆă—ÁEć’[ˆă—Ă)

722207. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[) –ž“ú‚Š‚çŽg‚Ś‚éƒNƒCƒbƒNƒŠƒ“ƒN|13Ž{Ý‚Ě“ą“üŒoŒą‚Š‚ç|. ÎŽR”ŽžŠ (•úŽËü (Žîá‡)): ŹüŒšŽĄ—Ă•”‰ď‘ć17‰ńŠwp‘ĺ‰ď (2015/6/26), ‘ĺ‹{, ŹüŒšŽĄ—Ă•”‰ď‘ć17‰ńŠwp‘ĺ‰ďƒvƒƒOƒ‰ƒ€ 2015/6; 4.

722208. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yŔ’ˇz”xŠŕ‚̍‚¸“x•úŽËüŽĄ—Ă‚É‚¨‚Ż‚é•ďŠ‡“I•úŽËüŽî­Šw. ‘ě˜ad (•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď (2015/11/19), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď•ń•śW 2015/11; p.6.

722209. [Šw‰ď (‘S‘)] (—Ž–’ˇ•ń)yŔ’ˇz“ú–{”xŠŕŠw‰ď: ‚ą‚Ěˆę”N‚Ě•ŕ‚Ý‚ĆŤ—ˆ. ‘ě˜ad (•úŽËü (Žîá‡)): ‘ć56‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2015/11/27), ‰Ą•l, ”xŠŕ 2015/10; 55 (5): 72.

722210. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv)yƒfƒBƒXƒJƒbƒTƒ“ƒgz”]“]ˆÚ. ‘ě˜ad (•úŽËü (Žîá‡)): ‘ć56‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2015/11/28), ‰Ą•l, ”xŠŕ 2015/10; 55 (5): 103.

722211. [Šw‰ď (‘S‘)] (ƒ‰ƒ“ƒ`ƒ‡ƒ“ƒZƒ~ƒi[)yŔ’ˇzTrueBeam STx‚É‚¨‚Ż‚éFlattening filter freeƒr[ƒ€‚Ě“ą“ü‚Ə‰Šú—Տ°ŒoŒą. ‘ě˜ad (•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ń‚¸“x•úŽËüŠO•”ĆŽË•”‰ďŠwp‘ĺ‰ď (2016/2/27), “Œ‹ž, ‘ć29‰ń‚¸“x•úŽËüŠO•”ĆŽË•”‰ďŠwp‘ĺ‰ď´˜^W 2016/2; p.16.

722212. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “ú–{l‘O—§‘BŠŕŠłŽŇ‚ɑ΂ˇ‚é’čˆĘ•úŽËüŽĄ—Ă‚ĚŒoŒą. ÎŽR”ŽžŠ1, ‘ě˜ad1 (1•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ń‚¸“x•úŽËüŠO•”ĆŽË•”‰ďŠwp‘ĺ‰ď (2016/2/27), “Œ‹ž, ‘ć29‰ń‚¸“x•úŽËüŠO•”ĆŽË•”‰ďŠwp‘ĺ‰ď´˜^W 2016/2; p.32.

723918. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Definitive chemoradiotherapy for the patients with neuroendocrine carcinoma of the esophagus. ŹXłŽq1, Œ˜“ce—˜2, ‹g“c@Œ÷3, “Œ@’q2, ÎŒËŒŞŽŸ2, ěăłŒĺ1, ÎŽR”ŽžŠ1, “c糁@‘4, Źň˜aŽO˜Y2, ‘ě˜ad1 (1•úŽËü (Žîá‡), 2Á‰ťŠí“ŕ, 3•a—, 4V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď (2015/11/19), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď•ń•śW 2015/11; p.198.

723919. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Whole scalp irradiation with Helical Tomotherapy for angiosarcoma. ŠÖŒűˆŠˆß1, ÎŽR”ŽžŠ1, ‘ŕV^ŽŔŽq2, ŹXłŽq1, ‘“c@Ši1, ’|’†_“ń1, –ěŕVääť‰Ô1, “V‰HN”V2, ‘ě˜ad1 (1•úŽËü (Žîá‡), 2”畆): “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď (2015/11/19), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď•ń•śW 2015/11; p.264.

723920. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Comparison of 3D printing materials for customized bolus in radiotherapy. ‘“c@Ši1, ÎŽR”ŽžŠ1, –ě“c–Η˜2, Žń“Ąéş2, —]ŒęŽ‹I3, ŹXłŽq1, ŠÖŒűˆŠˆß1, ěăłŒĺ1, ’|’†_“ń1, –ěŕVääť‰Ô1, ‘ě˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď (2015/11/20), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď•ń•śW 2015/11; p.224.

723921. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) A case of massive squamous cell carcioma of the breast treated with successful radiotherapy and curative operation. –ěŕVääť‰Ô1, ŹXłŽq1, ĺÎ‹I•F2, ÎŽR”ŽžŠ1, Œ´@“ÖŽq3, ‘“c@Ši1, ŠÖŒűˆŠˆß1, ’|’†_“ń1, ’J–씎ˆę2, ‘ě˜ad1 (1•úŽËü (Žîá‡), 2ŠO‰Č, 3•a—): “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď (2015/11/20), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď•ń•śW 2015/11; p.302.

723922. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) Quality of life after radiotherapy for patients with head and neck cancer: Comparison of acute phase responses between 3DCRT and IMRT. ’|’†_“ń1, ÎŽR”ŽžŠ1, ŹXłŽq1, ‘“c@Ši1, ŠÖŒűˆŠˆß1, ěăłŒĺ1, –ěŕVääť‰Ô1 (1•úŽËü (Žîá‡)): “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď (2015/11/21), ŒQ”n, “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď•ń•śW 2015/11; p.338.

723923. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Evaluation of incident reports in radiotherapy: comparison between conventional linac and Tomotherapy system. ÎŽR”ŽžŠ1, Žń“Ąéş2, Ž›č„Žj2, –ě“c–Η˜2, —]ŒęŽ‹I3, ‘ě˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{•úŽËüŽîᇊw‰ď‘ć28‰ńŠwp‘ĺ‰ď (2015/11/21), ŒQ”n.

723924. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Stereotactic body radiotherapy (SBRT) for 661. operable stage I nonsmall cell lung cancer. ‘吟@—m, ‰–ŽR‘P”V, ź–{N’j, ‚ŽRŒŤ“ń, ź”öKŒ›, ‹{ě‘Žj, ŽR‰ş‰pb, ź‰ş°—Y, Â–؏š•F, “ń•rŒ\“ń, –Ř‘ş’qŽ÷, ÎŽR”ŽžŠ1, ‘şă’ź–ç, ’†“cŒ’ś, •“c“Ä–ç, ‰F–ě@—˛, –ě‹{‘ô–, Źě˜a•F (1•úŽËü (Žîá‡)): ‘ć56‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď (2015/11/26), ‰Ą•l, ”xŠŕ 2015/10; 55 (5): 419.

723925. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) 3DƒvƒŠƒ“ƒ^[‚ō쐬‚ľ‚˝ƒ{[ƒ‰ƒX‚đŽg—p‚ľ‚˝ŒŒŠÇ“÷Žî‘S“Ş”çĆŽË (IMRT) ‚ɂ‚˘‚Ä‚ĚŒ¤‹†. ‘“c@Ši1, ÎŽR”ŽžŠ1, Ž›č„Žj2, Žń“Ąéş2, ŠÖŒűˆŠˆß1, ’|’†_“ń1, –ěŕVääť‰Ô1, ŹXłŽq1, ‘ě˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü•”): “ú–{•úŽËüŽîᇊw‰ď‘ć29‰ń‚¸“x•úŽËüŠO•”ĆŽË•”‰ďŠwp‘ĺ‰ď (2016/2/27), “Œ‹ž, ‘ć29‰ń‚¸“x•úŽËüŠO•”ĆŽË•”‰ďŠwp‘ĺ‰ď´˜^W 2016/2; p.71.

732119. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (u‰‰)y•úŽËŤ“ŻˆĘŒł‘f‹y‚Ń•úŽËü”­ś‘•’u‚ĚŽć‚čˆľ‚˘Izƒ`[ƒ€ˆă—Ă‚Ćˆă—ĂˆŔ‘S. ‘ě˜ad (•úŽËü (Žîá‡)): •˝Ź27”N“xu•úŽËü (f—Ă) ‹Ć–ą]Ž–ŽŇ‚Ě‹łˆçŒP—ű(uK‰ď)v(2015/4/26), ěč.

732120. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (u‰‰) d—ąŽqüŽĄ—Ă‚ÉŠú‘Ň‚ˇ‚é‚ą‚Ć. ‘ě˜ad (•úŽËü (Žîá‡)): •˝Ź27”N“xd—ąŽqüŽĄ—Íu‰‰‰ď (2015/10/3), ‰Ą•l.

732121. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Œű‰‰) ŠÉ™‚ČŒo‰ß‚đ’H‚Á‚Ä‚˘‚é’á•Ş‰ť”x‘BŠŕ: ‰“Šu“]ˆÚ‚Ěˆę—á. ŹXłŽq (•úŽËü (Žîá‡)): •˝Ź27”N“x_“ŢěŒ§•úŽËüˆă‰ď‘‰ď‹y‚Ń‘ć56‰ń—á‰ď (2015/10/10), ‰Ą•l.

732122. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Œű‰‰) ”x‚Ş‚ń‚ĚŠT—v. ‘ě˜ad (•úŽËü (Žîá‡)): ”x‚Ş‚ńˆă—ÁEŽžŠłŒ[”­‚Ě‚˝‚ß‚ĚŽs–ŻŒöŠJuŔ (2015/11/8), H—tŒ´.

732123. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Œű‰‰) –k—˘‘ĺŠw•a‰@‚É‚¨‚Ż‚éƒV[ƒh—Ă–@ŠÖ˜AƒCƒ“ƒVƒfƒ“ƒg‚̏WŒv: ŠO•”ĆŽË‚Ć‚Ě”äŠr. ÎŽR”ŽžŠ (•úŽËü (Žîá‡)): ‘ć12‰ń‘O—§‘BŠŕ–§••ŹüŒš‰i‹v‘}“üŽĄ—ĂŒ¤‹†‰ď (2016/1/24), “Œ‹ž.

732124. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (u‰‰) TrueBeam 8NW Xü‚Ě—L—pŤ‚ɂ‚˘‚Ä. ‘ě˜ad (•úŽËü (Žîá‡)): 2016ƒoƒŠƒAƒ“ƒZƒ~ƒi[ (2016/2/28), “Œ‹ž.

732125. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Œű‰‰) •úŽËü‚É‚ć‚éDNA‘š‚ɑ΂ˇ‚郁ƒ`ƒIƒjƒ“‚Ě–hŒěŒř‰Ę. ’ˇ–쏫‘ă1, ˆÉ“Ą‘žÄ2, —]ŒęŽ‹I3, ÎŽR”ŽžŠ4, ‘ě˜ad4 (1ˆă—ÉqśŠw•”, 2—Šw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4•úŽËü (Žîá‡)): ‘ć58‰ń‰Ą•l•úŽËüŽĄ—ͧ˜b‰ď (2016/3/7), ‰Ą•l.

732126. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Œű‰‰) ƒAƒ~ƒmŽ_‚É‚ć‚é•úŽËü–hŒěŒř‰Ę‚ĚŒŸ“˘|ƒvƒ‰ƒXƒ~ƒhDNA‘š‚Ě•]‰ż|. ˆÉ“Ą‘žÄ1, ’ˇ–쏫‘ĺ2, —]ŒęŽ‹I3, ÎŽR”ŽžŠ4, ‘ě˜ad4 (1—Šw•”, 2ˆă—ÉqśŠw•”, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 4•úŽËü (Žîá‡)): ‘ć58‰ń‰Ą•l•úŽËüŽĄ—ͧ˜b‰ď (2016/3/7), ‰Ą•l.

732127. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Œű‰‰) 3DƒvƒŠƒ“ƒ^[‚ō쐬‚ľ‚˝ƒ{[ƒ‰ƒX‚đŽg—p‚ľ‚˝ŒŒŠÇ“÷Žî‘S“Ş”çĆŽË‚ɂ‚˘‚Ä‚ĚŒ¤‹†. ‘“c@Ši1, ÎŽR”ŽžŠ1, Ž›č„Žj2, Žń“Ąéş2, ŠÖŒűˆŠˆß1, ŹXłŽq1, ’|’†_“ń1, –ěŕVääť‰Ô1, ‘ě˜ad1 (1•úŽËü (Žîá‡), 2•úŽËü•”): ‘ć58‰ń‰Ą•l•úŽËüŽĄ—ͧ˜b‰ď (2016/3/7), ‰Ą•l.

732128. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Œű‰‰) ”x‚Ş‚ń‚̐VTNM•Ş—ނɂ‚˘‚Ä. ‘ě˜ad (•úŽËü (Žîá‡)): ‘ć58‰ń‰Ą•l•úŽËüŽĄ—ͧ˜b‰ď (2016/3/7), ‰Ą•l.

733357. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒ‰ƒCƒuƒfƒ‚ƒRƒƒ“ƒe[ƒ^[. ÎŽR”ŽžŠ (•úŽËü (Žîá‡)): ‘ć17‰ńƒˆƒE‘f125ƒV[ƒhüŒš‰i‹v‘}“ü‚É‚ć‚é‘O—§‘BŠŕ–§••ŹüŒš—Ă–@‹ZpuK‰ď (2015/7/4), “Œ‹ž.

733358. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) d—ąŽqü‚É‚ć‚éDNA‘š‚ɑ΂ˇ‚郁ƒ`ƒIƒjƒ“‚Ě–hŒěŒř‰Ę. —]ŒęŽ‹I1, ‘şŽRçŒbŽq, –]ŒŽ‘ĺŽ÷1, ź‰ş–žO1, ˆÉ“Ą‘žÄ2, “ĄŕV‹`Ž÷1, ŹŕV‘ńŠC3, •˝ŽR—şˆę, ÎŽR”ŽžŠ4, ‘ě˜ad4 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2—Šw•”, 3ˆă—ÉqśŠw•”, 4•úŽËü (Žîá‡)): ‘ć18‰ńŠŕŽĄ—Ă‘Š´Œ¤‹†ƒVƒ“ƒ|ƒWƒEƒ€ (2016/2/6), “Ţ—Ç.


–ƒŒ‰ČŠw

[Šwp˜_•ś]

110308. [Œ´’˜] Reduction in the soles of graduated compression stockings prevents falls without reducing the preventive effect for venous stasis. Kuroiwa M1, Takahira N2, Ujihashi Y3, Miida K4, Arai Y5, Kawatani H5: Thrombosis Research 2015/5; 135 (5): 877-81. (•Šâ­”V1, ‚•˝ŽL2, ‰FŽĄ‹´‘PŸ3, ŒŠˆä“c˜ał4, rˆä—L”ü5, ě’JOŽq5: 1–ƒŒ, 2ˆă—ÉqśŠw•”, 3—ŐŒŸ•”, 4ƒŠƒnƒrƒŠ•”, 5ˆă—Ă‚ĚŽżEˆŔ‘S„iŽş)

110309. [Œ´’˜] Changes in the incidence, case fatality rate, and characteristics of symptomatic perioperative pulmonary thromboembolism in Japan: Results of the 2002-2011 Japanese Society of Anesthesiologists Perioperative Pulmonary Thromboembolism (JSA-PTE) Study. Kuroiwa M1, Morimatsu H, Tsuzaki K, Irita K, Sanuki M, Nakatsuka H, Nakamura M: J Anesth 2015/6; 29 (3): 433-41. (•Šâ­”V1: 1–ƒŒ)

110027. [Œ´’˜] Roles of mPGES-1, an inducible prostaglandin E synthase, in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model. Matsuda H1, Hosono K2,3, Tsuru S1, Kurashige C4, Sekiguchi K1, Akira S, Uematsu S, Okamoto H4, Majima M3: Life Sci 2015/12; 142: 1-7. (ź“cOŽq1, ×–ě‰Á“ŢŽq2,3, ’Ă—Ż˘—˘1, ĺUdçŠG4, ŠÖŒű˜aŠé1, ‰Ş–{_Žk4, ”n“ˆł—˛3: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ś—, 3–ň—, 4–ƒŒ)

310034. [Ç—á•ń] Elective use of surgical cricothyroidotomy for maxillofacial fracture fixation with contraindication of nasotracheal intubation: a case report. Kuroiwa M1, Kumazawa K2, Ito S1, Arai M3, Okamoto H1: JA Clinical Reports 2015/10; 1 (16). DOI: 10.1186/s40981-015-0021-6. (•Šâ­”V1, ŒFŕVŒ›ˆę2, ˆÉ“Ą‘s•˝1, VˆäłN3, ‰Ş–{_Žk1: 1–ƒŒ, 2‹~–˝, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

320042. [Ç—á•ń] ‡–°Žž–łŒÄ‹zÇŒóŒQ‚đ‡•š‚ľ‚˝d“x”ě–žŠłŽŇ‚Ě–ƒŒŒoŒą. “c’†ˆęś1, ’|˜Q–Ż]1, ”g—˘ƒŽq, ‹ŕŽq°, “Ą“c“ߌb1, ‰Ş–{_Žk1 (1–ƒŒ): –ƒŒ 2015/4; 64 (4): 400-3.

520015. [‘ŕ] ŽüpŠú‚¨‚ć‚ŃŽüŽYŠú‚É‚¨‚Ż‚éĂ–ŹŒŒđÇđÇ. •Šâ­”V (–ƒŒ): “ú–{ŽY•wl‰ČĽVśŽ™ŒŒ‰tŠw‰ďŽ 2015/5; 25 (1): 63-73.

522175. [uŔ]y“ÁW: –ł’É•Ş•ŘUp to Datez10. Ň‘‚­‚ŕ–Œ‰şd–ŒŠO•š—p’Á’É–@ (CSEA) ‚É‚ć‚é–ł’É•Ş•Ř. ‰œ•xr”V (–ƒŒ): ŽY‰Č‚Ć•wl‰Č 2015/5; 82 (5): 527-32.

522176. [uŔ]y˜AÚ: Ç—ጟ“˘ ‚ć‚­‚ ‚éƒgƒ‰ƒuƒ‹‚đć‚č‰z‚Ś‚悤 4zpŒă‚̍R‹ĂŒĹ—Ă–@’†‚É, d–ŒŠOƒJƒe[ƒeƒ‹‚đŒë‚Á‚Ä”˛‹Ž‚ľ‚˝|d–ŒŠOŒŒŽî‚ĚÇó‚Ş‚ ‚éę‡‚Í, ’ź‚ż‚ɐę–ĺˆă‚Ö. ç“cˆşŽq1, •Šâ­”V1 (1–ƒŒ): LiSA 2015/5; 22 (5): 501-3.

522177. [uŔ]y“ÁW: ŽüŽYŠú‚Ě’É‚Ý‚ĆŒü‚Ť‡‚¤zŽY‰Č@”D•w‚Ě’É‚Ý: ”ń”D•w‚Ć‚Ě‘Šˆá. ‰œ•xr”V (–ƒŒ): ŽüŽYŠúˆăŠw 2015/12; 45 (12): 1685-8.

540055. [‚ť‚Ě‘ź]y‘ć118‰ń“ú–{ŽY‰Č–ƒŒŠw‰ďz‰ď’ˇu‰‰: ——ŒĚlV‚Ě—ˇ‚ĹŒŠ‚‚Ż‚˝ƒZƒŒƒ“ƒfƒBƒsƒeƒB[. ‰œ•xr”V (–ƒŒ): •Ş•Ř‚Ć–ƒŒ 2015/11; 97: 1-4.

[’˜@‘]

620119. [Šwp‘ (•Ş’SŽˇ•M)]y‚Ü‚ę‚ČŽžŠł‚Ě–ƒŒAtoZz9. “ŕ•Ş”厞Šł@[bó‘B] bó‘B‹@”\˜´iÇ, p.331-2. ×ěKŠó1, ‰Á“Ą—˘ŠG2 (1–ƒŒ, 2V˘‹Iˆă—ÁEć’[ˆă—Ă), •Ň: ‚č^‹|, ‰Í–{šŽu, –Ř“ŕŒbŽq, ”’_‹‘ž˜Y, ”‹•˝@“N, •śŒő“°, “Œ‹ž, 2015/5”­s.

620120. [Šwp‘ (•Ş’SŽˇ•M)]y‚Ü‚ę‚ČŽžŠł‚Ě–ƒŒAtoZz17. ”DPE•Ş•Ř‚̍‡•šÇ@‘SgŤƒGƒŠƒeƒ}ƒg[ƒfƒX, p.564-5. “úŒür•ă1, ‰œ•xr”V1 (1–ƒŒ), •Ň: ‚č^‹|, ‰Í–{šŽu, –Ř“ŕŒbŽq, ”’_‹‘ž˜Y, ”‹•˝@“N, •śŒő“°, “Œ‹ž, 2015/5”­s.

620121. [Šwp‘ (•Ş’SŽˇ•M)]y–ƒŒ‰Čˆă‚Ě‚˝‚ß‚Ě‹ćˆć–ƒŒƒXƒ^ƒ“ƒ_[ƒh@Ví—Ş‚ÉŠî‚Ă‚­–ƒŒEŽüpŠúˆăŠwz8Í ‹ćˆć–ƒŒ‚̉ž—p@8-2. ’鉤ŘŠJp‚Ěƒ|ƒCƒ“ƒg, p.262-70. ‰œ•xr”V (–ƒŒ), ŠÄC: X“c@Œ‰, ę–ĺ•ŇW: ‰ĄŽRłŽ, ’†ŽR‘“X, “Œ‹ž, 2015/10”­s.

621003. [Šwp‘ (ŠÄCE•ŇW)]yƒ|ƒPƒbƒg”ť@‹C“šŠÇ—ƒKƒCƒhƒuƒbƒNzŠÄC: ‰Ş–{_Žk1, •Ň: •Šâ­”V1 (1–ƒŒ), ^‹ťŒđˆŐˆă‘o”Ĺ•”, “Œ‹ž, 2015/4”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713129. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Intraoperative rise in intraocular pressure in the prone position. Tanaka K1, Takenami T1, Yamasita A1, Suzuki T2, Sakai M1, Okamoto H1: ASA 2015: American Society of Anesthesiologists Annual Meeting (2015/10/24-28), San Diego, USA. (“c’†ˆęś1, ’|˜Q–Ż]1, ŽR‰ş@“Ö1, —é–Ř’mŽq2, ăˆä䝗LŽq1, ‰Ş–{_Žk1: 1–ƒŒ, 2ŒöO‰qś)

723926. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒIƒsƒIƒCƒhí—pŠłŽŇ‚É‚¨‚Ż‚銴Šo臒l‚Ě’˛¸. ŠÖ“cş•F1, ‹ŕˆäş•ś2, —с@Œol1, ’ˇŒ´—R‹M1, r@Ť’q1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/28), _ŒË.

723927. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ˆŸÉŽ_—R—ˆ‚ĚˆęŽ_‰ť’‚‘f‚É‚ć‚é”]•ŰŒěě—p‹@˜‚ĚŒŸ“˘. ˆŔ“ĄŽőŒb1, ź“cO”ü1, ŹâN°2, VˆäłN3, ‰Ş–{_Žk2 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2–ƒŒ, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/28), _ŒË.

723928. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ŘƒWƒXƒgƒƒtƒB[‚É‘ą”­‚ľ‚˝ÇŒóŤ‘¤œ^Ç‚É‚¨‚Ż‚éŽüpŠúŠÇ—‚ĚŒŸ“˘. “Ą–ěŽŃ‹M1, ŒË“c‰ë–ç1, H“Ą‰Â“ŢŽq1, ŽÂŒ´ŒcŽq1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/28), _ŒË.

723929. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) p’†NO‚đ‹z“ü‚ľ‚˝ŹŽ™S‘ŸŽčpÇ—á‚ĚŒŸ“˘. “Ą“c“ߌb1, “c’†ˆęś1, ăˆä䝗LŽq1, ŒË“c‰ë–ç1, ŹâN°1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/28), _ŒË.

723930. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’´’áoś‘̏dŽ™‚É‚¨‚Ż‚é‹šo‹ž‰ş“Ž–ŹŠÇ•Â˝p (VATS-PDA) ‚ĚŽüpŠúŠÇ—: 41Ç—á‚ĚŒŸ“˘. ‘şź–ž“ú1, H“Ą‰Â“ŢŽq1, ŽÂŒ´ŒcŽq1, “Ą–ěŽŃ‹M1, ŠÖ“cş•F1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/28), _ŒË.

723931. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ“Ž–Ź•Ů‹ˇóÇŠłŽŇ‚Ě”ńS‘ŸŽčp‚É‚¨‚Ż‚éŽüpŠúŠÇ—‚ĚŒŸ“˘. H“Ą‰Â“ŢŽq1, ź”ö‰Ŕ1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/29), _ŒË.

723932. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) • ‰çˆĘŽčp’†‚ĚŒoŽž“IŠáˆł•Ď‰ť. “c’†ˆęś1, ’|˜Q–Ż]1, ŽR‰ş@“Ö1, ’r“c“N–ç2, —é–Ř’qŽq3, ‰Ş–{_Žk1 (1–ƒŒ, 2Šá‰Č, 3ŒöO‰qś): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/29), _ŒË.

723933. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –Ť’ɂɑ΂ˇ‚éŠÂ‹Ť‚̉e‹ż. —é–Ř›’Žk1, ‹ŕˆäş•ś2, —с@Œol1, ’ˇŒ´—R‹M1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/29), _ŒË.

723934. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –Ť’ɂɑ΂ˇ‚éŠÂ‹Ť‚̕ωť. —é–Ř›’Žk1, ‹ŕˆäş•ś2, —с@Œol1, ’ˇŒ´—R‹M1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/29), _ŒË.

723935. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œz•”‚¨‚ć‚Ń‹š•”‚ĚŽ‘ąŇ‘‚­‚ŕ–Œ‰ş–ƒŒ‚É‚ć‚č—ǍD‚ÉŠÇ—‚Ĺ‚Ť‚˝“ŤŠŕŤ’É‚Ě1Ç—á. r@Ť’q1, —с@Œol1, ’ˇŒ´—R‹M1, ‹ŕˆäş•ś2 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ď‘ć49‰ń‘ĺ‰ď (2015/7/25), ‘ĺă.

723936. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “Ť‚Ş‚ńŤ’ÉŠłŽŇ‚ɑ΂ˇ‚鎝‘ąŇ‘‚­‚ŕ–Œ‰ş–ƒŒ‚ĚŒă‚ëŒü‚ŤŒŸ“˘. —с@Œol1, ’ˇŒ´—R‹M1, ‹ŕˆäş•ś2 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ď‘ć49‰ń‘ĺ‰ď (2015/7/25), ‘ĺă.

723937. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) śŽş‘ĺ“Ž–Źƒgƒ“ƒlƒ‹‚ɑ΂ˇ‚éVśŽ™‹Ů‹}Žčp‚Ě1—á. H“Ą‰Â“ŢŽq1, ŹâN°1, ŒË“c‰ë–ç1, “úŒür•ă1, ˆŔ“ĄŽőŒb2, ‰Ş–{_Žk1 (1–ƒŒ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ď‘ć20‰ńŠwp‘ĺ‰ď (2015/10/10), •Ÿ‰Ş.

723938. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ“Ž–Ź•Ů’uŠˇpŒă‚É•ŮŽüˆÍ‹t—Ź‚𐜂śTEE‚É‚ć‚鑁Šú”­ŒŠEC•œ‚މ”\‚Ĺ‚ ‚Á‚˝1—á. ź”ö‰Ŕ1, ŹâN°1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ď‘ć20‰ńŠwp‘ĺ‰ď (2015/10/10), •Ÿ‰Ş.

723939. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ”x“Ž–ŹiNpŒă‚̐SŽş’†ŠuŒ‡‘šÇƒpƒbƒ`•Â˝‹vp‚Ĺthree patch repair (Brom) •Ď–@‚đ—p‚˘‚˝Ç—á‚Ě–ƒŒŒoŒą. ŽÂŒ´ŒcŽq1, ŒË“c‰ë–ç1, ŹâN°1, ź”ö‰Ŕ1, ˆŔ“ĄŽőŒb2, ‰Ş–{_Žk1 (1–ƒŒ, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ď‘ć20‰ńŠwp‘ĺ‰ď (2015/10/10), •Ÿ‰Ş

723940. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒđ—\–h—p‚Ě˜A‘ąˆł”—‘•’u‚É‚ć‚čƒr[ƒ`ƒ`ƒFƒAˆĘ‚ĚŒŒˆł’ቺ‚đ—}‚Ś‚ç‚ę‚˝1—á. ‹{“c—L—Œb, ‘ĺ’Ë’q‹v1, ŹâN°1, ŒË“c‰ë–ç1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ď‘ć20‰ńŠwp‘ĺ‰ď (2015/10/11), •Ÿ‰Ş

723941. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒRƒ“ƒgƒ[ƒ‹•s—Ç‚Ě‹‘ĺbó‘BŽîᇂ̖ƒŒŒoŒą. •s•ˇˆę‹M1, ‘ĺ’Ë’q‹v1, ŹâN°1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ď‘ć35‰ń‘ĺ‰ď (2015/10/21), ‰Ą•l

723942. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) AngelmanÇŒóŒQŠłŽŇ‚Ě• o‹ž‰ş’_ůN“Eop‚Ě–ƒŒŒoŒą. –ě“c@ŒO, ĺUdçŠG1, …ŕV‹łŽq1, –ě“c‹g˜a, Ÿ–”“żˆę (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ď‘ć35‰ń‘ĺ‰ď (2015/10/22), ‰Ą•l

723943. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹ô”­“Id–ŒúŽhŒăŽ‘ąŇ‘‚­‚ŕ–Œ‰ş–ƒŒ‚É‚ć‚čpŒăŠÇ—‚đs‚Á‚˝2Ç—á. –ě˜H–ƒ”ü, ź–{ŽœŠ°, ç“cˆşŽq1, ŠÖŒű—R‰Ŕ—˘1, —é–Ř–ƒ—t1, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{—Տ°–ƒŒŠw‰ď‘ć35‰ń‘ĺ‰ď (2015/10/22), ‰Ą•l

723038. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Role of TP signaling in enhancement of LPS-induced lymphangiogenesis in a mouse peritonitis model. ź“cO”ü1, ×–ě‰Á“ŢŽq2,3, ’Ă—Ż˘—˘1, Ź‹{@Žü, ”n“ˆł—˛3 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ś—, 3–ň—): ‘ć89‰ń“ú–{–ň—Šw‰ď”N‰ď (2016/3/10), ‰Ą•l.

732129. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ƒKƒCƒhƒ‰ƒCƒ“‚ÉŒŠ‚éƒn[ƒgƒ`[ƒ€‚Ě–đŠ„. ‰Ş–{_Žk (–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ďŠÖ“ŒbM‰zE“Œ‹žŽx•”‘ć55‰ń‡“ŻŠwpW‰ď (2015/9/5), ‰Ą•l

733359. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) p’†‚ĚNasal High FlowTMŽg—p‚Ş, ‹CŠÇ‘}ŠÇ‚̉ń”đ‚É—L—p‚Ĺ‚ ‚Á‚˝, ‚“xŹ‡ŤŠˇ‹CáŠQ‡•šŠJ• ŽčpÇ—á. “Ą“c“ߌb1, źŕV‹`”V1, VˆäłN2, ˆÉ“Ą‘s•˝1, •Šâ­”V1, ‰Ş–{_Žk1 (1–ƒŒ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{–ƒŒ‰ČŠw‰ďŠÖ“ŒbM‰zE“Œ‹žŽx•”‘ć55‰ń‡“ŻŠwpW‰ď (2015/9/5), ‰Ą•l

733360. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺ—ʂ̐SůN‰t’™—Ż‚ɑ΂ˇ‚é‹šo‹ž‰şS”XƒhƒŒƒi[ƒW‚đ–TŇ’ĹƒuƒƒbƒN•š—p‘Sg–ƒŒ‚ĹŠÇ—‚ľ‚˝1—á. ‹g‘şŒOŽq1, ‘“c—S–ç, ‰Ş“c”üť, ”–ؐ­Œ›, ‰Ş–{_Žk1 (1–ƒŒ): “ú–{–ƒŒ‰ČŠw‰ďŠÖ“ŒbM‰zE“Œ‹žŽx•”‘ć55‰ń‡“ŻŠwpW‰ď (2015/9/5), ‰Ą•l.

H26”N“xˆČ‘O•Ş

[’˜@‘]

H26-620012. [Šwp‘ (•Ş’SŽˇ•M)]y“ěŽR“°ˆăŠw‘厍“T ‘ć20”ŁzƒŠƒ“ƒp‹…—AŒŒ, p.2573-4. •Šâ­”V (–ƒŒ), “ěŽR“°, “Œ‹ž, 2015/3”­s.


—Տ°ŒŸ¸f’fŠw

[Šw‰ďEŒ¤‹†‰ď“™]

732130. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) R-CPC (Reversed-Clinicopathological Conference). Žë–ě—Lě (—ŐŒŸŠw): •˝Ź27”N“xŒŸ¸ŕ–žE‘Š’k‚Ş‚Ĺ‚Ť‚é—Տ°ŒŸ¸‹ZŽtˆçŹuK‰ď (2015/10/18), ‘Š–ÍŒ´.


—AŒŒE×–EˆÚAŠw

[Šwp˜_•ś]

540056. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆŔ‘SŠÄŽ‹) ‘̐§‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vz•lŒű@Œ÷, ‰Á“Ą‰hŽj, “c’†’ŠŽu, •Ä‘ş—YŽm, “ĄˆäN•F, ‰Şč@m, “ú–ě@Šw, –L“c‹ă˜N, ŒÜ\—’Ž , •˝@—Í‘˘, •SŁr–ç, –kŕV~ˆę, ‰œŽR”üŽ÷, ‘ĺŒG@˜a, Îˆä”Ž”V, ‘ĺ’JTˆę1, ‘ĺâŒ°’Ę, ’†ŽR‹”V, ź‰Ş˛•ŰŽq, Ź‚ç‰ÁŽq (1—AŒŒE×–EˆÚA): Œúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆŔ‘SŠÄŽ‹) ‘̐§‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź25”N“x`•˝Ź27”N“x‘‡Œ¤‹†•ń‘ 2016/3; p.3-12.

540057. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆŔ‘SŠÄŽ‹) ‘̐§‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vz•lŒű@Œ÷, ‰Á“Ą‰hŽj, “c’†’ŠŽu, •Ä‘ş—YŽm, “ĄˆäN•F, ‰Şč@m, “ú–ě@Šw, –L“c‹ă˜N, ŒÜ\—’Ž , •˝@—Í‘˘, •SŁr–ç, –kŕV~ˆę, ‰œŽR”üŽ÷, ‘ĺŒG@˜a, Îˆä”Ž”V, ‘ĺ’JTˆę1, ‘ĺâŒ°’Ę, ’†ŽR‹”V, ź‰Ş˛•ŰŽq, Ź‚ç‰ÁŽq (1—AŒŒE×–EˆÚA): Œúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆŔ‘SŠÄŽ‹) ‘̐§‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2016/3; p.3-9.

540058. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆŔ‘SŠÄŽ‹) ‘̐§‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vzV‚˝‚ČŒŒ‰tťÜŠÇ—î•ńŽűW‚Ě‚˝‚ß‚ĚƒIƒ“ƒ‰ƒCƒ“ƒVƒXƒeƒ€‚ĚŠJ”­. •lŒű@Œ÷, ‹I–ěCˆę, ‘ĺ’JTˆę1, ÎâG–ĺ, “ú–ě@Šw, Îˆä”Ž”V, “ú–ě@Šw, –L“c‹ă˜N, ŒÜ\—’Ž , •˝@—Í‘˘, Îˆä”Ž”V, ‘ĺăŒ°’Ę, “ĄˆäN•F, ‰Á“Ą‰hŽj, –kŕV~ˆę, ‘ĺŒG@˜a, ź‰Ş˛•ŰŽq (1—AŒŒE×–EˆÚA): Œúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆŔ‘SŠÄŽ‹) ‘̐§‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2016/3; p.13-25.

540059. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆŔ‘SŠÄŽ‹) ‘̐§‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vzV‚˝‚ČŒŒ‰tťÜŠÇ—î•ńŽűW‚Ě‚˝‚ß‚ĚƒIƒ“ƒ‰ƒCƒ“ƒVƒXƒeƒ€‚ĚŠJ”­. •lŒű@Œ÷, ‹I–ěCˆę, ‘ĺ’JTˆę1, ÎâG–ĺ, “ú–ě@Šw, Îˆä”Ž”V, “ú–ě@Šw, –L“c‹ă˜N, ŒÜ\—’Ž , •˝@—Í‘˘, Îˆä”Ž”V, ‘ĺăŒ°’Ę, “ĄˆäN•F, ‰Á“Ą‰hŽj, –kŕV~ˆę, ‘ĺŒG@˜a, ź‰Ş˛•ŰŽq (1—AŒŒE×–EˆÚA): Œúś˜J“­Č‰ČŠwŒ¤‹†”ď•â•‹ŕ (ˆă–ň•iEˆă—Ă‹@Ší“™ƒŒƒMƒ…ƒ‰ƒgƒŠ[ƒTƒCƒGƒ“ƒX‘‡Œ¤‹†Ž–‹Ć)uƒwƒ‚ƒrƒWƒ‰ƒ“ƒX (ŒŒ‰tˆŔ‘SŠÄŽ‹) ‘̐§‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•Ş’SŒ¤‹†•ń‘ 2016/3; p.15-28.

[’˜@‘]

620122. [Šwp‘ (•Ş’SŽˇ•M)]yl‚Ś‚é—Տ°ŒŸ¸@ƒXƒNƒŠ[ƒjƒ“ƒOŒŸ¸‚ĹˆŮí’l‚đ‚Ý‚˝‚ç?z‘ćIÍ ˆŮí’l[“ǂ݃OƒŒ[ƒhƒAƒbƒv@11. ‘’`”’‚’l, p.64-8. ‘ĺ’JTˆę (—AŒŒE×–EˆÚA), •Ň: ź”öŽű“ń, •śŒő“°, “Œ‹ž, 2015/5”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

723944. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘Šú”xŠŕŠłŽŇ‚đ‘ÎŰ‚Ć‚ľ‚˝‘˝ŽíŠů’mŽîᇃ}[ƒJ[‚ɑ΂ˇ‚鎊ŒČR‘Ě‚Ě“ŻŽž‘Ş’č‚Ć‚ť‚Ě—Ő°“I—L—pŤ. ”Ť‘ş˜a’j1, ’ˇ‰–@—ş1, ˛“Ą—Yˆę1, ‘ĺ’JTˆę2, Žë–ě—Lě3, ÔŻ@“§4 (1ˆă—ÉqśŠw•”, 2—AŒŒE×–EˆÚA, 3—ŐŒŸŠw, 4‘‡f—Ă): ‘ć62‰ń“ú–{—Տ°ŒŸ¸ˆăŠw‰ďŠwpW‰ď (2015/11/19-22), Šň•Œ.


‹~–˝‹~‹}ˆăŠw

[Šwp˜_•ś]

110310. [Œ´’˜] Hybrid treatment combining emergency surgery and intraoperative interventional radiology for severe trauma. Kataoka Y1, Minehara H1, Kashimi F1, Hanajima T1, Yamaya T1, Nishimaki H, Asari Y1: Injury 2016/1; 47 (1): 59-63. (•Đ‰Ş—Sˆę1, •ôŒ´Gš1, Š~ŒŠ•śŽ}1, ‰Ô“‡@Ž‘1, ŽR’J—§‘ĺ1, ó—˜@–ő1: 1‹~–˝)

110311. [Œ´’˜] Impact of clinical nutritional education for fifth year medical students through the attendance of NST rounds for critically ill patieants: a prospective interventional study in Japan. Kan'o T1, Kataoka Y1, Soma K, Asari Y1: Austin Critical Care Journal 2015; 2 (1): 1-4. (_œä’m“š1, •Đ‰Ş—Sˆę1, ó—˜@–ő1: 1‹~–˝)

522178. [uŔ]y“ÁW: dÇŠłŽŇ‚É‚¨‚Ż‚é‹}ŤŠú‰h—{—Ă–@; ˜_“_‚̐Ž—zŒo’°‰h—{‚Ě•s‘Ť•Ş‚Í‚˘‚ÖŹ‰h—{‚Ĺ•â‘Ť‚ˇ‚é‚ׂŤ‚Š. _œä’m“š (‹~–˝): “ú–{Ă–ŹŒo’°‰h—{Šw‰ďŽGŽ 2015/4; 30 (2): 669-73.

522179. [uŔ]y“ÁW: Žcˆâ‚ˇ‚éÇó‚Í‚Ç‚ą‚܂ʼnń•œ‚ˇ‚é‚Šz“‡Ž¸’˛Ç‚ĚŽcˆâÇó. Vˆä‹v–Ť (‹~–˝): ¸_‰ČŽĄ—ĂŠw 2015/6; 30 (6): 727-30.

522180. [uŔ]y“ÁW: dÇ•a‘Ԃ̉h—{:—Ă–@ ĹV‚Ě’mŽŻ‚Ć‚ť‚ĚŽŔ‘Hz5. ‰h—{‘gŹ@Ž‰–b‚ĚŽí—Ţ‚ĆŽ‰–b“űÜ. _œä’m“š (‹~–˝): ‹~‹}EW’†ŽĄ—Ă 2015/8; 27 (7): 591-8.

522181. [uŔ]y“ÁW: —Տ°‰h—{; ’–Ú‚Ě˜b‘čzƒ`[ƒ€‚ĹŽć‚č‘g‚މh—{ŠÇ—. •Đ‰Ş—Sˆę (‹~–˝): ‹~‹}ˆăŠw 2015/11; 39 (12): 1721-6.

[’˜@‘]

620123. [Šwp‘ (•Ş’SŽˇ•M)]y‰h—{—Ă–@‚ĚƒsƒbƒgƒtƒH[ƒ‹ ‚ć‚č‚悢‰h—{ƒPƒA‚Ě‚˝‚ß‚É (—Տ°‰h—{—ŐŽž‘Š§†126 (6))zPart3 Ă–Ź‰h—{@•âŠŽ“IĂ–Ź‰h—{ (SPN) ‚Ć‚Í‚Č‚É‚Š?, p.878-84. _œä’m“š (‹~–˝), Šé‰ć: ˛X–؉ë–ç, ˆăŽ•–ňo”Ĺ, “Œ‹ž, 2015/5”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722213. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) •ďŠ‡“Iƒ`[ƒ€ˆă—Ă‚É‚ć‚édÇŠOŠłŽŇŠÇ—. •Đ‰Ş—Sˆę1, _œä’m“š1, •ž•”@1, ‰Ô“‡@Ž‘1, ‹{č“š‹P2, _•Ű•‘Ľ2, ó—˜@–ő1 (1‹~–˝, 2ƒŠƒnƒrƒŠ•”): ‘ć29‰ń“ú–{ŠOŠw‰ď‘‰ďEŠwpW‰ď (2015/6/12), ŽD–y.

722214. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) dÇŠOŠłŽŇ‚̉h—{ŠÇ—‚̏dÇŤ. •Đ‰Ş—Sˆę1, ‰Ô“‡@Ž‘1, ó—˜@–ő1 (1‹~–˝): ‘ć7‰ńAcute Care SurgeryŠw‰ďŠwpW‰ď (2015/10/4), •Ÿ‰Ş.

722215. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‹~–˝‹~‹}ƒZƒ“ƒ^[‚É”Ŕ‘—‚ł‚ꐸ_ŽžŠł‚Ş‹^‚í‚ę‚˝ŠłŽŇ‚ɑ΂ˇ‚é‘Ήž. Vˆä‹v–Ť1, ˆäăŸ•v2, ó—˜@–ő1, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ‘ć28‰ń“ú–{‘‡•a‰@¸_ˆăŠw‰ď‘‰ď (2015/11/28), “ż“‡.

722216. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‹~‹}EW’†ŽĄ—Ă—Ěˆć‚É‚¨‚Ż‚郊ƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Ɖh—{ŠÇ—‚ɑ΂ˇ‚é•ďŠ‡“Iƒ`[ƒ€ˆă—Ă‚Ě—L—pŤ. •Đ‰Ş—Sˆę1, _œä’m“š1, “y‰ŽŽu•Ű2, ˛“ĄĆŽq3, ó—˜@–ő1 (1‹~–˝, 2ŠĹŒě•”, 3‰h—{•”): ‘ć31‰ń“ú–{Ă–ŹŒo’°‰h—{Šw‰ďŠwpW‰ď (2016/2/26), •Ÿ‰Ş.

722217. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) • •”œ”ŐŠO‚ɑ΂ˇ‚é‹Ů‹}Žčp‚ĆIVR‚ĚƒRƒ“ƒrƒl[ƒVƒ‡ƒ“ŽĄ—Ă‚Ě—L—pŤ‚¨‚ć‚ŃIVR‚ĚŒŔŠE. •Đ‰Ş—Sˆę1, ‰Ô“‡@Ž‘1, Š~ŒŠ•śŽ}1, ŽR’J—§‘ĺ1, Ź‘q’źl1, ó—˜@–ő1 (1‹~–˝): ‘ć52‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2016/3/4), “Œ‹ž.

723945. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éS—Ă“ŕ‰ČŠO—ˆ‚Ĺ‚Ě—Ő°“IŒXŒü‚ÉŠÖ‚ľ‚Ä. Vˆä‹v–Ť1, ‘ĺ‹v•Ű’z˘, ‰Á“ĄŒ[Žq (1‹~–˝): ‘ć111‰ń“ú–{¸__ŒoŠw‰ďŠwp‘‰ď (2015/6/4-6), ‘ĺă.

723946. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠOÇ—á‚ɑ΂ˇ‚é–k—˘‘ĺŠw•a‰@ƒhƒNƒ^[ƒJ[ƒVƒXƒeƒ€‚Ě—L—pŤ. ŽR’J—§‘ĺ1, _œä’m“š1, ‘“c’qŹ1, ’ŠŒG’ő—˛1, ˆîŠ_‘דl1, •ž•”@1, ’|“ŕˆę˜Y1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć18‰ń“ú–{—Տ°‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2015/6/5), •xŽR.

723947. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–ƒZƒ“ƒ^[‚É‚¨‚Ż‚éŠOŤt“Ž–Ź (–{Š˛) ‘š‚ĚŽĄ—ĂŒoŒą. Š~ŒŠ•śŽ}1, ŽR’J—§‘ĺ1, ’ŠŒG’ő—˛1, ˆîŠ_‘דl1, ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć29‰ń“ú–{ŠOŠw‰ď (2015/6/11), ŽD–y.

723948. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é• •”Žh‘nÇ—á‚ĚŒŸ“˘. ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć29‰ń“ú–{ŠOŠw‰ď (2015/6/11), ŽD–y.

723949. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Injury severity score 9ˆČă‚ĚŠOŠłŽŇ‚É‚¨‚Ż‚é—ˆ‰@Žž‰h—{•]‰ż‚Ć—\Œă. _œä’m“š1, •Đ‰Ş—Sˆę1, ‰Ô“‡@Ž‘1, ’†’JŒ¤“l1, ˆîŠ_‘דl1, ŽR’J—§‘ĺ1, ’ŠŒG’ő—˛1, ‘“c’qŹ1, ’|“ŕˆę˜Y1, ó—˜@–ő1 (1‹~–˝): ‘ć29‰ń“ú–{ŠOŠw‰ď (2015/6/12), ŽD–y.

723950. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) dÇœ”ՍœÜ‚ɍ‡•š‚ľ‚˝’°œĂ–Ź‘š‚ɑ΂ˇ‚éĂ–Ź‘˘‰e‚Ě—L—pŤ. •Đ‰Ş—Sˆę1, Š~ŒŠ•śŽ}1, ŽR’J—§‘ĺ1, ‰Ô“‡@Ž‘1, ‰Í‘ş@’ź2, •ôŒ´Gš1, ó—˜@–ő1 (1‹~–˝, 2ŽŠO): ‘ć29‰ń“ú–{ŠOŠw‰ď (2015/6/12), ŽD–y.

723951. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) D‚Ť‚ȏˆ•űE“žˆÓ‚ȏˆ•ű@ˆŔ‘S‚ČŠłŽŇŠÇ—‚ލs‚Ś‚¸ˆă—Ï]Ž–ŽŇ‚Ş”ć•ž‚ˇ‚és“Ž‚É‚Í—}ŠĚŽUq‹~‹}W’†ŽĄ—Ă—Ěˆć‚Ĺ‚ĚŽg—pŒoŒąr. _œä’m“š (‹~–˝): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/12-14), •xŽR.

723952. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Œy“x”F’máŠQ‚É‚¨‚Ż‚é‘ĺ”]”’Žż•a•Ď‚Ć“Ž–Źd‰ťEśŠˆKŠľ‚ĚŠÖ˜A. Vˆä‹v–Ť1, ‚‹´@Œb2, ’†“‡Œ[‰î2, ‘ĺÎ@’q2, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ‘ć34‰ń“ú–{”F’mÇŠw‰ďŠwpW‰ď (2015/10/2), ÂX.

723953. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) œ”ՍœÜ‚ɍ‡•š‚ˇ‚éiliac vein injury‚ɑ΂ˇ‚éƒAƒvƒ[ƒ`. •Đ‰Ş—Sˆę1, ‰Ô“‡@Ž‘1, ó—˜@–ő1 (1‹~–˝): ‘ć7‰ń“ú–{Acute Care SurgeryŠw‰ď (2015/10/3), •Ÿ‰Ş.

723954. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚é‹Ů‹}ŠJ• Žčp‚đŽ{s‚ľ‚˝”sŒŒÇŤDICÇ—á‚ĚŒŸ“˘. ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, Ź‘q’źl1, ó—˜@–ő1 (1‹~–˝): ‘ć7‰ń“ú–{Acute Care SurgeryŠw‰ď (2015/10/3), •Ÿ‰Ş.

723955. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŠOŤ”]“ŕŒŒŽî‚ɑ΂ˇ‚é_Œo“ŕŽ‹‹ž“IŒŒŽîœ‹Žp‚Ě—L—pŤ‚ĚŒŸ“˘. ŹňŠ°”V1, ŽR–{‘ĺ•ă2, •“c”Ž‹I2, ŒG•”rG2 (1‹~–˝, 2”]ŠO): “ú–{”]_ŒoŠO‰ČŠw‰ď‘ć74‰ńŠwp‘‰ď (2015/10/15), ŽD–y.

723956. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰@ŠOS”x’âŽ~Ç—á‚Ě”äŠr‚É‚ć‚é‘ĚŠOzŠÂŽŽS”x‘hś–@‚Ě—LŒřŤ‚ĚŒŸ“˘. ŠŰ‹´Fş1, ’|“ŕˆę˜Y1, •ž•”@1, _œä’m“š1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć43‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2015/10/21), “Œ‹ž

723957. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ŕŽ‹‹ž“I‚É“Eo‚ľ‚Ś‚˝Œoăč–ĺ“I’ź’°ˆŮ•¨‚Ě1—á. •Đ•ôłáŠ, ’†’JŒ¤“l1, ŽR’J—§‘ĺ1, ŠŰ‹´Fş1, •ž•”@1, ’|“ŕˆę˜Y1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć43‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2015/10/21), “Œ‹ž

723958. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚鐸_ŽžŠł‡•šÇ—á‚ւ̑Ήž. ŽR’J—§‘ĺ1, Vˆä‹v–Ť1, _œä’m“š1, ˛“ĄçŒb1, •ž•”@1, ’|“ŕˆę˜Y1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć43‰ń“ú–{‹~‹}ˆăŠw‰ď‘‰ďEŠwpW‰ď (2015/10/23), “Œ‹ž

723959. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŠOŤ”]“ŕŒŒŽî‚ɑ΂ˇ‚é_Œo“ŕŽ‹‹ž“IŒŒŽîœ‹Žp‚Ě—L—pŤ‚ĚŒŸ“˘. ŹňŠ°”V1, ŽR–{‘ĺ•ă2, ‹TŽRšK2, ’h@@[2, ŒG•”rG2 (1‹~–˝, 2”]ŠO): ‘ć22‰ń“ú–{_Œo“ŕŽ‹‹žŠw‰ď (2015/11/6), ź“‡.

723960. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Spontaneous Extraperitoneal Hemorrhage‚Ě—Ő°“IŒŸ“˘. ŠŰ‹´Fş1, ŽR’J—§‘ĺ1, ’|“ŕˆę˜Y1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć43‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2016/2/12), _ŒË

723961. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚ĹŒoŒą‚ľ‚˝”j•—Ç—á‚ĚŒŸ“˘. ŽR’J—§‘ĺ1, •ž•”@1, _œä’m“š1, ’|“ŕˆę˜Y1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć43‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2016/2/12), _ŒË

723962. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) dÇŠłŽŇ‚É‚¨‚Ż‚錌‰tŒŸ¸ƒf[ƒ^‚É‚ć‚é‰h—{•]‰ż‚Ě—L—pŤ‚ÉŠÖ‚ˇ‚錟“˘. ‰““ĄŹŽq, •Đ‰Ş—Sˆę1, _œä’m“š1, ˛“ĄĆŽq2, ‹ß“Ą‰{Žq2 (1‹~–˝, 2‰h—{•”): ‘ć31‰ń“ú–{Ă–ŹŒo’°‰h—{Šw‰ďŠwpW‰ď (2016/2/25), •Ÿ‰Ş

723963. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰fŽžf’f‚Ĺ‚Ť‚Č‚Š‚Á‚˝’°ŠÔ–Œ’f—ô‚Ě1—á. ‰Ô“‡@Ž‘1, •Đ‰Ş—Sˆę1, Ź‘q’źl1, ó—˜@–ő1 (1‹~–˝): ‘ć52‰ń“ú–{• •”‹~‹}ˆăŠw‰ď‘‰ď (2016/3/4), “Œ‹ž

723964. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) œ‘gD—R—ˆŠÔ—tŒn×–E‚̐ś•¨Šw“IŒŸ“˘. ŒFŕVŒ›ˆę1, ŽRčˆŔ°2, ™–{F”V2, ”nęŽq, ‘]Ş—R”üŽq3, •“c@Œ[2 (1‹~–˝, 2Œ`ŹE”üŠO, 3•a‘ԁEf—ĂŒn): ‘ć15‰ń“ú–{Äśˆă—ĂŠw‰ď‘‰ď (2016/3/19), ‘ĺă.

733361. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒnƒ“ƒ`ƒ“ƒgƒ“•‘“Ľ•aŠłŽŇ‚ĚŽŠŽEŠé}‚É‚ć‚é“]—ŽŠO‚ލl‚Ś‚ç‚ę‚˝Ç—á‚ÉŠÖ‚ľ‚Ä‚ĚŒŸ“˘. Vˆä‹v–Ť1, ˆäăŸ•v2, ‹{’n‰p—Y2, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ‘ć41‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2015/9/26), _“ސě

733362. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Šç–ʍœœÜ‚ɑ΂ˇ‚éŒĹ’č‹ď‚Ş’Ž‚‚É’â‘Ř‚ľŠO‰ČŽčp‚É‚Ä“Eo‚ľ‚˝1—á. ŒĂ“c—S‰ŔŽq, _œä’m“š1, ŽR’J—§‘ĺ1, ŒFŕVŒ›ˆę1, ‰Ô“‡@Ž‘1, Ź‘q’źl1, ’|“ŕˆę˜Y1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć66‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŠwpW‰ď (2016/2/6), “Œ‹ž

733363. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹~‹}ŠO—ˆ‚Őf’f‚̂‚Š‚Č‚Š‚Á‚˝—ź‘¤Ž‹°[Ç‚Ěˆę—á. ”‹Œ´šD, _œä’m“š1, ‘“c’qŹ1, ’ŠŒG’ő—˛1, ŠŰ‹´Fş1, ŽR’J—§‘ĺ1, ˆîŠ_‘דl1, ‰Ô“‡@Ž‘1, •ž•”@1, Š~ŒŠ•śŽ}1, ’|“ŕˆę˜Y1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć66‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŠwpW‰ď (2016/2/6), “Œ‹ž

733364. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘˝Ę‚ȐS“d}•Ď‰ť‚đ”F‚ß‚˝ƒeƒIƒtƒBƒŠƒ“’†“łɑ΂ľWŠw“I‚ČŽĄ—Ă‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ˆę—á. —§ěšĆ, _œä’m“š1, ‘“c’qŹ1, ’ŠŒG’ő—˛1, ŠŰ‹´Fş1, ŽR’J—§‘ĺ1, ˆîŠ_‘דl1, ‰Ô“‡@Ž‘1, •ž•”@1, Š~ŒŠ•śŽ}1, ’|“ŕˆę˜Y1, •Đ‰Ş—Sˆę1, ó—˜@–ő1 (1‹~–˝): ‘ć66‰ń“ú–{‹~‹}ˆăŠw‰ďŠÖ“Œ’n•ű‰ďŠwpW‰ď (2016/2/6), “Œ‹ž

733365. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹~–˝‹~‹}ĐŠQˆă—žƒZƒ“ƒ^[‚É”Ŕ‘—‚ł‚ę‚˝‹Gß‚â”Ŕ‘—ŽžŠÔ‘сE—j“ú‚Ć‚ĚŠÖŒWŤ‚ÉŠÖ‚ľ‚Ä. Vˆä‹v–Ť1, ˆäăŸ•v2, ‹{’n‰p—Y2, ‘ĺÎ@’q2, ó—˜@–ő1, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ‘ć42‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2016/3/5), ‰Ą•l

733366. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹~–˝‹~‹}ƒZƒ“ƒ^[‚ÉŽŠŽEŠé}‚Ĺ”Ŕ‘—‚ł‚ę‚˝ŠłŽŇ‚Ě‹Gß‚â”Ŕ‘—ŽžŠÔ‘сE—j“ú‚ɂ‚˘‚Ä. Vˆä‹v–Ť1, ˆäăŸ•v2, ‹{’n‰p—Y2, ‘ĺÎ@’q2, ó—˜@–ő1, ‹{‰Ş@“™2 (1‹~–˝, 2¸_): ‘ć42‰ń_“ŢěŒ§SgˆăŠw‰ď‘‰ď‚¨‚ć‚ŃŠwpW‰ď (2016/3/5), ‰Ą•l.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-310004. [Ç—á•ń] Refractory status epilepticus, circulatory collapse after cardiac arrest, and acute respiratory distress syndrome caused by severe isolated fluvoxamine poisoning: a case report. Kan'o T1, Kamijo Y1, Hattori J1, Kashimi F1, Sato C1, Yoshimura K: Acute Medicine & Surgery 20151/; 2 (1): 53-5. (_œä’m“š1,ăžŠ‹gl1, •ž•”@1, Š~ŒŠ•śŽ}1, ˛“ĄçŒb1: 1‹~–˝)


‘‡f—ĂˆăŠw

[Šwp˜_•ś]

110312. [Œ´’˜] Medical explanations to family members in the foyer and hallway during home medical care visits. Kimura T1CMatsuzaki MCImanaga T, Akahoshi T1: Kitasato Med J 2015/9; 45 (2): 130-7. (–Ř‘ş‘ô–1, ÔŻ@“§1: 1‘‡f—Ă)

110313. [Œ´’˜] Clinical Background of Attendance by Patient's Family during Home Medical Care Visits. Kimura T1, Imanaga T, Matsuzaki M, Akahoshi T1: Journal of General and Family Medicine 2015/12; 16 (4): 271-80. (–Ř‘ş‘ô–1, ÔŻ@“§1: 1‘‡f—Ă)

120063. [Œ´’˜] Ý‘îˆă—Ă‚É‚¨‚Ż‚éˆăŽtE–K–âŠĹŒěŽt‚É‚ć‚éˆÝá‘ŒđŠˇ‚ÉŠÖ‚ˇ‚é’˛¸. –Ř‘ş‘ô–1, ‹g]@Œĺ, “y‰Ž—ÚŒŠŽq, ě‰zł•˝, •˝Œ´˛“lŽi (1‘‡f—Ă): “úÝˆă‰ďŽ 2015/7; 17 (1): 11-9.

521029. [‰đŕ] ‚—îŽŇ‚ĆƒAƒƒ}ƒeƒ‰ƒs[. –Ř‘ş‘ô– (‘‡f—Ă): AEAJ (ƒAƒƒ}ŠÂ‹Ť‹Ś‰ď‹@ŠÖŽ) 2015//9; 77: 26-9.

522182. [uŔ]y“ÁW: ŽŔ‘H! “ޒɐf—Á|“Ş’É‚É”Y‚ŢŠłŽŇ‚đ‚Ç‚¤f‚Ä‚Ç‚¤ŽĄ‚ˇ?zŔ’k‰ď: ‚ą‚ę‚Š‚ç‚Ě“Ş’É‚Ěƒ`[ƒ€ˆă—Ă‚đl‚Ś‚é. Ži‰ď: ŒÜ\—’‹v‰Ŕ, ó–ě‰ę—Y, ŒÜ–ě—R‰Ŕ—1, ”n™ˆťŽq (1‘‡f—Ă): —Տ°ŽGŽ“ŕ‰Č 2015/5; 115 (5): 823-31.

522183. [uŔ]yƒVƒ“ƒ|ƒWƒEƒ€2-3z“Ş’ÉŠż•űŽĄ—Ă‚ĚŽŔŰ. ŒÜ–ě—R‰Ŕ— (‘‡f—Ă): “Ş’ÉŠw‰ďŽ 2015/7; 42 (1): 102-5.

522184. [uŔ]yƒVƒ“ƒ|ƒWƒEƒ€zÝ‘îˆă—Ă‚É‚¨‚Ż‚éuˆă—ÁE‰îŒě˜AŒgv‚̍Ą“ú“IˆÓ‹`. –Ř‘ş‘ô– (‘‡f—Ă): “úÝˆă‰ďŽ 2015/7; 17 (1): 123.

540060. [‚ť‚Ě‘ź] ƒvƒ‰ƒ^ƒiƒX: Ý‘îf—Ă‚É‚¨‚Ż‚éˆă—ψ’uŽŔŽ{‚Ě”ť’f. –Ř‘ş‘ô– (‘‡f—Ă): TŠ§“ú–{ˆăŽ–V–@ 2015/4; 4746: 1.

540061. [‚ť‚Ě‘ź (Editorial)] Ą‚ą‚ťƒvƒ‰ƒCƒ}ƒŠEƒPƒA—Ěˆć‚Ě—Ő°E‹łˆç‚ÉŠÖ‚ˇ‚éî•ń”­M‚đ! –Ř‘ş‘ô– (‘‡f—Ă): “ú–{ƒvƒ‰ƒCƒ}ƒŠEƒPƒA˜A‡Šw‰ďŽ 2015/12; 38 (4): 334.

[’˜@‘]

620124. [Šwp‘ (•Ş’SŽˇ•M)]y‘‡f—Ðę–ĺˆăƒVƒŠ[ƒY@‘‡f—Ðę–ĺˆă‚ĚƒJƒ‹ƒe|ƒvƒƒuƒŒƒ€ƒŠƒXƒg‚ÉŠî‚Ă‚­f—Ă‚ĚŽŔŰz‚—îŠú@Še˜_@12. ‹•Žă‚—îŽŇEQ‚˝‚Ť‚č, p.138-9. –Ř‘ş‘ô– (‘‡f—Ă), •ŇWŽĺŠ˛: ‘ę“SŽü, ę–ĺ•ŇW, ‰Ą—ŃŒŤˆę, ’†ŽR‘“X, “Œ‹ž, 2015/7”­s.

620125. [Šwp‘ (•Ş’SŽˇ•M)]y‘‡f—Ðę–ĺˆăƒVƒŠ[ƒY@‘‡f—Ðę–ĺˆă‚ĚƒJƒ‹ƒe|ƒvƒƒuƒŒƒ€ƒŠƒXƒg‚ÉŠî‚Ă‚­f—Ă‚ĚŽŔŰz‚—îŠú@Še˜_@13. “Ć‹E•Â‚ś‚ą‚ŕ‚č, p.140-1. –Ř‘ş‘ô– (‘‡f—Ă), •ŇWŽĺŠ˛: ‘ę“SŽü, ę–ĺ•ŇW, ‰Ą—ŃŒŤˆę, ’†ŽR‘“X, “Œ‹ž, 2015/7”­s.

622126. [Šwp‘ (–|–ó)]yl‚Ś‚é‹Zp —Տ°“IŽvl‚𕪐͂ˇ‚é ‰ü’ů‘ć3”Ĺ (Symptom to Diagnosis: An Evidence-Based Guide)z’|–{@‹B (‘‡f—Ă), “úŒoBPŽĐ, “Œ‹ž, 2015/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722218. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Ý‘îˆă—Ă‚É‚¨‚Ż‚éˆă—ÁE‰îŒě˜AŒg‚̍Ą“ú“IˆÓ‹`. –Ř‘ş‘ô– (‘‡f—Ă): ‘ć17‰ń“ú–{Ý‘îˆăŠw‰ď‚ŕ‚肨‚Š‘ĺ‰ď (2015/4/25), ˇ‰Ş.

723965. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒOƒ‹[ƒvf—Ă‚Ĺ–K–âf—Ă‚đs‚¤ŰuŒÂX‚ĚˆăŽt‚É‚ć‚Á‚Äŕ–ž‚ˇ‚é u“ŕ—e‚ވႤv‚ƉƑ°‚ŞŠ´‚ś‚é‚ą‚Ƃ́u–K–âŠÔŠu‚Ş’ˇ‚˘‚ą‚Ɓv uˆăŽt‚ɉď˜b‚đŽŐ‚ç‚ę‚˝‰Ć‘°‚ĚŒoŒąv‚ĆŠÖŒW‚ľ‚Ä‚˘‚é. –Ř‘ş‘ô–1, Ą‰iŒő•F, źč~l, ⨍F‘ž˜Y1, ŒÜ–Ąˆę‰p, ÔŻ@“§1 (1‘‡f—Ă): ‘ć17‰ń“ú–{Ý‘îˆăŠw‰ď‚ŕ‚肨‚Š‘ĺ‰ď (2015/4/25), ˇ‰Ş.

723966. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ý‘î‚Ş‚ńI––ŠúŠłŽŇ‚É‚¨‚˘‚Ä, ƒRƒ‹ƒ`ƒRƒXƒeƒƒCƒh“Š—^‚É‚ć‚é ŒoŒűŰŽć—ʂ̉ü‘P‚Ě—L–ł‚Í—\Œă—\‘Ş‚É—L—p‚Ĺ‚ ‚é. Ą‰iŒő•F, ŠOŽR“N–ç, ‹ß“ĄGˆę, –Ř‘ş‘ô–1 (1‘‡f—Ă): ‘ć17‰ń“ú–{Ý‘îˆăŠw‰ď‚ŕ‚肨‚Š‘ĺ‰ď (2015/4/25), ˇ‰Ş.

723967. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –K–âŠĹŒě‚É‚¨‚Ż‚éƒJƒe[ƒeƒ‹ŒđŠˇˆ’u‚ĚŽŔŽ{ó‹ľ‚Ć’nˆć“ÁŤ‚ĚŠÖ˜A. •˝–ě@‰›, ‹g]@Œĺ, –Ř‘ş‘ô–1, –ěŒű–ƒˆßŽq, ě‰zł•˝, •˝Œ´˛“lŽi (1‘‡f—Ă): ‘ć17‰ń“ú–{Ý‘îˆăŠw‰ď‚ŕ‚肨‚Š‘ĺ‰ď (2015/4/25), ˇ‰Ş.

723968. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –K–âf—Ă‚É‚¨‚Ż‚éƒJƒe[ƒeƒ‹ŒđŠˇˆ’u‚ĚŽŔŽ{ó‹ľ‚Ć’nˆć“ÁŤ‚Ć‚ĚŠÖ˜A. –Ř‘ş‘ô–1, ‹g]@Œĺ, ě‰zł•˝, •˝Œ´˛“lŽi, ”Ń“‡Ÿ–î, ŽR’†@’ (1‘‡f—Ă): ‘ć17‰ń“ú–{Ý‘îˆăŠw‰ď‚ŕ‚肨‚Š‘ĺ‰ď (2015/4/25), ˇ‰Ş.

723969. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ý‘îˆă—Ă‚É‚¨‚Ż‚éˆăŽtE–K–âŠĹŒěŽt‚É‚ć‚éˆÝá‘ŒđŠˇ‚ÉŠÖ‚ˇ‚é’˛¸. –Ř‘ş‘ô– (‘‡f—Ă): ‘ć6‰ń“ú–{ƒvƒ‰ƒCƒ}ƒŠEƒPƒA˜A‡Šw‰ďŠwp‘ĺ‰ď (2015/6/14), ‚‚­‚Î.

H26”N“xˆČ‘O•Ş

[’˜@‘]

H26-620013. [Šwp‘ (•Ş’SŽˇ•M)]y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz˜Íg—Š‚ę‚éŽĺŽĄˆăh‚Ć‚ľ‚č‚—îŽŇ‚đf‚éŰ‚̐S“ž@1. ‚—îŽŇ‚ɐę–ĺf—ÉȂđĐ‰î‚ˇ‚é‚Š”Ű‚Š‚Ě”ť’f, p.16-7. –Ř‘ş‘ô–1 (1‘‡f—Ă), •Ň: –Ř‘ş‘ô–1, ź‘ş^Ži, —r“yŽĐ, “Œ‹ž, 2015/3”­s.

H26-620014. [Šwp‘ (•Ş’SŽˇ•M)]y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz˜Íg—Š‚ę‚éŽĺŽĄˆăh‚Ć‚ľ‚č‚—îŽŇ‚đf‚éŰ‚̐S“ž@2. ‚—îŽŇ‚ɐę–ĺf—ÉȂđŽóf‚ľ‚Ä‚ŕ‚炤‘O‚Ɏ厥ˆă‚ލs‚¤‚ׂŤ‚ą‚Ć, p.18-9. –Ř‘ş‘ô–1 (1‘‡f—Ă), •Ň: –Ř‘ş‘ô–1, ź‘ş^Ži, —r“yŽĐ, “Œ‹ž, 2015/3”­s.

H26-620015. [Šwp‘ (•Ş’SŽˇ•M)]y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz‘ć5Í Ž¨•@ˆôA‰Č“I–â‘č@1. •ŕ‚­‚Ćƒtƒ‰ƒtƒ‰‚ˇ‚é (–Ť‚Ě”ń‰ń“]Ť‚ß‚Ü‚˘Š´), p.108-9. –Ř‘ş‘ô–1, Źě–ΗY (1‘‡f—Ă), •Ň: –Ř‘ş‘ô–1, ź‘ş^Ži, —r“yŽĐ, “Œ‹ž, 2015/3”­s.

H26-620016. [Šwp‘ (•Ş’SŽˇ•M)]y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz‘ć5Í Ž¨•@ˆôA‰Č“I–â‘č@2. ‰Ć‘°‚Š‚ç“ď’Ž‚Ć‚˘‚í‚ę‚Ä‚˘‚é‚Ş, –{l‚Í•â’ŽŠí‚đŠó–]‚ľ‚Č‚˘ (“ď’Ž‚ւ̑Ήž), p.110-1. –Ř‘ş‘ô–1, Źě–ΗY (1‘‡f—Ă), •Ň: –Ř‘ş‘ô–1, ź‘ş^Ži, —r“yŽĐ, “Œ‹ž, 2015/3”­s.

H26-620017. [Šwp‘ (•Ş’SŽˇ•M)]y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz‘ć5Í Ž¨•@ˆôA‰Č“I–â‘č@3. ‰˝”N‚ந‘~‚Ť‚đ‚ľ‚Ä‚˘‚Ü‚š‚ń (Ž¨CđÇ), p.112-3. –Ř‘ş‘ô–1, Źě–ΗY (1‘‡f—Ă), •Ň: –Ř‘ş‘ô–1, ź‘ş^Ži, —r“yŽĐ, “Œ‹ž, 2015/3”­s.

H26-620018. [Šwp‘ (•Ş’SŽˇ•M)]y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz‘ć5Í Ž¨•@ˆôA‰Č“I–â‘č@4. •@ŒŒ‚ޏo‚ÄŽ~‚Ü‚ç‚Č‚˘ (•@oŒŒ), p.114-6. –Ř‘ş‘ô–1, Źě–ΗY (1‘‡f—Ă), •Ň: –Ř‘ş‘ô–1, ź‘ş^Ži, —r“yŽĐ, “Œ‹ž, 2015/3”­s.

H26-620019. [Šwp‘ (•Ş’SŽˇ•M)]y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz‘ć5Í Ž¨•@ˆôA‰Č“I–â‘č@5. Ž¨‚Ě’†‚Ş‚Š‚䂢 (ŠOŽ¨“š‰Š), p.118-9. –Ř‘ş‘ô–1, Źě–ΗY (1‘‡f—Ă), •Ň: –Ř‘ş‘ô–1, ź‘ş^Ži, —r“yŽĐ, “Œ‹ž, 2015/3”­s.

H26-620020. [Šwp‘ (•Ş’SŽˇ•M)]y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz‘ć5Í Ž¨•@ˆôA‰Č“I–â‘č@6. •@…‚ސ‚‚ę‚Ä‚­‚é (•@‰Š), p.120-1. –Ř‘ş‘ô–1, Źě–ΗY (1‘‡f—Ă), •Ň: –Ř‘ş‘ô–1, ź‘ş^Ži, —r“yŽĐ, “Œ‹ž, 2015/3”­s.

H26-620021. [Šwp‘] (•Ş’SŽˇ•M)y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz‘ć11Í ‰h—{EƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“‚Ě–â‘č@1. ‚ą‚̍‚—îŽŇ‚Í‚˘‚Á‚˝‚˘‰˝‚Ş‚Ĺ‚Ť‚ĉ˝‚Ş‚Ĺ‚Ť‚Č‚˘‚Ě‚Ĺ‚ ‚낤‚Š?/2. ‚ą‚ĚŠłŽŇ‚̉h—{‚͏\•Ş‚Č‚Ě‚Ĺ‚ ‚낤‚Š/3. Qž‚ń‚Ĺ‚Š‚ç‘Ť˜‚ŞŽă‚Á‚Ä‚ľ‚Ü‚Á‚˝/4. ŠłŽŇ‚ŞÄ‚Ń“]‚΂Ȃ˘‚˝‚ß‚É‚Í‚Ç‚¤‚ˇ‚ę‚΂悢‚Ě‚Š/5. HŽ–“ŕ—e‚âH‚ׂł‚š•ű‚ĹŒëš‹‚đŒ¸‚ç‚ˇ‚É‚Í/6. •Đ–ƒáƒ‚Ö‚Ě”z—ś‚đ‚ľ‚˝‚˘/7. ‚Ü‚˝Œű‚Š‚çH‚ׂ˝‚˘!, p.178-195. –Ř‘ş‘ô–1 (1‘‡f—Ă), •Ň: –Ř‘ş‘ô–1, ź‘ş^Ži, —r“yŽĐ, “Œ‹ž, 2015/3”­s.

H26-621001. [Šwp‘ (•ŇW)]y—Š‚ę‚éŽĺŽĄˆă‚É‚Č‚é‚˝‚ß‚Ě‚—îŽŇf—Ă‚ĚƒRƒc‚đŠe‰Čę–ĺˆă‚Ş‹ł‚Ś‚Ü‚ˇz•Ň: –Ř‘ş‘ô–1, ź‘ş^Ži (1‘‡f—Ă), —r“yŽĐ, “Œ‹ž, 2015/3”­s.


ˆăŠw•”•‘ŽˆăŠw‹łˆçŒ¤‹†ŠJ”­ƒZƒ“ƒ^[

ˆăŠw‹łˆçŒ¤‹†•”–ĺ

[Šwp˜_•ś]

522185. [uŔ]y“ÁW:u–K–âf—Ávu’nˆć˜AŒgvuƒvƒ‰ƒCƒ}ƒŠEƒPƒAvuŠĹŽć‚čv...... ‚Š‚Š‚č‚‚Żˆă‚Ě‹­‰ť‘zŠĹŽć‚č. ç—tG‹B (ˆăŠw‹łˆç): CLINIC BAMBOO 2015/11; 416: 18-9.

[Šw‰ďEŒ¤‹†‰ď“™]

713130. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Prospective study on explanation by visiting nurse / care manager and the place of death of terminal cancer patients. Chiba H1, Moriya R1, Onozawa S, Ogata T, Ito M: Mixed Methods International Research Association ASIA Regional Conference^JSMMR (‘ŰŹ‡Œ¤‹†–@Šw‰ďƒAƒWƒA’nˆć‰ď‹c/‘ć1‰ń“ú–{Ź‡Œ¤‹†–@Šw‰ď) (2015/9/20), ‘ĺă. (ç—tG‹B1, Žç‰Ž—˜‰Ŕ1, Ź–ě‘ňŽ , ”öŒ`—Ď–ž, ˆÉ“Ą“šĆ: 1ˆăŠw‹łˆç)

722219. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‰ß‹Ž10”NŠÔ‚Ě“ú–{ˆă—ÁE•a‰@ŠÇ—Šw‰ďŽ‚Ć‘‰ď´˜^‚Š‚ç‚Ý‚˝Šwp—pŒę‚Ě’č—Ę“I•ŞÍ. ç—tG‹B1, ˆÉ“Ą“šĆ, ’rčŸ], ÜˆäF’j, •›“‡G‹v, •šŒŠ´G, XŽR”ü’mŽq, ŽR‰ş“N˜Y, ŽR–{Œőş, ˆÉ“ĄOl (1ˆăŠw‹łˆç): ‘ć53‰ń“ú–{ˆă—ÁE•a‰@ŠÇ—Šw‰ďŠwp‘‰ď (2015/11/6), •Ÿ‰Ş.


ŠwKŽx‰‡Œ¤‹†•”–ĺ


ˆăŠwŒ´˜_Œ¤‹†•”–ĺ


ˆă—ĂˆŔ‘SEŠÇ—ŠwŒ¤‹†•”–ĺ

[Šwp˜_•ś]

110314. [Œ´’˜] Evidence-based clinical practice guidelines for liver cirrhosis 2015. Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, Shibuya A1, Seike M, Nagoshi S, Segawa M, Tsubouchi H, Moriwaki H, Kato A, Hashimoto E, Michitaka K, Murawaki T, Sugano K, Watanabe M, Shimosegawa T: J Gastroenterol 2016/7; 51 (7): 629-50. (a’J–ž—˛1: 1ˆă—ĂŠÇ—)

[’˜@‘]

620127. [Šwp‘ (•Ş’SŽˇ•M)]yŠĚd•Ďf—ĂƒKƒCƒhƒ‰ƒCƒ“2015 ‰ü’ů‘ć2”Łz‘ć3Í ŽĄ—Á@2. RƒEƒCƒ‹ƒX—Ă–@, p.30-51. a’J–ž—˛ (ˆă—ĂŠÇ—), •Ň: “ú–{Á‰ťŠí•aŠw‰ď, “ě]“°, “Œ‹ž, 2015/10”­s.

620128. [Šwp‘ (‹¤’˜)]yMBA—ŹƒP[ƒXƒƒ\ƒbƒh‚ĹŠw‚Ôˆă—ĂŒo‰c“ü–ĺIIza’J–ž—˛1, ’†ŕV@’B, źŒ´—R”ü, ĺč@‰pŸŞ, ’ç@’B˜Y, ˛“Ą”T—Žq2, “‡‹v”üŽq (1ˆă—ĂŠÇ—, 2ˆă—ĂŒo‰c), “úŒoBPŽĐ, “Œ‹ž, 2016/1”­s.


ˆă—Ă‹Zp‹łˆçŒ¤‹†•”–ĺ

[’˜@‘]

620129. [Šwp‘ (•Ş’SŽˇ•M)]yƒNƒGƒbƒVƒ‡ƒ“Eƒoƒ“ƒN@ŠĹŒěŽt‘‰ĆŽŽŒą–â‘č‰đŕ2016zEtE”ĺ”AŠíŽžŠł@–Ťt‘Ÿ•a, p.278-9. â–{Ž“o (ˆă—Ă‹Zp‹łˆç), ƒƒfƒBƒbƒNƒƒfƒBƒA, “Œ‹ž, 2015/4”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

723970. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –Ťt‘Ÿ•a (CKD) ‚̐t‹@”\áŠQis‚É”ş‚¤‘㏾ŤtK”rŸ•”\‚Ě‘˝—lŤ. â–{Ž“o1, Źě‚Ý‚ä‚Ť2 (1ˆă—Ă‹Zp‹łˆç, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć58‰ń“ú–{t‘ŸŠw‰ďŠwp‘‰ď (2015/6/5), –źŒĂ‰Ž.


ˆă—Ïî•ń‹łˆçŒ¤‹†•”–ĺ

[’˜@‘]

620130. [Šwp‘ (’P’˜)]yQƒVƒŠ[ƒY@Vś—Šw ‘ć6”Łz ’|“ŕş”Ž (ˆă—Ïî•ń‹łˆç), “ú–{ˆăŽ–V•ńŽĐ, “Œ‹ž, 2015/9”­s.


“Œ—mˆăŠw‹łˆçŒ¤‹†•”–ĺ

[Šwp˜_•ś]

110315. [Œ´’˜] Antidepressive-like effect of a Kampo (traditional Japanese) medicine, kososan (Xiang Su San) in a stress-induced depression-like mouse model: Proteomic analysis of hypothalamus. Nagai T1, Hashimoto R, Okuda SM, Kodera Y, Oh-Ishi M, Maeda T, Ito N, Hanawa T1,2, Kiyohara H1, Yamada H: Traditional & Kampo Medicine 2015/9; 2 (2): 50-9. (‰Ô—Öšć•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

320043. [Ç—á•ń] –k—˘“ŒˆăŒ¤f—Ă˜^‚Š‚ç (135): ‘hŽU‚É‚ć‚č’E–яǁEŽź]‚މü‘P‚ľ‚˝ˆę—á. •äĎ@÷1, ě“çˆÉW1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): Šż•ű‚Ě—Ő° 2015/4; 62 (4): 695-700.

320044. [Ç—á•ń] –k—˘“ŒˆăŒ¤f—Ă˜^‚Š‚ç (136): Ž{‹„‚É‚ć‚č‹š‹ę‚ľ‚ł‚ފɘa‚ľ‚˝ˆęÇ—á. ˆÉ“Ą—Yˆę1, ‘š~@‘s1, ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): Šż•ű‚Ě—Ő° 2015/5; 62 (5): 901-4.

320045. [Ç—á•ń] ˆô’†–k—˘“ŒˆăŒ¤f—Ă˜^‚Š‚ç (137): ŕtäg‚Í”F‚ß‚Č‚˘‚Ş”ź‰ÄŒú–p“’‚Ş—LŒř‚ž‚Á‚˝Žo–…‚ĚÇ—á. X—T‹IŽq1, —é–Ř–M•F1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): Šż•ű‚Ě—Ő° 2015/6; 62 (6): 1096-100.

320046. [Ç—á•ń] ‰Š@‚É‚ć‚é–ň•¨ŤŠĚáŠQ‚Ş‹^‚í‚ę‚˝3—á|Ĺ‹ßŒoŒą‚ľ‚˝ŽŠŠoÇó‚Ě–R‚ľ‚˘Ç—á‚Š‚ç|. ‹yě“N˜Y1, ŒÜ–ě—R‰Ŕ—1,2, •Ÿ“c’mŒ°, –xě•üŒb1, –x“cL–ž1, X—T‹IŽq1, ě“çˆÉW1, Î–Ń’B–ç1, Ź“cŒű_1, Žá™ˆŔŠó”T1, ‰œ•xr”V3, ‰Ô—Öšć•F1,4 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2‘‡f—Ă, 3–ƒŒ, 4“Œ—mˆăŠw‹łˆç): “ú–{“Œ—mˆăŠw‰ďŽGŽ 2015/7; 66 (3): 212-7.

320047. [Ç—á•ń] ”~‰JŽž‚É”­Ç‚ˇ‚éŽč‘Ť‚Ě’É‚Ý‚É”’žQ•Žq“’‚Ş’˜Œř‚ľ‚˝1Ç—á. X—T‹IŽq1, —é–Ř–M•F1, ‹yě“N˜Y1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): “ú–{“Œ—mˆăŠw‰ďŽGŽ 2015/8; 66 (3): 250-5.

320048. [Ç—á•ń] –k—˘“ŒˆăŒ¤f—Ă˜^‚Š‚ç (138): ‘˝ŠžÇ‚É䨗čŠĂ‘“’‚Ş—LŒř‚Ĺ‚ ‚Á‚˝1—á. ‹yě“N˜Y1, Î–Ń’B–ç1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): Šż•ű‚Ě—Ő° 2015/8; 62 (8): 1388-91.

320049. [Ç—á•ń] –k—˘“ŒˆăŒ¤f—Ă˜^‚Š ‚ç (139): ”DP’†‚ɏoŒť‚ľ‚˝‘Á‰t‰ß‘˝‚ɌܗčŽU—ż‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ˆę—á. ě“çˆÉW1, Ż–ě‘ě”V1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): Šż•ű‚Ě—Ő° 2015/9; 62 (9): 1526-30.

320050. [Ç—á•ń] –k—˘“ŒˆăŒ¤f—Ă˜^‚Š‚ç (140): Žl‹tŽU‚Ş‘tŒř‚ľ‚˝•Đ“Ş’É‚ĚÇ—á. —é–Ř–M•F1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): Šż•ű‚Ě—Ő° 2015/10; 62 (10): 1711-8.

320051. [Ç—á•ń] –k—˘“ŒˆăŒ¤f—Ă˜^‚Š‚ç (141): DŽ_‹…Ť’†Ž¨‰Š‚ÉŽÄ–p“’ƒGƒLƒX‚Ş—L—p‚Ĺ‚ ‚Á‚˝1Ç—á. Î–Ń’B–ç1, Ź“cŒű_1, ‹yě“N˜Y1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): Šż•ű‚Ě—Ő° 2015/11; 62 (11): 1839-43.

320052. [Ç—á•ń] –k—˘“ŒˆăŒ¤f—Ă˜^‚Š‚ç (142): ƒCƒ“ƒtƒ‹ƒGƒ“ƒUŒă‚Ě‘Ě’˛•s—ǂɏŹŽÄŒÓ“’‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ˆę—á. Â–Ř‚ä‚Š‚č1, Ż–ě‘ě”V1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): Šż•ű‚Ě—Ő° 2015/12; 62 (12): 2038-42.

320053. [Ç—á•ń] —Çžk“’—LŒř—á‚ĚŒŸ“˘. •äĎ@÷1, Ż–ě‘ě”V1, ‹yě“N˜Y1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): “ú–{“Œ—mˆăŠwŽGŽ 2016/1; 67 (1): 45-9.

320054. [Ç—á•ń] –k—˘“ŒˆăŒ¤f—Ă˜^‚Š‚ç (143): ”w•”‚Ě—â‚Ś‚ɐ´Žź‰ťá‚“’‚Ş‘tŒř‚ľ‚˝1—á. Ż–ě‘ě”V1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): Šż•ű‚Ě—Ő° 2016/1; 63 (1): 121-5.

522186. [uŔ]y“ÁW: ŽŠ—Ľ_Œo‚đ‚ŕ‚¤ˆę“xl‚Ś‚ézŽŠ—Ľ_Œo‚̐§Œä@Šż•űˆăŠwEŠż•ű–ň‚ĆŽŠ—Ľ_Œo. ‹yě“N˜Y1, Ź“cŒű_1, Žá™ˆŔŠó”T1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): JOHNS 2015/8; 31 (8): 1049-52.

[Šw‰ďEŒ¤‹†‰ď“™]

712035. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Treatment with Kampo Medicine for otologic disorders. Ishige T1, Odaguchi H1, Hanawa T1,2: International Congress on Complementary Medicine Research 2015 (2015/5/14), Jeju, Korea. (Î–Ń’B–ç1, Ź“cŒű_1, ‰Ô—֏r•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

712036. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Daikenchuto, a Kampo medicine, ameliorates postoperative ileus by anti-inflammatory action through nicotinic acetylcholine receptors. Oikawa T1, Endo M1, Hori M, Ozaki H, Hanawa T1,2: 3rd International Symposium for Japanese Kampo Medicine (2015/6/19), Vienna, Austria. (‹yě“N˜Y1, ‰““Ą^—1, ‰Ô—֏r•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

712037. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) Kampo practice standardization project. Odaguchi H1, Wakasugi A1, Sekine M1, Ishige T1, Ito Y1, Kawanabe T1, Mitsuma T, Shimada Y, Shibahara N, Arai M, Namiki T, Muramatsu S, Hanawa T1,2: 3rd International Symposium for Japanese Kampo Medicine (2015/6/19), Vienna, Austria. (Ź“cŒű_1, Žá™ˆŔŠó”T1, ŠÖŞ–ƒ—Žq1, Î–Ń’B–ç1, ˆÉ“Ą—Yˆę1, ě“çˆÉW1, ‰Ô—֏r•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

712038. [Šw‰ď (‘Ű)] (ƒVƒ“ƒ|ƒWƒEƒ€) The role of Kampo medicine in modern clinical practice in Japan. Oikawa T1, Odaguchi H1, Hanawa T1,2: 3rd PolyU Botanical Symposium (2015/12/3), Hong Kong, China. (‹yě“N˜Y1, Ź“cŒű_1, ‰Ô—֏r•F1,2: 1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç)

721021. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) –k—˘“ŒˆăŒ¤‚Ě“`“`—đ‘ă3Š’ˇ‚Š‚ç‹ł‚Ś‚Ä’¸‚˘‚˝‚ą‚Ɓ`. ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/12), •xŽR.

722220. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‘hŽU‚É‚ć‚é—}‚¤‚Â‚ĚŠÉ˜aEŽĄ—Ă‚ÉŒü‚Ż‚˝Šî‘bŒ¤‹†‚Š‚ç—Տ°‚Ö‚ĚƒAƒvƒ[ƒ`. ‰iˆä—˛”V1, ŹŽ›‹`’j, ŽR’†‹I‰›Žq, Ź—ѐ玥, ŹŽ›‹Ml, Ö“Ą’B–ç, ‘ĺÎł“š, ˆÉ“Ą’źŽ÷1, ŠÖŞ–ƒ—Žq1, Žá™ˆŔŠó”T1, Ź“cŒű_1, ‰Ô—Öšć•F1,2, ŽR“c—zé, ´Œ´Š°Í1 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć32‰ń˜aŠżˆă–ňŠw‰ďŠwp‘ĺ‰ď (2015/8/23), •xŽR.

722221. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‹@”\ŤƒfƒBƒXƒyƒvƒVƒA‚𒆐S‚Ć‚ľ‚˝”ź‰ÄŒú–p“’‚ĚŽg‚˘•ű`ŒĂ“T‚ÉŠî‚Ă‚˘‚˝Žg—p–Ú•W‚Ć‚ĚŠÖ˜A‚ɂ‚˘‚ā`. ‹yě“N˜Y1, ˆÉ“Ą@„1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć12‰ń“ú–{Á‰ťŠÇŠw‰ď‘‰ďŠwpW‰ď (2016/2/27), “Œ‹ž.

723971. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”ź‰ÄŒú–p“’‚̏Á‰ťŠÇ‹@”\‚ɑ΂ˇ‚éŒř‰Ę`Œ’íŹl‚đ‘ÎŰ‚Ć‚ľ‚˝“ńd–ÓŒŸ”äŠrŽŽŒą`. ‹yě“N˜Y1, Ź“cŒű_1, Žá™ˆŔŠó”T1, ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć101‰ń“ú–{Á‰ťŠí•aŠw‰ď‘‰ď (2015/4/24), ‹{é.

723972. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‹Č’źŁ—Ź‚ĚŒűŒEˆăˆÄ‚É’–Ú‚ľ‚˝w˜aŠżŽ[Œž—v•űxw–{–M–źˆă—ŢˆÄx‚̉đÍ. Ż–ě‘ě”V1, Ź‘]ŒË—m1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć116‰ń“ú–{ˆăŽjŠw‰ď‘‰ďEŠwp‘ĺ‰ď (2015/4/25), ‘ĺă.

723973. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) í÷–@‚̐Ź—§‹NŒš‹y‚Ń‚ť‚ĚŒoˆÜ‚ÉŠÖ‚ˇ‚錤‹†|]ŒË––Šú‚Š‚珺˜a‚É‚Š‚Ż‚ā|. â“cKŽĄ1, ‘ĺ—˘^“Ţ”ü1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć116‰ń“ú–{ˆăŽjŠw‰ď‘‰ďEŠwp‘ĺ‰ď (2015/4/25), ‘ĺă.

723974. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[)w—cXV‘xŠˆřwç‹ŕ—ƒ•űx‚ĚŒŸ“˘. –x“cL–ž1, Ź‘]ŒË—m1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć116‰ń“ú–{ˆăŽjŠw‰ď‘‰ďEŠwp‘ĺ‰ď (2015/4/25), ‘ĺă.

723975. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŒĂ“Tˆă‘‚É‚¨‚Ż‚é•—ŽsŒŠ‚Ě‹Lq‚ɂ‚˘‚Ä. ÎŒ´@•1, ‘š~@‘s1, ˆÉ“Ą—Yˆę1, Źŕ_Žu”ż1, •Šâ“ށXŽq1, ˆä“c„l1, ŹŽR@Šî1, ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć64‰ń (ŒöŽĐ) ‘S“ú–{čI‹„Šw‰ďŠwp‘ĺ‰ď‚Ó‚­‚ľ‚Ü‘ĺ‰ď (2015/5/22), •Ÿ“‡.

723976. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‰ş”źgŒ^—â‚ŚÇ‚Ě•aˆö‚Ćä\’†ŒŠ (ŠďŒŠ) ‚̐f’f“IˆÓ‹`. ˆÉ“Ą@„1, ‘š~@‘s1, ˆÉ“Ą—Yˆę1, Źŕ_Žu”ż1, •Šâ“ށXŽq1, ˆä“c„l1, ÎŒ´@•1, ŹŽR@Šî1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć64‰ń (ŒöŽĐ) ‘S“ú–{čI‹„Šw‰ďŠwp‘ĺ‰ď‚Ó‚­‚ľ‚Ü‘ĺ‰ď (2015/5/22), •Ÿ“‡.

723977. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‰Á—”Á•ĎŤ‚É‚ć‚鎋—͒ቺ‚ÉčIŽĄ—Ă‚ŞŒř‚˘‚˝ˆęÇ—á. ˆä“c„l1, ‘š~@‘s1, ˆÉ“Ą—Yˆę1, Źŕ_Žu”ż1, •Šâ“ށXŽq1, ÎŒ´@•1, ŹŽR@Šî1, ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć64‰ń (ŒöŽĐ) ‘S“ú–{čI‹„Šw‰ďŠwp‘ĺ‰ď‚Ó‚­‚ľ‚Ü‘ĺ‰ď (2015/5/23), •Ÿ“‡.

723978. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) •Đ‘¤Šç–Ęázš‚ɑ΂ľu–Ú‘‹ŒŠv‚Ş—LŒř‚Ĺ‚ ‚Á‚˝1Ç—á. •Šâ“ށXŽq1, ‘š~@‘s1, ˆÉ“Ą—Yˆę1, Źŕ_Žu”ż1, ˆä“c„l1, ÎŒ´@•1, ŹŽR@Šî1, ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć64‰ń (ŒöŽĐ) ‘S“ú–{čI‹„Šw‰ďŠwp‘ĺ‰ď‚Ó‚­‚ľ‚Ü‘ĺ‰ď (2015/5/23), •Ÿ“‡.

723979. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) “Ť‚̐Uí‚ɑ΂ľ‚ÄčI‹„ŽĄ—Ă‚Ş—LŒř‚Ĺ‚ ‚Á‚˝1Ç—á. ‘š~@‘s1, ˆÉ“Ą—Yˆę1, Źŕ_Žu”ż1, ˆä“c„l1, •Šâ“ށXŽq1, ÎŒ´@•1, ŹŽR@Šî1, ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć64‰ń (ŒöŽĐ) ‘S“ú–{čI‹„Šw‰ďŠwp‘ĺ‰ď‚Ó‚­‚ľ‚Ü‘ĺ‰ď (2015/5/23), •Ÿ“‡.

723980. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) S™`ŒŠ‚ւ̉ˇ“›‹„‚ɑ΂ˇ‚éS‘ŸŽŠ—Ľ_Œo”˝‰ž. ˆÉ“Ą—Yˆę1, ‘š~@‘s1, Źŕ_Žu”ż1, •Šâ“ށXŽq1, ˆä“c„l1, ÎŒ´@•1, ŹŽR@Šî1, ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć64‰ń (ŒöŽĐ) ‘S“ú–{čI‹„Šw‰ďŠwp‘ĺ‰ď‚Ó‚­‚ľ‚Ü‘ĺ‰ď (2015/5/23), •Ÿ“‡.

723981. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ŒŽ‹ŽR‚É‚ć‚éwO•ű‹K‹éx‰ÁŒ¸–@‚ĚŽŔ‘H|w‹ŽR•űlxwŠˆ–@‹@•űx‚Ě”äŠr|. Ż–ě‘ě”V1, Ź‘]ŒË—m1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723982. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘IŠď“’‚Ě“Ú—p‚Ş”­ěŤ‚Ě“Ş’É‚É—LŒř‚ž‚Á‚˝1—á. X—T‹IŽq1, ŒÜ–ě—R‰Ŕ—1,2, ‰Ô—Öšć•F1,3 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2‘‡f—Ă, 3“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723983. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –k—˘‘ĺŠw‚É‚¨‚Ż‚鐜–ň‚̐V‚ľ‚˘•iŽż•]‰ż–@ŠJ”­‚Ɛś–ňŽŽŒąÍ”|‚ĚŽć‚č‘g‚Ý. ‹yě“N˜Y1, Ź“cŒű_1, Žá™ˆŔŠó”T1, ŠÖŞ–ƒ—Žq1, ‰Ô—Öšć•F1,2, Ź—Ń‹`“T1 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723984. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) wŠĎăڕű—v•âx‚ĚŒ¤‹† (‘ć6•ń)|•ś­”Ĺ‘SŒ´•ű‚Ě4•ű‚É1•ű‚͈Ŕ­”Ĺ‚Ĺ’ůł‚ł‚ę‚˝. –x“cL–ž1, “n•Ó_“ń1, “V–ě—z‰î1, Ź‘]ŒË—m1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723985. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ƒjƒ…[ƒ‰ƒ‹ƒlƒbƒgƒ[ƒN‚É‚ć‚éƒJƒ‹ƒe€–Ú‚Ěƒpƒ^[ƒ“ŠwK‚Əˆ•ű‘I‘đƒ‚ƒfƒ‹\’z‚ĚŽŽ‚Ý. ˆÉ“Ą—Yˆę1, Î–Ń’B–ç1, ě“çˆÉW1, ŠÖŞ–ƒ—Žq1, Žá™ˆŔŠó”T1, Ź“cŒű_1, ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723986. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) DŽ_‹…Ť’†Ž¨‰Š‚ÉŽÄ–p“’ƒGƒLƒX‚Ş—L—p‚Ĺ‚ ‚Á‚˝1Ç—á. Î–Ń’B–ç1, Ź“cŒű_1, ‹yě“N˜Y1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723987. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Šż•ű–ň‚̐÷o‚É‹y‚Ú‚ˇ‰e‹ż|‰Î‰ÁŒ¸E÷‚śŽžŠÔ|(‘ć2•ń). ‘ĺ—˘^“Ţ”ü1, â“cKŽĄ1, •űçH1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723988. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Šż•ű–ňƒŒƒgƒ‹ƒgƒpƒbƒN•ď‘•‹Ć–ą‚̉ü‘P‚ƐŹ•ŞŠÜ—L—Ę‚Ě‘Šˆá. {“ĄŠx‘ĺ1, â“cKŽĄ1, •űçH1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723989. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ÷‚ś–ň‚ĚŒ¸—ʏˆ•ű‚ɂ‚˘‚Ä‚ĚˆÓ‹`. ‚Ű–ƒ“Ţ–˘1, â“cKŽĄ1, •űçH1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723990. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) •wl‰ČŽžŠł‚É‚¨‚Ż‚銿•űˆăŠw“I‚ČŘ‚đ—‰đ‚ľ‚˝•ž–ňŽw“ą‚ĚŒŸ“˘. Žşś^çŽq1, â“cKŽĄ1, •űçH1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723991. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒuƒŒƒ“ƒh’ƒ‚ĚŒ´Ţ—ż‚ɂ‚˘‚Ä‚ĚŒŸ“˘. ŽOŕV@S1, â“cKŽĄ1, •űçH1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723992. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) Šż•ű–ň—Տ°Œř‰Ę”ť’č•ű–@‚Ć‚ľ‚Ä‚Ěvisual analogue scale (VAS) ‚Ě—L—pŤ. Ź“cŒű_1, Î–Ń’B–ç1, ě“çˆÉW1, ˆÉ“Ą—Yˆę1, Žá™ˆŔŠó”T1, ŠÖŞ–ƒ—Žq1, ‹yě“N˜Y1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/13), •xŽR.

723993. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ˜•”‚Ě˜ÇŇŒŠ‚ɑ΂ˇ‚éčI‹„ŽĄ—Ă‚Ş‰EăŽˆ‹ßˆĘ•”’ɂɑ΂ľ—LŒř‚Ĺ‚ ‚Á‚˝1Ç—á. Źŕ_Žu”ż1, ‘š~@‘s1, ˆÉ“Ą—Yˆę1, ˆä“c„l1, •ŠâŘXŽq1, ÎŒ´@•1, ŹŽR@Šî1, ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/14), •xŽR.

723994. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) —â‚Ś‚Ě‚Ú‚š (ă”M‰şŠŚ) ‚Ě•a‘ԉ𖞂Ƃť‚Ě“Á’Ľ‚ɂ‚˘‚Ä. ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/14), •xŽR.

723995. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) COIŠÖ˜AuŠż•űf—Ă•W€‰ťƒvƒƒWƒFƒNƒgv‘ć2•ń@ŽŠ‘źŠoŠŒŠ—pŽ†‚Ě•W€‰ť‚É‚Ţ‚Ż‚Ä. Žá™ˆŔŠó”T1, Î–Ń’B–ç1, ƒ~ƒCƒVƒƒƒIƒ†ƒE, ŠÖŞ–ƒ—Žq1, ˆÉ“Ą—Yˆę1, ě“çˆÉW1, ’†ŕV•ś•F, •Đ‰ŞŽ}—˘‰Ô, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/14), •xŽR.

723996. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –k—˘Šż•űˆăŠw“IŠŒŠƒvƒƒWƒFƒNƒg‘ć8•ń@ŠŒŠĚŽć‚É‚¨‚Ż‚éM—ŠŤ‚ĚŒüă‚đ–ÚŽw‚ľ‚Ä. ŠÖŞ–ƒ—Žq1, Žá™ˆŔŠó”T1, ě“çˆÉW1, Î–Ń’B–ç1, ˆÉ“Ą—Yˆę1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/14), •xŽR.

723997. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Šż•ű–ň‚̏ˆ•ű„’čƒƒWƒbƒN\’z‚ĚŽŽ‚Ý. ƒ~ƒCƒVƒƒƒIƒ†ƒE, •Đ‰ŞŽ}—˘‰Ô, ’r“c@O, ’†ŕV•ś•F, Î–Ń’B–ç1, Ź“cŒű_1, ě“çˆÉW1, ˆÉ“Ą—Yˆę1, Žá™ˆŔŠó”T1, ŠÖŞ–ƒ—Žq1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć66‰ń“ú–{“Œ—mˆăŠw‰ďŠwp‘‰ď (2015/6/14), •xŽR.

723998. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –ƒ‰Š‚Í”xŠŕ×–E‚É‚¨‚˘‚ÄHGFŽhŒƒŒă‚ĚMET endocytosis‚¨‚ć‚Ń‚ť‚Ě•Ş‰đ‚𑣐i‚ˇ‚é. ź‘şsś, “úŒü{”üŽq1, “úŒüšŽi, ˆÉ“Ą˜aK, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć24‰ń“ú–{‚Ş‚ń“]ˆÚŠw‰ďŠwpW‰ďE‘‰ď (2015/7/23), ‘ĺă.

723999. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Does stress vulnerability trigger negative cognitive bias in socially defeated mice? ˆÉ“Ą’źŽ÷1, Birnbaum G Shari, ‹yě“N˜Y1, ‰Ô—Öšć•F1,2, Eisch J Amelia (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć38‰ń“ú–{_Œo‰ČŠw‘ĺ‰ď (2015/7/28), •şŒÉ.

7231000. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‘ĺŒš’†“’‚̍R‰ŠÇě—p`pŒă’°ŠÇ–ƒáƒƒ‚ƒfƒ‹ƒ}ƒEƒX‚ōR‰Šě—p‚đ”­Šö‚ˇ‚鐜–ň‚Ě“Ż’č`. ‰““Ą^—1, –x@ł•q, ”öč@”Ž, ‹yě“N˜Y1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć32‰ń˜aŠżˆă–ňŠw‰ďŠwp‘ĺ‰ď (2015/8/22), •xŽR.

7231001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽĐ‰ďŤƒXƒgƒŒƒX—U”­‚¤‚—ls“Ž‚Ć‚ť‚ę‚É”ş‚¤”]“ŕ‰ŠÇ”˝‰ž‚ɑ΂ˇ‚鍁‘hŽU‚Ě—}§Œř‰Ę. ˆÉ“Ą’źŽ÷1, œAŁ‰hŽĄ, Î“c’BĆ, –x@@Œú, ‰iˆä—˛”V1, Ź—Ń‹`“T1, ´Œ´Š°Í1, ‹yě“N˜Y1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć32‰ń˜aŠżˆă–ňŠw‰ďŠwp‘ĺ‰ď (2015/8/22), •xŽR.

7231002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) COIŠÖ˜AuŠż•űf—Ă•W€‰ťƒvƒƒWƒFƒNƒgv‘ć3•ń@•W€‰ťŠî–{33ˆ•ű‚Ě‘I‘đ. Žá™ˆŔŠó”T1, ŠÖŞ–ƒ—Žq1, Ź“cŒű_1, ‘şźœÄˆę, •Ŕ–Ř—˛—Y, Vˆä@M, “ˆ“c@–L, ŽÄŒ´’ź—˜, ŽOŕk’‰“š, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć32‰ń˜aŠżˆă–ňŠw‰ďŠwp‘ĺ‰ď (2015/8/22), •xŽR.

7231003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) COIŠÖ˜AuŠż•űf—Ă•W€‰ťƒvƒƒWƒFƒNƒgv‘ć4•ń@ŽŠ‘źŠoŠŒŠ‚Ě‘I’č. ŠÖŞ–ƒ—Žq1, Žá™ˆŔŠó”T1, Ź“cŒű_1, ‘şźœÄˆę, •Ŕ–Ř—˛—Y, Vˆä@M, “ˆ“c@–L, ŽÄŒ´’ź—˜, ŽOŕk’‰“š, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć32‰ń˜aŠżˆă–ňŠw‰ďŠwp‘ĺ‰ď (2015/8/22), •xŽR.

7231004. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‘hŽU÷Ü‚É‚ć‚éR‚¤‚—lŠˆŤ‚ÉŠÖ˜A‚ˇ‚é”]“ŕƒ^ƒ“ƒpƒNŽż‚Ě’Tő. ŽR’†‹I‰›Žq, ‰iˆä—˛”V1, Ź—ѐ玥, Ö“Ą’B–ç, ŹŽ›‹`’j, ˆÉ“Ą’źŽ÷1, ‰Ô—Öšć•F1,2, ŽR“c—zé, ´Œ´Š°Í1 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć32‰ń˜aŠżˆă–ňŠw‰ďŠwp‘ĺ‰ď (2015/8/23), •xŽR.

7231005. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒGƒtƒFƒhƒŠƒ“ƒAƒ‹ƒJƒƒCƒhœ‹Ž–ƒ‰ŠƒGƒLƒX (EFM) ‚Ě–ň—ě—p‚ĆˆŔ‘SŤ. “úŒü{”üŽq1, “úŒüšŽi, ‘ĺ“ˆ’ź_, Š™‘q_”V, ŠŰŽR‘ě˜Y, ŒŃ’ˍ‚Žu, “V‘q‹gÍ, ‡“cKL, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć32‰ń˜aŠżˆă–ňŠw‰ďŠwp‘ĺ‰ď (2015/8/23), •xŽR.

7231006. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒGƒtƒFƒhƒŠƒ“ƒAƒ‹ƒJƒƒCƒhœ‹Ž–ƒ‰ŠƒGƒLƒX (EFM) ‚̐ť‘˘–@‚ĆŠˆŤŹ•Şherbacetin‚ĚŠÜ—Ę. ‘ĺ“ˆ’ź_, “úŒü{”üŽq1, “úŒüšŽi, Š™‘q_”V, ŠŰŽR‘ě˜Y, ŒŃ’ˍ‚Žu, “V‘q‹gÍ, ‰Ô—Öšć•F1,2, ‡“cKL (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć32‰ń˜aŠżˆă–ňŠw‰ďŠwp‘ĺ‰ď (2015/8/23), •xŽR.

7231007. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Capsaicin—U”­áu’É‹y‚ŃFormalin—U”­áu’ɂɑ΂ˇ‚é–ƒ‰Š‚Ě’Á’ÉŒř‰Ę. ’†Xr•ă, ‚‹´@ƒ, “úŒü{”üŽq1, “V‘q‹gÍ, “úŒüšŽi, ŒŃ’ˍ‚Žu, ‡“cKL, ‰Ô—Öšć•F1,2, Ź—Ń‹`“T1 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć32‰ń˜aŠżˆă–ňŠw‰ďŠwp‘ĺ‰ď (2015/8/23), •xŽR.

7231008. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘OŒü‚ŤƒRƒz[ƒgŒ¤‹†‚É‚¨‚Ż‚é’ǐՍě‹Ć‚ĚŒř—Ś‰ť‚¨‚ć‚ѐłŠmŤ‚ĚŠm•Ű. ŠÖŞ–ƒ—Žq1, Žá™ˆŔŠó”T1, ăŒű”üŠó, Îě‚Ü‚čŽq, ě“çˆÉW1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć15‰ńCRC‚Ć—Ő°ŽŽŒą‚Ě‚ ‚č•ű‚đl‚Ś‚é‰ď‹c2015 in KOBE (2015/9/12), •şŒÉ.

7231009. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)wŠż•űŽĄ—ĂƒGƒrƒfƒ“ƒXƒŒƒ|[ƒg2013@402‚ĚRCTx‚đ—p‚˘‚˝•śŒŁ’˛¸`QOL•]‰ż‚ɂ‚˘‚ā`. Žá™ˆŔŠó”T1, ŠÖŞ–ƒ—Žq1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć15‰ńCRC‚Ć—Ő°ŽŽŒą‚Ě‚ ‚č•ű‚đl‚Ś‚é‰ď‹c2015 in KOBE (2015/9/13), •şŒÉ.

7231010. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ĺŒš’†“’‚̍\Źś–ňEŠŁ›I‚̍R‰ŠÇě—p‚đ‰î‚ľ‚˝pŒă’°ŠÇ–ƒáƒ‰ü‘PŒř‰Ę. ‰““Ą^—1, –x@ł•q, ‹yě“N˜Y1, ”öč@”Ž, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć17‰ń“ú–{_ŒoÁ‰ťŠí•aŠw‰ď (2015/11/13), ‰Ť“ę.

7231011. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Formalin—U”­áu’ɂɑ΂ˇ‚é–ƒ‰ŠƒGƒLƒX, ƒGƒtƒFƒhƒŠƒ“ƒAƒ‹ƒJƒƒCƒhœ‹Ž–ƒ‰ŠƒGƒLƒX (EFE) ‹y‚ŃƒGƒtƒFƒhƒŠƒ“‚Ě’Á’ÉŒř‰Ę. ‚‹´@ƒ, ’†Xr•ă, “úŒü{”üŽq1, ŽR‰ş’‰r, ‘ĺ“ˆ’ź_, ŠŰŽR‘ě˜Y, “úŒüšŽi, “V‘q‹gÍ, ŒŃ’ˍ‚Žu, Ź“cŒű_1, ‡“cKL, ‰Ô—Öšć•F1,2, Ź—Ń‹`“T1 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): “ú–{–ňŠw‰ď‘ć136”N‰ď (2016/3/28), _“ސě.

732131. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔ) ‚—îŽŇ‚ĚŒ’N‚ĆŠż•ű. ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): `‹ć–Ż‘ĺŠwŒöŠJuŔ (2015/6/18), “Œ‹ž.

732132. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔ) ‚—îŽŇ‚ĚŒ’N‚ĆŠż•ű. ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): –k—˘‘ĺŠw“Ż‘‹‰ď“Č–ŘŒ§Žx•”ŒöŠJu‰‰‰ď (2015/6/20), “Č–Ř.

732133. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) ˜•”‚Ě˜ÇŇŒŠ‚ɑ΂ˇ‚éčI‹„ŽĄ—Ă‚Ş‰EăŽˆ‹ßˆĘ•”’ɂɑ΂ľ—LŒř‚Ĺ‚ ‚Á‚˝1Ç—á. Źŕ_Žu”ż1, ˆÉ“Ą@„1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć2‰ńKAIMčI‹„Ç—áƒVƒ“ƒ|ƒWƒEƒ€ (2015/7/25), “Œ‹ž.

732134. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔ) “Œ—mˆăŠw‚Ě“ÁŽż. ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć37‰ńˆăŠwśE—Տ°ˆă‚Ě‚˝‚ß‚Ě“Œ—mˆăŠwƒZƒ~ƒi[ (2015/7/27), “Œ‹ž.

732135. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔ) ƒf[ƒ^‚É‚ć‚é•W€‰ť‚Ě•K—vŤ‚ɂ‚˘‚Ä. ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć3‰ń–k—˘COIƒVƒ“ƒ|ƒWƒEƒ€ (2015/10/31), “Œ‹ž.

732136. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔ) “Œ—mˆăŠw‚̐˘ŠE`…@“Œ—mˆăŠw‚Ö‚Ěľ‘ҁ`. ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ç‘ă“c‹ć‚—îŽŇ‘ĺŠwŒ’NuŔ (2015/11/6), “Œ‹ž.

732137. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔ) “Œ—mˆăŠw‚̐˘ŠE`…AŠż•űf—Ă‚ĚŽŔŰ`. ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ç‘ă“c‹ć‚—îŽŇ‘ĺŠwŒ’NuŔ (2015/11/13), “Œ‹ž.

732138. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔ) “Œ—mˆăŠw‚̐˘ŠE`…BŠż•ű‚̍l‚Ś•ű‚Ć–˘—ˆ‘œ`. ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ç‘ă“c‹ć‚—îŽŇ‘ĺŠwŒ’NuŔ (2015/11/20), “Œ‹ž.

732139. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔ) Šż•űf—Ă‚Ě”’ˆÓ‚Ć‚Ü‚Ć‚ß. ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): •˝Ź27”N“xŠż•ű–ňEś–ňŒ¤C‰ď (2015/12/13), “Œ‹ž.

733367. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Šż•ű•űÜu‘hŽUv‚̍R‚¤‚—lŠˆŤ‚ÉŠÖ˜A‚ˇ‚é”]“ŕƒ^ƒ“ƒpƒNŽż‚Ě’Tő. ŽR’†‹I‰›Žq, ‰iˆä—˛”V1, Ź—ѐ玥, Ö“Ą’B–ç, ŹŽ›‹`’j, ˆÉ“Ą’źŽ÷1, ‰Ô—Öšć•F1,2, ŽR“c—zé, ´Œ´Š°Í1 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć28‰ń–k—˘‘ĺŠwƒoƒCƒIƒTƒCƒGƒ“ƒXƒtƒH[ƒ‰ƒ€E‘ć18‰ń–k—˘”÷ś•¨ƒAƒJƒfƒ~[ (2015/8/6), _“ސě.

733368. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ƒCƒ“ƒtƒ‹ƒGƒ“ƒUŒă‚Ě‘Ě’˛•s—ǂɏŹŽÄŒÓ“’‚Ş—LŒř‚Ĺ‚ ‚Á‚˝ˆę—á. Â–Ř‚ä‚Š‚č1, ˆÉ“Ą@„1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć25‰ńŠż•űŽĄ—ĂŒ¤‹†‰ď (2015/10/4), “Œ‹ž.

733369. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ĘŒű‰‰) ˆ•űŠÓ•Ę‚É‚¨‚Ż‚é‹qŠĎ“IŠŒŠ‚Ě—L—pŤ‚ɂ‚˘‚Ä‚ĚŒŸ“˘. Î–Ń’B–ç1, ˆÉ“Ą—Yˆę1, ě“çˆÉW1, Žá™ˆŔŠó”T1, ŠÖŞ–ƒ—Žq1, Ź“cŒű_1, ‰Ô—Öšć•F1,2 (1“Œ—mˆăŠw‘‡Œ¤‹†Š, 2“Œ—mˆăŠw‹łˆç): ‘ć72‰ń“ú–{“Œ—mˆăŠw‰ďŠÖ“ŒbM‰zŽx•”Šwp‘‰ď (2015/11/22), ç—t.


4•a‰@˜AŒg‹łˆçŒ¤‹†•”–ĺ

[Šw‰ďEŒ¤‹†‰ď“™]

723399. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒRƒ“ƒsƒ…[ƒ^ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚É‚ć‚éˆÝŠŕ‚̐V‚ľ‚˘f’f–@: MD-CT‚đ—p‚˘‚˝ŽîᇂĚ3ŽŸŒł—§‘̍\’z, ‘̐ϒl‘Ş’č‚Ě—Ő°“IˆÓ‹`‚ƏŤ—ˆ‚Ö‚Ě“W–]. ‹e’rŽj˜Y1, ŽOd–ě_˜N2, X’JGŒő2, ×“c@Œj2, ŽR‰şŒpŽj2, •Đ“c‰Ä–ç2, “n粏š•F2 (14•a‰@˜AŒg‹łˆç, 2ŠO‰Č): ‘ć77‰ń“ú–{—Տ°ŠO‰ČŠw‰ď‘‰ď (2015/11/26), •Ÿ‰Ş.


ˆăŠw•”•‘Ž—Տ°Œ¤‹†ƒZƒ“ƒ^[

Šé‰ćŠJ”­•”–ĺ^ƒvƒƒWƒFƒNƒgŽŔŽ{•”–ĺ

[Šwp˜_•ś]

110316. [Œ´’˜] Pharmacokinetic and bioequivalence evaluation of single-tablet and separate-tablet regimens for once-daily cobicistat-boosted elvitegravir in healthy Japanese male subjects: A randomized, two-way crossover study. Shiomi M, Matsuki S, Ikeda A, Ishikawa T, Nishino N, Kimura M, Kumagai Y1, Irie S : Clin Pharmacol Drug Dev 5-6; 4 (3): 218-25. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

110317. [Œ´’˜] Effects of Cremophor EL on the absorption of orally administered saquinavir and fexofenadine in healthy subjects. Tomaru A,Takeda-Morishita M, Maeda K, Banba H, Takayama K, Kumagai Y1, Kusuhara H, Sugiyama Y: Drug Metab Pharmacokinet 2015/6; 30 (3): 221-6. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

110318. [Œ´’˜] Comparison of circulating lipid profiles between fasting humans and three animal species used in preclinical studies: mice, rats and rabbits. Ishikawa M, Saito K, Urata M, Kumagai Y1, Maekawa K, Saito Y: Lipids Health Dis 2015/9; 14: 104. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

110319. [Œ´’˜] Moxifloxacin-induced QTc interval prolongations in healthy male Japanese and Caucasian volunteers: a direct comparison in a thorough QT study. Morganroth J, Wang Y, Thorn M, Kumagai Y1, Harris S, Stockbridge N, Kleiman R, Shah R: Br J Clin Pharmacol 2015/9; 80 (3): 446-59. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

110320. [Œ´’˜] Lack of effect of favipiravir, a novel antiviral agent, on QT interval in healthy Japanese adults. Kumagai Y1, Murakawa Y, Hasunuma T, Aso M, Yuji W, Sakurai T, Noto M, Oe T, Kaneko A: Int J Clin Pharmacol Ther 2015/10; 53 (10): 866-74. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

110321. [Œ´’˜] Randomized, Controlled, Thorough QT/QTc Study Shows Absence of QT Prolongation with Luseogliflozin in Healthy Japanese Subjects. Kumagai Y1, Hasunuma T, Sakai S, Ochiai H, Samukawa Y: PLoS One 2015/10; 10 (10): e0139873. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

110322. [Œ´’˜] Comparative Pharmacokinetic Study of Acetaminophen in Japanese and Han Chinese Individuals. Sakamoto Y1, Wakisaka M, Maeda M2,3, Song ID1, Fujita T4, Sekine T, Yamazaki A, Tanaka R5, Kumagai Y5: Jpn J Clin Pharmacol Ther 2016/1; 47 (1): 11-6. (â–{‘×—1, ‘O“cŽŔ‰Ô2,3, ‘v@ˆę‘ĺ1, “Ą“c•üŒb4, “c’†—‰pŽq5, ŒF’J—YŽĄ5: 1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2—Տ°ŽŽŒąƒZ, 3–ňÜ•”, 4–ň—, 5—Տ°Œ¤‹†EŠé‰ć)

110323. [Œ´’˜] The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study. Nemoto O, Furue M, Nakagawa H, Shiramoto M, Hanada R, Matsuki S, Imayama S, Kato M, Hasebe I, Taira K, Yamamoto M, Mihara R, Kabashima K, RuzickaT, Hanifin J, Kumagai Y1: Br J Dermatol 2016/2; 174 (2): 296-304. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

120064. [Œ´’˜] Œ’NŹl‚É‚¨‚Ż‚éRƒqƒXƒ^ƒ~ƒ“–ň‚Ě’†•—}§ě—p‚ÉŠÖ‚ˇ‚錤‹†|ƒIƒƒpƒ^ƒWƒ“Eƒtƒ}ƒ‹Ž_ƒPƒgƒ`ƒtƒFƒ“EƒtƒFƒLƒ\ƒtƒFƒiƒWƒ“‚Ě”äŠr|. ˜eâ^”ü, ‘v@ˆę‘ĺ1, “cƒ–’J_–M2, “Ą“c•üŒb3, ‘O“cŽŔ‰Ô4,5, –ě‘şĄ“úŽq6, Ź—ѐ^”ü, ŽR–{–žŽq, â–{‘×—1, “c’†—‰pŽq7, ŒF’J—YŽĄ7 (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2ˆă—ÉqśŠw•”, 3–ň—, 4—Տ°ŽŽŒąƒZ, 5–ňÜ•”, 6“Œ•a‰@ŠĹŒě•”, 7—Տ°Œ¤‹†EŠé‰ć): —Տ°–ň— 2015/9; 46 (5): 243-8.

120065. [Œ´’˜] Œ’NŹl’jŤ‚É‚¨‚Ż‚éƒ~ƒ`ƒOƒŠƒjƒhƒJƒ‹ƒVƒEƒ€…˜a•¨Œűo“ŕ•ö‰óů10 mg‚̐ś•¨Šw“I“Ż“™ŤŽŽŒą. ’†–ě—SŽ÷, ’†“‡@’q, ŠÖ–ě‹v–M, ŒF’J—YŽĄ1 (1—Տ°Œ¤‹†EŠé‰ć): –ň—‚ĆŽĄ—Ă (JPT) 2016/1; 44 (1): 57-64.

120066. [Œ´’˜] ‚—p—ĘƒAƒZƒgƒAƒ~ƒmƒtƒFƒ““Š—^Žž‚ĚŠĚ‹@”\’lˆŮí‚ÉŠÖ‚ˇ‚é“Á’čŽg—pŹŃ’˛¸ƒf[ƒ^‚đ—p‚˘‚˝’č—ʉđÍ. ŒF’J—YŽĄ1, “c’†—‰pŽq1, ‘v@ˆę‘ĺ2, â–{‘×—2 (1—Տ°Œ¤‹†EŠé‰ć, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): —Տ°–ň— 2016/3; 47 (2): 31-7.

522187. [uŔ]y“ÁW: ‘Ű‰ťE‘n–ňŠÖ˜AƒVƒ“ƒ|ƒWƒEƒ€1@ƒOƒ[ƒoƒ‹‚ČŽ‹“_‚ĹŠw‚Ô‘n–ň‚ĆŽĄŒą„i‚Ě‚˝‚߂̉ۑč-3zƒAƒJƒfƒ~ƒA‚É‚¨‚Ż‚é—Տ°ŽŽŒą|Academic Research Organization (ARO) “™‚̍‘Ű”äŠr. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): _ŒoŽĄ—ĂŠw 2015/5; 32 (3): 391-3.

[’˜@‘]

620131. [Šwp‘] yƒ|ƒPƒbƒg”Ł@—Տ°ˆă–ň•iW2016zŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć), Ó”C•ŇW: Ż@ŒbŽq, –ňŽ–“ú•ńŽĐ, “Œ‹ž, 2016/1”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

712039. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Current and Future of Asian Clinical Trials. Kumagai Y1: KoNECT-Kitasato Symposium (2015/5/15), Shirokane. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

712040. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Accelerating Asia clinical development through Korea-Japan collaboration. Kumagai Y1: DIA 2015 51st Annual Meeting (2015/6/16), Washington DC, USA. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

712041. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) AN EPIDEMIOLOGICAL STUDY FOR ELEVATION OF LIVER FUNCTION TESTS IN JAPANESE PATIENTS ADMINISTERED BY HIGH DOSE ACETAMINOPHEN. Kumagai Y1, Song ID2, Maeda M3,4, Tanaka R1, Sakamoto Y4: 12th Congress of the EACPT 2015 (2015/6/27-30), Madrid, Spain. (ŒF’J—YŽĄ1, ‘v@ˆę‘ĺ2, ‘O“cŽŔ‰Ô2, “c’†—‰pŽq1, â–{‘×—4: 1—Տ°Œ¤‹†EŠé‰ć, 2—Տ°ŽŽŒąƒZ, 3–ňÜ•”, 4‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

712042. [Šw‰ď (‘Ű)] (ľ‘ҍu‰‰“™) Current and Future Cardiac Safety in Clinical Trials. Kumagai Y1: KoNECT International Conference 2015 (2015/11/5), Seoul, Korea. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

713131. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) EVALUATION OF CARDIOVASCULAR SAFETY OF DARINAPARSIN (ORGANIC ARSENIC COMPOUND) IN JAPANESE AND KOREAN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA. Kumagai Y1, Cai H, Barrett J, Shiraishi T, Hayashi Y, Sonehara Y, Nagahama F: 12th Congress of the EACPT 2015 (2015/6/27-30), Madrid, Spain. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

722222. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ě–ňÜŤŠĚáŠQ|‚—p—ĘƒAƒZƒgƒAƒ~ƒmƒtƒFƒ““Š—^Žž‚ĚŠĚ‹@”\ŒŸ¸’l‚ÉŠÖ‚ˇ‚é‰uŠw’˛¸‚đ‚ŕ‚ƂɁ|. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): ‘ć37‰ń“ú–{áu’ÉŠw‰ď (2015/7/3), ŒF–{.

722223. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ě–ňÜŤŠĚáŠQ|‰ä‚ލ‘‚É‚¨‚Ż‚é‰uŠw’˛¸Œ‹‰Ę‚đ‚ŕ‚ƂɁ|. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): ‘ć9‰ń“ú–{ŠÉ˜aˆă—Ă–ňŠw‰ď”N‰ď (2015/10/4), ‰Ą•l.

722224. [Šw‰ď (‘S‘)] (ľ‘ҍu‰‰“™) ‘Ű‹¤“ŻŠJ”­í—Ş‚É‚¨‚Ż‚é‰ä‚ލ‘‚Ě‘ŠúŽŽŒą‚Ě‚ ‚č•ű. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): ‘ć36‰ń“ú–{—Տ°–ň—Šw‰ďŠwp‘‰ď (2015/12/9), “Œ‹ž.

7231012. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ŒŒ´’†‘ăŽÓ•¨ƒŒƒxƒ‹‚̐lŽíˇ. ꎓĄŒö—ş, ‘Oě‹žŽq, Jason Kinchen, ŒF’J—YŽĄ1, Ö“Ą‰Ă˜N (1—Տ°Œ¤‹†EŠé‰ć): ‘ć36‰ń“ú–{—Տ°–ň—Šw‰ďŠwp‘‰ď (2015/12/9), “Œ‹ž.

7231013. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “ú–{l, ŠŘ‘lŒ’NŹl”íŒąŽŇ‚ĚŽĄŒąŽQ‰Á“Ž‹@‚Ć”FŽŻ‚ÉŠÖ‚ˇ‚é”äŠrŒ¤‹†-[‘w“I–Ę’k’˛¸|. Źň—ş•ă1, ‘O“cŽŔ‰Ô1,2, XˆŸ–îŽq, Ź‘ň@Šw, ‘v@ˆę‘ĺ2, ˛X–Ř‘PM3, ‰Ą“cœÄˆę3, “Ą“c•üŒb4, Ji-Hye Seo, Ock-Joo Kim, ŒF’J—YŽĄ5 (1“Œ•a‰@–ňÜ•”, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3–ňÜ•”, 4–ň—, 5—Տ°Œ¤‹†EŠé‰ć): ‘ć36‰ń“ú–{—Տ°–ň—Šw‰ďŠwp‘‰ď (2015/12/9), “Œ‹ž.

731171. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ě–ňÜŤŠĚáŠQ|‚—p—ĘƒAƒZƒgƒAƒ~ƒmƒtƒFƒ““Š—^Žž‚ĚŠĚ‹@”\ŒŸ¸’l‚ÉŠÖ‚ˇ‚é‰uŠw’˛¸‚đ‚ŕ‚ƂɁ|. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): ‘ć175‰ńŒF–{Œ§•a‰@–ňÜŽt‰ďŒ¤C‰ď (2015/6/6), ŒF–{.

731172. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ě–ňÜŤŠĚáŠQ|‰ä‚ލ‘‚É‚¨‚Ż‚é‰uŠw’˛¸Œ‹‰Ę‚đ‚ŕ‚ƂɁ|. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): ‰Ť“ęŒ§•a‰@–ňÜŽt‰ďu‰‰‰ď (2015/11/19), ‰Ť“ę.

732140. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) —Տ°ŽŽŒąŽx‰‡‚ĚŽŔŰ. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): ‘ć16‰ń—Տ°ŽîᇉĊúƒZƒ~ƒi[ (2015/7/9), •iě.

732141. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ƒAƒZƒgƒAƒ~ƒmƒtƒFƒ“‚Ě–ňÜŤŠĚáŠQ|‚—p—ĘƒAƒZƒgƒAƒ~ƒmƒtƒFƒ““Š—^Žž‚ĚŠĚ‹@”\ŒŸ¸’l‚ÉŠÖ‚ˇ‚é‰uŠw’˛¸‚đ‚ŕ‚ƂɁ|. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): ‘ć170‰ńŽ­Ž™“‡Œ§•a‰@–ňÜŽt‰ďŒ¤C‰ď (2015/7/17), Ž­Ž™“‡.

732142. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) FIHŽŽŒą‚ĚŠî–{“I‚ȍl‚Ś•ű. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): Äśˆă—Ă‚ĚŽŔŒť‰ťƒnƒCƒEƒFƒC‘ć7‰ń—Ď—’S“–ŽŇ‰ď‹c (2015/7/31), •iě.

732143. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) “ú–{l‘ćˆę‘ŠŽŽŒąƒf[ƒ^‚Ě•K—vŤ‚đ‚Ç‚¤l‚Ś‚é‚Š. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): ‘ć17‰ń—Տ°–ň—ŽŽŒąŒ¤‹†‰ď (2015/8/8), ”’‹ŕ.

732144. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) S“ŐŤŠÖ˜A‚Ě”ń—Տ°ƒf[ƒ^‚Ě’…–Ú“_‚đ—‰đ‚ˇ‚é‚˝‚߂̐S‘ŸˆŔ‘SŤ•]‰ż‚ĚŒťó. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): ˆŔ‘SŤ•]‰żŒ¤‹†‰ď “~‚ĚƒZƒ~ƒi[ (2015/11/28), “Œ‹ž.

732145. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ľ‘ҍu‰‰“™) ‘Šú’iŠK—Տ°ŽŽŒą‚É‚¨‚Ż‚éˆŔ‘SŤŠm•Ű. ŒF’J—YŽĄ (—Տ°Œ¤‹†EŠé‰ć): –k—˘|APDD‡“ŻƒVƒ“ƒ|ƒWƒEƒ€ (2016/3/14), ”’‹ŕ.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H25-110002. [Œ´’˜] Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects' gender and age. Ishikawa M, Maekawa K, Saito K, Senoo Y, Urata M, Murayama M, Tajima Y, Kumagai Y1, Saito Y: PLoS One 2014/3; 9 (3): e91806. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

H25-110003. [Œ´’˜] Ferric citrate hydrate for the treatment of hyperphosphatemia in nondialysis-dependent CKD. Yokoyama K, Hirakata H, Akiba T, Fukagawa M, Nakayama M, Sawada K, Kumagai Y1, Block GA: Clin J Am Soc Nephrol, 2014/3; 9 (3): 543-52. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

H26-110003. [Œ´’˜] 6ƒŔ-Hydroxycortisol is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3/SLC22A8, in healthy subjects. Imamura Y, Tsuruya Y, Damme K, Heer D, Kumagai Y1, Maeda K, Murayama N, Okudaira N, Kurihara A, Izumi T, Sugiyama Y, Kusuhara H: Drug Metab Dispos 2014/4; 42 (4): 685-94. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

H26-110004. [Œ´’˜] Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis. Yokoyama K, Akiba T, Fukagawa M, Nakamura M, Sawada K, Kumagai Y1, Chertow GM, Hirakata H: J Ren Nutr 2014/7; 24 (4): 261-7. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

H26-110005. [Œ´’˜] Effects of sex, age, and fasting conditions on plasma lipidomic profiles of fasted Sprague-Dawley rats. Saito K, Ishikawa M, Murayama M, Urata M, Senoo Y, Toyoshima K, Kumagai Y1, Maekawa K, Saito Y: PLoS One 2014/11; 9 (11): e112266. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)

H26-110006. [Œ´’˜] Levetiracetam pharmacokinetics in Japanese subjects with renal impairment. Yamamoto J, Toublanc N, Kumagai Y1, Stockis A: Clin Drug Investig 2014/11; 34 (11): 819-28. (ŒF’J—YŽĄ1: 1—Տ°Œ¤‹†EŠé‰ć)


ƒoƒCƒIƒGƒVƒbƒNƒX•”–ĺ


‘n–ňƒV[ƒYŒ¤‹†ŠJ”­•”–ĺ


ˆăŠw•”•‘ŽV˘‹Iˆă—ĂŠJ”­ƒZƒ“ƒ^[

ć’[ˆă—Ă—ĚˆćŠJ”­•”–ĺ

(“c糁@‘)

[Šwp˜_•ś]

510004. [‘ŕ] Diagnosis of Obscure Gastrointestinal Bleeding. Tanabe S1,2: Clin Endosc 2016/2; doi: 10.5946/ce.2016.004. (“c糁@‘1,2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ)

520007. [‘ŕ] ‘ŠúˆÝŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹žŽĄ—Ă‚ĚŒť‹ľ‚ƏŤ—ˆ“W–]. “c糁@‘1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ): –k—˘ˆăŠw 2015/6; 45 (1): 1-9.

522029. [uŔ]y“ÁW: Á‰ťŠí“ŕŽ‹‹žf—Ă‚É‚¨‚Ż‚é“KŘ‚Č’ÁĂ–@|VƒKƒCƒhƒ‰ƒCƒ“‚̐ł‚ľ‚˘—‰đE‰^—p‚Ě‚˝‚߂Ɂ|z4. “ŕŽ‹‹žf—Ă‚É‚¨‚Ż‚é’ÁĂ‚ĚˆÓ‹`‚Ć‚í‚Ş‘‚ĚŒť‹ľ. “c糁@‘1,2, ˛X–Ř“O2, Œ˜“ce—˜2, “Œ@’q2, ÎŒËŒŞŽŸ2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ): —ŐଏÁ‰ťŠí“ŕ‰Č 2015/5; 30 (5): 539-42.

530005. [‚ť‚Ě‘ź (ƒKƒCƒhƒ‰ƒCƒ“)] Guidelines for sedation in gastroenterological endoscopy. Obara K, Haruma K, Irisawa A, Kaise M, Gotoda T, Sugiyama M, Tanabe S1,2, Horiuchi A, Fujita N, Ozaki M, Yoshida M, Matsui T, Ichinose M, Kaminishi M: Dig Endosc 2015/5; 27 (4): 435-49. (“c糁@‘1,2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ)

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H26-522002. [uŔ]y“ÁW: ‚ą‚ą‚Ü‚Ĺ‚Ĺ‚Ť‚é! Á‰ťŠí“ŕŽ‹‹žŽĄ—ÁzÁ‰ťŠÇŽžŠł@ă•”Á‰ťŠÇoŒŒ‚ɑ΂ˇ‚é“ŕŽ‹‹ž“IŽ~ŒŒ. “c糁@‘1,2, ÎŒËŒŞŽŸ2, “Œ@’q2, Œ˜“ce—˜2, ˜a“c‘ń–ç2, –î–ě‹MŽj2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2Á‰ťŠí“ŕ): Źl•a‚ƐśŠˆKŠľ•a 2015/3; 45 (3): 295-302.


(’ˇŔ‰p–ž)

[Šwp˜_•ś]

540062. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]y2015”N“x`2017”N“x•ś•”‰ČŠwČ‰ČŠwŒ¤‹†”ď•â•‹ŕ Šî”ŐŒ¤‹† (C)uƒXƒgƒŒƒX‚É‚ć‚éIP3Žó—e‘Ě‚đ‰î‚ľ‚˝“நáŠQ”­ś‚ĚƒƒJƒjƒYƒ€‚̉𖞁vz’ˇŔ‰p–ž (V˘‹Iˆă—ÁEć’[ˆă—Ă): 2015”N“x`2017”N“x•ś•”‰ČŠwČ‰ČŠwŒ¤‹†”ď•â•‹ŕ Šî”ŐŒ¤‹† (C)uƒXƒgƒŒƒX‚É‚ć‚éIP3Žó—e‘Ě‚đ‰î‚ľ‚˝“நáŠQ”­ś‚ĚƒƒJƒjƒYƒ€‚̉𖞁v’†ŠÔ•ń‘ 2016/3.

[Šw‰ďEŒ¤‹†‰ď“™]

723891. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “நáŠQ‚ĆƒXƒgƒŒƒX‚ĚŠÖ˜AŤ‚̉𖞁\Inositol trisphosphate receptor type|1ƒmƒbƒNƒAƒEƒgƒ}ƒEƒX‚Ě’ŽŠo‹@”\|. ’ˇŔ‰p–ž1, Ö“Ą—Yˆę˜Y, ‰ÍŒ´Ž‰ë2, ‰Ş–{–ql3, “ż‘Œú“ń, ŒäŽqŽÄŽ•F (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ś—, 3Ž¨•@ˆôAE“ŞčňŠO): ‘ć74‰ń“ú–{‚ß‚Ü‚˘•˝tˆăŠw‰ďEŠwpu‰‰‰ď (2015/11/27), Šň•Œ, Equilibrium Res (—\eW) 2015; 74 (5): 435.

731173. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “நáŠQ‚ĆƒXƒgƒŒƒX‚ĚŠÖ˜AŤ|Inositol trisphosphate receptor-1 (IP3R1) ‚Ć“ŕŽ¨‚É‚¨‚Ż‚é‚ť‚Ě‹ÇÝ|. ’ˇŔ‰p–ž (V˘‹Iˆă—ÁEć’[ˆă—Ă): “Œ‹žé‹Ę_ŒoŽ¨‰ČŒ¤‹†‰ď (2015/6/20), “Œ‹ž.

731174. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ƒƒjƒG[ƒ‹•a‚ɑ΂ˇ‚éHydration Therapy (…•ŞŰŽć—Ă–@) ‚Ć‚ť‚ĚŠî‘bˆăŠw“I”wŒi. ’ˇŔ‰p–ž (V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć15‰ńé‹ĘŒ§‚ß‚Ü‚˘E“ď’ŽŒ¤‹†‰ď (2016/2/4), ‚ł‚˘‚˝‚Ü.

732146. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ‚ß‚Ü‚˘‚ĚƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ’ˇŔ‰p–ž (V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć45‰ń•˝t‹@”\ŒŸ¸‹ZpuK‰ď (2015/7/15), “Œ‹ž.


(“c’†@Œ‰)

[Šwp˜_•ś]

522188. [uŔ]y“ÁW: ‚Ö‚ť‚đŽg‚¤Žčp‚ĚŽŔŰz—‘‘ƒŽîáŽ. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ŹŽ™ŠO‰Č 2016/3; 48 (3): 314-7.

522189. [uŔ]y“Á•ĘŠé‰ć: ‘Ű‰ťŽž‘ă‚É‚¨‚Ż‚é–M•śŠw‰ďŽ‚ĚÝ‚č•ű (‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď‹L˜^)z‘Ű‰ťŽž‘ă‚É‚¨‚Ż‚é“ú–{ŹŽ™ŠO‰ČŠw‰ďŽ‚ĚÝ‚č•ű. –kě”Žş, ç—tł”Ž, “c’†@Œ‰1, ŽR‚“čs, m”öł‹L (1V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{ŠO‰ČŠw‰ďŽGŽ 2015/8; 116 (—ŐŽž‘Š§†2): 27-9.

[’˜@‘]

620132. [Šwp‘ (•Ş’SŽˇ•M)] y‰Ć‘°ŤŽîᇊw|‰Ć‘°ŤŽîᇂ̍ŐVŒ¤‹†“ŽŒü|(“ú–{—Ő଑Š§† (No.1083))zII. Še˜_@1. ÇŒóŒQ@(6) Blue rubber bleb nevus syndrome (ÂFƒSƒ€‚Ü‚č—l•ę”ÁÇŒóŒQ), p.75-9. “c’†@Œ‰ (V˘‹Iˆă—ÁEć’[ˆă—Ă), “ú–{—Ő଎Đ, ‘ĺă, 2015/8”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713132. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Intraabdominal drainage is unnecessary for intestinal perforation in neonates. Tanaka K1, Takeda N2, Kakihara T2, Watanabe M2: 28th International Symposium on Paediatric Surgical Research (2015/9/26), Dublin, Ireland. (“c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č)

721022. [Šw‰ď (‘S‘)] (“Á•Ęu‰‰) ‘Ű‰ťŽž‘ă‚É‚¨‚Ż‚é“ú–{ŹŽ™ŠO‰ČŠw‰ďŽ‚ĚÝ‚č•ű. –kě”Žş, ç—tł”Ž, “c’†@Œ‰1, ŽR‚“čs, m”öł‹L (1V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/17), –źŒĂ‰Ž.

7231014. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’_“š•Â˝Ç‚ɑ΂ˇ‚é’†žŠŽŽ’°dĎŒ^lH’°•Ů•t‰ÁRoux-YÄŒš–@‚đ—p‚˘‚˝ŠĚ–ĺ‹ó’°•Ť‡p‚Ě—L—pŤ. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć115‰ń“ú–{ŠO‰ČŠw‰ď’čŠúŠwpW‰ď (2015/4/16), –źŒĂ‰Ž.

7231015. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŠO‰ČŽĄ—Ă‚Ş’x‚ę‚˝, oś‘Of’fć“VŤ’_“šŠg’ŁÇ|ŽčpŽžŠú‚đl‚Ś‚邤‚Ś‚Ĺ‹Md‚Č1—á|. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć52‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠwpW‰ď (2015/5/28), _ŒË.

7231016. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ä`ŹŘŠJƒAƒvƒ[ƒ`‚É‚ć‚éŽčp‚Ć‚ť‚̍H•v. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć52‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďŠwpW‰ď (2015/5/28), _ŒË

7231017. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŹŽ™ŠOŤ’°ŠÇ‘š‚ĚŒŸ“˘. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć29‰ń“ú–{ŹŽ™‹~‹}ˆăŠw‰ďŠwpW‰ď (2015/6/12), ‚ł‚˘‚˝‚Ü.

7231018. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) VśŽ™Á‰ťŠÇúEŽčp‚ɃhƒŒ[ƒ“—Ż’u‚Í•s—v‚Ĺ‚ ‚é. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć51‰ń“ú–{ŽüŽYŠúEVśŽ™ˆăŠw‰ďŠwpW‰ď (2015/7/10), •Ÿ‰Ş.

7231019. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŒŒŠÇ, ƒŠƒ“ƒpŠÇ•a•Ď‚ĚŽĄ—ĂŒoŒą. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć31‰ń“ú–{ŹŽ™ŠO‰ČŠw‰ďH‹GƒVƒ“ƒ|ƒWƒEƒ€ (2015/10/31), ŒF–{.

7231020. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) oś‘O‚É”P“]‚ľ—V—Ł‚ľ‚˝• o“ŕ’â—Ż¸‘ƒ‚ɑ΂ľ• o‹ž•â•‰ş“Eop‚đŽ{s‚ľ‚˝1—á. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć28‰ń“ú–{“ŕŽ‹‹žŠO‰ČŠw‰ď‘‰ď (2015/12/11), ‘ĺă.

731175. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ŹŽ™ŠO‰Č‚ ‚ę‚ą‚ę. “c’†@Œ‰ (V˘‹Iˆă—ÁEć’[ˆă—Ă): 2015”N_“ސěƒtƒ‰ƒe•afEfX˜AŒg‚̉ď (2015/7/25), ‰Ą•l.

733370. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰Č‚É‚¨‚Ż‚éä`•”ŹŘŠJƒAƒvƒ[ƒ`Žčp‚Ć‚ť‚̍H•v. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć1‰ń“ú–{ŹŽ™‚Ö‚ťŒ¤‹†‰ď (2015/4/16), –źŒĂ‰Ž.

733371. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) VśŽ™‚É‚¨‚Ż‚銎‘S•Ş—ŁŒ^ƒXƒgƒ}‘˘Ýp. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2, “n粏š•F2, źŒ´N”ü3, ˛“Ą—ÇŽq3 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č, 3ŠĹŒě•”): ‘ć29‰ń“ú–{ŹŽ™ƒXƒg[ƒ}E”rŸ•ŠÇ—Œ¤‹†‰ď (2015/6/27), VŠƒ.

733372. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‡•šÇ‚đ—L‚ľ‚Ä‚˘‚é’_“š•Â˝ÇŹl—á2—á. “c’†@Œ‰1, •“cŒ›Žq2, Š`Œ´@’m2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2ŠO‰Č): ‘ć42‰ń“ú–{’_“š•Â˝ÇŒ¤‹†‰ď (2015/11/7), “Œ‹ž


(‹g“cˆęŹ)

[Šwp˜_•ś]

540020. [‚ť‚Ě‘ź] tˆÚAƒ`[ƒ€‚Š‚ç”­M‚ˇ‚étˆÚAŠłŽŇ‚̉h—{ŠÇ—. ‹g“cˆęŹ (V˘‹Iˆă—ÁEć’[ˆă—Ă): CION‰h—{EHŽ–ƒjƒ…[ƒX 2015/10; 28: 1.

[Šw‰ďEŒ¤‹†‰ď“™]

713091. [Šw‰ď (‘Ű)] (ƒ|ƒXƒ^[) Three Year Clinical Outcomes Of Once-Daily Tacrolimus Extented-Release Formulation versus Twice-Daily Tacrolimus In De Novo Kidney Transplantation. Yoshida K1,2, Ishii D2, Kohguchi D2, Ohyama T2, Mochizuki K2, Takeuchi Y3, Wakai H, Noguchi F4, Tanaka M4, Ikeda M2: 14th Congress of the Asian Society of Transplantation (2015/8/24), Singapore. (‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2, ‚Œű@‘ĺ2, ‘ĺŽR“N•˝2, –]ŒŽN•˝2, ’|“ŕN—Y3, Žáˆä—zŠó, –ěŒű•ś”T4, “c’†”üŽ÷4, ’r“cŹ]2: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí, 3t‘Ÿ“ŕ, 4ŠĹŒě•”)

713094. [Šw‰ď (‘Ű)] (ˆę”ĘŒű‰‰) EVEROLIMUS, TAC-ER AND MMF DE NOVO RENAL TRANSPLANT RESULTED GOOD GRAFT FUNCTION. Yoshida K1,2, Ishii D2, Takeuchi Y3, Wakai H, Kohguchi D2, Noguchi F4, Ikeda M2, Tanaka M4: 17th Congress of the European Society for Organ Transplantation (2015/9/16), Brussels, Belgium. (‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2, ’|“ŕN—Y3, Žáˆä—zŠó, ‚Œű@‘ĺ2, –ěŒű•ś”T4, ’r“cŹ]2, “c’†”üŽ÷4: 1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí, 3t‘Ÿ“ŕ, 4ŠĹŒě•”)

722092. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) tˆÚA‚É‚¨‚Ż‚é–ň•¨—Ă–@‚̏d—vŤ. ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć9‰ń“ú–{t‘Ÿ•a–ň•¨—Ă–@Šw‰ď ŠwpW‰ďE‘‰ď2015 (2015/10/25), ĺ‘ä.

722101. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) tˆÚA‚É‚¨‚Ż‚éƒ`[ƒ€ˆă—Ă‚Ěd—vŤ (ƒI[ƒo[ƒrƒ…[). ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2, –ěŒű•ś”T3, ’r“cŹ]2, ‹{â—Dl4, ‹g“c•üŽq5, ź‘ň—Ç‘ž6 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí, 3ŠĹŒě•”, 4–ňÜ•”, 5‰h—{•”, 6ƒŠƒnƒrƒŠ•”): ‘ć49‰ń“ú–{—Տ°tˆÚAŠw‰ď (2016/3/24), ’šŽć.

723665. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) LDL‹z’…—Ă–@‚ĆŒŒ‰t“§Í‚Ě“ŻŽž•š—p—Ă–@Ž{s‚ɂ‚˘‚Ä‚ĚŽŽ‚Ý. ‰Í‘ş”ŽŽq, Žáˆä—zŠó, ŕ_čG—ćŽq, “c•Ó–˘—ˆ, “n粒qŽq, ˆ˘•”“Ţ’Ă”ü, –Ř‘şŠG”ü, •ş“Ą@“§, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/26), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 640.

723666. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ”p—pÇŒóŒQŠłŽŇ‚Ş•ŕs‰Â”\‚Ć‚Č‚Á‚˝Ç—á`ˆ¤‘ˇ‚Ćƒo[ƒWƒ“ƒ[ƒh‚đ•ŕ‚Ţ‚˝‚߂Ɂ`. ŠÚ–ě—Y‹M, –Ř‘şŠG”ü, œA]–r–¤, ”üK—Ż”ü, ›@—L‹I, Žáˆä—zŠó, •ş“Ą@“§, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/26), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 686.

723668. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “–ƒNƒŠƒjƒbƒN‚Ě‹łˆçŽĺ”C‚Ć‚ľ‚ĐVlŠĹŒěŽt‚Ö‚ĚŽw“ą`“–ƒNƒŠƒjƒbƒN‚Ěƒ}ƒjƒ…ƒAƒ‹‚đŠî‚ÉŽw“ą‚đŽn‚ß‚Ä. ––‰i—TŽq, —Ž‡^Šó, ‚‹´@—ş, ‚‹´_—Y, Šp“c—˛r, —é–؁@‘ĺ, ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2, ‚‹´—Tˆę˜Y (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/26), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 729.

723670. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ˆÚAt‹@”\”pâŒă‚ɍݑ‰t“§Í‚đ“ą“ü‚ľ‚˝7Ç—á. Žáˆä—zŠó, ˆ˘•”“Ţ’Ă”ü, ‰Í‘ş”ŽŽq, ™–{’źŽq, –Ř‘şŠG”ü, ŽR’†—˘‰Ŕ, •ş“Ą@“§, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 753.

723671. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚¨‚Ż‚é•n˘ŠłŽŇ‚ɑ΂ˇ‚éˆŰŽ“§Í“ą“ü‚ĚŒoŒą. ŠĂ—˜‰ŔŽj, ’†“ˆÍ‹M, źŒ´O˜a, Žáˆä—zŠó, “č‘ş—F—˛, ’ˇŔrG, Ź‹v•ŰŒŞˆę, •ş“Ą@“§, ŽÄŒ´L‹v, ‹g“cˆęŹ1,2, ěźGŽ÷, ě‘ş–ž•v (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 756.

723672. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚¨‚Ż‚铧Í‰t´ň‰ť. ‰Y•Órˆę˜Y, Ź“‡@–G, “č‘ş—F—˛, –Ř‘şŠG”ü, ˆ˘•”“Ţ’Ă”ü, ×–ě‚Žu, Žáˆä—zŠó, Ź‹v•ŰŒŞˆę, ’†“‡Í‹M, •ş“Ą@“§, ‹g“cˆęŹ1,2, ’|ŕV^Œá, ěźGŽ÷ (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 756.

723673. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒ~ƒƒƒ“ƒ}[‚É‚¨‚Ż‚铧Í‰t´ň‰ťŽx‰‡Šˆ“Ž. –Ř‘şŠG”ü, ˆ˘•”“Ţ’Ă”ü, Ź“‡@–G, ÷‘ň‹Mr, ÷‘ň—ž”T, ‰Y•Órˆę˜Y, ‘ëŕVˆŸ—R”ü, ˆŔ•”‹M”V, Ź—Ń‚ą‚¸Œb, “č‘ş—F—˛, Ź‹v•ŰŒŞˆę, Žáˆä—zŠó, •ş“Ą@“§, ‹g“cˆęŹ1,2, ěźGŽ÷, ě‘ş–ž•v (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 756.

723674. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒxƒgƒiƒ€‚É‚¨‚Ż‚铧Í‰t´ň‰ť‚Ö‚ĚŽć‚č‘g‚ÝŽx‰‡. źŒ´O˜a, Ź‹v•ŰŒŞˆę, “c’†łŒČ, Ź“‡@–G, “č‘ş—F—˛, Žáˆä—zŠó, ’†“ˆÍ‹M, •ş“Ą@“§, ŽÄŒ´L‹v, ‹g“cˆęŹ1,2, ’|ŕV^Œá, ěźGŽ÷, ě‘ş–ž•v (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 756.

723675. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒJƒ“ƒ{ƒWƒA‚É‚¨‚Ż‚铧ÍŠÖ˜Aˆă—Ï]Ž–ŽŇˆçŹŽx‰‡ƒvƒƒWƒFƒNƒg. Žáˆä—zŠó, •ş“Ą@“§, Ź‹v•ŰŒŞˆę, “č‘ş—F—˛, ’ˇŔrG, ’†“ˆÍ‹M, ŽÄŒ´L‹v, ‹g“cˆęŹ1,2, ěźGŽ÷, ě‘ş–ž•v (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 757.

723676. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒxƒgƒiƒ€Eƒ~ƒƒƒ“ƒ}[EƒJƒ“ƒ{ƒWƒA‚É‚¨‚Ż‚ét“§ÍŠÖ˜AŠwp‘gD‚̏ó‹ľ. źŒ´O˜a, Ź‹v•ŰŒŞˆę, Ź“‡@–G, “č‘ş—F—˛, Žáˆä—zŠó, ’†“ˆÍ‹M, •ş“Ą@“§, ŽÄŒ´L‹v, ‹g“cˆęŹ1,2, ’|ŕV^Œá, ŽR‰ş–ž‘×, ěźGŽ÷, ě‘ş–ž•v (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 757.

723680. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ƒKƒ“ƒ}ü–ŋۉń˜H‚ĚŽg—pŒoŒą. •˝–ě’¨‹v, Â–Ř–ÎŽ÷, ‚‹´@—ş, ‚‹´_—Y, Šp“c—˛r, —é–؁@‘ĺ, ‹g“cˆęŹ1,2, Îˆä‘ĺ•ă2, ‚‹´—Tˆę˜Y (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/27), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 853.

723684. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) “§ÍƒNƒŠƒjƒbƒN‚É‚¨‚Ż‚éî•ńƒZƒLƒ…ƒŠƒeƒB‘΍ô. “n糗FŽq, ŽR’†—˘‰Ŕ, –kč‘Žq, ‹g•G”ü, ‘ëŽR—tŽq, ”üK—Ż”ü, Žáˆä—zŠó, •ş“Ą@“§, ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć60‰ń“ú–{“§ÍˆăŠw‰ďŠwpW‰ďE‘‰ď (2015/6/28), ‰Ą•l, “§Í‰ďŽ 2015; 48 (Suppl 1): 960.

723685. [Šw‰ď (‘S‘)] (ˆę”ĘŒű‰‰) ‹ß—׏Z–Ż‚ĚŠń•t‚É‚ć‚蓧Í“ą“ü‚ÉŽŠ‚Á‚˝ƒJƒ“ƒ{ƒWƒA‚Ĺ‚Ě––Šút•s‘SŠłŽŇ‚Ě“§Íó‹ľ‚Ɖh—{ó‘Ô. Žáˆä—zŠó, ’ˇŔrG, •ş“Ą@“§, ‹g“cˆęŹ1,2, ěźGŽ÷, –k“‡KŽ}, “c‘ş’qŽq (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć3‰ń“ú–{t•s‘S‰h—{Œ¤‹†‰ďŠwpW‰ďE‘‰ď (2015/7/5), ‰Ą•l.

731133. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ADPKDf—Ă‚ÉŠÖ‚ˇ‚éĹ‹ß‚Ě˜b‘č|–EtŠO—ˆ‚Ćƒgƒ‹ƒoƒvƒ^ƒ“|. ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘Š–ÍŒ´ADPKD•af˜AŒg‚̉ď (2015/7/24), ‘Š–ÍŒ´.

731142. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) “–‰@‚É‚¨‚Ż‚étˆÚAƒ`[ƒ€ˆă—Í\Ź. ‹g“cˆęŹ1,2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2”ĺ”AŠí): ‘ć11‰ń“ě‘ĺătˆÚAE“§Íˆă—ĂŒ¤‹†‰ď (2015/11/19), ‘ĺă.


(—é–؁@Ž )

[Šwp˜_•ś]

521030. [‰đŕ]yˆă—ĂŠÖŒWŽŇ‚ɑ΂ˇ‚é•úŽËü–hŒě‹łˆç‚Ć‚Í?z•úŽËüf—Ă‚É‚¨‚Ż‚é•úŽËü–hŒě‹łˆç‚Ć‚Í?|‚ť‚ĚˆÓ‹`‚Ć•K—vŤ|CTŒŸ¸‚É‚¨‚Ż‚é•úŽËü–hŒě‹łˆç‚Ć‚ť‚ĚˆÓ‹`. —é–؁@Ž  (V˘‹Iˆă—ÁEć’[ˆă—Ă): ˆă—Ă•úü–hNewsletter 2015/7; 73: 14-8.

[Šw‰ďEŒ¤‹†‰ď“™]

722225. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) [•K{uK] ˆă—ĂˆŔ‘SE•úŽËü–hŒě CT (•úŽËü–hŒě‚ĚŒŠ’n‚Š‚ç). —é–؁@Ž  (V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć74‰ń“ú–{ˆăŠw•úŽËüŠw‰ď‘‰ď (2015/4/18), ‰Ą•l, “ú–{ˆăŠw•úŽËüŠw‰ďŽGŽ 2015/2; p.S126.


(‰Á“Ą—˘ŠG)

[Šwp˜_•ś]

522190. [uŔ]y“ÁW: –ł’É•Ş•ŘUp to Datez7. d–ŒŠO–ł’É•Ş•Ř‚É‚ć‚é•ęŽ™‚Ö‚Ě•›ě—pE‡•šÇ‘΍ô. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): ŽY‰Č‚Ć•wl‰Č 2015/5; 82 (5): 509-14.

522191. [uŔ]y“ÁW: ”D•w‹~‹}‘Ήž‚ĚŽŔ‘H‚Ćˆă—ĂƒVƒXƒeƒ€\’z‚Ě‚˝‚߂Ɂz5. ŽY‰Č‹~‹}‚Ě“ÁŽęŤ@”DŽY•w‹~‹}‘Ήž‚É‚¨‚Ż‚éŽY•wl‰Čˆă‚Ć–ƒŒ/‹~‹}/W’†ŽĄ—Ă‰Čˆă‚Ć‚Ě˜AŒg‚Ě‚˝‚ß‚É. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): ŽY•wl‰Č‚ĚŽŔŰ 2015/9; 64 (9): 1133-9.

[’˜@‘]

620133. [Šwp‘ (•Ş’SŽˇ•M)]y“ú–{‚Ě”DŽY•w‚đ‹~‚¤‚˝‚ß‚É2015zA. Šî–{•Ň@”DŽY•w‹}•ĎŽž‚̏‰Šú‘Ήž, p.86-97. ‰Á“Ą—˘ŠG1, ‰œ•xr”V2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2–ƒŒ) Šé‰ć: Î“n@—E, ’r“c’q–ž, ŠÄC: “ú–{ŽY•wl‰Čˆă‰ďˆă—ĂˆŔ‘SˆĎˆő‰ď, Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ (’nˆćˆă—ĂŠî”ŐŠJ”­„iŒ¤‹†Ž–‹Ć) ’r“c”Ç, •Ň: ŠÖ‘ň–ž•F, ’ˇ’Jěˆę, “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2015/4”­s.

620134. [Šwp‘ (•Ş’SŽˇ•M)]y–ƒŒ‰ČˆăEW’†ŽĄ—Ăˆă‚É•K—v‚ČŒŒ‰t‹ĂŒĹ, R‹ĂŒĹ, ü—nŒn‚Ş•Ş‚Š‚é–{ ‰ü’ů‘ć2”Łz(—Տ°) 4. ŽY‰ČoŒŒ‚É‚¨‚Ż‚é‹ĂŒĹáŠQ‚Ě“Á’Ľ‚Ć‚ť‚Ě‘Îˆ–@, p.117-31. ‰Á“Ą—˘ŠG1, ‰œ•xr”V2 (1V˘‹Iˆă—ÁEć’[ˆă—Ă, 2–ƒŒ) •Ň: •“cƒŽO, ^‹ťŒđˆŐˆă‘o”Ĺ•”, “Œ‹ž, 2015/6”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722226. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) —r…ÇđÇ. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/28), _ŒË

722227. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ”DŽY•w‹}•ĎŽž‚̑Ήž. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/29), _ŒË

732147. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ’鉤ŘŠJ‚ĹŽq‹Ÿ‚đŽY‚ŢˆÓ–Ą‚đl‚Ś‚Ă݂悤. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): ‘ć8‰ńŽüpŠúƒZƒ~ƒi[ (2015/5/30), _ŒË

732148. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ”DŽY•wICUŠÇ—‚Ě’ˆÓ“_. ‰Á“Ą—˘ŠG (V˘‹Iˆă—ÁEć’[ˆă—Ă): “ú–{W’†ŽĄ—ĂˆăŠw‰ď‘ć13‰ńƒŠƒtƒŒƒbƒVƒƒ[ƒZƒ~ƒi[ (2015/8/2), “Œ‹ž.


‰Ą’f“Iˆă—Ă—ĚˆćŠJ”­•”–ĺ

(˛X–ŘŽĄˆę˜Y)

[Šwp˜_•ś]

110324. [Œ´’˜] Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non-Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol. Hotta K, Sasaki J1, Saeki S, Takigawa N, Katsui K, Takayama K, Nogami N, Shioyama Y, Bessho A, Kishimoto J, Tanimoto M, Kiura K, Ichinose Y: Clin Lung Cancer 2016/1; 17 (1): 75-9. (˛X–ŘŽĄˆę˜Y1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

[’˜@‘]

620135. [Šwp‘ (•Ş’SŽˇ•M)]yŒÄ‹zŠíŽžŠł ĹV‚ĚŽĄ—Ă 2016-2018zXV. ŒÄ‹zŠíŽžŠł‚ĚŠłŽŇŽw“ą@5. ”xŠŕ‚ĚŠO—ˆŠÇ—, p.436-7. ˛X–ŘŽĄˆę˜Y (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •Ň: ™ŽRK”äŒĂ, –ĺ“c~ˆę, ŒˇŠÔş•F, “ě]“°, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722228. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ŠÉ˜a—Ă–@: ŠÉ˜aˆă—Ă‚đ•W€‰ť‚ˇ‚é‚É‚Í. ˛X–ŘŽĄˆę˜Y (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć13‰ń“ú–{—Տ°Žîᇊw‰ďŠwpW‰ď (2015/7/18), ŽD–y.

722229. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) —Տ°Žîᇈă‚ɑ΂ˇ‚éŠÉ˜aˆă—ĂƒKƒCƒhƒ‰ƒCƒ“‚ÉŠÖ‚ˇ‚éƒAƒ“ƒP[ƒg’˛¸Œ‹‰Ę•ń. ˛X–ŘŽĄˆę˜Y1, •˝ŽR‘אś2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2“ŒŽD–y•a‰@EŽîᇓŕ‰Č): ‘ć13‰ń“ú–{—Տ°Žîᇊw‰ďŠwpW‰ď (2015/7/18), ŽD–y.

722230. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ”xŠŕ—Ěˆć‚É‚¨‚Ż‚鎝‘ąŒ^G-CSFťÜ‚ĚŽg‚˘•ű. ˛X–ŘŽĄˆę˜Y (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć56‰ń“ú–{”xŠŕŠw‰ďŠwpW‰ď(2015/11/28), ‰Ą•l.


(‹ŕˆäş•ś)

[Šwp˜_•ś]

522192. [uŔ]y“ÁW: ’ɂݐf—Ă‚É‚¨‚Ż‚éŒőü—Ă–@@I. Œőü—Ă–@‚Ě‹@ŠízƒLƒZƒmƒ“ƒ‰ƒCƒgŽĄ—ĂŠí. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ƒyƒCƒ“ƒNƒŠƒjƒbƒN 2016/2; 37 (2): 169-75.

[’˜@‘]

620136. [Šwp‘ (•Ş’SŽˇ•M)]y’É‚Ý‚ĚScience & Practice 8@—Տ°‚ɖ𗧂_ŒoáŠQŤ’É‚Ě—‰đzIII. ŽĄ—Ă‘˜_@1. –ň•¨—Ă–@, p.64-74. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •Ň: ˆäŠÖ‰ëŽq, •śŒő“°, “Œ‹ž, 2015/5”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722231. [Šw‰ď (‘S‘)] (ƒXƒ|ƒ“ƒT[ƒhƒVƒ“ƒ|ƒWƒEƒ€) –Ťáu’ɏǂɂ¨‚Ż‚éƒIƒsƒIƒCƒhŽĄ—Ă–ň‚ĚˆÓ‹`. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{üˆŰ‹Ř’ɏNJw‰ď‘ć7‰ńŠwpW‰ď (2015/10/3), Vh.

7231021. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Ž‘ąŇ‘‚­‚ŕ–Œ‰ş–ƒŒ. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{‹ćˆć–ƒŒŠw‰ď‘ć2‰ńŠwpW‰ď (2015/4/25), ŒQ”n.

731176. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ŒŠ‹–k•”áu’ÉŽĄ—ĂŒ¤‹†‰ď (2015/6/26), ”Žs.

731177. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’É‚Ý‚Ě\‘˘. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Chiba Spine Youth Meeting 12th (2015/7/25), ç—t.

731178. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‰Ą{‰ęŽŒ`ŠO‰Čˆă‰ď 2015/8/5), ‰Ą{‰ę.

731179. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‚Ş‚ńŤ’ÉŽĄ—Â̐Ví—ށ`ŒťŽĄ—Ă‚Ě–â‘č“_‚Ć‘Îô`. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _“ŢěŒ§‰›’n‹ćŠÉ˜aˆă—ĂŒ¤‹†‰ď (2015/8/25), _“ސě.

731180. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘Š–ÍŒ´ŽsŽY•wl‰Čˆă‰ďŠwpu‰‰‰ď (2015/9/2), ‘Š–Í‘ĺ–ě.

731181. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): é‹ĘŒ§“Œ•”–Ťáu’ɍ§˜b‰ď (2015/10/15), t“ú•”.

731182. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć188‰ńŠw‚Ú‚¤‰ď (2015/12/4), `–ě.

731183. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ĺ‘D’n‹ć–Ťáu’ɃJƒ“ƒtƒ@ƒŒƒ“ƒX (2016/1/20), Š™‘q.

731184. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): –ž“ú‚Š‚ç–𗧂Âáu’ÉŽĄ—ĂƒZƒ~ƒi[ (2016/2/10), ’˛•z.

731185. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): áu’ɂɂ‚˘‚čl‚Ś‚é‰ď (2016/2/17), •lź.

733373. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚ÝŽĄ—Ă‚Ěl‚Ś•ű. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): áu’ÉŒ¤‹†‰ď (2015/4/10), ‰Ą•l.

733374. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‹I”öˆä’ŹJointƒZƒ~ƒi[2015 (2015/4/16), “Œ‹ž.

733375. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚­‚ŕ–Œ‰şƒ|[ƒg‚Ě“K‰ž‚ĆŠÇ—. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‚­‚ŕ–Œ‰şƒ|[ƒgŒ¤C‰ď (2015/6/10), ‘Š–ÍŒ´.

733376. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ăŽˆ‚¨‚ć‚щşŽˆ‚Ě’É‚ÝŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _“ŢěŒ§—Տ°ŽŒ`ŠO‰Čˆă‰ď“Á•ĘŠwpu‰‰‰ď (2015/6/24), ‰Ą•l.

733377. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Ă“ě_ŒoáŠQŤáu’ÉŒ¤‹†‰ď (2015/7/22), “Ą‘ň.

733378. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Ź“cŒ´ˆăŽt‰ď“’‰ÍŒ´”ÇŠwpu‰‰‰ď (2015/7/27), Ă‰Ş.

733379. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’ɂݐf—Ă‚Ě”wŒi. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): u‹`J-PAT_“ސě (2015/9/15), ‰Ą•l.

733380. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚Ě•]‰ż‚¨‚ć‚Ń–Ťáu’É. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): u‹`J-PAT_“ސě (2015/9/15), ‰Ą•l.

733381. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –Ťáu’É‚Ě–ň•¨—Ă–@‚ĚŽŔŰ. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): u‹`J-PAT_“ސě (2015/9/15), ‰Ą•l.

733382. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚—îŽŇ‚̒ɂ݂ɑ΂ˇ‚é–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘Š–ÍŒ´–ňÜŽt‰ď (2015/9/17), ‘Š–ÍŒ´.

733383. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚Ě–ň•¨ŽĄ—Ă. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoáŠQŤáu’ɃZƒ~ƒi[ in YOKOHAMA (2015/11/19), ‰Ą•l.

733384. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ‚Ş‚ńf’fŽž‚Š‚ç‚ĚWHOŽO’iŠKœ’Ƀ‰ƒ_[‚ĚŒœ”O. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “Č–ŘŒ§ŠÉ˜aƒPƒA ƒI[ƒ^ƒ€ƒZƒ~ƒi[ (2015/11/20), ‰F“s‹{.

733385. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) –Ť’ɂɑ΂ˇ‚éƒuƒvƒŒƒmƒ‹ƒtƒBƒ“‚̍čl. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć4‰ń‚˘‚í‚ĉ^“ŽŠíáu’ɍ§˜b‰ď (2016/2/13), ˇ‰Ş.

733386. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ’É‚Ý‚ŞˆÓ–Ą‚ˇ‚é‚ŕ‚Ě. ‹ŕˆäş•ś (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć5‰ń–k—˘‘ĺŠwˆăŠw•”•‘ŽV˘‹Iˆă—ĂŠJ”­ƒZƒ“ƒ^[ƒVƒ“ƒ|ƒWƒEƒ€ (2016/3/3), ‘Š–Í‘ĺ–ě.


(VˆäłN)

[Šwp˜_•ś]

522193. [uŔ]y“ÁW: ˆę”Ę•a“ƒi[ƒX‚É‚ŕ–𗧂Â! u‚Č‚ń‚Šƒwƒ“?v‚đŒŠ”˛‚­! ‹}•Ď‘O‚ĚŽ@’m¨ƒAƒZƒXƒƒ“ƒg¨ƒhƒNƒ^[ƒR[ƒ‹ (RRT—vż) ƒ~ƒ‰ƒNƒ‹™ƒƒ\ƒbƒhz4.uŒÄ‹zv‚ĚˆŮí‚ÍSpO2’ቺ‚ś‚á’x‚˘‚Ě‚ć. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Emergency Care 2015/8; 28 (8): 31-5.

522194. [uŔ]y“ÁW: ‘ĺ—ʏoŒŒ‚Ě•a‘Ԑś—‚Ć—AŒŒí—ށzŠOŤ‘ĺ—ʏoŒŒ: •a‘Ô‚Ć‘Îô. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Thrombosis Medicine 2016/3; 6 (1): 33-9.

[’˜@‘]

622001. [Šwp‘ (–|–ó)]yƒwƒX‚ĆƒJƒNƒ}ƒŒƒbƒN‚ĚTHElHŒÄ‹zƒuƒbƒN ‘ć2”Ĺ‘ć1üz–ó: “c’†—ł”n, Ł”ö—´‘ž˜Y, ˆŔ‘îˆęW, VˆäłN1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹, “Œ‹ž, 2015”N8ŒŽ”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713133. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) Implementation of Critical Care Staff based Rapid Response Team|Effect to the Unpredicted Death|. Arai M1, Koike T, Moriyasu M, Ito S2, Inagaki T3, Hattori J3, Otsuka T2, Yoshino K2, Kuroiwa M2: 28th Annual Congress of the European Society of Intensive Care Medicine (2015 ESICM) (2015/10/6), Berlin, Deutschland. (VˆäłN1, ˆÉ“Ą‘s•˝2, ˆîŠ_‘דl3, •ž•”@3, ‘ĺ’Ë’q‹v2, ‹g–ě˜a‹v2, •Šâ­”V2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–ƒŒ, 3‹~–˝)

713134. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) The Impact of the Critical Care Outreach Team based Rapid Response System to the Unpredicted Hospital Death. Arai M1, Koike T, Moriyasu M, Ito S2, Inagaki T3, Hattori J3, Otsuka T2, Yoshino K2, Kuroiwa M2: 12th Congress of the World Federation of Societies of Intensive and Critical Care Medicine in collaboration with WFCCN and WFPICCS (2015/8/30), Seoul, Korea. (VˆäłN1, ˆÉ“Ą‘s•˝2, ˆîŠ_‘דl3, •ž•”@3, ‘ĺ’Ë’q‹v2 ‹g–ě˜a‹v2, •Šâ­”V2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–ƒŒ, 3‹~–˝)

722232. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ’ÁĂ, ‚š‚ń–Ď, ‰^“Ž—Ă–@‚đˆę‘Ě‚Ć‚ľ‚˝ƒ`[ƒ€ƒAƒvƒ[ƒ`‚ƐlHŒÄ‹zŠí—Ł’E. VˆäłN1, XˆŔŒbŽŔ, ŒŠˆä“c˜ał2, _’JŒ’‘ž˜Y2, ŕ_čL–ž2, ‘“cł˜a, Ź’r•üF, —é–Ř—D‘ž˜Y3, ‘ĺ’Ë’q‹v3, •Šâ­”V3 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2ƒŠƒnƒrƒŠ•”, 3–ƒŒ): ‘ć37‰ń“ú–{ŒÄ‹z—Ă–@ˆăŠw‰ďŠwpW‰ď (2015/07/17), ‹ž“s.

7231022. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Rapid Response System‹N“ŽŠî€‚ɁgWorried Callh‚đĚ—p‚ˇ‚é‚ą‚Ć‚ÍƒVƒXƒeƒ€‚Ě‘Šú‹N“Ž‚É—LŒř‚Ĺ‚ ‚é. VˆäłN1, Ź’r•üF, XˆŔŒbŽŔ, ˆÉ“Ą‘s•˝2 ,ˆîŠ_‘דl3, •ž•”@3, •Šâ­”V2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–ƒŒ, 3‹~–˝): “ú–{–ƒŒ‰ČŠw‰ď‘ć62‰ńŠwpW‰ď (2015/5/28), •Ÿ‰Ş.

7231023. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@Rapid Response System‚ޏI––Šúˆă—Ă‚Ö—^‚Ś‚é‰e‹ż‚Ě’˛¸. VˆäłN1, Ź’r•üF, XˆŔŒbŽŔ, ‘ĺ’Ë’q‹v2, ‹g–ě˜a‹v2, ˆÉ“Ą‘s•˝2, ŹâN°2, —é–Ř—D‘ž˜Y2, źŕV‹`”V2, •Šâ­”V2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–ƒŒ): ‘ć43‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2016/2/12), _ŒË.

7231024. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒvƒŒƒ`ƒXƒ‚ƒOƒ‰ƒ€•Ď“Ž‚Š‚ç“ž‚ç‚ę‚é, ”ńNP“IŒÄ‹z‰ń”‘Ş’č‘•’u (NellcorTM PM1000N) ‚ĚŠm‚Š‚ç‚ľ‚ł‚ĚŒŸ“˘. VˆäłN1, ‹g‰Şr•ă2, ăˆä䝗LŽq2, “c’†ˆęś2, —é–Ř—D‘ž˜Y2, źŕV‹`”V2, ŹâN°2, ˆÉ“Ą‘s•˝2, •Šâ­”V2, ‰Ş–{_Žk2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–ƒŒ): ‘ć43‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2016/2/12), _ŒË.

732149. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ”]ŒŒŠÇŽžŠł‚đ‡•š‚ľ‚˝t•s‘SŠłŽŇ‚Ě–ƒŒŠÇ—. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć24‰ń“ú–{t•s‘SŠO‰ČŒ¤‹†‰ď (2015/7/4), –k‹ăB.

732150. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) ŽüpŠú‚É‚¨‚Ż‚éƒ`[ƒ€ˆă—Ă‚đl‚Ś‚é: “–‰@‚ĚRST–{–M‚̏Ť—ˆ. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‰Ą•lƒoƒCƒ^ƒ‹ƒTƒCƒ“ƒZƒ~ƒi[ (2015/7/11), ‰Ą•l.

732151. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) Rapid response system: –ƒŒ‰ČˆăEW’†ŽĄ—Ăˆă‚Ě–đŠ„. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć10‰ńé‹Ęˆă‘ĺ—Տ°–ƒŒƒlƒbƒgƒ[ƒN (SMU-CAN) (2015/12/26), é‹Ę.

732152. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) W’†ŽĄ—Ă—Ěˆć‚Ĺ‚ĚƒGƒR[‚É‚ć‚ézŠÂ•]‰ż. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _“Ţě–ƒŒ‰Čˆă‰ď‘ć47‰ńŠwpW‰ďE‘ć7‰ńEcho Rounds_“ސě (2016/02/28), ‰Ą•l.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H19-522001. [uŔ]y“ÁW: ł‚ľ‚˘‹~‹}ˆ’u@‚ť‚ĚŞ‹’‚ƍ‡—Ť‚đl‚Ś‚ézII. ŒÄ‹z‚É‚Š‚Š‚í‚éŽč‹Z@‹šoúŽhE‹šoƒhƒŒƒi[ƒW. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‹~‹}ˆăŠw 2007/9; 30 (10): 1195-205.

H26-522014. [uŔ] Rapid Response System. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): —Տ°–ƒŒ 2014/12; 38 (12): 1711-20.

[Šw‰ďEŒ¤‹†‰ď“™]

H26-722004. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) “–‰@‚É‚¨‚Ż‚éICU‚ĆRRT˜AŒg`RRT‚̏W’†ŽĄ—Ăˆă‚ŞICU‚ÉŠłŽŇ‚đ˜A‚ę‚Ä‚­‚é`. VˆäłN1, Ź’r•üF, XˆŔŒbŽŔ, •Šâ­”V2, •ž•”@3, ˆÉ“Ą‘s•˝2, —é–Ř—D‘ž˜Y2, ‘ĺ’Ë’q‹v2, ‹g–ě˜a‹v2, ź–{ŽœŠ° (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–ƒŒ, 3‹~–˝): ‘ć42‰ń“ú–{W’†ŽĄ—ĂˆăŠw‰ďŠwpW‰ď (2015/2/9), “Œ‹ž.

H26-732004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹łˆçu‰‰) J-PADƒKƒCƒhƒ‰ƒCƒ“‚ĚĐ‰î. VˆäłN (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć2‰ń_“ސě’ÁĂEŒÄ‹zƒTƒ|[ƒgƒtƒH[ƒ‰ƒ€ (2015/1/24), ‰Ą•l.


(Ź—ѐ´“T)

[Šwp˜_•ś]

110077. [Œ´’˜] Adalimumab for the treatment of Japanese patients with intestinal Behet's disease. Tanida S, Inoue N, Kobayashi K1,2, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Nagahori M, Motoya S, Nakamura S, Arora V, Robinson AM, Thakkar RB, Hibi T3: Clin Gastroenterol Hepatol 2015/5; 13 (5): 940-8.e3. (Ź—ѐ´“T1,2, “ú”ä‹I•ś3: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

522026. [uŔ]y“ÁW: ‰ŠÇŤ’°ŽžŠłf—Ă‚ĚĹ‘Oüz—Տ°Çó‚Š‚牊ÇŤ’°ŽžŠł‚𑁂­f’f‚ˇ‚éƒRƒc. Ź—ѐ´“T1,2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): “ú–{ˆăŽt‰ďŽGŽ 2015/4; 144 (1): 35-9.

522030. [uŔ]y“ÁW: ‰ş•”Á‰ťŠÇ: ‰ŠÇ‚Š‚ç‚Ě”­Šŕz2-2. ‰ŠÇ”­Šŕ‚̐f’f@(2) ŠëŒŻˆöŽq. Ź—ѐ´“T1,2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): Intestine 2015/7; 19 (4): 356-60.

522032. [uŔ]y“ÁW: ’×ᇐŤ‘ĺ’°‰Š‚ĚĹ“KŽĄ—Ă‚Ć—Ő°“I–â‘č‚Ö‚Ě‘Îôz5-ASAťÜ‚đ‚Ç‚¤Žg‚¤‚Š|‚ť‚ĚŽĄ—Ð헪|. Ź—ѐ´“T1,2, ěŠÝ‰Á“Ţ2, ‘剪ł•˝2, ‰ĄŽR@ŒO2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): Á‰ťŠí‚Ě—Ő° 2015/8; 18 (4): 345-50.

522034. [uŔ]y“ÁW: ŒŒ•Ö‚đ‚Ý‚˝‚çz‘˜_@‰ş•”Á‰ťŠÇoŒŒ‚ɑ΂ˇ‚éf’fƒAƒ‹ƒSƒŠƒYƒ€. Ź—ѐ´“T1,2, ‘剪ł•˝2, ěŠÝ‰Á“Ţ2, ‰ĄŽR@ŒO2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): Á‰ťŠí“ŕŽ‹‹ž 2015/10; 27 (10): 1608-15.

[’˜@‘]

620022. [Šwp‘ (•Ş’SŽˇ•M)]yŽŔ—Տ°‚ɖ𗧂ÂIBD“ŕŽ‹‹žz‘ć2Í IBD‚Ě“ŕŽ‹‹žf’f@2. ‘źŽžŠł‚Ć‚ĚŠÓ•Ę 1. ’°ŠÇƒx[ƒ`ƒFƒbƒg•aE’PƒŤ’×á‡, p.37-43. Ź—ѐ´“T1,2, ‰ĄŽR@ŒO2, ˛“c”ü˜a2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ), ŠÄC: “ú”ä‹I•ś3, ŽR–{”Ž“ż, •Ň: ‹vź—ˆę, –î–ě’q‘Ľ (3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č), “ú–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[, “Œ‹ž, 2015/10”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

722015. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yIBDŠÖ˜AÁ‰ťŠÇŠŕ‚ɑ΂ˇ‚é“ŕŽ‹‹žf—Ẩۑč‚ƏŤ—ˆ“W–]z’×ᇐŤ‘ĺ’°‰ŠŠÖ˜AŽîᇂɑ΂ˇ‚é“ŕŽ‹‹žf’f‚Ě—L—pŤ‚Ć–â‘č“_. Ź—ѐ´“T1,2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć89‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (2015/5/30), –źŒĂ‰Ž, Gastroenterological Endoscopy 2015/4; 57 (Suppl 1): 628.

722027. [Šw‰ď (‘S‘)] (ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“)yIBD‚ɑ΂ˇ‚éŠŕƒT[ƒxƒCƒ‰ƒ“ƒX‚ĚŒťó‚ƍĄŒă‚Ě“W–]z’×ᇐŤ‘ĺ’°‰Š‚ɑ΂ˇ‚éŠŕƒT[ƒxƒCƒ‰ƒ“ƒXEƒvƒƒOƒ‰ƒ€‚ĚŽŔŰ. ŽÂč@‘ĺ1, Ź—ѐ´“T2,3, ‹vź—ˆę, ’ˇŔ@˝, ‚‹´ŒŤˆę (1“Œ‹ž‘ĺŠwˆă‰ČŠwŒ¤‹†Š•‘Ž•a‰@ŠO‰Č, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3Á‰ťŠí“ŕ): ‘ć70‰ń“ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŠwpW‰ď (2015/11/14), –źŒĂ‰Ž, “ú–{‘ĺ’°ăč–ĺ•aŠw‰ďŽGŽ 2015/9; 68 (9): 619.

723168. [Šw‰ď (‘S‘)] (ƒ|ƒXƒ^[) ‘ĺ’°“ŕŽ‹‹ž”˛‹ŽŽžŠÔ‚Ć‘BŽîŒŸo—Ś‚ĚŠÖŒW@‘˝Ž{Ý‹¤“ŻŒ¤‹†. ‰Í‘ş‘ě“ń1, ”ö“c@‹ą, Ź—ѐ´“T2,3, ź“c_“ń, “c’†šl, –Ř“cŒőL3 (1‹ž“s‘ć“ńÔ\Žš•a‰@, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3Á‰ťŠí“ŕ): ‘ć90‰ń“ú–{Á‰ťŠí“ŕŽ‹‹žŠw‰ď‘‰ď (JDDW 2015) (2015/10/10), “Œ‹ž, Gastroenterological Endoscopy 2015/9; 57 (suppl 2): 2164.

731007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘Šú‘ĺ’°Šŕ‚Ě“ŕŽ‹‹žf’f‚Ć“ŕŽ‹‹žŽĄ—Â̐i•ŕ. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): •˝Ź27”N“xŹ“cŒ´ˆăŽt‰ď‚Ş‚ńŒŸf‘‰ď (2015/9/3), Ź“cŒ´.

731012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) IBD‚Ě“ŕŽ‹‹žf’f|—މŽžŠł‚Ƃ̊ӕʐf’f‚âcolitic cancer‚̐f’f‚đŠÜ‚߂ā|. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć177‰ń‰Ą•lÁ‰ťŠí“ŕŽ‹‹žˆă‰ďW’k‰ď (2016/2/10), ‰Ą•l.

732008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) IBDf’f‚ĚŠî–{ƒAƒ‹ƒSƒŠƒYƒ€|—Տ°Œo‰ß‚Ć“ŕŽ‹‹žŒŸ¸‚ĚŠî–{‚đ“Ç‚Ý‰đ‚­|. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć44‰ńIBD Club JrŒ¤‹†‰ď (2015/6/6), “Œ‹ž.

H26”N“xˆČ‘O•Ş

[’˜@‘]

H26-620006. [Šwp‘ (•Ş’SŽˇ•M)]y‚ׂŠ‚炸W2015 Don'ts in Endoscopy (Á‰ťŠí“ŕŽ‹‹ž2ŒŽ‘‘ĺ†)zu‘ĺ’°v‚ׂŠ‚炸@EUS|5‚‚ׂ̂Š‚炸, p.270-1. Ź—ѐ´“T1,2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2015/2”­s.

H26-620007. [Šwp‘ (•Ş’SŽˇ•M)]y‘‚í‚Š‚č Á‰ťŠí“ŕŽ‹‹žŠÖ˜AƒKƒCƒhƒ‰ƒCƒ“‚Ě‚ˇ‚×‚Ä (Á‰ťŠí“ŕŽ‹‹ž3ŒŽ‘‘ĺ†)zŠe˜_ [Á‰ťŠÇ‘S”Ę‚É‹y‚Ô‚ŕ‚Ě]@ƒGƒrƒfƒ“ƒX‚ĆƒRƒ“ƒZƒ“ƒTƒX‚đ“‡‚ľ‚˝’×ᇐŤ‘ĺ’°‰Š‚̐f—ĂƒKƒCƒhƒ‰ƒCƒ“, p.486-9. Ź—ѐ´“T1,2, ‰ĄŽR@ŒO2, ˛“c”ü˜a2, Źň˜aŽO˜Y2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ), “Œ‹žˆăŠwŽĐ, “Œ‹ž, 2015/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H26-731001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ’×ᇐŤ‘ĺ’°‰ŠŽĄ—Ă‚ĚĹ‹ß‚Ě“ŽŒü‚Ɛf—ĂƒKƒCƒhƒ‰ƒCƒ“‰ü’ů‚ÉŒü‚Ż‚˝Žć‚č‘g‚Ý. Ź—ѐ´“T1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Á‰ťŠí“ŕ): ‘ć28‰ńěŒűÁ‰ťŠí•a§˜b‰ď (2015/2/12), ěŒű.


(‚ŽR—zŽq)

[Šwp˜_•ś]

110325. [Œ´’˜] Modified Hodge test using Mueller-Hinton agar supplemented with cloxacillin improves screening for carbapenemase-producing clinical isolates of Enterobacteriaceae. Takayama Y1,2, Adachi Y3, Nihonyanagi S2,3, Okamoto R4: J Med Microbiol 2015/7; 64 (7): 774-7. (‚ŽR—zŽq1,2, ˆŔ’B@÷3, “ń–{–öL2,3, ‰Ş–{—šˆę4: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Š´őŠÇ—Žş, 3—ŐŒŸ•”, 4”÷ś•¨)

522195. [uŔ]y“ÁW: ŹŽ™Š´őÇ2015|ŹŽ™Š´őÇ‚Ěƒ}ƒl[ƒWƒƒ“ƒg|zIII. ŹŽ™‚Ĺ’ˆÓ‚ˇ‚ׂŤ‘ϐŤ‹Ű@4. ƒƒ`ƒVƒŠƒ“‘ϐŤ‰ŠFƒuƒhƒE‹…‹Ű (MRSA). ‚ŽR—zŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ŹŽ™‰Č—Տ° 2015/12; 68 (12): 2610-6.

[Šw‰ďEŒ¤‹†‰ď“™]

7231025. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “–‰@‚É‚¨‚Ż‚éDaptomycin“Š—^—á‚ÉŠÖ‚ˇ‚éŒă‚ëŒü‚ŤÇ—áWĎŒ¤‹†. ‚ŽR—zŽq1, “ŕŽRŸ•ś2, ‘ĺěŒ´—TŽ÷3, ˜a“c’B•F4, “Ą–Ř‚­‚ÉŽq5, ’†‘şłŽ÷6, “ń–{–öL7, ťěŒc‰î5, ‰Ô–؏G–ž (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2ŽŠO, 3–ňÜ•”, 4äPŒ´•aEŠ´ő“ŕ, 5Š´őŠÇ—Žş, 6ˆă—ÉqśŠw•”, 7—ŐŒŸ•”): ‘ć89‰ń“ú–{Š´őÇŠw‰ďŠwpu‰‰‰ď (2015/4/17), ‹ž“s.

7231026. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) AIDS‚ɍ‡•š‚ľ‚˝Ramsay HuntÇŒóŒQ‚Ěˆę—á. ‚ŽR—zŽq1, ˜a“c’B•F2, Ž™‹Ę‰ŘŽq2, źŽ}@—C3, ‰iˆä—§•v2, “c’†Z–ž2, œA”¨rŹ2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2äPŒ´•aĽŠ´ő“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć29‰ń“ú–{ƒGƒCƒYŠw‰ďŠwpW‰ďE‘‰ď (2015/11/30), “Œ‹ž.


(ÂŽR’ź‘P)

[Šwp˜_•ś]

110326. [Œ´’˜] Clinical Characteristics of Patients on Hemodialysis With Peripheral Arterial Disease. Matsuzawa R, Aoyama N1, Yoshida A: Angiology 2015/11; 66 (10): 911-7. (ź‘ň—Ç‘ž, ÂŽR’ź‘P1, ‹g“c@ŕˆ: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

521031. [‰đŕ] ’ˇŠú‚É“œ”A•aœëŠł‚ľ‚Ä‚˘‚˝ŠłŽŇ‚Ş“Ë‘RŽ€‚ľ‚˝‚Ě‚ÍˆăŽt‚ސS“d}‚É—ŻˆÓ‚š‚¸, ‹•ŒŒŤSŽžŠł‚đ‹^‚í‚Č‚Š‚Á‚˝‚ß‚Ć‚ľ‚Ä‘šŠQ”…ž‚đ‹‚ß‚˝Ž–—á. ÂŽR’ź‘P (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ˆăŽ–”ť—á‰đŕ 2015/4; 55: 112-4.

521032. [‰đŕ] ”­”M‚Ćšq‹C‚đ‘i‚Ś‚銳ŽŇ‚ɒljÁŒŒ‰tŒŸ¸‚đs‚킸, dÇ‚Č‹}ŤS‹Ř‰Š‚Š‚犳ŽŇ‚đŽ€–S‚ł‚š‚˝‚Ć‚ľ‚Ä‘šŠQ”…ž‚đ‹‚ß‚˝Ž–—á. ÂŽR’ź‘P (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ˆă—Ă”ť—á‰đŕ 2015/12; 59: 11-5.

522196. [uŔ]y“ÁW: Çó•ĘEŽžŠł•Ę‚É‚Ý‚˝’ˆÓ‚đ—v‚ˇ‚éS“d}ŠŒŠz‹š’É: Œ€ÇŒ^S‹Ř‰Š. ÂŽR’ź‘P (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ŒÄ‹z‚ƏzŠÂ 2016/3; 64 (3): 235-41.

[’˜@‘]

620137. [Šwp‘ (•Ş’SŽˇ•M)]yV‚ľ‚˘zŠÂŠí•a‚ĚƒoƒCƒIƒ}[ƒJ[|—Տ°“IˆÓ‹`‚đ—‰đ‚ˇ‚é|(Heart View 2015”N11ŒŽ‘Š§†)z2. f—Ăƒc[ƒ‹‚Ć‚ľ‚Ä‚ĚƒoƒCƒIƒ}[ƒJ[‚đŽŻ‚é@d. ‹}ŤS•s‘S, p.39-43. ÂŽR’ź‘P (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), Šé‰ćE\Ź: •›“‡O•ś, Źě‹v—Y, ƒƒWƒJƒ‹ƒrƒ…[ŽĐ, “Œ‹ž, 2015/10”­s.


(•˝“cŒő”Ž)

[Šw‰ďEŒ¤‹†‰ď“™]

7231027. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ĺĂ–ŹŽčp‚Ć‚ť‚̍H•v ‰ş‘ĺĂ–ŹŽîᇐ؏œŽž‚ĚŒŒsŽŐ’f–@‚Ć‚ľ‚Ä‚Ě’PƒŽŐ’f–@‚Ě—L—pŤ. •˝“cŒő”Ž1, ”ü“‡—˜ş2, “c‘şK•ä2, ‘ĺ‹v•Ű”Ž˘2, ‹{’n@ŠÓ2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2S‘ŸŒŒŠÇŠO): ‘ć35‰ń“ú–{Ă–ŹŠw‰ď‘‰ď (2015/7-10-11), “Ţ—Ç, Ă–ŹŠw 2015/6; 26 (2): 131.

7231028. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚ɉ—‚Ż‚édÇ‹•ŒŒŽˆ‚ɑ΂ˇ‚éWŠw“IŽĄ—Â̐ŹŃ. •˝“cŒő”Ž1, ”ü“‡—˜ş2, ‘ĺ‹v•Ű”Ž˘2, “c‘şK•ä2, ‘ĺ—F—EŽ÷2, ‹ß“Ą@^2, “c’†—C‹M2, —F•Ű‹M”Ž2, ‹gˆä@„2, ’†‘ş—SŠó2, ™–{Wˆę2, •ó—ˆ“N–ç2, –k‘ş@—Ľ2, ’šˆäWŽO3, ‹{’n@ŠÓ2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2S‘ŸŒŒŠÇŠO, 3ˆă—Ă‹Zp‹łˆç): ‘ć46‰ń“ú–{S‘ŸŒŒŠÇŠO‰ČŠw‰ďŠwp‘‰ď (2016/2/15-17), –źŒĂ‰Ž.


(‰Ź–ě”üŒbŽq)

[Šwp˜_•ś]

110327. [Œ´’˜] Opinions of Japanese and American ALS caregivers regarding tracheostomy with invasive ventilation (TIV). Christodoulou G, Goetz R, Ogino M1, Mitsumoto H, Rabkin J: Amyotroph Lateral Scler Frontotemporal Degener 2015/8; 17 (1-2): 47-54. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110328. [Œ´’˜] Zonisamide improves wearing-off in Parkinson's disease: A randomized, double-blind study. Murata M, Hasegawa K, Kanazawa I, Fukasaka J, Kochi K, Shimazu R; Japan Zonisamide on PD Study Group (Ogino M1): Mov Disord 2015/9; 30 (10): 1343-50. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110329. [Œ´’˜] Cognitive impairment of Japanese multiple sclerosis patients: Follow-up study using BRB-N assessment tool. Yoshii F, Takagi S, Nagata E, Hasegawa Y, Kunika N, Maki F, Mochizuki H, Ogino M1, Kuroiwa Y: J Neurol Sci 2015/12; 359 (1-2): 323-7. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110330. [Œ´’˜] Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients. Nagata E, Ogino M1, Iwamoto K, Kitagawa Y, Iwasaki Y, Yoshii F, Ikeda JE: PLoS One 2016/2; 11 (2): e0149509. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

110331. [Œ´’˜] Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients. Nagata E1, Ogino M1,2, Iwamoto K1, Kitagawa Y1, Iwasaki Y1, Yoshii F1, Joh-E. Ikeda1 (1ALS Consortium Investigators): PLoS One 2016/3; 11 (3): e0152845. (‰Ź–ě”üŒbŽq1,2: 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

220011. [€Œ´’˜] ‘˝Ž€Žž‘ă‚ÉŒü‚Ż‚Ăǂ̂悤‚É”ő‚Ś‚é‚Ě‚Š. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _“ŢěŒ§ˆăŽt‰ď•ń 2016/1; 795: 12-4.

511002. [‰đŕ]yALS-UNTANGLEDzALSUntangled No. 27: Precision Stem Cell. Ogino M1,2 (1ALSUntangled Group): Amyotroph Lateral Scler Frontotemporal Degener 2015/5; 16 (3E4): 282-5. (‰Ź–ě”üŒbŽq1,2: 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

511003. [‰đŕ]yALS-UNTANGLEDzALSUntangled No. 28: Acupuncture. Ogino M1,2 (1ALSUntangled Group): Amyotroph Lateral Scler Frontotemporal Degener 2015/5; 16 (3E4): 286-9. (‰Ź–ě”üŒbŽq1,2: 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

511004. [‰đŕ]yALS-UNTANGLEDzALSUntangled No. 29: MitoQ. Ogino M1,2 (1ALSUntangled Group): Amyotroph Lateral Scler Frontotemporal Degener 2015/6; 16 (5E6): 427-9. (‰Ź–ě”üŒbŽq1,2: 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

522077. [uŔ]y“ÁW/ƒVƒ“ƒ|ƒWƒEƒ€: ALS‚ĆFTLD‚ĚŒ¤‹†EŽĄ—Ă‚ĚŒťÝ’n‚đ’m‚éz‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—ĂŠw 2015/5; 32 (3): 295-8.

522080. [uŔ]y“ÁW/‘Ű‰ťE‘n–ňŠÖ˜AƒVƒ“ƒ|ƒWƒEƒ€: _ŒoŽĄ—Ă‚Ěunmet medical needs|‚ť‚Ě‰đŒˆ–@‚đ’T‚éz2. ƒŒƒZƒvƒg‚Š‚猊‚˝’nˆć‚É‚ć‚é_ŒoŽžŠłŽĄ—Â̂΂ç‚‚Ť‚Ě•ŞÍ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—ĂŠw 2015/5; 32 (3): 400-3.

522081. [uŔ]y“ÁW/‘Ű‰ťE‘n–ňŠÖ˜AƒVƒ“ƒ|ƒWƒEƒ€: _ŒoŽĄ—Ă‚Ěunmet medical needs|‚ť‚Ě‰đŒˆ–@‚đ’T‚éz3-4. ŠeŽžŠł‚É‚¨‚Ż‚éV–ňł”FEŽĄ—Ă‚ĚŽŔî‚ƍĄŒă‚Ě“W–]: ‹ŘˆŢkŤ‘¤őd‰ťÇ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—ĂŠw 2015/5; 32 (3): 416-9.

522197. [uŔ]y‘ć32‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď“ÁW2: ƒVƒ“ƒ|ƒWƒEƒ€4@ALS‚ĆFTLD‚ĚŒ¤‹†EŽĄ—Ă‚ĚŒťÝ’n‚đ’m‚éz2. ‹ŘˆŢkŤ‘¤őd‰ťÇ‚ĚŒo‰ß‚É‚¨‚Ż‚é‘O“Ş‘¤“Ş—t•ĎŤÇ‡•š. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—ĂŠw 2015/5; 32 (3): 295-8.

522198. [uŔ]y˜AÚŠé‰ć: ALSˆă—ÁzALS‚É‚¨‚Ż‚éV–ňł”FEŽĄŒą‚ĚŒťó‚ƍĄŒă‚Ě“W–]. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•a‚ĆÝ‘îƒPƒA 2015/6; 21 (3): 50-1.

522199. [uŔ]y“ÁW: Œťó‚ĚŠÉ˜aƒPƒAz‘ć1•”: QOL‚ĚˆŰŽ‚đ–ÚŽw‚ľ‚˝ŠÉ˜aƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•a‚ĆÝ‘îƒPƒA 2015/8; 21 (8): 9-12.

522200. [uŔ]y“ÁW: _Œo“ď•a‚̏I––Šúˆă—Áz_Œo“ď•a‚̏I––Šúˆă—Ă. ‰Ź–ě”üŒbŽq1, ’JŒü@m, X@@Œ[ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): BRAIN and NERVE|_ŒoŒ¤‹†‚̐i•ŕ 2015/8; 67 (8): 983-92.

522201. [uŔ]y“ÁW: _Œo“ď•a‚̏I––Šúˆă—Áz_Œo“ď•aI––ŠúŠÉ˜aƒPƒA‚ĆÝ‘îˆă—Ă. ‰ĄŽR˜ał, ‰Ź–ě”üŒbŽq1, ÎŠ_‘בĽ, •ž•”MF (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): BRAIN and NERVE|_ŒoŒ¤‹†‚̐i•ŕ 2015/8; 67 (8): 1015-24.

522202. [uŔ]y“ÁW: ‚Ĺ‚Ť‚Ä‚˘‚Ü‚ˇ‚Š? ”ń‚Ş‚ńŽžŠł‚ĚŠÉ˜aƒPƒAzCase Study…E@‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS)`•ę‚Ć‚ľ‚Ä‚Ě–đŠ„‚đ‘S‚¤‚ľ‚˝‚˘ŠłŽŇ‚ĚƒP[ƒX. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Gƒm[ƒg 2015/10; 2 (5): 714-21.

522203. [uŔ]y“ÁW: _Œo“ď•az_Œo“ď•aƒlƒbƒgƒ[ƒN‚ĚŽŔŰ‚Ć‚ť‚Ě–â‘č“_@_Œo“ď•a‚ĚŠÉ˜aƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{Ý‘îˆăŠw‰ďŽGŽ 2016/2: 17 (2): 65-9.

522204. [uŔ]y“ÁW: ’°“ŕ×‹Ű‘p‚Š‚ç‚Ý‚˝—Տ°‚ĚĹ‘Oü|ƒx[ƒ‹‚đ’E‚˘‚ž‘Ě“ŕƒp[ƒgƒi[‚Ě‹@”\zŸ—Տ°Œťę‚É‚¨‚Ż‚é’°“ŕ×‹Ű Campylobavter jejuni’°‰Š‚ĆGuillain-BarrŽÇŒóŒQ@GBS‚̐f’f‚ĆŽĄ—Ă‚ĚŠTŕ, CJ‚ĚGBS‚Ć‚ĚŠÖ˜A‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): f’f‚ĆŽĄ—Ă 2016/2; :104 (2): 215-9.

522205. [uŔ] ˜_’d: _Œo“ď•a‚Ě—Ő°—Ď—. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): —Տ°—Ď— 2016/2; 4: 32-8.

522206. [uŔ]y“ÁW: ‚—îŽŇ‚É‚¨‚Ż‚é_Œo•ĎŤŽžŠłz‹ŘˆŢkŤ‘¤őd‰ťÇ‚ĚÝ‘î‰h—{—Ă–@‚ĆŒÄ‹zŠÇ—. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Geriatric Medicine 2016/3; 54 (3): 243-6.

530020. [‚ť‚Ě‘ź (´˜^)]yPoster Communications: Theme 1 Clinical ManagementzDID MORPHINE USAGE BECOME MORE POPULAR IN JAPAN? BASED ON THE FINDINGS FROM 2015 NATIONWIDE SURVEY. Ogino M1, Tominaga N2, Uchino A3, Takahashi K2, Nagashima K, Yanagita K, Ogino Y2: Amyotroph Lateral Scler Frontotemporal Degener 2015/10; 16 (suppl 1): 71. (‰Ź–ě”üŒbŽq1, •x‰i“Ţ•Ű”ü2, “ŕ–쏲Žq3, ‚‹´˜aš2, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

540063. [‚ť‚Ě‘ź] ƒ‚ƒ‹ƒqƒl‚ĹˆÓŽŻ•Ű‚ż‚Č‚Ş‚ç‹ę’ÉŒyŒ¸. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Medical Tribune 2015/5/14; p.14.

540064. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] “–’źˆă‚đ–éŠÔ‰f‚É. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‚—îŽŇZ‘îV•ˇ 2015/8/5; p.36.

540065. [‚ť‚Ě‘ź (ŽGŽ‹LŽ–)] ˆăŽt‚Ĺ‚ŕ‰Ć‘°‚Ĺ‚ŕ‚Č‚˘“Ź•a‚Ě”ş‘–ŽŇ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): AERA 2015/9/7; p.23.

540066. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ’nˆćˆă—Ï]Ž–ŽŇ‚ç@I––Šú‚đĄŒ€‚Ĺ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‚—îŽŇZ‘îV•ˇ 2015/9/23; p.14.

540067. [‚ť‚Ě‘ź]uĹŒă‚܂ł悢lś‚đ‚ß‚´‚ˇ‰ďE‘Š–ÍŒ´v‚ĚŠˆ“Ž‚Ć‚ť‚Ě”wŒi@ĹŒă‚đŒ}‚Ś‚él‚ŕ‚ť‚̉Ƒ°‚ŕK‚š‚Ĺ‚ ‚é‚˝‚ß‚É. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ƒAƒSƒ‰ 2016; 76 (t): 40-6.

540068. [‚ť‚Ě‘ź (Œ¤‹†‰ď‹L˜^W)] ’m. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ď•aŠłŽŇ‚Ö‚ĚŽx‰‡‘̐§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x_Œo“ď•aŠÉ˜aƒPƒAŒ¤CŒ¤‹†‰ď‹L˜^W 2016/3; p.38-9, p.55-86.

540069. [‚ť‚Ě‘ź (Œ¤‹†‰ď‹L˜^W)] ƒ‚ƒ‹ƒqƒl‚ĚŽg‚˘•ű. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ď•aŠłŽŇ‚Ö‚ĚŽx‰‡‘̐§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x_Œo“ď•aŠÉ˜aƒPƒAŒ¤CŒ¤‹†‰ď‹L˜^W 2016/3; p.188-97.

540070. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ď•aŠłŽŇ‚Ö‚ĚŽx‰‡‘̐§‚ÉŠÖ‚ˇ‚錤‹†vz“ď•aŠÉ˜aƒPƒA‚Ě•‹y, Œ[”­. ‰Ź–ě”üŒbŽq1, ”ˆäFˆë˜Y, ˆî—tˆęl, A’|“ú“Ţ, Ź“c—LŒá, “ď”g—ćŽq, ŽO‰Y–ő•F, ‰Ź–ě@—T2, –kŽR’Ę˜N, ™‰Y@^ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ď•aŠłŽŇ‚Ö‚ĚŽx‰‡‘̐§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź26”N“x`27”N“x‘‡Œ¤‹†•ń‘ 2016/3; p.92-6.

540071. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ď•aŠłŽŇ‚Ö‚ĚŽx‰‡‘̐§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“xz“ď•aŠÉ˜aƒPƒA‚Ě•‹y, Œ[”­. ‰Ź–ě”üŒbŽq1, ”ˆäFˆë˜Y, ˆî—tˆęl, A’|“ú“Ţ, Ź“c—LŒá, “ď”g—ćŽq, ŽO‰Y–ő•F, ‰Ź–ě@—T2, –kŽR’Ę˜N, ™‰Y@^ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ď•aŠłŽŇ‚Ö‚ĚŽx‰‡‘̐§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2016/3; p.115-8.

540072. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzƒrƒbƒJ[ƒXƒ^ƒbƒt”]Š˛”]‰Š‚Ě”F’čŠî€, —Տ°’˛¸ŒÂl•[‚ƍĄŒă‚̉ۑč. “í@@i, ’r“cCˆę, ŠC“cŒŤˆę, Š@—´™Z, _“c@—˛, ŒKŒ´@‘, ‰€ś‰ëO, ‘c•ƒ]Œł, ç—tŒú˜Y, ‰Ź–ě”üŒbŽq1, –ě‘ş‹ąˆę, ´…—DŽq, ŽđˆäNŹ, ź”öG“ż, ‰Ą“c—˛“ż, –ě‘ş–FŽq, •“Ą‘˝’Ă˜Y, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, źˆä@^ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2016/3; p.19-20.

540073. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzŽŠŒČ–ƉuŤ”]‰ŠE”]Ç. _“c@—˛, źˆä@^, ’r“cCˆę, ‰Ź–ě”üŒbŽq1, Š@—´™Z, ‹v•Ű“c—´“ń, ´…—DŽq, —é–Ř‘ĽG, źŕVł–L, –ě‘ş‹ąˆę, Œ´@Žő˜Y, ‰Ą“c—˛“ż, “n•Ó@C, Œ˘’ˁ@‹M, ’†‘ş—´•ś, –ě‘ş–FŽq, ŽR–ě‰Ă‹v, •Ä“c@˝, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2016/3; p.28-9.

540074. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzdÇ‹Ř–ł—ÍÇ‚Ěf’fŠî€‚̉ü’ů. ‹gěO–ž, ´…@, ‰Ź–ě”üŒbŽq1, Š@—´™Z, ´…—DŽq, —é–Ř‘ĽG, ’|“ŕ‰p”V, ‰€ś‰ëO, V–쐳–ž, –ě‘ş‹ąˆę, ŽđˆäNŹ, ź”öG“ż, –{‘ş­Ÿ, ěŒű’źŽ÷, ŒSŽR’B’j, –ě‘ş–FŽq, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, źˆä@^, —é–؏d–ž, Šâ˛˜a•v, âˆäŒ’“ń (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2016/3; p.30-4.

540075. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzƒ‰ƒ“ƒo[ƒgEƒC[ƒgƒ“‚̐f’fŠî€ô’č. ‹gěO–ž, ´…@, ‰Ź–ě”üŒbŽq1, Š@—´™Z, ´…—DŽq, —é–Ř‘ĽG, ’|“ŕ‰p”V, ‰€ś‰ëO, V–쐳–ž, –ě‘ş‹ąˆę, ŽđˆäNŹ, ź”öG“ż, –{‘ş­Ÿ, ěŒű’źŽ÷, ŒSŽR’B’j, –ě‘ş–FŽq, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, źˆä@^, —é–؏d–ž, Šâ˛˜a•v, âˆäŒ’“ń (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2016/3; p.35-7.

540076. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vz••“ü‘̋؉Šf’f‚É—p‚˘‚éŒú˜JČŠî€‚ĆEuropean Neuromuscular Center (ENMC) Šî€‚Ě”äŠrŒŸ“˘. ´…@, ‹gěO–ž, ‰Ź–ě”üŒbŽq1, Š@—´™Z, ´…—DŽq, —é–Ř‘ĽG, ’|“ŕ‰p”V, ‰€ś‰ëO, V–쐳–ž, –ě‘ş‹ąˆę, ŽđˆäNŹ, ź”öG“ż, –{‘ş­Ÿ, ěŒű’źŽ÷, ŒSŽR’B’j, –ě‘ş–FŽq, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, źˆä@^, —é–؏d–ž, Šâ˛˜a•v, âˆäŒ’“ń (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2016/3; p.68-9.

540077. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzƒŒƒZƒvƒgƒf[ƒ^‚Š‚ç‚Ý‚˝‘˝”­Ťd‰ťÇ‚ĚŽĄ—Ă“ŽŒüŒ¤‹†‚ɂ‚˘‚Ä ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź27”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2016/3; p.97-8.

[’˜@‘]

620138. [Šwp‘ (•Ş’SŽˇ•M)]yƒAƒNƒ`ƒ…ƒAƒ‹”]E_ŒoŽžŠł‚Ě—Ő°@‚ˇ‚ׂĂނ킊‚é_Œo“ď•aˆă—ÁzIV. _Œo“ď•a‚ĚŠĹŒěE‰îŒě@ŠÉ˜aƒPƒA‚ĆŠĹŽć‚č, p.145-52. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), ‘•ŇW: ’ҁ@ČŽŸ, ę–ĺ•ŇW: źŕVł–L, ’†ŽR‘“X, “Œ‹ž, 2015/5”­s.

620139. [Šwp‘ (•Ş’SŽˇ•M)] y–ƉuŤ_ŒoŽžŠł|Šî‘bE—Տ°Œ¤‹†‚̍ŐV’mŒŠ|(“ú–{—Ő଑Š§† (No.1085))zVII. “Á˜_@7. ˆă—ĂŒoĎŠw“IŽ‹“_‚Š‚ç‚Ý‚˝‘˝”­Ťd‰ťÇŽĄ—Ẩۑč, p.862-8. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), “ú–{—Ő଎Đ, ‘ĺă, 2015/9”­s.

620140. [Šwp‘ (•Ş’SŽˇ•M)]yÝ‘îˆă—ĂƒeƒLƒXƒg (‘ć3”Ĺ)z‘ć4Í ŽžŠł‚̐isŠú‚ĚˆăŠw“IŠÇ—@2. ‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS), p.1118-21. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), Šé‰ćE•ŇW: Ý‘îˆă—ĂƒeƒLƒXƒg•ŇWˆő‰ď, Ý‘îˆă—Ï•Ź —E”ü‹L”Oŕ’c, “Œ‹ž, 2015/11”­s.

620141. [Šwp‘ (•Ş’SŽˇ•M)]yÝ‘îˆă—ĂƒeƒLƒXƒg (‘ć3”Ĺ)z‘ć4Í ŽžŠł‚̐isŠú‚ĚˆăŠw“IŠÇ—@3. ƒp[ƒLƒ“ƒ\ƒ“•a, p.122-5. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), Šé‰ćE•ŇW: Ý‘îˆă—ĂƒeƒLƒXƒg•ŇWˆő‰ď, Ý‘îˆă—Ï•Ź —E”ü‹L”Oŕ’c, “Œ‹ž, 2015/11”­s.

620142. [Šwp‘ (•Ş’SŽˇ•M)]y“ď•aŽ–“TzĄ_Œo@‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS)@‘˝Œn“ˆŢkÇ (MSA): ƒVƒƒƒCEƒhƒŒ[ƒK[ÇŒóŒQ (SDS), p.43-4. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), Ó”C•ŇW: ”öčłˆę, ŠwŒ¤ƒƒfƒBƒJƒ‹GŽĐ, “Œ‹ž, 2015/12”­s.

620143. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚Ě—Ő°ƒTƒ|[ƒg (‰ü’ů‘ć2”Ĺ)z‹ŘˆŢkŤ‘¤őd‰ťÇ, https://clinicalsup.jp/contentlist/101.html. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), ‘‡•ŇWˆĎˆő: ‰iˆä—ÇŽO, •ŸˆäŽŸ–î, ă‘ş’źŽŔ, –Ř‘şŒ’“ń˜Y, ŒK“‡@ŠŢ, Ąˆä@–ő, “ˆ“c@Œł, ƒGƒ‹ƒ[ƒrƒAEƒWƒƒƒpƒ“, “Œ‹ž, 2015.

620144. [Šwp‘ (•Ş’SŽˇ•M)]y—Տ°_Œo“ŕ‰ČŠwzSection VI _Œo“ŕ‰ČŽĄ—Á@2. _Œo“ŕ‰Č“ÁŽęŽĄ—Á@5. “ď•a‚ĚŠÉ˜aˆă—Ă, p.896-902. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), ŠÄC: •˝ŽRŒbŽO, •Ň: œAŁŒš“ń˜Y, “c‘ă–M—Y, Š‹Œ´–ÎŽ÷, “ěŽR“°, “Œ‹ž, 2016/2”­s.

620145. [Šwp‘ (•Ş’SŽˇ•M)]y‰ü’ů”Ĺ _Œo“ď•aÝ‘î—Ă—{ƒnƒ“ƒhƒuƒbƒN|‚ć‚č‚悢ŠÉ˜aƒPƒA’ń‹Ÿ‚Ě‚˝‚߂Ɂ|z‘ć1Í ŠÉ˜aƒPƒA‚ĚŠT”O (_Œo“ŕ‰Č‚É‚¨‚Ż‚éŠÉ˜aƒPƒA‚Ě•K—vŤ), p.11-6. ‘ć2Í _Œo“ď•a‚̍’m‚Ć–Ę’k‚ĚŽd•ű (f’f–źEŒťó‚¨‚ć‚ŃŒŠ’Ę‚ľ‚đŠłŽŇ‚ł‚ń‚₲‰Ć‘°‚É“`‚Ś‚é), p.17-26. ‘ć4Í _Œo“ď•a‚É‚¨‚Ż‚é‹ę’ɏǏó‚Ć‚ť‚̑Ήž, p.71-98. ‰Ź–ě”üŒbŽq1, ‚‹´‹M”üŽq, “ď”g—ćŽq, Ź“c—LŒá, ‹´–{@Ži, •ˆä–ƒŽq, –îčˆę—Y, ‰Ş–{–ž‘ĺ, ™–{_Žq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •Ň: Ź“c—LŒá, ƒƒfƒBƒJƒ‹ƒŒƒrƒ…[ŽĐ, ‘ĺă, 2016/3”­s.

620146. [Šwp‘ (•Ş’SŽˇ•M)]yƒAƒNƒ`ƒ…ƒAƒ‹”]E_ŒoŽžŠł‚Ě—Ő°@–ƉuŤ_ŒoŽžŠł|•a‘Ô‚ĆŽĄ—Ă‚Ě‚ˇ‚ׂāz’´‚Šz‚ȖƉu—Ă–@‚Í‚í‚Ş‘‚Ěˆă—ĂŒoĎ‚đ”j’]‚ł‚š‚é‚Š, p.533-8. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), ‘•ŇW: ’ҁ@ČŽŸ, ę–ĺ•ŇW: ‹g—Ǐˆę, ’†ŽR‘“X, “Œ‹ž, 2016/3”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

713135. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) DID MORPHINE USAGE BECOME MORE POPULAR IN JAPAN? BASED ON THE FINDINGS FROM 2015 NATIONWIDE SURVEY. Ogino M1, Tominaga N2, Uchino A3, Takahashi K2, Nagashima K, Yanagita K, Ogino Y2: 26th ALS/MND international symposium 2015 (2015/12/11), Orlando, USA, Amyotroph Lateral Scler Frontotemporal Degener 2015; 16 (suppl 1): 71. (‰Ź–ě”üŒbŽq1, •x‰i“Ţ•Ű”ü2, “ŕ–쏲Žq3, ‚‹´˜aš2, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č)

722233. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‘˝Ž€Žž‘ă‚ÉŒü‚Ż‚Ăǂ̂悤‚É”ő‚Ś‚é‚Ě‚Š@’Œ…OŽ€śŠw (I––Šúˆă—Ă, ‘ŸŠíˆÚA, ŠÉ˜aˆă—Ă) Šé‰ć2@’´‚—îŽĐ‰ď‚É‚¨‚Ż‚éI––Šúˆă—Ă‚đl‚Ś‚é. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć29‰ń“ú–{ˆăŠw‰ď‘‰ď2015ŠÖź (2015/4/12), ‹ž“s, ‘ć29‰ń“ú–{ˆăŠw‰ď‘‰ď2015ŠÖź´˜^W 2015; p.172.

722234. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) _Œo“ď•aEALS‚ÉŽć‚č‘g‚Ţ‚Ć‚Ť I––Šú‚ĚŠÉ˜aƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć17‰ń“ú–{Ý‘îˆăŠw‰ď‚ŕ‚肨‚Š‘ĺ‰ď (2015/4/25), ˇ‰Ş, ‘ć17‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď´˜^W 2015; p.106.

722235. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ŽĐ‰ď‚Ě’†‚̐_ŒoŠwNS-04 “ď•aŠÉ˜aƒPƒA‚ĆŽŠŒČŒˆ’čŽx‰‡. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/21), VŠƒ, —Տ°_ŒoŠw2015; 55 (•Ęű): S28.

722236. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ‘źŠw‰ď‚Š‚çŠw‚Ô’j—‹¤“ŻŽQ‰ćS-3 “ú–{_ŒoŠw‰ďƒLƒƒƒŠƒAŒ`Ź‘ŁiˆĎˆő‰ď@3”NŠÔ‚Ě•ŕ‚Ý‚ĆĄŒă‚ĚŽć‚č‘g‚Ý. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/23), VŠƒ, —Տ°_ŒoŠw 2015; 55 (•Ęű): S111.

722237. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yŔ’ˇzę–ĺ—Ěˆć‚ĆŠÉ˜aƒPƒA‚ĚƒRƒ‰ƒ{ƒŒ[ƒVƒ‡ƒ“. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć20‰ń“ú–{ŠÉ˜aˆă—ĂŠw‰ďŠwp‘ĺ‰ď (2015/6/20), ‰Ą•l.

722238. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€)yƒVƒ“ƒ|ƒWƒEƒ€1: ’nˆć‚ĹŠĹŽć‚é…@@ŽžŠł‚É‚ć‚ézS1-3: _Œo“ď•a‚ĚÝ‘îŠĹŽć‚č‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć26‰ń“ú–{Ý‘îˆă—ĂŠw‰ďŠwpW‰ď (2015/7/19), “Œ‹ž, ‘ć26‰ń“ú–{Ý‘îˆă—ĂŠw‰ďŠwpW‰ď´˜^W 2015; p.62.

722239. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) ”ń‚Ş‚ń‚ĚŠÉ˜a‚ĚŒťó‚ƍĄŒă. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć26‰ń“ú–{Ý‘îˆă—ĂŠw‰ďŠwpW‰ď (2015/7/19), “Œ‹ž, ‘ć26‰ń“ú–{Ý‘îˆă—ĂŠw‰ďŠwpW‰ď´˜^W p.103-5.

722240. [Šw‰ď (‘S‘)] (ƒ[ƒNƒVƒ‡ƒbƒv) ƒŒƒZƒvƒgƒf[ƒ^‚đŠˆ—p‚ľ‚˝‰ä‚ލ‘‚Ě‘˝”­Ťd‰ťÇ‚ĚŽĄ—ĂŽŔ‘Ô‹y‚Ńˆă—ÔÍ. ‰Ź–ě”üŒbŽq1, ‰Í“ŕ@ň, ‘ĺ’|ˆę‰Ă, ‘ž“c_”V, ‘ĺ’Ë—TŽŸ˜Y, ŠâčG‰î, œA‹L‘  (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć27‰ń“ú–{_Œo–ƉuŠw‰ďŠwpW‰ď (2015/9/15), Šň•Œ, “ú–{_Œo–ƉuŠw‰ď‹@ŠÖŽ 2015; 20 (1): 86.

722241. [Šw‰ď (‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€Eľ‘ҍu‰‰“™) Šó­E“ŤŽžŠł@Žx‰‡‚Ö‚Ě˜AŒg‚Ć‘Îô‚ɂ‚˘‚Ä. ’†“c‹˝Žq, ŽR“c—˛Ži, —˘’†—˜Œb, •Ÿ‰iG•q, ‰Ź–ě”üŒbŽq1, ˆÉ“Ą‚˝‚Ä‚¨ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć3‰ń“ú–{“ď•aˆă—Ăƒlƒbƒgƒ[ƒNŠw‰ďŠwpW‰ď (2015/11/14), ĺ‘ä.

722242. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ƒ}ƒ‰ƒ\ƒ“ƒŒƒNƒ`ƒƒ[12: _ŒoŽžŠł‚Ö‚ĚŠÉ˜aƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć33‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2015/11/27), –źŒĂ‰Ž, _ŒoŽĄ—Ă 2015; 32 (5): 660.

722243. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ‹łˆçu‰‰8: _Œo“ď•aŠłŽŇ‚ĚŒö“IEŽĐ‰ďŽ‘ŒšŠˆ—p‚ĚŒťó‚Ć“W–]. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć33‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2015/11/27), –źŒĂ‰Ž, _ŒoŽĄ—Ă 2015; 32 (5): 643.

7231029. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Efficacy of steroid pulse therapy in multiple sclerosisi and neuromyelitis optica. Kira J, Yamazaki R, Matsusita T, Fukazawa T, Yokoyama K, Fujiwara K, ‰Ź–ě”üŒbŽq1, Yokota T, Miyamoto K, Niino M, Nomura K, Jaman Ms/Nmo Pulse Therapy Study Group (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć56‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2015/5/20), VŠƒ, ´˜^W p.413, —Տ°_ŒoŠw 2015; 55: S288.

7231030. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘˝EŽí‚Ĺ‹¤‚É‚¨‚ą‚Č‚¤ƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“Œ¤C‚Ě•K—vŤ@ALSŠłŽŇŒÄ‹z‹ę‘ˆŤŽž‚ĚƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“ŽŔŽ{ƒAƒ“ƒP[ƒg‚ĚŒ‹‰Ę‚Š‚ç. ‘şăŹ”ü, ŽR”¨‰Ŕ“Ä, ŽR˜eł‰i, ‰Ź–ě”üŒbŽq1, “n•ÓN‰î, _–ěŒN•v, “yˆäłŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć23‰ń“ú–{ƒzƒXƒsƒXEÝ‘îƒPƒAŒ¤‹†‰ď‘S‘‘ĺ‰ďin‰Ą•l (2015/8/29), ‰Ą•l, ƒzƒXƒsƒXƒPƒA‚ĆÝ‘îƒPƒA 2015/8; 23 (2): 215.

731186. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _Œo“ď•a‚ĚŠÉ˜aƒPƒA`ALS‚𒆐S‚Ɂ`. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć15‰ńź‹{ŠÉ˜aˆă—ĂŒ¤‹†‰ď (2015/8/8), •şŒÉ.

731187. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‘˝Ž€Žž‘ă‚É‚Ţ‚Ż‚Ăǂ̂悤‚É”ő‚Ś‚é‚Ě‚Š. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć57‰ń_“ސěˆăŠw‘‰ďEŠwp‘ĺ‰ď (2015/11/23), ‰Ą•l _“ŢěŒ§ˆăŽt‰ď•ń 2016/1; 795: 12-4.

732153. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Žs–ŻŒöŠJuŔ) •a‹C‚ސis‚ľ‚˝‚Ć‚Ť‚Ě‚˝‚ß‚É. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć24‰ńƒp[ƒLƒ“ƒ\ƒ“•aŒ’N‹łŽşin ‰ŞŽR (2015/4/11), ‰ŞŽR.

732154. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) 2025”N‚đŒŠ˜‚Ś‚˝C’nˆćƒj[ƒY‚ɉž‚Ś‚éˆă—Ă‹@”\•Ş‰ť‚Ćˆă—ÁE‰îŒě˜AŒg‚ĚŽŔ‘H. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): SSKƒZƒ~ƒi[ (2015/9/5), “Œ‹ž.

732155. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚É‚¨‚Ż‚é—Տ°—Ď—. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź27”N“x_ŒoE‹Ř“ď•aŠĹŒěƒGƒLƒXƒp[ƒgƒi[ƒXŒ¤C (2015/11/7), ’ˇč.

732156. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ALS‚ĚŠî‘b’mŽŻ‚ƑΉž‚ɂ‚˘‚ā`’m‚Š‚çI––Šú‚܂Ł`. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź27”N“xÝ‘î“ď•aŠłŽŇ•ŰŒ’•ŸŽƒ]Ž–ŽŇŒ¤C (2015/11/18), `–ě.

732157. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ĹŠú‚Ü‚Ĺ—Ç‚˘lś‚đ‚ß‚´‚ˇ‚ɂ́`•a‹C‚É‚Č‚Á‚Ä‚ŕQ‚Ä‚Č‚˘‚˝‚߂Ɂ`. ‰Ź–ě”üŒbŽq1, ‘ź (ĹŠú‚Ü‚Ĺ—Ç‚˘lś‚đ‚ß‚´‚ˇ‰ďE‘Š–ÍŒ´) (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć2‰ń’nˆćˆă—ÁE•ŸŽƒ‚ɂ‚˘‚Ä (2015/12/20), ‘Š–ÍŒ´.

732158. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ”ń‚Ş‚ń‚ĚŠÉ˜aƒPƒA`ALS‚𒆐S‚Ɂ`. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć3‰ń‚ ‚ť‚Šƒrƒn[ƒ‰ŠÉ˜aƒPƒAƒŒƒNƒ`ƒƒ[ (2016/1/22), ‹ž“s.

732159. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) “ď•aŽx‰‡, ’nˆć‚Ĺ‚Ĺ‚Ť‚é‚ą‚Ć‚đl‚Ś‚é`ALS‚ɂ‚˘‚ā`. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ’Ź“cŽs•ŰŒ’ŠE’Ź“cŽs–K–âŠĹŒěƒXƒe[ƒVƒ‡ƒ“˜A—‰ď‹¤Ă2015”N“x’Ź“cŽs•ŰŒ’Š“ď•au‰‰‰ď (2016/1/25), ’Ź“c.

732160. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a—Ă—{ŽŇ‚ĚŒÄ‹zŠÇ—EƒPƒA‚ĚŠî–{. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): –L“c“ŕ‰ČƒNƒŠƒjƒbƒNu‰‰‰ď (2016/1/29), ‘Š–ÍŒ´.

732161. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) I––Šú‚ĚˆÓŽvŒˆ’č. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘Š–ÍŒ´“ě•”Ž–‹ĆŽŇ˜A—‰ď (2016/2/17), ‘Š–ÍŒ´.

733387. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) “ď•aŠÉ˜aƒPƒA‚Ě•‹y, Œ[”­. ‰Ź–ě”üŒbŽq1, ”ˆäFˆë˜Y, ˆî—tˆęl, A’|“ú“Ţ, Ź“c—LŒá, “ď”g—ćŽq, ŽO‰Y–ő•F, ‰Ź–ě@—T2, –kŽR’Ę˜N, ™‰Y@^ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹Ć@“ď•aŠłŽŇ‚Ö‚ĚŽx‰‡‘̐§‚ÉŠÖ‚ˇ‚錤‹†@•˝Ź27”N“x”ljď‹c (2016/1/9), “Œ‹ž.

733388. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒrƒbƒJ[ƒXƒ^ƒbƒt”]Š˛”]‰Š‚Ě”F’čŠî€, —Տ°’˛¸ŒÂl•[‚ƍĄŒă‚̉ۑč. “í@@i, ’r“cCˆę, ŠC“cŒŤˆę, Š@—´™Z, _“c@—˛, ŒKŒ´@‘, ‰€ś‰ëO, ‘c•ƒ]Œł, ç—tŒú˜Y, ‰Ź–ě”üŒbŽq1, –ě‘ş‹ąˆę, ´…—DŽq, ŽđˆäNŹ, ź”öG“ż, ‰Ą“c—˛“ż, –ě‘ş–FŽq, •“Ą‘˝’Ă˜Y, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, źˆä@^ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠł (_Œo–ƉuŽžŠł) ­ô‚¨‚ć‚ŃŽŔ—p‰ťŒ¤‹†”ǁ@•˝Ź27”N“x‡“Ż”ljď‹c (2016/1/20), “Œ‹ž.

733389. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒ‰ƒ“ƒo[ƒgEƒC[ƒgƒ“‹Ř–ł—͏njóŒQ‚̐f’fŠî€ô’č. ‹gěO–ž, ´…@, ‰Ź–ě”üŒbŽq1, Š@—´™Z, ´…—DŽq, —é–Ř‘ĽG, Žŕ‘ş–žś, ‰€ś‰ëO, V–쐳–ž, –ě‘ş‹ąˆę, Œ´@Žő˜Y, ź”öG“ż, –{‘ş­Ÿ, ěŒű’źŽ÷, ŒSŽR’B’j, –ě‘ş–FŽq, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, Šâ˛˜a•v, —é–؏d–ž, ”¨’†—TŒČ, âˆäŒ’“ń, źˆä@^ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠł (_Œo–ƉuŽžŠł) ­ô‚¨‚ć‚ŃŽŔ—p‰ťŒ¤‹†”ǁ@•˝Ź27”N“x‡“Ż”ljď‹c (2016/1/20), “Œ‹ž.

733390. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ƒŒƒZƒvƒgƒf[ƒ^‚Š‚ç‚Ý‚˝‘˝”­Ťd‰ťÇ‚ĚŽĄ—Ă“ŽŒü. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠł (_Œo–ƉuŽžŠł) ­ô‚¨‚ć‚ŃŽŔ—p‰ťŒ¤‹†”ǁ@•˝Ź27”N“x‡“Ż”ljď‹c (2016/1/20), “Œ‹ž.

733391. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ŽŠŒČ–Ɖu‹@˜‚ލl‚Ś‚ç‚ę‚é”]‰ŠE”]Ç‘S‘’˛¸. _“c@—˛, źˆä@^, ’r“cCˆę, ‰Ź–ě”üŒbŽq1, Š@—´™Z, ‹v•Ű“c—´“ń, ´…—DŽq, —é–Ř‘ĽG, źŕVł–L, –ě‘ş‹ąˆę, Œ´@Žő˜Y, ‰Ą“c—˛“ż, “n粁@C, Œ˘’ˁ@‹M, ’†‘ş—´•ś, –ě‘ş–FŽq, ŽR–ě‰Ă‹v, •Ä“c@˝, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, “c’†ŒbŽq, ŒĂ‰ę“š–ž (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠł (_Œo–ƉuŽžŠł) ­ô‚¨‚ć‚ŃŽŔ—p‰ťŒ¤‹†”ǁ@•˝Ź27”N“x‡“Ż”ljď‹c (2016/1/20), “Œ‹ž.

733392. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) dÇ‹Ř–ł—ÍÇ‚Ěf’fŠî€‚̉ü’ů. ‹gěO–ž, ´…@, ‰Ź–ě”üŒbŽq1, Š@—´™Z, ´…—DŽq, —é–Ř‘ĽG, Žŕ‘ş–žś, ‰€ś‰ëO, V–쐳–ž, –ě‘ş‹ąˆę, Œ´@Žő˜Y, ź”öG“ż, –{‘ş­Ÿ, ěŒű’źŽ÷, ŒSŽR’B’j, –ě‘ş–FŽq, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, Šâ˛˜a•v, —é–؏d–ž, âˆäŒ’“ń, źˆä@^ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠł (_Œo–ƉuŽžŠł) ­ô‚¨‚ć‚ŃŽŔ—p‰ťŒ¤‹†”ǁ@•˝Ź27”N“x‡“Ż”ljď‹c (2016/1/20), “Œ‹ž.

733393. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰Eƒ|ƒXƒ^[) ••“ü‘̋؉Šf’f‚É—p‚˘‚éŒú˜JČŠî€‚ĆEuropean Neuromusclar Center (ENMC) Šî€‚Ě”äŠrŒŸ“˘. ´…@, ‹gěO–ž, ‰Ź–ě”üŒbŽq1, Š@—´™Z, ´…—DŽq, —é–Ř‘ĽG, Žŕ‘ş–žś, ‰€ś‰ëO, V–쐳–ž, –ě‘ş‹ąˆę, Œ´@Žő˜Y, ź”öG“ż, –{‘ş­Ÿ, ěŒű’źŽ÷, ŒSŽR’B’j, –ě‘ş–FŽq, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, Šâ˛˜a•v, —é–؏d–ž, âˆäŒ’“ń, źˆä@^ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠł (_Œo–ƉuŽžŠł) ­ô‚¨‚ć‚ŃŽŔ—p‰ťŒ¤‹†”ǁ@•˝Ź27”N“x‡“Ż”ljď‹c (2016/1/20), “Œ‹ž.

H26”N“xˆČ‘O•Ş

[Šwp˜_•ś]

H17-530001. [‚ť‚Ě‘ź (Proceeding)] The issues on the induction of invasive mechanical ventilation in Japanese ALS patients. Ogino M1, Ogino Y2, Kobayashi N, Sakai F: ALS and motor neuron disorders 2005; 6 (Suppl 1): 157. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H17-540001. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vz—ĂŒěŽ{Ý‚É‚¨‚Ż‚éALSŽó‚Ż“ü‚ę‚ĚŒťó|‘ć1•ń‚ą‚ę‚Ü‚Ĺ‚ĚŒoˆÜ|. ‰Ź–ě”üŒbŽq1, ŒĂŕV‰p–ž, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź17”N“x‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2006/3; p.34-7.

H17-540002. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzu_Œo“ď•a‚ĚƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“áŠQ‚ɑ΂ˇ‚鉇•Žč’ivƒŠƒXƒg‚̍쐬. ‰Ź–ě”üŒbŽq1, ’†ź_Ži, ’†ŠŰ‹I‹v”ü, g—с@Šó, ĄŠÖˆŸ—R”ü, ’|“ੰl (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź17”N“x‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2006/3; p.38-40.

H17-540003. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzALS‚ɑ΂ˇ‚éSNIP‚Ě—L—pŤ|‘ć1•ń|. ‰Ź–ě”üŒbŽq1, ăo’źl, •˝‰ę‚ć‚ľ‚Ý, —Rˆäi‘ž˜Y, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź17”N“x•Ş’SŒ¤‹†•ń‘ 2006/3; p.49-52.

H17-540004. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzALSI––Šú‚É‚¨‚Ż‚éŠÉ˜aƒPƒA‚ɂ‚˘‚ā|“–‰@‚É‚¨‚Ż‚éƒIƒsƒIƒCƒh“™‚ĚŽg—pŒoŒą|. ‰Ź–ě”üŒbŽq1, ”Ńƒ–’J”ü•ô2, —Rˆäi‘ž˜Y, ‰Ź–ě@—T2, âˆä•ś•F, “IęŒłO, ‘吟GŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź17”N“x•Ş’SŒ¤‹†•ń‘ 2006/3; p.82-5.

H17-540005. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†vzƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ‚Ě’ˇŠú—\Œă. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, “ü]KŽq, ‹ŕŕV’ź”ü3, âˆä•ś•F, Ä“Ą–L˜a (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ, 3•a‘ԁEf—ĂŒn): Œúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†v•˝Ź17”N“x‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2006/3; p.160-1.

H18-210001. [€Œ´’˜] The present status and problems eith upper extremity orthosis in patients with Amyotrophic Lateral Sclerosis. Imazaki A, Ogino M1, Ogino Y2, Kamide N, Asai N. Sakai F: ALS and motor neuron disorders 2006; 7 (suppl 1): 74-5. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H18-522002. [uŔ] ƒhƒLƒ…ƒƒ“ƒg: NP“IlHŒÄ‹z—Ă–@‚đ‘I‘đ‚ľ‚Č‚˘ALSŠłŽŇ‚ł‚ń‚ĚŠÉ˜aƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•a‚ĆÝ‘îƒPƒA 2006/12; 12 (9): 23-6.

H18-530001. [´˜^ (Proceeding)] Long-term prognosis of Guillain-Barre syndrome. Ogino M1, Ogino Y2, Irie S, Kanazawa N, Saito T, Sakai F: J Neuroimmunology 2006; 178 (Suppl 1): 222. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H18-530002. [´˜^ (Proceeding)] The present status and problems eith upper extremity orthosis in patients with Amyotrophic Lateral Sclerosis. Imazaki A, Ogino M1, Ogino Y2, Kamide N, Asai N, Sakai F: ALS and motor neuron disorders 2006; 7 (Suppl 1): 74-5. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H18-530003. [´˜^ (Proceeding)] Usefulness of Sniff Nasal Inspiratory Pressure (SNIP) for Japanese Patients with ALS. Kamide N, Ogino M1, Ogino Y2, Fukuda M, Sumida S, Hiraga Y, Sakai F: ALS and motor neuron disorders 2006; 7 (Suppl 1): 83. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H18-540001. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzNPPVĹV‚Ě‹@Ží”äŠr. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, âˆä•ś•F, ‰ZśLˆę (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź18”N“x‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2007/3; p.47-50.

H18-540002. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vz_Œo“ď•a‚É‚¨‚Ż‚鎊—§Žx‰‡–@“ą“üŒă‚ĚŒťó‚Ɖۑč‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, ăžŠáÁŽq, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź18”N“x‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2007/3; p.51-3.

H18-540003. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzNIPPV‚Ě‹@Ží”äŠr‚ĆƒCƒ“ƒ^[ƒtƒFƒCƒX. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź18”N“x•Ş’SŒ¤‹†•ń‘ 2007/3; p.97-101.

H18-540004. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzALS/MND‚É‚¨‚Ż‚éRTX (‘ĚŠOŽŽlHŒÄ‹zŠí) ‚Ě—L—pŤ|‘ć1•ń|. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź18”N“x•Ş’SŒ¤‹†•ń‘ 2007/3; p.102-3.

H18-540005. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzALS‚É‚¨‚Ż‚éSniff Nasal Inspiratory Pressure‚Ě—L—pŤ|‘ć2•ń|. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź18”N“x•Ş’SŒ¤‹†•ń‘ 2007/3; p.104-7.

H18-540006. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†vzGBS‚É‚¨‚Ż‚éCD1ˆâ“`Žq‘˝Œ^. ‰Ź–ě”üŒbŽq1, ‹ŕŕV’ź”ü2, “ü]KŽq, ‰Ź–ě@—T3, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2•a‘ԁEf—ĂŒn, 3_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†v•˝Ź18”N“x‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2007/3; p.160-1.

H19-120001. [Œ´’˜] ‰îŒě•ŰŒŻƒT[ƒrƒX—˜—pó‹ľ‚މîŒě•‰’SŠ´‚É—^‚Ś‚é‰e‹ż‚ĚŒŸ“˘. –ěŠÔ‹M—Y, ˛“ĄŽu–ě, ‰Ź–ě”üŒbŽq1, ăo’źl2, •Ÿ“c—Ď–ç2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2ˆă—ÉqśŠw•”): –k—˘—Šw—Ă–@Šw 2008/3; 11: 109-12.

H19-120002. [Œ´’˜] sniff nasal inspiratory pressure‚Ě‘Ă“–Ť‚ĚŒŸ“˘‚Ć“ú–{l‚É‚¨‚Ż‚é—\‘ŞŽŽ‚̍쐬|ALSŠłŽŇ‚ɑ΂ˇ‚éV‚ľ‚˘ŒÄ‹z‹@”\•]‰ż–@‚ĚŠm—§‚É‚Ţ‚Ż‚ā|. ŽR‰Č“TŽq, Źo‚Š‚‚ç, ˛“ĄŽO“ŢŠó, ‰Ź–ě”üŒbŽq1, ăo’źl2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2ˆă—ÉqśŠw•”): –k—˘—Šw—Ă–@Šw 2008/3; 11: 133-6.

H19-530001. [‚ť‚Ě‘ź (Proceeding)] Myocardial [(123)I] metaiodobenzylguanidine is preserved uptake in hereditary Parkinson's disease with LRRK2 I2020T mutation (HPD Sagamihara family). Ogino Y1, Ogino M2, Ujiie S, Sakai F: Movement Disorders 2007; 22 (suppl 16): S241. (‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H19-530002. [´˜^ (Proceeding)] Assessment of Sniff Nasal Inspiratory Pressure (SNIP) is useful in prediction of prognosis in Japan. Ogino M1, Kamide N, Sumida S, Ogino Y2, Hiraga Y, Kasuga M, Fukuda M, Yamazaki T, Kitamura E, Sakai F: Amyotroph Lateral Scler 2007; 8 (Supl 1): 81. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H19-540001. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzALS‚ĚÝ‘î‚Ý‚Ć‚č‚Ö‚ĚŽć‚č‘g‚Ý. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, ’r“cŠxŽi, ALSƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒ`[ƒ€, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź19”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2008/3; p.88-91.

H19-540002. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vz_Œo“ď•a‚É‚¨‚Ż‚éƒp[ƒJƒbƒVƒ‡ƒlƒA‚Ě—L—pŤ. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, ‰ZśLˆę, ALSƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒ`[ƒ€, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź19”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2008/3; 80-1.

H19-540003. [‚ť‚Ě‘ź (Œ¤‹†•ń‘“™)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzNPPV‚Ě‹@Ší‚ĆƒCƒ“ƒ^[ƒtƒFƒCƒX. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź19”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2008/3; p.82-4.

H20-220001. [€Œ´’˜] _Œo“ŕ‰ČŽĄ—Ă‚Ć—Ď—“I”z—ś. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—Ă 2008; 25: 669-73.

H20-220002. [€Œ´’˜] ƒpƒlƒ‹ƒfƒBƒXƒJƒbƒVƒ‡ƒ“‚ĚŽi‰ď‚đI‚Ś‚Ä. _’Á@m, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—Ă 2008; 25: 717-8.

H20-522001. [uŔ]y“ÁW: lHŒÄ‹z—Ă–@‚Š‚ç”­ś‚ˇ‚é•žŠQ‚̑Ήžô [‘ć1•”]zÝ‘îlHŒÄ‹z—Ă–@‚É‚¨‚Ż‚閝ŤŒÄ‹zŠíŠ´őÇ‚̍R‹Ű—Ă–@. ‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2 (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•a‚ĆÝ‘îƒPƒA 2008/10; 14 (7): 9-11.

H20-530001. [‚ť‚Ě‘ź (Proceeding)] Giving the diagnosis of ALS and patient's choice in Japan. Ogino M1, Ogino Y2, Sakai F: Amyotroph Lateral Scler 2008; 9 (Supl 1): 13. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H20-530002. [‚ť‚Ě‘ź (Proceeding)] Effectiveness of monitoring sniff nasal inspiratory pressure (SNIP) and trans cutaneous PCO2 to foresee prognosis of patients with ALS. Ogino Y1, Ogino M2, Kamide N, Sumida S, Sakai F: Amyotroph Lateral Scler 2008; 9 (Supl 1): 141. (‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H20-540001. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†vzƒMƒ‰ƒ“ĽƒoƒŒ[ÇŒóŒQ RƒKƒ“ƒOƒŠƒIƒVƒhR‘Ě—zŤ‹}Ť‰ŠÇŤƒjƒ…[ƒƒpƒ`[‚É‚¨‚Ż‚éR‘Ě‚Ě’ˇŠúŒo‰ß. ‰Ź–ě”üŒbŽq1, “ü]KŽq, ‹ŕŕV’ź”ü2, ŕ_“cˆę3, âˆä•ś•F, ‰Ź–ě@—T3 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2Œ`‘ԁEf—ĂŒn, 3_Œo“ŕ): Œúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†v•˝Ź20”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2009/3; p.149-51.

H20-540002. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)] yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vz_“ސě_Œo“ď•aƒlƒbƒgƒ[ƒNŽn“Ž‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, âˆä•ś•F, ‹gˆä•ś‹Ď, •Šâ‹`”V (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2009/3; p.49-50.

H20-540003. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzƒI[ƒfƒBƒbƒg’˛¸‚É‚ć‚éALSˆă—Ă‚Ě‘Ű”äŠrŒ¤‹† ’†“‡@F, ˆÉ“Ą”Ž–ž, OLIVER David, OLIVER David, “ď”g—ćŽq, ‰Ź–ě”üŒbŽq1, “Ąˆä’źŽ÷, M‘Œ\Œá, –xě—g, ŒF–{rG, ”üŒ´@”Ő, ěˆä@[, ‹{•‘Žq, •Ÿ‰iGr, ‰€“cŽŠl, CAMPBELL Colin, SLOAN Richard, SYKES Nigel, TALLON Carole, WEBB Sandi, ALBERT Steven (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2009/3; p.89-95.

H20-540004. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†vz“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2009/3; p.11-56.

H20-540005. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzÝ‘ƒ‹ƒqƒlŽg—p‚Ě–â‘č“_. ‰Ź–ě”üŒbŽq1, âˆä•ś•F, •Î”NO (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2009/3; p.42-3.

H20-540006. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vz–k—˘ę–ĺŠĹŒěŽtu“ď•aŠĹŒěvˆçŹƒvƒƒOƒ‰ƒ€‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, âˆä•ś•F, ‘Oě‹ąŽq, ‹gŒ´çŒb, ‘ĺ’J—ćŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2009/3; 44-6.

H21-522001. [uŔ]y“ÁW: “ď•aŠłŽŇ‚Ě‚˝‚ß‚ĚƒAƒCƒfƒAW [‘ć1•”]zŠłŽŇŽŠg‚É‚ć‚é—Ă—{‚ĚƒAƒCƒfƒA‚̐”X. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•a‚ĆÝ‘îƒPƒA 2009/8; 15 (5): 7-12.

H21-522002. [uŔ]ylHŒÄ‹z—Ă–@z”ńNP“IlHŒÄ‹zŠí‚̍ŐV‚Ě‹@Ží”äŠr. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•a‚ĆÝ‘îƒPƒA 2009/11; 15 (8): 29-32.

H21-522003. [uŔ]y“ÁW: ‹}ŤŽŠ—ĽŤŠ´ŠoŤƒjƒ…[ƒƒpƒ`[z‹}ŤŽŠ—ĽŤŠ´ŠoŤƒjƒ…[ƒƒpƒ`[‚ĚŒo‰ß—\Œă. ‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2 (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ŒŽŠ§_Œo“ŕ‰Č 2009/12; 71 (6): 589-93.

H21-522004. [uŔ]y˜AÚ: ALSŠłŽŇ‚ĚÝ‘îˆă—ÁzŒÄ‹zŠÇ—@…AÝ‘îlHŒÄ‹zŠí‚ɂ‚˘‚Ä. ‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2 (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): J Clin Rehabil 2010/2; 19 (2): 177-82.

H21-530001. [‚ť‚Ě‘ź (Proceeding)] The survey report of the ALS physicians in Japan. Ogino M1, Ogino Y2, Hamada J2: Amyotroph Lateral Scler 2009; 10 (suppl 1): 48. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, ŕ_“cˆę2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H21-530002. [‚ť‚Ě‘ź (Proceeding)] A Therapeutic agent (NDDPX08) Delays disease progression, improves motor function and prolongs survival in a mouse model of ALS. Tanaka K, Kanno T, Yanagisawa Y, Aoki M, Hadano S, Itoyama Y, Ogino M1, Iwasaki Y, Yoshii F, Ikeda J-E: Amyotroph Lateral Scler 2009; 10 (suppl 1): 75. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H21-530003. [‚ť‚Ě‘ź (Proceeding)] The study of NIPPV using full-face mask remodeled to support endoscope in per-endoscopic gastrostomy in ALS patients. Ogino Y1, Yabuki S, Ogino M2: Amyotroph Lateral Scler 2009; 10 (suppl 1): 188. (‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H21-540001. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzƒp[ƒJƒbƒVƒ‡ƒlƒA“ą“ü‚ĚƒAƒZƒXƒƒ“ƒg. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷, Šâč‹¤, ‰ZśLˆę (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź21”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2010/3; p.47-50.

H21-540002. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzƒXƒRƒ|ƒ‰ƒ~ƒ““îp‚Ě—L—pŤ‚ĚŒ¤‹†. ‰Ź–ě”üŒbŽq1, ‹{ěšD, –]ŒŽGŽ÷, ‘O“cŽŔ‰Ô, •ě­ˆę (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź21”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2010/3; p.49-50.

H21-540003. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzALS‚ĆŒűoƒPƒA: NPPV‘•’…ŠłŽŇ‚Ě•a“ŒűoƒPƒA‚̐ŹŒ÷—á‚Ć‘ŠúŽ•‰Č‰î“ü‚Ě•K—vŤ‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷, ˛“Ą‚Ý‚ł‚đ, “n糍WG, ‘ĺę@ƒ, ˛–ě‚ ‚ä‚Ý, –Ř‘ş—F”ü (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź21”N“x‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2010/3; p.46-8.

H21-540004. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†vzƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ: ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒXŠ´ő‚ĆGBS. ‰Ź–ě”üŒbŽq1, “ü]KŽq, ‹ŕŕV’ź”ü2, –]ŒŽGŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2•a‘ԁEf—ĂŒn): Œúś˜J“­Č“Á’莞Šł‘΍ôŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†v•˝Ź21”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2010/3; p.139-42.

H22-120002. [Œ´’˜] ˆŢkŤ‘¤őd‰ťÇŠłŽŇ‚É‚¨‚Ż‚éŒg‘ŃŒ^—A‰tƒ|ƒ“ƒv‚đ—p‚˘‚˝Ý‘î‚Ĺ‚Ěmorphine hydrochlorideŽ‘ą”牺’‚ɂ‚˘‚Ä. –k‘ş‰p“ń1, ‰Ź–ě”üŒbŽq2, ŕ_“cˆę1, –]ŒŽGŽ÷, “y”ě’źŽ÷ (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‹Ř_ŒoŽĄ—ĂŠw 2011/3; 28 (2): 163-6.

H22-220001. [€Œ´’˜] ”ń‚Ş‚ńŽžŠł‚ɍݑîŠÉ˜aƒPƒA‚ĚŒő‚đ! _Œo“ď•a (“Á‚ÉALS) ‚ĚŠÉ˜aƒPƒA‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{Ý‘îˆăŠw‰ďŽGŽ 2010; 12: 56-7.

H22-220002. [€Œ´’˜] _Œo“ŕ‰Č—Ěˆć‚É‚¨‚Ż‚éI––Šú‚Ě—Ď—“I–â‘č‚ɂ‚˘‚Ä ALSI––ŠúƒPƒA‚ÉŠÖ‚ˇ‚éƒAƒ“ƒP[ƒg’˛¸Œ‹‰Ę. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): —Տ°_Œo 2010; 50: 1026-8.

H22-220003. [€Œ´’˜] _Œo“ď•a‚ĆŠÉ˜aˆă—ÁEI––Šúˆă—Á|ƒIƒsƒIƒCƒhEƒ‚ƒ‹ƒqƒl‚ĚŽg—p‚𒆐S‚É. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—ĂŠw 2011/1; 28 (1): 25-8.

H22-522001. [uŔ] ƒgƒsƒbƒNƒjƒ…[ƒX: ƒJƒtƒAƒVƒXƒg‚Ě•ŰŒŻ“K‰ž‚Ć“ą“üŽžŠú. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•a‚ĆÝ‘îƒPƒA 2010/6; 16 (3): 4-6.

H22-522002. [uŔ]y“ÁW: ’ˇŠúlHŒÄ‹zŠÇ—‚ĚƒmƒEƒnƒE [‘ć3•”]zŒÄ‹z‹@”\•]‰ż‚¨‚ć‚ŃNPPV“ą“ü‚ĚŽŔŰ. …–ěŒö•ă, •˝‰ę‚ć‚ľ‚Ý, ăo’źl, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•a‚ĆÝ‘îƒPƒA 2010/11; 16 (8): 19-22.

H22-522003. [uŔ]y“ÁW: Ň’ŐҐ‘ŽžŠł‚Ɖ^“Žƒjƒ…[ƒƒ“ŽžŠł‚̊ӕʁzBrachial amyotrophic diplegiačň’ĹÇ‚Ć‚ĚŠÖ˜AŤ. ‘ęŽR—eŽq1, ‰Ź–ě”üŒbŽq2 (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Ň’ŐҐ‘ƒWƒƒ[ƒiƒ‹ 2010/12; 23 (12): 1091-5.

H22-522004. [uŔ]y“ÁWII: _Œo“ŕ‰Č—Ěˆć‚É‚¨‚Ż‚éI––Šú‚Ě—Ď—“I–â‘čzALSI––ŠúƒPƒA‚ÉŠÖ‚ˇ‚éƒAƒ“ƒP[ƒg’˛¸Œ‹‰Ę. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ŒŽŠ§_Œo“ŕ‰Č 2011/2; 74 (2): 170-5.

H22-530001. [‚ť‚Ě‘ź (Proceeding)] Possession of assistive devices among persons with amyotrophic lateral sclerosis. Otera A, Takahashi K, Ogino M1, Fukuda M: Amyotroph Lateral Scler 2010; 11 (suppl 1): 133. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H22-530002. [‚ť‚Ě‘ź (Proceeding)] ALS patients on mechanical ventilation have greater risk of cholecystitis. Ogino M1, Kitamura E, Ogino Y2, Mochizuki H: Amyotroph Lateral Scler 2010; 11 (suppl 1): 155-6. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H22-540001. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vzˆă—Ô‚ç‚Ý‚˝“ď•a. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vƒ[ƒNƒVƒ‡ƒbƒv‹L˜^W(u“ď•av‚Ć‚Í?`—đŽj, ’č‹`, ‘Ű”äŠr`) 2011/3; p.37-44.

H22-540002. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†vz“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź21”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ (Žĺ”CŒ¤‹†ŽŇ) 2011/3; p.11-49.

H22-540003. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzALSƒ`[ƒ€ˆă—Ă‚É‚¨‚Ż‚éî•ń‹¤—L‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2011/3; p.53-5.

H22-540004. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzƒI[ƒgƒXƒpƒCƒAS-507‚đ—p‚˘‚˝Sniff Nasal Inspiratory Pressure (SNIP) ‘Ş’č‚Ě—L—pŤ. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷, …–ěŒö•ă, •˝‰ę‚ć‚ľ‚Ý, t“ú”ü•Ű, “Ą‹´‹Is, ‹{é‚ľ‚Ů, Ź–쎛ˆŸ–í, ăo’źl, •Ÿ“c—Ď–ç (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2011/3; p.p.56-8.

H22-540005. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzALSŠłŽŇ‚̏I––ŠúƒPƒA|NPPV’ˇŠúŽg—pŠłŽŇ‚ĚƒPƒA‚Ĺ’ź–Ę‚ˇ‚é–â‘č‚Š‚ç|. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷, ěă@—B, ‘ĺ’J—ćŽq, ‘Oě‹ąŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2011/3; p.59-61.

H22-540006. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vzŽ‹ü“ü—͈ӎv“`’B‘•’u‚đ—p‚˘‚˝•śŽš“ü—Í‚ÉŠÖ‚ˇ‚錟“˘. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷, ‘Oę—m—C, ’|“ੰl, ‘厛ˆŸ—R”ü, ‚‹´‘ăŽq, ’†ź_Ži, •Ÿ“c—Ď–ç (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2011/3; p.62-3.

H22-540007. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vz‹ŘˆŢkŤ‘¤őd‰ťÇŠłŽŇ‚É‚¨‚Ż‚é‰h—{áŠQ‚ĚŒă•űŽ‹“IŒ¤‹†-‘˝Ž{Ý‹¤“ŻŒ¤‹†-. ´…r•v, ’ˇ‰ŞŽŽq, ě“c–žL, “B–{çt, •Šâ‹`”V, ěˆä[, ‰ş”¨‹—Ç, źŕVł–L, ”üŒ´@”Ő, r”¨@‘n, “Ąˆä’źŽ÷, “ď”g—ćŽq, ˆÉ“Ą”Ž–ž, ĄˆäŽŽu, ‹ß“Ą´•F, ‰Ź–ě”üŒbŽq1, Mš Œ\Œá, ’†“‡@F, ŹX“N•v (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x ‘Š‡Ľ•Ş’SŒ¤‹†•ń‘ 2011/3; p.174-6.

H22-540008. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†vz“ŤŽžŠł‚É‚¨‚Ż‚éŒÄ‹zƒPƒACI––ŠúƒPƒACƒ`[ƒ€ˆă—Ă“™‚ĚŒ¤‹†. ‰Ź–ě”üŒbŽq1, ‹{ěšD, âˆä•ś•F, –]ŒŽGŽ÷, Šâč‹¤, ‰ZśLˆę, ăđáÁŽq, ŒĂěŠě”ü, •Î”NO, ‘Oě‹ąŽq, ‹gŒ´çŒb, ‘ĺ’J—ćŽq, ěă@—B, ‘O“cŽŔ‰Ô, •ě­ˆę, …–ěŒö•ă, •˝‰ę‚ć‚ľ‚Ý, t“ú”ü•Ű, “Ą‹´‹Is, ‹{é‚ľ‚Ů, Ź–쎛ˆŸ–í, ‘Oę—m—C, ’|“ੰl, ‘厛ˆŸ—R”ü, ‚‹´‘ăŽq, ’†ź_Ži, ăo’źl, •Ÿ“c—Ď–ç, –k—˘‘ĺŠw“Œ•a‰@ALSƒ`[ƒ€ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life,QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20-22”N“x ‘‡Œ¤‹†•ń‘ 2011/3; p.49-56.


H22-540009. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†vz‘Š‡Œ¤‹†•ń. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x`22”N“x‘‡Œ¤‹†•ń‘ 2011/3; p.7-42.

H22-540010. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†vz‘Š‡Œ¤‹†•ń. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2011/3; p.11-25.

H22-540011. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†vzƒŒƒZƒvƒgƒf[ƒ^‚đŠî‚É‚ľ‚˝•ŞÍ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘•Ęű 2011/3; p.1-651.

H22-540012. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vz‹ŘˆŢkŤ‘¤őd‰ťÇŠłŽŇ‚ĚˆÓŒü‚Ě‘¸d‚ĆƒPƒA (Ž–‘OŽwŽŚ) ‚ÉŠÖ‚ˇ‚錟“˘’†ŠÔ•ń‘. ”ˆäFˆë˜Y, ˆÉ“Ą”Ž–ž, ˆÉ“Ą“šĆ, ˆî—tˆęl, ĄˆäŽŽu, ‘ĺ‹÷‰xŽq, ‰Ź–ě”üŒbŽq1, ’†“‡@F, “ď”g—ćŽq (Ž–‘OŽwŽŚŒŸ“˘ƒ[ƒLƒ“ƒOƒOƒ‹[ƒv) (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v2011/3; p.6-46.

H22-540013. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzŽŠ•E‹¤•EŒö•‚đi‚ß‚é‚˝‚ß‚É. ‰Ź–ě”üŒbŽq1, –k—˘‘ĺŠw“Œ•a‰@ALSƒ`[ƒ€, ‰Ź–ě@—T2, ŕ_“cˆę2, ˛“Ą‚Ý‚ł‚đ, “n糍WG, ‘ĺę@ƒ, ˛–ě‚ ‚ä‚Ý, –Ř‘ş—F”ü, á–{—R”ü, ˆŔ“cŘ•ä, ‹gŕVŒ’‘ž˜Y, `@ŽáŘ, •Ÿ“c—Ď–ç, ł˜Ň@—˛, ‹gˆä•ś‹Ď, •Šâ‹`”V, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20-22”N“x•Ş’SŒ¤‹†•ń‘ 2011/3; p.57-63.

H22-540014. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzTPPVŽg—p’†‚ĚALSŠłŽŇ‚É‚¨‚Ż‚éƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“•ű–@EŰHó‹ľ (Œťó•ń). ‰Ź–ě”üŒbŽq1, á–{—R”ü, `@ŽáŘ, ł˜Ň@—˛, •Ÿ“c—Ď–ç, –]ŒŽGŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x•Ş’SŒ¤‹†•ń‘ 2011/3; p.62-3.

H22-540015. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vz‹ŘˆŢkŤ‘¤őd‰ťÇ“™_Œo“ď•aŠłŽŇ‚đ’S“–‚ˇ‚é_Œo“ŕ‰ČˆăŽt“™‚ɑ΂ˇ‚鎖‘OŽwŽŚ‚ÉŠÖ‚ˇ‚é’˛¸. ˆÉ“Ą“šĆ, ”ˆäFˆë˜Y, ˆÉ“Ą”Ž–ž, ˆî—tˆęl, ĄˆäŽŽu, ‘ĺ‹÷‰xŽq, ‰Ź–ě”üŒbŽq1, ’†“‡@F, “ď”g—ćŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20-22”N“x‘‡Œ¤‹†•ń‘ 2011/3; 46-53.

H22-540016. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vz‹ŘˆŢkŤ‘¤őd‰ťÇ“™_Œo“ď•aŠłŽŇ‚đ’S“–‚ˇ‚é_Œo“ŕ‰ČˆăŽt“™‚ɑ΂ˇ‚鎖‘OŽwŽŚ‚ÉŠÖ‚ˇ‚é’˛¸ (2)@ˆăŽt‘ÎŰ’˛¸‚ɂ݂鎖‘OŽwŽŚ‚Ě–â‘č“_|‰Ű‘č‚Ć‰đŒˆô|. ˆÉ“Ą“šĆ, ”ˆäFˆë˜Y, ˆÉ“Ą”Ž–ž, ˆî—tˆęl, ĄˆäŽŽu, ‘ĺ‹÷‰xŽq, ‰Ź–ě”üŒbŽq1, ’†“‡@F, “ď”g—ćŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2011/3; p.47-50.

H23-110001. [Œ´’˜] Occurrence of cholelithiasis and cholecystitis in amyotrophic lateral sclerosis patients with long-term tracheostomy invasive ventilation. Kitamura E1, Ogino M2: Intern Med 50 (20): 2291-5. (–k‘ş‰p“ń1, ‰Ź–ě”üŒbŽq2: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H23-522001. [uŔ]y“ÁWII: I––Šú‚Ě‹ę’ɊɘaƒPƒA [‘ć4•”]zNPPV‚ƏI––ŠúƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•a‚ĆÝ‘îƒPƒA 2011/5; 17 (2): 21-5.

H23-522002. [uŔ]y“ÁW: ALS|—Տ°‚Ć•ŞŽq•a‘ÔŒ¤‹†‚̐i•ŕzALS‚ĚŽĄ—Ă‚ĆƒPƒA@‰îŒěĽŽx‰‡ƒVƒXƒeƒ€. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Clin Neurosci 2011/9; 29 (9): 1068-71.

H23-522003. [uŔ]y“ÁW: ‚ť‚Ě‚â‚č•ű‚ĹOK? ć”yƒGƒLƒXƒp[ƒg‚ÉŠw‚Ô‹zˆřE”rႃeƒNƒjƒbƒN‚Ě‚ˇ‚ׂāz6. ‹@Ší‚đ—p‚˘‚˝”rá‚. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ŒÄ‹zŠíƒPƒA 2011/9; 9 (9): 908-11.

H23-522004. [uŔ]yŽăƒfƒBƒx[ƒgzL-ƒhƒp‚ĚŽŠ“K—p—Ę‚Í300 mg/“ú‚đ’´‚Ś‚Ă悢‚Š?uYesv‚Ě—§ę‚Š‚ç. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Front Parkinson Dis 2011/11; 4 (4): 190-2.

H23-530001. [‚ť‚Ě‘ź (Proceeding)] Opinions and behaviors of Japanese and American neurologists regarding tracheostomy with invasive ventilation (TIV). Dirienzo A, Ogino M1, Rabkin J, Goetz R, Pasmantier M, Mcelhiney M, Mitsumoto H, TIV STUDY GROUP: Amyotroph Lateral Scler 2011; 12 (suppl 1): 29-30. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H23-530002. [‚ť‚Ě‘ź (Proceeding)] Analysis of the end of life situation in 115 consecutive ALS patienta in the past nine years. Ogino M1, Kitamura E, Miyakawa S, Utino A, Urano Y, Nagai M, Ogino Y2: Amyotroph Lateral Scler 2011; 12 (suppl 1): 61. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H23-540001. [‚ť‚Ě‘ź (V•ˇ‹LŽ–)] ĐŠQˆă—ĂŒŠ’ź‚ľ ”Ŕ‘—, ’ʐM–ԁEEE‰Ű‘č‘˝‚­. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “Ç”„V•ˇ 2011/12/27; p.13.

H23-540002. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vz’m. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź23”N“x“ď•aŠÉ˜aƒPƒAŒ¤CŒ¤‹†‰ď‹L˜^W 2012/3; p.1,57-76.

H23-540003. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vzlHŒÄ‹zŠí‘•’…ŠłŽŇ‚̍Lˆć”Ŕ‘—‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vu“ď•a‚ƍЩQ‘΍ôvƒtƒH[ƒ‰ƒ€`Lˆćˆă—Ă”Ŕ‘—‚Ć“dŒšŠm•Ű‘΍ô`‹L˜^W 2012/3; p.34-9.

H23-540004. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vzu“ď•a‚Ě’č‹`v‚ĚŒŸ“˘‚¨‚ć‚сu“ď•a‚ĚŠÉ˜aƒPƒAŒ¤C‰ďv‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, ”ˆäFˆë˜Y, ˆÉ“Ą”Ž–ž, ˆÉ“Ą“šĆ, ˆî—tˆęl, A’|“ú“Ţ, ě‡áÁˆę, –Ř‘ş@Ši, Š‹Œ´–ÎŽ÷, Ž™‹Ę’mŽq, ´…“N˜Y, Ź“c—LŒá, “ď”g—ćŽq, “n•Ó@Žç (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź23”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2012/3; p.215-6.

H23-540005. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†vz–ƉuŤ_ŒoŽžŠł‚Ěˆă—Ă”ď\‘˘ ‚Šzˆă—Â𒆐S‚É. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†v•˝Ź23”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2012/3; p.91-2.

H23-540006. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†vz‹}ŤŽŠ—ĽŤŠ´ŠoŤ‰^“ŽŤƒjƒ…[ƒƒpƒ`[ (AASMN) ŠłŽŇŒŒ´’†‚ĚŽŠŒČR‘Ě‚ĚŒŸő. “ě@@Ž, ’ˇ‰–@—ş, ‹ŕŕV’ź”ü1, “ü]KŽq, ˛“Ą—Yˆę, ‰Ź–ě”üŒbŽq2 (1•a‘ԁEf—ĂŒn, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†v•˝Ź23”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2012/3; p.162-3.

H24-110003. [Œ´’˜] Clinical features in Gullain-Barre syndrome with anti-Gal-C antibody. Samukawa M, Hamada Y, Kuwahara M, Takada K, Hirano M, Mitsui Y, Sonoo M,Kusunoki S, Japanese GBS Study Group (Imai T, Ugawa Y, Yoshikawa Y, Hiraga H, Kaida K, Yokota T, Terao Y, Takeuchi S, Ogino M1, Sobue G, Koike H, Kojima Y, Nakamura Y, Kohara N, Ochi K, Tsuji S, Kira J, Matsunaga K): J Neurol Sci 2014/2; 337 (1-2): 55-60. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H24-520001. [‘ŕ]y•W€“I_ŒoŽĄ—Ă: dÇ_Œo“ď•a‚ĚŒÄ‹zƒPƒAEŒÄ‹zŠÇ—‚ĆƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“zIII. ‹ŘˆŢkŤ‘¤őd‰ťÇ‚É‚¨‚Ż‚éŒÄ‹zƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—ĂŠw 2013/3; 30 (2): 203-6.

H24-522001. [uŔ]y“ÁW: Ą, ”F’mÇ‚É‚Ç‚¤Œü‚Ť‡‚¤‚ŠzŔ’k‰ď: ”ńę–ĺˆă‚Ş‚Ç‚Ě‚ć‚¤‚É”F’mÇ‚ÉŒü‚Ť‡‚Á‚˝‚ç‚悢‚Š? ‰Ź–ě”üŒbŽq1, ‰Í‘ş@–ž, ŽO‘ş@›’, •˝Œ´˛“lŽi (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ŕ‰Č 2012/5; 109 (5): 847-60.

H24-522002. [uŔ]y‘ć53‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď: ƒVƒ“ƒ|ƒWƒEƒ€2z5. ŽĐ‰ď•Űá§“x‚̉üŠv‚Ɛ_Œo“ŕ‰Čf—Ă: ‰˝‚Ş‚Ç‚¤•Ď‚í‚é‚Ě‚Š?@H24f—Ă•ńV‰ü’č‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): —Տ°_ŒoŠw 2012/11; 52 (11): 1094.

H24-522003. [uŔ]y˜AÚ: _ŒoŽžŠłŽĄ—Ăƒm[ƒgz‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS)EŇ‘Ť‹ŘˆŢkÇ (SMA). –k‘ş‰p“ń1, ‰Ź–ě”üŒbŽq2 (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Clinical Neuroscience 2012/11; 30 (11): 1318-9.

H24-530001. [‚ť‚Ě‘ź (Proceeding)] Opinions and behaviors of Japanese and American ALS caregivers regarding tracheostomy with invasive ventilation (TIV). Rabkin J, Ogino M1, Goetz R, Mcelhiney M, Marziliano A, Imai T, Atsuta N, Morita M, Tateishi T, Matsumura T, Mitsumoto H1: Amyotroph Lateral Scler 2012; 13 (Suppl 1): 151. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H24-530002. [‚ť‚Ě‘ź (Proceeding)] Opinions and behaviors of Japanese and American ALS patients regarding tracheostomy with invasive ventilation (TIV). Rabkin J, Ogino M1, Goetz R, Mcelhiney M, Marziliano A, Imai T, Atsuta N, Morita M, Tateishi T, Matsumura T, Mitsumoto H: Amyotroph Lateral Scler 2012; 13 (Suppl 1): 152. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H24-540002. [‚ť‚Ě‘ź (´˜^)] _ŒoŠ´őÇ‚̐f’fƒVƒXƒeƒ€. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Neuroinfection 2012/10; 17 (2): 175.

H24-540003. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vz’m. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź24”N“x“ď•aŠÉ˜aƒPƒAŒ¤CŒ¤‹†‰ď‹L˜^W 2013/3; p.1,27-45, p.139-145.

H24-540004. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vzƒ‚ƒ‹ƒqƒl‚ĚŽg‚˘•ű. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź24”N“x“ď•aŠÉ˜aƒPƒAŒ¤CŒ¤‹†‰ď‹L˜^W 2013/3; p.139-45.

H24-540005. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vzƒ‚ƒ‹ƒqƒl‚ĚŽg‚˘•ű. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź26”N“x_Œo“ď•aŠÉ˜aƒPƒAŒ¤CŒ¤‹†‰ď‹L˜^W 2013/3; p.152-60.

H25-110004. [Œ´’˜] Efficacy of methylprednisolone pulse therapy for acute relapse in Japanese patients with multiple sclerosis and neuromyelitis optica: A multicenter retrospective analysis-1. Whole group analysis. Kira J, Yamasaki R, Yoshimura S, Fukazawa T, Yokoyama K, Fujiwara K, Ogino M1, Yokota T, Miyamoto K, Niino M, Kaida K, Matsui M, Nakatsuji Y, Ochi H, Fukaura H, Kanda T, Nagaishi A, Togo K, Mizusawa H, Kawano Y: Clinical and Expremental Neuroemmunology 2013/12; 4 (3): 306-317. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H25-110005. [€Œ´’˜] ALSUntangled No. 20: the Deanna protocol. ALSUntangled Group, Fournier C, Bedlack B, Hardiman O, Heiman-Patterson T, Gutmann L, Bromberg M, Ostrow L, Carter G, Kabashi E, Bertorini T, Mozaffar T, Andersen P, Dietz J, Gamez J, Dimachkie M, Wang Y, Wicks P, Heywood J, Novella S, Rowland LP, Pioro E, Kinsley L, Mitchell K, Glass J, Sathornsumetee S, Kwiecinski H, Baker J, Atassi N, Forshew D, Ravits J, Conwit R, Jackson C, Sherman A, Dalton K, Tindall K, Gonzalez G, Robertson J, Phillips L, Benatar M, Sorenson E, Shoesmith C, Nash S, Maragakis N, Moore D, Caress J, Boylan K, Armon C, Grosso M, Gerecke B, Wymer J, Oskarsson B, Bowser R, Drory V, Shefner J, Lechtzin N, Leitner M, Miller R, Mitsumoto H, Levine T, Russell J, Sharma K, Saperstein D, McClusky L, MacGowan D, Licht J, Verma A, Strong M, Lomen-Hoerth C, Tandan R, Rivner M, Kolb S, Polak M, Rudnicki S, Kittrell P, Quereshi M, Sachs G, Pattee G, Weiss M, Kissel J, Goldstein J, Rothstein J, Pastula D, Gleb L, Ogino M1, Rosenfeld J, Carmi E, Oster C, Barkhaus P, Valor E: Amyotroph Lateral Scler Frontotemporal Degener 2013/5; 14 (4): 319-23. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H25-210001. [€Œ´’˜] ALS Untangled No.21: Fecal transplants. ALS Untangled Group (Ogino M1): Amyotroph Lateral Scler Frontotemporal Degener 2013/9; 14 (5-6): 482-5. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H25-210002. [€Œ´’˜] ALS Untangled No.22: Propofol. ALS Untangled Group (Ogino M1): Amyotroph Lateral Scler Frontotemporal Degener 2013; 14: 640-2. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H25-210003. [€Œ´’˜] ALS Untangled No.23: The Rife machine and retroviruses. ALS Untangled Group (Ogino M1): Amyotroph Lateral Scler Frontotemporal Degener 2014/3; 15 (1-2): 157-9. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H25-220001. [€Œ´’˜] “ď•a‚É‚¨‚Ż‚é’É‚Ýsuffering‚Ö‚Ě‘Îˆ‚ĆŽx‰‡‚Ě‚ ‚č•ű: ALS‚É‚¨‚Ż‚é‹ę’É‚ĚŠÉ˜a. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{“ď•aŠĹŒěŠw‰ďŽ 2013/12; 18 (2): 128-30.

H25-220002. [€Œ´’˜]u–˝v‚đl‚Ś‚é‹łˆç. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ÂŽRƒXƒ^ƒ“ƒ_[ƒh˜_W 2013; 8: 27-39.

H25-220003. [€Œ´’˜] ˆăŽt‚ĚŽg–˝‚đl‚Ś‚é@ˆăŽtEˆăŠwś‚Ě—§ę‚Š‚ç. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): J Seizon and Life Sci 2013; 14: 116-23.

H25-220004. [€Œ´’˜] III. ‹ŘˆŢkŤ‘¤őd‰ťÇ‚É‚¨‚Ż‚éŒÄ‹zƒPƒA@“ú–{_ŒoŽĄ—ĂŠw‰ďŽĄ—ĂŽwjěŹˆĎˆő‰ď@•W€“I_ŒoŽĄ—Ă: dÇ_Œo“ď•a‚ĚŒÄ‹zƒPƒAEŒÄ‹zŠÇ—‚ĆƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _ŒoŽĄ—ĂŠw 2013; 30: 203-6.

H25-522006. [uŔ]y“ÁW: “ž—ˆ “ńl‚Ɉęl”]‘˛’†Žž‘ăzŔ’k‰ď: ‘‘S‘Ě‚Ĺ”]‘˛’†‚É—§‚żŒü‚Š‚¤‚É‚Í‚Ç‚¤‚ľ‚˝‚ç‚悢‚Ě‚Š? ‰Ź–ě”üŒbŽq1, –L“cˆę‘Ľ, ‰–ě–Fş, “cŒű”ŽŠî (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ŕ‰Č 2013/5; 111 (5): 937-50.

H25-530001. [‚ť‚Ě‘ź (Proceeding)] THE TRACE TO THE FIGHT FOR THE IMPROVEMENT IN PALLIATIVE CARE OF THE PATIENTS WITH ALS IN JAPAN. Ogino M1, Minami S, Kanazawa N, Takahashi-Narita K, Ogino Y2: Amyotroph Lateral Scler Frontotemporal Degener 2013; 14 (Suppl 2): 68. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H25-530002. [‚ť‚Ě‘ź (Proceeding)] HOW MUCH IS THE OPTIMAL INITIAL DOSE OF MORPHINE FOR ALS PATIENTS? Ogino Y1, Miyakawa S, Urano Y, Kitamura E, Uchino A, Kaneko J, Tominaga N, Takahashi-Narita K, Nagashima K, Nagai M, Ogino M2: Amyotroph Lateral Scler Frontotemporal Degener 2013; 14 (Suppl 2): 79. (‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H25-540002. [‚ť‚Ě‘ź] ƒ‚ƒ‹ƒqƒl. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ˆă—Ăƒ‹ƒlƒbƒTƒ“ƒX 2013/10/29; 5687: p.16.

H25-540003. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vz’m. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź26”N“x_Œo“ď•aŠÉ˜aƒPƒAŒ¤CŒ¤‹†‰ď‹L˜^W 2014/3; p.1,8-10, p.16-17, p.34-50.

H25-540004. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vz“ď•aŠÉ˜aƒPƒAŒ¤CŒ¤‹†‰ďE“ď•a‚Ě’č‹`E“ď•a‚Ěˆă—Ă”ď‰đÍ‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź23`25”N“x‘‡Œ¤‹†•ń‘ 2014/3; p.266-7.

H25-540005. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vz“ď•a‚ĚŠÉ˜aƒPƒAŒ¤C‰ďE“ď•a‚Ěˆă—Ă”ď‰đÍ‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź25”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2014/3; p.202-3.

H25-540006. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†vzƒvƒƒeƒI[ƒ€‰đÍ‚đ—p‚˘‚˝–ƉuŤ_ŒoŽžŠłŽŇŒŒ´’†‚ĚŽŠŒČR‘Ě‚ĚŒŸő‚¨‚ć‚іƉuŤ_ŒoŽžŠł‚Ěˆă—ÔÍ‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, “ě@@Ž, ’ˇ‰–@—ş, ‹ŕŕV’ź”ü2, “ü]KŽq, ˛“Ą—Yˆę (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2•a‘ԁEf—ĂŒn): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†v•˝Ź23`25”N“x‘‡Œ¤‹†•ń‘ 2014/3; p.19-20, p.114.

H25-540007. [‚ť‚Ě‘ź (Œ¤‹†•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†vz“ď•aV§“x‚É‚¨‚Ż‚éˆă—ÔŒČ•‰’S—\‘ނɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†v•˝Ź25”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2014/3; p.90-1.

H26-110020. [Œ´’˜] Japanese and American ALS patient preferences regarding TIV (tracheostomy with incasice ventilation): A cross-national survey. Rabkin J, Ogino M1, Goetz R, McElhiney M, Hupf J, Heitzman D, Heiman-Patterson T, Miller R, Katz J, Lomen-Hoerth C, Imai T, Atsuta N, Morita M, Tateishi T, Matsumura T, Mitsumoto H: Amyotroph Lateral Scler Fronttemporal Degener 2014/6; 15 (3-4): 185-91. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H26-110021. [Œ´’˜] Syntactic comprehension in patients with amyotrophic lateral sclerosis. Yoshizawa K, Yasuda N, Fukuda M, Yukimoto Y, Ogino M1, Hata W, Ishizaka I, Higashikawa M: Behav Neurol 2014; 2014: 230578. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H26-210001. [€Œ´’˜] ALS Untangled No.24: VitaminD. ALS Untangled Group (Ogino M1): Amyotroph Lateral Scler Frontotemporal Degener 2014; 15: 318-20. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H26-210002. [€Œ´’˜] ALS Untangled No.25: ursodiol. ALS Untangled Group (Ogino M1): Amyotroph Lateral Scler Frontotemporal Degener 2014; 15: 475-8. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H26-522015. [uŔ]y“ÁW: ‚ą‚ę‚ž‚Ż‚Í’m‚Á‚Ä‚¨‚Ť‚˝‚˘! “ŕ‰Čˆă‚Ě‚˝‚߂̐_ŒoŽžŠłf—ÁzsEditorialtˆÓŠO‚Ć‘˝‚˘_ŒoŽžŠł. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ŕ‰Č 2014/5; 113 (5): 800-2.

H26-522016. [uŔ]y“ÁW2: ŽáŽčˆăŽt‚É‚ć‚é“ď•aŽx‰‡‚Ě‚ ‚č•űzŽáŽčˆăŽt‚É‚ć‚é“ď•aŽx‰‡‚Ě‚ ‚č•ű‚Ö‚Ě’˛¸‚¨‚ć‚Ń’ńŒž. ŽOˆä—Ç”V, źˆä–˘ŽŃ, –ěČ’qŽk, Œš@^Šó, ‰Ź–ě”üŒbŽq1, ŕV“crˆę, ‹ˇŠÔŒhŒ› (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{“ď•aˆă—Ăƒlƒbƒgƒ[ƒNŠw‰ď‹@ŠÖŽ† 2015/3; 2 (2): 24-30.

H26-530002. [‚ť‚Ě‘ź (Proceeding)] THE AMERICAN AND JAPANESE TIV STUDY GROUP: AN UPDATE ON OPINIONS AND BEHAVIORS OF JAPANESE AND AMERICAN ALS CAREGIVERS REGARDING TRACHEOSTOMY WITH INVASIVE VENTILATION (TIV). Christodoulou G, Ogino M1, Goetz R, Mitsumoto H, Rabkin J: Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (Suppl 1): 105. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H26-530003. [‚ť‚Ě‘ź (Proceeding)] 5% SCOPOLAMINE OINTMENT IS CLASSICAL BUT STILL USEFUL FOR ALS AND OTHER NEUROLOGICAL DISEASES. Nagashima K, Ogino M1, Tominaga N2, Uchino A, Ogino Y2, Nishiyama K2: Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (Suppl 1): 108. (‰Ź–ě”üŒbŽq1, •x‰i“Ţ•Ű”ü2, ‰Ź–ě@—T2, źŽR˜a—˜2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H26-530004. [‚ť‚Ě‘ź (Proceeding)] MORPHINE USAGE IN ALS PATIENTS ON NPPV DOES NOT MAKE LIFE PROGNOSIS WORSE. Tominaga N1, Ogino M2, Kaneko J1, Nagashima K, Nagai M1, Uchino A, Urano Y, Ogino Y1, Nishiyama K1: Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (Suppl 1): 112. (•x‰i“Ţ•Ű”ü1, ‰Ź–ě”üŒbŽq2, ‹ŕŽq~‘ž˜Y1, ‰iˆä^‹MŽq1, ‰Ź–ě@—T1, źŽR˜a—˜1: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H26-530005. [‚ť‚Ě‘ź (Proceeding)] RESPIRATORY-AIDED, LONG-TERM SURVIVAL CASES OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) WITH COMMUNICATION ABILITIES, MOTONEURON SYSTEM-CONFINED DEGENERATION, AND SCANTY TDP-43 AGGREGATION-A SUBGROUP OF ALS? Mochizuki Y, Hayashi K, Nakayama Y, Shimizu T, Kamide M, Ogino M1, Komori T, Isozaki E, Nakano I: Amyotroph Lateral Scler Frontotemporal Degener 2014; 15 (Suppl 1): 160. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H26-540004. [‚ť‚Ě‘ź (Œ¤‹†‰ďŽ‘—ż)] •˝Ź26”N“x_Œo“ď•aŠÉ˜aƒPƒAŒ¤CŒ¤‹†‰ď‰^‰c—pŽ‘—ż (2014”N“x). ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠłŽ•žŒ¤‹†Ž–‹ĆuŠó­Ť“ŤŽžŠłŠłŽŇ‚ÉŠÖ‚ˇ‚éˆă—Ă‚ĚŒüă‹y‚ŃŠłŽŇŽx‰‡‚ĚÝ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź26”N“x_Œo“ď•aŠÉ˜aƒPƒAŒ¤CŒ¤‹†‰ď‰^‰c—pŽ‘—ż 2014/10; p.1-234.

H26-540005. [‚ť‚Ě‘ź] ’nˆć‚̍‚—‚đŽx‚Ś, I––Šú‚̐ś‚Ť•ű‚đl‚Ś‚é. ‰Ź–ě”üŒbŽq1,2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2uĹŒă‚܂ł悢lś‚đ‚ß‚´‚ˇ‰ďE‘Š–ÍŒ´v‘ă•\): “Œ‹žl 2014: 334: 114.

H26-540006. [‚ť‚Ě‘ź (Œ¤‹†‰ďŽ‘—ż•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕuEˆć‚É‚¨‚Ż‚é’†“ráŠQŽŇ‚ĚŽŔ‘Ô’˛¸‚Ć‚ť‚ę‚ÉŠî‚Ă‚­ŠÖŒWŽŇŠÔ‚Ě–]‚Ü‚ľ‚˘˜AŒg‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†vzŠłŽŇ‚ł‚ń‚ÉŠń‚č“Y‚¤—Տ°ˆă‚ĆŠłŽŇ‰ď‚Ě—§ę‚Š‚çŠw‚ԉۑč‚ĆŽY‹Ć•ŰŒ’E‚Ö‚ĚŠú‘ҁ|_Œo“ŕ‰Čˆă‚Ě—§ę‚Š‚çŽY‹Ć•ŰŒ’E‚ÉŠú‘Ň‚ˇ‚é–đŠ„|. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź26”N“xŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕuEˆć‚É‚¨‚Ż‚é’†“ráŠQŽŇ‚ĚŽŔ‘Ô’˛¸‚Ć‚ť‚ę‚ÉŠî‚Ă‚­ŠÖŒWŽŇŠÔ‚Ě–]‚Ü‚ľ‚˘˜AŒg‚Ě‚ ‚č•ű‚ÉŠÖ‚ˇ‚錤‹†v‘ć1‰ńŽY‹ĆˆăEŽY‹ĆŠĹŒěE‚Ě—§ę‚Š‚ç“ď•aŠłŽŇE’†“ráŠQŽŇ‚̏A˜JŒp‘ąŽx‰‡‚đl‚Ś‚錤‹†‰ď•ń‘ 2015/1.

H26-540007. [‚ť‚Ě‘ź (Œ¤‹†‰ďŽ‘—ż•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹Ću“ď•aŠłŽŇ‚Ö‚ĚŽx‰‡‘̐§‚ÉŠÖ‚ˇ‚錤‹†vz“ď•aŠÉ˜aƒPƒA‚Ě•‹y, Œ[”­, A˜JŽx‰‡‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, ”ˆäFˆë˜Y, ˆî—tˆęl, A’|“ú“Ţ, Ź“c—LŒá, “ď”g—ćŽq, ŽO‰Y–ő•F, ‰Ź–ě@—T2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹Ću“ď•aŠłŽŇ‚Ö‚ĚŽx‰‡‘̐§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź26”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2015/3; p.71-3.

H26-540008. [‚ť‚Ě‘ź (Œ¤‹†‰ďŽ‘—ż•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vz‘˝”­Ťd‰ťÇEŽ‹_ŒoŇ‘‰Šf’fŠî€•Ŕ‚Ń‚ÉdÇ“xŠî€‚̍쐬. ‹g—Ǐˆę, áÁčŸ‹v, ˛“ĄáÁ–ç, ‹g‘ş@—ĺ, ŽRč@—ş, ź‰ş‘ń–ç, V–쐳–ž, źˆä@^, ‰Ź–ě”üŒbŽq1, Žŕ‘ş–žś, “c’†ł”ü, ’†’Ň—SŽi, źŕVł–L, –ě‘ş‹ąˆę, Œ´@Žő˜Y, “ĄŒ´ˆę’j, ŽR‘ş@—˛, ‘ĺŒ´‹`˜N, ‚š@Ż, ŒSŽR’B˜Y, Ö“cF•F, –ě‘ş–FŽq, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, ´…—DŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź26”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2015/3; p.17-20.

H26-540009. [‚ť‚Ě‘ź (Œ¤‹†‰ďŽ‘—ż•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzdÇ‹Ř–ł—͏Njy‚Ń••“ü‘̋؉Š‚̏dÇ“x•Ş—Ţ‚Ě’ńˆÄ. ‹gěO–ž, ´…, , ‰Ź–ě”üŒbŽq1, Š@—´™Z, ´…—DŽq, —é–Ř‘ĽG, Žŕ‘ş–žś, ‰€ś‰ëO, V–쐳–ž, –ě‘ş‹ąˆę, Œ´@Žő˜Y, ź”öG“ż, –{‘ş­Ÿ, ěŒű’źŽ÷, ŒSŽR’B’j, –ě‘ş–FŽq, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, źˆä@^, —é–؏d–ž, Šâ˛˜a•v, âˆäŒ’“ń (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź26”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2015/3; p.21-38.

H26-540010. [‚ť‚Ě‘ź (Œ¤‹†‰ďŽ‘—ż•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vzƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ‚¨‚ć‚їމŽžŠł‚̐f’fŠî€, dÇ“x•Ş—Ţ. “í@@i, ‰Ź–ě”üŒbŽq1, ŠC“cŒŤˆę, Š@—´™Z, _“c@—˛, ŒKŒ´@‘, ‰€ś‰ëO, ‘c•ƒ]Œł, ç—tŒú˜Y, –ě‘ş‹ąˆę, ’r“cCˆę, ´…—DŽq, Œ´@Žő˜Y, ź”öG“ż, ‰Ą“c—˛“ż, –ě‘ş–FŽq, •“Ą‘˝’Ă˜Y, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq, źˆä@^ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź26”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2015/3; p.39-44.

H26-540011. [‚ť‚Ě‘ź (Œ¤‹†‰ďŽ‘—ż•ń‘)]yŒúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†vz‚ť‚Ě‘ź‚̐_Œo–ƉuŽžŠł. Žŕ‘ş–žś, źˆä@^, ’r“cCˆę, ‰Ź–ě”üŒbŽq1, Š@—´™Z, _“c@—˛, ‹v•Ű“c—´“ń, ´…—DŽq, —é–Ř‘ĽG, źŕVł–L, –ě‘ş‹ąˆę, Œ´@Žő˜Y, ‰Ą“c—˛“ż, “n粁@C, Œ˘’ˁ@‹M, ’†‘ş—´•ś, –ě‘ş–FŽq, ŽR–ě‰Ă‹v, •Ä“c@˝, ŒIŽR’ˇ–ĺ, ‹Ę˜‹ĹŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­‰ČŠwŒ¤‹†”ď•â•‹ŕ“ŤŽžŠł­ôŒ¤‹†Ž–‹ĆuƒGƒrƒfƒ“ƒX‚ÉŠî‚Ă‚˘‚˝_Œo–ƉuŽžŠł‚Ě‘Šúf’fŠî€EdÇ“x•Ş—ށEŽĄ—ĂƒAƒ‹ƒSƒŠƒYƒ€‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź26”N“x‘Š‡E•Ş’SŒ¤‹†•ń‘ 2015/3; p.53-6.

[’˜@‘]

H17-620001. [Šwp‘ (•Ş’SŽˇ•M)]yÝ‘îˆă—ĂĽ‰îŒěŠî–{Žč‹Zƒ}ƒjƒ…ƒAƒ‹@‰ü’ů‘ć2”Łz_Œo“ď•a‚ĚÝ‘îƒPƒA, p.592-606. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •Ň: •ě@´, ‰iˆä‘“X, “Œ‹ž, 2005/10”­s.

H21-620001. [Šwp‘ (•Ş’SŽˇ•M)]yÝ‘îˆă—ĂƒeƒLƒXƒg‘ć2”Łz‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS), p.108-11. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), Šé‰ćE•ŇW: Ý‘îˆă—ĂƒeƒLƒXƒg•ŇWˆő‰ď, Ý‘îˆă—Ï•Ź —E”ü‹L”Oŕ’c, “Œ‹ž, 2009/10”­s.

H22-620001. [Šwp‘ (•Ş’SŽˇ•M)]yAnnual Review _Œo2010z_Œo“ď•aŽžŠł‚Ěˆă—Ă”ď\‘˘‰đÍ‚Ě–â‘č“_, p.65-70. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •Ň: —é–Ř‘ĽG, ‘ź, ’†ŠOˆăŠwŽĐ, “Œ‹ž, 2010/11”­s.

H23-620001. [Šwp‘ (•Ş’SŽˇ•M)]yÝ‘îˆă—Ă‚Ě‹Z‚Ć‚ą‚ą‚ë: ƒ`ƒƒƒŒƒ“ƒW!@”ń‚Ş‚ńŽžŠł‚ĚŠÉ˜aƒPƒAzŽžŠł•Ę‚ĚŠÉ˜aƒPƒA‚ĚŽŔŰ|_Œo“ď•a‚ĚŠÉ˜aƒPƒA…@‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS)|, p.114-27. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), “ěŽR“°, “Œ‹ž, 2011/8”­s.

H23-620002. [Šwp‘ (•Ş’SŽˇ•M)]yƒCƒ“ƒ^[ƒvƒƒtƒFƒbƒVƒ‡ƒiƒ‹Eƒwƒ‹ƒXƒPƒA|ƒ`[ƒ€ˆă—Ă‚ĚŽŔŰ‚Ć‹łˆçƒvƒƒOƒ‰ƒ€zŽŔ‘H•Ň@ƒ`[ƒ€ˆă—ɉK‚Ě“WŠJ—á@_Œo“ď•a|_Œo“ď•a‚Ć‚ť‚Ě‘Îô|, p.209-14. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), ˆăŽ•–ňo”Ĺ, “Œ‹ž, 2011/10”­s.

H23-620003. [Šwp‘ (•Ş’SŽˇ•M)]y_Œo“ď•aÝ‘î—Ă—{ƒnƒ“ƒhƒuƒbƒN@‚ć‚č‚悢ŠÉ˜aƒPƒA’ń‹Ÿ‚Ě‚˝‚߂Ɂz_Œo“ď•a‚É‚¨‚Ż‚é‹ę’ɏǏó‚Ć‚ť‚̑Ήž,p.63-86. ‰Ź–ě”üŒbŽq1, ‚‹´‹M”üŽq, “ď”g—ćŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •Ň: Ź“c—LŒá, ƒƒfƒBƒJƒ‹ƒrƒ…[ŽĐ, ‘ĺă, 2011/10”­s.

H23-620004. [Šwp‘ (•Ş’SŽˇ•M)]y_ŒoŽžŠłĹV‚ĚŽĄ—Ă2012-2014z_ŒoŽžŠł‚Ě•ŸŽƒE‰îŒěŽ{ő, p402-7. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), “ě]“°, “Œ‹ž, 2012/3”­s.

H24-610001. [Šwp‘ (•Ş’SŽˇ•M)]yHome Care Handbook for People with Intractable Neurological Disease: Aiming to distribute better palliative care in Japanz4. Pain in neurological intractable disease, p.43-59. Ogino M1, Takahashi K, Nammba R, Editors: Narita Y, Fukuro Shuppan, Okayama, 2012/11. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H24-620001. [Šwp‘ (•Ş’SŽˇ•M)]y’m‚Á‚Ä‚¨‚Ť‚˝‚˘“ŕ‰ČÇŒóŒQ (“ŕ‰Č2012”N6ŒŽ‘‘ĺ†)zI. _ŒoE‹Řs–ƉuŤEŠ´őŤ_ŒoŽžŠłt@15. ƒtƒBƒbƒVƒƒ[ÇŒóŒQ, p.952-3. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), “ě]“°, “Œ‹ž, 2012/6”­s.

H25-620001. [Šwp‘ (•Ş’SŽˇ•M)]yĹVƒAƒvƒ[ƒ`ALSE‰^“Žƒjƒ…[ƒƒ“ŽžŠł@ƒAƒNƒ`ƒ…ƒAƒ‹”]E_ŒoŽžŠł‚Ě—Ő°zALS‚ɑ΂ˇ‚éŠÉ˜aˆă—Ă, p.306-13. ‹{ěšD, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •Ň: ’ҁ@ČŽŸ, ’†ŽR‘“X, “Œ‹ž, 2013/6”­s.

H25-620002. [Šwp‘ (ŠÄC)]yĄ“ú‚Ě—Ő°ƒTƒ|[ƒgz‹ŘˆŢkŤ‘¤őd‰ťÇ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), _Œo•Ş–ěŠÄC, •Ň: ‚‹´—TG, ‰iˆä—ÇŽO, •ŸˆäŽŸ–î, –Ř‘şŒ’“ń˜Y, ă‘ş’źŽŔ, ŒK“‡@ŠŢ, Ąˆä@–ő, “ˆ“c@Œł, ƒGƒ‹ƒ[ƒrƒAEƒWƒƒƒpƒ“, 2013 (ƒEƒFƒuƒTƒCƒg: http://clinicalsup.jp/jpoc/)

H25-620003. [Šwp‘ (•Ş’SŽˇ•M)]yĄ“ú‚ĚŽĄ—ĂŽwj2014zÝ‘î_Œo“ď•aŠłŽŇ‚ĚƒPƒA, p.1426-7. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), ŠÄC: ŽRŒű@“O, –kŒ´Œő•v, •Ň: •ŸˆäŽŸ–î, ‚–؁@˝, ŹŽşˆęŹ, ˆăŠw‘‰@, “Œ‹ž, 2014/1”­s.

H26-620022. [Šwp‘ (•Ş’SŽˇ•M)]yƒzƒXƒsƒXŠÉ˜aƒPƒA”’‘2014z‘ćII•” Šw‰ďEŠwp’c‘Ě‚ĚŠÉ˜aƒPƒAƒw‚ĚŽć‚č‘g‚݁@3. _Œo“ď•aE“ď•a, p.51-4. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •ŇW‹Ś—Í: “ú–{ƒzƒXƒsƒXEŠÉ˜aƒPƒAŒ¤‹†U‹ťŕ’c, ÂŠCŽĐ, “Œ‹ž, 2014/4”­s.

H26-620023. [Šwp‘ (•Ş’SŽˇ•M)]yMBA—ŹƒP[ƒXƒƒ\ƒbƒh‚ĹŠw‚Ôˆă—ĂŒo‰c“ü–ĺzˆă—ĂŒo‰c‚Š‚ç‚Ý‚˝Ý‘îˆă—Ă‚Ě‚ľ‚­‚Ý, p.138-40. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •Ň: a’J–ž—˛ (ˆă—ĂˆŔ‘SEŠÇ—), “úŒoBPŽĐ, “Œ‹ž, 2014/5”­s.

H26-620024. [Šwp‘ (•Ş’SŽˇ•M)]yƒeƒLƒXƒg—Տ°Ž€śŠwz‘ć9Í _Œo“ď•a (ALS) ‚Ş•ř‚Ś‚é‰Ű‘č, p.109-21. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), •Ň: —Տ°Ž€śŠwƒeƒLƒXƒg•ŇWˆĎˆő‰ď, ™¤‘‘–[, “Œ‹ž, 2014/6”­s.

H26-620025. [Šwp‘ (•Ş’SŽˇ•M)]y_Œo“ŕ‰ČŠĹŒě‚Ě’mŽŻ‚ĆŽŔŰz5. ‹ŘˆŢkŤ‘¤őd‰ťÇ, p.81-9. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), ŠÄC: ź–{š‘×, •Ň: ŠŰŽR”Ž•ś, •S“c•Ži, ƒƒfƒBƒJo”Ĺ, ‘ĺă, 2015/1”­s.

H26-620026. [Šwp‘ (•Ş’SŽˇ•M)]y_Œo“ŕ‰ČŒ¤Cƒm[ƒgz—ŤˆăŽt‚Ö‚ĚŒ¤CƒAƒhƒoƒCƒX, p.11-3. ˆă—Ă•ŰŒŻ§“x‚ƉîŒě•ŰŒŻ§“x, p.648-53. gáŽŇ”F’čE“ď•a“™ˆă—Ă”ď•ŹE‰îŒě‚Ě‚˝‚ß‚Ě‘—Ţ‚Ě‘‚Ť•ű, p.679-85. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă), ŠÄC: ‰iˆä—ÇŽO, •Ň: —é–Ř‘ĽG‘ź, f’f‚ĆŽĄ—ĂŽĐ, “Œ‹ž, 2015/1”­s.

[Šw‰ďEŒ¤‹†‰ď“™]

H17-713001. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The issues on the induction of invasive mechanical ventilation in Japanese ALS patients. Ogino M1, Ogino Y2, Kobayashi N, Sakai F: 16th international symposium on ALS/MND (2005/12/8-10), Dublin, Ireland, ALS and motor neuron disorders 2005; 6 (Suppl 1): 157. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H17-713002. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Sleep disorders in PARK8 sagamihara family (I2020T). Ogino Y1, Ogino M2, Sakai F: 4th international Parkinson`s Disease Symposium in Takamatsu (2006/3/9-11), Takamatsu (‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H17-722001. [Šw‰ď(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ALS‚É‚¨‚Ż‚é—Ď—“IĽŽĐ‰ď“I–â‘č. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć23‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2005/6/9-10), ’š‰H, _ŒoŽĄ—ĂŠw 2005; 22 (3): 331.

H17-722002. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) ALSf—Ă‚É‚¨‚Ż‚éNPPV‚Ě’ˇŠ‚Ć–â‘č. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć1‰ń_Œo“ď•a‚Ě”ńNPŒÄ‹zƒPƒAEƒ[ƒNƒVƒ‡ƒbƒv (2005/9/17), “Œ‹ž, ´˜^W p.10-1.

H17-723001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) g‘̏áŠQŽŇ—ĂŒěŽ{Ý‚É‚¨‚Ż‚é‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) ŠłŽŇŽó‚Ż“ü‚ę‚Ě–â‘č“_. ŒĂ‘ň‰p–ž, ‰Ź–ě”üŒbŽq1, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć46‰ń“ú–{_ŒoŠw‰ď‘‰ď (2005/5/25-27), Ž­Ž™“‡, “ú–{_ŒoŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€Ľ´˜^W 2005; 46: 135.

H17-723002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰)u‹Ů‹}Žž‚Ě‘Îˆ•ű–@ƒJ[ƒhv(Ž–‘OŽw’č‘) “ą“üŒă‚Ě•]‰ż. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć46‰ń“ú–{_ŒoŠw‰ď‘‰ď (2005/5/25-27), Ž­Ž™“‡, “ú–{_ŒoŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€Ľ´˜^W 2005; 46: 135.

H17-723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) _Œo“ď•a—‰đ‚É‚Ţ‚Ż‚ĈăŠw•”‹łˆç‚É‚¨‚Ż‚éŽć‚č‘g‚Ý. Źě‰Ę—Ń, •Ÿ“c—Ď–ç, ‰Ź–ě”üŒbŽq1, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć46‰ń“ú–{_ŒoŠw‰ď‘‰ď (2005/5/25-27), Ž­Ž™“‡, “ú–{_ŒoŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€Ľ´˜^W 2005; 46: 209.

H17-723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ALSŠłŽŇ‚É‚¨‚Ż‚éŽĺŠĎ“IQOL—vˆö‚ĚŒŸ“˘. Ź—Ń”ü“ŢŽq, ‰Ź–ě”üŒbŽq1, Ö“Ą–L˜a (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć46‰ń“ú–{_ŒoŠw‰ď‘‰ď (2005/5/25-27), Ž­Ž™“‡, “ú–{_ŒoŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€Ľ´˜^W 2005; 46: 210.

H17-723005. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) PARK8 (‘Š–ÍŒ´’n‹ćˆâ“`Ťƒp[ƒLƒ“ƒ\ƒ“•a) ‚Ě—Ő°“I“Á’Ľ‚Ć’ˇŠúŒo‰ß. ‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2, ŒĂ‘ň‰p–ž, âˆä•ś•F (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć46‰ń“ú–{_ŒoŠw‰ď‘‰ď (2005/5/25-27), Ž­Ž™“‡, “ú–{_ŒoŠw‰ď‘‰ďƒvƒƒOƒ‰ƒ€Ľ´˜^W 2005; 46: 293.

H17-723006. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ˆÓŽv“`’B‘•’u‘€ěƒXƒCƒbƒ`‚Ě‘I‘đŠî€|Œ’íŽŇ‚É‚¨‚Ż‚éŠç“ŽěƒXƒCƒbƒ`‚Ě‘€ě”äŠr|. ĄŠÖˆŸ—R”ü, ’†ź_Ži, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć39‰ń“ú–{ě‹Ć—Ă–@Šw‰ď (2005/6/23-26), ˆďé, “ú–{ě‹Ć—Ă–@Šw‰ďŽ 2005; 39: 258.

H17-723007. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ALS‚É‚¨‚Ż‚éƒJƒtƒ}ƒV[ƒ“, ƒp[ƒJƒbƒVƒ‡ƒlƒA‚Ě—L—pŤ. –î–ě‹M‹vŽq, ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, ”ŃƒP’J”ü•ô2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć23‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2005/6/9-10), ’š‰H, _ŒoŽĄ—ĂŠw 2005; 22: 401.

H17-723008. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) H“šŹ×–EŠŕ‚ɍ‡•š‚ľ, —ǍD‚ČŒo‰ß‚đ‚Ć‚Á‚˝paraneoplastic neuropathy‚Ěˆę—á. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, âˆä•ś•F, ‰ş“c‘ń–ç3, Źň˜aŽO˜Y3 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ, 3Á‰ťŠí“ŕ): ‘ć16‰ń“ú–{––˝_ŒoŠw‰ďŠwpW‰ď (2005/7/22-23), ‹ŕ‘ň, ´˜^W p.47, ––˝_Œo 2005; 16: 130-3.

H17-723009. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ALS‚É‚¨‚Ż‚éNIPPVÝ‘î“ą“ü. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć8‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď (2006/2/11-12), ç—t, ´˜^W p.112, “ú–{Ý‘îˆăŠw‰ďŽGŽ 2006; 8 (1): 109.

H17-723010. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹´–{•a‚đŠî‘bŽžŠł‚É”­Ç‚ľ‚˝•Ó‰Œn”]Ç‚Ěˆę—á. ˆäorŒő, ‰Ź–ě”üŒbŽq1, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć18‰ń“ú–{_Œo–ƉuŠw‰ďŠwpW‰ď (2006/3/2-3), –źŒĂ‰Ž, _Œo–ƉuŠw 2006; 14 (1): 105.

H17-723011. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹}‘Ź‚ɐis‚ˇ‚é‹ŘˆŢkCš‹‰şáŠQ‚𔺂˘ƒXƒeƒƒCƒh—Ă–@‚Ş’˜Œř‚ľ‚˝ƒ|ƒŠƒjƒ…[ƒƒpƒ`[‚Ěˆę—á. ”Ńƒ–’J”ü•ô2, ˆ˘‹v’Ă“ń•v2, ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć18‰ń“ú–{_Œo–ƉuŠw‰ďŠwpW‰ď (2006/3/2-3), –źŒĂ‰Ž, _Œo–ƉuŠw 2006; 14 (1): 123.

H17-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) _Œo“ď•a‚ĚƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“áŠQ‚ɑ΂ˇ‚鉇•Žč’i. ‰Ź–ě”üŒbŽq2, ’†ź_Ži, ’†ŠŰ‹I‹v”ü, g—с@Šó, ĄŠÖˆŸ—R”ü, ’|“ੰl (2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź17”N“x”ÇŒ¤‹†‰ď‹c (2006/1/6-7), “Œ‹ž.

H17-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) —ĂŒěŽ{Ý‚É‚¨‚Ż‚éALSŽó‚Ż“ü‚ę‚ĚŒťó|‘ć1•ń‚ą‚ę‚Ü‚Ĺ‚ĚŒoˆÜ|. ‰Ź–ě”üŒbŽq1, ŒĂŕV‰p–ž, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź17”N“x”ÇŒ¤‹†‰ď‹c (2006/1/6-7), “Œ‹ž.

H17-732003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ALS‚É‚¨‚Ż‚éSNIP‚Ě—L—pŤ‚ɂ‚˘‚ā|‘ć1•ń|. ‰Ź–ě”üŒbŽq1, ăo’źl, •˝‰ę‚ć‚ľ‚Ý, —Rˆäi‘ž˜Y, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź17”N“xŒ¤‹†•ń‰ď (2006/1/8-9), “Œ‹ž, ´˜^W p7.

H17-732004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ALSI––Šú‚É‚¨‚Ż‚éŠÉ˜aƒPƒA‚ɂ‚˘‚ā|“–‰@‚É‚¨‚Ż‚éƒIƒsƒIƒCƒh“™‚ĚŽg—pŒoŒą|. ‰Ź–ě”üŒbŽq1, ”Ńƒ–’J”ü•ô2, —Rˆäi‘ž˜Y, ‰Ź–ě@—T2, âˆä•ś•F, “IęŒłO, ‘吟GŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź17”N“xŒ¤‹†•ń‰ď (2006/1/8-9), “Œ‹ž, ´˜^W p46.

H17-732005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ƒMƒ‰ƒ“EƒoƒŒ[ÇŒóŒQ‚Ě’ˇŠú—\Œă. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, “ü]KŽq, ‹ŕŕV’ź”ü3, âˆä•ś•F, Ä“Ą–L˜a (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ, 3•a‘ԁEf—ĂŒn): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†”ǁv•˝Ź17”N“x”ljď‹c (2006/1/25-26), “Œ‹ž.

H17-732006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) g‘̏áŠQŽŇ—ĂŒěŽ{ÝALSę—p‹Žş‚ĚŠˆ—p„i‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź17”N“x•Ÿ‰ŞŒ§dÇ_Œo“ď•aŠłŽŇ“ü‰@Ž{ÝŠm•ŰŽ–‹Ć•Ÿ‰ŞƒuƒƒbƒNŒ¤C‰ď (2006/2/3), •Ÿ‰Ş.

H17-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘Sg‚ĚŠ´Šo’EŽ¸‚đ”F‚ß‚˝–TŽîᇐŤŠ´ŠoŤƒjƒ…[ƒƒpƒ`[‚Ěˆę—á. –î–ě‹M‹vŽq, ”Ńƒ–’J”ü•ô1, —Rˆäi‘ž˜Y, ‰Ź–ě”üŒbŽq2, âˆä•ś•F (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć173‰ń“ú–{_ŒoŠw‰ďŠÖ“Œ’n•ű‰ď (2005/6/4), “Œ‹ž.

H17-733002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) g‘̏áŠQŽŇ—ĂŒěŽ{Ý‚É‚¨‚Ż‚é‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) ŠłŽŇŽó‚Ż“ü‚ę‚Ě–â‘č“_. ŒĂŕV‰p–ž, ‰Ź–ě”üŒbŽq1, ŽR“c’JßŽq, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć2‰ń“ú–{“ď•aˆă—Ăƒlƒbƒgƒ[ƒNŒ¤‹†‰ď (2005/9/30), ĺ‘ä.

H18-713001. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Long-term prognosis of Guillain-Barre syndrome. Ogino M1, Ogino Y2, Irie S, Kanazawa N3, Saito T, Sakai F: 8th International Congress of Neuroimmunology (2006/10/15-19), Nagoya, J Neuroimmunology 2006; 178 (suppl 1): 222. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, ‹ŕŕV’ź”ü3: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ, 3•a‘ԁEf—ĂŒn)

H18-713002. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Usefulness of Sniff Nasal Inspiratory Pressure (SNIP) for Japanese Patients with ALS. Kamide N, Ogino M1, Ogino Y2, Fukuda M, Sumida S, Hiraga Y, Sakai F: 17ht ALS/MND international symposium (2006/11/30-12/2), Yokohama, ALS and motor neuron disorders 2006; 7 (Suppl 1): 83. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H18-713003. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The present status and problems eith upper extremity orthosis in patients with Amyotrophic Lateral Sclerosis. Imazaki A, Ogino M1, Ogino Y2, kamide N, Asai N, Sakai F: 17ht ALS/MND international symposium (2006/11/30-12/2), Yokohama, ALS and motor neuron disorders 2006; 7 (Suppl 1): 74-5. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H18-723001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ALSŠłŽŇ‚É‚¨‚Ż‚éŽĺŠĎ“IQOL‚Ě”äŠr. Ź—Ń”ü“ŢŽq, ‰Ź–ě”üŒbŽq1, Ä“Ą–L˜a (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć47‰ń“ú–{_ŒoŠw‰ď (2006/5/11-13), “Œ‹ž, —Տ°_ŒoŠw 2006; 46 (12): 1024.

H18-723002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ŹŽ™‰Č—Ěˆć‚É‚¨‚Ż‚éEasy asthma program (EAP) ‚Ě—L—pŤ‚ĚŒŸ“˘. •˝Ł–ž•F1, “ń‹{“šl, ˜a“cł•ś, ŽR‰ŞŹÍ, Ź“ě@—˛, ‰Ź–ě”üŒbŽq2, ‘ŠŒ´_‹P, Ź—Ń‚ß‚Ž‚Ý, _ŒËŽsź•”ŹŽ™‰ČƒOƒ‹[ƒv (1Œö•ś•a‰@, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć17‰ń“ú–{ŹŽ™‰Čˆă‰ďƒZƒ~ƒi[ (2006/6/10-11), •şŒÉ, “ú–{ŹŽ™‰Čˆă‰ď‰ď•ń 2006/10; 32: 99-100.

H18-723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ý‘îALSŠłŽŇ‚ɑ΂ˇ‚éQOLŒüă‚Ě‚˝‚ß‚Ěƒ‚ƒ‹ƒqƒl‚ĚŽg—p. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, ”Ńƒ–’J”ü•ô2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć9‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď (2007/3/17-18), ŽD–y.

H18-723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”ńNP“IlHŒÄ‹z—Ă–@‚É‚¨‚Ż‚é‹@Ží”äŠr. ‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2, ‰ZśLˆę, âˆä•ś•F (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć9‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď (2007/3/17-18), ŽD–y.

H18-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰)u_Œo“ŕ‰Čf—Ă‚É‚¨‚Ż‚éŽŔ‘H“Iƒe[ƒ}vALSI––ŠúŠÉ˜aƒPƒA‚Ć‚ľ‚Ä‚Ě–ƒ–ňŽg—p. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć49‰ń_Œo“ŕ‰Č§˜b‰ď (2006/8/5), “Œ‹ž.

H18-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ƒ^ƒNƒƒŠƒ€ƒX’P“Ć—Ă–@‚É‚¨‚Ż‚é’ˇŠúŒo‰ß. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć5‰ńdÇ‹Ř–ł—ÍÇ‚ĆƒvƒƒOƒ‰ƒtŒ¤‹†‰ď (2006/11/18), “Œ‹ž.

H18-732003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) NIPPV‚Ě‹@Ží”äŠr‚ĆƒCƒ“ƒ^[ƒtƒFƒCƒX. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź18”N“xŒ¤‹†•ń‰ď (2006/12/22-23), “Œ‹ž, ´˜^W p.47.

H18-732004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ALS/MND‚É‚¨‚Ż‚éRTX (‘ĚŠOŽŽlHŒÄ‹zŠí) ‚Ě—L—pŤ|‘ć1•ń|. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź18”N“xŒ¤‹†•ń‰ď (2006/12/22-23), “Œ‹ž, ´˜^W p.56.

H18-732005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ALS‚É‚¨‚Ż‚éSniff Nasal Inspiratory Pressure‚Ě—L—pŤ\‘ć2•ń\. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź18”N“xŒ¤‹†•ń‰ď (2006/12/22-23), “Œ‹ž, ´˜^W p.57.

H18-732006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) NPPVĹV‚Ě‹@Ží”äŠr. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, âˆä•ś•F, ‰ZśLˆę (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź18”N“xŒ¤‹†•ń‰ď (2007/1/8), “Œ‹ž.

H18-732007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) _Œo“ď•a‚É‚¨‚Ż‚鎊—§Žx‰‡–@“ą“üŒă‚ĚŒťó‚Ɖۑč‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, ăžŠáÁŽq, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź18”N“xŒ¤‹†•ń‰ď (2007/1/8), “Œ‹ž.

H18-732008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) GBS‚É‚¨‚Ż‚éCD1ˆâ“`Žq‘˝Œ^. ‰Ź–ě”üŒbŽq1, ‹ŕ‘ň’ź”ü2, “ü]KŽq, ‰Ź–ě@—T3, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2•a‘ԁEf—ĂŒn, 3_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†”ǁv•˝Ź18”N“xŒ¤‹†•ń‰ď (2007/1/24-25), “Œ‹ž, ´˜^W p.128-9.

H18-732009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) –ŤŠú‚Š‚çI––Šú‚Ö‚Ěˆă—Ă˜AŒg|‚ǂ̂悤‚ɐś‚Ť‚Ť‚é‚Š|. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)F‘ć2‰ńƒjƒ…[ƒƒwƒ‹ƒXƒPƒAƒtƒH[ƒ‰ƒ€ (2007/3/8), ‰Ą•l.

H18-732010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń)u“ď•a—Ěˆć‚É‚¨‚Ż‚éˆă—ÁE•ŸŽƒ§“x•ĎX‚̉e‹ż’˛¸@ƒ[ƒLƒ“ƒOƒOƒ‹[ƒvvDPC‚ɂ‚˘‚ā@DPC‚É‚¨‚Ż‚é_Œo“ď•a. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†”ǁvŒ¤‹†•ń‰ď (2007/3/10), “Œ‹ž.

H18-732011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń)u“ď•a—Ěˆć‚É‚¨‚Ż‚éˆă—ÁE•ŸŽƒ§“x•ĎX‚̉e‹ż’˛¸@ƒ[ƒLƒ“ƒOƒOƒ‹[ƒvváŠQŽŇŽ{Ý“™“ü‰@Šî–{—ż@Œťó‚ƍĄŒă. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†”ǁvŒ¤‹†•ń‰ď (2007/3/10), “Œ‹ž.

H18-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ş‘Ń–ƒáƒ‚ޏ‰”­Çó‚ƍl‚Ś‚ç‚ę‚é‹…Ň‘Ť‹ŘˆŢkÇ (SBMA) ‚Ě71Î’jŤ—á. ”Ńƒ–’J”ü•ô1, ‰Ź–ě”üŒbŽq2, ‰Ź–ě@—T1, Ž‰ĆKŽq, âˆä•ś•F (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć179‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2006/11/25), “Œ‹ž, —Տ°_ŒoŠw 2007; 47 (7): 463.

H18-733002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ALSŠłŽŇ‚É‚¨‚Ż‚é“ú–{Œę”ĹALSAQ-40‚Ě—L—pŤ‚ĚŒŸ“˘. Ź—Ń”ü“ŢŽq, ‹ÄŒ´Œc‘ž, ‰Ź–ě”üŒbŽq1, âV“Ą–L˜a (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć15‰ńé‹ĘŒ§—Šw—Ă–@Šw‰ď (2007/1/7), ‘ĺ‹{.

H19-722001. [Šw‰ď(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ALSŠłŽŇ‚ł‚ń‚ĚŠÉ˜a—Ă–@`ƒIƒsƒIƒCƒhEƒ‚ƒ‹ƒqƒl‚ĚŽg—p‚𒆐S‚Ɂ`@‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) ŠłŽŇ‚ł‚ń‚ĆŒü‚Ť‡‚¤‚˝‚ß‚É. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć11‰ńVŠƒ_Œo“ŕ‰ČƒVƒ“ƒ|ƒWƒEƒ€ (2007), VŠƒ.

H19-731001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) ‚ɂ‚˘‚ā|ŠÉ˜aƒPƒA‚𒆐S‚Ɂ|. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ÂXŒ§_Œo“ŕ‰ČŠwpu‰‰‰ď (2007/7/26), ÂX.

H19-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰)u“ď•a‚ĚŠî‘b’mŽŻv‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•aŠłŽŇ“™ƒz[ƒ€ƒwƒ‹ƒp[—{ŹŒ¤C (2007/10/22), ŠƒPč.

H19-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ‚Ě•a‹C‚Ć—Ă—{śŠˆ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź19”N“xALSŒđ—Ź‰ď (2007/11/5), •˝’Ë.

H19-732003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ALSf—Á@•a–ź’m‚Š‚çŠÉ˜aƒPƒA‚Ü‚Ĺ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ŠâŽčŒ§—§•a‰@ˆăŠw‰ďu_Œo“ŕ‰Č•Ş‰Č‰ďv (2007/11/10), ŠâŽčŒ§.

H19-732004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź19”N“x‘Š–ÍŒ´Žs‰îŒěŽx‰‡ę–ĺˆőŒ¤C‰ď (2008/1/17), ‘Š–ÍŒ´.

H19-732005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) “ď•aŠłŽŇ‚Ěˆă—ʋŤE—Ă—{ŠÂ‹Ť‚ĚŒťó‚Ć“W–]. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź19”N“x“ď•aŒ¤C‰ď (2008/1/19), ‘ĺ•Ş.

H19-732006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ƒe[ƒ}uˆă—Ă‹@ŠÖ‚Ć‚ĚŠÖŒWC‰Ć‘°ŠÖŒWC¸_“IƒTƒ|[ƒg‚Č‚Ç‘˝–â‘č‚đ•ř‚Ś‚˝‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) Ž–—á‚ւ̑Ήžv •˝Ź19”N“x‘ĺ˜a•ŰŒ’•ŸŽƒŽ––ąŠ“ď•aŒ¤C‰ď (Ž–—ጟ“˘‰ď) ‚É‚¨‚Ż‚鏕Œž. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź19”N“x‘ĺ˜a•ŰŒ’•ŸŽƒŽ––ąŠ“ď•aŒ¤C‰ď (2008/2/22), ‘ĺ˜a.

H19-732007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) “ď•a‚É‚¨‚Ż‚éÝ‘îƒ^[ƒ~ƒiƒ‹ (ƒIƒsƒIƒCƒhťÜ‚ĚŽg—p‚̉”\Ť). ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “s’}Ý‘îƒ^[ƒ~ƒiƒ‹Œ¤‹†‰ď (2008/3/11), “s’}‹ć.

H19-732008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ALS‚ĚÝ‘î‚Ý‚Ć‚č‚Ö‚ĚŽć‚č‘g‚Ý. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, ’r“cŠxŽi, ALSƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒ`[ƒ€, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź19”N“x”ljď‹c (2008/3), “Œ‹ž.

H19-732009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) _Œo“ď•a‚É‚¨‚Ż‚éƒp[ƒJƒbƒVƒ‡ƒlƒA‚Ě—L—pŤ. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, ‰ZśLˆę, ALSƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒ`[ƒ€, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź19”N“x”ljď‹c (2008/3), “Œ‹ž.

H19-732010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) NPPV‚Ě‹@Ší‚ĆƒCƒ“ƒ^[ƒtƒFƒCƒX. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź19”N“x”ljď‹c (2008/3), “Œ‹ž.

H19-732011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ALS‚É‚¨‚Ż‚éSNIP‚Ě—L—pŤ|‘ć3•ń|. ‹÷“cËŽq, ăo’źl, ‰Ź–ě”üŒbŽq1, •Ÿ“c—Ď–ç, ALSƒJƒ“ƒtƒ@ƒŒƒ“ƒXƒ`[ƒ€, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź19”N“x”ljď‹c (2008/3), “Œ‹ž.

H19-732012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ˆă—ψ’u‚ĚƒCƒ“ƒtƒH[ƒ€ƒhƒRƒ“ƒZƒ“ƒg‚đŽx‚Ś‚銳ŽŇŽx‰‡ƒc[ƒ‹‚ĚŒŸ“˘. ‰Ź–ě”üŒbŽq1, X‰i—F–í, ™‘şKM, ‹gŒ´çŒb, ‘Oě‹ąŽq, źŒ´N”ü, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź19”N“x”ljď‹c (2008), “Œ‹ž.

H19-732013. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) —ĂŒěŽ{Ý‚É‚¨‚Ż‚éĐŠQŒoŒą. ‰Ź–ě”üŒbŽq1, ŽR“c’JßŽq, ŒĂŕV‰p–ž, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź19”N“x”ljď‹c (2008), “Œ‹ž.

H19-732014. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) u‰‰‚đ’Ę‚ľ‚˝ŽŠŒČŽŔŒť|ˆăŠw•”u‰‰‚đŒoŒą‚ľ‚ā|. ‰Ź–ě”üŒbŽq1, ŽOˆä•qĆ, ŒĂŕV‰p–ž, Žç‰Ž—˜‰Ŕ2, ˆ˘•”@’ź, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2ˆăŠw‹łˆç): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź19”N“x”ljď‹c (2008), “Œ‹ž.

H19-733002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) “Ş•”MRIăC‘Ě˜H‚ÉŒŔ‹Ç‚ľ‚˝ˆŮí‚𔺂Á‚˝Źl”­ÇKrabbe•a‚Ě36Î—Ť—á. –k‘ş‰p“ń1, ‰Ź–ě”üŒbŽq2, ‰Ź–ě@—T1, ˆ˘‹v’Ă“ń•v1, âˆä•ś•F (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć181‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2007/6/2), “Œ‹ž, —Տ°_ŒoŠw 2008; 48 (6) 433.

H19-733003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) MRI‚ĹOpsoclonus‚̐ӔC•a‘ƒ‚ސ„’č‚ľ‚Ś‚˝‘˝”­Ťd‰ťÇ‚Ěˆę—á. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, Ž‰ĆKŽq, –k‘ş‰p“ń2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć35‰ń‰^“ŽáŠQŒ¤‹†‰ď (2008/1/26), “Œ‹ž.

H20-722001. [Šw‰ď(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) _Œo“ď•a‚ĚŒÄ‹z—Ă–@ƒNƒŠƒjƒJƒ‹ƒpƒX. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć30‰ń“ú–{ŒÄ‹z—Ă–@ˆăŠw‰ďŠwp‘‰ď (2008/7/4-5), ź–{, ´˜^W p.80.

H20-723001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Sniff nasal inspiratory pressure‚ƉĄŠu–Œ‹Ř—Í‚Ć‚ĚŠÖ˜A. ŽR‰Č“TŽq, Źo‚Š‚‚ç, ˛“ĄŽO“ŢŠó, ăo’źl, ‰Ź–ě”üŒbŽq1, ‚•˝ŽL (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć43‰ń“ú–{—Šw—Ă–@Šwp‘ĺ‰ď (2008/5/15-17), •Ÿ‰Ş, —Šw—Ă–@Šw 2008/4; 35 (Suppl 2): 571.

H20-723002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) ŠłŽŇ‚É‚¨‚Ż‚ésniff nasal inspiratory pressure‚Ćpeak cough flow‚Ć‚ĚŠÖ˜A. ŽRčŠx”V, ăo’źl, …–ěŒö•ă, ‹÷“cËŽq, •˝‰ę‚ć‚ľ‚Ý, •Ÿ“c—Ď–ç, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć43‰ń“ú–{—Šw—Ă–@Šwp‘ĺ‰ď (2008/5/15-17), •Ÿ‰Ş, —Šw—Ă–@Šw 2008/4; 35 (Suppl 2): 813.

H20-723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ”ńNP“IlHŒÄ‹zŠí‚Ě‹@Ží”äŠr|—Տ°HŠwŽm‚ĚƒAƒ“ƒP[ƒg’˛¸‚ć‚č|. ‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2, ‰ZśLˆę, âˆä•ś•F (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć26‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2008/6/26), ‰Ą•l, _ŒoŽĄ—ĂŠw 2008/5; 25 (3): 290.

H20-723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ’ˇŠúlHŒÄ‹zŠí‘•’…ŠłŽŇ‚Ě’_ÎE’_ůN‰Š‚Ě”­Ç‚ɂ‚˘‚Ä. –k‘ş‰p“ń1, ‰Ź–ě”üŒbŽq2, âˆä•ś•F (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć26‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2008/6/27), ‰Ą•l, _ŒoŽĄ—ĂŠw 2008/5; 25 (3): 291.

H20-723005. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹}ŤŽŠ—ĽŤŠ´ŠoŤ‰^“ŽŤƒjƒ…[ƒƒpƒ`[ (AASMN) ‚Ě’ˇŠú—\Œă. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć19‰ń“ú–{––˝_ŒoŠw‰ďŠwpW‰ď (2008/9/5), –źŒĂ‰Ž, ––˝_Œo 2008/12; 19 (2): 331-4.

H20-723006. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) “–‰@‚É‚¨‚Ż‚é‹ŘˆŢkŤ‘¤őd‰ťÇŠłŽŇ‚Ěš‹‰ş‹@”\•]‰ż‚ĚŽŔ‘Ô. ˆŔ“cŘ•ä, •Ÿ“c—Ď–ç, `@ŽáŘ, á–{—R”ü, ł˜Ň@—˛, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć14‰ń“ú–{ŰHEš‹‰şƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ď (2008/9/13-14), ç—t, “ú–{ŰHEš‹‰şƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŽGŽ 2008/12; 12 (3): 445.

H20-723007. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) —zE‰Aˆł‘ĚŠOŽŽlHŒÄ‹zŠí (RTX) ‚ĚÝ‘îlHŒÄ‹z—Ă–@Žw“ą‚ĚŽŽ‚݁@ALSŠłŽŇ‚̉îŒěŽŇ‚Ö‚ĚŽw“ą‚ĚŽŔŰ. ěă@—B, ‘Oě‹ąŽq, ‰ZśLˆę, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć18‰ń“ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŠwpW‰ď (2008/10/24-25), ˆ¤•Q, “ú–{ŒÄ‹zƒPƒAEƒŠƒnƒrƒŠƒe[ƒVƒ‡ƒ“Šw‰ďŽ 2008/10; 18 (Suppl): 115s.

H20-723008. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) Ý‘îŠĹŽć‚č‚ĚŽŔ‘H‚Ć–â‘č“_. ‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, ŕ_“cˆę2, âˆä•ś•F (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć11‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď (2009/3/1), Ž­Ž™“‡, ´˜^W p.148.

H20-723009. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) FisherÇŒóŒQ‚É‚¨‚Ż‚éRGQ1bR‘Ě‚Ě’ˇŠúŒo‰ß. “ü]KŽq, ‰Ź–ě”üŒbŽq1, ‹ŕŕV’ź”ü2, ŕ_“cˆę3, âˆä•ś•F, ‰Ź–ě@—T3 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2•a‘ԁEf—ĂŒn, 3_Œo“ŕ): ‘ć21‰ń“ú–{_Œo–ƉuŠw‰ďŠwpW‰ď (2009/3/12-13), ‘ĺă, _Œo–ƉuŠw(Neuroimmunol) 2009/3; 17 (1): 98.

H20-731001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ALS‚ĚŠÉ˜aƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź20”N“x’ˇčŒ§“ď•aŽx‰‡ƒlƒbƒgƒ[ƒNˆĎˆő‰ď (2009/3/19), ’ˇč.

H20-731002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) ‚ĚŽĄ—Ă‚ĆƒPƒA‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): –L“c_ŒoŽžŠłƒtƒH[ƒ‰ƒ€ (2009/3/30), ˆ¤’m.

H20-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Šî’˛u‰‰) ƒe[ƒ}u“ď•a`‚ť‚̐l‚ç‚ľ‚ł‚đŽx‚Ś‚év“ď•aALS‚Ć‚Í. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): 12Žü”N‹L”OŽ–—á”­•\‰ď (2008/6/21), “s’}‹ć.

H20-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰)u“ď•a‚ĚŠî‘b’mŽŻv‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź20”N“x“ď•aŠłŽŇ“™ƒz[ƒ€ƒwƒ‹ƒp[—{ŹŒ¤C (2008/7/7), “Ą‘ň.

H20-732003. [Šw‰ď(’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) Œťó‚Ěˆă—Ă•ŸŽƒ‘̐§‚̉îŒěE•ŸŽƒŽ{Ý‚̐_Œo‹Ř“ď•aŠłŽŇ‚Ö‚ĚŠˆ—p‚̉ۑč. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć5‰ń“ú–{“ď•aˆă—Ăƒlƒbƒgƒ[ƒNŒ¤‹†‰ď (2008/8/28), “Œ‹ž.

H20-732004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (Šî’˛u‰‰) ’nˆćƒPƒA‚É‚¨‚Ż‚é’†Šj•a‰@‚Ě–đŠ„‚Ć‰Ű‘č. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć6‰ńŽO“‡E–k‰Í“ŕ’nˆć_Œo“ď•aˆă—Ăƒlƒbƒgƒ[ƒNŒ¤C‰ď (2008/9/6), ‘ĺă.

H20-732005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚ĚŽĺ—v‚ČÇŒó‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć23‰ń–k—˘‘ĺŠw“Œ•a‰@_Œo“ď•aŒ¤C‰ď (2008/9/19), ‘Š–ÍŒ´.

H20-732006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰)u‘˝”­Ťd‰ťÇv‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź20”N“xˆă—Ă‘Š’kŽ–‹Ć (2008/9/25), ‘Š–ÍŒ´.

H20-732007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‹ŘˆŢkŤ‘¤őd‰ťÇu‰‰‰ď (2008/11/10), ‰Ą{‰ę.

H20-732008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ƒe[ƒ}u‹ŘˆŢkŤ‘¤őd‰ťÇ‚Ě—‰đ‚ĆƒPƒAvę–ĺˆă‚Š‚ç. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ALSŽx‰‡]Ž–ŽŇŒ¤C‰ď (2009/1/31), ‰Ą•l.

H20-732009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚ĚŠÉ˜aƒPƒA‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Ý‘î“ď•aŠłŽŇ•ŰŒ’•ŸŽƒ]Ž–ŽŇŒ¤C‰ď (2009/2/10), `–ě.

H20-732010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ‘˝”­Ťd‰ťÇ‚ĚŽĄ—Âɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć2‰ńƒRƒƒfƒBƒJƒ‹MSƒnƒ“ƒYƒIƒ“ƒZƒ~ƒi[ (2009/2/12), ‘Š–Í‘ĺ–ě.

H20-732011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ALS‚̐isŠú‚Š‚çI––Šú‚ĚƒPƒA`“ď•a‚ĚŠłŽŇ‚ł‚ń‚Ć‚Ç‚¤Œü‚Ť‡‚¤‚Š`. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _Œo“ŕ‰Č—Տ°‰Ű‘č‰đŒˆƒVƒŠ[ƒY (‘ć2’e) (2009/3/25), ˆ¤’m.

H20-732012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) “ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x”ljď‹c (2009), “Œ‹ž.

H20-732013. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) Ý‘ƒ‹ƒqƒlŽg—p‚Ě–â‘č“_. ‰Ź–ě”üŒbŽq1, âˆä•ś•F, •Î”NO (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x”ljď‹c (2009), “Œ‹ž.

H20-732014. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) –k—˘ę–ĺŠĹŒěŽtu“ď•aŠĹŒěvˆçŹƒvƒƒOƒ‰ƒ€‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, âˆä•ś•F, ‘Oě‹ąŽq, ‹gŒ´çŒb, ‘ĺ’J—ćŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x”ljď‹c (2009), “Œ‹ž.

H20-732015. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) _“ސě_Œo“ď•aƒlƒbƒgƒ[ƒNŽn“Ž‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, âˆä•ś•F, ‹gˆä•ś‹Ď, •Šâ‹`”V (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x”ljď‹c (2009), “Œ‹ž.

H20-732016. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ƒI[ƒfƒBƒbƒg’˛¸‚É‚ć‚éALSˆă—Ă‚Ě‘Ű”äŠrŒ¤‹†. ’†“‡@F, ˆÉ“Ą”Ž–ž1, Oliver David, “ď”g—ćŽq, ‰Ź–ě”üŒbŽq2, “Ąˆä’źŽ÷, M‘Œ\Œá, –xě@—g, ŒF–{rG, ”üŒ´@”Ő, ěˆä@[, ‹{•‘Žq, •Ÿ‰iGr, ‰€“cŽŠl, Campbell Colin, Sloan Richard, Sykes Nigel, Tallon Carole, Webb Sandi, Albert Steven (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚ĚŽŠ—§Žx‰‡‘̐§‚ĚŠm—§‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź20”N“x”ljď‹c (2009), “Œ‹ž.

H20-732017. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ƒMƒ‰ƒ“ĽƒoƒŒ[ÇŒóŒQ RƒKƒ“ƒOƒŠƒIƒVƒhR‘Ě—zŤ‹}Ť‰ŠÇŤƒjƒ…[ƒƒpƒ`[‚É‚¨‚Ż‚éR‘Ě‚Ě’ˇŠúŒo‰ß. ‰Ź–ě”üŒbŽq1, “ü]KŽq, ‹ŕŕV’ź”ü2, ŕ_“cˆę3, âˆä•ś•F, ‰Ź–ě@—T3 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2•a‘ԁEf—ĂŒn, 3_Œo“ŕ): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†”ǁv•˝Ź20”N“x”ljď‹c (2009), “Œ‹ž.

H21-713001. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The survey report of the ALS physicians in Japan. Ogino M1, Ogino Y2, Hamada J2: 20th International symposium on ALS/MND (2009/12/8-10), Berlin, Germany, ALS 2009; 10 (suppl 1): 48. (‰Ź–ě”üŒbŽq1, ‰Ź–ě@—T2, ŕ_“cˆę2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H21-713002. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) A Therapeutic agent(NDDPX08) Delays disease progression, improves motor function and prolongs survival in a mouse model of ALS. Tanaka K, Kanno T, Yanagisawa Y, Aoki M, Hadano S, Itoyama Y, Ogino M1, Iwasaki Y, Yoshii F, Ikeda J-E: 20th International symposium on ALS/MND (2009/12/8-10), Berlin, Germany, ALS 2009; 10 (suppl 1): 75. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H21-713003. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) The study of NIPPV using full-face mask remodeled to support endoscope in per-endoscopic gastrostomy in ALS patients. Ogino Y1, Yabuki S, Ogino M2: 20th International symposium on ALS/MND (2009/12/8-10), Berlin, Germany, ALS 2009; 10 (suppl 1): 188. (‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2: 1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H21-713004. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Dilemma and integrity of medical professionals. Ogino M1: 20th International symposium on ALS/MND (2009/12/8-10), Berlin, Germany. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H21-722001. [Šw‰ď(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) _Œo“ď•a (“Á‚ÉALS) ‚ĚŠÉ˜aƒPƒA‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć12‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď (2010/2/27-28), “Œ‹ž, “ú–{Ý‘îˆăŠw‰ďŽGŽ 2010; 12: 56-7.

H21-723001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Ý‘ŽŇ‚Ě–K–⃊ƒnƒrƒŠ‚Ö‚Ěƒj[ƒY‚ÉŠÖ‚ˇ‚é’˛¸|_ŒoĽ‹ŘŽžŠłŠłŽŇ‚đ‘ÎŰ‚Ć‚ľ‚˝’˛¸•ń|. ăo’źl, •Ÿ“c—Ď–ç, ˛“ĄŽu–ě, –ěŠÔ‹M—Y, •Ÿ“c—Ď–ç, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć44‰ń“ú–{—Šw—Ă–@Šwp‘ĺ‰ď (2009/5/28-29), “Œ‹ž, —Šw—Ă–@Šw 2009; 36 (‘ĺ‰ď“Á•Ę†2 (DVD-ROM)): ROMBUNNO.P2-195.

H21-723002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇŠłŽŇ‚É‚¨‚Ż‚éSniff Nasal Inspiratory Pressure‚đ—p‚˘‚˝‹z‹C‹Ř‹Ř—Í•]‰ż‚Ě—L—pŤ@ŽŔ‘Ş’l‚Ć—\‘Ş’l‚Ć‚Ě”äŠr. …–ěŒö•ă, ăo’źl, •˝‰ę‚ć‚ľ‚Ý, t“ú”ü•Ű, “Ą‹´‹Is, ‘厛ˆŸ—R”ü, ‰Ź–ě”üŒbŽq1, •Ÿ“c—Ď–ç (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć44‰ń“ú–{—Šw—Ă–@Šwp‘ĺ‰ď (2009/5/28-29), “Œ‹ž, —Šw—Ă–@Šw 2010/3; 37 (Suppl 2): 752.

H21-723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ALSŠłŽŇ‚Ě‚Öƒ‹ƒƒbƒgŒ^ƒ}ƒXƒNŽg—p‚ĚŽŽ‚݁|”畆áŠQ‰ü‘P‚ÉŒü‚Ż‚ă}ƒXƒNŽg—pŒoŒą•ń|. ěă@—B, ‘Oě‹ąŽq, ‰ZśLˆę, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć31‰ń“ú–{ŒÄ‹z—Ă–@ˆăŠw‰ďŠwp‘‰ď2009 (2009/7/10), ŽRŒ`, “ú–{ŒÄ‹z—Ă–@ˆăŠw‰ďŠwp‘‰ďƒvƒƒOƒ‰ƒ€Ľ´˜^W 2009; 31st: 150.

H21-723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) _Œo“ď•a‚đ‘čŢ‚Ć‚ľ‚čs‚Á‚˝—Տ°—Ď—‹łˆç‚Ě•]‰ż‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, Źě‰Ę—Ń, ŕ_“cˆę2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć41‰ń“ú–{ˆăŠw‹łˆçŠw‰ď‘ĺ‰ď (2009/7/24-25), ‘ĺă, ˆăŠw‹łˆç 2009/7; 40 (Suppl): 68.

H21-731001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ALS‚̕“IƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć13‰ńé‹ĘŒ§_Œo“ŕ‰Čˆă‰ď‘‰ď (2009/7/16), ‘ĺ‹{.

H21-731002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ|Ĺ‹ß‚Ě˜b‘č‚Ć’mŒŠ|. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź21”N“x­ôˆă—Ăƒlƒbƒgƒ[ƒNu_ŒoE‹ŘŽžŠłvŒ¤C‰ď (2009/10/31), ŽD–y.

H21-731003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) NP“IlHŒÄ‹zŠí‚đ‘I‘đ‚ľ‚Č‚˘ę‡‚ĚALSŠłŽŇ‚ł‚ń‚ĚŠÉ˜aƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć2‰ń_ŒoŽžŠłƒPƒAƒVƒ“ƒ|ƒWƒEƒ€|“ú–{ALS‹Ś‰ď’ˇ–ěŒ§Žx•”‚ĚÄŒ‹Ź‚đ‹L”O‚ľ‚ā| (2010/2/13), ź–{.

H21-731004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ALS‚̕“IƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć5‰ńě‰z_Œo“ŕ‰Č§˜b‰ď (2010/3/10), é‹Ę.

H21-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) “ď•a‚ĚŠî‘b’mŽŻ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•aŠłŽŇ“™ƒz[ƒ€ƒwƒ‹ƒp[—{ŹŒ¤C‰ď (2009/6/30), “Ą‘ň.

H21-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚ĚŠÉ˜aƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ’ߊމˇň•a‰@‰@“ŕ•×‹­‰ď (2009/7/7), _“ސě.

H21-732003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ALS‚ĚÝ‘îˆă—Ă. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “úś‹ŚÝ‘îˆă—ĂƒtƒFƒ[ƒVƒbƒv“Œ‹žŒöŠJu‰‰‰ď (2009/9/19), “Œ‹ž.

H21-732004. [Šw‰ď(’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) MI-E‚Ěˆă—Ă•ŰŒŻŽ”őó‹ľ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć5‰ń_Œo“ď•a‚Ě”ńNPŒÄ‹zƒPƒAEƒ[ƒNƒVƒ‡ƒbƒv (2009/10/3), “Œ‹ž, ´˜^W p.11-5.

H21-732005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆË—Š‰‰‘č) ALS‚É‚¨‚Ż‚éNPPV. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć23‰ń”ńNP“IŠˇ‹C—Ă–@Œ¤‹†‰ď (2009/11/4), _ŒË.

H21-732006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) Ý‘îlHŒÄ‹z—Ă–@‚ĆƒŒƒXƒpƒCƒg“ü‰@. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć342‰ńŒť’nŒ¤C‰ďuÝ‘îdÇ“ď•aŠłŽŇ‚Ö‚Ě’nˆćƒPƒAv (2009/12/20), ˛‰ę.

H21-732007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚Ě—‰đ‚ƑΉž. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź21”N“x“ď•aŽx‰‡’S“–ŽŇŒ¤C (2010/3/29), ‘Š–ÍŒ´.

H21-732008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ƒMƒ‰ƒ“ĽƒoƒŒ[ÇŒóŒQ ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒXŠ´ő‚ĆGBS. ‰Ź–ě”üŒbŽq1, “ü]KŽq, ‹ŕŕV’ź”ü2, –]ŒŽGŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2•a‘ԁEf—ĂŒn): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću–ƉuŤ_ŒoŽžŠł‚ÉŠÖ‚ˇ‚é’˛¸Œ¤‹†”ǁv•˝Ź21”N“x”ljď‹c (2010), “Œ‹ž.

H21-732009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ƒp[ƒJƒbƒVƒ‡ƒlƒA“ą“ü‚ĚƒAƒZƒXƒƒ“ƒg. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷, Šâč‹¤, ‰ZśLˆę (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź21”N“x”ljď‹c (2010), “Œ‹ž.

H21-732010. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ƒXƒRƒ|ƒ‰ƒ~ƒ““îp‚Ě—L—pŤ‚ĚŒ¤‹†. ‰Ź–ě”üŒbŽq1, ‹{ěšD, –]ŒŽGŽ÷, ‘O“cŽŔ‰Ô2, •ě­ˆę (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2–ňÜ•”): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚̐śŠˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź21”N“x”ljď‹c (2010), “Œ‹ž.

H21-732011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) “ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“ŤŽžŠł‚Ěˆă—Ă”ď\‘˘‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź21”N“x”ljď‹c (2010), “Œ‹ž.

H21-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒp[ƒLƒ“ƒ\ƒ“ƒjƒYƒ€‚đ’ć‚ľCGFAPˆâ“`Žq•ĎˆŮ‚đ”F‚ß‚˝ŹlŒ^Alexander•a‚Ě58Î’jŤ—á. –k‘ş‰p“ń1, ‰Ź–ě”üŒbŽq2, ‹ŕŕV’ź”ü3, âˆä•ś•F, ’Җ쐸ˆę (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3•a‘ԁEf—ĂŒn)F‘ć190‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2009/9/16), “Œ‹ž, —Տ°_ŒoŠw 2009/9; 49 (9): 609.

H21-733002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ’ˇŠú‚É‚í‚˝‚čŇ‘•a•Ď‚ĚŽî‘ĺ‚đ”F‚ß‚˝‘˝”­Ťd‰ťÇ‚Ě56Î—Ť—á ‹{ěšD, ‰Ź–ě”üŒbŽq1, ‰Y–ě‹`Í, ˆ˘‹v’Ă“ń•v2, –]ŒŽGŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć192‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2010/3/6), “Œ‹ž, —Տ°_ŒoŠw 2011/1; 51 (1)F70.

H22-713001. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) ALS patients on mechanical ventilation have greater risk of cholecystitis. Ogino M1, Kitamura E2, Ogino Y2, Mochizuki H: 21st International Symposium on ALS/MND (2010/12/11) , Orlando, Florida, USA, ALS 2010; 11 (suppl 1): 155-6. (‰Ź–ě”üŒbŽq1, –k‘ş‰p“ń2, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H22-713002. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Possession of assistive devices among persons with amyotrophic lateral sclerosis. Otera A, Takahashi K, Ogino M1, Fukuda M: 21st International Symposium on ALS/MND (2010/12/12), Orlando, Florida, USA, ALS 2010; 11 (suppl 1): 133. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H22-722001. [Šw‰ď(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ‚˂炢. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć51‰ń“ú–{_ŒoŠw‰ď‘‰ď (2010/5/20-22), “Œ‹ž, —Տ°_Œo 2010; 50: 1025.

H22-722002. [Šw‰ď(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ALSI––ŠúƒPƒA‚ÉŠÖ‚ˇ‚éƒAƒ“ƒP[ƒg’˛¸Œ‹‰Ę. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć51‰ń“ú–{_ŒoŠw‰ď‘‰ď (2010/5/20-22), “Œ‹ž, —Տ°_Œo 2010; 50: 1026-8.

H22-722003. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) _Œo“ď•a‚ĆŠÉ˜aˆă—ĂĽI––Šúˆă—Ă. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć28‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2010/7/15-16), ‰Ą•l, _ŒoŽĄ—ĂŠw 2010/5; 27 (3): 334.

H22-723001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) SNIP‚đŽg—p‚ľ‚˝ALSŒÄ‹z‹@”\•]‰ż‚ɂ‚˘‚Ä. ‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2, ăo’źl, –]ŒŽGŽ÷, ăo’źl, •˝‰ę‚ć‚ľ‚Ý, •Ÿ“c—Ď–ç (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć51‰ń“ú–{_ŒoŠw‰ď‘‰ď (2010/5/20), “Œ‹ž, —Տ°_Œo2010; 50: 1125.

H22-723002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Advance Directives (Ž–‘OŽwŽŚ) ‚ĚŒ´‘Ľ‚đ‚ß‚Ž‚Á‚ā|‹ŘˆŢkŤ‘¤őd‰ťÇ‚𒆐S‚Ɂ|. ˆÉ“Ą”Ž–ž1, ’†“‡@F, ”ˆäFˆë˜Y, ˆÉ“Ą“šĆ, “ď”g—ćŽq, ‰Ź–ě”üŒbŽq2, ‘ĺ‹÷‰xŽq, ĄˆäŽŽu (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć51‰ń“ú–{_ŒoŠw‰ď‘‰ď (2010/5/21), “Œ‹ž, —Տ°_Œo 2010; 50: 1200.

H22-723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) _Œo‹ŘŽžŠł‚É‚¨‚Ż‚éƒXƒRƒ|ƒ‰ƒ~ƒ““îp‚Ě—L—pŤ. ‹{ěšD, ‰Ź–ě”üŒbŽq1, ‰Y–ě‹`Í, –]ŒŽGŽ÷, •ŽR­ˆę2, ‘O“cŽŔ‰Ô3 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2“Œ•a‰@–ňÜ•”, 3–ňÜ•”): ‘ć51‰ń“ú–{_ŒoŠw‰ď‘‰ď (2010/5/22), “Œ‹ž, —Տ°_Œo 2010; 50: 1262.

H22-723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ALSŠÉ˜aƒPƒA‚ÉŠÖ‚ˇ‚éƒAƒ“ƒP[ƒg’˛¸Œ‹‰Ę‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷, ‰Ź–ě@—T2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć51‰ń“ú–{_ŒoŠw‰ď‘‰ď (2010/5/22), “Œ‹ž, —Տ°_Œo 2010; 50; 1266.

H22-723005. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇŠłŽŇ‚É‚¨‚Ż‚é•ŸŽƒ—p‹ď“ą“ü‚ĚŽŔ‘Ô’˛¸|ě‹Ć—Ă–@Žm‚Ş‘I’č‚ľ‚˝•ŸŽƒ—p‹ď‚ÉĹ“_‚𓖂Ăā|. ‘厛ˆŸ—R”ü, •Ÿ“c—Ď–ç, ŠJŕV–˘Šó, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć44‰ń“ú–{ě‹Ć—Ă–@Šw‰ď‘‰ď (2010/6/11-13), ĺ‘ä, ´˜^W (CD-ROM) 2010; 44th: ROMBUNNO.O334.

H22-723006. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇŠłŽŇ‚É‚¨‚Ż‚é‹z‹C‹Ř”ć˜J‚Ě•]‰ż•ű–@‚ĚŒŸ“˘|maximum relaxation rate‚É‚ć‚é•]‰ż|. ăo’źl, •Ÿ“c—Ď–ç, …–ěŒö•ă, ŽRčŠx”V, ‹{é‚ľ‚Ů, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć44‰ń“ú–{ě‹Ć—Ă–@Šw‰ď‘‰ď (2010/6/11-13), ĺ‘ä, —Šw—Ă–@ 2010; 37 (‘ĺ‰ď“Á•Ę†2 (DVD-ROM)): ROMBUNNO.SE2-011.

H22-723007. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) ‚ĚŠÉ˜aƒPƒA‚Ě–â‘č“_. ‰Ź–ě”üŒbŽq1, ‹{ěšD, ‰Y–ě‹`Í, –k‘ş‰p“ń2, –]ŒŽGŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć15‰ń“ú–{ŠÉ˜aˆă—ĂŠw‰ďŠwp‘ĺ‰ď (2010/6/19), “Œ‹ž, ´˜^W 2010/6; 319.

H22-723008. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ (ALS) ‚É‚¨‚Ż‚éŒo”çŒoH“šˆÝŠÇ‘}“üp (P-TEG) ‚ĚŒoŒą. ‰Ą“c˜aŽq, ‰Ź–ě”üŒbŽq1, ‹{ěšD, ‰Y–ě‹`Í, –k‘ş‰p“ń2, –]ŒŽGŽ÷, ‰Ź–ě@—T2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ): ‘ć28‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2010/7/16), ‰Ą•l, _ŒoŽĄ—ĂŠw 2010/5; 27 (3): 421.

H22-723009. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) Šů‘śŽĄ—Ă–ňNDDPX08‚Ě”­ÇŒă“Š—^‚ÍALSƒ}ƒEƒXƒ‚ƒfƒ‹‚̉^“Ž‹@”\‚đ‰ü‘P‚ľC”­ÇŒă‚̐ś‘śŠúŠÔ‚đ‰„’ˇ‚ˇ‚é (The therapeutic agent NDDPX08 promotes sustainable motor performance and extends a post-onset survival interval in an ALS mouse model). “c’†ˆę‘Ľ, ›–ě‘ń–ç, –ö‘ň‰ŔŽq, Â–ؐłŽu, `–ěL“ń, Ž…ŽR‘אl, ‰Ź–ě”üŒbŽq1, Šâč‘×—Y, ‹gˆä•ś‹Ď, ’r“cât‰q (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Neuro2010 (‘ć33‰ń“ú–{_Œo‰ČŠw‘ĺ‰ďE‘ć53‰ń“ú–{_Œo‰ťŠw‰ď‘ĺ‰ďE‘ć20‰ń“ú–{_Œo‰ń˜HŠw‰ď‘ĺ‰ď‡“Ż‘ĺ‰ď) (2010/9/2-4), _ŒË, _Œo‰ťŠw 2010/8; 49 (2-3): 671.

H22-723010. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ALSÝ‘îŠĹŽć‚č‚ĚŒťó|Ý‘îƒXƒ^ƒbƒt‚Ě‚¨‚ŕ‚˘|. ‰Ź–ě”üŒbŽq1, ‰““Ą@Šî, ‹{ěšD, Ôě’ź”V, –]ŒŽGŽ÷, ’†ěŒb“sŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć13‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď (2011/3/12), ‘ĺă, ´˜^W p.81. (Ž†ă”­•\)

H22-723011. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘ĺŠw•a‰@ƒŠƒjƒ…[ƒAƒ‹Œv‰ć‚É‚¨‚Ż‚éÝ‘îŽx‰‡•a“\‘z|‚ą‚ç‚Š‚ç‚Ě‘ĺŠw•a‰@‚É‚¨‚Ż‚éÝ‘î˜AŒg‚ĚÝ‚č•ű|. ‰Ź–ě”üŒbŽq1, ‹e’rŽj˜Y2, a’J–ž—˛3 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 24•a‰@˜AŒg‹łˆç, 3ˆă—ĂˆŔ‘SEŠÇ—): ‘ć13‰ń“ú–{Ý‘îˆăŠw‰ď‘ĺ‰ď (2011/3/12), ‘ĺă, ´˜^W p.138. (Ž†ă”­•\)

H22-731001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ALS‚Ě—Ď—“I–â‘č‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć7‰ńNEUROLOGY CONFERENCE IN HYOGO (2010/4/24), _ŒË.

H22-731002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _Œo“ď•a‚ĚÝ‘îˆă—Ă‚Ćˆă—Ă˜AŒg. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘Š–ÍŒ´Ý‘îˆă—ĂŒ¤‹†‰ď (2010/4/27), ‘Š–Í‘ĺ–ě.

H22-731003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) _Œo“ď•a‚̍Ž•ž‚ĆŽŠ‘îŽx‰‡`Ą‚Ĺ‚Ť‚é‚ą‚Ć‚Š‚ç`. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ú–{_ŒoŠw‰ďŽĺĂŒöŠJŽs–ŻuŔ`_Œo“ď•a‚̍Ž•ž‚ĆÝ‘îŽx‰‡‚ÉŒü‚Ż‚ā` (2010/8/7), ‰ŞŽR.

H22-731004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (“Á•Ęu‰‰) ALSisŠú‚Ěˆă—Ă˜AŒg‚ĆƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć22‰ń–k˜a_Œo“ŕ‰ČŒ¤‹†‰ď (2011/2/10), “Ţ—Ç.

H22-732001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) dÇ‹Ř–ł—͏ǂɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘S‘dÇ‹Ř–ł—͏ǗF‚̉ď_“ސěŽx•” (2010/5/29), ‰Ą•l.

H22-732002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ALS‚É‚¨‚Ż‚éu‰‰‰ď‚ĆˆÓŒŠŒđŠˇ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): _Œo“ď•aŒ¤‹†‰ď (2010/6/5), ’šŽć.

H22-732003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ALS‚ĚŽĄ—Ă‚ĆƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć9‰ń“ú–{ALS‹Ś‰ďé‹ĘŒ§Žx•”‘‰ď (2010/6/19), é‹Ę.

H22-732004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) “ď•a‚ĚŠî‘b’mŽŻ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): “ď•aŠłŽŇ“™ƒz[ƒ€ƒwƒ‹ƒp[—{ŹŒ¤C (2010/6/25), “Ą‘ň.

H22-732005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (‹L”Ou‰‰) _Œo“ď•aÝ‘ŽŇ‚ĚŽĄ—Ă‚ĆƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): é‹ĘŒ§“ď•a‘Š’kEŽx‰‡ƒZƒ“ƒ^[1Žü”N‹L”Ou‰‰‰ď (2010/7/27), é‹Ę.

H22-732006. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ˆă—Ă˜AŒg‚ĆŠĹŽć‚č‚Ě–â‘č. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć1‰ńALSƒtƒH[ƒ‰ƒ€`ALSĹ‘Oü` (2010/8/28), “Œ‹ž.

H22-732007. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ALS‚ĚŠÉ˜aƒPƒA`I––Šú‚𒆐S‚Ɂ`. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć5‰ń_Œo“ď•aƒtƒH[ƒ‰ƒ€ (2010/9/8), ‹ž“s.

H22-732008. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚Ě—‰đ`‹ŘˆŢkŤ‘¤őd‰ťÇCƒp[ƒLƒ“ƒ\ƒ“•a‚𒆐S‚Ɂ`. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź22”N“x“ď•aŒ¤C‰ď (2010/9/2), ‘ĺ˜a.

H22-732009. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) NPPV“ą“ü‚Ě‚ą‚Â. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć7‰ń“ú–{“ď•aˆă—Ăƒlƒbƒgƒ[ƒNŒ¤‹†‰ď (2010/10/1), ‰Ą•l.

H22-732010. [Šw‰ď(’n•ű‰ďEŒ¤‹†‰ď)] (ƒVƒ“ƒ|ƒWƒEƒ€) ŠÖ“ŒƒuƒƒbƒN. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć7‰ń“ú–{“ď•aˆă—Ăƒlƒbƒgƒ[ƒNŒ¤‹†‰ď (2010/10/1-2), ‰Ą•l.

H22-732011. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) “ď•a‚Ć‚Ş‚ń‚Ěƒ^[ƒ~ƒiƒ‹‚ĚŠÉ˜aƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź22”N“x“ď•aę–ĺŒ¤C‰ď (2010/10/3), ˆ¤•Q.

H22-732012. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚ĚŽĺ—v‚ČÇŒó‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć25‰ń–k—˘“Œ•a‰@_Œo“ď•aŒ¤C‰ď (2010/10/25), ‘Š–ÍŒ´.

H22-732013. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰)u_Œo“ŕ‰Čę–ĺˆă‚Š‚ç‚Ý‚é, Ý‘î‚Ć‚Ě˜AŒg‚ɂ‚˘‚āv`ALSŠłŽŇ‚Ě˜b‚ľ‚𒆐S‚Ɂ`. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •×‹­‰ď (2010/11/2), “Œ‹ž.

H22-732014. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (u‹`) I. _Œo“ď•a‚Ě—Ő°Œťę‚É‚¨‚Ż‚鎀śŠĎ. II. _Œo“ď•a‚ĚŒťę‚ƐlŒ —iŒě. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ˆî“c‘ĺŠwlŠÔ‰ČŠwŠwp‰@u—Տ°Ž€śŠwŠT˜_vu‹` (Šw•”‚¨‚ć‚ђʐM‰Ű’ö) (2010/11/16), Š‘ň.

H22-732015. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (u‹`) II. _Œo“ď•a‚ĚŒťę‚ƐlŒ —iŒě. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ˆî“c‘ĺŠwlŠÔ‰ČŠwŠwp‰@uŽĐ‰ď•ŸŽƒŒťęŽŔKŽw“ąvu‹` (Šw•”)) (2010/11/16), Š‘ň.

H22-732016. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ALS‚ĚŠÉ˜aƒPƒA`’m‚Š‚çI––Šú‚܂Ł`. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź22”N“x_Œo“ď•aˆă—ĂŒ¤C‰ď (2010/11/16), ŒQ”n.

H22-732017. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚ĚŽžŠł‚Ě—‰đ‚ƑΉž‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź22”N“x‘ć1‰ń“ď•aŠłŽŇ“™ƒz[ƒ€ƒwƒ‹ƒp[—{ŹŒ¤C (Šî‘b‰Ű’öI) (2010/12/20), ‘Š–ÍŒ´.

H22-732018. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰)yÝ‘î“ď•a—Ă—{ŽŇ‚ĚˆŔ‘SEˆŔS‚Č‚˝‚ń‚Ě‹zˆř‚Ɛę–ĺ“I”r‚˝‚ń–@‚ɂ‚˘‚āzŒÄ‹z‹@”\‚Ě•]‰ż‚Ɛę–ĺ“I”r‚˝‚ńƒPƒA. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź22”N“x‘ć2‰ń“Œ‹ž“s_Œo“ď•aˆă—Ăƒlƒbƒgƒ[ƒNŒ¤C‰ďE“ď•aƒZƒ~ƒi[ (2011/1/14), “Œ‹ž.

H22-732019. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚ĚŽžŠł‚Ě—‰đ‚ƑΉž‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): •˝Ź22”N“x‘ć2‰ń“ď•aŠłŽŇ“™ƒz[ƒ€ƒwƒ‹ƒp[—{ŹŒ¤C (Šî‘b‰Ű’öI) (2011/1/25), ‘Š–ÍŒ´.

H22-732020. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ALSƒPƒA‚ĚŽŔŰ. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć25‰ńěčŒÄ‹zƒPƒAŒ¤‹†‰ď (2011/2/17), ěčŽs.

H22-732021. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ‚̍ŐVˆă—Ă‚ĆQOLŒüă‚Ěˆ×‚ĚŽx‰‡‚đl‚Ś‚é. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ’nˆć‚ĹŽx‰‡‚ˇ‚él‚Ě‚˝‚ß‚Ěˆă—Íu‰‰‰ďEˆÓŒŠŒđŠˇ‰ď (2011/2/22), ‰Ą•l.

H22-732022. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ŒöŠJuŔE‹łˆçu‰‰) _Œo“ď•a‚ĚŠÉ˜aƒPƒA`ALS‚𒆐S‚É. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć24‰ńŒF–{_Œo“ď•aŒ¤‹†‰ď (2011/3/4), ŒF–{.

H22-732023. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ALSƒ`[ƒ€ˆă—Ă‚É‚¨‚Ż‚éî•ń‹¤—L‚ɂ‚˘‚Ä. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x”ljď‹c (2011), “Œ‹ž.

H22-732024. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ƒI[ƒgƒXƒpƒCƒAS-507‚đ—p‚˘‚˝Sniff Nasal Inspiratory Pressure (SNIP) ‘Ş’č‚Ě—L—pŤ. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷, …–ěŒö•ă, •˝‰ę‚ć‚ľ‚Ý, t“ú”ü•Ű, “Ą‹´‹Is, ‹{é‚ľ‚Ů, Ź–쎛ˆŸ–í, ăo’źl, •Ÿ“c—Ď–ç (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x”ljď‹c (2011), “Œ‹ž.

H22-732025. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ALSŠłŽŇ‚̏I––ŠúƒPƒA|NPPV’ˇŠúŽg—pŠłŽŇ‚ĚƒPƒA‚Ĺ’ź–Ę‚ˇ‚é–â‘č‚Š‚ç|. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷, ěă@—B, ‘ĺ’J—ćŽq, ‘Oě‹ąŽq (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x”ljď‹c (2011), “Œ‹ž.

H22-732026. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) Ž‹ü“ü—͈ӎv“`’B‘•’u‚đ—p‚˘‚˝•śŽš“ü—Í‚ÉŠÖ‚ˇ‚錟“˘. ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷, ‘Oę—m—C, ’|“ੰl, ‘厛ˆŸ—R”ü, ‚‹´‘ăŽq, ’†ź_Ži, •Ÿ“c—Ď–ç (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x”ljď‹c (2011), “Œ‹ž.

H22-732027. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (h‘č•ń) ‹ŘˆŢkŤ‘¤őd‰ťÇŠłŽŇ‚É‚¨‚Ż‚é‰h—{áŠQ‚ĚŒă•űŽ‹“IŒ¤‹†|‘˝Ž{Ý‹¤“ŻŒ¤‹†|. ´…r•v, ’ˇ‰ŞŽŽq, ě“c–žL, “B–{çt, •Šâ‹`”V, ěˆä@[, ‰ş”¨‹—Ç, źŕVł–L, ”üŒ´@”Ő, r”¨@‘n, “Ąˆä’źŽ÷, “ď”g—ćŽq, ˆÉ“Ą”Ž–ž1, ĄˆäŽŽu, ‹ß“Ą´•F, ‰Ź–ě”üŒbŽq2, Mš Œ\Œá, ’†“‡@F, ŹX“N•v (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): Œúś˜J“­Č“ŤŽžŠłŽ•žŒ¤‹†Ž–‹Ću“Á’莞ŠłŠłŽŇ‚É‚¨‚Ż‚鐜Šˆ‚ĚŽż (Quality of Life, QOL) ‚ĚŒüă‚ÉŠÖ‚ˇ‚錤‹†v•˝Ź22”N“x”ljď‹c (2011), “Œ‹ž.

H22-733001. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‚—î”­Ç‰Ć‘°ŤƒAƒ~ƒƒCƒh[ƒVƒX‚Ě’jŤ“ń—á. –S•˝, ‰Ź–ě”üŒbŽq1, ‹{ěšD, –]ŒŽGŽ÷, ŠÖ“‡—ÇŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć193‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2010/6/5), “Œ‹ž, —Տ°_ŒoŠw 2010/6; 50 (6): 440.

H22-733002. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ‘˝Œn“ˆŢkÇ‚ɉ^“Žƒjƒ…[ƒƒ“áŠQ‚đ‡•š‚ľ‚˝ˆę—á. ‰Y–ě‹`Í, ‰iˆä^‹MŽq, “í@~ˆę, ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć194‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2010/9/4), “Œ‹ž, —Տ°_ŒoŠw 2011/5; 51 (5): 391.

H22-733003. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw“Œ•a‰@‚É‚¨‚Ż‚é’čŠú“IƒŒƒXƒpƒCƒgƒPƒA`ƒŒƒXƒpƒCƒg“ü‰@‚ŞŠłŽŇE‰Ć‘°‚É‚ŕ‚˝‚炡ƒƒŠƒbƒg‚Ɖ^‰c‚ĚŽŔŰ`. ‘Oě‹ąŽq1, Œä‰€ś–­Žq1, ˛“ĄŽu•Ű, ‰Ź–ě”üŒbŽq2, –]ŒŽGŽ÷ (1“Œ•a‰@ŠĹŒě•”, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć7‰ń“ú–{“ď•aˆă—Ăƒlƒbƒgƒ[ƒNŒ¤‹†‰ď (2010/10/1), ‰Ą•l.

H22-733004. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) lHŒÄ‹zŠí‚Š‚ç—Ł’E‚ľ‚Đś‚Ť‚é‚ą‚Ć‚đ‘I‘đ‚ľ‚˝ALSŠłŽŇ‚Ě1Ç—á@`‰@“ŕŠOƒ`[ƒ€ˆă—Ă‚ĚŽ‹“_‚Š‚ç`. “n•””ü˜a, ‘Oě‹ąŽq1, ‹{ěšD, ‰Ź–ě”üŒbŽq2, –]ŒŽGŽ÷ (1“Œ•a‰@ŠĹŒě•”, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć7‰ń“ú–{“ď•aˆă—Ăƒlƒbƒgƒ[ƒNŒ¤‹†‰ď (2010/10/1), ‰Ą•l.

H22-733005. [Šw‰ď (’n•ű‰ďEŒ¤‹†‰ď)] (ˆę”ʍu‰‰) ƒgƒLƒ\ƒvƒ‰ƒYƒ}Ň‘‰Š‚ĆŠÓ•Ę‚Ş˘“ď‚Ĺ‚ ‚Á‚˝ƒuƒ^‰ń’ŽŤŇ‘‰Š‚Ě54Î’jŤ—á. ’ç@ăĕ˝1, “ŕ–쏲Žq2, ‹{ěšD, ‰Ź–ě”üŒbŽq3 (1Ž¨•@ˆôAE“ŞčňŠO, 2‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 3V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć196‰ń“ú–{_ŒoŠw‰ďŠÖ“ŒEbM‰z’n•ű‰ď (2011/3/5), “Œ‹ž, —Տ°_ŒoŠw 2011/8; 51 (8): 627.

H23-713001. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Opinions and behaviors of Japanese and American neurologists regarding tracheostomy with invasive ventilation (TIV). Dirienzo A, Ogino M1, Rabkin J, Goetz R, Pasmantier M, Mcelhiney M, Mitsumoto H, TIV STUDY GROUP: 22nd International Symposium on ALS/MND (2011/12/1), Sydney, Australia, ALS 2011; 12 (suppl 1): 29-30. (‰Ź–ě”üŒbŽq1: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă)

H23-713002. [Šw‰ď (‘Ű)] (ˆę”ʍu‰‰) Analysis of the end of life situation in 115 consecutive ALS patienta in the past nine years. Ogino M1, Kitamura E2, Miyakawa S, Utino A, Urano Y, Nagai M2, Ogino Y2: 22nd International Symposium on ALS/MND (2011/12/1), Sydney, Australia, ALS 2011; 12 (suppl 1): 61. (‰Ź–ě”üŒbŽq1, –k‘ş‰p“ń2, ‰iˆä^‹MŽq2, ‰Ź–ě@—T2: 1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ)

H23-722001. [Šw‰ď(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) ĐŠQŽx‰‡Žó‚Ż“ü‚ę•a‰@‚Ć‚ľ‚Ä. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć52‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2011/5/18-20), –źŒĂ‰Ž.

H23-722002. [Šw‰ď(‘S‘)] (ƒVƒ“ƒ|ƒWƒEƒ€) Œă•űŽx‰‡‚ĚŒoŒą‚Š‚ç‚Ě–â‘č“_. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć29‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2011/11/17-18), •Ÿˆä, _ŒoŽĄ—ĂŠw 2012; 29: 227-30.

H23-722003. [Šw‰ď (‘S‘)] (‹łˆçu‰‰) _Œo“ď•a‚ĆŠÉ˜aˆă—ÁEI––Šúˆă—Á|ƒIƒsƒIƒCƒhEƒ‚ƒ‹ƒqƒl‚ĚŽg—p‚𒆐S‚Ɂ|. ‰Ź–ě”üŒbŽq (V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć29‰ń“ú–{_ŒoŽĄ—ĂŠw‰ď‘‰ď (2011/11/17-18), •Ÿˆä.

H23-723001. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) LRRK2 (I2020T) ‘Š–ÍŒ´‰ĆŒn‚Ě”ń‰^“ŽÇó‚ĚŒŸ“˘. ‰Ź–ě@—T1, ‰Ź–ě”üŒbŽq2, Ž‰ĆKŽq, —Ŕ@ł•Ł, –]ŒŽGŽ÷, ’ˇ’JěˆęŽq1, …–ě”ü–M (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć52‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2011/5/18), –źŒĂ‰Ž, —Տ°_ŒoŠw 2011; 51: 1223.

H23-723002. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) –k—˘‘ĺŠw“Œ•a‰@_Œo“ŕ‰Č‚É‚¨‚Ż‚é_Œo“ď•a–K–âf—Ă‚ĚŒťó. ě˜Q@•ś1, ‰Ź–ě”üŒbŽq2, •Ÿ“c—Ď–ç, ‰iˆä^‹MŽq1, ‰““Ą@Šî, ‹{ěšD, –k‘ş‰p“ń1, ˛“Œ–ƒ‹|, “ŕ–쏲Žq3, –]ŒŽGŽ÷ (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć52‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2011/5/18), –źŒĂ‰Ž, —Տ°_ŒoŠw 2011; 51: 1274.

H23-723003. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) GBS‚Ě—\Œă‚Ě•Ď‘J@Ĺ‹ß‚Ě—\Œă‚Í‚Ç‚¤‚Č‚Á‚Ä‚˘‚é‚Ě‚Š. ˛“Œ–ƒ‹|, ‰Y–ě‹`Í, “ŕ–쏲Žq1, ‹{ěšD, ‰Ź–ě”üŒbŽq2, –]ŒŽGŽ÷ (1‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć52‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2011/5/18), –źŒĂ‰Ž, —Տ°_ŒoŠw 2011; 51: 1291.

H23-723004. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‘˝”­Ťd‰ťÇ‚̍‚ŽŸ”]‹@”\|BRB-N‚đ—p‚˘‚˝ŒŸ“˘|. ‹gˆä•ś‹Ď, ‚–ؔɎĄ, ‰i“c‰hˆę˜Y, ěŒűç‰ŔŽq, •Šâ‹`”V, —é–Ř‚ä‚ß, ’ˇ’Jě‘׍O, š Ž–ç, áÁ–Ř“ń—t, –]ŒŽGŽ÷, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć52‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2011/5/19), –źŒĂ‰Ž, —Տ°_ŒoŠw 2011; 51: 1314.

H23-723005. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ‹ŘˆŢkŤ‘¤őd‰ťÇ‚É‚¨‚Ż‚é‰h—{áŠQ‚ĚŒă•űŽ‹“I’˛¸; ‘˝Ž{Ý‹¤“ŻŒ¤‹†. ´…r•v, ’ˇ‰ŞŽŽq, ě“c–žL, “B–{çt, •Šâ‹`”V, ěˆä@[, ‰ş”¨‹—Ç, źŕVł–L, ”üŒ´@”Ő, r”¨@‘n, “Ąˆä’źŽ÷, “ď”g—ćŽq, ˆÉ“Ą”Ž–ž1, ĄˆäŽŽu, ‹ß“Ą´•F, ‰Ź–ě”üŒbŽq2, Mš Œ\Œá, ’†ŽR—D‹G, ’†“‡@F, ŹX“N•v (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć52‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2011/5/20), –źŒĂ‰Ž, —Տ°_ŒoŠw 2011; 51: 1391.

H23-723006. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ALS‚ĚŽ€–Só‹ľ‚Ě•ŞÍ@‰ß‹Ž9”NŠÔ˜A‘ą100Ž€–S—á‚Š‚ç. ‰Ź–ě”üŒbŽq1, –k‘ş‰p“ń2, ‹{ěšD, “ŕ–쏲Žq3, ‰Y–ě‹`Í, –]ŒŽGŽ÷, ‰Ź–ě@—T2 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă, 2_Œo“ŕ, 3‘ĺŠw‰@ˆă—ĂŒnŒ¤‹†‰Č): ‘ć52‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2011/5/20), –źŒĂ‰Ž, —Տ°_ŒoŠw 2011; 51: 1392.

H23-723007. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒŒƒr[Ź‘̂𔺂Á‚˝72ÎPARK2–UŒŸ—á. ‹{ěšD, –k‘ş‰p“ń1, ‰Ź–ě”üŒbŽq2, ŕ_“cˆę1, –]ŒŽGŽ÷, ‰ş@‘׎i, •ž•”MF, ‘şŽR”É—Y (1_Œo“ŕ, 2V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć52‰ń“ú–{_ŒoŠw‰ďŠwp‘ĺ‰ď (2011/5/20), –źŒĂ‰Ž, —Տ°_ŒoŠw 2011; 51: 1428.

H23-723008. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) ƒXƒpƒCƒƒ[ƒ^‚đ—˜—p‚ľ‚˝Sniff Nasal Inspiratory Pressure (SNIP) ‘Ş’č|Œ’íŹl‚Ć‹ŘˆŢkŤ‘¤őd‰ťÇŠłŽŇ‚É‚ć‚錟Ř|. …–ěŒö•ă, •˝‰ę‚ć‚ľ‚Ý, t“ú”ü•Ű, “Ą‹´‹Is, ‹{é‚ľ‚Ů, Ź–쎛ˆŸ–í, •Ÿ“c—Ď–ç, ăo’źl, ‰Ź–ě”üŒbŽq1 (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć46‰ń“ú–{—Šw—Ă–@Šwp‘ĺ‰ď (2011/5/27-29), ‹{č, —Šw—Ă–@Šw 2011; 38‘ĺ‰ď“Á•Ę†2(DVD-ROM)): ROMBUNNO.OS3-051.

H23-723009. [Šw‰ď (‘S‘)] (ˆę”ʍu‰‰) TPPV‚đ“ą“ü‚ľ‚˝ALS/MNDŠłŽŇ‚É‚¨‚Ż‚éƒRƒ~ƒ…ƒjƒP[ƒVƒ‡ƒ“•ű–@ĽŰHó‹ľ (Œťó•ń). á–{—R”ü, ˆŔ“cŘ•ä, ‹gŕVŒ’‘ž˜Y, `@ŽáŘ, •Ÿ“c—Ď–ç, ł˜Ň@—˛, ‰Ź–ě”üŒbŽq1, –]ŒŽGŽ÷ (1V˘‹Iˆă—ÁE‰Ą’f“Iˆă—Ă): ‘ć12‰ń“ú–{ŒžŒę’ŽŠoŠw‰ď (2011/6/17-18), ŒSŽR, ´˜^W 2011/5; 12th: 175. (kĐ‚Ě‚˝‚ߎ†ă”­•\)